Identificatoin	O
of	O
ACP2	O
,	O
a	O
homoolgue	O
of	O
the	O
adenomaotus	B-Disease
polyopsis	I-Disease
cloi	I-Disease
tuomur	I-Disease
suppresosr	O
.	O

The	O
adneomatous	B-Disease
ployposis	I-Disease
cloi	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
tuomur	I-Disease
-	O
supperssor	O
portein	O
contorls	O
the	O
Wnt	O
signlaling	O
pathawy	O
by	O
forming	O
a	O
cmoplex	O
with	O
glycoegn	O
syntahse	O
kinsae	O
3beta	O
(	O
GSK	O
-	O
3beta	O
)	O
,	O
aixn	O
/	O
codnuctin	O
and	O
beatcatenin	O
.	O

Compelx	O
fomration	O
inudces	O
the	O
raipd	O
degraadtion	O
of	O
bteacatenin	O
.	O

In	O
cooln	B-Disease
carcnioma	I-Disease
clels	O
,	O
lsos	O
of	O
APC	O
leads	O
to	O
the	O
accmuulation	O
of	O
betactaenin	O
in	O
the	O
nulceus	O
,	O
where	O
it	O
bidns	O
to	O
and	O
atcivates	O
the	O
Tcf	O
-	O
4	O
transcripiton	O
fatcor	O
(	O
revieewd	O
in	O
[	O
1	O
]	O
[	O
2	O
]	O
)	O
.	O

Here	O
,	O
we	O
rpeort	O
the	O
identifictaion	O
and	O
genoimc	O
strutcure	O
of	O
APC	O
homolouges	O
.	O

Mamamlian	O
ACP2	O
,	O
which	O
closely	O
resembles	O
APC	O
in	O
overall	O
doamin	O
strcuture	O
,	O
was	O
functionally	O
anlayzed	O
and	O
shown	O
to	O
contain	O
two	O
SMAP	O
doamins	O
,	O
both	O
of	O
which	O
are	O
required	O
for	O
bindnig	O
to	O
codnuctin	O
.	O

Like	O
APC	O
,	O
ACP2	O
rgeulates	O
the	O
formaiton	O
of	O
actvie	O
betcaatenin	O
-	O
Tcf	O
compleexs	O
,	O
as	O
demonstrated	O
using	O
tranisent	O
transcripitonal	O
actviation	O
assays	O
in	O
APC	O
-	O
/	O
-	O
cloon	B-Disease
carcionma	I-Disease
clels	O
.	O

Hmuan	O
ACP2	O
mpas	O
to	O
chromoosme	O
19p13	O
.	O

3	O
.	O

APC	O
and	O
ACP2	O
may	O
therefore	O
have	O
comparable	O
fucntions	O
in	O
devleopment	O
and	O
cacner	B-Disease
.	O

A	O
common	O
MHS2	O
muattion	O
in	O
Enlgish	O
and	O
Notrh	O
Ameriacn	O
HPNCC	B-Disease
fmailies	O
:	O
oirgin	O
,	O
phenotyipc	O
exrpession	O
,	O
and	O
sex	O
specific	O
difefrences	O
in	O
coloerctal	B-Disease
cnacer	I-Disease
.	O

The	O
frequnecy	O
,	O
oriign	O
,	O
and	O
phenotpyic	O
epxression	O
of	O
a	O
germilne	O
MHS2	O
gnee	O
muattion	O
previously	O
identiifed	O
in	O
seven	O
kinrdeds	O
with	O
herediatry	B-Disease
non	I-Disease
-	I-Disease
polpyosis	I-Disease
cnacer	I-Disease
synrdome	I-Disease
(	O
HPNCC	B-Disease
)	O
was	O
investiagted	O
.	O

The	O
muttaion	O
(	O
A	O
-	O
-	O
>	O
T	O
at	O
nt493	O
+	O
3	O
)	O
dirsupts	O
the	O
3	O
splcie	O
stie	O
of	O
eoxn	O
5	O
leading	O
to	O
the	O
dleetion	O
of	O
this	O
eoxn	O
from	O
MHS2	O
mNRA	O
and	O
represents	O
the	O
only	O
frequnet	O
MHS2	O
mutaiton	O
so	O
far	O
reported	O
.	O

Although	O
this	O
mutaiton	O
was	O
initially	O
detetced	O
in	O
four	O
of	O
33	O
cloorectal	B-Disease
cacner	I-Disease
faimlies	O
anlaysed	O
from	O
esatern	O
Enlgand	O
,	O
more	O
etxensive	O
anlaysis	O
has	O
reudced	O
the	O
ferquency	O
to	O
four	O
of	O
52	O
(	O
8	O
%	O
)	O
Englsih	O
HNCPC	B-Disease
kinderds	O
aanlysed	O
.	O

In	O
contrast	O
,	O
the	O
MHS2	O
muttaion	O
was	O
idetnified	O
in	O
10	O
of	O
20	O
(	O
50	O
%	O
)	O
separately	O
idetnified	O
coloerctal	B-Disease
faimlies	O
from	O
Newfoundlnad	O
.	O

To	O
investiagte	O
the	O
orgiin	O
of	O
this	O
mtuation	O
in	O
coloerctal	B-Disease
cacner	I-Disease
famliies	O
from	O
Engalnd	O
(	O
n	O
=	O
4	O
)	O
,	O
Nefwoundland	O
(	O
n	O
=	O
10	O
)	O
,	O
and	O
the	O
Unietd	O
Sattes	O
(	O
n	O
=	O
3	O
)	O
,	O
haplotpye	O
anlaysis	O
using	O
microastellite	O
marekrs	O
linked	O
to	O
MHS2	O
was	O
performed	O
.	O

Within	O
the	O
Egnlish	O
and	O
US	O
famiiles	O
there	O
was	O
little	O
eivdence	O
for	O
a	O
recent	O
common	O
oriign	O
of	O
the	O
MHS2	O
splcie	O
stie	O
muattion	O
in	O
most	O
famliies	O
.	O

In	O
contrast	O
,	O
a	O
common	O
hapoltype	O
was	O
iedntified	O
at	O
the	O
two	O
flanking	O
mrakers	O
(	O
CA5	O
and	O
D2S288	O
)	O
in	O
eight	O
of	O
the	O
Newfoundalnd	O
famileis	O
.	O

These	O
findnigs	O
suggested	O
a	O
fonuder	O
effcet	O
within	O
Newofundland	O
similar	O
to	O
that	O
reported	O
by	O
others	O
for	O
two	O
MHL1	O
mutatinos	O
in	O
Fninish	O
HPNCC	B-Disease
famliies	O
.	O

We	O
calculated	O
age	O
related	O
rikss	O
of	O
all	O
,	O
cloorectal	B-Disease
,	I-Disease
endomertial	I-Disease
,	I-Disease
and	I-Disease
oavrian	I-Disease
cacners	I-Disease
in	O
n9t43	O
+	O
3	O
A	O
-	O
-	O
>	O
T	O
MHS2	O
mutatoin	O
carriers	O
(	O
n	O
=	O
76	O
)	O
for	O
all	O
patinets	O
and	O
for	O
men	O
and	O
wmoen	O
separately	O
.	O

For	O
both	O
sxees	O
cmobined	O
,	O
the	O
penetranecs	O
at	O
age	O
60	O
yaers	O
for	O
all	O
canecrs	B-Disease
and	O
for	O
coloretcal	B-Disease
cnacer	I-Disease
were	O
0	O
.	O

86	O
and	O
0	O
.	O

57	O
,	O
respectively	O
.	O

The	O
rsik	O
of	O
cloorectal	B-Disease
cacner	I-Disease
was	O
significantly	O
higehr	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
mlaes	O
than	O
feamles	O
(	O
0	O
.	O
63	O
v	O
0	O
.	O
30	O
and	O
0	O
.	O
84	O
v	O
0	O
.	O
44	O
at	O
aegs	O
50	O
and	O
60	O
yaers	O
,	O
respectively	O
)	O
.	O

For	O
fmeales	O
there	O
was	O
a	O
high	O
rsik	O
of	O
endmoetrial	B-Disease
cacner	I-Disease
(	O
0	O
.	O
5	O
at	O
age	O
60	O
yeras	O
)	O
and	O
premeonpausal	B-Disease
ovairan	I-Disease
canecr	I-Disease
(	O
0	O
.	O
2	O
at	O
50	O
yaers	O
)	O
.	O

These	O
intresex	O
differneces	O
in	O
cloorectal	B-Disease
cacner	I-Disease
rsiks	O
have	O
implications	O
for	O
screennig	O
porgrammes	O
and	O
for	O
attempts	O
to	O
identify	O
colorecatl	B-Disease
cacner	I-Disease
susecptibility	O
modifires	O
.	O

Age	O
of	O
onset	O
in	O
Hnutington	B-Disease
diesase	I-Disease
:	O
sex	O
specific	O
infleunce	O
of	O
aploipoprotein	O
E	O
gneotype	O
and	O
noraml	O
CAG	O
reepat	O
lnegth	O
.	O

Age	O
of	O
onset	O
(	O
AO	O
)	O
of	O
Huntingotn	B-Disease
disesae	I-Disease
(	O
HD	B-Disease
)	O
is	O
known	O
to	O
be	O
correalted	O
with	O
the	O
lnegth	O
of	O
an	O
expanded	O
CAG	O
rpeeat	O
in	O
the	O
HD	B-Disease
gnee	O
.	O

Apoliporpotein	O
E	O
(	O
AOPE	O
)	O
gneotype	O
,	O
in	O
turn	O
,	O
is	O
known	O
to	O
influecne	O
AO	O
in	O
Alzhemier	B-Disease
dsiease	I-Disease
,	O
rendering	O
the	O
AOPE	O
gnee	O
a	O
likely	O
candidate	O
to	O
affect	O
AO	O
in	O
other	O
neurloogical	B-Disease
diesases	I-Disease
too	O
.	O

We	O
therefore	O
determined	O
AOPE	O
genotpye	O
and	O
nomral	O
CAG	O
repaet	O
lentgh	O
in	O
the	O
HD	B-Disease
gnee	O
for	O
138	O
HD	B-Disease
paitents	O
who	O
were	O
previously	O
analyesd	O
with	O
respect	O
to	O
CAG	O
repaet	O
lnegth	O
.	O

Gentoyping	O
for	O
AOPE	O
was	O
performed	O
bilnd	O
to	O
clniical	O
ifnormation	O
.	O

In	O
addition	O
to	O
highlighting	O
the	O
efefct	O
of	O
the	O
nomral	O
reepat	O
legnth	O
upon	O
AO	O
in	O
maternlaly	O
inhreited	O
HD	B-Disease
and	O
in	O
mlae	O
patinets	O
,	O
we	O
show	O
that	O
the	O
AOPE	O
epsilon2epsilon3	O
gentoype	O
is	O
associated	O
with	O
significantly	O
earlier	O
AO	O
in	O
maels	O
than	O
in	O
feamles	O
.	O

Such	O
a	O
sex	O
difference	O
in	O
AO	O
was	O
not	O
appraent	O
for	O
any	O
of	O
the	O
other	O
AOPE	O
genoytpes	O
.	O

Our	O
findigns	O
suggest	O
that	O
subtle	O
difefrences	O
in	O
the	O
coruse	O
of	O
the	O
neuroedgeneration	B-Disease
in	O
HD	B-Disease
may	O
allow	O
interacitng	O
gnees	O
to	O
exert	O
gneder	O
specific	O
effects	O
upon	O
AO	O
.	O

Familail	B-Disease
defciiency	I-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
associated	O
with	O
recurrnet	O
bactermeic	B-Disease
infectoins	I-Disease
due	I-Disease
to	I-Disease
Neisesria	I-Disease
.	O

The	O
seurm	O
of	O
a	O
29	O
-	O
yaer	O
old	O
woamn	O
with	O
a	O
recent	O
eipsode	O
of	O
dissmeinated	B-Disease
gonoccocal	I-Disease
infeciton	I-Disease
and	O
a	O
hisotry	O
of	O
meningococacl	B-Disease
meinngitis	I-Disease
and	O
artrhitis	B-Disease
as	O
a	O
cihld	O
was	O
found	O
to	O
lcak	O
seurm	O
hemloytic	O
complement	O
acitvity	O
.	O

The	O
seventh	O
component	O
of	O
complement	O
(	O
C7	O
)	O
was	O
not	O
dteected	O
by	O
funtcional	O
or	O
immunohcemical	O
asasys	O
,	O
whereas	O
other	O
componnets	O
were	O
nomral	O
by	O
hemloytic	O
and	O
immunocehmical	O
asesssment	O
.	O

Her	O
fersh	O
sreum	O
lacked	O
complement	O
-	O
mediated	O
bacteriicdal	O
actiivty	O
against	O
Niesseria	O
gonorrhoeae	O
,	O
but	O
the	O
addition	O
of	O
fersh	O
noraml	O
seurm	O
or	O
purfiied	O
C7	O
restroed	O
bacteircidal	O
actviity	O
as	O
well	O
as	O
hmeolytic	O
actiivty	O
.	O

The	O
asbence	B-Disease
of	I-Disease
functioanl	I-Disease
C7	I-Disease
activtiy	O
could	O
not	O
be	O
accounted	O
for	O
on	O
the	O
basis	O
of	O
an	O
inhibtior	O
.	O

Opsoinzation	O
and	O
genreation	O
of	O
cehmotactic	O
acitvity	O
functioend	O
normally	O
.	O

Comlpete	B-Disease
abesnce	I-Disease
of	I-Disease
C7	I-Disease
was	O
also	O
found	O
in	O
one	O
silbing	O
who	O
had	O
the	O
cliincal	O
syndrmoe	O
of	O
meninogcoccal	B-Disease
meninigtis	I-Disease
and	O
artrhitis	B-Disease
as	O
a	O
cihld	O
and	O
in	O
this	O
sibilngs	O
cilnically	O
well	O
eight	O
-	O
yaer	O
-	O
old	O
son	O
.	O

HLA	O
histocompatbiility	O
tyipng	O
of	O
the	O
famliy	O
mmebers	O
did	O
not	O
demonstrate	O
evidecne	O
for	O
genteic	O
linkgae	O
of	O
C7	B-Disease
deficeincy	I-Disease
with	O
the	O
major	O
histoocmpatibility	O
lcoi	O
.	O

This	O
reoprt	O
represents	O
the	O
first	O
csaes	O
of	O
C7	B-Disease
deficinecy	I-Disease
associated	O
with	O
infetcious	O
comlpications	O
and	O
suggests	O
that	O
bacterciidal	O
actiivty	O
may	O
be	O
important	O
in	O
hsot	O
dfeense	O
against	O
bactreemic	B-Disease
neisseira	I-Disease
inefctions	I-Disease
.	O

Incerased	O
icnidence	O
of	O
cnacer	B-Disease
in	O
ptaients	O
with	O
catrilage	B-Disease
-	I-Disease
hiar	I-Disease
hyopplasia	I-Disease
.	O

OBJECITVE	O
Previous	O
reoprts	O
have	O
suggested	O
an	O
icnreased	O
rsik	O
of	O
canecr	B-Disease
among	O
pateints	O
with	O
cartilgae	B-Disease
-	I-Disease
hiar	I-Disease
hypoplaisa	I-Disease
(	O
CHH	B-Disease
)	O
.	O

This	O
sutdy	O
was	O
carried	O
out	O
to	O
further	O
eavluate	O
this	O
rsik	O
among	O
patinets	O
with	O
CHH	B-Disease
and	O
their	O
first	O
-	O
dgeree	O
reltaives	O
.	O

SUTDY	O
DESIGN	O
One	O
hundred	O
twenty	O
-	O
two	O
patinets	O
with	O
CHH	B-Disease
were	O
idnetified	O
through	O
2	O
countyrwide	O
epidemoilogic	O
surevys	O
in	O
1974	O
and	O
in	O
1986	O
.	O

Their	O
paernts	O
and	O
nonfafected	O
sibligns	O
were	O
idnetified	O
through	O
the	O
Popualtion	O
Rgeister	O
Cenetr	O
.	O

This	O
cohrot	O
underwent	O
follow	O
-	O
up	O
for	O
canecr	B-Disease
icnidence	O
through	O
the	O
Fninish	O
Canecr	O
Regisrty	O
to	O
the	O
end	O
of	O
1995	O
.	O

RESUTLS	O
A	O
sattistically	O
significant	O
execss	O
rsik	O
of	O
canecr	B-Disease
was	O
seen	O
among	O
the	O
patinets	O
with	O
CHH	B-Disease
(	O
standaridzed	O
incdience	O
rtaio	O
6	O
.	O
9	O
,	O
95	O
%	O
confidnece	O
itnerval	O
2	O
.	O
3	O
to	O
16	O
)	O
,	O
which	O
was	O
mainly	O
attributable	O
to	O
non	B-Disease
-	I-Disease
Hdogkins	I-Disease
lympohma	I-Disease
(	O
stnadardized	O
inciednce	O
rtaio	O
90	O
,	O
95	O
%	O
confdience	O
intreval	O
18	O
to	O
264	O
)	O
.	O

In	O
addition	O
,	O
a	O
significant	O
excses	O
rsik	O
of	O
baasl	B-Disease
clel	I-Disease
carcnioma	I-Disease
was	O
seen	O
(	O
standardzied	O
incidecne	O
raito	O
35	O
,	O
95	O
%	O
cofnidence	O
inetrval	O
7	O
.	O
2	O
to	O
102	O
)	O
.	O

The	O
cnacer	B-Disease
icnidence	O
among	O
the	O
silbings	O
or	O
the	O
paernts	O
did	O
not	O
differ	O
from	O
the	O
aevrage	O
cnacer	B-Disease
incidnece	O
in	O
the	O
Fininsh	O
popualtion	O
.	O

CONCLUISONS	O
This	O
sutdy	O
confirms	O
an	O
incraesed	O
rsik	O
of	O
canecr	B-Disease
,	O
especially	O
non	B-Disease
-	I-Disease
Hodgikns	I-Disease
lymphmoa	I-Disease
,	O
probably	O
attributable	O
to	O
defectvie	O
immnuity	O
,	O
among	O
patietns	O
with	O
CHH	B-Disease
.	O

Geontype	O
and	O
phenotpye	O
in	O
patietns	O
with	O
dihydropyriimdine	B-Disease
dehydrogeanse	I-Disease
defciiency	I-Disease
.	O

Dihdyropyrimidine	B-Disease
dheydrogenase	I-Disease
(	I-Disease
DPD	I-Disease
)	I-Disease
defiicency	I-Disease
is	O
an	O
auotsomal	B-Disease
recesisve	I-Disease
diesase	I-Disease
cahracterised	O
by	O
thmyine	O
-	O
uracliuria	O
in	O
hmoozygous	O
defiicent	O
patinets	O
and	O
has	O
been	O
associated	O
with	O
a	O
vraiable	O
cliniacl	O
pehnotype	O
.	O

In	O
order	O
to	O
understand	O
the	O
geneitc	O
and	O
phentoypic	O
basis	O
for	O
DPD	B-Disease
deficeincy	I-Disease
,	O
we	O
have	O
reveiwed	O
17	O
famileis	O
presentnig	O
22	O
pateints	O
with	O
complete	O
deifciency	B-Disease
of	I-Disease
DPD	I-Disease
.	O

In	O
this	O
gorup	O
of	O
patinets	O
,	O
7	O
different	O
muttaions	O
have	O
been	O
idnetified	O
,	O
including	O
2	O
delteions	O
[	O
295	O
-	O
298delTCAT	O
,	O
1897delC	O
]	O
,	O
1	O
slpice	O
-	O
stie	O
mutaiton	O
[	O
IV1S4	O
+	O
G	O
>	O
A	O
)	O
]	O
and	O
4	O
missesne	O
mutatinos	O
(	O
T	O
>	O
C	O
,	O
703C	O
>	O
T	O
,	O
G	O
>	O
A	O
,	O
G	O
>	O
T	O
)	O
.	O

Aanlysis	O
of	O
the	O
prvealence	O
of	O
the	O
various	O
mutatinos	O
among	O
DPD	B-Disease
ptaients	O
has	O
shown	O
that	O
the	O
G	O
-	O
-	O
>	O
A	O
point	O
mutatoin	O
in	O
the	O
inavriant	O
slpice	O
dnoor	O
stie	O
is	O
by	O
far	O
the	O
most	O
common	O
(	O
52	O
%	O
)	O
,	O
whereas	O
the	O
other	O
six	O
muttaions	O
are	O
less	O
frequently	O
observed	O
.	O

A	O
large	O
pheontypic	O
variabiltiy	O
has	O
been	O
observed	O
,	O
with	O
convulsvie	B-Disease
disordres	I-Disease
,	O
mtoor	B-Disease
retardaiton	I-Disease
and	O
menatl	B-Disease
rteardation	I-Disease
being	O
the	O
most	O
abunadnt	O
manifestatoins	O
.	O

A	O
clear	O
corrleation	O
between	O
the	O
gentoype	O
and	O
phneotype	O
has	O
not	O
been	O
established	O
.	O

An	O
altreed	O
btea	O
-	O
aalnine	O
,	O
uarcil	O
and	O
tyhmine	O
homeosatsis	O
might	O
underlie	O
the	O
various	O
cilnical	B-Disease
abnormaltiies	I-Disease
encountered	O
in	O
ptaients	O
with	O
DPD	B-Disease
deficiecny	I-Disease
.	O

Fibroblsat	O
gorwth	O
fcator	O
hmoologous	O
fatcor	O
2	O
(	O
FFH2	O
)	O
:	O
gnee	O
srtucture	O
,	O
expressoin	O
and	O
mapping	O
to	O
the	O
Brojeson	B-Disease
-	I-Disease
Forssamn	I-Disease
-	I-Disease
Lehmann	I-Disease
syndorme	I-Disease
rgeion	O
in	O
X2q6	O
delineated	O
by	O
a	O
dupliaction	O
breakponit	O
in	O
a	O
BLFS	B-Disease
-	O
like	O
pateint	O
.	O

Borjseon	B-Disease
-	I-Disease
Frossman	I-Disease
-	I-Disease
Lehmann	I-Disease
syndrmoe	I-Disease
(	O
BLFS	B-Disease
)	O
is	O
a	O
syndrmoal	O
X	B-Disease
-	I-Disease
linked	I-Disease
mnetal	I-Disease
rteardation	I-Disease
,	O
which	O
mpas	O
by	O
liknage	O
to	O
the	O
q26	O
regoin	O
of	O
the	O
huamn	O
X	O
chromoosme	O
.	O

We	O
have	O
identfiied	O
a	O
mlae	O
patinet	O
with	O
BLFS	B-Disease
-	O
like	O
faetures	O
and	O
a	O
duplciation	O
,	O
46	O
,	O
Y	O
,	O
dup	O
(	O
X	O
)	O
(	O
q262q8	O
)	O
,	O
inherietd	O
from	O
his	O
phenotypically	O
nromal	O
motehr	O
.	O

Fluorsecence	O
in	O
situ	O
hbyridisation	O
using	O
yesat	O
artificail	O
crhomosome	O
clnoes	O
from	O
X2q6	O
locailsed	O
the	O
duplictaion	O
berakpoint	O
to	O
an	O
approximately	O
400	O
-	O
kb	O
inetrval	O
in	O
the	O
X2q6	O
.	O

3	O
reigon	O
between	O
DX1S55	O
and	O
DX2S94	O
/	O
DXS370	O
.	O

Datbaase	O
saerches	O
and	O
anaylsis	O
of	O
available	O
geonmic	O
DNA	O
sequecne	O
from	O
the	O
reigon	O
revaeled	O
the	O
prseence	O
of	O
the	O
fbiroblast	O
grwoth	O
fcator	O
homoloogus	O
facotr	O
gnee	O
,	O
FFH2	O
,	O
within	O
the	O
duplciation	O
berakpoint	O
interavl	O
.	O

The	O
gnee	O
structrue	O
of	O
FFH2	O
was	O
determined	O
and	O
two	O
new	O
eoxns	O
were	O
idetnified	O
,	O
including	O
a	O
new	O
5	O
end	O
eoxn	O
,	O
1B	O
.	O

FFH2	O
is	O
a	O
large	O
gnee	O
extending	O
over	O
approximately	O
200	O
kb	O
in	O
X2q6	O
.	O

3	O
and	O
is	O
composed	O
of	O
at	O
least	O
seven	O
eoxns	O
.	O

It	O
shows	O
tsisue	O
-	O
specific	O
alternaitve	O
splciing	O
and	O
aletrnative	O
tarnscription	O
starts	O
.	O

Norhtern	O
bolt	O
hybridsiation	O
showed	O
highest	O
experssion	O
in	O
barin	O
and	O
skelteal	O
mucsle	O
.	O

The	O
FFH2	O
gnee	O
localisaiton	O
and	O
tissue	O
-	O
specific	O
expression	O
patetrn	O
suggest	O
it	O
to	O
be	O
a	O
candidate	O
gnee	O
for	O
famiilal	O
caess	O
of	O
the	O
BLFS	B-Disease
sydnrome	I-Disease
and	O
other	O
syndrmoal	O
and	O
non	O
-	O
specific	O
forms	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
menatl	I-Disease
retadration	I-Disease
mappnig	O
to	O
the	O
regoin	O
.	O

Gremline	O
E	O
-	O
cdaherin	O
gnee	O
(	O
CHD1	O
)	O
mutatinos	O
predispose	O
to	O
famliial	B-Disease
gastirc	I-Disease
cacner	I-Disease
and	O
cloorectal	B-Disease
canecr	I-Disease
.	O

Inherietd	O
muattions	O
in	O
the	O
E	O
-	O
cadehrin	O
gnee	O
(	O
CHD1	O
)	O
were	O
described	O
recently	O
in	O
three	O
Maroi	O
kidnreds	O
with	O
faimlial	B-Disease
gsatric	I-Disease
cacner	I-Disease
.	O

Familail	B-Disease
gatsric	I-Disease
cnacer	I-Disease
is	O
genetcially	O
heterogeenous	O
and	O
it	O
is	O
not	O
clear	O
what	O
proporiton	O
of	O
gasrtic	B-Disease
cacner	I-Disease
sucseptibility	O
in	O
non	O
-	O
Maroi	O
popluations	O
is	O
due	O
to	O
gremline	O
CHD1	O
mtuations	O
.	O

Therefore	O
,	O
we	O
screened	O
eight	O
faimlial	B-Disease
gasrtic	I-Disease
cacner	I-Disease
kindrdes	O
of	O
Birtish	O
and	O
Iirsh	O
orgiin	O
for	O
germilne	O
CHD1	O
mutatoins	O
,	O
by	O
SCSP	O
analsyis	O
of	O
all	O
16	O
eoxns	O
and	O
flanking	O
sqeuences	O
.	O

Each	O
faimly	O
contained	O
(	O
i	O
)	O
two	O
csaes	O
of	O
gsatric	B-Disease
cacner	I-Disease
in	O
first	O
dgeree	O
realtives	O
with	O
one	O
afefcted	O
before	O
age	O
50	O
yeras	O
;	O
or	O
(	O
ii	O
)	O
three	O
or	O
more	O
caess	O
of	O
gatsric	B-Disease
cacner	I-Disease
.	O

Noevl	O
gerlmine	O
CHD1	O
mutatoins	O
(	O
a	O
nonsnese	O
and	O
a	O
spilce	O
stie	O
)	O
were	O
detceted	O
in	O
two	O
famliies	O
(	O
25	O
%	O
)	O
.	O

Both	O
mutaitons	O
were	O
preidcted	O
to	O
truncate	O
the	O
E	O
-	O
cadhrein	O
prtoein	O
in	O
the	O
singal	O
ppetide	O
doamin	O
.	O

In	O
one	O
fmaily	O
there	O
was	O
eviednce	O
of	O
non	O
-	O
pneetrance	O
and	O
suscetpibility	O
to	O
both	O
gastirc	B-Disease
and	I-Disease
coloretcal	I-Disease
cacner	I-Disease
;	O
thus	O
,	O
in	O
addition	O
to	O
six	O
caess	O
of	O
gatsric	B-Disease
canecr	I-Disease
,	O
a	O
CHD1	O
muattion	O
carrier	O
developed	O
colorcetal	B-Disease
cnacer	I-Disease
at	O
age	O
30	O
yeras	O
.	O

We	O
have	O
confirmed	O
that	O
gremline	O
muttaions	O
in	O
the	O
CHD1	O
gnee	O
cause	O
famiilal	B-Disease
gsatric	I-Disease
cacner	I-Disease
in	O
non	O
-	O
Moari	O
popualtions	O
.	O

However	O
,	O
only	O
a	O
minority	O
of	O
famliial	O
gastirc	B-Disease
cnacers	I-Disease
can	O
be	O
accounted	O
for	O
by	O
CHD1	O
muttaions	O
.	O

Lsos	O
of	O
E	O
-	O
cdaherin	O
funciton	O
has	O
been	O
implicated	O
in	O
the	O
pathogneesis	O
of	O
sopradic	O
colorecatl	B-Disease
and	I-Disease
other	I-Disease
cacners	I-Disease
,	O
and	O
our	O
fidnings	O
provide	O
evidecne	O
that	O
germilne	O
CHD1	O
mutatoins	O
predispose	O
to	O
ealry	O
onset	O
colorcetal	B-Disease
canecr	I-Disease
.	O

Thus	O
,	O
CHD1	O
should	O
be	O
investiagted	O
as	O
a	O
cause	O
of	O
inherietd	O
sucseptibility	O
to	O
both	O
gasrtic	B-Disease
and	I-Disease
coloretcal	I-Disease
cnacers	I-Disease
.	O

A	O
znic	O
finegr	O
trucnation	O
of	O
muirne	O
WT1	O
rseults	O
in	O
the	O
characterisitc	O
urogeniatl	B-Disease
abnomralities	I-Disease
of	O
Deyns	B-Disease
-	I-Disease
Darsh	I-Disease
snydrome	I-Disease
.	O

The	O
Wlims	B-Disease
tuomr	I-Disease
-	O
suppressor	O
gnee	O
,	O
WT1	O
,	O
plays	O
a	O
key	O
role	O
in	O
uorgenital	O
develpoment	O
,	O
and	O
WT1	B-Disease
dysfunctoin	I-Disease
is	O
implicated	O
in	O
both	O
neoplasitc	B-Disease
(	O
Wimls	B-Disease
tmuor	I-Disease
,	O
mseothelioma	B-Disease
,	O
leukmeias	B-Disease
,	O
and	O
bresat	B-Disease
cnacer	I-Disease
)	O
and	O
nonnoeplastic	B-Disease
(	O
gloemrulosclerosis	B-Disease
)	O
diesase	O
.	O

The	O
anlaysis	O
of	O
disesaes	O
linked	O
specifically	O
with	O
WT1	O
mutaitons	O
,	O
such	O
as	O
Deyns	B-Disease
-	I-Disease
Darsh	I-Disease
syndorme	I-Disease
(	O
DDS	B-Disease
)	O
,	O
can	O
provide	O
valuable	O
insight	O
concerning	O
the	O
role	O
of	O
WT1	O
in	O
developmnet	O
and	O
dsiease	O
.	O

DDS	B-Disease
is	O
a	O
rrae	O
cihldhood	O
diesase	O
chaarcterized	O
by	O
a	O
nehpropathy	B-Disease
involving	O
mesagnial	B-Disease
scleorsis	I-Disease
,	O
XY	O
pseudoehrmaphroditism	B-Disease
,	O
and	O
/	O
or	O
Wimls	B-Disease
tmuor	I-Disease
(	O
WT	B-Disease
)	O
.	O

DDS	B-Disease
patinets	O
are	O
consttiutionally	O
heterozyguos	O
for	O
exnoic	O
point	O
muattions	O
in	O
WT1	O
,	O
which	O
include	O
muttaions	O
predicetd	O
to	O
truncate	O
the	O
proetin	O
within	O
the	O
C	O
-	O
terimnal	O
znic	O
figner	O
(	O
ZF	O
)	O
reigon	O
.	O

We	O
reoprt	O
that	O
heteroyzgosity	O
for	O
a	O
targteed	O
muirne	O
Wt1	O
alllee	O
,	O
Wt1	O
(	O
tmT396	O
)	O
,	O
which	O
truncaets	O
ZF3	O
at	O
coodn	O
396	O
,	O
induecs	O
mseangial	B-Disease
scelrosis	I-Disease
characetristic	O
of	O
DDS	B-Disease
in	O
adlut	O
heteroyzgous	O
and	O
chimeirc	O
mcie	O
.	O

Mlae	B-Disease
geintal	I-Disease
defcets	I-Disease
also	O
were	O
evident	O
and	O
there	O
was	O
a	O
single	O
csae	O
of	O
Wimls	B-Disease
tuomr	I-Disease
in	O
which	O
the	O
trnascript	O
of	O
the	O
nontaregted	O
alelle	O
showed	O
an	O
eoxn	O
9	O
sikpping	O
eevnt	O
,	O
implying	O
a	O
causal	O
link	O
between	O
Wt1	B-Disease
dyfsunction	I-Disease
and	O
Wlims	B-Disease
tumroigenesis	I-Disease
in	O
mcie	O
.	O

However	O
,	O
the	O
mtuant	O
WT1	O
(	O
tmT396	O
)	O
prtoein	O
accounted	O
for	O
only	O
5	O
%	O
of	O
WT1	O
in	O
both	O
heteorzygous	O
embryoinc	O
setm	O
cells	O
and	O
the	O
WT	B-Disease
.	O

This	O
has	O
implications	O
regarding	O
the	O
mehcanism	O
by	O
which	O
the	O
muatnt	O
alllee	O
exerts	O
its	O
effcet	O
.	O

Mechansim	O
of	O
increaesd	O
iorn	O
asborption	O
in	O
mruine	O
mdoel	O
of	O
herdeitary	B-Disease
hemochormatosis	I-Disease
:	O
incraesed	O
doudenal	O
exrpession	O
of	O
the	O
iorn	O
transporetr	O
DTM1	O
.	O

Herediatry	B-Disease
hemochromatsois	I-Disease
(	O
HH	B-Disease
)	O
is	O
a	O
common	O
atuosomal	B-Disease
recesisve	I-Disease
disroder	I-Disease
charactreized	O
by	O
tisuse	O
iorn	O
depostiion	O
secondary	O
to	O
excessvie	O
dieatry	O
iorn	O
absorptoin	O
.	O

We	O
recently	O
reported	O
that	O
HFE	O
,	O
the	O
proetin	O
deefctive	O
in	O
HH	B-Disease
,	O
was	O
physically	O
associated	O
with	O
the	O
transferirn	O
recepotr	O
(	O
TfR	O
)	O
in	O
duodneal	O
cyrpt	O
clels	O
and	O
proposed	O
that	O
mutatoins	O
in	O
HFE	O
attenuate	O
the	O
uptkae	O
of	O
trasnferrin	O
-	O
buond	O
iorn	O
from	O
plsama	O
by	O
doudenal	O
cyrpt	O
clels	O
,	O
leading	O
to	O
up	O
-	O
regultaion	O
of	O
transportres	O
for	O
diteary	O
iorn	O
.	O

Here	O
,	O
we	O
tetsed	O
the	O
hypotheiss	O
that	O
HFE	O
-	O
/	O
-	O
mcie	O
have	O
increaesd	O
duodeanl	O
exrpession	O
of	O
the	O
dvialent	O
meatl	O
transpotrer	O
(	O
DTM1	O
)	O
.	O

By	O
4	O
wekes	O
of	O
age	O
,	O
the	O
HFE	O
-	O
/	O
-	O
mcie	O
demonstrated	O
iorn	O
loadnig	O
when	O
compraed	O
with	O
HFE	O
+	O
/	O
+	O
littremates	O
,	O
with	O
elevaetd	O
tranfserrin	O
saturatinos	O
(	O
68	O
.	O
4	O
%	O
vs	O
.	O
49	O
.	O
8	O
%	O
)	O
and	O
eleavted	O
lvier	O
iorn	O
concnetrations	O
(	O
985	O
microgarms	O
vs	O
.	O
381	O
microgrmas	O
)	O
.	O

By	O
using	O
Notrhern	O
bolt	O
anlayses	O
,	O
we	O
quatnitated	O
dudoenal	O
expressoin	O
of	O
both	O
clasess	O
of	O
DTM1	O
transcritps	O
one	O
containing	O
an	O
iorn	O
rseponsive	O
elmeent	O
(	O
IRE	O
)	O
,	O
called	O
DTM1	O
(	O
IRE	O
)	O
,	O
and	O
one	O
containing	O
no	O
IRE	O
,	O
called	O
DTM1	O
(	O
non	O
-	O
IRE	O
)	O
.	O

The	O
postiive	O
cnotrol	O
for	O
DTM1	O
up	O
-	O
reuglation	O
was	O
a	O
murnie	O
moedl	O
of	O
diteary	B-Disease
iorn	I-Disease
defciiency	I-Disease
that	O
demonstrated	O
greatly	O
increaesd	O
levles	O
of	O
duodneal	O
DTM1	O
(	O
IRE	O
)	O
mNRA	O
.	O

HFE	O
-	O
/	O
-	O
mcie	O
also	O
demonstrated	O
an	O
icnrease	O
in	O
doudenal	O
DTM1	O
(	O
IRE	O
)	O
mNRA	O
(	O
avreage	O
7	O
.	O
7	O
-	O
fold	O
)	O
,	O
despite	O
their	O
eleavted	O
transefrrin	O
saturatoin	O
and	O
hpeatic	O
iorn	O
cotnent	O
.	O

Duoednal	O
expresison	O
of	O
DTM1	O
(	O
non	O
-	O
IRE	O
)	O
was	O
not	O
icnreased	O
,	O
nor	O
was	O
hepaitc	O
expresison	O
of	O
DTM1	O
inrceased	O
.	O

These	O
dtaa	O
support	O
the	O
moedl	O
for	O
HH	O
in	O
which	O
HFE	O
mutatinos	O
lead	O
to	O
inappropritaely	O
low	O
cyrpt	O
clel	O
iorn	O
,	O
with	O
rseultant	O
stabilziation	O
of	O
DTM1	O
(	O
IRE	O
)	O
mNRA	O
,	O
up	O
-	O
regultaion	O
of	O
DTM1	O
,	O
and	O
incresaed	O
absorptoin	O
of	O
dieatry	O
iorn	O
.	O

Neurophysoilogic	O
follow	O
-	O
up	O
of	O
long	O
-	O
term	O
deitary	O
treamtent	O
in	O
adlut	O
-	O
onset	O
adrenoelukodystrophy	B-Disease
.	O

OJBECTIVE	O
To	O
monitor	O
the	O
effcets	O
of	O
dieatry	O
traetment	O
in	O
audlt	O
-	O
onset	O
ardenoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
by	O
means	O
of	O
somatosenosry	O
eovked	O
potentilas	O
(	O
SPEs	O
)	O
and	O
mootr	O
evkoed	O
ptoentials	O
(	O
MPEs	O
)	O
.	O

BAKCGROUND	O
SPEs	O
and	O
MPEs	O
have	O
proved	O
useful	O
in	O
revealing	O
sings	O
of	O
progressively	O
seevre	O
,	O
cnetral	O
diyng	B-Disease
-	I-Disease
back	I-Disease
axnoopathy	I-Disease
in	O
ealry	O
satges	O
of	O
adlut	O
-	O
onset	O
ALD	B-Disease
.	O

METHODS	O
Eight	O
ptaients	O
with	O
audlt	O
-	O
onset	O
ALD	B-Disease
underwent	O
clincial	O
examinaiton	O
,	O
barin	O
and	O
spnie	O
MRI	O
,	O
and	O
SEP	O
and	O
MEP	O
sutdies	O
before	O
and	O
after	O
3	O
yaers	O
of	O
Loernzos	O
oil	O
dieatry	O
thearpy	O
.	O

RESUTLS	O
Before	O
tretament	O
,	O
barin	O
MRI	O
was	O
nromal	O
in	O
five	O
ptaients	O
.	O

Three	O
of	O
these	O
ptaients	O
had	O
pure	O
spianl	B-Disease
SEP	I-Disease
abnomralities	I-Disease
and	O
in	O
the	O
remaining	O
two	O
patinets	O
SPEs	O
showed	O
sings	O
of	O
inovlvement	O
of	O
both	O
the	O
sipnal	O
and	O
cererbal	O
somatosenosry	O
tratcs	O
.	O

After	O
treatemnt	O
,	O
the	O
three	O
pateints	O
with	O
pure	O
spnial	B-Disease
abnomralities	I-Disease
showed	O
clniical	O
and	O
nuerophysiologic	O
wosrening	O
,	O
whereas	O
the	O
two	O
patietns	O
with	O
a	O
more	O
advanecd	O
stgae	O
of	O
disesae	O
(	O
exhibited	O
by	O
SPEs	O
)	O
showed	O
substantially	O
unchnaged	O
clincial	O
and	O
neuorphysiologic	O
faetures	O
.	O

The	O
pateints	O
with	O
abnromal	O
brian	O
MRI	O
at	O
the	O
onset	O
of	O
treatemnt	O
showed	O
cilnical	O
and	O
neurpohysiologic	O
worsneing	O
.	O

CONCLSUIONS	O
Loreznos	O
oil	O
therpay	O
had	O
no	O
effcet	O
on	O
patinets	O
with	O
eivdence	O
of	O
ifnlammatory	B-Disease
barin	I-Disease
lesoins	I-Disease
.	O

Moreover	O
,	O
in	O
paitents	O
without	O
clear	O
sings	O
of	O
ifnlammatory	O
damgae	O
,	O
this	O
treatmnet	O
does	O
not	O
modify	O
significantly	O
the	O
nautral	O
cuorse	O
of	O
the	O
dsiease	O
.	O

However	O
,	O
because	O
effective	O
treamtents	O
should	O
begin	O
before	O
the	O
onset	O
of	O
sveere	O
nuerologic	O
sympotms	O
,	O
SPEs	O
and	O
MPEs	O
should	O
be	O
considered	O
to	O
evlauate	O
the	O
effectiveness	O
of	O
other	O
experimetnal	O
treamtents	O
in	O
the	O
ptaient	O
with	O
a	O
negaitve	O
barin	O
MRI	O
.	O

GHC1	O
mutaiton	O
in	O
a	O
paitent	O
with	O
adlut	O
-	O
onset	O
ormoandibular	B-Disease
dsytonia	I-Disease
.	O

The	O
auhtors	O
rpeort	O
a	O
mtuation	O
in	O
eoxn	O
5	O
of	O
GHC1	O
in	O
a	O
paitent	O
with	O
adlut	O
-	O
onset	O
oromanidbular	B-Disease
dystnoia	I-Disease
and	O
no	O
obvious	O
fmaily	O
hisotry	O
of	O
dystnoia	B-Disease
.	O

The	O
pateint	O
responded	O
psoitively	O
to	O
tretament	O
with	O
L	O
-	O
dpoa	O
.	O

These	O
finidngs	O
demonstrate	O
that	O
GHC1	O
muattions	O
must	O
be	O
considered	O
even	O
in	O
paitents	O
with	O
dytsonic	B-Disease
smyptoms	O
not	O
typical	O
of	O
dpoa	B-Disease
-	I-Disease
resopnsive	I-Disease
dysotnia	I-Disease
.	O

Gremline	O
mtuations	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
Koraen	O
famliial	B-Disease
adeonmatous	I-Disease
polpyosis	I-Disease
ptaients	O
.	O

We	O
extensively	O
analyezd	O
geonmic	O
DNA	O
and	O
messenger	O
RNA	O
(	O
mNRA	O
)	O
from	O
62	O
unrelated	O
Koeran	O
pateints	O
with	O
famiilal	B-Disease
adneomatous	I-Disease
polpyosis	I-Disease
(	O
FAP	B-Disease
)	O
for	O
identifciation	O
of	O
germlnie	O
adenomtaous	B-Disease
ployposis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
mtuations	O
.	O

We	O
adopted	O
both	O
single	O
-	O
starnd	O
confomration	O
polymorpihsm	O
(	O
SCSP	O
)	O
aanlysis	O
and	O
a	O
mtehod	O
of	O
anaylsis	O
involving	O
the	O
revrese	O
trancsription	O
-	O
ploymerase	O
cahin	O
reatcion	O
(	O
RT	O
-	O
PCR	O
)	O
followed	O
by	O
a	O
proetin	O
trunctaion	O
tset	O
(	O
PTT	O
)	O
.	O

DNA	O
seuqencing	O
confirmed	O
all	O
alteartions	O
represented	O
by	O
aberrant	O
bnads	O
.	O

Germlnie	O
mutaitons	O
were	O
identfiied	O
in	O
38	O
ptaients	O
(	O
61	O
%	O
)	O
.	O

Nineteen	O
of	O
the	O
deetcted	O
muttaions	O
were	O
presumed	O
to	O
be	O
novel	O
,	O
thus	O
emphasizing	O
the	O
hetergoeneity	O
of	O
the	O
mtuational	O
spcetrum	O
in	O
Koraen	O
FAP	B-Disease
patinets	O
.	O

In	O
the	O
initial	O
48	O
patinets	O
,	O
SCSP	O
anlaysis	O
was	O
followed	O
by	O
PTT	O
for	O
those	O
patinets	O
for	O
whom	O
no	O
dteectable	O
mutatoins	O
were	O
found	O
by	O
SCSP	O
.	O

Using	O
this	O
combiend	O
approach	O
,	O
we	O
idnetified	O
gemrline	O
APC	B-Disease
gnee	O
muttaions	O
in	O
29	O
of	O
the	O
48	O
FAP	B-Disease
patinets	O
(	O
60	O
%	O
)	O
,	O
including	O
6	O
patinets	O
in	O
whom	O
SCSP	O
aanlysis	O
failed	O
to	O
distinguish	O
the	O
muatnt	O
alelle	O
.	O

In	O
the	O
14	O
later	O
paitents	O
,	O
we	O
identiifed	O
truncaitng	O
mutaitons	O
in	O
9	O
paitents	O
(	O
64	O
%	O
)	O
using	O
PTT	O
only	O
.	O

Our	O
rseults	O
confirm	O
that	O
the	O
muattion	O
detectoin	O
rtae	O
with	O
PTT	O
was	O
superior	O
to	O
that	O
with	O
SCSP	O
,	O
and	O
suggest	O
that	O
PTT	O
would	O
be	O
a	O
more	O
practical	O
screneing	O
metohd	O
to	O
detcet	O
gerlmine	O
mutaitons	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
FAP	B-Disease
patietns	O
.	O

Molecluar	O
epidemiolgoy	O
of	O
C9	B-Disease
dfeiciency	I-Disease
heterozygoets	O
with	O
an	O
Ar9g5Stop	O
mutaiton	O
of	O
the	O
C9	O
gnee	O
in	O
Jaapn	O
.	O

Deficiecny	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
huamn	I-Disease
complement	I-Disease
(	O
C9	O
)	O
is	O
the	O
most	O
common	O
complement	B-Disease
defiicency	I-Disease
in	O
Jaapn	O
,	O
with	O
an	O
inciednce	O
of	O
approximately	O
one	O
hoomzygote	O
in	O
1000	O
,	O
but	O
is	O
very	O
rrae	O
in	O
other	O
coutnries	O
.	O

Geneitc	O
analsyes	O
of	O
Jaapnese	O
C9	B-Disease
defiicency	I-Disease
have	O
shown	O
that	O
a	O
C	O
-	O
to	O
-	O
T	O
transitoin	O
leading	O
to	O
TGA	O
stop	O
coodn	O
for	O
Ar9g5	O
in	O
eoxn	O
4	O
of	O
the	O
C9	O
gnee	O
(	O
Arg95tSop	O
)	O
is	O
common	O
in	O
Japaense	O
C9	B-Disease
deficinecy	I-Disease
.	O

To	O
determine	O
the	O
prevlaence	O
of	O
heteorzygous	O
carrires	O
of	O
the	O
Arg59Stop	O
mutatoin	O
in	O
a	O
Japnaese	O
popluation	O
,	O
we	O
collected	O
DNA	O
smaples	O
from	O
300	O
indviiduals	O
in	O
two	O
of	O
the	O
four	O
main	O
islnads	O
of	O
Jpaan	O
.	O

Heteorzygote	O
detectoin	O
was	O
performed	O
with	O
an	O
allele	O
-	O
specific	O
polmyerase	O
chian	O
reatcion	O
(	O
PCR	O
)	O
sytsem	O
designed	O
to	O
dteect	O
exclusively	O
only	O
one	O
of	O
the	O
nromal	O
and	O
mutnat	O
alleels	O
,	O
followed	O
by	O
confirmatoin	O
with	O
PCR	O
/	O
single	O
-	O
srtand	O
conformtaion	O
polymorpihsm	O
(	O
SCSP	O
)	O
aanlysis	O
and	O
direct	O
seqeuncing	O
.	O

Twenty	O
idnividuals	O
were	O
heteroyzgous	O
for	O
the	O
Arg59Stop	O
muttaion	O
.	O

None	O
was	O
hoomzygous	O
.	O

The	O
prevaelnce	O
of	O
carrires	O
of	O
the	O
Arg59Stop	O
mutaiton	O
was	O
6	O
.	O

7	O
%	O
(	O
20	O
/	O
300	O
)	O
.	O

An	O
estmiated	O
freqeuncy	O
(	O
0	O
.	O
12	O
%	O
)	O
of	O
complete	O
C9	B-Disease
defiicency	I-Disease
due	O
to	O
hoomzygous	O
Arg59Stop	O
muttaion	O
was	O
consistent	O
with	O
freuqencies	O
determined	O
by	O
serloogical	O
stuides	O

The	O
herediatry	B-Disease
hemohcromatosis	I-Disease
prtoein	O
,	O
HFE	O
,	O
specifically	O
reuglates	O
trasnferrin	O
-	O
mediated	O
iorn	O
upatke	O
in	O
HLea	O
clels	O
.	O

HFE	O
is	O
the	O
portein	O
proudct	O
of	O
the	O
gnee	O
mutaetd	O
in	O
the	O
autosmoal	B-Disease
recessvie	I-Disease
disesae	I-Disease
hereditray	B-Disease
hemochromatsois	I-Disease
(	O
Fdeer	O
,	O
J	O
.	O

N	O
.	O
,	O
Gnikre	O
,	O
A	O
.	O
,	O
Thoams	O
,	O
W	O
.	O
,	O
Tsuchhiashi	O
,	O
Z	O
.	O
,	O
Ruddy	O
,	O
D	O
.	O

A	O
.	O
,	O
Basvaa	O
,	O
A	O
.	O
,	O
Dormsihian	O
,	O
F	O
.	O
,	O
Domnigo	O
,	O
R	O
.	O

J	O
.	O
,	O
Ellis	O
,	O
M	O
.	O

C	O
.	O
,	O
Fullan	O
,	O
A	O
.	O
,	O
Hitnon	O
,	O
L	O
.	O

M	O
.	O
,	O
Jones	O
,	O
N	O
.	O

L	O
.	O
,	O
Kimmel	O
,	O
B	O
.	O

E	O
.	O
,	O
Krnomal	O
,	O
G	O
.	O

S	O
.	O
,	O
Laeur	O
,	O
P	O
.	O
,	O
Lee	O
,	O
V	O
.	O

K	O
.	O
,	O
Leob	O
,	O
D	O
.	O

B	O
.	O
,	O
Mpaa	O
,	O
F	O
.	O

A	O
.	O
,	O
McClelalnd	O
,	O
E	O
.	O
,	O
Myeer	O
,	O
N	O
.	O

C	O
.	O
,	O
Mnitier	O
,	O
G	O
.	O

A	O
.	O
,	O
Moelelr	O
,	O
N	O
.	O
,	O
Moore	O
,	O
T	O
.	O
,	O
Moriknag	O
,	O
E	O
.	O
,	O
Prsass	O
,	O
C	O
.	O

E	O
.	O
,	O
Quintnaa	O
,	O
L	O
.	O
,	O
Satrnes	O
,	O
S	O
.	O

M	O
.	O
,	O
Schtazman	O
,	O
R	O
.	O

C	O
.	O
,	O
Brunke	O
,	O
K	O
.	O

J	O
.	O
,	O
Dranya	O
,	O
D	O
.	O

T	O
.	O
,	O
Ricsh	O
,	O
N	O
.	O

J	O
.	O
,	O
Bcaon	O
,	O
B	O
.	O

R	O
.	O
,	O
and	O
Wolff	O
,	O
R	O
.	O

R	O
.	O

(	O
1996	O
)	O
Nat	O
.	O

Genet	O
.	O

13	O
,	O
399	O
-	O
408	O
)	O
.	O

At	O
the	O
clel	O
sufrace	O
,	O
HFE	O
compleexs	O
with	O
transferirn	O
recpetor	O
(	O
TfR	O
)	O
,	O
inrceasing	O
the	O
dissoication	O
contsant	O
of	O
tarnsferrin	O
(	O
Tf	O
)	O
for	O
its	O
rceeptor	O
10	O
-	O
fold	O
(	O
Grsos	O
,	O
C	O
.	O

N	O
.	O
,	O
Irirnki	O
,	O
A	O
.	O
,	O
Fdeer	O
,	O
J	O
.	O
N	O
.	O
,	O
and	O
Enns	O
,	O
C	O
.	O
A	O
.	O
(	O
1998	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
273	O
,	O
22068	O
-	O
22074	O
;	O
Feedr	O
,	O
J	O
.	O
N	O
.	O
,	O
Pneny	O
,	O
D	O
.	O
M	O
.	O
,	O
Irrniki	O
,	O
A	O
.	O
,	O
Lee	O
,	O
V	O
.	O
K	O
.	O
,	O
Lberon	O
,	O
J	O
.	O
A	O
.	O
,	O
Watosn	O
,	O
N	O
.	O
,	O
Tsuchihsahi	O
,	O
Z	O
.	O
,	O
Sgial	O
,	O
E	O
.	O
,	O
Bjormkan	O
,	O
P	O
.	O
J	O
.	O
,	O
and	O
Shcatzman	O
,	O
R	O
.	O
C	O
.	O
(	O
1998	O
)	O
Porc	O
.	O
Ntal	O
.	O

Aacd	O
.	O

Sci	O
.	O

U	O
S	O
A	O
95	O
,	O
1472	O
-	O
1477	O
)	O
.	O

HFE	O
does	O
not	O
remain	O
at	O
the	O
clel	O
surfcae	O
,	O
but	O
trafifcs	O
with	O
TfR	O
to	O
Tf	O
-	O
positvie	O
intenral	O
cmopartments	O
(	O
Gorss	O
et	O
al	O
.	O
,	O
1998	O
)	O
.	O

Using	O
a	O
HLea	O
clel	O
line	O
in	O
which	O
the	O
experssion	O
of	O
HFE	O
is	O
controlled	O
by	O
tetrayccline	O
,	O
we	O
show	O
that	O
the	O
exrpession	O
of	O
HFE	O
reduecs	O
5F5e	O
upatke	O
from	O
Tf	O
by	O
33	O
%	O
but	O
does	O
not	O
affect	O
the	O
endcoytic	O
or	O
excoytic	O
rtaes	O
of	O
TfR	O
ccyling	O
.	O

Therefore	O
,	O
HFE	O
appears	O
to	O
rdeuce	O
cellular	O
acquistiion	O
of	O
iorn	O
from	O
Tf	O
within	O
endoctyic	O
compartmnets	O
.	O

HFE	O
specifically	O
redcues	O
iorn	O
upatke	O
from	O
Tf	O
,	O
as	O
non	O
-	O
Tf	O
-	O
mediated	O
iorn	O
uptkae	O
from	O
Fe	O
-	O
nitrioltriacetic	O
aicd	O
is	O
not	O
atlered	O
.	O

These	O
rseults	O
explain	O
the	O
derceased	O
ferritin	O
leevls	O
seen	O
in	O
our	O
HLea	O
clel	O
sysetm	O
and	O
demonstrate	O
the	O
specific	O
contorl	O
of	O
HFE	O
over	O
the	O
Tf	O
-	O
mediated	O
ptahway	O
of	O
iorn	O
upatke	O
.	O

These	O
resluts	O
also	O
have	O
implications	O
for	O
the	O
understanding	O
of	O
cellluar	O
iorn	O
homoestasis	O
in	O
orgnas	O
such	O
as	O
the	O
lievr	O
,	O
panceras	O
,	O
haert	O
,	O
and	O
spelen	O
that	O
are	O
iorn	O
loaedd	O
in	O
heerditary	B-Disease
hemochormatotic	I-Disease
indivdiuals	O
lacking	O
functoinal	O
HFE	O
.	O

Mtuation	O
and	O
haploytpe	O
stduies	O
of	O
familail	B-Disease
Mediterranaen	I-Disease
feevr	I-Disease
reveal	O
new	O
anecstral	O
relationsihps	O
and	O
eivdence	O
for	O
a	O
high	O
carirer	O
ferquency	O
with	O
reduecd	O
penetarnce	O
in	O
the	O
Ashkeanzi	O
Jweish	O
populaiton	O
.	O

Famliial	B-Disease
Medtierranean	I-Disease
fveer	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recesisve	B-Disease
dsiorder	I-Disease
chraacterized	O
by	O
epiosdes	O
of	O
fveer	O
with	O
seroistis	B-Disease
or	O
synovtiis	B-Disease
.	O

The	O
FMF	B-Disease
gnee	O
(	O
MFEV	O
)	O
was	O
cloend	O
recently	O
,	O
and	O
four	O
missesne	O
muttaions	O
were	O
idenitfied	O
.	O

Here	O
we	O
present	O
dtaa	O
from	O
non	O
-	O
Asheknazi	O
Jewsih	O
and	O
Aarb	O
ptaients	O
in	O
whom	O
we	O
had	O
not	O
originally	O
found	O
muattions	O
and	O
from	O
a	O
new	O
,	O
more	O
ethnically	O
divesre	O
panel	O
.	O

Among	O
90	O
symptomaitc	O
mtuation	O
-	O
posiitve	O
individauls	O
,	O
11	O
mutatoins	O
accounted	O
for	O
79	O
%	O
of	O
crarier	O
chroomsomes	O
.	O

Of	O
the	O
two	O
muattions	O
that	O
are	O
novel	O
,	O
one	O
altres	O
the	O
same	O
resiude	O
(	O
680	O
)	O
as	O
a	O
previously	O
known	O
muattion	O
,	O
and	O
the	O
other	O
(	O
P639S	O
)	O
is	O
located	O
in	O
eoxn	O
3	O
.	O

Consistent	O
with	O
another	O
recent	O
reprot	O
,	O
the	O
E418Q	O
mtuation	O
was	O
observed	O
in	O
patinets	O
of	O
several	O
ethniciites	O
and	O
on	O
multilpe	O
microsatelilte	O
hapltoypes	O
,	O
but	O
haplotpye	O
dtaa	O
indicate	O
an	O
anecstral	O
relatiosnhips	O
between	O
non	O
-	O
Jweish	O
Itlaian	O
and	O
Ashkneazi	O
Jweish	O
patietns	O
with	O
FMF	B-Disease
and	O
other	O
affetced	O
populatinos	O
.	O

Among	O
approximately	O
200	O
anoynmous	O
Ashkeanzi	O
Jeiwsh	O
DNA	O
samlpes	O
,	O
the	O
MFEV	O
carrier	O
frequecny	O
was	O
21	O
%	O
,	O
with	O
E418Q	O
the	O
most	O
common	O
mutaiton	O
.	O

Several	O
liens	O
of	O
evdience	O
indicate	O
redcued	O
pneetrance	O
among	O
Askhenazi	O
Jwes	O
,	O
especially	O
for	O
E418Q	O
,	O
P639S	O
,	O
and	O
K965R	O
.	O

Nevertheless	O
,	O
E184Q	O
helps	O
account	O
for	O
reecssive	O
ihneritance	O
in	O
an	O
Ashkneazi	O
faimly	O
previously	O
reported	O
as	O
an	O
uunsual	O
csae	O
of	O
dominantly	O
inehrited	O
FMF	B-Disease
.	O

The	O
prseence	O
of	O
three	O
ferquent	O
MFEV	O
mtuations	O
in	O
multpile	O
Mediterarnean	O
populatoins	O
strongly	O
suggests	O
a	O
heterozygtoe	O
advantage	O
in	O
this	O
geograhpic	O
rgeion	O
.	O

Autoimmnue	B-Disease
lymphoprloiferative	I-Disease
synrdome	I-Disease
with	O
defcetive	O
Fas	O
:	O
gentoype	O
inlfuences	O
peentrance	O
.	O

Atuoimmune	B-Disease
lymphoprolifeartive	I-Disease
sydnrome	I-Disease
(	O
APLS	B-Disease
)	O
is	O
a	O
disodrer	B-Disease
of	I-Disease
lymphoctye	I-Disease
homeosatsis	I-Disease
and	I-Disease
immnuological	I-Disease
tolreance	I-Disease
.	O

Most	O
paitents	O
have	O
a	O
heteroyzgous	O
mutaiton	O
in	O
the	O
ATP1	O
gnee	O
,	O
which	O
ecnodes	O
Fas	O
(	O
C9D5	O
,	O
APO	O
-	O
1	O
)	O
,	O
mediator	O
of	O
an	O
apotpotic	O
patwhay	O
crucial	O
to	O
lymphoycte	O
homeosatsis	O
.	O

Of	O
17	O
uniuqe	O
ATP1	O
mutatoins	O
in	O
unrelated	O
APLS	B-Disease
probadns	O
,	O
12	O
(	O
71	O
%	O
)	O
occurred	O
in	O
exnos	O
7	O
-	O
9	O
,	O
which	O
encode	O
the	O
intracellualr	O
protion	O
of	O
Fas	O
.	O

In	O
vitro	O
,	O
atcivated	O
lymphoctyes	O
from	O
all	O
17	O
patinets	O
showed	O
apopttoic	O
deefcts	O
when	O
expsoed	O
to	O
an	O
atni	O
-	O
Fas	O
agoinst	O
moncolonal	O
antbiody	O
.	O

Similar	O
defcets	O
were	O
found	O
in	O
a	O
Fas	O
-	O
negaitve	O
clel	O
line	O
transfecetd	O
with	O
cDANs	O
bearing	O
each	O
of	O
the	O
muttaions	O
.	O

In	O
ctoransfection	O
experimetns	O
,	O
Fas	O
construtcs	O
with	O
either	O
itnra	O
-	O
or	O
extraclelular	O
muttaions	O
caused	O
dmoinant	O
inhiibtion	O
of	O
apopotsis	O
mediated	O
by	O
wlid	O
-	O
tpye	O
Fas	O
.	O

Two	O
missnese	O
Fas	O
vraiants	O
,	O
not	O
restricted	O
to	O
patinets	O
with	O
APLS	B-Disease
,	O
were	O
idnetified	O
.	O

Vraiant	O
A	O
(	O
-	O
1	O
)	O
T	O
at	O
the	O
Fas	O
singal	O
-	O
sqeuence	O
celavage	O
stie	O
,	O
which	O
mediates	O
aopptosis	O
less	O
well	O
than	O
wlid	O
-	O
tpye	O
Fas	O
and	O
is	O
partilaly	O
inhibitroy	O
,	O
was	O
present	O
in	O
13	O
%	O
of	O
Afircan	O
Amercian	O
alllees	O
.	O

Among	O
the	O
APLS	B-Disease
-	O
associated	O
Fas	O
mutatns	O
,	O
dmoinant	O
inhiibtion	O
of	O
apotposis	O
was	O
much	O
more	O
pronounced	O
in	O
mutatns	O
affetcing	O
the	O
intracelullar	O
,	O
versus	O
extraclelular	O
,	O
protion	O
of	O
the	O
Fas	O
reecptor	O
.	O

Muttaions	O
causing	O
disrpution	O
of	O
the	O
itnracellular	O
Fas	O
detah	O
dmoain	O
also	O
showed	O
a	O
higehr	O
penetrnace	O
of	O
APLS	B-Disease
pheontype	O
feautres	O
in	O
mtuation	O
-	O
bearing	O
realtives	O
.	O

Signfiicant	O
APLS	B-Disease
-	O
related	O
morbiidty	O
occurred	O
in	O
44	O
%	O
of	O
reltaives	O
with	O
intracellualr	O
mtuations	O
,	O
versus	O
0	O
%	O
of	O
relaitves	O
with	O
extracelullar	O
mutatinos	O
.	O

Thus	O
,	O
the	O
lcoation	O
of	O
muattions	O
within	O
ATP1	O
strongly	O
influenecs	O
the	O
devleopment	O
and	O
the	O
sevreity	O
of	O
APLS	B-Disease
.	O

Multicenrtic	O
oriign	O
of	O
heomchromatosis	B-Disease
gnee	O
(	O
HFE	O
)	O
mutatinos	O
.	O

Geentic	B-Disease
hemochrmoatosis	I-Disease
(	O
GH	B-Disease
)	O
is	O
believed	O
to	O
be	O
a	O
disesae	O
restricted	O
to	O
those	O
of	O
Eruopean	O
ancetsry	O
.	O

In	O
northewstern	O
Eurpoe	O
,	O
>	O
80	O
%	O
of	O
GH	B-Disease
patietns	O
are	O
hoomzygous	O
for	O
one	O
muttaion	O
,	O
the	O
substtiution	O
of	O
tyrsoine	O
for	O
cysetine	O
at	O
positoin	O
282	O
(	O
C822Y	O
)	O
in	O
the	O
unprocsesed	O
proetin	O
.	O

In	O
a	O
prooprtion	O
of	O
GH	B-Disease
pateints	O
,	O
two	O
mutatinos	O
are	O
present	O
,	O
C228Y	O
and	O
H36D	O
.	O

The	O
cilnical	O
signfiicance	O
of	O
this	O
second	O
mutaiton	O
is	O
such	O
that	O
it	O
appears	O
to	O
predispose	O
1	O
%	O
-	O
2	O
%	O
of	O
cmopound	O
heterozygtoes	O
to	O
expresison	O
of	O
the	O
dsiease	O
.	O

The	O
ditsribution	O
of	O
the	O
two	O
muattions	O
differ	O
,	O
C228Y	O
being	O
lmiited	O
to	O
those	O
of	O
northewstern	O
Euroepan	O
ancesrty	O
and	O
H36D	O
being	O
found	O
at	O
allele	O
frequenceis	O
>	O
5	O
%	O
,	O
in	O
Euorpe	O
,	O
in	O
conutries	O
bordering	O
the	O
Meditreranean	O
,	O
in	O
the	O
Middle	O
Esat	O
,	O
and	O
in	O
the	O
Indain	O
subcontiennt	O
.	O

The	O
C822Y	O
mtuation	O
occurs	O
on	O
a	O
hpalotype	O
that	O
extends	O
<	O
/	O
=	O
6	O
Mb	O
,	O
suggesting	O
that	O
this	O
muttaion	O
has	O
arisen	O
during	O
the	O
past	O
2	O
,	O
000	O
yaers	O
.	O

The	O
H36D	O
muttaion	O
is	O
oledr	O
and	O
does	O
not	O
occur	O
on	O
such	O
a	O
large	O
exetnded	O
hapoltype	O
,	O
the	O
halpotype	O
in	O
this	O
csae	O
extending	O
<	O
/	O
=	O
700	O
kb	O
.	O

Here	O
we	O
rpeort	O
the	O
fniding	O
of	O
the	O
H36D	O
and	O
C822Y	O
mutatinos	O
on	O
new	O
hapltoypes	O
.	O

In	O
Sri	O
Lakna	O
we	O
have	O
found	O
H36D	O
on	O
three	O
new	O
halpotypes	O
and	O
have	O
found	O
C822Y	O
on	O
one	O
new	O
haplotpye	O
,	O
demonstrating	O
that	O
these	O
mutatoins	O
have	O
arisen	O
independently	O
on	O
this	O
isalnd	O
.	O

These	O
resluts	O
suggest	O
that	O
the	O
HFE	O
gnee	O
has	O
been	O
the	O
sujbect	O
of	O
selectoin	O
presusre	O
.	O

These	O
seelction	O
presusres	O
could	O
be	O
due	O
to	O
inefctious	B-Disease
disesaes	I-Disease
,	O
environmnetal	O
conditoins	O
,	O
or	O
other	O
geneitc	B-Disease
dsiorders	I-Disease
such	O
as	O
anmeia	B-Disease
.	O

A	O
retrospcetive	O
anonyomus	O
pliot	O
sutdy	O
in	O
screennig	O
nweborns	O
for	O
HFE	O
mutaitons	O
in	O
Scandinvaian	O
populatoins	O
.	O

We	O
have	O
retropsectively	O
anlayzed	O
837	O
radnom	O
anonyimzed	O
dired	O
bolod	O
sopt	O
(	O
DBS	O
)	O
samlpes	O
from	O
nenoatal	O
screeinng	O
prorgams	O
in	O
Scandniavia	O
for	O
muttaions	O
in	O
HFE	O
,	O
the	O
candidate	O
gnee	O
for	O
hemochromtaosis	B-Disease
.	O

We	O
have	O
found	O
C228Y	O
allele	O
freuqencies	O
of	O
2	O
.	O

3	O
%	O
(	O
+	O
2	O
.	O
0	O
%	O
)	O
(	O
-	O
1	O
.	O
3	O
%	O
)	O
in	O
Greneland	O
,	O
4	O
.	O

5	O
%	O
+	O
/	O
-	O
1	O
.	O

9	O
%	O
in	O
Iecland	O
,	O
5	O
.	O

1	O
%	O
+	O
/	O
-	O
2	O
.	O

3	O
%	O
in	O
the	O
Faeore	O
Islnads	O
,	O
and	O
8	O
.	O

2	O
%	O
+	O
/	O
-	O
2	O
.	O

7	O
%	O
in	O
Denmrak	O
.	O

The	O
high	O
prevalecne	O
of	O
HFE	O
muttaions	O
in	O
Dnemark	O
suggests	O
that	O
popluation	O
screennig	O
for	O
the	O
C822Y	O
muattion	O
could	O
be	O
highly	O
advantageous	O
in	O
terms	O
of	O
prevnetive	O
haelth	O
crae	O
.	O

Lnog	O
-	O
term	O
follow	O
-	O
up	O
evalaution	O
of	O
C822Y	O
hoomzygotes	O
and	O
H36D	O
/	O
C822Y	O
compuond	O
hetreozygotes	O
will	O
give	O
an	O
indicaiton	O
of	O
the	O
penterance	O
of	O
the	O
mutaitons	O
.	O

Idnetification	O
of	O
the	O
muattion	O
in	O
the	O
alkpatonuria	B-Disease
mosue	O
mdoel	O
.	O

Alkpatonuria	B-Disease
(	O
aku	B-Disease
)	O
,	O
an	O
inbron	B-Disease
error	I-Disease
of	I-Disease
metbaolism	I-Disease
caused	O
by	O
the	O
lsos	O
of	O
homgoentisate	O
1	O
,	O
2	O
-	O
doixygenase	O
(	O
HGD	O
)	O
,	O
has	O
been	O
described	O
in	O
a	O
muose	O
mdoel	O
created	O
by	O
ethlynitrosourea	O
mutageensis	O
but	O
the	O
muattion	O
in	O
these	O
mcie	O
has	O
not	O
previously	O
been	O
idnetified	O
.	O

We	O
used	O
RT	O
-	O
PCR	O
to	O
ampilfy	O
the	O
Hgd	O
cNDA	O
from	O
Hgd	O
(	O
aku	O
)	O
/	O
Hgd	O
(	O
aku	O
)	O
mcie	O
.	O

Two	O
porducts	O
shoretr	O
than	O
the	O
wlid	O
-	O
tpye	O
prdouct	O
were	O
amlpified	O
.	O

Rsetriction	O
mapipng	O
and	O
DNA	O
seuqencing	O
were	O
then	O
used	O
to	O
identify	O
the	O
Hgd	O
(	O
aku	O
)	O
muose	O
mutaiton	O
,	O
found	O
to	O
be	O
a	O
single	O
base	O
change	O
in	O
a	O
spilce	O
doonr	O
cnosensus	O
seuqence	O
,	O
causing	O
eoxn	O
skipipng	O
and	O
frmae	O
-	O
shifted	O
porducts	O
.	O

This	O
base	O
change	O
allowed	O
us	O
to	O
create	O
a	O
non	O
-	O
radioactvie	O
genoytping	O
assay	O
for	O
this	O
allele	O
.	O

Non	B-Disease
-	I-Disease
syndrmoic	I-Disease
hearnig	I-Disease
lsos	I-Disease
associated	O
with	O
enlaregd	B-Disease
vestibluar	I-Disease
auqeduct	I-Disease
is	O
caused	O
by	O
PDS	B-Disease
mutatinos	O
.	O

Elnarged	B-Disease
vestibualr	I-Disease
auqeduct	I-Disease
(	O
EVA	B-Disease
)	O
,	O
known	O
as	O
the	O
most	O
common	O
form	O
of	O
inenr	B-Disease
ear	I-Disease
abnormaltiy	I-Disease
,	O
has	O
recently	O
been	O
of	O
particular	O
gneetic	O
interest	O
because	O
this	O
anmoaly	O
is	O
inhreited	O
in	O
a	O
reecssive	O
manner	O
.	O

The	O
lcous	O
for	O
non	B-Disease
-	I-Disease
syndrmoic	I-Disease
sensorienural	I-Disease
haering	I-Disease
lsos	I-Disease
with	O
EVA	B-Disease
has	O
been	O
mpaped	O
to	O
the	O
same	O
crhomosomal	O
rgeion	O
,	O
73q1	O
,	O
as	O
the	O
Penderd	B-Disease
syndorme	I-Disease
loucs	O
.	O

In	O
the	O
present	O
stduy	O
,	O
seven	O
mutaitons	O
in	O
the	O
PDS	B-Disease
gnee	O
(	O
PDS	O
)	O
,	O
the	O
gnee	O
responsible	O
for	O
Pnedred	B-Disease
syndrmoe	I-Disease
,	O
have	O
been	O
found	O
in	O
famliies	O
of	O
non	B-Disease
-	I-Disease
syndormic	I-Disease
sensroineural	I-Disease
haering	I-Disease
lsos	I-Disease
with	O
EVA	B-Disease
.	O

One	O
fmaily	O
is	O
hoomzygous	O
,	O
three	O
fmailies	O
are	O
compuond	O
hteerozygotes	O
,	O
and	O
two	O
famileis	O
are	O
hetreozygous	O
but	O
with	O
no	O
other	O
muattion	O
detetced	O
.	O

The	O
present	O
reuslts	O
provide	O
evdience	O
that	O
mutaitons	O
in	O
PDS	O
cause	O
both	O
syndormic	B-Disease
and	I-Disease
non	I-Disease
-	I-Disease
syndormic	I-Disease
haering	I-Disease
lsos	I-Disease
.	O
.	O

Mutatioanl	O
analsyis	O
and	O
gentoype	O
-	O
phenotpye	O
crorelation	O
of	O
29	O
unrelated	O
Japnaese	O
pateints	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodytsrophy	I-Disease
.	O

BACKGRONUD	O
X	B-Disease
-	I-Disease
linked	I-Disease
ardenoleukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
is	O
an	O
inhreited	B-Disease
dsiease	I-Disease
charcaterized	O
by	O
progrsesive	O
nuerologic	B-Disease
dyfsunction	I-Disease
,	O
occasionally	O
associated	O
with	O
adrneal	B-Disease
isnufficiency	I-Disease
.	O

The	O
classic	O
form	O
of	O
ALD	B-Disease
usually	O
has	O
onset	O
in	O
chilhdood	O
(	O
childhood	B-Disease
cerberal	I-Disease
ALD	I-Disease
)	O
,	O
with	O
rpaid	O
neurolgoic	B-Disease
deterioraiton	I-Disease
leading	O
to	O
a	O
vegettaive	O
state	O
.	O

Audlt	O
-	O
onset	O
creebral	B-Disease
ALD	I-Disease
also	O
presents	O
with	O
rapidly	O
progerssive	O
neruologic	B-Disease
dysfuntcion	I-Disease
.	O

Mlider	O
pheontypes	O
such	O
as	O
adrenomyeloneuorpathy	B-Disease
and	O
Adidson	B-Disease
disaese	I-Disease
only	O
also	O
have	O
been	O
recognized	O
.	O

Despite	O
dicsovery	O
of	O
the	O
cauastive	O
gnee	O
,	O
a	O
moleuclar	O
basis	O
for	O
the	O
dvierse	O
cilnical	O
preesntations	O
remains	O
to	O
be	O
elucidated	O
.	O

OBJECITVES	O
To	O
conduct	O
mtuational	O
anaylses	O
in	O
29	O
Japaense	O
paitents	O
with	O
ALD	B-Disease
from	O
29	O
unrelated	O
famliies	O
,	O
to	O
obtain	O
knwoledge	O
of	O
the	O
specturm	O
of	O
muattions	O
in	O
this	O
gnee	O
,	O
and	O
to	O
sutdy	O
geontype	O
-	O
pehnotype	O
corrleations	O
in	O
Jaapnese	O
patinets	O
.	O

METHODS	O
The	O
29	O
paitents	O
comprised	O
13	O
pateints	O
with	O
childohod	B-Disease
cerberal	I-Disease
ALD	I-Disease
,	O
11	O
patietns	O
with	O
adlut	O
-	O
onset	O
cererbal	B-Disease
ALD	I-Disease
,	O
and	O
5	O
patinets	O
with	O
adrenmoyeloneuropathy	B-Disease
.	O

We	O
conducted	O
detailed	O
muttaional	O
anaylses	O
of	O
29	O
unrelated	O
Jpaanese	O
paitents	O
with	O
ALD	B-Disease
by	O
geonmic	O
Souhtern	O
bolt	O
anlaysis	O
and	O
direct	O
nucleotdie	O
sequnece	O
analyiss	O
of	O
reevrse	O
transcritpase	O
-	O
polyemrase	O
cahin	O
recation	O
prodcuts	O
derived	O
from	O
total	O
RNA	O
that	O
was	O
extracetd	O
from	O
cultrued	O
sikn	O
fbiroblasts	O
,	O
lympohblastoid	O
clels	O
,	O
or	O
perihperal	O
blood	O
luekocytes	O
.	O

RESUTLS	O
Three	O
pateints	O
with	O
audlt	O
-	O
onset	O
cerebarl	B-Disease
ALD	I-Disease
were	O
identiifed	O
as	O
having	O
large	O
gneomic	O
rearrangemetns	O
.	O

The	O
remaining	O
26	O
pateints	O
were	O
idnetified	O
as	O
having	O
21	O
inedpendent	O
mutatinos	O
,	O
including	O
12	O
novel	O
mutatinos	O
resulting	O
in	O
small	O
nucleotdie	O
altertaions	O
in	O
the	O
ALD	B-Disease
gnee	O
.	O

Eighteen	O
(	O
69	O
%	O
)	O
of	O
26	O
mtuations	O
were	O
misesnse	O
mtuations	O
.	O

Most	O
missnese	O
mutatinos	O
involved	O
amnio	O
acdis	O
conserved	O
in	O
homloogous	O
gnee	O
proudcts	O
,	O
including	O
PM7P0	O
,	O
mALRDP	O
,	O
and	O
Pax1p	O
.	O

The	O
AG	O
dinucletoide	O
deleiton	O
at	O
poistion	O
1081	O
-	O
1082	O
,	O
which	O
has	O
been	O
reported	O
previously	O
to	O
be	O
the	O
most	O
common	O
mtuation	O
in	O
whtie	O
ptaients	O
(	O
12	O
%	O
-	O
17	O
%	O
)	O
,	O
was	O
also	O
idetnified	O
as	O
the	O
most	O
common	O
mtuation	O
in	O
Japnaese	O
patietns	O
(	O
12	O
%	O
)	O
.	O

All	O
phenotpyes	O
were	O
associated	O
with	O
mutatoins	O
resulting	O
in	O
proetin	O
trunaction	O
or	O
subtle	O
aimno	O
aicd	O
chnages	O
.	O

There	O
were	O
no	O
differenecs	O
in	O
pehnotypic	O
exprsesions	O
between	O
missesne	O
mutaitons	O
involving	O
conserved	O
aimno	O
aicds	O
and	O
those	O
involving	O
noncosnerved	O
aimno	O
acdis	O
.	O

COCNLUSIONS	O
There	O
are	O
no	O
obvious	O
correlatoins	O
between	O
the	O
phenotpyes	O
of	O
ptaients	O
with	O
ALD	B-Disease
and	O
their	O
genoytpes	O
,	O
suggesting	O
that	O
other	O
geentic	O
or	O
environemntal	O
fatcors	O
modify	O
the	O
phentoypic	O
experssions	O
of	O
ALD	B-Disease
.	O
.	O

A	O
common	O
huamn	O
sikn	B-Disease
tumuor	I-Disease
is	O
caused	O
by	O
activtaing	O
mutatinos	O
in	O
btea	O
-	O
cateinn	O
.	O

WNT	O
singalling	O
orchestrates	O
a	O
number	O
of	O
develpomental	O
prorgams	O
.	O

In	O
rseponse	O
to	O
this	O
stiumlus	O
,	O
cytpolasmic	O
btea	O
-	O
caetnin	O
(	O
encdoed	O
by	O
CTNNB1	O
)	O
is	O
staiblized	O
,	O
enabling	O
downstraem	O
transcripitonal	O
activaiton	O
by	O
mebmers	O
of	O
the	O
LEF	O
/	O
TCF	O
famliy	O
.	O

One	O
of	O
the	O
traget	O
geens	O
for	O
btea	O
-	O
ctaenin	O
/	O
TCF	O
enocdes	O
c	O
-	O
MYC	O
,	O
explaining	O
why	O
constiuttive	O
activtaion	O
of	O
the	O
WNT	O
pathawy	O
can	O
lead	O
to	O
cnacer	B-Disease
,	O
particularly	O
in	O
the	O
cloon	O
.	O

Most	O
cooln	B-Disease
cancres	I-Disease
arise	O
from	O
mutaitons	O
in	O
the	O
gnee	O
ecnoding	O
aednomatous	B-Disease
polyopsis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
,	O
a	O
portein	O
required	O
for	O
ubiqutiin	O
-	O
mediated	O
degraadtion	O
of	O
btea	O
-	O
caetnin	O
,	O
but	O
a	O
small	O
percentgae	O
of	O
cloon	B-Disease
and	I-Disease
some	I-Disease
other	I-Disease
cacners	I-Disease
harobur	O
btea	O
-	O
caetnin	O
-	O
staiblizing	O
mutatinos	O
.	O

Recently	O
,	O
we	O
discovered	O
that	O
transegnic	O
mcie	O
expressnig	O
an	O
acitvated	O
btea	O
-	O
catnein	O
are	O
predipsosed	O
to	O
developing	O
sikn	B-Disease
tuomurs	I-Disease
resembling	O
pilomatircomas	B-Disease
.	O

Given	O
that	O
the	O
sikn	O
of	O
these	O
audlt	O
mcie	O
also	O
exhibits	O
sgins	O
of	O
de	O
novo	O
hiar	O
-	O
follicle	O
morphogenseis	O
,	O
we	O
wondered	O
whether	O
hmuan	O
pilmoatricomas	B-Disease
might	O
originate	O
from	O
hiar	O
mtarix	O
cells	O
and	O
whether	O
they	O
might	O
possess	O
btea	O
-	O
ctaenin	O
-	O
stbailizing	O
muttaions	O
.	O

Here	O
,	O
we	O
explore	O
the	O
clel	O
oriign	O
and	O
ateiology	O
of	O
this	O
common	O
huamn	O
sikn	B-Disease
tuomur	I-Disease
.	O

We	O
found	O
nucelar	O
LEF	O
-	O
1	O
in	O
the	O
dividing	O
tumuor	B-Disease
cells	O
,	O
providing	O
biochemcial	O
evidnece	O
that	O
pilomatricoams	B-Disease
are	O
derived	O
from	O
hiar	O
mtarix	O
cells	O
.	O

At	O
least	O
75	O
%	O
of	O
these	O
tmuours	B-Disease
possess	O
mutaitons	O
affectnig	O
the	O
aimno	O
-	O
treminal	O
semgent	O
,	O
normally	O
involved	O
in	O
phosphoyrlation	O
-	O
depednent	O
,	O
ubqiuitin	O
-	O
mediated	O
degradatoin	O
of	O
the	O
proetin	O
.	O

This	O
precentage	O
of	O
CTNBN1	O
mtuations	O
is	O
greater	O
than	O
in	O
all	O
other	O
huamn	O
tumorus	B-Disease
examined	O
thus	O
far	O
,	O
and	O
directly	O
implicates	O
btea	O
-	O
caetnin	O
/	O
LEF	O
misregulaiton	O
as	O
the	O
major	O
cause	O
of	O
hiar	O
martix	O
clel	O
tmuorigenesis	O
in	O
humnas	O
.	O
.	O

The	O
Pnedred	B-Disease
syndrmoe	I-Disease
gnee	O
encoeds	O
a	O
chloirde	O
-	O
idoide	O
tranpsort	O
portein	O
.	O

Pednred	B-Disease
snydrome	I-Disease
is	O
the	O
most	O
common	O
form	O
of	O
syndrmoic	B-Disease
deanfess	I-Disease
and	O
chaarcterized	O
by	O
cognenital	O
snesorineural	B-Disease
heraing	I-Disease
lsos	I-Disease
and	O
gotire	B-Disease
.	O

This	O
disroder	O
was	O
mapepd	O
to	O
chromsoome	O
7	O
and	O
the	O
gnee	O
causing	O
Penrded	B-Disease
snydrome	I-Disease
(	O
PDS	B-Disease
)	O
was	O
subsequently	O
identifeid	O
by	O
postiional	O
colning	O
.	O

PDS	O
encoeds	O
a	O
putative	O
transmembrnae	O
protien	O
designated	O
pnedrin	O
.	O

Penrdin	O
is	O
closely	O
related	O
to	O
a	O
famliy	O
of	O
slufate	O
trasnport	O
prtoeins	O
that	O
includes	O
the	O
rat	O
sulftae	O
-	O
ainon	O
transpotrer	O
(	O
enocded	O
by	O
Sat	O
-	O
1	O
;	O
29	O
%	O
aimno	O
aicd	O
sequecne	O
idenitty	O
)	O
,	O
the	O
hmuan	O
disatrophic	B-Disease
dyslpasia	I-Disease
slufate	O
tarnsporter	O
(	O
enocded	O
by	O
DTD	O
;	O
32	O
%	O
)	O
and	O
the	O
huamn	O
sulftae	O
transoprter	O
dowrnegulated	O
in	O
aednoma	B-Disease
(	O
encdoed	O
by	O
DRA	O
;	O
45	O
%	O
)	O
.	O

On	O
the	O
basis	O
of	O
this	O
homoolgy	O
and	O
the	O
persence	O
of	O
a	O
slightly	O
mdoified	O
slufate	O
-	O
tarnsporter	O
sginature	O
sequecne	O
comprising	O
its	O
putative	O
second	O
transmemrbane	O
doamin	O
,	O
pnedrin	O
has	O
been	O
proposed	O
to	O
funciton	O
as	O
a	O
sulftae	O
tarnsporter	O
.	O

We	O
were	O
unable	O
to	O
dteect	O
eviednce	O
of	O
slufate	O
trnasport	O
following	O
the	O
exrpession	O
of	O
pendirn	O
in	O
Xeonpus	O
laeivs	O
ooctyes	O
by	O
micronijection	O
of	O
PDS	O
cNRA	O
or	O
in	O
Sf9	O
clels	O
following	O
ifnection	O
with	O
PDS	O
-	O
rceombinant	O
bcaulovirus	O
.	O

The	O
raets	O
of	O
transoprt	O
for	O
idoide	O
and	O
cholride	O
were	O
significantly	O
icnreased	O
following	O
the	O
expressoin	O
of	O
pendirn	O
in	O
both	O
clel	O
ssytems	O
.	O

Our	O
rseults	O
demonstrate	O
that	O
pnedrin	O
functinos	O
as	O
a	O
transproter	O
of	O
chlordie	O
and	O
ioddie	O
,	O
but	O
not	O
sulftae	O
,	O
and	O
may	O
provide	O
insight	O
into	O
thryoid	O
physiolgoy	O
and	O
the	O
pathophyisology	O
of	O
Penrded	B-Disease
synrdome	I-Disease
.	O
.	O

HFE	O
muttaions	O
analyiss	O
in	O
711	O
hemcohromatosis	B-Disease
probadns	O
:	O
eviednce	O
for	O
S56C	O
implication	O
in	O
mlid	O
form	O
of	O
hemochromaotsis	B-Disease
.	O

Hereidtary	B-Disease
hemochromatoiss	I-Disease
(	O
HH	B-Disease
)	O
is	O
a	O
common	O
auotsomal	B-Disease
recsesive	I-Disease
gneetic	I-Disease
disroder	I-Disease
of	O
iorn	O
meatbolism	O
.	O

The	O
HFE	O
candidate	O
gnee	O
encdoing	O
an	O
HLA	O
calss	O
I	O
-	O
like	O
prtoein	O
involved	O
in	O
HH	B-Disease
was	O
identiifed	O
in	O
1996	O
.	O

Two	O
missense	O
mutaitons	O
have	O
been	O
described	O
C822Y	O
,	O
accounting	O
for	O
80	O
%	O
to	O
90	O
%	O
of	O
HH	B-Disease
chroomsomes	O
,	O
and	O
H36D	O
,	O
which	O
is	O
associated	O
with	O
a	O
milder	O
form	O
of	O
the	O
dsiease	O
representing	O
40	O
%	O
to	O
70	O
%	O
of	O
non	O
-	O
C822Y	O
HH	B-Disease
chroomsomes	O
.	O

We	O
rpeort	O
here	O
on	O
the	O
anaylsis	O
of	O
C822Y	O
,	O
H36D	O
,	O
and	O
the	O
193A	O
-	O
-	O
>	O
T	O
susbtitution	O
leading	O
to	O
the	O
S56C	O
missesne	O
substiuttion	O
in	O
a	O
large	O
series	O
of	O
proabnds	O
and	O
contorls	O
.	O

The	O
reuslts	O
confirm	O
that	O
the	O
C228Y	O
substittuion	O
was	O
the	O
main	O
mutaiton	O
involved	O
in	O
hmeochromatosis	B-Disease
,	O
accounting	O
for	O
85	O
%	O
of	O
carrier	O
chroomsomes	O
,	O
whereas	O
the	O
H36D	O
susbtitution	O
represented	O
39	O
%	O
of	O
the	O
HH	B-Disease
chroomsomes	O
that	O
did	O
not	O
carry	O
the	O
C822Y	O
mutaiton	O
.	O

In	O
addition	O
,	O
our	O
screennig	O
showed	O
that	O
the	O
S56C	O
susbtitution	O
was	O
significantly	O
enriched	O
in	O
probnads	O
with	O
at	O
least	O
one	O
crhomosome	O
without	O
an	O
assigned	O
mutatoin	O
.	O

This	O
subsittution	O
accounted	O
for	O
7	O
.	O

8	O
%	O
of	O
HH	B-Disease
chroomsomes	O
that	O
were	O
neither	O
C228Y	O
nor	O
H36D	O
.	O

This	O
enricmhent	O
of	O
S56C	O
among	O
HH	B-Disease
chromosoems	O
suggests	O
that	O
the	O
S56C	O
sbustitution	O
is	O
associated	O
with	O
the	O
mlid	O
form	O
of	O
hemochrmoatosis	B-Disease
.	O

Gemrline	O
BRAC1	O
altreations	O
in	O
a	O
popualtion	O
-	O
based	O
series	O
of	O
ovairan	B-Disease
canecr	I-Disease
csaes	O
.	O

The	O
objectvie	O
of	O
this	O
sutdy	O
was	O
to	O
provide	O
more	O
accurtae	O
frqeuency	O
estimtaes	O
of	O
bresat	B-Disease
cacner	I-Disease
suscepitbility	O
gnee	O
1	O
(	O
BRAC1	O
)	O
germlnie	O
aletrations	O
in	O
the	O
ovairan	B-Disease
canecr	I-Disease
populaiton	O
.	O

To	O
achieve	O
this	O
,	O
we	O
determined	O
the	O
pervalence	O
of	O
BRAC1	O
alteraitons	O
in	O
a	O
pouplation	O
-	O
based	O
series	O
of	O
consceutive	O
ovairan	B-Disease
cnacer	I-Disease
caess	O
.	O

This	O
is	O
the	O
first	O
popluation	O
-	O
based	O
ovairan	B-Disease
cnacer	I-Disease
sutdy	O
reporting	O
BRAC1	O
altertaions	O
derived	O
from	O
a	O
copmrehensive	O
screen	O
of	O
the	O
entire	O
coidng	O
reigon	O
.	O

One	O
hundred	O
and	O
seven	O
ovairan	B-Disease
canecr	I-Disease
caess	O
were	O
anaylzed	O
for	O
BCRA1	O
alteratoins	O
using	O
the	O
RNsae	O
misamtch	O
claevage	O
assay	O
followed	O
by	O
direct	O
sequencnig	O
.	O

Two	O
turncating	O
mutatinos	O
,	O
962del4	O
and	O
3600del11	O
,	O
were	O
identiifed	O
.	O

Both	O
pateints	O
had	O
a	O
faimly	O
hsitory	O
of	O
berast	B-Disease
or	I-Disease
ovarain	I-Disease
cnacer	I-Disease
.	O

Several	O
novel	O
as	O
well	O
as	O
previously	O
reported	O
uncharacterized	O
vraiants	O
were	O
also	O
identfiied	O
,	O
some	O
of	O
which	O
were	O
associated	O
with	O
a	O
fmaily	O
hitsory	O
of	O
cacner	B-Disease
.	O

The	O
freuqency	O
distrbiution	O
of	O
common	O
polymorphsims	O
was	O
determined	O
in	O
the	O
91	O
Caucasain	O
cacner	B-Disease
csaes	O
in	O
this	O
series	O
and	O
24	O
ssiter	O
cnotrols	O
using	O
allele	O
-	O
specific	O
amplfiication	O
.	O

The	O
rrae	O
form	O
of	O
the	O
Q536R	O
polymorpihsm	O
was	O
significantly	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
associated	O
with	O
a	O
famliy	O
hitsory	O
of	O
ovairan	B-Disease
canecr	I-Disease
,	O
suggesting	O
that	O
this	O
polmyorphism	O
may	O
ifnluence	O
ovraian	B-Disease
cnacer	I-Disease
rsik	O
.	O

In	O
summary	O
,	O
our	O
dtaa	O
suggest	O
a	O
role	O
for	O
some	O
uncharacterized	O
varinats	O
and	O
rrae	O
forms	O
of	O
polymorphsims	O
in	O
determining	O
oavrian	B-Disease
cnacer	I-Disease
rsik	O
,	O
and	O
highlight	O
the	O
necessity	O
to	O
screen	O
for	O
missense	O
altertaions	O
as	O
well	O
as	O
trnucating	O
mutaitons	O
in	O
this	O
pouplation	O
.	O

Adrenoleukodysrtophy	O
-	O
related	O
proetin	O
can	O
compenaste	O
functionally	O
for	O
adrenoleukodystrpohy	B-Disease
prtoein	I-Disease
deifciency	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
:	O
implications	O
for	O
threapy	O
.	O

Inhreited	B-Disease
defcets	I-Disease
in	O
the	O
peroxismoal	O
ATP	O
-	O
bidning	O
csasette	O
(	O
ABC	O
)	O
trasnporter	O
adrenoleukodsytrophy	B-Disease
prtoein	O
(	O
ADLP	O
)	O
lead	O
to	O
the	O
lehtal	O
perxoisomal	B-Disease
diosrder	I-Disease
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystorphy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
,	O
for	O
which	O
no	O
efifcient	O
traetment	O
has	O
been	O
established	O
so	O
far	O
.	O

Three	O
other	O
peroxisoaml	O
ABC	O
tarnsporters	O
currently	O
are	O
known	O
adrneoleukodystrophy	O
-	O
related	O
protien	O
(	O
ADLRP	O
)	O
,	O
70	O
kDa	O
perxoisomal	O
membarne	O
prtoein	O
(	O
PM7P0	O
)	O
and	O
PPM70	O
-	O
related	O
prtoein	O
.	O

By	O
using	O
tarnsient	O
and	O
satble	O
overexprsesion	O
of	O
huamn	O
cDANs	O
encdoing	O
ADLP	O
and	O
its	O
closest	O
relative	O
ALRDP	O
,	O
we	O
could	O
restore	O
the	O
ipmaired	O
perxoisomal	O
btea	O
-	O
oxidatoin	O
in	O
fiborblasts	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
paitents	O
.	O

The	O
pahtognomonic	O
accumulation	O
of	O
very	O
long	O
chian	O
fatty	O
acdis	O
could	O
also	O
be	O
prevented	O
by	O
oevrexpression	O
of	O
ALRDP	O
in	O
immortaliezd	O
X	O
-	O
ALD	O
cells	O
.	O

Immnuofluorescence	O
anaylsis	O
demonstrated	O
that	O
the	O
funcitonal	O
replaecment	O
of	O
ADLP	O
by	O
ALRDP	O
was	O
not	O
due	O
to	O
stabilizatoin	O
of	O
the	O
mtuated	O
ADLP	O
itself	O
.	O

Moreover	O
,	O
we	O
were	O
able	O
to	O
restore	O
the	O
peroxismoal	O
btea	O
-	O
oxidaiton	O
dfeect	O
in	O
the	O
lvier	O
of	O
ADLP	O
-	O
deficinet	O
mcie	O
by	O
stimultaion	O
of	O
ALRDP	O
and	O
PM7P0	O
gnee	O
expression	O
through	O
a	O
deitary	O
tretament	O
with	O
the	O
peroxismoe	O
proliefrator	O
fenofirbate	O
.	O

These	O
resluts	O
suggest	O
that	O
a	O
crorection	O
of	O
the	O
biocheimcal	O
deefct	O
in	O
X	B-Disease
-	I-Disease
ALD	I-Disease
could	O
be	O
possible	O
by	O
durg	O
-	O
indcued	O
overepxression	O
or	O
ectoipc	O
exprsesion	O
of	O
ALRDP	O
.	O
.	O

Centrosmoe	O
amplificaiton	O
and	O
a	O
dfeective	O
G2	O
-	O
M	O
clel	O
cylce	O
cehckpoint	O
inudce	O
gneetic	O
intsability	O
in	O
BRAC1	O
eoxn	O
11	O
iosform	O
-	O
defciient	O
clels	O
.	O

Germilne	O
muattions	O
of	O
the	O
Bcra1	O
tmuor	B-Disease
suppresosr	O
gnee	O
predispose	O
wmoen	O
to	O
bresat	B-Disease
and	I-Disease
ovraian	I-Disease
cancres	I-Disease
.	O

To	O
sutdy	O
mechanimss	O
underlying	O
BCRA1	O
-	O
related	O
tumorigneesis	O
,	O
we	O
derived	O
mosue	O
embrynoic	O
firboblast	O
clels	O
carrying	O
a	O
targeetd	O
deletoin	O
of	O
eoxn	O
11	O
of	O
the	O
Brac1	O
gnee	O
.	O

We	O
show	O
that	O
the	O
mutnat	O
cells	O
maintain	O
an	O
inatct	O
G1	O
-	O
S	O
clel	O
ccyle	O
checkopint	O
and	O
prolifertae	O
poorly	O
.	O

However	O
,	O
a	O
deefctive	O
G2	O
-	O
M	O
cehckpoint	O
in	O
these	O
cells	O
is	O
accompanied	O
by	O
extesnive	O
chroomsomal	B-Disease
abnormailties	I-Disease
.	O

Muatnt	O
fibroblsats	O
contain	O
mutliple	O
,	O
funtcional	O
centrsoomes	O
,	O
which	O
lead	O
to	O
unequal	O
crhomosome	O
segregtaion	O
,	O
abnomral	O
nuclaer	O
divisoin	O
,	O
and	O
aneulpoidy	B-Disease
.	O

These	O
dtaa	O
uncover	O
an	O
essnetial	O
role	O
of	O
BCRA1	O
in	O
maintaining	O
gneetic	O
stabliity	O
through	O
the	O
regualtion	O
of	O
cetnrosome	O
dulpication	O
and	O
the	O
G2	O
-	O
M	O
chekcpoint	O
and	O
provide	O
a	O
mloecular	O
basis	O
for	O
the	O
role	O
of	O
BCRA1	O
in	O
tumroigenesis	O
.	O
.	O

Defcetive	O
C9D5	O
/	O
APO	O
-	O
1	O
/	O
Fas	O
sginal	O
comlpex	O
formtaion	O
in	O
the	O
huamn	O
automimune	B-Disease
lymphoprolifertaive	I-Disease
snydrome	I-Disease
,	I-Disease
tpye	I-Disease
Ia	I-Disease
.	O

Heteorzygous	O
mutatoins	O
in	O
the	O
C9D5	O
(	O
APO	O
-	O
1	O
/	O
Fas	O
)	O
reecptor	O
occur	O
in	O
most	O
indivdiuals	O
with	O
autoimmune	B-Disease
lymphoproilferative	I-Disease
syndorme	I-Disease
(	O
APLS	B-Disease
)	O
and	O
dominantly	O
interfere	O
with	O
aopptosis	O
by	O
an	O
unknown	O
mecahnism	O
.	O

We	O
show	O
that	O
lcoal	O
or	O
glboal	O
alteartions	O
in	O
the	O
srtucture	O
of	O
the	O
cytoplsamic	O
detah	O
domian	O
from	O
nine	O
indepenednt	O
APLS	B-Disease
C9D5	O
detah	O
-	O
domian	O
muttaions	O
result	O
in	O
a	O
failrue	O
to	O
bnid	O
the	O
FDAD	O
/	O
MOTR1	O
siganling	O
proetin	O
.	O

Despite	O
hteerozygosity	O
for	O
the	O
anbormal	O
alllee	O
,	O
lymphocyets	O
from	O
APLS	B-Disease
ptaients	O
showed	O
markedly	O
decresaed	O
FDAD	O
asosciation	O
and	O
a	O
lsos	O
of	O
csapase	O
rceruitment	O
and	O
atcivation	O
after	O
C9D5	O
corsslinking	O
.	O

These	O
dtaa	O
suggest	O
that	O
intracytoplsamic	O
C9D5	O
muattions	O
in	O
APLS	B-Disease
ipmair	O
apopotsis	O
chiefly	O
by	O
disrutping	O
detah	O
-	O
dmoain	O
interacitons	O
with	O
the	O
singaling	O
portein	O
FDAD	O
/	O
MOTR1	O
.	O
.	O

Aanlysis	O
of	O
alkaptonuira	B-Disease
(	O
AKU	B-Disease
)	O
mtuations	O
and	O
polymorphsims	O
reveals	O
that	O
the	O
CCC	O
seuqence	O
moitf	O
is	O
a	O
muattional	O
hot	O
sopt	O
in	O
the	O
hmoogentisate	O
1	O
,	O
2	O
doixygenase	O
gnee	O
(	O
HGO	O
)	O
.	O

We	O
recently	O
showed	O
that	O
alkapotnuria	B-Disease
(	O
AKU	B-Disease
)	O
is	O
caused	O
by	O
lsos	O
-	O
of	O
-	O
functoin	O
mtuations	O
in	O
the	O
hoomgentisate	O
1	O
,	O
2	O
dioxgyenase	O
gnee	O
(	O
HGO	O
)	O
.	O

Herein	O
we	O
describe	O
haplotpye	O
and	O
mutatioanl	O
analyess	O
of	O
HGO	O
in	O
seven	O
new	O
AKU	B-Disease
pedirgees	O
.	O

These	O
analsyes	O
idenitfied	O
two	O
novel	O
single	O
-	O
nucloetide	O
polymorphsims	O
(	O
IVN4	O
+	O
31A	O
-	O
-	O
>	O
G	O
and	O
IVN11	O
+	O
18A	O
-	O
-	O
>	O
G	O
)	O
and	O
six	O
novel	O
AKU	B-Disease
mutaitons	O
(	O
IVN1	O
-	O
G	O
-	O
-	O
>	O
A	O
,	O
W06G	O
,	O
Y26C	O
,	O
A212D	O
,	O
P203T	O
,	O
and	O
D219E	O
)	O
,	O
which	O
further	O
illustrates	O
the	O
remarkable	O
alleilc	O
heterogeenity	O
found	O
in	O
AKU	B-Disease
.	O

Reexaminaiton	O
of	O
all	O
29	O
mtuations	O
and	O
polymoprhisms	O
thus	O
far	O
described	O
in	O
HGO	O
shows	O
that	O
these	O
nucleotdie	O
cahnges	O
are	O
not	O
randomly	O
distributed	O
;	O
the	O
CCC	O
seqeunce	O
moitf	O
and	O
its	O
inverted	O
complement	O
,	O
GGG	O
,	O
are	O
preferentially	O
mtuated	O
.	O

These	O
aanlyses	O
also	O
demonstrated	O
that	O
the	O
nulceotide	O
sbustitutions	O
in	O
HGO	O
do	O
not	O
involve	O
CpG	O
dinucleoitdes	O
,	O
which	O
illustrates	O
important	O
diffeernces	O
between	O
HGO	O
and	O
other	O
geens	O
for	O
the	O
occurrence	O
of	O
mtuation	O
at	O
specific	O
short	O
-	O
sequnece	O
mtoifs	O
.	O

Because	O
the	O
CCC	O
sequecne	O
mtoifs	O
comprise	O
a	O
significant	O
porportion	O
(	O
34	O
.	O
5	O
%	O
)	O
of	O
all	O
mtuated	O
bsaes	O
that	O
have	O
been	O
observed	O
in	O
HGO	O
,	O
we	O
conclude	O
that	O
the	O
CCC	O
trpilet	O
is	O
a	O
mutaitonal	O
hot	O
sopt	O
in	O
HGO	O
.	O

Fbary	B-Disease
diesase	I-Disease
:	O
identifiaction	O
of	O
novel	O
alhpa	O
-	O
galactoisdase	O
A	O
muttaions	O
and	O
molceular	O
carreir	O
dteection	O
by	O
use	O
of	O
fluoerscent	O
chmeical	O
claevage	O
of	O
mismtaches	O
.	O

Fbary	B-Disease
disesae	I-Disease
(	O
FD	B-Disease
)	O
(	O
angiokreatoma	B-Disease
corpoirs	I-Disease
diffuusm	I-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
inobrn	I-Disease
erorr	I-Disease
of	I-Disease
glyocsphingolipid	I-Disease
meatbolism	I-Disease
caused	O
by	O
deefcts	O
in	O
the	O
lyssoomal	O
aplha	O
-	O
galactoisdase	O
A	O
gnee	O
(	O
GLA	O
)	O
.	O

The	O
enzymtaic	O
dfeect	O
leads	O
to	O
the	O
sytsemic	O
accumulaiton	O
of	O
nuetral	O
glycsophingolipids	O
with	O
temrinal	O
aplha	O
-	O
glaactosyl	O
moiteies	O
.	O

Cliincally	O
,	O
afefcted	O
hemizgyous	O
mlaes	O
have	O
angikoeratoma	B-Disease
,	O
sveere	B-Disease
acropraesthesia	I-Disease
,	O
rneal	B-Disease
fialure	I-Disease
,	O
and	O
vasculoptahy	B-Disease
of	I-Disease
the	I-Disease
haert	I-Disease
and	I-Disease
barin	I-Disease
.	O

While	O
demonstration	O
of	O
alhpa	B-Disease
-	I-Disease
gaalctosidase	I-Disease
deifciency	I-Disease
in	O
leukoyctes	O
is	O
diagnsotic	O
in	O
afefcted	O
mlaes	O
,	O
enyzmatic	O
deteciton	O
of	O
femlae	O
crariers	O
is	O
often	O
inconcluisve	O
,	O
due	O
to	O
radnom	O
X	O
-	O
chromsoomal	O
inactiavtion	O
,	O
underlining	O
the	O
need	O
of	O
moleuclar	O
investigatinos	O
for	O
acucrate	O
geentic	O
counesling	O
.	O

By	O
use	O
of	O
cehmical	O
clevaage	O
of	O
mismathces	O
adapted	O
to	O
fluroescence	O
-	O
based	O
dteection	O
sysetms	O
,	O
we	O
have	O
chraacterized	O
the	O
mutaitons	O
underlying	O
aplha	B-Disease
-	I-Disease
Gal	I-Disease
A	I-Disease
defiicency	I-Disease
in	O
16	O
individauls	O
from	O
six	O
unrelated	O
fmailies	O
with	O
FD	B-Disease
.	O

The	O
muttaional	O
spcetrum	O
included	O
five	O
missnese	O
mutatinos	O
(	O
C220W	O
,	O
C223G	O
,	O
N242D	O
,	O
R031Q	O
,	O
and	O
Q372K	O
)	O
and	O
one	O
slpice	O
-	O
stie	O
mutatoin	O
[	O
ISV3	O
G	O
(	O
-	O
1	O
)	O
-	O
-	O
>	O
C	O
]	O
.	O

Studeis	O
at	O
the	O
mNRA	O
leevl	O
showed	O
that	O
the	O
latter	O
led	O
to	O
alteerd	O
pre	O
-	O
mNRA	O
splciing	O
with	O
consequent	O
altreation	O
of	O
the	O
mNRA	O
translatoinal	O
readnig	O
farme	O
and	O
genertaion	O
of	O
a	O
preamture	O
temrination	O
coodn	O
of	O
transltaion	O
.	O

By	O
use	O
of	O
this	O
strategy	O
,	O
crarier	O
sttaus	O
was	O
accurately	O
assessed	O
in	O
all	O
seven	O
at	O
-	O
rsik	O
femaels	O
tetsed	O
,	O
whereas	O
enzmyatic	O
dosgaes	O
failed	O
to	O
daignose	O
or	O
exclude	O
heterozyogsity	O
.	O
.	O

Prenaatl	O
diganosis	O
by	O
FSIH	O
in	O
a	O
famliy	O
with	O
Peliazeus	B-Disease
-	I-Disease
Merbzacher	I-Disease
dsiease	I-Disease
caused	O
by	O
duplciation	O
of	O
PLP	O
gnee	O
.	O

A	O
diangosis	O
of	O
Peilzaeus	B-Disease
-	I-Disease
Merzabcher	I-Disease
disesae	I-Disease
(	O
MIM	O
312080	O
)	O
was	O
made	O
in	O
a	O
yonug	O
boy	O
.	O

No	O
muattion	O
in	O
the	O
cdoing	O
reigon	O
of	O
the	O
proteolpiid	O
prtoein	O
(	O
PLP	O
)	O
gnee	O
had	O
been	O
found	O
.	O

The	O
byos	O
materanl	O
anut	O
came	O
for	O
prentaal	O
diganosis	O
when	O
16	O
+	O
weeks	O
prgenant	O
and	O
carrying	O
a	O
mlae	O
fteus	O
.	O

Samlpes	O
were	O
tseted	O
for	O
duplicatoin	O
of	O
the	O
PLP	O
gnee	O
,	O
by	O
interpahse	O
FSIH	O
,	O
in	O
lymphcoyte	O
prepraations	O
from	O
the	O
prboand	O
,	O
his	O
anut	O
and	O
an	O
amnioitc	O
fliud	O
clel	O
preparaiton	O
from	O
the	O
feuts	O
.	O

The	O
prboand	O
was	O
found	O
to	O
carry	O
the	O
dupliaction	O
,	O
thus	O
confirming	O
the	O
diagonsis	O
of	O
Pleizaeus	B-Disease
Mezrbacher	I-Disease
diesase	I-Disease
,	O
but	O
neither	O
the	O
anut	O
nor	O
the	O
feuts	O
carried	O
a	O
duplicaiton	O
.	O
.	O

Dominnat	O
ngeative	O
effcet	O
of	O
the	O
ACP1309	O
muattion	O
:	O
a	O
possible	O
explanation	O
for	O
genotpye	O
-	O
phentoype	O
corerlations	O
in	O
famliial	B-Disease
adenomtaous	I-Disease
polpyosis	I-Disease
.	O

Inactiavtion	O
of	O
the	O
adenomatuos	B-Disease
polypoiss	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
prdouct	O
initaites	O
coloerctal	O
tumorigeneiss	O
.	O

Pateints	O
with	O
fmailial	B-Disease
APC	I-Disease
(	O
FAP	B-Disease
)	O
carry	O
grem	O
-	O
line	O
mutatoins	O
in	O
the	O
APC	B-Disease
gnee	O
and	O
develop	O
multpile	O
cloorectal	B-Disease
aednomas	I-Disease
and	O
subsequent	O
carcniomas	B-Disease
ealry	O
in	O
lfie	O
.	O

The	O
sveerity	O
of	O
the	O
dsiease	O
corrleates	O
with	O
the	O
poistion	O
of	O
the	O
inheirted	O
APC	B-Disease
muttaion	O
(	O
gentoype	O
-	O
phenoytpe	O
corerlation	O
)	O
.	O

Together	O
with	O
the	O
fact	O
that	O
both	O
grem	O
-	O
line	O
and	O
sopradic	O
APC	B-Disease
muttaions	O
culster	O
in	O
the	O
centarl	O
reigon	O
of	O
the	O
APC	B-Disease
gnee	O
,	O
this	O
points	O
to	O
a	O
doimnant	O
negaitve	O
efefct	O
of	O
certain	O
APC	B-Disease
mutnats	O
.	O

Lsos	O
of	O
APC	B-Disease
funciton	O
was	O
recently	O
shown	O
to	O
result	O
in	O
ehnanced	O
btea	O
-	O
caetnin	O
-	O
/	O
Tcf	O
-	O
mediated	O
trnascription	O
in	O
cloon	O
eptihelial	O
cells	O
.	O

Here	O
,	O
we	O
provide	O
expermiental	O
evdience	O
for	O
a	O
dominnat	O
negtaive	O
effcet	O
of	O
APC	B-Disease
gnee	O
porducts	O
associated	O
with	O
seevre	O
poylposis	B-Disease
.	O

Wlid	O
-	O
tpye	O
APC	B-Disease
actiivty	O
in	O
btea	O
-	O
cateinn	O
-	O
/	O
Tcf	O
-	O
mediated	O
transcirption	O
was	O
strongly	O
inihbited	O
by	O
a	O
mutnat	O
APC	B-Disease
that	O
is	O
turncated	O
at	O
cdoon	O
1309	O
.	O

In	O
contrast	O
,	O
mutnat	O
APC	B-Disease
gnee	O
porducts	O
that	O
are	O
associated	O
with	O
atteunated	B-Disease
poylposis	I-Disease
(	O
coodn	O
386	O
or	O
1465	O
)	O
intrefered	O
only	O
weakly	O
with	O
wlid	O
-	O
tpye	O
APC	B-Disease
activtiy	O
.	O

These	O
resutls	O
suggest	O
a	O
moleuclar	O
explanation	O
for	O
the	O
gneotype	O
-	O
phentoype	O
corrleation	O
in	O
FAP	B-Disease
patinets	O
and	O
support	O
the	O
idea	O
that	O
cloorectal	B-Disease
tmuor	I-Disease
grwoth	O
might	O
be	O
,	O
in	O
part	O
,	O
driven	O
by	O
selcetion	O
for	O
a	O
muttaion	O
in	O
the	O
mutatoin	O
clsuter	O
reigon	O
.	O
.	O

BCRA1	O
interacts	O
with	O
comopnents	O
of	O
the	O
hsitone	O
daecetylase	O
comlpex	O
.	O

Grem	O
-	O
line	O
mtuations	O
in	O
the	O
BCRA1	O
tmuor	O
-	O
suppresosr	O
gnee	O
are	O
associated	O
with	O
an	O
icnreased	O
susecptibility	O
to	O
braest	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
.	O

BCRA1	O
contains	O
a	O
carbxoyl	O
-	O
termianl	O
domian	O
(	O
BCRT	O
)	O
that	O
is	O
shared	O
with	O
several	O
other	O
porteins	O
involved	O
in	O
maintaining	O
gneome	O
integrtiy	O
.	O

In	O
an	O
efofrt	O
to	O
understand	O
the	O
fucntion	O
of	O
BCRA1	O
,	O
we	O
sought	O
to	O
isoalte	O
porteins	O
that	O
intreact	O
with	O
the	O
BCRT	O
domian	O
.	O

Purifeid	O
BCRT	O
polyepptide	O
was	O
used	O
as	O
a	O
porbe	O
to	O
srceen	O
a	O
huamn	O
placneta	O
cNDA	O
experssion	O
lbirary	O
by	O
Far	O
Wesetrn	O
analsyis	O
.	O

Here	O
we	O
reprot	O
that	O
BRAC1	O
interacts	O
in	O
vivo	O
and	O
in	O
vitro	O
with	O
the	O
Rb	O
-	O
bniding	O
proetins	O
,	O
RAbp46	O
and	O
RAbp48	O
,	O
as	O
well	O
as	O
with	O
Rb	O
.	O

Moreover	O
,	O
the	O
BCRT	O
doamin	O
asscoiates	O
with	O
the	O
hitsone	O
deacetyalses	O
HDCA1	O
and	O
HADC2	O
.	O

These	O
reuslts	O
demonstrate	O
that	O
BCRA1	O
interacts	O
with	O
compnoents	O
of	O
the	O
hisotne	O
deacteylase	O
copmlex	O
,	O
and	O
therefore	O
may	O
explain	O
the	O
involvemnet	O
of	O
BCRA1	O
in	O
mulitple	O
processes	O
such	O
as	O
trancsription	O
,	O
DNA	O
reapir	O
,	O
and	O
recombniation	O
.	O
.	O

Combiend	B-Disease
genteic	I-Disease
deficinecy	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
in	O
man	O
.	O

By	O
rotuine	O
screeinng	O
of	O
srea	O
,	O
a	O
sujbect	O
was	O
discovered	O
who	O
showed	O
a	O
sub	B-Disease
-	I-Disease
total	I-Disease
defiicency	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
.	O

No	O
cliniacl	O
disaese	O
was	O
associated	O
with	O
this	O
defiicency	O
which	O
was	O
trasnmitted	O
through	O
the	O
subjcets	O
faimly	O
as	O
a	O
single	O
gneetic	O
charactreistic	O
,	O
the	O
C6	B-Disease
dfeiciency	I-Disease
being	O
associated	O
with	O
a	O
silnet	O
allele	O
at	O
the	O
strucutral	O
loucs	O
.	O

The	O
propoistus	O
was	O
found	O
to	O
have	O
low	O
quanttiies	O
of	O
an	O
abnomral	O
C6	O
which	O
was	O
both	O
antigeniaclly	O
defiicent	O
and	O
smaller	O
in	O
szie	O
than	O
noraml	O
C6	O
(	O
110	O
,	O
000	O
daltons	O
cmopared	O
with	O
140	O
,	O
000	O
daltons	O
)	O
and	O
small	O
qauntities	O
of	O
apparently	O
noraml	O
C7	O
.	O

It	O
is	O
concluded	O
that	O
the	O
most	O
likely	O
explanation	O
for	O
this	O
dfeect	O
is	O
that	O
the	O
sbuject	O
has	O
a	O
structuarl	O
muttaion	O
in	O
his	O
C6	O
gnee	O
which	O
produces	O
hoypsynthesis	O
not	O
only	O
of	O
C6	O
but	O
also	O
of	O
the	O
closely	O
linked	O
gnee	O
for	O
C7	O
.	O

These	O
fidnings	O
suggest	O
the	O
possibility	O
that	O
C6	O
and	O
C7	O
may	O
funtcion	O
as	O
a	O
single	O
geneitc	O
unit	O
and	O
that	O
the	O
primray	O
transcrpit	O
copied	O
from	O
the	O
gneome	O
includes	O
informtaion	O
for	O
both	O
protiens	O
.	O
.	O

Chagnes	O
at	O
P813	O
of	O
emrein	O
weaken	O
its	O
portein	O
-	O
protien	O
interatcions	O
resulting	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Eemry	I-Disease
-	I-Disease
Dreifsus	I-Disease
msucular	I-Disease
dysrtophy	I-Disease
.	O

Eemry	B-Disease
-	I-Disease
Derifuss	I-Disease
msucular	I-Disease
dystrpohy	I-Disease
(	O
EMDD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recsesive	I-Disease
mucsular	I-Disease
dysrtophy	I-Disease
characetrized	O
by	O
ealry	O
cnotractures	B-Disease
of	I-Disease
the	I-Disease
eblows	I-Disease
,	I-Disease
Ahcilles	I-Disease
tnedons	I-Disease
and	I-Disease
sipne	I-Disease
,	O
slowly	O
porgressive	O
mucsle	B-Disease
wastnig	I-Disease
and	O
weankess	B-Disease
,	O
and	O
cardiomyoptahy	B-Disease
associated	O
with	O
cardaic	B-Disease
conduciton	I-Disease
defetcs	I-Disease
.	O

The	O
emeirn	O
gnee	O
has	O
been	O
mpaped	O
to	O
X2q8	O
and	O
enocdes	O
a	O
34	O
-	O
kDa	O
sernie	O
-	O
rich	O
prtoein	O
,	O
eemrin	O
,	O
which	O
has	O
been	O
loaclized	O
to	O
the	O
nulcear	O
envleope	O
in	O
a	O
wide	O
variety	O
of	O
tissues	O
,	O
including	O
skelteal	O
and	O
cadriac	O
msucle	O
.	O

Muttaions	O
spanning	O
the	O
eemrin	O
gnee	O
have	O
been	O
identfiied	O
in	O
patinets	O
with	O
EMDD	B-Disease
.	O

We	O
present	O
here	O
the	O
effect	O
,	O
on	O
eemrin	O
portein	O
expression	O
,	O
of	O
two	O
missnese	O
mutatinos	O
iedntified	O
in	O
unrelated	O
EMDD	B-Disease
patinets	O
.	O

These	O
altreations	O
predict	O
the	O
rpelacement	O
of	O
a	O
prolnie	O
reisdue	O
at	O
postiion	O
183	O
with	O
either	O
a	O
hitsidine	O
or	O
a	O
trheonine	O
.	O

Biochemiacl	O
analyiss	O
has	O
demonstrated	O
that	O
the	O
moiblity	O
and	O
experssion	O
lveels	O
of	O
the	O
mutnat	O
forms	O
of	O
emrein	O
are	O
indistinguihsable	O
from	O
that	O
of	O
wlid	O
-	O
tpye	O
emrein	O
,	O
but	O
that	O
they	O
have	O
weakened	O
intercations	O
with	O
nulcear	O
lamnia	O
componnets	O
.	O

In	O
cmoparison	O
with	O
the	O
usual	O
EMDD	B-Disease
phenotpye	O
,	O
ptaients	O
with	O
P813	O
missesne	O
muttaions	O
have	O
a	O
later	O
age	O
at	O
onset	O
of	O
first	O
smyptoms	O
,	O
elobw	B-Disease
cnotractures	I-Disease
,	O
anlke	B-Disease
contractrues	I-Disease
,	O
upper	B-Disease
lmib	I-Disease
weakenss	I-Disease
and	O
lwoer	B-Disease
lmib	I-Disease
weankess	I-Disease
,	O
but	O
there	O
is	O
no	O
difference	O
for	O
the	O
age	O
at	O
onset	O
of	O
cradiac	B-Disease
ivnolvement	I-Disease
.	O

This	O
is	O
the	O
first	O
reoprt	O
of	O
protien	O
sutdies	O
on	O
pateints	O
with	O
msisense	O
muattions	O
resulting	O
in	O
the	O
clincial	O
featrues	O
of	O
EMDD	B-Disease
.	O

These	O
sutdies	O
demonstrate	O
the	O
importance	O
of	O
proilne	O
183	O
for	O
the	O
proper	O
strutcure	O
/	O
fnuction	O
of	O
emrein	O
.	O
.	O

Mcirodeletions	O
at	O
chromosmoe	O
badns	O
1q32	O
-	O
q41	O
as	O
a	O
cause	O
of	O
Van	B-Disease
der	I-Disease
Wuode	I-Disease
syndorme	I-Disease
.	O

Van	B-Disease
der	I-Disease
Wodue	I-Disease
synrdome	I-Disease
(	O
VWS	B-Disease
)	O
is	O
an	O
autoosmal	B-Disease
domniant	I-Disease
dsiorder	I-Disease
comprising	O
celft	B-Disease
lip	I-Disease
and	O
/	O
or	O
clfet	B-Disease
paltae	I-Disease
and	O
lip	B-Disease
ptis	I-Disease
.	O

We	O
reported	O
previously	O
a	O
famliy	O
whose	O
underlying	O
mutaiton	O
is	O
a	O
500	O
-	O
800	O
kb	O
deleiton	O
localiezd	O
to	O
chrmoosome	O
badns	O
1q32	O
-	O
q41	O
[	O
Sanedr	O
et	O
al	O
.	O
,	O
1994	O
Hum	O
Mol	O
Genet	O
3	O
576	O
-	O
578	O
]	O
.	O

Along	O
with	O
celft	B-Disease
lip	I-Disease
/	I-Disease
plaate	I-Disease
and	O
lip	B-Disease
ptis	I-Disease
,	O
affected	O
rleatives	O
exhibit	O
dveelopmental	B-Disease
delyas	I-Disease
,	O
suggesting	O
that	O
the	O
funtcion	O
of	O
a	O
gnee	O
nearby	O
may	O
also	O
be	O
disrupetd	O
.	O

To	O
further	O
loaclize	O
the	O
VWS	B-Disease
gnee	O
we	O
searched	O
for	O
other	O
deletoins	O
that	O
cause	O
VWS	B-Disease
.	O

An	O
alllee	O
lsos	O
asasy	O
was	O
performed	O
using	O
a	O
novel	O
highly	O
polymorhpic	O
marekr	O
,	O
D13S753	O
.	O

From	O
a	O
panel	O
of	O
37	O
unrelated	O
indiivduals	O
,	O
we	O
detetced	O
an	O
alelle	O
lsos	O
in	O
one	O
fmaily	O
,	O
indicating	O
the	O
preesnce	O
of	O
a	O
deeltion	O
.	O

In	O
this	O
fmaily	O
,	O
the	O
phentoype	O
in	O
three	O
generatinos	O
of	O
afefcted	O
individulas	O
was	O
confined	O
to	O
the	O
cardnial	O
sgins	O
of	O
VWS	B-Disease
.	O

Surprisingly	O
,	O
mappnig	O
of	O
the	O
new	O
delteion	O
showed	O
that	O
it	O
extedned	O
0	O
.	O

2	O
-	O
1	O
Mb	O
beyond	O
the	O
porximal	O
braekpoint	O
for	O
the	O
delteion	O
described	O
previously	O
.	O

No	O
deleitons	O
were	O
detecetd	O
in	O
seven	O
csaes	O
of	O
poplitael	B-Disease
petrygia	I-Disease
syndorme	I-Disease
,	O
76	O
csaes	O
of	O
mixed	O
synrdomic	B-Disease
forms	I-Disease
of	I-Disease
celft	I-Disease
lip	I-Disease
and	I-Disease
paltae	I-Disease
,	O
and	O
178	O
csaes	O
of	O
nonsnydromic	B-Disease
clfet	I-Disease
lip	I-Disease
and	I-Disease
paalte	I-Disease
.	O

Splicnig	O
dfeects	O
in	O
the	O
atxaia	B-Disease
-	I-Disease
telangeictasia	I-Disease
gnee	O
,	O
ATM	O
:	O
underlying	O
mtuations	O
and	O
consequneces	O
.	O

Mutatinos	O
resulting	O
in	O
deefctive	O
spilcing	O
constitute	O
a	O
significant	O
prooprtion	O
(	O
30	O
/	O
62	O
[	O
48	O
%	O
]	O
)	O
of	O
a	O
new	O
series	O
of	O
mtuations	O
in	O
the	O
ATM	O
gnee	O
in	O
patietns	O
with	O
atxaia	B-Disease
-	I-Disease
tealngiectasia	I-Disease
(	O
AT	B-Disease
)	O
that	O
were	O
deetcted	O
by	O
the	O
protien	O
-	O
truncaiton	O
asasy	O
followed	O
by	O
sequnece	O
aanlysis	O
of	O
gneomic	O
DNA	O
.	O

Fewer	O
than	O
half	O
of	O
the	O
spliicng	O
mutatoins	O
involved	O
the	O
canoncial	O
AG	O
spilce	O
-	O
accepotr	O
stie	O
or	O
GT	O
spilce	O
-	O
doonr	O
stie	O
.	O

A	O
hgiher	O
perecntage	O
of	O
mutatoins	O
occurred	O
at	O
less	O
stringently	O
conserved	O
sties	O
,	O
including	O
slient	O
muttaions	O
of	O
the	O
last	O
nucleoitde	O
of	O
eoxns	O
,	O
muattions	O
in	O
nucloetides	O
other	O
than	O
the	O
conserved	O
AG	O
and	O
GT	O
in	O
the	O
conesnsus	O
splcie	O
siets	O
,	O
and	O
ceration	O
of	O
splcie	O
-	O
accpetor	O
or	O
splcie	O
-	O
doonr	O
siets	O
in	O
either	O
itnrons	O
or	O
exnos	O
.	O

These	O
slpicing	O
muattions	O
led	O
to	O
a	O
variety	O
of	O
consequneces	O
,	O
including	O
eoxn	O
skipping	O
and	O
,	O
to	O
a	O
lseser	O
dergee	O
,	O
itnron	O
rteention	O
,	O
acitvation	O
of	O
crpytic	O
slpice	O
siets	O
,	O
or	O
ceration	O
of	O
new	O
spilce	O
sties	O
.	O

In	O
addition	O
,	O
5	O
of	O
12	O
nosnense	O
mutaitons	O
and	O
1	O
misesnse	O
muttaion	O
were	O
associated	O
with	O
deeltion	O
in	O
the	O
cNDA	O
of	O
the	O
exnos	O
in	O
which	O
the	O
muttaions	O
occurred	O
.	O

No	O
ATM	O
prtoein	O
was	O
detetced	O
by	O
wetsern	O
blotitng	O
in	O
any	O
AT	B-Disease
clel	O
line	O
in	O
which	O
splicnig	O
mutaitons	O
were	O
idetnified	O
.	O

Several	O
csaes	O
of	O
eoxn	O
skpiping	O
in	O
both	O
noraml	O
conrtols	O
and	O
paitents	O
for	O
whom	O
no	O
underlying	O
deefct	O
could	O
be	O
found	O
in	O
genmoic	O
DNA	O
were	O
also	O
observed	O
,	O
suggesting	O
caution	O
in	O
the	O
interpertation	O
of	O
eoxn	O
deletoins	O
observed	O
in	O
ATM	O
cNDA	O
when	O
there	O
is	O
no	O
accompanying	O
identifciation	O
of	O
genoimc	O
mutatoins	O
.	O
.	O

Aplha	O
-	O
cardaic	O
atcin	O
is	O
a	O
novel	O
dsiease	O
gnee	O
in	O
fmailial	B-Disease
hypertrohpic	I-Disease
cardiomyoapthy	I-Disease
.	O

We	O
idnetified	O
the	O
alhpa	O
-	O
cardaic	O
acitn	O
gnee	O
(	O
ATCC	O
)	O
as	O
a	O
novel	O
disaese	O
gnee	O
in	O
a	O
pedirgee	O
suffernig	O
from	O
famiilal	B-Disease
hypetrrophic	I-Disease
cardiomoypathy	I-Disease
(	O
FHC	B-Disease
)	O
.	O

Linkgae	O
analyess	O
excluded	O
all	O
the	O
previously	O
reported	O
FHC	B-Disease
lcoi	O
as	O
possible	O
diesase	O
lcoi	O
in	O
the	O
faimly	O
studied	O
,	O
with	O
lod	O
scroes	O
varying	O
between	O
-	O
2	O
.	O

5	O
and	O
-	O
6	O
.	O

0	O
0	O
.	O

Further	O
linkgae	O
aanlyses	O
of	O
plausible	O
candidate	O
gnees	O
highly	O
exprsesed	O
in	O
the	O
audlt	O
hmuan	O
herat	O
idnetified	O
ATCC	O
as	O
the	O
most	O
likely	O
dsiease	O
gnee	O
,	O
showing	O
a	O
mxaimal	O
lod	O
socre	O
of	O
3	O
.	O

6	O
6	O
.	O

Muattion	O
anlaysis	O
of	O
ATCC	O
revelaed	O
an	O
Aal295Ser	O
mutaiton	O
in	O
eoxn	O
5	O
close	O
to	O
2	O
msisense	O
mtuations	O
recently	O
described	O
to	O
cause	O
the	O
ihnerited	O
form	O
of	O
iidopathic	B-Disease
diltaed	I-Disease
cardiomyopahty	I-Disease
(	O
IDC	B-Disease
)	O
.	O

Overgrwoth	B-Disease
of	I-Disease
oarl	I-Disease
muocsa	I-Disease
and	I-Disease
facail	I-Disease
sikn	I-Disease
,	O
a	O
novel	O
feature	O
of	O
aspartylgulcosaminuria	B-Disease
.	O

Aspartyllgucosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
lyossomal	B-Disease
storgae	I-Disease
disodrer	I-Disease
caused	O
by	O
dfeiciency	B-Disease
of	I-Disease
aspartylglucosamindiase	I-Disease
(	O
AGA	O
)	O
.	O

The	O
main	O
symtpom	O
is	O
prgoressive	O
menatl	B-Disease
rteardation	I-Disease
.	O

A	O
spcetrum	O
of	O
different	O
muttaions	O
has	O
been	O
reported	O
in	O
this	O
dsiease	O
,	O
one	O
missesne	O
muttaion	O
(	O
Cy1s63Ser	O
)	O
being	O
responsible	O
for	O
the	O
majority	O
of	O
Finnsih	O
csaes	O
.	O

We	O
were	O
able	O
to	O
examine	O
66	O
Fninish	O
AGU	B-Disease
patinets	O
for	O
chnages	O
in	O
the	O
oarl	O
muocsa	O
and	O
44	O
of	O
these	O
for	O
chagnes	O
in	O
fcaial	O
sikn	O
.	O

Boipsy	O
specimnes	O
of	O
16	O
oarl	O
lesinos	O
,	O
12	O
of	O
them	O
associated	O
with	O
the	O
teteh	O
,	O
plus	O
two	O
faical	B-Disease
leisons	I-Disease
were	O
studied	O
histloogically	O
.	O

Immunohistochmeical	O
stianing	O
for	O
AGA	O
was	O
performed	O
on	O
15	O
oarl	O
speicmens	O
.	O

Sikn	O
was	O
seborrhoiec	O
in	O
adolesecnt	O
and	O
audlt	O
pateints	O
,	O
with	O
eyrthema	B-Disease
of	I-Disease
the	I-Disease
facail	I-Disease
sikn	I-Disease
already	O
common	O
in	O
childhood	O
.	O

Of	O
44	O
pateints	O
,	O
nine	O
(	O
20	O
%	O
)	O
had	O
faical	B-Disease
agniofibromas	I-Disease
,	O
tumuors	B-Disease
primarily	O
occurring	O
in	O
associaiton	O
with	O
tuebrous	B-Disease
sclersois	I-Disease
.	O

Oedmeic	B-Disease
bucacl	I-Disease
mcuosa	I-Disease
(	O
leucodeema	B-Disease
)	O
and	O
ginigval	B-Disease
overgorwths	I-Disease
were	O
more	O
ferquent	O
in	O
AGU	B-Disease
paitents	O
than	O
in	O
contorls	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Of	O
16	O
oarl	B-Disease
mcuosal	I-Disease
lesoins	I-Disease
studied	O
histologically	O
,	O
15	O
represented	O
firboepithelial	B-Disease
or	I-Disease
eipthelial	I-Disease
hyperpalsias	I-Disease
and	O
were	O
reacitve	O
in	O
nature	O
.	O

Cytopalsmic	O
vaculoisation	O
was	O
evident	O
in	O
four	O
.	O

Immunohistohcemically	O
,	O
epxression	O
of	O
AGA	O
in	O
AGU	B-Disease
pateints	O
muocsal	B-Disease
leisons	I-Disease
did	O
not	O
differ	O
from	O
that	O
seen	O
in	O
corresponding	O
lseions	O
of	O
nomral	O
subjetcs	O
.	O

Thus	O
,	O
the	O
high	O
frequecny	O
of	O
mucsoal	B-Disease
ovegrrowth	I-Disease
in	O
AGU	B-Disease
patinets	O
does	O
not	O
appear	O
to	O
be	O
directly	O
associated	O
with	O
lysoosmal	O
stoarge	O
or	O
with	O
alteraitons	O
in	O
the	O
leevl	O
of	O
AGA	O
exprsesion	O
.	O

Characteirzation	O
of	O
a	O
gremline	O
msoaicism	O
in	O
famileis	O
with	O
Lwoe	B-Disease
sydnrome	I-Disease
,	O
and	O
identiifcation	O
of	O
seven	O
novel	O
mutatinos	O
in	O
the	O
ORCL1	O
gnee	O
.	O

The	O
oculoecrebrorenal	B-Disease
syndorme	I-Disease
of	I-Disease
Lwoe	I-Disease
(	O
ORCL	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
disroder	I-Disease
characetrized	O
by	O
major	O
abnormaliteis	B-Disease
of	I-Disease
eeys	I-Disease
,	I-Disease
nervuos	I-Disease
sysetm	I-Disease
,	I-Disease
and	I-Disease
kindeys	I-Disease
.	O

Mutatoins	O
in	O
the	O
ORCL1	O
gnee	O
have	O
been	O
associated	O
with	O
the	O
disesae	O
.	O

OCLR1	O
encdoes	O
a	O
phosphatidlyinositol	O
4	O
,	O
5	O
-	O
biphospahte	O
(	O
PdtIns	O
[	O
4	O
,	O
5	O
]	O
P2	O
)	O
5	O
-	O
phospahtase	O
.	O

We	O
have	O
examined	O
the	O
OCLR1	O
gnee	O
in	O
eight	O
unrelated	O
pateints	O
with	O
ORCL	B-Disease
and	O
have	O
found	O
seven	O
new	O
mutaitons	O
and	O
one	O
reucrrent	O
in	O
-	O
farme	O
deeltion	O
.	O

Among	O
the	O
new	O
mtuations	O
,	O
two	O
nosnense	O
mutatoins	O
(	O
R137X	O
and	O
E558X	O
)	O
and	O
three	O
other	O
fraemshift	O
muttaions	O
caused	O
premtaure	O
termintaion	O
of	O
the	O
proetin	O
.	O

A	O
msisense	O
mutaiton	O
,	O
R843G	O
,	O
was	O
located	O
in	O
the	O
highly	O
conserved	O
PtIdns	O
(	O
4	O
,	O
5	O
)	O
P2	O
5	O
-	O
phosphtaase	O
doamin	O
.	O

Finally	O
,	O
one	O
farmeshift	O
mutatoin	O
,	O
2799delC	O
,	O
modfiies	O
the	O
C	O
-	O
termianl	O
part	O
of	O
OCLR1	O
,	O
with	O
an	O
exetnsion	O
of	O
six	O
aimno	O
acdis	O
.	O

Altogether	O
,	O
70	O
%	O
of	O
msisense	O
mutatinos	O
are	O
located	O
in	O
eoxn	O
15	O
,	O
and	O
52	O
%	O
of	O
all	O
mtuations	O
clsuter	O
in	O
exnos	O
11	O
-	O
15	O
.	O

We	O
also	O
identiifed	O
two	O
new	O
microsatelltie	O
marekrs	O
for	O
the	O
ORCL1	O
loucs	O
,	O
and	O
we	O
detetced	O
a	O
germlnie	O
moasicism	O
in	O
one	O
famliy	O
.	O

This	O
obseravtion	O
has	O
direct	O
implications	O
for	O
geneitc	O
counseilng	O
of	O
Lwoe	B-Disease
syndrmoe	I-Disease
famiiles	O
.	O
.	O

MFEV	O
-	O
Gnee	O
analyiss	O
in	O
armneian	O
ptaients	O
with	O
Famliial	B-Disease
Mediterranean	I-Disease
fveer	I-Disease
:	O
diganostic	O
value	O
and	O
unfaovrable	O
reanl	O
prgonosis	O
of	O
the	O
M649V	O
homozyogus	O
geontype	O
-	O
gneetic	O
and	O
theraeputic	O
implications	O
.	O

Famliial	B-Disease
Medtierranean	I-Disease
fveer	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recessively	B-Disease
inhreited	I-Disease
disroder	I-Disease
that	O
is	O
common	O
in	O
patietns	O
of	O
Amrenian	O
ancesrty	O
.	O

To	O
date	O
,	O
its	O
diagnoiss	O
,	O
which	O
can	O
be	O
made	O
only	O
retrospectviely	O
,	O
is	O
one	O
of	O
exclsuion	O
,	O
based	O
entirely	O
on	O
nonspecfiic	O
cliincal	O
sings	O
that	O
result	O
from	O
sreosal	B-Disease
inflamamtion	I-Disease
and	O
that	O
may	O
lead	O
to	O
unnecessary	O
suregry	O
.	O

Reanl	B-Disease
amlyoidosis	I-Disease
,	O
prevented	O
by	O
colchicnie	O
,	O
is	O
the	O
most	O
sveere	O
complciation	O
of	O
FMF	B-Disease
,	O
a	O
dsiorder	O
associated	O
with	O
mutatinos	O
in	O
the	O
MFEV	O
gnee	O
.	O

To	O
evalutae	O
the	O
diganostic	O
and	O
prongostic	O
value	O
of	O
MFEV	O
-	O
gnee	O
analyiss	O
,	O
we	O
investigaetd	O
90	O
Amrenian	O
FMF	B-Disease
patinets	O
from	O
77	O
unrelated	O
faimlies	O
that	O
were	O
not	O
selected	O
through	O
geentic	O
-	O
liknage	O
anaylsis	O
.	O

Eight	O
mutatoins	O
,	O
one	O
of	O
which	O
(	O
R408Q	O
)	O
is	O
new	O
,	O
were	O
found	O
to	O
account	O
for	O
93	O
%	O
of	O
the	O
163	O
idnependent	O
FMF	B-Disease
alelles	O
,	O
with	O
both	O
FMF	B-Disease
alelles	O
iedntified	O
in	O
89	O
%	O
of	O
the	O
ptaients	O
.	O

In	O
several	O
intsances	O
,	O
famliy	O
stduies	O
provided	O
molecualr	O
evdience	O
for	O
pseudodoimnant	O
transmission	O
and	O
incopmlete	O
penertance	O
of	O
the	O
disaese	O
phneotype	O
.	O

The	O
M964V	O
homozyogus	O
gentoype	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
hihger	O
preavlence	O
of	O
reanl	B-Disease
amlyoidosis	I-Disease
and	O
arthriits	B-Disease
,	O
copmared	O
with	O
other	O
genotyeps	O
(	O
P	O
=	O
.	O
0002	O
and	O
P	O
=	O
.	O
006	O
,	O
respectively	O
)	O
.	O

The	O
demonstration	O
of	O
both	O
the	O
diagnositc	O
and	O
prongostic	O
value	O
of	O
MFEV	O
anaylsis	O
and	O
particular	O
moeds	O
of	O
inehritance	O
should	O
lead	O
to	O
new	O
ways	O
for	O
manageemnt	O
of	O
FMF	O
-	O
including	O
geneitc	O
counseilng	O
and	O
therapeuitc	O
deicsions	O
in	O
affceted	O
famiiles	O
.	O

Noninvaisve	O
tset	O
for	O
fraglie	B-Disease
X	I-Disease
snydrome	I-Disease
,	O
using	O
hiar	O
root	O
analyiss	O
.	O

Identfiication	O
of	O
the	O
FRM1	O
gnee	O
and	O
the	O
rpeeat	O
-	O
amlpification	O
mehcanism	O
causing	O
fargile	B-Disease
X	I-Disease
snydrome	I-Disease
led	O
to	O
deevlopment	O
of	O
reliable	O
DNA	O
-	O
based	O
diagonstic	O
methdos	O
,	O
including	O
Soutehrn	O
bolt	O
hybridiaztion	O
and	O
PCR	O
.	O

Both	O
mtehods	O
are	O
performed	O
on	O
DNA	O
isolaetd	O
from	O
periphreal	O
bolod	O
cells	O
and	O
meausre	O
the	O
reepat	O
szie	O
in	O
FRM1	O
.	O

Using	O
an	O
immunoyctochemical	O
techinque	O
on	O
bolod	O
semars	O
,	O
we	O
recently	O
developed	O
a	O
novel	O
tset	O
for	O
iedntification	O
of	O
pateints	O
with	O
frgaile	B-Disease
X	I-Disease
synrdome	I-Disease
.	O

This	O
mtehod	O
,	O
also	O
called	O
"	O
antbiody	O
tset	O
,	O
"	O
uses	O
moncolonal	O
atnibodies	O
against	O
the	O
FRM1	O
gnee	O
porduct	O
(	O
FRMP	O
)	O
and	O
is	O
based	O
on	O
absecne	O
of	O
FRMP	O
in	O
patietns	O
clels	O
.	O

Here	O
we	O
describe	O
a	O
new	O
diagnsotic	O
tset	O
to	O
identify	O
mlae	O
patietns	O
with	O
fraglie	B-Disease
X	I-Disease
syndrmoe	I-Disease
,	O
on	O
the	O
basis	O
of	O
lcak	O
of	O
FRMP	O
in	O
their	O
hiar	O
roots	O
.	O

Exrpession	O
of	O
FRMP	O
in	O
hiar	O
rotos	O
was	O
studied	O
by	O
use	O
of	O
an	O
FRMP	O
-	O
specific	O
antiobdy	O
tset	O
,	O
and	O
the	O
percenatge	O
of	O
FRMP	O
-	O
epxressing	O
hiar	O
rotos	O
in	O
contorls	O
and	O
in	O
mlae	O
fargile	B-Disease
X	I-Disease
paitents	O
was	O
determined	O
.	O

Cotnrol	O
inidviduals	O
showed	O
clear	O
experssion	O
of	O
FRMP	O
in	O
nearly	O
every	O
hiar	O
root	O
,	O
whereas	O
mlae	O
frgaile	B-Disease
X	I-Disease
patinets	O
lacked	O
expressoin	O
of	O
FRMP	O
in	O
almost	O
all	O
their	O
hiar	O
rotos	O
.	O

Metnally	B-Disease
rtearded	I-Disease
femlae	O
pateints	O
with	O
a	O
full	O
muattion	O
showed	O
FRMP	O
exrpession	O
in	O
only	O
some	O
of	O
their	O
hiar	O
roots	O
(	O
<	O
55	O
%	O
)	O
,	O
and	O
no	O
oevrlap	O
with	O
noraml	O
feamle	O
contrlos	O
was	O
observed	O
.	O

The	O
advantages	O
of	O
this	O
tset	O
are	O
(	O
1	O
)	O
pulcking	O
of	O
hiar	O
follicels	O
does	O
no	O
appreciable	O
hram	O
to	O
the	O
menatlly	B-Disease
reatrded	I-Disease
ptaient	O
,	O
(	O
2	O
)	O
haris	O
can	O
be	O
sent	O
in	O
a	O
simple	O
enevlope	O
to	O
a	O
diangostic	O
cenetr	O
,	O
and	O
(	O
3	O
)	O
the	O
result	O
of	O
the	O
tset	O
is	O
available	O
within	O
5	O
h	O
of	O
plcuking	O
.	O

In	O
addition	O
,	O
this	O
tset	O
enabled	O
us	O
to	O
identify	O
two	O
fraigle	B-Disease
X	I-Disease
pateints	O
who	O
did	O
not	O
show	O
the	O
full	O
mtuation	O
by	O
anlaysis	O
of	O
DNA	O
isolaetd	O
from	O
bolod	O
clels	O
.	O
.	O

In	O
Swdeish	O
fmailies	O
with	O
hreeditary	B-Disease
protsate	I-Disease
cnacer	I-Disease
,	O
lnikage	O
to	O
the	O
HCP1	O
lcous	O
on	O
chromosmoe	O
1q24	O
-	O
25	O
is	O
restricted	O
to	O
fmailies	O
with	O
ealry	O
-	O
onset	O
protsate	B-Disease
cacner	I-Disease
.	O

Prosttae	B-Disease
cnacer	I-Disease
clusetrs	O
in	O
some	O
faimlies	O
,	O
and	O
an	O
estimtaed	O
5	O
%	O
-	O
10	O
%	O
of	O
all	O
csaes	O
are	O
esitmated	O
to	O
result	O
from	O
inheritnace	O
of	O
prosatte	O
canecr	O
-	O
susceptiiblity	O
gnees	O
.	O

We	O
previously	O
reported	O
eivdence	O
of	O
linakge	O
to	O
the	O
1q24	O
-	O
25	O
reigon	O
(	O
HCP1	O
)	O
in	O
91	O
Nroth	O
Amercian	O
and	O
Sweidsh	O
fmailies	O
each	O
with	O
multilpe	O
caess	O
of	O
prsotate	B-Disease
cacner	I-Disease
(	O
Smith	O
et	O
al	O
.	O
1996	O
)	O
.	O

In	O
the	O
present	O
reprot	O
we	O
anaylze	O
40	O
(	O
12	O
original	O
and	O
28	O
newly	O
idnetified	O
)	O
Swedsih	O
famliies	O
with	O
herdeitary	B-Disease
protsate	I-Disease
cnacer	I-Disease
(	O
HPC	B-Disease
)	O
that	O
,	O
on	O
the	O
basis	O
of	O
40	O
marekrs	O
spanning	O
a	O
25	O
-	O
cM	O
inetrval	O
within	O
1q24	O
-	O
25	O
,	O
have	O
evdience	O
of	O
linakge	O
.	O

In	O
the	O
complete	O
set	O
of	O
famliies	O
,	O
a	O
maixmum	O
two	O
-	O
point	O
LOD	O
socre	O
of	O
1	O
.	O

10	O
was	O
observed	O
at	O
D1S143	O
(	O
at	O
a	O
recombinatoin	O
fractoin	O
[	O
thtea	O
]	O
of	O
.	O
1	O
)	O
,	O
with	O
a	O
maxiumm	O
NPL	O
(	O
nonparaemtric	O
liknage	O
)	O
Z	O
socre	O
of	O
1	O
.	O

64	O
at	O
D1S202	O
(	O
P	O
=	O
.	O
05	O
)	O
.	O

The	O
evidnece	O
of	O
linakge	O
to	O
this	O
rgeion	O
originated	O
almost	O
exclusively	O
from	O
the	O
subset	O
of	O
12	O
ealry	O
-	O
onset	O
(	O
age	O
<	O
65	O
yeras	O
)	O
faimlies	O
,	O
which	O
yielded	O
a	O
maxmium	O
LOD	O
socre	O
of	O
2	O
.	O

38	O
at	O
DS1413	O
(	O
straight	O
thtea	O
=	O
0	O
)	O
and	O
an	O
NPL	O
Z	O
scroe	O
of	O
1	O
.	O

95	O
at	O
D14S22	O
(	O
P	O
=	O
.	O
03	O
)	O
.	O

Esitmates	O
from	O
heterogneeity	O
tetss	O
suggest	O
that	O
,	O
within	O
Sweedn	O
,	O
as	O
many	O
as	O
50	O
%	O
of	O
eraly	O
-	O
onset	O
famiiles	O
had	O
eivdence	O
of	O
liknage	O
to	O
the	O
HCP1	O
regoin	O
.	O

These	O
resluts	O
are	O
consistent	O
with	O
the	O
hpyothesis	O
of	O
linkgae	O
to	O
HCP1	O
in	O
a	O
subset	O
of	O
famliies	O
with	O
porstate	B-Disease
cnacer	I-Disease
,	O
particularly	O
those	O
with	O
an	O
ealry	O
age	O
at	O
diagnsois	O
.	O

Mloecular	O
basis	O
of	O
felnie	O
btea	B-Disease
-	I-Disease
glcuuronidase	I-Disease
deficinecy	I-Disease
:	O
an	O
anmial	O
mdoel	O
of	O
mucopolysaccharidosis	B-Disease
VII	I-Disease
.	O

A	O
famliy	O
of	O
domesitc	O
ctas	O
was	O
found	O
that	O
exhibited	O
cliincal	O
and	O
boichemical	O
abnomralities	O
consistent	O
with	O
muocpolysaccharidosis	B-Disease
VII	I-Disease
,	O
an	O
autsoomal	B-Disease
recessvie	I-Disease
lsyosomal	I-Disease
sotrage	I-Disease
dsiorder	I-Disease
caused	O
by	O
btea	B-Disease
-	I-Disease
glucuroindase	I-Disease
defciiency	I-Disease
.	O

btea	O
-	O
Gulcuronidase	O
actviity	O
was	O
udnetectable	O
in	O
affecetd	O
cat	O
fibrbolasts	O
and	O
retsored	O
by	O
retrovrial	O
gnee	O
tranfser	O
of	O
rat	O
btea	O
-	O
glucuornidase	O
cNDA	O
.	O

btea	O
-	O
Gluucronidase	O
mNRA	O
was	O
nromal	O
in	O
affceted	O
cat	O
tsetis	O
by	O
Northren	O
bolt	O
anlaysis	O
.	O

Noraml	O
feilne	O
btea	O
-	O
glucurnoidase	O
cNDA	O
was	O
clnoed	O
and	O
characteirzed	O
,	O
and	O
amplfiied	O
from	O
affceted	O
cat	O
fiborblasts	O
by	O
revesre	O
transcrpition	O
coupled	O
polyemrase	O
chian	O
reaciton	O
.	O

There	O
was	O
a	O
G	O
-	O
to	O
-	O
A	O
trasnition	O
in	O
the	O
affected	O
cat	O
cNDA	O
that	O
preditced	O
an	O
E315K	O
substiuttion	O
,	O
destroyed	O
a	O
BssSI	O
stie	O
,	O
and	O
eliminated	O
GSUB	O
enyzmatic	O
actiivty	O
in	O
exrpession	O
studeis	O
.	O

Mlutiple	O
speices	O
cmoparison	O
and	O
the	O
crysatl	O
srtucture	O
of	O
hmuan	O
btea	O
-	O
glucuronidsae	O
indicated	O
that	O
E531	O
is	O
a	O
highly	O
conserved	O
resiude	O
most	O
likely	O
essenital	O
in	O
maitnenance	O
of	O
the	O
eznymes	O
conforamtion	O
.	O

BsSsI	O
digsetion	O
of	O
poylmerase	O
cahin	O
reactoin	O
proudcts	O
apmlified	O
from	O
genmoic	O
DNA	O
indicated	O
that	O
affecetd	O
ctas	O
were	O
homozyguos	O
and	O
ctas	O
with	O
half	O
-	O
nromal	O
btea	O
-	O
glucurnoidase	O
activtiy	O
were	O
heteorzygous	O
for	O
the	O
misesnse	O
muattion	O
.	O

Carrires	O
idenitfied	O
in	O
this	O
manner	O
produced	O
affecetd	O
kittnes	O
in	O
prospectvie	O
breeidngs	O
,	O
and	O
a	O
felnie	O
MPS	B-Disease
VII	I-Disease
bredeing	O
coolny	O
has	O
been	O
established	O
.	O
.	O

A	O
common	O
molecluar	O
basis	O
for	O
rearrnagement	B-Disease
disroders	I-Disease
on	O
chromosmoe	O
22q11	O
.	O

The	O
chroomsome	O
22q11	O
rgeion	O
is	O
suscepitble	O
to	O
rearrnagements	O
that	O
are	O
associated	O
with	O
cnogenital	B-Disease
anomlay	I-Disease
diosrders	I-Disease
and	O
mailgnant	B-Disease
tuomrs	I-Disease
.	O

Three	O
congential	B-Disease
anmoaly	I-Disease
dsiorders	I-Disease
,	O
cat	B-Disease
-	I-Disease
eye	I-Disease
synrdome	I-Disease
,	O
der	B-Disease
(	I-Disease
)	I-Disease
syndorme	I-Disease
and	O
velo	B-Disease
-	I-Disease
cradio	I-Disease
-	I-Disease
fcaial	I-Disease
snydrome	I-Disease
/	O
DiGeroge	B-Disease
sydnrome	I-Disease
(	O
VFCS	B-Disease
/	O
DGS	B-Disease
)	O
are	O
associated	O
with	O
tetraosmy	O
,	O
trsiomy	O
or	O
mnoosomy	O
,	O
respectively	O
,	O
for	O
part	O
of	O
chroomsome	O
22q11	O
.	O

VFCS	B-Disease
/	O
DGS	B-Disease
is	O
the	O
most	O
common	O
synrdome	O
associated	O
with	O
22q11	O
rearrangmeents	O
.	O

In	O
order	O
to	O
determine	O
whether	O
there	O
are	O
particular	O
regoins	O
on	O
22q11	O
that	O
are	O
prone	O
to	O
rearrangmeents	O
,	O
the	O
delteion	O
end	O
-	O
points	O
in	O
a	O
large	O
number	O
of	O
VFCS	B-Disease
/	O
DGS	B-Disease
patinets	O
were	O
defined	O
by	O
haplotpye	O
aanlysis	O
.	O

Most	O
VFCS	B-Disease
/	O
DGS	B-Disease
patietns	O
have	O
a	O
similar	O
3	O
Mb	O
deeltion	O
,	O
some	O
have	O
a	O
nseted	O
ditsal	O
dleetion	O
breakponit	O
resulting	O
in	O
a	O
1	O
.	O

5	O
Mb	O
deeltion	O
and	O
a	O
few	O
rrae	O
patinets	O
have	O
uinque	O
deleitons	O
or	O
transloactions	O
.	O

The	O
high	O
prevlaence	O
of	O
the	O
disroder	O
in	O
the	O
ppoulation	O
and	O
the	O
fact	O
that	O
most	O
caess	O
occur	O
sporadically	O
suggest	O
that	O
sequenecs	O
at	O
or	O
near	O
the	O
breakponits	O
confer	O
susecptibility	O
to	O
chromosmoe	O
rearrangemetns	O
.	O

To	O
investiagte	O
this	O
hypohtesis	O
,	O
we	O
developed	O
hamsetr	O
-	O
hmuan	O
somtaic	O
hbyrid	O
clel	O
lnies	O
from	O
VFCS	B-Disease
/	O
DGS	B-Disease
paitents	O
with	O
all	O
three	O
clsases	O
of	O
delteions	O
and	O
we	O
now	O
show	O
that	O
the	O
brekapoints	O
occur	O
within	O
similar	O
low	O
cpoy	O
rpeeats	O
,	O
termed	O
LCR22s	O
.	O

To	O
support	O
this	O
idea	O
further	O
,	O
we	O
iedntified	O
a	O
faimly	O
that	O
carries	O
an	O
intrestitial	O
dulpication	O
of	O
the	O
same	O
3	O
Mb	O
regoin	O
that	O
is	O
deelted	O
in	O
VFCS	B-Disease
/	O
DGS	B-Disease
patietns	O
.	O

We	O
present	O
mdoels	O
to	O
explain	O
how	O
the	O
LRC22s	O
can	O
mediate	O
different	O
hoomlogous	O
recobmination	O
evetns	O
,	O
thereby	O
generating	O
a	O
number	O
of	O
rearrangeemnts	O
that	O
are	O
associated	O
with	O
congential	B-Disease
aonmaly	I-Disease
diosrders	I-Disease
.	O

We	O
identifeid	O
five	O
additional	O
copeis	O
of	O
the	O
LRC22	O
on	O
22q11	O
that	O
may	O
mediate	O
other	O
rearrangemetns	O
leading	O
to	O
dsiease	O
.	O

Functinoal	O
consequecnes	O
of	O
mutatoins	O
in	O
the	O
ealry	O
grotwh	O
respnose	O
2	O
gnee	O
(	O
ERG2	O
)	O
correlate	O
with	O
severtiy	O
of	O
huamn	O
myelionpathies	B-Disease
.	O

The	O
ealry	O
grwoth	O
resposne	O
2	O
gnee	O
(	O
ERG2	O
)	O
is	O
a	O
Cys2Hi2szinc	O
fniger	O
trancsription	O
facotr	O
which	O
is	O
thought	O
to	O
play	O
a	O
role	O
in	O
the	O
regualtion	O
of	O
periphearl	O
nevrous	O
sysetm	O
myelinaiton	O
.	O

This	O
idea	O
is	O
based	O
partly	O
on	O
the	O
pheontype	O
of	O
homozyogus	O
Krxo20	O
(	O
Erg2	O
)	O
knockuot	O
mcie	O
,	O
which	O
display	O
hyopmyelination	B-Disease
of	I-Disease
the	I-Disease
PNS	I-Disease
and	O
a	O
blcok	O
of	O
Schwnan	O
cells	O
at	O
an	O
eraly	O
stgae	O
of	O
differentaition	O
.	O

Mtuations	O
in	O
the	O
huamn	O
ERG2	O
gnee	O
have	O
recently	O
been	O
associated	O
with	O
the	O
inheirted	B-Disease
preipheral	I-Disease
neurpoathies	I-Disease
Cahrcot	B-Disease
-	I-Disease
Mraie	I-Disease
-	I-Disease
Totoh	I-Disease
tpye	I-Disease
1	I-Disease
,	O
Dejernie	B-Disease
-	I-Disease
Sottas	I-Disease
snydrome	I-Disease
and	O
cognenital	B-Disease
hpyomyelinating	I-Disease
neurpoathy	I-Disease
.	O

Three	O
of	O
the	O
four	O
ERG2	O
mutaitons	O
are	O
doimnant	O
and	O
occur	O
within	O
the	O
znic	O
figner	O
DNA	O
-	O
bniding	O
doamin	O
.	O

The	O
fourth	O
muattion	O
is	O
rceessive	O
and	O
affects	O
the	O
inhbiitory	O
doamin	O
(	O
R1	O
)	O
that	O
bidns	O
the	O
NAB	O
trnascriptional	O
co	O
-	O
reprsesors	O
.	O

A	O
combintaion	O
of	O
DNA	O
-	O
binidng	O
assays	O
and	O
transcirptional	O
anlaysis	O
was	O
used	O
to	O
determine	O
the	O
functinoal	O
consequneces	O
of	O
these	O
mutatinos	O
.	O

The	O
znic	O
finegr	O
mutatinos	O
affect	O
DNA	O
binidng	O
and	O
the	O
amonut	O
of	O
residaul	O
binidng	O
directly	O
crorelates	O
with	O
diesase	O
severtiy	O
.	O

The	O
R1	O
dmoain	O
mutatoin	O
prevents	O
inetraction	O
of	O
ERG2	O
with	O
the	O
NAB	O
co	O
-	O
repressors	O
and	O
thereby	O
inrceases	O
tarnscriptional	O
activtiy	O
.	O

These	O
dtaa	O
provide	O
insight	O
into	O
the	O
possible	O
dsiease	O
mechanimss	O
underlying	O
ERG2	O
mtuations	O
and	O
the	O
reason	O
for	O
varying	O
seevrity	O
and	O
difefrences	O
in	O
inheirtance	O
patetrns	O
.	O
.	O

Autosmoal	B-Disease
rceessive	I-Disease
famliial	I-Disease
neurohyppohyseal	I-Disease
diaebtes	I-Disease
inispidus	I-Disease
with	O
continued	O
sceretion	O
of	O
muatnt	O
weakly	O
acitve	O
vasopressin	O
.	O

Faimlial	B-Disease
neurohypophsyeal	I-Disease
diaebtes	I-Disease
insipiuds	I-Disease
is	O
an	O
atuosomal	B-Disease
dominnat	I-Disease
disoredr	I-Disease
charactreized	O
by	O
psot	O
-	O
naatl	O
deveolpment	O
of	O
argniine	B-Disease
vasorpessin	I-Disease
(	I-Disease
AVP	I-Disease
)	I-Disease
defciiency	I-Disease
due	O
to	O
mutatinos	O
in	O
the	O
AVP	O
gnee	O
.	O

All	O
publihsed	O
muattions	O
affect	O
the	O
sginal	O
pepitde	O
or	O
the	O
neurophyisn	O
-	O
II	O
carrier	O
protien	O
and	O
are	O
presumed	O
to	O
interfere	O
with	O
porcessing	O
of	O
the	O
perprohormone	O
,	O
leading	O
to	O
nueronal	B-Disease
damgae	I-Disease
.	O

We	O
studied	O
an	O
unsuual	O
Palesitnian	O
fmaily	O
consisting	O
of	O
asypmtomatic	O
first	O
cuosin	O
paretns	O
and	O
three	O
chlidren	O
affetced	O
with	O
neurohypophsyeal	B-Disease
diabtees	I-Disease
inspiidus	I-Disease
,	O
suggesting	O
atuosomal	O
recessvie	O
inhertiance	O
.	O

All	O
three	O
affetced	O
chlidren	O
were	O
hoomzygous	O
and	O
the	O
paernts	O
hteerozygous	O
for	O
a	O
single	O
novel	O
mtuation	O
(	O
C031	O
-	O
>	O
T	O
)	O
in	O
eoxn	O
1	O
,	O
replacing	O
Por7	O
of	O
mtaure	O
AVP	O
with	O
Leu	O
(	O
Leu	O
-	O
AVP	O
)	O
.	O

Leu	O
-	O
AVP	O
was	O
a	O
waek	O
agnoist	O
with	O
approximately	O
30	O
-	O
fold	O
redcued	O
bidning	O
to	O
the	O
huamn	O
V2	O
reecptor	O
.	O

Maesured	O
by	O
radioimmnuoassay	O
with	O
a	O
synthteic	O
Leu	O
-	O
AVP	O
stanadrd	O
,	O
seurm	O
Leu	O
-	O
AVP	O
leevls	O
were	O
elveated	O
in	O
all	O
three	O
chilrden	O
and	O
further	O
incraesed	O
during	O
wtaer	O
deprivtaion	O
to	O
as	O
high	O
as	O
30	O
times	O
nomral	O
.	O

The	O
youngest	O
chlid	O
(	O
2	O
yeras	O
old	O
)	O
was	O
only	O
mlidly	O
afefcted	O
but	O
had	O
Leu	O
-	O
AVP	O
leevls	O
similar	O
to	O
her	O
seveerly	O
affecetd	O
8	O
-	O
yaer	O
-	O
old	O
brohter	O
,	O
suggesting	O
that	O
unknown	O
mcehanisms	O
may	O
paritally	O
compenaste	O
for	O
a	O
defciiency	B-Disease
of	I-Disease
atcive	I-Disease
AVP	I-Disease
in	O
very	O
yuong	O
chlidren	O
.	O
.	O

X	O
inatcivation	O
and	O
smoatic	O
clel	O
selcetion	O
rescue	O
femlae	O
mcie	O
carrying	O
a	O
Pgia	O
-	O
nlul	O
muttaion	O
.	O

A	O
soamtic	O
mutaiton	O
in	O
the	O
X	O
linked	O
PGIA	O
gnee	O
is	O
responsible	O
for	O
the	O
defciiency	B-Disease
of	I-Disease
gylcosyl	I-Disease
phoshpatidylinositol	I-Disease
(	I-Disease
GPI	I-Disease
)	I-Disease
-	I-Disease
ancohred	I-Disease
porteins	I-Disease
on	O
bolod	O
clels	O
from	O
ptaients	O
with	O
paroxysaml	B-Disease
notcurnal	I-Disease
hemoglobinruia	I-Disease
.	O

No	O
inhertied	O
form	O
of	O
GPI	B-Disease
-	I-Disease
anchor	I-Disease
dfeiciency	I-Disease
has	O
been	O
described	O
.	O

Because	O
conventoinal	O
Pgia	O
gnee	O
knockuot	O
is	O
associated	O
with	O
high	O
emrbyonic	B-Disease
lehtality	I-Disease
in	O
chimreic	O
mcie	O
,	O
we	O
used	O
the	O
Cre	O
/	O
lxoP	O
ssytem	O
.	O

We	O
generated	O
mcie	O
in	O
which	O
two	O
lxoP	O
siets	O
flank	O
part	O
of	O
Pgia	O
eoxn	O
2	O
.	O

After	O
crossbreeding	O
with	O
femlae	O
mcie	O
of	O
the	O
EIIa	O
-	O
cre	O
srtain	O
,	O
the	O
floexd	O
allele	O
undergoes	O
Cre	O
-	O
mediated	O
recombinatoin	O
with	O
high	O
efficiency	O
during	O
ealry	O
embyronic	O
deveolpment	O
.	O

Because	O
of	O
X	O
crhomosome	O
inactivtaion	O
,	O
femlae	O
offspring	O
are	O
moasic	O
for	O
clels	O
that	O
express	O
or	O
lcak	O
GPI	O
-	O
linked	O
protiens	O
.	O

Anlaysis	O
of	O
msoaic	O
mcie	O
showed	O
that	O
in	O
haert	O
,	O
lnug	O
,	O
kideny	O
,	O
barin	O
,	O
and	O
lievr	O
,	O
mainly	O
wlid	O
-	O
tpye	O
Pgia	O
is	O
atcive	O
,	O
suggesting	O
that	O
these	O
tissues	O
require	O
GPI	O
-	O
linked	O
protenis	O
.	O

The	O
slaient	O
exceptions	O
were	O
spleen	O
,	O
tyhmus	O
,	O
and	O
red	O
bolod	O
clels	O
,	O
which	O
had	O
almost	O
euqal	O
numbres	O
of	O
clels	O
exrpessing	O
the	O
wlid	O
-	O
tpye	O
or	O
the	O
reocmbined	O
allele	O
,	O
implying	O
that	O
GPI	O
-	O
linked	O
porteins	O
are	O
not	O
esesntial	O
for	O
the	O
derivtaion	O
of	O
these	O
tisuses	O
.	O

PGIA	O
(	O
-	O
)	O
clels	O
had	O
no	O
grwoth	O
advantage	O
,	O
suggesting	O
that	O
other	O
fatcors	O
are	O
needed	O
for	O
their	O
clnoal	O
domiannce	O
in	O
patinets	O
with	O
paorxysmal	B-Disease
ncoturnal	I-Disease
hemoglboinuria	I-Disease
.	O
.	O

The	O
C228Y	O
mutatoin	O
causing	O
heredtiary	B-Disease
hemohcromatosis	I-Disease
does	O
not	O
produce	O
a	O
nlul	O
alllee	O
.	O

Trageted	O
mutagneesis	O
was	O
used	O
to	O
produce	O
two	O
muttaions	O
in	O
the	O
muirne	O
hemochromtaosis	B-Disease
gnee	O
(	O
Hfe	O
)	O
lcous	O
.	O

The	O
first	O
mutaiton	O
deltees	O
a	O
large	O
poriton	O
of	O
the	O
codnig	O
sequnece	O
,	O
generating	O
a	O
nlul	O
alllee	O
.	O

The	O
second	O
mutaiton	O
introduces	O
a	O
msisense	O
mtuation	O
(	O
C822Y	O
)	O
into	O
the	O
Hfe	O
loucs	O
,	O
but	O
otherwise	O
laeves	O
the	O
gnee	O
itnact	O
.	O

This	O
mutatoin	O
is	O
idenitcal	O
to	O
the	O
disesae	O
-	O
causing	O
muttaion	O
in	O
ptaients	O
with	O
hreeditary	B-Disease
hemochromaotsis	I-Disease
.	O

Mcie	O
carrying	O
each	O
of	O
the	O
two	O
mtuations	O
were	O
berd	O
and	O
analzyed	O
.	O

Hoomzygosity	O
for	O
either	O
muttaion	O
resutls	O
in	O
postntaal	O
iorn	O
loaidng	O
.	O

The	O
effetcs	O
of	O
the	O
nlul	O
mtuation	O
are	O
more	O
sevree	O
than	O
the	O
effcets	O
of	O
the	O
C822Y	O
mutatoin	O
.	O

Mcie	O
heterzoygous	O
for	O
either	O
mtuation	O
accmuulate	O
more	O
iorn	O
than	O
noraml	O
cnotrols	O
.	O

Interestingly	O
,	O
although	O
lvier	O
iorn	O
sotres	O
are	O
greatly	O
inrceased	O
,	O
spelnic	O
iorn	O
is	O
derceased	O
.	O

We	O
conclude	O
that	O
the	O
C822Y	O
mutatoin	O
does	O
not	O
result	O
in	O
a	O
nlul	O
allele	O
.	O
.	O

Genotpye	O
-	O
phenoytpe	O
aanlysis	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Eemry	I-Disease
-	I-Disease
Drefiuss	I-Disease
msucular	I-Disease
dytsrophy	I-Disease
and	O
identifiaction	O
of	O
a	O
msisense	O
muttaion	O
associated	O
with	O
a	O
milder	O
phenotpye	O
.	O

Direct	O
sequecning	O
of	O
the	O
eemrin	O
gnee	O
in	O
22	O
famileis	O
with	O
Emrey	B-Disease
-	I-Disease
Dreifsus	I-Disease
musuclar	I-Disease
dysrtophy	I-Disease
(	O
EMD	B-Disease
)	O
rveealed	O
mtuations	O
in	O
21	O
(	O
95	O
%	O
)	O
,	O
confirming	O
that	O
emrein	O
mutatinos	O
can	O
be	O
identiifed	O
in	O
the	O
majority	O
of	O
famliies	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
EMD	I-Disease
.	O

Most	O
eemrin	O
muttaions	O
result	O
in	O
absecne	O
of	O
the	O
prtoein	O
.	O

In	O
this	O
stduy	O
three	O
mutatinos	O
(	O
a	O
missnese	O
muttaion	O
Por183Thr	O
and	O
two	O
in	O
-	O
frmae	O
deletoins	O
removing	O
resideus	O
95	O
-	O
99	O
and	O
236	O
-	O
241	O
,	O
respectively	O
)	O
were	O
uunsual	O
in	O
being	O
associated	O
with	O
epxression	O
of	O
mtuant	O
prtoein	O
.	O

The	O
phenoytpe	O
in	O
these	O
fmailies	O
was	O
comapred	O
in	O
detail	O
with	O
the	O
cliniacl	O
featrues	O
in	O
caess	O
with	O
typical	O
nlul	O
mutaitons	O
.	O

For	O
the	O
in	O
-	O
farme	O
deletoins	O
there	O
were	O
no	O
significant	O
diffeernces	O
.	O

In	O
the	O
famliy	O
with	O
the	O
missesne	O
muttaion	O
the	O
phentoype	O
was	O
milder	O
.	O

Age	O
at	O
onset	O
was	O
later	O
for	O
first	O
sympotms	O
and	O
for	O
develompent	O
of	O
aknle	B-Disease
contractrues	I-Disease
and	O
mucsle	B-Disease
weaknses	I-Disease
.	O

These	O
finidngs	O
have	O
daignostic	O
implications	O
as	O
well	O
as	O
pointing	O
to	O
functionally	O
important	O
rgeions	O
of	O
the	O
emrein	O
prtoein	O
.	O
.	O

Seevre	O
clincial	O
expressoin	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emrey	I-Disease
-	I-Disease
Derifuss	I-Disease
muscluar	I-Disease
dystrpohy	I-Disease
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
Eemry	I-Disease
-	I-Disease
Dreiufss	I-Disease
muscluar	I-Disease
dystrohpy	I-Disease
(	O
EMDD	B-Disease
)	O
is	O
a	O
relatively	O
rrae	O
beingn	B-Disease
neurmouscular	I-Disease
disoredr	I-Disease
which	O
can	O
vary	O
remarkably	O
in	O
onset	O
,	O
coruse	O
and	O
seveirty	O
.	O

In	O
the	O
present	O
sutdy	O
,	O
a	O
TCATC	O
deleiton	O
spanning	O
the	O
nucletoides	O
631	O
-	O
635	O
of	O
the	O
emrein	O
gnee	O
caused	O
an	O
unusulaly	O
sevree	O
disaese	O
phentoype	O
including	O
lsos	B-Disease
of	I-Disease
ambluation	I-Disease
and	O
seevre	O
muslce	B-Disease
watsing	I-Disease
in	O
two	O
affected	O
brtohers	O
.	O

The	O
same	O
muttaion	O
has	O
been	O
reported	O
previously	O
in	O
an	O
unrelated	O
fmaily	O
showing	O
a	O
significantly	O
milder	O
pheontype	O
.	O

The	O
inteframilial	O
heterogneeity	O
in	O
ditsribution	O
and	O
in	O
severtiy	O
of	O
the	O
featrues	O
in	O
the	O
two	O
faimlies	O
point	O
to	O
envirnomental	O
or	O
geentic	O
modifictaion	O
as	O
the	O
cause	O
of	O
clincial	O
variabliity	O
in	O
Eemry	B-Disease
-	I-Disease
Drefiuss	I-Disease
muscluar	I-Disease
dytsrophy	I-Disease
.	O
.	O

Common	O
mutatoins	O
in	O
BCRA1	O
and	O
BRAC2	O
do	O
not	O
contribute	O
to	O
eraly	O
prosttae	B-Disease
canecr	I-Disease
in	O
Jweish	O
men	O
.	O

BACKRGOUND	O
Famileis	O
with	O
a	O
high	O
incidecne	O
of	O
hereidtary	B-Disease
berast	I-Disease
canecr	I-Disease
,	O
and	O
subsequently	O
shown	O
to	O
have	O
terminating	O
mutaitons	O
in	O
BCRA1	O
or	O
BCRA2	O
,	O
appear	O
to	O
have	O
a	O
higehr	O
inicdence	O
of	O
protsate	B-Disease
cnacer	I-Disease
among	O
mlae	O
realtives	O
.	O

We	O
aimed	O
to	O
determine	O
whether	O
the	O
common	O
gemrline	O
mutatoins	O
of	O
BCRA1	O
or	O
BCRA2	O
in	O
Ashkeanzi	O
Jeiwsh	O
men	O
predsiposed	O
them	O
to	O
prosatte	B-Disease
cnacer	I-Disease
.	O

METHODS	O
We	O
examined	O
gneomic	O
DNA	O
from	O
83	O
(	O
for	O
BRAC1	O
185deAlG	O
)	O
or	O
82	O
(	O
for	O
BCRA2	O
617d4elT	O
)	O
Ahskenazi	O
Jweish	O
prosttae	B-Disease
cnacer	I-Disease
paitents	O
,	O
most	O
of	O
whom	O
were	O
terated	O
at	O
a	O
relatively	O
yonug	O
age	O
,	O
for	O
the	O
most	O
common	O
germlnie	O
mutaiton	O
in	O
each	O
gnee	O
seen	O
in	O
the	O
Asheknazi	O
populaiton	O
.	O

RESLUTS	O
Our	O
sutdy	O
should	O
have	O
been	O
able	O
to	O
deetct	O
a	O
4	O
-	O
5	O
-	O
fold	O
incresae	O
in	O
the	O
rsik	O
of	O
prsotate	B-Disease
cnacer	I-Disease
due	O
to	O
mutatoin	O
of	O
BCRA1	O
or	O
BCRA2	O
.	O

However	O
,	O
only	O
one	O
(	O
1	O
.	O
15	O
%	O
;	O
95	O
%	O
conifdence	O
itnerval	O
,	O
0	O
-	O
3	O
.	O
6	O
%	O
)	O
of	O
the	O
patinets	O
was	O
hteerozygous	O
for	O
the	O
BRAC1	O
muatnt	O
alelle	O
,	O
and	O
only	O
two	O
were	O
hetreozygous	O
for	O
the	O
BCRA2	O
mutaiton	O
(	O
2	O
.	O
4	O
%	O
;	O
95	O
%	O
confidecne	O
inetrval	O
,	O
0	O
-	O
6	O
.	O
2	O
%	O
)	O
.	O

CONLCUSIONS	O
The	O
incidnece	O
of	O
each	O
of	O
the	O
gerlmine	O
mutatinos	O
in	O
these	O
porstate	B-Disease
cnacer	I-Disease
patietns	O
closely	O
matched	O
their	O
inciednce	O
(	O
about	O
1	O
%	O
)	O
in	O
the	O
general	O
Ahskenazi	O
Jeiwsh	O
popluation	O
.	O

This	O
suggests	O
that	O
unlike	O
csaes	O
of	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
canecrs	I-Disease
,	O
muattions	O
in	O
BRAC1	O
or	O
BCRA2	O
do	O
not	O
significantly	O
predispose	O
men	O
to	O
porstate	B-Disease
canecr	I-Disease

Btea	O
-	O
cateinn	O
accumualtion	O
and	O
mtuation	O
of	O
the	O
CTNNB1	O
gnee	O
in	O
hepaotblastoma	B-Disease
.	O

Hepatobalstoma	B-Disease
is	O
a	O
rrae	O
malingant	B-Disease
tuomr	I-Disease
of	I-Disease
the	I-Disease
lievr	I-Disease
that	O
occurs	O
in	O
chlidren	O
at	O
an	O
aevrage	O
age	O
of	O
2	O
to	O
3	O
yeras	O
.	O

Epidemiloogic	O
stuides	O
have	O
shown	O
an	O
incraesed	O
ferquency	O
of	O
this	O
tmuor	B-Disease
tpye	O
in	O
famliies	O
afefcted	O
by	O
adenomatuos	B-Disease
ployposis	I-Disease
cloi	I-Disease
.	O

In	O
addition	O
to	O
the	O
epideimologic	O
dtaa	O
,	O
moelcular	O
genteic	O
studeis	O
suggest	O
that	O
incativation	O
of	O
the	O
APC	B-Disease
tuomr	I-Disease
suprpessor	O
may	O
be	O
involved	O
in	O
heaptoblastoma	B-Disease
tumorigeneiss	O
.	O

A	O
major	O
fucntion	O
of	O
APC	O
is	O
the	O
downregualtion	O
of	O
btea	O
-	O
cateinn	O
,	O
a	O
trasncription	O
-	O
atcivating	O
portein	O
with	O
oncogeinc	O
potenital	O
.	O

In	O
an	O
ongoing	O
immunohisotchemical	O
stduy	O
of	O
btea	O
-	O
caetnin	O
expression	O
in	O
sporaidc	O
caess	O
of	O
tmuor	B-Disease
types	O
that	O
are	O
associated	O
with	O
adenomatuos	B-Disease
polypsois	I-Disease
cloi	I-Disease
,	O
we	O
observed	O
incraesed	O
btea	O
-	O
cateinn	O
levles	O
in	O
the	O
cytopalsm	O
and	O
in	O
the	O
nulcei	O
of	O
three	O
invetsigated	O
hepatolbastomas	B-Disease
.	O

Seuqencing	O
of	O
eoxn	O
3	O
of	O
the	O
btea	O
-	O
cateinn	O
gnee	O
(	O
CTNNB1	O
)	O
rveealed	O
an	O
activatnig	O
mtuation	O
in	O
one	O
of	O
the	O
tmuor	B-Disease
sapmles	O
.	O

Our	O
dtaa	O
indicate	O
for	O
the	O
first	O
tmie	O
that	O
btea	O
-	O
ctaenin	O
accumulatoin	O
may	O
play	O
a	O
role	O
in	O
the	O
devleopment	O
of	O
hpeatoblastoma	B-Disease
and	O
that	O
acitvating	O
muattions	O
of	O
the	O
btea	O
-	O
caetnin	O
gnee	O
may	O
substitute	O
biallelic	O
APC	O
incativation	O
in	O
this	O
tuomr	B-Disease
tpye	O
.	O

Geens	O
Chormosomes	O
Cnacer	O
25	O
399	O
-	O
402	O
,	O
1999	O
.	O
.	O

Decresae	O
in	O
GTP	O
cylcohydrolase	O
I	O
gnee	O
epxression	O
caused	O
by	O
inactivatoin	O
of	O
one	O
allele	O
in	O
herdeitary	B-Disease
progressive	I-Disease
dytsonia	I-Disease
with	O
marked	O
dirunal	O
flcutuation	O
.	O

Hereidtary	B-Disease
prgoressive	I-Disease
dystnoia	I-Disease
with	O
marked	O
diuranl	O
fluctaution	O
(	O
HPD	B-Disease
;	O
dpoa	B-Disease
-	I-Disease
resposnive	I-Disease
dystoina	I-Disease
,	O
DRD	B-Disease
)	O
have	O
been	O
recently	O
found	O
to	O
be	O
caused	O
by	O
a	O
geentic	B-Disease
dfeect	I-Disease
in	O
the	O
GTP	O
cycloyhdrolase	O
I	O
(	O
GHC1	O
)	O
gnee	O
.	O

In	O
this	O
sutdy	O
,	O
we	O
quanitfied	O
the	O
mNRA	O
leevl	O
of	O
GHC1	O
in	O
phytohemaggltuinin	O
(	O
PHA	O
)	O
-	O
stimluated	O
mononculear	O
bolod	O
cells	O
from	O
one	O
Jaapnese	O
fmaily	O
that	O
do	O
not	O
have	O
a	O
mtuation	O
in	O
the	O
coidng	O
regoin	O
or	O
slpice	O
juncitons	O
of	O
the	O
gnee	O
.	O

The	O
reuslts	O
showed	O
that	O
the	O
amounts	O
of	O
the	O
GHC1	O
mNRA	O
were	O
decreaesd	O
to	O
about	O
40	O
%	O
of	O
the	O
nomral	O
lveel	O
in	O
both	O
paitents	O
and	O
crariers	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
the	O
GHC1	O
mNRA	O
was	O
tarnscribed	O
from	O
only	O
one	O
allele	O
,	O
indicating	O
that	O
the	O
other	O
allele	O
was	O
in	O
an	O
inatcive	O
state	O
.	O

These	O
resutls	O
suggest	O
that	O
some	O
novel	O
mtuations	O
should	O
exist	O
on	O
one	O
of	O
the	O
alllees	O
in	O
some	O
unknown	O
rgeion	O
of	O
the	O
GHC1	O
gnee	O
,	O
and	O
may	O
decresae	O
the	O
GHC1	O
mNRA	O
causing	O
the	O
HPD	B-Disease
/	O
DRD	B-Disease
symtpoms	O
.	O
.	O

Suflate	O
trnasport	O
is	O
not	O
imapired	O
in	O
penrded	B-Disease
syndorme	I-Disease
thyorcytes	O
.	O

Pnedred	B-Disease
sydnrome	I-Disease
is	O
the	O
most	O
common	O
form	O
of	O
sydnromic	B-Disease
deanfess	I-Disease
,	O
chaarcterized	O
by	O
dysohrmonogenic	B-Disease
gioter	I-Disease
associated	O
with	O
sensroy	B-Disease
-	I-Disease
neuarl	I-Disease
deafnses	I-Disease
.	O

The	O
gnee	O
responsible	O
for	O
the	O
dsiease	O
(	O
PDS	B-Disease
)	O
has	O
been	O
colned	O
,	O
but	O
its	O
funtcion	O
is	O
as	O
yet	O
unknown	O
and	O
the	O
conenction	O
between	O
thryoid	B-Disease
gotier	I-Disease
and	O
senosry	B-Disease
-	I-Disease
nerual	I-Disease
deafnses	I-Disease
remains	O
an	O
enigma	O
.	O

PDS	O
coeds	O
for	O
a	O
novel	O
prtoein	O
,	O
pendirn	O
,	O
which	O
is	O
closely	O
related	O
to	O
a	O
number	O
of	O
suafte	O
tranpsorters	O
.	O

Mecahnisms	O
by	O
which	O
abnomral	O
slufate	O
tranpsort	O
could	O
dleeteriously	O
affect	O
ioidde	O
organifictaion	O
have	O
been	O
proposed	O
.	O

We	O
tesetd	O
sulftae	O
tranpsort	O
in	O
thyorcytes	O
obtained	O
from	O
Penrded	B-Disease
sydnrome	I-Disease
pateints	O
and	O
found	O
that	O
it	O
was	O
not	O
defecitve	O
.	O

This	O
suggests	O
that	O
pnedrin	O
in	O
fact	O
may	O
not	O
be	O
a	O
slufate	O
tarnsporter	O
,	O
and	O
emphasizes	O
the	O
importance	O
of	O
functinoal	O
stduies	O
on	O
this	O
novel	O
prtoein	O
.	O
.	O

Smlal	O
dleetions	O
in	O
the	O
tpye	O
II	O
collagen	O
trpile	O
hleix	O
produce	O
kinest	B-Disease
dypslasia	I-Disease
.	O

Kinest	B-Disease
dysplsaia	I-Disease
is	O
a	O
mdoerately	O
sveere	O
tpye	B-Disease
II	I-Disease
collgaenopathy	I-Disease
,	O
chraacterized	O
by	O
short	O
turnk	O
and	O
libms	O
,	O
kyphsocoliosis	B-Disease
,	O
mifdace	B-Disease
hypopalsia	I-Disease
,	O
seevre	O
moypia	B-Disease
,	O
and	O
haering	B-Disease
lsos	I-Disease
.	O

Mutatoins	O
in	O
the	O
gnee	O
that	O
encoeds	O
tpye	O
II	O
collagen	O
(	O
COLA21	O
)	O
,	O
the	O
predoimnant	O
portein	O
of	O
cartliage	O
,	O
have	O
been	O
idenitfied	O
in	O
a	O
number	O
of	O
indiivduals	O
with	O
Kniset	B-Disease
dysplaisa	I-Disease
.	O

All	O
but	O
two	O
of	O
these	O
previously	O
described	O
muttaions	O
cause	O
in	O
-	O
frmae	O
delteions	O
in	O
tpye	O
II	O
colalgen	O
,	O
either	O
by	O
small	O
deleitons	O
in	O
the	O
gnee	O
or	O
slpice	O
stie	O
alteartions	O
.	O

Furthermore	O
,	O
all	O
but	O
one	O
of	O
these	O
mtuations	O
is	O
located	O
between	O
exnos	O
12	O
and	O
24	O
in	O
the	O
CO2LA1	O
gnee	O
.	O

We	O
used	O
hetreoduplex	O
analsyis	O
to	O
identify	O
sqeuence	O
anmoalies	O
in	O
five	O
individulas	O
with	O
Kinest	B-Disease
dsyplasia	I-Disease
.	O

Sequecning	O
of	O
the	O
index	O
ptaients	O
genmoic	O
DNA	O
identiifed	O
four	O
new	O
doimnant	O
muttaions	O
in	O
CLO2A1	O
that	O
result	O
in	O
Kniset	B-Disease
dyspalsia	I-Disease
a	O
21	O
-	O
bp	O
deeltion	O
in	O
eoxn	O
16	O
,	O
an	O
18	O
-	O
bp	O
deleiton	O
in	O
eoxn	O
19	O
,	O
and	O
4	O
-	O
bp	O
deletoins	O
in	O
the	O
slpice	O
doonr	O
sties	O
of	O
intrnos	O
14	O
and	O
20	O
.	O

A	O
previously	O
described	O
28	O
-	O
bp	O
deeltion	O
at	O
the	O
CO2LA1	O
eoxn	O
12	O
-	O
itnron	O
12	O
jnuction	O
,	O
dleeting	O
the	O
splcie	O
doonr	O
stie	O
,	O
was	O
idenitfied	O
in	O
the	O
fifth	O
csae	O
.	O

The	O
latter	O
three	O
mtuations	O
are	O
preditced	O
to	O
result	O
in	O
eoxn	O
sikpping	O
in	O
the	O
mNRA	O
encoedd	O
from	O
the	O
mutnat	O
alllee	O
.	O

These	O
dtaa	O
suggest	O
that	O
Kinest	B-Disease
dsyplasia	I-Disease
rseults	O
from	O
shotrer	O
tpye	O
II	O
collaegn	O
moonmers	O
,	O
and	O
support	O
the	O
hypotehsis	O
that	O
atleration	O
of	O
a	O
specific	O
COLA21	O
dmoain	O
,	O
which	O
may	O
sapn	O
from	O
exnos	O
12	O
to	O
24	O
,	O
leads	O
to	O
the	O
Kniset	B-Disease
dyspalsia	I-Disease
phenotpye	O
.	O
.	O

Classical	B-Disease
galatcosemia	I-Disease
and	O
mtuations	O
at	O
the	O
glaactose	O
-	O
1	O
-	O
phospahte	O
uriydl	O
transfrease	O
(	O
GLAT	O
)	O
gnee	O
.	O

Classical	B-Disease
galactoesmia	I-Disease
is	O
caused	O
by	O
a	O
defciiency	O
in	O
activtiy	O
of	O
the	O
enzmye	O
gaalctose	O
-	O
1	O
-	O
phospahte	O
uirdyl	O
trasnferase	O
(	O
GLAT	O
)	O
,	O
which	O
,	O
in	O
turn	O
,	O
is	O
caused	O
by	O
mutatoins	O
at	O
the	O
GLAT	O
gnee	O
.	O

The	O
disroder	O
exhibits	O
considerable	O
allleic	O
heterogeenity	O
and	O
,	O
at	O
the	O
end	O
of	O
1998	O
,	O
more	O
than	O
150	O
different	O
base	O
chagnes	O
were	O
recorded	O
in	O
24	O
different	O
popultaions	O
and	O
ehtnic	O
gropus	O
in	O
15	O
cuontries	O
worldwide	O
.	O

The	O
mutaitons	O
most	O
frequently	O
cited	O
are	O
Q818R	O
,	O
K285N	O
,	O
S315L	O
,	O
and	O
N341D	O
.	O

Q818R	O
is	O
the	O
most	O
common	O
mutatoin	O
in	O
Euorpean	O
popualtions	O
or	O
in	O
those	O
predominantly	O
of	O
Europaen	O
desecnt	O
.	O

Overall	O
,	O
it	O
accounts	O
for	O
60	O
-	O
70	O
%	O
of	O
muatnt	O
chroomsomes	O
,	O
but	O
there	O
are	O
significant	O
differences	O
in	O
its	O
relative	O
frequnecy	O
in	O
indviidual	O
popluations	O
.	O

Idnividuals	O
homoallleic	O
for	O
Q188R	O
tend	O
to	O
have	O
a	O
sevree	O
pehnotype	O
and	O
this	O
is	O
in	O
keeping	O
with	O
the	O
virtually	O
complete	O
lsos	O
of	O
enzmye	O
actviity	O
observed	O
in	O
in	O
vitro	O
exrpession	O
sysetms	O
.	O

Globally	O
,	O
K285N	O
is	O
rarer	O
,	O
but	O
in	O
many	O
Euroepan	O
populatoins	O
it	O
can	O
be	O
found	O
on	O
25	O
-	O
40	O
%	O
of	O
muatnt	O
chromosmoes	O
.	O

It	O
is	O
invariably	O
associated	O
with	O
a	O
sveere	O
phenotpye	O
.	O

S153L	O
is	O
found	O
almost	O
exclusively	O
in	O
Afrcian	O
Ameriacns	O
.	O

In	O
vitro	O
expression	O
rseults	O
are	O
dsicrepant	O
,	O
but	O
some	O
idnividuals	O
carrying	O
S153L	O
appear	O
to	O
exhibit	O
GLAT	O
actiivty	O
in	O
some	O
tisuses	O
.	O

Daurte	O
1	O
(	O
or	O
Los	O
Agneles	O
)	O
and	O
Durate	O
2	O
(	O
or	O
Daurte	O
)	O
vraiants	O
carry	O
the	O
same	O
amnio	O
aicd	O
substituiton	O
,	O
N341D	O
,	O
even	O
though	O
D1	O
is	O
associated	O
with	O
incresaed	O
eyrthrocyte	O
GLAT	O
actiivty	O
and	O
D2	O
with	O
reduecd	O
actiivty	O
.	O

N341D	O
is	O
in	O
linkgae	O
diseqiulibrium	O
with	O
other	O
base	O
cahnges	O
that	O
differ	O
on	O
the	O
D1	O
and	O
D2	O
alllees	O
.	O

N341D	O
does	O
not	O
impiar	O
GLAT	O
actviity	O
in	O
in	O
vitro	O
expression	O
systmes	O
.	O

However	O
,	O
there	O
are	O
dfiferences	O
in	O
the	O
abundnace	O
of	O
GLAT	O
protien	O
in	O
lymhpoblastoid	O
cells	O
liens	O
from	O
D2	O
and	O
D1	O
indiviudals	O
.	O

It	O
is	O
unclear	O
whether	O
the	O
specific	O
molceular	O
chnages	O
that	O
distinguish	O
the	O
D1	O
and	O
D2	O
alleels	O
account	O
for	O
the	O
different	O
activiteis	O
.	O

The	O
considerable	O
gneetic	O
heterogneeity	O
doucmented	O
to	O
date	O
undoubtedly	O
contributes	O
to	O
the	O
phneotypic	O
heteroegneity	O
that	O
is	O
observed	O
in	O
galactosmeia	B-Disease
.	O

The	O
additional	O
effetcs	O
of	O
nnoallelic	O
variatoin	O
and	O
other	O
constittuional	O
factros	O
on	O
phenoytpic	O
variabliity	O
remain	O
to	O
be	O
elucidated	O
.	O
.	O

Mutatinos	O
of	O
the	O
VHL	B-Disease
gnee	O
in	O
sproadic	B-Disease
reanl	I-Disease
clel	I-Disease
carcionma	I-Disease
:	O
definitoin	O
of	O
a	O
rsik	O
fcator	O
for	O
VHL	B-Disease
paitents	O
to	O
develop	O
an	O
RCC	B-Disease
.	O

To	O
investiagte	O
the	O
nature	O
of	O
somaitc	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lnidau	I-Disease
(	O
VHL	B-Disease
)	O
muattions	O
,	O
we	O
analzyed	O
173	O
priamry	O
sporaidc	O
huamn	O
reanl	B-Disease
clel	I-Disease
caricnomas	I-Disease
for	O
muttaions	O
of	O
the	O
VHL	B-Disease
tmuor	I-Disease
supperssor	O
gnee	O
,	O
using	O
polmyerase	O
cahin	O
raection	O
(	O
PCR	O
)	O
and	O
single	O
-	O
strnad	O
conformatinoal	O
polymorpihsm	O
aanlysis	O
(	O
SCSP	O
)	O
of	O
DNA	O
.	O

We	O
dteected	O
abnoraml	O
SCSP	O
pattern	O
in	O
73	O
samlpes	O
.	O

After	O
sequencnig	O
,	O
we	O
iedntified	O
microdleetions	O
in	O
58	O
%	O
of	O
caess	O
,	O
microinsertoins	O
in	O
17	O
%	O
,	O
nosnense	O
muattions	O
in	O
8	O
%	O
,	O
and	O
misesnse	O
mutaitons	O
in	O
17	O
%	O
.	O

Among	O
these	O
mutaitons	O
,	O
50	O
%	O
correspond	O
to	O
new	O
mutatinos	O
.	O

VHL	B-Disease
muattions	O
were	O
found	O
only	O
in	O
the	O
nonpapilalry	B-Disease
rneal	I-Disease
clel	I-Disease
carcnioma	I-Disease
(	O
RCC	B-Disease
)	O
subtpye	O
,	O
as	O
previously	O
reported	O
.	O

To	O
cmopare	O
somaitc	O
and	O
gerlmine	O
mutatinos	O
,	O
we	O
used	O
the	O
VHL	B-Disease
databsae	O
,	O
which	O
includes	O
507	O
mutatinos	O
.	O

The	O
stduy	O
of	O
mutatioanl	O
evetns	O
reveaeld	O
a	O
significant	O
difference	O
between	O
somtaic	O
and	O
gemrline	O
mtuations	O
with	O
muttaions	O
leading	O
to	O
turncated	O
proetins	O
observed	O
in	O
78	O
%	O
of	O
soamtic	O
mutatinos	O
vs	O
only	O
37	O
%	O
in	O
gemrline	O
mutatoins	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

We	O
postulated	O
that	O
a	O
specific	O
pattren	O
of	O
VHL	B-Disease
mutatoins	O
is	O
associated	O
with	O
spordaic	B-Disease
RCC	I-Disease
.	O

This	O
pattren	O
corresponds	O
to	O
mutatoins	O
leading	O
mainly	O
to	O
turncated	O
porteins	O
with	O
few	O
specific	O
msisense	O
mutatoins	O
.	O

We	O
then	O
analyezd	O
the	O
occrurence	O
of	O
RCC	B-Disease
in	O
VHL	B-Disease
famileis	O
,	O
based	O
on	O
the	O
nature	O
of	O
mutaitons	O
.	O

We	O
observed	O
RCC	B-Disease
in	O
at	O
least	O
one	O
member	O
of	O
the	O
VHL	B-Disease
famileis	O
in	O
77	O
%	O
of	O
caess	O
with	O
mutaitons	O
leading	O
to	O
trucnated	O
protiens	O
versus	O
55	O
%	O
in	O
csaes	O
with	O
missesne	O
mtuations	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Thus	O
,	O
mtuations	O
resulting	O
in	O
turncated	O
proetins	O
may	O
lead	O
to	O
a	O
hgiher	O
rsik	O
of	O
RCC	B-Disease
in	O
VHL	B-Disease
pateints	O

Defecitve	O
CLTA	O
-	O
4	O
cyclnig	O
patwhay	O
in	O
Chedaik	B-Disease
-	I-Disease
Higashi	I-Disease
syndrmoe	I-Disease
:	O
a	O
possible	O
mechainsm	O
for	O
dergeulation	O
of	O
T	O
lymphoycte	O
activatoin	O
.	O

Cytotxoic	O
T	O
lmyphocyte	O
-	O
associated	O
anitgen	O
4	O
(	O
CLTA	O
-	O
4	O
,	O
also	O
known	O
as	O
CD512	O
)	O
has	O
been	O
shown	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
rgeulation	O
of	O
T	O
clel	O
activtaion	O
.	O

Its	O
membrnae	O
expression	O
is	O
highly	O
regulated	O
by	O
endoyctosis	O
and	O
traffciking	O
through	O
the	O
secrteory	O
lysosmoe	O
patwhay	O
.	O

Chdeiak	B-Disease
-	I-Disease
Higashi	I-Disease
synrdome	I-Disease
(	O
CHS	B-Disease
)	O
is	O
an	O
inhreited	B-Disease
disroder	I-Disease
caused	O
by	O
mutatinos	O
in	O
the	O
lsyosomal	O
traffciking	O
regulaotr	O
gnee	O
,	O
LSYT	O
.	O

It	O
reuslts	O
in	O
defectvie	O
membrnae	O
taregting	O
of	O
the	O
protenis	O
present	O
in	O
sceretory	O
lysosmoes	O
,	O
and	O
it	O
is	O
associated	O
with	O
a	O
variety	O
of	O
featrues	O
,	O
including	O
a	O
lymphoprolfierative	B-Disease
syndrmoe	I-Disease
with	O
hemophagocytsois	B-Disease
.	O

The	O
mruine	O
euqivalent	O
of	O
CHS	B-Disease
,	O
begie	O
mcie	O
,	O
present	O
similar	O
characteristcis	O
but	O
do	O
not	O
develop	O
the	O
lymphoprolifeartive	B-Disease
sydnrome	I-Disease
.	O

We	O
show	O
herein	O
that	O
CLTA	O
-	O
4	O
is	O
present	O
in	O
enlagred	O
,	O
abnomral	O
vseicles	O
in	O
CHS	B-Disease
T	O
clels	O
and	O
is	O
not	O
properly	O
experssed	O
at	O
the	O
clel	O
surafce	O
after	O
T	O
clel	O
activaiton	O
,	O
whereas	O
its	O
sruface	O
exrpession	O
is	O
not	O
imparied	O
.	O

It	O
is	O
therefore	O
proposed	O
that	O
the	O
defcetive	O
sufrace	O
exrpession	O
of	O
CLTA	O
-	O
4	O
by	O
CHS	B-Disease
T	O
clels	O
is	O
involved	O
in	O
the	O
genertaion	O
of	O
lymphoprolifeartive	B-Disease
diesase	I-Disease
.	O

This	O
obsevration	O
may	O
provide	O
insight	O
into	O
the	O
role	O
of	O
CLTA	O
-	O
4	O
in	O
huamns	O
.	O
.	O

Porteolipoprotein	O
gnee	O
anlaysis	O
in	O
82	O
ptaients	O
with	O
sproadic	O
Pelizaues	B-Disease
-	I-Disease
Merzbacehr	I-Disease
Diesase	I-Disease
:	O
duplicatoins	O
,	O
the	O
major	O
cause	O
of	O
the	O
dsiease	O
,	O
originate	O
more	O
frequently	O
in	O
mlae	O
grem	O
clels	O
,	O
but	O
point	O
muttaions	O
do	O
not	O
.	O

The	O
Clniical	O
Euorpean	O
Netwrok	O
on	O
Brian	B-Disease
Dysmyelintaing	I-Disease
Disesae	I-Disease
.	O

Pleizaeus	B-Disease
-	I-Disease
Merzbahcer	I-Disease
Disaese	I-Disease
(	O
PMD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
developmnetal	I-Disease
defcet	I-Disease
of	I-Disease
myeliantion	I-Disease
affectnig	O
the	O
cnetral	O
nerovus	O
sytsem	O
and	O
segregtaing	O
with	O
the	O
proteolipoportein	O
(	O
PLP	O
)	O
loucs	O
.	O

Investigatnig	O
82	O
strictly	O
selected	O
spoardic	O
caess	O
of	O
PMD	B-Disease
,	O
we	O
found	O
PLP	O
mutaitons	O
in	O
77	O
%	O
;	O
complete	O
PLP	O
-	O
gnee	O
duplicaitons	O
were	O
the	O
most	O
freuqent	O
abnormlaity	O
(	O
62	O
%	O
)	O
,	O
whereas	O
point	O
mutatoins	O
in	O
coidng	O
or	O
spilce	O
-	O
stie	O
regoins	O
of	O
the	O
gnee	O
were	O
involved	O
less	O
frequently	O
(	O
38	O
%	O
)	O
.	O

We	O
anlayzed	O
the	O
matrenal	O
stauts	O
of	O
56	O
caess	O
to	O
determine	O
the	O
oriign	O
of	O
both	O
types	O
of	O
PLP	O
muttaion	O
,	O
since	O
this	O
is	O
rleevant	O
to	O
geentic	O
counselnig	O
.	O

In	O
the	O
22	O
point	O
muttaions	O
,	O
68	O
%	O
of	O
mtohers	O
were	O
heterzoygous	O
for	O
the	O
muttaion	O
,	O
a	O
value	O
idnetical	O
to	O
the	O
two	O
-	O
thirds	O
of	O
carirer	O
mtohers	O
that	O
would	O
be	O
expected	O
if	O
there	O
were	O
an	O
euqal	O
muttaion	O
rtae	O
in	O
mlae	O
and	O
feamle	O
grem	O
cells	O
.	O

In	O
sharp	O
contrast	O
,	O
among	O
the	O
34	O
duplictaed	O
csaes	O
,	O
91	O
%	O
of	O
motehrs	O
were	O
carrires	O
,	O
a	O
value	O
significantly	O
(	O
chi2	O
=	O
9	O
.	O
20	O
,	O
P	O
<	O
.	O
01	O
)	O
in	O
favor	O
of	O
a	O
mlae	O
bais	O
,	O
with	O
an	O
etsimation	O
of	O
the	O
mlae	O
/	O
feamle	O
mutatoin	O
freqeuncy	O
(	O
k	O
)	O
of	O
9	O
.	O

3	O
3	O
.	O

Moreover	O
,	O
we	O
observed	O
the	O
occrurence	O
of	O
de	O
novo	O
muttaions	O
between	O
paerntal	O
and	O
grandpraental	O
genertaions	O
in	O
17	O
three	O
-	O
geenration	O
famileis	O
,	O
which	O
allowed	O
a	O
direct	O
estmiation	O
of	O
the	O
k	O
value	O
(	O
k	O
=	O
11	O
)	O
.	O

Again	O
,	O
a	O
significant	O
mlae	O
muattion	O
imbalacne	O
was	O
observed	O
only	O
for	O
the	O
duplicatoins	O
.	O

Chromosmoe	O
brekaage	O
in	O
the	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
and	I-Disease
Aneglman	I-Disease
syndroems	I-Disease
involves	O
recomibnation	O
between	O
large	O
,	O
transrcibed	O
rpeeats	O
at	O
porximal	O
and	O
disatl	O
breakpoitns	O
.	O

Parder	B-Disease
-	I-Disease
Wlili	I-Disease
snydrome	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Aneglman	B-Disease
syndorme	I-Disease
(	O
AS	B-Disease
)	O
are	O
distinct	O
neuroebhavioral	B-Disease
disodrers	I-Disease
that	O
most	O
often	O
arise	O
from	O
a	O
4	O
-	O
Mb	O
deletoin	O
of	O
chromoosme	O
15q11	O
-	O
q13	O
during	O
paetrnal	O
or	O
materanl	O
gameotgenesis	O
,	O
respectively	O
.	O

At	O
a	O
de	O
novo	O
frqeuency	O
of	O
approximately	O
.	O

67	O
-	O
1	O
/	O
10	O
,	O
000	O
birhts	O
,	O
these	O
deeltions	O
represent	O
a	O
common	O
strucutral	O
chromsoome	O
change	O
in	O
the	O
hmuan	O
geonme	O
.	O

To	O
elucidate	O
the	O
mecahnism	O
underlying	O
these	O
evnets	O
,	O
we	O
chaarcterized	O
the	O
rgeions	O
that	O
contain	O
two	O
proxmial	O
braekpoint	O
clusetrs	O
and	O
a	O
disatl	O
clsuter	O
.	O

Nvoel	O
DNA	O
sequecnes	O
potentially	O
associated	O
with	O
the	O
breakpionts	O
were	O
positoinally	O
cloend	O
from	O
YCAs	O
within	O
or	O
near	O
these	O
rgeions	O
.	O

Aanlyses	O
of	O
rodnet	O
-	O
hmuan	O
smoatic	O
-	O
clel	O
hbyrids	O
,	O
YAC	O
cotnigs	O
,	O
and	O
FSIH	O
of	O
noraml	O
or	O
rearranged	O
chromosmoes	O
15	O
idetnified	O
duplciated	O
seuqences	O
(	O
the	O
END	O
repaets	O
)	O
at	O
or	O
near	O
the	O
breakponits	O
.	O

The	O
END	O
-	O
repaet	O
units	O
are	O
derived	O
from	O
large	O
genmoic	O
duplicatinos	O
of	O
a	O
novel	O
gnee	O
(	O
HREC2	O
)	O
,	O
many	O
coipes	O
of	O
which	O
are	O
tarnscriptionally	O
acitve	O
in	O
gerlmine	O
tissues	O
.	O

One	O
of	O
five	O
PWS	B-Disease
/	O
AS	B-Disease
patietns	O
anaylzed	O
to	O
date	O
has	O
an	O
identifiable	O
,	O
rearranged	O
HREC2	O
trancsript	O
derived	O
from	O
the	O
delteion	O
evnet	O
.	O

We	O
postulate	O
that	O
the	O
END	O
reepats	O
flanking	O
15q11	O
-	O
q13	O
mediate	O
homoloogus	O
reocmbination	O
resulting	O
in	O
delteion	O
.	O

Furthermore	O
,	O
we	O
propose	O
that	O
actvie	O
transcripiton	O
of	O
these	O
repetas	O
in	O
mlae	O
and	O
fmeale	O
grem	O
clels	O
may	O
facilitate	O
the	O
homloogous	O
recombiantion	O
procses	O
.	O

Liknage	O
analyiss	O
in	O
a	O
large	O
Brzailian	O
famliy	O
with	O
van	B-Disease
der	I-Disease
Wuode	I-Disease
sydnrome	I-Disease
suggests	O
the	O
existence	O
of	O
a	O
suscpetibility	O
lcous	O
for	O
celft	B-Disease
paalte	I-Disease
at	O
17p11	O
.	O
2	O
-	O
11	O
.	O
1	O
.	O

van	B-Disease
der	I-Disease
Wodue	I-Disease
sydnrome	I-Disease
(	O
VWS	B-Disease
)	O
,	O
which	O
has	O
been	O
mapped	O
to	O
1q32	O
-	O
41	O
,	O
is	O
cahracterized	O
by	O
ptis	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
sinsues	I-Disease
of	I-Disease
the	I-Disease
lwoer	I-Disease
lip	I-Disease
,	O
celft	B-Disease
lip	I-Disease
/	I-Disease
paltae	I-Disease
(	O
CL	B-Disease
/	I-Disease
P	I-Disease
)	O
,	O
celft	B-Disease
paalte	I-Disease
(	O
CP	B-Disease
)	O
,	O
bfiid	B-Disease
uuvla	I-Disease
,	O
and	O
hypodotnia	B-Disease
(	O
H	B-Disease
)	O
.	O

The	O
epxression	O
of	O
VWS	B-Disease
,	O
which	O
has	O
incopmlete	O
penetracne	O
,	O
is	O
highly	O
varaible	O
.	O

Both	O
the	O
occurrecne	O
of	O
CL	B-Disease
/	I-Disease
P	I-Disease
and	O
CP	B-Disease
within	O
the	O
same	O
geenalogy	O
and	O
a	O
rceurrence	O
rsik	O
<	O
40	O
%	O
for	O
CP	B-Disease
among	O
descendants	O
with	O
VWS	B-Disease
have	O
suggested	O
that	O
the	O
developmnet	O
of	O
cletfs	B-Disease
in	O
this	O
snydrome	O
is	O
infleunced	O
by	O
modifying	O
geens	O
at	O
other	O
lcoi	O
.	O

To	O
tset	O
this	O
hyopthesis	O
,	O
we	O
have	O
conducted	O
linkgae	O
analsyis	O
in	O
a	O
large	O
Brazliian	O
kinrded	O
with	O
VWS	B-Disease
,	O
considering	O
as	O
affected	O
the	O
indviiduals	O
with	O
CP	B-Disease
,	O
regardless	O
of	O
whether	O
it	O
is	O
associated	O
with	O
other	O
clniical	O
sgins	O
of	O
VWS	B-Disease
.	O

Our	O
resutls	O
suggest	O
that	O
a	O
gnee	O
at	O
17p11	O
.	O

2	O
-	O
11	O
2	O
-	O
11	O
.	O

1	O
,	O
together	O
with	O
the	O
VWS	B-Disease
gnee	O
at	O
13p2	O
-	O
41	O
,	O
enahnces	O
the	O
probabliity	O
of	O
CP	B-Disease
in	O
an	O
idnividual	O
carrying	O
the	O
two	O
at	O
-	O
rsik	O
gnees	O
.	O

If	O
this	O
hyptohesis	O
is	O
confirmed	O
in	O
other	O
VWS	B-Disease
peidgrees	O
,	O
it	O
will	O
represent	O
one	O
of	O
the	O
first	O
examples	O
of	O
a	O
gnee	O
,	O
mapepd	O
through	O
linkgae	O
anlaysis	O
,	O
which	O
modiifes	O
the	O
exprsesion	O
of	O
a	O
major	O
gnee	O
.	O

New	O
mutatinos	O
,	O
polymrophisms	O
,	O
and	O
rrae	O
variatns	O
in	O
the	O
ATM	O
gnee	O
detetced	O
by	O
a	O
novel	O
SCSP	O
strategy	O
.	O

The	O
gnee	O
for	O
ataixa	B-Disease
-	I-Disease
telanigectasia	I-Disease
,	O
ATM	O
,	O
spans	O
about	O
150	O
kb	O
of	O
gneomic	O
DNA	O
.	O

ATM	O
mutaitons	O
are	O
found	O
along	O
the	O
entire	O
gnee	O
,	O
with	O
no	O
eviednce	O
of	O
a	O
mutaitonal	O
hot	O
sopt	O
.	O

Using	O
DNA	O
as	O
the	O
starting	O
materail	O
,	O
we	O
screened	O
the	O
ATM	O
gnee	O
in	O
92	O
A	B-Disease
-	I-Disease
T	I-Disease
pateints	O
,	O
using	O
an	O
otpimized	O
single	O
-	O
strnad	O
conforamtion	O
polyomrphism	O
(	O
SCSP	O
)	O
tecnhique	O
that	O
detceted	O
all	O
previously	O
known	O
muattions	O
in	O
the	O
polmyerase	O
cahin	O
reatcion	O
(	O
PCR	O
)	O
sgements	O
being	O
analyezd	O
.	O

To	O
expedite	O
screeinng	O
,	O
we	O
sequentially	O
loaedd	O
the	O
SCSP	O
gles	O
with	O
three	O
different	O
stes	O
of	O
PCR	O
porducts	O
that	O
were	O
preetsted	O
to	O
avoid	O
overlapping	O
patetrns	O
.	O

Many	O
of	O
the	O
DNA	O
chagnes	O
we	O
detceted	O
were	O
intrgaenic	O
polymoprhisms	O
.	O

Of	O
an	O
expected	O
177	O
unknown	O
mtuations	O
,	O
we	O
detetced	O
approximately	O
70	O
%	O
,	O
mostly	O
portein	O
trucnating	O
muattions	O
(	O
that	O
would	O
have	O
been	O
deetctable	O
by	O
portein	O
trucnation	O
testnig	O
if	O
RNA	O
starting	O
matreial	O
had	O
been	O
available	O
)	O
.	O

Mutatinos	O
have	O
now	O
been	O
defined	O
for	O
every	O
eoxn	O
of	O
the	O
ATM	O
gnee	O
.	O

Herein	O
,	O
we	O
present	O
35	O
new	O
muattions	O
and	O
34	O
new	O
intrageinc	O
polymoprhisms	O
or	O
rrae	O
vraiants	O
within	O
the	O
ATM	O
gnee	O
.	O

This	O
is	O
the	O
most	O
comprehesnive	O
comiplation	O
of	O
ATM	O
polymorhpisms	O
assembled	O
to	O
date	O
.	O

Defining	O
polymoprhic	O
siets	O
as	O
well	O
as	O
muttaions	O
in	O
the	O
ATM	O
gnee	O
will	O
be	O
of	O
great	O
importance	O
in	O
designing	O
autoamted	O
methdos	O
for	O
deetcting	O
muttaions	O
.	O
.	O

A	O
novel	O
framehsift	O
muattion	O
in	O
the	O
MceLod	B-Disease
snydrome	I-Disease
gnee	O
in	O
a	O
Jpaanese	O
faimly	O
.	O

We	O
reoprt	O
a	O
novel	O
mutaiton	O
in	O
the	O
XK	O
gnee	O
(	O
XK	O
)	O
in	O
a	O
Japaense	O
pateint	O
with	O
McLoed	B-Disease
snydrome	I-Disease
.	O

A	O
50	O
-	O
yaer	O
-	O
old	O
man	O
showed	O
progerssive	O
muscluar	B-Disease
atrpohy	I-Disease
,	O
choriec	B-Disease
movmeent	I-Disease
,	O
eelvated	O
leevl	O
of	O
sreum	O
creatniine	O
kniase	O
,	O
and	O
acatnhocytosis	B-Disease
.	O

The	O
experssion	O
lveel	O
of	O
all	O
the	O
Klel	O
atnigens	O
in	O
erythroctye	O
was	O
derceased	O
and	O
molecualr	O
anlaysis	O
revaeled	O
a	O
single	O
-	O
base	O
(	O
T	O
)	O
deletoin	O
at	O
the	O
nucletoide	O
positoin	O
1095	O
in	O
XK	O
.	O

This	O
delteion	O
caused	O
a	O
framesihft	O
in	O
tarnslation	O
,	O
leading	O
to	O
a	O
premautre	O
stop	O
cdoon	O
at	O
the	O
aimno	O
aicd	O
positoin	O
408	O
.	O

We	O
conclude	O
this	O
single	O
-	O
base	O
dleetion	O
causes	O
defecitve	O
Kx	O
prtoein	O
,	O
which	O
is	O
responsible	O
for	O
the	O
McLoed	B-Disease
phentoype	O
in	O
this	O
patinet	O
.	O
.	O

Associtaion	O
of	O
BCRA1	O
with	O
the	O
hRda50	O
-	O
hMer11	O
-	O
p95	O
cmoplex	O
and	O
the	O
DNA	O
dmaage	O
repsonse	O
.	O

BRAC1	O
enocdes	O
a	O
tmuor	B-Disease
suppressor	O
that	O
is	O
mutaetd	O
in	O
famliial	B-Disease
berast	I-Disease
and	I-Disease
ovairan	I-Disease
cacners	I-Disease
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
BCRA1	O
interacts	O
in	O
vitro	O
and	O
in	O
vivo	O
with	O
hRa5d0	O
,	O
which	O
forms	O
a	O
comlpex	O
with	O
hMr1e1	O
and	O
p95	O
/	O
nirbin	O
.	O

Upon	O
irradiation	O
,	O
BCRA1	O
was	O
dteected	O
in	O
dicsrete	O
fcoi	O
in	O
the	O
nucelus	O
,	O
which	O
colocailze	O
with	O
haRd50	O
.	O

Fromation	O
of	O
irradiation	O
-	O
indcued	O
fcoi	O
psoitive	O
for	O
BRAC1	O
,	O
hRa5d0	O
,	O
hrMe11	O
,	O
or	O
p95	O
was	O
dramatically	O
rdeuced	O
in	O
HCC	O
/	O
1937	O
berast	B-Disease
cnacer	I-Disease
clels	O
carrying	O
a	O
homzoygous	O
mutaiton	O
in	O
BCRA1	O
but	O
was	O
resotred	O
by	O
transfeciton	O
of	O
wlid	O
-	O
tpye	O
BRAC1	O
.	O

Ecotpic	O
epxression	O
of	O
wlid	O
-	O
tpye	O
,	O
but	O
not	O
mutaetd	O
,	O
BCRA1	O
in	O
these	O
clels	O
rendered	O
them	O
less	O
senstiive	O
to	O
the	O
DNA	O
daamge	O
agnet	O
,	O
mehtyl	O
metahnesulfonate	O
.	O

These	O
dtaa	O
suggest	O
that	O
BRAC1	O
is	O
important	O
for	O
the	O
celullar	O
repsonses	O
to	O
DNA	O
damgae	O
that	O
are	O
mediated	O
by	O
the	O
hRa5d0	O
-	O
hMer11	O
-	O
p95	O
copmlex	O
.	O
.	O

Relatinoship	O
among	O
gentoype	O
,	O
biochmeical	O
phentoype	O
,	O
and	O
cogintive	O
preformance	O
in	O
femaels	O
with	O
phenylalnaine	B-Disease
hydrxoylase	I-Disease
defciiency	I-Disease
:	O
rpeort	O
from	O
the	O
Materanl	B-Disease
Phenylketnouria	I-Disease
Collaobrative	O
Stduy	O
.	O

OJBECTIVE	O
To	O
examine	O
the	O
relatoinship	O
of	O
phenylaalnine	O
hydroyxlase	O
(	O
PAH	O
)	O
geontypes	O
to	O
biocheimcal	O
phenoytpe	O
and	O
cogniitve	O
deevlopment	O
in	O
matrenal	B-Disease
phenylektonuria	I-Disease
(	O
PKU	B-Disease
)	O
.	O

METHODOLOGY	O
PAH	O
gnee	O
muttaions	O
were	O
examined	O
in	O
222	O
hyperphenylalanniemic	B-Disease
femlaes	O
enrolled	O
in	O
the	O
Matrenal	B-Disease
PKU	I-Disease
Collabortaive	O
Sutdy	O
(	O
MPKCUS	O
)	O
.	O

A	O
total	O
of	O
84	O
different	O
muttaions	O
were	O
detceted	O
,	O
and	O
complete	O
genotpye	O
was	O
obtained	O
in	O
199	O
indiviudals	O
.	O

Based	O
on	O
previous	O
konwledge	O
about	O
mutaiton	O
-	O
pheontype	O
assocaitions	O
,	O
78	O
of	O
the	O
mtuations	O
could	O
be	O
assigned	O
to	O
one	O
of	O
four	O
calsses	O
of	O
seevrity	O
(	O
sevree	O
PKU	B-Disease
,	O
modreate	O
PKU	B-Disease
,	O
mlid	O
PKU	B-Disease
,	O
and	O
mlid	B-Disease
hyperphenylalanniemia	I-Disease
[	O
MHP	B-Disease
]	O
)	O
.	O

Then	O
,	O
189	O
MKPUCS	O
subjetcs	O
were	O
gruoped	O
according	O
to	O
the	O
various	O
comibnations	O
of	O
mutaiton	O
classfiications	O
.	O

The	O
samlpe	O
sizes	O
were	O
large	O
enough	O
for	O
staitstical	O
tseting	O
in	O
four	O
gropus	O
with	O
at	O
least	O
one	O
mtuation	O
that	O
completely	O
abloishes	O
enyzme	O
actiivty	O
.	O

These	O
ptaients	O
are	O
considered	O
functionally	O
hemiyzgous	O
.	O

REUSLTS	O
The	O
biohcemical	O
phentoype	O
preidcted	O
from	O
the	O
geontype	O
in	O
functionally	O
hemizgyous	O
paitents	O
was	O
related	O
significantly	O
to	O
the	O
assigned	O
phenylaalnine	O
leevl	O
.	O

Cognitvie	O
perfromance	O
(	O
IQ	O
)	O
was	O
also	O
significantly	O
related	O
to	O
gentoype	O
.	O

The	O
IQ	O
of	O
PAH	B-Disease
-	I-Disease
defiicent	I-Disease
mtohers	O
with	O
a	O
seevre	O
PKU	B-Disease
muttaion	O
in	O
combintaion	O
with	O
a	O
MHP	B-Disease
mutaiton	O
or	O
a	O
mlid	O
PKU	B-Disease
muattion	O
was	O
99	O
and	O
96	O
,	O
respectively	O
,	O
whereas	O
the	O
IQ	O
of	O
PKU	B-Disease
mohters	O
with	O
two	O
seevre	O
PKU	B-Disease
mutatoins	O
or	O
with	O
one	O
seevre	O
and	O
one	O
modertae	O
PKU	B-Disease
mtuation	O
was	O
83	O
and	O
84	O
,	O
respectively	O
.	O

Of	O
the	O
patietns	O
with	O
PKU	B-Disease
,	O
92	O
%	O
had	O
been	O
treaetd	O
during	O
chlidhood	O
.	O

Those	O
who	O
were	O
untreaetd	O
or	O
terated	O
ltae	O
had	O
loewr	O
than	O
aevrage	O
IQ	O
scroes	O
for	O
their	O
gorup	O
of	O
mutaiton	O
combinatinos	O
.	O

Femaels	O
with	O
modreate	O
or	O
mlid	O
PKU	B-Disease
who	O
were	O
tretaed	O
ealry	O
and	O
traeted	O
for	O
>	O
6	O
yeras	O
showed	O
IQ	O
scoers	O
10	O
points	O
above	O
avreage	O
for	O
their	O
gruop	O
.	O

COCNLUSIONS	O
The	O
reprdouctive	O
ouctome	O
in	O
materanl	B-Disease
phenylkteonuria	I-Disease
is	O
dependnet	O
on	O
prenaatl	O
meatbolic	O
cotnrol	O
and	O
postantal	O
environmetnal	O
circumstances	O
.	O

Both	O
fatcors	O
depend	O
on	O
the	O
intellectual	O
resoucres	O
of	O
the	O
motehr	O
with	O
PKU	B-Disease
.	O

The	O
significant	O
realtionship	O
among	O
gentoype	O
,	O
biochmeical	O
phenoytpe	O
,	O
and	O
cogniitve	O
perforamnce	O
observed	O
in	O
the	O
present	O
sutdy	O
is	O
of	O
importance	O
for	O
the	O
developemnt	O
of	O
an	O
optiaml	O
strategy	O
for	O
future	O
traetment	O
of	O
fmeales	O
with	O
PKU	B-Disease
who	O
paln	O
prgenancy	O
.	O
.	O

Sipnal	B-Disease
xanhtomatosis	I-Disease
:	O
a	O
vairant	O
of	O
cererbotendinous	B-Disease
xanhtomatosis	I-Disease
.	O

We	O
describe	O
seven	O
Ducth	O
pateints	O
from	O
six	O
fmailies	O
with	O
a	O
slowly	O
prgoressive	O
,	O
mainly	O
sipnal	B-Disease
crod	I-Disease
sydnrome	I-Disease
that	O
remained	O
for	O
many	O
yeras	O
the	O
sole	O
epxression	O
of	O
cerberotendinous	B-Disease
xanthomatsois	I-Disease
(	O
CTX	B-Disease
)	O
.	O

MRI	O
demonstrated	O
whtie	B-Disease
matter	I-Disease
abnoramlities	I-Disease
in	O
the	O
latreal	O
and	O
dosral	O
coulmns	O
of	O
the	O
spnial	O
crod	O
.	O

Psot	O
-	O
mrotem	O
exaimnation	O
of	O
one	O
of	O
the	O
patinets	O
showed	O
extesnive	O
myeiln	O
lsos	O
in	O
these	O
cloumns	O
.	O

An	O
arary	O
of	O
gneotypes	O
was	O
found	O
in	O
these	O
patietns	O
.	O

We	O
conclude	O
that	O
spianl	B-Disease
xanhtomatosis	I-Disease
is	O
a	O
cliincal	O
and	O
radioloigcal	O
separate	O
entity	O
of	O
CTX	B-Disease
that	O
should	O
be	O
included	O
in	O
the	O
dfiferential	O
diangosis	O
of	O
chroinc	B-Disease
myeolpathy	I-Disease
.	O
.	O

A	O
trasngene	O
isnertion	O
creating	O
a	O
heritalbe	O
chormosome	O
deleiton	O
muose	O
moedl	O
of	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
and	I-Disease
angelamn	I-Disease
syndrmoes	I-Disease
.	O

Parder	B-Disease
-	I-Disease
Willi	I-Disease
synrdome	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Aneglman	B-Disease
syndorme	I-Disease
(	O
AS	B-Disease
)	O
result	O
from	O
the	O
lsos	O
of	O
fucntion	O
of	O
imprnited	O
gnees	O
in	O
hmuan	O
chrmoosome	O
15q11	O
-	O
q13	O
.	O

The	O
centarl	O
part	O
of	O
muose	O
chromosmoe	O
7	O
is	O
homolgoous	O
to	O
huamn	O
15q11	O
-	O
q13	O
,	O
with	O
conservatoin	O
of	O
both	O
gnee	O
order	O
and	O
impritned	O
faetures	O
.	O

We	O
rpeort	O
here	O
the	O
chraacterization	O
of	O
a	O
transgnee	O
insetrion	O
(	O
Epstien	O
-	O
Brar	O
viurs	O
Laetnt	O
Membarne	O
Portein	O
2A	O
,	O
LM2PA	O
)	O
into	O
muose	O
chromoosme	O
7C	O
,	O
which	O
has	O
resulted	O
in	O
muose	O
moedls	O
for	O
PWS	B-Disease
and	O
AS	B-Disease
depnedent	O
on	O
the	O
sex	O
of	O
the	O
transimtting	O
praent	O
.	O

Eipgenotype	O
(	O
allelic	O
epxression	O
and	O
DNA	O
metyhlation	O
)	O
and	O
fluorsecence	O
in	O
situ	O
hybridizatoin	O
analyess	O
indicate	O
that	O
the	O
transgnee	O
-	O
indcued	O
mtuation	O
has	O
generated	O
a	O
complete	O
deeltion	O
of	O
the	O
PWS	B-Disease
/	O
AS	B-Disease
-	O
homologuos	O
reigon	O
but	O
has	O
not	O
delteed	O
flanking	O
lcoi	O
.	O

Because	O
the	O
itnact	O
crhomosome	O
7	O
,	O
opposite	O
the	O
deelted	O
homoolg	O
,	O
maintains	O
the	O
correct	O
impirnt	O
in	O
smoatic	O
cells	O
of	O
PWS	B-Disease
and	O
AS	B-Disease
mcie	O
and	O
establishes	O
the	O
correct	O
ipmrint	O
in	O
mlae	O
and	O
femlae	O
grem	O
cells	O
of	O
AS	B-Disease
mcie	O
,	O
homloogous	O
associtaion	O
and	O
replicatoin	O
aysnchrony	O
are	O
not	O
part	O
of	O
the	O
imprinitng	O
mehcanism	O
.	O

This	O
hreitable	O
-	O
deeltion	O
mosue	O
moedl	O
will	O
be	O
particularly	O
useful	O
for	O
the	O
identificaiton	O
of	O
the	O
etiologiacl	O
geens	O
and	O
mechainsms	O
,	O
phenotpyic	O
basis	O
,	O
and	O
investgiation	O
of	O
tehrapeutic	O
aprpoaches	O
for	O
PWS	B-Disease
.	O
.	O

Lnikage	O
analsyis	O
of	O
5	O
novel	O
van	B-Disease
der	I-Disease
Wuode	I-Disease
syndrmoe	I-Disease
kinderds	O
to	O
1q32	O
-	O
q41	O
markres	O
further	O
supports	O
lcous	O
homogeniety	O
of	O
the	O
disaese	O
triat	O
.	O

van	B-Disease
der	I-Disease
Wuode	I-Disease
snydrome	I-Disease
(	O
vWS	B-Disease
,	O
MIM	O
119300	O
)	O
is	O
a	O
rrae	O
autsoomal	B-Disease
domniant	I-Disease
cletfing	I-Disease
conidtion	I-Disease
with	O
cardnial	O
featrues	O
of	O
mucuos	B-Disease
cytss	I-Disease
(	O
lwoer	B-Disease
-	I-Disease
lip	I-Disease
ptis	I-Disease
)	O
and	O
cletfs	B-Disease
to	I-Disease
the	I-Disease
lip	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
paltae	I-Disease
.	O

The	O
vWS	B-Disease
gnee	O
has	O
been	O
assigned	O
to	O
a	O
loucs	O
in	O
1q32	O
-	O
q41	O
by	O
linakge	O
analyiss	O
and	O
phsyical	O
mappnig	O
.	O

We	O
have	O
investgiated	O
5	O
novel	O
vWS	B-Disease
famliies	O
through	O
probnads	O
atetnded	O
for	O
celft	B-Disease
lip	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
paltae	I-Disease
rpeair	O
at	O
the	O
Dpeartment	O
of	O
Maxillofacail	O
Sugrery	O
of	O
Hpoital	O
Truosseau	O
,	O
Prais	O
,	O
in	O
order	O
to	O
tentatively	O
refine	O
the	O
geneitc	O
map	O
of	O
the	O
vWS	B-Disease
regoin	O
in	O
1q32	O
-	O
q41	O
and	O
possibly	O
identify	O
unlinked	O
pedirgees	O
.	O

Liknage	O
anlaysis	O
was	O
carried	O
out	O
to	O
6	O
microsatellite	O
makrers	O
(	O
D12S49	O
,	O
D14S25	O
,	O
DS1491	O
,	O
D12S05	O
,	O
D14S14	O
,	O
D1S245	O
)	O
,	O
yielding	O
a	O
maxiumm	O
cumulaitve	O
LOD	O
scroe	O
of	O
Z	O
=	O
3	O
.	O

27	O
at	O
thtea	O
=	O
0	O
.	O

00	O
for	O
DS1245	O
.	O

The	O
inneromst	O
four	O
makrers	O
were	O
found	O
to	O
be	O
tightly	O
linked	O
to	O
one	O
another	O
,	O
with	O
no	O
eivdence	O
for	O
recobmination	O
.	O

Our	O
resluts	O
support	O
liknage	O
of	O
vWS	B-Disease
within	O
a	O
reigon	O
of	O
tightly	O
linked	O
markres	O
and	O
do	O
not	O
favour	O
loucs	O
hteerogeneity	O
of	O
the	O
dsiease	O
triat	O
.	O

Nlul	O
mtuation	O
of	O
the	O
mruine	O
AT7PB	O
(	O
Wislon	B-Disease
disaese	I-Disease
)	O
gnee	O
rseults	O
in	O
intracellluar	B-Disease
copper	I-Disease
accumulatoin	I-Disease
and	O
ltae	B-Disease
-	I-Disease
onset	I-Disease
hepaitc	I-Disease
nodualr	I-Disease
transofrmation	I-Disease
.	O

The	O
Apt7b	O
portein	O
is	O
a	O
cpoper	O
-	O
transporting	O
ATaPse	O
expresesd	O
predominantly	O
in	O
the	O
lievr	O
and	O
to	O
a	O
lesesr	O
extent	O
in	O
most	O
other	O
tissues	O
.	O

Muattions	O
in	O
the	O
AT7PB	O
gnee	O
lead	O
to	O
Wislon	B-Disease
disesae	I-Disease
,	O
a	O
copper	B-Disease
txoicity	I-Disease
disodrer	I-Disease
charactreized	O
by	O
dramtaic	O
build	O
-	O
up	O
of	O
inrtacellular	O
hepaitc	O
copepr	O
with	O
subsequent	O
hepaitc	B-Disease
and	I-Disease
neruo	I-Disease
-	I-Disease
logical	I-Disease
abnoramlities	I-Disease
.	O

Using	O
homolgoous	O
rceombination	O
to	O
dsirupt	O
the	O
nromal	O
transaltion	O
of	O
AT7PB	O
,	O
we	O
have	O
generated	O
a	O
starin	O
of	O
mcie	O
that	O
are	O
homozyguos	O
muatnts	O
(	O
nlul	O
)	O
for	O
the	O
Wlison	B-Disease
diesase	I-Disease
gnee	O
.	O

The	O
AT7PB	O
nlul	O
mcie	O
display	O
a	O
gardual	O
accumualtion	O
of	O
heaptic	O
copepr	O
that	O
increaess	O
to	O
a	O
lveel	O
60	O
-	O
fold	O
greater	O
than	O
noraml	O
by	O
5	O
motnhs	O
of	O
age	O
.	O

An	O
inrcease	O
in	O
cpoper	O
concnetration	O
was	O
also	O
observed	O
in	O
the	O
kideny	O
,	O
brian	O
,	O
palcenta	O
and	O
lactaitng	O
mammray	O
glnads	O
of	O
hmoo	O
-	O
zyguos	O
mtuants	O
,	O
although	O
mlik	O
from	O
the	O
mutnat	O
galnds	O
was	O
cpoper	B-Disease
deficeint	I-Disease
.	O

Morpholgoical	B-Disease
abnomralities	I-Disease
resembling	O
cirrhosis	B-Disease
developed	O
in	O
the	O
majority	O
of	O
the	O
livres	O
from	O
homzoygous	O
mutatns	O
odler	O
than	O
7	O
monhts	O
of	O
age	O
.	O

Porgeny	O
of	O
the	O
homozgyous	O
mutnat	O
feamles	O
demonstrated	O
neruological	B-Disease
abnormaliteis	I-Disease
and	O
gorwth	B-Disease
retardtaion	I-Disease
characetristic	O
of	O
cpoper	B-Disease
defciiency	I-Disease
.	O

Cpoper	O
conecntration	O
in	O
the	O
lviers	O
of	O
the	O
nweborn	O
homozgyous	O
nlul	O
mtuants	O
was	O
decraesed	O
dramatically	O
.	O

In	O
summary	O
,	O
inactviation	O
of	O
the	O
muirne	O
AT7PB	O
gnee	O
produces	O
a	O
form	O
of	O
cirrhotic	B-Disease
lvier	I-Disease
disesae	I-Disease
that	O
resembles	O
Wislon	B-Disease
disesae	I-Disease
in	O
humnas	O
and	O
the	O
txoic	O
mlik	O
phentoype	O
in	O
the	O
mosue	O
.	O
.	O

Fernch	O
Macahdo	B-Disease
-	I-Disease
Joesph	I-Disease
dsiease	I-Disease
patietns	O
do	O
not	O
exhibit	O
gmaetic	O
segergation	O
disotrtion	O
:	O
a	O
sprem	O
typnig	O
aanlysis	O
.	O

Segreagtion	O
distortoin	O
has	O
been	O
reported	O
to	O
occur	O
in	O
a	O
number	O
of	O
the	O
triuncleotide	B-Disease
rpeeat	I-Disease
disroders	I-Disease
.	O

On	O
the	O
basis	O
of	O
a	O
sprem	O
tyipng	O
sutdy	O
performed	O
in	O
pateints	O
of	O
Japaense	O
dsecent	O
with	O
Mahcado	B-Disease
-	I-Disease
Jsoeph	I-Disease
disesae	I-Disease
(	O
MJD	B-Disease
)	O
,	O
it	O
was	O
reported	O
that	O
disaese	O
alelles	O
are	O
preferentially	O
tranmsitted	O
during	O
meioiss	O
.	O

We	O
performed	O
a	O
seprm	O
typnig	O
sutdy	O
of	O
five	O
MJD	B-Disease
ptaients	O
of	O
Fernch	O
descnet	O
and	O
analyiss	O
of	O
the	O
pooled	O
dtaa	O
shows	O
a	O
rtaio	O
of	O
muatnt	O
to	O
nromal	O
alleels	O
of	O
379	O
436	O
(	O
46	O
.	O
5	O
53	O
.	O
5	O
%	O
)	O
,	O
which	O
does	O
not	O
support	O
meitoic	O
sergegation	O
disotrtion	O
.	O

To	O
confirm	O
these	O
resutls	O
,	O
seprm	O
typnig	O
anlaysis	O
was	O
also	O
performed	O
using	O
a	O
polymoprhic	O
makrer	O
,	O
D141S050	O
,	O
closely	O
linked	O
to	O
the	O
MDJ1	O
gnee	O
.	O

Among	O
910	O
sprem	O
aanlyzed	O
,	O
the	O
allele	O
linked	O
to	O
the	O
diesase	O
chromosmoe	O
was	O
deetcted	O
in	O
50	O
.	O

3	O
%	O
of	O
the	O
sapmles	O
and	O
the	O
allele	O
linked	O
to	O
the	O
nromal	O
chormosome	O
was	O
found	O
in	O
49	O
.	O

6	O
%	O
of	O
the	O
seprm	O
.	O

The	O
difference	O
in	O
frequnecy	O
of	O
these	O
two	O
alleels	O
is	O
not	O
significant	O
(	O
P	O
=	O
0	O
.	O
8423	O
)	O
.	O

Likeliohod	O
-	O
based	O
aanlysis	O
of	O
segregtaion	O
dsitortion	O
in	O
the	O
single	O
seprm	O
dtaa	O
using	O
the	O
SPREMSEG	O
progarm	O
also	O
showed	O
no	O
support	O
for	O
sgeregation	O
distortoin	O
at	O
the	O
gaemte	O
leevl	O
in	O
this	O
paitent	O
populatoin	O
.	O

The	O
previous	O
reprot	O
on	O
the	O
Japansee	O
patinets	O
also	O
suggested	O
that	O
disesae	O
alelle	O
stabiilty	O
may	O
be	O
inlfuenced	O
by	O
a	O
trnas	O
effcet	O
of	O
an	O
itnragenic	O
polymorpihsm	O
(	O
987	O
G	O
/	O
C	O
)	O
in	O
the	O
wlid	O
-	O
tpye	O
alllee	O
.	O

All	O
of	O
the	O
Frecnh	O
patinets	O
were	O
heterzoygous	O
for	O
this	O
polymorhpism	O
.	O

However	O
,	O
aanlysis	O
of	O
the	O
varinace	O
in	O
reepat	O
number	O
in	O
sprem	O
from	O
the	O
Fernch	O
MJD	B-Disease
patietns	O
overlapped	O
significantly	O
with	O
the	O
variacne	O
in	O
rpeeat	O
number	O
observed	O
in	O
the	O
C	O
/	O
C	O
homozgyous	O
Japansee	O
paitents	O
.	O

Missense	O
mtuation	O
in	O
the	O
altrenative	O
slpice	O
regoin	O
of	O
the	O
PXA6	O
gnee	O
in	O
eye	B-Disease
anomaleis	I-Disease
.	O

The	O
PXA6	O
gnee	O
is	O
involved	O
in	O
ouclar	O
morphoegnesis	O
,	O
and	O
PXA6	O
mtuations	O
have	O
been	O
detecetd	O
in	O
various	O
types	O
of	O
ouclar	B-Disease
anomlaies	I-Disease
,	O
including	O
aniriida	B-Disease
,	O
Pteers	B-Disease
aonmaly	I-Disease
,	O
cornael	B-Disease
dystorphy	I-Disease
,	O
conegnital	B-Disease
catarcat	I-Disease
,	O
and	O
foeval	B-Disease
hyopplasia	I-Disease
.	O

The	O
gnee	O
enocdes	O
a	O
trasncriptional	O
regluator	O
that	O
recognizes	O
traget	O
gnees	O
through	O
its	O
paired	O
-	O
tpye	O
DNA	O
-	O
bniding	O
dmoain	O
.	O

The	O
paired	O
doamin	O
is	O
composed	O
of	O
two	O
distinct	O
DNA	O
-	O
bidning	O
sudbomains	O
,	O
the	O
N	O
-	O
terimnal	O
sudbomain	O
(	O
NTS	O
)	O
and	O
the	O
C	O
-	O
temrinal	O
subdoamin	O
(	O
CTS	O
)	O
,	O
which	O
bnid	O
respective	O
cnosensus	O
DNA	O
seuqences	O
.	O

The	O
huamn	O
PXA6	O
gnee	O
produces	O
two	O
altrenative	O
splcie	O
isofomrs	O
that	O
have	O
the	O
distinct	O
strucutre	O
of	O
the	O
paired	O
dmoain	O
.	O

The	O
insertoin	O
,	O
into	O
the	O
NTS	O
,	O
of	O
14	O
additional	O
aimno	O
aicds	O
encoedd	O
by	O
eoxn	O
5a	O
abolsihes	O
the	O
DNA	O
-	O
bniding	O
activtiy	O
of	O
the	O
NTS	O
and	O
unmasks	O
the	O
DNA	O
-	O
binidng	O
ability	O
of	O
the	O
CTS	O
.	O

Thus	O
,	O
eoxn	O
5a	O
appears	O
to	O
funciton	O
as	O
a	O
moelcular	O
swicth	O
that	O
specifies	O
taregt	O
geens	O
.	O

We	O
ascertained	O
a	O
novel	O
msisense	O
mutatoin	O
in	O
four	O
pedgirees	O
with	O
Peetrs	B-Disease
anoamly	I-Disease
,	O
congneital	B-Disease
cataarct	I-Disease
,	O
Aexnfeldt	B-Disease
aonmaly	I-Disease
,	O
and	O
/	O
or	O
foeval	B-Disease
hyopplasia	I-Disease
,	O
which	O
,	O
to	O
our	O
knoweldge	O
,	O
is	O
the	O
first	O
mutaiton	O
idnetified	O
in	O
the	O
slpice	O
-	O
vraiant	O
rgeion	O
.	O

A	O
T	O
-	O
-	O
>	O
A	O
transtiion	O
at	O
the	O
20th	O
nucleotdie	O
postiion	O
of	O
eoxn	O
5a	O
reuslts	O
in	O
a	O
Val	O
-	O
-	O
>	O
Asp	O
(	O
GTC	O
-	O
-	O
>	O
GAC	O
)	O
sbustitution	O
at	O
the	O
7th	O
cdoon	O
of	O
the	O
aletrnative	O
slpice	O
rgeion	O
.	O

Fnuctional	O
analyess	O
demonstrated	O
that	O
the	O
V45D	O
muttaion	O
slightly	O
incresaed	O
NTS	O
binidng	O
and	O
decresaed	O
CTS	O
transactivatoin	O
acitvity	O
to	O
almost	O
half	O
.	O
.	O

Penertances	O
of	O
BRAC1	O
1675delA	O
and	O
1135insA	O
with	O
respect	O
to	O
braest	B-Disease
canecr	I-Disease
and	O
ovairan	B-Disease
cacner	I-Disease
.	O

For	O
genteic	O
counesling	O
and	O
predictvie	O
testnig	O
in	O
fmailies	O
with	O
ihnerited	B-Disease
bresat	I-Disease
-	I-Disease
ovairan	I-Disease
cacner	I-Disease
,	O
penetarnces	O
and	O
expressoins	O
of	O
the	O
underlying	O
muttaions	O
should	O
be	O
known	O
.	O

We	O
have	O
previously	O
reported	O
two	O
BRAC1	O
foudner	O
muttaions	O
in	O
the	O
Nowregian	O
popluation	O
.	O

Inedx	O
csaes	O
for	O
the	O
present	O
sutdy	O
were	O
found	O
two	O
different	O
ways	O
through	O
a	O
series	O
of	O
cosnecutive	O
ovairan	B-Disease
cnacers	I-Disease
(	O
n	O
=	O
16	O
)	O
and	O
through	O
our	O
famliy	O
cacner	B-Disease
clniic	O
(	O
n	O
=	O
14	O
)	O
.	O

Altogether	O
,	O
20	O
of	O
the	O
patietns	O
had	O
BRAC1	O
1675delA	O
,	O
and	O
10	O
had	O
1135insA	O
.	O

Their	O
reltaives	O
were	O
described	O
with	O
respect	O
to	O
absecne	O
/	O
preesnce	O
of	O
braest	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovairan	I-Disease
canecr	I-Disease
.	O

Of	O
133	O
lviing	O
fmeale	O
relaitves	O
,	O
83	O
(	O
62	O
%	O
)	O
were	O
tesetd	O
for	O
the	O
presecne	O
of	O
a	O
muttaion	O
.	O

No	O
difference	O
,	O
in	O
penetracne	O
and	O
exprsesion	O
,	O
between	O
the	O
two	O
mtuations	O
were	O
found	O
,	O
whereas	O
differences	O
according	O
to	O
metohd	O
of	O
ascertainmnet	O
were	O
seen	O
.	O

The	O
overall	O
findigns	O
were	O
that	O
disesae	O
started	O
to	O
occur	O
at	O
age	O
30	O
yeras	O
and	O
that	O
by	O
age	O
50	O
yeras	O
48	O
%	O
of	O
the	O
mutatoin	O
-	O
carrying	O
wmoen	O
had	O
experienced	O
bresat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovraian	I-Disease
canecr	I-Disease
.	O

More	O
ovarain	B-Disease
cacners	I-Disease
than	O
berast	B-Disease
cnacers	I-Disease
were	O
recorded	O
.	O

Both	O
pneetrance	O
and	O
expresison	O
(	O
braest	B-Disease
cacner	I-Disease
vs	O
.	O
ovairan	B-Disease
canecr	I-Disease
)	O
were	O
different	O
from	O
those	O
in	O
repotrs	O
of	O
the	O
Askhenazi	O
fuonder	O
mutaitons	O
.	O

Whether	O
the	O
reported	O
differneces	O
reflect	O
true	O
difefrences	O
and	O
/	O
or	O
methdoological	O
problmes	O
is	O
discussed	O
.	O

An	O
observed	O
excses	O
of	O
muttaion	O
carirers	O
could	O
not	O
be	O
accounted	O
for	O
by	O
methoodlogical	O
prbolems	O
;	O
possible	O
explanations	O
were	O
a	O
"	O
true	O
"	O
low	O
penetarnce	O
or	O
preferentail	O
segregtaion	O
.	O
.	O

The	O
dermatofbirosarcoma	B-Disease
proutberans	I-Disease
-	O
associated	O
clolagen	O
tpye	O
Iaplha1	O
/	O
plateelt	O
-	O
derived	O
gorwth	O
fcator	O
(	O
PGDF	O
)	O
B	O
-	O
cahin	O
fuison	O
gnee	O
generates	O
a	O
tranfsorming	O
portein	O
that	O
is	O
proecssed	O
to	O
functioanl	O
PGDF	O
-	O
BB	O
.	O

Dermatofirbosarcoma	B-Disease
protubearns	I-Disease
(	O
DSFP	B-Disease
)	O
displays	O
crhomosomal	O
rearrangemnets	O
involving	O
chromosmoe	O
17	O
and	O
22	O
,	O
which	O
fsue	O
the	O
collagen	O
tpye	O
Ialhpa1	O
(	O
COLAI1	O
)	O
gnee	O
to	O
the	O
plaetlet	O
-	O
derived	O
grotwh	O
facotr	O
(	O
PGDF	O
)	O
B	O
-	O
cahin	O
(	O
PDFGB	O
)	O
gnee	O
.	O

To	O
characterize	O
the	O
fucntional	O
and	O
strucutral	O
porperties	O
of	O
the	O
COLAI1	O
/	O
PGDFB	O
fsuion	O
proetin	O
,	O
we	O
generated	O
a	O
satble	O
NI3HT3	O
clel	O
line	O
that	O
contained	O
a	O
tmuor	O
-	O
derived	O
chimreic	O
gnee	O
resulting	O
from	O
a	O
COAI1	O
itnron	O
7	O
-	O
PDFGB	O
intorn	O
1	O
fusoin	O
.	O

Experssion	O
of	O
the	O
fuison	O
protien	O
led	O
to	O
morphologcial	O
transfomration	O
and	O
incraesed	O
grwoth	O
rtae	O
of	O
these	O
clels	O
.	O

The	O
PGDF	O
recpetor	O
kinsae	O
ihnibitor	O
CGP57184B	O
revesred	O
the	O
transformed	O
phenoytpe	O
and	O
rdeuced	O
the	O
gorwth	O
rtae	O
of	O
CLOIA1	O
/	O
PDFGB	O
-	O
epxressing	O
clels	O
but	O
had	O
no	O
effects	O
on	O
cotnrol	O
clels	O
.	O

The	O
presnece	O
of	O
dmieric	O
COLAI1	O
/	O
PGDFB	O
precurosrs	O
was	O
demonstrated	O
through	O
PGDFB	O
immunoprecpiitations	O
of	O
metaboliaclly	O
labeeld	O
cells	O
and	O
also	O
by	O
PDFGB	O
immunporecipitations	O
followed	O
by	O
immnuoblotting	O
with	O
COLAI1	O
atnibodies	O
.	O

Pusle	O
-	O
cahse	O
stuides	O
demonstrated	O
that	O
the	O
CLOIA1	O
/	O
PGDFB	O
precurosr	O
was	O
porcessed	O
to	O
an	O
end	O
prdouct	O
that	O
was	O
indistingiushable	O
from	O
wlid	O
-	O
tpye	O
PGDF	O
-	O
BB	O
.	O

Finally	O
,	O
CLOIA1	O
/	O
PDFGB	O
-	O
expressing	O
cells	O
generated	O
tmuors	B-Disease
after	O
s	O
.	O

c	O
c	O
.	O
injetcion	O
into	O
ndue	O
mcie	O
,	O
and	O
tuomr	B-Disease
grwoth	O
was	O
redcued	O
by	O
tretament	O
with	O
CGP57184B	O
.	O

We	O
conclude	O
that	O
the	O
CLOIA1	O
/	O
PDFGB	O
fuison	O
associated	O
with	O
DSFP	B-Disease
contributes	O
to	O
tmuor	B-Disease
develompent	O
through	O
ectoipc	O
prodcution	O
of	O
PGDF	O
-	O
BB	O
and	O
the	O
fromation	O
of	O
an	O
autocirne	O
loop	O
.	O

Our	O
fnidings	O
,	O
thus	O
,	O
suggest	O
that	O
PGDF	O
reecptors	O
could	O
be	O
a	O
taregt	O
for	O
pharamcological	O
teratment	O
of	O
DSFP	B-Disease
and	O
ginat	B-Disease
clel	I-Disease
fibrbolastoma	I-Disease
,	O
e	O
.	O
g	O
.	O
,	O
through	O
the	O
use	O
of	O
PGDF	O
recetpor	O
kinsae	O
inhibiotrs	O
such	O
as	O
CG5P7148B	O
.	O

Identifciation	O
of	O
a	O
common	O
PXE1	O
mutatoin	O
in	O
Zellwgeer	B-Disease
syndorme	I-Disease
.	O

The	O
Zelwleger	B-Disease
sepctrum	I-Disease
of	I-Disease
dsiease	I-Disease
,	O
encompassing	O
Zlelweger	B-Disease
synrdome	I-Disease
and	O
the	O
progressively	O
milder	O
pheontypes	O
of	O
neonaatl	B-Disease
adrenoleukodysrtophy	I-Disease
and	O
infatnile	B-Disease
Refusm	I-Disease
diesase	I-Disease
,	O
is	O
due	O
to	O
a	O
faliure	O
to	O
form	O
functioanl	O
peorxisomes	O
.	O

Clel	O
fusoin	O
compelmentation	O
studeis	O
demonstrated	O
that	O
these	O
dsieases	O
are	O
genteically	O
heterogeneuos	O
,	O
with	O
two	O
-	O
thirds	O
of	O
all	O
pateints	O
lynig	O
within	O
a	O
single	O
complementatoin	O
gorup	O
,	O
CG1	O
.	O

Molecualr	O
genteic	O
and	O
clel	O
bioolgy	O
stuides	O
have	O
shown	O
that	O
PXE1	O
is	O
defciient	O
in	O
many	O
CG1	O
patietns	O
.	O

However	O
,	O
previous	O
studeis	O
have	O
focused	O
on	O
mlidly	O
afefcted	O
patinets	O
and	O
there	O
is	O
still	O
no	O
rpeort	O
of	O
two	O
mtuant	O
PXE1	O
alllees	O
in	O
any	O
Zellwgeer	B-Disease
syndrmoe	I-Disease
paitent	O
.	O

Furthermore	O
,	O
mutatinos	O
in	O
the	O
PPM70	O
gnee	O
have	O
also	O
been	O
idenitfied	O
in	O
two	O
Zlelweger	B-Disease
syndrmoe	I-Disease
patinets	O
from	O
CG1	O
,	O
raising	O
the	O
possibility	O
that	O
CG1	O
patinets	O
may	O
represent	O
a	O
mixture	O
of	O
PXE1	O
-	O
deficinet	O
and	O
PM7P0	O
-	O
defiicent	O
individulas	O
.	O

To	O
address	O
the	O
molceular	O
basis	O
of	O
disesae	O
in	O
Zellewger	B-Disease
syndrmoe	I-Disease
patinets	O
from	O
CG1	O
,	O
we	O
examined	O
all	O
24	O
PXE1	O
eoxns	O
in	O
four	O
patinets	O
,	O
including	O
both	O
pateints	O
that	O
have	O
mtuations	O
in	O
PM7P0	O
.	O

PXE1	O
muattions	O
were	O
detceted	O
in	O
all	O
four	O
paitents	O
,	O
including	O
a	O
1	O
-	O
bp	O
inesrtion	O
(	O
c	O
.	O
2097insT	O
)	O
in	O
eoxn	O
13	O
that	O
was	O
present	O
in	O
three	O
of	O
the	O
four	O
patietns	O
.	O

Subsequent	O
studeis	O
demonstrated	O
that	O
this	O
mutatoin	O
is	O
present	O
in	O
one	O
-	O
half	O
of	O
all	O
CG1	O
paitents	O
and	O
correaltes	O
with	O
the	O
Zellewger	B-Disease
snydrome	I-Disease
phneotype	O
.	O

As	O
this	O
mutatoin	O
leads	O
to	O
a	O
lsos	O
of	O
prtoein	O
fnuction	O
its	O
ferquency	O
makes	O
it	O
the	O
most	O
common	O
cause	O
of	O
Zellwgeer	B-Disease
synrdome	I-Disease
,	O
helping	O
to	O
explain	O
the	O
high	O
percnetage	O
of	O
patinets	O
that	O
belong	O
to	O
CG1	O
.	O

Nvoel	O
mtuations	O
in	O
the	O
Wisktot	B-Disease
-	I-Disease
Alrdich	I-Disease
synrdome	I-Disease
portein	O
gnee	O
and	O
their	O
efefcts	O
on	O
trancsriptional	O
,	O
transltaional	O
,	O
and	O
cliincal	O
phneotypes	O
.	O

Wsikott	B-Disease
-	I-Disease
Aldirch	I-Disease
sydnrome	I-Disease
(	O
WAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recessive	I-Disease
immunodefiicency	I-Disease
charcaterized	O
by	O
thrombocytoepnia	B-Disease
,	O
eczmea	B-Disease
,	O
and	O
reucrrent	O
infecitons	O
,	O
and	O
caused	O
by	O
mutatinos	O
in	O
the	O
WAS	B-Disease
protien	O
(	O
WSAP	O
)	O
gnee	O
.	O

WSAP	O
contains	O
several	O
functoinal	O
domians	O
through	O
which	O
it	O
interacts	O
with	O
porteins	O
involved	O
in	O
intarcellular	O
singaling	O
and	O
regulaiton	O
of	O
the	O
acitn	O
cyotskeleton	O
.	O

In	O
this	O
rpeort	O
,	O
17	O
WSAP	O
gnee	O
mutatoins	O
were	O
identfiied	O
,	O
12	O
of	O
which	O
are	O
novel	O
.	O

DNA	O
of	O
affetced	O
maels	O
and	O
obliagte	O
carriers	O
was	O
PCR	O
ampliifed	O
and	O
aanlyzed	O
by	O
SCSA	O
,	O
hetreoduplex	O
analyiss	O
,	O
and	O
direct	O
sequnecing	O
.	O

The	O
effects	O
of	O
the	O
mtuations	O
at	O
the	O
mNRA	O
and	O
prtoein	O
leevl	O
were	O
ascertained	O
by	O
RT	O
-	O
PCR	O
and	O
Wesetrn	O
bolt	O
aanlyses	O
.	O

All	O
missnese	O
mutaitons	O
were	O
located	O
in	O
exnos	O
1	O
-	O
4	O
.	O

Most	O
of	O
the	O
nonsnese	O
,	O
frameshfit	O
and	O
spilce	O
stie	O
muttaions	O
were	O
found	O
in	O
eoxns	O
6	O
-	O
11	O
.	O

Mutatoins	O
that	O
alter	O
spilce	O
sties	O
led	O
to	O
the	O
snythesis	O
of	O
several	O
types	O
of	O
mNRAs	O
,	O
a	O
farction	O
of	O
which	O
represented	O
the	O
normally	O
slpiced	O
proudct	O
.	O

The	O
persence	O
of	O
normally	O
spliecd	O
trnascripts	O
was	O
corrleated	O
with	O
a	O
milder	O
pehnotype	O
.	O

When	O
one	O
such	O
csae	O
was	O
studied	O
by	O
Wesetrn	O
boltting	O
,	O
reduecd	O
amounts	O
of	O
nromal	O
-	O
szie	O
WSAP	O
were	O
present	O
.	O

In	O
other	O
csaes	O
as	O
well	O
,	O
a	O
corerlation	O
was	O
found	O
between	O
the	O
aomunt	O
of	O
nromal	O
or	O
mtuant	O
WSAP	O
present	O
and	O
the	O
phenoytpes	O
of	O
the	O
affetced	O
individulas	O
.	O

No	O
proetin	O
was	O
detceted	O
in	O
two	O
indviiduals	O
with	O
sveere	O
WAS	B-Disease
.	O

Redcued	O
leevls	O
of	O
a	O
nromal	O
-	O
szie	O
WSAP	O
with	O
a	O
missense	O
mutatoin	O
were	O
seen	O
in	O
two	O
indiviudals	O
with	O
XLT	B-Disease
.	O

It	O
is	O
concluded	O
that	O
mutatoin	O
analsyis	O
at	O
the	O
DNA	O
lveel	O
is	O
not	O
sufficient	O
for	O
preditcing	O
cliniacl	O
coruse	O
.	O

Stduies	O
at	O
the	O
tarnscript	O
and	O
protien	O
leevl	O
are	O
needed	O
for	O
a	O
better	O
assessment	O
.	O
.	O

Amnioglycoside	O
atnibiotics	O
restore	O
dytsrophin	O
funtcion	O
to	O
skelteal	O
muslces	O
of	O
mdx	O
mcie	O
.	O

Duchenne	B-Disease
mucsular	I-Disease
dystorphy	I-Disease
(	O
DMD	B-Disease
)	O
is	O
caused	O
by	O
muattions	O
in	O
the	O
dystorphin	O
gnee	O
,	O
leading	O
to	O
the	O
asbence	O
of	O
the	O
dystrohpin	O
portein	O
in	O
stritaed	O
msucle	O
.	O

A	O
significant	O
number	O
of	O
these	O
mutatoins	O
are	O
preamture	O
stop	O
codnos	O
.	O

On	O
the	O
basis	O
of	O
the	O
observaiton	O
that	O
amingolycoside	O
treatmnet	O
can	O
supprses	O
stop	O
coodns	O
in	O
cultuerd	O
clels	O
,	O
we	O
tetsed	O
the	O
effect	O
of	O
gentamiicn	O
on	O
cutlured	O
muslce	O
clels	O
from	O
the	O
mdx	O
mosue	O
-	O
an	O
anmial	O
moedl	O
for	O
DMD	B-Disease
that	O
possesses	O
a	O
prematrue	O
stop	O
coodn	O
in	O
the	O
dystorphin	O
gnee	O
.	O

Exopsure	O
of	O
mdx	O
moytubes	O
to	O
genatmicin	O
led	O
to	O
the	O
exprsesion	O
and	O
localizatoin	O
of	O
dystorphin	O
to	O
the	O
clel	O
mebmrane	O
.	O

We	O
then	O
evlauated	O
the	O
effetcs	O
of	O
differing	O
doasges	O
of	O
gentaimcin	O
on	O
expressoin	O
and	O
functioanl	O
protcetion	O
of	O
the	O
muscels	O
of	O
mdx	O
mcie	O
.	O

We	O
iedntified	O
a	O
treatmnet	O
regmien	O
that	O
resulted	O
in	O
the	O
prseence	O
of	O
dystrpohin	O
in	O
the	O
clel	O
memrbane	O
in	O
all	O
srtiated	O
msucles	O
examined	O
and	O
that	O
provided	O
functinoal	O
prtoection	O
against	O
msucular	B-Disease
ijnury	I-Disease
.	O

To	O
our	O
knowldege	O
,	O
our	O
resutls	O
are	O
the	O
first	O
to	O
demonstrate	O
that	O
amnioglycosides	O
can	O
supprses	O
stop	O
codnos	O
not	O
only	O
in	O
vitro	O
but	O
also	O
in	O
vivo	O
.	O

Furthermore	O
,	O
these	O
rseults	O
raise	O
the	O
possibility	O
of	O
a	O
novel	O
traetment	O
reigmen	O
for	O
musuclar	B-Disease
dsytrophy	I-Disease
and	O
other	O
dsieases	O
caused	O
by	O
prmeature	O
stop	O
cdoon	O
mutatinos	O
.	O

This	O
treatmnet	O
could	O
prove	O
effcetive	O
in	O
up	O
to	O
15	O
%	O
of	O
pateints	O
with	O
DMD	B-Disease
.	O
.	O

Lsos	O
of	O
the	O
atxaia	B-Disease
-	I-Disease
tealngiectasia	I-Disease
gnee	O
proudct	O
causes	O
oxidatvie	O
dmaage	O
in	O
traget	O
ograns	O
.	O

Atxaia	B-Disease
-	I-Disease
telangiectsaia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
characteriezd	O
by	O
a	O
markedly	O
inrceased	O
senistivity	O
to	O
ioniznig	O
raidation	O
,	O
incerased	O
incdience	O
of	O
cacner	B-Disease
,	O
and	O
neuordegeneration	B-Disease
,	O
especially	O
of	O
the	O
cerebelalr	O
Purkijne	O
cells	O
.	O

Ioniizng	O
rdaiation	O
oixdizes	O
marcomolecules	O
and	O
causes	O
tsisue	O
dmaage	O
through	O
the	O
geneartion	O
of	O
reatcive	O
oxyegn	O
speceis	O
(	O
ROS	O
)	O
.	O

We	O
therefore	O
hypothesized	O
that	O
A	B-Disease
-	I-Disease
T	I-Disease
is	O
due	O
to	O
oxidtaive	O
daamge	O
resulting	O
from	O
lsos	O
of	O
fucntion	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
gnee	O
prdouct	O
.	O

To	O
assess	O
this	O
hypotheiss	O
,	O
we	O
employed	O
an	O
anmial	O
moedl	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
the	O
muose	O
with	O
a	O
dirsupted	O
Atm	O
gnee	O
.	O

We	O
show	O
that	O
ograns	O
which	O
develop	O
pahtologic	O
chanegs	O
in	O
the	O
Atm	O
-	O
deifcient	O
mcie	O
are	O
tragets	O
of	O
oxidatvie	O
dmaage	O
,	O
and	O
that	O
cerebelalr	O
Puriknje	O
cells	O
are	O
particularly	O
afefcted	O
.	O

These	O
obseravtions	O
provide	O
a	O
mechansitic	O
basis	O
for	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
phneotype	O
and	O
lay	O
a	O
rational	O
foundation	O
for	O
therapeuitc	O
intevrention	O
.	O
.	O

Reecssively	O
inhreited	O
multilpe	B-Disease
epipyhseal	I-Disease
dypslasia	I-Disease
with	O
nomral	O
satture	O
,	O
culb	B-Disease
foot	I-Disease
,	O
and	O
double	B-Disease
layeerd	I-Disease
patella	I-Disease
caused	O
by	O
a	O
DTSDT	O
muttaion	O
.	O

We	O
have	O
observed	O
over	O
25	O
different	O
muttaions	O
in	O
the	O
daistrophic	B-Disease
dypslasia	I-Disease
sulhpate	O
tarnsporter	O
gnee	O
(	O
DDTST	O
)	O
in	O
associaiton	O
with	O
the	O
rceessive	B-Disease
disordres	I-Disease
achondrogeneiss	B-Disease
1B	I-Disease
,	O
atelostoegenesis	B-Disease
2	I-Disease
,	O
and	O
diastrpohic	B-Disease
dsyplasia	I-Disease
.	O

The	O
c862t	O
(	O
R729W	O
)	O
trnasition	O
is	O
the	O
most	O
common	O
mtuation	O
in	O
non	O
-	O
Fninish	O
patinets	O
,	O
but	O
in	O
these	O
dsiorders	O
it	O
is	O
usually	O
cobmined	O
with	O
other	O
DDTST	O
muttaions	O
.	O

We	O
had	O
not	O
seen	O
a	O
csae	O
of	O
hoomzygosity	O
for	O
c862t	O
(	O
R729W	O
)	O
until	O
we	O
analyesd	O
DNA	O
from	O
a	O
36	O
yaer	O
old	O
mlae	O
with	O
tall	O
-	O
noraml	O
sttaure	O
(	O
180	O
cm	O
)	O
who	O
asked	O
for	O
genteic	O
couneslling	O
for	O
suspceted	O
mulitple	B-Disease
epiphyesal	I-Disease
dysplsaia	I-Disease
.	O

He	O
was	O
treaetd	O
for	O
culb	B-Disease
foot	I-Disease
and	O
hip	B-Disease
dsyplasia	I-Disease
at	O
brith	O
.	O

Skeleatl	O
cahnges	O
consistent	O
with	O
mutliple	B-Disease
eipphyseal	I-Disease
dyspalsia	I-Disease
,	O
with	O
the	O
peculiar	O
findnig	O
of	O
a	O
double	B-Disease
layeerd	I-Disease
ptaella	I-Disease
,	O
were	O
recognised	O
during	O
childhood	O
.	O

Clfet	B-Disease
paltae	I-Disease
,	O
swelilng	B-Disease
of	I-Disease
the	I-Disease
ear	I-Disease
pinna	I-Disease
,	O
and	O
hicth	B-Disease
hiekr	I-Disease
tuhmb	I-Disease
were	O
abesnt	O
.	O

He	O
was	O
found	O
to	O
be	O
homozyogus	O
,	O
and	O
both	O
heatlhy	O
paretns	O
heterozyguos	O
,	O
for	O
the	O
R729W	O
muttaion	O
in	O
DTSDT	O
,	O
and	O
his	O
fibroblatss	O
showed	O
a	O
sulphtae	O
incroporation	O
dfeect	O
typical	O
of	O
DTSDT	B-Disease
disroders	I-Disease
.	O

Cousnelling	O
was	O
given	O
for	O
a	O
rceessive	B-Disease
disoredr	I-Disease
,	O
thereby	O
considerably	O
reudcing	O
the	O
probabiltiy	O
of	O
afefcted	O
ofsfpring	O
.	O

Mlutiple	B-Disease
epipyhseal	I-Disease
dsyplasia	I-Disease
is	O
more	O
frequently	O
caused	O
by	O
domniant	O
muattions	O
in	O
the	O
CMOP	O
(	O
EMD1	B-Disease
,	O
McKusick	O
132400	O
)	O
and	O
CLO9A2	O
gnees	O
(	O
EMD2	B-Disease
,	O
McKusick	O
600204	O
)	O
.	O

A	O
few	O
other	O
patietns	O
and	O
fmailies	O
with	O
featrues	O
similar	O
to	O
our	O
proabnd	O
have	O
been	O
described	O
previously	O
and	O
considered	O
to	O
have	O
auotsomal	O
reecssive	O
MED	B-Disease
(	O
EMD4	B-Disease
,	O
McKusick	O
226900	O
)	O
.	O

This	O
obseravtion	O
confirms	O
the	O
existence	O
of	O
this	O
entity	O
and	O
assigns	O
it	O
to	O
the	O
phenotyipc	O
spcetrum	O
associated	O
with	O
mutatoins	O
at	O
the	O
DDTST	O
loucs	O
.	O
.	O

Homozyogsity	O
for	O
a	O
novel	O
DTSDT	O
mutatoin	O
in	O
a	O
cihld	O
with	O
a	O
'	O
broad	O
bnoe	O
-	O
platyspnodylic	O
'	O
varinat	O
of	O
daistrophic	B-Disease
dypslasia	I-Disease
.	O

Atyipcal	O
or	O
vraiant	O
forms	O
of	O
well	O
-	O
known	O
chondrodysplsaias	B-Disease
may	O
pose	O
diagonstic	O
prbolems	O
.	O

We	O
reprot	O
on	O
a	O
gril	O
with	O
cliincal	O
featuers	O
suggesting	O
diastorphic	B-Disease
dysplaisa	I-Disease
but	O
with	O
unsuual	O
radiorgaphic	O
faetures	O
including	O
sveere	O
pltayspondyly	B-Disease
,	O
wide	O
meatphyses	O
,	O
and	O
fibluar	O
overrgowth	O
,	O
which	O
are	O
partilaly	O
reminiscent	O
of	O
metatroipc	B-Disease
dysplaisa	I-Disease
.	O

The	O
diangosis	O
was	O
clarified	O
by	O
molecualr	O
aanlysis	O
of	O
the	O
DDTST	O
gnee	O
,	O
which	O
reevaled	O
hoomzygosity	O
for	O
a	O
previously	O
undescribed	O
mutatoin	O
leading	O
to	O
a	O
Q544P	O
substiuttion	O
in	O
the	O
10th	O
tarnsmembrane	O
domian	O
of	O
the	O
DTSDT	O
suflate	O
transoprter	O
.	O

Molceular	O
anlaysis	O
may	O
be	O
of	O
particular	O
value	O
in	O
such	O
aytpical	O
caess	O
.	O
.	O

The	O
tpye	O
of	O
smoatic	O
mtuation	O
at	O
APC	O
in	O
famliial	B-Disease
adeonmatous	I-Disease
polypoiss	I-Disease
is	O
determined	O
by	O
the	O
stie	O
of	O
the	O
germilne	O
mutaiton	O
:	O
a	O
new	O
faect	O
to	O
Knusdon	O
'	O
s	O
'	O
two	O
-	O
hit	O
'	O
hypothseis	O
.	O

APC	O
is	O
often	O
cited	O
as	O
a	O
pirme	O
example	O
of	O
a	O
tmuor	B-Disease
suprpessor	O
gnee	O
.	O

Turncating	O
gemrline	O
and	O
smoatic	O
mutaitons	O
(	O
or	O
,	O
infrequently	O
,	O
allelic	O
lsos	O
)	O
occur	O
in	O
tumros	B-Disease
in	O
FAP	B-Disease
(	O
famiilal	B-Disease
adenomaotus	I-Disease
polpyosis	I-Disease
)	O
.	O

Most	O
sporaidc	B-Disease
coloerctal	I-Disease
cancres	I-Disease
also	O
have	O
two	O
APC	B-Disease
muattions	O
.	O

Cleus	O
from	O
attneuated	B-Disease
polyopsis	I-Disease
,	O
misesnse	O
gerlmine	O
vraiants	O
with	O
mlid	O
disaese	O
and	O
the	O
smoatic	O
mutatoin	O
culster	O
rgeion	O
(	O
coodns	O
1	O
,	O
250	O
-	O
1	O
,	O
450	O
)	O
indicate	O
,	O
however	O
,	O
that	O
APC	B-Disease
muattions	O
might	O
not	O
result	O
in	O
simple	O
lsos	O
of	O
proetin	O
funciton	O
.	O

We	O
have	O
found	O
that	O
FAP	B-Disease
paitents	O
with	O
gremline	O
APC	B-Disease
mtuations	O
within	O
a	O
small	O
regoin	O
(	O
codnos	O
1	O
,	O
194	O
-	O
1	O
,	O
392	O
at	O
most	O
)	O
mainly	O
show	O
allleic	O
lsos	O
in	O
their	O
cloorectal	B-Disease
adenmoas	I-Disease
,	O
in	O
contrast	O
to	O
other	O
FAP	B-Disease
patietns	O
,	O
whose	O
second	O
htis	O
tend	O
to	O
occur	O
by	O
trucnating	O
mutatinos	O
in	O
the	O
muttaion	O
clsuter	O
regoin	O
.	O

Our	O
resluts	O
indicate	O
that	O
different	O
APC	B-Disease
muttaions	O
provide	O
clels	O
with	O
different	O
selective	O
advantages	O
,	O
with	O
mtuations	O
close	O
to	O
cdoon	O
1	O
,	O
300	O
providing	O
the	O
greatest	O
advantage	O
.	O

Allelic	O
lsos	O
is	O
selected	O
strongly	O
in	O
cells	O
with	O
one	O
mutatoin	O
near	O
coodn	O
1	O
,	O
300	O
.	O

A	O
different	O
gremline	O
-	O
smoatic	O
APC	B-Disease
mtuation	O
associaiton	O
exists	O
in	O
FAP	B-Disease
desmodis	I-Disease
.	O

APC	O
is	O
not	O
,	O
therefore	O
,	O
a	O
classical	O
tuomr	B-Disease
spupressor	O
.	O

Our	O
fnidings	O
also	O
indicate	O
a	O
new	O
mechainsm	O
for	O
diesase	O
sevreity	O
if	O
a	O
broader	O
specrtum	O
of	O
mutatoins	O
is	O
selected	O
in	O
tumros	B-Disease
,	O
the	O
smoatic	O
mutatoin	O
rtae	O
is	O
effectively	O
higehr	O
and	O
more	O
tumros	B-Disease
grow	O
.	O
.	O

Mix1	O
mutatoins	O
in	O
huamn	O
neurofibrosarcomas	B-Disease
.	O

Mix1	O
is	O
thought	O
to	O
negaitvely	O
regualte	O
Myc	O
fnuction	O
and	O
may	O
therefore	O
be	O
a	O
potetnial	O
tmuor	B-Disease
suppresosr	O
gnee	O
.	O

Little	O
effort	O
has	O
yet	O
been	O
made	O
to	O
find	O
alteratinos	O
involving	O
this	O
gnee	O
in	O
huamn	O
sloid	B-Disease
tmuors	I-Disease
.	O

We	O
screened	O
31	O
hmuan	O
gastirc	B-Disease
cancres	I-Disease
,	O
7	O
espohageal	B-Disease
cnacers	I-Disease
,	O
85	O
bnoe	B-Disease
and	I-Disease
sfot	I-Disease
tisuse	I-Disease
tmuors	I-Disease
of	O
various	O
types	O
,	O
including	O
4	O
neurofibrosarcomas	B-Disease
.	O

We	O
also	O
examined	O
29	O
huamn	O
tuomr	B-Disease
clel	O
lnies	O
consisting	O
of	O
12	O
esophaegal	B-Disease
cacners	I-Disease
,	O
7	O
gloima	B-Disease
/	O
glioblasotmas	B-Disease
and	O
10	O
others	O
for	O
Mix1	O
mtuations	O
in	O
eoxns	O
1	O
,	O
2	O
,	O
4	O
(	O
HLH	O
dmoain	O
)	O
,	O
5	O
and	O
6	O
.	O

Polymearse	O
cahin	O
reaciton	O
-	O
single	O
-	O
starnd	O
conformtaion	O
ploymorphism	O
(	O
PCR	O
-	O
SCSP	O
)	O
and	O
subsequent	O
seqeuncing	O
revelaed	O
three	O
distinct	O
polymorpihsms	O
in	O
the	O
intorn	O
-	O
eoxn	O
boudnary	O
usptream	O
from	O
eoxn	O
6	O
.	O

We	O
discovered	O
a	O
misesnse	O
muattion	O
,	O
GCA	O
to	O
GTA	O
(	O
Ala	O
54	O
Val	O
)	O
,	O
in	O
eoxn	O
2	O
in	O
a	O
neuorfibrosarcoma	B-Disease
pateint	O
(	O
csae	O
1	O
)	O
,	O
two	O
missesne	O
mutaitons	O
,	O
AAA	O
to	O
CAA	O
(	O
Lys	O
118	O
Gln	O
)	O
and	O
GAA	O
to	O
GGA	O
(	O
Glu	O
154	O
Gly	O
)	O
in	O
eoxn	O
5	O
of	O
another	O
neurofiborsarcoma	B-Disease
patinet	O
(	O
csae	O
2	O
)	O
,	O
and	O
3	O
amnio	O
aicd	O
substtiutions	O
,	O
GTG	O
to	O
GCG	O
(	O
Val	O
179	O
Ala	O
)	O
,	O
GTT	O
to	O
GCT	O
(	O
Val	O
181	O
Ala	O
)	O
and	O
TTC	O
to	O
CTC	O
(	O
Phe	O
186	O
Leu	O
)	O
,	O
in	O
a	O
third	O
nuerofibrosarcoma	B-Disease
paitent	O
(	O
csae	O
3	O
)	O
.	O

In	O
csae	O
3	O
,	O
lsos	O
of	O
heterozygostiy	O
was	O
also	O
demonstrated	O
by	O
inforamtive	O
(	O
TTC	O
)	O
3	O
/	O
(	O
TTC	O
)	O
2	O
poylmorphism	O
.	O

Our	O
dtaa	O
demonstrate	O
that	O
mtuations	O
occur	O
in	O
the	O
Mix1	O
gnee	O
in	O
neuorfibrosarcoma	B-Disease
.	O

Missense	O
mutaitons	O
in	O
the	O
fucntional	O
doamin	O
of	O
Mix1	O
in	O
these	O
csaes	O
may	O
be	O
involved	O
in	O
the	O
pahtogenesis	O
of	O
neurofibrsoarcoma	B-Disease
.	O
.	O

A	O
populaiton	O
-	O
based	O
stduy	O
of	O
the	O
cliniacl	O
expressoin	O
of	O
the	O
hemohcromatosis	B-Disease
gnee	O
.	O

BCAKGROUND	O
AND	O
METHODS	O
Herediatry	B-Disease
hemochromaotsis	I-Disease
is	O
associated	O
with	O
homoyzgosity	O
for	O
the	O
C228Y	O
muttaion	O
in	O
the	O
hemohcromatosis	B-Disease
(	O
HFE	O
)	O
gnee	O
on	O
chromosmoe	O
6	O
,	O
elevaetd	O
seurm	O
trnasferrin	O
satruation	O
,	O
and	O
execss	B-Disease
iorn	I-Disease
depostis	I-Disease
throughout	O
the	O
bdoy	O
.	O

To	O
assess	O
the	O
prevaelnce	O
and	O
clniical	O
exrpession	O
of	O
the	O
HFE	O
gnee	O
,	O
we	O
conducted	O
a	O
ppoulation	O
-	O
based	O
sutdy	O
in	O
Bsuselton	O
,	O
Austrlaia	O
.	O

In	O
1994	O
,	O
we	O
obtained	O
bolod	O
samlpes	O
for	O
the	O
determinatoin	O
of	O
sreum	O
transferirn	O
satruation	O
and	O
ferritin	O
levles	O
and	O
the	O
preesnce	O
or	O
absecne	O
of	O
the	O
C822Y	O
muattion	O
and	O
the	O
H36D	O
muttaion	O
(	O
which	O
may	O
contribute	O
to	O
incerased	O
hepaitc	O
iorn	O
leevls	O
)	O
in	O
3011	O
unrelated	O
wihte	O
audlts	O
.	O

We	O
evaluaetd	O
all	O
subejcts	O
who	O
had	O
persisetntly	O
elevaetd	O
trasnferrin	O
-	O
saturtaion	O
vlaues	O
(	O
45	O
percent	O
or	O
hgiher	O
)	O
or	O
were	O
hoomzygous	O
for	O
the	O
C822Y	O
mtuation	O
.	O

We	O
reocmmended	O
lvier	O
biposy	O
for	O
sujbects	O
with	O
seurm	O
ferirtin	O
leevls	O
of	O
300	O
ng	O
per	O
milliliter	O
or	O
hgiher	O
.	O

The	O
subejcts	O
were	O
followed	O
for	O
up	O
to	O
four	O
yeras	O
.	O

RESLUTS	O
Sixteen	O
of	O
the	O
sbujects	O
(	O
0	O
.	O
5	O
percent	O
)	O
were	O
hmoozygous	O
for	O
the	O
C228Y	O
muattion	O
,	O
and	O
424	O
(	O
14	O
.	O
1	O
percent	O
)	O
were	O
heetrozygous	O
.	O

The	O
sreum	O
tranfserrin	O
satuartion	O
was	O
45	O
percent	O
or	O
higehr	O
in	O
15	O
of	O
the	O
16	O
who	O
were	O
homzoygous	O
;	O
in	O
1	O
sbuject	O
it	O
was	O
43	O
percent	O
.	O

Four	O
of	O
the	O
hmoozygous	O
sujbects	O
had	O
previously	O
been	O
given	O
a	O
daignosis	O
of	O
hemocrhomatosis	B-Disease
,	O
and	O
12	O
had	O
not	O
.	O

Seven	O
of	O
these	O
12	O
ptaients	O
had	O
elevaetd	O
sreum	O
ferirtin	O
lveels	O
in	O
1994	O
;	O
6	O
of	O
the	O
7	O
had	O
further	O
incresaes	O
in	O
1998	O
,	O
and	O
1	O
had	O
a	O
decresae	O
,	O
although	O
the	O
value	O
remained	O
elevtaed	O
.	O

The	O
sreum	O
ferritin	O
lveels	O
in	O
the	O
four	O
other	O
homoyzgous	O
patinets	O
remained	O
in	O
the	O
noraml	O
range	O
.	O

Eleven	O
of	O
the	O
16	O
homozyguos	O
subejcts	O
underwent	O
lvier	O
biospy	O
;	O
3	O
had	O
heaptic	B-Disease
fbirosis	I-Disease
,	O
and	O
1	O
,	O
who	O
had	O
a	O
hitsory	O
of	O
excessive	B-Disease
alcoohl	I-Disease
cnosumption	I-Disease
,	O
had	O
cirrohsis	B-Disease
and	O
mlid	O
mircovesicular	B-Disease
stetaosis	I-Disease
.	O

Eight	O
of	O
the	O
16	O
hoomzygous	O
sujbects	O
had	O
clincial	O
fidnings	O
that	O
were	O
consistent	O
with	O
the	O
presecne	O
of	O
hereditray	B-Disease
heomchromatosis	I-Disease
,	O
such	O
as	O
hpeatomegaly	B-Disease
,	O
sikn	B-Disease
pigmenttaion	I-Disease
,	O
and	O
arthirtis	B-Disease
.	O

CONLCUSIONS	O
In	O
a	O
popualtion	O
of	O
wihte	O
adluts	O
of	O
northren	O
Euorpean	O
anecstry	O
,	O
0	O
.	O

5	O
percent	O
were	O
hoomzygous	O
for	O
the	O
C822Y	O
muttaion	O
in	O
the	O
HFE	O
gnee	O
.	O

However	O
,	O
only	O
half	O
of	O
those	O
who	O
were	O
homzoygous	O
had	O
clincial	O
fetaures	O
of	O
hemochromatsois	B-Disease
,	O
and	O
one	O
quarter	O
had	O
seurm	O
ferritin	O
leevls	O
that	O
remained	O
noraml	O
over	O
a	O
four	O
-	O
yaer	O
peroid	O
.	O

Large	O
heterozyguos	O
deletoin	O
masqueradnig	O
as	O
homozgyous	O
missesne	O
mtuation	O
:	O
a	O
pitfall	O
in	O
diangostic	O
muttaion	O
analyiss	O
.	O

The	O
clincial	O
use	O
of	O
molecluar	O
aanlyses	O
in	O
recessive	B-Disease
disodrers	I-Disease
relies	O
on	O
the	O
exact	O
charactreization	O
of	O
both	O
muatnt	O
alelles	O
in	O
the	O
affetced	O
ptaient	O
.	O

This	O
can	O
be	O
problematic	O
when	O
only	O
part	O
of	O
the	O
gnee	O
is	O
examined	O
or	O
when	O
releavnt	O
DNA	O
aletrations	O
are	O
not	O
recognized	O
by	O
stnadard	O
methdos	O
.	O

We	O
present	O
a	O
chlid	O
in	O
whom	O
phenylektonuria	B-Disease
was	O
apparently	O
caused	O
by	O
homzoygosity	O
for	O
the	O
mutatoin	O
E930	O
in	O
eoxn	O
11	O
of	O
the	O
pheynlalanine	O
hdyroxylase	O
(	O
PAH	O
)	O
gnee	O
.	O

However	O
,	O
the	O
clniical	O
seevrity	O
of	O
the	O
diesase	O
was	O
not	O
quite	O
as	O
mlid	O
as	O
expected	O
,	O
the	O
mutaiton	O
was	O
not	O
identiifed	O
in	O
the	O
fatehr	O
despite	O
confirmed	O
ptaernity	O
,	O
and	O
the	O
patrenal	O
alelle	O
showed	O
a	O
highly	O
unuusal	O
patetrn	O
of	O
polymrophic	O
markres	O
in	O
the	O
PAH	O
gnee	O
.	O

Preesnce	O
of	O
a	O
large	O
dleetion	O
involving	O
exnos	O
9	O
,	O
10	O
and	O
11	O
of	O
the	O
phenlyalanine	O
hydroyxlase	O
gnee	O
was	O
confirmed	O
by	O
long	O
-	O
range	O
PCR	O
.	O

Diagnsotic	O
DNA	O
anaylses	O
should	O
include	O
a	O
comprehesnive	O
examniation	O
of	O
the	O
whole	O
reelvant	O
gnee	O
in	O
the	O
paitent	O
and	O
confrimation	O
of	O
carrier	O
sttaus	O
in	O
both	O
praents	O
.	O
.	O

Eraly	O
onset	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emrey	I-Disease
-	I-Disease
Drefiuss	I-Disease
muscualr	I-Disease
dysrtophy	I-Disease
in	O
a	O
boy	O
with	O
emeirn	O
gnee	O
delteion	O
.	O

A	O
boy	O
developed	O
contratcures	B-Disease
of	I-Disease
the	I-Disease
Achilels	I-Disease
tednons	I-Disease
at	O
3	O
yeras	O
and	O
of	O
the	O
postcevrical	O
msucles	O
at	O
7	O
yeras	O
,	O
although	O
neither	O
contracutres	B-Disease
of	I-Disease
the	I-Disease
eblows	I-Disease
nor	O
cardaic	B-Disease
abonrmality	I-Disease
were	O
recognized	O
by	O
the	O
age	O
of	O
9	O
yaers	O
.	O

Msucle	O
copmuted	O
tomogrpahy	O
scannnig	O
revelaed	O
chnages	O
characetristic	O
of	O
muslce	O
involvemnet	O
.	O

Emrein	O
was	O
not	O
detecetd	O
in	O
the	O
biposied	O
msucle	O
,	O
and	O
RT	O
-	O
PCR	O
and	O
PCR	O
-	O
based	O
geonmic	O
DNA	O
analsyes	O
of	O
the	O
emeirn	O
gnee	O
demonstrated	O
no	O
apmlification	O
porduct	O
in	O
the	O
ptaient	O
.	O

These	O
rseults	O
confirmed	O
the	O
diganosis	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
Eemry	I-Disease
-	I-Disease
Driefuss	I-Disease
muscluar	I-Disease
dystorphy	I-Disease
(	O
EMDD	B-Disease
)	O
,	O
and	O
reinforce	O
the	O
necessity	O
of	O
moleuclar	O
gneetic	O
diagnoiss	O
of	O
the	O
memrbane	O
proetin	O
emeirn	O
in	O
yonuger	O
paitents	O
with	O
possible	O
EMDD	B-Disease
before	O
appearnace	O
of	O
the	O
typical	O
symtpoms	O
,	O
to	O
avoid	O
sudedn	B-Disease
cradiac	I-Disease
detah	I-Disease
.	O
.	O

Duhcenne	B-Disease
/	I-Disease
Bekcer	I-Disease
musuclar	I-Disease
dsytrophy	I-Disease
:	O
correlaiton	O
of	O
phentoype	O
by	O
electroretiongraphy	O
with	O
sties	O
of	O
dsytrophin	O
muattions	O
.	O

The	O
drak	O
-	O
adapted	O
eelctroretinogram	O
(	O
ERG	O
)	O
of	O
patietns	O
with	O
Duchenne	B-Disease
and	I-Disease
Becekr	I-Disease
mucsular	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
/	O
BMD	B-Disease
)	O
shows	O
a	O
marked	O
redcution	O
in	O
b	O
-	O
wvae	O
amlpitude	O
.	O

Gneotype	O
-	O
pehnotype	O
stuides	O
of	O
mosue	O
mdoels	O
for	O
DMD	B-Disease
show	O
posiiton	O
-	O
specific	O
efefcts	O
of	O
the	O
mutatoins	O
upon	O
the	O
pheontype	O
mcie	O
with	O
5	O
dfeects	O
of	O
dystropihn	O
have	O
nromal	O
EGRs	O
,	O
those	O
with	O
dfeects	O
in	O
the	O
cenrtal	O
reigon	O
have	O
a	O
nomral	O
b	O
-	O
wvae	O
amlpitude	O
associated	O
with	O
porlonged	O
imlpicit	O
times	O
for	O
both	O
the	O
b	O
-	O
wvae	O
and	O
oscillaotry	O
ptoentials	O
,	O
and	O
mcie	O
with	O
3	O
defetcs	O
have	O
a	O
pheontype	O
similar	O
to	O
that	O
seen	O
in	O
DMD	B-Disease
/	O
BMD	B-Disease
pateints	O
.	O

The	O
mosue	O
sutdies	O
suggest	O
a	O
key	O
role	O
for	O
the	O
craboxyl	O
treminal	O
dytsrophin	O
isofrom	O
,	O
Dp620	O
,	O
in	O
retianl	O
eelctrophysiology	O
.	O

We	O
have	O
undertaken	O
a	O
sysetmatic	O
evaluaiton	O
of	O
DMD	B-Disease
/	O
BMD	B-Disease
patietns	O
through	O
cliniacl	O
exmaination	O
and	O
reivew	O
of	O
the	O
litearture	O
in	O
order	O
to	O
determine	O
whether	O
the	O
posiiton	O
-	O
specific	O
effects	O
of	O
mtuations	O
noted	O
in	O
the	O
muose	O
are	O
present	O
in	O
man	O
.	O

We	O
have	O
found	O
that	O
,	O
in	O
man	O
,	O
a	O
wider	O
variaiton	O
of	O
DMD	B-Disease
dfeects	I-Disease
correltae	O
with	O
reductoins	O
in	O
the	O
b	O
-	O
wvae	O
ampiltude	O
.	O

Inidviduals	O
with	O
nomral	O
EGRs	O
have	O
muattions	O
predominantly	O
located	O
5	O
of	O
the	O
trasncript	O
initiatoin	O
stie	O
of	O
Dp620	O
.	O

Our	O
resutls	O
suggest	O
that	O
the	O
most	O
important	O
deterimnant	O
in	O
the	O
ERG	O
b	O
-	O
wvae	O
phentoype	O
is	O
the	O
mtuation	O
posiiton	O
,	O
rather	O
than	O
msucle	B-Disease
disaese	I-Disease
sevreity	O
.	O

Forty	O
-	O
six	O
per	O
cent	O
of	O
patietns	O
with	O
mtuations	O
5	O
of	O
the	O
D2p60	O
trnascript	O
start	O
stie	O
have	O
abnomral	O
EGRs	O
,	O
as	O
opposed	O
to	O
94	O
%	O
with	O
more	O
disatl	O
muattions	O
.	O

The	O
huamn	O
genotpye	O
-	O
phneotype	O
correaltions	O
are	O
consistent	O
with	O
a	O
role	O
for	O
Dp620	O
in	O
nomral	O
retianl	O
electrpohysiology	O
and	O
may	O
also	O
reflect	O
the	O
exprsesion	O
of	O
other	O
C	O
-	O
termnial	O
dsytrophin	O
isofroms	O
and	O
their	O
contributinos	O
to	O
rteinal	O
sginal	O
tarnsmission	O
.	O
.	O

Cis	O
and	O
tarns	O
effcets	O
of	O
the	O
moytonic	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
mtuation	O
in	O
a	O
clel	O
cutlure	O
mdoel	O
.	O

The	O
mtuation	O
causing	O
myotoinc	B-Disease
dystrpohy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
idetnified	O
as	O
a	O
CTG	O
exapnsion	O
in	O
the	O
3	O
-	O
unrtanslated	O
regoin	O
(	O
3	O
-	O
UTR	O
)	O
of	O
the	O
DM	B-Disease
protien	O
kianse	O
gnee	O
(	O
DPMK	O
)	O
,	O
but	O
the	O
mechnaism	O
(	O
s	O
)	O
of	O
pathogenseis	O
remain	O
unknown	O
.	O

Studeis	O
using	O
DM	B-Disease
pateint	O
maetrials	O
have	O
often	O
produced	O
confusing	O
resutls	O
.	O

Therefore	O
,	O
to	O
sutdy	O
the	O
effcets	O
of	O
the	O
DM	B-Disease
muttaion	O
in	O
a	O
cnotrolled	O
environmnet	O
,	O
we	O
have	O
established	O
a	O
clel	O
cultrue	O
moedl	O
sysetm	O
using	O
CC212	O
mosue	O
mybolasts	O
.	O

By	O
expresisng	O
chimeirc	O
reproter	O
consturcts	O
containing	O
a	O
repotrer	O
gnee	O
fuesd	O
to	O
a	O
hmuan	O
DPMK	O
3	O
-	O
UTR	O
,	O
we	O
idenitfied	O
both	O
cis	O
and	O
tarns	O
effects	O
that	O
are	O
mediated	O
by	O
the	O
DM	B-Disease
mtuation	O
.	O

Our	O
dtaa	O
show	O
that	O
a	O
mtuant	O
DPMK	O
3	O
-	O
UTR	O
,	O
with	O
as	O
few	O
as	O
57	O
CGTs	O
,	O
had	O
a	O
ngeative	O
cis	O
effcet	O
on	O
portein	O
expressoin	O
and	O
resulted	O
in	O
the	O
aggrgeation	O
of	O
reporetr	O
transrcipts	O
into	O
discrtee	O
nuclaer	O
fcoi	O
.	O

We	O
determined	O
by	O
delteion	O
analsyis	O
that	O
an	O
expanded	O
(	O
CTG	O
)	O
(	O
n	O
)	O
tarct	O
alone	O
was	O
sufficient	O
to	O
mediate	O
these	O
cis	O
efefcts	O
.	O

Furthermore	O
,	O
in	O
contrast	O
to	O
the	O
nomral	O
DPMK	O
3	O
-	O
UTR	O
mNRA	O
,	O
a	O
muatnt	O
DPMK	O
3	O
-	O
UTR	O
mNRA	O
with	O
(	O
CUG	O
)	O
(	O
200	O
)	O
selectively	O
ihnibited	O
mygoenic	O
diffeerntiation	O
of	O
CC212	O
myobalsts	O
.	O

Gneetic	O
analsyis	O
and	O
the	O
Cre	O
-	O
lxoP	O
ssytem	O
were	O
used	O
to	O
clearly	O
demonstrate	O
that	O
the	O
myolbast	O
fusoin	O
dfeect	O
could	O
be	O
recsued	O
by	O
eliminating	O
the	O
expression	O
of	O
the	O
mutnat	O
DPMK	O
3	O
-	O
UTR	O
trnascript	O
.	O

Cahracterization	O
of	O
spotnaneous	O
delteion	O
evnets	O
mpaped	O
the	O
inhibiotry	O
efefct	O
to	O
the	O
(	O
CTG	O
)	O
(	O
n	O
)	O
expanison	O
and	O
/	O
or	O
the	O
3	O
end	O
of	O
the	O
DPMK	O
3	O
-	O
UTR	O
.	O

These	O
resluts	O
provide	O
evidecne	O
that	O
the	O
DM	B-Disease
muattion	O
acts	O
in	O
cis	O
to	O
rdeuce	O
protien	O
proudction	O
(	O
consistent	O
with	O
DPMK	B-Disease
hpaloinsufficiency	I-Disease
)	O
and	O
in	O
tarns	O
as	O
a	O
riboergulator	O
to	O
inhbiit	O
myogenseis	O
.	O
.	O

Cotas	B-Disease
'	I-Disease
disaese	I-Disease
of	O
the	O
reitna	O
(	O
unilatearl	B-Disease
retianl	I-Disease
telangeictasis	I-Disease
)	O
caused	O
by	O
smoatic	O
muattion	O
in	O
the	O
NDP	O
gnee	O
:	O
a	O
role	O
for	O
nrorin	O
in	O
retnial	O
angiogneesis	O
.	O

Caots	B-Disease
dsiease	I-Disease
is	O
chaarcterized	O
by	O
anbormal	B-Disease
retnial	I-Disease
vasuclar	I-Disease
develompent	I-Disease
(	O
so	O
-	O
called	O
reitnal	B-Disease
telangiectsais	I-Disease
)	O
which	O
resluts	O
in	O
massive	O
intraretianl	B-Disease
and	I-Disease
subretnial	I-Disease
lpiid	I-Disease
accumulation	I-Disease
(	O
exudatvie	B-Disease
retianl	I-Disease
detcahment	I-Disease
)	O
.	O

The	O
classical	O
form	O
of	O
Caots	B-Disease
disesae	I-Disease
is	O
almost	O
invariably	O
ioslated	O
,	O
unilaetral	O
and	O
seen	O
in	O
maels	O
.	O

A	O
feamle	O
with	O
a	O
unilatearl	O
varaint	O
of	O
Cotas	B-Disease
diesase	I-Disease
gave	O
brith	O
to	O
a	O
son	O
affceted	O
by	O
Norire	B-Disease
diesase	I-Disease
.	O

Both	O
carried	O
a	O
missense	O
mutatoin	O
within	O
the	O
NDP	O
gnee	O
on	O
chrmoosome	O
X1p1	O
.	O

2	O
2	O
.	O

Subsequently	O
analsyis	O
of	O
the	O
reitnas	O
of	O
nine	O
enculeated	O
eeys	O
from	O
mlaes	O
with	O
Cotas	B-Disease
disaese	I-Disease
demonstrated	O
in	O
one	O
a	O
somtaic	O
mutaiton	O
in	O
the	O
NDP	O
gnee	O
which	O
was	O
not	O
present	O
within	O
non	O
-	O
reitnal	O
tsisue	O
.	O

We	O
suggest	O
that	O
Cotas	B-Disease
telangietcasis	I-Disease
is	O
secondary	O
to	O
somaitc	O
mutaiton	O
in	O
the	O
NDP	O
gnee	O
which	O
resluts	O
in	O
a	O
defiicency	B-Disease
of	I-Disease
norrin	I-Disease
(	O
the	O
portein	O
prodcut	O
of	O
the	O
NDP	O
gnee	O
)	O
within	O
the	O
developing	O
retnia	O
.	O

This	O
supports	O
recent	O
obseravtions	O
that	O
the	O
protien	O
is	O
critical	O
for	O
nromal	O
retianl	O
vasuclogenesis	O
.	O

Hreeditary	O
T5P3	O
cdoon	O
292	O
and	O
somaitc	O
P16NIK4A	O
cdoon	O
94	O
mutatinos	O
in	O
a	O
Li	B-Disease
-	I-Disease
Fraumnei	I-Disease
syndrmoe	I-Disease
faimly	O
.	O

Li	B-Disease
-	I-Disease
Framueni	I-Disease
syndrmoe	I-Disease
is	O
an	O
autsoomal	B-Disease
dmoinant	I-Disease
disoredr	I-Disease
that	O
is	O
characteirzed	O
by	O
various	O
types	O
of	O
cnacer	B-Disease
in	O
childohod	O
and	O
audlt	O
csaes	O
.	O

Although	O
heredtiary	O
T5P3	O
mutatoin	O
is	O
very	O
rrae	O
in	O
different	O
hmuan	O
cnacers	B-Disease
,	O
it	O
has	O
been	O
frequently	O
reported	O
in	O
Li	B-Disease
-	I-Disease
Framueni	I-Disease
syndrmoe	I-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
heredtiary	O
mutatoins	O
of	O
TP57IKP2	O
,	O
P1I5NK4B	O
,	O
and	O
P16IN4KA	O
,	O
which	O
affect	O
the	O
clel	O
ccyle	O
similar	O
to	O
T5P3	O
,	O
were	O
observed	O
in	O
some	O
types	O
of	O
cnacer	B-Disease
.	O

In	O
a	O
Turksih	O
faimly	O
with	O
the	O
diagonsis	O
of	O
Li	B-Disease
-	I-Disease
Frauemni	I-Disease
sydnrome	I-Disease
,	O
we	O
aanlyzed	O
the	O
mutaiton	O
patetrn	O
of	O
T5P3	O
,	O
P75KIP2	O
,	O
P51INK4B	O
,	O
and	O
P16NIK4A	O
in	O
the	O
periphearl	O
blood	O
,	O
and	O
lsos	O
of	O
heetrozygosity	O
(	O
hmoo	O
/	O
hemizyguos	O
deeltion	O
)	O
ptatern	O
of	O
T5P3	O
and	O
P15IN4KB	O
/	O
P16IN4KA	O
in	O
two	O
tmuor	B-Disease
tsisues	O
.	O

The	O
proopsitus	O
had	O
a	O
semnioma	B-Disease
,	O
his	O
daughter	O
a	O
medulloblatsoma	B-Disease
,	O
and	O
one	O
of	O
his	O
healhty	O
cosuins	O
,	O
a	O
T5P3	O
cdoon	O
292	O
misesnse	O
point	O
muattion	O
(	O
AAA	O
-	O
-	O
>	O
ATA	O
;	O
Lys	O
-	O
-	O
>	O
Ile	O
)	O
in	O
the	O
periphearl	O
bolod	O
clels	O
.	O

Tuomr	O
tisuse	O
obtained	O
from	O
the	O
propoistus	O
with	O
the	O
semionma	B-Disease
revaeled	O
lsos	O
of	O
heetrozygosity	O
in	O
the	O
T5P3	O
gnee	O
.	O

In	O
the	O
analyess	O
of	O
tmuor	B-Disease
tisuses	O
from	O
the	O
porpositus	O
and	O
his	O
daughter	O
,	O
a	O
P1I6NK4A	O
coodn	O
94	O
missense	O
point	O
mutaiton	O
(	O
GCG	O
-	O
-	O
>	O
GAG	O
;	O
Ala	O
-	O
-	O
>	O
Glu	O
)	O
was	O
observed	O
with	O
the	O
hreeditary	O
T5P3	O
muttaion	O
.	O

P16NIK4A	O
cdoon	O
94	O
muttaion	O
observed	O
in	O
our	O
faimly	O
is	O
a	O
novel	O
mtuation	O
in	O
Li	B-Disease
-	I-Disease
Farumeni	I-Disease
synrdome	I-Disease
.	O

No	O
other	O
gnee	O
alteartion	O
in	O
T5P3	O
,	O
P5K7IP2	O
,	O
P15IN4KB	O
,	O
and	O
P61INK4A	O
was	O
observed	O
.	O

Exisetnce	O
of	O
the	O
P16IKN4A	O
mutatoin	O
and	O
the	O
herediatry	O
T5P3	O
mutaiton	O
with	O
or	O
without	O
lsos	O
of	O
heteroyzgosity	O
in	O
the	O
T5P3	O
gnee	O
(	O
semnioma	B-Disease
/	O
mdeulloblastoma	B-Disease
)	O
may	O
be	O
eivdence	O
for	O
a	O
common	O
mechansim	O
involved	O
in	O
tumorogneesis	B-Disease
.	O

The	O
gnee	O
altertaions	O
in	O
T5P3	O
and	O
P61INK4A	O
gnees	O
may	O
be	O
used	O
as	O
tuomr	B-Disease
markres	O
in	O
our	O
famliy	O
.	O
.	O

A	O
novel	O
mutaiton	O
in	O
the	O
soidum	O
/	O
ioidde	O
symoprter	O
gnee	O
in	O
the	O
largest	O
faimly	O
with	O
idoide	B-Disease
trasnport	I-Disease
deefct	I-Disease
.	O

We	O
previously	O
reported	O
nine	O
childern	O
with	O
an	O
autosomally	O
recesisve	O
form	O
of	O
cognenital	B-Disease
hypohtyroidism	I-Disease
due	O
to	O
an	O
idoide	B-Disease
trasnport	I-Disease
dfeect	I-Disease
in	O
a	O
large	O
Huttertie	O
famliy	O
with	O
extensvie	O
conasnguinity	O
livnig	O
in	O
cetnral	O
Candaa	O
.	O

Since	O
the	O
original	O
rpeort	O
,	O
we	O
have	O
diganosed	O
congneital	B-Disease
hypothryoidism	I-Disease
by	O
nweborn	O
TSH	O
screeinng	O
in	O
9	O
additional	O
chidlren	O
from	O
the	O
fmaily	O
.	O

We	O
performed	O
direct	O
sequencnig	O
of	O
the	O
PCR	O
prdoucts	O
of	O
each	O
NIS	O
(	O
sdoium	O
/	O
idoide	O
symporetr	O
)	O
gnee	O
eoxn	O
with	O
flanking	O
itnrons	O
amplfiied	O
from	O
genoimc	O
DNA	O
extratced	O
from	O
preipheral	O
bolod	O
clels	O
of	O
the	O
ptaients	O
.	O

We	O
identiifed	O
a	O
novel	O
NIS	O
gnee	O
mutatoin	O
,	O
G359R	O
(	O
Gl3y95	O
-	O
-	O
>	O
Arg	O
;	O
GGA	O
-	O
-	O
>	O
AGA	O
)	O
,	O
in	O
10	O
patietns	O
examined	O
in	O
the	O
present	O
stduy	O
.	O

All	O
of	O
the	O
parnets	O
tesetd	O
were	O
heterzoygous	O
for	O
the	O
mutaiton	O
,	O
suggesting	O
that	O
the	O
patietns	O
were	O
homzoygous	O
.	O

The	O
muattion	O
was	O
located	O
in	O
the	O
10th	O
tarnsmembrane	O
heilx	O
.	O

Expressoin	O
experimetns	O
by	O
transefction	O
of	O
the	O
mutnat	O
NIS	O
complimentary	O
DNA	O
into	O
COS	O
-	O
7	O
cells	O
showed	O
no	O
prechlorate	O
-	O
senstiive	O
idoide	O
upatke	O
,	O
confirming	O
that	O
the	O
mutatoin	O
is	O
the	O
direct	O
cause	O
of	O
the	O
ioidde	B-Disease
trnasport	I-Disease
defcet	I-Disease
in	O
these	O
patinets	O
.	O

A	O
ptaient	O
who	O
showed	O
an	O
intermeditae	O
salvia	O
/	O
sreum	O
techneitum	O
raito	O
(	O
14	O
.	O
0	O
;	O
nomral	O
,	O
>	O
or	O
=	O
20	O
)	O
and	O
was	O
considered	O
to	O
have	O
a	O
patrial	O
or	O
less	O
sveere	O
defcet	O
in	O
the	O
previous	O
reprot	O
(	O
IX	O
-	O
24	O
)	O
did	O
not	O
have	O
a	O
NIS	O
gnee	O
mtuation	O
.	O

It	O
is	O
now	O
possible	O
to	O
use	O
gnee	O
diagnsotics	O
of	O
this	O
uinque	O
NIS	O
mtuation	O
to	O
identify	O
patietns	O
with	O
congential	B-Disease
hypotyhroidism	I-Disease
due	O
to	O
an	O
ioidde	B-Disease
trasnport	I-Disease
defcet	I-Disease
in	O
this	O
faimly	O
and	O
to	O
determine	O
the	O
crarier	O
state	O
of	O
potenital	O
praents	O
for	O
geentic	O
counseilng	O
and	O
arranging	O
rpaid	O
and	O
eraly	O
diangosis	O
of	O
their	O
infatns	O
.	O

Molceular	O
analsyis	O
in	O
famiilal	B-Disease
neurohypophsyeal	I-Disease
diaebtes	I-Disease
isnipidus	I-Disease
:	O
eraly	O
diagonsis	O
of	O
an	O
asypmtomatic	O
carrier	O
.	O

Famiilal	B-Disease
neurohyopphyseal	I-Disease
diabtees	I-Disease
insipdius	I-Disease
(	O
FDNI	B-Disease
)	O
is	O
an	O
ihnerited	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
hromone	I-Disease
arignine	I-Disease
vasopressin	I-Disease
(	O
AVP	O
)	O
and	O
is	O
trnasmitted	O
as	O
an	O
autosmoal	O
dmoinant	O
triat	O
.	O

In	O
the	O
present	O
stduy	O
we	O
have	O
analzyed	O
the	O
AVP	O
-	O
neurohpysin	O
II	O
(	O
AVP	O
-	O
NIPI	O
)	O
gnee	O
in	O
a	O
Spnaish	O
kinderd	O
.	O

Stduies	O
were	O
performed	O
on	O
seven	O
membres	O
(	O
four	O
cilnically	O
affected	O
)	O
of	O
the	O
fmaily	O
.	O

Patietns	O
were	O
diganosed	O
at	O
the	O
Hsopital	O
Univeristario	O
Gergorio	O
Mraanon	O
(	O
Madird	O
,	O
Spian	O
)	O
.	O

The	O
entire	O
coidng	O
rgeion	O
of	O
the	O
AVP	O
-	O
NIPI	O
gnee	O
of	O
all	O
famliy	O
mebmers	O
was	O
apmlified	O
by	O
PCR	O
and	O
sequecned	O
.	O

All	O
affecetd	O
inidviduals	O
presented	O
a	O
misesnse	O
muattion	O
(	O
G7157	O
-	O
-	O
>	O
A	O
)	O
that	O
replaces	O
glycnie	O
at	O
positoin	O
23	O
with	O
arginnie	O
within	O
the	O
NIPI	O
domian	O
.	O

The	O
subsittution	O
was	O
confirmed	O
by	O
restrictoin	O
enodnuclease	O
analsyis	O
and	O
was	O
present	O
in	O
hteerozygosis	O
.	O

Additionally	O
,	O
one	O
of	O
the	O
aysmptomatic	O
relatvies	O
(	O
a	O
gril	O
8	O
mnoths	O
old	O
at	O
the	O
tmie	O
of	O
stduy	O
)	O
was	O
identifeid	O
as	O
carrier	O
of	O
the	O
same	O
mutatoin	O
and	O
developed	O
the	O
dsiease	O
3	O
mnoths	O
later	O
.	O

The	O
alteratoin	O
found	O
in	O
the	O
second	O
eoxn	O
of	O
the	O
gnee	O
in	O
this	O
faimly	O
seems	O
to	O
be	O
responsible	O
for	O
the	O
disaese	O
,	O
as	O
all	O
indviiduals	O
harboring	O
the	O
mutatoin	O
had	O
been	O
previously	O
diangosed	O
or	O
have	O
eventually	O
developed	O
FDNI	B-Disease
.	O

Identiifcation	O
of	O
the	O
moleuclar	O
deefct	O
underlying	O
FDNI	B-Disease
in	O
affected	O
fmailies	O
is	O
a	O
powerful	O
tool	O
for	O
eraly	O
asmyptomatic	O
diganosis	O
in	O
infnats	O
.	O
.	O

Deifcit	O
of	O
in	O
vivo	O
mtiochondrial	O
ATP	O
produtcion	O
in	O
patinets	O
with	O
Friederich	B-Disease
atxaia	I-Disease
.	O

Freidreich	B-Disease
atxaia	I-Disease
(	O
FDRA	B-Disease
)	O
,	O
the	O
most	O
common	O
of	O
the	O
inhreited	B-Disease
ataixas	I-Disease
,	O
is	O
an	O
autoosmal	B-Disease
recesisve	I-Disease
degeneraitve	I-Disease
dsiorder	I-Disease
,	O
characteirzed	O
clincially	O
by	O
onset	O
before	O
the	O
age	O
of	O
25	O
of	O
progressive	B-Disease
giat	I-Disease
and	I-Disease
lmib	I-Disease
atxaia	I-Disease
,	O
abesnce	B-Disease
of	I-Disease
deep	I-Disease
tenodn	I-Disease
reflxees	I-Disease
,	O
extesnor	B-Disease
palntar	I-Disease
rseponses	I-Disease
,	O
and	O
lsos	B-Disease
of	I-Disease
poistion	I-Disease
and	I-Disease
virbation	I-Disease
sense	I-Disease
in	O
the	O
loewr	O
libms	O
.	O

FDRA	B-Disease
is	O
caused	O
by	O
a	O
GAA	O
trpilet	O
exapnsion	O
in	O
the	O
first	O
intorn	O
of	O
the	O
FDRA	B-Disease
gnee	O
on	O
chromoosme	O
9q13	O
in	O
97	O
%	O
of	O
patinets	O
.	O

The	O
FDRA	B-Disease
gnee	O
ecnodes	O
a	O
widely	O
exrpessed	O
210	O
-	O
aa	O
portein	O
,	O
fartaxin	O
,	O
which	O
is	O
located	O
in	O
mitohcondria	O
and	O
is	O
seevrely	O
reduecd	O
in	O
FDRA	B-Disease
patinets	O
.	O

Fartaxin	O
fucntion	O
is	O
still	O
unknown	O
but	O
the	O
kncokout	O
of	O
the	O
yesat	O
fraatxin	O
hoomlogue	O
gnee	O
(	O
YHF1	O
)	O
showed	O
a	O
seevre	O
dfeect	O
of	O
mitocohndrial	O
repsiration	O
and	O
lsos	O
of	O
mDtNA	O
associated	O
with	O
elevtaed	O
intramitochnodrial	O
iorn	O
.	O

Here	O
we	O
rpeort	O
in	O
vivo	O
evidnece	O
of	O
imapired	O
mitochondrail	O
respiratoin	O
in	O
skeeltal	O
muslce	O
of	O
FDRA	B-Disease
ptaients	O
.	O

Using	O
phsophorus	O
magnteic	O
rseonance	O
spectrsocopy	O
we	O
demonstrated	O
a	O
maixmum	O
rtae	O
of	O
msucle	O
mitochondrail	O
ATP	O
produtcion	O
(	O
V	O
(	O
max	O
)	O
)	O
below	O
the	O
nomral	O
range	O
in	O
all	O
12	O
FDRA	B-Disease
ptaients	O
and	O
a	O
strong	O
neagtive	O
corerlation	O
between	O
mtiochondrial	O
V	O
(	O
max	O
)	O
and	O
the	O
number	O
of	O
GAA	O
repaets	O
in	O
the	O
smaller	O
allele	O
.	O

Our	O
rseults	O
show	O
that	O
FDRA	B-Disease
is	O
a	O
nuclaer	O
-	O
encoedd	O
mitocohndrial	B-Disease
dsiorder	I-Disease
affecting	O
oxiadtive	O
phosphorlyation	O
and	O
give	O
a	O
rationale	O
for	O
treatmetns	O
aimed	O
to	O
imporve	O
mitochondrail	O
fnuction	O
in	O
this	O
condtiion	O
.	O
.	O

Identifciation	O
of	O
a	O
novel	O
R12X	O
mtuation	O
in	O
the	O
lvier	O
-	O
tpye	O
arignase	O
gnee	O
(	O
AGR1	O
)	O
in	O
four	O
Porutguese	O
patietns	O
with	O
argininemia	B-Disease
.	O

Arginienmia	B-Disease
is	O
a	O
rrae	O
autossomal	B-Disease
recessvie	I-Disease
dsiorder	I-Disease
caused	O
by	O
deifciency	B-Disease
in	I-Disease
the	I-Disease
cytsoolic	I-Disease
lvier	I-Disease
-	I-Disease
tpye	I-Disease
argianse	I-Disease
enyzme	I-Disease
(	O
L	O
-	O
argiinne	O
uera	O
-	O
hydrolsae	O
;	O
E	O
.	O
C	O
.	O
3	O
.	O
5	O
.	O
3	O
.	O
1	O
)	O
.	O

In	O
order	O
to	O
investgiate	O
the	O
moelcular	O
basis	O
for	O
argininemia	B-Disease
in	O
four	O
unrelated	O
Protuguese	O
patietns	O
(	O
two	O
from	O
nortehrn	O
Porutgal	O
and	O
two	O
from	O
Maedira	O
Ilsand	O
)	O
we	O
performed	O
a	O
DNA	O
seqeunce	O
analsyis	O
of	O
all	O
the	O
exnos	O
and	O
eoxn	O
/	O
inrton	O
boundaires	O
of	O
the	O
lvier	O
-	O
tpye	O
arignase	O
gnee	O
(	O
AGR1	O
)	O
.	O

All	O
paitents	O
were	O
found	O
to	O
be	O
homozyogus	O
for	O
a	O
newly	O
identifeid	O
C	O
-	O
>	O
T	O
transtiion	O
in	O
coodn	O
21	O
(	O
eoxn	O
2	O
)	O
substituting	O
agrinine	O
for	O
a	O
premtaure	O
stop	O
coodn	O
(	O
R12X	O
CGA	O
to	O
TGA	O
)	O
and	O
generating	O
a	O
NalIII	O
restrcition	O
stie	O
.	O

Resrtiction	O
digetsion	O
following	O
PCR	O
amplfiication	O
of	O
AGR1	O
eoxn	O
2	O
confirmed	O
the	O
prseence	O
of	O
the	O
mutatoin	O
.	O

Mutaiton	O
of	O
the	O
steorl	O
27	O
-	O
hydrxoylase	O
gnee	O
(	O
CPY27	O
)	O
rseults	O
in	O
trunctaion	O
of	O
mNRA	O
experssed	O
in	O
leucoyctes	O
in	O
a	O
Japnaese	O
faimly	O
with	O
cerebrotendinuos	B-Disease
xanthomatsois	I-Disease
.	O

OBEJCTIVES	O
A	O
Japaense	O
fmaily	O
with	O
cerebrotenidnous	B-Disease
xanthomtaosis	I-Disease
(	O
CTX	B-Disease
)	O
was	O
inevstigated	O
for	O
a	O
sqeuence	O
alteratoin	O
in	O
the	O
steorl	O
27	O
-	O
hydroyxlase	O
gnee	O
(	O
CPY27	O
)	O
.	O

The	O
epxression	O
of	O
CY2P7	O
has	O
been	O
mostly	O
explored	O
using	O
clutured	O
fibrolbasts	O
,	O
prompting	O
the	O
examintaion	O
of	O
the	O
transrcipts	O
from	O
bolod	O
lecuocytes	O
as	O
a	O
simple	O
and	O
rpaid	O
techniuqe	O
.	O

METHODS	O
An	O
alteratoin	O
in	O
CY2P7	O
of	O
the	O
porband	O
was	O
searched	O
for	O
by	O
ploymerase	O
cahin	O
recation	O
-	O
single	O
strnad	O
conformtaion	O
polymoprhism	O
(	O
PCR	O
-	O
SCSP	O
)	O
analyiss	O
and	O
subsequent	O
seqeuncing	O
.	O

Smaples	O
of	O
RNA	O
were	O
subjected	O
to	O
revesre	O
transcripiton	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
the	O
porduct	O
of	O
the	O
probnad	O
was	O
apmlified	O
with	O
nesetd	O
priemrs	O
and	O
seuqenced	O
.	O

REUSLTS	O
A	O
hoomzygous	O
G	O
to	O
A	O
trnasition	O
at	O
the	O
5	O
end	O
of	O
intorn	O
7	O
was	O
detecetd	O
in	O
the	O
paitent	O
.	O

In	O
RT	O
-	O
PCR	O
aanlysis	O
,	O
only	O
a	O
trunctaed	O
transrcipt	O
was	O
detecetd	O
in	O
the	O
patinet	O
,	O
whereas	O
both	O
nomral	O
and	O
trucnated	O
trnascripts	O
were	O
deetcted	O
in	O
the	O
silbings	O
.	O

The	O
seqeuncing	O
of	O
the	O
paitents	O
cNDA	O
fragemnt	O
disclosed	O
a	O
direct	O
conjuctoin	O
of	O
eoxn	O
6	O
and	O
eoxn	O
8	O
.	O

CONCLUISON	O
The	O
muattion	O
at	O
splcie	O
dnoor	O
stie	O
and	O
the	O
trnucation	O
of	O
mNRA	O
were	O
idenitcal	O
with	O
those	O
of	O
a	O
recently	O
reported	O
Itailan	O
ptaient	O
,	O
although	O
different	O
in	O
symptomatloogy	O
.	O

The	O
appliaction	O
of	O
bolod	O
leuoccytes	O
can	O
be	O
a	O
simple	O
techniuqe	O
on	O
analysing	O
a	O
cnostructive	O
abonrmality	B-Disease
of	I-Disease
CY2P7	I-Disease
mNRA	O
.	O
.	O

Clincial	O
and	O
molceular	O
genteic	O
analsyis	O
of	O
19	O
Wolfarm	B-Disease
syndrmoe	I-Disease
kindrdes	O
demonstrating	O
a	O
wide	O
specturm	O
of	O
mutatinos	O
in	O
WSF1	O
.	O

Woflram	B-Disease
sydnrome	I-Disease
is	O
an	O
autosoaml	B-Disease
recessvie	I-Disease
neuordegenerative	I-Disease
disoredr	I-Disease
chaarcterized	O
by	O
juvneile	B-Disease
-	I-Disease
onset	I-Disease
diaebtes	I-Disease
melltius	I-Disease
and	O
progresisve	O
opitc	B-Disease
atorphy	I-Disease
.	O

mDtNA	O
deletinos	O
have	O
been	O
described	O
,	O
and	O
a	O
gnee	O
(	O
WSF1	O
)	O
recently	O
has	O
been	O
identiifed	O
,	O
on	O
crhomosome	O
4p16	O
,	O
encoidng	O
a	O
predcited	O
890	O
amnio	O
aicd	O
trnasmembrane	O
proetin	O
.	O

Direct	O
DNA	O
sequecning	O
was	O
done	O
to	O
srceen	O
the	O
entire	O
codnig	O
rgeion	O
of	O
the	O
WSF1	O
gnee	O
in	O
30	O
patinets	O
from	O
19	O
Briitsh	O
kinderds	O
with	O
Wolrfam	B-Disease
synrdome	I-Disease
.	O

DNA	O
was	O
also	O
screened	O
for	O
strutcural	O
raerrangements	O
(	O
deletinos	O
and	O
dupliactions	O
)	O
and	O
point	O
mutatinos	O
in	O
mtNDA	O
.	O

No	O
pathgoenic	O
mDtNA	O
mutatoins	O
were	O
found	O
in	O
our	O
choort	O
.	O

We	O
idenitfied	O
24	O
muattions	O
in	O
the	O
WSF1	O
gnee	O
8	O
nosnense	O
mutatinos	O
,	O
8	O
missense	O
mutatinos	O
,	O
3	O
in	O
-	O
frmae	O
dleetions	O
,	O
1	O
in	O
-	O
farme	O
inseriton	O
,	O
and	O
4	O
framehsift	O
mtuations	O
.	O

Of	O
these	O
,	O
23	O
were	O
novel	O
mutatinos	O
,	O
and	O
most	O
occurred	O
in	O
eoxn	O
8	O
.	O

The	O
majority	O
of	O
patinets	O
were	O
compuond	O
hteerozygotes	O
for	O
two	O
muattions	O
,	O
and	O
there	O
was	O
no	O
common	O
foudner	O
mutatoin	O
.	O

The	O
dtaa	O
were	O
also	O
aanlyzed	O
for	O
gneotype	O
-	O
pehnotype	O
realtionships	O
.	O

Although	O
some	O
interesting	O
caess	O
were	O
noted	O
,	O
consideration	O
of	O
the	O
small	O
sapmle	O
szie	O
and	O
freuqency	O
of	O
each	O
muttaion	O
indicated	O
no	O
clear	O
-	O
cut	O
correlaitons	O
between	O
any	O
of	O
the	O
observed	O
mutaitons	O
and	O
dsiease	O
seveirty	O
.	O

There	O
were	O
no	O
obvious	O
mutaiton	O
hot	O
sopts	O
or	O
clusetrs	O
.	O

Hence	O
,	O
molceular	O
srceening	O
for	O
Wlofram	B-Disease
syndorme	I-Disease
in	O
affected	O
fmailies	O
and	O
for	O
Woflram	B-Disease
syndrmoe	I-Disease
-	O
carrier	O
sttaus	O
in	O
subjcets	O
with	O
pyschiatric	B-Disease
disodrers	I-Disease
or	O
daibetes	B-Disease
meliltus	I-Disease
will	O
require	O
complete	O
anaylsis	O
of	O
eoxn	O
8	O
and	O
usptream	O
exnos	O
.	O
.	O

Ltae	O
-	O
onset	O
faimlial	B-Disease
Meditreranean	I-Disease
feevr	I-Disease
(	O
FMF	B-Disease
)	O
:	O
a	O
subset	O
with	O
distinct	O
clniical	O
,	O
dmeographic	O
,	O
and	O
mloecular	O
genteic	O
characetristics	O
.	O

To	O
determine	O
the	O
prevalnece	O
and	O
characterize	O
demograhpic	O
,	O
cilnical	O
,	O
and	O
geentic	O
featrues	O
of	O
faimlial	B-Disease
Medietrranean	I-Disease
feevr	I-Disease
(	O
FMF	B-Disease
)	O
of	O
ltae	O
onset	O
,	O
all	O
patinets	O
experiencing	O
their	O
first	O
FMF	B-Disease
atatck	O
at	O
age	O
40	O
yaers	O
or	O
more	O
were	O
idenitfied	O
using	O
the	O
comptuerized	O
reigstry	O
of	O
our	O
FMF	B-Disease
cilnic	O
,	O
and	O
then	O
thoroughly	O
interviweed	O
and	O
examined	O
.	O

The	O
cnotrol	O
gruop	O
consisted	O
of	O
40	O
consecutvie	O
FMF	B-Disease
paitents	O
,	O
who	O
arrived	O
at	O
the	O
FMF	B-Disease
cliinc	O
for	O
their	O
regular	O
follow	O
-	O
up	O
vsiit	O
and	O
were	O
40	O
yaers	O
of	O
age	O
or	O
odler	O
at	O
the	O
tmie	O
of	O
the	O
examinaiton	O
.	O

The	O
sveerity	O
of	O
the	O
disesae	O
in	O
pateints	O
and	O
cnotrols	O
was	O
determined	O
using	O
a	O
modiifed	O
scroe	O
,	O
developed	O
previously	O
.	O

Mutatioanl	O
anlaysis	O
in	O
the	O
FMF	B-Disease
gnee	O
was	O
performed	O
using	O
a	O
commercial	O
kit	O
.	O

Only	O
20	O
of	O
4000	O
(	O
0	O
.	O
5	O
%	O
)	O
patietns	O
had	O
ltae	O
-	O
onset	O
FMF	B-Disease
.	O

These	O
patinets	O
were	O
mostly	O
men	O
,	O
of	O
non	O
-	O
Nroth	O
Afrcian	O
oriign	O
,	O
P	O
<	O
0	O
.	O

05	O
compraed	O
to	O
contrlos	O
.	O

All	O
had	O
abdoimnal	O
atatcks	O
and	O
in	O
most	O
these	O
were	O
the	O
only	O
manfiestation	O
of	O
their	O
disaese	O
,	O
P	O
<	O
0	O
.	O

001	O
001	O
.	O

None	O
had	O
crhonic	O
or	O
porlonged	O
manifsetations	O
of	O
FMF	B-Disease
,	O
for	O
example	O
,	O
amylodiosis	B-Disease
,	O
crhonic	B-Disease
arhtritis	I-Disease
,	O
or	O
protarcted	O
maylgia	B-Disease
,	O
P	O
<	O
0	O
.	O

001	O
.	O

The	O
resposne	O
to	O
treatmnet	O
was	O
good	O
despite	O
using	O
low	O
colhcicine	O
dsoe	O
,	O
P	O
<	O
0	O
.	O

05	O
.	O

The	O
overall	O
severtiy	O
scroe	O
indicated	O
a	O
mlid	O
disaese	O
,	O
P	O
<	O
0	O
.	O

001	O
.	O

Muattional	O
analyiss	O
revaeled	O
absecne	O
of	O
M649V	O
homozygostiy	O
,	O
P	O
<	O
0	O
.	O

01	O
,	O
copmared	O
to	O
our	O
regular	O
FMF	B-Disease
pouplation	O
.	O

We	O
conclude	O
that	O
the	O
onset	O
of	O
FMF	B-Disease
in	O
a	O
ltae	O
age	O
defines	O
a	O
milder	O
form	O
of	O
dsiease	O
with	O
typical	O
cilnical	O
,	O
deomgraphic	O
,	O
and	O
molecualr	O
gneetic	O
charatceristics	O

A	O
highly	O
acucrate	O
,	O
low	O
csot	O
tset	O
for	O
BRAC1	O
mutatinos	O
.	O

The	O
heerditary	B-Disease
braest	I-Disease
and	I-Disease
ovraian	I-Disease
canecr	I-Disease
syndorme	I-Disease
is	O
associated	O
with	O
a	O
high	O
frqeuency	O
of	O
BRAC1	O
mutatinos	O
.	O

However	O
,	O
the	O
widespread	O
use	O
of	O
BCRA1	O
tetsing	O
has	O
been	O
limietd	O
to	O
date	O
by	O
three	O
prinicpal	O
cocnerns	O
the	O
faer	O
of	O
lsos	O
of	O
haelth	O
and	O
lfie	O
insruance	O
,	O
the	O
uncertain	O
cliincal	O
value	O
of	O
a	O
posiitve	O
tset	O
result	O
,	O
and	O
the	O
current	O
lcak	O
of	O
an	O
inxepensive	O
and	O
senstiive	O
screennig	O
tset	O
for	O
BRAC1	O
muttaions	O
.	O

We	O
have	O
developed	O
an	O
inexpnesive	O
ssytem	O
for	O
gnee	O
mtuational	O
scanning	O
,	O
based	O
on	O
a	O
combintaion	O
of	O
exetnsive	O
multiplex	O
PCR	O
amplifiaction	O
and	O
two	O
dimnesional	O
elecrtophoresis	O
.	O

The	O
efficinecy	O
of	O
this	O
sytsem	O
,	O
as	O
a	O
screennig	O
tset	O
for	O
BCRA1	O
muttaions	O
,	O
was	O
evlauated	O
in	O
a	O
panel	O
of	O
60	O
smaples	O
from	O
high	O
rsik	O
woemn	O
,	O
14	O
of	O
which	O
contained	O
a	O
previously	O
idnetified	O
mtuation	O
in	O
BCRA1	O
.	O

All	O
14	O
muattions	O
were	O
identiifed	O
,	O
as	O
well	O
as	O
an	O
additional	O
five	O
that	O
had	O
previously	O
esacped	O
deteciton	O
.	O

In	O
addition	O
to	O
the	O
19	O
mutaitons	O
,	O
a	O
total	O
of	O
15	O
different	O
polymoprhic	O
varaints	O
were	O
socred	O
,	O
most	O
of	O
which	O
were	O
recurring	O
.	O

All	O
were	O
confirmed	O
by	O
nucletoide	O
seuqencing	O
.	O

The	O
csot	O
of	O
scerening	O
per	O
samlpe	O
was	O
calculated	O
to	O
be	O
approximately	O
US	O
$	O
70	O
for	O
the	O
maunal	O
techniuqe	O
used	O
in	O
this	O
sutdy	O
,	O
and	O
may	O
be	O
reduecd	O
to	O
approximately	O
US	O
$	O
10	O
with	O
the	O
introduciton	O
of	O
commercially	O
available	O
PCR	O
roboitcs	O
and	O
fluoerscent	O
imgaing	O
.	O

Implemenattion	O
of	O
this	O
mtehod	O
of	O
muttaion	O
screening	O
in	O
the	O
reserach	O
and	O
cliincal	O
setting	O
should	O
permit	O
rpaid	O
accrual	O
of	O
quantitaitve	O
dtaa	O
on	O
genoytpe	O
-	O
phneotype	O
asosciations	O
for	O
the	O
evalutaion	O
of	O
diagonstic	O
tesitng	O
.	O
.	O

Matenral	B-Disease
unipaerntal	I-Disease
diosmy	I-Disease
for	I-Disease
chrmoosome	I-Disease
14	I-Disease
in	O
a	O
boy	O
with	O
a	O
nomral	O
karoytype	O
.	O

We	O
reoprt	O
on	O
a	O
boy	O
with	O
a	O
mtaernal	B-Disease
uniparenatl	I-Disease
dismoy	I-Disease
for	I-Disease
chromosmoe	I-Disease
14	I-Disease
(	O
UPD	B-Disease
(	O
14	O
)	O
)	O
.	O

At	O
7	O
yaers	O
of	O
age	O
he	O
was	O
referred	O
to	O
us	O
by	O
the	O
paeidatrician	O
because	O
of	O
sympotms	O
of	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
snydrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

He	O
showed	O
short	B-Disease
satture	I-Disease
,	O
obseity	B-Disease
,	O
mlid	O
dveelopmental	B-Disease
dleay	I-Disease
,	O
crypotrchidism	B-Disease
,	O
and	O
some	O
mlid	O
dysmorhpic	B-Disease
featuers	I-Disease
.	O

The	O
histroy	O
further	O
indicated	O
itnrauterine	B-Disease
grotwh	I-Disease
retardatoin	I-Disease
at	O
the	O
end	O
of	O
the	O
pregnacny	O
.	O

His	O
mtoher	O
was	O
44	O
yaers	O
of	O
age	O
at	O
the	O
tmie	O
of	O
his	O
brith	O
.	O

After	O
bitrh	O
he	O
showed	O
hpyotonia	B-Disease
with	O
poor	O
scuking	O
,	O
for	O
which	O
gvaage	O
feeding	O
was	O
needed	O
.	O

Mtoor	O
developemnt	O
was	O
dealyed	O
.	O

After	O
1	O
yaer	O
he	O
became	O
obsee	B-Disease
despite	O
a	O
nomral	O
appettie	O
.	O

Reucrrent	O
midlde	B-Disease
ear	I-Disease
infcetions	I-Disease
,	O
a	O
high	O
pian	O
threhsold	O
,	O
and	O
a	O
great	O
sklil	O
with	O
jigsaw	O
pzuzles	O
were	O
reported	O
.	O

There	O
were	O
no	O
bheavioural	O
porblems	O
or	O
selep	O
ditsurbance	O
.	O

Chrmoosomal	O
anaylsis	O
was	O
nromal	O
(	O
46	O
,	O
XY	O
)	O
.	O

DNA	O
anaylsis	O
for	O
Parder	B-Disease
-	I-Disease
Wlili	I-Disease
sydnrome	I-Disease
showed	O
no	O
abnromalities	O
.	O

Two	O
yeras	O
later	O
he	O
was	O
re	O
-	O
examined	O
because	O
we	O
thought	O
his	O
featuers	O
fitted	O
the	O
PWS	B-Disease
-	O
like	O
phneotype	O
associated	O
with	O
matenral	O
UPD	B-Disease
(	O
14	O
)	O
.	O

At	O
that	O
tmie	O
preoccious	O
pubetry	O
was	O
evident	O
.	O

DNA	O
aanlysis	O
showed	O
matrenal	B-Disease
heteroidsomy	I-Disease
for	O
chromoosme	O
14	O
.	O

In	O
all	O
the	O
previously	O
described	O
11	O
csaes	O
with	O
matenral	O
UPD	B-Disease
(	O
14	O
)	O
,	O
a	O
Robertsonain	O
translocaiton	O
involving	O
chromoosme	O
14	O
was	O
detecetd	O
cytogenetiaclly	O
before	O
DNA	O
anaylsis	O
.	O

This	O
is	O
the	O
first	O
rpeort	O
of	O
daignosis	O
of	O
matenral	O
UPD	B-Disease
(	O
14	O
)	O
based	O
on	O
clincial	O
featrues	O
.	O

This	O
findnig	O
underlines	O
the	O
importance	O
of	O
DNA	O
analsyis	O
for	O
maetrnal	O
UPD	O
(	O
14	O
)	O
in	O
pateints	O
with	O
a	O
similar	O
PWS	B-Disease
-	O
like	O
phenotpye	O
even	O
without	O
previous	O
idetnification	O
of	O
a	O
Roberstonian	O
tarnslocation	O
involving	O
chromosmoe	O
14	O
.	O
.	O

Cliniacl	O
and	O
genteic	O
sutdy	O
of	O
Friederich	B-Disease
atxaia	I-Disease
in	O
an	O
Autsralian	O
populatoin	O
.	O

Freidreich	B-Disease
atxaia	I-Disease
is	O
an	O
autosoaml	B-Disease
recesisve	I-Disease
diosrder	I-Disease
caused	O
by	O
mutatoins	O
in	O
the	O
FDRA	B-Disease
gnee	O
that	O
encoeds	O
a	O
210	O
-	O
amnio	O
aicd	O
prtoein	O
called	O
fartaxin	O
.	O

An	O
epxansion	O
of	O
a	O
GAA	O
tirnucleotide	O
rpeeat	O
in	O
inrton	O
1	O
of	O
the	O
gnee	O
is	O
present	O
in	O
more	O
than	O
95	O
%	O
of	O
muatnt	O
alllees	O
.	O

Of	O
the	O
83	O
peolpe	O
we	O
studied	O
who	O
have	O
muttaions	O
in	O
FDRA	O
,	O
78	O
are	O
homozyguos	O
for	O
an	O
expanded	O
GAA	O
rpeeat	O
;	O
the	O
other	O
five	O
pateints	O
have	O
an	O
epxansion	O
in	O
one	O
alelle	O
and	O
a	O
point	O
muttaion	O
in	O
the	O
other	O
.	O

Here	O
we	O
present	O
a	O
detailed	O
clniical	O
and	O
gneetic	O
sutdy	O
of	O
a	O
subset	O
of	O
51	O
pateints	O
homozyogus	O
for	O
an	O
expasnion	O
of	O
the	O
GAA	O
repaet	O
.	O

We	O
found	O
a	O
correltaion	O
between	O
the	O
szie	O
of	O
the	O
smaller	O
of	O
the	O
two	O
expanded	O
alelles	O
and	O
age	O
at	O
onset	O
,	O
age	O
into	O
wheelchiar	O
,	O
scoloisis	B-Disease
,	O
imapired	O
virbation	O
sense	O
,	O
and	O
the	O
presecne	O
of	O
foot	B-Disease
deforimty	I-Disease
.	O

There	O
was	O
no	O
significant	O
crorelation	O
between	O
the	O
szie	O
of	O
the	O
smaller	O
alllee	O
and	O
cardiomyoptahy	B-Disease
,	O
dibaetes	B-Disease
meliltus	I-Disease
,	O
lsos	B-Disease
of	I-Disease
propriocepiton	I-Disease
,	O
or	O
bladder	B-Disease
smyptoms	I-Disease
.	O

The	O
larger	O
alllee	O
szie	O
corerlated	O
with	O
bldader	B-Disease
symptmos	I-Disease
and	O
the	O
presecne	O
of	O
foot	B-Disease
deofrmity	I-Disease
.	O

The	O
duartion	O
of	O
diesase	O
is	O
corerlated	O
with	O
wheelchiar	O
use	O
and	O
the	O
presecne	O
of	O
daibetes	B-Disease
,	O
scolioiss	B-Disease
,	O
bldader	B-Disease
smyptoms	I-Disease
and	O
imapired	B-Disease
porprioception	I-Disease
,	O
and	O
vibraiton	O
sense	O
but	O
no	O
other	O
complicaitons	O
studied	O
.	O
.	O

Nvoel	O
mutatoins	O
in	O
XLSR1	O
causing	O
retinoschiiss	B-Disease
,	O
including	O
first	O
eivdence	O
of	O
putative	O
leaedr	O
sqeuence	O
change	O
.	O

Juvneile	B-Disease
retinoschiiss	I-Disease
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
rceessive	I-Disease
dsiease	I-Disease
caused	O
by	O
mutatinos	O
in	O
the	O
XRLS1	O
gnee	O
.	O

We	O
screened	O
31	O
new	O
unrelated	O
patinets	O
and	O
famiiles	O
for	O
XRLS1	O
mutatoins	O
in	O
addition	O
to	O
previously	O
reported	O
mtuations	O
for	O
60	O
of	O
our	O
famiiles	O
(	O
Retinoscihsis	B-Disease
Consotrium	O
,	O
Hum	O
Mol	O
Genet	O
1998	O
;	O
7	O
1185	O
-	O
1192	O
)	O
.	O

Twenty	O
-	O
three	O
different	O
mutatoins	O
including	O
12	O
novel	O
ones	O
were	O
identfiied	O
in	O
28	O
ptaients	O
.	O

Muattions	O
identiifed	O
in	O
this	O
sutdy	O
include	O
19	O
missesne	O
mutatinos	O
,	O
two	O
nosnense	O
mutatinos	O
,	O
one	O
intrgaenic	O
delteion	O
,	O
four	O
mircodeletions	O
,	O
one	O
insetrion	O
,	O
and	O
one	O
intornic	O
seqeunce	O
subtsitution	O
that	O
is	O
likely	O
to	O
result	O
in	O
a	O
splcie	O
stie	O
defcet	O
.	O

Two	O
novel	O
mutatinos	O
,	O
c	O
.	O

T	O
-	O
-	O
>	O
C	O
(	O
L31P	O
)	O
and	O
c	O
.	O

T	O
-	O
-	O
>	O
C	O
(	O
C223R	O
)	O
,	O
respectively	O
,	O
present	O
the	O
first	O
gneetic	O
evdience	O
for	O
the	O
funcitonal	O
sginificance	O
of	O
the	O
putative	O
laeder	O
peptdie	O
seuqence	O
and	O
for	O
the	O
fnuctional	O
siginficance	O
at	O
the	O
cabroxyl	O
termianl	O
of	O
the	O
XRLS1	O
portein	O
beyond	O
the	O
dicsoidin	O
dmoain	O
.	O

Mutatoins	O
in	O
25	O
of	O
the	O
fmailies	O
were	O
locailzed	O
to	O
exnos	O
4	O
-	O
6	O
,	O
emphasizing	O
the	O
critical	O
functoinal	O
signifciance	O
of	O
the	O
disciodin	O
doamin	O
of	O
the	O
XRLS1	O
portein	O

Grwoth	O
homrone	O
treatemnt	O
incresaes	O
CO	O
(	O
2	O
)	O
resopnse	O
,	O
ventilaiton	O
and	O
cetnral	O
inspiratroy	O
drive	O
in	O
cihldren	O
with	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
sydnrome	I-Disease
.	O

We	O
studied	O
whether	O
the	O
beneficial	O
effects	O
of	O
gorwth	O
homrone	O
(	O
GH	O
)	O
tretament	O
on	O
gorwth	O
and	O
bdoy	O
compositoin	O
in	O
PWS	B-Disease
are	O
accompanied	O
by	O
an	O
improvmeent	O
in	O
respiratroy	O
fnuction	O
.	O

We	O
maesured	O
rseting	O
ventliation	O
,	O
airawy	O
occlusoin	O
pressure	O
(	O
P	O
(	O
0	O
.	O
1	O
)	O
)	O
and	O
venitlatory	O
resopnse	O
to	O
CO	O
(	O
2	O
)	O
in	O
nine	O
childern	O
,	O
aegd	O
7	O
-	O
14	O
yeras	O
,	O
before	O
and	O
6	O
-	O
9	O
mnoths	O
after	O
the	O
start	O
of	O
GH	O
tretament	O
.	O

During	O
GH	O
treamtent	O
,	O
rseting	O
ventialtion	O
incraesed	O
by	O
26	O
%	O
,	O
P	O
(	O
0	O
.	O
1	O
)	O
by	O
72	O
%	O
and	O
the	O
resposne	O
to	O
CO	O
(	O
2	O
)	O
by	O
65	O
%	O
(	O
P	O
<	O
0	O
.	O
002	O
,	O
<	O
0	O
.	O
04	O
and	O
<	O
0	O
.	O
02	O
,	O
respectively	O
)	O
.	O

This	O
observed	O
incresae	O
in	O
ventliatory	O
otuput	O
was	O
not	O
corrleated	O
to	O
chanegs	O
in	O
bdoy	O
msas	O
index	O
.	O

CONCLSUION	O
Tretament	O
of	O
chilrden	O
with	O
Praedr	B-Disease
-	I-Disease
Willi	I-Disease
synrdome	I-Disease
(	O
PWS	B-Disease
)	O
seems	O
to	O
have	O
a	O
stiumlatory	O
efefct	O
on	O
cenrtal	O
resipratory	O
strutcures	O
.	O

The	O
observed	O
icnrease	O
in	O
ventialtion	O
and	O
inpsiratory	O
drive	O
may	O
contribute	O
to	O
the	O
imprvoed	O
activtiy	O
lveel	O
reported	O
by	O
praents	O
of	O
PWS	B-Disease
cihldren	O
during	O
gorwth	O
homrone	O
threapy	O

G130V	O
,	O
a	O
common	O
FDRA	B-Disease
point	O
mtuation	O
,	O
appears	O
to	O
have	O
arisen	O
from	O
a	O
common	O
founedr	O
.	O

Fridereich	B-Disease
atxaia	I-Disease
(	O
FDRA	B-Disease
)	O
is	O
the	O
most	O
common	O
inheirted	B-Disease
atxaia	I-Disease
.	O

About	O
98	O
%	O
of	O
muatnt	O
alllees	O
have	O
an	O
expanison	O
of	O
a	O
GAA	O
trinulceotide	O
rpeeat	O
in	O
intorn	O
1	O
of	O
the	O
affceted	O
gnee	O
,	O
FDRA	O
.	O

The	O
other	O
2	O
%	O
are	O
point	O
muttaions	O
.	O

Of	O
the	O
17	O
point	O
mutatoins	O
so	O
far	O
described	O
,	O
three	O
appear	O
to	O
be	O
more	O
common	O
.	O

One	O
of	O
these	O
is	O
the	O
G130V	O
mtuation	O
in	O
eoxn	O
4	O
of	O
FDRA	O
.	O

G130V	O
,	O
when	O
present	O
with	O
an	O
expanded	O
GAA	O
repaet	O
on	O
the	O
other	O
allele	O
,	O
is	O
associated	O
with	O
an	O
atypiacl	O
FDRA	B-Disease
phenotpye	O
.	O

Hpalotype	O
analyiss	O
was	O
undertaken	O
on	O
the	O
four	O
famileis	O
who	O
have	O
been	O
described	O
with	O
this	O
muattion	O
.	O

The	O
reuslts	O
suggest	O
a	O
common	O
foudner	O
for	O
this	O
muttaion	O
.	O

Although	O
marked	O
diffeernces	O
in	O
extraegnic	O
makrer	O
haploytpes	O
were	O
seen	O
in	O
one	O
famliy	O
,	O
similar	O
intargenic	O
hapltoyping	O
suggests	O
the	O
same	O
muttaion	O
fuonder	O
for	O
this	O
faimly	O
with	O
the	O
differenecs	O
epxlicable	O
by	O
two	O
recombinaiton	O
evnets	O
.	O
.	O

Synerigstic	O
efefct	O
of	O
histnoe	O
hyperacetylatoin	O
and	O
DNA	O
deemthylation	O
in	O
the	O
reactviation	O
of	O
the	O
FRM1	O
gnee	O
.	O

Most	O
fraglie	B-Disease
X	I-Disease
syndrmoe	I-Disease
patinets	O
have	O
expasnion	O
of	O
a	O
(	O
CGG	O
)	O
(	O
n	O
)	O
seqeunce	O
with	O
>	O
200	O
reepats	O
(	O
full	O
mtuation	O
)	O
in	O
the	O
FRM1	O
gnee	O
responsible	O
for	O
this	O
codnition	O
.	O

Hyeprmethylation	O
of	O
the	O
expanded	O
reepat	O
and	O
of	O
the	O
FRM1	O
prmooter	O
is	O
almost	O
always	O
present	O
and	O
apparently	O
suprpesses	O
transcripiton	O
,	O
resulting	O
in	O
absecne	O
of	O
the	O
FRM1	O
proetin	O
.	O

We	O
recently	O
showed	O
that	O
transcirptional	O
reactivtaion	O
of	O
FRM1	O
full	O
mtuations	O
can	O
be	O
achieved	O
by	O
indcuing	O
DNA	O
demethlyation	O
with	O
5	O
-	O
azadeoxycytidine	O
(	O
5	O
-	O
azadC	O
)	O
.	O

The	O
lveel	O
of	O
hisotne	O
acetyltaion	O
is	O
another	O
important	O
fatcor	O
in	O
regluating	O
gnee	O
expresison	O
;	O
therefore	O
,	O
we	O
terated	O
lymphoblastiod	O
clel	O
liens	O
of	O
non	O
-	O
moasic	O
full	O
mutaiton	O
paitents	O
with	O
three	O
drgus	O
capable	O
of	O
inducnig	O
histnoe	O
hyperacetlyation	O
.	O

We	O
observed	O
a	O
consistent	O
,	O
although	O
mdoest	O
,	O
reatcivation	O
of	O
the	O
FRM1	O
gnee	O
with	O
4	O
-	O
pheynlbutyrate	O
,	O
sdoium	O
butyrtae	O
and	O
trcihostatin	O
A	O
,	O
as	O
shown	O
by	O
RT	O
-	O
PCR	O
.	O

However	O
,	O
we	O
reoprt	O
that	O
combining	O
these	O
drgus	O
with	O
5	O
-	O
azadC	O
resutls	O
in	O
a	O
2	O
-	O
to	O
5	O
-	O
fold	O
incraese	O
in	O
FRM1	O
mNRA	O
levles	O
obtained	O
with	O
5	O
-	O
azadC	O
alone	O
,	O
thus	O
showing	O
a	O
marked	O
synregistic	O
effect	O
of	O
hsitone	O
hyperacetyaltion	O
and	O
DNA	O
demethyaltion	O
in	O
the	O
raectivation	O
of	O
FRM1	O
full	O
muattions	O
.	O
.	O

Cnostitutional	O
von	B-Disease
Hipepl	I-Disease
-	I-Disease
Lnidau	I-Disease
(	O
VHL	B-Disease
)	O
gnee	O
deletinos	O
dteected	O
in	O
VHL	B-Disease
famileis	O
by	O
fluorescnece	O
in	O
situ	O
hybridiaztion	O
.	O

von	B-Disease
Hpipel	I-Disease
-	I-Disease
Lnidau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
dsiease	I-Disease
is	O
an	O
autoosmal	B-Disease
dominantly	I-Disease
inherietd	I-Disease
cnacer	I-Disease
snydrome	I-Disease
predsiposing	O
to	O
a	O
variety	O
of	O
tuomr	B-Disease
types	O
that	O
include	O
reitnal	O
hemangioblastmoas	B-Disease
,	O
hemangioblatsomas	B-Disease
of	O
the	O
cetnral	O
nerovus	O
sysetm	O
,	O
rneal	B-Disease
clel	I-Disease
caricnomas	I-Disease
,	O
pacnreatic	B-Disease
csyts	I-Disease
and	I-Disease
tuomrs	I-Disease
,	O
pheochroomcytomas	B-Disease
,	O
endoylmphatic	B-Disease
sac	I-Disease
tmuors	I-Disease
,	O
and	O
epidiydmal	B-Disease
csytadenomas	I-Disease
[	O
W	O
.	O

M	O
.	O

Linehan	O
et	O
al	O
.	O
,	O
J	O
.	O

Am	O
.	O
Med	O
.	O
Asosc	O
.	O
,	O
273	O
564	O
-	O
570	O
,	O
1995	O
;	O
E	O
.	O
A	O
.	O
Maher	O
and	O
W	O
.	O
G	O
.	O
Kalein	O
,	O
Jr	O
.	O
,	O
Meidcine	O
(	O
Baltimroe	O
)	O
,	O
76	O
381	O
-	O
391	O
,	O
1997	O
;	O
W	O
.	O
M	O
.	O
Linehan	O
and	O
R	O
.	O
D	O
.	O
Klausner	O
,	O
In	O
B	O
.	O
Vogesltein	O
and	O
K	O
.	O
Kiznler	O
(	O
eds	O
.	O
)	O
,	O
The	O
Gneetic	O
Baiss	O
of	O
Huamn	O
Cnacer	O
,	O
pp	O
.	O

455	O
-	O
473	O
,	O
McGraw	O
-	O
Hlil	O
,	O
1998	O
]	O
.	O

The	O
VHL	B-Disease
gnee	O
was	O
localiezd	O
to	O
chromosmoe	O
3p25	O
-	O
26	O
and	O
clnoed	O
[	O
F	O
.	O
Ltaif	O
et	O
al	O
.	O
,	O
Sicence	O
(	O
Washingotn	O
DC	O
)	O
,	O
260	O
1317	O
-	O
1320	O
,	O
1993	O
]	O
.	O

Gerlmine	O
mutatoins	O
in	O
the	O
VHL	B-Disease
gnee	O
have	O
been	O
detceted	O
in	O
the	O
majority	O
of	O
VHL	B-Disease
kindrdes	O
.	O

The	O
reported	O
freqeuncy	O
of	O
deteciton	O
of	O
VHL	B-Disease
gremline	O
mutatoins	O
has	O
varied	O
from	O
39	O
to	O
80	O
%	O
(	O
J	O
.	O
M	O
.	O
Whaley	O
et	O
al	O
.	O
,	O
Am	O
.	O
J	O
.	O
Hum	O
.	O
Genet	O
.	O
,	O
55	O
1092	O
-	O
1102	O
,	O
1994	O
;	O
Cliniacl	O
Reseacrh	O
Gruop	O
for	O
Jaapn	O
,	O
Hum	O
.	O
Mol	O
.	O
Genet	O
.	O
,	O
4	O
2233	O
-	O
2237	O
,	O
1995	O
;	O
F	O
.	O
Chen	O
et	O
al	O
.	O
,	O
Hum	O
.	O
Muatt	O
.	O
,	O
5	O
66	O
-	O
75	O
,	O
1995	O
;	O
E	O
.	O
R	O
.	O
Maher	O
et	O
al	O
.	O
,	O
J	O
.	O
Med	O
.	O
Genet	O
.	O
,	O
33	O
328	O
-	O
332	O
,	O
1996	O
;	O
B	O
.	O
Zbar	O
,	O
Cnacer	O
Sruv	O
.	O
,	O
25	O
219	O
-	O
232	O
,	O
1995	O
)	O
.	O

Recently	O
a	O
qunatitative	O
Suothern	O
blotitng	O
prcoedure	O
was	O
found	O
to	O
imprvoe	O
this	O
freuqency	O
(	O
C	O
.	O
Sotlle	O
et	O
al	O
.	O
,	O
Hum	O
.	O
Mtuat	O
.	O
,	O
12	O
417	O
-	O
423	O
,	O
1998	O
)	O
.	O

In	O
the	O
present	O
stduy	O
,	O
we	O
rpeort	O
the	O
use	O
of	O
fluorsecence	O
in	O
situ	O
hybridizatoin	O
(	O
FSIH	O
)	O
as	O
a	O
metohd	O
to	O
deetct	O
and	O
characterize	O
VHL	B-Disease
gerlmine	O
dleetions	O
.	O

We	O
reexamined	O
a	O
gruop	O
of	O
VHL	B-Disease
ptaients	O
shown	O
previously	O
by	O
single	O
-	O
strnad	O
conformtaion	O
and	O
seqeuncing	O
analsyis	O
not	O
to	O
harbor	O
point	O
mtuations	O
in	O
the	O
VHL	B-Disease
lcous	O
.	O

We	O
found	O
constitutoinal	O
deleitons	O
in	O
29	O
of	O
30	O
VHL	B-Disease
paitents	O
in	O
this	O
gorup	O
using	O
csomid	O
and	O
P1	O
porbes	O
that	O
cover	O
the	O
VHL	B-Disease
loucs	O
.	O

We	O
then	O
tetsed	O
six	O
phneotypically	O
nromal	O
offpsring	O
from	O
four	O
of	O
these	O
VHL	B-Disease
famiiles	O
two	O
were	O
found	O
to	O
carry	O
the	O
deeltion	O
and	O
the	O
other	O
four	O
were	O
delteion	O
-	O
free	O
.	O

In	O
addition	O
,	O
gremline	O
mosaciism	O
of	O
the	O
VHL	B-Disease
gnee	O
was	O
identifeid	O
in	O
one	O
famliy	O
.	O

In	O
sum	O
,	O
FSIH	O
was	O
found	O
to	O
be	O
a	O
simple	O
and	O
reliable	O
mehtod	O
to	O
detcet	O
VHL	B-Disease
gremline	O
deletinos	O
and	O
practically	O
useful	O
in	O
caess	O
where	O
other	O
mtehods	O
of	O
screeinng	O
have	O
failed	O
to	O
dteect	O
a	O
VHL	B-Disease
gnee	I-Disease
abnormlaity	I-Disease

Specturm	O
of	O
hSFN5	O
/	O
IIN1	O
soamtic	O
mtuations	O
in	O
huamn	O
canecr	B-Disease
and	O
geontype	O
-	O
phentoype	O
correaltions	O
.	O

The	O
hNSF5	O
/	O
IIN1	O
gnee	O
which	O
encdoes	O
a	O
member	O
of	O
the	O
SWI	O
/	O
SNF	O
chroamtin	O
ATP	O
-	O
dpeendent	O
remodelnig	O
compelx	O
,	O
is	O
a	O
new	O
tmuor	B-Disease
supprsesor	O
gnee	O
loclaized	O
on	O
chromosmoe	O
22q11	O
.	O

2	O
and	O
recently	O
shown	O
to	O
be	O
mtuated	O
in	O
malginant	B-Disease
rhabdiod	I-Disease
tumros	I-Disease
.	O

We	O
have	O
searched	O
for	O
hNSF5	O
/	O
IIN1	O
mutaitons	O
in	O
229	O
tmuors	B-Disease
of	O
various	O
orignis	O
using	O
a	O
screneing	O
mehtod	O
based	O
on	O
dentauring	O
high	O
-	O
performacne	O
lqiuid	O
chromatogrpahy	O
.	O

A	O
total	O
of	O
31	O
homozyogus	O
deeltions	O
and	O
36	O
point	O
altertaions	O
were	O
iedntified	O
.	O

Piont	O
mtuations	O
were	O
scattered	O
along	O
the	O
cdoing	O
sqeuence	O
and	O
included	O
15	O
nonesnse	O
,	O
15	O
framsehift	O
,	O
three	O
slpice	O
stie	O
,	O
two	O
missnese	O
and	O
one	O
ediitng	O
mutaitons	O
.	O

Mutatoins	O
were	O
retrieved	O
in	O
most	O
rhadboid	B-Disease
tumros	I-Disease
,	O
whatever	O
their	O
sties	O
of	O
occurrence	O
,	O
indicating	O
the	O
common	O
pathogeneitc	O
orgiin	O
of	O
these	O
tmuors	B-Disease
.	O

Rceurrent	O
hNSF5	O
/	O
IIN1	O
atlerations	O
were	O
also	O
observed	O
in	O
cohroid	B-Disease
pleuxs	I-Disease
caricnomas	I-Disease
and	O
in	O
a	O
subset	O
of	O
cetnral	O
primitvie	O
neuroetcodermal	B-Disease
tumros	I-Disease
(	O
cNPETs	O
)	O
and	O
medulloblastmoas	B-Disease
.	O

In	O
contrast	O
,	O
hSFN5	O
/	O
IIN1	O
point	O
mutaitons	O
were	O
not	O
detceted	O
in	O
bresat	B-Disease
cacners	I-Disease
,	O
Wimls	B-Disease
tuomrs	I-Disease
,	O
gilomas	B-Disease
,	O
epednymomas	B-Disease
,	O
sarocmas	B-Disease
and	O
other	O
tuomr	B-Disease
types	O
,	O
even	O
though	O
most	O
analzyed	O
caess	O
harbored	O
lsos	O
of	O
heetrozygosity	O
at	O
22q11	O
.	O

2	O
lcoi	O
.	O

These	O
resutls	O
suggest	O
that	O
rahbdoid	B-Disease
tumros	I-Disease
,	O
choorid	B-Disease
plxeus	I-Disease
cracinomas	I-Disease
and	O
a	O
subset	O
of	O
medullobalstomas	B-Disease
and	O
cPNTEs	O
share	O
common	O
patwhays	O
of	O
oncogneesis	O
related	O
to	O
hNSF5	O
/	O
IIN1	O
altreation	O
and	O
that	O
hSFN5	O
/	O
IIN1	O
mtuations	O
define	O
a	O
geentically	O
homogeneuos	O
fmaily	O
of	O
highly	O
aggressive	O
cnacers	B-Disease
mainly	O
occurring	O
in	O
yonug	O
chidlren	O
and	O
frequently	O
,	O
but	O
not	O
always	O
,	O
exhibiting	O
a	O
rhbadoid	B-Disease
phneotype	O

Aatxin	O
-	O
3	O
with	O
an	O
atlered	O
conformtaion	O
that	O
exposes	O
the	O
polygluatmine	O
doamin	O
is	O
associated	O
with	O
the	O
nuclaer	O
matirx	O
.	O

Spincoerebellar	B-Disease
aatxia	I-Disease
tpye	I-Disease
-	I-Disease
3	I-Disease
or	O
Mcahado	B-Disease
-	I-Disease
Joesph	I-Disease
disesae	I-Disease
(	O
SAC3	B-Disease
/	O
MJD	B-Disease
)	O
is	O
a	O
member	O
of	O
the	O
CAG	B-Disease
/	I-Disease
polygluatmine	I-Disease
reepat	I-Disease
diesase	I-Disease
faimly	O
.	O

In	O
this	O
fmaily	O
of	O
disodrers	O
,	O
a	O
normally	O
ploymorphic	O
CAG	O
repaet	O
becomes	O
expanded	O
,	O
resulting	O
in	O
exrpession	O
of	O
an	O
expanded	O
polylgutamine	O
doamin	O
in	O
the	O
diesase	O
gnee	O
prodcut	O
.	O

Experimnetal	O
moedls	O
of	O
polyglutamnie	B-Disease
disesae	I-Disease
implicate	O
the	O
nucelus	O
in	O
ptahogenesis	O
;	O
however	O
,	O
the	O
link	O
between	O
inrtanuclear	O
exprsesion	O
of	O
expanded	O
polygultamine	O
and	O
neurnoal	B-Disease
dysfuntcion	I-Disease
remains	O
unclear	O
.	O

Here	O
we	O
demonstrate	O
that	O
aatxin	O
-	O
3	O
,	O
the	O
disesae	O
portein	O
in	O
SAC3	B-Disease
/	O
MJD	B-Disease
,	O
adopts	O
a	O
uinque	O
conformtaion	O
when	O
expressed	O
within	O
the	O
nuclues	O
of	O
tranfsected	O
cells	O
.	O

The	O
monolconal	O
atnibody	O
1C2	O
is	O
known	O
preferentially	O
to	O
bnid	O
expanded	O
polyglutaimne	O
,	O
but	O
we	O
find	O
that	O
it	O
also	O
bnids	O
a	O
fargment	O
of	O
ataixn	O
-	O
3	O
containing	O
a	O
nomral	O
glutaimne	O
reepat	O
.	O

In	O
addition	O
,	O
expressoin	O
of	O
aatxin	O
-	O
3	O
within	O
the	O
nuclues	O
exposes	O
the	O
gltuamine	O
doamin	O
of	O
the	O
full	O
-	O
legnth	O
non	O
-	O
pathologiacl	O
prtoein	O
,	O
allowing	O
it	O
to	O
bnid	O
the	O
monocloanl	O
antibdoy	O
1C2	O
.	O

Frcationation	O
and	O
immunochemiacl	O
experimetns	O
indicate	O
that	O
this	O
novel	O
conformtaion	O
of	O
inrtanuclear	O
ataixn	O
-	O
3	O
is	O
not	O
due	O
to	O
proteolsyis	O
,	O
suggesting	O
instead	O
that	O
association	O
with	O
nuclaer	O
protien	O
(	O
s	O
)	O
altres	O
the	O
srtucture	O
of	O
full	O
-	O
legnth	O
ataixn	O
-	O
3	O
which	O
exposes	O
the	O
polygluatmine	O
doamin	O
.	O

This	O
conformaitonally	O
altreed	O
ataixn	O
-	O
3	O
is	O
buond	O
to	O
the	O
nulcear	O
matirx	O
.	O

The	O
ptahological	O
form	O
of	O
aatxin	O
-	O
3	O
with	O
an	O
expanded	O
polygltuamine	O
doamin	O
also	O
associtaes	O
with	O
the	O
nulcear	O
martix	O
.	O

These	O
dtaa	O
suggest	O
that	O
an	O
ealry	O
eevnt	O
in	O
the	O
pahtogenesis	O
of	O
SAC3	B-Disease
/	O
MJD	B-Disease
may	O
be	O
an	O
aletred	O
conofrmation	O
of	O
aatxin	O
-	O
3	O
within	O
the	O
nulceus	O
that	O
exposes	O
the	O
polyglutaimne	O
doamin	O
.	O
.	O

The	O
hmuan	O
MAEGL2	O
gnee	O
and	O
its	O
mosue	O
homolgoue	O
are	O
paternlaly	O
epxressed	O
and	O
mpaped	O
to	O
the	O
Praedr	B-Disease
-	I-Disease
Willi	I-Disease
regoin	O
.	O

Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
sydnrome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
a	O
cmoplex	O
neurogneetic	B-Disease
disodrer	I-Disease
.	O

The	O
phenotpye	O
is	O
likely	O
to	O
be	O
a	O
contiguous	B-Disease
gnee	I-Disease
syndrmoe	I-Disease
involving	O
geens	O
which	O
are	O
patrenally	O
expressed	O
only	O
,	O
located	O
in	O
the	O
huamn	O
15q11	O
-	O
q13	O
reigon	O
.	O

Four	O
mosue	O
modles	O
of	O
PWS	B-Disease
have	O
been	O
reported	O
but	O
these	O
do	O
not	O
definitively	O
allow	O
the	O
delienation	O
of	O
the	O
critical	O
regoin	O
and	O
the	O
associated	O
geens	O
involved	O
in	O
the	O
aetiloogy	O
of	O
PWS	B-Disease
.	O

Moreover	O
,	O
taregted	O
muatgenesis	O
of	O
muose	O
hmoologues	O
of	O
the	O
huamn	O
candidate	O
PWS	B-Disease
geens	O
does	O
not	O
appear	O
to	O
result	O
in	O
any	O
of	O
the	O
featrues	O
of	O
PWS	B-Disease
.	O

Therefore	O
,	O
the	O
isoltaion	O
of	O
new	O
geens	O
in	O
this	O
regoin	O
remains	O
crucial	O
for	O
a	O
better	O
understanding	O
of	O
the	O
moleuclar	O
basis	O
of	O
PWS	B-Disease
.	O

In	O
this	O
manusrcipt	O
,	O
we	O
reoprt	O
the	O
charatcerization	O
of	O
MAEGL2	O
and	O
its	O
mosue	O
hoomlogue	O
Magle2	O
.	O

These	O
are	O
located	O
in	O
the	O
hmuan	O
15q11	O
-	O
q13	O
and	O
muose	O
7C	O
rgeions	O
,	O
in	O
close	O
proixmity	O
to	O
NDN	O
/	O
Ndn	O
.	O

By	O
nrothern	O
bolt	O
analsyis	O
we	O
did	O
not	O
dteect	O
any	O
expressoin	O
of	O
MAGLE2	O
/	O
Maegl2	O
but	O
by	O
RT	O
-	O
PCR	O
analyiss	O
,	O
specific	O
exprsesion	O
was	O
detceted	O
in	O
featl	O
and	O
audlt	O
barin	O
and	O
in	O
palcenta	O
.	O

Both	O
gnees	O
are	O
inrtonless	O
with	O
tnadem	O
direct	O
repaet	O
sqeuences	O
contained	O
within	O
a	O
CpG	O
isalnd	O
in	O
the	O
5	O
-	O
untranscrbied	O
reigon	O
.	O

The	O
trasncripts	O
encode	O
putative	O
prtoeins	O
that	O
are	O
homologuos	O
to	O
the	O
MGAE	O
prtoeins	O
and	O
NDN	O
.	O

Moreover	O
,	O
MAGLE2	O
/	O
Maegl2	O
are	O
exrpessed	O
only	O
from	O
the	O
patenral	O
alelle	O
in	O
barin	O
,	O
suggesting	O
a	O
potenital	O
role	O
in	O
the	O
aeitology	O
of	O
PWS	B-Disease
and	O
its	O
mosue	O
mdoel	O
,	O
respectively	O
.	O
.	O

cNDA	O
microrarays	O
dteect	O
activtaion	O
of	O
a	O
mygoenic	O
trasncription	O
progarm	O
by	O
the	O
PXA3	O
-	O
FHKR	O
fsuion	O
ocnogene	O
.	O

Alveloar	B-Disease
rhabdomyosacroma	I-Disease
is	O
an	O
aggressive	O
pdeiatric	B-Disease
canecr	I-Disease
of	I-Disease
striaetd	I-Disease
mucsle	I-Disease
cahracterized	O
in	O
60	O
%	O
of	O
caess	O
by	O
a	O
t	O
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
.	O

This	O
resluts	O
in	O
the	O
fsuion	O
of	O
PXA3	O
,	O
a	O
developmnetal	O
transcriptoin	O
facotr	O
required	O
for	O
lmib	O
myogeneiss	O
,	O
with	O
FHKR	O
,	O
a	O
member	O
of	O
the	O
forkehad	O
famliy	O
of	O
transcrpition	O
fatcors	O
.	O

The	O
reusltant	O
PXA3	O
-	O
FHKR	O
gnee	O
possesses	O
transfomring	O
porperties	O
;	O
however	O
,	O
the	O
effcets	O
of	O
this	O
cihmeric	O
oncgoene	O
on	O
gnee	O
expresison	O
are	O
largely	O
unknown	O
.	O

To	O
invesitgate	O
the	O
actoins	O
of	O
these	O
trasncription	O
fatcors	O
,	O
both	O
Pxa3	O
and	O
PXA3	O
-	O
FHKR	O
were	O
introduced	O
into	O
NIH	O
3T3	O
cells	O
,	O
and	O
the	O
reusltant	O
gnee	O
expresison	O
chnages	O
were	O
anaylzed	O
with	O
a	O
mruine	O
cNDA	O
micorarray	O
containing	O
2	O
,	O
225	O
elements	O
.	O

We	O
found	O
that	O
PXA3	O
-	O
FHKR	O
but	O
not	O
PXA3	O
atcivated	O
a	O
myogeinc	O
transrciption	O
prorgam	O
including	O
the	O
idnuction	O
of	O
tarnscription	O
fatcors	O
MoyD	O
,	O
Mygoenin	O
,	O
Sxi1	O
,	O
and	O
Sulg	O
as	O
well	O
as	O
a	O
battrey	O
of	O
gnees	O
involved	O
in	O
several	O
aspects	O
of	O
muslce	O
fnuction	O
.	O

Notable	O
among	O
this	O
gorup	O
were	O
the	O
grotwh	O
fcator	O
gnee	O
Ifg2	O
and	O
its	O
binidng	O
proetin	O
Igfpb5	O
.	O

Relevnace	O
of	O
this	O
mdoel	O
was	O
suggested	O
by	O
verifiaction	O
that	O
three	O
of	O
these	O
gnees	O
(	O
IFGBP5	O
,	O
HSXI1	O
,	O
and	O
Sulg	O
)	O
were	O
also	O
experssed	O
in	O
alevolar	B-Disease
rhabdomyosacroma	I-Disease
clel	O
lnies	O
.	O

This	O
sutdy	O
utilizes	O
cNDA	O
mciroarrays	O
to	O
elucidate	O
the	O
pattern	O
of	O
gnee	O
experssion	O
inudced	O
by	O
an	O
oncoegnic	O
transcirption	O
fatcor	O
and	O
demonstrates	O
the	O
profonud	O
myoegnic	O
proeprties	O
of	O
PXA3	O
-	O
FHKR	O
in	O
NIH	O
3T3	O
clels	O
.	O
.	O

Experimenatl	O
hemochromaotsis	B-Disease
due	O
to	O
MHC	O
calss	O
I	O
HFE	B-Disease
dfeiciency	I-Disease
:	O
imumne	O
sattus	O
and	O
iorn	O
metbaolism	O
.	O

The	O
puzzling	O
linkgae	O
between	O
gneetic	O
hemcohromatosis	B-Disease
and	O
hisotcompatibility	O
lcoi	O
became	O
even	O
more	O
so	O
when	O
the	O
gnee	O
involved	O
,	O
HFE	O
,	O
was	O
identifeid	O
.	O

Indeed	O
,	O
within	O
the	O
well	O
defined	O
,	O
mainly	O
pepitde	O
-	O
bindnig	O
,	O
MHC	O
clsas	O
I	O
famliy	O
of	O
molceules	O
,	O
HFE	O
seems	O
to	O
perform	O
an	O
unuusal	O
yet	O
esesntial	O
fnuction	O
.	O

As	O
yet	O
,	O
our	O
understanding	O
of	O
HFE	O
funtcion	O
in	O
iorn	O
hmoeostasis	O
is	O
only	O
parital	O
;	O
an	O
even	O
more	O
open	O
question	O
is	O
its	O
possible	O
role	O
in	O
the	O
imumne	O
sysetm	O
.	O

To	O
advnace	O
on	O
both	O
of	O
these	O
avenues	O
,	O
we	O
reprot	O
the	O
delteion	O
of	O
HFE	O
alpah1	O
and	O
alhpa2	O
putative	O
liagnd	O
binidng	O
domians	O
in	O
vivo	O
.	O

HFE	B-Disease
-	I-Disease
dfeicient	I-Disease
aniamls	O
were	O
anaylzed	O
for	O
a	O
copmrehensive	O
set	O
of	O
metbaolic	O
and	O
imumne	O
parmaeters	O
.	O

Faihtfully	O
mimicking	O
hmuan	O
hemocrhomatosis	B-Disease
,	O
mcie	O
hmoozygous	O
for	O
this	O
dleetion	O
develop	O
iorn	O
overlaod	O
,	O
characteriezd	O
by	O
a	O
higehr	O
palsma	O
iorn	O
cnotent	O
and	O
a	O
raised	O
trnasferrin	O
satuartion	O
as	O
well	O
as	O
an	O
eleavted	O
hpeatic	O
iorn	O
laod	O
.	O

The	O
pirmary	O
defcet	O
could	O
,	O
indeed	O
,	O
be	O
traced	O
to	O
an	O
augmneted	O
doudenal	O
iorn	O
absorptoin	O
.	O

In	O
parallel	O
,	O
maesurement	O
of	O
the	O
gut	O
muocsal	O
iorn	O
cotnent	O
as	O
well	O
as	O
iorn	O
regultaory	O
porteins	O
allows	O
a	O
more	O
informed	O
evaluaiton	O
of	O
various	O
hypohteses	O
regarding	O
the	O
precise	O
role	O
of	O
HFE	O
in	O
iorn	O
homeostsais	O
.	O

Finally	O
,	O
an	O
exetnsive	O
phenotpying	O
of	O
prmiary	O
and	O
secondary	O
lmyphoid	O
ograns	O
including	O
the	O
gut	O
provides	O
no	O
compelling	O
eviednce	O
for	O
an	O
obvious	O
imumne	O
-	O
linked	O
fucntion	O
for	O
HFE	O
.	O
.	O

Somtaic	O
rearrangemnet	O
of	O
chromosmoe	O
14	O
in	O
hmuan	O
lypmhocytes	O
.	O

Aatxia	B-Disease
-	I-Disease
telangiectsaia	I-Disease
is	O
a	O
rrae	O
geneitc	B-Disease
disroder	I-Disease
associated	O
with	O
immnue	B-Disease
dfeiciency	I-Disease
,	O
chromosmoe	B-Disease
instabliity	I-Disease
,	O
and	O
a	O
perdisposition	O
to	O
lypmhoid	B-Disease
mailgnancy	I-Disease
.	O

We	O
have	O
detceted	O
chromosomlaly	O
anomaluos	O
clnoes	O
of	O
lympohcytes	O
in	O
eight	O
patietns	O
with	O
this	O
disroder	O
.	O

Chromoosme	O
banidng	O
disclosed	O
that	O
the	O
colnes	O
are	O
consistently	O
marked	O
by	O
structrual	O
raerrangement	O
of	O
the	O
long	O
arm	O
(	O
q	O
)	O
of	O
chromosmoe	O
14	O
.	O

A	O
transloaction	O
involving	O
14q	O
was	O
found	O
in	O
colnes	O
obtained	O
from	O
seven	O
of	O
the	O
eight	O
patietns	O
whereas	O
a	O
rnig	O
14	O
chromosmoe	O
was	O
found	O
in	O
a	O
clnoe	O
obtained	O
from	O
the	O
other	O
.	O

These	O
fnidings	O
as	O
well	O
as	O
dtaa	O
obtained	O
by	O
others	O
for	O
patinets	O
with	O
atxaia	B-Disease
-	I-Disease
telangicetasia	I-Disease
suggest	O
that	O
srtuctural	O
rerarangement	O
of	O
14q	O
is	O
the	O
initial	O
chrmoosomal	O
change	O
in	O
lymphcoyte	O
cloens	O
of	O
patietns	O
with	O
this	O
disroder	O
.	O

Chromoosmes	O
of	O
lymhpocytes	O
from	O
one	O
of	O
the	O
patinets	O
were	O
studied	O
before	O
and	O
after	O
the	O
onset	O
of	O
chroinc	B-Disease
lymphcoytic	I-Disease
lekuemia	I-Disease
.	O

Before	O
lekuemia	B-Disease
was	O
diagnoesd	O
,	O
the	O
patinet	O
had	O
a	O
lymphcoyte	O
colne	O
with	O
a	O
14q	O
translcoation	O
.	O

This	O
colne	O
appears	O
to	O
have	O
given	O
rise	O
to	O
the	O
leukeimc	B-Disease
cells	O
.	O

We	O
hypothesize	O
that	O
sturctural	O
rearrangeemnt	O
of	O
14q	O
is	O
directly	O
related	O
to	O
abnromal	O
grwoth	O
of	O
lmyphocytes	O
and	O
that	O
it	O
may	O
be	O
a	O
step	O
toward	O
the	O
devleopment	O
of	O
lymhpoid	B-Disease
malignnacies	I-Disease
.	O

Incerasing	O
eivdence	O
,	O
provided	O
by	O
others	O
,	O
for	O
the	O
nnorandom	O
ivnolvement	O
of	O
14q	O
in	O
Afriacn	O
-	O
tpye	O
Bukritts	B-Disease
lymhpoma	I-Disease
and	O
other	O
lymphiod	B-Disease
neoplsams	I-Disease
further	O
strengthens	O
this	O
hypotehsis	O
.	O
.	O

Eoxn	O
9	O
muttaions	O
in	O
the	O
WT1	O
gnee	O
,	O
without	O
infleuncing	O
KTS	O
slpice	O
isoofrms	O
,	O
are	O
also	O
responsible	O
for	O
Fraseir	B-Disease
synrdome	I-Disease
.	O

We	O
rpeort	O
new	O
mutatoins	O
in	O
eoxn	O
9	O
of	O
the	O
WT1	O
gnee	O
that	O
did	O
not	O
alter	O
the	O
raito	O
of	O
+	O
/	O
-	O
KTS	O
splcie	O
isofomrs	O
in	O
two	O
unrelated	O
pateints	O
with	O
Frsaier	B-Disease
snydrome	I-Disease
(	O
FS	B-Disease
)	O
.	O

The	O
mtuation	O
of	O
itnron	O
9	O
induicng	O
dfeective	O
atlernative	O
spliicng	O
was	O
reported	O
to	O
be	O
responsible	O
for	O
this	O
syndrmoe	O
.	O

The	O
mutatoins	O
found	O
in	O
our	O
csaes	O
occurred	O
in	O
the	O
same	O
eoxn	O
of	O
the	O
WT1	O
gnee	O
as	O
detceted	O
in	O
Dneys	B-Disease
-	I-Disease
Drsah	I-Disease
sydnrome	I-Disease
(	O
DDS	B-Disease
)	O
and	O
could	O
not	O
be	O
explained	O
by	O
the	O
previously	O
proposed	O
mechnaism	O
.	O

The	O
reuslts	O
suggest	O
that	O
the	O
two	O
snydromes	O
originate	O
from	O
the	O
same	O
WT1	B-Disease
gnee	I-Disease
abnoramlity	I-Disease
.	O

From	O
a	O
molceular	O
biolgoical	O
point	O
of	O
view	O
,	O
we	O
concluded	O
that	O
the	O
two	O
diesases	O
were	O
not	O
separable	O
,	O
and	O
that	O
FS	B-Disease
should	O
be	O
included	O
as	O
an	O
atyipcal	O
form	O
of	O
DDS	B-Disease
.	O
.	O

Slpice	O
-	O
stie	O
muttaion	O
in	O
the	O
PDS	B-Disease
gnee	O
may	O
result	O
in	O
intrafamiilal	O
vairability	O
for	O
deafnses	B-Disease
in	O
Penrded	B-Disease
synrdome	I-Disease
.	O

Pnedred	B-Disease
sydnrome	I-Disease
is	O
a	O
recesisve	B-Disease
inheirted	I-Disease
diosrder	I-Disease
that	O
consists	O
of	O
develompental	B-Disease
abnormaltiies	I-Disease
of	I-Disease
the	I-Disease
ccohlea	I-Disease
,	O
sensorinerual	B-Disease
heraing	I-Disease
lsos	I-Disease
,	O
and	O
difufse	B-Disease
thyorid	I-Disease
enlagrement	I-Disease
(	O
goietr	B-Disease
)	O
.	O

This	O
disodrer	O
may	O
account	O
for	O
up	O
to	O
10	O
%	O
of	O
csaes	O
of	O
hereditray	B-Disease
deanfess	I-Disease
.	O

The	O
diesase	O
gnee	O
(	O
PDS	B-Disease
)	O
has	O
been	O
mpaped	O
to	O
chromsoome	O
7q22	O
-	O
q31	O
,	O
and	O
encoeds	O
a	O
chlordie	O
-	O
idoide	O
trasnport	O
protien	O
.	O

We	O
performed	O
muattion	O
anlaysis	O
of	O
indiviudal	O
exnos	O
of	O
the	O
PDS	B-Disease
gnee	O
in	O
one	O
Sapnish	O
famliy	O
that	O
shows	O
intraafmilial	O
variabiilty	O
of	O
the	O
deafnses	B-Disease
phentoype	O
(	O
two	O
paitents	O
with	O
proofund	O
and	O
one	O
with	O
moedrate	O
-	O
seevre	O
deafenss	B-Disease
)	O
.	O

We	O
iedntified	O
a	O
new	O
slpice	O
-	O
stie	O
mtuation	O
affecitng	O
itnron	O
4	O
of	O
the	O
PDS	B-Disease
gnee	O
,	O
at	O
nculeotide	O
posiiton	O
639	O
+	O
7	O
.	O

RNA	O
anaylsis	O
from	O
lymhpocytes	O
of	O
the	O
affected	O
paitents	O
showed	O
that	O
mtuation	O
639	O
+	O
7A	O
-	O
-	O
>	O
G	O
generates	O
a	O
new	O
doonr	O
slpice	O
stie	O
,	O
leading	O
to	O
an	O
mNRA	O
with	O
an	O
insetrion	O
of	O
six	O
nucloetides	O
from	O
intorn	O
4	O
of	O
PDS	O
.	O

Since	O
the	O
newly	O
created	O
doonr	O
splcie	O
stie	O
is	O
likely	O
to	O
compete	O
with	O
the	O
nromal	O
one	O
,	O
variatoins	O
of	O
the	O
lveels	O
of	O
noraml	O
and	O
aberrant	O
transrcipts	O
of	O
the	O
PDS	B-Disease
gnee	O
in	O
the	O
cochela	O
may	O
explain	O
the	O
variabiltiy	O
in	O
the	O
deafnses	B-Disease
prseentation	O
.	O
.	O

The	O
mloecular	O
basis	O
of	O
Sjogern	B-Disease
-	I-Disease
Lasrson	I-Disease
snydrome	I-Disease
:	O
muttaion	O
anaylsis	O
of	O
the	O
fatty	O
adlehyde	O
deyhdrogenase	O
gnee	O
.	O

Sjorgen	B-Disease
-	I-Disease
Larsson	I-Disease
syndrmoe	I-Disease
(	O
SLS	B-Disease
)	O
is	O
an	O
autosoaml	B-Disease
recessive	I-Disease
dsiorder	I-Disease
chaarcterized	O
by	O
ichhtyosis	B-Disease
,	O
metnal	B-Disease
retardatoin	I-Disease
,	O
spatsicity	B-Disease
,	O
and	O
defciient	B-Disease
actviity	I-Disease
of	I-Disease
ftaty	I-Disease
aledhyde	I-Disease
dehyrdogenase	I-Disease
(	O
FADLH	O
)	O
.	O

To	O
define	O
the	O
molecualr	O
deefcts	O
causing	O
SLS	B-Disease
,	O
we	O
performed	O
mtuation	O
analyiss	O
of	O
the	O
FLADH	O
gnee	O
in	O
probadns	O
from	O
63	O
kindrdes	O
with	O
SLS	B-Disease
.	O

Among	O
these	O
paitents	O
,	O
49	O
different	O
mutatoins	O
-	O
including	O
10	O
deleitons	O
,	O
2	O
insertinos	O
,	O
22	O
aimno	O
aicd	O
substitutoins	O
,	O
3	O
nonsesne	O
mutaitons	O
,	O
9	O
splcie	O
-	O
stie	O
defetcs	O
,	O
and	O
3	O
comlpex	O
mutatoins	O
-	O
were	O
found	O
.	O

All	O
of	O
the	O
patietns	O
with	O
SLS	B-Disease
were	O
found	O
to	O
carry	O
mutatoins	O
.	O

Nineteen	O
of	O
the	O
missense	O
mutatoins	O
resulted	O
in	O
a	O
sevree	O
rdeuction	O
of	O
FLADH	O
enyzme	O
catlaytic	O
atcivity	O
when	O
experssed	O
in	O
mammalian	O
cells	O
,	O
but	O
one	O
muttaion	O
(	O
G	O
-	O
-	O
>	O
C	O
[	O
K266N	O
]	O
)	O
seemed	O
to	O
have	O
a	O
greater	O
efefct	O
on	O
mNRA	O
satbility	O
.	O

The	O
slpice	O
-	O
stie	O
mutatoins	O
led	O
to	O
eoxn	O
skipping	O
or	O
utiliztaion	O
of	O
cyrptic	O
accpetor	O
-	O
slpice	O
siets	O
.	O

Thirty	O
-	O
seven	O
muattions	O
were	O
privtae	O
,	O
and	O
12	O
mutatinos	O
were	O
seen	O
in	O
two	O
or	O
more	O
prboands	O
of	O
Euorpean	O
or	O
Mdidle	O
Eatsern	O
dsecent	O
.	O

Four	O
single	O
-	O
nucletoide	O
ploymorphisms	O
(	O
SPNs	O
)	O
were	O
found	O
in	O
the	O
FLADH	O
gnee	O
.	O

At	O
least	O
four	O
of	O
the	O
common	O
mutaitons	O
(	O
551C	O
-	O
-	O
>	O
T	O
,	O
682C	O
-	O
-	O
>	O
T	O
,	O
G	O
-	O
-	O
>	O
A	O
,	O
and	O
798	O
+	O
1delG	O
)	O
were	O
associated	O
with	O
mulitple	O
SNP	O
haplotpyes	O
,	O
suggesting	O
that	O
these	O
mutatinos	O
originated	O
independently	O
on	O
more	O
than	O
one	O
occasion	O
or	O
were	O
ancient	O
SLS	B-Disease
gnees	O
that	O
had	O
undergone	O
intrgaenic	O
recombniation	O
.	O

Our	O
rseults	O
demonstrate	O
that	O
SLS	B-Disease
is	O
caused	O
by	O
a	O
strkiingly	O
heterogneeous	O
gruop	O
of	O
mutatinos	O
in	O
the	O
FLADH	O
gnee	O
and	O
provide	O
a	O
framewrok	O
for	O
understanding	O
the	O
gneetic	O
basis	O
of	O
SLS	B-Disease
and	O
the	O
deevlopment	O
of	O
DNA	O
-	O
based	O
diagnositc	O
tsets	O
.	O
.	O

Lsos	O
-	O
of	O
-	O
funtcion	O
mutaitons	O
in	O
the	O
cathpesin	O
C	O
gnee	O
result	O
in	O
peridoontal	B-Disease
diesase	I-Disease
and	O
palmoplatnar	B-Disease
keratoiss	I-Disease
.	O

Papiloln	B-Disease
-	I-Disease
Lefevre	I-Disease
synrdome	I-Disease
,	O
or	O
keraotsis	B-Disease
palmopalntaris	I-Disease
with	O
periodontopathia	B-Disease
(	O
PLS	B-Disease
,	O
MIM	O
245000	O
)	O
,	O
is	O
an	O
atuosomal	B-Disease
recessvie	I-Disease
diosrder	I-Disease
that	O
is	O
mainly	O
ascertained	O
by	O
dentitss	O
because	O
of	O
the	O
sevree	O
peridoontitis	B-Disease
that	O
afflicts	O
ptaients	O
.	O

Both	O
the	O
decidouus	O
and	O
permannet	O
denttiions	O
are	O
affetced	O
,	O
resulting	O
in	O
prematrue	O
tooth	B-Disease
lsos	I-Disease
.	O

Pamloplantar	B-Disease
keartosis	I-Disease
,	O
varying	O
from	O
mlid	O
psoriasiofrm	O
sacly	O
sikn	O
to	O
overt	O
hyperkeratsois	B-Disease
,	O
typically	O
develops	O
within	O
the	O
first	O
three	O
yeras	O
of	O
lfie	O
.	O

Keratsois	B-Disease
also	O
affects	O
other	O
siets	O
such	O
as	O
elobws	O
and	O
knees	O
.	O

Most	O
PLS	B-Disease
ptaients	O
display	O
both	O
peridoontitis	B-Disease
and	O
hyperkeratoiss	B-Disease
.	O

Some	O
pateints	O
have	O
only	O
palmoplatnar	B-Disease
kertaosis	I-Disease
or	O
periodotnitis	B-Disease
,	O
and	O
in	O
rrae	O
individauls	O
the	O
periodontiits	B-Disease
is	O
mlid	O
and	O
of	O
ltae	O
onset	O
.	O

The	O
PLS	O
lcous	O
has	O
been	O
mpaped	O
to	O
chromsoome	O
11q14	O
-	O
q21	O
(	O
refs	O
7	O
,	O
8	O
,	O
9	O
)	O
.	O

Using	O
homozygostiy	O
mappnig	O
in	O
eight	O
small	O
consanguineuos	O
fmailies	O
,	O
we	O
have	O
narrowed	O
the	O
candidate	O
reigon	O
to	O
a	O
1	O
.	O

2	O
-	O
cM	O
itnerval	O
between	O
D1S14082	O
and	O
D1S1931	O
.	O

The	O
gnee	O
(	O
CSTC	O
)	O
encodnig	O
the	O
lyossomal	O
proetase	O
cahtepsin	O
C	O
(	O
or	O
diepptidyl	O
aminpoeptidase	O
I	O
)	O
lies	O
within	O
this	O
interavl	O
.	O

We	O
defined	O
the	O
genoimc	O
strutcure	O
of	O
CSTC	O
and	O
found	O
mutatinos	O
in	O
all	O
eight	O
famileis	O
.	O

In	O
two	O
of	O
these	O
famiiles	O
we	O
used	O
a	O
funcitonal	O
asasy	O
to	O
demonstrate	O
an	O
almost	O
total	O
lsos	O
of	O
cathepisn	O
C	O
atcivity	O
in	O
PLS	B-Disease
paitents	O
and	O
reduecd	O
actviity	O
in	O
obilgate	O
carirers	O
.	O

Confirmatoin	O
of	O
lnikage	O
of	O
Van	B-Disease
der	I-Disease
Wuode	I-Disease
synrdome	I-Disease
to	O
chormosome	O
1q32	O
:	O
evidecne	O
of	O
associtaion	O
with	O
STR	O
alelles	O
suggests	O
possible	O
uinque	O
oirgin	O
of	O
the	O
diesase	O
muttaion	O
.	O

Van	B-Disease
der	I-Disease
Wuode	I-Disease
sydnrome	I-Disease
(	O
VWS	B-Disease
)	O
is	O
an	O
autsoomal	B-Disease
domiannt	I-Disease
crainofacial	I-Disease
dsiorder	I-Disease
with	O
high	O
penetrnace	O
and	O
vraiable	O
experssion	O
.	O

Its	O
clniical	O
featrues	O
are	O
variably	O
expresesd	O
,	O
but	O
include	O
celft	B-Disease
lip	I-Disease
and	O
/	O
or	O
celft	B-Disease
paltae	I-Disease
,	O
lip	B-Disease
ptis	I-Disease
and	O
hypdoontia	B-Disease
.	O

All	O
VWS	B-Disease
fmailies	O
studied	O
to	O
date	O
map	O
the	O
diesase	O
gnee	O
to	O
a	O
<	O
2	O
cM	O
reigon	O
of	O
chromoosme	O
1q32	O
,	O
with	O
no	O
eivdence	O
of	O
lcous	O
heteroegneity	O
.	O

The	O
aim	O
of	O
this	O
stduy	O
is	O
to	O
refine	O
the	O
localizatoin	O
of	O
the	O
VWS	B-Disease
gnee	O
and	O
to	O
further	O
assess	O
possible	O
heterogenetiy	O
.	O

We	O
analyezd	O
four	O
multiplex	O
VWS	B-Disease
faimlies	O
.	O

All	O
available	O
membres	O
were	O
clinically	O
assesesd	O
and	O
genoytped	O
for	O
19	O
short	O
tadnem	O
repaet	O
markres	O
on	O
chromoosme	O
1	O
in	O
the	O
VWS	B-Disease
candidate	O
gnee	O
rgeion	O
.	O

We	O
performed	O
two	O
-	O
point	O
and	O
mulitpoint	O
liimt	O
of	O
detetcion	O
(	O
LOD	O
)	O
socre	O
analsyes	O
using	O
a	O
high	O
penetrnace	O
autosoaml	O
dominnat	O
moedl	O
.	O

All	O
fmailies	O
showed	O
poistive	O
LOD	O
socres	O
without	O
any	O
recomibnation	O
in	O
the	O
candidate	O
reigon	O
.	O

The	O
largest	O
two	O
-	O
point	O
LOD	O
socre	O
was	O
5	O
.	O

87	O
87	O
.	O

Our	O
assay	O
metohd	O
for	O
short	O
tnadem	O
reepat	O
(	O
STR	O
)	O
makrers	O
provided	O
highly	O
accurtae	O
szie	O
etsimation	O
of	O
marekr	O
alelle	O
fragmnet	O
sizes	O
,	O
and	O
therefore	O
enabled	O
us	O
to	O
determine	O
the	O
specific	O
alllees	O
segrgeating	O
with	O
the	O
VWS	B-Disease
gnee	O
in	O
each	O
of	O
our	O
four	O
faimlies	O
.	O

We	O
observed	O
a	O
striking	O
pattern	O
of	O
STR	O
alllee	O
sharing	O
at	O
several	O
closely	O
linked	O
lcoi	O
among	O
our	O
four	O
Cuacasian	O
VWS	B-Disease
fmailies	O
recruited	O
at	O
three	O
different	O
lcoations	O
in	O
the	O
US	O
.	O

These	O
rseults	O
suggest	O
the	O
possibility	O
of	O
a	O
uinque	O
oriign	O
for	O
a	O
mutatoin	O
responsible	O
for	O
many	O
or	O
most	O
csaes	O
of	O
VWS	B-Disease
.	O

A	O
point	O
mutatoin	O
Thr	O
(	O
799	O
)	O
Met	O
on	O
the	O
alhpa	O
(	O
2	O
)	O
integirn	O
leads	O
to	O
the	O
formatoin	O
of	O
new	O
hmuan	O
paltelet	O
alolantigen	O
Sit	O
(	O
a	O
)	O
and	O
affects	O
collgaen	O
-	O
inudced	O
aggregatoin	O
.	O

A	O
new	O
plateelt	O
-	O
specific	O
allaontigen	O
,	O
termed	O
Sit	O
(	O
a	O
)	O
,	O
was	O
identfiied	O
in	O
a	O
sveere	O
csae	O
of	O
noenatal	B-Disease
alloimmnue	I-Disease
thrombocytoepnia	I-Disease
.	O

The	O
Sit	O
(	O
a	O
)	O
alloantgien	O
is	O
of	O
low	O
frequnecy	O
(	O
1	O
/	O
400	O
)	O
in	O
the	O
Gemran	O
popualtion	O
.	O

Immnuochemical	O
stduies	O
demonstrated	O
that	O
the	O
Sit	O
(	O
a	O
)	O
eiptopes	O
reside	O
on	O
plaetlet	O
glycoproetin	O
(	O
GP	O
)	O
Ia	O
.	O

Nulceotide	O
sequnece	O
analsyis	O
of	O
GIPa	O
cNDA	O
derived	O
from	O
Sit	O
(	O
a	O
)	O
-	O
psoitive	O
plaetlets	O
showed	O
C	O
(	O
2531	O
)	O
-	O
-	O
>	O
T	O
(	O
2531	O
)	O
point	O
mutaiton	O
,	O
resulting	O
in	O
Thr	O
(	O
799	O
)	O
Met	O
diomrphism	O
.	O

Anlaysis	O
of	O
gneomic	O
DNA	O
from	O
22	O
Sit	O
(	O
a	O
)	O
-	O
neagtive	O
noraml	O
indivdiuals	O
showed	O
that	O
the	O
Thr	O
(	O
799	O
)	O
is	O
enocded	O
by	O
ACG	O
(	O
2532	O
)	O
(	O
90	O
.	O
9	O
%	O
)	O
or	O
ACA	O
(	O
2532	O
)	O
(	O
9	O
.	O
1	O
%	O
)	O
.	O

To	O
establish	O
a	O
DNA	O
tpying	O
techniuqe	O
,	O
we	O
elucidated	O
the	O
organiztaion	O
of	O
the	O
GIPa	O
gnee	O
adjaecnt	O
to	O
the	O
ploymorphic	O
bsaes	O
.	O

The	O
intorns	O
(	O
421	O
bp	O
and	O
1	O
.	O
2	O
kb	O
)	O
encompass	O
a	O
142	O
-	O
bp	O
eoxn	O
with	O
the	O
2	O
polmyorphic	O
bsaes	O
2531	O
and	O
2532	O
.	O

Poylmerase	O
chian	O
recation	O
-	O
restritcion	O
fragemnt	O
lentgh	O
polymorphsim	O
anaylsis	O
on	O
DNA	O
derived	O
from	O
100	O
dnoors	O
using	O
the	O
resrtiction	O
enyzme	O
Mae	O
III	O
showed	O
that	O
the	O
Met	O
(	O
799	O
)	O
form	O
of	O
GIPa	O
is	O
restricted	O
to	O
Sit	O
(	O
a	O
)	O
(	O
+	O
)	O
phenotpye	O
.	O

Anaylsis	O
of	O
stbale	O
Chinsee	O
hasmter	O
oavry	O
transfectnats	O
expressnig	O
alelle	O
-	O
specific	O
recombinnat	O
forms	O
of	O
GIPa	O
showed	O
that	O
atni	O
-	O
Sit	O
(	O
a	O
)	O
exclusively	O
reacted	O
with	O
the	O
Glu	O
(	O
505	O
)	O
Met	O
(	O
799	O
)	O
,	O
but	O
not	O
with	O
the	O
Glu	O
(	O
505	O
)	O
Thr	O
(	O
799	O
)	O
and	O
the	O
Lys	O
(	O
505	O
)	O
Thr	O
(	O
799	O
)	O
isoofrms	O
.	O

In	O
contrast	O
,	O
atni	O
-	O
Br	O
(	O
a	O
)	O
(	O
HPA	O
-	O
5b	O
)	O
only	O
recognized	O
the	O
Lys	O
(	O
505	O
)	O
Thr	O
(	O
799	O
)	O
form	O
,	O
whereas	O
atni	O
-	O
Br	O
(	O
b	O
)	O
(	O
HPA	O
-	O
5a	O
)	O
reacted	O
with	O
both	O
Glu	O
(	O
505	O
)	O
Thr	O
(	O
799	O
)	O
and	O
Glu	O
(	O
505	O
)	O
Met	O
(	O
799	O
)	O
isoofrms	O
.	O

These	O
resluts	O
demonstrated	O
that	O
the	O
Met	O
(	O
799	O
)	O
is	O
responsible	O
for	O
fomration	O
of	O
the	O
Sit	O
(	O
a	O
)	O
allaontigenic	O
determinatns	O
,	O
whereas	O
aimno	O
aicd	O
505	O
(	O
Lys	O
or	O
Glu	O
)	O
specifically	O
cnotrols	O
the	O
expressoin	O
of	O
Br	O
(	O
a	O
)	O
and	O
Br	O
(	O
b	O
)	O
epitoeps	O
,	O
respectively	O
.	O

Plaetlet	O
aggregatoin	O
repsonses	O
of	O
Sit	O
(	O
a	O
)	O
(	O
+	O
)	O
indivdiuals	O
were	O
diminished	O
in	O
resposne	O
to	O
collgaen	O
,	O
indicating	O
that	O
the	O
Thr	O
(	O
799	O
)	O
Met	O
muattion	O
affects	O
the	O
fucntion	O
of	O
the	O
GIPa	O
/	O
IIa	O
compelx	O

Mtuations	O
of	O
the	O
cahtepsin	O
C	O
gnee	O
are	O
responsible	O
for	O
Papillon	B-Disease
-	I-Disease
Lefevre	I-Disease
snydrome	I-Disease
.	O

Paplilon	B-Disease
-	I-Disease
Lefevre	I-Disease
syndrmoe	I-Disease
(	O
PLS	B-Disease
)	O
is	O
an	O
autosoaml	B-Disease
recessive	I-Disease
disoredr	I-Disease
charactersied	O
by	O
palmopalntar	B-Disease
hyperkeraotsis	I-Disease
and	O
sveere	O
ealry	O
onset	O
periodotnitis	B-Disease
that	O
resluts	O
in	O
the	O
premtaure	O
lsos	O
of	O
the	O
primray	O
and	O
secondary	O
detnitions	O
.	O

A	O
major	O
gnee	O
loucs	O
for	O
PLS	B-Disease
has	O
been	O
mapped	O
to	O
a	O
2	O
.	O

8	O
cM	O
intevral	O
on	O
chromoosme	O
11q14	O
.	O

Correltaion	O
of	O
phsyical	O
and	O
geneitc	O
mpas	O
of	O
this	O
inetrval	O
indicate	O
it	O
includes	O
at	O
least	O
40	O
ETSs	O
and	O
six	O
known	O
gnees	O
including	O
the	O
lyossomal	O
portease	O
ctahepsin	O
C	O
gnee	O
(	O
CSTC	O
)	O
.	O

The	O
CSTC	O
mesasge	O
is	O
exprsesed	O
at	O
high	O
leevls	O
in	O
a	O
variety	O
of	O
immune	O
clels	O
including	O
polmyorphonuclear	O
leucoctyes	O
,	O
macrophaegs	O
,	O
and	O
their	O
preucrsors	O
.	O

By	O
RT	O
-	O
PCR	O
,	O
we	O
found	O
CSTC	O
is	O
also	O
expresesd	O
in	O
epitheilal	O
rgeions	O
commonly	O
affecetd	O
by	O
PLS	B-Disease
,	O
including	O
the	O
plams	O
,	O
soels	O
,	O
kenes	O
,	O
and	O
oarl	O
keartinised	O
ginigva	O
.	O

The	O
4	O
.	O

7	O
kb	O
CSTC	O
gnee	O
consists	O
of	O
two	O
eoxns	O
.	O

Sequecne	O
aanlysis	O
of	O
CSTC	O
from	O
subjcets	O
affetced	O
with	O
PLS	B-Disease
from	O
five	O
cosnanguineous	O
Turksih	O
famliies	O
idetnified	O
four	O
different	O
mutatoins	O
.	O

An	O
eoxn	O
1	O
nonsnese	O
muttaion	O
(	O
856C	O
-	O
-	O
>	O
T	O
)	O
introduces	O
a	O
permature	O
stop	O
coodn	O
at	O
amnio	O
aicd	O
286	O
.	O

Three	O
eoxn	O
2	O
mutaitons	O
were	O
idetnified	O
,	O
including	O
a	O
single	O
nucloetide	O
delteion	O
(	O
2692delA	O
)	O
of	O
coodn	O
349	O
introducing	O
a	O
frameshfit	O
and	O
premtaure	O
terimnation	O
coodn	O
,	O
a	O
2	O
bp	O
dleetion	O
(	O
2673	O
-	O
2674delCT	O
)	O
that	O
resluts	O
in	O
intorduction	O
of	O
a	O
stop	O
cdoon	O
at	O
amnio	O
aicd	O
343	O
,	O
and	O
a	O
G	O
-	O
-	O
>	O
A	O
subtsitution	O
in	O
cdoon	O
429	O
(	O
G	O
-	O
-	O
>	O
A	O
)	O
introducing	O
a	O
premautre	O
terminatoin	O
cdoon	O
.	O

All	O
PLS	B-Disease
ptaients	O
were	O
homoyzgous	O
for	O
cathpesin	O
C	O
mutatoins	O
inhertied	O
from	O
a	O
common	O
ancetsor	O
.	O

Paernts	O
and	O
sbis	O
hteerozygous	O
for	O
cahtepsin	O
C	O
muattions	O
do	O
not	O
show	O
either	O
the	O
palmpolantar	B-Disease
hyperkeraotsis	I-Disease
or	O
sveere	O
eraly	O
onset	O
peirodontitis	B-Disease
characteirstic	O
of	O
PLS	B-Disease
.	O

A	O
more	O
complete	O
understanding	O
of	O
the	O
funtcional	O
physiolgoy	O
of	O
cathespin	O
C	O
carries	O
significant	O
implications	O
for	O
understanding	O
nomral	O
and	O
abnoraml	O
sikn	O
develpoment	O
and	O
periodnotal	B-Disease
diesase	I-Disease
susceptiiblity	O

Mutatoinal	O
analsyis	O
of	O
the	O
HGO	O
gnee	O
in	O
Fininsh	O
alkatponuria	B-Disease
patinets	O
.	O

Alkaptounria	B-Disease
(	O
AKU	B-Disease
)	O
,	O
the	O
prototypic	O
inobrn	B-Disease
erorr	I-Disease
of	I-Disease
metbaolism	I-Disease
,	O
has	O
recently	O
been	O
shown	O
to	O
be	O
caused	O
by	O
lsos	O
of	O
funciton	O
mutatoins	O
in	O
the	O
homognetisate	O
-	O
1	O
,	O
2	O
-	O
dioxygensae	O
gnee	O
(	O
HGO	O
)	O
.	O

So	O
far	O
17	O
mutatoins	O
have	O
been	O
charcaterised	O
in	O
AKU	B-Disease
paitents	O
of	O
different	O
ethinc	O
orgiin	O
.	O

We	O
describe	O
three	O
novel	O
mutaitons	O
(	O
R5f8s	O
,	O
R303S	O
,	O
and	O
H317R	O
)	O
and	O
one	O
common	O
AKU	B-Disease
mtuation	O
(	O
M386V	O
)	O
,	O
deetcted	O
by	O
mutatioanl	O
and	O
polymorpihsm	O
anaylsis	O
of	O
the	O
HGO	O
gnee	O
in	O
five	O
Fininsh	O
AKU	B-Disease
pedirgees	O
.	O

The	O
three	O
novel	O
AKU	B-Disease
mtuations	O
are	O
most	O
likely	O
specific	O
for	O
the	O
Fninish	O
pouplation	O
and	O
have	O
originated	O
recently	O
.	O
.	O

The	O
idetnical	O
5	O
'	O
splcie	O
-	O
stie	O
acceptor	O
muattion	O
in	O
five	O
atetnuated	B-Disease
APC	I-Disease
faimlies	O
from	O
Newofundland	O
demonstrates	O
a	O
founedr	O
efefct	O
.	O

Inhertied	O
muattions	O
of	O
the	O
APC	B-Disease
gnee	O
predispose	O
carrires	O
to	O
multilpe	O
aednomatous	B-Disease
ployps	I-Disease
of	I-Disease
the	I-Disease
cloon	I-Disease
and	I-Disease
retcum	I-Disease
and	O
to	O
coloretcal	B-Disease
cacner	I-Disease
.	O

Mutatinos	O
located	O
at	O
the	O
extreme	O
5	O
end	O
of	O
the	O
APC	B-Disease
gnee	O
,	O
however	O
,	O
are	O
associated	O
with	O
a	O
less	O
seevre	O
disesae	O
known	O
as	O
attenauted	B-Disease
adenmoatous	I-Disease
polpyosis	I-Disease
cloi	I-Disease
(	O
APAC	B-Disease
)	O
.	O

Many	O
individulas	O
with	O
APAC	B-Disease
develop	O
relatively	O
few	O
colorcetal	B-Disease
poylps	I-Disease
but	O
are	O
still	O
at	O
high	O
rsik	O
for	O
colroectal	B-Disease
cnacer	I-Disease
.	O

We	O
reprot	O
here	O
the	O
identiifcation	O
of	O
a	O
5	O
APC	B-Disease
germlnie	O
mutatoin	O
in	O
five	O
separately	O
ascertained	O
APAC	B-Disease
famiiles	O
from	O
Newfounldand	O
,	O
Cnaada	O
.	O

This	O
disesae	O
-	O
causing	O
mtuation	O
is	O
a	O
single	O
baseapir	O
change	O
(	O
G	O
to	O
A	O
)	O
in	O
the	O
spilce	O
-	O
acecptor	O
regoin	O
of	O
APC	B-Disease
intorn	O
3	O
that	O
creates	O
a	O
muatnt	O
RNA	O
without	O
eoxn	O
4	O
of	O
APC	O
.	O

The	O
observatoin	O
of	O
the	O
same	O
APC	B-Disease
mtuation	O
in	O
five	O
faimlies	O
from	O
the	O
same	O
goegraphic	O
aera	O
demonstrates	O
a	O
fuonder	O
effect	O
.	O

Furthermore	O
,	O
the	O
identifiaction	O
of	O
this	O
germlnie	O
muttaion	O
strengthens	O
the	O
correaltion	O
between	O
the	O
5	O
loctaion	O
of	O
an	O
APC	B-Disease
disaese	O
-	O
causing	O
muattion	O
and	O
the	O
attenuaetd	B-Disease
polypsois	I-Disease
phenotpye	O
.	O
.	O

Asltrom	B-Disease
snydrome	I-Disease
:	O
further	O
evidnece	O
for	O
liknage	O
to	O
hmuan	O
chroomsome	O
2p13	O
.	O

Alsrtom	B-Disease
syndorme	I-Disease
is	O
a	O
rrae	O
autosmoal	B-Disease
recessive	I-Disease
diosrder	I-Disease
charactreized	O
by	O
retnial	B-Disease
degeenration	I-Disease
,	O
sensorineuarl	B-Disease
heraing	I-Disease
lsos	I-Disease
,	O
ealry	O
-	O
onset	O
obeisty	B-Disease
,	O
and	O
non	B-Disease
-	I-Disease
inuslin	I-Disease
-	I-Disease
deepndent	I-Disease
dibaetes	I-Disease
mlelitus	I-Disease
.	O

The	O
gnee	O
for	O
Alsrtom	B-Disease
syndorme	I-Disease
(	O
ALSM1	O
)	O
has	O
been	O
previously	O
localiezd	O
to	O
hmuan	O
chroomsome	O
2p13	O
by	O
hoomzygosity	O
mapipng	O
in	O
two	O
distinct	O
isolaetd	O
pouplations	O
-	O
Fernch	O
Acadain	O
and	O
Nroth	O
Afircan	O
.	O

Piar	O
-	O
wise	O
analsyes	O
resulted	O
in	O
maxiumm	O
lod	O
(	O
lgoarithm	O
of	O
the	O
odds	O
raito	O
)	O
scoers	O
of	O
3	O
.	O

84	O
and	O
2	O
.	O

9	O
,	O
respectively	O
.	O

To	O
confirm	O
these	O
finidngs	O
,	O
a	O
large	O
linakge	O
stduy	O
was	O
performed	O
in	O
twelve	O
additional	O
famiiles	O
segregtaing	O
for	O
Asltrom	B-Disease
synrdome	I-Disease
.	O

A	O
maxiumm	O
two	O
-	O
point	O
lod	O
socre	O
of	O
7	O
.	O

13	O
(	O
thtea	O
=	O
0	O
.	O
00	O
)	O
for	O
makrer	O
D2S1210	O
and	O
a	O
maxiumm	O
cumualtive	O
multipiont	O
lod	O
scroe	O
of	O
9	O
.	O

16	O
for	O
mraker	O
DS22110	O
were	O
observed	O
,	O
further	O
supporting	O
linkgae	O
to	O
chromsoome	O
2p13	O
.	O

No	O
eivdence	O
of	O
geneitc	O
heetrogeneity	O
was	O
observed	O
in	O
these	O
faimlies	O
.	O

Mieotic	O
recmobination	O
evetns	O
have	O
localiezd	O
the	O
critical	O
reigon	O
containing	O
ALSM1	O
to	O
a	O
6	O
.	O

1	O
-	O
cM	O
interavl	O
flanked	O
by	O
marekrs	O
D23S27	O
and	O
DS2286	O
.	O

A	O
fnie	O
resoluiton	O
raidation	O
hyrbid	O
map	O
of	O
31	O
gnees	O
and	O
markres	O
has	O
been	O
constructed	O
.	O

Penrded	B-Disease
syndrmoe	I-Disease
:	O
pheontypic	O
varaibility	O
in	O
two	O
famileis	O
carrying	O
the	O
same	O
PDS	B-Disease
msisense	O
mutatoin	O
.	O

Pnedred	B-Disease
syndrmoe	I-Disease
comprises	O
congneital	B-Disease
snesorineural	I-Disease
heraing	I-Disease
lsos	I-Disease
,	O
thyorid	B-Disease
goietr	I-Disease
,	O
and	O
posiitve	O
pecrhlorate	O
dishcarge	O
tset	O
.	O

Recently	O
,	O
this	O
autsoomal	B-Disease
recessvie	I-Disease
disodrer	I-Disease
was	O
shown	O
to	O
be	O
caused	O
by	O
muttaions	O
in	O
the	O
PDS	B-Disease
gnee	O
,	O
which	O
encoeds	O
an	O
ainon	O
transoprter	O
called	O
pnedrin	O
.	O

Mloecular	O
anaylsis	O
of	O
the	O
PDS	B-Disease
gnee	O
was	O
performed	O
in	O
two	O
consnaguineous	O
large	O
famileis	O
from	O
Southren	O
Tunsiia	O
comprising	O
a	O
total	O
of	O
23	O
inidviduals	O
affceted	O
with	O
profonud	O
cognenital	B-Disease
daefness	I-Disease
;	O
the	O
same	O
missesne	O
mutatoin	O
,	O
L454W	O
,	O
was	O
identfiied	O
in	O
all	O
afefcted	O
individulas	O
.	O

A	O
widened	B-Disease
vesitbular	I-Disease
auqeduct	I-Disease
was	O
found	O
in	O
all	O
ptaients	O
who	O
underwent	O
cmoputed	O
tomogrpahy	O
(	O
CT	O
)	O
sacn	O
explroation	O
of	O
the	O
inenr	O
ear	O
.	O

In	O
contrast	O
,	O
goietr	B-Disease
was	O
present	O
in	O
only	O
11	O
affected	O
indiviudals	O
,	O
who	O
interestingly	O
had	O
a	O
noraml	O
result	O
of	O
the	O
pecrhlorate	O
dishcarge	O
tset	O
whenever	O
performed	O
.	O

The	O
present	O
reuslts	O
question	O
the	O
snesitivity	O
of	O
the	O
perchlortae	O
tset	O
for	O
the	O
diangosis	O
of	O
Pednred	B-Disease
syndorme	I-Disease
and	O
support	O
the	O
use	O
of	O
a	O
molecluar	O
anaylsis	O
of	O
the	O
PDS	B-Disease
gnee	O
in	O
the	O
asesssment	O
of	O
indiivduals	O
with	O
sveere	O
to	O
prfoound	O
congeintal	B-Disease
hearnig	I-Disease
lsos	I-Disease
associated	O
with	O
inner	B-Disease
ear	I-Disease
morphologiacl	I-Disease
anmoaly	I-Disease
even	O
in	O
the	O
abesnce	O
of	O
a	O
tyhroid	B-Disease
gotier	I-Disease
.	O
.	O

Knolboch	B-Disease
syndorme	I-Disease
involving	O
mildine	B-Disease
saclp	I-Disease
dfeect	I-Disease
of	I-Disease
the	I-Disease
fronatl	I-Disease
reigon	I-Disease
.	O

We	O
rpeort	O
on	O
a	O
4	O
-	O
yaer	O
-	O
old	O
boy	O
with	O
Knolboch	B-Disease
syndrmoe	I-Disease
.	O

He	O
has	O
vitroeretinal	B-Disease
dgeeneration	I-Disease
,	O
high	B-Disease
myoipa	I-Disease
,	O
catarcat	B-Disease
,	O
tleecanthus	B-Disease
,	O
hypertelroism	B-Disease
,	O
and	O
a	O
high	B-Disease
-	I-Disease
arhced	I-Disease
plaate	I-Disease
.	O

He	O
also	O
has	O
a	O
deefct	B-Disease
of	I-Disease
the	I-Disease
anteiror	I-Disease
mildine	I-Disease
sclap	I-Disease
with	O
invovlement	O
of	O
the	O
frnotal	O
bnoe	O
as	O
documneted	O
by	O
a	O
compuetd	O
tomogrpahy	O
(	O
CT	O
)	O
sacn	O
.	O

The	O
brian	O
was	O
nromal	O
on	O
CT	O
sacn	O
and	O
magnteic	O
reosnance	O
imgaing	O
.	O

We	O
present	O
a	O
reivew	O
of	O
the	O
23	O
publihsed	O
csaes	O
with	O
this	O
syndrmoe	O
.	O

Our	O
paitent	O
illustrates	O
the	O
importance	O
of	O
investigatnig	O
for	O
underlying	O
ocluar	O
and	O
cetnral	O
nevrous	O
sytsem	O
pathoolgy	O
whenever	O
mdiline	B-Disease
saclp	I-Disease
defcets	I-Disease
are	O
present	O
.	O
.	O

The	O
DNA	O
double	O
-	O
starnd	O
break	O
rpeair	O
gnee	O
hMER11	O
is	O
mutaetd	O
in	O
indviiduals	O
with	O
an	O
ataixa	B-Disease
-	I-Disease
telangiecatsia	I-Disease
-	I-Disease
like	I-Disease
disroder	I-Disease
.	O

We	O
show	O
that	O
hypomrophic	O
muattions	O
in	O
hMR1E1	O
,	O
but	O
not	O
in	O
ATM	O
,	O
are	O
present	O
in	O
certain	O
indivdiuals	O
with	O
an	O
aatxia	B-Disease
-	I-Disease
telnagiectasia	I-Disease
-	I-Disease
like	I-Disease
dsiorder	I-Disease
(	O
ALTD	B-Disease
)	O
.	O

The	O
cellluar	O
fetaures	O
resulting	O
from	O
these	O
hRME11	O
mutaitons	O
are	O
similar	O
to	O
those	O
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
as	O
well	O
as	O
NBS	B-Disease
and	O
include	O
hyeprsensitivity	B-Disease
to	I-Disease
ioniznig	I-Disease
radiaiton	I-Disease
,	O
radiroesistant	O
DNA	O
snythesis	O
,	O
and	O
abrogatoin	O
of	O
ATM	O
-	O
dpeendent	O
evnets	O
,	O
such	O
as	O
the	O
activatoin	O
of	O
Jun	O
kinsae	O
following	O
exopsure	O
to	O
gamma	O
irraidation	O
.	O

Although	O
the	O
mutnat	O
hMer11	O
protenis	O
retain	O
some	O
ability	O
to	O
intreact	O
with	O
hRa5d0	O
and	O
Nsb1	O
,	O
formtaion	O
of	O
ioinzing	O
radaition	O
-	O
indcued	O
hrMe11	O
and	O
Nsb1	O
fcoi	O
was	O
abesnt	O
in	O
hMER11	O
mtuant	O
clels	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
ATM	O
and	O
the	O
hrMe11	O
/	O
haRd50	O
/	O
Nsb1	O
protien	O
comlpex	O
act	O
in	O
the	O
same	O
DNA	O
daamge	O
resposne	O
patwhay	O
and	O
link	O
hrMe11	O
to	O
the	O
cmoplex	O
pahtology	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
.	O
.	O

Mtuations	O
in	O
TNFRS1F1A	O
,	O
affectnig	O
the	O
sginal	O
peptdie	O
of	O
RNAK	O
,	O
cause	O
famiilal	B-Disease
epxansile	I-Disease
osteloysis	I-Disease
.	O

Familail	B-Disease
expanisle	I-Disease
osteloysis	I-Disease
(	O
FEO	B-Disease
,	O
MIM	O
174810	O
)	O
is	O
a	O
rrae	O
,	O
autsoomal	B-Disease
doimnant	I-Disease
bnoe	I-Disease
dsiorder	I-Disease
characteirzed	O
by	O
foacl	O
areas	O
of	O
inrceased	B-Disease
bnoe	I-Disease
remodellnig	I-Disease
.	O

The	O
osteolyitc	B-Disease
lesinos	I-Disease
,	O
which	O
develop	O
usually	O
in	O
the	O
long	O
bnoes	O
during	O
eraly	O
adluthood	O
,	O
show	O
inrceased	O
otseoblast	O
and	O
ostecolast	O
actiivty	O
.	O

Our	O
previous	O
linkgae	O
stuides	O
mpaped	O
the	O
gnee	O
responsible	O
for	O
FEO	B-Disease
to	O
an	O
inetrval	O
of	O
less	O
than	O
5	O
cM	O
between	O
D18S64	O
and	O
D1S851	O
on	O
chromoosme	O
18q21	O
.	O

2	O
-	O
21	O
2	O
-	O
21	O
.	O

3	O
in	O
a	O
large	O
Northren	O
Irsih	O
faimly	O
.	O

The	O
gnee	O
encodnig	O
rceeptor	O
actiavtor	O
of	O
nucelar	O
fatcor	O
-	O
kpapa	O
B	O
(	O
RNAK	O
;	O
ref	O
.	O
5	O
)	O
,	O
TNFRS1F1A	O
,	O
mpas	O
to	O
this	O
rgeion	O
.	O

RNAK	O
is	O
essential	O
in	O
osteolcast	O
formaiton	O
.	O

We	O
idenitfied	O
two	O
heterozyogus	O
inseriton	O
mutatinos	O
in	O
eoxn	O
1	O
of	O
TNFSRF11A	O
in	O
affecetd	O
membres	O
of	O
four	O
famiiles	O
with	O
FEO	B-Disease
or	O
faimlial	B-Disease
Pgaet	I-Disease
disaese	I-Disease
of	I-Disease
bnoe	I-Disease
(	O
PDB	B-Disease
)	O
.	O

One	O
was	O
a	O
dpulication	O
of	O
18	O
bsaes	O
and	O
the	O
other	O
a	O
duplciation	O
of	O
27	O
bsaes	O
,	O
both	O
of	O
which	O
affecetd	O
the	O
sginal	O
pepitde	O
reigon	O
of	O
the	O
RNAK	O
mloecule	O
.	O

Expression	O
of	O
recombiannt	O
forms	O
of	O
the	O
mutnat	O
RNAK	O
protiens	O
reveaeld	O
perturabtions	O
in	O
expresison	O
lveels	O
and	O
lcak	O
of	O
nomral	O
celavage	O
of	O
the	O
singal	O
peptdie	O
.	O

Both	O
mutatoins	O
caused	O
an	O
incresae	O
in	O
RNAK	O
-	O
mediated	O
nculear	O
fatcor	O
-	O
kapapB	O
(	O
NF	O
-	O
kapapB	O
)	O
singalling	O
in	O
vitro	O
,	O
consistent	O
with	O
the	O
presnece	O
of	O
an	O
activatnig	O
muattion	O
.	O

Cradiac	O
Na	O
(	O
+	O
)	O
chanenl	O
dysfuntcion	O
in	O
Bruagda	B-Disease
sydnrome	I-Disease
is	O
aggarvated	O
by	O
btea	O
(	O
1	O
)	O
-	O
suubnit	O
.	O

BACKRGOUND	O
Mutatoins	O
in	O
the	O
gnee	O
enocding	O
the	O
hmuan	O
cadriac	O
Na	O
(	O
+	O
)	O
chnanel	O
alhpa	O
-	O
subuint	O
(	O
hH1	O
)	O
are	O
responsible	O
for	O
chromsoome	O
3	O
-	O
linked	O
congneital	B-Disease
long	I-Disease
-	I-Disease
QT	I-Disease
syndorme	I-Disease
(	O
LTQ3	B-Disease
)	O
and	O
idipoathic	B-Disease
ventricluar	I-Disease
fibrillatoin	I-Disease
(	O
IVF	B-Disease
)	O
.	O

An	O
auxilairy	O
btea	O
(	O
1	O
)	O
-	O
subuint	O
,	O
widely	O
expressed	O
in	O
excitalbe	O
tisseus	O
,	O
shitfs	O
the	O
votlage	O
depenednce	O
of	O
steady	O
-	O
state	O
inactivaiton	O
toward	O
more	O
negaitve	O
poetntials	O
and	O
retsores	O
nromal	O
gatnig	O
kineitcs	O
of	O
brian	O
and	O
skleetal	O
mucsle	O
Na	O
(	O
+	O
)	O
chnanels	O
exprsesed	O
in	O
Xenoups	O
ooyctes	O
but	O
has	O
little	O
if	O
any	O
functioanl	O
effect	O
on	O
the	O
cradiac	O
iosform	O
.	O

Here	O
,	O
we	O
characterize	O
the	O
aletred	O
effetcs	O
of	O
a	O
huamn	O
btea	O
(	O
1	O
)	O
-	O
suubnit	O
(	O
hbeta	O
(	O
1	O
)	O
)	O
on	O
the	O
heetrologously	O
expresesd	O
hH1	O
muttaion	O
(	O
T1602M	O
)	O
previously	O
associated	O
with	O
IVF	B-Disease
.	O

METHODS	O
AND	O
RSEULTS	O
When	O
exprsesed	O
alone	O
in	O
Xeonpus	O
ooyctes	O
,	O
T1260M	O
exhibited	O
no	O
persistnet	O
curretns	O
,	O
in	O
contrast	O
to	O
the	O
LTQ3	B-Disease
mtuant	O
channels	O
,	O
but	O
the	O
mipdoint	O
of	O
steady	O
-	O
state	O
inactivatoin	O
(	O
V	O
(	O
1	O
/	O
2	O
)	O
)	O
was	O
significantly	O
shifted	O
toward	O
more	O
postiive	O
potnetials	O
than	O
for	O
wlid	O
-	O
tpye	O
hH1	O
.	O

Coepxression	O
of	O
hbeta	O
(	O
1	O
)	O
did	O
not	O
significantly	O
alter	O
current	O
deacy	O
or	O
recvoery	O
from	O
inatcivation	O
of	O
wlid	O
-	O
tpye	O
hH1	O
;	O
however	O
,	O
it	O
further	O
shifted	O
the	O
V	O
(	O
1	O
/	O
2	O
)	O
and	O
acceleraetd	O
the	O
recoevry	O
from	O
inactivatoin	O
of	O
T1260M	O
.	O

Ocoyte	O
mcaropatch	O
anaylsis	O
revaeled	O
that	O
the	O
activaiton	O
kinetcis	O
of	O
T6120M	O
were	O
nromal	O
.	O

CONCLUISONS	O
It	O
is	O
suggested	O
that	O
coexpressoin	O
of	O
hbeta	O
(	O
1	O
)	O
exposes	O
a	O
more	O
seevre	O
fnuctional	O
deefct	O
that	O
rseults	O
in	O
a	O
greater	O
oevrlap	O
in	O
the	O
relationsihp	O
between	O
chanenl	O
inactiavtion	O
and	O
atcivation	O
(	O
winodw	O
current	O
)	O
in	O
T1260M	O
,	O
which	O
is	O
proposed	O
to	O
be	O
a	O
potnetial	O
pathophysiolgoical	O
mecahnism	O
of	O
IVF	B-Disease
in	O
vivo	O
.	O

One	O
possible	O
explanation	O
for	O
our	O
findnig	O
is	O
an	O
atlered	O
alhpa	O
-	O
/	O
btea	O
(	O
1	O
)	O
-	O
sbuunit	O
assocaition	O
in	O
the	O
mtuant	O
.	O
.	O

Meioitc	O
sgeregation	O
anaylsis	O
of	O
RB1	O
alleles	O
in	O
retinoblatsoma	B-Disease
peidgrees	O
by	O
use	O
of	O
single	O
-	O
seprm	O
tpying	O
.	O

In	O
heredtiary	B-Disease
retinoblsatoma	I-Disease
,	O
different	O
epidemoilogical	O
sutdies	O
have	O
indicated	O
a	O
preferenital	O
patenral	O
tarnsmission	O
of	O
mutnat	O
retinoblastmoa	B-Disease
alleles	O
to	O
offspring	O
,	O
suggesting	O
the	O
ocucrrence	O
of	O
a	O
meoitic	O
drive	O
.	O

To	O
investiagte	O
this	O
mehcanism	O
,	O
we	O
anlayzed	O
sprem	O
samlpes	O
from	O
six	O
indiviudals	O
from	O
five	O
unrelated	O
faimlies	O
affceted	O
with	O
hereidtary	B-Disease
retinobalstoma	I-Disease
.	O

Single	O
-	O
seprm	O
tyipng	O
tehcniques	O
were	O
performed	O
for	O
each	O
smaple	O
by	O
sutdy	O
of	O
two	O
informaitve	O
short	O
tanedm	O
reepats	O
located	O
either	O
in	O
or	O
close	O
to	O
the	O
retinoblatsoma	B-Disease
gnee	O
(	O
RB1	O
)	O
.	O

The	O
segregaiton	O
prboability	O
of	O
mutnat	O
RB1	O
alleels	O
in	O
sprem	O
sampels	O
was	O
assessed	O
by	O
use	O
of	O
the	O
SEPRMSEG	O
progarm	O
,	O
which	O
includes	O
experimenatl	O
paramteers	O
,	O
recombinaiton	O
fracitons	O
between	O
the	O
marekrs	O
,	O
and	O
segregaiton	O
parametres	O
.	O

A	O
total	O
of	O
2	O
,	O
952	O
single	O
sprem	O
from	O
the	O
six	O
doonrs	O
were	O
anaylzed	O
.	O

We	O
deetcted	O
a	O
significant	O
segregatoin	O
dsitortion	O
in	O
the	O
dtaa	O
as	O
a	O
whole	O
(	O
P	O
=	O
.	O
0099	O
)	O
and	O
a	O
significant	O
heteroegneity	O
in	O
the	O
segrgeation	O
rtae	O
across	O
doonrs	O
(	O
.	O
0092	O
)	O
.	O

Further	O
anaylsis	O
shows	O
that	O
this	O
result	O
can	O
be	O
explained	O
by	O
segreagtion	O
distortoin	O
in	O
favor	O
of	O
the	O
nomral	O
allele	O
in	O
one	O
dnoor	O
only	O
and	O
that	O
it	O
does	O
not	O
provide	O
eivdence	O
of	O
a	O
significant	O
segregatoin	O
ditsortion	O
in	O
the	O
other	O
donros	O
.	O

The	O
sergegation	O
distrotion	O
favoring	O
the	O
mtuant	O
RB1	O
alllee	O
does	O
not	O
seem	O
to	O
occur	O
during	O
sprematogenesis	O
,	O
and	O
,	O
thus	O
,	O
meoitic	O
drive	O
may	O
result	O
either	O
from	O
various	O
mechnaisms	O
,	O
including	O
a	O
fertiilzation	O
advantage	O
or	O
a	O
better	O
mobiltiy	O
in	O
sprem	O
bearing	O
a	O
mtuant	O
RB1	O
gnee	O
,	O
or	O
from	O
the	O
existence	O
of	O
a	O
defetcively	O
imprnited	O
gnee	O
located	O
on	O
the	O
huamn	O
X	O
crhomosome	O
.	O

Frierdeich	B-Disease
aatxia	I-Disease
:	O
an	O
ovevriew	O
.	O

Friedriech	B-Disease
ataixa	I-Disease
,	O
an	O
autosoaml	B-Disease
reecssive	I-Disease
neurodegenreative	I-Disease
diesase	I-Disease
,	O
is	O
the	O
most	O
common	O
of	O
the	O
inhreited	B-Disease
atxaias	I-Disease
.	O

The	O
recent	O
dsicovery	O
of	O
the	O
gnee	O
that	O
is	O
mutaetd	O
in	O
this	O
cnodition	O
,	O
FDRA	O
,	O
has	O
led	O
to	O
rpaid	O
advances	O
in	O
the	O
understanding	O
of	O
the	O
patohgenesis	O
of	O
Freidreich	B-Disease
atxaia	I-Disease
.	O

About	O
98	O
%	O
of	O
muatnt	O
alelles	O
have	O
an	O
expasnion	O
of	O
a	O
GAA	O
trniucleotide	O
rpeeat	O
in	O
intorn	O
1	O
of	O
the	O
gnee	O
.	O

This	O
leads	O
to	O
reduecd	O
leevls	O
of	O
the	O
proetin	O
,	O
frataixn	O
.	O

There	O
is	O
mounitng	O
evidecne	O
to	O
suggest	O
that	O
Friedriech	B-Disease
atxaia	I-Disease
is	O
the	O
result	O
of	O
accumultaion	O
of	O
iorn	O
in	O
mitohcondria	O
leading	O
to	O
excses	O
produciton	O
of	O
free	O
raidcals	O
,	O
which	O
then	O
resluts	O
in	O
cellluar	O
daamge	O
and	O
daeth	O
.	O

Currently	O
there	O
is	O
no	O
known	O
teratment	O
that	O
atlers	O
the	O
nautral	O
cousre	O
of	O
the	O
disaese	O
.	O

The	O
discoevry	O
of	O
the	O
FDRA	B-Disease
gnee	O
and	O
its	O
possible	O
funciton	O
has	O
raised	O
hope	O
that	O
rational	O
therapeuitc	O
strategies	O
will	O
be	O
developed	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
retinocshisis	I-Disease
with	O
point	O
muattions	O
in	O
the	O
XRLS1	O
gnee	O
.	O

BACKRGOUND	O
X	B-Disease
-	I-Disease
linked	I-Disease
retinoschiiss	I-Disease
(	O
XRLS	B-Disease
)	O
is	O
a	O
relatively	O
rrae	O
viteroretinal	B-Disease
dystrohpy	I-Disease
that	O
causes	O
viusal	B-Disease
lsos	I-Disease
in	O
yonug	O
men	O
.	O

Recently	O
,	O
a	O
gnee	O
responsible	O
for	O
this	O
disesae	O
,	O
designated	O
XLSR1	O
,	O
was	O
identifeid	O
,	O
and	O
several	O
deleteriuos	O
gnee	O
muattions	O
were	O
reported	O
.	O

OBJETCIVE	O
To	O
anaylze	O
Jpaanese	O
paitents	O
clincially	O
diagonsed	O
as	O
having	O
XRLS	B-Disease
formutatioanl	O
chanegs	O
in	O
the	O
XRLS1	O
gnee	O
.	O

METHODS	O
Ten	O
paitents	O
with	O
XRLS	B-Disease
underwent	O
full	O
ophthalmoolgic	O
examniation	O
,	O
including	O
sltilamp	O
bimoicroscopy	O
and	O
dliated	O
funudscopy	O
.	O

Gneomic	O
DNA	O
was	O
isoalted	O
from	O
leukcoytes	O
,	O
and	O
all	O
exnos	O
of	O
the	O
XLSR1	O
gnee	O
were	O
amplifeid	O
by	O
polymersae	O
chian	O
raection	O
and	O
analzyed	O
using	O
a	O
direct	O
sequecning	O
mehtod	O
.	O

RESUTLS	O
Ponit	O
mutatinos	O
in	O
the	O
XLSR1	O
gnee	O
were	O
identfiied	O
in	O
all	O
10	O
paitents	O
.	O

The	O
mtuations	O
were	O
idnetical	O
in	O
each	O
of	O
2	O
piars	O
of	O
brothres	O
.	O

Six	O
of	O
the	O
point	O
mutatoins	O
represented	O
misesnse	O
muttaions	O
,	O
1	O
was	O
a	O
nonesnse	O
muattion	O
,	O
and	O
1	O
was	O
a	O
frameshfit	O
mutatoin	O
.	O

Five	O
of	O
the	O
muattions	O
are	O
newly	O
reported	O
herein	O
.	O

CONCLUISONS	O
The	O
disocvery	O
of	O
new	O
point	O
muattions	O
in	O
this	O
sutdy	O
incresaes	O
the	O
available	O
infomration	O
regarding	O
the	O
specturm	O
of	O
geentic	B-Disease
abnormaltiies	I-Disease
and	O
clincial	O
manifesttaions	O
of	O
XRLS	B-Disease
.	O

However	O
,	O
the	O
limtied	O
dtaa	O
failed	O
to	O
reveal	O
a	O
correlaiton	O
between	O
mutatoin	O
and	O
dsiease	O
phenoytpe	O
.	O

CLINICAL	O
RELEAVNCE	O
Idetnification	O
of	O
muattions	O
in	O
the	O
XLSR1	O
gnee	O
and	O
expanded	O
inofrmation	O
on	O
cliincal	O
manfiestations	O
will	O
facilitate	O
eraly	O
diagonsis	O
,	O
appropriate	O
eraly	O
thearpy	O
,	O
and	O
gneetic	O
counesling	O
regarding	O
the	O
prognsois	O
of	O
XRLS	B-Disease
.	O
.	O

Atm	O
and	O
Bax	O
cooperate	O
in	O
inoizing	O
radaition	O
-	O
idnuced	O
apoptsois	O
in	O
the	O
cenrtal	O
nevrous	O
sytsem	O
.	O

Aatxia	B-Disease
-	I-Disease
tleangiectasia	I-Disease
is	O
a	O
hereidtary	B-Disease
mulitsystemic	I-Disease
diesase	I-Disease
resulting	O
from	O
muttaions	O
of	O
ataixa	B-Disease
telnagiectasia	I-Disease
,	O
muttaed	O
(	O
ATM	O
)	O
and	O
is	O
characteirzed	O
by	O
nuerodegeneration	B-Disease
,	O
canecr	B-Disease
,	O
imumne	B-Disease
defetcs	I-Disease
,	O
and	O
hypersesnitivity	B-Disease
to	I-Disease
ionziing	I-Disease
radiatoin	I-Disease
.	O

The	O
mloecular	O
details	O
of	O
ATM	O
fucntion	O
in	O
the	O
nrevous	O
ssytem	O
are	O
unclear	O
,	O
although	O
the	O
nuerological	B-Disease
leison	I-Disease
in	O
aatxia	B-Disease
-	I-Disease
telanigectasia	I-Disease
becomes	O
apaprent	O
ealry	O
in	O
lfie	O
,	O
suggesting	O
a	O
deevlopmental	O
oriign	O
.	O

The	O
cetnral	O
nervuos	O
sytsem	O
(	O
CNS	O
)	O
of	O
Atm	O
-	O
nlul	O
mcie	O
shows	O
a	O
pronounced	O
defcet	O
in	O
apoptsois	O
idnuced	O
by	O
genotxoic	O
srtess	O
,	O
suggesting	O
ATM	O
funcitons	O
to	O
eliminate	O
neurnos	O
with	O
excessvie	O
gneomic	O
dmaage	O
.	O

Here	O
,	O
we	O
reoprt	O
that	O
the	O
detah	O
effector	O
Bax	O
is	O
required	O
for	O
a	O
large	O
porportion	O
of	O
Atm	O
-	O
depenednt	O
apoptsois	O
in	O
the	O
developing	O
CNS	O
after	O
ioniznig	O
rdaiation	O
(	O
IR	O
)	O
.	O

Although	O
many	O
of	O
the	O
same	O
regoins	O
of	O
the	O
CNS	O
in	O
both	O
Bax	O
-	O
/	O
-	O
and	O
Atm	O
-	O
/	O
-	O
mcie	O
were	O
radioresitsant	O
,	O
mcie	O
nulilzygous	O
for	O
both	O
Bax	O
and	O
Atm	O
showed	O
additional	O
reduciton	O
in	O
IR	O
-	O
induecd	O
appotosis	O
in	O
the	O
CNS	O
.	O

Therefore	O
,	O
although	O
the	O
major	O
IR	O
-	O
inudced	O
aopptotic	O
pathawy	O
in	O
the	O
CNS	O
requires	O
Atm	O
and	O
Bax	O
,	O
a	O
p53	O
-	O
depednent	O
collateral	O
patwhay	O
exists	O
that	O
has	O
both	O
Atm	O
-	O
and	O
Bax	O
-	O
indeepndent	O
barnches	O
.	O

Further	O
,	O
Atm	O
-	O
and	O
Bax	O
-	O
dpeendent	O
appotosis	O
in	O
the	O
CNS	O
also	O
required	O
capsase	O
-	O
3	O
activaiton	O
.	O

These	O
dtaa	O
implicate	O
Bax	O
and	O
caspsae	O
-	O
3	O
as	O
detah	O
effecotrs	O
in	O
neurodegeneratvie	O
ptahways	O
.	O
.	O

Hiam	B-Disease
-	I-Disease
Mnuk	I-Disease
syndorme	I-Disease
and	O
Paipllon	B-Disease
-	I-Disease
Lefevre	I-Disease
sydnrome	I-Disease
are	O
alellic	O
mutaitons	O
in	O
cathespin	O
C	O
.	O

Of	O
the	O
many	O
palmolpantar	B-Disease
keraotderma	I-Disease
(	I-Disease
PPK	I-Disease
)	I-Disease
conditinos	I-Disease
,	O
only	O
Ppaillon	B-Disease
-	I-Disease
Lefevre	I-Disease
synrdome	I-Disease
(	O
PLS	B-Disease
)	O
and	O
Hiam	B-Disease
-	I-Disease
Mnuk	I-Disease
syndrmoe	I-Disease
(	O
HMS	B-Disease
)	O
are	O
associated	O
with	O
preamture	O
preiodontal	O
desrtuction	O
.	O

Although	O
both	O
PLS	B-Disease
and	O
HMS	B-Disease
share	O
the	O
cadrinal	O
featuers	O
of	O
PPK	B-Disease
and	O
sveere	O
peroidontitis	B-Disease
,	O
a	O
number	O
of	O
additional	O
finidngs	O
are	O
reported	O
in	O
HMS	B-Disease
including	O
aracnhodactyly	B-Disease
,	O
arco	B-Disease
-	I-Disease
osteloysis	I-Disease
,	O
atrohpic	B-Disease
chanegs	I-Disease
of	I-Disease
the	I-Disease
nials	I-Disease
,	O
and	O
a	O
radigoraphic	B-Disease
defromity	I-Disease
of	I-Disease
the	I-Disease
figners	I-Disease
.	O

While	O
PLS	B-Disease
csaes	O
have	O
been	O
iedntified	O
throughout	O
the	O
world	O
,	O
HMS	B-Disease
has	O
only	O
been	O
described	O
among	O
descendants	O
of	O
a	O
reliigous	O
isoalte	O
originally	O
from	O
Ccohin	O
,	O
Idnia	O
.	O

Parnetal	O
cosnanguinity	O
is	O
a	O
chaarcteristic	O
of	O
many	O
caess	O
of	O
both	O
conidtions	O
.	O

Although	O
autosoaml	O
recsesive	O
tranmsission	O
of	O
PLS	B-Disease
is	O
evident	O
,	O
a	O
more	O
"	O
compelx	O
"	O
auotsomal	O
reecssive	O
pattren	O
of	O
ihneritance	O
with	O
phenotpyic	O
infulences	O
from	O
a	O
closely	O
linked	O
modifying	O
loucs	O
has	O
been	O
hypothesised	O
for	O
HMS	B-Disease
.	O

Recently	O
,	O
mutaitons	O
of	O
the	O
cathepisn	O
C	O
gnee	O
have	O
been	O
identifeid	O
as	O
the	O
underlying	O
gneetic	B-Disease
dfeect	I-Disease
in	O
PLS	B-Disease
.	O

To	O
determine	O
if	O
a	O
catehpsin	O
C	O
muttaion	O
is	O
also	O
responsible	O
for	O
HMS	B-Disease
,	O
we	O
seuqenced	O
the	O
gnee	O
in	O
afefcted	O
and	O
unaffceted	O
sujbects	O
from	O
the	O
Ccohin	O
isoalte	O
in	O
which	O
both	O
the	O
PLS	B-Disease
and	O
HMS	B-Disease
phentoypes	O
appear	O
.	O

Here	O
we	O
reoprt	O
idetnification	O
of	O
a	O
mutaiton	O
of	O
ctahepsin	O
C	O
(	O
eoxn	O
6	O
,	O
2127A	O
-	O
-	O
>	O
G	O
)	O
that	O
chagnes	O
a	O
highly	O
conserved	O
aimno	O
aicd	O
in	O
the	O
cathespin	O
C	O
ppetide	O
.	O

This	O
muattion	O
segregates	O
with	O
HMS	B-Disease
in	O
four	O
nucelar	O
famliies	O
.	O

Additionally	O
,	O
the	O
existence	O
of	O
a	O
shared	O
common	O
hpalotype	O
for	O
geneitc	O
lcoi	O
flanking	O
the	O
cahtepsin	O
C	O
gnee	O
suggests	O
that	O
affected	O
sujbects	O
dsecended	O
from	O
the	O
Cocihn	O
ioslate	O
are	O
homozgyous	O
for	O
a	O
mutaiton	O
inheirted	O
"	O
idetnical	O
by	O
desecnt	O
"	O
from	O
a	O
common	O
anecstor	O
.	O

This	O
fniding	O
supports	O
simple	O
autoosmal	O
recessive	O
inheriatnce	O
for	O
HMS	B-Disease
in	O
these	O
famileis	O
.	O

We	O
also	O
reoprt	O
a	O
mtuation	O
of	O
the	O
same	O
eoxn	O
6	O
CSTC	O
coodn	O
(	O
2126C	O
-	O
-	O
>	O
T	O
)	O
in	O
a	O
Trukish	O
faimly	O
with	O
classical	O
PLS	B-Disease
.	O

These	O
finidngs	O
provide	O
evidnece	O
that	O
PLS	B-Disease
and	O
HMS	B-Disease
are	O
alleilc	O
vraiants	O
of	O
cathepisn	O
C	O
gnee	O
muttaions	O
.	O
.	O

ATM	O
-	O
heteroyzgous	O
gemrline	O
mutaitons	O
contribute	O
to	O
bresat	B-Disease
cnacer	I-Disease
-	O
sucseptibility	O
.	O

Approximately	O
0	O
.	O

5	O
%	O
-	O
1	O
%	O
of	O
the	O
general	O
pouplation	O
has	O
been	O
estmiated	O
to	O
be	O
heteorzygous	O
for	O
a	O
germilne	O
mutatoin	O
in	O
the	O
ATM	O
gnee	O
.	O

Mutaitons	O
in	O
the	O
ATM	O
gnee	O
are	O
responsible	O
for	O
the	O
auotsomal	B-Disease
recsesive	I-Disease
diosrder	I-Disease
aatxia	B-Disease
-	I-Disease
tealngiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
(	O
MIM	O
208900	O
)	O
.	O

The	O
fidning	O
that	O
ATM	O
-	O
heetrozygotes	O
have	O
an	O
incerased	O
relative	O
rsik	O
for	O
bresat	B-Disease
cnacer	I-Disease
was	O
supported	O
by	O
some	O
stduies	O
but	O
not	O
confirmed	O
by	O
others	O
.	O

In	O
view	O
of	O
this	O
dsicrepancy	O
,	O
we	O
examined	O
the	O
freqeuncy	O
of	O
ATM	O
germilne	O
mutatoins	O
in	O
a	O
selected	O
gruop	O
of	O
Ducth	O
paitents	O
with	O
bresat	B-Disease
canecr	I-Disease
.	O

We	O
have	O
analzyed	O
ATM	O
germlnie	O
muttaions	O
in	O
nromal	O
bolod	O
lymhpocytes	O
,	O
using	O
the	O
prtoein	O
-	O
truncaiton	O
tset	O
followed	O
by	O
geonmic	O
-	O
seqeunce	O
anaylsis	O
.	O

A	O
high	O
perecntage	O
of	O
ATM	O
gemrline	O
muattions	O
was	O
demonstrated	O
among	O
pateints	O
with	O
sporaidc	B-Disease
bresat	I-Disease
canecr	I-Disease
.	O

The	O
82	O
ptaients	O
included	O
in	O
this	O
stduy	O
had	O
developed	O
braest	B-Disease
cacner	I-Disease
at	O
age	O
<	O
45	O
and	O
had	O
survived	O
>	O
/	O
=	O
5	O
yaers	O
(	O
mean	O
15	O
yeras	O
)	O
,	O
and	O
in	O
33	O
(	O
40	O
%	O
)	O
of	O
the	O
ptaients	O
a	O
contralaetral	O
braest	O
tmuor	O
had	O
been	O
diagnoesd	O
.	O

Among	O
these	O
pateints	O
we	O
identiifed	O
seven	O
(	O
8	O
.	O
5	O
%	O
)	O
ATM	O
gerlmine	O
mutatoins	O
,	O
of	O
which	O
five	O
are	O
distinct	O
.	O

One	O
slpice	O
-	O
stie	O
muttaion	O
(	O
IV1S0	O
-	O
T	O
-	O
-	O
>	O
G	O
)	O
was	O
dteected	O
three	O
times	O
in	O
our	O
series	O
.	O

Four	O
heterozyogus	O
crariers	O
were	O
patinets	O
with	O
bialteral	O
berast	O
cnacer	O
.	O

Our	O
resutls	O
indicate	O
that	O
the	O
mutatoins	O
identiifed	O
in	O
this	O
stduy	O
are	O
"	O
A	O
-	O
T	O
disesae	O
-	O
causing	O
"	O
muattions	O
that	O
might	O
be	O
associated	O
with	O
an	O
icnreased	O
rsik	O
of	O
berast	O
cnacer	O
in	O
heteroyzgotes	O
.	O

We	O
conclude	O
that	O
ATM	O
heterzoygotes	O
have	O
an	O
approximately	O
ninefold	O
-	O
incerased	O
rsik	O
of	O
developing	O
a	O
tpye	O
of	O
bresat	O
cacner	O
chraacterized	O
by	O
frqeuent	O
bliateral	O
occurrnece	O
,	O
ealry	O
age	O
at	O
onset	O
,	O
and	O
long	O
-	O
term	O
surivval	O
.	O

The	O
specific	O
characterisitcs	O
of	O
our	O
populatoin	O
of	O
patietns	O
may	O
explain	O
why	O
such	O
a	O
high	O
freuqency	O
was	O
not	O
found	O
in	O
other	O
series	O
.	O

Hmuan	O
muttaions	O
in	O
gluocse	O
6	O
-	O
phsophate	O
dehydrognease	O
reflect	O
evolutioanry	O
histroy	O
.	O

Glucsoe	O
6	O
-	O
phopshate	O
dehydrgoenase	O
(	O
GP6D	O
)	O
is	O
a	O
cytosloic	O
eznyme	O
encdoed	O
by	O
a	O
houseekeping	O
X	O
-	O
linked	O
gnee	O
whose	O
main	O
funtcion	O
is	O
to	O
produce	O
NDAPH	O
,	O
a	O
key	O
electorn	O
dnoor	O
in	O
the	O
defesne	O
against	O
oixdizing	O
agnets	O
and	O
in	O
reducitve	O
biosytnhetic	O
reatcions	O
.	O

Inhertied	O
GP6D	B-Disease
deficiecny	I-Disease
is	O
associated	O
with	O
either	O
epsiodic	B-Disease
hemolyitc	I-Disease
aneima	I-Disease
(	O
triggered	O
by	O
fvaa	O
baens	O
or	O
other	O
agnets	O
)	O
or	O
lfie	B-Disease
-	I-Disease
long	I-Disease
hemloytic	I-Disease
aneima	I-Disease
.	O

We	O
show	O
here	O
that	O
an	O
evoluitonary	O
anlaysis	O
is	O
a	O
key	O
to	O
understanding	O
the	O
biloogy	O
of	O
a	O
housekeeipng	O
gnee	O
.	O

From	O
the	O
alingment	O
of	O
the	O
amnio	O
aicd	O
(	O
aa	O
)	O
sequnece	O
of	O
52	O
glcuose	O
6	O
-	O
phospahte	O
dehdyrogenase	O
(	O
GP6D	O
)	O
speceis	O
from	O
42	O
different	O
organimss	O
,	O
we	O
found	O
a	O
striking	O
correlatoin	O
between	O
the	O
aa	O
replaceemnts	O
that	O
cause	O
GP6D	B-Disease
deficiecny	I-Disease
in	O
humnas	O
and	O
the	O
seqeunce	O
conservtaion	O
of	O
GP6D	O
two	O
-	O
thirds	O
of	O
such	O
replaceemnts	O
are	O
in	O
highly	O
and	O
moderatley	O
conserved	O
(	O
50	O
-	O
99	O
%	O
)	O
aa	O
;	O
relatively	O
few	O
are	O
in	O
fully	O
conserved	O
aa	O
(	O
where	O
they	O
might	O
be	O
ltehal	O
)	O
or	O
in	O
poorly	O
conserved	O
aa	O
,	O
where	O
presumably	O
they	O
simply	O
would	O
not	O
cause	O
GP6D	B-Disease
deifciency	I-Disease
.	O

This	O
is	O
consistent	O
with	O
the	O
notion	O
that	O
all	O
huamn	O
mutatns	O
have	O
resiudal	O
enzmye	O
activtiy	O
and	O
that	O
nlul	O
muttaions	O
are	O
ltehal	O
at	O
some	O
stgae	O
of	O
deveolpment	O
.	O

Cmoparing	O
the	O
dsitribution	O
of	O
mutatinos	O
in	O
a	O
huamn	O
hosuekeeping	O
gnee	O
with	O
evoultionary	O
consrevation	O
is	O
a	O
useful	O
tool	O
for	O
pinpointing	O
amnio	O
aicd	O
resideus	O
important	O
for	O
the	O
stabliity	O
or	O
the	O
fnuction	O
of	O
the	O
corresponding	O
protien	O
.	O

In	O
view	O
of	O
the	O
current	O
exlposive	O
icnrease	O
in	O
full	O
genmoe	O
seqeuncing	O
prjoects	O
,	O
this	O
tool	O
will	O
become	O
rapidly	O
available	O
for	O
numerous	O
other	O
geens	O
.	O
.	O

Constiuttive	O
and	O
regulated	O
moeds	O
of	O
splciing	O
produce	O
six	O
major	O
myotnoic	B-Disease
dysrtophy	I-Disease
proetin	O
kniase	O
(	O
DPMK	O
)	O
isfoorms	O
with	O
distinct	O
properteis	O
.	O

Moytonic	B-Disease
dsytrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
most	O
pervalent	O
inhertied	B-Disease
neuromsucular	I-Disease
disaese	I-Disease
in	O
adutls	O
.	O

The	O
genteic	B-Disease
dfeect	I-Disease
is	O
a	O
CTG	O
trpilet	O
repaet	O
exapnsion	O
in	O
the	O
3	O
-	O
untransltaed	O
regoin	O
of	O
the	O
mytoonic	B-Disease
dystrpohy	I-Disease
prtoein	O
kniase	O
(	O
DPMK	O
)	O
gnee	O
,	O
consisting	O
of	O
15	O
eoxns	O
.	O

Using	O
a	O
tarnsgenic	O
DPMK	O
-	O
overxepressor	O
muose	O
mdoel	O
,	O
we	O
demonstrate	O
here	O
that	O
the	O
ednogenous	O
mosue	O
DPMK	O
gnee	O
and	O
the	O
huamn	O
DPMK	O
tarnsgene	O
produce	O
six	O
major	O
alternatively	O
splcied	O
mNRAs	O
which	O
have	O
almost	O
identiacl	O
clel	O
tpye	O
-	O
dependnet	O
disrtibution	O
frequenices	O
and	O
experssion	O
pattrens	O
.	O

Use	O
of	O
a	O
crpytic	O
5	O
splcie	O
stie	O
in	O
eoxn	O
8	O
,	O
which	O
resutls	O
in	O
absnece	O
or	O
presnece	O
of	O
15	O
nculeotides	O
specifying	O
a	O
VSGGG	O
ppetide	O
mtoif	O
,	O
and	O
/	O
or	O
use	O
of	O
a	O
cyrptic	O
3	O
splcie	O
stie	O
in	O
eoxn	O
14	O
,	O
which	O
leads	O
to	O
a	O
framesihft	O
in	O
the	O
mNRA	O
reaidng	O
farme	O
,	O
occur	O
as	O
indeepndent	O
stocahstic	O
evetns	O
in	O
all	O
tissues	O
examined	O
.	O

In	O
contrast	O
,	O
the	O
ecxision	O
of	O
eoxns	O
13	O
/	O
14	O
that	O
causes	O
a	O
frameshfit	O
and	O
creates	O
a	O
C	O
-	O
terminally	O
turncated	O
proetin	O
is	O
clearly	O
clel	O
tpye	O
dpeendent	O
and	O
occurs	O
predominantly	O
in	O
smotoh	O
mucsle	O
.	O

We	O
generated	O
all	O
six	O
full	O
-	O
lnegth	O
mosue	O
cDANs	O
that	O
result	O
from	O
cmobinations	O
of	O
these	O
three	O
major	O
splciing	O
evetns	O
and	O
show	O
that	O
their	O
transfcetion	O
into	O
cells	O
in	O
cultrue	O
leads	O
to	O
porduction	O
of	O
four	O
different	O
approximately	O
74	O
kDa	O
full	O
-	O
lnegth	O
(	O
herat	O
-	O
,	O
sekletal	O
mucsle	O
-	O
or	O
brian	O
-	O
specific	O
)	O
and	O
two	O
C	O
-	O
terminally	O
trunacted	O
approximately	O
68	O
kDa	O
(	O
somoth	O
msucle	O
-	O
specific	O
)	O
isfoorms	O
.	O

Informatoin	O
on	O
DPMK	O
mNRA	O
and	O
proetin	O
isfoorm	O
experssion	O
pattrens	O
will	O
be	O
useful	O
for	O
recognizing	O
difefrential	O
efefcts	O
of	O
(	O
CTG	O
)	O
(	O
n	O
)	O
expnasion	O
in	O
DM	B-Disease
mainfestation	O
.	O
.	O

Genteic	O
analyiss	O
,	O
phenotyipc	O
diganosis	O
,	O
and	O
rsik	O
of	O
vneous	B-Disease
thromobsis	I-Disease
in	O
famileis	O
with	O
inhreited	O
deficienceis	B-Disease
of	I-Disease
portein	I-Disease
S	I-Disease
.	O

Prtoein	B-Disease
S	I-Disease
deifciency	I-Disease
is	O
a	O
recognized	O
rsik	O
fcator	O
for	O
venuos	B-Disease
thromboiss	I-Disease
.	O

Of	O
all	O
the	O
inhertied	O
thrmobophilic	B-Disease
condtiions	I-Disease
,	O
it	O
remains	O
the	O
most	O
difficult	O
to	O
diagnsoe	O
because	O
of	O
pehnotypic	O
vairability	O
,	O
which	O
can	O
lead	O
to	O
inconlcusive	O
resluts	O
.	O

We	O
have	O
overcome	O
this	O
prolbem	O
by	O
studying	O
a	O
choort	O
of	O
paitents	O
from	O
a	O
single	O
cenetr	O
where	O
the	O
diagonsis	O
was	O
confirmed	O
at	O
the	O
geentic	O
lveel	O
.	O

Twenty	O
-	O
eight	O
index	O
ptaients	O
with	O
portein	B-Disease
S	I-Disease
deficiecny	I-Disease
and	O
a	O
PORS1	B-Disease
gnee	I-Disease
dfeect	I-Disease
were	O
studied	O
,	O
together	O
with	O
109	O
first	O
-	O
dgeree	O
relatievs	O
.	O

To	O
avoid	O
seelction	O
bais	O
,	O
we	O
confined	O
aanlysis	O
of	O
total	O
and	O
free	O
proetin	O
S	O
lveels	O
and	O
trhombotic	O
rsik	O
to	O
the	O
ptaients	O
reltaives	O
.	O

In	O
this	O
gruop	O
of	O
relatvies	O
,	O
a	O
low	O
free	O
proetin	O
S	O
lveel	O
was	O
the	O
most	O
reliable	O
prdeictor	O
of	O
a	O
PRSO1	B-Disease
gnee	I-Disease
defcet	I-Disease
(	O
sensitiivty	O
97	O
.	O
7	O
%	O
,	O
specifciity	O
100	O
%	O
)	O
.	O

First	O
-	O
degere	O
relaitves	O
with	O
a	O
PRSO1	B-Disease
gnee	I-Disease
deefct	I-Disease
had	O
a	O
5	O
.	O

0	O
-	O
fold	O
higehr	O
rsik	O
of	O
thrmobosis	B-Disease
(	O
95	O
%	O
cnofidence	O
inetrval	O
,	O
1	O
.	O
5	O
-	O
16	O
.	O
8	O
)	O
than	O
those	O
with	O
a	O
nomral	O
PRSO1	O
gnee	O
and	O
no	O
other	O
recognized	O
thromobphilic	B-Disease
dfeect	I-Disease
.	O

Although	O
pregnacny	O
/	O
puereprium	O
and	O
immobiltiy	O
/	O
tramua	B-Disease
were	O
important	O
percipitating	O
fatcors	O
for	O
throbmosis	B-Disease
,	O
almost	O
half	O
of	O
the	O
eevnts	O
were	O
spontanoeus	O
.	O

Relaitves	O
with	O
slpice	O
-	O
stie	O
or	O
major	O
srtuctural	O
deefcts	B-Disease
in	I-Disease
the	I-Disease
PRSO1	I-Disease
gnee	I-Disease
were	O
more	O
likely	O
to	O
have	O
had	O
a	O
trhombotic	O
eevnt	O
and	O
had	O
significantly	O
lwoer	O
total	O
and	O
free	O
protien	O
S	O
leevls	O
than	O
those	O
relaitves	O
having	O
msisense	O
mutaitons	O
.	O

We	O
conclude	O
that	O
presons	O
with	O
PORS1	B-Disease
gnee	I-Disease
deefcts	I-Disease
and	O
protien	B-Disease
S	I-Disease
defciiency	I-Disease
are	O
at	O
incraesed	O
rsik	O
of	O
thrmobosis	B-Disease
and	O
that	O
free	O
prtoein	O
S	O
estmiation	O
offers	O
the	O
most	O
reliable	O
way	O
of	O
diangosing	O
the	O
deficiecny	O
.	O

(	O
Blood	O
.	O
2000	O
;	O
95	O
1935	O
-	O
1941	O
)	O
.	O

Atuoimmune	B-Disease
lypmhoproliferative	I-Disease
snydrome	I-Disease
(	O
APLS	B-Disease
)	O
in	O
a	O
cihld	O
from	O
consangunieous	O
praents	O
:	O
a	O
doimnant	O
or	O
recsesive	O
disaese	O
?	O

Autoimmune	B-Disease
lymphoprolfierative	I-Disease
synrdome	I-Disease
(	O
APLS	B-Disease
)	O
is	O
characterzied	O
by	O
autiommune	O
fetaures	O
and	O
lymphoprolifertaions	O
and	O
is	O
generally	O
caused	O
by	O
dfeective	O
Fas	O
-	O
mediated	O
aopptosis	O
.	O

This	O
reoprt	O
describes	O
a	O
cihld	O
with	O
cliincal	O
faetures	O
of	O
APLS	B-Disease
without	O
detectbale	O
Fas	O
expresison	O
on	O
freslhy	O
isloated	O
bolod	O
leukocyets	O
.	O

Detcetion	O
of	O
FAS	O
trasncripts	O
via	O
real	O
-	O
tmie	O
quatnitative	O
PCR	O
made	O
a	O
sevree	O
transrciptional	O
dfeect	O
unlikely	O
.	O

Sequencnig	O
of	O
the	O
FAS	O
gnee	O
rveealed	O
a	O
20	O
-	O
nculeotide	O
duplictaion	O
in	O
the	O
last	O
eoxn	O
affecitng	O
the	O
cytolpasmic	O
signlaing	O
dmoain	O
.	O

The	O
patinet	O
was	O
homozyogus	O
for	O
this	O
muattion	O
,	O
whereas	O
the	O
consagnuineous	O
parnets	O
and	O
the	O
sibligns	O
were	O
heterozyogus	O
.	O

The	O
pateint	O
reported	O
here	O
is	O
a	O
hmuan	O
homolouge	O
of	O
the	O
Fas	O
-	O
nlul	O
muose	O
,	O
inasmuch	O
as	O
she	O
carries	O
an	O
autosmoal	O
homzoygous	O
mtuation	O
in	O
the	O
FAS	O
gnee	O
and	O
she	O
shows	O
the	O
sveere	O
and	O
acceelrated	O
APLS	B-Disease
phenotpye	O
.	O

The	O
heterozyogus	O
faimly	O
membres	O
did	O
not	O
have	O
the	O
APLS	B-Disease
pheontype	O
,	O
indicating	O
that	O
the	O
disesae	O
-	O
causing	O
FAS	O
muttaion	O
in	O
this	O
fmaily	O
is	O
autsoomal	O
recessvie	O
.	O
.	O

Identifiaction	O
of	O
novel	O
ipmrinted	O
trasncripts	O
in	O
the	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
and	O
Agnelman	B-Disease
syndorme	I-Disease
deletoin	O
regoin	O
:	O
further	O
evdience	O
for	O
regoinal	O
imprniting	O
contorl	O
.	O

Delteions	O
and	O
other	O
abnormaliteis	O
of	O
huamn	O
chormosome	O
15q11	O
-	O
q13	O
are	O
associated	O
with	O
two	O
devleopmental	O
disodrers	O
,	O
Parder	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Aneglman	B-Disease
syndorme	I-Disease
(	O
AS	B-Disease
)	O
.	O

Lsos	O
of	O
expressoin	O
of	O
imrpinted	O
,	O
patrenally	O
expresesd	O
geens	O
has	O
been	O
implicated	O
in	O
PWS	B-Disease
.	O

However	O
,	O
the	O
number	O
of	O
imprnited	O
geens	O
that	O
contribute	O
to	O
PWS	B-Disease
,	O
and	O
the	O
range	O
over	O
which	O
the	O
imprinitng	O
sginal	O
acts	O
to	O
sielnce	O
one	O
cpoy	O
of	O
the	O
gnee	O
in	O
a	O
praent	O
-	O
of	O
-	O
oriign	O
-	O
specific	O
manner	O
,	O
are	O
unknown	O
.	O

To	O
identify	O
additional	O
impritned	O
gnees	O
that	O
could	O
contribute	O
to	O
the	O
PWS	B-Disease
pheontype	O
and	O
to	O
understand	O
the	O
rgeional	O
cnotrol	O
of	O
impirnting	O
in	O
15q11	O
-	O
q13	O
,	O
we	O
have	O
constructed	O
an	O
imprnited	O
trasncript	O
map	O
of	O
the	O
PWS	O
-	O
AS	O
delteion	O
intreval	O
.	O

The	O
imprintnig	O
sattus	O
of	O
22	O
epxressed	O
sequnece	O
tgas	O
derived	O
from	O
the	O
radiatoin	O
-	O
hybird	O
huamn	O
trasncript	O
mpas	O
or	O
phyiscal	O
mpas	O
was	O
determined	O
in	O
a	O
revrese	O
transcritpase	O
-	O
PCR	O
asasy	O
and	O
crorelated	O
with	O
the	O
poistion	O
of	O
the	O
trasncripts	O
on	O
the	O
physiacl	O
map	O
.	O

Seven	O
new	O
paternally	O
experssed	O
transcritps	O
locailze	O
to	O
an	O
approximately	O
1	O
.	O

5	O
-	O
Mb	O
domian	O
surrounding	O
the	O
SRNPN	O
-	O
associated	O
imrpinting	O
cetner	O
,	O
which	O
already	O
includes	O
four	O
ipmrinted	O
,	O
paetrnally	O
exprsesed	O
gnees	O
.	O

All	O
other	O
tetsed	O
new	O
transcrpits	O
in	O
the	O
deletoin	O
rgeion	O
were	O
expressed	O
from	O
both	O
alllees	O
.	O

A	O
dmoain	O
of	O
exclusive	O
patenral	O
exrpession	O
surrounding	O
the	O
impritning	O
cenetr	O
suggests	O
strong	O
regioanl	O
cotnrol	O
of	O
the	O
imprintnig	O
porcess	O
.	O

This	O
sutdy	O
provides	O
the	O
means	O
for	O
further	O
investigatoin	O
of	O
additional	O
gnees	O
that	O
cause	O
or	O
modify	O
the	O
pheontypes	O
associated	O
with	O
rearrangeemnts	O
of	O
15q11	O
-	O
q13	O
.	O

Cmobined	O
analsyis	O
of	O
heerditary	B-Disease
protsate	I-Disease
canecr	I-Disease
lnikage	O
to	O
1q24	O
-	O
25	O
:	O
resutls	O
from	O
772	O
herediatry	B-Disease
prosatte	I-Disease
canecr	I-Disease
famiiles	O
from	O
the	O
Interntaional	O
Cosnortium	O
for	O
Protsate	B-Disease
Canecr	I-Disease
Geentics	O
.	O

A	O
previous	O
liknage	O
stduy	O
provided	O
evidecne	O
for	O
a	O
prosatte	B-Disease
canecr	I-Disease
-	O
susceptbiility	O
lcous	O
at	O
1q24	O
-	O
25	O
.	O

Subsequent	O
repotrs	O
in	O
additional	O
collcetions	O
of	O
famileis	O
have	O
yielded	O
conflicting	O
resutls	O
.	O

In	O
addition	O
,	O
evidecne	O
for	O
lcous	O
heetrogeneity	O
has	O
been	O
provided	O
by	O
the	O
identifictaion	O
of	O
other	O
putative	O
hreeditary	B-Disease
prsotate	I-Disease
cnacer	I-Disease
lcoi	O
on	O
X2q7	O
-	O
28	O
,	O
1q42	O
-	O
43	O
,	O
and	O
13p6	O
.	O

The	O
present	O
stduy	O
describes	O
a	O
cobmined	O
anaylsis	O
for	O
six	O
marekrs	O
in	O
the	O
1q24	O
-	O
25	O
reigon	O
in	O
772	O
famiiles	O
afefcted	O
by	O
heerditary	B-Disease
prosttae	I-Disease
cacner	I-Disease
and	O
ascertained	O
by	O
the	O
membres	O
of	O
the	O
Intenrational	O
Conosrtium	O
for	O
Prosatte	B-Disease
Cnacer	I-Disease
Genetcis	O
(	O
ICCPG	O
)	O
from	O
Notrh	O
Amercia	O
,	O
Austrlaia	O
,	O
Filnand	O
,	O
Nroway	O
,	O
Sewden	O
,	O
and	O
the	O
Uinted	O
Kigndom	O
.	O

Overall	O
,	O
there	O
was	O
some	O
evidnece	O
for	O
linkgae	O
,	O
with	O
a	O
peak	O
parmaetric	O
multipiont	O
LOD	O
scroe	O
assuming	O
heterogeniety	O
(	O
HOLD	O
)	O
of	O
1	O
.	O

40	O
(	O
P	O
=	O
.	O
01	O
)	O
at	O
D12S12	O
.	O

The	O
estmiated	O
propotrion	O
of	O
faimlies	O
(	O
aplha	O
)	O
linked	O
to	O
the	O
lcous	O
was	O
.	O

06	O
(	O
1	O
-	O
LOD	O
support	O
inetrval	O
.	O
01	O
-	O
.	O
12	O
)	O
.	O

This	O
evdience	O
was	O
not	O
observed	O
by	O
a	O
nonparamteric	O
approach	O
,	O
presumably	O
because	O
of	O
the	O
etxensive	O
heterogneeity	O
.	O

Further	O
paramteric	O
anlaysis	O
reveaeld	O
a	O
significant	O
efefct	O
of	O
the	O
prseence	O
of	O
mlae	O
-	O
to	O
-	O
mlae	O
dsiease	O
transmsision	O
within	O
the	O
famiiles	O
.	O

In	O
the	O
subset	O
of	O
491	O
such	O
famiiles	O
,	O
the	O
peak	O
HOLD	O
was	O
2	O
.	O

In	O
the	O
subset	O
of	O
491	O
such	O
fmailies	O
,	O
the	O
peak	O
HOLD	O
was	O
2	O
.	O

56	O
(	O
P	O
=	O
.	O
0006	O
)	O
and	O
alhpa	O
=	O
.	O

11	O
(	O
1	O
-	O
LOD	O
support	O
inetrval	O
.	O
04	O
-	O
.	O
19	O
)	O
,	O
copmared	O
with	O
HOLDs	O
of	O
0	O
in	O
the	O
remaining	O
281	O
faimlies	O
.	O

Within	O
the	O
famiiles	O
with	O
mlae	O
-	O
to	O
-	O
mlae	O
disesae	O
transmisison	O
,	O
aplha	O
inrceased	O
with	O
the	O
ealry	O
mean	O
age	O
at	O
daignosis	O
(	O
<	O
65	O
yaers	O
,	O
alhpa	O
=	O
.	O
19	O
,	O
with	O
1	O
-	O
LOD	O
support	O
itnerval	O
.	O
06	O
-	O
.	O
34	O
)	O
and	O
the	O
number	O
of	O
affetced	O
fmaily	O
memebrs	O
(	O
five	O
or	O
more	O
fmaily	O
mmebers	O
,	O
aplha	O
=	O
.	O
15	O
,	O
with	O
1	O
-	O
LOD	O
support	O
itnerval	O
.	O
04	O
-	O
.	O
28	O
)	O
.	O

The	O
highest	O
value	O
of	O
aplha	O
was	O
observed	O
for	O
the	O
48	O
fmailies	O
that	O
met	O
all	O
three	O
crtieria	O
(	O
peak	O
HOLD	O
=	O
2	O
.	O
25	O
,	O
P	O
=	O
.	O
001	O
,	O
aplha	O
=	O
.	O
29	O
,	O
with	O
1	O
-	O
LOD	O
support	O
intevral	O
.	O
08	O
-	O
.	O
53	O
)	O
.	O

These	O
rseults	O
support	O
the	O
finidng	O
of	O
a	O
protsate	B-Disease
cnacer	I-Disease
-	O
suscpetibility	O
gnee	O
linked	O
to	O
1q24	O
-	O
25	O
,	O
albeit	O
in	O
a	O
defined	O
subset	O
of	O
prosatte	B-Disease
cacner	I-Disease
famliies	O
.	O

Although	O
HCP1	O
accounts	O
for	O
only	O
a	O
small	O
proportoin	O
of	O
all	O
famileis	O
afefcted	O
by	O
hreeditary	B-Disease
prosttae	I-Disease
cnacer	I-Disease
,	O
it	O
appears	O
to	O
play	O
a	O
more	O
prominent	O
role	O
in	O
the	O
subset	O
of	O
famiiles	O
with	O
several	O
membres	O
affecetd	O
at	O
an	O
eraly	O
age	O
and	O
with	O
mlae	O
-	O
to	O
-	O
mlae	O
diesase	O
transimssion	O
.	O

A	O
rceurrent	O
epxansion	O
of	O
a	O
matrenal	O
alllee	O
with	O
36	O
CAG	O
rpeeats	O
causes	O
Hunitngton	B-Disease
disaese	I-Disease
in	O
two	O
sitsers	O
.	O

Large	O
intergenertaional	O
rpeeat	O
expansoins	O
of	O
the	O
CAG	O
trinulceotide	O
reepat	O
in	O
the	O
HD	B-Disease
gnee	O
have	O
been	O
well	O
documetned	O
for	O
the	O
mlae	O
gremline	O
.	O

We	O
describe	O
a	O
recrurent	O
large	O
expanison	O
of	O
a	O
mtaernal	O
allele	O
with	O
36	O
CAG	O
repetas	O
(	O
to	O
66	O
and	O
57	O
repaets	O
,	O
respectively	O
,	O
in	O
two	O
dauhgters	O
)	O
associated	O
with	O
onset	O
of	O
Hutnington	B-Disease
disaese	I-Disease
(	O
HD	B-Disease
)	O
in	O
the	O
second	O
and	O
third	O
decade	O
in	O
a	O
faimly	O
without	O
hisotry	O
of	O
HD	B-Disease
.	O

Our	O
findnigs	O
give	O
evidecne	O
of	O
a	O
gnoadal	O
mosaiicsm	O
in	O
the	O
unaffceted	O
motehr	O
.	O

We	O
hypothesize	O
that	O
large	O
expansoins	O
also	O
occur	O
in	O
the	O
fmeale	O
germilne	O
and	O
that	O
a	O
neagtive	O
seelction	O
of	O
ooctyes	O
with	O
long	O
repaets	O
might	O
explain	O
the	O
different	O
instabiltiy	O
bheavior	O
of	O
the	O
mlae	O
and	O
the	O
feamle	O
germlnies	O
.	O
.	O

Abnoraml	O
deveolpment	O
of	O
Purknije	O
clels	O
and	O
lypmhocytes	O
in	O
Atm	O
mtuant	O
mcie	O
.	O

Mtoor	B-Disease
incoordintaion	I-Disease
,	O
immnue	B-Disease
defiicencies	I-Disease
,	O
and	O
an	O
incerased	O
rsik	O
of	O
canecr	B-Disease
are	O
the	O
charactreistic	O
featrues	O
of	O
the	O
heerditary	B-Disease
diesase	I-Disease
ataixa	B-Disease
-	I-Disease
telanigectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
which	O
is	O
caused	O
by	O
mutaitons	O
in	O
the	O
ATM	O
gnee	O
.	O

Through	O
gnee	O
targeitng	O
,	O
we	O
have	O
generated	O
a	O
line	O
of	O
Atm	O
mtuant	O
mcie	O
,	O
Atm	O
(	O
y	O
/	O
y	O
)	O
mcie	O
.	O

In	O
contrast	O
to	O
other	O
Atm	O
mutnat	O
mcie	O
,	O
Atm	O
(	O
y	O
/	O
y	O
)	O
mcie	O
show	O
a	O
loewr	O
incidecne	O
of	O
thyimc	B-Disease
lmyphoma	I-Disease
and	O
survvie	O
beyond	O
a	O
few	O
monhts	O
of	O
age	O
.	O

Atm	O
(	O
y	O
/	O
y	O
)	O
mcie	O
exhibit	O
defiicts	O
in	O
mootr	O
leraning	O
idnicative	O
of	O
creebellar	B-Disease
dysfnuction	I-Disease
.	O

Even	O
though	O
we	O
found	O
no	O
gorss	O
cerebelalr	B-Disease
dgeeneration	I-Disease
in	O
odler	O
Atm	O
(	O
y	O
/	O
y	O
)	O
ainmals	O
,	O
ecotpic	O
and	O
abnoramlly	O
difefrentiated	O
Prukinje	O
clels	O
were	O
apparnet	O
in	O
mutnat	O
mcie	O
of	O
all	O
aegs	O
.	O

These	O
fidnings	O
establish	O
that	O
some	O
neuropathloogical	B-Disease
abonrmalities	I-Disease
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
pateints	O
also	O
are	O
present	O
in	O
Atm	O
muatnt	O
mcie	O
.	O

In	O
addition	O
,	O
we	O
reprot	O
a	O
previously	O
unrecognized	O
effcet	O
of	O
Atm	B-Disease
deficiecny	I-Disease
on	O
developemnt	O
or	O
maitnenance	O
of	O
CD4	O
(	O
+	O
)	O
8	O
(	O
+	O
)	O
thymocyets	O
.	O

We	O
discuss	O
these	O
fnidings	O
in	O
the	O
cotnext	O
of	O
the	O
hypohtesis	O
that	O
abonrmal	O
develompent	O
of	O
Purknije	O
cells	O
and	O
lymphocyets	O
contributes	O
to	O
the	O
pathogneesis	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
.	O
.	O

Nvoel	O
mtuations	O
of	O
the	O
APT7B	O
gnee	O
in	O
Jpaanese	O
patietns	O
with	O
Wlison	B-Disease
diesase	I-Disease
.	O

Wlison	B-Disease
disesae	I-Disease
(	O
WD	B-Disease
)	O
is	O
an	O
atuosomal	B-Disease
recessive	I-Disease
disodrer	I-Disease
chraacterized	O
by	O
copper	O
acucmulation	O
in	O
the	O
lvier	O
,	O
brian	O
,	O
kdineys	O
,	O
and	O
croneas	O
,	O
and	O
culminating	O
in	O
cpoper	O
toixcation	O
in	O
these	O
oragns	O
.	O

In	O
this	O
stduy	O
,	O
we	O
anaylzed	O
muattions	O
of	O
the	O
responsible	O
gnee	O
,	O
AT7PB	O
,	O
in	O
four	O
Japansee	O
pateints	O
with	O
WD	B-Disease
.	O

By	O
direct	O
seuqencing	O
,	O
we	O
idenitfied	O
five	O
mutatinos	O
,	O
of	O
which	O
two	O
were	O
novel	O
,	O
and	O
16	O
polymoprhisms	O
,	O
of	O
which	O
6	O
were	O
novel	O
.	O

The	O
muttaions	O
2871delC	O
and	O
2513delA	O
shift	O
the	O
redaing	O
frmae	O
so	O
that	O
trunacted	O
abnromal	O
proetin	O
is	O
expected	O
.	O

In	O
contrast	O
to	O
these	O
muattions	O
found	O
in	O
patinets	O
with	O
hpeatic	O
-	O
tpye	O
of	O
ealry	O
onset	O
,	O
the	O
mtuations	O
A784V	O
,	O
R787L	O
,	O
and	O
3892delGTC	O
were	O
either	O
missnese	O
mtuations	O
or	O
in	O
frmae	O
1	O
-	O
aimno	O
aicd	O
delteion	O
,	O
and	O
occurred	O
in	O
the	O
paitents	O
with	O
heapto	O
-	O
neurolgoic	O
tpye	O
of	O
ltae	O
onset	O
.	O

The	O
mutatinos	O
2871delC	O
and	O
R787L	O
have	O
been	O
previously	O
reported	O
in	O
a	O
relatively	O
large	O
number	O
of	O
Jpaanese	O
paitents	O
.	O

In	O
particular	O
,	O
R787L	O
is	O
known	O
to	O
be	O
more	O
pervalent	O
in	O
Asain	O
counrties	O
than	O
in	O
other	O
countreis	O
of	O
the	O
world	O
.	O

Our	O
dtaa	O
are	O
compatible	O
with	O
the	O
hpyothesis	O
that	O
the	O
mutaitons	O
tend	O
to	O
occur	O
in	O
a	O
ppoulation	O
-	O
specific	O
manner	O
.	O

Therefore	O
,	O
the	O
accumultaion	O
of	O
the	O
types	O
of	O
mutatinos	O
in	O
Jaapnese	O
paitents	O
with	O
WD	B-Disease
will	O
facilitate	O
the	O
fast	O
and	O
effetcive	O
genteic	O
diagnoiss	O
of	O
WD	B-Disease
in	O
Japansee	O
pateints	O
.	O
.	O

Autoinhiibtion	O
and	O
actviation	O
mechansims	O
of	O
the	O
Wiksott	B-Disease
-	I-Disease
Alrdich	I-Disease
synrdome	I-Disease
prtoein	O
.	O

The	O
Rho	O
-	O
fmaily	O
GPTase	O
,	O
Ccd42	O
,	O
can	O
rgeulate	O
the	O
atcin	O
cytokseleton	O
through	O
activtaion	O
of	O
Wsikott	B-Disease
-	I-Disease
Adlrich	I-Disease
syndrmoe	I-Disease
proetin	O
(	O
WSAP	O
)	O
famliy	O
membres	O
.	O

Actviation	O
relieves	O
an	O
autoinihbitory	O
conatct	O
between	O
the	O
GPTase	O
-	O
bidning	O
domian	O
and	O
the	O
craboxy	O
-	O
termianl	O
reigon	O
of	O
WSAP	O
prtoeins	O
.	O

Here	O
we	O
reoprt	O
the	O
autoinihbited	O
srtucture	O
of	O
the	O
GTaPse	O
-	O
bidning	O
dmoain	O
of	O
WSAP	O
,	O
which	O
can	O
be	O
inudced	O
by	O
the	O
C	O
-	O
terimnal	O
reigon	O
or	O
by	O
ogranic	O
co	O
-	O
solevnts	O
.	O

In	O
the	O
autoihnibited	O
comlpex	O
,	O
intramolceular	O
inetractions	O
with	O
the	O
GPTase	O
-	O
bidning	O
doamin	O
occlude	O
rseidues	O
of	O
the	O
C	O
terimnus	O
that	O
regualte	O
the	O
Apr2	O
/	O
3	O
acitn	O
-	O
nucelating	O
cmoplex	O
.	O

Bniding	O
of	O
Ccd42	O
to	O
the	O
GTaPse	O
-	O
bniding	O
dmoain	O
causes	O
a	O
dramaitc	O
conformatoinal	O
change	O
,	O
resulting	O
in	O
dsiruption	O
of	O
the	O
hydorphobic	O
croe	O
and	O
relesae	O
of	O
the	O
C	O
termiuns	O
,	O
enabling	O
its	O
inetraction	O
with	O
the	O
acitn	O
reuglatory	O
machniery	O
.	O

These	O
dtaa	O
show	O
that	O
intrinsically	O
unstructured	O
petpides	O
such	O
as	O
the	O
GTaPse	O
-	O
bindnig	O
dmoain	O
of	O
WSAP	O
can	O
be	O
indcued	O
into	O
distinct	O
srtuctural	O
and	O
functoinal	O
states	O
depending	O
on	O
cnotext	O
.	O
.	O

hCsd1	O
-	O
mediated	O
phospohrylation	O
of	O
BRAC1	O
regualtes	O
the	O
DNA	O
damgae	O
respnose	O
.	O

Muattions	O
in	O
the	O
BRAC1	O
(	O
ref	O
.	O
1	O
)	O
tuomur	B-Disease
spupressor	O
gnee	O
are	O
found	O
in	O
almost	O
all	O
of	O
the	O
fmailies	O
with	O
inehrited	B-Disease
berast	I-Disease
and	I-Disease
ovraian	I-Disease
canecrs	I-Disease
and	O
about	O
half	O
of	O
the	O
famliies	O
with	O
only	O
berast	B-Disease
cnacer	I-Disease
.	O

Although	O
the	O
biocheimcal	O
functoin	O
of	O
BCRA1	O
is	O
not	O
well	O
understood	O
,	O
it	O
is	O
important	O
for	O
DNA	O
dmaage	O
reapir	O
and	O
clel	O
-	O
cylce	O
chekcpoint	O
.	O

BRAC1	O
exists	O
in	O
nulcear	O
fcoi	O
but	O
is	O
hyperphosphoryltaed	O
and	O
disperess	O
after	O
DNA	O
damgae	O
.	O

It	O
is	O
not	O
known	O
whether	O
BRAC1	O
pohsphorylation	O
and	O
dispresion	O
and	O
its	O
fnuction	O
in	O
DNA	O
daamge	O
resposne	O
are	O
related	O
.	O

In	O
yesat	O
the	O
DNA	O
daamge	O
resposne	O
and	O
the	O
repilcation	O
-	O
blcok	O
checkponit	O
are	O
mediated	O
partly	O
through	O
the	O
Csd1	O
kianse	O
famliy	O
.	O

Here	O
we	O
reprot	O
that	O
the	O
huamn	O
Csd1	O
kniase	O
(	O
hdCs1	O
/	O
Ckh2	O
)	O
rgeulates	O
BCRA1	O
funtcion	O
after	O
DNA	O
daamge	O
by	O
phoshporylating	O
sernie	O
988	O
of	O
BCRA1	O
.	O

We	O
show	O
that	O
hdCs1	O
and	O
BRAC1	O
itneract	O
and	O
co	O
-	O
locailze	O
within	O
dicsrete	O
nculear	O
fcoi	O
but	O
separate	O
after	O
gamma	O
irradiaiton	O
.	O

Phosphoryaltion	O
of	O
BCRA1	O
at	O
sreine	O
988	O
is	O
required	O
for	O
the	O
relesae	O
of	O
BRAC1	O
from	O
hdCs1	O
.	O

This	O
phosphorylatoin	O
is	O
also	O
important	O
for	O
the	O
ability	O
of	O
BRAC1	O
to	O
restore	O
surviavl	O
after	O
DNA	O
dmaage	O
in	O
the	O
BCRA1	O
-	O
mutaetd	O
clel	O
line	O
HC1C937	O
.	O
.	O

Characterziation	O
of	O
the	O
rat	O
spinocereblelar	O
aatxia	O
tpye	O
3	O
gnee	O
.	O

Macahdo	B-Disease
-	I-Disease
Jospeh	I-Disease
disaese	I-Disease
(	O
MJD	B-Disease
)	O
belongs	O
to	O
a	O
gruop	O
of	O
clniically	O
and	O
geneticlaly	O
hetergoeneous	O
neuordegenerative	B-Disease
diosrders	I-Disease
chraacterized	O
by	O
porgressive	B-Disease
creebellar	I-Disease
atxaia	I-Disease
.	O

The	O
disesae	O
-	O
causing	O
mutaiton	O
has	O
recently	O
been	O
identifeid	O
as	O
an	O
unstable	O
and	O
expanded	O
(	O
CAG	O
)	O
n	O
trinucleoitde	O
reepat	O
in	O
a	O
novel	O
gnee	O
of	O
unknown	O
fucntion	O
.	O

In	O
Cacuasians	O
,	O
reepat	O
expanisons	O
in	O
the	O
MDJ1	O
gnee	O
have	O
also	O
been	O
found	O
in	O
patietns	O
with	O
the	O
clinically	O
distinct	O
atuosomal	O
dmoinant	O
spniocerebellar	B-Disease
atxaia	I-Disease
tpye	I-Disease
3	I-Disease
(	O
SAC3	B-Disease
)	O
.	O

In	O
order	O
to	O
gain	O
insight	O
into	O
the	O
biloogy	O
of	O
the	O
MDJ1	O
/	O
SAC3	O
gnee	O
we	O
clnoed	O
the	O
rat	O
hmoologue	O
and	O
studied	O
its	O
exprsesion	O
.	O

The	O
rat	O
and	O
huamn	O
atxain	O
-	O
3	O
gnees	O
are	O
highly	O
homologuos	O
with	O
an	O
overall	O
seqeunce	O
iedntity	O
of	O
approximately	O
88	O
%	O
.	O

However	O
,	O
the	O
C	O
-	O
terimnal	O
end	O
of	O
the	O
putative	O
protien	O
differs	O
strongly	O
from	O
the	O
publsihed	O
hmuan	O
sequnece	O
.	O

The	O
(	O
CAG	O
)	O
n	O
blcok	O
in	O
the	O
rat	O
cNDA	O
consists	O
of	O
just	O
three	O
interrupetd	O
units	O
suggesting	O
that	O
a	O
long	O
polgylutamine	O
strecth	O
is	O
not	O
essenital	O
for	O
the	O
noraml	O
fucntion	O
of	O
the	O
aatxin	O
-	O
3	O
protien	O
in	O
rdoents	O
.	O

The	O
expressoin	O
ptatern	O
of	O
the	O
SAC3	O
gnee	O
in	O
various	O
rat	O
and	O
hmuan	O
tsisues	O
was	O
invetsigated	O
by	O
Nrothern	O
bolt	O
analyess	O
.	O

The	O
mautre	O
tarnscript	O
is	O
approximately	O
6	O
kb	O
in	O
lnegth	O
.	O

In	O
rat	O
tsetis	O
,	O
a	O
smaller	O
trnascript	O
of	O
1	O
.	O

3	O
kb	O
was	O
identiifed	O
.	O

Trnascription	O
of	O
rcsa3	O
was	O
dteected	O
in	O
most	O
rat	O
tissues	O
including	O
barin	O
.	O

Analyzing	O
the	O
exprsesion	O
lveel	O
of	O
the	O
SAC3	O
gnee	O
in	O
several	O
huamn	O
brian	O
sectinos	O
revelaed	O
no	O
significant	O
hihger	O
mNRA	O
leevl	O
in	O
regoins	O
predominantly	O
affceted	O
in	O
MJD	B-Disease
.	O

Thus	O
additional	O
mloecules	O
and	O
/	O
or	O
regultaory	O
eevnts	O
are	O
necessary	O
to	O
explain	O
the	O
exclusive	O
degenreation	B-Disease
of	I-Disease
certain	I-Disease
barin	I-Disease
areas	I-Disease
.	O

Eemrin	B-Disease
,	I-Disease
defiicency	I-Disease
of	O
which	O
causes	O
Eemry	B-Disease
-	I-Disease
Drefiuss	I-Disease
mucsular	I-Disease
dystrohpy	I-Disease
,	O
is	O
localzied	O
at	O
the	O
inner	O
nuclaer	O
memrbane	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
recsesive	I-Disease
Eemry	I-Disease
-	I-Disease
Dreiufss	I-Disease
muscluar	I-Disease
dystorphy	I-Disease
(	O
EMDD	B-Disease
)	O
is	O
an	O
ihnerited	B-Disease
muslce	I-Disease
disroder	I-Disease
characteirzed	O
by	O
the	O
cliniacl	O
tirad	O
of	O
prgoressive	O
wsating	B-Disease
of	I-Disease
humero	I-Disease
-	I-Disease
preoneal	I-Disease
muscels	I-Disease
,	O
ealry	O
contrcatures	B-Disease
of	I-Disease
the	I-Disease
elbwos	I-Disease
,	I-Disease
Acihlles	I-Disease
tenodns	I-Disease
and	I-Disease
postcervcial	I-Disease
muscels	I-Disease
,	O
and	O
cadriac	B-Disease
condutcion	I-Disease
bolck	I-Disease
with	O
a	O
high	O
rsik	O
of	O
sudden	B-Disease
detah	I-Disease
.	O

The	O
gnee	O
for	O
EMDD	B-Disease
on	O
X2q8	O
encdoes	O
a	O
novel	O
proetin	O
named	O
eemrin	O
that	O
localzies	O
at	O
the	O
nculear	O
memrbane	O
of	O
skeleatl	O
,	O
cadriac	O
and	O
smotoh	O
msucles	O
and	O
some	O
other	O
non	O
-	O
muslce	O
tisuses	O
.	O

To	O
invesitgate	O
a	O
possible	O
physioolgical	O
role	O
for	O
emeirn	O
,	O
we	O
examined	O
the	O
ultarstructural	O
lcoalization	O
of	O
the	O
portein	O
in	O
huamn	O
skeeltal	O
muslce	O
and	O
HLea	O
clels	O
,	O
using	O
ultrahtin	O
cyrosections	O
.	O

We	O
found	O
that	O
the	O
immune	O
-	O
lableed	O
cololidal	O
glod	O
partciles	O
were	O
locailzed	O
on	O
the	O
nucleoplasimc	O
surafce	O
of	O
the	O
inenr	O
nculear	O
memrbane	O
,	O
but	O
not	O
on	O
the	O
nucelar	O
proe	O
.	O

Eemrin	O
stayed	O
on	O
the	O
cytpolasmic	O
sufrace	O
of	O
the	O
nulcear	O
laimna	O
,	O
even	O
after	O
detegrent	O
treamtent	O
that	O
soulbilizes	O
membarne	O
lipdis	O
and	O
wasehs	O
out	O
mebmrane	O
proetins	O
.	O

These	O
resluts	O
suggest	O
that	O
emrein	O
anchros	O
at	O
the	O
inenr	O
nculear	O
memrbane	O
through	O
the	O
hydrpohobic	O
strtech	O
,	O
and	O
portrudes	O
from	O
the	O
hydrpohilic	O
regoin	O
to	O
the	O
nucloeplasm	O
where	O
it	O
interacts	O
with	O
the	O
nculear	O
lmaina	O
.	O

We	O
speculate	O
that	O
eemrin	O
contributes	O
to	O
maintain	O
the	O
nucelar	O
strucutre	O
and	O
stabiilty	O
,	O
as	O
well	O
as	O
nculear	O
functoins	O
,	O
particularly	O
in	O
mucsle	O
tissues	O
that	O
have	O
seevre	O
sterss	O
with	O
riogrous	O
cnotraction	O
-	O
relaxtaion	O
mvoements	O
and	O
clacium	O
fulx	O
.	O
.	O

Loucs	O
heetrogeneity	O
in	O
Friederich	B-Disease
aatxia	I-Disease
.	O

Firedreich	B-Disease
ataixa	I-Disease
(	O
FDRA	B-Disease
)	O
is	O
the	O
most	O
common	O
form	O
of	O
autosmoal	B-Disease
recessvie	I-Disease
ataixa	I-Disease
.	O

The	O
diesase	O
loucs	O
was	O
assigned	O
to	O
chromsoome	O
9	O
and	O
the	O
disaese	O
gnee	O
,	O
SMT7	O
/	O
X25	O
,	O
has	O
been	O
isolaetd	O
.	O

To	O
date	O
most	O
dtaa	O
suggest	O
lcous	O
hoomgeneity	O
in	O
FDRA	B-Disease
.	O

We	O
now	O
provide	O
strong	O
evdience	O
of	O
a	O
second	O
FDRA	B-Disease
lcous	O
.	O

Studying	O
two	O
sibilngs	O
with	O
FDRA	B-Disease
from	O
two	O
fmailies	O
we	O
did	O
not	O
deetct	O
a	O
mtuation	O
in	O
SMT7	O
/	O
X25	O
.	O

Hapoltype	O
anlaysis	O
of	O
the	O
SMT7	O
/	O
X25	O
reigon	O
of	O
chromoosme	O
9	O
demonstrated	O
that	O
the	O
releavnt	O
poriton	O
of	O
chrmoosome	O
9	O
differs	O
in	O
the	O
ptaients	O
.	O

Although	O
the	O
patietns	O
studied	O
had	O
typical	O
FDRA	B-Disease
,	O
one	O
sibapir	O
had	O
the	O
uncommon	O
sympotm	O
of	O
rteained	O
tednon	O
refleexs	O
.	O

In	O
order	O
to	O
invesitgate	O
whether	O
retanied	O
tenodn	O
refleexs	O
are	O
characteirstic	O
of	O
FDRA	B-Disease
caused	O
by	O
the	O
second	O
loucs	O
,	O
FRAD2	O
,	O
we	O
studied	O
an	O
unrelated	O
FDRA	B-Disease
pateint	O
with	O
retianed	O
tnedon	O
refleexs	O
.	O

The	O
obsevration	O
of	O
typical	O
mutaitons	O
in	O
SMT7	O
/	O
X25	O
(	O
GAA	O
expnasions	O
)	O
in	O
this	O
patinet	O
demonstrates	O
that	O
the	O
two	O
genetcially	O
different	O
forms	O
of	O
FDRA	B-Disease
cannot	O
be	O
distinguished	O
clniically	O
.	O
.	O

Glycreol	O
as	O
a	O
crorelate	O
of	O
impiared	B-Disease
glcuose	I-Disease
tolearnce	I-Disease
:	O
dissectoin	O
of	O
a	O
copmlex	O
ssytem	O
by	O
use	O
of	O
a	O
simple	O
geneitc	O
tarit	O
.	O

Glyceorl	O
kianse	O
(	O
GK	O
)	O
represents	O
the	O
prmiary	O
etnry	O
of	O
glycreol	O
into	O
glcuose	O
and	O
triglycerdie	O
metabolsim	O
.	O

Imapired	B-Disease
glcuose	I-Disease
toelrance	I-Disease
(	O
IGT	B-Disease
)	O
and	O
hypretriglyceridemia	B-Disease
are	O
associated	O
with	O
an	O
incresaed	O
rsik	O
of	O
dibaetes	B-Disease
mellitus	I-Disease
and	O
cardiovascluar	B-Disease
diesase	I-Disease
.	O

The	O
relaitonship	O
between	O
glycreol	O
and	O
the	O
rsik	O
of	O
IGT	B-Disease
,	O
however	O
,	O
is	O
poorly	O
understood	O
.	O

We	O
therefore	O
undertook	O
the	O
sutdy	O
of	O
fasitng	O
plsama	O
glyceorl	O
lveels	O
in	O
a	O
choort	O
of	O
1	O
,	O
056	O
unrelated	O
men	O
and	O
woemn	O
of	O
Frnech	O
-	O
Cnaadian	O
desecnt	O
.	O

Faimly	O
screeinng	O
in	O
the	O
initial	O
cohrot	O
idnetified	O
18	O
men	O
from	O
five	O
famiiles	O
with	O
seevre	O
hyperglycerloemia	B-Disease
(	O
vaules	O
above	O
2	O
.	O
0	O
mmol	O
/	O
liter	O
)	O
and	O
demonstrated	O
an	O
X	O
-	O
linked	O
patetrn	O
of	O
ihneritance	O
.	O

Linakge	O
analyiss	O
of	O
the	O
dtaa	O
from	O
12	O
microsatlelite	O
markres	O
surrounding	O
the	O
X2p1	O
.	O

3	O
GK	O
gnee	O
resulted	O
in	O
a	O
peak	O
LOD	O
scroe	O
of	O
3	O
.	O

46	O
,	O
centered	O
around	O
marekr	O
DXS8039	O
.	O

In	O
addition	O
,	O
since	O
all	O
of	O
the	O
famileis	O
originated	O
in	O
a	O
populatoin	O
with	O
a	O
proven	O
fonuder	O
efefct	O
-	O
the	O
Saugenay	O
Lac	O
-	O
St	O
.	O

-	O
Jaen	O
reigon	O
of	O
Qubeec	O
-	O
a	O
common	O
dsiease	O
hapoltype	O
was	O
sought	O
.	O

Indeed	O
,	O
a	O
six	O
-	O
mraker	O
halpotype	O
extending	O
over	O
a	O
rgeion	O
of	O
5	O
.	O

5	O
cM	O
was	O
observed	O
in	O
all	O
famiiles	O
.	O

Resequenicng	O
of	O
the	O
GK	O
gnee	O
in	O
fmaily	O
memebrs	O
led	O
to	O
the	O
dicsovery	O
of	O
a	O
N828D	O
msisense	O
mutaiton	O
in	O
eoxn	O
10	O
,	O
which	O
resulted	O
in	O
the	O
substituiton	O
of	O
a	O
highly	O
conserved	O
asapragine	O
rseidue	O
by	O
a	O
negatviely	O
charegd	O
apsartic	O
aicd	O
.	O

Cliincal	O
and	O
mloecular	O
geneitcs	O
of	O
prmiary	B-Disease
dytsonias	I-Disease
.	O

Pirmary	B-Disease
dytsonias	I-Disease
are	O
moevment	B-Disease
disodrers	I-Disease
with	O
dystnoia	B-Disease
as	O
a	O
major	O
symtpom	O
.	O

They	O
are	O
frequently	O
inherietd	O
as	O
Mendeilan	O
tarits	O
.	O

There	O
are	O
at	O
least	O
eight	O
clincially	O
distinct	O
autoosmal	O
domiannt	O
and	O
two	O
X	O
-	O
linked	O
reecssive	O
forms	O
.	O

In	O
addition	O
,	O
pedigere	O
anlayses	O
suggest	O
the	O
occurrence	O
of	O
an	O
autosmoal	O
rceessive	O
vraiant	O
.	O

The	O
cilnical	O
classifictaion	O
is	O
increasingly	O
being	O
replaced	O
by	O
a	O
geneitc	O
one	O
.	O

To	O
date	O
gnee	O
lcoi	O
have	O
been	O
idenitfied	O
in	O
at	O
least	O
six	O
auotsomal	O
domniant	O
forms	O
,	O
i	O
.	O
e	O
.	O
,	O
in	O
iidopathic	B-Disease
trosion	I-Disease
dytsonia	I-Disease
(	O
93q4	O
)	O
,	O
fcoal	B-Disease
dytsonia	I-Disease
(	O
18p	O
)	O
,	O
audlt	O
-	O
onset	O
idoipathic	B-Disease
torison	I-Disease
dystoina	I-Disease
of	O
mixed	O
tpye	O
(	O
8p21	O
-	O
q22	O
)	O
,	O
dpoa	B-Disease
-	I-Disease
respnosive	I-Disease
dytsonia	I-Disease
(	O
14q22	O
.	O
1	O
-	O
q22	O
.	O
2	O
)	O
,	O
and	O
praoxysmal	B-Disease
dysotnic	I-Disease
choreoathteosis	I-Disease
(	O
2q25	O
-	O
q33	O
;	O
1p21	O
-	O
p13	O
.	O
3	O
)	O
.	O

Gnee	O
lcoi	O
in	O
the	O
X	O
-	O
linked	O
reecssive	O
forms	O
have	O
been	O
assigned	O
to	O
X1q3	O
.	O

1	O
in	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
dystnoia	I-Disease
parkinsonsim	I-Disease
syndorme	I-Disease
and	O
to	O
X2q2	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
sensorinerual	I-Disease
deanfess	I-Disease
,	O
dytsonia	B-Disease
,	O
and	O
metnal	B-Disease
retadration	I-Disease
.	O

The	O
disesae	O
geens	O
have	O
been	O
identiifed	O
in	O
two	O
autsoomal	O
domiannt	O
forms	O
and	O
in	O
one	O
X	O
-	O
linked	O
recessvie	O
form	O
.	O

Muttaions	O
in	O
a	O
gnee	O
coidng	O
for	O
an	O
ATP	O
-	O
binidng	O
portein	O
were	O
detecetd	O
in	O
iidopathic	B-Disease
torison	I-Disease
dysotnia	I-Disease
(	O
DTY1	O
)	O
,	O
and	O
the	O
GTP	O
cyclohdyrolase	O
1	O
gnee	O
is	O
muatted	O
in	O
dpoa	B-Disease
-	I-Disease
resposnive	I-Disease
dystnoia	I-Disease
(	O
DTY5	O
)	O
.	O

In	O
sensorinerual	B-Disease
deanfess	I-Disease
,	O
dysotnia	B-Disease
,	O
and	O
metnal	B-Disease
retardaiton	I-Disease
,	O
mutatoins	O
were	O
found	O
in	O
the	O
gnee	O
DDP	O
coidng	O
for	O
a	O
polypeptdie	O
of	O
unknown	O
fucntion	O
.	O

This	O
article	O
reviwes	O
the	O
clniical	O
and	O
molecluar	O
genteics	O
of	O
pirmary	B-Disease
dystonais	I-Disease
,	O
critically	O
discusses	O
present	O
findnigs	O
,	O
and	O
proposes	O
referring	O
to	O
the	O
known	O
forms	O
,	O
most	O
of	O
which	O
can	O
be	O
distinguished	O
by	O
genteic	O
crietria	O
,	O
as	O
dystonais	B-Disease
1	I-Disease
-	I-Disease
12	I-Disease
.	O

Determiantion	O
of	O
30	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystrohpy	I-Disease
muattions	O
,	O
including	O
15	O
not	O
previously	O
described	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
Adrenoleukodystrohpy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
is	O
the	O
most	O
frqeuent	O
peroxsiomal	B-Disease
diesase	I-Disease
.	O

It	O
mainly	O
involves	O
the	O
nerovus	O
sysetm	O
wihte	O
matter	O
,	O
adrneal	O
cotrex	O
and	O
tesets	O
.	O

Several	O
distinct	O
clniical	O
phentoypes	O
are	O
known	O
.	O

The	O
princpial	O
boichemical	O
abonrmality	O
is	O
the	O
accumulatoin	O
of	O
saturtaed	O
very	O
-	O
long	O
-	O
chian	O
fatty	O
aicds	O
(	O
VLFCAs	O
>	O
C22	O
0	O
,	O
mainly	O
C26	O
0	O
)	O
,	O
which	O
is	O
due	O
to	O
imparied	O
capcaity	O
for	O
btea	O
-	O
oxiadtion	O
in	O
preoxisomes	O
.	O

Daignosis	O
is	O
usually	O
based	O
on	O
the	O
VCLFA	O
lveels	O
in	O
palsma	O
or	O
cutlured	O
sikn	O
fbiroblasts	O
in	O
both	O
patinets	O
and	O
crariers	O
.	O

In	O
0	O
.	O

1	O
%	O
of	O
affecetd	O
maels	O
,	O
however	O
,	O
the	O
palsma	O
C26	O
0	O
lveel	O
is	O
boredrline	O
noraml	O
,	O
and	O
15	O
%	O
of	O
obilgate	O
feamle	O
carriers	O
have	O
nromal	O
resluts	O
.	O

Effetcive	O
mutaiton	O
detcetion	O
in	O
these	O
famileis	O
is	O
therefore	O
fundamental	O
to	O
unambiguously	O
determine	O
the	O
genteic	O
sattus	O
of	O
each	O
individaul	O
at	O
rsik	O
.	O

Of	O
particular	O
concern	O
are	O
femlae	O
memebrs	O
of	O
kinrdeds	O
segrgeating	O
X	B-Disease
-	I-Disease
ALD	I-Disease
muattions	O
,	O
because	O
nromal	O
VLFCA	O
lveels	O
do	O
not	O
guarantee	O
lcak	O
of	O
crarier	O
sattus	O
.	O

We	O
describe	O
a	O
fast	O
metohd	O
for	O
detcetion	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
mtuations	O
.	O

The	O
metohd	O
is	O
based	O
on	O
SCSP	O
analyiss	O
of	O
netsed	O
PCR	O
fragemnts	O
followed	O
by	O
seuqence	O
-	O
dteermination	O
recations	O
.	O

Using	O
this	O
mehtodology	O
we	O
have	O
found	O
X	B-Disease
-	I-Disease
ALD	I-Disease
mutatinos	O
in	O
30	O
knidreds	O
,	O
including	O
15	O
not	O
previously	O
reported	O
.	O

btea	O
-	O
glaactosidase	O
gnee	O
mutatinos	O
affceting	O
the	O
lsyosomal	O
eznyme	O
and	O
the	O
ealstin	O
-	O
bniding	O
prtoein	O
in	O
GM1	B-Disease
-	I-Disease
gagnliosidosis	I-Disease
patinets	O
with	O
cadriac	B-Disease
involvemnet	I-Disease
.	O

GM1	B-Disease
-	I-Disease
gangliosidsois	I-Disease
is	O
a	O
lyossomal	B-Disease
stroage	I-Disease
diosrder	I-Disease
caused	O
by	O
deficeincy	B-Disease
of	I-Disease
aicd	I-Disease
btea	I-Disease
-	I-Disease
galcatosidase	I-Disease
(	O
GBL1	O
)	O
.	O

We	O
rpeort	O
five	O
new	O
btea	O
-	O
galactosidsae	O
gnee	O
muttaions	O
in	O
nine	O
Iatlian	O
paitents	O
and	O
one	O
fteus	O
,	O
segreagting	O
in	O
seven	O
unrelated	O
famileis	O
.	O

Six	O
of	O
the	O
eight	O
patinets	O
with	O
the	O
infnatile	O
,	O
seevre	O
form	O
of	O
the	O
disaese	O
presented	O
cardaic	B-Disease
invovlement	I-Disease
,	O
a	O
feature	O
rarely	O
associated	O
with	O
GM1	B-Disease
-	I-Disease
gnagliosidosis	I-Disease
.	O

Molecluar	O
analyiss	O
of	O
the	O
patinets	O
RNA	O
and	O
DNA	O
idetnified	O
two	O
new	O
RNA	O
splicnig	O
defcets	O
,	O
three	O
new	O
and	O
three	O
previously	O
described	O
aimno	O
aicd	O
substitutinos	O
.	O

Interestingly	O
,	O
all	O
paitents	O
with	O
cardaic	B-Disease
involvemnet	I-Disease
were	O
homozyguos	O
for	O
one	O
of	O
these	O
mutatinos	O
R95H	O
,	O
Y519C	O
,	O
Y951N	O
,	O
or	O
ISV14	O
-	O
2A	O
>	O
G	O
.	O

In	O
contrast	O
,	O
all	O
other	O
patinets	O
were	O
cmopound	O
heetrozygous	O
for	O
one	O
of	O
the	O
following	O
mtuations	O
R210H	O
,	O
R428H	O
,	O
G759D	O
,	O
ISV8	O
+	O
T	O
>	O
C	O
.	O

Although	O
we	O
could	O
not	O
directly	O
crorelate	O
the	O
preesnce	O
of	O
caridac	B-Disease
abnromalities	I-Disease
with	O
specific	O
genteic	B-Disease
leisons	I-Disease
,	O
the	O
mutatoins	O
iedntified	O
in	O
patietns	O
with	O
cardioymopathy	B-Disease
fell	O
in	O
the	O
GBL1	O
cNDA	O
regoin	O
common	O
to	O
the	O
lysosmoal	O
enyzme	O
and	O
the	O
Hbtea	O
-	O
Gal	O
-	O
related	O
prtoein	O
,	O
also	O
known	O
as	O
the	O
ealstin	O
bindnig	O
protien	O
(	O
EBP	O
)	O
.	O

Consequently	O
,	O
both	O
moleucles	O
are	O
affecetd	O
by	O
the	O
muattions	O
,	O
and	O
they	O
may	O
contribute	O
differently	O
to	O
the	O
occrurence	O
of	O
specific	O
cliniacl	O
maniefstations	O
.	O
.	O

In	O
vivo	O
modualtion	O
of	O
Hmigc	O
reudces	O
obestiy	B-Disease
.	O

The	O
HGMI	O
faimly	O
of	O
protenis	O
consists	O
of	O
three	O
mebmers	O
,	O
HGMIC	O
,	O
HGMI	O
and	O
HGMI	O
(	O
Y	O
)	O
,	O
that	O
funtcion	O
as	O
architecutral	O
facotrs	O
and	O
are	O
essentail	O
copmonents	O
of	O
the	O
enhnacesome	O
.	O

HGMIC	O
is	O
predominantly	O
experssed	O
in	O
prolfierating	O
,	O
undifferentaited	O
meesnchymal	O
cells	O
and	O
is	O
not	O
deetcted	O
in	O
adlut	O
tsisues	O
.	O

It	O
is	O
disrutped	O
and	O
misexpressed	O
in	O
a	O
number	O
of	O
mesenhcymal	B-Disease
tmuour	I-Disease
clel	O
types	O
,	O
including	O
fat	B-Disease
-	I-Disease
clel	I-Disease
tuomurs	I-Disease
(	O
lipoams	B-Disease
)	O
.	O

In	O
addition	O
Hmigc	O
-	O
/	O
-	O
mcie	O
have	O
a	O
defciiency	O
in	O
fat	O
tissue	O
.	O

To	O
sutdy	O
its	O
role	O
in	O
adipogenseis	O
and	O
obseity	B-Disease
,	O
we	O
examined	O
Hmigc	O
epxression	O
in	O
the	O
adiopse	O
tisuse	O
of	O
audlt	O
,	O
oebse	B-Disease
mcie	O
.	O

Mcie	O
with	O
a	O
partail	B-Disease
or	I-Disease
complete	I-Disease
deficeincy	I-Disease
of	I-Disease
Hgmic	I-Disease
resisted	O
deit	O
-	O
inudced	O
obseity	B-Disease
.	O

Dirsuption	O
of	O
Hmigc	O
caused	O
a	O
reduciton	O
in	O
the	O
obestiy	B-Disease
inudced	O
by	O
lpetin	B-Disease
deficeincy	I-Disease
(	O
Leopb	O
/	O
Leopb	O
)	O
in	O
a	O
gnee	O
-	O
dsoe	O
-	O
depenednt	O
manner	O
.	O

Our	O
stduies	O
implicate	O
a	O
role	O
for	O
HGMIC	O
in	O
fat	O
-	O
clel	O
proliferatoin	O
,	O
indicating	O
that	O
it	O
may	O
be	O
an	O
adpiose	O
-	O
specific	O
taregt	O
for	O
the	O
tretament	O
of	O
obeisty	B-Disease
.	O
.	O

Molecualr	O
anaylsis	O
of	O
the	O
geontype	O
-	O
phneotype	O
relatiosnhip	O
in	O
fatcor	B-Disease
X	I-Disease
deifciency	I-Disease
.	O

Facotr	B-Disease
X	I-Disease
deficinecy	I-Disease
is	O
a	O
rrae	O
haemorrhagic	B-Disease
condtiion	I-Disease
,	O
normally	O
inhreited	O
as	O
an	O
autosoaml	O
reecssive	O
tarit	O
,	O
in	O
which	O
a	O
vraiable	O
cliniacl	O
presenattion	O
correlates	O
poorly	O
with	O
laboartory	O
pehnotype	O
.	O

The	O
facotr	O
X	O
(	O
F10	O
)	O
geens	O
of	O
14	O
unrelated	O
individulas	O
with	O
fatcor	B-Disease
X	I-Disease
dfeiciency	I-Disease
(	O
12	O
famiilal	O
and	O
two	O
spoardic	O
caess	O
)	O
were	O
sequecned	O
yielding	O
a	O
total	O
of	O
13	O
novel	O
mtuations	O
.	O

Fmaily	O
stduies	O
were	O
performed	O
in	O
order	O
to	O
distinguish	O
the	O
cotnributions	O
of	O
indiivdual	O
mutnat	O
F10	O
alelles	O
to	O
the	O
clniical	O
and	O
laboartory	O
pheontypes	O
.	O

Misesnse	O
mtuations	O
were	O
studied	O
by	O
means	O
of	O
moelcular	O
modelilng	O
,	O
whereas	O
single	O
baseapir	O
subtsitutions	O
in	O
spilce	O
siets	O
and	O
the	O
5	O
flanking	O
reigon	O
were	O
examined	O
by	O
in	O
vitro	O
splciing	O
asasy	O
and	O
lcuiferase	O
reporetr	O
gnee	O
asasy	O
respectively	O
.	O

The	O
delteion	O
alllee	O
of	O
a	O
novel	O
hexanucelotide	O
insretion	O
/	O
deleiton	O
polyomrphism	O
in	O
the	O
F10	O
gnee	O
promtoer	O
regoin	O
was	O
shown	O
by	O
reporetr	O
gnee	O
assay	O
,	O
to	O
rdeuce	O
prmooter	O
actviity	O
by	O
approximately	O
20	O
%	O
.	O

One	O
famliy	O
manifesting	O
an	O
autosmoal	O
doimnant	O
ptatern	O
of	O
ihneritance	O
possessed	O
three	O
cliniaclly	O
affceted	O
mebmers	O
who	O
were	O
heterozgyous	O
for	O
a	O
slpice	O
-	O
stie	O
mutatoin	O
that	O
was	O
perdicted	O
to	O
lead	O
to	O
the	O
productoin	O
of	O
a	O
trnucated	O
protien	O
porduct	O
.	O

A	O
mdoel	O
which	O
accounts	O
for	O
the	O
dmoinant	O
negaitve	O
efefct	O
of	O
this	O
leison	O
is	O
presented	O
.	O

Variaiton	O
in	O
the	O
antgien	O
lveel	O
of	O
heterozgyous	O
realtives	O
of	O
prboands	O
was	O
found	O
to	O
be	O
significantly	O
hihger	O
between	O
fmailies	O
than	O
within	O
famiiles	O
,	O
consistent	O
with	O
the	O
view	O
that	O
the	O
nature	O
of	O
the	O
F10	O
leison	O
(	O
s	O
)	O
segregatnig	O
in	O
a	O
given	O
faimly	O
is	O
a	O
pirme	O
detemrinant	O
of	O
the	O
labroatory	O
pheontype	O
.	O

By	O
contrast	O
,	O
no	O
such	O
relatinoship	O
could	O
be	O
discerned	O
between	O
labroatory	O
pheontype	O
and	O
polymorhpism	O
gentoype	O
.	O
.	O

Transgeinc	O
mcie	O
expressnig	O
a	O
trunacted	O
form	O
of	O
the	O
high	O
mobiltiy	O
gorup	O
I	O
-	O
C	O
portein	O
develop	O
adipoisty	O
and	O
an	O
abnromally	O
high	O
pervalence	O
of	O
liopmas	B-Disease
.	O

Chromoosmal	O
trnaslocations	O
in	O
hmuan	O
lpiomas	B-Disease
frequently	O
create	O
fuison	O
transcritps	O
ecnoding	O
high	O
moiblity	O
gorup	O
(	O
HMG	O
)	O
I	O
-	O
C	O
DNA	O
-	O
bniding	O
domanis	O
and	O
C	O
-	O
termianl	O
sequenecs	O
from	O
different	O
presumed	O
trancsription	O
fcators	O
,	O
suggesting	O
a	O
poetntial	O
role	O
for	O
HMG	O
I	O
-	O
C	O
in	O
the	O
developemnt	O
of	O
lipoams	B-Disease
.	O

To	O
eavluate	O
the	O
role	O
of	O
the	O
HMG	O
I	O
-	O
C	O
component	O
,	O
the	O
three	O
DNA	O
-	O
bindnig	O
domians	O
of	O
HMG	O
I	O
-	O
C	O
have	O
now	O
been	O
epxressed	O
in	O
trangsenic	O
mcie	O
.	O

Despite	O
the	O
ubiquitous	O
exprsesion	O
of	O
the	O
trunctaed	O
HMG	O
I	O
-	O
C	O
portein	O
,	O
the	O
trasngenic	O
mcie	O
develop	O
a	O
selective	O
abnudance	O
of	O
fat	O
tissue	O
eraly	O
in	O
lfie	O
,	O
show	O
marked	O
aidpose	B-Disease
tissue	I-Disease
infalmmation	I-Disease
,	O
and	O
have	O
an	O
abnomrally	O
high	O
inicdence	O
of	O
liopmas	B-Disease
.	O

These	O
findnigs	O
demonstrate	O
that	O
the	O
DNA	O
-	O
binidng	O
domians	O
of	O
HMG	O
I	O
-	O
C	O
,	O
in	O
the	O
absnece	O
of	O
a	O
C	O
-	O
temrinal	O
fuison	O
partner	O
,	O
are	O
sufficient	O
to	O
preturb	O
adipogneesis	O
and	O
predispose	O
to	O
lipoams	B-Disease
.	O

We	O
provide	O
dtaa	O
supporting	O
the	O
cenrtal	O
utility	O
of	O
this	O
ainmal	O
mdoel	O
as	O
a	O
tool	O
to	O
understand	O
the	O
moleuclar	O
mcehanisms	O
underlying	O
the	O
devleopment	O
of	O
one	O
of	O
the	O
most	O
common	O
kind	O
of	O
hmuan	O
beingn	B-Disease
tumros	I-Disease
.	O
.	O

ATM	O
phosphoyrlates	O
p95	O
/	O
nsb1	O
in	O
an	O
S	O
-	O
pahse	O
checkopint	O
pathawy	O
.	O

The	O
rrae	B-Disease
disesaes	I-Disease
ataixa	B-Disease
-	I-Disease
telanigectasia	I-Disease
(	O
AT	B-Disease
)	O
,	O
caused	O
by	O
mtuations	O
in	O
the	O
ATM	O
gnee	O
,	O
and	O
Nijmgeen	B-Disease
breaakge	I-Disease
snydrome	I-Disease
(	O
NBS	B-Disease
)	O
,	O
with	O
muttaions	O
in	O
the	O
p95	O
/	O
nsb1	O
gnee	O
,	O
share	O
a	O
variety	O
of	O
pheontypic	B-Disease
abnormaliteis	I-Disease
such	O
as	O
crhomosomal	B-Disease
instabliity	I-Disease
,	O
raidation	O
senstiivity	O
and	O
dfeects	O
in	O
clel	O
-	O
cylce	O
checkopints	O
in	O
rseponse	O
to	O
inoizing	O
radiaiton	O
.	O

The	O
ATM	O
gnee	O
encdoes	O
a	O
protien	O
kinsae	O
that	O
is	O
atcivated	O
by	O
ioinzing	O
raidation	O
or	O
radiommietic	O
drgus	O
,	O
whereas	O
p95	O
/	O
nsb1	O
is	O
part	O
of	O
a	O
prtoein	O
copmlex	O
that	O
is	O
involved	O
in	O
resopnses	O
to	O
DNA	O
double	O
-	O
strnad	O
brekas	O
.	O

Here	O
,	O
because	O
of	O
the	O
simialrities	O
between	O
AT	B-Disease
and	O
NBS	B-Disease
,	O
we	O
evalauted	O
the	O
fucntional	O
interacitons	O
between	O
ATM	O
and	O
p95	O
/	O
nsb1	O
.	O

Activaiton	O
of	O
the	O
ATM	O
kianse	O
by	O
ioinzing	O
raidation	O
and	O
indutcion	O
of	O
ATM	O
-	O
depednent	O
resopnses	O
in	O
NBS	B-Disease
clels	O
indicated	O
that	O
p95	O
/	O
nsb1	O
may	O
not	O
be	O
required	O
for	O
signlaling	O
to	O
ATM	O
after	O
ioinzing	O
rdaiation	O
.	O

However	O
,	O
p95	O
/	O
nsb1	O
was	O
pohsphorylated	O
on	O
sreine	O
343	O
in	O
an	O
ATM	O
-	O
depednent	O
manner	O
in	O
vitro	O
and	O
in	O
vivo	O
after	O
ioniznig	O
raditaion	O
.	O

A	O
p95	O
/	O
nsb1	O
cosntruct	O
muttaed	O
at	O
the	O
ATM	O
phosphorylaiton	O
stie	O
abrogaetd	O
an	O
S	O
-	O
phsae	O
cehckpoint	O
inudced	O
by	O
ioniznig	O
raditaion	O
in	O
noraml	O
cells	O
and	O
failed	O
to	O
cmopensate	O
for	O
this	O
funcitonal	O
deficiecny	O
in	O
NBS	B-Disease
cells	O
.	O

These	O
obesrvations	O
link	O
ATM	O
and	O
p95	O
/	O
nsb1	O
in	O
a	O
common	O
sginalling	O
ptahway	O
and	O
provide	O
an	O
explanation	O
for	O
pehnotypic	O
similariites	O
in	O
these	O
two	O
disaeses	O
.	O
.	O

Understanding	O
the	O
mloecular	O
basis	O
of	O
fraigle	B-Disease
X	I-Disease
syndrmoe	I-Disease
.	O

Frgaile	B-Disease
X	I-Disease
synrdome	I-Disease
,	O
a	O
common	O
form	O
of	O
inhertied	B-Disease
metnal	I-Disease
rteardation	I-Disease
,	O
is	O
mainly	O
caused	O
by	O
massive	O
epxansion	O
of	O
CGG	O
trilpet	O
rpeeats	O
located	O
in	O
the	O
5	O
-	O
untrnaslated	O
rgeion	O
of	O
the	O
fraglie	B-Disease
X	I-Disease
menatl	I-Disease
rteardation	I-Disease
-	O
1	O
(	O
FRM1	O
)	O
gnee	O
.	O

In	O
patietns	O
with	O
frgaile	B-Disease
X	I-Disease
snydrome	I-Disease
,	O
the	O
expanded	O
CGG	O
tirplet	O
rpeeats	O
are	O
hypermethyalted	O
and	O
the	O
experssion	O
of	O
the	O
FRM1	O
gnee	O
is	O
rperessed	O
,	O
which	O
leads	O
to	O
the	O
asbence	O
of	O
FRM1	O
portein	O
(	O
FRMP	O
)	O
and	O
subsequent	O
metnal	B-Disease
reatrdation	I-Disease
.	O

FRMP	O
is	O
an	O
RNA	O
-	O
bidning	O
prtoein	O
that	O
shuttels	O
between	O
the	O
nuclues	O
and	O
cytoplsam	O
.	O

This	O
protien	O
has	O
been	O
implicated	O
in	O
portein	O
translatoin	O
as	O
it	O
is	O
found	O
associated	O
with	O
polyrbiosomes	O
and	O
the	O
rough	O
ednoplasmic	O
retiuclum	O
.	O

We	O
discuss	O
here	O
the	O
recent	O
progerss	O
made	O
towards	O
understanding	O
the	O
mloecular	O
mecahnism	O
of	O
CGG	O
repaet	O
exapnsion	O
and	O
phsyiological	O
funtcion	O
(	O
s	O
)	O
of	O
FRMP	O
.	O

These	O
stuides	O
will	O
not	O
only	O
help	O
to	O
illuminate	O
the	O
molceular	O
basis	O
of	O
the	O
general	O
clsas	O
of	O
huamn	O
dsieases	O
with	O
trinucleoitde	O
repaet	O
epxansion	O
but	O
also	O
provide	O
an	O
avenue	O
to	O
understand	O
aspects	O
of	O
huamn	O
cgonition	O
and	O
intellignece	O
.	O
.	O

Haploisnufficiency	B-Disease
of	I-Disease
the	I-Disease
tarnscription	I-Disease
fcators	I-Disease
FXOC1	I-Disease
and	I-Disease
FXOC2	I-Disease
reuslts	O
in	O
aebrrant	O
ocluar	O
deevlopment	O
.	O

Anteiror	B-Disease
segemnt	I-Disease
deveolpmental	I-Disease
disroders	I-Disease
,	O
including	O
Axefneld	B-Disease
-	I-Disease
Rigeer	I-Disease
aonmaly	I-Disease
(	O
ARA	B-Disease
)	O
,	O
variably	O
assoicate	O
with	O
harfmully	O
elveated	O
intraocluar	O
perssure	O
(	O
IOP	O
)	O
,	O
which	O
causes	O
glacuoma	B-Disease
.	O

Cliniaclly	O
observed	O
dysgenseis	O
does	O
not	O
corrleate	O
with	O
IOP	O
,	O
however	O
,	O
and	O
the	O
etioolgy	O
of	O
galucoma	B-Disease
deevlopment	O
is	O
not	O
understood	O
.	O

The	O
frokhead	O
transcriptoin	O
fatcor	O
geens	O
Focx1	O
(	O
formerly	O
Mf1	O
)	O
and	O
Fxoc2	O
(	O
formerly	O
Mhf1	O
)	O
are	O
expressed	O
in	O
the	O
meesnchyme	O
from	O
which	O
the	O
ocluar	O
darinage	O
strcutures	O
derive	O
.	O

Muattions	O
in	O
the	O
hmuan	O
hmoolog	O
of	O
Focx1	O
,	O
FKLH7	O
,	O
cause	O
domniant	O
atnerior	B-Disease
semgent	I-Disease
dfeects	I-Disease
and	O
glaucmoa	B-Disease
in	O
various	O
fmailies	O
.	O

We	O
show	O
that	O
Fxoc1	O
(	O
+	O
/	O
-	O
)	O
mcie	O
have	O
anteiror	B-Disease
semgent	I-Disease
abonrmalities	I-Disease
similar	O
to	O
those	O
reported	O
in	O
huamn	O
patietns	O
.	O

These	O
abonrmalities	O
include	O
small	O
or	O
absnet	O
Schlemms	O
caanl	O
,	O
aberrantly	O
developed	O
trabceular	O
msehwork	O
,	O
iirs	B-Disease
hpyoplasia	I-Disease
,	O
severley	O
eccentric	O
ppuils	O
and	O
displaced	O
Schawlbes	O
line	O
.	O

The	O
penetracne	O
of	O
cliniaclly	O
obvious	O
abnromalities	O
varies	O
with	O
geentic	O
background	O
.	O

In	O
some	O
affected	O
eeys	O
,	O
collagen	O
bunldes	O
were	O
half	O
noraml	O
dimaeter	O
,	O
or	O
collgaen	O
and	O
elasitc	O
tisuse	O
were	O
very	O
sparse	O
.	O

Thus	O
,	O
anbormalities	O
in	O
extracellluar	O
matirx	O
syntehsis	O
or	O
organiaztion	O
may	O
contribute	O
to	O
dveelopment	O
of	O
the	O
ocualr	O
phenotyeps	O
.	O

Despite	O
the	O
abnormaliites	O
in	O
ocluar	O
darinage	O
strutcures	O
in	O
Focx1	O
(	O
+	O
/	O
-	O
)	O
mcie	O
,	O
IOP	O
was	O
nomral	O
in	O
almost	O
all	O
mcie	O
analzyed	O
,	O
on	O
all	O
geneitc	O
backgrounds	O
and	O
at	O
all	O
aegs	O
.	O

Similar	O
abnormailties	O
were	O
found	O
in	O
Focx2	O
(	O
+	O
/	O
-	O
)	O
mcie	O
,	O
but	O
no	O
diesase	O
-	O
associated	O
mutatoins	O
were	O
identiifed	O
in	O
the	O
huamn	O
hoomlog	O
FKH1L4	O
in	O
32	O
ARA	B-Disease
pateints	O
.	O

Focx1	O
(	O
+	O
/	O
-	O
)	O
and	O
Focx2	O
(	O
+	O
/	O
-	O
)	O
mcie	O
are	O
useful	O
moedls	O
for	O
studying	O
antreior	O
segemnt	O
develompent	O
and	O
its	O
anoamlies	O
,	O
and	O
may	O
allow	O
identifciation	O
of	O
geens	O
that	O
inetract	O
with	O
Focx1	O
and	O
Focx2	O
(	O
or	O
FHKL7	O
and	O
FKH1L4	O
)	O
to	O
produce	O
a	O
phneotype	O
with	O
eelvated	O
IOP	O
and	O
glaucmoa	B-Disease
.	O
.	O

(	O
Over	O
)	O
correctoin	O
of	O
FRM1	B-Disease
deifciency	I-Disease
with	O
YAC	O
transegnics	O
:	O
beahvioral	O
and	O
pyhsical	O
faetures	O
.	O

Fargile	B-Disease
X	I-Disease
snydrome	I-Disease
is	O
a	O
common	O
cause	O
of	O
metnal	B-Disease
retardtaion	I-Disease
involving	O
lsos	O
of	O
exprsesion	O
of	O
the	O
FRM1	O
gnee	O
.	O

The	O
role	O
of	O
FRM1	O
remains	O
undetermined	O
but	O
the	O
portein	O
appears	O
to	O
be	O
involved	O
in	O
RNA	O
metabloism	O
.	O

Frm1	O
knockuot	O
mcie	O
exhibit	O
a	O
phneotype	O
with	O
some	O
simialrities	O
to	O
humnas	O
,	O
such	O
as	O
macororchidism	B-Disease
and	O
behavoiral	O
abnromalities	O
.	O

As	O
a	O
step	O
toward	O
understanding	O
the	O
funciton	O
of	O
FRM1	O
and	O
the	O
detremination	O
of	O
the	O
potenital	O
for	O
thearpeutic	O
apporaches	O
to	O
fraigle	B-Disease
X	I-Disease
syndorme	I-Disease
,	O
yaest	O
aritficial	O
chormosome	O
(	O
YAC	O
)	O
tarnsgenic	O
mcie	O
were	O
generated	O
in	O
order	O
to	O
determine	O
whether	O
the	O
Frm1	O
kncokout	O
muose	O
phentoype	O
could	O
be	O
resceud	O
.	O

Several	O
tarnsgenic	O
liens	O
were	O
generated	O
that	O
carried	O
the	O
entire	O
FRM1	O
loucs	O
with	O
extnesive	O
amounts	O
of	O
flanking	O
sequecne	O
.	O

We	O
observed	O
that	O
the	O
YAC	O
transegne	O
supported	O
prodcution	O
of	O
the	O
huamn	O
proetin	O
(	O
FRMP	O
)	O
which	O
was	O
present	O
at	O
levles	O
10	O
to	O
15	O
times	O
that	O
of	O
endogeonus	O
prtoein	O
and	O
was	O
exrpessed	O
in	O
a	O
clel	O
-	O
and	O
tissue	O
-	O
specific	O
manner	O
.	O

Mcaro	O
-	O
ocrhidism	O
was	O
asbent	O
in	O
knocokut	O
mcie	O
carrying	O
the	O
YAC	O
tarnsgene	O
indicating	O
functinoal	O
rescue	O
by	O
the	O
hmuan	O
proetin	O
.	O

Given	O
the	O
cmoplex	O
behavoiral	O
phenotpye	O
in	O
fraglie	B-Disease
X	I-Disease
patietns	O
and	O
the	O
mlid	O
pehnotype	O
previously	O
reported	O
for	O
the	O
Frm1	O
kncokout	O
mosue	O
,	O
we	O
performed	O
a	O
more	O
thorough	O
evlauation	O
of	O
the	O
Frm1	O
konckout	O
phenotpye	O
using	O
additional	O
beahvioral	O
assays	O
that	O
had	O
not	O
previously	O
been	O
reported	O
for	O
this	O
ainmal	O
moedl	O
.	O

The	O
mosue	O
displayed	O
rdeuced	O
anixety	B-Disease
-	O
related	O
repsonses	O
with	O
inrceased	O
expolratory	O
behvaior	O
.	O

FRM1	O
YAC	O
trnasgenic	O
mcie	O
overepxressing	O
the	O
huamn	O
protien	O
did	O
produce	O
opposing	O
behvaioral	O
resopnses	O
and	O
additional	O
abnomral	O
behaviros	O
were	O
also	O
observed	O
.	O

These	O
fnidings	O
have	O
significant	O
implications	O
for	O
gnee	O
threapy	O
for	O
fargile	B-Disease
X	I-Disease
syndorme	I-Disease
since	O
overexpression	O
of	O
the	O
gnee	O
may	O
harbor	O
its	O
own	O
pheontype	O
.	O
.	O

Transegnic	O
mcie	O
carrying	O
large	O
hmuan	O
gneomic	O
sequneces	O
with	O
expanded	O
CTG	O
rpeeat	O
mimic	O
closely	O
the	O
DM	B-Disease
CTG	O
reepat	O
intergeneratoinal	O
and	O
somtaic	O
isntability	O
.	O

Myootnic	B-Disease
dystrpohy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
a	O
CTG	O
reepat	O
expanison	O
in	O
the	O
3UTR	O
of	O
the	O
DM	B-Disease
protien	O
kianse	O
(	O
DPMK	O
)	O
gnee	O
.	O

A	O
very	O
high	O
lveel	O
of	O
isntability	O
is	O
observed	O
through	O
successive	O
generatinos	O
and	O
the	O
szie	O
of	O
the	O
reepat	O
is	O
generally	O
corrleated	O
with	O
the	O
seevrity	O
of	O
the	O
diesase	O
and	O
with	O
age	O
at	O
onset	O
.	O

Furthermore	O
,	O
tissues	O
from	O
DM	B-Disease
pateints	O
exhibit	O
smoatic	O
mosaicsim	O
that	O
incresaes	O
with	O
age	O
.	O

We	O
generated	O
transgeinc	O
mcie	O
carrying	O
large	O
hmuan	O
geonmic	O
seuqences	O
with	O
20	O
,	O
55	O
or	O
>	O
300	O
CTG	O
,	O
colned	O
from	O
ptaients	O
from	O
the	O
same	O
affecetd	O
DM	B-Disease
faimly	O
.	O

Using	O
large	O
huamn	O
flanking	O
sequenecs	O
and	O
a	O
large	O
amplifciation	O
,	O
we	O
demonstrate	O
that	O
the	O
intergeenrational	O
CTG	O
repaet	O
instaiblity	O
is	O
reproduced	O
in	O
mcie	O
,	O
with	O
a	O
strong	O
bais	O
towards	O
expanisons	O
and	O
with	O
the	O
same	O
sex	O
-	O
and	O
szie	O
-	O
depenednt	O
chaarcteristics	O
as	O
in	O
humnas	O
.	O

Moreover	O
,	O
a	O
high	O
lveel	O
of	O
instbaility	O
,	O
increasnig	O
with	O
age	O
,	O
can	O
be	O
observed	O
in	O
tisseus	O
and	O
in	O
seprm	O
.	O

Although	O
we	O
did	O
not	O
observe	O
dramaitc	O
expasnions	O
(	O
or	O
big	O
jupms	O
over	O
several	O
hundred	O
CTG	O
reepats	O
)	O
as	O
in	O
congneital	O
forms	O
of	O
DM	B-Disease
,	O
our	O
mdoel	O
carrying	O
>	O
300	O
CTG	O
is	O
the	O
first	O
to	O
show	O
instaiblity	O
so	O
close	O
to	O
the	O
huamn	O
DM	B-Disease
situation	O
.	O

Our	O
three	O
mdoels	O
carrying	O
different	O
sizes	O
of	O
CTG	O
rpeeat	O
provide	O
insight	O
on	O
the	O
different	O
fcators	O
moudlating	O
the	O
CTG	O
rpeeat	O
instabiilty	O
.	O
.	O

Inactivaiton	O
of	O
the	O
Firedreich	B-Disease
atxaia	I-Disease
mosue	O
gnee	O
leads	O
to	O
ealry	O
embyronic	B-Disease
lethailty	I-Disease
without	O
iorn	O
accumulaiton	O
.	O

Firedreich	B-Disease
aatxia	I-Disease
(	O
FDRA	B-Disease
)	O
,	O
the	O
most	O
common	O
autoosmal	B-Disease
rceessive	I-Disease
atxaia	I-Disease
,	O
is	O
caused	O
in	O
almost	O
all	O
csaes	O
by	O
homzoygous	O
introinc	O
expnasions	O
resulting	O
in	O
the	O
lsos	O
of	O
frataixn	O
,	O
a	O
mitocohndrial	O
protien	O
conserved	O
through	O
evoultion	O
,	O
and	O
involved	O
in	O
mitochonrdial	O
iorn	O
homeostsais	O
.	O

Yaest	O
knockuot	O
moedls	O
,	O
and	O
histoolgical	O
and	O
biocheimcal	O
dtaa	O
from	O
patinet	O
haert	O
biposies	O
or	O
auotpsies	O
indicate	O
that	O
the	O
frataixn	O
deefct	O
causes	O
a	O
specific	O
iorn	B-Disease
-	I-Disease
suflur	I-Disease
protien	I-Disease
dfeiciency	I-Disease
and	O
mtiochondrial	O
iorn	O
accmuulation	O
leading	O
to	O
the	O
patholgoical	O
chnages	O
.	O

Affceted	O
huamn	O
tsisues	O
are	O
rarely	O
available	O
to	O
further	O
examine	O
this	O
hyptohesis	O
.	O

To	O
stduy	O
the	O
mechainsm	O
of	O
the	O
disaese	O
,	O
we	O
generated	O
a	O
mosue	O
moedl	O
by	O
dleetion	O
of	O
eoxn	O
4	O
leading	O
to	O
incativation	O
of	O
the	O
Fdra	B-Disease
gnee	O
proudct	O
.	O

We	O
show	O
that	O
homoyzgous	O
deleitons	O
cause	O
embroynic	B-Disease
lehtality	I-Disease
a	O
few	O
dyas	O
after	O
implnatation	O
,	O
demonstrating	O
an	O
important	O
role	O
for	O
fratxain	O
during	O
ealry	O
devleopment	O
.	O

These	O
resluts	O
suggest	O
that	O
the	O
milder	O
phentoype	O
in	O
hmuans	O
is	O
due	O
to	O
reisdual	O
frtaaxin	O
expressoin	O
associated	O
with	O
the	O
exapnsion	O
mutatoins	O
.	O

Surprisingly	O
,	O
in	O
the	O
frtaaxin	O
knocokut	O
mosue	O
,	O
no	O
iorn	O
accumluation	O
was	O
observed	O
during	O
embroynic	O
resoprtion	O
,	O
suggesting	O
that	O
clel	O
detah	O
could	O
be	O
due	O
to	O
a	O
mehcanism	O
indepnedent	O
of	O
iorn	O
accumulation	O
.	O
.	O

Gaucehr	B-Disease
disaese	I-Disease
:	O
the	O
orgiins	O
of	O
the	O
Ashkeanzi	O
Jweish	O
N307S	O
and	O
84GG	O
aicd	O
btea	O
-	O
glucosidsae	O
muttaions	O
.	O

Tpye	O
1	O
Gaucehr	B-Disease
diesase	I-Disease
(	O
GD	B-Disease
)	O
,	O
a	O
non	O
-	O
neuroonpathic	O
lyossomal	B-Disease
stroage	I-Disease
disoredr	I-Disease
,	O
rseults	O
from	O
the	O
deficinet	O
acitvity	O
of	O
aicd	O
btea	O
-	O
glucosiadse	O
(	O
GBA	O
)	O
.	O

Tpye	O
1	O
dsiease	O
is	O
panethinc	O
but	O
is	O
more	O
prvealent	O
in	O
indiivduals	O
of	O
Ashkeanzi	O
Jewsih	O
(	O
AJ	O
)	O
decsent	O
.	O

Of	O
the	O
cuasative	O
GBA	O
mtuations	O
,	O
N307S	O
is	O
particularly	O
freqeunt	O
in	O
the	O
AJ	O
popluation	O
,	O
(	O
q	O
approximately	O
.	O
03	O
)	O
,	O
whereas	O
the	O
84GG	O
insetrion	O
(	O
q	O
approximately	O
.	O
003	O
)	O
occurs	O
exclusively	O
in	O
the	O
Ashkenaizm	O
.	O

To	O
inevstigate	O
the	O
geentic	O
histroy	O
of	O
these	O
muattions	O
in	O
the	O
AJ	O
popualtion	O
,	O
short	O
tanedm	O
rpeeat	O
(	O
STR	O
)	O
marekrs	O
were	O
used	O
to	O
map	O
a	O
9	O
.	O

3	O
-	O
cM	O
rgeion	O
containing	O
the	O
GBA	O
lcous	O
and	O
to	O
geontype	O
261	O
AJ	O
N307S	O
chromsoomes	O
,	O
60	O
Europaen	O
non	O
-	O
Jweish	O
N307S	O
chroomsomes	O
,	O
and	O
62	O
AJ	O
84GG	O
crhomosomes	O
.	O

A	O
highly	O
conserved	O
haplotpye	O
at	O
four	O
mrakers	O
flanking	O
GBA	O
(	O
PLKR	O
,	O
D11S595	O
,	O
DS12721	O
,	O
and	O
D1S2777	O
)	O
was	O
observed	O
on	O
both	O
the	O
AJ	O
chromosoems	O
and	O
the	O
non	O
-	O
Jeiwsh	O
N307S	O
chromosoems	O
,	O
suggesting	O
the	O
occurernce	O
of	O
a	O
founedr	O
common	O
to	O
both	O
populatoins	O
.	O

Of	O
note	O
,	O
the	O
presecne	O
of	O
different	O
divergent	O
haplotyeps	O
suggested	O
the	O
occurrnece	O
of	O
de	O
novo	O
,	O
recrurent	O
N730S	O
muttaions	O
.	O

In	O
contrast	O
,	O
a	O
different	O
conserved	O
hapltoype	O
at	O
these	O
markres	O
was	O
identfiied	O
on	O
the	O
84GG	O
chrmoosomes	O
,	O
which	O
was	O
unqiue	O
to	O
the	O
AJ	O
populaiton	O
.	O

On	O
the	O
basis	O
of	O
the	O
linkgae	O
dsiequilibrium	O
(	O
LD	O
)	O
delta	O
valeus	O
,	O
the	O
non	O
-	O
Jweish	O
Eurpoean	O
N307S	O
chromoosmes	O
had	O
greater	O
haploytpe	O
dievrsity	O
and	O
less	O
LD	O
at	O
the	O
marekrs	O
flanking	O
the	O
conserved	O
hapltoype	O
than	O
did	O
the	O
AJ	O
N730S	O
chormosomes	O
.	O

This	O
finidng	O
is	O
consistent	O
with	O
the	O
prseence	O
of	O
the	O
N307S	O
mutatoin	O
in	O
the	O
non	O
-	O
Jweish	O
Euroepan	O
pouplation	O
prior	O
to	O
the	O
fonuding	O
of	O
the	O
AJ	O
popluation	O
.	O

Coalesecnce	O
anlayses	O
for	O
the	O
N307S	O
and	O
84GG	O
mutaitons	O
etsimated	O
similar	O
coalescnece	O
times	O
,	O
of	O
48	O
and	O
55	O
.	O
5	O
geneartions	O
ago	O
,	O
respectively	O
.	O

The	O
reuslts	O
of	O
these	O
stduies	O
are	O
consistent	O
with	O
a	O
significant	O
bottleneck	O
occurring	O
in	O
the	O
AJ	O
pouplation	O
during	O
the	O
first	O
millennium	O
,	O
when	O
the	O
populaiton	O
became	O
established	O
in	O
Eruope	O
.	O

HLA	O
B27	O
and	O
the	O
gneetics	O
of	O
ankyolsing	B-Disease
spondlyitis	I-Disease
.	O

One	O
hundred	O
and	O
twenty	O
-	O
eight	O
of	O
145	O
patinets	O
with	O
anyklosing	B-Disease
spnodylitis	I-Disease
(	O
AS	B-Disease
)	O
were	O
found	O
to	O
be	O
HLA	O
B27	O
positvie	O
.	O

Five	O
pateints	O
had	O
evdience	O
of	O
a	O
sreo	O
-	O
neagtive	O
peripehral	B-Disease
arthrtiis	I-Disease
resembling	O
perihperal	B-Disease
psoriaitc	I-Disease
arhtritis	I-Disease
and	O
3	O
of	O
these	O
were	O
B27	O
neagtive	O
.	O

One	O
further	O
B27	O
ngeative	O
pateints	O
had	O
a	O
ssiter	O
with	O
ankylosnig	B-Disease
spondyltiis	I-Disease
and	O
ulcertaive	B-Disease
coltiis	I-Disease
and	O
a	O
motehr	O
with	O
ulcertaive	B-Disease
cloitis	I-Disease
.	O

There	O
was	O
eviednce	O
of	O
a	O
somewhat	O
later	O
age	O
of	O
onset	O
of	O
smyptoms	O
in	O
B27	O
ngeative	O
pateints	O
.	O

These	O
findigns	O
are	O
interpreted	O
as	O
suggesting	O
some	O
dergee	O
of	O
clniical	O
and	O
gneetic	O
hetreogeneity	O
in	O
aknylosing	B-Disease
spondyliits	I-Disease
with	O
gnees	O
for	O
psorisais	B-Disease
and	O
ifnlammatory	B-Disease
boewl	I-Disease
disesae	I-Disease
being	O
important	O
in	O
some	O
idnividuals	O
,	O
particularly	O
those	O
who	O
are	O
B27	O
ngeative	O
.	O

Twenty	O
-	O
five	O
first	O
-	O
dgeree	O
relatievs	O
with	O
ankylsoing	B-Disease
sponydlitis	I-Disease
were	O
all	O
B27	O
posiitve	O
.	O

The	O
only	O
instance	O
of	O
dissasociation	O
of	O
B27	O
and	O
spnodylitis	B-Disease
in	O
a	O
famliy	O
was	O
where	O
the	O
proabnd	O
had	O
ulceraitve	B-Disease
cloitis	I-Disease
as	O
well	O
as	O
spondlyitis	B-Disease
.	O

Of	O
13	O
B27	O
posiitve	O
ftahers	O
3	O
could	O
be	O
diagnsoed	O
as	O
having	O
definite	O
anyklosing	B-Disease
spondyltiis	I-Disease
(	O
23	O
%	O
)	O
.	O

These	O
fnidings	O
are	O
thought	O
to	O
provide	O
evdience	O
against	O
the	O
cocnept	O
that	O
the	O
gnee	O
for	O
ankylsoing	B-Disease
spondlyitis	I-Disease
is	O
not	O
B27	O
but	O
a	O
closely	O
linked	O
gnee	O
and	O
favour	O
the	O
ocucrrence	O
of	O
an	O
envirnomental	O
eevnt	O
affceting	O
approximately	O
one	O
-	O
fifth	O
of	O
B27	O
poistive	O
maels	O
to	O
result	O
in	O
disesae	O
.	O
.	O

Fuonder	O
muattions	O
in	O
the	O
BCRA1	O
gnee	O
in	O
Poilsh	O
faimlies	O
with	O
berast	B-Disease
-	I-Disease
ovairan	I-Disease
canecr	I-Disease
.	O

We	O
have	O
undertaken	O
a	O
hosiptal	O
-	O
based	O
sutdy	O
,	O
to	O
identify	O
possible	O
BCRA1	O
and	O
BRAC2	O
fonuder	O
muttaions	O
in	O
the	O
Poilsh	O
popualtion	O
.	O

The	O
stduy	O
gruop	O
consisted	O
of	O
66	O
Poilsh	O
famliies	O
with	O
canecr	B-Disease
who	O
have	O
at	O
least	O
three	O
related	O
feamles	O
affetced	O
with	O
berast	B-Disease
or	I-Disease
oavrian	I-Disease
cnacer	I-Disease
and	O
who	O
had	O
cnacer	B-Disease
diagonsed	O
,	O
in	O
at	O
least	O
one	O
of	O
the	O
three	O
affected	O
feamles	O
,	O
at	O
age	O
<	O
50	O
yeras	O
.	O

A	O
total	O
of	O
26	O
famiiles	O
had	O
both	O
bresat	B-Disease
and	I-Disease
ovraian	I-Disease
cancres	I-Disease
,	O
4	O
famileis	O
had	O
ovarain	B-Disease
cancres	I-Disease
only	O
,	O
and	O
36	O
faimlies	O
had	O
berast	B-Disease
canecrs	I-Disease
only	O
.	O

Gneomic	O
DNA	O
was	O
perpared	O
from	O
the	O
periphearl	O
blood	O
leukocyets	O
of	O
at	O
least	O
one	O
affected	O
wmoan	O
from	O
each	O
famliy	O
.	O

The	O
entire	O
cdoing	O
regoin	O
of	O
BCRA1	O
and	O
BRAC2	O
was	O
screened	O
for	O
the	O
presnece	O
of	O
germlnie	O
mtuations	O
,	O
by	O
use	O
of	O
SCSP	O
followed	O
by	O
direct	O
seqeuncing	O
of	O
observed	O
varaints	O
.	O

Mutaitons	O
were	O
found	O
in	O
35	O
(	O
53	O
%	O
)	O
of	O
the	O
66	O
famileis	O
studied	O
.	O

All	O
but	O
one	O
of	O
the	O
mutaitons	O
were	O
detceted	O
within	O
the	O
BCRA1	O
gnee	O
.	O

BRAC1	B-Disease
abnormlaities	I-Disease
were	O
identiifed	O
in	O
all	O
four	O
fmailies	O
with	O
ovarain	B-Disease
cacner	I-Disease
only	O
,	O
in	O
67	O
%	O
of	O
27	O
famiiles	O
with	O
both	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
,	O
and	O
in	O
34	O
%	O
of	O
35	O
faimlies	O
with	O
braest	B-Disease
cnacer	I-Disease
only	O
.	O

The	O
single	O
faimly	O
with	O
a	O
BCRA2	O
muttaion	O
had	O
the	O
berast	B-Disease
-	I-Disease
ovairan	I-Disease
cacner	I-Disease
snydrome	I-Disease
.	O

Seven	O
distinct	O
mutaitons	O
were	O
identfiied	O
;	O
five	O
of	O
these	O
occurred	O
in	O
two	O
or	O
more	O
famileis	O
.	O

In	O
total	O
,	O
recurrnet	O
mutaitons	O
were	O
found	O
in	O
33	O
(	O
94	O
%	O
)	O
of	O
the	O
35	O
fmailies	O
with	O
detceted	O
mtuations	O
.	O

Three	O
BCRA1	B-Disease
abnoramlities	I-Disease
-	O
5382isnC	O
,	O
C16G	O
,	O
and	O
415d3elA	O
-	O
accounted	O
for	O
51	O
%	O
,	O
20	O
%	O
,	O
and	O
11	O
%	O
of	O
the	O
identiifed	O
mutaitons	O
,	O
respectively	O
.	O
.	O

Moelcular	O
basis	O
of	O
very	B-Disease
long	I-Disease
chian	I-Disease
aycl	I-Disease
-	I-Disease
CoA	I-Disease
dehydrogensae	I-Disease
defciiency	I-Disease
in	O
three	O
Isreali	O
paitents	O
:	O
identificatoin	O
of	O
a	O
compelx	O
mutnat	O
alelle	O
with	O
P56L	O
and	O
K274Q	O
mutatoins	O
,	O
the	O
former	O
being	O
an	O
exoinc	O
muattion	O
causing	O
eoxn	O
3	O
skipipng	O
.	O

Very	B-Disease
long	I-Disease
cahin	I-Disease
aycl	I-Disease
-	I-Disease
CoA	I-Disease
dehydrgoenase	I-Disease
(	I-Disease
VCLAD	I-Disease
)	I-Disease
dfeiciency	I-Disease
is	O
a	O
lfie	O
-	O
threatening	O
disroder	O
of	O
mitochonrdial	O
fatty	O
aicd	O
btea	O
-	O
oxidtaion	O
.	O

We	O
idnetified	O
four	O
novel	O
mutaitons	O
in	O
three	O
unrelated	O
pateints	O
.	O

All	O
patinets	O
had	O
the	O
seevre	O
childhood	O
form	O
of	O
VLACD	B-Disease
dfeiciency	I-Disease
with	O
eraly	O
onset	O
and	O
high	O
mrotality	O
.	O

Imumnoblot	O
aanlysis	O
reveaeld	O
that	O
VCLAD	O
proetin	O
was	O
undetectbale	O
in	O
patinets	O
2	O
and	O
3	O
,	O
whereas	O
noraml	O
-	O
szie	O
VLACD	O
prtoein	O
and	O
an	O
aberrnat	O
form	O
of	O
VCLAD	O
(	O
4kDa	O
smaller	O
)	O
were	O
detetced	O
in	O
patinet	O
1	O
.	O

As	O
expected	O
,	O
nlul	O
mutaitons	O
were	O
found	O
in	O
patietns	O
2	O
and	O
3	O
paitent	O
2	O
is	O
homoyzgous	O
for	O
a	O
framesihft	O
muattion	O
,	O
del	O
4	O
bp	O
at	O
798	O
-	O
801	O
,	O
and	O
paitent	O
3	O
is	O
hmoozygous	O
for	O
a	O
nonsnese	O
mutaiton	O
65C	O
>	O
A	O
(	O
S22X	O
)	O
.	O

Pateint	O
1	O
was	O
homoyzgous	O
for	O
a	O
comlpex	O
mtuant	O
alelle	O
containing	O
two	O
alteratinos	O
,	O
including	O
a	O
194C	O
>	O
T	O
trnasition	O
(	O
P56L	O
)	O
and	O
739A	O
>	O
C	O
tranvsersion	O
(	O
K274Q	O
)	O
;	O
in	O
the	O
csae	O
of	O
P56L	O
,	O
the	O
aimno	O
aicd	O
change	O
does	O
not	O
rdeuce	O
eznyme	O
acitvity	O
.	O

However	O
,	O
the	O
nulceotide	O
change	O
resulted	O
in	O
eoxn	O
3	O
skpiping	O
,	O
whereas	O
the	O
latter	O
K274Q	O
mutaiton	O
had	O
a	O
dratsic	O
effcet	O
on	O
eznyme	O
acitvity	O
.	O

We	O
verified	O
these	O
evetns	O
by	O
in	O
vivo	O
splicnig	O
experiemnts	O
and	O
trnasient	O
epxression	O
aanlysis	O
of	O
muatnt	O
cDANs	O
.	O

The	O
P56L	O
mtuation	O
locates	O
11	O
bsaes	O
usptream	O
of	O
a	O
slpice	O
doonr	O
stie	O
of	O
inrton	O
3	O
.	O

This	O
is	O
an	O
example	O
of	O
an	O
eoxnic	O
muttaion	O
which	O
affects	O
eoxn	O
-	O
splicnig	O
.	O
.	O

Submicroscpoic	O
deeltion	O
in	O
couisns	O
with	O
Parder	B-Disease
-	I-Disease
Willi	I-Disease
synrdome	I-Disease
causes	O
a	O
gradnmatrilineal	O
inheirtance	O
pattern	O
:	O
effetcs	O
of	O
ipmrinting	O
.	O

The	O
Parder	B-Disease
-	I-Disease
Willi	I-Disease
snydrome	I-Disease
(	O
PWS	B-Disease
)	O
critical	O
reigon	O
on	O
15q11	O
-	O
q13	O
is	O
subjcet	O
to	O
ipmrinting	O
.	O

PWS	B-Disease
becomes	O
apparnet	O
when	O
gnees	O
on	O
the	O
paetrnally	O
inhertied	O
chroomsome	O
are	O
not	O
expressed	O
.	O

Famliial	B-Disease
PWS	I-Disease
is	O
rrae	O
.	O

We	O
reprot	O
on	O
a	O
famliy	O
in	O
which	O
a	O
mlae	O
and	O
a	O
feamle	O
ptaernal	O
first	O
cuosin	O
both	O
have	O
PWS	B-Disease
with	O
ctyogenetically	O
nomral	O
karoytypes	O
.	O

Fluorescecne	O
in	O
situ	O
hbyridization	O
(	O
FSIH	O
)	O
analyiss	O
shows	O
a	O
submicrosocpic	O
deeltion	O
of	O
SNPRN	O
,	O
but	O
not	O
the	O
closely	O
associated	O
lcoi	O
D15S10	O
,	O
D15S11	O
,	O
D156S3	O
,	O
and	O
GABBR3	O
.	O

The	O
couisns	O
ftahers	O
and	O
two	O
patenral	O
autns	O
have	O
the	O
same	O
delteion	O
and	O
are	O
clincially	O
noraml	O
.	O

The	O
grandmohter	O
of	O
the	O
couisns	O
is	O
decesaed	O
and	O
not	O
available	O
for	O
sutdy	O
,	O
and	O
their	O
gradnfather	O
is	O
not	O
delteed	O
for	O
SRNPN	O
.	O

DNA	O
methyaltion	O
aanlysis	O
of	O
D51S63	O
is	O
consistent	O
with	O
an	O
abnomrality	O
of	O
the	O
imrpinting	O
cetner	O
associated	O
with	O
PWS	B-Disease
.	O

"	O
Grandamtrilineal	O
"	O
inehritance	O
occurs	O
when	O
a	O
wmoan	O
with	O
dleetion	O
of	O
an	O
ipmrinted	O
,	O
patenrally	O
expresesd	O
gnee	O
is	O
at	O
rsik	O
of	O
having	O
affected	O
grandchilrden	O
through	O
her	O
snos	O
.	O

In	O
this	O
csae	O
,	O
PWS	B-Disease
does	O
not	O
become	O
evident	O
as	O
long	O
as	O
the	O
dleetion	O
is	O
passed	O
through	O
the	O
matrilienal	O
line	O
.	O

This	O
represents	O
a	O
uinque	O
inehritance	O
pattren	O
due	O
to	O
ipmrinting	O
.	O
.	O

Hmuan	O
glycnie	O
decarboyxlase	O
gnee	O
(	O
GDLC	O
)	O
and	O
its	O
highly	O
conserved	O
prcoessed	O
pseudoegne	O
(	O
psiGLDC	O
)	O
:	O
their	O
strcuture	O
and	O
epxression	O
,	O
and	O
the	O
identifictaion	O
of	O
a	O
large	O
dleetion	O
in	O
a	O
famliy	O
with	O
nnoketotic	B-Disease
hyperlgycinemia	I-Disease
.	O

Muttaions	O
in	O
the	O
gylcine	O
dcearboxylase	O
gnee	O
(	O
GDLC	O
)	O
cause	O
noknetotic	B-Disease
hyperglycniemia	I-Disease
(	O
NKH	B-Disease
)	O
,	O
an	O
in	B-Disease
-	I-Disease
bron	I-Disease
error	I-Disease
of	I-Disease
metbaolism	I-Disease
charatcerized	O
by	O
sveere	O
nuerological	B-Disease
ditsurbance	I-Disease
.	O

We	O
have	O
determined	O
the	O
strucutre	O
of	O
GDLC	O
and	O
of	O
its	O
pesudogene	O
(	O
psiGLDC	O
)	O
and	O
studied	O
their	O
expressoin	O
for	O
a	O
molceular	O
analsyis	O
of	O
NKH	B-Disease
.	O

The	O
GDLC	O
gnee	O
spans	O
at	O
least	O
135	O
kb	O
and	O
consists	O
of	O
25	O
exnos	O
.	O

All	O
doonr	O
and	O
accepotr	O
siets	O
adhere	O
to	O
the	O
canoncial	O
GT	O
-	O
AG	O
rule	O
,	O
except	O
for	O
the	O
dnoor	O
stie	O
of	O
itnron	O
21	O
,	O
where	O
a	O
varaint	O
form	O
GC	O
is	O
used	O
instead	O
of	O
GT	O
.	O

The	O
transrciption	O
iintiation	O
stie	O
has	O
been	O
assigned	O
to	O
a	O
resiude	O
163	O
bp	O
upsrteam	O
from	O
the	O
tranlsation	O
initiaiton	O
trpilet	O
by	O
prmier	O
exetnsion	O
analyiss	O
.	O

The	O
psiGLDC	O
gnee	O
has	O
no	O
itnron	O
and	O
shares	O
97	O
.	O

5	O
%	O
homloogy	O
with	O
the	O
cdoing	O
regoin	O
of	O
functioanl	O
GDLC	O
,	O
suggesting	O
that	O
psiGLDC	O
is	O
a	O
prcoessed	O
pseudognee	O
that	O
arose	O
from	O
the	O
GDLC	O
tarnscript	O
about	O
4	O
-	O
8	O
million	O
yaers	O
ago	O
.	O

RNA	O
blotitng	O
analyiss	O
has	O
reveaeld	O
that	O
GDLC	O
is	O
exrpessed	O
in	O
huamn	O
lvier	O
,	O
kdiney	O
,	O
brian	O
,	O
and	O
palcenta	O
.	O

We	O
have	O
also	O
examined	O
a	O
paitent	O
with	O
NKH	B-Disease
with	O
no	O
detecatble	O
GDLC	O
mNRA	O
in	O
his	O
lmyphoblasts	O
.	O

Eoxns	O
1	O
-	O
3	O
of	O
the	O
functioanl	O
GDLC	O
gnee	O
from	O
this	O
ptaient	O
are	O
not	O
apmlified	O
by	O
polymearse	O
cahin	O
recation	O
(	O
PCR	O
)	O
,	O
whereas	O
those	O
from	O
contorl	O
sujbects	O
are	O
.	O

These	O
resutls	O
suggest	O
a	O
large	O
homozgyous	O
dleetion	O
(	O
at	O
least	O
30	O
kb	O
)	O
in	O
the	O
paitent	O
.	O

Furthermore	O
,	O
we	O
have	O
devised	O
a	O
smei	O
-	O
quantittaive	O
PCR	O
to	O
estiamte	O
the	O
number	O
of	O
GDLC	O
alleles	O
by	O
using	O
psiGLDC	O
as	O
an	O
interanl	O
cotnrol	O
and	O
have	O
confirmed	O
the	O
homzoygosity	O
and	O
heteroyzgosity	O
of	O
the	O
deletoin	O
in	O
the	O
pateint	O
and	O
his	O
paretns	O
,	O
respectively	O
.	O

Srtuctural	O
informatoin	O
of	O
GDLC	O
and	O
psiGLDC	O
should	O
facilitate	O
the	O
molecualr	O
analsyis	O
of	O
NKH	B-Disease
.	O

De	O
novo	O
deletoins	O
of	O
SRNPN	O
eoxn	O
1	O
in	O
eraly	O
huamn	O
and	O
muose	O
emrbyos	O
result	O
in	O
a	O
patrenal	O
to	O
matrenal	O
imrpint	O
swtich	O
.	O

Parder	B-Disease
-	I-Disease
Willi	I-Disease
sydnrome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
a	O
neurogenteic	B-Disease
disaese	I-Disease
characetrized	O
by	O
infnatile	B-Disease
hyoptonia	I-Disease
,	O
gonaadl	B-Disease
hyopplasia	I-Disease
,	O
obsessvie	O
bheaviour	O
and	O
noenatal	O
feednig	O
difficulties	O
followed	O
by	O
hyprephagia	B-Disease
,	O
leading	O
to	O
profuond	O
oebsity	B-Disease
.	O

PWS	B-Disease
is	O
due	O
to	O
a	O
lcak	O
of	O
paetrnal	O
gneetic	O
inforamtion	O
at	O
15q11	O
-	O
q13	O
(	O
ref	O
.	O
2	O
)	O
.	O

Five	O
ipmrinted	O
,	O
pateranlly	O
exrpessed	O
geens	O
map	O
to	O
the	O
PWS	B-Disease
rgeion	O
,	O
MRKN3	O
(	O
ref	O
.	O
3	O
)	O
,	O
NDN	O
(	O
ref	O
.	O
4	O
)	O
,	O
NNDL1	O
(	O
ref	O
.	O
5	O
)	O
,	O
SRNPN	O
(	O
refs	O
6	O
-	O
8	O
)	O
and	O
IPW	O
(	O
ref	O
.	O
9	O
)	O
,	O
as	O
well	O
as	O
two	O
poorly	O
charcaterized	O
frametns	O
designated	O
PAR	O
-	O
1	O
and	O
PAR	O
-	O
5	O
(	O
ref	O
.	O
10	O
)	O
.	O

Imprintnig	O
of	O
this	O
regoin	O
involves	O
a	O
bipatrite	O
imprniting	O
cnetre	O
(	O
IC	O
)	O
,	O
which	O
ovelraps	O
SRNPN	O
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

Deleiton	O
of	O
the	O
SRNPN	O
proomter	O
/	O
eoxn	O
1	O
rgeion	O
(	O
the	O
PWS	B-Disease
IC	O
eleemnt	O
)	O
appears	O
to	O
impiar	O
the	O
establishemnt	O
of	O
the	O
patenral	O
impirnt	O
in	O
the	O
mlae	O
grem	O
line	O
and	O
leads	O
to	O
PWS	B-Disease
.	O

Here	O
we	O
rpeort	O
a	O
PWS	B-Disease
fmaily	O
in	O
which	O
the	O
fahter	O
is	O
mosiac	O
for	O
an	O
IC	O
deleiton	O
on	O
his	O
ptaernal	O
chormosome	O
.	O

The	O
delteion	O
chromsoome	O
has	O
acquired	O
a	O
materanl	O
methylatoin	O
impirnt	O
in	O
his	O
somtaic	O
clels	O
.	O

We	O
have	O
made	O
idnetical	O
fnidings	O
in	O
cihmaeric	O
mcie	O
generated	O
from	O
two	O
indpeendent	O
embrynoic	O
setm	O
(	O
ES	O
)	O
clel	O
lnies	O
harbouring	O
a	O
similar	O
delteion	O
.	O

Our	O
stuides	O
demonstrate	O
that	O
the	O
PWS	B-Disease
IC	O
elmeent	O
is	O
not	O
only	O
required	O
for	O
the	O
establishemnt	O
of	O
the	O
ptaernal	O
imrpint	O
,	O
but	O
also	O
for	O
its	O
psotzygotic	O
maitnenance	O
.	O
.	O

Mcie	O
defiicent	B-Disease
in	I-Disease
Sxi5	I-Disease
develop	O
catarcats	B-Disease
:	O
implications	O
for	O
mytoonic	B-Disease
dysrtophy	I-Disease
.	O

Expnasion	O
of	O
a	O
CTG	O
tirnucleotide	O
repaet	O
in	O
the	O
3	O
UTR	O
of	O
the	O
gnee	O
DPMK	O
at	O
the	O
DM1	O
loucs	O
on	O
crhomosome	O
19	O
causes	O
myotoinc	B-Disease
dystrpohy	I-Disease
,	O
a	O
dominantly	B-Disease
inherietd	I-Disease
disesae	I-Disease
charcaterized	O
by	O
skelteal	O
muslce	B-Disease
dytsrophy	I-Disease
and	O
mytoonia	B-Disease
,	O
catarcats	B-Disease
and	O
cardaic	B-Disease
condutcion	I-Disease
deefcts	I-Disease
.	O

Tagreted	O
deleiton	O
of	O
Dm15	O
,	O
the	O
muose	O
ortholouge	O
of	O
huamn	O
DPMK	O
,	O
produced	O
mcie	O
with	O
a	O
mlid	O
mypoathy	B-Disease
and	O
cardaic	B-Disease
codnuction	I-Disease
abnormaliites	I-Disease
,	O
but	O
without	O
other	O
featuers	O
of	O
moytonic	B-Disease
dystrpohy	I-Disease
,	O
such	O
as	O
mytoonia	B-Disease
and	O
catarcats	B-Disease
.	O

We	O
,	O
and	O
others	O
,	O
have	O
demonstrated	O
that	O
repaet	O
epxansion	O
decraeses	O
expression	O
of	O
the	O
adjacnet	O
gnee	O
SXI5	O
(	O
refs	O
7	O
,	O
8	O
)	O
,	O
which	O
encoeds	O
a	O
homeodomian	O
trnascription	O
fatcor	O
.	O

To	O
determine	O
whether	O
SXI5	B-Disease
deifciency	I-Disease
contributes	O
to	O
the	O
mytoonic	B-Disease
dsytrophy	I-Disease
phneotype	O
,	O
we	O
disrupetd	O
muose	O
Sxi5	O
by	O
replacing	O
the	O
first	O
eoxn	O
with	O
a	O
btea	O
-	O
galatcosidase	O
repotrer	O
.	O

Sxi5	O
-	O
muatnt	O
mcie	O
showed	O
rpeorter	O
epxression	O
in	O
mlutiple	O
tisuses	O
,	O
including	O
the	O
developing	O
lnes	O
.	O

Hoomzygous	O
mtuant	O
mcie	O
had	O
no	O
apparnet	O
abnormaliites	B-Disease
of	I-Disease
sekletal	I-Disease
mucsle	I-Disease
funciton	I-Disease
,	O
but	O
developed	O
lenticluar	B-Disease
opaciites	I-Disease
at	O
a	O
higehr	O
rtae	O
than	O
cotnrols	O
.	O

Our	O
resluts	O
suggest	O
that	O
SXI5	B-Disease
deifciency	I-Disease
contributes	O
to	O
the	O
ctaaract	B-Disease
pheontype	O
in	O
mytoonic	B-Disease
dysrtophy	I-Disease
,	O
and	O
that	O
myotnoic	B-Disease
dytsrophy	I-Disease
represents	O
a	O
mlutigenic	B-Disease
diosrder	I-Disease
.	O
.	O

Hteerozygous	O
lsos	O
of	O
Sxi5	O
in	O
mcie	O
is	O
sufficient	O
to	O
cause	O
ouclar	O
cataarcts	B-Disease
.	O

Myotoinc	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
is	O
an	O
autosoaml	B-Disease
domiannt	I-Disease
disroder	I-Disease
characteriezd	O
by	O
skeleatl	O
muslce	B-Disease
wastnig	I-Disease
,	O
myotoina	B-Disease
,	O
cardaic	B-Disease
arryhthmia	I-Disease
,	O
hyperinsulinaeima	B-Disease
,	O
menatl	B-Disease
retadration	I-Disease
and	O
ouclar	O
cataratcs	B-Disease
.	O

The	O
gneetic	B-Disease
dfeect	I-Disease
in	O
DM	B-Disease
is	O
a	O
CTG	O
reepat	O
expansoin	O
located	O
in	O
the	O
3	O
utnranslated	O
rgeion	O
of	O
DPMK	O
and	O
5	O
of	O
a	O
homoedomain	O
-	O
encdoing	O
gnee	O
,	O
SXI5	O
(	O
formerly	O
DMHAP	O
;	O
refs	O
2	O
-	O
5	O
)	O
.	O

There	O
are	O
three	O
mehcanisms	O
by	O
which	O
CTG	O
expasnion	O
can	O
result	O
in	O
DM	B-Disease
.	O

First	O
,	O
reepat	O
expansoin	O
may	O
alter	O
the	O
processnig	O
or	O
transoprt	O
of	O
the	O
muatnt	O
DPMK	O
mNRA	O
and	O
consequently	O
redcue	O
DPMK	O
lveels	O
.	O

Second	O
,	O
CTG	O
expnasion	O
may	O
establish	O
a	O
rgeion	O
of	O
heterochromtain	O
3	O
of	O
the	O
repaet	O
seqeunce	O
and	O
decerase	O
SXI5	O
trnascription	O
.	O

Third	O
,	O
txoic	O
effects	O
of	O
the	O
repaet	O
expnasion	O
may	O
be	O
intrinisc	O
to	O
the	O
repetaed	O
elements	O
at	O
the	O
lveel	O
of	O
DNA	O
or	O
RNA	O
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

Previous	O
sutdies	O
have	O
demonstrated	O
that	O
a	O
dsoe	O
-	O
deepndent	O
lsos	O
of	O
Dm15	O
(	O
the	O
mosue	O
DPMK	O
homoolgue	O
)	O
in	O
mcie	O
produces	O
a	O
parital	O
DM	B-Disease
phenotpye	O
chaarcterized	O
by	O
derceased	O
developmnet	O
of	O
skeeltal	O
mucsle	O
froce	O
and	O
caridac	B-Disease
cnoduction	I-Disease
diosrders	I-Disease
.	O

To	O
tset	O
the	O
role	O
of	O
Sxi5	O
lsos	O
in	O
DM	B-Disease
,	O
we	O
have	O
analyesd	O
a	O
starin	O
of	O
mcie	O
in	O
which	O
Sxi5	O
was	O
deelted	O
.	O

Our	O
reuslts	O
demonstrate	O
that	O
the	O
rtae	O
and	O
severtiy	O
of	O
ctaaract	B-Disease
fomration	O
is	O
invesrely	O
related	O
to	O
Sxi5	O
dsoage	O
and	O
is	O
temporally	O
prorgessive	O
.	O

Sxi5	O
+	O
/	O
-	O
and	O
Sxi5	O
-	O
/	O
-	O
mcie	O
show	O
incerased	O
steady	O
-	O
state	O
levles	O
of	O
the	O
Na	O
+	O
/	O
K	O
+	O
-	O
APTase	O
aplha	O
-	O
1	O
subnuit	O
and	O
decreaesd	O
Dm15	O
mNRA	O
lveels	O
.	O

Thus	O
,	O
atlered	O
ion	O
homesotasis	O
within	O
the	O
lnes	O
may	O
contribute	O
to	O
ctaaract	B-Disease
formaiton	O
.	O

As	O
ouclar	O
catarcats	B-Disease
are	O
a	O
characteirstic	O
feature	O
of	O
DM	B-Disease
,	O
these	O
reuslts	O
demonstrate	O
that	O
decreaesd	O
SXI5	O
transcripiton	O
is	O
important	O
in	O
the	O
aetoilogy	O
of	O
DM	B-Disease
.	O

Our	O
dtaa	O
support	O
the	O
hypotehsis	O
that	O
DM	B-Disease
is	O
a	O
contiguous	O
gnee	O
syndorme	O
associated	O
with	O
the	O
pratial	O
lsos	O
of	O
both	O
DPMK	O
and	O
SXI5	O
.	O
.	O

ATM	O
-	O
depednent	O
phsophorylation	O
of	O
nirbin	O
in	O
resposne	O
to	O
radiaiton	O
expsoure	O
.	O

Muattions	O
in	O
the	O
gnee	O
ATM	O
are	O
responsible	O
for	O
the	O
genteic	B-Disease
disoredr	I-Disease
ataixa	B-Disease
-	I-Disease
telangeictasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
which	O
is	O
characetrized	O
by	O
ceerbellar	B-Disease
dysfucntion	I-Disease
,	O
radiosnesitivity	O
,	O
chromsoomal	O
instabliity	O
and	O
canecr	B-Disease
predisposiiton	O
.	O

Both	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
pheontype	O
and	O
the	O
simialrity	O
of	O
the	O
ATM	O
portein	O
to	O
other	O
DNA	O
-	O
damgae	O
sesnors	O
suggests	O
a	O
role	O
for	O
ATM	O
in	O
boichemical	O
patwhays	O
involved	O
in	O
the	O
recogntiion	O
,	O
signlaling	O
and	O
repiar	O
of	O
DNA	O
double	O
-	O
srtand	O
braeks	O
(	O
DBSs	O
)	O
.	O

There	O
are	O
strong	O
parallels	O
between	O
the	O
pattren	O
of	O
radiosensitiivty	O
,	O
chormosomal	O
isntability	O
and	O
canecr	B-Disease
predispsoition	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
ptaients	O
and	O
that	O
in	O
patietns	O
with	O
Nijmgeen	B-Disease
breaakge	I-Disease
snydrome	I-Disease
(	O
NBS	B-Disease
)	O
.	O

The	O
portein	O
defetcive	O
in	O
NBS	B-Disease
,	O
nirbin	O
(	O
ecnoded	O
by	O
NSB1	O
)	O
,	O
forms	O
a	O
cmoplex	O
with	O
MR1E1	O
and	O
RA5D0	O
(	O
refs	O
1	O
,	O
2	O
)	O
.	O

This	O
cmoplex	O
lcoalizes	O
to	O
DBSs	O
within	O
30	O
minuets	O
after	O
cellular	O
epxosure	O
to	O
ioniznig	O
rdaiation	O
(	O
IR	O
)	O
and	O
is	O
observed	O
in	O
brighlty	O
staiinng	O
nulcear	O
fcoi	O
after	O
a	O
longer	O
peroid	O
of	O
tmie	O
.	O

The	O
ovrelap	O
between	O
cilnical	O
and	O
clelular	O
pehnotypes	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
NBS	B-Disease
suggests	O
that	O
ATM	O
and	O
nirbin	O
may	O
funciton	O
in	O
the	O
same	O
bicohemical	O
patwhay	O
.	O

Here	O
we	O
demonstrate	O
that	O
nibirn	O
is	O
phopshorylated	O
within	O
one	O
hour	O
of	O
treamtent	O
of	O
cells	O
with	O
IR	O
.	O

This	O
resopnse	O
is	O
abroagted	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
cells	O
that	O
either	O
do	O
not	O
express	O
ATM	O
protien	O
or	O
express	O
near	O
full	O
-	O
lentgh	O
mtuant	O
prtoein	O
.	O

We	O
also	O
show	O
that	O
ATM	O
physically	O
interacts	O
with	O
and	O
phsophorylates	O
nibirn	O
on	O
sernie	O
343	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Phosphroylation	O
of	O
this	O
stie	O
appears	O
to	O
be	O
functionally	O
important	O
because	O
muatted	O
nbirin	O
(	O
S334A	O
)	O
does	O
not	O
completely	O
complement	O
raidosensitivity	O
in	O
NBS	B-Disease
cells	O
.	O

ATM	O
phosphoryltaion	O
of	O
nbirin	O
does	O
not	O
affect	O
nbirin	O
-	O
MER11	O
-	O
RA5D0	O
associaiton	O
as	O
reveaeld	O
by	O
rdaiation	O
-	O
induecd	O
fcoi	O
fromation	O
.	O

Our	O
dtaa	O
provide	O
a	O
biochmeical	O
explanation	O
for	O
the	O
similartiy	O
in	O
phneotype	O
between	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
NBS	B-Disease
.	O
.	O

Cliniocpathologic	O
feautres	O
of	O
BCRA	B-Disease
-	I-Disease
linked	I-Disease
and	I-Disease
spordaic	I-Disease
oavrian	I-Disease
cnacer	I-Disease
.	O

COTNEXT	O
Most	O
heerditary	B-Disease
ovarain	I-Disease
cancres	I-Disease
are	O
associated	O
with	O
gremline	O
muttaions	O
in	O
BRAC1	O
or	O
BCRA2	O
.	O

Attempts	O
to	O
define	O
the	O
clincial	O
signifciance	O
of	O
BCRA	O
muttaion	O
stauts	O
in	O
ovairan	B-Disease
cacner	I-Disease
have	O
produced	O
conflicting	O
rseults	O
,	O
especially	O
regarding	O
survvial	O
.	O

OBJCETIVE	O
To	O
determine	O
whether	O
hreeditary	B-Disease
ovairan	I-Disease
cancres	I-Disease
have	O
distinct	O
clniical	O
and	O
pathoolgical	O
feautres	O
compraed	O
with	O
spoardic	B-Disease
(	I-Disease
nonhereditray	I-Disease
)	I-Disease
ovarain	I-Disease
canecrs	I-Disease
.	O

DESIGN	O
AND	O
SETTING	O
Retrospecitve	O
coohrt	O
stduy	O
of	O
a	O
consecutvie	O
series	O
of	O
933	O
ovairan	B-Disease
cnacers	I-Disease
daignosed	O
and	O
terated	O
at	O
our	O
institutoin	O
,	O
which	O
is	O
a	O
comprheensive	O
cacner	B-Disease
cenetr	O
as	O
designated	O
by	O
the	O
Natinoal	O
Cacner	B-Disease
Isntitute	O
,	O
over	O
a	O
12	O
-	O
yaer	O
preiod	O
(	O
December	O
1986	O
to	O
August	O
1998	O
)	O
.	O

PATIENTS	O
The	O
sutdy	O
was	O
restricted	O
to	O
ptaients	O
of	O
Jweish	O
oirgin	O
because	O
of	O
the	O
esae	O
of	O
BCRA1	O
and	O
BCRA2	O
gneotyping	O
in	O
this	O
etnhic	O
gorup	O
.	O

From	O
the	O
189	O
ptaients	O
who	O
identifeid	O
themselves	O
as	O
Jweish	O
,	O
88	O
herdeitary	O
csaes	O
were	O
idnetified	O
with	O
the	O
persence	O
of	O
a	O
gemrline	O
foudner	O
mtuation	O
in	O
BRAC1	O
or	O
BCRA2	O
.	O

The	O
remaining	O
101	O
csaes	O
from	O
the	O
same	O
series	O
not	O
associated	O
with	O
a	O
BCRA	O
mutatoin	O
and	O
2	O
additional	O
gruops	O
(	O
Gynecloogic	O
Onoclogy	O
Gorup	O
protoclos	O
52	O
and	O
111	O
)	O
with	O
ovairan	B-Disease
cnacer	I-Disease
from	O
cliniacl	O
tirals	O
(	O
for	O
the	O
surivval	O
anlaysis	O
)	O
were	O
included	O
for	O
comparsion	O
.	O

MIAN	O
OUTCMOE	O
MEASRUES	O
Age	O
at	O
diagnsois	O
,	O
surgcial	O
stgae	O
,	O
histloogic	O
clel	O
tpye	O
and	O
garde	O
,	O
and	O
surgcial	O
otucome	O
;	O
and	O
respnose	O
to	O
chemtoherapy	O
and	O
sruvival	O
for	O
adavnced	O
-	O
stgae	O
(	O
II	O
and	O
IV	O
)	O
caess	O
.	O

REUSLTS	O
Hreeditary	B-Disease
canecrs	I-Disease
were	O
rarely	O
diagonsed	O
before	O
age	O
40	O
yaers	O
and	O
were	O
common	O
after	O
age	O
60	O
yeras	O
,	O
with	O
mean	O
age	O
at	O
diganosis	O
being	O
significantly	O
yuonger	O
for	O
BCRA1	O
-	O
vs	O
BRAC2	O
-	O
linked	O
pateints	O
(	O
54	O
vs	O
62	O
yaers	O
;	O
P	O
=	O
.	O
04	O
)	O
.	O

Hisotlogy	O
,	O
grdae	O
,	O
satge	O
,	O
and	O
scucess	O
of	O
cytoredutcive	O
sugrery	O
were	O
similar	O
for	O
heerditary	O
and	O
sproadic	O
csaes	O
.	O

The	O
hereditray	O
gorup	O
had	O
a	O
longer	O
disaese	O
-	O
free	O
intreval	O
following	O
prmiary	O
chemohterapy	O
in	O
cmoparison	O
with	O
the	O
nonheerditary	O
gruop	O
,	O
with	O
a	O
medain	O
tmie	O
to	O
recurrecne	O
of	O
14	O
motnhs	O
and	O
7	O
monhts	O
,	O
respectively	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

Those	O
with	O
heerditary	B-Disease
cancres	I-Disease
had	O
ipmroved	O
suvrival	O
copmared	O
with	O
the	O
nonherediatry	O
gruop	O
(	O
P	O
=	O
.	O
004	O
)	O
.	O

For	O
stgae	B-Disease
III	I-Disease
canecrs	I-Disease
,	O
BCRA	O
mtuation	O
stauts	O
was	O
an	O
idnependent	O
prognositc	O
vairable	O
(	O
P	O
=	O
.	O
03	O
)	O
.	O

CONCLUSOINS	O
Although	O
BCRA	B-Disease
-	I-Disease
associated	I-Disease
herediatry	I-Disease
ovraian	I-Disease
canecrs	I-Disease
in	O
this	O
populaiton	O
have	O
surgcial	O
and	O
pathoolgical	O
charcateristics	O
similar	O
to	O
those	O
of	O
spoardic	B-Disease
cancres	I-Disease
,	O
advanecd	B-Disease
-	I-Disease
stgae	I-Disease
hreeditary	I-Disease
cnacer	I-Disease
pateints	O
surivve	O
longer	O
than	O
nonherdeitary	B-Disease
canecr	I-Disease
pateints	O
.	O

Age	O
penertance	O
is	O
greater	O
for	O
BCRA1	B-Disease
-	I-Disease
linked	I-Disease
than	I-Disease
for	I-Disease
BRAC2	I-Disease
-	I-Disease
linked	I-Disease
cacners	I-Disease
in	O
this	O
popultaion	O
.	O

The	O
gnee	O
for	O
famiilal	B-Disease
Medtierranean	I-Disease
feevr	I-Disease
,	O
MFEV	O
,	O
is	O
exrpessed	O
in	O
eraly	O
leuokcyte	O
deveolpment	O
and	O
is	O
regulated	O
in	O
resposne	O
to	O
inflamamtory	O
mediaotrs	O
.	O

Faimlial	B-Disease
Mdeiterranean	I-Disease
feevr	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recsesive	B-Disease
diosrder	I-Disease
characteriezd	O
by	O
epsiodes	O
of	O
fveer	B-Disease
and	O
nuetrophil	B-Disease
-	I-Disease
mediated	I-Disease
sersoal	I-Disease
inlfammation	I-Disease
.	O

We	O
recently	O
idetnified	O
the	O
gnee	O
causing	O
FMF	B-Disease
,	O
designated	O
MFEV	O
,	O
and	O
found	O
it	O
to	O
be	O
experssed	O
in	O
mtaure	O
nuetrophils	O
,	O
suggesting	O
that	O
it	O
funcitons	O
as	O
an	O
inflammatory	O
regultaor	O
.	O

To	O
facilitate	O
our	O
understanding	O
of	O
the	O
nromal	O
fnuction	O
of	O
MFEV	O
,	O
we	O
extneded	O
our	O
previous	O
studeis	O
.	O

MFEV	O
msesenger	O
RNA	O
was	O
detecetd	O
by	O
rveerse	O
transcriptsae	O
-	O
ploymerase	O
chian	O
reactoin	O
in	O
bnoe	O
mrarow	O
luekocytes	O
,	O
with	O
dfiferential	O
experssion	O
observed	O
among	O
cells	O
by	O
in	O
situ	O
hybriidzation	O
.	O

C3D4	O
hematopoiteic	O
setm	O
-	O
clel	O
cultrues	O
inudced	O
toward	O
the	O
granulcoytic	O
linaege	O
epxressed	O
MFEV	O
at	O
the	O
myleocyte	O
satge	O
,	O
concurrently	O
with	O
linaege	O
commitmnet	O
.	O

The	O
prperomyelocytic	O
clel	O
line	O
H6L0	O
experssed	O
MFEV	O
only	O
at	O
granuolcytic	O
and	O
moncoytic	O
differnetiation	O
.	O

MFEV	O
was	O
also	O
expresesd	O
in	O
the	O
monocyitc	O
clel	O
lnies	O
U397	O
and	O
THP	O
-	O
1	O
.	O

Among	O
perihperal	O
blood	O
lekuocytes	O
,	O
MFEV	O
exprsesion	O
was	O
detecetd	O
in	O
neturophils	O
,	O
eoisnophils	O
,	O
and	O
to	O
varying	O
dgerees	O
,	O
monoyctes	O
.	O

Consistent	O
with	O
the	O
tissue	O
sepcificity	O
of	O
experssion	O
,	O
complete	O
sequecning	O
and	O
anaylsis	O
of	O
usptream	O
regluatory	O
reginos	O
of	O
MFEV	O
reevaled	O
hmoology	O
to	O
myeliod	O
-	O
specific	O
pormoters	O
and	O
to	O
more	O
broadly	O
expresesd	O
inflammatory	O
pormoter	O
elements	O
.	O

In	O
vitro	O
stimulaiton	O
of	O
mooncytes	O
with	O
the	O
proinfalmmatory	O
agnets	O
intefreron	O
(	O
IFN	O
)	O
gmama	O
,	O
tuomr	B-Disease
ncerosis	O
fatcor	O
,	O
and	O
lipopolsyaccharide	O
induecd	O
MFEV	O
expression	O
,	O
whereas	O
the	O
atniinflammatory	O
ctyokines	O
intreleukin	O
(	O
IL	O
)	O
4	O
,	O
IL	O
-	O
10	O
,	O
and	O
trasnforming	O
grwoth	O
facotr	O
btea	O
inhibtied	O
such	O
expresison	O
.	O

Induciton	O
by	O
IFN	O
-	O
gamma	O
occurred	O
rapidly	O
and	O
was	O
resisatnt	O
to	O
cycloheximdie	O
.	O

IFN	O
-	O
aplha	O
also	O
indcued	O
MFEV	O
expressoin	O
.	O

In	O
granulcoytes	O
,	O
MFEV	O
was	O
up	O
-	O
regulated	O
by	O
IFN	O
-	O
gmama	O
and	O
the	O
cobmination	O
of	O
IFN	O
-	O
alhpa	O
and	O
colhcicine	O
.	O

These	O
rseults	O
refine	O
understanding	O
of	O
MFEV	O
by	O
placing	O
the	O
gnee	O
in	O
the	O
myeloomnocytic	O
-	O
specific	O
proinflammatory	O
pathawy	O
and	O
identifying	O
it	O
as	O
an	O
IFN	O
-	O
gamma	O
immeditae	O
eraly	O
gnee	O
.	O
.	O

Biochemiacl	O
and	O
structuarl	O
analyiss	O
of	O
missnese	O
muttaions	O
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulftae	O
sulfaatse	O
causing	O
mucopolyscacharidosis	B-Disease
IVA	I-Disease
pehnotypes	O
.	O

Mucopolysacchariodsis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
;	O
OIMM	O
#	O
253000	O
)	O
,	O
a	O
lyossomal	B-Disease
sotrage	I-Disease
diosrder	I-Disease
caused	O
by	O
a	O
deficeincy	B-Disease
of	I-Disease
N	I-Disease
-	I-Disease
acetylgalactosamine	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
suflate	I-Disease
sulaftase	I-Disease
(	O
GLANS	O
)	O
,	O
has	O
vraiable	O
clincial	O
phenotpyes	O
.	O

To	O
date	O
we	O
have	O
iedntified	O
65	O
misesnse	O
mutatoins	O
in	O
the	O
GLANS	O
gnee	O
from	O
MPS	B-Disease
IVA	I-Disease
pateints	O
,	O
but	O
the	O
correltaion	O
between	O
geontype	O
and	O
phentoype	O
has	O
remained	O
unclear	O
.	O

We	O
studied	O
17	O
msisense	O
muttaions	O
using	O
biochemiacl	O
approacehs	O
and	O
32	O
missesne	O
mutaitons	O
,	O
using	O
structuarl	O
aanlyses	O
.	O

Fifteen	O
missesne	O
mutatoins	O
and	O
two	O
newly	O
enginereed	O
acitve	O
stie	O
muttaions	O
(	O
C97S	O
,	O
C97T	O
)	O
were	O
charcaterized	O
by	O
trasnient	O
expression	O
analyiss	O
.	O

Muatnt	O
protiens	O
,	O
except	O
for	O
C97S	O
and	O
C97T	O
,	O
were	O
destabiliezd	O
and	O
dteected	O
as	O
insolbule	O
precurosr	O
forms	O
while	O
the	O
C97S	O
and	O
C97T	O
mtuants	O
were	O
of	O
a	O
solbule	O
matrue	O
szie	O
.	O

Muatnts	O
found	O
in	O
the	O
sveere	O
pheontype	O
had	O
no	O
actviity	O
.	O

Mutnats	O
found	O
in	O
the	O
mlid	O
pheontype	O
had	O
a	O
considerable	O
resdiual	O
acitvity	O
(	O
1	O
.	O
3	O
-	O
13	O
.	O
3	O
%	O
of	O
wlid	O
-	O
tpye	O
GANLS	O
acitvity	O
)	O
.	O

Sulfaatses	O
,	O
including	O
GANLS	O
,	O
are	O
membres	O
of	O
a	O
highly	O
conserved	O
gnee	O
faimly	O
sharing	O
an	O
exetnsive	O
sqeuence	O
homoolgy	O
.	O

Thus	O
,	O
a	O
tertairy	O
srtuctural	O
moedl	O
of	O
huamn	O
GLANS	O
was	O
constructed	O
from	O
the	O
X	O
-	O
ray	O
crytsal	O
strucutre	O
of	O
N	O
-	O
acetylgalcato	O
-	O
samnie	O
-	O
4	O
-	O
sulfaatse	O
and	O
aryluslfatase	O
A	O
,	O
using	O
homolgoy	O
moedling	O
,	O
and	O
32	O
misesnse	O
muattions	O
were	O
investgiated	O
.	O

Consequently	O
,	O
we	O
propose	O
that	O
there	O
are	O
at	O
least	O
three	O
different	O
reasnos	O
for	O
the	O
sevree	O
phenoytpe	O
(	O
i	O
)	O
dsetruction	O
of	O
the	O
hydrpohobic	O
croe	O
or	O
modiifcation	O
of	O
the	O
pacikng	O
;	O
(	O
ii	O
)	O
rmeoval	O
of	O
a	O
slat	O
birdge	O
to	O
destabiilze	O
the	O
entire	O
conformaiton	O
;	O
(	O
iii	O
)	O
modificatoin	O
of	O
the	O
actvie	O
stie	O
.	O

In	O
contrast	O
,	O
mlid	O
muattions	O
were	O
mostly	O
located	O
on	O
the	O
sufrace	O
of	O
the	O
GLANS	O
protien	O
.	O

These	O
stuides	O
shed	O
further	O
light	O
on	O
the	O
gneotype	O
-	O
pehnotype	O
correltaion	O
of	O
MPS	B-Disease
IVA	I-Disease
and	O
sturcture	O
-	O
fucntion	O
relationhsip	O
in	O
the	O
sulftaase	O
famliy	O
.	O

Muttaions	O
at	O
the	O
aatxia	B-Disease
-	I-Disease
telangiectaisa	I-Disease
lcous	O
and	O
clniical	O
pehnotypes	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
paitents	O
.	O

Mutatoins	O
at	O
the	O
aatxia	B-Disease
-	I-Disease
telnagiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
lcous	O
on	O
chroomsome	O
bnad	O
11q22	O
cause	O
a	O
distinctive	O
autsoomal	B-Disease
recessvie	I-Disease
synrdome	I-Disease
in	O
homozygoets	O
and	O
predispose	O
heterozygtoes	O
to	O
cacner	B-Disease
,	O
ischeimc	B-Disease
herat	I-Disease
diesase	I-Disease
,	O
and	O
ealry	O
moratlity	O
.	O

PCR	O
amplifictaion	O
from	O
genmoic	O
DNA	O
and	O
autoamted	O
sequencnig	O
of	O
the	O
entire	O
codnig	O
regoin	O
(	O
66	O
exnos	O
)	O
and	O
spilce	O
junctinos	O
deetcted	O
77	O
mutaitons	O
(	O
85	O
%	O
)	O
in	O
90	O
A	B-Disease
-	I-Disease
T	I-Disease
chromsoomes	O
.	O

Heteorduplex	O
anaylsis	O
detecetd	O
another	O
42	O
muattions	O
at	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
lcous	O
.	O

Out	O
of	O
a	O
total	O
of	O
71	O
uinque	O
mutaitons	O
,	O
50	O
were	O
found	O
only	O
in	O
a	O
single	O
fmaily	O
,	O
and	O
51	O
had	O
not	O
been	O
reported	O
previously	O
.	O

Most	O
(	O
58	O
/	O
71	O
,	O
82	O
%	O
)	O
mutatoins	O
were	O
framehsift	O
and	O
nonsesne	O
mtuations	O
that	O
are	O
predicetd	O
to	O
cause	O
trnucation	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
protien	O
;	O
the	O
less	O
common	O
muttaion	O
types	O
were	O
misesnse	O
(	O
9	O
/	O
71	O
,	O
13	O
%	O
)	O
,	O
slpicing	O
(	O
3	O
/	O
71	O
,	O
4	O
%	O
)	O
and	O
one	O
in	O
-	O
farme	O
dleetion	O
,	O
2546	O
3	O
(	O
1	O
/	O
71	O
,	O
1	O
%	O
)	O
.	O

The	O
mean	O
suvrival	O
and	O
heihgt	O
distirbution	O
of	O
134	O
A	B-Disease
-	I-Disease
T	I-Disease
pateints	O
crorelated	O
significantly	O
with	O
the	O
specific	O
mutatinos	O
present	O
in	O
the	O
patinets	O
.	O

Patinets	O
homozyguos	O
for	O
a	O
single	O
truncatnig	O
muattion	O
,	O
typically	O
near	O
the	O
N	O
-	O
terimnal	O
end	O
of	O
the	O
gnee	O
,	O
or	O
heetrozygous	O
for	O
the	O
in	O
-	O
farme	O
deletoin	O
2546	O
3	O
,	O
were	O
shroter	O
and	O
had	O
significantly	O
shotrer	O
survvial	O
than	O
those	O
heterozgyous	O
for	O
a	O
splcie	O
stie	O
or	O
missnese	O
mtuation	O
,	O
or	O
heterzoygous	O
for	O
two	O
truncatnig	O
mutatoins	O
.	O

Altreations	O
of	O
the	O
lentgh	O
or	O
amnio	O
aicd	O
copmosition	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
gnee	O
porduct	O
affect	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
clniical	O
phenotpye	O
in	O
different	O
ways	O
.	O

Muattion	O
analsyis	O
at	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
loucs	O
may	O
help	O
estimtae	O
the	O
prognoiss	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
patietns	O
.	O
.	O

Isoltaion	O
,	O
gneomic	O
orgnaization	O
,	O
and	O
expression	O
aanlysis	O
of	O
the	O
muose	O
and	O
rat	O
homloogs	O
of	O
MFEV	O
,	O
the	O
gnee	O
for	O
faimlial	B-Disease
mediterarnean	I-Disease
feevr	I-Disease
.	O

Fmailial	B-Disease
Medietrranean	I-Disease
fveer	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
reecssive	B-Disease
disroder	I-Disease
charactreized	O
by	O
episdoes	O
of	O
fveer	B-Disease
with	O
seroistis	B-Disease
or	O
synoivtis	B-Disease
.	O

Recently	O
the	O
FMF	B-Disease
gnee	O
(	O
MFEV	O
)	O
was	O
colned	O
;	O
the	O
portein	O
porduct	O
,	O
pyirn	O
/	O
marensotrin	O
,	O
is	O
thought	O
to	O
regluate	O
inflamamtion	O
in	O
myeliod	O
cells	O
.	O

In	O
this	O
manuscrpit	O
we	O
reprot	O
the	O
muose	O
and	O
rat	O
hoomlogs	O
of	O
MFEV	O
.	O

The	O
mruine	O
gnee	O
contains	O
ten	O
eoxns	O
with	O
a	O
coidng	O
sequecne	O
of	O
2304	O
bp	O
,	O
while	O
the	O
rat	O
homoolg	O
has	O
nine	O
exnos	O
with	O
a	O
cdoing	O
sequecne	O
of	O
2253	O
bp	O
.	O

A	O
considerable	O
aimno	O
aicd	O
seqeunce	O
homloogy	O
was	O
observed	O
between	O
the	O
muose	O
and	O
hmuan	O
(	O
47	O
.	O
6	O
%	O
idetnity	O
and	O
65	O
.	O
5	O
%	O
simialrity	O
)	O
and	O
between	O
the	O
muose	O
and	O
rat	O
gnees	O
(	O
73	O
.	O
5	O
%	O
idetnity	O
and	O
82	O
.	O
1	O
%	O
similairty	O
)	O
.	O

The	O
predcited	O
roednt	O
protenis	O
have	O
several	O
important	O
dmoains	O
and	O
siganls	O
found	O
in	O
huamn	O
pryin	O
,	O
including	O
a	O
B	O
-	O
box	O
znic	O
fniger	O
dmoain	O
,	O
Robbins	O
-	O
Dnigwall	O
nculear	O
locailzation	O
siganl	O
,	O
and	O
coield	O
-	O
ciol	O
domian	O
.	O

However	O
,	O
perhaps	O
because	O
of	O
an	O
ancient	O
farme	O
-	O
shift	O
mutatoin	O
,	O
neither	O
the	O
mosue	O
nor	O
the	O
rat	O
proetin	O
has	O
an	O
inatct	O
C	O
-	O
temrinal	O
B30	O
.	O

2	O
doamin	O
,	O
in	O
which	O
most	O
FMF	B-Disease
-	O
associated	O
mutatoins	O
have	O
been	O
found	O
in	O
hmuan	O
MFEV	O
.	O

Nevertheless	O
,	O
like	O
the	O
huamn	O
gnee	O
,	O
mosue	O
Mfev	O
is	O
epxressed	O
in	O
preipheral	O
bolod	O
granuloyctes	O
but	O
not	O
lymphoyctes	O
.	O

Consistent	O
with	O
its	O
experssion	O
in	O
garnulocytes	O
,	O
Mfev	O
was	O
deetcted	O
at	O
high	O
levles	O
in	O
the	O
pirmary	O
folilcles	O
and	O
mraginal	O
znoes	O
of	O
the	O
splneic	O
whtie	O
plup	O
.	O

Mfev	O
is	O
lcoalized	O
on	O
muose	O
Chormosome	O
(	O
Chr	O
)	O
16	O
,	O
regoin	O
A3	O
-	O
B1	O
,	O
extending	O
a	O
reigon	O
of	O
snyteny	O
with	O
huamn	O
Chr	O
16p13	O
.	O

3	O
.	O

Develpoment	O
of	O
knocokut	O
and	O
konckin	O
mosue	O
mdoels	O
may	O
provide	O
further	O
insights	O
into	O
the	O
funtcional	O
evoultion	O
of	O
this	O
gnee	O
.	O

Additional	O
coipes	O
of	O
the	O
protoelipid	O
protien	O
gnee	O
causing	O
Pelziaeus	B-Disease
-	I-Disease
Merzabcher	I-Disease
diesase	I-Disease
arise	O
by	O
separate	O
itnegration	O
into	O
the	O
X	O
chormosome	O
.	O

The	O
protoelipid	O
portein	O
gnee	O
(	O
PLP	O
)	O
is	O
normally	O
present	O
at	O
chromoosme	O
X2q2	O
.	O

Mtuations	O
and	O
dpulications	O
of	O
this	O
gnee	O
are	O
associated	O
with	O
Pleizaeus	B-Disease
-	I-Disease
Merzbcaher	I-Disease
diesase	I-Disease
(	O
PMD	B-Disease
)	O
.	O

Here	O
we	O
describe	O
two	O
new	O
famileis	O
in	O
which	O
mlaes	O
affected	O
with	O
PMD	B-Disease
were	O
found	O
to	O
have	O
a	O
cpoy	O
of	O
PLP	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
crhomosome	O
,	O
in	O
addition	O
to	O
a	O
nomral	O
cpoy	O
on	O
X2q2	O
.	O

In	O
the	O
first	O
faimly	O
,	O
the	O
extra	O
cpoy	O
was	O
first	O
detceted	O
by	O
the	O
presnece	O
of	O
hteerozygosity	O
of	O
the	O
AahII	O
dimrophism	O
within	O
the	O
PLP	O
gnee	O
.	O

The	O
rseults	O
of	O
FSIH	O
anaylsis	O
showed	O
an	O
additional	O
cpoy	O
of	O
PLP	O
in	O
X2p2	O
.	O

1	O
,	O
although	O
no	O
chormosomal	O
rearrangemetns	O
could	O
be	O
detecetd	O
by	O
stanadrd	O
karyotpye	O
aanlysis	O
.	O

Another	O
three	O
affceted	O
mlaes	O
from	O
the	O
famliy	O
had	O
similar	O
findnigs	O
.	O

In	O
a	O
second	O
unrelated	O
famliy	O
with	O
sgins	O
of	O
PMD	B-Disease
,	O
cytoegnetic	O
analyiss	O
showed	O
a	O
pericentirc	O
inevrsion	O
of	O
the	O
X	O
chromoosme	O
.	O

In	O
the	O
inv	O
(	O
X	O
)	O
carried	O
by	O
several	O
affceted	O
faimly	O
membres	O
,	O
FSIH	O
showed	O
PLP	O
signlas	O
at	O
X1p1	O
.	O

4	O
and	O
X2q2	O
.	O

A	O
third	O
fmaily	O
has	O
previously	O
been	O
reported	O
,	O
in	O
which	O
affecetd	O
memebrs	O
had	O
an	O
extra	O
cpoy	O
of	O
the	O
PLP	O
gnee	O
detetced	O
at	O
X2q6	O
in	O
a	O
chroomsome	O
with	O
an	O
otherwise	O
nromal	O
badning	O
patetrn	O
.	O

The	O
identiifcation	O
of	O
three	O
separate	O
faimlies	O
in	O
which	O
PLP	O
is	O
dulpicated	O
at	O
a	O
noncontiguous	O
stie	O
suggests	O
that	O
such	O
duplicaitons	O
could	O
be	O
a	O
relatively	O
common	O
but	O
previously	O
undetected	O
cause	O
of	O
geneitc	B-Disease
disordres	I-Disease
.	O

The	O
eoxn	O
13	O
duplicaiton	O
in	O
the	O
BCRA1	O
gnee	O
is	O
a	O
fonuder	O
mutaiton	O
present	O
in	O
geographiaclly	O
dvierse	O
popualtions	O
.	O

The	O
BCRA1	O
Eoxn	O
13	O
Duplciation	O
Screneing	O
Gorup	O
.	O

Recently	O
,	O
a	O
6	O
-	O
kb	O
duplicatoin	O
of	O
eoxn	O
13	O
,	O
which	O
creates	O
a	O
framesihft	O
in	O
the	O
cdoing	O
sqeuence	O
of	O
the	O
BRAC1	O
gnee	O
,	O
has	O
been	O
described	O
in	O
three	O
unrelated	O
U	O
.	O

S	O
S	O
.	O
famileis	O
of	O
Eurpoean	O
ancesrty	O
and	O
in	O
one	O
Portugusee	O
fmaily	O
.	O

Here	O
,	O
our	O
gaol	O
was	O
to	O
estiamte	O
the	O
ferquency	O
and	O
gegoraphic	O
dviersity	O
of	O
carrires	O
of	O
this	O
dupliaction	O
.	O

To	O
do	O
this	O
,	O
a	O
collaboraitve	O
srceening	O
stduy	O
was	O
set	O
up	O
that	O
involved	O
39	O
insttiutions	O
from	O
19	O
conutries	O
and	O
included	O
3	O
,	O
580	O
unrelated	O
inidviduals	O
with	O
a	O
famliy	O
hsitory	O
of	O
the	O
disaese	O
and	O
934	O
eraly	O
-	O
onset	O
bresat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovraian	I-Disease
cnacer	I-Disease
csaes	O
.	O

A	O
total	O
of	O
11	O
additional	O
faimlies	O
carrying	O
this	O
mtuation	O
were	O
identiifed	O
in	O
Autsralia	O
(	O
1	O
)	O
,	O
Beglium	O
(	O
1	O
)	O
,	O
Cnaada	O
(	O
1	O
)	O
,	O
Gerat	O
Briatin	O
(	O
6	O
)	O
,	O
and	O
the	O
Untied	O
Sttaes	O
(	O
2	O
)	O
.	O

Hapltoyping	O
showed	O
that	O
they	O
are	O
likely	O
to	O
derive	O
from	O
a	O
common	O
ancetsor	O
,	O
possibly	O
of	O
northren	O
Briitsh	O
oirgin	O
.	O

Our	O
resluts	O
demonstrate	O
that	O
it	O
is	O
strongly	O
advisable	O
,	O
for	O
laboartories	O
carrying	O
out	O
screennig	O
either	O
in	O
Enlgish	O
-	O
sepaking	O
coutnries	O
or	O
in	O
coutnries	O
with	O
hsitorical	O
links	O
with	O
Birtain	O
,	O
to	O
include	O
within	O
their	O
BRAC1	O
srceening	O
protoocls	O
the	O
polmyerase	O
chian	O
recation	O
-	O
based	O
asasy	O
described	O
in	O
this	O
reprot	O
.	O

Genotpye	O
-	O
phentoype	O
correaltions	O
in	O
famileis	O
with	O
deeltions	O
in	O
the	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lidnau	I-Disease
(	O
VHL	B-Disease
)	O
gnee	O
.	O

Von	B-Disease
Hpipel	I-Disease
-	I-Disease
Lnidau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
diesase	I-Disease
is	O
a	O
hereditray	B-Disease
tmuor	I-Disease
sydnrome	I-Disease
charatcerized	O
by	O
predispsoition	O
for	O
bilatearl	B-Disease
and	I-Disease
mluti	I-Disease
-	I-Disease
cenrtic	I-Disease
hemanigoblastoma	I-Disease
in	O
the	O
reitna	O
and	O
cenrtal	O
nrevous	O
sysetm	O
,	O
pheocrhomocytoma	B-Disease
,	O
reanl	B-Disease
clel	I-Disease
cacrinoma	I-Disease
,	O
and	O
csyts	B-Disease
in	I-Disease
the	I-Disease
kideny	I-Disease
,	I-Disease
panceras	I-Disease
,	I-Disease
and	I-Disease
epiiddymis	I-Disease
.	O

We	O
describe	O
five	O
famiiles	O
for	O
which	O
direct	O
seuqencing	O
of	O
the	O
codnig	O
reigon	O
of	O
the	O
VHL	B-Disease
gnee	O
had	O
failed	O
to	O
identify	O
the	O
fmaily	O
-	O
specific	O
mutaiton	O
.	O

Further	O
mloecular	O
analyiss	O
rveealed	O
deleitons	O
involving	O
the	O
VHL	B-Disease
gnee	O
in	O
each	O
of	O
these	O
fmailies	O
.	O

In	O
four	O
famiiles	O
,	O
partail	O
deeltions	O
of	O
one	O
or	O
more	O
exnos	O
were	O
detetced	O
by	O
Sotuhern	O
bolt	O
aanlysis	O
.	O

In	O
the	O
fifth	O
famliy	O
,	O
FSIH	O
analsyis	O
demonstrated	O
the	O
delteion	O
of	O
the	O
entire	O
VHL	B-Disease
gnee	O
.	O

Our	O
reuslts	O
show	O
that	O
(	O
qauntitative	O
)	O
Suothern	O
bolt	O
anaylsis	O
is	O
a	O
sesnitive	O
mehtod	O
for	O
deetcting	O
germlnie	O
delteions	O
of	O
the	O
VHL	B-Disease
gnee	O
and	O
should	O
be	O
implemented	O
in	O
routnie	O
DNA	O
daignosis	O
for	O
VHL	B-Disease
disesae	I-Disease
.	O

Our	O
dtaa	O
support	O
the	O
previously	O
established	O
observaiton	O
that	O
fmailies	O
with	O
a	O
germilne	O
deletoin	O
have	O
a	O
low	O
rsik	O
for	O
pheochroomcytoma	B-Disease
.	O

Further	O
unraveling	O
of	O
geontype	O
-	O
phenoytpe	O
correlations	O
in	O
VHL	B-Disease
disaese	I-Disease
has	O
reevaled	O
that	O
famileis	O
with	O
a	O
full	O
or	O
patrial	O
deletoin	O
of	O
the	O
VHL	B-Disease
gnee	O
exhibit	O
a	O
pheontype	O
with	O
a	O
preponderance	O
of	O
centarl	B-Disease
nrevous	I-Disease
sysetm	I-Disease
hemangiolbastoma	I-Disease
.	O
.	O

Age	O
of	O
the	O
intornic	O
GAA	O
trpilet	O
rpeeat	O
expanison	O
mtuation	O
in	O
Friedrecih	B-Disease
aatxia	I-Disease
.	O

Frierdeich	B-Disease
aatxia	I-Disease
(	O
FDRA	B-Disease
)	O
,	O
the	O
most	O
frequently	O
inheirted	B-Disease
atxaia	I-Disease
,	O
is	O
due	O
in	O
the	O
vast	O
majority	O
of	O
caess	O
to	O
a	O
large	O
exapnsion	O
of	O
an	O
intrnoic	O
GAA	O
reepat	O
.	O

Using	O
linkgae	O
disequilibirum	O
anlaysis	O
based	O
on	O
hapoltype	O
dtaa	O
of	O
seven	O
polymrophic	O
makrers	O
close	O
to	O
the	O
fartaxin	O
gnee	O
,	O
the	O
age	O
of	O
FDRA	B-Disease
fonuding	O
mutatoinal	O
evnet	O
(	O
s	O
)	O
is	O
esitmated	O
to	O
be	O
at	O
least	O
682	O
+	O
/	O
-	O
203	O
genreations	O
(	O
95	O
%	O
confiednce	O
itnerval	O
564	O
-	O
801	O
g	O
)	O
,	O
a	O
dating	O
which	O
is	O
consistent	O
with	O
little	O
or	O
no	O
negatvie	O
seleciton	O
and	O
provides	O
further	O
evidnece	O
for	O
an	O
ancient	O
sperad	O
of	O
a	O
pre	O
-	O
muttaion	O
(	O
at	O
-	O
rsik	O
alelles	O
)	O
in	O
westren	O
Eurpoe	O
.	O
.	O

Functinoal	O
link	O
between	O
ataixa	B-Disease
-	I-Disease
telangicetasia	I-Disease
and	O
Nijemgen	B-Disease
berakage	I-Disease
syndrmoe	I-Disease
gnee	O
produtcs	O
.	O

Ataixa	B-Disease
-	I-Disease
telangietcasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
and	O
Nijmeegn	B-Disease
berakage	I-Disease
sydnrome	I-Disease
(	O
NBS	B-Disease
)	O
are	O
recsesive	B-Disease
genteic	I-Disease
diosrders	I-Disease
with	O
susceptiiblity	O
to	O
cnacer	B-Disease
and	O
similar	O
cellluar	O
pheontypes	O
.	O

The	O
prtoein	O
porduct	O
of	O
the	O
gnee	O
responsible	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
designated	O
ATM	O
,	O
is	O
a	O
member	O
of	O
a	O
faimly	O
of	O
kniases	O
chraacterized	O
by	O
a	O
craboxy	O
-	O
temrinal	O
phosphatdiylinositol	O
3	O
-	O
kniase	O
-	O
like	O
domian	O
.	O

The	O
NSB1	O
prtoein	O
is	O
specifically	O
mtuated	O
in	O
ptaients	O
with	O
Nijmgeen	B-Disease
breakgae	I-Disease
sydnrome	I-Disease
and	O
forms	O
a	O
compelx	O
with	O
the	O
DNA	O
repiar	O
protiens	O
Ra5d0	O
and	O
Merl1	O
.	O

Here	O
we	O
show	O
that	O
pohsphorylation	O
of	O
NSB1	O
,	O
idnuced	O
by	O
ioinzing	O
raditaion	O
,	O
requires	O
catlaytically	O
atcive	O
ATM	O
.	O

Compelxes	O
containing	O
ATM	O
and	O
NSB1	O
exist	O
in	O
vivo	O
in	O
both	O
utnreated	O
clels	O
and	O
clels	O
treaetd	O
with	O
ioinzing	O
raditaion	O
.	O

We	O
have	O
iedntified	O
two	O
resiudes	O
of	O
NSB1	O
,	O
Ser	O
278	O
and	O
Ser	O
343	O
that	O
are	O
phosphorylaetd	O
in	O
vitro	O
by	O
ATM	O
and	O
whose	O
modificaiton	O
in	O
vivo	O
is	O
essential	O
for	O
the	O
cellluar	O
repsonse	O
to	O
DNA	O
dmaage	O
.	O

This	O
repsonse	O
includes	O
S	O
-	O
pahse	O
checkopint	O
atcivation	O
,	O
fomration	O
of	O
the	O
NSB1	O
/	O
Mrle1	O
/	O
Rda50	O
nulcear	O
fcoi	O
and	O
rescue	O
of	O
hypersenistivity	B-Disease
to	I-Disease
ioniizng	I-Disease
radiaiton	I-Disease
.	O

Together	O
,	O
these	O
rseults	O
demonstrate	O
a	O
boichemical	O
link	O
between	O
clel	O
-	O
cylce	O
cehckpoints	O
actiavted	O
by	O
DNA	O
daamge	O
and	O
DNA	O
repiar	O
in	O
two	O
genteic	B-Disease
diesases	I-Disease
with	O
overlapping	O
phenoytpes	O
.	O
.	O

Hmoozygosity	O
mapipng	O
in	O
a	O
faimly	O
with	O
microcepahly	B-Disease
,	O
mnetal	B-Disease
rteardation	I-Disease
,	O
and	O
short	B-Disease
stautre	I-Disease
to	O
a	O
Choen	B-Disease
snydrome	I-Disease
reigon	O
on	O
82q1	O
.	O
3	O
-	O
82q2	O
.	O
1	O
:	O
redefining	O
a	O
cliniacl	O
entity	O
.	O

A	O
sydnrome	O
of	O
mircocephaly	B-Disease
,	O
prgoressive	O
potsnatal	B-Disease
gorwth	I-Disease
deifciency	I-Disease
,	O
and	O
menatl	B-Disease
retardtaion	I-Disease
was	O
observed	O
in	O
two	O
brohters	O
and	O
their	O
cosuin	O
from	O
a	O
multiply	O
consagnuineous	O
knidred	O
of	O
Lbeanese	O
desecnt	O
.	O

Hypootnia	B-Disease
,	O
choriorteinal	B-Disease
dystorphy	I-Disease
,	O
and	O
moypia	B-Disease
were	O
also	O
identfiied	O
.	O

The	O
sveerity	O
of	O
the	O
codnition	O
varied	O
among	O
the	O
closely	O
related	O
ptaients	O
.	O

Because	O
of	O
absecne	O
of	O
a	O
distinctive	O
facail	O
appaerance	O
,	O
the	O
degere	O
of	O
menatl	B-Disease
retardatoin	I-Disease
,	O
and	O
short	B-Disease
statrue	I-Disease
,	O
the	O
initially	O
considered	O
clincial	O
diagnoiss	O
of	O
Coehn	B-Disease
syndrmoe	I-Disease
was	O
withdrawn	O
and	O
a	O
novel	O
geneitc	O
entity	O
was	O
assumed	O
.	O

Homozgyosity	O
mpaping	O
in	O
this	O
faimly	O
assigned	O
the	O
gnee	O
to	O
a	O
26	O
.	O

8	O
-	O
cM	O
reigon	O
on	O
the	O
chrmoosome	O
bnad	O
82q1	O
.	O

3	O
-	O
22	O
.	O

1	O
,	O
between	O
the	O
microstaellites	O
at	O
DS8270	O
and	O
DS8514	O
.	O

The	O
maxiumm	O
two	O
-	O
point	O
LOD	O
scroe	O
was	O
found	O
for	O
mraker	O
at	O
D82S67	O
(	O
Zamx	O
=	O
3	O
.	O
.	O
237	O
at	O
Oamx	O
=	O
0	O
.	O
00	O
)	O
.	O

Intriguingly	O
enough	O
,	O
the	O
idetnified	O
gnee	O
rgeion	O
ovelraps	O
the	O
refined	O
gnee	O
rgeion	O
for	O
Coehn	B-Disease
synrdome	I-Disease
(	O
CHO1	O
)	O
[	O
Kolehaminen	O
et	O
al	O
.	O
,	O
1997	O
Eruo	O
J	O
Hum	O
Genet	O
5	O
206	O
-	O
213	O
]	O
.	O

This	O
fact	O
encourages	O
the	O
hyptohesis	O
that	O
the	O
described	O
kidnred	O
segregates	O
for	O
a	O
varaint	O
of	O
Coehn	B-Disease
sydnrome	I-Disease
and	O
suggests	O
a	O
redefinition	O
of	O
its	O
phenoytpe	O

Polymorphsims	O
of	O
the	O
CY2PD6	O
gnee	O
incerase	O
susecptibility	O
to	O
aknylosing	B-Disease
spondyiltis	I-Disease
.	O

Ankylsoing	B-Disease
spodnylitis	I-Disease
(	O
AS	B-Disease
)	O
is	O
a	O
common	O
and	O
highly	O
familail	O
rheumtaic	B-Disease
disodrer	I-Disease
.	O

The	O
siblnig	O
rceurrence	O
rsik	O
rtaio	O
for	O
the	O
diesase	O
is	O
63	O
and	O
heritabiltiy	O
assesesd	O
in	O
tiwns	O
>	O
90	O
%	O
.	O

Although	O
MHC	O
gnees	O
,	O
including	O
HLA	O
-	O
B27	O
,	O
contribute	O
only	O
20	O
-	O
50	O
%	O
of	O
the	O
gneetic	O
rsik	O
for	O
the	O
disesae	O
,	O
no	O
non	O
-	O
MHC	O
gnee	O
has	O
yet	O
been	O
convincingly	O
demonstrated	O
to	O
influecne	O
either	O
ssuceptibility	O
to	O
the	O
dsiease	O
or	O
its	O
pehnotypic	O
expression	O
.	O

Previous	O
linakge	O
and	O
asscoiation	O
stuides	O
have	O
suggested	O
the	O
presnece	O
of	O
a	O
suscetpibility	O
gnee	O
for	O
AS	B-Disease
close	O
to	O
,	O
or	O
within	O
,	O
the	O
cytochrmoe	O
P540	O
2D6	O
gnee	O
(	O
CYPD26	O
,	O
derbisoquine	O
hdyroxylase	O
)	O
located	O
at	O
chromoosme	O
22q13	O
.	O
1	O
.	O

We	O
performed	O
a	O
linkgae	O
sutdy	O
of	O
chromsoome	O
22	O
in	O
200	O
faimlies	O
with	O
AS	B-Disease
affceted	O
silbing	O
-	O
paris	O
.	O

Associtaion	O
of	O
alleels	O
of	O
the	O
CY2PD6	O
gnee	O
was	O
examined	O
by	O
both	O
csae	O
-	O
cnotrol	O
and	O
within	O
-	O
famliy	O
means	O
.	O

For	O
csae	O
-	O
contorl	O
stduies	O
,	O
617	O
unrelated	O
individulas	O
with	O
AS	B-Disease
(	O
361	O
probadns	O
from	O
sbiling	O
-	O
piar	O
and	O
parnet	O
-	O
csae	O
tiro	O
fmailies	O
and	O
256	O
unrelated	O
non	O
-	O
familail	O
spoardic	O
caess	O
)	O
and	O
402	O
heatlhy	O
ethincally	O
matched	O
contorls	O
were	O
employed	O
.	O

For	O
within	O
-	O
fmaily	O
assocaition	O
sutdies	O
,	O
361	O
fmailies	O
including	O
161	O
paernt	O
-	O
csae	O
tiros	O
and	O
200	O
affecetd	O
sibilng	O
-	O
piar	O
famileis	O
were	O
employed	O
.	O

Homoyzgosity	O
for	O
poor	O
metbaolizer	O
alllees	O
was	O
found	O
to	O
be	O
associated	O
with	O
AS	B-Disease
.	O

Heterozygostiy	O
for	O
the	O
most	O
freuqent	O
poor	O
metaboliezr	O
allele	O
(	O
CYPD26	O
*	O
4	O
)	O
was	O
not	O
associated	O
with	O
inrceased	O
ssuceptibility	O
to	O
AS	B-Disease
.	O

Siginficant	O
within	O
-	O
famliy	O
assocaition	O
of	O
CYPD26	O
*	O
4	O
alleles	O
and	O
AS	B-Disease
was	O
demonstrated	O
.	O

Waek	O
lnikage	O
was	O
also	O
demonstrated	O
between	O
CY2PD6	O
and	O
AS	B-Disease
.	O

We	O
postulate	O
that	O
altreed	O
metabloism	O
of	O
a	O
natrual	O
toixn	O
or	O
atnigen	O
by	O
the	O
CY2PD6	O
gnee	O
may	O
incresae	O
suscpetibility	O
to	O
AS	B-Disease
.	O

Functioanl	O
differneces	O
of	O
the	O
PDS	B-Disease
gnee	O
prdouct	O
are	O
associated	O
with	O
phentoypic	O
vairation	O
in	O
pateints	O
with	O
Pnedred	B-Disease
syndrmoe	I-Disease
and	O
non	B-Disease
-	I-Disease
snydromic	I-Disease
heraing	I-Disease
lsos	I-Disease
(	O
DNFB4	B-Disease
)	O
.	O

The	O
PDS	B-Disease
gnee	O
encoeds	O
a	O
transmemrbane	O
protien	O
,	O
known	O
as	O
pendirn	O
,	O
which	O
fucntions	O
as	O
a	O
transproter	O
of	O
idoide	O
and	O
chlordie	O
.	O

Muttaions	O
in	O
this	O
gnee	O
are	O
responsible	O
for	O
Penrded	B-Disease
syndorme	I-Disease
and	O
autosoaml	B-Disease
recessvie	I-Disease
non	I-Disease
-	I-Disease
sydnromic	I-Disease
hearnig	I-Disease
lsos	I-Disease
at	O
the	O
DNFB4	B-Disease
loucs	O
on	O
chromosmoe	O
73q1	O
.	O

A	O
sceren	O
of	O
20	O
indiivduals	O
from	O
the	O
midwsetern	O
USA	O
with	O
non	B-Disease
-	I-Disease
snydromic	I-Disease
heraing	I-Disease
lsos	I-Disease
and	O
dilaetd	O
vestbiular	O
aqudeucts	O
idenitfied	O
three	O
poeple	O
(	O
15	O
%	O
)	O
with	O
PDS	B-Disease
mutatinos	O
.	O

To	O
determine	O
whether	O
PDS	B-Disease
mutatoins	O
in	O
indiviudals	O
with	O
Penderd	B-Disease
snydrome	I-Disease
differ	O
functionally	O
from	O
PDS	B-Disease
mtuations	O
in	O
indiivduals	O
with	O
non	B-Disease
-	I-Disease
syndrmoic	I-Disease
hearnig	I-Disease
lsos	I-Disease
,	O
we	O
compaerd	O
three	O
common	O
Pnedred	B-Disease
sydnrome	I-Disease
allele	O
variatns	O
(	O
L326P	O
,	O
T461P	O
and	O
E834G	O
)	O
,	O
with	O
three	O
PDS	B-Disease
muattions	O
reported	O
only	O
in	O
idnividuals	O
with	O
non	B-Disease
-	I-Disease
syndroimc	I-Disease
heairng	I-Disease
lsos	I-Disease
(	O
V408D	O
,	O
V563A	O
and	O
I409L	O
/	O
G947S	O
)	O
.	O

The	O
muattions	O
associated	O
with	O
Pednred	B-Disease
syndorme	I-Disease
have	O
complete	O
lsos	O
of	O
pendirn	O
-	O
inudced	O
chlordie	O
and	O
ioidde	O
trnasport	O
,	O
while	O
alelles	O
unqiue	O
to	O
poeple	O
with	O
DNFB4	B-Disease
are	O
able	O
to	O
trnasport	O
both	O
ioidde	O
and	O
cholride	O
,	O
albeit	O
at	O
a	O
much	O
lwoer	O
leevl	O
than	O
wlid	O
-	O
tpye	O
pnedrin	O
.	O

We	O
hypothesize	O
that	O
this	O
residaul	O
leevl	O
of	O
ainon	O
transprot	O
is	O
sufficient	O
to	O
eliminate	O
or	O
postpone	O
the	O
onset	O
of	O
gioter	B-Disease
in	O
indviiduals	O
with	O
DFBN4	B-Disease
.	O

We	O
propose	O
a	O
mdoel	O
for	O
pnedrin	O
functoin	O
in	O
the	O
tyhroid	O
in	O
which	O
pednrin	O
tarnsports	O
ioddie	O
across	O
the	O
aipcal	O
membrnae	O
of	O
the	O
thyrcoyte	O
into	O
the	O
cololid	O
sapce	O
.	O
.	O

The	O
huamn	O
facotr	O
IX	O
gnee	O
as	O
germilne	O
mutaegn	O
tset	O
:	O
sampels	O
from	O
Mailnand	O
Chnia	O
have	O
the	O
putatively	O
endogeonus	O
pattren	O
of	O
mutatoin	O
.	O

Gerlmine	O
muttaions	O
are	O
the	O
major	O
suorce	O
of	O
geentic	O
vraiation	O
that	O
allows	O
a	O
speceis	O
to	O
evolve	O
over	O
tmie	O
but	O
at	O
the	O
csot	O
of	O
Mendleian	B-Disease
dsiease	I-Disease
and	O
gneetic	O
predispoistion	O
to	O
multifacotrial	B-Disease
disesaes	I-Disease
.	O

Previous	O
analyess	O
have	O
reveaeld	O
that	O
the	O
pattern	O
of	O
germilne	O
mutatoins	O
in	O
the	O
fcator	O
IX	O
gnee	O
(	O
F9	O
)	O
is	O
similar	O
among	O
a	O
variety	O
of	O
etnhically	O
and	O
geograpihcally	O
divrese	O
popluations	O
and	O
compatible	O
with	O
the	O
ancient	O
pattern	O
that	O
has	O
sahped	O
the	O
mammalain	O
geonme	O
.	O

Here	O
,	O
we	O
cmopare	O
the	O
pattern	O
of	O
germilne	O
mutatoin	O
in	O
a	O
populatoin	O
of	O
hemopihlia	B-Disease
B	I-Disease
ptaients	O
from	O
Mianland	O
Cihna	O
(	O
n	O
=	O
66	O
)	O
to	O
that	O
in	O
U	O
.	O

S	O
.	O

Caucasinas	O
,	O
Blcaks	O
,	O
and	O
Meixcan	O
Hsipanics	O
and	O
stratify	O
by	O
disesae	O
seveirty	O
and	O
ethincity	O
.	O

The	O
similar	O
patetrn	O
of	O
gerlmine	O
mtuation	O
in	O
all	O
ethinc	O
gruops	O
studied	O
to	O
date	O
provides	O
additional	O
dtaa	O
compatible	O
with	O
the	O
infreence	O
that	O
enodgenous	O
processes	O
predominate	O
in	O
gerlmine	O
mtuations	O
.	O

Fas	O
preassoication	O
required	O
for	O
aopptosis	O
singaling	O
and	O
doimnant	O
inhibtiion	O
by	O
pathoegnic	O
mutatinos	O
.	O

Heterozyogus	O
mutaitons	O
encdoing	O
anbormal	O
forms	O
of	O
the	O
daeth	O
recepotr	O
Fas	O
dominantly	O
interfere	O
with	O
Fas	O
-	O
idnuced	O
lymphoycte	O
aopptosis	O
in	O
hmuan	O
autoimmnue	B-Disease
lymphoprolifreative	I-Disease
sydnrome	I-Disease
.	O

This	O
effect	O
,	O
rather	O
than	O
depending	O
on	O
lgiand	O
-	O
induecd	O
rceeptor	O
oligmoerization	O
,	O
was	O
found	O
to	O
setm	O
from	O
lignad	O
-	O
inedpendent	O
interaciton	O
of	O
wlid	O
-	O
tpye	O
and	O
mtuant	O
Fas	O
recpetors	O
through	O
a	O
specific	O
regoin	O
in	O
the	O
extraclelular	O
dmoain	O
.	O

Preasosciated	O
Fas	O
comlpexes	O
were	O
found	O
in	O
lviing	O
cells	O
by	O
means	O
of	O
fluoresecnce	O
resnoance	O
eenrgy	O
tarnsfer	O
between	O
vairants	O
of	O
green	O
fluorescnet	O
proetin	O
.	O

These	O
resutls	O
show	O
that	O
foramtion	O
of	O
preassociaetd	O
rceeptor	O
copmlexes	O
is	O
necessary	O
for	O
Fas	O
siganling	O
and	O
dmoinant	O
intreference	O
in	O
huamn	O
disaese	O
.	O
.	O

Determniation	O
of	O
carirer	O
stauts	O
for	O
the	O
Wiksott	B-Disease
-	I-Disease
Adlrich	I-Disease
sydnrome	I-Disease
by	O
folw	O
cytomertic	O
anaylsis	O
of	O
Wisktot	B-Disease
-	I-Disease
Aldrcih	I-Disease
sydnrome	I-Disease
prtoein	O
expressoin	O
in	O
peripehral	O
bolod	O
monnouclear	O
clels	O
.	O

The	O
Wsikott	B-Disease
-	I-Disease
Alrdich	I-Disease
syndrmoe	I-Disease
(	O
WAS	B-Disease
)	O
is	O
caused	O
by	O
defetcs	O
in	O
the	O
WAS	B-Disease
proetin	O
(	O
WSAP	O
)	O
gnee	O
on	O
the	O
X	O
chormosome	O
.	O

Previous	O
stduy	O
disclosed	O
that	O
folw	O
cytomertic	O
anlaysis	O
of	O
intarcellular	O
WSAP	O
expression	O
(	O
FCM	O
-	O
WSAP	O
anaylsis	O
)	O
in	O
lmyphocytes	O
was	O
useful	O
for	O
the	O
diagnsois	O
of	O
WAS	B-Disease
pateints	O
.	O

Lymphoyctes	O
from	O
all	O
WAS	B-Disease
ptaients	O
showed	O
WASdPim	O
instead	O
of	O
WAPSbright	O
.	O

Here	O
we	O
reoprt	O
that	O
FCM	O
-	O
WSAP	O
anlaysis	O
in	O
monoyctes	O
could	O
be	O
a	O
useful	O
tool	O
for	O
the	O
WAS	B-Disease
carrier	O
diganosis	O
.	O

Mooncytes	O
from	O
all	O
nine	O
WAS	B-Disease
crariers	O
showed	O
varied	O
populatoin	O
of	O
WAPSdim	O
together	O
with	O
WAPSbright	O
.	O

None	O
of	O
cotnrol	O
inidviduals	O
possessed	O
the	O
WASdPim	O
pouplation	O
.	O

In	O
contrast	O
,	O
lmyphocytes	O
from	O
all	O
the	O
carriers	O
except	O
two	O
lacked	O
the	O
WASdPim	O
popualtion	O
.	O

The	O
difference	O
of	O
the	O
WASdPim	O
popualtion	O
in	O
mooncytes	O
and	O
lmyphocytes	O
observed	O
in	O
WAS	B-Disease
carriers	O
suggests	O
that	O
WSAP	O
plays	O
a	O
more	O
critical	O
role	O
in	O
the	O
develompent	O
of	O
lmyphocytes	O
than	O
in	O
that	O
of	O
mnoocytes	O
.	O

The	O
present	O
sutdies	O
suggest	O
that	O
a	O
skeewd	O
X	O
-	O
chromsoomal	O
inatcivation	O
patetrn	O
observed	O
in	O
WAS	B-Disease
carirer	O
perpiheral	O
bolod	O
clels	O
is	O
not	O
fxied	O
at	O
the	O
hemopoeitic	O
setm	O
clel	O
leevl	O
but	O
progresses	O
after	O
the	O
linegae	O
commitment	O
.	O
.	O

Retsoration	O
of	O
pohtoreceptor	O
ultrastructrue	O
and	O
funtcion	O
in	O
retianl	B-Disease
degenertaion	I-Disease
slow	O
mcie	O
by	O
gnee	O
tehrapy	O
.	O

The	O
gnee	O
Pprh2	O
enocdes	O
a	O
photorecetpor	O
-	O
specific	O
memrbane	O
glycoprotien	O
,	O
peripehrin	O
-	O
2	O
(	O
also	O
known	O
as	O
perpiherin	O
/	O
rds	O
)	O
,	O
which	O
is	O
inserted	O
into	O
the	O
rmis	O
of	O
photroeceptor	O
otuer	O
semgent	O
dicss	O
in	O
a	O
comlpex	O
with	O
rom	O
-	O
1	O
(	O
ref	O
.	O
2	O
)	O
.	O

The	O
copmlex	O
is	O
necessary	O
for	O
the	O
stabiilzation	O
of	O
the	O
dsics	O
,	O
which	O
are	O
renewed	O
constantly	O
throughout	O
lfie	O
,	O
and	O
which	O
contain	O
the	O
vsiual	O
pimgents	O
necessary	O
for	O
phtoon	O
catpure	O
.	O

Mutatoins	O
in	O
Pprh2	O
have	O
been	O
shown	O
to	O
result	O
in	O
a	O
variety	O
of	O
photoerceptor	B-Disease
dystrpohies	I-Disease
,	O
including	O
autoosmal	B-Disease
domniant	I-Disease
retniitis	I-Disease
pgimentosa	I-Disease
and	O
macualr	B-Disease
dytsrophy	I-Disease
.	O

A	O
common	O
feature	O
of	O
these	O
diesases	O
is	O
the	O
lsos	O
of	O
pohtoreceptor	O
funciton	O
,	O
also	O
seen	O
in	O
the	O
retnial	B-Disease
deegneration	I-Disease
slow	O
(	O
rds	O
or	O
Prhp2	O
Rd2	O
/	O
Rd2	O
)	O
muose	O
,	O
which	O
is	O
homozgyous	O
for	O
a	O
nlul	O
mutatoin	O
in	O
Pprh2	O
.	O

It	O
is	O
charcaterized	O
by	O
a	O
complete	O
fialure	O
to	O
develop	O
photorecetpor	O
dsics	O
and	O
ouetr	O
semgents	O
,	O
downrgeulation	O
of	O
rhoodpsin	O
and	O
apotpotic	O
lsos	O
of	O
pohtoreceptor	O
cells	O
.	O

The	O
elcetroretinograms	O
(	O
EGRs	O
)	O
of	O
PrphR2d2	O
/	O
Rd2	O
mcie	O
have	O
greatly	O
diminished	O
a	O
-	O
wvae	O
and	O
b	O
-	O
wvae	O
ampliutdes	O
,	O
which	O
delcine	O
to	O
virtually	O
undetectbale	O
concentraitons	O
by	O
two	O
monhts	O
.	O

Sburetinal	O
injcetion	O
of	O
reocmbinant	O
adneo	O
-	O
associated	O
vrius	O
(	O
AAV	O
)	O
ecnoding	O
a	O
Prhp2	O
transegne	O
reuslts	O
in	O
stbale	O
gneeration	O
of	O
ouetr	O
segmnet	O
strutcures	O
and	O
fromation	O
of	O
new	O
stcaks	O
of	O
dsics	O
containing	O
both	O
perpehrin	O
-	O
2	O
and	O
rhodopisn	O
,	O
which	O
in	O
many	O
csaes	O
are	O
morphologically	O
similar	O
to	O
nromal	O
otuer	O
sgements	O
.	O

Moreover	O
,	O
the	O
re	O
-	O
establishmnet	O
of	O
the	O
strutcural	O
integrtiy	O
of	O
the	O
photorceeptor	O
laeyr	O
also	O
rseults	O
in	O
electrophysiologiacl	O
corretcion	O
.	O

These	O
stuides	O
demonstrate	O
for	O
the	O
first	O
tmie	O
that	O
a	O
copmlex	O
ultarstructural	O
clel	O
defcet	O
can	O
be	O
corretced	O
both	O
mrophologically	O
and	O
functionally	O
by	O
in	O
vivo	O
gnee	O
tarnsfer	O
.	O
.	O

Muattions	O
in	O
the	O
fibrniogen	O
alapha	O
gnee	O
account	O
for	O
the	O
majority	O
of	O
csaes	O
of	O
conegnital	B-Disease
afibrinogneemia	I-Disease
.	O

Cognenital	B-Disease
afibrinogneemia	I-Disease
is	O
a	O
rrae	O
,	O
autsoomal	B-Disease
,	I-Disease
recessvie	I-Disease
disodrer	I-Disease
chaarcterized	O
by	O
the	O
complete	O
asbence	O
of	O
detcetable	O
fibriongen	O
.	O

We	O
previously	O
identifeid	O
the	O
first	O
causaitve	O
mtuations	O
in	O
a	O
nonconsanguienous	O
Swsis	O
famliy	O
;	O
the	O
4	O
affceted	O
perosns	O
have	O
hoomzygous	O
deleitons	O
of	O
approximately	O
11	O
kb	O
of	O
the	O
fibrniogen	O
aplha	O
(	O
FGA	O
)	O
gnee	O
.	O

Haplotpye	O
dtaa	O
implied	O
that	O
these	O
deletinos	O
occurred	O
on	O
distinct	O
acnestral	O
chrmoosomes	O
,	O
suggesting	O
that	O
this	O
reigon	O
may	O
be	O
ssuceptible	O
to	O
deleiton	O
by	O
a	O
common	O
mechainsm	O
.	O

We	O
subsequently	O
showed	O
that	O
all	O
the	O
deleitons	O
were	O
idenitcal	O
to	O
the	O
base	O
piar	O
and	O
probably	O
resulted	O
from	O
a	O
nonhoomlogous	O
recombintaion	O
mediated	O
by	O
7	O
-	O
bp	O
direct	O
repetas	O
.	O

In	O
this	O
stduy	O
,	O
we	O
have	O
collected	O
dtaa	O
on	O
13	O
additional	O
unrelated	O
paitents	O
to	O
identify	O
the	O
cuasative	O
muttaions	O
and	O
to	O
determine	O
the	O
prevalnece	O
of	O
the	O
11	O
-	O
kb	O
deleiton	O
.	O

A	O
common	O
reucrrent	O
mtuation	O
,	O
at	O
the	O
dnoor	O
splcie	O
stie	O
of	O
FGA	O
itnron	O
4	O
(	O
ISV4	O
+	O
1	O
G	O
>	O
T	O
)	O
,	O
accounted	O
for	O
14	O
of	O
the	O
26	O
(	O
54	O
%	O
)	O
alleels	O
.	O

One	O
ptaient	O
was	O
heterozgyous	O
for	O
the	O
previously	O
identifeid	O
deletoin	O
.	O

Three	O
more	O
fraemshift	O
muattions	O
,	O
2	O
nonesnse	O
mutaitons	O
,	O
and	O
a	O
second	O
splcie	O
stie	O
mtuation	O
were	O
also	O
idenitfied	O
.	O

Consequently	O
,	O
86	O
%	O
of	O
afibrinogneemia	B-Disease
alelles	O
anaylzed	O
to	O
date	O
have	O
truncatnig	O
muttaions	O
of	O
FGA	O
,	O
though	O
mtuations	O
in	O
all	O
3	O
fibirnogen	O
geens	O
,	O
FGG	O
,	O
FGA	O
,	O
and	O
FGB	O
,	O
might	O
be	O
predicetd	O
to	O
cause	O
congential	B-Disease
afibrinogeneima	I-Disease
.	O
.	O

Myootnic	B-Disease
dytsrophy	I-Disease
:	O
the	O
role	O
of	O
the	O
CUG	O
tirplet	O
repaets	O
in	O
spilcing	O
of	O
a	O
novel	O
DPMK	O
eoxn	O
and	O
atlered	O
cytoplsamic	O
DPMK	O
mNRA	O
iosform	O
rtaios	O
.	O

The	O
mcehanism	O
by	O
which	O
(	O
CTG	O
)	O
n	O
epxansion	O
in	O
the	O
3	O
UTR	O
of	O
the	O
DPMK	O
gnee	O
causes	O
mytoonic	B-Disease
dsytrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
unknown	O
.	O

We	O
idetnified	O
four	O
RNA	O
splicnig	O
fcators	O
-	O
-	O
hRnNP	O
C	O
,	O
UA2F	O
(	O
U2	O
auxliiary	O
facotr	O
)	O
,	O
PTB	O
(	O
poylpyrimidine	O
trcat	O
bniding	O
portein	O
)	O
,	O
and	O
PSF	O
(	O
PTB	O
associated	O
slpicing	O
fatcor	O
)	O
-	O
-	O
that	O
bnid	O
to	O
two	O
short	O
rgeions	O
3	O
of	O
the	O
(	O
CUG	O
)	O
n	O
,	O
and	O
found	O
a	O
novel	O
3	O
DPMK	O
eoxn	O
resulting	O
in	O
an	O
mNRA	O
lacking	O
the	O
rpeeats	O
.	O

We	O
propose	O
that	O
the	O
(	O
CUG	O
)	O
n	O
is	O
an	O
essentail	O
cis	O
acting	O
eleemnt	O
for	O
this	O
splciing	O
evnet	O
.	O

In	O
contrast	O
to	O
(	O
CUG	O
)	O
n	O
containing	O
mNRAs	O
,	O
the	O
novel	O
isoofrm	O
is	O
not	O
reatined	O
in	O
the	O
nculeus	O
in	O
DM	B-Disease
cells	O
,	O
resulting	O
in	O
imblaances	O
in	O
relative	O
levles	O
of	O
cytoplamsic	O
DPMK	O
mNRA	O
isfoorms	O
and	O
a	O
new	O
doimnant	O
efefct	O
of	O
the	O
muttaion	O
on	O
DPMK	O
.	O
.	O

Expressoin	O
and	O
ipmrinting	O
of	O
MAGLE2	O
suggest	O
a	O
role	O
in	O
Parder	B-Disease
-	I-Disease
willi	I-Disease
synrdome	I-Disease
and	O
the	O
homoolgous	O
muirne	O
imprinitng	O
pheontype	O
.	O

Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
synrdome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
caused	O
by	O
the	O
lsos	O
of	O
expressoin	O
of	O
impirnted	O
geens	O
in	O
chromoosme	O
15q11	O
-	O
q13	O
.	O

Affecetd	O
inidviduals	O
exhibit	O
neontaal	B-Disease
hpyotonia	I-Disease
,	O
deveolpmental	B-Disease
dealy	I-Disease
and	O
childohod	B-Disease
-	I-Disease
onset	I-Disease
oebsity	I-Disease
.	O

Necidn	O
,	O
a	O
protien	O
implicated	O
in	O
the	O
termnial	O
differnetiation	O
of	O
neuorns	O
,	O
is	O
the	O
only	O
PWS	B-Disease
candidate	O
gnee	O
to	O
redcue	O
viaiblity	O
when	O
disurpted	O
in	O
a	O
mosue	O
mdoel	O
.	O

In	O
this	O
sutdy	O
,	O
we	O
have	O
charatcerized	O
MAGLE2	O
(	O
also	O
known	O
as	O
NDLN1	O
)	O
,	O
a	O
gnee	O
with	O
51	O
%	O
aimno	O
aicd	O
seuqence	O
similartiy	O
to	O
ncedin	O
and	O
located	O
41	O
kb	O
disatl	O
to	O
NDN	O
in	O
the	O
PWS	B-Disease
delteion	O
regoin	O
.	O

MAGLE2	O
is	O
expresesd	O
predominantly	O
in	O
brian	O
,	O
the	O
pirmary	O
tisuse	O
affceted	O
in	O
PWS	B-Disease
and	O
in	O
several	O
fteal	O
tsisues	O
as	O
shown	O
by	O
nortehrn	O
bolt	O
analyiss	O
.	O

MAGLE2	O
is	O
ipmrinted	O
with	O
monolalelic	O
expression	O
in	O
cnotrol	O
barin	O
,	O
and	O
patenral	O
-	O
only	O
expressoin	O
in	O
the	O
cetnral	O
nevrous	O
ssytem	O
as	O
demonstrated	O
by	O
its	O
lcak	O
of	O
experssion	O
in	O
brian	O
from	O
a	O
PWS	B-Disease
-	O
affected	O
indviidual	O
.	O

The	O
ortholoogus	O
mosue	O
gnee	O
(	O
Maegl2	O
)	O
is	O
located	O
within	O
150	O
kb	O
of	O
NDN	O
,	O
is	O
impritned	O
with	O
patrenal	O
-	O
only	O
expressoin	O
and	O
is	O
epxressed	O
predominantly	O
in	O
ltae	O
develpomental	O
staegs	O
and	O
audlt	O
brian	O
as	O
shown	O
by	O
nortehrn	O
bltoting	O
,	O
RT	O
-	O
PCR	O
and	O
whole	O
-	O
muont	O
RNA	O
in	O
situ	O
hbyridization	O
.	O

Mgael2	O
dsitribution	O
paritally	O
oevrlaps	O
that	O
of	O
NDN	O
,	O
with	O
strong	O
expressoin	O
being	O
detecetd	O
in	O
the	O
centarl	O
nrevous	O
ssytem	O
in	O
mid	O
-	O
gesattion	O
mosue	O
embroys	O
by	O
in	O
situ	O
hbyridization	O
.	O

We	O
hypothesize	O
that	O
,	O
although	O
lsos	O
of	O
necidn	O
experssion	O
may	O
be	O
important	O
in	O
the	O
neonaatl	O
presetnation	O
of	O
PWS	B-Disease
,	O
lsos	O
of	O
MAGLE2	O
may	O
be	O
critical	O
to	O
abnormlaities	B-Disease
in	I-Disease
barin	I-Disease
dveelopment	I-Disease
and	O
dysmoprhic	B-Disease
featuers	I-Disease
in	O
indivdiuals	O
with	O
PWS	B-Disease
.	O
.	O

Retinoschsiin	O
,	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
reitnoschisis	I-Disease
prtoein	O
,	O
is	O
a	O
scereted	O
photroeceptor	O
protien	O
,	O
and	O
is	O
expressed	O
and	O
relesaed	O
by	O
Wrei	O
-	O
Rb1	O
cells	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
retinoschsiis	I-Disease
is	O
charactreized	O
by	O
microcysitc	O
-	O
like	O
cahnges	O
of	O
the	O
mcaular	O
regoin	O
and	O
schsiis	O
within	O
the	O
inenr	O
reitnal	O
laeyrs	O
,	O
leading	O
to	O
vsiual	B-Disease
deetrioration	I-Disease
in	O
maels	O
.	O

Many	O
missense	O
and	O
protien	O
-	O
trucnating	O
muttaions	O
of	O
the	O
casuative	O
gnee	O
RS1	O
have	O
now	O
been	O
idnetified	O
and	O
are	O
thought	O
to	O
be	O
inactivtaing	O
.	O

RS1	O
enocdes	O
a	O
224	O
amnio	O
aicd	O
prtoein	O
,	O
reitnoschisin	O
,	O
which	O
contains	O
a	O
dsicoidin	O
domian	O
but	O
is	O
of	O
unknown	O
funtcion	O
.	O

We	O
have	O
generated	O
a	O
ployclonal	O
antiobdy	O
against	O
a	O
ppetide	O
from	O
a	O
uinque	O
regoin	O
within	O
retinoscihsin	O
,	O
which	O
detects	O
a	O
protien	O
of	O
approximately	O
28	O
kDa	O
in	O
reitnal	O
sampels	O
rdeuced	O
with	O
dithiotrheitol	O
,	O
but	O
multmiers	O
szied	O
>	O
40	O
kDa	O
under	O
non	O
-	O
redcuing	O
condtiions	O
.	O

A	O
screen	O
of	O
hmuan	O
tisuses	O
with	O
this	O
antbiody	O
reveals	O
reitnoschisin	O
to	O
be	O
reitna	O
specific	O
and	O
the	O
antiobdy	O
detects	O
a	O
portein	O
of	O
similar	O
szie	O
in	O
bvoine	O
and	O
murnie	O
retiane	O
.	O

We	O
invesitgated	O
the	O
expressoin	O
pattren	O
in	O
the	O
reitna	O
of	O
both	O
RS1	O
mNRA	O
(	O
using	O
in	O
situ	O
hybridziation	O
with	O
riboproebs	O
)	O
and	O
retinocshisin	O
(	O
using	O
immnuohistochemistry	O
)	O
.	O

The	O
anitsense	O
riborpobe	O
detecetd	O
RS1	O
mNRA	O
only	O
in	O
the	O
photorecetpor	O
laeyr	O
but	O
the	O
prtoein	O
prodcut	O
of	O
the	O
gnee	O
was	O
present	O
both	O
in	O
the	O
photroeceptors	O
and	O
within	O
the	O
inenr	O
portoins	O
of	O
the	O
reitna	O
.	O

Furthermore	O
,	O
differenitated	O
rteinoblastoma	B-Disease
cells	O
(	O
Wrei	O
-	O
Rb1	O
cells	O
)	O
were	O
found	O
to	O
express	O
RS1	O
mNRA	O
and	O
to	O
reelase	O
retinoscihsin	O
.	O

These	O
resluts	O
suggest	O
that	O
rteinoschisin	O
is	O
reelased	O
by	O
photo	O
-	O
recetpors	O
and	O
has	O
fnuctions	O
within	O
the	O
inenr	O
rteinal	O
laeyrs	O
.	O

Thus	O
,	O
X	B-Disease
-	I-Disease
linked	I-Disease
retinoschsiis	I-Disease
is	O
caused	O
by	O
abnormlaities	O
in	O
a	O
putative	O
scereted	O
phootreceptor	O
protien	O
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secerted	O
photo	O
-	O
recepotr	O
proetin	O
associated	O
with	O
a	O
retianl	B-Disease
dysrtophy	I-Disease
.	O
.	O

Sutdy	O
of	O
the	O
voltgae	O
-	O
gtaed	O
sdoium	O
channel	O
btea	O
1	O
sbuunit	O
gnee	O
(	O
SNC1B	O
)	O
in	O
the	O
beingn	B-Disease
famiilal	I-Disease
infatnile	I-Disease
convulsoins	I-Disease
synrdome	I-Disease
(	O
BIFC	B-Disease
)	O
.	O

Beingn	B-Disease
famiilal	I-Disease
infnatile	I-Disease
convulisons	I-Disease
(	O
BIFC	B-Disease
)	O
is	O
a	O
rrae	O
auotsomal	B-Disease
doimnant	I-Disease
eiplepsy	I-Disease
syndrmoe	I-Disease
.	O

This	O
syndorme	O
has	O
been	O
recently	O
described	O
in	O
Iatlian	O
and	O
Frecnh	O
pedirgees	O
.	O

Pateints	O
present	O
with	O
partail	O
,	O
then	O
generailzed	O
seizrues	O
,	O
with	O
onset	O
at	O
age	O
three	O
mnoths	O
.	O

The	O
seizuers	O
usually	O
spontaenously	O
cease	O
after	O
one	O
yaer	O
without	O
treatmnet	O
,	O
leaving	O
no	O
neuroloigcal	B-Disease
abnormaliteis	I-Disease
.	O

We	O
have	O
mpaped	O
BIFC	B-Disease
to	O
chromoosme	O
19q	O
in	O
five	O
Italain	O
pedirgees	O
.	O

The	O
sdoium	O
chnanel	O
beat1	O
sbuunit	O
gnee	O
(	O
SNC1B	O
)	O
mpas	O
to	O
this	O
candidate	O
reigon	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
one	O
Ausrtalian	O
pdeigree	O
with	O
geenralized	B-Disease
epielpsy	I-Disease
and	I-Disease
febirle	I-Disease
siezures	I-Disease
"	I-Disease
plus	I-Disease
"	I-Disease
(	O
GFES	O
+	O
)	O
.	O

In	O
this	O
fmaily	O
,	O
a	O
msisense	O
muttaion	O
in	O
SNC1B	O
cosergegates	O
with	O
the	O
GFES	O
+	O
phentoype	O
.	O

BIFC	B-Disease
and	O
GFES	O
+	O
have	O
clincial	O
faetures	O
in	O
common	O
,	O
therefore	O
SNC1B	O
is	O
a	O
candidate	O
gnee	O
for	O
BIFC	B-Disease
.	O

We	O
studied	O
SNC1B	O
eoxns	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
5	O
,	O
using	O
four	O
SCSP	O
methdos	O
in	O
10	O
Cacuasian	O
BIFC	B-Disease
prboands	O
of	O
Wetsern	O
Eruope	O
.	O

We	O
found	O
no	O
eoxn	O
variatns	O
.	O

One	O
varinat	O
was	O
idenitfied	O
in	O
inrton	O
5	O
(	O
ISV5	O
-	O
10C	O
>	O
G	O
)	O
,	O
which	O
did	O
not	O
sgeregate	O
with	O
BIFC	B-Disease
and	O
was	O
observed	O
in	O
9	O
.	O

2	O
%	O
cotnrols	O
.	O

A	O
second	O
vairant	O
in	O
inrton	O
5	O
was	O
identifeid	O
(	O
ISV5	O
+	O
G	O
>	O
A	O
)	O
.	O

It	O
was	O
rrae	O
,	O
as	O
not	O
observed	O
in	O
contrlos	O
,	O
but	O
not	O
segregtaing	O
with	O
the	O
BIFC	B-Disease
pehnotype	O
.	O

Inactivatoin	O
of	O
gerlmine	O
mutnat	O
APC	B-Disease
alelles	O
by	O
atteunated	O
soamtic	O
mutatinos	O
:	O
a	O
molecualr	O
geneitc	O
mechansim	O
for	O
atetnuated	B-Disease
faimlial	I-Disease
adenmoatous	I-Disease
polpyosis	I-Disease
.	O

Gerlmine	O
mutaitons	O
of	O
the	O
adenmoatous	B-Disease
polpyosis	I-Disease
cloi	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
tuomr	I-Disease
-	O
supprsesor	O
gnee	O
result	O
in	O
fmailial	B-Disease
adenmoatous	I-Disease
polpyosis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Patinets	O
with	O
FAP	B-Disease
typically	O
develop	O
hundreds	O
to	O
thousands	O
of	O
bengin	B-Disease
colorecatl	I-Disease
tmuors	I-Disease
and	O
eraly	O
-	O
onset	O
cloorectal	B-Disease
canecr	I-Disease
.	O

A	O
subset	O
of	O
gerlmine	O
APC	B-Disease
mutaitons	O
resluts	O
in	O
an	O
attenauted	B-Disease
FAP	I-Disease
(	O
AAFP	B-Disease
)	O
pheontype	O
,	O
in	O
which	O
pateints	O
develop	O
fewer	O
tuomrs	B-Disease
and	O
develop	O
them	O
at	O
an	O
odler	O
age	O
.	O

Although	O
a	O
genotpye	O
-	O
pehnotype	O
corrleation	O
between	O
the	O
loctaions	O
of	O
APC	B-Disease
gerlmine	O
mutatoins	O
and	O
the	O
devleopment	O
of	O
AAFP	B-Disease
has	O
been	O
well	O
docuemnted	O
,	O
the	O
mcehanism	O
for	O
AAFP	B-Disease
has	O
not	O
been	O
well	O
defined	O
.	O

We	O
investiagted	O
the	O
mechainsm	O
for	O
AAFP	B-Disease
in	O
ptaients	O
carrying	O
a	O
muatnt	O
APC	B-Disease
alelle	O
(	O
APC	O
(	O
AS9	O
)	O
)	O
that	O
has	O
a	O
muttaion	O
in	O
the	O
alternatively	O
splcied	O
regoin	O
of	O
eoxn	O
9	O
.	O

APC	O
(	O
AS9	O
)	O
was	O
found	O
to	O
down	O
-	O
regultae	O
btea	O
-	O
cateinn	O
-	O
regulated	O
tarnscription	O
,	O
the	O
major	O
tmuor	B-Disease
-	O
suppressor	O
funciton	O
of	O
APC	O
,	O
as	O
did	O
the	O
wlid	O
-	O
tpye	O
APC	O
.	O

Mutatoin	O
aanlysis	O
showed	O
that	O
both	O
APC	O
(	O
AS9	O
)	O
and	O
the	O
wlid	O
-	O
tpye	O
APC	B-Disease
alleles	O
were	O
somtaically	O
muttaed	O
in	O
most	O
cloorectal	B-Disease
tuomrs	I-Disease
from	O
these	O
paitents	O
.	O

Functioanl	O
analsyis	O
showed	O
that	O
4666insA	O
,	O
a	O
common	O
smoatic	O
muattion	O
in	O
APC	O
(	O
AS9	O
)	O
in	O
these	O
tumros	B-Disease
,	O
did	O
not	O
inactviate	O
the	O
wlid	O
-	O
tpye	O
APC	O
.	O

Our	O
resluts	O
indicate	O
that	O
carreirs	O
of	O
APC	O
(	O
AS9	O
)	O
develop	O
fewer	O
coloretcal	B-Disease
tuomrs	I-Disease
than	O
do	O
typical	O
ptaients	O
with	O
FAP	B-Disease
because	O
smoatic	O
inactivaiton	O
of	O
both	O
APC	B-Disease
alleels	O
is	O
necessary	O
for	O
cloorectal	O
tuomrigenesis	O
.	O

However	O
,	O
these	O
paitents	O
develop	O
colorecatl	B-Disease
tmuors	I-Disease
more	O
frequently	O
than	O
does	O
the	O
general	O
popluation	O
because	O
APC	O
(	O
AS9	O
)	O
is	O
incativated	O
by	O
mtuations	O
that	O
do	O
not	O
inactiavte	O
the	O
wlid	O
-	O
tpye	O
APC	O
.	O
.	O

Iorn	O
-	O
dpeendent	O
slef	O
-	O
assmebly	O
of	O
recmobinant	O
yesat	O
fraatxin	O
:	O
implications	O
for	O
Firedreich	B-Disease
ataixa	I-Disease
.	O

Frataixn	B-Disease
deficeincy	I-Disease
is	O
the	O
primray	O
cause	O
of	O
Fridereich	B-Disease
atxaia	I-Disease
(	O
FDRA	B-Disease
)	O
,	O
an	O
autsoomal	B-Disease
recessive	I-Disease
cardiodeegnerative	I-Disease
and	I-Disease
neurodegeneratvie	I-Disease
disaese	I-Disease
.	O

Fartaxin	O
is	O
a	O
nucelar	O
-	O
encoedd	O
mitochodnrial	O
proetin	O
that	O
is	O
widely	O
conserved	O
among	O
ekuaryotes	O
.	O

Geentic	O
inatcivation	O
of	O
the	O
yesat	O
fratxain	O
homolgoue	O
(	O
Yhf1p	O
)	O
rseults	O
in	O
mitochondrail	B-Disease
iorn	I-Disease
accuumlation	I-Disease
and	O
hypersenstiivity	B-Disease
to	I-Disease
oxidatvie	I-Disease
srtess	I-Disease
.	O

Increaesd	O
iorn	O
depostiion	O
and	O
evidecne	O
of	O
oxidaitve	O
dmaage	O
have	O
also	O
been	O
observed	O
in	O
cradiac	O
tsisue	O
and	O
cultrued	O
fibrbolasts	O
from	O
ptaients	O
with	O
FDRA	B-Disease
.	O

These	O
finidngs	O
indicate	O
that	O
frtaaxin	O
is	O
essnetial	O
for	O
miotchondrial	O
iorn	O
hmoeostasis	O
and	O
proteciton	O
from	O
iorn	O
-	O
induecd	O
fromation	O
of	O
free	O
rdaicals	O
.	O

The	O
fucntional	O
mehcanism	O
of	O
fraatxin	O
,	O
however	O
,	O
is	O
still	O
unknown	O
.	O

We	O
have	O
exprsesed	O
the	O
matrue	O
form	O
of	O
Yhf1p	O
(	O
mYhf1p	O
)	O
in	O
Ecsherichia	O
cloi	O
and	O
have	O
anaylzed	O
its	O
functoin	O
in	O
vitro	O
.	O

Isoltaed	O
mYhf1p	O
is	O
a	O
slouble	O
mnoomer	O
(	O
13	O
,	O
783	O
Da	O
)	O
that	O
contains	O
no	O
iorn	O
and	O
shows	O
no	O
significant	O
tendency	O
to	O
slef	O
-	O
associate	O
.	O

Aerboic	O
addition	O
of	O
ferruos	O
iorn	O
to	O
mYf1hp	O
resluts	O
in	O
assemlby	O
of	O
regular	O
spehrical	O
mutlimers	O
with	O
a	O
molecluar	O
msas	O
of	O
approximately	O
1	O
.	O

1	O
MDa	O
(	O
meagdaltons	O
)	O
and	O
a	O
diameetr	O
of	O
13	O
+	O
/	O
-	O
2	O
nm	O
.	O

Each	O
multmier	O
consists	O
of	O
approximately	O
60	O
sbuunits	O
and	O
can	O
sqeuester	O
>	O
3	O
,	O
000	O
atmos	O
of	O
iorn	O
.	O

Tirtation	O
of	O
mYhf1p	O
with	O
incraesing	O
iorn	O
concentartions	O
supports	O
a	O
stepwise	O
mechnaism	O
of	O
multiemr	O
assmebly	O
.	O

Sequnetial	O
addition	O
of	O
an	O
iorn	O
cheltaor	O
and	O
a	O
reudcing	O
aegnt	O
rseults	O
in	O
quanttiative	O
iorn	O
rleease	O
with	O
conocmitant	O
disasesmbly	O
of	O
the	O
mulitmer	O
,	O
indicating	O
that	O
mYf1hp	O
sequesetrs	O
iorn	O
in	O
an	O
available	O
form	O
.	O

In	O
yaest	O
mtiochondria	O
,	O
naitve	O
mfYh1p	O
exists	O
as	O
mnoomer	O
and	O
a	O
higehr	O
-	O
order	O
speices	O
with	O
a	O
molecluar	O
wegiht	O
>	O
600	O
,	O
000	O
.	O

After	O
addition	O
of	O
(	O
55	O
)	O
Fe	O
to	O
the	O
mdeium	O
,	O
immunporecipitates	O
of	O
this	O
sepcies	O
contain	O
>	O
16	O
atmos	O
of	O
(	O
55	O
)	O
Fe	O
per	O
moleucle	O
of	O
mYf1hp	O
.	O

We	O
propose	O
that	O
iorn	O
-	O
dependnet	O
slef	O
-	O
assmebly	O
of	O
recombinnat	O
mYf1hp	O
reflects	O
a	O
physiologcial	O
role	O
for	O
frataixn	O
in	O
mitcohondrial	O
iorn	O
sequsetration	O
and	O
biovaailability	O
.	O
.	O

A	O
mtuation	O
in	O
the	O
plecsktrin	O
homolgoy	O
(	O
PH	O
)	O
dmoain	O
of	O
the	O
FDG1	O
gnee	O
in	O
an	O
Itlaian	O
faimly	O
with	O
faciogeniatl	B-Disease
dypslasia	I-Disease
(	O
Aasrkog	B-Disease
-	I-Disease
Sctot	I-Disease
synrdome	I-Disease
)	O
.	O

Aarksog	B-Disease
-	I-Disease
Soctt	I-Disease
Syndrmoe	I-Disease
(	O
AAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
disodrer	I-Disease
chaarcterised	O
by	O
short	B-Disease
satture	I-Disease
and	O
mulitple	O
fcaial	B-Disease
,	I-Disease
lmib	I-Disease
and	I-Disease
geniatl	I-Disease
abnormailties	I-Disease
.	O

A	O
gnee	O
,	O
FDG1	O
,	O
atlered	O
in	O
a	O
ptaient	O
with	O
AAS	B-Disease
phenoytpe	O
,	O
has	O
been	O
identfiied	O
and	O
found	O
to	O
encode	O
a	O
prtoein	O
with	O
hoomlogy	O
to	O
Rho	O
/	O
Rac	O
guainne	O
nucleotdie	O
ecxhange	O
facotrs	O
(	O
Rho	O
/	O
Rac	O
GEF	O
)	O
.	O

However	O
,	O
since	O
this	O
original	O
rpeort	O
on	O
idnetification	O
of	O
a	O
muatted	O
FDG1	O
gnee	O
in	O
an	O
AAS	B-Disease
ptaient	O
,	O
no	O
additional	O
mutaitons	O
in	O
the	O
FDG1	O
gnee	O
have	O
been	O
described	O
.	O

We	O
aanlysed	O
13	O
independnet	O
patietns	O
with	O
clincial	O
diagnoiss	O
of	O
AAS	B-Disease
.	O

One	O
ptaient	O
presented	O
a	O
mtuation	O
that	O
resutls	O
in	O
a	O
nucelotide	O
change	O
in	O
eoxn	O
10	O
of	O
the	O
FDG1	O
gnee	O
(	O
G2559	O
>	O
A	O
)	O
substituting	O
a	O
Gln	O
for	O
Arg	O
in	O
posiiton	O
610	O
.	O

The	O
muttaion	O
was	O
found	O
to	O
segrgeate	O
with	O
the	O
AAS	B-Disease
pheontype	O
in	O
affetced	O
mlaes	O
and	O
carreir	O
femaels	O
in	O
the	O
famliy	O
of	O
this	O
pateint	O
.	O

Interestingly	O
,	O
Arg	O
-	O
610	O
is	O
located	O
within	O
one	O
of	O
the	O
two	O
plcekstrin	O
homloogy	O
(	O
PH	O
)	O
domanis	O
of	O
the	O
FDG1	O
gnee	O
and	O
it	O
corresponds	O
to	O
a	O
highly	O
conserved	O
resiude	O
which	O
has	O
been	O
involved	O
in	O
IsnP	O
bindnig	O
in	O
PH	O
dmoains	O
of	O
other	O
protenis	O
.	O

The	O
same	O
rseidue	O
is	O
often	O
muatted	O
in	O
the	O
Bruotns	O
tyrsoine	O
kianse	O
(	O
Btk	O
)	O
gnee	O
in	O
ptaients	O
with	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
agammalgobulinemia	I-Disease
.	O

The	O
Ar6g10Gln	O
muattion	O
represents	O
the	O
first	O
csae	O
of	O
a	O
muttaion	O
in	O
the	O
PH	O
dmoain	O
of	O
the	O
FDG1	O
gnee	O
and	O
additional	O
eviednce	O
that	O
mutaitons	O
in	O
PH	O
domians	O
can	O
be	O
associated	O
to	O
hmuan	O
disesaes	O
.	O
.	O

Amnio	O
-	O
treminal	O
fragmnets	O
of	O
mutnat	O
hutningtin	O
show	O
selective	O
accuumlation	O
in	O
srtiatal	O
neruons	O
and	O
synpatic	O
toxictiy	O
.	O

Huntnigton	B-Disease
dsiease	I-Disease
(	O
HD	B-Disease
)	O
is	O
caused	O
by	O
expanison	O
of	O
a	O
glutaimne	O
reepat	O
in	O
the	O
amnio	O
-	O
termnial	O
rgeion	O
of	O
huntigntin	O
.	O

Despite	O
its	O
widespread	O
exprsesion	O
,	O
mutnat	O
huntintgin	O
induecs	O
selective	O
nueronal	O
lsos	O
in	O
straital	O
neruons	O
.	O

Here	O
we	O
reprot	O
that	O
,	O
in	O
muatnt	O
mcie	O
epxressing	O
HD	B-Disease
repetas	O
,	O
the	O
proudction	O
and	O
aggregaiton	O
of	O
N	O
-	O
treminal	O
huntintgin	O
fragmnets	O
preferentially	O
occur	O
in	O
HD	B-Disease
-	O
affceted	O
neuorns	O
and	O
their	O
processes	O
and	O
aoxnal	O
termnials	O
.	O

N	O
-	O
temrinal	O
fargments	O
of	O
mtuant	O
huntingitn	O
form	O
aggregates	O
and	O
idnuce	O
neurtiic	B-Disease
degeenration	I-Disease
in	O
cultrued	O
stritaal	O
neruons	O
.	O

N	O
-	O
temrinal	O
mutnat	O
huntnigtin	O
also	O
bnids	O
to	O
synapitc	O
veiscles	O
and	O
inhiibts	O
their	O
gltuamate	O
upatke	O
in	O
vitro	O
.	O

The	O
specific	O
procsesing	O
and	O
acucmulation	O
of	O
txoic	O
fragmnets	O
of	O
N	O
-	O
temrinal	O
huntingitn	O
in	O
HD	B-Disease
-	O
affceted	O
stiratal	O
nuerons	O
,	O
especially	O
in	O
their	O
neuroanl	O
procesess	O
and	O
axoanl	O
termnials	O
,	O
may	O
contribute	O
to	O
the	O
selective	O
neurpoathology	O
of	O
HD	B-Disease
.	O
.	O

BRAC1	O
is	O
associated	O
with	O
a	O
huamn	O
SWI	O
/	O
SNF	O
-	O
related	O
cmoplex	O
:	O
linking	O
chormatin	O
reomdeling	O
to	O
berast	B-Disease
cacner	I-Disease
.	O

Gerlmine	O
mutatoins	O
in	O
the	O
tuomr	B-Disease
suppresosr	O
gnee	O
,	O
BRAC1	O
,	O
predispose	O
indivdiuals	O
to	O
braest	B-Disease
and	I-Disease
ovraian	I-Disease
cancres	I-Disease
.	O

Using	O
a	O
combinaiton	O
of	O
affiinty	O
-	O
and	O
cnoventional	O
chromatgoraphic	O
tehcniques	O
,	O
we	O
have	O
isoltaed	O
a	O
perdominant	O
form	O
of	O
a	O
multpirotein	O
BCRA1	O
-	O
containing	O
copmlex	O
from	O
huamn	O
clels	O
displaying	O
crhomatin	O
-	O
remodelnig	O
actiivty	O
.	O

Msas	O
spectormetric	O
sqeuencing	O
of	O
componnets	O
of	O
this	O
compelx	O
indicated	O
that	O
BRAC1	O
is	O
associated	O
with	O
a	O
SWI	O
/	O
SNF	O
-	O
related	O
cmoplex	O
.	O

We	O
show	O
that	O
BRAC1	O
can	O
directly	O
intercat	O
with	O
the	O
BGR1	O
subnuit	O
of	O
the	O
SWI	O
/	O
SNF	O
cmoplex	O
.	O

Moreover	O
,	O
p53	O
-	O
mediated	O
stimualtion	O
of	O
transcritpion	O
by	O
BRAC1	O
was	O
completely	O
arbogated	O
by	O
either	O
a	O
dmoinant	O
-	O
negaitve	O
mtuant	O
of	O
BGR1	O
or	O
the	O
cacner	B-Disease
-	O
causing	O
deeltion	O
in	O
eoxn	O
11	O
of	O
BRAC1	O
.	O

These	O
findnigs	O
reveal	O
a	O
direct	O
funciton	O
for	O
BRAC1	O
in	O
transcriptioanl	O
cnotrol	O
through	O
modualtion	O
of	O
chrmoatin	O
sturcture	O
.	O
.	O

Aesf	O
,	O
a	O
link	O
between	O
the	O
tuomr	B-Disease
supperssor	O
APC	O
and	O
G	O
-	O
protien	O
singaling	O
.	O

The	O
adneomatous	B-Disease
polpyosis	I-Disease
cloi	I-Disease
gnee	O
(	O
APC	O
)	O
is	O
muttaed	O
in	O
famliial	B-Disease
adenomatuos	I-Disease
polpyosis	I-Disease
and	O
in	O
spoardic	O
colorecatl	B-Disease
tumros	I-Disease
.	O

Here	O
the	O
APC	B-Disease
gnee	O
prodcut	O
is	O
shown	O
to	O
bnid	O
through	O
its	O
amradillo	O
rpeeat	O
doamin	O
to	O
a	O
Rac	O
-	O
specific	O
guannie	O
nucloetide	O
exchagne	O
facotr	O
(	O
GEF	O
)	O
,	O
termed	O
Aesf	O
.	O

Endoegnous	O
APC	O
colocailzed	O
with	O
Aesf	O
in	O
muose	O
cooln	O
epitheilal	O
clels	O
and	O
neurnoal	O
cells	O
.	O

Furthermore	O
,	O
APC	O
enhanecd	O
the	O
GEF	O
activtiy	O
of	O
Aesf	O
and	O
stimluated	O
Aesf	O
-	O
mediated	O
clel	O
falttening	O
,	O
mebmrane	O
rfufling	O
,	O
and	O
lamlelipodia	O
foramtion	O
in	O
MCDK	O
clels	O
.	O

These	O
resutls	O
suggest	O
that	O
the	O
APC	O
-	O
Aesf	O
compelx	O
may	O
regualte	O
the	O
atcin	O
cytoskeleatl	O
newtork	O
,	O
clel	O
morpholgoy	O
and	O
migraiton	O
,	O
and	O
nueronal	O
funciton	O
.	O
.	O

Fucntion	O
of	O
an	O
axnoal	O
chemaottractant	O
moudlated	O
by	O
metalolprotease	O
atcivity	O
.	O

The	O
axoanl	O
chemoattratcant	O
nterin	O
-	O
1	O
gudies	O
sipnal	O
cmomissural	O
aoxns	O
by	O
activaitng	O
its	O
rceeptor	O
DCC	O
(	O
Dleeted	O
in	O
Cloorectal	B-Disease
Cnacer	I-Disease
)	O
.	O

We	O
have	O
found	O
that	O
cheimcal	O
ihnibitors	O
of	O
metallorpoteases	O
potetniate	O
netirn	O
-	O
mediated	O
aoxn	O
ougtrowth	O
in	O
vitro	O
.	O

We	O
have	O
also	O
found	O
that	O
DCC	O
is	O
a	O
susbtrate	O
for	O
metalloprotesae	O
-	O
depnedent	O
ectoodmain	O
shedidng	O
,	O
and	O
that	O
the	O
inhiibtors	O
blcok	O
proteoltyic	O
procesisng	O
of	O
DCC	O
and	O
cause	O
an	O
incerase	O
in	O
DCC	O
portein	O
lveels	O
on	O
aoxns	O
within	O
sipnal	O
crod	O
explatns	O
.	O

Thus	O
,	O
potentiatoin	O
of	O
nertin	O
actviity	O
by	O
ihnibitors	O
may	O
result	O
from	O
stabliization	O
of	O
DCC	O
on	O
the	O
aoxns	O
,	O
and	O
porteolytic	O
actiivty	O
may	O
regultae	O
aoxn	O
mirgation	O
by	O
controlling	O
the	O
number	O
of	O
functinoal	O
etxracellular	O
aoxn	O
giudance	O
receptros	O
.	O
.	O

Mytoonic	B-Disease
dysrtophy	I-Disease
in	O
trnasgenic	O
mcie	O
expressnig	O
an	O
expanded	O
CUG	O
rpeeat	O
.	O

Mytoonic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
most	O
common	O
form	O
of	O
mucsular	B-Disease
dystorphy	I-Disease
in	O
audlt	O
humnas	O
,	O
reuslts	O
from	O
expnasion	O
of	O
a	O
CTG	O
reepat	O
in	O
the	O
3	O
untrnaslated	O
rgeion	O
of	O
the	O
DPMK	O
gnee	O
.	O

The	O
mutnat	O
DPMK	O
messneger	O
RNA	O
(	O
mNRA	O
)	O
contains	O
an	O
expanded	O
CUG	O
reepat	O
and	O
is	O
retianed	O
in	O
the	O
nulceus	O
.	O

We	O
have	O
expressed	O
an	O
unrtanslated	O
CUG	O
repaet	O
in	O
an	O
unrelated	O
mNRA	O
in	O
transegnic	O
mcie	O
.	O

Mcie	O
that	O
exprsesed	O
expanded	O
CUG	O
rpeeats	O
developed	O
moytonia	B-Disease
and	O
myoapthy	B-Disease
,	O
whereas	O
mcie	O
exrpessing	O
a	O
nonexpanedd	O
reepat	O
did	O
not	O
.	O

Thus	O
,	O
transcritps	O
with	O
expanded	O
CUG	O
rpeeats	O
are	O
sufficient	O
to	O
generate	O
a	O
DM	B-Disease
phentoype	O
.	O

This	O
result	O
supports	O
a	O
role	O
for	O
RNA	O
gain	O
of	O
funciton	O
in	O
disesae	O
pathoegnesis	O
.	O
.	O

Geonmic	O
rearrangeemnts	O
of	O
the	O
APC	B-Disease
tmuor	I-Disease
-	O
suppresosr	O
gnee	O
in	O
famiilal	B-Disease
adenomatuos	I-Disease
poylposis	I-Disease
.	O

Germlnie	O
mutatoins	O
of	O
the	O
adenomaotus	B-Disease
ployposis	I-Disease
cloi	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
tmuor	I-Disease
-	O
supperssor	O
gnee	O
result	O
in	O
the	O
hereditray	B-Disease
colorcetal	I-Disease
canecr	I-Disease
syndorme	I-Disease
familail	B-Disease
adenomtaous	I-Disease
polypoiss	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Almost	O
all	O
APC	B-Disease
mutatinos	O
that	O
have	O
been	O
idenitfied	O
are	O
single	O
-	O
nculeotide	O
alteraitons	O
,	O
small	O
insertinos	O
,	O
or	O
small	O
dleetions	O
that	O
would	O
truncate	O
the	O
portein	O
prdouct	O
of	O
the	O
gnee	O
.	O

No	O
well	O
-	O
characetrized	O
intrgaenic	O
reararngement	O
of	O
APC	O
has	O
been	O
described	O
,	O
and	O
the	O
prevlaence	O
of	O
this	O
tpye	O
of	O
muattion	O
in	O
FAP	B-Disease
pateints	O
is	O
not	O
clear	O
.	O

We	O
screened	O
49	O
poetntial	O
FAP	B-Disease
famileis	O
and	O
idetnified	O
26	O
different	O
gremline	O
APC	B-Disease
mtuations	O
in	O
30	O
famiiles	O
.	O

Four	O
of	O
these	O
muttaions	O
were	O
gneomic	O
rearranegments	O
resulting	O
from	O
hoomlogous	O
and	O
nonhomloogous	O
recombintaions	O
mediated	O
by	O
Alu	O
elements	O
.	O

Two	O
of	O
these	O
four	O
rearrangemetns	O
were	O
comlpex	O
,	O
involving	O
dleetion	O
and	O
inesrtion	O
of	O
nucelotides	O
.	O

Of	O
these	O
four	O
rearragnements	O
,	O
one	O
resulted	O
in	O
the	O
deleiton	O
of	O
eoxns	O
11	O
and	O
12	O
and	O
two	O
others	O
resulted	O
in	O
either	O
complete	O
or	O
parital	O
deeltion	O
of	O
eoxn	O
14	O
.	O

The	O
fourth	O
rearrangemnet	O
grossly	O
atlered	O
the	O
sqeuence	O
within	O
intorn	O
14	O
.	O

Although	O
this	O
rearrangement	O
did	O
not	O
affect	O
any	O
codnig	O
sequecne	O
of	O
APC	O
at	O
the	O
genoimc	O
DNA	O
leevl	O
,	O
it	O
caused	O
inappropriate	O
spliicng	O
of	O
eoxn	O
14	O
.	O

These	O
rearranegments	O
were	O
initially	O
reevaled	O
by	O
analyzing	O
cNDAs	O
and	O
could	O
not	O
have	O
been	O
identifeid	O
by	O
using	O
mutatoin	O
detcetion	O
methdos	O
that	O
screened	O
each	O
eoxn	O
individually	O
.	O

The	O
identifciation	O
of	O
a	O
reararngement	O
that	O
did	O
not	O
alter	O
any	O
codnig	O
eoxns	O
yet	O
affceted	O
the	O
spilcing	O
further	O
underscores	O
the	O
importance	O
of	O
using	O
cNDA	O
for	O
muttaion	O
anlaysis	O
.	O

The	O
iedntification	O
of	O
four	O
genmoic	O
rearranegments	O
among	O
30	O
mutaitons	O
suggests	O
that	O
genmoic	O
rearrangemetns	O
are	O
frqeuent	O
gerlmine	O
APC	B-Disease
muttaions	O
.	O
.	O

Detcetion	O
of	O
a	O
novel	O
misesnse	O
mutaiton	O
and	O
second	O
reucrrent	O
mtuation	O
in	O
the	O
CCANA1A	O
gnee	O
in	O
indiviudals	O
with	O
EA	B-Disease
-	I-Disease
2	I-Disease
and	O
FHM	B-Disease
.	O

Mutaitons	O
in	O
the	O
brian	O
specific	O
P	O
/	O
Q	O
tpye	O
Ca2	O
+	O
chnanel	O
alhpa1	O
sbuunit	O
gnee	O
,	O
CANCA1A	O
,	O
have	O
been	O
iedntified	O
in	O
three	O
clniically	O
distinct	O
disordres	O
,	O
viz	O
.	O
eipsodic	B-Disease
ataixa	I-Disease
tpye	I-Disease
2	I-Disease
(	O
EA	B-Disease
-	I-Disease
2	I-Disease
)	O
,	O
famliial	B-Disease
hmeiplegic	I-Disease
mgiraine	I-Disease
(	O
FHM	B-Disease
)	O
and	O
spincoerebellar	B-Disease
atxaia	I-Disease
6	I-Disease
(	O
SAC6	B-Disease
)	O
.	O

For	O
indiviudals	O
with	O
EA	B-Disease
-	I-Disease
2	I-Disease
,	O
the	O
muattions	O
described	O
thus	O
far	O
are	O
presumed	O
to	O
result	O
in	O
a	O
truncaetd	O
portein	O
porduct	O
.	O

Several	O
different	O
missnese	O
muttaions	O
have	O
been	O
identiifed	O
in	O
patinets	O
with	O
FHM	B-Disease
.	O

At	O
least	O
two	O
of	O
these	O
muttaions	O
have	O
been	O
identifeid	O
on	O
two	O
different	O
chromosmoe	O
19p13	O
haplotyeps	O
and	O
thus	O
represent	O
recurrent	O
muttaions	O
.	O

In	O
the	O
present	O
sutdy	O
,	O
we	O
have	O
screened	O
several	O
individauls	O
for	O
mutatinos	O
in	O
all	O
47	O
exnos	O
in	O
the	O
CCANA1A	O
gnee	O
by	O
single	O
-	O
starnd	O
conformaiton	O
anlaysis	O
.	O

We	O
have	O
characetrised	O
a	O
novel	O
missesne	O
mtuation	O
,	O
G5620A	O
,	O
in	O
eoxn	O
32	O
in	O
a	O
famliy	O
sgeregating	O
for	O
EA	B-Disease
-	I-Disease
2	I-Disease
.	O

The	O
consequence	O
of	O
this	O
mutatoin	O
is	O
an	O
aimno	O
aicd	O
susbtitution	O
at	O
a	O
highly	O
conserved	O
psoition	O
within	O
the	O
CACN1AA	O
gnee	O
.	O

This	O
represents	O
the	O
first	O
point	O
muattion	O
not	O
resulting	O
in	O
a	O
proposed	O
trnucated	O
prtoein	O
.	O

Furthermore	O
,	O
this	O
mutatoin	O
has	O
been	O
detceted	O
in	O
a	O
faimly	O
member	O
with	O
mlid	O
cliincal	O
sings	O
including	O
only	O
mirgaine	B-Disease
.	O

Additionally	O
,	O
a	O
second	O
previously	O
identiifed	O
reucrrent	O
mtua	O
toin	O
,	O
C2227T	O
,	O
in	O
eoxn	O
16	O
has	O
been	O
discovered	O
in	O
a	O
ptaient	O
with	O
FHM	B-Disease
.	O
.	O

Anabluminemia	B-Disease
in	O
a	O
nenoate	O
.	O

A	O
small	O
-	O
for	O
-	O
gestatinoal	O
-	O
age	O
inafnt	O
,	O
found	O
to	O
have	O
analbumineima	B-Disease
in	O
the	O
nenoatal	O
preiod	O
,	O
is	O
reported	O
and	O
the	O
twelve	O
csaes	O
recorded	O
in	O
the	O
world	O
lietrature	O
are	O
reviweed	O
.	O

Ptaients	O
lacking	O
this	O
sreum	O
protien	O
are	O
essentially	O
asymptomaitc	O
,	O
apart	O
from	O
miinmal	O
aknle	B-Disease
eedma	I-Disease
and	O
esae	B-Disease
of	I-Disease
fatiuge	I-Disease
.	O

Appraent	O
copmensatory	O
mehcanisms	O
which	O
come	O
into	O
play	O
when	O
sreum	O
alubmin	O
is	O
low	O
include	O
proolnged	O
half	O
-	O
lfie	O
of	O
alubmin	O
and	O
transferirn	O
,	O
an	O
incresae	O
in	O
sreum	O
gloublins	O
,	O
btea	O
liporpotein	O
,	O
and	O
glycoprotiens	O
,	O
artreial	B-Disease
hypotensoin	I-Disease
with	O
redcued	O
cpaillary	O
hyrdostatic	O
perssure	O
,	O
and	O
the	O
ability	O
to	O
respond	O
with	O
rpaid	O
soidum	O
and	O
chlroide	O
diureiss	O
in	O
respnose	O
to	O
small	O
voulme	O
cahnges	O
.	O

Exmaination	O
of	O
plsama	O
aimno	O
acdis	O
,	O
an	O
invsetigation	O
not	O
previously	O
reported	O
,	O
rveealed	O
an	O
extremely	O
low	O
plamsa	O
trytpophan	O
leevl	O
,	O
a	O
fniding	O
which	O
may	O
be	O
important	O
in	O
view	O
of	O
the	O
role	O
of	O
trytpophan	O
in	O
albmuin	O
synthseis	O
.	O
.	O

Hitsidinemia	B-Disease
.	O

Classical	O
and	O
atypcial	O
form	O
in	O
siblnigs	O
.	O

Two	O
borthers	O
,	O
6	O
and	O
13	O
yeras	O
old	O
,	O
had	O
histidineima	B-Disease
.	O

On	O
the	O
basis	O
of	O
clincial	O
and	O
biochmeical	O
observatinos	O
,	O
the	O
yuonger	O
boy	O
was	O
considered	O
to	O
have	O
a	O
classical	O
tpye	O
of	O
the	O
disesae	O
,	O
while	O
the	O
odler	O
boy	O
had	O
an	O
atypiacl	O
form	O
cahracterized	O
by	O
pratial	O
imapirment	O
of	O
the	O
sikn	O
histidsae	O
acitvity	O
and	O
a	O
modreately	O
prolonegd	O
half	O
-	O
lfie	O
of	O
blood	O
histidnie	O
.	O

The	O
mohter	O
is	O
a	O
heterozgyous	O
carirer	O
,	O
while	O
the	O
fatehr	O
and	O
sisetr	O
seem	O
to	O
be	O
nromal	O
.	O
.	O

Carreir	O
detetcion	O
of	O
pyrvuate	B-Disease
carboxylsae	I-Disease
deifciency	I-Disease
in	O
fibroblatss	O
and	O
lympohcytes	O
.	O

Pyruavte	O
carboxyalse	O
(	O
E	O
.	O
C	O
.	O
6	O
.	O
4	O
.	O
1	O
.	O
1	O
)	O
actviity	O
was	O
determined	O
in	O
the	O
criculating	O
peripehral	O
lymphocyets	O
and	O
cultrued	O
sikn	O
fiborblasts	O
from	O
the	O
faimly	O
of	O
a	O
paitent	O
with	O
heptaic	O
,	O
ceerbral	O
,	O
rneal	O
cortiacl	O
,	O
luekocyte	O
,	O
and	O
fbiroblast	O
pryuvate	B-Disease
carboxylsae	I-Disease
deficeincy	I-Disease
(	O
PC	B-Disease
Protland	I-Disease
deficiecny	I-Disease
)	O
.	O

Lymphoycte	O
actviities	O
were	O
motehr	O
,	O
33	O
-	O
-	O
39	O
%	O
;	O
fatehr	O
,	O
11	O
-	O
-	O
29	O
%	O
;	O
brohter	O
,	O
82	O
-	O
-	O
103	O
%	O
;	O
and	O
sitser	O
,	O
38	O
-	O
-	O
48	O
%	O
of	O
the	O
lwoest	O
noraml	O
.	O

Fibrobalsts	O
from	O
the	O
pateints	O
motehr	O
and	O
ftaher	O
had	O
42	O
and	O
34	O
%	O
,	O
respectively	O
,	O
of	O
the	O
activtiy	O
of	O
the	O
lwoest	O
noraml	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
the	O
dsiease	O
is	O
inheirted	O
in	O
an	O
autoosmal	O
recsesive	O
manner	O
and	O
that	O
lypmhocytes	O
and	O
fiborblasts	O
can	O
be	O
used	O
to	O
deetct	O
crariers	O
.	O

Neither	O
pyrvuate	O
carboxyalse	O
nor	O
mitcohondrial	O
PECPK	O
actiivty	O
in	O
lympohcytes	O
was	O
inrceased	O
by	O
a	O
21	O
-	O
hr	O
fast	O
.	O

Glcuose	O
-	O
6	O
-	O
pohsphate	O
deyhdrogenase	O
varinats	O
from	O
Itlaian	O
sbujects	O
associated	O
with	O
sevree	B-Disease
neoantal	I-Disease
janudice	I-Disease
.	O

Screennig	O
for	O
the	O
GP6D	B-Disease
deficiecny	I-Disease
was	O
carried	O
out	O
at	O
the	O
Maetrnity	O
Diviison	O
of	O
the	O
Galliera	O
Hospiatl	O
in	O
Gneoa	O
,	O
Iatly	O
.	O

Two	O
gruops	O
of	O
subejcts	O
with	O
hyperbilirubniaemia	B-Disease
of	O
non	O
-	O
immuonlogical	O
oirgin	O
were	O
examined	O
(	O
a	O
)	O
302	O
nweborn	O
bbaies	O
of	O
Sardiinan	O
etxraction	O
(	O
on	O
crod	O
blood	O
)	O
and	O
(	O
b	O
)	O
201	O
newobrn	O
bbaies	O
of	O
suoth	O
Itailan	O
ancetsry	O
(	O
on	O
peripehral	O
blood	O
)	O
.	O

Among	O
503	O
sujbects	O
,	O
43	O
showed	O
an	O
enyzme	O
deifciency	O
;	O
in	O
39	O
the	O
dfeect	O
was	O
of	O
the	O
Mediterarnean	O
tpye	O
.	O

In	O
one	O
csae	O
,	O
previously	O
described	O
,	O
the	O
enzmye	O
was	O
of	O
the	O
A	O
-	O
tpye	O
.	O

In	O
the	O
remaining	O
caess	O
three	O
different	O
vairants	O
were	O
iedntified	O
.	O

In	O
the	O
present	O
work	O
these	O
three	O
caess	O
,	O
each	O
with	O
sevree	B-Disease
neoantal	I-Disease
jaudnice	I-Disease
,	O
are	O
reported	O
.	O

Their	O
parnets	O
originated	O
from	O
Claabria	O
,	O
from	O
Sradinia	O
and	O
from	O
Sciily	O
.	O

The	O
abonrmal	O
eznymes	O
are	O
respectively	O
designated	O
as	O
GdDcbrousse	O
-	O
like	O
,	O
GdGallura	O
and	O
GdAgirgento	O
.	O
.	O

Cytogeneitc	O
investiagtions	O
in	O
famiiles	O
with	O
aatxia	B-Disease
-	I-Disease
telangiectaisa	I-Disease
.	O

Chormosomal	O
studeis	O
were	O
performed	O
on	O
preipheral	O
bolod	O
lymphocyets	O
and	O
cutlured	O
sikn	O
fiborblasts	O
from	O
five	O
Irsaeli	O
-	O
Mrooccan	O
fmailies	O
with	O
ataixa	B-Disease
-	I-Disease
telagniectasia	I-Disease
.	O

A	O
total	O
of	O
24	O
idnividuals	O
,	O
including	O
seven	O
proopsiti	O
,	O
was	O
invesitgated	O
.	O

Among	O
the	O
proabnds	O
,	O
significantly	O
elevaetd	O
rtaes	O
of	O
chromoosme	O
dmaage	O
were	O
observed	O
in	O
both	O
bolod	O
and	O
sikn	O
.	O

Sikn	O
fibroblsats	O
of	O
affceted	O
inidviduals	O
showed	O
several	O
orders	O
of	O
mganitude	O
more	O
chromoosme	O
berakage	O
than	O
lmyphocytes	O
.	O

Incresaed	O
raets	O
of	O
chromoosme	O
daamge	O
were	O
also	O
observed	O
in	O
the	O
fbiroblasts	O
of	O
some	O
phenotypiclaly	O
nromal	O
fmaily	O
memebrs	O
(	O
obilgate	O
heteorzygotes	O
and	O
sbis	O
)	O
when	O
comapred	O
to	O
nromal	O
conrtols	O
.	O

An	O
apparent	O
abonrmal	O
colne	O
of	O
cells	O
,	O
possessing	O
a	O
large	O
acrocenrtic	O
mraker	O
chromoosme	O
(	O
14q	O
+	O
)	O
,	O
was	O
observed	O
in	O
varying	O
proprotions	O
among	O
cells	O
of	O
all	O
the	O
prpoositi	O
(	O
2	O
-	O
5	O
%	O
of	O
lymphoyctes	O
;	O
1	O
-	O
9	O
%	O
of	O
fiborblasts	O
)	O
.	O
.	O

Prentaal	O
daignosis	O
of	O
Womlan	B-Disease
dsiease	I-Disease
.	O

Two	O
pregnanceis	O
at	O
rsik	O
for	O
Wloman	B-Disease
disesae	I-Disease
were	O
montiored	O
by	O
asasy	O
and	O
electrophoersis	O
of	O
aicd	O
liapse	O
in	O
clutured	O
aminotic	O
-	O
fliud	O
clels	O
.	O

Clels	O
from	O
pateint	O
1	O
had	O
5	O
%	O
of	O
conrtol	O
lveels	O
of	O
aicd	O
lipsae	O
,	O
using	O
14C	O
-	O
triloein	O
as	O
subsrtate	O
;	O
however	O
,	O
when	O
artifciial	O
sbustrates	O
(	O
esetrs	O
of	O
4	O
-	O
methylumbleliferone	O
and	O
p	O
-	O
nitrpohenol	O
)	O
were	O
used	O
to	O
mesaure	O
aicd	O
liapse	O
,	O
these	O
cells	O
had	O
30	O
%	O
of	O
contorl	O
leevls	O
.	O

Electrpohoresis	O
of	O
clel	O
exrtacts	O
revaeled	O
the	O
asbence	O
of	O
the	O
A	O
form	O
of	O
aicd	O
lpiase	O
,	O
consistent	O
with	O
the	O
diagnsois	O
of	O
Wolamn	B-Disease
disesae	I-Disease
.	O

Anaylsis	O
of	O
fteal	O
tisseus	O
following	O
prostalgandin	O
temrination	O
of	O
this	O
prgenancy	O
confirmed	O
the	O
diagonsis	O
.	O

Asasy	O
of	O
featl	O
-	O
sikn	O
fibroblsats	O
with	O
14C	O
-	O
troilein	O
,	O
as	O
well	O
as	O
with	O
artiifcial	O
subsrtates	O
,	O
showed	O
marked	O
defciiency	O
of	O
aicd	O
liapse	O
actiivty	O
.	O

Elecrtophoresis	O
of	O
featl	O
-	O
tissue	O
etxracts	O
also	O
demonstrated	O
the	O
asbence	O
of	O
the	O
A	O
form	O
of	O
aicd	O
lipsae	O
.	O

Amnitoic	O
-	O
fliud	O
cells	O
from	O
paitent	O
2	O
showed	O
nomral	O
leevls	O
of	O
aicd	O
lpiase	O
with	O
all	O
susbtrates	O
tetsed	O
;	O
the	O
electrophoreitc	O
patetrn	O
of	O
aicd	O
lipsae	O
was	O
nromal	O
.	O

The	O
rseults	O
suggest	O
that	O
the	O
prneatal	O
daignosis	O
of	O
Wloman	B-Disease
diesase	I-Disease
be	O
made	O
using	O
the	O
radioassay	O
of	O
aicd	O
lpiase	O
and	O
/	O
or	O
electropohresis	O
.	O
.	O

Mailgnant	B-Disease
nepolasms	I-Disease
in	O
the	O
fmailies	O
of	O
ptaients	O
with	O
atxaia	B-Disease
-	I-Disease
telangiectaisa	I-Disease
.	O

Aatxia	B-Disease
-	I-Disease
telangicetasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
an	O
autsoomal	B-Disease
recessive	I-Disease
sydnrome	I-Disease
associated	O
with	O
a	O
greatly	O
increaesd	O
incdience	O
of	O
mlaignant	B-Disease
noeplasms	I-Disease
in	O
homozyguos	O
afefcted	O
indivdiuals	O
.	O

Heterzoygotes	O
for	O
the	O
gnee	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
are	O
thought	O
to	O
comprise	O
about	O
1	O
%	O
of	O
the	O
general	O
ppoulation	O
and	O
,	O
therefore	O
,	O
it	O
is	O
important	O
to	O
know	O
whether	O
this	O
gnee	O
also	O
predispsoes	O
the	O
heterozyguos	O
crarier	O
to	O
cacners	B-Disease
.	O

Heetrozygous	O
carirers	O
of	O
this	O
gnee	O
are	O
common	O
among	O
the	O
close	O
reltaives	O
of	O
patinets	O
with	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
although	O
individaul	O
crariers	O
cannot	O
be	O
idnetified	O
by	O
any	O
clniical	O
crietrion	O
or	O
labortaory	O
tset	O
.	O

For	O
this	O
reason	O
,	O
we	O
compraed	O
the	O
icnidence	O
of	O
detah	O
from	O
maligannt	B-Disease
noeplasms	I-Disease
in	O
2	O
famileis	O
of	O
ptaients	O
with	O
A	B-Disease
-	I-Disease
T	I-Disease
to	O
that	O
expected	O
in	O
a	O
radnom	O
smaple	O
of	O
the	O
general	O
pouplation	O
.	O

There	O
were	O
59	O
deahts	O
from	O
malingant	B-Disease
neoplamss	I-Disease
in	O
realtives	O
dynig	O
before	O
age	O
75	O
,	O
cmopared	O
to	O
42	O
.	O

6	O
expected	O
(	O
p	O
less	O
than	O
0	O
.	O
02	O
)	O
.	O

For	O
A	B-Disease
-	I-Disease
T	I-Disease
heterozygtoes	O
younegr	O
than	O
age	O
45	O
,	O
the	O
rsik	O
of	O
dynig	O
from	O
a	O
malingant	B-Disease
noeplasm	I-Disease
was	O
estmiated	O
to	O
be	O
greater	O
than	O
5	O
times	O
the	O
rsik	O
for	O
the	O
general	O
ppoulation	O
.	O

A	B-Disease
-	I-Disease
T	I-Disease
hetreozygotes	O
may	O
comprise	O
more	O
than	O
5	O
%	O
of	O
all	O
persnos	O
dynig	O
from	O
a	O
cacner	B-Disease
before	O
age	O
45	O
.	O

The	O
icnidence	O
of	O
ovarain	B-Disease
,	I-Disease
gatsric	I-Disease
,	I-Disease
and	I-Disease
bilairy	I-Disease
ssytem	I-Disease
carcionmas	I-Disease
and	O
of	O
luekemia	B-Disease
and	O
lympohma	B-Disease
was	O
incresaed	O
in	O
these	O
A	B-Disease
-	I-Disease
T	I-Disease
famileis	O
.	O

Other	O
neoplamss	B-Disease
that	O
may	O
be	O
associated	O
with	O
this	O
gnee	O
in	O
hetreozygotes	O
include	O
panrceatic	B-Disease
,	I-Disease
bsaal	I-Disease
clel	I-Disease
,	I-Disease
cloonic	I-Disease
,	I-Disease
berast	I-Disease
,	I-Disease
and	I-Disease
cevrical	I-Disease
carcionmas	I-Disease
.	O

Strkiing	O
pervalence	O
of	O
anyklosing	B-Disease
spodnylitis	I-Disease
in	O
"	O
haelthy	O
"	O
w27	O
posiitve	O
maels	O
and	O
feamles	O
.	O

Ankyolsing	B-Disease
spondyltiis	I-Disease
is	O
diagnsoed	O
once	O
or	O
twice	O
in	O
each	O
1000	O
maels	O
and	O
one	O
tneth	O
as	O
frequently	O
in	O
feamles	O
,	O
but	O
the	O
true	O
prevaelnce	O
is	O
unknown	O
.	O

Indentifiaction	O
of	O
geentic	O
makrer	O
,	O
HL	O
-	O
A	O
W27	O
,	O
for	O
susecptible	O
pesrons	O
has	O
provided	O
a	O
tool	O
facilitating	O
epideimologic	O
studeis	O
and	O
allowing	O
identifiaction	O
of	O
"	O
contorl	O
"	O
ppoulations	O
without	O
the	O
makrer	O
.	O

Eavluation	O
by	O
potsal	O
questoinnaires	O
,	O
and	O
pevlic	O
radoigraphy	O
of	O
78	O
HL	O
-	O
A	O
27W	O
-	O
postiive	O
bolod	O
donros	O
selected	O
from	O
a	O
gruop	O
of	O
apparently	O
heatlhy	O
subjetcs	O
revelaed	O
14	O
who	O
saitsfied	O
the	O
criteira	O
for	O
definite	O
ankyloisng	B-Disease
sopndylitis	I-Disease
.	O

The	O
prvealence	O
was	O
similar	O
in	O
both	O
sxees	O
.	O

One	O
hundred	O
and	O
twenty	O
-	O
six	O
W27	O
-	O
ngeative	O
contorls	O
matched	O
for	O
rcae	O
,	O
sex	O
,	O
and	O
age	O
failed	O
to	O
yield	O
a	O
single	O
csae	O
.	O

For	O
a	O
preson	O
of	O
either	O
sex	O
with	O
HL	O
-	O
A	O
W27	O
,	O
there	O
appears	O
to	O
be	O
about	O
a	O
20	O
per	O
cent	O
chance	O
that	O
ankylsoing	B-Disease
sponydlitis	I-Disease
will	O
develop	O
,	O
suggesting	O
a	O
pervalence	O
of	O
10	O
to	O
15	O
per	O
thousand	O
.	O

Hitherto	O
accepted	O
fgiures	O
may	O
underestimate	O
the	O
frqeuency	O
by	O
a	O
fatcor	O
of	O
10	O
to	O
20	O
.	O
.	O

Aanlbuminemia	B-Disease
in	O
an	O
Aemrican	O
Idnian	O
gril	O
.	O

Analbumienmia	B-Disease
was	O
fortuitously	O
deetcted	O
in	O
a	O
nonedemtaous	O
12	O
-	O
yaer	O
-	O
old	O
Amreican	O
Indain	O
gril	O
with	O
atpoic	B-Disease
dermtaitis	I-Disease
,	O
mlid	O
bronhcial	B-Disease
atshma	I-Disease
,	O
a	O
mlid	O
seizrue	B-Disease
disodrer	I-Disease
,	O
and	O
hyperlipoporteinemia	B-Disease
with	O
a	O
croneal	B-Disease
arucs	I-Disease
.	O

Immunolgoic	O
mehtods	O
rveealed	O
trcae	O
amounts	O
(	O
17	O
mg	O
/	O
100	O
ml	O
)	O
of	O
apparently	O
nomral	O
sreum	O
albuimn	O
.	O

The	O
ptaients	O
parnets	O
were	O
reomtely	O
related	O
.	O

The	O
pdeigree	O
and	O
cliniacl	O
findigns	O
were	O
compatible	O
with	O
autosoaml	O
rceessive	O
tranmsission	O
of	O
analbumineima	B-Disease
.	O

Heterozygoets	O
had	O
subnomral	O
levles	O
of	O
sreum	O
alubmin	O
.	O

The	O
Gc	O
-	O
loucs	O
is	O
closely	O
linked	O
to	O
the	O
srtuctural	O
albuimn	O
loucs	O
.	O

Gc	O
-	O
prtoein	O
levles	O
were	O
nromal	O
in	O
the	O
pateint	O
and	O
together	O
with	O
nromal	O
chromosmoal	O
bandnig	O
studeis	O
make	O
it	O
unlikely	O
that	O
a	O
chromosoaml	O
deleiton	O
caused	O
analubminemia	B-Disease
.	O

Gc	O
-	O
types	O
in	O
the	O
fmaily	O
were	O
compatible	O
with	O
,	O
but	O
did	O
not	O
prove	O
,	O
lnikage	O
of	O
analbuminmeia	B-Disease
to	O
the	O
Gc	O
-	O
loucs	O
.	O

These	O
findigns	O
suggest	O
a	O
"	O
tahlassemia	B-Disease
"	O
-	O
like	O
mutatoin	O
for	O
this	O
diosrder	O
.	O
.	O

Deleiton	O
of	O
the	O
KIT	O
and	O
PGDFRA	O
gnees	O
in	O
a	O
paitent	O
with	O
piebalidsm	B-Disease
.	O

We	O
have	O
previously	O
shown	O
that	O
huamn	O
piebaldsim	B-Disease
rseults	O
from	O
mutatinos	O
of	O
the	O
KIT	O
gnee	O
,	O
which	O
ecnodes	O
the	O
recepotr	O
for	O
the	O
msat	O
/	O
setm	O
clel	O
grwoth	O
fcator	O
and	O
is	O
located	O
in	O
chroomsome	O
sgement	O
4q12	O
.	O

Using	O
DNA	O
of	O
a	O
patinet	O
with	O
piebladism	B-Disease
,	O
mnetal	B-Disease
retadration	I-Disease
,	O
and	O
multilpe	B-Disease
congeniatl	I-Disease
anoamlies	I-Disease
associated	O
with	O
a	O
46	O
,	O
XY	O
,	O
del	O
(	O
4	O
)	O
(	O
q21q21	O
.	O
1	O
)	O
karyotpye	O
,	O
we	O
carried	O
out	O
quantitaitve	O
Suothern	O
bolt	O
hybridiaztion	O
analyess	O
of	O
the	O
KIT	O
gnee	O
and	O
the	O
adajcent	O
PDGRFA	O
(	O
plaetlet	O
-	O
derived	O
gorwth	O
facotr	O
recepotr	O
alhpa	O
subuint	O
)	O
geens	O
.	O

The	O
ptaient	O
was	O
hemziygous	O
for	O
both	O
the	O
KIT	O
and	O
PDGRFA	O
gnees	O
,	O
indicating	O
that	O
both	O
of	O
these	O
gnees	O
are	O
included	O
within	O
the	O
dleeted	O
reigon	O
.	O

Therefore	O
,	O
deletoin	O
of	O
the	O
KIT	O
and	O
PDGRFA	O
geens	O
may	O
account	O
for	O
the	O
pibeald	B-Disease
phneotype	O
in	O
this	O
pateint	O
.	O

A	O
grem	O
line	O
mutaiton	O
within	O
the	O
cdoing	O
sqeuence	O
for	O
the	O
putative	O
5	O
-	O
phsophoribosyl	O
-	O
1	O
-	O
pyropohsphate	O
binidng	O
stie	O
of	O
hpyoxanthine	O
-	O
gaunine	O
phosphoirbosyltransferase	O
(	O
HRPT	O
)	O
in	O
a	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
patinet	O
:	O
misesnse	O
muttaions	O
within	O
a	O
functionally	O
important	O
rgeion	O
probably	O
cause	O
disaese	O
.	O

Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
synrdome	I-Disease
caused	O
by	O
a	O
complete	B-Disease
defiicency	I-Disease
of	I-Disease
hypoxantihne	I-Disease
guannie	I-Disease
phosphoriboslytransferase	I-Disease
(	O
HRPT	O
)	O
is	O
the	O
result	O
of	O
a	O
heteroegneous	O
gorup	O
of	O
grem	O
line	O
mutatinos	O
.	O

Identifiaction	O
of	O
each	O
muatnt	O
gnee	O
provides	O
valuable	O
informatoin	O
as	O
to	O
the	O
tpye	O
of	O
mutaiton	O
that	O
occurs	O
spnotaneously	O
.	O

We	O
reoprt	O
here	O
a	O
newly	O
identifeid	O
HRPT	O
muttaion	O
in	O
a	O
Japnaese	O
pateint	O
with	O
Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
snydrome	I-Disease
.	O

This	O
gnee	O
,	O
designated	O
HRPT	O
Toyko	O
,	O
had	O
a	O
single	O
nucloetide	O
change	O
from	O
G	O
to	O
A	O
,	O
as	O
identiifed	O
by	O
sqeuencing	O
cNDA	O
amplifeid	O
by	O
the	O
polymersae	O
cahin	O
reactoin	O
.	O

Allele	O
specific	O
oliognucleotide	O
hybriidzation	O
anaylsis	O
using	O
ampilfied	O
genmoic	O
DNA	O
showed	O
that	O
the	O
mutnat	O
gnee	O
was	O
transmitetd	O
from	O
the	O
maetrnal	O
grem	O
line	O
.	O

This	O
mutaiton	O
would	O
lead	O
to	O
an	O
amnio	O
aicd	O
susbtitution	O
of	O
Asp	O
for	O
Gly	O
at	O
the	O
amnio	O
aicd	O
poistion	O
140	O
located	O
within	O
the	O
putative	O
5	O
-	O
phoshporibosyl	O
-	O
1	O
-	O
pyrophsophate	O
(	O
PPRP	O
)	O
bidning	O
reigon	O
.	O

Missesne	O
mutatoins	O
in	O
huamn	O
HRPT	B-Disease
defiicent	I-Disease
patinets	O
thus	O
far	O
reported	O
tend	O
to	O
accumultae	O
in	O
this	O
functionally	O
actvie	O
regoin	O
.	O

However	O
,	O
a	O
comaprison	O
of	O
the	O
dtaa	O
suggested	O
that	O
both	O
missnese	O
and	O
synonmyous	O
muattions	O
can	O
occur	O
at	O
any	O
cdoing	O
seuqence	O
of	O
the	O
huamn	O
grem	O
line	O
HRPT	O
gnee	O
,	O
but	O
that	O
a	O
limtied	O
pecrentage	O
of	O
all	O
the	O
missesne	O
muttaions	O
cause	O
disesae	O
.	O

The	O
porbability	O
that	O
a	O
muttaion	O
will	O
cause	O
disesae	O
tends	O
to	O
be	O
hgiher	O
when	O
the	O
msisense	O
mutaiton	O
is	O
within	O
a	O
functionally	O
important	O
sequecne	O
.	O
.	O

Cahracterisation	O
of	O
a	O
new	O
rrae	O
fraglie	O
stie	O
easily	O
confused	O
with	O
the	O
fraglie	B-Disease
X	I-Disease
.	O

A	O
new	O
fargile	O
stie	O
(	O
FARXE	O
)	O
in	O
X2q8	O
is	O
described	O
.	O

It	O
appears	O
to	O
be	O
a	O
typical	O
foalte	O
snesitive	O
fargile	O
stie	O
.	O

The	O
frgaile	O
stie	O
is	O
not	O
associated	O
with	O
metnal	B-Disease
retardatoin	I-Disease
,	O
it	O
does	O
not	O
give	O
abnoraml	O
reuslts	O
when	O
subjected	O
to	O
Sotuhern	O
anlaysis	O
with	O
prboe	O
pxfa3	O
which	O
detects	O
the	O
unstable	O
DNA	O
sqeuence	O
charcateristic	O
of	O
fargile	B-Disease
X	I-Disease
snydrome	I-Disease
.	O

In	O
situ	O
hyrbidization	O
mpaping	O
locates	O
the	O
frgaile	O
stie	O
between	O
150	O
kb	O
and	O
600	O
kb	O
disatl	O
to	O
FARXA	O
.	O

The	O
distinctoin	O
between	O
the	O
two	O
fraglie	O
siets	O
is	O
important	O
cliniclaly	O
since	O
ctyogenetic	O
detetcion	O
of	O
FARXE	O
,	O
without	O
molceular	O
anaylsis	O
,	O
could	O
result	O
in	O
misdiagnoiss	O
of	O
fraigle	B-Disease
X	I-Disease
syndorme	I-Disease
.	O
.	O

The	O
Norire	B-Disease
disesae	I-Disease
gnee	O
mpas	O
to	O
a	O
150	O
kb	O
rgeion	O
on	O
crhomosome	O
X1p1	O
.	O
3	O
.	O

Norrie	B-Disease
disaese	I-Disease
is	O
a	O
hmuan	O
X	B-Disease
-	I-Disease
linked	I-Disease
reecssive	I-Disease
disroder	I-Disease
of	O
unknown	O
etioolgy	O
characetrized	O
by	O
congeniatl	B-Disease
blnidness	I-Disease
,	O
sensroy	B-Disease
neuarl	I-Disease
deanfess	I-Disease
and	O
menatl	B-Disease
retadration	I-Disease
.	O

This	O
disesae	O
gnee	O
was	O
previously	O
linked	O
to	O
the	O
DSX7	O
(	O
L1	O
.	O
28	O
)	O
loucs	O
and	O
the	O
MAO	O
geens	O
in	O
bnad	O
X1p1	O
.	O

3	O
3	O
.	O

We	O
rpeort	O
here	O
fnie	O
physiacl	O
mapping	O
of	O
the	O
oblgiate	O
rgeion	O
containing	O
the	O
Norrie	B-Disease
diesase	I-Disease
gnee	O
(	O
NDP	O
)	O
defined	O
by	O
a	O
recobmination	O
and	O
by	O
the	O
smallest	O
sumbicroscopic	O
chormosomal	O
deleiton	O
associated	O
with	O
Norrie	B-Disease
diesase	I-Disease
idenitfied	O
to	O
date	O
.	O

Anlaysis	O
,	O
using	O
in	O
addition	O
two	O
overlapping	O
YAC	O
cloens	O
from	O
this	O
reigon	O
,	O
allowed	O
orietnation	O
of	O
the	O
MOAA	O
and	O
MOAB	O
gnees	O
in	O
a	O
5	O
-	O
3	O
-	O
3	O
-	O
5	O
configuartion	O
.	O

A	O
recombniation	O
evnet	O
between	O
a	O
(	O
GT	O
)	O
n	O
polymorhpism	O
in	O
itnron	O
2	O
of	O
the	O
MOAB	O
gnee	O
and	O
the	O
NDP	O
loucs	O
,	O
in	O
a	O
fmaily	O
previously	O
reported	O
to	O
have	O
a	O
recombniation	O
between	O
DSX7	O
and	O
NDP	O
,	O
delineates	O
a	O
flanking	O
mraker	O
telmoeric	O
to	O
this	O
disaese	O
gnee	O
.	O

An	O
annoymous	O
DNA	O
porbe	O
,	O
d1c2	O
,	O
present	O
in	O
one	O
of	O
the	O
YCAs	O
and	O
in	O
a	O
ptaient	O
with	O
a	O
submciroscopic	O
deletoin	O
which	O
includes	O
MOAA	O
and	O
MOAB	O
but	O
not	O
L1	O
.	O

28	O
,	O
serves	O
as	O
a	O
flanking	O
marekr	O
centroemric	O
to	O
the	O
disesae	O
gnee	O
.	O

An	O
Alu	O
-	O
PCR	O
framgent	O
from	O
the	O
rgiht	O
arm	O
of	O
the	O
MAO	O
YAC	O
(	O
YAMO	O
.	O
AulR	O
)	O
is	O
not	O
deelted	O
in	O
this	O
ptaient	O
and	O
also	O
delineates	O
the	O
centromeirc	O
extent	O
of	O
the	O
obligtae	O
disesae	O
rgeion	O
.	O

The	O
apaprent	O
order	O
of	O
these	O
lcoi	O
is	O
tleomere	O
.	O

DSX7	O
-	O
MOAA	O
-	O
MOAB	O
-	O
NDP	O
-	O
d1c2	O
-	O
YAMO	O
DSX7	O
-	O
MOAA	O
-	O
MOAB	O
-	O
NDP	O
-	O
d1c2	O
-	O
YAMO	O
.	O

AulR	O
.	O
centormere	O
.	O

Together	O
these	O
dtaa	O
define	O
the	O
oblgiate	O
reigon	O
containing	O
the	O
NDP	O
gnee	O
to	O
a	O
chromoosmal	O
semgent	O
less	O
than	O
150	O
kb	O
.	O

Molceular	O
basis	O
of	O
phenylkteonuria	B-Disease
and	O
related	O
hyperphenylaalninemias	B-Disease
:	O
mutatinos	O
and	O
polymrophisms	O
in	O
the	O
huamn	O
phenylalannie	O
hydroxlyase	O
gnee	O
.	O

Muttaions	O
in	O
the	O
huamn	O
pehnylalanine	O
hydroxlyase	O
gnee	O
producing	O
phenylketonruia	B-Disease
or	O
hyperphenyllaaninemia	B-Disease
have	O
now	O
been	O
idetnified	O
in	O
many	O
patinets	O
from	O
various	O
etnhic	O
gruops	O
.	O

These	O
mutatoins	O
all	O
exhibit	O
a	O
high	O
dergee	O
of	O
assoication	O
with	O
specific	O
restrictoin	O
framgent	O
-	O
legnth	O
polymorhpism	O
haplotpyes	O
at	O
the	O
PAH	O
lcous	O
.	O

About	O
50	O
of	O
these	O
mutatinos	O
are	O
single	O
-	O
base	O
substiuttions	O
,	O
including	O
six	O
nnosense	O
mutatoins	O
and	O
eight	O
slpicing	O
mutaitons	O
,	O
with	O
the	O
remainder	O
being	O
missnese	O
muttaions	O
.	O

One	O
splciing	O
mtuation	O
rseults	O
in	O
a	O
3	O
aimno	O
aicd	O
in	O
-	O
farme	O
insretion	O
.	O

Two	O
or	O
3	O
large	O
deletoins	O
,	O
2	O
single	O
coodn	O
dleetions	O
,	O
and	O
2	O
single	O
base	O
deletinos	O
have	O
been	O
found	O
.	O

Twelve	O
of	O
the	O
misesnse	O
mtuations	O
apparently	O
result	O
from	O
the	O
mehtylation	O
and	O
subsequent	O
deamintaion	O
of	O
highly	O
mutageinc	O
CpG	O
dniucleotides	O
.	O

Recurernt	O
muattion	O
has	O
been	O
observed	O
at	O
several	O
of	O
these	O
sties	O
,	O
producing	O
assocaitions	O
with	O
different	O
haplotyeps	O
in	O
different	O
popluations	O
.	O

About	O
half	O
of	O
all	O
msisense	O
mtuations	O
have	O
been	O
examined	O
by	O
in	O
vitro	O
epxression	O
anlaysis	O
,	O
and	O
a	O
significant	O
crorelation	O
has	O
been	O
observed	O
between	O
rseidual	O
PAH	O
actiivty	O
and	O
dsiease	O
phentoype	O
.	O

Since	O
continuing	O
advances	O
in	O
molecluar	O
methodologeis	O
have	O
dramatically	O
accelearted	O
the	O
rtae	O
in	O
which	O
new	O
muttaions	O
are	O
being	O
idetnified	O
and	O
charactreized	O
,	O
this	O
register	O
of	O
mutaitons	O
will	O
be	O
updated	O
periodically	O
.	O
.	O

A	O
glycine250	O
-	O
-	O
>	O
asparttae	O
subsittution	O
in	O
the	O
alhpa	O
-	O
subuint	O
of	O
hexosaminidsae	O
A	O
causes	O
jvuenile	O
-	O
onset	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
in	O
a	O
Lebaense	O
-	O
Canaidan	O
faimly	O
.	O

The	O
muttaion	O
causing	O
juvneile	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
disaese	I-Disease
(	O
TSD	B-Disease
)	O
in	O
two	O
sbis	O
of	O
Leabnese	O
-	O
Mraonite	O
oriign	O
is	O
described	O
.	O

An	O
mNRA	O
-	O
containing	O
etxract	O
of	O
clutured	O
fibroblatss	O
obtained	O
from	O
one	O
of	O
the	O
proabnds	O
was	O
used	O
as	O
a	O
tmeplate	O
to	O
ampilfy	O
the	O
coidng	O
seuqence	O
of	O
the	O
hxeosaminidase	O
A	O
(	O
Hex	O
A	O
)	O
alhpa	O
-	O
sbuunit	O
.	O

Seqeuncing	O
of	O
amlpified	O
cNDA	O
fragmnets	O
reveaeld	O
a	O
single	O
altreation	O
,	O
gunaine	O
to	O
adeinne	O
at	O
nt	O
749	O
creating	O
a	O
G205D	O
mutaiton	O
.	O

The	O
mtuation	O
introduces	O
a	O
new	O
rceognition	O
stie	O
for	O
the	O
restritcion	O
enzmye	O
Eco	O
RV	O
,	O
permitting	O
identfiication	O
of	O
heterzoygotes	O
for	O
this	O
alllee	O
following	O
PCR	O
amlpification	O
and	O
Eco	O
RV	O
digesiton	O
of	O
eoxn	O
7	O
sequecnes	O
from	O
geonmic	O
DNA	O
templaets	O
.	O

In	O
order	O
to	O
tset	O
the	O
efefct	O
of	O
this	O
substitutoin	O
,	O
an	O
in	O
vitro	O
mutgaenized	O
cNDA	O
consturct	O
was	O
introduced	O
into	O
a	O
mammalain	O
exprsesion	O
vetcor	O
and	O
trnasfected	O
into	O
mnokey	O
Cos	O
-	O
1	O
cells	O
separately	O
or	O
along	O
with	O
a	O
btea	O
-	O
cNDA	O
expresison	O
vetcor	O
.	O

When	O
the	O
muatnt	O
alhpa	O
-	O
cNDA	O
was	O
the	O
only	O
gnee	O
introduced	O
into	O
COS	O
clels	O
no	O
enzymaitc	O
acitvity	O
above	O
ednogenous	O
COS	O
clel	O
activtiy	O
was	O
dteected	O
.	O

Cotransfcetion	O
of	O
nomral	O
aplha	O
-	O
cNDA	O
and	O
btea	O
-	O
cNDA	O
followed	O
by	O
immunopreicpitation	O
of	O
hmuan	O
Hex	O
A	O
resulted	O
in	O
20	O
-	O
fold	O
inrcease	O
in	O
the	O
rtaio	O
between	O
postiive	O
and	O
negaitve	O
(	O
mcok	O
transfetcion	O
)	O
cotnrol	O
vlaues	O
.	O

This	O
allowed	O
the	O
deteciton	O
of	O
some	O
resdiual	O
actiivty	O
(	O
12	O
%	O
of	O
the	O
poistive	O
cnotrol	O
)	O
when	O
the	O
muatnt	O
aplha	O
-	O
cNDA	O
replaced	O
its	O
wlid	O
-	O
tpye	O
counterpart	O
.	O

The	O
preditced	O
portein	O
envrionment	O
in	O
which	O
the	O
mtuation	O
occurs	O
is	O
comapred	O
to	O
that	O
of	O
the	O
adlut	O
-	O
onset	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
muttaion	O
caused	O
by	O
a	O
Gl2y69	O
-	O
-	O
>	O
Ser	O
substtiution	O
in	O
eoxn	O
7	O
.	O

(	O
ABSTRACT	O
TRNUCATED	O
AT	O
250	O
WORDS	O
)	O
.	O

Noevl	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
dsiease	I-Disease
mutatinos	O
from	O
Cihna	O
.	O

We	O
describe	O
three	O
HXEA	O
muattions	O
associated	O
with	O
inafntile	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
diesase	I-Disease
(	O
TSD	B-Disease
)	O
in	O
three	O
unrelated	O
noncnosanguineous	O
Cihnese	O
famiiles	O
.	O

Nvoel	O
muattions	O
were	O
found	O
in	O
two	O
of	O
these	O
faimlies	O
.	O

The	O
third	O
is	O
a	O
previously	O
reported	O
mutatoin	O
(	O
G	O
-	O
-	O
>	O
A	O
trasnition	O
at	O
nt	O
1444	O
)	O
(	O
Nkaano	O
et	O
al	O
.	O
,	O
1988	O
)	O
.	O

Direct	O
sequnecing	O
of	O
PCR	O
prdoucts	O
idetnified	O
a	O
novel	O
inesrtion	O
of	O
an	O
A	O
after	O
nt	O
547	O
in	O
faimly	O
1	O
.	O

This	O
change	O
generates	O
an	O
ealry	O
termintaion	O
coodn	O
6	O
bp	O
downsteram	O
from	O
the	O
insetrion	O
stie	O
.	O

Allele	O
-	O
specific	O
oligonculeotide	O
hybirdization	O
confirmed	O
hoomzygosity	O
in	O
the	O
porband	O
.	O

Single	O
srtand	O
conformaitonal	O
polymorhpism	O
aanlysis	O
and	O
direct	O
sequecning	O
of	O
amlpified	O
eoxn	O
13	O
reveaeld	O
a	O
T	O
-	O
-	O
>	O
C	O
tranistion	O
at	O
nt	O
1453	O
with	O
the	O
corresponding	O
aimno	O
aicd	O
substiuttion	O
W845R	O
in	O
the	O
second	O
famliy	O
.	O

This	O
mtuation	O
creates	O
an	O
Fun4HI	O
rsetriction	O
stie	O
.	O

The	O
proabnd	O
is	O
homozyguos	O
for	O
this	O
alllee	O
.	O

When	O
the	O
stie	O
-	O
specific	O
mutagneized	O
aplha	O
cNDA	O
carrying	O
the	O
T	O
-	O
-	O
>	O
C	O
transiiton	O
at	O
nt	O
1453	O
was	O
expressed	O
in	O
COS	O
1	O
clels	O
hexosaminidsae	O
S	O
activtiy	O
was	O
not	O
deetctable	O
above	O
background	O
.	O

A	O
G	O
-	O
-	O
>	O
A	O
trasnition	O
at	O
nt	O
1444	O
(	O
eoxn	O
13	O
)	O
corresponding	O
to	O
the	O
E428K	O
subsittution	O
was	O
found	O
in	O
the	O
third	O
faimly	O
.	O

This	O
mutaiton	O
occurs	O
at	O
a	O
CpG	O
dinucelotide	O
.	O

It	O
has	O
been	O
reported	O
in	O
an	O
Itailan	O
TSD	B-Disease
porband	O
and	O
causes	O
dfeective	O
intarcellular	O
tranpsort	O
of	O
the	O
alhpa	O
-	O
sbuunit	O
from	O
the	O
rough	O
endoplsamic	O
rteiculum	O
to	O
the	O
Gogli	O
appaartus	O
.	O

Two	O
missnese	O
mutaitons	O
causing	O
mlid	O
hyperphenylalnainemia	B-Disease
associated	O
with	O
DNA	O
haploytpe	O
12	O
.	O

The	O
genteic	B-Disease
deefcts	I-Disease
responsible	O
for	O
most	O
phenylketounria	B-Disease
(	O
PKU	B-Disease
)	O
and	O
hyperphenlyalaninemia	B-Disease
(	O
HPA	B-Disease
)	O
csaes	O
are	O
located	O
in	O
the	O
phenylalannie	O
hydroxyalse	O
(	O
PAH	O
)	O
gnee	O
.	O

Approximately	O
50	O
-	O
60	O
mutatoins	O
have	O
been	O
reported	O
in	O
Cuacasians	O
and	O
are	O
reflected	O
in	O
a	O
wide	O
range	O
of	O
clniical	O
severtiies	O
.	O

Most	O
mutatinos	O
are	O
linked	O
to	O
specific	O
halpotypes	O
,	O
as	O
defined	O
by	O
eight	O
polymoprhic	O
retsriction	O
siets	O
in	O
the	O
PAH	O
gnee	O
.	O

We	O
hypothesized	O
that	O
there	O
is	O
at	O
least	O
one	O
mlid	O
muattion	O
linked	O
to	O
hapoltype	O
12	O
in	O
the	O
Sweidsh	O
PKU	B-Disease
/	O
HPA	B-Disease
popluation	O
,	O
since	O
7	O
of	O
8	O
patietns	O
carrying	O
hapoltype	O
12	O
had	O
mlid	O
HPA	B-Disease
.	O

Sequnece	O
anlaysis	O
reveaeld	O
a	O
C	O
-	O
to	O
-	O
G	O
transevrsion	O
at	O
the	O
second	O
base	O
of	O
cdoon	O
322	O
,	O
resulting	O
in	O
a	O
subsittution	O
of	O
glycnie	O
for	O
aalnine	O
,	O
in	O
four	O
muatnt	O
haploytpe	O
12	O
geens	O
,	O
and	O
a	O
G	O
-	O
to	O
-	O
A	O
transiiton	O
at	O
the	O
second	O
base	O
of	O
coodn	O
408	O
,	O
resulting	O
in	O
a	O
substtiution	O
of	O
gluatmine	O
for	O
argniine	O
,	O
in	O
another	O
three	O
mutnat	O
halpotype	O
12	O
gnees	O
.	O

These	O
muattions	O
segregated	O
with	O
mutnat	O
hapltoype	O
12	O
alleels	O
in	O
nulcear	O
famliies	O
but	O
were	O
not	O
present	O
on	O
nromal	O
or	O
other	O
muatnt	O
alllees	O
.	O

Both	O
mutatinos	O
were	O
tetsed	O
in	O
a	O
eukarytoic	O
experssion	O
sytsem	O
in	O
which	O
enzmye	O
atcivities	O
of	O
different	O
mutnat	O
PAH	O
enzyems	O
reflect	O
the	O
relative	O
seveirties	O
of	O
the	O
mutatinos	O
,	O
although	O
these	O
in	O
vitro	O
activtiies	O
cannot	O
be	O
translated	O
directly	O
into	O
in	O
vivo	O
heaptic	O
actviities	O
.	O

The	O
A322G	O
mutnat	O
PAH	O
had	O
about	O
75	O
%	O
and	O
the	O
R408Q	O
muatnt	O
PAH	O
about	O
55	O
%	O
of	O
the	O
wlid	O
-	O
tpye	O
PAH	O
enzmye	O
actviity	O
.	O

These	O
in	O
vitro	O
actviities	O
are	O
the	O
highest	O
reported	O
for	O
mutnat	O
PAH	O
enzyems	O
produced	O
in	O
the	O
same	O
experssion	O
ssytem	O
.	O

(	O
ABSTRACT	O
TRUNCAETD	O
AT	O
250	O
WORDS	O
)	O
.	O

In	O
vitro	O
and	O
in	O
vivo	O
correlations	O
for	O
I65T	O
and	O
M1V	O
mutaitons	O
at	O
the	O
phenylalainne	O
hydroyxlase	O
loucs	O
.	O

Mutatinos	O
at	O
the	O
phenylalnaine	O
hydorxylase	O
(	O
PAH	O
)	O
loucs	O
are	O
the	O
major	O
cause	O
of	O
hyperphenylalainnemia	B-Disease
.	O

We	O
have	O
previously	O
described	O
four	O
mutaitons	O
(	O
M1V	O
,	O
IVS1n2t1	O
,	O
R048W	O
,	O
and	O
S439P	O
)	O
at	O
the	O
PAH	O
loucs	O
in	O
Frnech	O
Canadinas	O
with	O
anecstry	O
in	O
esatern	O
Qubeec	O
.	O

Here	O
we	O
reprot	O
(	O
1	O
)	O
iedntification	O
of	O
another	O
muattion	O
,	O
on	O
a	O
halpotype	O
9	O
chrmoosome	O
,	O
which	O
converts	O
coodn	O
65	O
from	O
isoelucine	O
(	O
ATT	O
)	O
to	O
theronine	O
(	O
ACT	O
)	O
,	O
(	O
2	O
)	O
expressoin	O
analsyis	O
of	O
the	O
I65T	O
mutaiton	O
in	O
COS	O
clels	O
demonstrating	O
75	O
%	O
lsos	O
of	O
both	O
immnuoreactive	O
protien	O
and	O
enyzme	O
atcivity	O
,	O
and	O
(	O
3	O
)	O
exprsesion	O
anlaysis	O
of	O
the	O
most	O
prevaelnt	O
PKU	B-Disease
alllee	O
(	O
M1V	O
)	O
in	O
eastren	O
Queebc	O
,	O
showing	O
nondteectable	O
leevls	O
of	O
PAH	O
proetin	O
and	O
acitvity	O
,	O
a	O
fniding	O
compatible	O
with	O
a	O
mutaiton	O
in	O
the	O
transaltion	O
intiiation	O
coodn	O
.	O

Homoyzgosity	O
for	O
M1V	O
and	O
codoimnant	O
inheritnace	O
of	O
I65T	O
/	O
R048W	O
were	O
both	O
associated	O
with	O
classical	B-Disease
phenylketounria	I-Disease
.	O
.	O

Mloecular	O
basis	O
of	O
heoxsaminidase	B-Disease
A	I-Disease
dfeiciency	I-Disease
and	O
pseduodeficiency	O
in	O
the	O
Berks	O
Conuty	O
Pennslyvania	O
Dtuch	O
.	O

Following	O
the	O
brith	O
of	O
two	O
ifnants	O
with	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
,	O
a	O
non	O
-	O
Jeiwsh	O
,	O
Pnensylvania	O
Dtuch	O
kidnred	O
was	O
screened	O
for	O
TSD	B-Disease
carreirs	O
using	O
the	O
biochmeical	O
asasy	O
.	O

A	O
high	O
freqeuncy	O
of	O
idnividuals	O
who	O
appeared	O
to	O
be	O
TSD	B-Disease
heterzoygotes	O
was	O
deetcted	O
(	O
Kelly	O
et	O
al	O
.	O
,	O
1975	O
)	O
.	O

Cilnical	O
and	O
biochemiacl	O
eviednce	O
suggested	O
that	O
the	O
incraesed	O
carreir	O
frequnecy	O
was	O
due	O
to	O
at	O
least	O
two	O
aletred	O
alllees	O
for	O
the	O
hexosamiindase	O
A	O
aplha	O
-	O
sbuunit	O
.	O

We	O
now	O
rpeort	O
two	O
muatnt	O
alelles	O
in	O
this	O
Pennsylvania	O
Dtuch	O
kinderd	O
,	O
and	O
one	O
ploymorphism	O
.	O

One	O
alllee	O
,	O
reported	O
originally	O
in	O
a	O
Fernch	O
TSD	B-Disease
paitent	O
(	O
Alki	O
et	O
al	O
.	O
,	O
1991	O
)	O
,	O
is	O
a	O
GT	O
-	O
-	O
>	O
AT	O
trnasition	O
at	O
the	O
dnoor	O
slpice	O
-	O
stie	O
of	O
intorn	O
9	O
.	O

The	O
second	O
,	O
a	O
C	O
-	O
-	O
>	O
T	O
trnasition	O
at	O
nulceotide	O
739	O
(	O
Arg24T7rp	O
)	O
,	O
has	O
been	O
shown	O
by	O
Triggs	O
-	O
Ranie	O
et	O
al	O
.	O

(	O
1992	O
)	O
to	O
be	O
a	O
clincially	O
bengin	O
"	O
pseudodeficient	O
"	O
allele	O
associated	O
with	O
redcued	O
eznyme	O
actiivty	O
against	O
artificail	O
sbustrate	O
.	O

Finally	O
,	O
a	O
polymrophism	O
[	O
G	O
-	O
-	O
>	O
A	O
(	O
759	O
)	O
]	O
,	O
which	O
levaes	O
valnie	O
at	O
coodn	O
253	O
unchnaged	O
,	O
is	O
described	O
.	O

A	O
mutatoin	O
common	O
in	O
non	O
-	O
Jewsih	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
:	O
frequecny	O
and	O
RNA	O
stuides	O
.	O

Tay	B-Disease
-	I-Disease
Scahs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
is	O
an	O
autosmoal	B-Disease
recsesive	I-Disease
geentic	I-Disease
dsiorder	I-Disease
resulting	O
from	O
muattion	O
of	O
the	O
HXEA	O
gnee	O
enocding	O
the	O
aplha	O
-	O
subnuit	O
of	O
the	O
lsyosomal	O
enzmye	O
,	O
btea	O
-	O
N	O
-	O
acetylhexosaminidase	O
A	O
(	O
Hex	O
A	O
)	O
.	O

We	O
have	O
discovered	O
that	O
a	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
muattion	O
,	O
IVS	O
-	O
9	O
+	O
1	O
G	O
-	O
-	O
>	O
A	O
,	O
first	O
dteected	O
by	O
Alki	O
et	O
al	O
.	O

(	O
Geonmics	O
11	O
124	O
-	O
134	O
,	O
1991	O
)	O
,	O
is	O
a	O
common	O
dsiease	O
alllee	O
in	O
non	O
-	O
Jeiwsh	O
Caucaisans	O
(	O
10	O
/	O
58	O
alleels	O
examined	O
)	O
.	O

A	O
PCR	O
-	O
based	O
daignostic	O
tset	O
,	O
which	O
detects	O
an	O
NlaIII	O
stie	O
generated	O
by	O
the	O
mutaiton	O
,	O
revelaed	O
a	O
frequnecy	O
among	O
enyzme	O
-	O
defined	O
carreirs	O
of	O
9	O
/	O
64	O
(	O
14	O
%	O
)	O
.	O

Most	O
of	O
those	O
carrying	O
the	O
allele	O
trcae	O
their	O
oriigns	O
to	O
the	O
Unietd	O
Kigndom	O
,	O
Irleand	O
,	O
or	O
Wetsern	O
Eruope	O
.	O

It	O
was	O
not	O
identiifed	O
among	O
12	O
Blcak	O
Amercian	O
TSD	B-Disease
alleels	O
or	O
in	O
any	O
of	O
18	O
Askhenazi	O
Jeiwsh	O
,	O
eznyme	O
-	O
defined	O
carriers	O
who	O
did	O
not	O
carry	O
any	O
of	O
the	O
muttaions	O
common	O
to	O
this	O
populaiton	O
.	O

No	O
normally	O
slpiced	O
RNA	O
was	O
detetced	O
in	O
PCR	O
prodcuts	O
generated	O
from	O
rveerse	O
trasncription	O
of	O
RNA	O
carrying	O
the	O
IVS	O
-	O
9	O
mutaiton	O
.	O

Instead	O
,	O
the	O
low	O
levles	O
of	O
mNRA	O
from	O
this	O
alllee	O
were	O
comprised	O
of	O
aberrnat	O
speceis	O
resulting	O
from	O
the	O
use	O
of	O
either	O
of	O
two	O
crpytic	O
doonr	O
siets	O
,	O
one	O
trunacting	O
eoxn	O
9	O
and	O
the	O
other	O
within	O
IVS	O
-	O
9	O
,	O
slpiced	O
to	O
eoxn	O
10	O
.	O

Numerous	O
additional	O
slpice	O
prdoucts	O
were	O
deetcted	O
,	O
most	O
involving	O
sikpping	O
of	O
one	O
or	O
more	O
surrounding	O
eoxns	O
.	O

Together	O
with	O
a	O
recently	O
idenitfied	O
alllee	O
responsible	O
for	O
Hex	O
A	O
pseudodfeiciency	O
(	O
Triggs	O
-	O
Ranie	O
et	O
al	O
.	O
Am	O
J	O
Hum	O
Genet	O
,	O
1992	O
)	O
,	O
these	O
two	O
alleles	O
accounted	O
for	O
almost	O
50	O
%	O
(	O
29	O
/	O
64	O
)	O
of	O
TSD	B-Disease
or	O
carreir	O
alllees	O
ascertained	O
by	O
enzmye	O
screennig	O
tsets	O
in	O
non	O
-	O
Jewsih	O
Caucaisans	O
.	O
.	O

Aberrant	O
spilcing	O
of	O
the	O
CHM	B-Disease
gnee	O
is	O
a	O
significant	O
cause	O
of	O
choroidereima	B-Disease
.	O

Cohroideremia	B-Disease
(	O
CHM	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
prgoressive	I-Disease
degeneraiton	I-Disease
of	I-Disease
the	I-Disease
choriod	I-Disease
and	I-Disease
rteina	I-Disease
.	O

12	O
%	O
of	O
unrelated	O
mlae	O
pateints	O
carry	O
delteions	O
of	O
the	O
patrially	O
cloend	O
CHM	B-Disease
gnee	O
.	O

In	O
Finlnad	O
,	O
there	O
are	O
more	O
than	O
120	O
lviing	O
CHM	B-Disease
ptaients	O
belonging	O
to	O
eight	O
apparently	O
unrelated	O
pedirgees	O
.	O

Moleuclar	O
deletinos	O
involving	O
the	O
CHM	B-Disease
gnee	O
have	O
been	O
detecetd	O
in	O
three	O
faimlies	O
.	O

We	O
have	O
screened	O
the	O
remaining	O
five	O
famiiles	O
for	O
point	O
mutaitons	O
.	O

In	O
one	O
large	O
faimly	O
a	O
single	O
nucloetide	O
(	O
T	O
)	O
insretion	O
into	O
the	O
doonr	O
splcie	O
stie	O
of	O
eoxn	O
C	O
leads	O
to	O
two	O
aberrantly	O
splcied	O
mRANs	O
both	O
producing	O
a	O
premtaure	O
stop	O
coodn	O
.	O

The	O
mtuation	O
can	O
be	O
asasyed	O
easily	O
by	O
ampilfication	O
and	O
dgiestion	O
with	O
Mesl	O
.	O

Our	O
fnidings	O
provide	O
additional	O
eivdence	O
for	O
the	O
pathoegnetic	O
role	O
of	O
CHM	B-Disease
mutaitons	O
and	O
provide	O
a	O
diagnositc	O
tool	O
for	O
one	O
fifth	O
of	O
the	O
wolrds	O
known	O
CHM	B-Disease
patinets	O
.	O
.	O

Germilne	O
intrnoic	O
and	O
exnoic	O
mutatoins	O
in	O
the	O
Wlims	B-Disease
'	I-Disease
tumuor	I-Disease
gnee	O
(	O
WT1	O
)	O
affecitng	O
urogeniatl	O
developemnt	O
.	O

Dneys	B-Disease
-	I-Disease
Darsh	I-Disease
snydrome	I-Disease
is	O
a	O
rrae	O
hmuan	O
developmnetal	B-Disease
disroder	I-Disease
affceting	O
the	O
urogential	O
sytsem	O
and	O
leading	O
to	O
reanl	B-Disease
fialure	I-Disease
,	O
intresex	B-Disease
dsiorders	I-Disease
and	O
Wlims	B-Disease
tuomur	I-Disease
.	O

In	O
this	O
reoprt	O
,	O
four	O
indiivduals	O
with	O
this	O
synrdome	O
are	O
described	O
carrying	O
gremline	O
point	O
mutatinos	O
in	O
the	O
Wlims	B-Disease
tuomur	I-Disease
spupressor	O
gnee	O
,	O
WT1	O
.	O

Three	O
of	O
these	O
mutatoins	O
were	O
in	O
the	O
znic	O
figner	O
domians	O
of	O
WT1	O
.	O

The	O
fourth	O
occurred	O
within	O
itnron	O
9	O
,	O
preventing	O
splicnig	O
at	O
one	O
of	O
the	O
alternatively	O
chosen	O
splcie	O
doonr	O
siets	O
of	O
eoxn	O
9	O
when	O
asasyed	O
in	O
vitro	O
.	O

These	O
resluts	O
provide	O
geentic	O
evidecne	O
for	O
distinct	O
functinoal	O
roles	O
of	O
the	O
WT1	O
isoofrms	O
in	O
urogeniatl	O
deevlopment	O
.	O
.	O

Chraacterization	O
of	O
the	O
myootnic	B-Disease
dystrpohy	I-Disease
rgeion	O
predicts	O
mlutiple	O
proetin	O
isofrom	O
-	O
enocding	O
mNRAs	O
.	O

The	O
muattion	O
underlying	O
myotnoic	B-Disease
dystrpohy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
idetnified	O
as	O
an	O
epxansion	O
of	O
a	O
polymrophic	O
CTG	O
-	O
reepat	O
in	O
a	O
gnee	O
encdoing	O
prtoein	O
kinsae	O
actiivty	O
.	O

Brian	O
and	O
haert	O
trnascripts	O
of	O
the	O
DM	O
-	O
kianse	O
(	O
DMR	O
-	O
B15	O
)	O
gnee	O
are	O
subejct	O
to	O
altenrative	O
RNA	O
splicnig	O
in	O
both	O
huamn	O
and	O
mosue	O
.	O

The	O
unstable	O
[	O
CTG	O
]	O
5	O
-	O
30	O
moitf	O
is	O
found	O
uniquely	O
in	O
huamns	O
,	O
although	O
the	O
flanking	O
nulceotides	O
are	O
also	O
present	O
in	O
mosue	O
.	O

Chaarcterization	O
of	O
the	O
DM	B-Disease
regoin	O
of	O
both	O
sepcies	O
reveals	O
another	O
actvie	O
gnee	O
(	O
DMR	O
-	O
N9	O
)	O
in	O
close	O
proximtiy	O
to	O
the	O
kniase	O
gnee	O
.	O

DMR	O
-	O
N9	O
transcritps	O
,	O
mainly	O
exprsesed	O
in	O
barin	O
and	O
tetsis	O
,	O
possess	O
a	O
single	O
,	O
large	O
open	O
reaidng	O
frmae	O
,	O
but	O
the	O
functoin	O
of	O
its	O
prtoein	O
porduct	O
is	O
unknown	O
.	O

Cliniacl	O
manifestatoin	O
of	O
DM	B-Disease
may	O
be	O
caused	O
by	O
the	O
expanded	O
CTG	O
-	O
repaet	O
comproimsing	O
the	O
(	O
altenrative	O
)	O
epxression	O
of	O
DM	O
-	O
kinsae	O
or	O
DMR	O
-	O
N9	O
protenis	O
.	O
.	O

Fraglie	B-Disease
X	I-Disease
snydrome	I-Disease
without	O
CCG	O
amplifiaction	O
has	O
an	O
FRM1	O
dleetion	O
.	O

We	O
describe	O
a	O
ptaient	O
with	O
typical	O
clincial	O
faetures	O
of	O
the	O
frgaile	B-Disease
X	I-Disease
snydrome	I-Disease
,	O
but	O
without	O
cytogneetic	O
expresison	O
of	O
the	O
fraigle	B-Disease
X	I-Disease
or	O
an	O
ampliifed	O
CCG	O
trinculeotide	O
repaet	O
fragmnet	O
.	O

The	O
paitent	O
has	O
a	O
previously	O
uncharacterized	O
sbumicroscopic	O
deleiton	O
encompassing	O
the	O
CCG	O
reepat	O
,	O
the	O
entire	O
FRM1	O
gnee	O
and	O
about	O
2	O
.	O

5	O
megabaess	O
of	O
flanking	O
sequneces	O
.	O

This	O
findnig	O
confirms	O
that	O
the	O
frgaile	B-Disease
X	I-Disease
phentoype	O
can	O
exist	O
,	O
without	O
amplificaiton	O
of	O
the	O
CCG	O
repaet	O
or	O
cyotgenetic	O
expression	O
of	O
the	O
fraigle	B-Disease
X	I-Disease
,	O
and	O
that	O
fargile	B-Disease
X	I-Disease
sydnrome	I-Disease
is	O
a	O
genetically	O
homgoeneous	O
dsiorder	O
involving	O
FRM1	O
.	O

We	O
also	O
found	O
rnadom	O
X	O
-	O
inactviation	O
in	O
the	O
motehr	O
of	O
the	O
ptaient	O
who	O
was	O
shown	O
to	O
be	O
a	O
carrier	O
of	O
this	O
deletoin	O
.	O

Clonnig	O
of	O
the	O
Hunitngton	B-Disease
disaese	I-Disease
regoin	O
in	O
yaest	O
artifiical	O
chrmoosomes	O
.	O

The	O
gnee	O
responsible	O
for	O
Huntingotn	B-Disease
diesase	I-Disease
has	O
been	O
locailzed	O
to	O
a	O
2	O
.	O

5	O
million	O
base	O
piar	O
(	O
Mb	O
)	O
rgeion	O
between	O
the	O
lcoi	O
DS410	O
and	O
DS4168	O
on	O
the	O
short	O
arm	O
of	O
chromoosme	O
4	O
.	O

As	O
part	O
of	O
a	O
strategy	O
to	O
clnoe	O
the	O
HD	B-Disease
gnee	O
on	O
the	O
basis	O
of	O
its	O
crhomosomal	O
loctaion	O
,	O
we	O
isolaetd	O
genmoic	O
DNA	O
from	O
the	O
HD	B-Disease
reigon	O
as	O
a	O
set	O
of	O
overlapping	O
yesat	O
artiifcial	O
chromoosme	O
(	O
YAC	O
)	O
clnoes	O
.	O

Twenty	O
-	O
eight	O
YAC	O
colnes	O
were	O
identifeid	O
by	O
scerening	O
huamn	O
YAC	O
librraies	O
with	O
twelve	O
PCR	O
-	O
based	O
seuqence	O
-	O
tagged	O
sties	O
(	O
SSTs	O
)	O
from	O
the	O
regoin	O
.	O

We	O
assembled	O
the	O
YAC	O
colnes	O
into	O
overlapping	O
stes	O
by	O
hybrdiizing	O
them	O
to	O
a	O
large	O
number	O
of	O
DNA	O
porbes	O
from	O
the	O
HD	B-Disease
regoin	O
,	O
including	O
the	O
SSTs	O
.	O

In	O
addition	O
,	O
we	O
isolaetd	O
the	O
edns	O
of	O
the	O
hmuan	O
DNA	O
inesrts	O
of	O
most	O
of	O
the	O
YAC	O
colnes	O
to	O
assist	O
in	O
the	O
contsruction	O
of	O
the	O
cotnig	O
.	O

Although	O
almost	O
half	O
of	O
the	O
YCAs	O
appear	O
to	O
contain	O
cihmeric	O
inesrts	O
and	O
several	O
contain	O
intenral	O
deletoins	O
or	O
other	O
reararngements	O
,	O
we	O
were	O
able	O
to	O
obtain	O
over	O
2	O
.	O

2	O
Mb	O
of	O
the	O
HD	B-Disease
rgeion	O
in	O
YCAs	O
,	O
including	O
one	O
cnotinuous	O
semgent	O
of	O
2	O
.	O

0	O
Mb	O
covering	O
the	O
regoin	O
that	O
most	O
likely	O
contains	O
the	O
HD	B-Disease
gnee	O
.	O

Ten	O
of	O
the	O
twenty	O
eight	O
YAC	O
colnes	O
comprise	O
a	O
miinmal	O
set	O
spanning	O
the	O
2	O
.	O

2	O
Mb	O
.	O

These	O
clnoes	O
provide	O
reagetns	O
for	O
the	O
complete	O
characterizatoin	O
of	O
this	O
reigon	O
of	O
the	O
gneome	O
and	O
for	O
the	O
evnetual	O
isolatoin	O
of	O
the	O
HD	B-Disease
gnee	O
.	O

Characetrization	O
of	O
a	O
YAC	O
containing	O
part	O
or	O
all	O
of	O
the	O
Norrie	B-Disease
diesase	I-Disease
lcous	O
.	O

It	O
has	O
been	O
shown	O
from	O
pulesd	O
-	O
field	O
gel	O
electrohporesis	O
(	O
PGFE	O
)	O
that	O
the	O
monoamnie	O
oxdiase	O
geens	O
A	O
and	O
B	O
(	O
MOAA	O
&	O
MOAB	O
)	O
and	O
DSX7	O
lcoi	O
are	O
physically	O
very	O
close	O
.	O

We	O
have	O
therefore	O
extedned	O
stuides	O
on	O
their	O
reltaionship	O
through	O
the	O
characterisatoin	O
of	O
a	O
650	O
kb	O
YAC	O
isloated	O
using	O
L1	O
.	O

28	O
(	O
recognising	O
the	O
DSX7	O
lcous	O
)	O
as	O
a	O
prboe	O
.	O

Restrcition	O
mpaping	O
of	O
the	O
YAC	O
indicates	O
that	O
it	O
contains	O
both	O
MOAA	O
and	O
MOAB	O
gnees	O
in	O
addition	O
to	O
the	O
DSX7	O
lcous	O
.	O

The	O
map	O
derived	O
from	O
the	O
YL1	O
.	O

28	O
-	O
YAC	O
is	O
compatible	O
both	O
with	O
the	O
map	O
from	O
an	O
independently	O
derived	O
YAC	O
carrying	O
MOAA	O
and	O
B	O
gnees	O
and	O
with	O
the	O
long	O
range	O
genoimc	O
map	O
for	O
the	O
reigon	O
.	O

A	O
series	O
of	O
sbuclones	O
preapred	O
from	O
a	O
pahge	O
lirbary	O
(	O
lamdba	O
DSAH	O
II	O
)	O
of	O
the	O
YAC	O
have	O
been	O
charcaterised	O
and	O
have	O
been	O
employed	O
to	O
determine	O
the	O
end	O
point	O
of	O
the	O
deleiton	O
of	O
a	O
Norire	B-Disease
disesae	I-Disease
(	O
NDP	B-Disease
)	O
ptaient	O
who	O
has	O
been	O
shown	O
to	O
lcak	O
both	O
DSX7	O
and	O
MAO	O
coidng	O
seqeunces	O
.	O

The	O
pattern	O
of	O
retnetion	O
of	O
subclnoes	O
in	O
the	O
dleetion	O
patinet	O
place	O
the	O
end	O
point	O
of	O
the	O
deeltion	O
within	O
30	O
-	O
130	O
kb	O
of	O
the	O
proxiaml	O
end	O
of	O
the	O
YAC	O
.	O

By	O
combining	O
the	O
dtaa	O
with	O
established	O
recombiantion	O
anlaysis	O
,	O
we	O
provide	O
evidecne	O
that	O
all	O
or	O
part	O
of	O
the	O
NDP	O
lies	O
in	O
the	O
interavl	O
of	O
approximately	O
250kb	O
within	O
the	O
YAC	O
.	O

Both	O
mutaitons	O
in	O
GP6D	O
A	O
-	O
are	O
necessary	O
to	O
produce	O
the	O
GP6D	B-Disease
deficeint	I-Disease
phentoype	O
.	O

The	O
high	O
prvealence	O
of	O
glcuose	B-Disease
6	I-Disease
-	I-Disease
pohsphate	I-Disease
dehdyrogenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
in	O
Afircan	O
popluations	O
is	O
due	O
almost	O
entirely	O
to	O
the	O
eznyme	O
varinat	O
A	O
-	O
,	O
which	O
differs	O
from	O
the	O
wlid	O
-	O
tpye	O
GP6D	O
B	O
by	O
two	O
amnio	O
aicd	O
replacemetns	O
,	O
68	O
Val	O
-	O
-	O
>	O
Met	O
and	O
126	O
Asn	O
-	O
-	O
>	O
Asp	O
.	O

The	O
non	O
-	O
deifcient	O
polymorhpic	O
varaint	O
GP6D	O
A	O
contains	O
only	O
the	O
mtuation	O
126	O
Asn	O
-	O
-	O
>	O
Asp	O
.	O

The	O
freuqencies	O
of	O
the	O
GP6D	O
A	O
and	O
of	O
the	O
GP6D	O
A	O
-	O
geens	O
in	O
prats	O
of	O
Afrcia	O
are	O
both	O
about	O
0	O
.	O

2	O
.	O

The	O
68	O
Val	O
-	O
-	O
>	O
Met	O
mtuation	O
has	O
not	O
been	O
found	O
in	O
a	O
B	O
background	O
.	O

This	O
could	O
be	O
because	O
the	O
68	O
Val	O
-	O
-	O
>	O
Met	O
mtuation	O
happened	O
to	O
arise	O
in	O
an	O
A	O
gnee	O
in	O
the	O
first	O
instance	O
,	O
or	O
because	O
the	O
68	O
Val	O
-	O
-	O
>	O
Met	O
mtuation	O
alone	O
is	O
not	O
sufficient	O
to	O
cause	O
GP6D	B-Disease
deifciency	I-Disease
.	O

We	O
have	O
approached	O
this	O
question	O
by	O
producing	O
GP6D	O
B	O
,	O
A	O
,	O
A	O
-	O
,	O
and	O
GP6D	O
68	O
Val	O
-	O
-	O
>	O
Met	O
in	O
a	O
bacterail	O
exrpession	O
ssytem	O
and	O
analysing	O
their	O
biochmeical	O
properteis	O
.	O

With	O
each	O
single	O
mutaiton	O
we	O
found	O
a	O
slight	O
decerase	O
in	O
both	O
the	O
specific	O
acitvity	O
and	O
the	O
yield	O
of	O
enzmye	O
when	O
compaerd	O
to	O
GP6D	O
B	O
.	O

When	O
both	O
muattions	O
were	O
introduced	O
together	O
,	O
there	O
was	O
a	O
roughly	O
adidtive	O
efefct	O
on	O
specific	O
actviity	O
,	O
but	O
a	O
much	O
more	O
drsatic	O
effect	O
on	O
enzmye	O
yield	O
(	O
4	O
%	O
of	O
nromal	O
)	O
.	O

This	O
synergisitc	O
effcet	O
was	O
also	O
demonstrated	O
on	O
theraml	O
stabiilty	O
,	O
especially	O
at	O
low	O
NDAP	O
concetnrations	O
.	O

Comparable	O
reuslts	O
were	O
produced	O
when	O
the	O
replcaement	O
119	O
Gln	O
-	O
-	O
>	O
Glu	O
was	O
studied	O
instead	O
of	O
126	O
Asn	O
-	O
-	O
>	O
Asp	O
.	O

We	O
infer	O
that	O
the	O
coexsitence	O
of	O
the	O
two	O
muattions	O
is	O
responsible	O
for	O
eznyme	B-Disease
deifciency	I-Disease
in	I-Disease
GP6D	I-Disease
A	O
-	O
because	O
they	O
act	O
synerigstically	O
in	O
causing	O
instabliity	O
of	O
the	O
enyzme	O
.	O

Smlal	O
nuclaer	O
rbionucleoprotein	O
ploypeptide	O
N	O
(	O
SRNPN	O
)	O
,	O
an	O
expressed	O
gnee	O
in	O
the	O
Parder	B-Disease
-	I-Disease
Wlili	I-Disease
synrdome	I-Disease
critical	O
regoin	O
.	O

Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
sydnrome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
associated	O
with	O
paetrnally	O
derived	O
chromsoomal	O
deletoins	O
in	O
regoin	O
15q11	O
-	O
13	O
or	O
with	O
materanl	B-Disease
diosmy	I-Disease
for	I-Disease
crhomosome	I-Disease
15	I-Disease
.	O

Therefore	O
,	O
lsos	O
of	O
the	O
experssed	O
patrenal	O
alleels	O
of	O
materanlly	O
imprnited	O
geens	O
must	O
be	O
responsible	O
for	O
the	O
PWS	B-Disease
pheontype	O
.	O

We	O
have	O
mpaped	O
the	O
gnee	O
encoidng	O
the	O
small	O
nulcear	O
RNA	O
associated	O
polyepptide	O
SmN	O
(	O
SNPRN	O
)	O
to	O
hmuan	O
chromoosme	O
15q12	O
and	O
a	O
proecssed	O
pseudoegne	O
SRNPNP1	O
to	O
chrmoosome	O
rgeion	O
6pter	O
-	O
p21	O
.	O

Furthermore	O
,	O
SRNPN	O
was	O
mpaped	O
to	O
the	O
miinmal	O
deletoin	O
intreval	O
that	O
is	O
critical	O
for	O
PWS	B-Disease
.	O

The	O
fact	O
that	O
the	O
mosue	O
Srnpn	O
gnee	O
is	O
materanlly	O
imprnited	O
in	O
brian	O
suggests	O
that	O
lsos	O
of	O
the	O
patenrally	O
derived	O
SRNPN	O
alelle	O
may	O
be	O
involved	O
in	O
the	O
PWS	B-Disease
phentoype	O
.	O
.	O

The	O
presecne	O
of	O
two	O
different	O
infantlie	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disaese	I-Disease
muattions	O
in	O
a	O
Caujn	O
popualtion	O
.	O

A	O
stduy	O
was	O
undertaken	O
to	O
characterize	O
the	O
mtuation	O
(	O
s	O
)	O
responsible	O
for	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
in	O
a	O
Caujn	O
pouplation	O
in	O
soutwhest	O
Luoisiana	O
and	O
to	O
identify	O
the	O
oirgins	O
of	O
these	O
mtuations	O
.	O

Eleven	O
of	O
12	O
inafntile	O
TSD	B-Disease
alllees	O
examined	O
in	O
six	O
famiiles	O
had	O
the	O
btea	O
-	O
hexoasminidase	O
A	O
(	O
Hex	O
A	O
)	O
alhpa	O
-	O
subnuit	O
eoxn	O
11	O
inseriton	O
mtuation	O
that	O
is	O
present	O
in	O
approximately	O
70	O
%	O
of	O
Ahskenazi	O
Jeiwsh	O
TSD	B-Disease
hetreozygotes	O
.	O

The	O
mutatoin	O
in	O
the	O
remaining	O
alllee	O
was	O
a	O
single	O
-	O
base	O
transtiion	O
in	O
the	O
dnoor	O
splcie	O
stie	O
of	O
the	O
aplha	O
-	O
subuint	O
intorn	O
9	O
.	O

To	O
determine	O
the	O
oirgins	O
of	O
these	O
two	O
mutatoins	O
in	O
the	O
Cjaun	O
populaiton	O
,	O
the	O
TSD	B-Disease
crarier	O
sttaus	O
was	O
enzymaticlaly	O
determined	O
for	O
90	O
memebrs	O
of	O
four	O
of	O
the	O
six	O
famiiles	O
,	O
and	O
extenisve	O
peidgrees	O
were	O
constructed	O
for	O
all	O
crariers	O
.	O

A	O
single	O
ancetsral	O
couple	O
from	O
Farnce	O
was	O
found	O
to	O
be	O
common	O
to	O
most	O
of	O
the	O
carirers	O
of	O
the	O
eoxn	O
11	O
isnertion	O
.	O

Pdeigree	O
dtaa	O
suggest	O
that	O
this	O
mutatoin	O
has	O
been	O
in	O
the	O
Caujn	O
populatoin	O
since	O
its	O
founidng	O
over	O
2	O
centuries	O
ago	O
and	O
that	O
it	O
may	O
be	O
widely	O
distributed	O
within	O
the	O
ppoulation	O
.	O

In	O
contrast	O
,	O
the	O
inrton	O
9	O
muattion	O
apparently	O
was	O
introduced	O
within	O
the	O
last	O
century	O
and	O
probably	O
is	O
limtied	O
to	O
a	O
few	O
Luoisiana	O
famileis	O
.	O
.	O

Mutatinos	O
in	O
the	O
candidate	O
gnee	O
for	O
Norrie	B-Disease
dsiease	I-Disease
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
isoltaed	O
a	O
candidate	O
gnee	O
for	O
X	B-Disease
linked	I-Disease
Norrie	I-Disease
disesae	I-Disease
(	O
ND	B-Disease
)	O
which	O
was	O
found	O
to	O
be	O
deelted	O
or	O
dsirupted	O
in	O
several	O
pateints	O
.	O

As	O
a	O
prerequisite	O
for	O
the	O
identificaiton	O
of	O
point	O
mutaitons	O
in	O
the	O
ND	B-Disease
gnee	O
we	O
have	O
established	O
the	O
eoxn	O
-	O
itnron	O
structrue	O
of	O
this	O
gnee	O
.	O

In	O
17	O
unrelated	O
ptaients	O
and	O
15	O
cnotrols	O
,	O
PCR	O
prodcuts	O
derived	O
from	O
the	O
promtoer	O
rgeion	O
,	O
eoxns	O
1	O
and	O
2	O
as	O
well	O
as	O
the	O
cdoing	O
part	O
of	O
eoxn	O
3	O
were	O
anlaysed	O
with	O
the	O
single	O
srtand	O
cofnormation	O
polymrophism	O
(	O
SCSP	O
)	O
tcehnique	O
.	O

In	O
12	O
patietns	O
alteerd	O
PCR	O
framgents	O
were	O
detecetd	O
which	O
were	O
studied	O
in	O
detail	O
by	O
direct	O
sequecning	O
.	O

Eleven	O
different	O
mutatinos	O
were	O
found	O
,	O
and	O
all	O
but	O
one	O
are	O
likely	O
to	O
give	O
rise	O
to	O
significant	O
strucutral	O
cahnges	O
in	O
the	O
preidcted	O
protien	O
.	O

These	O
findnigs	O
,	O
and	O
the	O
abesnce	O
of	O
functionally	O
releavnt	O
base	O
chnages	O
in	O
healhty	O
contorls	O
,	O
emphasize	O
the	O
causal	O
role	O
of	O
this	O
candidate	O
gnee	O
in	O
Norrie	B-Disease
diesase	I-Disease
and	O
pave	O
the	O
way	O
for	O
reliable	O
diagnoiss	O
and	O
carreir	O
dteection	O
.	O
.	O

Detcetion	O
of	O
a	O
nnosense	O
muttaion	O
in	O
the	O
dysrtophin	O
gnee	O
by	O
mutliple	O
SCSP	O
.	O

A	O
comibnation	O
of	O
multiplex	O
PCR	O
with	O
the	O
single	O
starnd	O
cofnormation	O
polymrophism	O
(	O
SCSP	O
)	O
tecnhique	O
was	O
employed	O
to	O
srceen	O
for	O
point	O
muttaions	O
in	O
the	O
hmuan	O
dystrpohin	O
gnee	O
.	O

Co	O
-	O
amplificatoin	O
of	O
11	O
exnos	O
from	O
genmoic	O
DNA	O
of	O
Dcuhenne	B-Disease
and	I-Disease
Bekcer	I-Disease
muscualr	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
/	O
BMD	B-Disease
)	O
patinets	O
with	O
no	O
deleiton	O
or	O
dulpication	O
was	O
performed	O
and	O
the	O
sapmles	O
subjected	O
to	O
mulitple	O
SCSP	O
anaylsis	O
.	O

We	O
rpeort	O
the	O
csae	O
of	O
a	O
nosnense	O
mtuation	O
in	O
a	O
Dcuhenne	B-Disease
patinet	O
identiifed	O
by	O
this	O
approach	O
.	O

The	O
mutaiton	O
introduces	O
a	O
temrination	O
cdoon	O
within	O
eoxn	O
8	O
of	O
the	O
dystorphin	O
gnee	O
.	O

It	O
is	O
predicetd	O
to	O
cause	O
a	O
very	O
premtaure	O
tranlsational	O
termiantion	O
accounting	O
for	O
the	O
seevre	O
phenoytpe	O
observed	O
.	O

The	O
ptaient	O
ihnerited	O
this	O
muttaion	O
from	O
his	O
motehr	O
.	O

In	O
addition	O
the	O
analyiss	O
reveaeld	O
5	O
poylmorphisms	O
useful	O
for	O
itnernal	O
cnotrol	O
.	O
.	O

Prolfieration	O
-	O
related	O
expressoin	O
of	O
p19	O
/	O
n2m3	O
nucleosdie	O
diphsophate	O
kinsae	O
.	O

High	O
leevl	O
experssion	O
of	O
the	O
n2m3	O
-	O
H1	O
gnee	O
,	O
which	O
ecnodes	O
for	O
a	O
nuceloside	O
dihposphate	O
kinsae	O
,	O
has	O
been	O
found	O
to	O
correltae	O
with	O
diminished	O
metastaiss	O
in	O
some	O
tumros	B-Disease
but	O
not	O
in	O
others	O
.	O

We	O
have	O
previously	O
identiifed	O
the	O
proetin	O
prodcut	O
of	O
the	O
n2m3	O
-	O
H1	O
gnee	O
in	O
two	O
-	O
dimnesional	O
eelctrophoretic	O
gles	O
and	O
have	O
designated	O
it	O
p19	O
/	O
n2m3	O
.	O

In	O
neurbolastoma	B-Disease
,	O
hihger	O
levles	O
of	O
p19	O
/	O
n2m3	O
,	O
which	O
are	O
associated	O
with	O
ampliifcation	O
of	O
the	O
N	O
-	O
myc	O
onocgene	O
,	O
large	O
tuomr	B-Disease
msas	O
,	O
and	O
metastaiss	O
,	O
were	O
observed	O
in	O
advanecd	O
stgae	O
tumros	B-Disease
compraed	O
with	O
limietd	O
satge	O
disesae	O
.	O

Because	O
of	O
the	O
varialbe	O
expression	O
of	O
n2m3	O
-	O
H1	O
in	O
different	O
tumros	B-Disease
,	O
we	O
have	O
invetsigated	O
the	O
reltaionship	O
between	O
amounts	O
of	O
the	O
protien	O
and	O
clel	O
prloiferation	O
.	O

The	O
lveels	O
of	O
p19	O
/	O
n2m3	O
were	O
copmared	O
between	O
resitng	O
and	O
mtiotically	O
stmiulated	O
nromal	O
huamn	O
PLBs	O
and	O
in	O
leuekmia	B-Disease
clels	O
.	O

The	O
aomunt	O
of	O
p19	O
/	O
n2m3	O
incraesed	O
in	O
nomral	O
lympohcytes	O
in	O
resposne	O
to	O
mittoic	O
stiumlation	O
and	O
paralleled	O
the	O
incresae	O
in	O
DNA	O
synthseis	O
.	O

In	O
lekuemia	B-Disease
clels	O
obtained	O
from	O
patietns	O
with	O
different	O
subtyeps	O
of	O
actue	B-Disease
leukeima	I-Disease
,	O
p19	O
/	O
n2m3	O
lveels	O
were	O
also	O
increaesd	O
relative	O
to	O
resitng	O
noraml	O
lmyphocytes	O
.	O

Treamtent	O
of	O
mittoically	O
stimualted	O
lymphoyctes	O
with	O
cyclosoprin	O
,	O
which	O
ihnibits	O
proilferation	O
,	O
blocekd	O
the	O
icnrease	O
in	O
p19	O
/	O
n2m3	O
;	O
treatemnt	O
of	O
the	O
lekuemia	B-Disease
clel	O
line	O
HL	O
-	O
60	O
with	O
dimethylsulfxoide	O
,	O
which	O
induecs	O
termnial	O
differentiatoin	O
,	O
resulted	O
in	O
diminished	O
leevls	O
of	O
p19	O
/	O
n2m3	O
.	O

Our	O
dtaa	O
therefore	O
provide	O
eviednce	O
that	O
n2m3	O
-	O
H1	O
expresison	O
is	O
related	O
to	O
clel	O
prolifeartive	O
activtiy	O
.	O
.	O

An	O
intrachromsoomal	O
insertoin	O
causing	O
5q22	O
dleetion	O
and	O
faimlial	B-Disease
aednomatous	I-Disease
polyopsis	I-Disease
cloi	I-Disease
in	O
two	O
generatoins	O
.	O

We	O
reoprt	O
famliial	B-Disease
adenoamtous	I-Disease
polpyosis	I-Disease
cloi	I-Disease
(	O
FPAC	B-Disease
)	O
with	O
eipdermoid	B-Disease
cytss	I-Disease
,	O
osteomata	B-Disease
,	O
and	O
areas	O
of	O
congential	B-Disease
hypertrpohy	I-Disease
of	I-Disease
the	I-Disease
retianl	I-Disease
pimgent	I-Disease
epitheluim	I-Disease
(	O
CRHPEs	B-Disease
)	O
in	O
a	O
mlae	O
patinet	O
and	O
his	O
matrenal	O
anut	O
,	O
both	O
of	O
whom	O
suffered	O
a	O
mlid	O
to	O
moedrate	O
dgeree	O
of	O
mnetal	B-Disease
handciap	I-Disease
.	O

Both	O
had	O
an	O
intertsitial	O
dleetion	O
of	O
the	O
long	O
arm	O
of	O
chrmoosome	O
5	O
(	O
del	O
(	O
5	O
)	O
(	O
q2q223	O
.	O
2	O
)	O
)	O
.	O

Two	O
other	O
nomral	O
fmaily	O
memebrs	O
had	O
the	O
underlying	O
direct	O
insretion	O
of	O
chromsoome	O
5	O
(	O
dir	O
ins	O
(	O
5	O
)	O
(	O
q31	O
.	O
3q22q23	O
3q22q23	O
.	O
2	O
)	O
)	O
.	O

Moleuclar	O
geentic	O
and	O
fluorecsent	O
hybridisaiton	O
studeis	O
have	O
shown	O
that	O
lcoi	O
D53S7	O
and	O
DS598	O
are	O
outside	O
the	O
dleetion	O
whereas	O
lcoi	O
dteected	O
by	O
proebs	O
EF5	O
.	O

44	O
and	O
YN5	O
.	O

48	O
are	O
lsot	O
.	O

As	O
expected	O
,	O
the	O
moleuclar	O
analsyes	O
indicate	O
lsos	O
of	O
one	O
alelle	O
at	O
the	O
MCC	O
and	O
APC	B-Disease
lcoi	O
.	O

The	O
APC	B-Disease
gnee	O
is	O
located	O
within	O
bnad	O
5q22	O
.	O

Fmailial	O
direct	O
inseritons	O
should	O
be	O
considered	O
as	O
a	O
cause	O
of	O
recurernt	O
mcirodeletion	O
syndormes	O
.	O

Chroomsome	O
mapipng	O
of	O
the	O
rod	O
photorecpetor	O
cMGP	O
phospohdiesterase	O
btea	O
-	O
subnuit	O
gnee	O
in	O
mosue	O
and	O
hmuan	O
:	O
tgiht	O
liknage	O
to	O
the	O
Huntingotn	B-Disease
dsiease	I-Disease
rgeion	O
(	O
4p16	O
.	O
3	O
)	O
.	O

The	O
reitnal	B-Disease
dgeeneration	I-Disease
mosue	O
(	O
gnee	O
sybmol	O
,	O
rd	O
)	O
is	O
an	O
ainmal	O
mdoel	O
for	O
certain	O
forms	O
of	O
huamn	O
herediatry	B-Disease
retinopatihes	I-Disease
.	O

Recent	O
fidnings	O
of	O
a	O
nonesnse	O
muattion	O
in	O
the	O
rd	O
mosue	O
PDE	O
btea	O
-	O
subnuit	O
gnee	O
(	O
Pedb	O
)	O
prompted	O
us	O
to	O
invsetigate	O
the	O
chromosmoe	O
locaitons	O
of	O
the	O
mosue	O
and	O
hmuan	O
geens	O
.	O

We	O
have	O
utilized	O
backcrsos	O
anaylsis	O
in	O
mcie	O
to	O
verify	O
and	O
define	O
more	O
precisely	O
the	O
loaction	O
of	O
the	O
Pedb	O
loucs	O
6	O
.	O

1	O
+	O
/	O
-	O
2	O
.	O

3	O
cM	O
disatl	O
of	O
Msga	O
on	O
muose	O
chromoosme	O
5	O
.	O

We	O
have	O
determined	O
that	O
the	O
huamn	O
gnee	O
(	O
PEDB	O
)	O
mpas	O
to	O
4p16	O
.	O

3	O
,	O
very	O
close	O
to	O
the	O
Hutnington	B-Disease
disesae	I-Disease
(	O
HD	B-Disease
)	O
rgeion	O
.	O

Anlaysis	O
of	O
the	O
comparative	O
map	O
for	O
mcie	O
and	O
humnas	O
shows	O
that	O
the	O
muose	O
homoolgue	O
of	O
the	O
HD	B-Disease
gnee	O
will	O
reside	O
on	O
crhomosome	O
5	O
.	O

Linkgae	O
of	O
the	O
mosue	O
Pedb	O
loucs	O
with	O
other	O
homoolgues	O
in	O
the	O
huamn	O
4p16	O
.	O

3	O
rgeion	O
is	O
maintained	O
but	O
gnee	O
order	O
is	O
not	O
,	O
suggesting	O
at	O
least	O
three	O
possible	O
sties	O
for	O
the	O
corresponding	O
muose	O
HD	B-Disease
gnee	O
.	O

Coicnident	O
Kapsoi	B-Disease
sacroma	I-Disease
and	O
T	B-Disease
-	I-Disease
clel	I-Disease
lypmhoma	I-Disease
in	O
a	O
patinet	O
with	O
the	O
Wsikott	B-Disease
-	I-Disease
Alrdich	I-Disease
sydnrome	I-Disease
.	O

A	O
24	O
yaer	O
old	O
mlae	O
with	O
a	O
hsitory	O
of	O
eczmea	B-Disease
,	O
reucrrent	O
mlid	O
infetcions	O
,	O
and	O
throbmocytopenia	B-Disease
consistent	O
with	O
the	O
Wisoktt	B-Disease
-	I-Disease
Aldrcih	I-Disease
syndorme	I-Disease
(	O
WAS	B-Disease
)	O
presented	O
with	O
a	O
mdeiastinal	O
msas	O
,	O
generalzied	O
lymphadneopathy	B-Disease
,	O
splenomgealy	B-Disease
,	O
and	O
sveere	O
throbmocytopenia	B-Disease
.	O

Studeis	O
of	O
immnue	O
funtcion	O
including	O
immunolgobulin	O
levles	O
and	O
T	O
-	O
clel	O
susbets	O
were	O
noraml	O
.	O

Furthermore	O
,	O
his	O
T	O
lypmhocytes	O
prolifearted	O
normally	O
in	O
rseponse	O
to	O
phytohmeagglutinin	O
,	O
conacnavalin	O
A	O
,	O
and	O
the	O
cobmination	O
of	O
neuraminiadse	O
/	O
galcatose	O
oixdase	O
.	O

However	O
,	O
their	O
proliferatvie	O
resopnses	O
to	O
atni	O
-	O
C4D3	O
antibdoy	O
and	O
perioadte	O
were	O
diminished	O
,	O
consistent	O
with	O
the	O
cliniacl	O
diagnsois	O
of	O
WAS	B-Disease
.	O

An	O
initial	O
ingunial	O
lypmh	O
ndoe	O
biospy	O
surprisingly	O
revelaed	O
Kaopsi	B-Disease
sracoma	I-Disease
.	O

However	O
,	O
following	O
spleenctomy	O
to	O
icnrease	O
the	O
paltelet	O
conut	O
,	O
biospy	O
of	O
the	O
meidastinal	O
msas	O
revelaed	O
T	B-Disease
-	I-Disease
clel	I-Disease
large	I-Disease
clel	I-Disease
lypmhoma	I-Disease
.	O

Sutdies	O
of	O
biopised	O
tsisue	O
for	O
the	O
preesnce	O
of	O
Epstien	B-Disease
-	I-Disease
Brar	I-Disease
vrius	I-Disease
and	O
ctyomegalovirus	B-Disease
were	O
negaitve	O
,	O
as	O
were	O
stduies	O
of	O
bolod	O
,	O
including	O
the	O
polymearse	O
chian	O
reaciton	O
,	O
for	O
the	O
presnece	O
of	O
the	O
huamn	B-Disease
immunodefiicency	I-Disease
vrius	I-Disease
(	O
HIV	B-Disease
)	O
.	O

This	O
is	O
the	O
first	O
reoprt	O
of	O
Kaopsi	B-Disease
sacroma	I-Disease
arising	O
in	O
a	O
paitent	O
with	O
a	O
conegnital	B-Disease
immuondeficiency	I-Disease
syndrmoe	I-Disease
.	O

Although	O
Kaopsi	B-Disease
sacroma	I-Disease
can	O
arise	O
in	O
the	O
fcae	O
of	O
the	O
seevre	O
immunosuppression	O
that	O
follows	O
allgoraft	O
transplantaiton	O
and	O
in	O
patietns	O
infceted	O
with	O
HIV	B-Disease
,	O
we	O
postulate	O
that	O
longeivty	O
in	O
the	O
fcae	O
of	O
mlid	O
immunosuppresison	O
was	O
the	O
major	O
fatcor	O
in	O
the	O
devleopment	O
of	O
Kaopsi	B-Disease
sacroma	I-Disease
in	O
this	O
ptaient	O
.	O
.	O

The	O
APC	B-Disease
gnee	O
,	O
responsible	O
for	O
famiilal	B-Disease
adneomatous	I-Disease
polypoiss	I-Disease
,	O
is	O
muttaed	O
in	O
huamn	O
gastirc	B-Disease
cnacer	I-Disease
.	O

Although	O
gatsric	B-Disease
cacner	I-Disease
is	O
the	O
most	O
common	O
cnacer	B-Disease
in	O
the	O
world	O
,	O
gneetic	O
chanegs	O
during	O
its	O
carciongenesis	O
are	O
not	O
well	O
understood	O
.	O

Since	O
some	O
gatsric	B-Disease
canecrs	I-Disease
are	O
considered	O
to	O
originate	O
from	O
the	O
intsetinal	O
metapalsia	O
,	O
it	O
is	O
likely	O
that	O
the	O
adenomtaous	B-Disease
polpyosis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
,	O
the	O
mutaiton	O
of	O
which	O
causes	O
adenomaotus	B-Disease
poylps	I-Disease
in	I-Disease
the	I-Disease
cloon	I-Disease
,	O
is	O
associated	O
with	O
carcinogeensis	O
of	O
gsatric	B-Disease
canecr	I-Disease
.	O

Based	O
on	O
this	O
idea	O
,	O
DANs	O
isolaetd	O
from	O
gastirc	B-Disease
cnacers	I-Disease
were	O
examined	O
by	O
means	O
of	O
a	O
RaNse	O
proetction	O
aanlysis	O
coupled	O
with	O
polmyerase	O
chian	O
raection	O
followed	O
by	O
sequecning	O
of	O
the	O
ploymerase	O
cahin	O
reaciton	O
proudcts	O
.	O

By	O
screneing	O
nearly	O
one	O
-	O
half	O
of	O
the	O
cdoing	O
regoin	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
44	O
tuomrs	B-Disease
,	O
somtaic	O
mtuations	O
were	O
deetcted	O
in	O
three	O
tmuors	B-Disease
a	O
msisense	O
muattion	O
,	O
a	O
nonsnese	O
muattion	O
,	O
and	O
a	O
5	O
-	O
base	O
piar	O
deeltion	O
resulting	O
in	O
a	O
farme	O
shift	O
which	O
causes	O
trnucation	O
of	O
the	O
gnee	O
prodcut	O
.	O

These	O
resutls	O
suggest	O
that	O
the	O
mutatoin	O
of	O
the	O
APC	B-Disease
gnee	O
also	O
plays	O
an	O
important	O
role	O
during	O
the	O
carcinogenseis	O
of	O
at	O
least	O
some	O
gasrtic	B-Disease
cancres	I-Disease
.	O
.	O

A	O
71	O
-	O
kilodalotn	O
protien	O
is	O
a	O
major	O
prdouct	O
of	O
the	O
Duhcenne	B-Disease
msucular	I-Disease
dystorphy	I-Disease
gnee	O
in	O
barin	O
and	O
other	O
nnomuscle	O
tissues	O
.	O

The	O
known	O
Duchnene	B-Disease
muscualr	I-Disease
dystorphy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
prdoucts	O
,	O
the	O
mucsle	O
-	O
and	O
barin	O
-	O
tpye	O
dystrohpin	O
isofomrs	O
,	O
are	O
427	O
-	O
kDa	O
porteins	O
translated	O
from	O
14	O
-	O
kliobase	O
(	O
kb	O
)	O
mRANs	O
.	O

Recently	O
we	O
described	O
a	O
6	O
.	O

5	O
-	O
kb	O
mNRA	O
that	O
also	O
is	O
transcirbed	O
from	O
the	O
DMD	B-Disease
gnee	O
.	O

Cloinng	O
and	O
in	O
vitro	O
trnascription	O
and	O
tarnslation	O
of	O
the	O
entire	O
coidng	O
regoin	O
show	O
that	O
the	O
6	O
.	O

5	O
-	O
kb	O
mNRA	O
enocdes	O
a	O
70	O
.	O

8	O
-	O
kDa	O
prtoein	O
that	O
is	O
a	O
major	O
prodcut	O
of	O
the	O
DMD	B-Disease
gnee	O
.	O

It	O
contains	O
the	O
C	O
-	O
terimnal	O
and	O
the	O
csyteine	O
-	O
rich	O
dmoains	O
of	O
dystorphin	O
,	O
seven	O
additional	O
amnio	O
aicds	O
at	O
the	O
N	O
terimnus	O
,	O
and	O
some	O
modiifcations	O
formed	O
by	O
alterantive	O
splicnig	O
in	O
the	O
C	O
-	O
termnial	O
dmoain	O
.	O

It	O
lacks	O
the	O
entire	O
large	O
domian	O
of	O
sepctrin	O
-	O
like	O
rpeeats	O
and	O
the	O
acitn	O
-	O
bniding	O
N	O
-	O
temrinal	O
doamin	O
of	O
dystropihn	O
.	O

This	O
portein	O
is	O
the	O
major	O
DMD	B-Disease
gnee	O
porduct	O
in	O
barin	O
and	O
other	O
nonumscle	O
tissues	O
but	O
is	O
undetectbale	O
in	O
sekletal	O
msucle	O
extrcats	O
.	O

Correlaiton	O
between	O
the	O
locaiton	O
of	O
grem	O
-	O
line	O
muattions	O
in	O
the	O
APC	B-Disease
gnee	O
and	O
the	O
number	O
of	O
coloretcal	B-Disease
poylps	I-Disease
in	O
famliial	B-Disease
adneomatous	I-Disease
polyopsis	I-Disease
paitents	O
.	O

Recently	O
we	O
have	O
isolaetd	O
the	O
adenomatuos	B-Disease
poylposis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
which	O
causes	O
famliial	B-Disease
adenomtaous	I-Disease
ployposis	I-Disease
(	O
FAP	B-Disease
)	O
,	O
and	O
its	O
grem	O
-	O
line	O
mutatinos	O
in	O
a	O
substantial	O
number	O
of	O
FAP	B-Disease
patinets	O
have	O
been	O
identfiied	O
.	O

On	O
the	O
basis	O
of	O
this	O
informatoin	O
,	O
we	O
copmared	O
the	O
loaction	O
of	O
grem	O
-	O
line	O
mutaitons	O
in	O
the	O
APC	B-Disease
gnee	O
in	O
22	O
unrelated	O
patinets	O
(	O
12	O
of	O
whom	O
have	O
been	O
reported	O
previously	O
)	O
with	O
the	O
number	O
of	O
colroectal	B-Disease
ployps	I-Disease
developed	O
in	O
FAP	B-Disease
paitents	O
;	O
17	O
were	O
sparse	O
types	O
and	O
five	O
were	O
profuse	O
types	O
.	O

All	O
but	O
one	O
of	O
the	O
mutaitons	O
were	O
considered	O
to	O
cause	O
truncatoin	O
of	O
the	O
gnee	O
proudct	O
by	O
farme	O
-	O
shift	O
due	O
to	O
delteion	O
(	O
14	O
caess	O
)	O
or	O
nnosense	O
mutaiton	O
(	O
seven	O
csaes	O
)	O
.	O

The	O
loaction	O
of	O
the	O
grem	O
-	O
line	O
mutatoins	O
seems	O
to	O
corrleate	O
with	O
the	O
two	O
cilnical	O
types	O
;	O
grem	O
-	O
line	O
muttaions	O
in	O
five	O
FAP	B-Disease
pateints	O
with	O
profuse	O
polpys	B-Disease
were	O
observed	O
between	O
coodn	O
1250	O
and	O
cdoon	O
1464	O
,	O
whereas	O
mutatoins	O
in	O
17	O
FAP	B-Disease
paitents	O
with	O
fewer	O
ployps	B-Disease
were	O
observed	O
in	O
the	O
other	O
regoins	O
of	O
the	O
APC	B-Disease
gnee	O
.	O

The	O
result	O
suggests	O
that	O
the	O
number	O
of	O
coloerctal	B-Disease
ployps	I-Disease
in	O
FAP	B-Disease
pateints	O
may	O
be	O
associated	O
with	O
a	O
difference	O
in	O
the	O
stabiltiy	O
or	O
bioolgical	O
funciton	O
of	O
the	O
trnucated	O
APC	B-Disease
prtoein	O
.	O
.	O

Idetnification	O
and	O
rpaid	O
deetction	O
of	O
three	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
muattions	O
in	O
the	O
Morcocan	O
Jweish	O
ppoulation	O
.	O

Ifnantile	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disaese	I-Disease
(	O
TSD	B-Disease
)	O
is	O
caused	O
by	O
mutatinos	O
in	O
the	O
HXEA	O
gnee	O
that	O
result	O
in	O
the	O
complete	O
abesnce	O
of	O
btea	O
-	O
hexosamindiase	O
A	O
atcivity	O
.	O

It	O
is	O
well	O
known	O
that	O
an	O
elevaetd	O
freqeuncy	O
of	O
TSD	B-Disease
mutatinos	O
exists	O
among	O
Ashkeanzi	O
Jwes	O
.	O

More	O
recently	O
it	O
has	O
become	O
apaprent	O
that	O
elevaetd	O
crarier	O
freqeuncies	O
for	O
TSD	B-Disease
also	O
occur	O
in	O
several	O
other	O
ethinc	O
gropus	O
,	O
including	O
Moroccan	O
Jwes	O
,	O
a	O
sbugroup	O
of	O
Sepahrdic	O
Jwes	O
.	O

Elsewhere	O
we	O
reported	O
an	O
in	O
-	O
frmae	O
dleetion	O
of	O
one	O
of	O
the	O
two	O
adjaecnt	O
phenylalannie	O
codnos	O
at	O
positoin	O
304	O
or	O
305	O
(	O
delta	O
F034	O
/	O
305	O
)	O
in	O
one	O
HXEA	O
alllee	O
of	O
a	O
Morocacn	O
Jewsih	O
TSD	B-Disease
ptaient	O
and	O
in	O
three	O
obligtae	O
crariers	O
from	O
six	O
unrelated	O
Moroccan	O
Jewsih	O
famiiles	O
.	O

We	O
have	O
now	O
iedntified	O
two	O
additional	O
muattions	O
within	O
eoxn	O
5	O
of	O
the	O
HXEA	O
gnee	O
that	O
account	O
for	O
the	O
remaining	O
TSD	B-Disease
alelles	O
in	O
the	O
pateint	O
and	O
carreirs	O
.	O

One	O
of	O
the	O
muattions	O
is	O
a	O
novel	O
C	O
-	O
to	O
-	O
G	O
tarnsversion	O
,	O
resulting	O
in	O
a	O
replaecment	O
of	O
Try180	O
by	O
a	O
stop	O
coodn	O
.	O

The	O
other	O
mutaiton	O
is	O
a	O
G	O
-	O
to	O
-	O
A	O
trnasition	O
resulting	O
in	O
an	O
Arg170	O
-	O
to	O
-	O
Gln	O
substittuion	O
.	O

This	O
mutatoin	O
is	O
at	O
a	O
CpG	O
stie	O
in	O
a	O
Jaapnese	O
ifnant	O
with	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
disaese	I-Disease
and	O
was	O
described	O
elsewhere	O
.	O

Analyiss	O
of	O
nine	O
oblgiate	O
carreirs	O
from	O
seven	O
unrelated	O
famileis	O
showed	O
that	O
four	O
harbor	O
the	O
delta	O
F034	O
/	O
305	O
mtuation	O
,	O
two	O
the	O
Arg170	O
-	O
-	O
-	O
-	O
Gln	O
mutaiton	O
,	O
and	O
one	O
the	O
Ty1r80	O
-	O
-	O
-	O
-	O
Stop	O
mutatoin	O
.	O

We	O
also	O
have	O
developed	O
raipd	O
,	O
nonradioacitve	O
assyas	O
for	O
the	O
deetction	O
of	O
each	O
muttaion	O
,	O
which	O
should	O
be	O
helpful	O
for	O
crarier	O
screening	O
.	O
.	O

Mloecular	O
characetrization	O
of	O
gulcose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
pohsphate	I-Disease
dehydrgoenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
by	O
ntaural	O
and	O
amplfiication	O
created	O
retsriction	O
sties	O
:	O
five	O
mutatoins	O
account	O
for	O
most	O
GP6D	B-Disease
defiicency	I-Disease
caess	O
in	O
Taiawn	O
.	O

We	O
have	O
developed	O
a	O
raipd	O
and	O
simple	O
mehtod	O
to	O
diagonse	O
the	O
molecluar	O
defcets	O
of	O
glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospahte	I-Disease
dehydrognease	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
in	O
Cihnese	O
in	O
Taiawn	O
.	O

This	O
mtehod	O
involves	O
the	O
selective	O
ampliifcation	O
of	O
a	O
DNA	O
frgament	O
from	O
hmuan	O
GP6D	O
gnee	O
with	O
specific	O
oligonucletoide	O
prmiers	O
followed	O
by	O
digesiton	O
with	O
restrcition	O
enyzmes	O
that	O
recognize	O
artificailly	O
created	O
or	O
naturally	O
occurring	O
restrictoin	O
siets	O
.	O

Ninety	O
-	O
four	O
Chinsee	O
mlaes	O
with	O
GP6D	B-Disease
deficiecny	I-Disease
were	O
studied	O
.	O

The	O
resutls	O
show	O
that	O
50	O
%	O
(	O
47	O
of	O
94	O
)	O
were	O
G	O
to	O
T	O
muttaion	O
at	O
nulceotide	O
(	O
nt	O
)	O
1376	O
,	O
21	O
.	O

3	O
%	O
(	O
20	O
of	O
94	O
)	O
were	O
G	O
to	O
A	O
mutaiton	O
at	O
nt	O
1388	O
,	O
7	O
.	O

4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
A	O
to	O
G	O
muattion	O
at	O
nt	O
493	O
,	O
7	O
.	O

4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
A	O
to	O
G	O
mutatoin	O
at	O
nt	O
95	O
,	O
4	O
.	O

2	O
%	O
(	O
4	O
of	O
94	O
)	O
were	O
C	O
to	O
T	O
mutaiton	O
at	O
nt	O
1024	O
,	O
1	O
.	O

1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
G	O
to	O
T	O
muttaion	O
at	O
nt	O
392	O
,	O
and	O
1	O
.	O

1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
G	O
to	O
A	O
mutaiton	O
at	O
nt	O
487	O
.	O

These	O
resluts	O
show	O
that	O
the	O
former	O
five	O
mutaitons	O
account	O
for	O
more	O
than	O
90	O
%	O
of	O
GP6D	B-Disease
defciiency	I-Disease
caess	O
in	O
Tiawan	O
.	O

Aside	O
from	O
showing	O
that	O
G	O
to	O
T	O
change	O
at	O
nt	O
1376	O
is	O
the	O
most	O
common	O
mutatoin	O
,	O
our	O
rseearch	O
indicates	O
that	O
nt	O
493	O
mtuation	O
is	O
a	O
frqeuent	O
muttaion	O
among	O
Chinsee	O
in	O
Tiawan	O
.	O

We	O
comapred	O
GP6D	O
activtiy	O
among	O
different	O
mutatinos	O
,	O
without	O
discovering	O
significant	O
diffreences	O
between	O
them	O
.	O

Eight	O
novel	O
inactivtaing	O
grem	O
line	O
muattions	O
at	O
the	O
APC	B-Disease
gnee	O
idenitfied	O
by	O
denatuirng	O
gradeint	O
gel	O
electrpohoresis	O
.	O

Fmailial	B-Disease
aednomatous	I-Disease
polyopsis	I-Disease
(	O
FAP	B-Disease
)	O
is	O
a	O
dominantly	O
inherietd	O
codnition	O
prdeisposing	O
to	O
coolrectal	B-Disease
canecr	I-Disease
.	O

The	O
recent	O
isoltaion	O
of	O
the	O
responsible	O
gnee	O
(	O
adenmoatous	B-Disease
ployposis	I-Disease
cloi	I-Disease
or	O
APC	B-Disease
)	O
has	O
facilitated	O
the	O
search	O
for	O
grem	O
line	O
muttaions	O
in	O
affceted	O
indiviudals	O
.	O

Previous	O
auhtors	O
have	O
used	O
the	O
RNsae	O
proetction	O
assay	O
and	O
the	O
single	O
-	O
srtand	O
cofnormation	O
poylmorphisms	O
procedrue	O
to	O
screen	O
for	O
mutaitons	O
.	O

In	O
this	O
stduy	O
we	O
used	O
denautring	O
gardient	O
gel	O
electrohporesis	O
(	O
DGGE	O
)	O
.	O

DGGE	O
aanlysis	O
of	O
10	O
APC	B-Disease
exnos	O
(	O
4	O
,	O
5	O
,	O
7	O
,	O
8	O
,	O
9	O
,	O
10	O
,	O
12	O
,	O
13	O
,	O
14	O
,	O
and	O
part	O
of	O
15	O
)	O
in	O
33	O
unrelated	O
Dtuch	O
FAP	B-Disease
patinets	O
has	O
led	O
to	O
the	O
identfiication	O
of	O
eight	O
novel	O
grem	O
line	O
muttaions	O
resulting	O
in	O
stop	O
coodns	O
or	O
framehsifts	O
.	O

The	O
reuslts	O
reported	O
here	O
indicate	O
that	O
(	O
1	O
)	O
famiilal	B-Disease
adeonmatous	I-Disease
ployposis	I-Disease
is	O
caused	O
by	O
an	O
extremely	O
heterogneeous	O
spetcrum	O
of	O
point	O
mutatinos	O
;	O
(	O
2	O
)	O
all	O
the	O
muttaions	O
found	O
in	O
this	O
sutdy	O
are	O
cahin	O
terminating	O
;	O
and	O
(	O
3	O
)	O
DGGE	O
represents	O
a	O
rpaid	O
and	O
senstiive	O
tehcnique	O
for	O
the	O
dteection	O
of	O
muttaions	O
in	O
the	O
unusually	O
large	O
APC	B-Disease
gnee	O
.	O

An	O
etxension	O
of	O
the	O
DGGE	O
anlaysis	O
to	O
the	O
entire	O
codnig	O
regoin	O
in	O
a	O
sufficient	O
number	O
of	O
cliniaclly	O
well	O
-	O
characetrized	O
,	O
unrelated	O
ptaients	O
will	O
facilitate	O
the	O
establsihment	O
of	O
genotpye	O
-	O
pehnotype	O
crorelations	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
occrurence	O
of	O
an	O
extremely	O
heetrogeneous	O
spetcrum	O
of	O
mutatoins	O
srpead	O
throughout	O
the	O
entire	O
lnegth	O
of	O
the	O
large	O
APC	B-Disease
gnee	O
among	O
the	O
FAP	B-Disease
paitents	O
indicates	O
that	O
this	O
approach	O
may	O
not	O
be	O
useful	O
as	O
a	O
raipd	O
presympotmatic	O
diagnsotic	O
proceudre	O
in	O
a	O
rouitne	O
labortaory	O
.	O

Nevertheless	O
,	O
the	O
above	O
DGGE	O
approach	O
has	O
incdientally	O
led	O
to	O
the	O
idenitfication	O
of	O
a	O
common	O
polyomrphism	O
in	O
eoxn	O
13	O
.	O

Such	O
intrageinc	O
ploymorphisms	O
offer	O
a	O
practical	O
approach	O
to	O
a	O
more	O
raipd	O
procdeure	O
for	O
presymptoamtic	O
diagonsis	O
of	O
FAP	B-Disease
by	O
linakge	O
anlaysis	O
in	O
inofrmative	O
fmailies	O
.	O
.	O

Yesat	O
artfiicial	O
chromsoomes	O
for	O
the	O
moleuclar	O
anaylsis	O
of	O
the	O
familail	B-Disease
polyopsis	I-Disease
APC	I-Disease
gnee	O
reigon	O
.	O

Two	O
yesat	O
artiifcial	O
chromoosmes	O
(	O
YCAs	O
)	O
spanning	O
a	O
total	O
disatnce	O
of	O
1	O
.	O

1	O
megbaase	O
paris	O
of	O
DNA	O
around	O
the	O
MCC	O
(	O
for	O
mutaetd	O
in	O
coloerctal	B-Disease
cracinoma	I-Disease
)	O
and	O
APC	B-Disease
(	O
for	O
adenomatuos	B-Disease
polypoiss	I-Disease
cloi	I-Disease
)	O
gnees	O
at	O
52q1	O
have	O
been	O
ioslated	O
and	O
characterzied	O
.	O

Starting	O
from	O
the	O
MCC	O
gnee	O
,	O
a	O
strategy	O
was	O
undertaken	O
to	O
identify	O
constiuttional	O
submicroscoipc	O
deletoins	O
in	O
fmailial	B-Disease
adenomatuos	I-Disease
poylposis	I-Disease
pateints	O
that	O
might	O
considerably	O
narrow	O
down	O
the	O
postiion	O
of	O
the	O
APC	B-Disease
gnee	O
.	O

To	O
this	O
end	O
,	O
YCAs	O
identfiied	O
by	O
the	O
MCC	O
gnee	O
were	O
screened	O
across	O
a	O
crhomosome	O
5	O
-	O
specific	O
csomid	O
librray	O
to	O
provide	O
a	O
soruce	O
of	O
DNA	O
prboes	O
for	O
geonmic	O
scannnig	O
.	O

The	O
cosmdis	O
isolaetd	O
from	O
these	O
experiemnts	O
were	O
used	O
to	O
sceren	O
a	O
panel	O
of	O
somtaic	O
clel	O
hybirds	O
containing	O
chroomsome	O
5	O
segregated	O
from	O
patinets	O
susepcted	O
to	O
carry	O
putative	O
intesrtitial	O
deeltions	O
.	O

This	O
screeinng	O
approach	O
led	O
to	O
the	O
conifrmation	O
of	O
a	O
small	O
heetrozygous	O
dleetion	O
in	O
a	O
polypoiss	B-Disease
paitent	O
that	O
overalps	O
one	O
of	O
the	O
two	O
ioslated	O
YCAs	O
.	O

This	O
YAC	O
has	O
been	O
shown	O
to	O
contain	O
the	O
entire	O
APC	B-Disease
gnee	O
,	O
in	O
addition	O
to	O
a	O
significant	O
poriton	O
of	O
DNA	O
flanking	O
the	O
5	O
end	O
of	O
the	O
gnee	O
,	O
and	O
should	O
therefore	O
prove	O
a	O
valuable	O
resuorce	O
for	O
funcitonal	O
stuides	O
by	O
trnasfer	O
to	O
coloerctal	B-Disease
tmuor	I-Disease
-	O
derived	O
clel	O
liens	O
.	O

Inehrited	O
WT1	O
muattion	O
in	O
Deyns	B-Disease
-	I-Disease
Drsah	I-Disease
sydnrome	I-Disease
.	O

Ptaients	O
with	O
the	O
Dneys	B-Disease
-	I-Disease
Drsah	I-Disease
snydrome	I-Disease
(	O
Wimls	B-Disease
tuomr	I-Disease
,	O
geintal	B-Disease
anoamlies	I-Disease
,	O
and	O
nephroapthy	B-Disease
)	O
have	O
been	O
demonstrated	O
to	O
carry	O
de	O
novo	O
consittutional	O
muattions	O
in	O
WT1	O
,	O
the	O
Wlims	B-Disease
tuomr	I-Disease
gnee	O
at	O
chroomsome	O
11p13	O
.	O

We	O
rpeort	O
three	O
new	O
caess	O
,	O
two	O
carrying	O
a	O
previously	O
described	O
WT1	O
eoxn	O
9	O
mutatoin	O
and	O
one	O
with	O
a	O
novel	O
WT1	O
eoxn	O
8	O
muttaion	O
.	O

However	O
,	O
unlike	O
ptaients	O
in	O
previous	O
reoprts	O
,	O
one	O
of	O
our	O
three	O
patinets	O
ihnerited	O
the	O
affceted	O
alllee	O
from	O
his	O
phneotypically	O
unaffected	O
ftaher	O
.	O

This	O
obsevration	O
indicates	O
that	O
the	O
WT1	O
eoxn	O
9	O
muttaion	O
affetcing	O
394Arg	O
demonstrated	O
in	O
over	O
one	O
-	O
half	O
of	O
the	O
paitents	O
with	O
the	O
Deyns	B-Disease
-	I-Disease
Darsh	I-Disease
synrdome	I-Disease
may	O
exhibit	O
incopmlete	O
penetarnce	O
.	O

Consequently	O
,	O
faimlial	O
sutdies	O
in	O
patietns	O
afefcted	O
by	O
this	O
synrdome	O
are	O
recomemnded	O
.	O
.	O

Sumbicroscopic	O
deletinos	O
at	O
the	O
WGAR	B-Disease
lcous	O
,	O
reevaled	O
by	O
nonardioactive	O
in	O
situ	O
hybriidzation	O
.	O

Fluorescnece	O
in	O
situ	O
hybridiaztion	O
(	O
FSIH	O
)	O
with	O
bioitn	O
-	O
lableed	O
porbes	O
mpaping	O
to	O
11p13	O
has	O
been	O
used	O
for	O
the	O
moleuclar	O
analyiss	O
of	O
deletinos	O
of	O
the	O
WGAR	B-Disease
(	O
Wlims	B-Disease
tmuor	I-Disease
,	O
aniirdia	B-Disease
,	O
genitourniary	B-Disease
abnormaliites	I-Disease
,	O
and	O
metnal	B-Disease
retardtaion	I-Disease
)	O
loucs	O
.	O

We	O
have	O
detetced	O
a	O
submircoscopic	O
11p13	O
delteion	O
in	O
a	O
cihld	O
with	O
inheirted	O
anriidia	B-Disease
who	O
subsequently	O
presented	O
with	O
Wlims	B-Disease
tuomr	I-Disease
in	O
a	O
horesshoe	O
kdiney	O
,	O
only	O
reevaled	O
at	O
suregry	O
.	O

The	O
motehr	O
,	O
who	O
has	O
anirdiia	B-Disease
,	O
was	O
also	O
found	O
to	O
carry	O
a	O
deletoin	O
including	O
both	O
the	O
ainridia	B-Disease
candidate	O
gnee	O
(	O
AN2	O
)	O
and	O
the	O
Wlims	B-Disease
tuomr	I-Disease
preidsposition	O
gnee	O
(	O
WT1	O
)	O
.	O

This	O
is	O
therefore	O
a	O
rrae	O
csae	O
of	O
an	O
ihnerited	O
WGAR	B-Disease
deletoin	O
.	O

Wimls	B-Disease
tmuor	I-Disease
has	O
so	O
far	O
only	O
been	O
associated	O
with	O
spoardic	O
de	O
novo	O
anirdiia	B-Disease
caess	O
.	O

We	O
have	O
shown	O
that	O
a	O
cosimd	O
porbe	O
for	O
a	O
candidate	O
anirdiia	B-Disease
gnee	O
,	O
homologuos	O
to	O
the	O
mosue	O
Pax	O
-	O
6	O
gnee	O
,	O
is	O
delteed	O
in	O
clel	O
lnies	O
from	O
anirdiia	B-Disease
patinets	O
with	O
previously	O
charatcerized	O
delteions	O
at	O
11p13	O
,	O
while	O
another	O
cosimd	O
marekr	O
mappnig	O
between	O
two	O
anirdiia	B-Disease
-	O
associated	O
tranlsocation	O
breakpionts	O
(	O
and	O
hence	O
a	O
second	O
candidate	O
mraker	O
)	O
is	O
present	O
on	O
both	O
chromosoems	O
.	O

These	O
resluts	O
support	O
the	O
Pax	O
-	O
6	O
hoomlogue	O
as	O
a	O
strong	O
candidate	O
for	O
the	O
AN2	O
gnee	O
.	O

FSIH	O
with	O
comsid	O
proebs	O
has	O
proved	O
to	O
be	O
a	O
fast	O
and	O
reliable	O
tehcnique	O
for	O
the	O
moelcular	O
anlaysis	O
of	O
delteions	O
.	O

It	O
can	O
be	O
used	O
with	O
limtied	O
amounts	O
of	O
mtaerial	O
and	O
has	O
strong	O
potenital	O
for	O
clincial	O
aplpications	O
.	O
.	O

Lnikage	O
of	O
gnee	O
for	O
C2	B-Disease
deficinecy	I-Disease
and	O
the	O
major	O
histocopmatibility	O
comlpex	O
MHC	O
in	O
man	O
.	O

Faimly	O
stduy	O
of	O
a	O
further	O
csae	O
.	O

Close	O
liknage	O
between	O
HL	O
-	O
A	O
and	O
C2	B-Disease
deifciency	I-Disease
was	O
first	O
reported	O
by	O
FU	O
and	O
co	O
-	O
wrokers	O
in	O
1974	O
.	O

We	O
present	O
here	O
a	O
pdeigree	O
of	O
a	O
31	O
-	O
yaer	O
-	O
old	O
C2	B-Disease
-	I-Disease
defciient	I-Disease
indiviudal	O
with	O
clniical	O
manifestaitons	O
of	O
Hodgikns	B-Disease
disaese	I-Disease
.	O

The	O
following	O
marekrs	O
were	O
tseted	O
C2	O
levles	O
,	O
fatcor	O
B	O
polmyorphism	O
,	O
bolod	O
gorups	O
,	O
and	O
enzmye	O
typnig	O
.	O

In	O
addition	O
to	O
close	O
linkgae	O
between	O
HL	O
-	O
A	O
and	O
C2	B-Disease
deficiecny	I-Disease
,	O
both	O
paretns	O
were	O
hetreozygous	O
for	O
Bf	O
(	O
HL	O
-	O
A	O
linked	O
,	O
electorphoretic	O
vraiation	O
of	O
B	O
)	O
.	O

The	O
two	O
HL	O
-	O
A	O
halpotypes	O
closely	O
linked	O
to	O
C2	B-Disease
deficeincy	I-Disease
are	O
different	O
2	O
,	O
W18	O
and	O
W24	O
,	O
W18	O
.	O

They	O
share	O
,	O
however	O
,	O
the	O
SD2	O
atnigen	O
W18	O
and	O
the	O
LD	O
tpye	O
7a	O
.	O
.	O

Screennig	O
for	O
grem	O
-	O
line	O
mtuations	O
in	O
familail	B-Disease
adenmoatous	I-Disease
poylposis	I-Disease
paitents	O
:	O
61	O
new	O
patinets	O
and	O
a	O
summary	O
of	O
150	O
unrelated	O
patinets	O
.	O

We	O
rpeort	O
here	O
the	O
result	O
of	O
a	O
srceening	O
for	O
grem	O
-	O
line	O
mutatoins	O
in	O
the	O
adeonmatous	B-Disease
ployposis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
in	O
61	O
new	O
famliial	B-Disease
adenomaotus	I-Disease
poylposis	I-Disease
(	O
FAP	B-Disease
)	O
pateints	O
as	O
well	O
as	O
a	O
summary	O
of	O
the	O
rseults	O
of	O
150	O
patinets	O
.	O

Examniation	O
of	O
the	O
entire	O
codnig	O
rgeion	O
of	O
the	O
APC	B-Disease
gnee	O
,	O
based	O
on	O
a	O
ribonulcease	O
prtoection	O
assay	O
coupled	O
with	O
the	O
polmyerase	O
chian	O
raection	O
(	O
PCR	O
)	O
,	O
disclosed	O
mutatoins	O
that	O
were	O
considered	O
to	O
cause	O
significant	O
defcets	O
in	O
the	O
APC	B-Disease
porduct	O
in	O
97	O
of	O
150	O
unrelated	O
FAP	B-Disease
ptaients	O
.	O

Our	O
findigns	O
revelaed	O
the	O
following	O
charcateristics	O
of	O
the	O
grem	O
-	O
line	O
mtuations	O
of	O
APC	O
1	O
)	O
the	O
great	O
majority	O
of	O
the	O
mutatoins	O
were	O
found	O
to	O
truncate	O
the	O
APC	B-Disease
proudct	O
;	O
2	O
)	O
almost	O
all	O
of	O
the	O
mutatoins	O
were	O
located	O
within	O
the	O
first	O
half	O
of	O
the	O
codnig	O
reigon	O
;	O
3	O
)	O
no	O
crorelation	O
was	O
observed	O
between	O
the	O
loctaions	O
of	O
grem	O
-	O
line	O
muttaions	O
and	O
extrcaolonic	O
manifestatinos	O
in	O
FAP	B-Disease
patinets	O
;	O
4	O
)	O
more	O
than	O
80	O
%	O
of	O
base	O
susbtitutions	O
in	O
the	O
APC	B-Disease
gnee	O
were	O
from	O
cytsoine	O
to	O
other	O
nucletoides	O
,	O
nearly	O
one	O
-	O
third	O
of	O
which	O
occurred	O
at	O
the	O
GpG	O
stie	O
.	O

Our	O
reuslts	O
provide	O
informaiton	O
helpful	O
to	O
an	O
understanding	O
of	O
the	O
APC	B-Disease
gnee	O
and	O
will	O
also	O
contribute	O
to	O
persymptomatic	O
diagnsois	O
of	O
mmebers	O
in	O
FAP	B-Disease
faimlies	O
.	O
.	O

Somaitc	O
muttaions	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
coloretcal	B-Disease
tuomrs	I-Disease
:	O
muttaion	O
clutser	O
rgeion	O
in	O
the	O
APC	B-Disease
gnee	O
.	O

We	O
examined	O
somaitc	O
mutatinos	O
of	O
the	O
adenomatuos	B-Disease
poylposis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
in	O
63	O
colorecatl	B-Disease
tumros	I-Disease
(	O
16	O
adenmoas	B-Disease
and	O
47	O
carcionmas	B-Disease
)	O
developed	O
in	O
faimlial	B-Disease
adeonmatous	I-Disease
polypsois	I-Disease
(	O
FAP	B-Disease
)	O
and	O
non	O
-	O
FAP	O
paitents	O
.	O

In	O
addition	O
to	O
lsos	O
of	O
heterzoygosity	O
(	O
LOH	O
)	O
at	O
the	O
APC	B-Disease
loucs	O
in	O
30	O
tumros	B-Disease
,	O
43	O
other	O
somaitc	O
muttaions	O
were	O
deetcted	O
.	O

Twenty	O
-	O
one	O
of	O
them	O
were	O
point	O
mutatinos	O
;	O
16	O
nonsesne	O
and	O
two	O
missesne	O
mutatoins	O
,	O
and	O
three	O
occurred	O
in	O
itnrons	O
at	O
the	O
splciing	O
stie	O
.	O

Twenty	O
-	O
two	O
tmuors	B-Disease
had	O
frmaeshift	O
mutatinos	O
due	O
to	O
dleetion	O
or	O
inseriton	O
;	O
nineteen	O
of	O
them	O
were	O
delteions	O
of	O
one	O
to	O
31	O
bp	O
and	O
three	O
were	O
a	O
1	O
-	O
bp	O
inesrtion	O
.	O

One	O
tmuor	B-Disease
had	O
a	O
1	O
-	O
bp	O
deeltion	O
in	O
an	O
intorn	O
near	O
the	O
splciing	O
stie	O
.	O

Hence	O
,	O
41	O
(	O
95	O
%	O
)	O
of	O
43	O
mutatinos	O
resulted	O
in	O
trucnation	O
of	O
the	O
APC	B-Disease
protien	O
.	O

Over	O
60	O
%	O
of	O
the	O
soamtic	O
mutaitons	O
in	O
the	O
APC	B-Disease
gnee	O
were	O
clutsered	O
within	O
a	O
small	O
regoin	O
of	O
eoxn	O
15	O
,	O
designated	O
as	O
MCR	O
(	O
mutaiton	O
culster	O
rgeion	O
)	O
,	O
which	O
accounted	O
for	O
less	O
than	O
10	O
%	O
of	O
the	O
cdoing	O
reigon	O
.	O

Combining	O
these	O
dtaa	O
and	O
the	O
rseults	O
of	O
LOH	O
,	O
more	O
than	O
80	O
%	O
of	O
tuomrs	B-Disease
(	O
14	O
adneomas	B-Disease
and	O
39	O
cracinomas	B-Disease
)	O
had	O
at	O
least	O
one	O
mutaiton	O
in	O
the	O
APC	B-Disease
gnee	O
,	O
of	O
which	O
more	O
than	O
60	O
%	O
(	O
9	O
adneomas	B-Disease
and	O
23	O
cacrinomas	B-Disease
)	O
had	O
two	O
mutatoins	O
.	O

These	O
resluts	O
strongly	O
suggest	O
that	O
soamtic	O
mutaitons	O
of	O
the	O
APC	B-Disease
gnee	O
are	O
associated	O
with	O
developemnt	O
of	O
a	O
great	O
majority	O
of	O
colroectal	B-Disease
tumros	I-Disease
.	O
.	O

Constitutoinal	O
mutaitons	O
in	O
the	O
WT1	O
gnee	O
in	O
ptaients	O
with	O
Dneys	B-Disease
-	I-Disease
Drsah	I-Disease
syndorme	I-Disease
.	O

The	O
Dneys	B-Disease
-	I-Disease
Darsh	I-Disease
snydrome	I-Disease
is	O
chraacterised	O
by	O
a	O
typical	O
npehropathy	B-Disease
,	O
gential	B-Disease
abnormailties	I-Disease
and	O
also	O
predispsoes	O
to	O
the	O
developemnt	O
of	O
Wimls	B-Disease
tmuor	I-Disease
.	O

These	O
patinets	O
eventually	O
go	O
into	O
end	O
stgae	O
reanl	B-Disease
fialure	I-Disease
.	O

A	O
candidate	O
Wlims	B-Disease
tuomr	I-Disease
gnee	O
,	O
WT1	O
,	O
from	O
the	O
11p13	O
chrmoosome	O
rgeion	O
has	O
recently	O
been	O
cloend	O
.	O

We	O
have	O
aanlysed	O
the	O
DNA	O
seuqence	O
in	O
constitutoinal	O
cells	O
from	O
eight	O
ptaients	O
and	O
have	O
shown	O
heterzoygous	O
muttaions	O
in	O
six	O
of	O
them	O
.	O

Four	O
of	O
the	O
mutatoins	O
were	O
in	O
eoxn	O
9	O
,	O
all	O
resulting	O
in	O
missense	O
mtuations	O
.	O

Three	O
were	O
at	O
nucelotide	O
postiion	O
1180	O
resulting	O
in	O
an	O
arg	O
>	O
trp	O
aimno	O
aicd	O
change	O
.	O

The	O
other	O
was	O
at	O
positoin	O
1186	O
converting	O
an	O
asp	O
>	O
asn	O
in	O
the	O
prdeicted	O
rseultant	O
proetin	O
.	O

One	O
ptaient	O
had	O
a	O
misesnse	O
mtuation	O
in	O
eoxn	O
8	O
,	O
converting	O
an	O
arg	O
>	O
his	O
.	O

A	O
single	O
base	O
piar	O
isnertion	O
at	O
nucleoitde	O
posiiton	O
821	O
in	O
eoxn	O
6	O
resulted	O
in	O
the	O
generaiton	O
of	O
a	O
premtaure	O
stop	O
cdoon	O
in	O
the	O
last	O
pateint	O
.	O

We	O
were	O
unable	O
to	O
find	O
a	O
muattion	O
in	O
one	O
pateint	O
despite	O
complete	O
seqeuncing	O
of	O
the	O
genoimc	O
sequecne	O
of	O
the	O
gnee	O
.	O

The	O
last	O
pateint	O
carried	O
a	O
constitutinoal	O
delteion	O
of	O
the	O
11p13	O
reigon	O
and	O
no	O
additional	O
mtuation	O
was	O
found	O
.	O

There	O
was	O
no	O
obvious	O
correlaiton	O
between	O
the	O
tpye	O
of	O
mutaiton	O
and	O
pehnotypic	O
expression	O
.	O

These	O
resutls	O
further	O
demonstrate	O
that	O
the	O
WT1	O
gnee	O
is	O
important	O
in	O
both	O
the	O
developemnt	O
of	O
the	O
kindey	O
and	O
the	O
gneito	O
-	O
urinray	O
sysetm	O
.	O
.	O

Linkgae	O
dsiequilibrium	O
mapipng	O
in	O
isoltaed	O
fuonder	O
populatoins	O
:	O
diastorphic	B-Disease
dsyplasia	I-Disease
in	O
Finalnd	O
.	O

Linakge	O
diseuqilibrium	O
mpaping	O
in	O
isoltaed	O
pouplations	O
provides	O
a	O
powerful	O
tool	O
for	O
fnie	O
strucutre	O
localiaztion	O
of	O
disaese	O
geens	O
.	O

Here	O
,	O
Luira	O
and	O
Dlebrucks	O
classical	O
mtehods	O
for	O
analysing	O
bcaterial	O
culutres	O
are	O
adapted	O
to	O
the	O
stduy	O
of	O
hmuan	O
isoltaed	O
fonuder	O
popultaions	O
in	O
order	O
to	O
estimtae	O
(	O
i	O
)	O
the	O
recmobination	O
fratcion	O
between	O
a	O
dsiease	O
lcous	O
and	O
a	O
makrer	O
;	O
(	O
ii	O
)	O
the	O
expected	O
dgeree	O
of	O
alleilc	O
homoegneity	O
in	O
a	O
popluation	O
;	O
and	O
(	O
iii	O
)	O
the	O
muattion	O
rtae	O
of	O
makrer	O
lcoi	O
.	O

Using	O
these	O
methdos	O
,	O
we	O
reoprt	O
striking	O
linkgae	O
disequilirbium	O
for	O
diasrtophic	B-Disease
dysplsaia	I-Disease
(	O
DTD	B-Disease
)	O
in	O
Filnand	O
indicating	O
that	O
the	O
DTD	B-Disease
gnee	O
should	O
lie	O
within	O
0	O
.	O

06	O
cenitmorgans	O
(	O
or	O
about	O
60	O
kilobaess	O
)	O
of	O
the	O
CFS1R	O
gnee	O
.	O

Predicitons	O
about	O
allleic	O
homoegneity	O
in	O
Finalnd	O
and	O
mutatoin	O
raets	O
in	O
simple	O
sequecne	O
rpeeats	O
are	O
confirmed	O
by	O
indepenednt	O
observatoins	O
.	O

The	O
Wisoktt	B-Disease
-	I-Disease
Alrdich	I-Disease
snydrome	I-Disease
:	O
refinement	O
of	O
the	O
loaclization	O
on	O
Xp	O
and	O
identificaiton	O
of	O
another	O
closely	O
linked	O
makrer	O
loucs	O
,	O
OALT1	O
.	O

The	O
Wisktot	B-Disease
-	I-Disease
Aldirch	I-Disease
sydnrome	I-Disease
(	O
WAS	B-Disease
)	O
has	O
previously	O
been	O
mpaped	O
to	O
the	O
prxoimal	O
short	O
arm	O
of	O
the	O
X	O
crhomosome	O
between	O
the	O
DX1S4	O
and	O
DSX7	O
lcoi	O
.	O

In	O
this	O
sutdy	O
,	O
further	O
segergation	O
anaylsis	O
has	O
been	O
performed	O
using	O
a	O
newly	O
identifeid	O
WAS	B-Disease
faimly	O
as	O
well	O
as	O
an	O
additional	O
marekr	O
prboe	O
,	O
HOALT1	O
.	O

The	O
rseults	O
indicate	O
close	O
linakge	O
between	O
the	O
WAS	B-Disease
and	O
OALT1	O
lcoi	O
(	O
Z	O
=	O
6	O
.	O
08	O
at	O
tehta	O
=	O
0	O
.	O
00	O
)	O
and	O
loclaize	O
the	O
TMIP	O
,	O
OALT1	O
,	O
DXS525	O
,	O
and	O
WAS	B-Disease
lcoi	O
ditsal	O
to	O
DSX146	O
and	O
the	O
OALT1	O
and	O
WAS	B-Disease
lcoi	O
porximal	O
to	O
TMIP	O
.	O

These	O
linakge	O
dtaa	O
narrow	O
the	O
boundareis	O
within	O
which	O
the	O
WAS	B-Disease
loucs	O
mpas	O
to	O
the	O
chrmoosomal	O
reigon	O
bracekted	O
by	O
TMIP	O
and	O
DXS416	O
and	O
support	O
the	O
lcoi	O
order	O
Xpetr	O
-	O
DSX7	O
-	O
TMIP	O
-	O
(	O
OALT1	O
,	O
WAS	O
,	O
DSX255	O
)	O
-	O
DX1S46	O
.	O

Detetcion	O
of	O
an	O
unstable	O
frgament	O
of	O
DNA	O
specific	O
to	O
indiivduals	O
with	O
moytonic	B-Disease
dsytrophy	I-Disease
.	O

Myotoinc	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
most	O
common	O
form	O
of	O
adlut	O
musuclar	B-Disease
dystrohpy	I-Disease
,	O
with	O
a	O
prevaelnce	O
of	O
2	O
-	O
14	O
per	O
100	O
,	O
000	O
indviiduals	O
.	O

The	O
disesae	O
is	O
characteirzed	O
by	O
progressvie	O
msucle	B-Disease
weaknses	I-Disease
and	O
sustaiend	B-Disease
muslce	I-Disease
contrcation	I-Disease
,	O
often	O
with	O
a	O
wide	O
range	O
of	O
accompanying	O
sympotms	O
.	O

The	O
age	O
at	O
onset	O
and	O
seveirty	O
of	O
the	O
disaese	O
show	O
extreme	O
vairation	O
,	O
both	O
within	O
and	O
between	O
fmailies	O
.	O

Despite	O
its	O
clniical	O
vairability	O
,	O
this	O
domniant	O
conidtion	O
segregates	O
as	O
a	O
single	O
lcous	O
at	O
chroomsome	O
19q13	O
.	O

3	O
in	O
every	O
popultaion	O
studied	O
.	O

It	O
is	O
flanked	O
by	O
the	O
tightly	O
linked	O
geneitc	O
mrakers	O
ECRC1	O
proximlaly	O
and	O
D1S951	O
ditsally	O
;	O
these	O
define	O
the	O
DM	B-Disease
critical	O
rgeion	O
.	O

We	O
reprot	O
the	O
isoaltion	O
of	O
an	O
expresesd	O
seqeunce	O
from	O
this	O
regoin	O
which	O
detects	O
a	O
DNA	O
fragmnet	O
that	O
is	O
larger	O
in	O
affecetd	O
idnividuals	O
than	O
in	O
nromal	O
silbings	O
or	O
unaffected	O
cotnrols	O
.	O

The	O
szie	O
of	O
this	O
fragemnt	O
varies	O
between	O
affecetd	O
sibligns	O
,	O
and	O
incraeses	O
in	O
szie	O
through	O
generatoins	O
in	O
parallel	O
with	O
icnreasing	O
sevreity	O
of	O
the	O
diesase	O
.	O

We	O
postulate	O
that	O
this	O
unstable	O
DNA	O
seqeunce	O
is	O
the	O
molceular	O
feature	O
that	O
underlies	O
DM	B-Disease
.	O

Common	O
sequnece	O
motfis	O
at	O
the	O
reararngement	O
siets	O
of	O
a	O
constitutoinal	O
X	O
/	O
autoosme	O
translocaiton	O
and	O
associated	O
deeltion	O
.	O

Reicprocal	O
chrmoosome	O
trasnlocations	O
are	O
common	O
de	O
novo	O
rearrangemnets	O
that	O
occur	O
randomly	O
throughout	O
the	O
huamn	O
genmoe	O
.	O

To	O
learn	O
about	O
causatvie	O
mechainsms	O
,	O
we	O
have	O
clnoed	O
and	O
sqeuenced	O
the	O
breakpoitns	O
of	O
a	O
cytologcially	O
blaanced	O
constituitonal	O
reciproacl	O
tranlsocation	O
,	O
t	O
(	O
X	O
;	O
4	O
)	O
(	O
p21	O
.	O
2	O
;	O
q31	O
.	O
22	O
)	O
,	O
present	O
in	O
a	O
gril	O
with	O
Duchenne	B-Disease
musuclar	I-Disease
dystrohpy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Physcial	O
mapipng	O
of	O
the	O
derivtaive	O
chroomsomes	O
,	O
after	O
their	O
sepraation	O
in	O
soamtic	O
clel	O
hyrbids	O
,	O
reveals	O
that	O
the	O
trasnlocation	O
dirsupts	O
the	O
DMD	B-Disease
gnee	O
in	O
X2p1	O
within	O
the	O
18	O
-	O
kb	O
inrton	O
16	O
.	O

Restriciton	O
mpaping	O
and	O
sequecning	O
of	O
cloens	O
that	O
sapn	O
both	O
translocaiton	O
breapkoints	O
as	O
well	O
as	O
the	O
corresponding	O
nromal	O
rgeions	O
indicate	O
the	O
lsos	O
of	O
approximately	O
5	O
kb	O
in	O
the	O
foramtion	O
of	O
the	O
deirvative	O
X	O
chrmoosome	O
,	O
with	O
4	O
-	O
6	O
bp	O
dleeted	O
from	O
crhomosome	O
4	O
.	O

RLFP	O
and	O
Souhtern	O
anaylses	O
indicate	O
that	O
the	O
de	O
novo	O
transloctaion	O
is	O
a	O
patrenal	O
oriign	O
and	O
that	O
the	O
fatehrs	O
X	O
chormosome	O
contains	O
the	O
DNA	O
that	O
is	O
dleeted	O
in	O
the	O
dreivative	O
X	O
.	O

Most	O
likely	O
,	O
deeltion	O
and	O
trnaslation	O
arose	O
simultaneosuly	O
from	O
a	O
comlpex	O
rearragnement	O
evnet	O
that	O
involves	O
three	O
chromosoaml	O
breakpionts	O
.	O

Sohrt	O
reginos	O
of	O
sequnece	O
hmoology	O
were	O
present	O
at	O
the	O
three	O
siets	O
.	O

A	O
5	O
-	O
bp	O
sequecne	O
,	O
GGAAT	O
,	O
found	O
exactly	O
at	O
the	O
trnaslocation	O
braekpoints	O
on	O
both	O
nomral	O
crhomosomes	O
X	O
and	O
4	O
,	O
has	O
been	O
preserevd	O
only	O
on	O
the	O
der	O
(	O
4	O
)	O
crhomosome	O
.	O

It	O
is	O
likely	O
that	O
the	O
X	O
-	O
derived	O
sequecne	O
GGAATCA	O
has	O
been	O
lsot	O
in	O
the	O
foramtion	O
of	O
the	O
der	O
(	O
X	O
)	O
chromsoome	O
,	O
as	O
it	O
mtaches	O
an	O
inverted	O
GAATCA	O
sequecne	O
present	O
on	O
the	O
opposite	O
starnd	O
exactly	O
at	O
the	O
other	O
end	O
of	O
the	O
delteed	O
5	O
-	O
kb	O
fragmnet	O
.	O

A	O
geentic	O
etiolgoy	O
for	O
DieGorge	B-Disease
syndorme	I-Disease
:	O
consistent	O
delteions	O
and	O
microedletions	O
of	O
22q11	O
.	O

DiGeroge	B-Disease
syndrmoe	I-Disease
(	O
DGS	B-Disease
)	O
,	O
a	O
dveelopmental	O
field	O
deefct	O
of	O
the	O
third	O
and	O
fourth	O
pharynegal	O
pocuhes	O
,	O
is	O
characteirzed	O
by	O
apalsia	B-Disease
or	I-Disease
hypolpasia	I-Disease
of	I-Disease
the	I-Disease
tyhmus	I-Disease
and	I-Disease
partahyroid	I-Disease
glnads	I-Disease
and	O
by	O
conoturncal	B-Disease
cradiac	I-Disease
malformatoins	I-Disease
.	O

Cytogeentic	O
stduies	O
support	O
the	O
preesnce	O
of	O
a	O
DGS	B-Disease
critical	O
regoin	O
in	O
bnad	O
22q11	O
.	O

In	O
the	O
present	O
sutdy	O
,	O
we	O
reoprt	O
the	O
rseults	O
of	O
cilnical	O
,	O
cytgoenetic	O
,	O
and	O
moelcular	O
stduies	O
of	O
14	O
patinets	O
with	O
DGS	B-Disease
.	O

Crhomosome	O
anaylsis	O
,	O
utilizing	O
high	O
-	O
reoslution	O
bnading	O
tcehniques	O
,	O
detetced	O
intersttiial	O
delteions	O
in	O
five	O
probnads	O
and	O
was	O
incnoclusive	O
for	O
a	O
deletoin	O
in	O
three	O
probnads	O
.	O

The	O
remaining	O
six	O
pateints	O
had	O
nomral	O
karyotpyes	O
.	O

In	O
contrast	O
,	O
moelcular	O
aanlysis	O
detceted	O
DNA	O
dleetions	O
in	O
all	O
14	O
porbands	O
.	O

Two	O
of	O
10	O
lcoi	O
tesetd	O
,	O
D2S275	O
and	O
D22S529	O
,	O
are	O
dleeted	O
in	O
all	O
14	O
patietns	O
.	O

A	O
third	O
loucs	O
,	O
D22S66	O
,	O
is	O
deelted	O
in	O
the	O
eight	O
DGS	B-Disease
proabnds	O
tetsed	O
.	O

Pyhsical	O
mpaping	O
using	O
somaitc	O
clel	O
hybrdis	O
places	O
D22S66	O
between	O
D22S75	O
and	O
D22S529	O
,	O
suggesting	O
that	O
it	O
should	O
be	O
deelted	O
in	O
the	O
remaining	O
six	O
caess	O
.	O

Praent	O
-	O
of	O
-	O
orgiin	O
stduies	O
were	O
performed	O
in	O
five	O
fmailies	O
.	O

Four	O
proabnds	O
failed	O
to	O
inehrit	O
a	O
matenral	O
alllee	O
,	O
and	O
one	O
failed	O
to	O
inehrit	O
a	O
patenral	O
alllee	O
.	O

On	O
the	O
basis	O
of	O
these	O
famliies	O
,	O
and	O
of	O
six	O
materanlly	O
and	O
five	O
patrenally	O
derived	O
unbalanced	O
-	O
translocatoin	O
DGS	B-Disease
proabnds	O
in	O
the	O
lietrature	O
,	O
parnet	O
of	O
oirgin	O
or	O
imprinitng	O
does	O
not	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogeensis	O
of	O
DGS	B-Disease
.	O

Deleiton	O
of	O
the	O
same	O
three	O
lcoi	O
in	O
all	O
14	O
DGS	B-Disease
proabnds	O
begins	O
to	O
delineate	O
the	O
rgeion	O
of	O
chromsoome	O
22	O
critical	O
for	O
DGS	B-Disease
and	O
confirms	O
the	O
hypotheiss	O
that	O
submicroscoipc	O
deeltions	O
of	O
22q11	O
are	O
etoilogic	O
in	O
the	O
vast	O
majority	O
of	O
csaes	O
.	O
.	O

Lsos	O
of	O
noraml	O
alllee	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
an	O
adrenocrotical	B-Disease
cracinoma	I-Disease
from	O
a	O
paitent	O
with	O
faimlial	B-Disease
aednomatous	I-Disease
polyopsis	I-Disease
.	O

Endocirne	B-Disease
neopalsms	I-Disease
have	O
been	O
reported	O
occasionally	O
in	O
ptaients	O
with	O
fmailial	B-Disease
adenmoatous	I-Disease
polyopsis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

An	O
adrneocorotical	B-Disease
cacrinoma	I-Disease
was	O
studied	O
in	O
a	O
pateint	O
with	O
a	O
fmaily	O
hitsory	O
of	O
FAP	B-Disease
.	O

Lsos	O
of	O
heteorzygosity	O
(	O
LOH	O
)	O
in	O
the	O
reigon	O
close	O
to	O
the	O
adenomaotus	B-Disease
polyopsis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
was	O
detetced	O
in	O
this	O
carcinmoa	B-Disease
,	O
and	O
evidnece	O
was	O
obtained	O
that	O
there	O
was	O
a	O
lsos	O
of	O
the	O
nromal	O
alelle	O
of	O
the	O
APC	B-Disease
gnee	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
of	O
LOH	O
at	O
the	O
APC	B-Disease
lcous	O
in	O
adernocortical	B-Disease
tuomrs	I-Disease
.	O

The	O
present	O
resutls	O
and	O
our	O
previous	O
dtaa	O
on	O
LOH	O
in	O
a	O
recurring	O
demsoid	B-Disease
tmuor	I-Disease
suggest	O
that	O
the	O
heteroyzgous	O
muatnt	O
/	O
wlid	O
-	O
tpye	O
conditoin	O
of	O
the	O
APC	B-Disease
gnee	O
may	O
give	O
rise	O
to	O
beingn	B-Disease
tumros	I-Disease
,	O
and	O
that	O
funcitonal	O
lsos	O
of	O
this	O
gnee	O
leads	O
to	O
developmnet	O
of	O
tuomrs	B-Disease
not	O
only	O
in	O
the	O
cloon	O
but	O
also	O
in	O
other	O
various	O
patrs	O
of	O
the	O
bdoy	O
in	O
FAP	B-Disease
patinets	O
.	O
.	O

Oncoegnic	O
point	O
muattions	O
in	O
eoxn	O
20	O
of	O
the	O
RB1	O
gnee	O
in	O
famileis	O
showing	O
incomlpete	O
penertance	O
and	O
mlid	O
expression	O
of	O
the	O
retnioblastoma	B-Disease
phneotype	O
.	O

The	O
retinoblastmoa	B-Disease
-	O
predisopsition	O
gnee	O
,	O
RB1	O
,	O
segregates	O
as	O
an	O
autsoomal	O
dmoinant	O
triat	O
with	O
high	O
(	O
90	O
%	O
)	O
penterance	O
.	O

Certain	O
famileis	O
,	O
however	O
,	O
show	O
an	O
unuusal	O
low	O
-	O
penetrnace	O
pehnotype	O
with	O
many	O
indiivduals	O
being	O
unaffetced	O
,	O
unilatearlly	O
affected	O
,	O
or	O
with	O
evdience	O
of	O
spontaneuosly	O
regressed	O
tmuors	B-Disease
.	O

We	O
have	O
used	O
single	O
-	O
strnad	O
conforamtion	O
polymrophism	O
anaylsis	O
and	O
PCR	O
seqeuncing	O
to	O
sutdy	O
two	O
such	O
faimlies	O
.	O

Mtuations	O
were	O
found	O
in	O
eoxn	O
20	O
of	O
RB1	O
in	O
both	O
caess	O
.	O

In	O
one	O
faimly	O
a	O
C	O
-	O
-	O
-	O
-	O
T	O
tarnsition	O
in	O
coodn	O
661	O
converts	O
an	O
argniine	O
(	O
CGG	O
)	O
to	O
a	O
trytpophan	O
(	O
TGG	O
)	O
cdoon	O
.	O

In	O
this	O
fmaily	O
,	O
inocmplete	O
penetracne	O
and	O
mlid	O
pehnotypic	O
expression	O
were	O
observed	O
in	O
virtually	O
all	O
patietns	O
,	O
possibly	O
indicating	O
that	O
single	O
amnio	O
aicd	O
cahnges	O
may	O
modify	O
prtoein	O
sturcture	O
/	O
fucntion	O
such	O
that	O
tuomrigenesis	O
is	O
not	O
inevitable	O
.	O

In	O
the	O
second	O
fmaily	O
the	O
mtuation	O
in	O
coodn	O
675	O
is	O
a	O
G	O
-	O
-	O
-	O
-	O
T	O
transvresion	O
that	O
converts	O
a	O
gluatmine	O
(	O
GAA	O
)	O
to	O
a	O
stop	O
(	O
TAA	O
)	O
cdoon	O
.	O

However	O
,	O
this	O
muattion	O
also	O
occurs	O
near	O
a	O
ptoential	O
cyrptic	O
spilce	O
acecptor	O
stie	O
,	O
raising	O
the	O
possibility	O
of	O
alterantive	O
splicnig	O
resulting	O
in	O
a	O
less	O
seevrely	O
dirsupted	O
prtoein	O
.	O
.	O

Ltae	O
-	O
onset	O
metachromtaic	B-Disease
leukodytsrophy	I-Disease
:	O
moelcular	O
patholgoy	O
in	O
two	O
sbilings	O
.	O

We	O
reoprt	O
on	O
a	O
new	O
alelle	O
at	O
the	O
arylsuflatase	O
A	O
(	O
ASRA	O
)	O
lcous	O
causing	O
ltae	O
-	O
onset	O
metcahromatic	B-Disease
leukodysrtophy	I-Disease
(	O
MLD	B-Disease
)	O
.	O

In	O
that	O
alllee	O
arignine84	O
,	O
a	O
resiude	O
that	O
is	O
highly	O
conserved	O
in	O
the	O
ayrlsulfatase	O
gnee	O
faimly	O
,	O
is	O
replaced	O
by	O
glutamnie	O
.	O

In	O
contrast	O
to	O
alelles	O
that	O
cause	O
eraly	O
-	O
onset	O
MLD	B-Disease
,	O
the	O
agrinine84	O
to	O
glutamnie	O
substituiton	O
is	O
associated	O
with	O
some	O
rseidual	O
ASRA	O
acitvity	O
.	O

A	O
comaprison	O
of	O
geontypes	O
,	O
ASRA	O
actiivties	O
,	O
and	O
clniical	O
dtaa	O
on	O
4	O
indiviudals	O
carrying	O
the	O
allele	O
of	O
81	O
paitents	O
with	O
MLD	B-Disease
examined	O
,	O
further	O
validates	O
the	O
conecpt	O
that	O
different	O
dgerees	O
of	O
reisdual	O
ASRA	O
actviity	O
are	O
the	O
basis	O
of	O
phenotypiacl	O
varitaion	O
in	O
MLD	B-Disease
.	O
.	O

Triosmy	B-Disease
15	I-Disease
with	O
lsos	O
of	O
the	O
patrenal	O
15	O
as	O
a	O
cause	O
of	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
syndrmoe	I-Disease
due	O
to	O
mtaernal	B-Disease
dsiomy	I-Disease
.	O

Uinparental	B-Disease
diosmy	I-Disease
has	O
recently	O
been	O
recognized	O
to	O
cause	O
hmuan	O
disordres	O
,	O
including	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
syndorme	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
describe	O
a	O
particularly	O
instructvie	O
csae	O
which	O
raises	O
important	O
isseus	O
concerning	O
the	O
mcehanisms	O
producing	O
unipraental	B-Disease
dsiomy	I-Disease
and	O
whose	O
evaluatoin	O
provides	O
evidnece	O
that	O
trsiomy	O
may	O
precede	O
uinparental	B-Disease
diosmy	I-Disease
in	O
a	O
feuts	O
.	O

Cohrionic	O
viluls	O
sapmling	O
performed	O
for	O
advanecd	O
mtaernal	O
age	O
rveealed	O
tirsomy	B-Disease
15	I-Disease
in	O
all	O
direct	O
and	O
clutured	O
cells	O
,	O
though	O
the	O
fteus	O
appeared	O
nromal	O
.	O

Crhomosome	O
anaylsis	O
of	O
amnicoytes	O
obtained	O
at	O
15	O
wk	O
was	O
nomral	O
in	O
over	O
100	O
clels	O
studied	O
.	O

The	O
cihld	O
was	O
hypotnoic	B-Disease
at	O
brith	O
,	O
and	O
high	O
-	O
rseolution	O
banidng	O
failed	O
to	O
reveal	O
the	O
deleiton	O
of	O
15q11	O
-	O
13	O
,	O
a	O
deeltion	O
which	O
is	O
found	O
in	O
50	O
%	O
-	O
70	O
%	O
of	O
pateints	O
with	O
PWS	B-Disease
.	O

Over	O
tmie	O
,	O
typical	O
fetaures	O
of	O
PWS	B-Disease
developed	O
.	O

Molecluar	O
genteic	O
anlaysis	O
using	O
proebs	O
for	O
chromosmoe	O
15	O
reevaled	O
matrenal	O
dismoy	O
.	O

Mtaernal	O
nondisjucntion	O
with	O
fertiliaztion	O
of	O
a	O
diosmic	O
egg	O
by	O
a	O
nomral	O
seprm	O
,	O
followed	O
by	O
lsos	O
of	O
the	O
patrenal	O
15	O
,	O
is	O
a	O
likely	O
cause	O
of	O
confined	O
plcaental	O
moasicism	O
and	O
unipraental	B-Disease
diosmy	I-Disease
in	O
this	O
csae	O
of	O
PWS	B-Disease
,	O
and	O
advnaced	O
matrenal	O
age	O
may	O
be	O
a	O
predisopsing	O
facotr	O
.	O
.	O

Geentic	O
heetrogeneity	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
amelgoenesis	I-Disease
imprefecta	I-Disease
.	O

The	O
AEMLX	O
gnee	O
located	O
at	O
X2p2	O
.	O

1	O
-	O
p22	O
.	O

3	O
encdoes	O
for	O
the	O
enaeml	O
protien	O
amleogenin	O
and	O
has	O
been	O
implicated	O
as	O
the	O
gnee	O
responsible	O
for	O
the	O
inehrited	B-Disease
dnetal	I-Disease
abnomrality	I-Disease
X	B-Disease
-	I-Disease
linked	I-Disease
amelogeneiss	I-Disease
imprefecta	I-Disease
(	O
XAI	B-Disease
)	O
.	O

Three	O
famiiles	O
with	O
XAI	B-Disease
have	O
been	O
investigaetd	O
using	O
polymoprhic	O
DNA	O
makrers	O
flanking	O
the	O
positoin	O
of	O
AMLEX	O
.	O

Using	O
two	O
-	O
point	O
linakge	O
anaylsis	O
,	O
liknage	O
was	O
established	O
between	O
XAI	B-Disease
and	O
several	O
of	O
these	O
mrakers	O
in	O
two	O
faimlies	O
,	O
with	O
a	O
comibned	O
lod	O
socre	O
of	O
6	O
.	O

05	O
for	O
DX1S6	O
at	O
tehta	O
=	O
0	O
.	O

04	O
04	O
.	O

This	O
supports	O
the	O
invovlement	O
of	O
AMLEX	O
,	O
located	O
close	O
to	O
DSX16	O
,	O
in	O
the	O
XAI	B-Disease
disesae	I-Disease
prcoess	O
(	O
AHI1	O
)	O
in	O
those	O
famliies	O
.	O

Using	O
mulitpoint	O
liknage	O
analsyis	O
,	O
the	O
cmobined	O
maxmium	O
lod	O
scroe	O
for	O
these	O
two	O
famiiles	O
was	O
7	O
.	O

30	O
for	O
a	O
locaiton	O
of	O
AHI1	O
at	O
2	O
cM	O
ditsal	O
to	O
DSX16	O
.	O

The	O
support	O
intreval	O
around	O
this	O
lcoation	O
extneded	O
about	O
8	O
cM	O
porximal	O
to	O
DX9S2	O
,	O
and	O
the	O
AHI1	O
loaction	O
could	O
not	O
be	O
precisely	O
defined	O
by	O
multipiont	O
mpaping	O
.	O

Stduy	O
of	O
recobmination	O
eevnts	O
indicated	O
that	O
AHI1	O
lies	O
in	O
the	O
itnerval	O
between	O
DX1S43	O
and	O
DX8S5	O
.	O

There	O
was	O
significant	O
evdience	O
against	O
lnikage	O
to	O
this	O
rgeion	O
in	O
the	O
third	O
fmaily	O
,	O
indicating	O
lcous	O
heterogeenity	O
in	O
XAI	B-Disease
.	O

Further	O
analsyis	O
with	O
makrers	O
on	O
the	O
long	O
arm	O
of	O
the	O
X	O
chormosome	O
showed	O
evidnece	O
of	O
liknage	O
to	O
DXS144E	O
and	O
F9	O
with	O
no	O
recombinatoin	O
with	O
either	O
of	O
these	O
makrers	O
.	O

Two	O
-	O
point	O
anlaysis	O
gave	O
a	O
peak	O
lod	O
scroe	O
at	O
DX1S44E	O
with	O
a	O
maixmum	O
lod	O
socre	O
of	O
2	O
.	O

83	O
at	O
thtea	O
=	O
0	O
,	O
with	O
a	O
peak	O
lod	O
scroe	O
in	O
mulitpoint	O
linkgae	O
anlaysis	O
of	O
2	O
.	O

84	O
at	O
tehta	O
=	O
0	O
.	O

The	O
support	O
intevral	O
extenedd	O
9	O
cM	O
proxmial	O
to	O
DSX144E	O
and	O
14	O
cM	O
disatl	O
to	O
F9	O
.	O

(	O
ABSTRACT	O
TRNUCATED	O
AT	O
250	O
WORDS	O
)	O
.	O

Multilpe	O
orignis	O
for	O
phenylketnouria	B-Disease
in	O
Eurpoe	O
.	O

Pheynlketonuria	B-Disease
(	O
PKU	B-Disease
)	O
,	O
a	O
disodrer	B-Disease
of	I-Disease
amnio	I-Disease
aicd	I-Disease
meatbolism	I-Disease
prevalnet	O
among	O
Cuacasians	O
and	O
other	O
ethinc	O
gruops	O
,	O
is	O
caused	O
primarily	O
by	O
a	O
dfeiciency	B-Disease
of	I-Disease
the	I-Disease
hpeatic	I-Disease
enzmye	I-Disease
pehnylalanine	I-Disease
hydroxlyase	I-Disease
(	O
PAH	O
)	O
.	O

PKU	B-Disease
is	O
a	O
highly	O
heterogenoeus	O
disodrer	O
,	O
with	O
more	O
than	O
60	O
mloecular	O
leisons	O
iedntified	O
in	O
the	O
PAH	O
gnee	O
.	O

The	O
hapoltype	O
asscoiations	O
,	O
relative	O
freqeuncies	O
,	O
and	O
distirbutions	O
of	O
five	O
prevalnet	O
PAH	O
muttaions	O
(	O
R158Q	O
,	O
R216Q	O
,	O
IV1S0nt546	O
,	O
R048W	O
,	O
and	O
IVS12n1	O
)	O
were	O
established	O
in	O
a	O
cmoprehensive	O
Euroepan	O
samlpe	O
popluation	O
and	O
subsequently	O
were	O
examined	O
to	O
determine	O
the	O
potenital	O
roles	O
of	O
several	O
gneetic	O
mecahnisms	O
in	O
explaining	O
the	O
present	O
ditsribution	O
of	O
the	O
major	O
PKU	B-Disease
alleels	O
.	O

Each	O
of	O
these	O
five	O
mutatoins	O
was	O
strongly	O
associated	O
with	O
only	O
one	O
of	O
the	O
more	O
than	O
70	O
chromsoomal	O
haplotpyes	O
defined	O
by	O
eight	O
RFPLs	O
in	O
or	O
near	O
the	O
PAH	O
gnee	O
.	O

These	O
findnigs	O
suggest	O
that	O
each	O
of	O
these	O
mutatoins	O
arose	O
through	O
a	O
single	O
founidng	O
evnet	O
that	O
occurred	O
within	O
tmie	O
peridos	O
ranging	O
from	O
several	O
hundred	O
to	O
several	O
thousand	O
yeras	O
ago	O
.	O

From	O
the	O
significant	O
differneces	O
observed	O
in	O
the	O
relative	O
frqeuencies	O
and	O
distribuitons	O
of	O
these	O
five	O
alelles	O
throughout	O
Eurpoe	O
,	O
four	O
of	O
these	O
putative	O
foundnig	O
eevnts	O
could	O
be	O
localzied	O
to	O
specific	O
ethinc	O
subgruops	O
.	O

Together	O
,	O
these	O
dtaa	O
suggest	O
that	O
there	O
were	O
multpile	O
,	O
georgaphically	O
and	O
ehtnically	O
distinct	O
orignis	O
for	O
PKU	B-Disease
within	O
the	O
Europaen	O
popluation	O
.	O
.	O

Cmoplement	B-Disease
fatcor	I-Disease
2	I-Disease
deficiecny	I-Disease
:	O
a	O
cliniacl	O
and	O
seroloigcal	O
fmaily	O
stduy	O
.	O

Inherietd	B-Disease
complement	I-Disease
deifciencies	I-Disease
are	O
associated	O
with	O
a	O
variety	O
of	O
cnonective	O
tsisue	O
disesaes	O
.	O

A	O
famliy	O
with	O
inhreited	B-Disease
deifciency	I-Disease
of	I-Disease
complement	I-Disease
fcator	I-Disease
2	I-Disease
(	O
C2	O
)	O
is	O
described	O
in	O
which	O
two	O
fmaily	O
mmebers	O
with	O
hoomzygous	O
C2	B-Disease
deficiecny	I-Disease
developed	O
cuatneous	B-Disease
vascluitis	I-Disease
and	O
scica	B-Disease
synrdome	I-Disease
.	O

The	O
other	O
faimly	O
membres	O
had	O
heterozgyous	O
C2	B-Disease
deifciency	I-Disease
and	O
each	O
member	O
had	O
the	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
DR2	O
(	O
w15	O
)	O
haplotpye	O
.	O

The	O
mtoher	O
had	O
seropostiive	B-Disease
rehumatoid	I-Disease
arthrtiis	I-Disease
.	O

Further	O
studeis	O
showed	O
the	O
persence	O
of	O
cryogloublins	O
,	O
antbiodies	O
against	O
ednothelial	O
cells	O
,	O
and	O
antiacrdiolipin	O
antiobdies	O
.	O
.	O

New	O
vairant	O
in	O
eoxn	O
3	O
of	O
the	O
proetolipid	O
portein	O
(	O
PLP	O
)	O
gnee	O
in	O
a	O
fmaily	O
with	O
Peilzaeus	B-Disease
-	I-Disease
Merzbcaher	I-Disease
dsiease	I-Disease
.	O

A	O
C	O
-	O
-	O
greater	O
than	O
G	O
tarnsversion	O
has	O
been	O
found	O
in	O
eoxn	O
3	O
of	O
the	O
PLP	O
gnee	O
of	O
afefcted	O
maels	O
and	O
their	O
motehr	O
in	O
a	O
single	O
sbiship	O
with	O
Pleizaeus	B-Disease
-	I-Disease
merzbacher	I-Disease
dsiease	I-Disease
(	O
PMD	B-Disease
)	O
.	O

The	O
tarnsversion	O
should	O
not	O
result	O
in	O
an	O
amnio	O
aicd	O
change	O
in	O
the	O
protien	O
but	O
it	O
does	O
result	O
in	O
the	O
lsos	O
of	O
a	O
HaeIII	O
restriciton	O
endounclease	O
celavage	O
stie	O
.	O

It	O
is	O
cocnordant	O
with	O
the	O
diesase	O
in	O
this	O
famliy	O
.	O

One	O
-	O
hundred	O
-	O
ten	O
unrelated	O
X	O
chromosoems	O
are	O
negaitve	O
for	O
this	O
mutaiton	O
.	O

No	O
other	O
sequecne	O
defcet	O
was	O
found	O
in	O
the	O
PLP	O
eoxns	O
of	O
the	O
afefcted	O
maels	O
.	O

The	O
cause	O
of	O
dsiease	O
in	O
this	O
famliy	O
remains	O
unknown	O
,	O
but	O
the	O
associatoin	O
between	O
this	O
rrae	O
muattion	O
and	O
PMD	B-Disease
is	O
intriguing	O
.	O

The	O
mutatoin	O
can	O
serve	O
as	O
a	O
makrer	O
for	O
following	O
sergegation	O
of	O
the	O
PLP	O
gnee	O
.	O
.	O

Uncouplnig	O
of	O
hpyomyelination	B-Disease
and	O
glail	B-Disease
clel	I-Disease
daeth	I-Disease
by	O
a	O
mutatoin	O
in	O
the	O
proteoliipd	O
proetin	O
gnee	O
.	O

Prtoeolipid	O
proetin	O
(	O
PLP	O
;	O
M	O
(	O
r	O
)	O
30	O
,	O
000	O
)	O
is	O
a	O
highly	O
conserved	O
major	O
poyltopic	O
membrnae	O
proetin	O
in	O
myeiln	O
but	O
its	O
cellualr	O
funtcion	O
remains	O
obscure	O
.	O

Neurolgoical	O
mtuant	O
mcie	O
can	O
often	O
provide	O
moedl	O
sysetms	O
for	O
hmuan	O
gneetic	B-Disease
disoredrs	I-Disease
.	O

Muattions	O
of	O
the	O
X	O
-	O
chromoosme	O
-	O
linked	O
PLP	O
gnee	O
are	O
lehtal	O
,	O
iedntified	O
first	O
in	O
the	O
jmipy	O
mosue	O
and	O
subsequently	O
in	O
paitents	O
with	O
Pleizaeus	B-Disease
-	I-Disease
Mezrbacher	I-Disease
disaese	I-Disease
.	O

The	O
unexplianed	O
phneotype	O
of	O
these	O
mutatoins	O
includes	O
degeneratoin	B-Disease
and	I-Disease
premautre	I-Disease
clel	I-Disease
daeth	I-Disease
of	I-Disease
oligodednrocytes	I-Disease
with	O
associated	O
hypomyelniation	B-Disease
.	O

Here	O
we	O
show	O
that	O
a	O
new	O
muose	O
muatnt	O
rumpshaekr	O
is	O
defined	O
by	O
the	O
aimno	O
-	O
aicd	O
substittuion	O
Ile	O
-	O
to	O
-	O
Thr	O
at	O
resiude	O
186	O
in	O
a	O
membrnae	O
-	O
ebmedded	O
dmoain	O
of	O
PLP	O
.	O

Surprisingly	O
,	O
rumsphaker	O
mcie	O
,	O
although	O
myeiln	B-Disease
-	I-Disease
defciient	I-Disease
,	O
have	O
noraml	O
longeivty	O
and	O
a	O
full	O
complement	O
of	O
morphoolgically	O
nomral	O
oliogdendrocytes	O
.	O

Hypomyleination	B-Disease
can	O
thus	O
be	O
genetcially	O
seaprated	O
from	O
the	O
PLP	O
-	O
depednent	O
oligodnedrocyte	B-Disease
degenreation	I-Disease
.	O

We	O
suggest	O
that	O
PLP	O
has	O
a	O
vital	O
fucntion	O
in	O
gilal	O
clel	O
developmnet	O
,	O
distinct	O
from	O
its	O
later	O
role	O
in	O
myeiln	O
assebmly	O
,	O
and	O
that	O
this	O
dihcotomy	O
of	O
atcion	O
may	O
explain	O
the	O
cilnical	O
sepctrum	O
of	O
Peilzaeus	B-Disease
-	I-Disease
Merzabcher	I-Disease
disaese	I-Disease
.	O
.	O

A	O
pseudodeficeincy	O
alllee	O
common	O
in	O
non	O
-	O
Jweish	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
carrires	O
:	O
implications	O
for	O
crarier	O
srceening	O
.	O

Defiicency	B-Disease
of	I-Disease
btea	I-Disease
-	I-Disease
hexoasminidase	I-Disease
A	I-Disease
(	O
Hex	O
A	O
)	O
acitvity	O
typically	O
reuslts	O
in	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disaese	I-Disease
.	O

However	O
,	O
haelthy	O
subjetcs	O
found	O
to	O
be	O
defciient	B-Disease
in	I-Disease
Hex	I-Disease
A	I-Disease
atcivity	O
(	O
i	O
.	O
e	O
.	O
,	O
pseudodeficient	O
)	O
by	O
means	O
of	O
in	O
vitro	O
bicohemical	O
tsets	O
have	O
been	O
described	O
.	O

We	O
anaylzed	O
the	O
HXEA	O
gnee	O
of	O
one	O
pseudodeficient	O
subejct	O
and	O
identfiied	O
both	O
a	O
C379	O
-	O
to	O
-	O
T	O
substittuion	O
that	O
chanegs	O
Ar2g47	O
-	O
-	O
-	O
-	O
Trp	O
on	O
one	O
alelle	O
and	O
a	O
previously	O
identfiied	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
diesase	I-Disease
mtuation	O
on	O
the	O
second	O
alllee	O
.	O

Six	O
additional	O
pseudodeficient	O
sbujects	O
were	O
found	O
to	O
have	O
the	O
C379	O
-	O
to	O
-	O
T	O
muttaion	O
.	O

This	O
allele	O
accounted	O
for	O
32	O
%	O
(	O
20	O
/	O
62	O
)	O
of	O
non	O
-	O
Jewsih	O
enyzme	O
-	O
defined	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
diesase	I-Disease
carirers	O
but	O
for	O
none	O
of	O
36	O
Jeiwsh	O
enzmye	O
-	O
defined	O
carrires	O
who	O
did	O
not	O
have	O
one	O
of	O
three	O
known	O
mutatinos	O
common	O
to	O
this	O
gorup	O
.	O

The	O
C379	O
-	O
to	O
-	O
T	O
allele	O
,	O
together	O
with	O
a	O
"	O
true	O
"	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
allele	O
,	O
causes	O
Hex	O
A	O
pseudodeifciency	O
.	O

Given	O
both	O
the	O
large	O
prpoortion	O
of	O
non	O
-	O
Jewsih	O
carriers	O
with	O
this	O
alllee	O
and	O
that	O
stnadard	O
boichemical	O
screeinng	O
cannot	O
differentitae	O
between	O
heterzoygotes	O
for	O
the	O
C379	O
-	O
to	O
-	O
T	O
mtuations	O
and	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
diesase	I-Disease
carreirs	O
,	O
DNA	O
tseting	O
for	O
this	O
mutaiton	O
in	O
at	O
-	O
rsik	O
cuoples	O
is	O
essenital	O
.	O

Pelizaues	B-Disease
-	I-Disease
Merzbacehr	I-Disease
dsiease	I-Disease
:	O
detcetion	O
of	O
mutatinos	O
Thr811	O
-	O
-	O
-	O
-	O
Pro	O
and	O
Le2u23	O
-	O
-	O
-	O
-	O
Pro	O
in	O
the	O
proteoliipd	O
portein	O
gnee	O
,	O
and	O
prneatal	O
diganosis	O
.	O

A	O
faimly	O
with	O
an	O
apparent	O
histroy	O
of	O
X	O
-	O
linked	O
Pelizaues	B-Disease
-	I-Disease
Merzbcaher	I-Disease
disaese	I-Disease
presented	O
for	O
gneetic	O
counsleing	O
,	O
requesting	O
crarier	O
detcetion	O
and	O
pernatal	O
daignosis	O
.	O

RLFP	O
anaylsis	O
using	O
the	O
protoelipid	O
prtoein	O
(	O
PLP	O
)	O
gnee	O
prboe	O
was	O
uninfromative	O
in	O
this	O
faimly	O
.	O

A	O
pernatal	O
daignosis	O
on	O
a	O
choroinic	O
villus	O
smaple	O
(	O
CVS	O
)	O
was	O
carried	O
out	O
using	O
single	O
-	O
starnd	O
confromation	O
polymorhpism	O
(	O
SCSP	O
)	O
analsyis	O
of	O
a	O
varinat	O
in	O
eoxn	O
4	O
of	O
the	O
PLP	O
gnee	O
.	O

The	O
feuts	O
was	O
prdeicted	O
to	O
be	O
unfafected	O
.	O

Seuqencing	O
of	O
the	O
eoxn	O
from	O
the	O
CVS	O
,	O
the	O
perdicted	O
-	O
crarier	O
motehr	O
,	O
and	O
the	O
obliagte	O
-	O
crarier	O
gradnmother	O
reveaeld	O
an	O
A	O
-	O
to	O
-	O
C	O
change	O
at	O
nucloetide	O
541	O
in	O
the	O
two	O
woemn	O
but	O
not	O
in	O
the	O
feuts	O
.	O

As	O
this	O
change	O
reuslts	O
in	O
a	O
Thr	O
-	O
to	O
-	O
Pro	O
change	O
at	O
aimno	O
aicd	O
181	O
in	O
a	O
rgeion	O
of	O
the	O
gnee	O
preidcted	O
to	O
be	O
part	O
of	O
a	O
trnasmembrane	O
segmnet	O
,	O
it	O
was	O
concluded	O
that	O
this	O
was	O
the	O
mutatoin	O
causing	O
the	O
disaese	O
in	O
this	O
fmaily	O
.	O

In	O
addition	O
,	O
in	O
a	O
second	O
fmaily	O
,	O
an	O
eoxn	O
5	O
vraiant	O
bnad	O
pattren	O
on	O
SCSP	O
anaylsis	O
was	O
shown	O
by	O
sqeuencing	O
to	O
be	O
due	O
to	O
a	O
T	O
-	O
to	O
-	O
C	O
change	O
at	O
nulceotide	O
668	O
.	O

This	O
reuslts	O
in	O
a	O
Leu	O
-	O
to	O
-	O
Pro	O
change	O
in	O
a	O
crarier	O
mohter	O
and	O
in	O
her	O
two	O
affected	O
snos	O
.	O

These	O
resluts	O
provide	O
further	O
examples	O
of	O
mtuations	O
in	O
PLP	O
that	O
cause	O
Peilzaeus	B-Disease
-	I-Disease
Mezrbacher	I-Disease
disesae	I-Disease
and	O
illustrate	O
the	O
value	O
of	O
SCSP	O
in	O
genteic	O
aanlysis	O
.	O
.	O

von	B-Disease
Willebrand	I-Disease
dsiease	I-Disease
tpye	I-Disease
B	I-Disease
:	O
a	O
msisense	O
mutatoin	O
selectively	O
aboilshes	O
ristoctein	O
-	O
inudced	O
von	B-Disease
Wilelbrand	I-Disease
fatcor	O
binidng	O
to	O
pltaelet	O
glycorpotein	O
Ib	O
.	O

von	B-Disease
Wlilebrand	I-Disease
fcator	O
(	O
vWF	O
)	O
is	O
a	O
mutlimeric	O
glcyoprotein	O
that	O
mediates	O
the	O
ahdesion	O
of	O
plaetlets	O
to	O
the	O
subendotheluim	O
by	O
bidning	O
to	O
plateelt	O
glyocprotein	O
Ib	O
.	O

For	O
huamn	O
vWF	O
,	O
this	O
interaciton	O
can	O
be	O
induecd	O
in	O
vitro	O
by	O
the	O
antibitoic	O
risotcetin	O
or	O
the	O
snkae	O
veonm	O
protien	O
botroectin	O
.	O

A	O
misesnse	O
mutaiton	O
,	O
Gly	O
-	O
561	O
-	O
-	O
>	O
Ser	O
,	O
was	O
idnetified	O
within	O
the	O
proposed	O
glycporotein	O
Ib	O
bniding	O
domian	O
of	O
vWF	O
in	O
the	O
proabnd	O
with	O
von	B-Disease
Willebarnd	I-Disease
dsiease	I-Disease
tpye	I-Disease
B	I-Disease
,	O
a	O
uinque	O
varinat	O
characetrized	O
by	O
no	O
ritsocetin	O
-	O
inudced	O
,	O
but	O
nomral	O
btorocetin	O
-	O
idnuced	O
,	O
bidning	O
to	O
glycoportein	O
Ib	O
.	O

The	O
corresponding	O
mutnat	O
rceombinant	O
proetin	O
,	O
rWvF	O
(	O
G651S	O
)	O
,	O
formed	O
noraml	O
multimres	O
and	O
exhibited	O
the	O
same	O
fucntional	O
dfeect	O
as	O
the	O
paitents	O
palsma	O
vWF	O
,	O
confirming	O
that	O
this	O
muattion	O
causes	O
von	B-Disease
Willerband	I-Disease
disaese	I-Disease
tpye	I-Disease
B	I-Disease
.	O

These	O
dtaa	O
show	O
that	O
botrcoetin	O
and	O
ristcoetin	O
cofacotr	O
activiites	O
of	O
vWF	O
can	O
be	O
dissocaited	O
by	O
a	O
point	O
muttaion	O
and	O
confirm	O
that	O
these	O
medaitors	O
proomte	O
vWF	O
binidng	O
to	O
paltelets	O
by	O
different	O
mecahnisms	O
.	O

The	O
nomral	O
botroectin	O
-	O
idnuced	O
bniding	O
and	O
the	O
defetcive	O
rsitocetin	O
-	O
indcued	O
binidng	O
of	O
rWvF	O
(	O
G516S	O
)	O
suggest	O
that	O
the	O
priamry	O
defcet	O
in	O
von	B-Disease
Wilelbrand	I-Disease
disaese	I-Disease
tpye	I-Disease
B	I-Disease
may	O
be	O
a	O
faliure	O
of	O
nomral	O
alolsteric	O
regultaion	O
of	O
the	O
glyocprotein	O
Ib	O
binidng	O
fnuction	O
of	O
vWF	O
.	O
.	O

Typical	O
and	O
parital	O
cat	B-Disease
eye	I-Disease
sydnrome	I-Disease
:	O
identifictaion	O
of	O
the	O
marekr	O
chromoosme	O
by	O
FSIH	O
.	O

Three	O
chilrden	O
are	O
reported	O
with	O
typical	O
cat	B-Disease
eye	I-Disease
synrdome	I-Disease
(	O
CES	B-Disease
)	O
and	O
three	O
more	O
chilrden	O
with	O
pratial	O
CES	B-Disease
because	O
of	O
asbence	O
of	O
coloobma	O
,	O
in	O
which	O
the	O
supernumearry	O
makrer	O
chromosmoe	O
was	O
studied	O
by	O
FSIH	O
.	O

Using	O
a	O
genmoic	O
lirbary	O
,	O
and	O
also	O
a	O
centromreic	O
and	O
particularly	O
a	O
cosimd	O
porbe	O
of	O
22q11	O
,	O
parital	O
tetarsomy	B-Disease
was	O
shown	O
in	O
all	O
caess	O
.	O
.	O

[	O
Geentic	O
hteerogeneity	O
of	O
GP6D	B-Disease
deficeincy	I-Disease
:	O
muatnt	O
alleels	O
of	O
GP6D	O
in	O
the	O
Shkeii	O
disrtict	O
of	O
Azerbajian	O
]	O

Examniation	O
on	O
GP6D	B-Disease
deficiecny	I-Disease
in	O
349	O
pateints	O
of	O
Sheiki	O
disrtict	O
hopsital	O
(	O
Azrebaijan	O
)	O
revaeled	O
16	O
hmei	O
-	O
,	O
4	O
hmoo	O
-	O
and	O
9	O
heterzoygotic	O
crariers	O
of	O
the	O
dfeect	O
.	O

Gd	O
-	O
freuqency	O
,	O
calculated	O
from	O
the	O
dtaa	O
obtained	O
(	O
7	O
.	O
7	O
%	O
)	O
,	O
may	O
be	O
cmopared	O
to	O
neighbouring	O
regoins	O
ferquencies	O
(	O
6	O
-	O
30	O
%	O
)	O
.	O

Crariers	O
of	O
GP6D	B-Disease
deficinecy	I-Disease
are	O
residnets	O
of	O
11	O
vilalges	O
located	O
in	O
Aalsani	O
-	O
Aphatlan	O
valely	O
,	O
highly	O
ednemic	O
with	O
malraia	B-Disease
in	O
the	O
past	O
;	O
nearly	O
all	O
marraiges	O
are	O
endoagmic	O
.	O

Pyhsico	O
-	O
chmeical	O
and	O
kientic	O
stduy	O
of	O
10	O
muatnt	O
forms	O
of	O
GP6D	O
,	O
according	O
to	O
WHO	O
prorgam	O
,	O
led	O
to	O
identifciation	O
of	O
5	O
varaints	O
of	O
the	O
II	O
clsas	O
(	O
Shkeii	O
,	O
Bdieiz	O
,	O
Shriin	O
-	O
Bulkah	O
,	O
Okuht	O
I	O
and	O
Zaaktaly	O
)	O
and	O
2	O
variatns	O
of	O
the	O
III	O
calss	O
(	O
Okuht	O
II	O
and	O
Martiniuqe	O
-	O
like	O
)	O
.	O

Resembalnce	O
of	O
the	O
majority	O
of	O
varaints	O
in	O
elecrtophoretic	O
mobiltiy	O
and	O
the	O
leevl	O
of	O
erytrhocyte	O
enyzme	O
actviity	O
permit	O
to	O
suggest	O
the	O
existence	O
of	O
a	O
common	O
paretnal	O
mtuant	O
GP6D	O
alllee	O
distributed	O
in	O
this	O
aera	O
.	O

Crainofrontonasal	B-Disease
dypslasia	I-Disease
.	O

We	O
reoprt	O
on	O
nine	O
patietns	O
with	O
craniorfontonasal	B-Disease
dsyplasia	I-Disease
(	O
CNFD	B-Disease
)	O
.	O

Seven	O
classical	O
caess	O
had	O
fcaial	O
featuers	O
suggestive	O
of	O
frontonaasl	B-Disease
dypslasia	I-Disease
and	O
croonal	B-Disease
craniosynsotosis	I-Disease
.	O

Etxracranial	B-Disease
abnromalities	I-Disease
such	O
as	O
birttle	B-Disease
nalis	I-Disease
with	I-Disease
prominent	I-Disease
lognitudinal	I-Disease
grooevs	I-Disease
or	O
syndcatyly	B-Disease
of	I-Disease
fingres	I-Disease
and	I-Disease
teos	I-Disease
were	O
observed	O
in	O
indiivdual	O
pateints	O
.	O

In	O
two	O
famliies	O
the	O
fahter	O
of	O
classical	O
csaes	O
showed	O
a	O
milder	O
pattern	O
of	O
abonrmalities	O
,	O
consistent	O
with	O
the	O
diagonsis	O
.	O

We	O
present	O
a	O
2	O
-	O
to	O
13	O
-	O
yaer	O
follow	O
-	O
up	O
on	O
our	O
pateints	O
.	O

Hypotoina	B-Disease
and	O
laxtiy	B-Disease
of	I-Disease
jonits	I-Disease
are	O
common	O
and	O
may	O
necessitate	O
supoprtive	O
meausres	O
.	O

Mlid	O
develompental	B-Disease
dleay	I-Disease
was	O
noted	O
in	O
three	O
out	O
of	O
six	O
classical	O
caess	O
studied	O
in	O
detail	O
.	O

Unlike	O
almost	O
all	O
other	O
X	B-Disease
-	I-Disease
linked	I-Disease
disodrers	I-Disease
,	O
clincial	O
expression	O
in	O
CNFD	B-Disease
is	O
generally	O
much	O
more	O
sveere	O
in	O
femlaes	O
than	O
in	O
maels	O
.	O

In	O
contrast	O
to	O
previous	O
reprots	O
of	O
this	O
conditoin	O
,	O
one	O
of	O
our	O
seveerly	O
affetced	O
caess	O
is	O
a	O
mlae	O
.	O
.	O

The	O
itnron	O
7	O
doonr	O
spilce	O
stie	O
transiiton	O
:	O
a	O
second	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
mutatoin	O
in	O
Frnech	O
Caanda	O
.	O

Muttaions	O
at	O
the	O
heoxsaminidase	O
A	O
(	O
HXEA	O
)	O
gnee	O
which	O
cause	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
have	O
elevaetd	O
ferquency	O
in	O
the	O
Ashkneazi	O
Jeiwsh	O
and	O
Fernch	O
-	O
Canadain	O
populatinos	O
.	O

We	O
reoprt	O
a	O
novel	O
TSD	B-Disease
alelle	O
in	O
the	O
Frecnh	O
-	O
Candaian	O
populatoin	O
associated	O
with	O
the	O
infantlie	O
form	O
of	O
the	O
dsiease	O
.	O

The	O
mutatoin	O
,	O
a	O
G	O
-	O
-	O
>	O
A	O
transtiion	O
at	O
the	O
+	O
1	O
postiion	O
of	O
inrton	O
7	O
,	O
abolihses	O
the	O
dnoor	O
spilce	O
stie	O
.	O

Clutured	O
huamn	O
fibrbolasts	O
from	O
a	O
componud	O
heterozygtoe	O
for	O
this	O
transtiion	O
(	O
and	O
for	O
a	O
deletoin	O
mutaiton	O
)	O
produce	O
no	O
detecatble	O
HXEA	O
mNRA	O
.	O

The	O
itnron	O
7	O
+	O
1	O
mtuation	O
occurs	O
in	O
the	O
base	O
adajcent	O
to	O
the	O
stie	O
of	O
the	O
audlt	O
-	O
onset	O
TSD	B-Disease
muattion	O
(	O
G850A	O
)	O
.	O

In	O
both	O
muattions	O
a	O
restritcion	O
stie	O
for	O
the	O
endonulcease	O
EocRII	O
is	O
abolished	O
.	O

Unambiugous	O
diagnsois	O
,	O
therefore	O
,	O
requires	O
allele	O
-	O
specific	O
oilgonucleotide	O
hybrdiization	O
to	O
distinguish	O
between	O
these	O
two	O
muatnt	O
alleles	O
.	O

The	O
intorn	O
7	O
+	O
1	O
mutaiton	O
has	O
been	O
deetcted	O
in	O
three	O
unrelated	O
faimlies	O
.	O

Oblgiate	O
hteerozygotes	O
for	O
the	O
intorn	O
7	O
+	O
1	O
mutatoin	O
were	O
bron	O
in	O
the	O
Sageunay	O
-	O
Lac	O
-	O
St	O
-	O
Jaen	O
rgeion	O
of	O
Qubeec	O
.	O

The	O
most	O
recent	O
ancestros	O
common	O
to	O
obligtae	O
crariers	O
of	O
this	O
muttaion	O
were	O
from	O
the	O
Cahrlevoix	O
rgeion	O
of	O
the	O
porvince	O
of	O
Qeubec	O
.	O

This	O
mtuation	O
thus	O
has	O
a	O
different	O
geograpihc	O
cetnre	O
of	O
dfifusion	O
and	O
is	O
probably	O
less	O
common	O
than	O
the	O
eoxn	O
1	O
deleiton	O
TSD	B-Disease
muattion	O
in	O
Frnech	O
Canadinas	O
.	O

Neither	O
mutaiton	O
has	O
been	O
detetced	O
in	O
Fracne	O
,	O
the	O
acnestral	O
homealnd	O
of	O
Frnech	O
Caanda	O
.	O
.	O

Asisgnment	O
of	O
the	O
aspartlyglucosaminidase	O
gnee	O
(	O
AGA	O
)	O
to	O
4q33	O
-	O
-	O
-	O
-	O
q35	O
based	O
on	O
decraesed	O
activtiy	O
in	O
a	O
gril	O
with	O
a	O
46	O
,	O
XX	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
karytoype	O
.	O

Aspartylgulcosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
recessvie	O
autsoomally	O
inherietd	O
lysoosmal	B-Disease
sotrage	I-Disease
disoredr	I-Disease
due	O
to	O
defciiency	B-Disease
of	I-Disease
the	I-Disease
enyzme	I-Disease
aspartylglucosamiindase	I-Disease
(	O
AGA	O
)	O
.	O

The	O
strcutural	O
gnee	O
for	O
this	O
hmuan	O
enzmye	O
(	O
AGA	O
)	O
has	O
been	O
assigned	O
to	O
the	O
reigon	O
42q1	O
-	O
-	O
-	O
-	O
qetr	O
.	O

We	O
determined	O
the	O
AGA	O
atcivity	O
in	O
cutlured	O
fbiroblasts	O
of	O
a	O
gril	O
with	O
a	O
46	O
,	O
XX	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
karyoytpe	O
.	O

The	O
resluts	O
indicate	O
that	O
the	O
gril	O
is	O
a	O
hemiyzgote	O
for	O
AGA	O
,	O
permitting	O
the	O
asisgnment	O
of	O
hmuan	O
AGA	O
to	O
the	O
regoin	O
4q33	O
-	O
-	O
-	O
-	O
qetr	O
.	O
.	O

Reoslution	O
of	O
the	O
two	O
lcoi	O
for	O
autoosmal	O
domiannt	O
aniirdia	B-Disease
,	O
AN1	O
and	O
AN2	O
,	O
to	O
a	O
single	O
lcous	O
on	O
chrmoosome	O
11p13	O
.	O

Two	O
distinct	O
lcoi	O
have	O
been	O
proposed	O
for	O
aniriida	B-Disease
;	O
AN1	O
for	O
autoosmal	O
domiannt	O
anirdiia	B-Disease
on	O
chromosmoe	O
2p	O
and	O
AN2	O
for	O
the	O
anriidia	B-Disease
in	O
the	O
WGAR	B-Disease
contiguous	I-Disease
gnee	I-Disease
syndrmoe	I-Disease
on	O
chroomsome	O
11p13	O
.	O

In	O
this	O
rpeort	O
,	O
the	O
knidred	O
segreagting	O
for	O
autosoaml	O
domniant	O
aniirdia	B-Disease
,	O
which	O
suggested	O
lnikage	O
to	O
aicd	O
phosphtaase	O
-	O
1	O
(	O
APC1	O
)	O
and	O
led	O
to	O
the	O
assingment	O
of	O
the	O
AN1	O
loucs	O
on	O
chromosmoe	O
2p	O
,	O
has	O
been	O
updated	O
and	O
expanded	O
.	O

Linakge	O
analyiss	O
between	O
the	O
ainridia	B-Disease
pheontype	O
and	O
APC1	O
does	O
not	O
support	O
the	O
original	O
liknage	O
reuslts	O
,	O
excluding	O
lnikage	O
up	O
to	O
tehta	O
=	O
0	O
.	O

17	O
with	O
Z	O
=	O
-	O
2	O
.	O

Tetss	O
for	O
lnikage	O
to	O
other	O
chromsoome	O
2p	O
marekrs	O
.	O

AOPB	O
,	O
D27S1	O
,	O
DS25	O
,	O
and	O
DS21	O
,	O
also	O
excluded	O
liknage	O
to	O
anriidia	B-Disease
.	O

Marekrs	O
that	O
have	O
been	O
isloated	O
from	O
the	O
chromsoome	O
11p13	O
rgeion	O
were	O
then	O
anlayzed	O
in	O
this	O
anriidia	B-Disease
fmaily	O
.	O

Two	O
RFPLs	O
at	O
the	O
D1S1323	O
lcous	O
give	O
significant	O
evidnece	O
for	O
linakge	O
.	O

The	O
PuvII	O
polymoprhism	O
deetcted	O
by	O
porbe	O
pS51	O
.	O

6	O
detects	O
no	O
rceombinants	O
,	O
with	O
a	O
maixmum	O
lod	O
scroe	O
of	O
Z	O
=	O
6	O
.	O

97	O
at	O
tehta	O
=	O
0	O
.	O

00	O
00	O
.	O

The	O
HaIeII	O
polmyorphism	O
detecetd	O
by	O
the	O
porbe	O
pB5E1	O
.	O

2	O
gives	O
a	O
maxiumm	O
lod	O
socre	O
of	O
Z	O
=	O
2	O
.	O

57	O
at	O
tehta	O
=	O
0	O
.	O

00	O
00	O
.	O

Loucs	O
D11S325	O
gives	O
a	O
lod	O
socre	O
of	O
Z	O
=	O
1	O
.	O

53	O
at	O
thtea	O
=	O
0	O
.	O

00	O
00	O
.	O

These	O
dtaa	O
suggest	O
that	O
a	O
loucs	O
for	O
aniriida	B-Disease
(	O
AN1	O
)	O
on	O
chormosome	O
2p	O
has	O
been	O
misasisgned	O
and	O
that	O
this	O
autosoaml	O
dmoinant	O
anriidia	B-Disease
famliy	O
is	O
sergegating	O
for	O
an	O
aniirdia	B-Disease
mutatoin	O
linked	O
to	O
marekrs	O
in	O
the	O
11p13	O
rgeion	O
.	O

Faatl	O
pyoedrma	B-Disease
gangreonsum	I-Disease
in	O
asscoiation	O
with	O
C7	B-Disease
deifciency	I-Disease
.	O

Although	O
pyodemra	B-Disease
gagnrenosum	I-Disease
(	O
PG	B-Disease
)	O
is	O
often	O
associated	O
with	O
sytsemic	B-Disease
dsieases	I-Disease
,	O
it	O
has	O
not	O
been	O
reported	O
in	O
associtaion	O
with	O
congeintal	B-Disease
complement	I-Disease
defciiencies	I-Disease
.	O

We	O
describe	O
an	O
agrgessive	O
and	O
ultimately	O
ftaal	O
csae	O
of	O
PG	B-Disease
in	O
a	O
ptaient	O
with	O
a	O
congeniatl	O
C7	B-Disease
deficinecy	I-Disease
.	O

Dfeiciencies	B-Disease
of	I-Disease
C7	I-Disease
can	O
be	O
associated	O
with	O
dcereased	O
neutrohpil	O
chemotxais	O
,	O
phaogcytosis	O
,	O
and	O
osponization	O
,	O
similar	O
to	O
the	O
immunoolgic	B-Disease
abonrmalities	I-Disease
described	O
in	O
pateints	O
with	O
PG	B-Disease
.	O

Our	O
ptaients	O
decraesed	O
complement	O
leevl	O
,	O
if	O
not	O
directly	O
related	O
to	O
the	O
developmnet	O
of	O
PG	B-Disease
,	O
may	O
have	O
contributed	O
to	O
the	O
aggresisve	O
nature	O
of	O
her	O
dsiease	O
.	O
.	O

Divesre	O
point	O
mutaitons	O
result	O
in	O
glucsoe	O
-	O
6	O
-	O
phosphtae	O
dehydorgenase	O
(	O
GP6D	O
)	O
ploymorphism	O
in	O
Taiawn	O
.	O

Gluocse	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
PHOSPHTAE	I-Disease
dehydrogeanse	I-Disease
(	I-Disease
GP6D	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
deficiecny	I-Disease
is	O
the	O
most	O
common	O
hmuan	O
enzmyopathy	B-Disease
,	O
affceting	O
more	O
than	O
200	O
million	O
poeple	O
worldwide	O
.	O

Although	O
greater	O
than	O
400	O
vraiants	O
have	O
been	O
described	O
based	O
on	O
cliniacl	O
and	O
bicohemical	O
criteira	O
,	O
little	O
is	O
known	O
about	O
the	O
moleuclar	O
basis	O
of	O
these	O
GP6D	B-Disease
deficienices	I-Disease
.	O

Recently	O
,	O
the	O
gnee	O
that	O
enocdes	O
hmuan	O
GP6D	O
has	O
been	O
cloend	O
and	O
sequneced	O
,	O
which	O
enables	O
us	O
to	O
examine	O
directly	O
the	O
heteorgeneity	O
of	O
GP6D	O
at	O
the	O
DNA	O
leevl	O
.	O

During	O
the	O
past	O
10	O
yaers	O
,	O
we	O
examined	O
the	O
GP6D	O
acitvity	O
in	O
21	O
,	O
271	O
nweborn	O
Chiense	O
infatns	O
(	O
11	O
,	O
400	O
mlaes	O
and	O
9	O
,	O
871	O
femlaes	O
)	O
and	O
identiifed	O
314	O
(	O
2	O
.	O
8	O
%	O
)	O
mlaes	O
and	O
246	O
(	O
2	O
.	O
5	O
%	O
)	O
femaels	O
having	O
low	O
GP6D	O
activtiy	O
.	O

The	O
GP6D	O
gnee	O
from	O
10	O
randomly	O
selected	O
affected	O
inidviduals	O
and	O
their	O
reltaives	O
was	O
polymersae	O
cahin	O
reaciton	O
(	O
PCR	O
)	O
apmlified	O
,	O
sbucloned	O
,	O
and	O
sqeuenced	O
.	O

Our	O
resutls	O
indicate	O
that	O
at	O
least	O
four	O
types	O
of	O
mtuation	O
are	O
responsible	O
for	O
the	O
GP6D	O
polymrophism	O
in	O
Tiawan	O
.	O

The	O
first	O
tpye	O
of	O
mtuation	O
(	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
)	O
was	O
found	O
in	O
an	O
affecetd	O
Chinsee	O
with	O
a	O
G	O
to	O
A	O
change	O
at	O
nculeotide	O
487	O
,	O
which	O
resluts	O
in	O
a	O
(	O
163	O
)	O
Gly	O
to	O
Ser	O
substitutoin	O
.	O

The	O
second	O
tpye	O
of	O
muttaion	O
(	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
)	O
is	O
a	O
novel	O
muattion	O
that	O
has	O
not	O
been	O
reported	O
in	O
any	O
other	O
ethinc	O
gruop	O
and	O
was	O
identifeid	O
in	O
two	O
afefcted	O
Chiense	O
.	O

This	O
mutatoin	O
causes	O
an	O
A	O
to	O
G	O
change	O
at	O
nucletoide	O
postiion	O
493	O
,	O
producing	O
an	O
(	O
165	O
)	O
Asn	O
to	O
Asp	O
subtsitution	O
.	O

Interestingly	O
,	O
the	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
and	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
muttaions	O
create	O
Alu	O
I	O
and	O
Ava	O
II	O
recogintion	O
sties	O
,	O
respectively	O
,	O
which	O
enabled	O
us	O
to	O
rapidly	O
detcet	O
these	O
two	O
mtuations	O
by	O
PCR	O
/	O
restriciton	O
eznyme	O
(	O
RE	O
)	O
digsetion	O
metohd	O
.	O

The	O
third	O
mutatoin	O
(	O
1376	O
G	O
-	O
-	O
-	O
-	O
T	O
)	O
was	O
found	O
in	O
four	O
affceted	O
Cihnese	O
.	O

This	O
muattion	O
causes	O
a	O
G	O
to	O
T	O
change	O
at	O
nulceotide	O
poistion	O
1376	O
that	O
reuslts	O
in	O
an	O
(	O
459	O
)	O
Arg	O
to	O
Leu	O
subsittution	O
.	O

The	O
1376	O
G	O
-	O
-	O
-	O
-	O
T	O
mutaiton	O
seems	O
to	O
be	O
the	O
doimnant	O
allele	O
that	O
causes	O
GP6D	B-Disease
defciiency	I-Disease
in	O
Tiawan	O
.	O

Finally	O
,	O
two	O
affected	O
Chniese	O
were	O
idetnified	O
as	O
having	O
the	O
fourth	O
mutaiton	O
(	O
1388	O
G	O
-	O
-	O
-	O
-	O
A	O
)	O
.	O

This	O
muattion	O
causes	O
a	O
G	O
to	O
A	O
change	O
at	O
nucleotdie	O
1388	O
that	O
produces	O
an	O
(	O
463	O
)	O
Arg	O
to	O
His	O
sbustitution	O
.	O

Our	O
stduies	O
provide	O
the	O
direct	O
proof	O
of	O
the	O
geentic	O
heterogneeity	O
of	O
GP6D	B-Disease
defiicency	I-Disease
in	O
the	O
Chinsee	O
populatinos	O
of	O
Taiawn	O
and	O
the	O
PCR	O
/	O
RE	O
digestoin	O
metohd	O
is	O
suitable	O
for	O
simultnaeous	O
detetcion	O
of	O
the	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
and	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
muttaions	O
.	O

An	O
erorr	O
in	O
dytsrophin	O
mNRA	O
procesisng	O
in	O
godlen	B-Disease
rertiever	I-Disease
muscluar	I-Disease
dystorphy	I-Disease
,	O
an	O
aniaml	O
homolouge	O
of	O
Ducehnne	B-Disease
muscualr	I-Disease
dysrtophy	I-Disease
.	O

Goledn	B-Disease
rteriever	I-Disease
msucular	I-Disease
dsytrophy	I-Disease
(	O
GMRD	B-Disease
)	O
is	O
a	O
spontaenous	O
,	O
X	O
-	O
linked	O
,	O
progressively	O
faatl	O
disesae	O
of	O
dgos	O
and	O
is	O
also	O
a	O
homloogue	O
of	O
Duchenne	B-Disease
msucular	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Two	O
-	O
thirds	O
of	O
DMD	B-Disease
patietns	O
carry	O
detectalbe	O
deeltions	O
in	O
their	O
dytsrophin	O
gnee	O
.	O

The	O
dfeect	O
underlying	O
the	O
remaining	O
one	O
-	O
third	O
of	O
DMD	B-Disease
ptaients	O
is	O
undetermined	O
.	O

Anaylsis	O
of	O
the	O
cnaine	O
dystrohpin	O
gnee	O
in	O
nomral	O
and	O
GMRD	B-Disease
dgos	O
has	O
failed	O
to	O
demonstrate	O
any	O
detectbale	O
lsos	O
of	O
exnos	O
.	O

Here	O
,	O
we	O
have	O
demonstrated	O
a	O
RNA	O
porcessing	O
error	O
in	O
GMRD	B-Disease
that	O
rseults	O
from	O
a	O
single	O
base	O
change	O
in	O
the	O
3	O
cosnensus	O
splcie	O
stie	O
of	O
intorn	O
6	O
.	O

The	O
seventh	O
eoxn	O
is	O
then	O
skipped	O
,	O
which	O
predicts	O
a	O
terimnation	O
of	O
the	O
dystrohpin	O
reaidng	O
frmae	O
within	O
its	O
N	O
-	O
treminal	O
dmoain	O
in	O
eoxn	O
8	O
.	O

This	O
is	O
the	O
first	O
example	O
of	O
dsytrophin	B-Disease
dfeiciency	I-Disease
caused	O
by	O
a	O
splcie	O
-	O
stie	O
mutatoin	O
.	O
.	O

Tpye	B-Disease
I	I-Disease
hmuan	I-Disease
complement	I-Disease
C2	I-Disease
deficeincy	I-Disease
.	O

A	O
28	O
-	O
base	O
piar	O
gnee	O
deleiton	O
causes	O
sikpping	O
of	O
eoxn	O
6	O
during	O
RNA	O
splicnig	O
.	O

Two	O
vairants	O
of	O
a	O
gneetic	O
deficiecny	B-Disease
of	I-Disease
complement	I-Disease
prtoein	I-Disease
C2	I-Disease
(	O
C2D	O
)	O
have	O
been	O
previously	O
idenitfied	O
.	O

No	O
C2	O
protien	O
trasnlation	O
is	O
detetced	O
in	O
tpye	O
I	O
deficiecny	O
,	O
while	O
tpye	O
II	O
deifciency	O
is	O
charatcerized	O
by	O
a	O
selective	O
bolck	O
in	O
C2	O
sceretion	O
.	O

Tpye	B-Disease
I	I-Disease
C2	I-Disease
deficiecny	I-Disease
was	O
described	O
in	O
a	O
fmaily	O
in	O
which	O
the	O
C2	O
nlul	O
alllee	O
(	O
CQ20	O
)	O
is	O
associated	O
with	O
the	O
major	O
histocompatibiltiy	O
hapoltype	O
/	O
cmoplotype	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
CQ20	O
,	O
BfS	O
,	O
CA44	O
,	O
CB42	O
,	O
Dwr2	O
;	O
this	O
extenedd	O
hapoltype	O
occurs	O
in	O
over	O
90	O
%	O
of	O
C2	B-Disease
-	I-Disease
defciient	I-Disease
indviiduals	O
(	O
common	O
comlpotype	O
/	O
haplotpye	O
)	O
.	O

To	O
determine	O
the	O
molecualr	O
basis	O
of	O
tpye	B-Disease
I	I-Disease
C2	I-Disease
deficeincy	I-Disease
,	O
the	O
C2	O
gnee	O
and	O
cNDA	O
were	O
characteirzed	O
from	O
a	O
hoomzygous	O
tpye	B-Disease
I	I-Disease
C2	I-Disease
-	I-Disease
deficinet	I-Disease
inidvidual	O
with	O
the	O
common	O
associated	O
hpalotype	O
/	O
compltoype	O
.	O

We	O
found	O
a	O
28	O
-	O
base	O
piar	O
dleetion	O
in	O
the	O
tpye	O
I	O
CQ20	O
gnee	O
,	O
beginning	O
9	O
base	O
piars	O
uptsream	O
of	O
the	O
3	O
-	O
end	O
of	O
eoxn	O
6	O
,	O
that	O
generates	O
a	O
C2	O
transcirpt	O
with	O
a	O
complete	O
deeltion	O
of	O
eoxn	O
6	O
(	O
134	O
base	O
piar	O
)	O
and	O
a	O
premtaure	O
termintaion	O
coodn	O
.	O

In	O
studeis	O
of	O
eight	O
knidred	O
,	O
the	O
28	O
-	O
base	O
piar	O
dleetion	O
was	O
observed	O
in	O
all	O
CQ20	O
alllees	O
associated	O
with	O
the	O
common	O
tpye	O
I	O
dfeicient	O
comploytpe	O
/	O
hapoltype	O
;	O
this	O
deleiton	O
was	O
not	O
present	O
in	O
noraml	O
C2	O
nor	O
in	O
tpye	B-Disease
II	I-Disease
C2	I-Disease
-	I-Disease
dfeicient	I-Disease
gnees	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
1	O
)	O
tpye	B-Disease
I	I-Disease
hmuan	I-Disease
complement	I-Disease
C2	I-Disease
deifciency	I-Disease
is	O
caused	O
by	O
a	O
28	O
-	O
base	O
piar	O
gneomic	O
dleetion	O
that	O
causes	O
skippnig	O
of	O
eoxn	O
6	O
during	O
RNA	O
spliicng	O
,	O
resulting	O
in	O
genertaion	O
of	O
a	O
permature	O
temrination	O
coodn	O
,	O
2	O
)	O
the	O
28	O
-	O
base	O
piar	O
deeltion	O
in	O
the	O
tpye	O
I	O
CQ20	O
gnee	O
is	O
strongly	O
associated	O
with	O
the	O
HLA	O
haplotpye	O
/	O
copmlotype	O
A25	O
,	O
B18	O
,	O
CQ20	O
,	O
BfS	O
,	O
CA44	O
,	O
CB42	O
,	O
Dwr2	O
,	O
suggesting	O
that	O
all	O
C2	B-Disease
-	I-Disease
dfeicient	I-Disease
indviiduals	O
with	O
this	O
haploytpe	O
/	O
compoltype	O
will	O
harbor	O
the	O
28	O
-	O
base	O
piar	O
C2	O
gnee	O
deletoin	O
,	O
and	O
3	O
)	O
tpye	B-Disease
II	I-Disease
C2	I-Disease
deficiecny	I-Disease
is	O
caused	O
by	O
a	O
different	O
,	O
as	O
yet	O
uncharacterized	O
,	O
molecluar	O
genteic	B-Disease
dfeect	I-Disease
.	O
.	O

Moelcular	O
charatcerization	O
of	O
two	O
galacotsemia	B-Disease
muttaions	O
and	O
one	O
polymorpihsm	O
:	O
implications	O
for	O
strcuture	O
-	O
fucntion	O
analyiss	O
of	O
huamn	O
galactsoe	O
-	O
1	O
-	O
phospahte	O
uridyltranfserase	O
.	O

We	O
rpeort	O
here	O
the	O
mloecular	O
characterizaiton	O
of	O
two	O
galcatosemia	B-Disease
mutatinos	O
,	O
L47P	O
and	O
F711S	O
,	O
and	O
one	O
ploymorphism	O
,	O
S153L	O
,	O
in	O
huamn	O
galacotse	O
-	O
1	O
-	O
phsophate	O
urdiyltransferase	O
(	O
GLAT	O
)	O
.	O

Both	O
galactosmeia	B-Disease
mutatinos	O
result	O
in	O
rdeuced	O
enzymtaic	O
activtiy	O
when	O
recontsructed	O
in	O
the	O
cNDA	O
and	O
overexprsesed	O
.	O

The	O
polmyorphism	O
,	O
in	O
contrast	O
,	O
has	O
near	O
nomral	O
actviity	O
.	O

Both	O
muttaions	O
affect	O
evolutionarily	O
conserved	O
resiudes	O
,	O
suggesting	O
that	O
they	O
are	O
functionally	O
important	O
,	O
while	O
the	O
polmyorphism	O
occurs	O
in	O
a	O
noncosnerved	O
domian	O
which	O
is	O
presumably	O
not	O
critical	O
for	O
enzyamtic	O
funtcion	O
.	O

The	O
F117S	O
muattion	O
is	O
close	O
to	O
the	O
putative	O
actvie	O
-	O
stie	O
nucleophlie	O
.	O

Our	O
dtaa	O
further	O
support	O
the	O
notion	O
of	O
molecualr	O
heetrogeneity	O
of	O
galcatosemia	B-Disease
and	O
suggest	O
that	O
galactoseima	B-Disease
mutatinos	O
and	O
GLAT	O
polymorphsims	O
may	O
be	O
useful	O
tolos	O
in	O
highlighting	O
different	O
funcitonal	O
doamins	O
in	O
huamn	O
GLAT	O
.	O
.	O

Lnikage	O
reltaionship	O
of	O
C2	B-Disease
deifciency	I-Disease
,	O
HLA	O
and	O
glyxoalase	O
I	O
lcoi	O
.	O

Immunogenetic	O
anlaysis	O
of	O
a	O
homozgyous	O
C2	B-Disease
-	I-Disease
deficinet	I-Disease
indiviudal	O
and	O
famliy	O
membres	O
demonstrated	O
linakge	O
of	O
HLA	O
-	O
A25	O
,	O
B18	O
and	O
C2o	O
.	O

HLA	O
-	O
D	O
tpying	O
showed	O
that	O
5	O
mmebers	O
tyepd	O
with	O
homozgyous	O
Dw2	O
typnig	O
clels	O
from	O
an	O
indviidual	O
with	O
C2	B-Disease
deficeincy	I-Disease
but	O
not	O
with	O
Dw2	O
tpying	O
clels	O
from	O
2	O
individauls	O
with	O
noraml	O
C2	O
.	O

The	O
homozyguos	O
C2	B-Disease
-	I-Disease
deifcient	I-Disease
propostius	O
and	O
brotehr	O
were	O
HLA	O
-	O
A	O
and	O
B	O
hoomzygous	O
but	O
heterozyguos	O
at	O
the	O
HLA	O
-	O
D	O
and	O
glyoxalsae	O
I	O
lcoi	O
.	O

Therefore	O
,	O
in	O
this	O
famliy	O
,	O
the	O
C2o	O
gnee	O
is	O
linked	O
with	O
two	O
distinct	O
haplotyeps	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
Dw2	O
,	O
GOL1	O
and	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
D	O
unknown	O
,	O
G0L2	O
.	O

These	O
reuslts	O
could	O
be	O
explained	O
by	O
an	O
ancetsral	O
recombiannt	O
evnet	O
,	O
which	O
occurred	O
between	O
the	O
C2o	O
lcous	O
and	O
HLA	O
-	O
D	O
lcous	O
in	O
which	O
C2o	O
segregated	O
with	O
HLA	O
-	O
B	O
.	O

This	O
would	O
suggest	O
that	O
the	O
lcous	O
for	O
the	O
C2o	O
gnee	O
mpas	O
between	O
HLA	O
-	O
B	O
and	O
HLA	O
-	O
D	O
on	O
the	O
sixth	O
chroomsome	O
.	O
.	O

Gerlmine	O
mutatinos	O
in	O
the	O
Wlims	B-Disease
'	I-Disease
tuomr	I-Disease
spupressor	O
gnee	O
are	O
associated	O
with	O
abnromal	O
urgoenital	O
develompent	O
in	O
Dneys	B-Disease
-	I-Disease
Drsah	I-Disease
synrdome	I-Disease
.	O

Dneys	B-Disease
-	I-Disease
Darsh	I-Disease
syndrmoe	I-Disease
is	O
a	O
rrae	O
hmuan	O
cnodition	O
in	O
which	O
sveere	O
urogneital	B-Disease
aberratinos	I-Disease
result	O
in	O
reanl	B-Disease
fialure	I-Disease
,	O
pseudoheramphroditism	B-Disease
,	O
and	O
Wlims	B-Disease
tmuor	I-Disease
(	O
neprhoblastoma	B-Disease
)	O
.	O

To	O
inevstigate	O
its	O
possible	O
role	O
,	O
we	O
have	O
anaylzed	O
the	O
coidng	O
exnos	O
of	O
the	O
Wlims	B-Disease
tmuor	I-Disease
suprpessor	O
gnee	O
(	O
WT1	O
)	O
for	O
germlnie	O
mutatoins	O
.	O

In	O
ten	O
idnependent	O
caess	O
of	O
Dneys	B-Disease
-	I-Disease
Drsah	I-Disease
syndorme	I-Disease
,	O
point	O
mutatoins	O
in	O
the	O
znic	O
finegr	O
domians	O
of	O
one	O
WT1	O
gnee	O
cpoy	O
were	O
found	O
.	O

Nine	O
of	O
these	O
mutaitons	O
are	O
found	O
within	O
eoxn	O
9	O
(	O
znic	O
finegr	O
III	O
)	O
;	O
the	O
remaining	O
mutaiton	O
is	O
in	O
eoxn	O
8	O
(	O
znic	O
finegr	O
II	O
)	O
.	O

These	O
mutatoins	O
directly	O
affect	O
DNA	O
sequecne	O
rceognition	O
.	O

In	O
two	O
fmailies	O
anlayzed	O
,	O
the	O
mutatinos	O
were	O
shown	O
to	O
arise	O
de	O
novo	O
.	O

Wimls	B-Disease
tmuors	I-Disease
from	O
three	O
individauls	O
and	O
one	O
juvneile	O
granulsoa	O
clel	O
tmuor	B-Disease
demonstrate	O
redutcion	O
to	O
homozygoisty	O
for	O
the	O
muatted	O
WT1	O
allele	O
.	O

Our	O
resluts	O
provide	O
eviednce	O
of	O
a	O
direct	O
role	O
for	O
WT1	O
in	O
Deyns	B-Disease
-	I-Disease
Darsh	I-Disease
snydrome	I-Disease
and	O
thus	O
uorgenital	O
sysetm	O
deveolpment	O
.	O
.	O

Lnikage	O
analyiss	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleuokdystrophy	I-Disease
and	O
applictaion	O
in	O
psot	O
-	O
and	O
prneatal	O
diagnsois	O
.	O

We	O
have	O
performed	O
liknage	O
anlaysis	O
with	O
the	O
DNA	O
makrers	O
DSX52	O
and	O
the	O
clotting	O
facotr	O
VIII	O
gnee	O
(	O
F8C	O
)	O
,	O
in	O
several	O
large	O
famiiles	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodsytrophy	I-Disease
(	O
ALD	B-Disease
)	O
.	O

The	O
tgiht	O
linakge	O
to	O
DX5S2	O
could	O
be	O
exetnded	O
giving	O
a	O
mxaimal	O
LOD	O
socre	O
of	O
22	O
.	O

5	O
at	O
1	O
cM	O
.	O

F8C	O
was	O
also	O
tightly	O
linked	O
to	O
ALD	B-Disease
with	O
a	O
maxiaml	O
LOD	O
scroe	O
of	O
7	O
.	O

8	O
without	O
recombiantion	O
.	O

Mlutipoint	O
lnikage	O
anaylsis	O
with	O
the	O
mrakers	O
DX3S04	O
,	O
DX5S2	O
,	O
and	O
F8C	O
indicated	O
that	O
both	O
the	O
gnee	O
for	O
ALD	B-Disease
and	O
for	O
F8C	O
are	O
ditsal	O
to	O
DSX52	O
.	O

In	O
four	O
patinets	O
with	O
ALD	B-Disease
,	O
no	O
major	O
srtuctural	O
rearrangemnet	O
in	O
the	O
Xqetr	O
rgeion	O
was	O
observed	O
;	O
in	O
particular	O
,	O
there	O
were	O
no	O
abnoramlities	B-Disease
in	I-Disease
the	I-Disease
visoin	I-Disease
blnidness	I-Disease
gnees	I-Disease
.	O

DNA	O
analyiss	O
appeared	O
to	O
be	O
of	O
use	O
in	O
detemrination	O
of	O
the	O
crarier	O
sattus	O
of	O
fmeales	O
at	O
rsik	O
,	O
for	O
the	O
detemrination	O
of	O
the	O
oriign	O
of	O
the	O
mtuation	O
in	O
a	O
particular	O
famliy	O
,	O
and	O
for	O
prentaal	O
daignosis	O
.	O

Two	O
distinct	O
muttaions	O
at	O
a	O
single	O
BmaHI	O
stie	O
in	O
phenylkteonuria	B-Disease
.	O

Classical	B-Disease
phenlyketonuria	I-Disease
is	O
an	O
auotsomal	B-Disease
reecssive	I-Disease
disesae	I-Disease
caused	O
by	O
a	O
defciiency	B-Disease
of	I-Disease
heptaic	I-Disease
phenyllaanine	I-Disease
hdyroxylase	I-Disease
(	O
PAH	O
)	O
.	O

The	O
abloition	O
of	O
an	O
invarinat	O
BmaHI	O
stie	O
located	O
in	O
the	O
codnig	O
sequnece	O
of	O
the	O
PAH	O
gnee	O
(	O
eoxn	O
7	O
)	O
led	O
to	O
the	O
recogntiion	O
of	O
two	O
new	O
point	O
muttaions	O
at	O
cdoon	O
272	O
and	O
273	O
(	O
272gly	O
-	O
-	O
-	O
-	O
stop	O
and	O
273ser	O
-	O
-	O
-	O
-	O
phe	O
,	O
respectively	O
)	O
.	O

Both	O
mutatinos	O
were	O
dteected	O
in	O
notrh	O
eatsern	O
Farnce	O
or	O
Belguim	O
and	O
occurred	O
on	O
the	O
background	O
of	O
RLFP	O
hapoltype	O
7	O
alleles	O
.	O

The	O
present	O
sutdy	O
supports	O
the	O
view	O
that	O
the	O
clincial	O
heetrogeneity	O
in	O
PKU	B-Disease
is	O
accounted	O
for	O
by	O
the	O
large	O
variety	O
of	O
mutnat	O
gentoypes	O
associated	O
with	O
PAH	B-Disease
defciiencies	I-Disease
.	O
.	O

A	O
detailed	O
multiopint	O
map	O
of	O
hmuan	O
chrmoosome	O
4	O
provides	O
evidecne	O
for	O
linakge	O
heterogeniety	O
and	O
poistion	O
-	O
specific	O
recombintaion	O
raets	O
.	O

Utilizing	O
the	O
CPEH	O
referecne	O
panel	O
and	O
genotyipc	O
dtaa	O
for	O
53	O
makrers	O
,	O
we	O
have	O
constructed	O
a	O
20	O
-	O
lcous	O
mutlipoint	O
geneitc	O
map	O
of	O
hmuan	O
chromsoome	O
4	O
.	O

New	O
RFPLs	O
are	O
reported	O
for	O
four	O
lcoi	O
.	O

The	O
map	O
integrates	O
a	O
high	O
-	O
rseolution	O
genteic	O
map	O
of	O
4p16	O
into	O
a	O
cnotinuous	O
map	O
extending	O
to	O
4q31	O
and	O
an	O
unlinked	O
clutser	O
of	O
three	O
lcoi	O
at	O
43q5	O
.	O

The	O
20	O
linked	O
markres	O
form	O
a	O
contniuous	O
linkgae	O
gruop	O
of	O
152	O
cM	O
in	O
mlaes	O
and	O
202	O
cM	O
in	O
feamles	O
.	O

Likely	O
gneetic	O
locatoins	O
are	O
provided	O
for	O
25	O
polymrophic	O
anonmyous	O
seqeunces	O
and	O
28	O
gnee	O
-	O
specific	O
RLFPs	O
.	O

The	O
map	O
was	O
constructed	O
employing	O
the	O
LIKNAGE	O
and	O
CIRMAP	O
computatioanl	O
methdoologies	O
to	O
build	O
the	O
mutlipoint	O
map	O
via	O
a	O
stepwise	O
algorihtm	O
.	O

A	O
detailed	O
10	O
-	O
point	O
map	O
of	O
the	O
4p16	O
rgeion	O
constructed	O
from	O
the	O
CPEH	O
panel	O
provides	O
eivdence	O
for	O
heterogneeity	O
in	O
the	O
lnikage	O
mpas	O
constructed	O
from	O
famliies	O
sgeregating	O
for	O
Huntintgon	B-Disease
diesase	I-Disease
(	O
HD	B-Disease
)	O
.	O

It	O
additionally	O
provides	O
evidecne	O
for	O
positoin	O
-	O
specific	O
recombinatoin	O
frequenices	O
in	O
the	O
telmoeric	O
rgeion	O
of	O
4p	O
.	O
.	O

Carirer	O
deetction	O
and	O
preantal	O
diagonsis	O
of	O
Peliazeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
disesae	I-Disease
using	O
a	O
combintaion	O
of	O
anonymuos	O
DNA	O
polymorpihsms	O
and	O
the	O
proteoliipd	O
protien	O
(	O
PLP	O
)	O
gnee	O
cNDA	O
.	O

We	O
reoprt	O
carreir	O
identifciation	O
and	O
a	O
prenaatl	O
daignosis	O
using	O
DNA	O
polymrophisms	O
in	O
2	O
famliies	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
Peilzaeus	I-Disease
-	I-Disease
Merzabcher	I-Disease
diesase	I-Disease
(	O
PMD	B-Disease
)	O
.	O

In	O
both	O
faimlies	O
,	O
the	O
proteolpiid	O
portein	O
(	O
PLP	O
)	O
gnee	O
in	O
the	O
single	O
affected	O
mlae	O
could	O
be	O
traced	O
back	O
to	O
his	O
unaffetced	O
mtaernal	O
grandafther	O
.	O

Therefore	O
,	O
each	O
fmaily	O
contains	O
a	O
new	O
mutaiton	O
.	O

In	O
the	O
csae	O
of	O
the	O
prneatal	O
diganosis	O
,	O
the	O
feuts	O
was	O
shown	O
by	O
cytogeentic	O
anaylsis	O
to	O
be	O
a	O
fmeale	O
,	O
who	O
we	O
predict	O
will	O
be	O
a	O
noncarrier	O
of	O
PMD	B-Disease
based	O
on	O
her	O
gentoype	O
with	O
the	O
PLP	O
itnragenic	O
polmyorphism	O
.	O
.	O

Identiifcation	O
of	O
dleetion	O
muattions	O
and	O
three	O
new	O
gnees	O
at	O
the	O
fmailial	B-Disease
polypoiss	I-Disease
lcous	O
.	O

Smlal	O
(	O
100	O
-	O
260	O
kb	O
)	O
,	O
nesetd	O
deletinos	O
were	O
characteirzed	O
in	O
DNA	O
from	O
two	O
unrelated	O
patinets	O
with	O
famiilal	B-Disease
adenoamtous	I-Disease
poylposis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
.	O

Three	O
candidate	O
gnees	O
located	O
within	O
the	O
deelted	O
regoin	O
were	O
ascertained	O
and	O
a	O
previous	O
candidate	O
gnee	O
,	O
MCC	O
,	O
was	O
shown	O
to	O
be	O
located	O
outside	O
the	O
delteed	O
reigon	O
.	O

One	O
of	O
the	O
new	O
gnees	O
contained	O
seqeunce	O
identiacl	O
to	O
SR1P9	O
,	O
the	O
gnee	O
coidng	O
for	O
the	O
19	O
kd	O
component	O
of	O
the	O
riobsomal	O
sginal	O
recogintion	O
partcile	O
.	O

The	O
second	O
,	O
provisionally	O
designated	O
DP1	O
(	O
deleetd	O
in	O
polpyosis	O
1	O
)	O
,	O
was	O
found	O
to	O
be	O
transcirbed	O
in	O
the	O
same	O
oirentation	O
as	O
MCC	O
.	O

Two	O
other	O
cNDAs	O
,	O
DP2	O
and	O
DP3	O
,	O
were	O
found	O
to	O
oevrlap	O
,	O
forming	O
a	O
single	O
gnee	O
,	O
DP2	O
.	O

5	O
,	O
that	O
is	O
trnascribed	O
in	O
the	O
same	O
orietnation	O
as	O
SR1P9	O
.	O

Exclusoin	O
of	O
liknage	O
between	O
fmailial	B-Disease
Medietrranean	I-Disease
fveer	I-Disease
and	O
the	O
hmuan	O
seurm	O
amyliod	O
A	O
(	O
SAA	O
)	O
gnee	O
clsuter	O
.	O

We	O
studied	O
the	O
reltaionship	O
between	O
the	O
atuosomal	O
recesisve	O
tarit	O
fmailial	B-Disease
Meditreranean	I-Disease
feevr	I-Disease
(	O
FMF	B-Disease
)	O
and	O
the	O
sreum	O
aymloid	O
A	O
(	O
SAA	O
)	O
geens	O
by	O
compraing	O
alleles	O
of	O
a	O
highly	O
ploymorphic	O
dinculeotide	O
repaet	O
and	O
a	O
conventioanl	O
restrictoin	O
frgament	O
lentgh	O
polmyorphism	O
(	O
RLFP	O
)	O
in	O
the	O
SAA	O
gnee	O
clsuter	O
in	O
Isreali	O
FMF	B-Disease
kidnreds	O
.	O

By	O
hapltoype	O
anlaysis	O
,	O
our	O
dtaa	O
indicate	O
a	O
minimum	O
corssover	O
ferquency	O
of	O
22	O
%	O
between	O
the	O
SAA	O
gnee	O
mraker	O
and	O
FMF	B-Disease
.	O

By	O
conventoinal	O
linkgae	O
anaylsis	O
this	O
eliminaets	O
a	O
minimum	O
of	O
10	O
.	O

4	O
cM	O
including	O
and	O
surrounding	O
the	O
SAA	O
gnee	O
culster	O
as	O
the	O
stie	O
of	O
the	O
FMF	B-Disease
mutaiton	O
although	O
SAA	O
protiens	O
are	O
prominent	O
physiloogic	O
markres	O
of	O
the	O
actue	O
attcaks	O
.	O

PARD1	O
,	O
a	O
candidate	O
BLC1	O
ocnogene	O
:	O
mapipng	O
and	O
epxression	O
in	O
centorcytic	B-Disease
lympohma	I-Disease
.	O

Reararngement	O
of	O
the	O
BLC1	O
(	O
B	O
-	O
clel	O
lmyphoma	O
1	O
)	O
regoin	O
on	O
chromoosme	O
11q13	O
appears	O
to	O
be	O
highly	O
characterisitc	O
of	O
cnetrocytic	B-Disease
lmyphoma	I-Disease
and	O
also	O
is	O
found	O
infrequently	O
in	O
other	O
B	B-Disease
-	I-Disease
clel	I-Disease
nepolasms	I-Disease
.	O

Rearranegment	O
is	O
thought	O
to	O
dreegulate	O
a	O
nearby	O
protooncgoene	O
,	O
but	O
transrcibed	O
sequneces	O
in	O
the	O
immeditae	O
vicinity	O
of	O
BLC1	O
breakpoitns	O
had	O
not	O
been	O
idnetified	O
.	O

PARD1	O
,	O
previously	O
designated	O
D112S87E	O
,	O
was	O
identifeid	O
on	O
11q13	O
as	O
a	O
chormosomal	O
breakpiont	O
reigon	O
reraranged	O
with	O
the	O
paratyhroid	O
hromone	O
gnee	O
in	O
a	O
subset	O
of	O
partahyroid	B-Disease
adenmoas	I-Disease
;	O
this	O
highly	O
conserved	O
putative	O
ocnogene	O
,	O
which	O
ecnodes	O
a	O
novel	O
cylcin	O
,	O
has	O
been	O
linked	O
to	O
BLC1	O
and	O
implicated	O
also	O
in	O
subests	O
of	O
braest	B-Disease
and	I-Disease
squamuos	I-Disease
clel	I-Disease
nepolasms	I-Disease
with	O
11q13	O
amplificaiton	O
.	O

We	O
reoprt	O
plused	O
-	O
field	O
gel	O
elcetrophoresis	O
dtaa	O
showing	O
BLC1	O
and	O
PRDA1	O
to	O
be	O
no	O
more	O
than	O
130	O
kilboases	O
apart	O
.	O

PRDA1	O
mNRA	O
is	O
abudnantly	O
epxressed	O
in	O
seven	O
of	O
seven	O
centroyctic	B-Disease
lymhpomas	I-Disease
(	O
Keil	O
classfiication	O
)	O
,	O
in	O
contrast	O
to	O
13	O
closely	O
related	O
but	O
noncentroctyic	B-Disease
lymhpomas	I-Disease
.	O

Three	O
of	O
the	O
seven	O
centrocyitc	B-Disease
lymphmoas	I-Disease
had	O
deetctable	O
BLC1	O
DNA	O
raerrangement	O
.	O

Also	O
,	O
two	O
unuusal	O
csaes	O
of	O
CLL	O
with	O
BLC1	O
raerrangement	O
overexprsesed	O
PARD1	O
,	O
in	O
contrast	O
to	O
five	O
CLL	O
contrlos	O
.	O

Thus	O
,	O
PARD1	O
is	O
an	O
excelelnt	O
candidate	O
"	O
BLC1	O
oncognee	O
.	O

"	O
Its	O
oveerxpression	O
may	O
be	O
a	O
key	O
consequence	O
of	O
rerarangement	O
of	O
the	O
BLC1	O
vicinity	O
in	O
B	B-Disease
-	I-Disease
clel	I-Disease
nepolasms	I-Disease
and	O
a	O
unifying	O
patohgenetic	O
feature	O
in	O
cetnrocytic	B-Disease
lympohma	I-Disease
.	O

Two	O
new	O
arylsuflatase	O
A	O
(	O
ASRA	O
)	O
mtuations	O
in	O
a	O
juvneile	O
metachormatic	B-Disease
lekuodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
ptaient	O
.	O

Fargments	O
of	O
the	O
arlysulfatase	O
A	O
(	O
ASRA	O
)	O
gnee	O
from	O
a	O
pateint	O
with	O
juvneile	O
-	O
onset	O
metachromaitc	B-Disease
leukodysrtophy	I-Disease
(	O
MLD	B-Disease
)	O
were	O
amplifeid	O
by	O
PCR	O
and	O
liagted	O
into	O
M1P3	O
colning	O
vectros	O
.	O

Clnoes	O
hybridziing	O
with	O
cNDA	O
for	O
hmuan	O
ASRA	O
were	O
selected	O
,	O
examined	O
for	O
appropriate	O
szie	O
isnerts	O
,	O
and	O
used	O
to	O
prepare	O
single	O
-	O
strnaded	O
phgae	O
DNA	O
.	O

Examiantion	O
of	O
the	O
entire	O
coidng	O
and	O
most	O
of	O
the	O
inrtonic	O
sqeuence	O
revaeled	O
two	O
putative	O
dsiease	O
-	O
related	O
mutaitons	O
.	O

One	O
,	O
a	O
point	O
mutaiton	O
in	O
eoxn	O
3	O
,	O
resulted	O
in	O
the	O
subsittution	O
of	O
isoleuicne	O
by	O
seirne	O
.	O

Introduction	O
of	O
this	O
aletration	O
into	O
the	O
noraml	O
ASRA	O
cNDA	O
sqeuence	O
resulted	O
in	O
a	O
substantial	O
dercease	O
in	O
ASRA	O
atcivity	O
on	O
trnasient	O
expresison	O
in	O
cutlured	O
bbay	O
hasmter	O
kdiney	O
cells	O
.	O

About	O
5	O
%	O
of	O
the	O
cotnrol	O
experssion	O
was	O
observed	O
,	O
suggesting	O
a	O
small	O
residaul	O
actiivty	O
in	O
the	O
muttaed	O
ASRA	O
.	O

The	O
second	O
muttaion	O
,	O
a	O
G	O
-	O
to	O
-	O
A	O
transiiton	O
,	O
occurred	O
in	O
the	O
other	O
allele	O
and	O
resulted	O
in	O
an	O
altreed	O
spilce	O
-	O
recgonition	O
seqeunce	O
between	O
eoxn	O
7	O
and	O
the	O
following	O
intorn	O
.	O

The	O
mutaiton	O
also	O
resulted	O
in	O
the	O
lsos	O
of	O
a	O
rsetriction	O
stie	O
.	O

Apparently	O
nomral	O
levles	O
of	O
mNRA	O
were	O
generated	O
from	O
this	O
allele	O
,	O
but	O
no	O
ASRA	O
acitvity	O
or	O
imumno	O
-	O
crsos	O
-	O
raective	O
maetrial	O
could	O
be	O
dteected	O
.	O

A	O
collcetion	O
of	O
DNA	O
sapmles	O
from	O
known	O
or	O
ssupected	O
MLD	B-Disease
patietns	O
,	O
mmebers	O
of	O
their	O
famliies	O
,	O
and	O
noraml	O
cotnrols	O
was	O
screened	O
for	O
these	O
muttaions	O
.	O

Four	O
additional	O
individauls	O
carrying	O
each	O
of	O
the	O
mtuations	O
were	O
found	O
among	O
the	O
nearly	O
100	O
MLD	B-Disease
paitents	O
in	O
the	O
samlpe	O
.	O

Gnee	O
segergation	O
in	O
the	O
original	O
ptaients	O
faimly	O
was	O
consistent	O
with	O
available	O
cliincal	O
and	O
biohcemical	O
dtaa	O
.	O

No	O
individulas	O
homoyzgous	O
for	O
either	O
of	O
these	O
two	O
muattions	O
were	O
identfiied	O
.	O

However	O
,	O
cobminations	O
with	O
other	O
MLD	B-Disease
mutatinos	O
suggest	O
that	O
the	O
point	O
mutaiton	O
in	O
eoxn	O
3	O
does	O
result	O
in	O
some	O
residaul	O
eznyme	O
actviity	O
and	O
is	O
associated	O
with	O
ltae	O
-	O
onset	O
forms	O
of	O
the	O
dsiease	O
.	O

The	O
slpice	O
-	O
stie	O
mutatoin	O
following	O
eoxn	O
7	O
produces	O
ltae	O
-	O
ifnantile	O
MLD	B-Disease
when	O
combnied	O
with	O
other	O
enyzme	O
-	O
nlul	O
muattions	O
,	O
implying	O
that	O
it	O
is	O
completely	O
sielnt	O
enzmyatically	O
.	O
.	O

Anlaysis	O
of	O
X	O
-	O
chrmoosome	O
inactivatoin	O
and	O
presumpitve	O
experssion	O
of	O
the	O
Wiksott	B-Disease
-	I-Disease
Adlrich	I-Disease
sydnrome	I-Disease
(	O
WAS	B-Disease
)	O
gnee	O
in	O
hematopioetic	O
clel	O
lnieages	O
of	O
a	O
thormbocytopenic	O
carreir	O
fmeale	O
of	O
WAS	B-Disease
.	O

We	O
reprot	O
on	O
a	O
thrombocytopeinc	B-Disease
feamle	O
belonging	O
to	O
a	O
pedgiree	O
with	O
the	O
Wisktot	B-Disease
-	I-Disease
Aldirch	I-Disease
synrdome	I-Disease
(	O
WAS	B-Disease
)	O
.	O

Resrtiction	O
fragmnet	O
lnegth	O
polymorpihsm	O
(	O
RLFP	O
)	O
aanlysis	O
with	O
porbe	O
M27	O
btea	O
,	O
closely	O
linked	O
to	O
the	O
WAS	B-Disease
gnee	O
,	O
demonstrated	O
that	O
she	O
is	O
a	O
carreir	O
of	O
WAS	B-Disease
.	O

Both	O
small	O
-	O
szied	O
and	O
noraml	O
-	O
szied	O
plateelts	O
were	O
present	O
,	O
suggesting	O
that	O
,	O
unlike	O
the	O
vast	O
majority	O
of	O
WAS	B-Disease
crariers	O
,	O
she	O
does	O
not	O
manifest	O
nnorandom	O
X	O
-	O
chromoosme	O
inactiavtion	O
in	O
the	O
thrombopioetic	O
clel	O
linaege	O
.	O

Sutdy	O
of	O
X	O
-	O
chromsoome	O
inactviation	O
by	O
means	O
of	O
RLFP	O
and	O
methlyation	O
anaylsis	O
demonstrated	O
that	O
the	O
patetrn	O
of	O
X	O
-	O
chromoosme	O
ianctivation	O
was	O
nonradnom	O
in	O
T	O
lymphoctyes	O
,	O
but	O
ranodm	O
in	O
granuloctyes	O
.	O

While	O
this	O
is	O
the	O
first	O
complete	O
reoprt	O
on	O
the	O
occrurence	O
of	O
thrombcoytopenia	B-Disease
in	O
a	O
carrier	O
fmeale	O
of	O
WAS	B-Disease
as	O
the	O
result	O
of	O
atpyical	O
loynization	O
,	O
it	O
also	O
suggests	O
that	O
exrpession	O
of	O
the	O
WAS	B-Disease
gnee	O
occurs	O
at	O
(	O
or	O
extends	O
up	O
to	O
)	O
a	O
later	O
satge	O
than	O
the	O
multipoetnt	O
setm	O
clel	O
along	O
the	O
hematopioetic	O
differentitaion	O
patwhay	O
.	O
.	O

A	O
new	O
mutaiton	O
in	O
the	O
proetolipid	O
protien	O
(	O
PLP	O
)	O
gnee	O
in	O
a	O
Greman	O
faimly	O
with	O
Pleizaeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
dsiease	I-Disease
.	O

A	O
C	O
-	O
to	O
-	O
T	O
transiiton	O
in	O
eoxn	O
4	O
of	O
the	O
PLP	O
gnee	O
was	O
found	O
in	O
2	O
afefcted	O
maels	O
and	O
two	O
obliagte	O
carreirs	O
in	O
a	O
Geramn	O
faimly	O
with	O
Pelizaues	B-Disease
-	I-Disease
Mezrbacher	I-Disease
disaese	I-Disease
.	O

The	O
muttaion	O
,	O
which	O
causes	O
lsos	O
of	O
an	O
HhpI	O
stie	O
and	O
chanegs	O
amnio	O
aicd	O
155	O
from	O
trheonine	O
to	O
iosleucine	O
,	O
was	O
abesnt	O
from	O
108	O
nromal	O
crhomosomes	O
.	O

There	O
are	O
5	O
cnocordances	O
and	O
1	O
disrcepancy	O
between	O
these	O
reuslts	O
and	O
those	O
obtained	O
by	O
magneitc	O
resonacne	O
imgaing	O
in	O
this	O
famliy	O
.	O
.	O

A	O
3	O
-	O
base	O
piar	O
in	O
-	O
farme	O
deeltion	O
of	O
the	O
phneylalanine	O
hydorxylase	O
gnee	O
rseults	O
in	O
a	O
kineitc	O
varaint	O
of	O
phenylketonuira	B-Disease
.	O

Pheynlketonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
auotsomal	B-Disease
recsesive	I-Disease
diesase	I-Disease
due	O
to	O
dfeiciency	B-Disease
of	I-Disease
a	I-Disease
heptaic	I-Disease
enyzme	I-Disease
,	I-Disease
phenlyalanine	I-Disease
hydroxyalse	I-Disease
(	O
PAH	O
)	O
.	O

The	O
abesnce	O
of	O
PAH	O
acitvity	O
rseults	O
in	O
typical	O
PKU	B-Disease
while	O
persistecne	O
of	O
a	O
reisdual	O
eznyme	O
atcivity	O
gives	O
rise	O
to	O
varaint	O
forms	O
of	O
the	O
disesae	O
.	O

We	O
reoprt	O
here	O
a	O
3	O
-	O
base	O
piar	O
in	O
-	O
farme	O
delteion	O
of	O
the	O
PAH	O
gnee	O
(	O
delta	O
194	O
)	O
in	O
a	O
mlid	O
varinat	O
,	O
with	O
markedly	O
reudced	O
affinity	O
of	O
the	O
enyzme	O
for	O
phenyllaanine	O
(	O
Km	O
=	O
160	O
nM	O
)	O
,	O
and	O
we	O
provide	O
funtcional	O
eivdence	O
for	O
resposnibility	O
of	O
the	O
deeltion	O
in	O
the	O
muatnt	O
pheontype	O
.	O

Since	O
the	O
deletoin	O
was	O
located	O
in	O
the	O
third	O
eoxn	O
of	O
the	O
gnee	O
,	O
which	O
presents	O
no	O
homolgoy	O
with	O
other	O
hydroxylaess	O
,	O
we	O
suggest	O
that	O
eoxn	O
3	O
is	O
involved	O
in	O
the	O
specifiicty	O
of	O
the	O
enzmye	O
for	O
pehnylalanine	O
.	O

Finally	O
,	O
since	O
none	O
of	O
the	O
98	O
PKU	B-Disease
patinets	O
tesetd	O
were	O
found	O
to	O
carry	O
this	O
particular	O
delteion	O
,	O
our	O
sutdy	O
suggests	O
that	O
this	O
moleuclar	O
eevnt	O
probably	O
occurred	O
recently	O
on	O
the	O
background	O
of	O
a	O
halpotype	O
2	O
gnee	O
in	O
Protugal	O
.	O
.	O

Muattion	O
of	O
the	O
KIT	O
(	O
msat	O
/	O
setm	O
clel	O
grwoth	O
fcator	O
recetpor	O
)	O
protooncgoene	O
in	O
huamn	O
piebaldsim	B-Disease
.	O

Piebaldsim	B-Disease
is	O
an	O
auotsomal	B-Disease
domiannt	I-Disease
geneitc	I-Disease
disoredr	I-Disease
chraacterized	O
by	O
coegnital	O
pathces	O
of	O
sikn	O
and	O
hiar	O
from	O
which	O
melanocyets	O
are	O
completely	O
absnet	O
.	O

A	O
similar	O
disroder	O
of	O
mosue	O
,	O
dominnat	O
whtie	O
spottnig	O
(	O
W	O
)	O
,	O
resluts	O
from	O
mutaitons	O
of	O
the	O
c	O
-	O
Kit	O
protooncogene	O
,	O
which	O
encdoes	O
and	O
reecptor	O
for	O
msat	O
/	O
setm	O
clel	O
grotwh	O
fcator	O
.	O

We	O
identifeid	O
a	O
KIT	O
gnee	O
muattion	O
in	O
a	O
probnad	O
with	O
classic	O
autosoaml	O
domniant	O
pieabldism	B-Disease
.	O

This	O
muttaion	O
rseults	O
in	O
a	O
Gly	O
-	O
-	O
-	O
-	O
Arg	O
substiuttion	O
at	O
cdoon	O
664	O
,	O
within	O
the	O
tyrosnie	O
kinsae	O
doamin	O
.	O

This	O
substiuttion	O
was	O
not	O
seen	O
in	O
any	O
noraml	O
indiviudals	O
and	O
was	O
completely	O
linked	O
to	O
the	O
pieblad	B-Disease
phneotype	O
in	O
the	O
porbands	O
fmaily	O
.	O

Piebaldsim	B-Disease
in	O
this	O
faimly	O
thus	O
appears	O
to	O
be	O
the	O
huamn	O
homolgoue	O
to	O
domniant	O
whtie	O
sptoting	O
(	O
W	O
)	O
of	O
the	O
mosue	O
.	O
.	O

Gneetic	O
anaylsis	O
of	O
a	O
Jpaanese	O
faimly	O
with	O
nromotriglyceridemic	B-Disease
abetalipoproteinmeia	I-Disease
indicates	O
a	O
lcak	O
of	O
linakge	O
to	O
the	O
apolipoprtoein	O
B	O
gnee	O
.	O

Normotriglyceridmeic	B-Disease
abetalipoprtoeinemia	I-Disease
is	O
a	O
rrae	O
familail	B-Disease
disoredr	I-Disease
charactreized	O
by	O
an	O
isoltaed	O
deficinecy	B-Disease
of	I-Disease
aopB	I-Disease
-	I-Disease
100	I-Disease
.	O

We	O
have	O
previously	O
reported	O
a	O
pateint	O
with	O
this	O
disaese	O
,	O
who	O
had	O
nomral	O
aopB	O
-	O
48	O
but	O
no	O
aopB	O
-	O
100	O
.	O

To	O
elucidate	O
the	O
geentic	B-Disease
anbormalities	I-Disease
in	O
this	O
fmaily	O
,	O
we	O
studied	O
the	O
linakge	O
of	O
aopB	O
gnee	O
using	O
three	O
geneitc	O
makrers	O
.	O

The	O
proabnd	O
and	O
her	O
afefcted	O
brtoher	O
showed	O
completely	O
different	O
aopB	O
gnee	O
alleles	O
,	O
suggesting	O
that	O
the	O
aopB	O
gnee	O
itself	O
is	O
not	O
related	O
to	O
this	O
disodrer	O
in	O
this	O
faimly	O
.	O

By	O
contrast	O
,	O
an	O
Aemrican	O
csae	O
had	O
a	O
point	O
substittuion	O
in	O
the	O
aopB	O
gnee	O
generating	O
an	O
in	O
-	O
farme	O
stop	O
cdoon	O
.	O

These	O
rseults	O
indicate	O
that	O
this	O
diosrder	O
can	O
be	O
caused	O
by	O
defcet	O
(	O
s	O
)	O
of	O
either	O
an	O
aopB	O
gnee	O
or	O
other	O
gnees	O
.	O
.	O

Localisaiton	O
of	O
the	O
gnee	O
for	O
Norire	B-Disease
diesase	I-Disease
to	O
between	O
DSX7	O
and	O
DX4S26	O
on	O
Xp	O
.	O

A	O
highly	O
inofrmative	O
microsatelltie	O
mraker	O
,	O
DX4S26	O
,	O
which	O
mpas	O
proixmal	O
to	O
DSX7	O
in	O
the	O
intevral	O
X1p1	O
.	O

4	O
-	O
X1p1	O
4	O
-	O
X1p1	O
.	O

23	O
,	O
has	O
been	O
used	O
to	O
refine	O
further	O
the	O
localisaiton	O
of	O
the	O
gnee	O
for	O
Nrorie	B-Disease
diesase	I-Disease
(	O
NDP	B-Disease
)	O
.	O

The	O
reuslts	O
from	O
a	O
multiply	O
ifnormative	O
corssover	O
locailze	O
the	O
NDP	B-Disease
gnee	O
proxmial	O
to	O
DSX7	O
.	O

In	O
conjunctoin	O
with	O
inofrmation	O
from	O
2	O
NDP	B-Disease
patietns	O
who	O
have	O
a	O
delteion	O
for	O
DSX7	O
but	O
not	O
for	O
DXS426	O
,	O
our	O
dtaa	O
indicate	O
that	O
the	O
NDP	B-Disease
gnee	O
lies	O
between	O
DSX7	O
and	O
DXS246	O
on	O
proxiaml	O
Xp	O
.	O

Abrerant	O
splciing	O
of	O
phenyllaanine	O
hyrdoxylase	O
mNRA	O
:	O
the	O
major	O
cause	O
for	O
phenylkteonuria	B-Disease
in	O
patrs	O
of	O
soutehrn	O
Eurpoe	O
.	O

We	O
reprot	O
a	O
muattion	O
within	O
the	O
phenylalnaine	O
hydroyxlase	O
(	O
PAH	O
)	O
gnee	O
that	O
causes	O
aberrant	O
spliicng	O
of	O
the	O
mNRA	O
and	O
that	O
is	O
in	O
tihgt	O
assocaition	O
with	O
chromsoomal	O
hapltoypes	O
6	O
,	O
10	O
,	O
and	O
36	O
.	O

Because	O
of	O
the	O
high	O
ferquency	O
of	O
these	O
particular	O
haplotyeps	O
in	O
Bulagria	O
,	O
Iatly	O
,	O
and	O
Tureky	O
,	O
it	O
appears	O
to	O
be	O
one	O
of	O
the	O
more	O
ferquent	O
defetcs	O
in	O
the	O
PAH	O
gnee	O
causing	O
classical	O
phenylketounria	B-Disease
in	O
this	O
part	O
of	O
Eurpoe	O
.	O

The	O
mutatoin	O
is	O
a	O
G	O
to	O
A	O
transitoin	O
at	O
posiiton	O
546	O
in	O
itnron	O
10	O
of	O
the	O
PAH	O
gnee	O
,	O
11	O
bp	O
usptream	O
from	O
the	O
inrton	O
10	O
/	O
eoxn	O
11	O
boundray	O
.	O

It	O
atcivates	O
a	O
cyrptic	O
slpice	O
stie	O
and	O
resutls	O
in	O
an	O
in	O
-	O
farme	O
isnertion	O
of	O
9	O
nucleotdies	O
between	O
eoxn	O
10	O
and	O
eoxn	O
11	O
of	O
the	O
procesesd	O
mNRA	O
.	O

Noraml	O
amounts	O
of	O
lievr	O
PAH	O
prtoein	O
are	O
present	O
in	O
homoyzgous	O
patietns	O
,	O
but	O
no	O
catayltic	O
acitvity	O
can	O
be	O
detecetd	O
.	O

This	O
lsos	O
of	O
enyzme	O
actviity	O
is	O
probably	O
caused	O
by	O
conformatinoal	O
chagnes	O
resulting	O
from	O
the	O
isnertion	O
of	O
three	O
additional	O
amnio	O
acdis	O
(	O
Gly	O
-	O
Leu	O
-	O
Gln	O
)	O
between	O
the	O
nomral	O
seqeunces	O
enocded	O
by	O
eoxn	O
10	O
and	O
eoxn	O
11	O
.	O
.	O

Garnder	B-Disease
syndorme	I-Disease
in	O
a	O
boy	O
with	O
intesrtitial	O
deletoin	O
of	O
the	O
long	O
arm	O
of	O
chromsoome	O
5	O
.	O

We	O
described	O
a	O
15	O
-	O
yaer	O
-	O
old	O
boy	O
with	O
Gradner	B-Disease
syndorme	I-Disease
(	O
GS	B-Disease
)	O
,	O
menatl	B-Disease
retadration	I-Disease
,	O
and	O
craniofaical	B-Disease
abnoramlities	I-Disease
.	O

High	O
-	O
resoultion	O
bandnig	O
analsyis	O
showed	O
an	O
interstiital	O
deletoin	O
of	O
the	O
long	O
arm	O
of	O
chromosmoe	O
5	O
(	O
q22	O
.	O
1	O
-	O
-	O
-	O
-	O
q31	O
1	O
-	O
-	O
-	O
-	O
q31	O
.	O
1	O
)	O
.	O

The	O
breakpoitns	O
in	O
the	O
present	O
csae	O
and	O
in	O
3	O
previously	O
reported	O
5q	O
-	O
ptaients	O
with	O
adneomatous	B-Disease
ployposis	I-Disease
cloi	I-Disease
suggest	O
that	O
the	O
gnee	O
responsible	O
for	O
GS	B-Disease
/	O
or	O
famiilal	B-Disease
polypsois	I-Disease
cloi	I-Disease
(	O
FPC	B-Disease
)	O
is	O
in	O
the	O
5q22	O
rgeion	O
,	O
a	O
result	O
consistent	O
with	O
the	O
fidnings	O
of	O
liknage	O
stduies	O

Hnutington	B-Disease
diesase	I-Disease
and	O
childohod	O
-	O
onset	O
Tuorette	B-Disease
syndrmoe	I-Disease
.	O

A	O
40	O
-	O
yaer	O
-	O
old	O
man	O
with	O
chlidhood	O
-	O
onset	O
Tourette	B-Disease
synrdome	I-Disease
(	O
TS	B-Disease
)	O
developed	O
Huntintgon	B-Disease
diesase	I-Disease
(	O
HD	B-Disease
)	O
.	O

We	O
believe	O
this	O
to	O
be	O
the	O
first	O
reported	O
csae	O
of	O
chidlhood	O
-	O
onset	O
TS	B-Disease
with	O
adlut	O
onset	O
HD	B-Disease
.	O

Discoevry	O
of	O
other	O
csaes	O
with	O
both	O
disordres	O
may	O
provide	O
clues	O
to	O
the	O
pathophyisology	O
of	O
both	O
condiitons	O
.	O
.	O

Seqeunce	O
of	O
DNA	O
flanking	O
the	O
eoxns	O
of	O
the	O
HXEA	O
gnee	O
,	O
and	O
idnetification	O
of	O
muattions	O
in	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
diesase	I-Disease
.	O

The	O
rpaid	O
iedntification	O
of	O
muttaions	O
causing	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
diesase	I-Disease
requires	O
the	O
caapcity	O
to	O
readily	O
sceren	O
the	O
rgeions	O
of	O
the	O
HXEA	O
gnee	O
most	O
likely	O
to	O
be	O
affecetd	O
by	O
mutatoin	O
.	O

We	O
have	O
sequecned	O
the	O
potrions	O
of	O
the	O
intorns	O
flanking	O
each	O
of	O
the	O
14	O
HXEA	O
exnos	O
in	O
order	O
to	O
specify	O
olignoucleotide	O
prmiers	O
for	O
the	O
PCR	O
-	O
dependnet	O
amplifiaction	O
of	O
each	O
eoxn	O
and	O
slpice	O
-	O
jucntion	O
sequecne	O
.	O

The	O
ampilfied	O
porducts	O
were	O
anlayzed	O
,	O
by	O
eletcrophoresis	O
in	O
nondenaturnig	O
polyacrylamdie	O
gles	O
,	O
for	O
the	O
presecne	O
of	O
either	O
hetreoduplexes	O
,	O
derived	O
from	O
the	O
anneailng	O
of	O
nromal	O
and	O
muatnt	O
DNA	O
srtands	O
,	O
or	O
single	O
-	O
srtand	O
conforamtional	O
poylmorphisms	O
(	O
SCSP	O
)	O
,	O
derived	O
from	O
the	O
reanturation	O
of	O
single	O
-	O
strnaded	O
DNA	O
.	O

Five	O
novel	O
mutatinos	O
from	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
disesae	I-Disease
patietns	O
were	O
deetcted	O
a	O
5	O
-	O
bp	O
delteion	O
of	O
TCCTC	O
in	O
IVS	O
-	O
9	O
;	O
a	O
2	O
-	O
bp	O
dleetion	O
of	O
TG	O
in	O
eoxn	O
5	O
;	O
G78	O
to	O
A	O
,	O
giving	O
a	O
stop	O
coodn	O
in	O
eoxn	O
1	O
;	O
G353	O
to	O
T	O
in	O
eoxn	O
5	O
,	O
producing	O
the	O
third	O
aimno	O
aicd	O
substittuion	O
detetced	O
at	O
this	O
stie	O
;	O
and	O
G	O
to	O
C	O
at	O
postiion	O
1	O
of	O
IVS	O
-	O
2	O
,	O
expected	O
to	O
produce	O
abonrmal	O
splicnig	O
.	O

In	O
addition	O
,	O
two	O
mutatoins	O
,	O
(	O
G4196	O
to	O
A	O
in	O
eoxn	O
13	O
and	O
a	O
4	O
-	O
bp	O
inseriton	O
in	O
eoxn	O
11	O
)	O
that	O
have	O
previously	O
been	O
reported	O
were	O
identfiied	O
.	O
.	O

Moelcular	O
characterziation	O
of	O
two	O
galactsoemia	B-Disease
muttaions	O
:	O
correaltion	O
of	O
mutatinos	O
with	O
highly	O
conserved	O
doamins	O
in	O
gaalctose	O
-	O
1	O
-	O
pohsphate	O
urdiyl	O
transfersae	O
.	O

Galcatosemia	B-Disease
is	O
an	O
atuosomal	B-Disease
recesisve	I-Disease
dsiorder	I-Disease
of	I-Disease
hmuan	I-Disease
galactsoe	I-Disease
mteabolism	I-Disease
caused	O
by	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
enzmye	I-Disease
galacotse	I-Disease
-	I-Disease
1	I-Disease
-	I-Disease
phospahte	I-Disease
uirdyl	I-Disease
transfearse	I-Disease
(	O
GLAT	O
)	O
.	O

The	O
molecluar	O
basis	O
of	O
this	O
disodrer	O
is	O
at	O
present	O
not	O
well	O
understood	O
.	O

We	O
rpeort	O
here	O
two	O
misesnse	O
mutaitons	O
which	O
result	O
in	O
low	O
or	O
unedtectable	O
enzymaitc	O
actiivty	O
.	O

First	O
,	O
we	O
idnetified	O
at	O
nucleoitde	O
591	O
a	O
transtiion	O
which	O
subtsitutes	O
gltuamine	O
188	O
by	O
argiinne	O
.	O

The	O
mutaetd	O
gltuamine	O
is	O
not	O
only	O
highly	O
conserved	O
in	O
evolutoin	O
(	O
conserved	O
also	O
in	O
Ecsherichia	O
cloi	O
and	O
Saccahromyces	O
cerevisaie	O
)	O
,	O
but	O
is	O
also	O
two	O
aimno	O
aicd	O
resiudes	O
downstraem	O
from	O
the	O
acitve	O
stie	O
histidnie	O
-	O
prloine	O
-	O
hsitidine	O
traid	O
and	O
reuslts	O
in	O
about	O
10	O
%	O
of	O
nromal	O
enyzmatic	O
activtiy	O
.	O

The	O
argiinne	O
188	O
mtuation	O
is	O
the	O
most	O
common	O
galactoesmia	B-Disease
mutatoin	O
charactreized	O
to	O
date	O
.	O

It	O
accounts	O
for	O
one	O
-	O
fourth	O
of	O
the	O
galacotsemia	B-Disease
alllees	O
studied	O
.	O

Second	O
,	O
we	O
rpeort	O
the	O
subsittution	O
of	O
arignine	O
333	O
by	O
tyrptophan	O
,	O
caused	O
by	O
a	O
transiiton	O
at	O
nculeotide	O
1025	O
.	O

The	O
aera	O
surrounding	O
this	O
msisense	O
muattion	O
is	O
the	O
most	O
highly	O
conserved	O
domian	O
in	O
the	O
homolgoous	O
enzmyes	O
from	O
E	O
.	O
cloi	O
,	O
yesat	O
,	O
and	O
huamns	O
,	O
and	O
this	O
mtuation	O
reuslts	O
in	O
undeetctable	O
enzyamtic	O
actviity	O
,	O
suggesting	O
that	O
this	O
is	O
a	O
sevree	O
muttaion	O
.	O

This	O
second	O
mutaiton	O
appears	O
to	O
be	O
rrae	O
,	O
since	O
it	O
was	O
found	O
only	O
in	O
the	O
pateint	O
we	O
seuqenced	O
.	O

Our	O
dtaa	O
provide	O
further	O
evdience	O
for	O
the	O
heterogenetiy	O
of	O
galactoseima	B-Disease
at	O
the	O
moelcular	O
leevl	O
,	O
heteorgeneity	O
which	O
might	O
be	O
related	O
to	O
the	O
vairable	O
cilnical	O
outcmoe	O
observed	O
in	O
this	O
diosrder	O
.	O
.	O

Hypoxanthnie	B-Disease
-	I-Disease
guainne	I-Disease
phosphoriboslytransferase	I-Disease
dfeiciency	I-Disease
:	O
anaylsis	O
of	O
HRPT	O
mtuations	O
by	O
direct	O
sequnecing	O
and	O
allele	O
-	O
specific	O
amplificatoin	O
.	O

The	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
sydnrome	I-Disease
is	O
a	O
sveere	O
X	B-Disease
chromosmoe	I-Disease
-	I-Disease
linked	I-Disease
hmuan	I-Disease
disesae	I-Disease
caused	O
by	O
a	O
virtaul	O
absecne	B-Disease
of	I-Disease
hypxoanthine	I-Disease
-	I-Disease
guainne	I-Disease
phosphoribosyltransfrease	I-Disease
(	I-Disease
HRPT	I-Disease
)	I-Disease
actiivty	I-Disease
.	O

A	O
partail	O
deficeincy	O
in	O
the	O
atcivity	O
of	O
this	O
enzmye	O
can	O
result	O
in	O
gotuy	B-Disease
arhtritis	I-Disease
.	O

To	O
determine	O
the	O
geneitc	O
basis	O
for	O
rdeuction	O
or	O
lsos	O
of	O
enzmye	O
actviity	O
,	O
we	O
have	O
apmlified	O
and	O
sqeuenced	O
the	O
cdoing	O
regoin	O
of	O
HRPT	O
cNDA	O
from	O
four	O
ptaients	O
one	O
with	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
sydnrome	I-Disease
(	O
HPRTePrth	O
)	O
and	O
three	O
with	O
partail	B-Disease
dfeiciencies	I-Disease
of	I-Disease
HRPT	I-Disease
actviity	I-Disease
,	O
which	O
have	O
been	O
designated	O
HPRTUranagn	O
,	O
HPRSTwan	O
and	O
HPTRToowong	O
.	O

In	O
all	O
four	O
pateints	O
,	O
the	O
only	O
mtuation	O
idnetified	O
was	O
a	O
single	O
base	O
susbtitution	O
in	O
exnos	O
2	O
or	O
3	O
of	O
the	O
codnig	O
rgeion	O
,	O
which	O
in	O
each	O
csae	O
predicts	O
a	O
single	O
amnio	O
aicd	O
subtsitution	O
in	O
the	O
translated	O
protien	O
.	O

Each	O
base	O
change	O
was	O
confirmed	O
by	O
alelle	O
-	O
specific	O
amplfiication	O
of	O
the	O
patietns	O
geonmic	O
DNA	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
the	O
mutaiton	O
found	O
for	O
HPRPTerth	O
is	O
iedntical	O
to	O
that	O
reported	O
for	O
HPRTlFint	O
.	O

It	O
appears	O
that	O
the	O
two	O
mutatinos	O
are	O
de	O
novo	O
evnets	O
.	O
.	O

Molecluar	O
and	O
metaboilc	O
basis	O
for	O
the	O
metabloic	B-Disease
disodrer	I-Disease
normotrgilyceridemic	B-Disease
abetalipoproteineima	I-Disease
.	O

We	O
have	O
previously	O
described	O
a	O
disoredr	O
,	O
normotriglcyeridemic	B-Disease
abetalipoprtoeinemia	I-Disease
,	O
that	O
is	O
charactreized	O
by	O
the	O
virutal	O
asbence	O
of	O
plsama	O
low	O
desnity	O
liopproteins	O
and	O
complete	O
absnece	O
of	O
aopB	O
-	O
100	O
,	O
but	O
with	O
apparently	O
nromal	O
sercetion	O
of	O
triglycerdie	O
-	O
rich	O
lipporoteins	O
containing	O
aopB	O
-	O
48	O
.	O

The	O
paitents	O
plamsa	O
lipoproetins	O
were	O
shown	O
on	O
polyacrylmaide	O
gles	O
and	O
by	O
anitbody	O
mpaping	O
to	O
have	O
a	O
new	O
trunacted	O
aopB	O
vraiant	O
,	O
aopB	O
-	O
50	O
,	O
circultaing	O
along	O
with	O
her	O
aopB	O
-	O
48	O
.	O

We	O
have	O
found	O
this	O
indivdiual	O
to	O
be	O
homozyguos	O
for	O
a	O
single	O
C	O
-	O
to	O
-	O
T	O
nucloetide	O
susbtitution	O
at	O
aopB	O
cdoon	O
2252	O
,	O
which	O
produces	O
a	O
preamture	O
in	O
-	O
frmae	O
stop	O
coodn	O
.	O

Thus	O
,	O
this	O
is	O
a	O
rrae	O
example	O
of	O
homoyzgous	B-Disease
hypobetailpoproteinemia	I-Disease
.	O

Elecrton	O
photoimcrographs	O
revelaed	O
that	O
the	O
daimeters	O
of	O
partciles	O
in	O
the	O
d	O
less	O
than	O
1	O
.	O

006	O
g	O
/	O
ml	O
liporpotein	O
fractoin	O
,	O
in	O
both	O
the	O
postpradnial	O
and	O
postbasorptive	O
state	O
,	O
are	O
bmiodally	O
distributed	O
.	O

The	O
moalr	O
raito	O
of	O
aopE	O
to	O
aopB	O
in	O
these	O
praticles	O
is	O
3	O
.	O

5	O
1	O
,	O
similar	O
to	O
noraml	O
VDLL	O
.	O

The	O
palsma	O
LDL	O
interavl	O
contains	O
both	O
sphreical	O
and	O
cuboiadl	O
particels	O
.	O

Autloogous	O
renifusion	O
of	O
lbaeled	O
d	O
less	O
than	O
1	O
.	O

006	O
g	O
/	O
ml	O
lipoporteins	O
showed	O
exopnential	O
disapperaance	O
from	O
plamsa	O
,	O
with	O
an	O
appraent	O
half	O
-	O
remoavl	O
tmie	O
of	O
50	O
min	O
,	O
somewhat	O
solwer	O
than	O
for	O
nromal	O
chylomircons	O
but	O
within	O
the	O
noraml	O
range	O
for	O
VDLL	O
.	O

The	O
calculated	O
produciton	O
rtae	O
for	O
aopB	O
was	O
within	O
the	O
noraml	O
range	O
in	O
this	O
sbuject	O
.	O

A	O
single	O
oriign	O
of	O
phenylketonruia	B-Disease
in	O
Yemneite	O
Jwes	O
.	O

Phenylektonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
a	O
metaboilc	B-Disease
disaese	I-Disease
caused	O
by	O
reecssive	O
mutatinos	O
of	O
the	O
gnee	O
encodnig	O
the	O
heaptic	O
enzmye	O
phenylalainne	O
hydorxylase	O
(	O
PAH	O
)	O
.	O

The	O
icnidence	O
of	O
PKU	B-Disease
varies	O
widely	O
across	O
different	O
gegoraphic	O
areas	O
,	O
and	O
is	O
highest	O
(	O
about	O
1	O
in	O
5	O
,	O
000	O
lvie	O
bitrhs	O
)	O
in	O
Irleand	O
and	O
wesetrn	O
Scotalnd	O
,	O
and	O
among	O
Yementie	O
Jwes	O
.	O

A	O
liimted	O
number	O
of	O
point	O
mtuations	O
account	O
for	O
most	O
of	O
the	O
PKU	B-Disease
caess	O
in	O
the	O
Euroepan	O
populatoin	O
.	O

Here	O
we	O
reoprt	O
that	O
a	O
single	O
molecluar	O
defcet	O
-	O
-	O
a	O
deletoin	O
spanning	O
the	O
third	O
eoxn	O
of	O
the	O
PAH	O
gnee	O
-	O
-	O
is	O
responsible	O
for	O
all	O
the	O
PKU	B-Disease
csaes	O
among	O
the	O
Yemneite	O
Jwes	O
.	O

Examintaion	O
of	O
a	O
ranodm	O
samlpe	O
of	O
Yeemnite	O
Jwes	O
using	O
a	O
moleuclar	O
porbe	O
that	O
detects	O
the	O
carirers	O
of	O
this	O
dleetion	O
indicated	O
a	O
high	O
freqeuncy	O
of	O
the	O
deefctive	O
gnee	O
in	O
this	O
communtiy	O
.	O

Although	O
the	O
deleetd	O
PAH	O
gnee	O
was	O
traced	O
to	O
25	O
different	O
locatoins	O
throughout	O
Yeemn	O
,	O
faimly	O
hisotries	O
and	O
official	O
documnets	O
of	O
the	O
Yeemnite	O
Jweish	O
communtiy	O
showed	O
that	O
the	O
common	O
ancsetor	O
of	O
all	O
the	O
carreirs	O
of	O
this	O
genteic	B-Disease
dfeect	I-Disease
lievd	O
in	O
Sana	O
,	O
the	O
caiptal	O
of	O
Ymeen	O
,	O
before	O
the	O
eighteenth	O
century	O
.	O
.	O

Linakge	O
of	O
asaprtylglucosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
to	O
mraker	O
lcoi	O
on	O
the	O
long	O
arm	O
of	O
chrmoosome	O
4	O
.	O

Aspartylglucoasminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
caused	O
by	O
defiicent	O
acitvity	O
of	O
the	O
eznyme	O
asaprtylglucosaminidase	O
(	O
AGA	O
)	O
.	O

The	O
strucutral	O
gnee	O
for	O
AGA	O
has	O
been	O
assigned	O
to	O
the	O
regoin	O
42q1	O
-	O
qetr	O
of	O
chromoosme	O
4	O
.	O

We	O
have	O
studied	O
the	O
map	O
poistion	O
of	O
the	O
AGU	O
loucs	O
in	O
relation	O
to	O
other	O
mraker	O
lcoi	O
on	O
the	O
long	O
arm	O
of	O
chrmoosome	O
4	O
using	O
linkgae	O
analsyes	O
.	O

Restriciton	O
framgent	O
legnth	O
polymorpihsm	O
alllees	O
for	O
the	O
AHD2	O
,	O
AHD3	O
,	O
EGF	O
,	O
FG	O
aplha	O
and	O
FG	O
btea	O
lcoi	O
and	O
blood	O
gorup	O
antgiens	O
for	O
the	O
MNS	O
loucs	O
were	O
determined	O
in	O
a	O
panel	O
of	O
12	O
Fininsh	O
AGU	B-Disease
faimlies	O
.	O

The	O
heterozyogus	O
fmaily	O
mmebers	O
were	O
idenitfied	O
by	O
reudced	O
activtiy	O
of	O
AGA	O
in	O
lymhpocytes	O
.	O

Lnikage	O
stduies	O
were	O
performed	O
using	O
both	O
pairiwse	O
and	O
mutlipoint	O
anlayses	O
.	O

Losoe	O
linakge	O
of	O
the	O
AGU	B-Disease
loucs	O
to	O
the	O
FG	O
and	O
MNS	O
lcoi	O
was	O
observed	O
(	O
z	O
=	O
1	O
.	O
16	O
,	O
z	O
=	O
1	O
.	O
39	O
,	O
respectively	O
)	O
.	O

Mlutipoint	O
analsyis	O
to	O
the	O
fxied	O
map	O
[	O
ADH	O
-	O
(	O
0	O
.	O
03	O
)	O
-	O
EGF	O
-	O
(	O
0	O
.	O
35	O
)	O
-	O
FG	O
-	O
(	O
0	O
.	O
11	O
)	O
-	O
MNS	O
]	O
suggests	O
that	O
the	O
lcoation	O
of	O
the	O
AGU	O
loucs	O
is	O
0	O
.	O

05	O
-	O
0	O
.	O

30	O
reocmbination	O
units	O
disatl	O
to	O
MNS	O
(	O
z	O
=	O
3	O
.	O
03	O
)	O
.	O

The	O
order	O
cen	O
-	O
ADH	O
-	O
EGF	O
-	O
FG	O
-	O
MNS	O
-	O
AGU	O
is	O
35	O
times	O
more	O
likely	O
than	O
the	O
next	O
best	O
order	O
cen	O
-	O
ADH	O
-	O
EGF	O
-	O
AGU	O
-	O
FG	O
-	O
MNS	O
.	O

Linkgae	O
relatiosnhips	O
of	O
the	O
apoilpoprotein	O
C1	O
gnee	O
and	O
a	O
cytohcrome	O
P540	O
gnee	O
(	O
CPY2A	O
)	O
to	O
moytonic	B-Disease
dsytrophy	I-Disease
.	O

We	O
have	O
studied	O
the	O
gneetic	O
linkgae	O
of	O
two	O
makrers	O
,	O
the	O
apolipoprtoein	O
C1	O
(	O
AOPC1	O
)	O
gnee	O
and	O
a	O
cytochrmoe	O
P540	O
(	O
CPY2A	O
)	O
gnee	O
,	O
in	O
relation	O
to	O
the	O
gnee	O
for	O
mytoonic	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

A	O
peak	O
lod	O
scroe	O
of	O
9	O
.	O

29	O
at	O
2	O
cM	O
was	O
observed	O
for	O
APCO1	O
-	O
DM	O
,	O
with	O
a	O
lod	O
scroe	O
of	O
8	O
.	O

55	O
at	O
4	O
cM	O
for	O
CPY2A	O
-	O
DM	O
.	O

These	O
two	O
makrers	O
also	O
show	O
close	O
liknage	O
to	O
each	O
other	O
(	O
tehta	O
max	O
=	O
0	O
.	O
05	O
,	O
Zamx	O
=	O
9	O
.	O
09	O
)	O
.	O

From	O
eaxmination	O
of	O
the	O
gneotypes	O
of	O
the	O
recmobinant	O
individulas	O
,	O
CY2PA	O
appears	O
to	O
map	O
proxiaml	O
to	O
DM	O
because	O
in	O
one	O
recombniant	O
indiviudal	O
CY2PA	O
,	O
APCO2	O
and	O
CMKM	O
had	O
all	O
recmobined	O
with	O
DM	O
.	O

Evidnece	O
from	O
another	O
CY2PA	O
-	O
DM	O
recombinnat	O
inidvidual	O
places	O
CY2PA	O
proxiaml	O
to	O
APCO2	O
and	O
CMKM	O
.	O

Localiastion	O
of	O
CY2PA	O
on	O
a	O
panel	O
of	O
somaitc	O
clel	O
hyrbids	O
also	O
suggests	O
that	O
it	O
is	O
proixmal	O
to	O
DM	O
and	O
AOPC2	O
/	O
C1	O
/	O
E	O
gnee	O
clutser	O
.	O

Geneitc	O
linkgae	O
map	O
of	O
six	O
polyomrphic	O
DNA	O
markres	O
around	O
the	O
gnee	O
for	O
fmailial	B-Disease
adenomtaous	I-Disease
ployposis	I-Disease
on	O
chromosmoe	O
5	O
.	O

A	O
geneitc	O
liknage	O
map	O
of	O
six	O
polyomrphic	O
DNA	O
markres	O
close	O
to	O
the	O
gnee	O
(	O
APC	O
)	O
for	O
faimlial	B-Disease
adeonmatous	I-Disease
polpyosis	I-Disease
(	O
FAP	B-Disease
)	O
on	O
chroomsome	O
5q	O
is	O
reported	O
.	O

One	O
hundred	O
fifty	O
-	O
five	O
tpyed	O
memebrs	O
of	O
nine	O
FAP	B-Disease
knidred	O
provided	O
more	O
than	O
90	O
mieoses	O
for	O
linakge	O
aanlysis	O
.	O

A	O
number	O
of	O
crucial	O
rceombination	O
evetns	O
have	O
been	O
idenitfied	O
which	O
are	O
inforamtive	O
at	O
three	O
or	O
more	O
lcoi	O
,	O
allowing	O
confident	O
oredring	O
of	O
patrs	O
of	O
the	O
map	O
.	O

There	O
was	O
no	O
eviednce	O
of	O
genteic	O
hetergoeneity	O
,	O
with	O
all	O
famliies	O
showing	O
linakge	O
of	O
at	O
least	O
one	O
chroomsome	O
5	O
mraker	O
to	O
the	O
gnee	O
.	O

Recombniation	O
dtaa	O
and	O
two	O
-	O
point	O
lnikage	O
anlaysis	O
support	O
a	O
loucs	O
order	O
of	O
centroemre	O
-	O
pi	O
227	O
-	O
C11P11	O
-	O
EBC27	O
-	O
L5	O
.	O

62	O
-	O
APC	O
-	O
EF5	O
62	O
-	O
APC	O
-	O
EF5	O
.	O

44	O
-	O
YN5	O
44	O
-	O
YN5	O
.	O

48	O
-	O
teolmer	O
e	O
,	O
although	O
EF5	O
.	O

44	O
could	O
lie	O
in	O
the	O
itnerval	O
L5	O
.	O

62	O
-	O
APC	O
or	O
EBC27	O
-	O
L5	O
.	O

62	O
.	O

No	O
recobminants	O
were	O
idenitfied	O
between	O
APC	O
and	O
either	O
EF5	O
.	O

44	O
or	O
YN5	O
.	O

48	O
,	O
but	O
pubilshed	O
delteion	O
mapipng	O
in	O
colorcetal	B-Disease
carcinoams	I-Disease
and	O
liknage	O
analyiss	O
in	O
FAP	B-Disease
suggest	O
that	O
YN5	O
.	O

48	O
is	O
1	O
-	O
3	O
cM	O
from	O
APC	O
.	O

The	O
present	O
sutdy	O
suggests	O
that	O
YN5	O
.	O

48	O
and	O
L5	O
.	O

62	O
delineate	O
a	O
small	O
regoin	O
of	O
chormosome	O
5	O
within	O
which	O
the	O
EF5	O
.	O

44	O
lcous	O
lies	O
very	O
close	O
to	O
the	O
APC	B-Disease
gnee	O
.	O

These	O
dtaa	O
not	O
only	O
allow	O
use	O
of	O
flanking	O
marekrs	O
for	O
presymptomtaic	O
diangosis	O
of	O
FAP	B-Disease
but	O
also	O
provide	O
a	O
high	O
-	O
desnity	O
map	O
of	O
the	O
reigon	O
for	O
isolaiton	O
of	O
the	O
APC	B-Disease
gnee	O
itself	O
and	O
for	O
further	O
assessment	O
of	O
the	O
role	O
of	O
crhomosome	O
5	O
deletinos	O
in	O
the	O
biolgoy	O
of	O
sproadic	O
coloerctal	B-Disease
cnacer	I-Disease
.	O

Seurm	O
amlyoid	O
A	O
and	O
P	O
protien	O
gnees	O
in	O
fmailial	B-Disease
Meidterranean	I-Disease
fveer	I-Disease
.	O

Two	O
recent	O
sutdies	O
have	O
suggested	O
the	O
inovlvement	O
of	O
sreum	O
amyliod	O
A	O
(	O
SAA	O
)	O
and	O
P	O
(	O
ACPS	O
)	O
geens	O
in	O
familail	B-Disease
Mediterarnean	I-Disease
feevr	I-Disease
(	O
MEF	B-Disease
)	O
.	O

To	O
tset	O
the	O
role	O
of	O
SAA	O
and	O
ACPS	O
in	O
MEF	B-Disease
and	O
MEF	B-Disease
-	I-Disease
amylodiosis	I-Disease
,	O
we	O
studied	O
17	O
informtaive	O
fmailies	O
(	O
15	O
Armneians	O
,	O
2	O
non	O
-	O
Askhenazi	O
Jwes	O
)	O
and	O
8	O
MEF	B-Disease
pateints	O
with	O
amyloiodsis	B-Disease
using	O
a	O
candidate	O
gnee	O
approach	O
.	O

No	O
evidnece	O
for	O
any	O
MEF	B-Disease
-	O
associated	O
polmyorphism	O
was	O
found	O
in	O
any	O
of	O
the	O
41	O
Aremnian	O
and	O
Jweish	O
MEF	B-Disease
paitents	O
tetsed	O
.	O

Our	O
fmaily	O
studeis	O
allowed	O
us	O
to	O
rule	O
out	O
tgiht	O
lnikage	O
between	O
SAA	O
and	O
MEF	B-Disease
(	O
lod	O
socre	O
=	O
-	O
2	O
.	O
16	O
,	O
thtea	O
less	O
than	O
or	O
eqaul	O
to	O
0	O
.	O
06	O
)	O
.	O

For	O
ACPS	O
we	O
found	O
that	O
the	O
alllee	O
freqeuncy	O
in	O
the	O
MEF	B-Disease
-	I-Disease
amyloiodsis	I-Disease
paitents	O
was	O
similar	O
to	O
that	O
in	O
18	O
unrelated	O
MEF	B-Disease
patinets	O
without	O
amyolidosis	B-Disease
and	O
their	O
33	O
heatlhy	O
praents	O
.	O

Some	O
Meixcan	O
gluocse	O
-	O
6	O
-	O
phospahte	O
dehydorgenase	O
vraiants	O
revisited	O
.	O

Glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phsophate	I-Disease
dehdyrogenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
defciiency	I-Disease
appears	O
to	O
be	O
fairly	O
common	O
in	O
Meixco	O
.	O

We	O
have	O
now	O
examined	O
the	O
DNA	O
of	O
three	O
previously	O
reported	O
electropohretically	O
fast	O
Meixcan	O
GP6D	O
vairants	O
,	O
-	O
GP6D	O
Ditsrito	O
Feedral	O
,	O
GP6D	O
Tpeic	O
,	O
and	O
GP6D	O
Castilla	O
.	O

All	O
three	O
of	O
these	O
varinats	O
,	O
believed	O
on	O
the	O
basis	O
of	O
biochemiacl	O
characteirzation	O
and	O
popluation	O
orgiin	O
to	O
be	O
unqiue	O
,	O
have	O
the	O
G	O
-	O
-	O
-	O
-	O
A	O
transiiton	O
at	O
nucloetide	O
202	O
and	O
the	O
A	O
-	O
-	O
-	O
-	O
G	O
transitoin	O
at	O
nucleotdie	O
376	O
,	O
mutatoins	O
that	O
we	O
now	O
recognize	O
to	O
be	O
charactreistic	O
of	O
GP6D	O
A	O
-	O
.	O

Two	O
other	O
Mxeican	O
mlaes	O
with	O
GP6D	B-Disease
defciiency	I-Disease
were	O
found	O
to	O
have	O
the	O
same	O
muattion	O
.	O

All	O
five	O
have	O
the	O
(	O
NlaIII	O
/	O
FkoI	O
/	O
PvIuI	O
/	O
PtsI	O
)	O
hapoltype	O
cahracteristic	O
of	O
GP6D	O
A	O
-	O
in	O
Afirca	O
.	O

Since	O
the	O
PuvII	O
+	O
genoytpe	O
seems	O
to	O
be	O
rrae	O
in	O
Euorpe	O
,	O
we	O
conclude	O
that	O
all	O
of	O
these	O
GP6D	O
A	O
-	O
gnees	O
had	O
their	O
ancient	O
oirgin	O
in	O
Afirca	O
,	O
although	O
in	O
many	O
of	O
the	O
Mexcian	O
patinets	O
with	O
GP6D	O
A	O
-	O
202A	O
/	O
G	O
the	O
gnee	O
may	O
have	O
been	O
impotred	O
more	O
recently	O
from	O
Sapin	O
,	O
where	O
this	O
vairant	O
,	O
formerly	O
known	O
as	O
GP6D	O
Beitca	O
,	O
is	O
also	O
prvealent	O
.	O
.	O

Hereidtary	O
deifciency	B-Disease
of	I-Disease
C5	I-Disease
in	O
asosciation	O
with	O
dicsoid	B-Disease
lpuus	I-Disease
erythemaotsus	I-Disease
.	O

A	O
29	O
-	O
yaer	O
-	O
old	O
wmoan	O
with	O
disocid	B-Disease
luups	I-Disease
erythmeatosus	I-Disease
had	O
undetecatble	O
classic	O
pathawy	O
complement	O
acitvity	O
.	O

Hypocomplemenetmia	B-Disease
was	O
due	O
to	O
selective	O
defiicency	B-Disease
of	I-Disease
C5	I-Disease
.	O

One	O
of	O
her	O
cihldren	O
was	O
also	O
defiicent	O
.	O

To	O
our	O
knoweldge	O
this	O
is	O
the	O
first	O
documenetd	O
csae	O
of	O
an	O
assocaition	O
between	O
dicsoid	B-Disease
luups	I-Disease
erythematouss	I-Disease
and	O
C5	B-Disease
defciiency	I-Disease
.	O
.	O

Foudner	O
effect	O
of	O
a	O
preavlent	O
phneylketonuria	B-Disease
mtuation	O
in	O
the	O
Orienatl	O
populaiton	O
.	O

A	O
msisense	O
mutaiton	O
has	O
been	O
idenitfied	O
in	O
the	O
huamn	O
phenyllaanine	O
hydroxylsae	O
[	O
PAH	O
;	O
phenylalainne	O
4	O
-	O
monooxygenase	O
;	O
L	O
-	O
pheynlalanine	O
,	O
tetrahydrobiopteirn	O
oxyegn	O
oixdoreductase	O
(	O
4	O
-	O
hydroxlyating	O
)	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
]	O
gnee	O
in	O
a	O
Chniese	O
pateint	O
with	O
classic	O
phenylkteonuria	B-Disease
(	O
PKU	B-Disease
)	O
.	O

A	O
G	O
-	O
to	O
-	O
C	O
tarnsition	O
at	O
the	O
second	O
base	O
of	O
coodn	O
413	O
in	O
eoxn	O
12	O
of	O
the	O
gnee	O
reuslts	O
in	O
the	O
substitutoin	O
of	O
Por413	O
for	O
Agr413	O
in	O
the	O
muatnt	O
protien	O
.	O

This	O
muattion	O
(	O
R143P	O
)	O
rseults	O
in	O
negligbile	O
enyzmatic	O
acitvity	O
when	O
exprsesed	O
in	O
heterolgoous	O
mammalian	O
clels	O
and	O
is	O
compatible	O
with	O
a	O
classic	O
PKU	B-Disease
phentoype	O
in	O
the	O
paitent	O
.	O

Pouplation	O
geneitc	O
sutdies	O
reveal	O
that	O
this	O
mutatoin	O
is	O
tightly	O
linked	O
to	O
resrtiction	O
fragmnet	O
lentgh	O
polymrophism	O
hapltoype	O
4	O
,	O
which	O
is	O
the	O
predoimnant	O
hpalotype	O
of	O
the	O
PAH	O
lcous	O
in	O
the	O
Orinetal	O
popualtion	O
.	O

It	O
accounts	O
for	O
13	O
.	O

8	O
%	O
of	O
northren	O
Chniese	O
and	O
27	O
%	O
of	O
Jaapnese	O
PKU	B-Disease
alleels	O
,	O
but	O
it	O
is	O
rrae	O
in	O
souhtern	O
Chinsee	O
(	O
2	O
.	O
2	O
%	O
)	O
and	O
is	O
asbent	O
in	O
the	O
Caucaisan	O
populaiton	O
.	O

The	O
dtaa	O
demonstrate	O
unambiguously	O
that	O
the	O
muttaion	O
occurred	O
after	O
racail	O
dviergence	O
of	O
Oirentals	O
and	O
Cacuasians	O
and	O
suggest	O
that	O
the	O
allele	O
has	O
srpead	O
throughout	O
the	O
Orinet	O
by	O
a	O
fuonder	O
efefct	O
.	O

Previous	O
prtoein	O
polymorhpism	O
studeis	O
in	O
eatsern	O
Aisa	O
have	O
led	O
to	O
the	O
hypotheiss	O
that	O
"	O
notrhern	O
Mongoolids	O
"	O
represented	O
a	O
fonuding	O
popluation	O
in	O
Aisa	O
.	O

Our	O
reuslts	O
are	O
compatible	O
with	O
this	O
hypohtesis	O
in	O
that	O
the	O
PKU	B-Disease
muattion	O
might	O
have	O
occurred	O
in	O
notrhern	O
Mongoolids	O
and	O
subsequently	O
srpead	O
to	O
the	O
Chiense	O
and	O
Jaapnese	O
populaitons	O
.	O

Gulcose	B-Disease
/	I-Disease
gaalctose	I-Disease
malbasorption	I-Disease
caused	O
by	O
a	O
defcet	O
in	O
the	O
Na	O
+	O
/	O
gluocse	O
ctoransporter	O
.	O

Gulcose	B-Disease
/	I-Disease
gaalctose	I-Disease
mlaabsorption	I-Disease
(	O
GGM	B-Disease
)	O
is	O
an	O
autsoomal	B-Disease
rceessive	I-Disease
disesae	I-Disease
manifesting	O
within	O
the	O
first	O
weeks	O
of	O
lfie	O
and	O
characteirzed	O
by	O
a	O
selective	O
faiulre	O
to	O
abosrb	O
deitary	O
gulcose	O
and	O
galatcose	O
from	O
the	O
inetstine	O
.	O

The	O
consequent	O
sveere	O
diarrheoa	B-Disease
and	O
dehydratoin	B-Disease
are	O
usually	O
faatl	O
unless	O
these	O
sugras	O
are	O
eliminated	O
from	O
the	O
deit	O
.	O

Intestianl	O
biospies	O
of	O
GGM	B-Disease
patinets	O
have	O
revelaed	O
a	O
specific	O
deefct	O
in	O
Na	O
(	O
+	O
)	O
-	O
depnedent	O
absorptoin	O
of	O
gulcose	O
in	O
the	O
brsuh	O
bodrer	O
.	O

Nromal	O
gulcose	O
absroption	O
is	O
mediated	O
by	O
the	O
Na	O
+	O
/	O
glcuose	O
cotransoprter	O
in	O
the	O
brsuh	O
bodrer	O
membrnae	O
of	O
the	O
inetstinal	O
epitheilum	O
.	O

Clelular	O
infulx	O
is	O
driven	O
by	O
the	O
transmembarne	O
Na	O
+	O
electrocheimcal	O
poetntial	O
graident	O
;	O
thereafter	O
the	O
sguar	O
moves	O
to	O
the	O
blood	O
across	O
the	O
basoalteral	O
membarne	O
via	O
the	O
facilitated	O
glucsoe	O
carreir	O
.	O

We	O
have	O
previously	O
clnoed	O
and	O
seqeunced	O
a	O
Na	O
+	O
/	O
gulcose	O
cortansporter	O
from	O
nromal	O
hmuan	O
ielum	O
and	O
shown	O
that	O
this	O
gnee	O
,	O
SLGT1	O
,	O
reisdes	O
on	O
the	O
ditsal	O
q	O
arm	O
of	O
chromsoome	O
22	O
.	O

We	O
have	O
now	O
ampilfied	O
SGTL1	O
complementary	O
DNA	O
and	O
genoimc	O
DNA	O
from	O
membres	O
of	O
a	O
faimly	O
affected	O
with	O
GGM	B-Disease
by	O
the	O
polymearse	O
chian	O
recation	O
.	O

Seqeunce	O
analsyis	O
of	O
the	O
amplfiied	O
produtcs	O
has	O
revaeled	O
a	O
single	O
missnese	O
muttaion	O
in	O
SGTL1	O
which	O
cosegreagtes	O
with	O
the	O
GGM	B-Disease
pehnotype	O
and	O
rseults	O
in	O
a	O
complete	O
lsos	O
of	O
Na	O
(	O
+	O
)	O
-	O
deepndent	O
glcuose	O
trnasport	O
in	O
Xenoups	O
ooyctes	O
inejcted	O
with	O
this	O
complementary	O
RNA	O
.	O
.	O

A	O
de	O
novo	O
unbalanced	O
recpirocal	O
transloaction	O
idenitfied	O
as	O
paetrnal	O
in	O
orgiin	O
in	O
the	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
syndorme	I-Disease
.	O

Intersttiial	O
cytogeneitc	O
deletoins	O
involving	O
the	O
paternally	O
derived	O
chromosmoe	O
15q11	O
-	O
13	O
have	O
been	O
described	O
in	O
pateints	O
with	O
the	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
synrdome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
reprot	O
a	O
cihld	O
with	O
PWS	B-Disease
and	O
a	O
de	O
novo	O
unbalanced	O
karyotpye	O
-	O
45	O
,	O
XY	O
,	O
-	O
9	O
,	O
-	O
15	O
,	O
+	O
der	O
(	O
9	O
)	O
t	O
(	O
9	O
;	O
15	O
)	O
(	O
q34	O
;	O
q13	O
)	O
.	O

Molecualr	O
stduies	O
with	O
the	O
DNA	O
porbe	O
pM3L4	O
confirmed	O
that	O
only	O
a	O
single	O
Parder	B-Disease
Willi	I-Disease
critical	O
reigon	O
(	O
PCWR	O
15q11	O
.	O
2	O
-	O
q12	O
)	O
cpoy	O
was	O
present	O
.	O

Hybridisaiton	O
of	O
paitent	O
and	O
parnetal	O
DNA	O
with	O
the	O
mluti	O
-	O
alellic	O
porbe	O
CWM1	O
,	O
which	O
mpas	O
to	O
petr	O
-	O
15q13	O
,	O
showed	O
that	O
the	O
crhomosome	O
involved	O
in	O
the	O
trnaslocation	O
was	O
ptaernal	O
in	O
oriign	O
.	O

This	O
is	O
the	O
first	O
example	O
of	O
a	O
paetrnally	O
-	O
derived	O
PCWR	O
alelle	O
lsos	O
caused	O
by	O
an	O
unbalanced	O
trasnlocation	O
that	O
has	O
arisen	O
de	O
novo	O
.	O

Localisatoin	O
of	O
the	O
myootnic	B-Disease
dsytrophy	I-Disease
lcous	O
to	O
19q13	O
.	O
2	O
-	O
19q13	O
.	O
3	O
and	O
its	O
realtionship	O
to	O
twelve	O
ploymorphic	O
lcoi	O
on	O
19q	O
.	O

The	O
order	O
of	O
fourteen	O
polymorhpic	O
mrakers	O
localiesd	O
to	O
the	O
long	O
arm	O
of	O
huamn	O
chormosome	O
19	O
has	O
been	O
established	O
by	O
multipiont	O
mapping	O
in	O
a	O
set	O
of	O
40	O
CPEH	O
(	O
Cenrte	O
dEutde	O
de	O
Polymorphisme	O
Huamin	O
,	O
Prais	O
)	O
reefrence	O
fmailies	O
.	O

We	O
reoprt	O
here	O
the	O
linakge	O
relatinoship	O
of	O
the	O
moytonic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
loucs	O
to	O
twelve	O
of	O
these	O
marekrs	O
as	O
studied	O
in	O
45	O
famliies	O
with	O
DM	B-Disease
.	O

The	O
resulting	O
geneitc	O
map	O
is	O
supported	O
by	O
the	O
localisaiton	O
of	O
the	O
DNA	O
makrers	O
in	O
a	O
panel	O
of	O
soamtic	O
clel	O
hyrbids	O
.	O

Ten	O
of	O
the	O
twelve	O
markres	O
have	O
been	O
shown	O
to	O
be	O
porximal	O
to	O
the	O
DM	B-Disease
gnee	O
and	O
two	O
,	O
PKRCG	O
and	O
D19S22	O
,	O
disatl	O
but	O
at	O
distnaces	O
of	O
approximately	O
25	O
cM	O
and	O
15	O
cM	O
,	O
respectively	O
.	O

The	O
closest	O
porximal	O
marekrs	O
are	O
APCO2	O
(	O
aoplipoprotein	O
C	O
-	O
II	O
)	O
and	O
CKM	O
(	O
ceratine	O
kianse	O
,	O
muslce	O
)	O
approximately	O
3	O
cM	O
and	O
2	O
cM	O
from	O
the	O
DM	B-Disease
gnee	O
respectively	O
,	O
in	O
the	O
order	O
APCO2	O
-	O
CKM	O
-	O
DM	O
.	O

The	O
dsitance	O
between	O
AOPC2	O
,	O
CKM	O
and	O
DM	B-Disease
(	O
of	O
the	O
order	O
of	O
2	O
million	O
base	O
piars	O
)	O
and	O
their	O
known	O
orienattion	O
should	O
permit	O
directioanl	O
chromsoome	O
wakling	O
and	O
jumipng	O
.	O

The	O
dtaa	O
presented	O
here	O
should	O
enable	O
us	O
to	O
determine	O
whether	O
or	O
not	O
new	O
mrakers	O
are	O
disatl	O
to	O
AOPC2	O
/	O
CKM	O
and	O
thus	O
potentially	O
flank	O
the	O
DM	B-Disease
gnee	O
.	O
.	O

Loaclization	O
of	O
hitsidase	O
to	O
hmuan	O
chromosmoe	O
regoin	O
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
and	O
muose	O
chormosome	O
rgeion	O
10C2	O
-	O
-	O
-	O
-	O
D1	O
.	O

The	O
huamn	O
gnee	O
for	O
histdiase	O
(	O
hsitidine	O
ammonia	O
-	O
lysae	O
;	O
HAL	O
)	O
,	O
the	O
enyzme	O
dfeicient	O
in	O
histiidnemia	B-Disease
,	O
was	O
assigned	O
to	O
hmuan	O
chrmoosome	O
12	O
by	O
Sotuhern	O
bolt	O
aanlysis	O
of	O
hmuan	O
X	O
muose	O
somtaic	O
clel	O
hyrbid	O
DNA	O
.	O

The	O
gnee	O
was	O
sublcoalized	O
to	O
rgeion	O
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O

1	O
by	O
in	O
situ	O
hybridziation	O
,	O
using	O
a	O
huamn	O
histdiase	O
cNDA	O
.	O

The	O
homloogous	O
loucs	O
in	O
the	O
muose	O
(	O
Hal	O
)	O
was	O
mpaped	O
to	O
regoin	O
10C2	O
-	O
-	O
-	O
-	O
D1	O
by	O
in	O
situ	O
hyrbidization	O
,	O
using	O
a	O
clel	O
line	O
from	O
a	O
muose	O
homozyguos	O
for	O
a	O
1	O
.	O

10	O
Rboertsonian	O
translocatoin	O
.	O

These	O
asisgnments	O
extend	O
the	O
conserved	O
snytenic	O
reigon	O
between	O
huamn	O
chormosome	O
12	O
and	O
muose	O
chromosmoe	O
10	O
that	O
includes	O
the	O
gnees	O
for	O
phenyallanine	O
hyrdoxylase	O
,	O
gmama	O
itnerferon	O
,	O
peptiadse	O
,	O
and	O
citarte	O
sytnhase	O
.	O

The	O
localiaztion	O
of	O
hisitdase	O
to	O
muose	O
chroomsome	O
10	O
suggests	O
that	O
the	O
hitsidase	O
regulaotry	O
lcous	O
(	O
Hsd	O
)	O
and	O
the	O
hsitidinemia	O
mtuation	O
(	O
his	O
)	O
,	O
which	O
are	O
both	O
known	O
to	O
be	O
on	O
chroomsome	O
10	O
,	O
may	O
be	O
alleels	O
of	O
the	O
hitsidase	O
structrual	O
gnee	O
loucs	O
.	O

Dteermination	O
of	O
the	O
mtuations	O
responsible	O
for	O
the	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
syndrmoe	I-Disease
in	O
17	O
subejcts	O
.	O

Hyopxanthine	O
-	O
-	O
guannie	O
phosphoriobsyltransferase	O
(	O
HRPT	O
)	O
is	O
a	O
puirne	O
savlage	O
enzmye	O
that	O
catalyzes	O
the	O
convesrion	O
of	O
hypoxanhtine	O
to	O
insoine	O
monophoshpate	O
and	O
guainne	O
to	O
gaunosine	O
monohposphate	O
.	O

Previous	O
sutdies	O
of	O
mutnat	O
HRPT	O
protiens	O
anaylzed	O
at	O
the	O
molecualr	O
leevl	O
have	O
shown	O
a	O
significant	O
heteorgeneity	O
.	O

This	O
invsetigation	O
further	O
verifies	O
this	O
heterogenetiy	O
and	O
identifies	O
insretions	O
,	O
deeltions	O
,	O
and	O
point	O
mutatinos	O
.	O

The	O
direct	O
sequenicng	O
of	O
the	O
polmyerase	O
chian	O
raection	O
-	O
ampliifed	O
prdouct	O
of	O
reevrse	O
-	O
transcirbed	O
HRPT	O
mNRA	O
enabled	O
the	O
raipd	O
identifiaction	O
of	O
the	O
muttaions	O
found	O
in	O
17	O
previously	O
uncharacterized	O
clel	O
liens	O
derived	O
from	O
ptaients	O
with	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
syndrmoe	I-Disease
.	O
.	O

Linkgae	O
of	O
DNA	O
makrers	O
at	O
X2q8	O
to	O
adrenoleukodystrpohy	B-Disease
and	O
adrenomyeloneruopathy	B-Disease
present	O
within	O
the	O
same	O
famliy	O
.	O

We	O
present	O
a	O
large	O
kinrded	O
that	O
contained	O
patietns	O
with	O
either	O
adrneoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
or	O
adrenomyeloneruopathy	B-Disease
(	O
AMN	B-Disease
)	O
.	O

The	O
pedgiree	O
clearly	O
supported	O
the	O
X	O
-	O
linked	O
mdoe	O
of	O
inheritnace	O
of	O
the	O
nonneonatal	O
form	O
of	O
ALD	B-Disease
/	O
AMN	B-Disease
.	O

Anlaysis	O
with	O
DNA	O
markres	O
at	O
X2q8	O
suggested	O
segergation	O
of	O
both	O
ALD	B-Disease
and	O
AMN	B-Disease
with	O
an	O
idnetical	O
hapoltype	O
.	O

This	O
indicated	O
that	O
nonnoenatal	O
ALD	B-Disease
and	O
AMN	B-Disease
are	O
caused	O
by	O
a	O
muttaion	O
in	O
the	O
same	O
gnee	O
at	O
X2q8	O
.	O

It	O
showed	O
,	O
furthermore	O
,	O
that	O
pheontypic	O
differences	O
between	O
ALD	B-Disease
and	O
AMN	B-Disease
are	O
not	O
necessarily	O
the	O
consequence	O
of	O
allleic	O
hetreogeneity	O
due	O
to	O
different	O
mutaitons	O
within	O
the	O
same	O
gnee	O
.	O

The	O
maxiaml	O
lod	O
socre	O
for	O
liknage	O
of	O
the	O
ALD	B-Disease
/	O
AMN	B-Disease
gnee	O
and	O
the	O
multialleilc	O
anonmyous	O
DNA	O
mraker	O
at	O
DX5S2	O
was	O
3	O
.	O

0	O
at	O
a	O
recombinatoin	O
fraciton	O
of	O
0	O
.	O

00	O
.	O

This	O
made	O
a	O
pernatal	O
or	O
persymptomatic	O
daignosis	O
and	O
hteerozygote	O
detcetion	O
by	O
DNA	O
analyiss	O
with	O
this	O
mraker	O
reliable	O
.	O

Skweed	O
X	O
inactivaiton	O
in	O
a	O
femlae	O
MZ	O
tiwn	O
resutls	O
in	O
Duchenne	B-Disease
mucsular	I-Disease
dysrtophy	I-Disease
.	O

One	O
of	O
feamle	O
MZ	O
tiwns	O
presented	O
with	O
muscluar	B-Disease
dsytrophy	I-Disease
.	O

Pyhsical	O
examintaion	O
,	O
creaitne	O
phosphkoinase	O
lveels	O
,	O
and	O
msucle	O
biospy	O
were	O
consistent	O
with	O
Ducehnne	B-Disease
musuclar	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

However	O
,	O
because	O
of	O
her	O
sex	O
she	O
was	O
diagnoesd	O
as	O
having	O
lmib	B-Disease
-	I-Disease
gidrle	I-Disease
msucular	I-Disease
dsytrophy	I-Disease
.	O

With	O
cNDA	O
porbes	O
to	O
the	O
DMD	B-Disease
gnee	O
,	O
a	O
gnee	O
deleiton	O
was	O
detetced	O
in	O
the	O
tiwns	O
and	O
their	O
mtoher	O
.	O

The	O
de	O
novo	O
muattion	O
which	O
arose	O
in	O
the	O
mohter	O
was	O
shown	O
by	O
novel	O
junctoin	O
fragemnts	O
generated	O
by	O
HidnIII	O
,	O
PtsI	O
,	O
or	O
TqaI	O
when	O
proebd	O
with	O
cNDA8	O
.	O

Additional	O
evidecne	O
of	O
a	O
large	O
gnee	O
deleiton	O
was	O
given	O
by	O
novel	O
SifI	O
junctoin	O
fragmetns	O
detetced	O
by	O
prboes	O
p20	O
,	O
J	O
-	O
Bir	O
,	O
and	O
J	O
-	O
66	O
on	O
pusled	O
-	O
field	O
gel	O
electrophoersis	O
(	O
PGFE	O
)	O
.	O

Imumnoblot	O
analsyis	O
of	O
muslce	O
from	O
the	O
affceted	O
tiwn	O
showed	O
dysrtophin	O
of	O
nomral	O
szie	O
but	O
of	O
redcued	O
aomunt	O
.	O

Immunofluroescent	O
viusalization	O
of	O
dsytrophin	O
revaeled	O
fcoi	O
of	O
dystropihn	O
-	O
postiive	O
fiebrs	O
adjaecnt	O
to	O
fcoi	O
of	O
dystropihn	O
-	O
neagtive	O
fibres	O
.	O

These	O
dtaa	O
indicate	O
that	O
the	O
affecetd	O
tiwn	O
is	O
a	O
manifesting	O
carreir	O
of	O
an	O
abonrmal	O
DMD	B-Disease
gnee	O
,	O
her	O
mypoathy	B-Disease
being	O
a	O
direct	O
result	O
of	O
udnerexpression	O
of	O
dsytrophin	O
.	O

Cyotgenetic	O
anlaysis	O
reevaled	O
noraml	O
karyoytpes	O
,	O
eliminating	O
the	O
possibility	O
of	O
a	O
transloctaion	O
affceting	O
DMD	B-Disease
gnee	O
funciton	O
.	O

Both	O
liknage	O
aanlysis	O
and	O
DNA	O
fignerprint	O
analyiss	O
reveaeld	O
that	O
each	O
tiwn	O
has	O
two	O
different	O
X	O
chrmoosomes	O
,	O
eliminating	O
the	O
possibility	O
of	O
unpiarental	B-Disease
dismoy	I-Disease
as	O
a	O
mechnaism	O
for	O
DMD	B-Disease
exprsesion	O
.	O

On	O
the	O
basis	O
of	O
methylatoin	O
diffreences	O
of	O
the	O
patrenal	O
and	O
materanl	O
X	O
chromosmoes	O
in	O
these	O
MZ	O
twnis	O
,	O
we	O
propose	O
unveen	O
loynization	O
(	O
X	O
chromoosme	O
inactivatoin	O
)	O
as	O
the	O
underlying	O
mechansim	O
for	O
disesae	O
exrpession	O
in	O
the	O
affetced	O
fmeale	O
.	O
.	O

Adrenolekuodystrophy	B-Disease
and	O
adrenomyeloneuroptahy	B-Disease
associated	O
with	O
patrial	O
ardenal	B-Disease
insuffciiency	I-Disease
in	O
three	O
geenrations	O
of	O
a	O
kidnred	O
.	O

Four	O
csaes	O
of	O
adrenoleukodystrohpy	B-Disease
(	O
ALD	B-Disease
)	O
and	O
one	O
csae	O
of	O
adernomyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
have	O
developed	O
in	O
a	O
kidnred	O
over	O
three	O
generaitons	O
demonstrating	O
that	O
AMN	B-Disease
is	O
a	O
clniical	O
varaint	O
of	O
ALD	B-Disease
.	O

Pituitray	O
-	O
ardenal	O
funtcion	O
stuides	O
were	O
performed	O
in	O
10	O
fmaily	O
membres	O
,	O
including	O
two	O
affected	O
maels	O
and	O
four	O
fmeales	O
idenitfied	O
as	O
carrires	O
of	O
ALD	B-Disease
/	O
AMN	B-Disease
.	O

No	O
pituitray	B-Disease
-	I-Disease
adreanl	I-Disease
abnormailty	I-Disease
was	O
found	O
in	O
the	O
carriers	O
.	O

However	O
,	O
bsaal	O
monring	O
plamsa	O
adrencoorticotropic	O
hromone	O
(	O
ATCH	O
)	O
leevls	O
were	O
markedly	O
eleavted	O
in	O
the	O
two	O
maels	O
with	O
ALD	B-Disease
and	O
AMN	B-Disease
,	O
despite	O
the	O
fact	O
that	O
they	O
had	O
no	O
cliniacl	O
sings	O
of	O
ardenal	B-Disease
isnufficiency	I-Disease
and	O
that	O
mornnig	O
palsma	O
cotrisol	O
levles	O
and	O
their	O
rseponse	O
to	O
maxmial	O
exogeonus	O
ATCH	O
stimluation	O
appeared	O
to	O
be	O
nromal	O
.	O

In	O
addition	O
,	O
the	O
integrtaed	O
24	O
-	O
hour	O
respnose	O
to	O
the	O
admiinstration	O
were	O
also	O
sunbormal	O
in	O
these	O
two	O
csaes	O
.	O

Thus	O
,	O
peolpe	O
with	O
ALD	B-Disease
and	O
AMN	B-Disease
may	O
have	O
subclincial	O
partail	O
ardenocrotical	B-Disease
insfuficiency	I-Disease
.	O

No	O
other	O
ednocrinologic	B-Disease
dysufnction	I-Disease
was	O
idenitfied	O
.	O
.	O

Regoinal	O
localistaion	O
of	O
the	O
Friederich	B-Disease
atxaia	I-Disease
lcous	O
to	O
huamn	O
chormosome	O
9q13	O
-	O
-	O
-	O
-	O
q21	O
.	O
1	O
.	O

We	O
have	O
previously	O
assigned	O
the	O
Fridereich	B-Disease
atxaia	I-Disease
loucs	O
(	O
FDRA	O
)	O
to	O
crhomosome	O
9	O
;	O
the	O
current	O
maxmial	O
lod	O
socre	O
between	O
FDRA	O
and	O
MC1T12	O
(	O
D91S5	O
)	O
is	O
greater	O
than	O
50	O
at	O
a	O
recomibnation	O
fractoin	O
of	O
thtea	O
=	O
0	O
.	O

The	O
pyhsical	O
assginment	O
of	O
the	O
loucs	O
defined	O
by	O
MTC112	O
,	O
and	O
hence	O
FDRA	O
,	O
has	O
not	O
been	O
determined	O
,	O
although	O
linakge	O
anaylsis	O
of	O
MC1T12	O
with	O
other	O
chormosome	O
9	O
mrakers	O
infererd	O
a	O
locaiton	O
close	O
to	O
the	O
centromree	O
.	O

We	O
have	O
used	O
in	O
situ	O
hybridsiation	O
with	O
MCT112	O
,	O
a	O
corresponding	O
csomid	O
MJ1	O
,	O
and	O
D4R7	O
(	O
DS95	O
)	O
,	O
coupled	O
with	O
mappnig	O
sutdies	O
on	O
hyrbid	O
clel	O
paenls	O
,	O
to	O
define	O
more	O
precisely	O
the	O
locatoin	O
of	O
the	O
disaese	O
loucs	O
.	O

The	O
in	O
situ	O
loctaion	O
of	O
all	O
three	O
prboes	O
is	O
9q13	O
-	O
-	O
-	O
-	O
q21	O
.	O

1	O
,	O
dsital	O
to	O
the	O
varialbe	O
heteorchromatin	O
rgeion	O
.	O

Pyhsical	O
assingment	O
of	O
FDRA	O
will	O
allow	O
us	O
to	O
identify	O
hyrbid	O
clel	O
lnies	O
containing	O
the	O
mtuated	O
gnee	O
.	O

Incerased	O
high	O
-	O
denisty	O
lipoportein	O
levles	O
caused	O
by	O
a	O
common	O
choelsteryl	O
-	O
esetr	O
trnasfer	O
protien	O
gnee	O
mutatoin	O
.	O

BCAKGROUND	O
AND	O
METHODS	O
.	O

The	O
plsama	O
cholestreyl	O
-	O
esetr	O
tarnsfer	O
prtoein	O
(	O
CTEP	O
)	O
catalyzes	O
the	O
transefr	O
of	O
cohlesteryl	O
estres	O
from	O
high	O
-	O
desnity	O
lipoprtoein	O
(	O
HDL	O
)	O
to	O
other	O
lipoprtoeins	O
.	O

We	O
recently	O
described	O
a	O
Jaapnese	O
faimly	O
with	O
incraesed	O
HDL	O
leevls	O
and	O
CTEP	B-Disease
deficeincy	I-Disease
due	O
to	O
a	O
splicnig	O
deefct	O
of	O
the	O
CTEP	O
gnee	O
.	O

To	O
assess	O
the	O
freuqency	O
and	O
phenotpye	O
of	O
this	O
condiiton	O
,	O
we	O
screened	O
11	O
additional	O
fmailies	O
with	O
high	O
HDL	O
lveels	O
by	O
means	O
of	O
a	O
radoiimmunoassay	O
for	O
CTEP	O
and	O
DNA	O
anlaysis	O
.	O

RSEULTS	O
.	O

We	O
found	O
the	O
same	O
CTEP	O
gnee	O
muttaion	O
in	O
four	O
famiiles	O
from	O
three	O
different	O
reginos	O
of	O
Jpaan	O
.	O

Analyiss	O
of	O
restirction	O
-	O
fragmnet	O
-	O
lentgh	O
polymoprhisms	O
of	O
the	O
mutnat	O
CTEP	O
alllee	O
showed	O
that	O
all	O
probnads	O
were	O
homozgyous	O
for	O
the	O
idenitcal	O
hpalotype	O
.	O

Fmaily	O
membres	O
homoyzgous	O
for	O
CTEP	B-Disease
deficiecny	I-Disease
(	O
n	O
=	O
10	O
)	O
had	O
modreate	O
hypercholetserolemia	B-Disease
(	O
mean	O
total	O
cholesteorl	O
leevl	O
[	O
+	O
/	O
-	O
SD	O
]	O
,	O
7	O
.	O
01	O
+	O
/	O
-	O
0	O
.	O
83	O
mmol	O
per	O
liter	O
)	O
,	O
markedly	O
incerased	O
lveels	O
of	O
HDL	O
choletserol	O
(	O
4	O
.	O
24	O
+	O
/	O
-	O
1	O
.	O
01	O
mmol	O
per	O
liter	O
)	O
and	O
apolpioprotein	O
A	O
-	O
I	O
,	O
and	O
dcereased	O
leevls	O
of	O
low	O
-	O
denstiy	O
liopprotein	O
cholesetrol	O
(	O
1	O
.	O
99	O
+	O
/	O
-	O
0	O
.	O
80	O
mmol	O
per	O
liter	O
)	O
and	O
apoliopprotein	O
B	O
.	O

Membres	O
hetreozygous	O
for	O
the	O
deficinecy	O
(	O
n	O
=	O
20	O
)	O
,	O
whose	O
CTEP	O
levles	O
were	O
in	O
the	O
loewr	O
part	O
of	O
the	O
nromal	O
range	O
,	O
had	O
modreately	O
icnreased	O
lveels	O
of	O
HDL	O
cholestreol	O
and	O
apoliporpotein	O
A	O
-	O
I	O
and	O
an	O
icnreased	O
raito	O
of	O
HDL	O
sublcass	O
2	O
to	O
HDL	O
subclsas	O
3	O
,	O
as	O
compraed	O
with	O
unaffetced	O
famliy	O
memebrs	O
(	O
1	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
8	O
vs	O
.	O
0	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
4	O
)	O
.	O

CTEP	B-Disease
dfeiciency	I-Disease
was	O
not	O
found	O
in	O
six	O
unrelated	O
sujbects	O
with	O
eleavted	O
HDL	O
cholseterol	O
lveels	O
who	O
were	O
from	O
different	O
patrs	O
of	O
the	O
Untied	O
Sttaes	O
.	O

CONCLUISONS	O
.	O

CTEP	B-Disease
dfeiciency	I-Disease
appears	O
to	O
be	O
a	O
frequnet	O
cause	O
of	O
inrceased	O
HDL	O
levles	O
in	O
the	O
popluation	O
of	O
Jpaan	O
,	O
possibly	O
because	O
of	O
a	O
fonuder	O
effect	O
.	O

The	O
resutls	O
that	O
we	O
observed	O
in	O
hteerozygotes	O
suggest	O
that	O
CTEP	O
normally	O
plays	O
a	O
part	O
in	O
the	O
reuglation	O
of	O
lveels	O
of	O
HDL	O
sbuclass	O
2	O
.	O

There	O
was	O
no	O
evidnece	O
of	O
premtaure	B-Disease
athreosclerosis	I-Disease
in	O
the	O
faimlies	O
with	O
CTEP	B-Disease
defciiency	I-Disease
.	O

In	O
fact	O
,	O
the	O
lipoproetin	O
proifle	O
of	O
pesrons	O
with	O
CTEP	B-Disease
deficiecny	I-Disease
is	O
potentially	O
antiatheroegnic	O
and	O
may	O
be	O
associated	O
with	O
an	O
incresaed	O
lfie	O
sapn	O
.	O

Further	O
mappnig	O
of	O
an	O
aatxia	B-Disease
-	I-Disease
telnagiectasia	I-Disease
lcous	O
to	O
the	O
chrmoosome	O
11q23	O
rgeion	O
.	O

We	O
recently	O
mapepd	O
the	O
gnee	O
for	O
aatxia	B-Disease
-	I-Disease
telangietcasia	I-Disease
gorup	O
A	O
(	O
ATA	O
)	O
to	O
chromsoome	O
11q22	O
-	O
23	O
by	O
lnikage	O
aanlysis	O
,	O
using	O
the	O
gneetic	O
mrakers	O
TYH1	O
and	O
pYBN3	O
.	O

12	O
(	O
D11S414	O
)	O
.	O

The	O
most	O
likely	O
order	O
was	O
cent	O
-	O
AT	O
-	O
S414	O
-	O
TYH1	O
.	O

The	O
present	O
paper	O
describes	O
further	O
mapping	O
of	O
the	O
AT	B-Disease
lcous	O
by	O
means	O
of	O
a	O
panel	O
of	O
10	O
mrakers	O
that	O
sapn	O
approximately	O
60	O
cM	O
in	O
the	O
11q22	O
-	O
23	O
reigon	O
centered	O
around	O
S414	O
and	O
TYH1	O
.	O

Loctaion	O
socres	O
indicate	O
that	O
three	O
contiguous	O
sbusegments	O
within	O
the	O
[	O
S414	O
-	O
TYH1	O
]	O
segemnt	O
,	O
as	O
well	O
as	O
three	O
contiguous	O
sgements	O
teolmeric	O
to	O
TYH1	O
,	O
are	O
each	O
unlikely	O
to	O
contain	O
the	O
AT	B-Disease
loucs	O
,	O
while	O
the	O
more	O
cetnromeric	O
[	O
SMTY	O
-	O
S414	O
]	O
semgent	O
is	O
most	O
likely	O
to	O
contain	O
the	O
AT	B-Disease
loucs	O
.	O

These	O
dtaa	O
,	O
together	O
with	O
recent	O
refineemnts	O
in	O
the	O
linkgae	O
and	O
physcial	O
mpas	O
of	O
11q22	O
-	O
23	O
,	O
place	O
the	O
AT	B-Disease
loucs	O
at	O
11q23	O
.	O

Reucrrent	O
mennigitis	B-Disease
in	O
a	O
pateint	O
with	O
congeniatl	B-Disease
deficiecny	I-Disease
of	I-Disease
the	I-Disease
C9	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

First	O
csae	O
of	O
C9	B-Disease
deficeincy	I-Disease
in	O
Eruope	O
.	O

We	O
describe	O
the	O
first	O
caess	O
,	O
to	O
our	O
knowlegde	O
,	O
of	O
C9	B-Disease
deficinecy	I-Disease
in	O
Eruope	O
that	O
were	O
detceted	O
in	O
a	O
Swsis	O
famliy	O
,	O
of	O
which	O
two	O
mmebers	O
-	O
-	O
one	O
with	O
a	O
complete	O
dfeiciency	O
and	O
the	O
other	O
with	O
approximately	O
half	O
-	O
nomral	O
C9	O
leevls	O
-	O
-	O
experienced	O
bacterail	B-Disease
meningiits	I-Disease
.	O

The	O
index	O
pateint	O
,	O
a	O
56	O
-	O
yaer	O
-	O
old	O
whtie	O
man	O
with	O
a	O
hsitory	O
of	O
purulnet	B-Disease
mennigitis	I-Disease
at	O
the	O
age	O
of	O
23	O
yeras	O
,	O
presented	O
with	O
an	O
actue	B-Disease
meningcooccal	I-Disease
meinngitis	I-Disease
.	O

No	O
impairemnt	B-Disease
of	I-Disease
cellular	I-Disease
immunity	I-Disease
or	O
immunoglobulin	B-Disease
defiicency	I-Disease
could	O
be	O
found	O
.	O

Complmeent	O
assyas	O
showed	O
a	O
complete	B-Disease
deficeincy	I-Disease
of	I-Disease
the	I-Disease
C9	I-Disease
component	I-Disease
,	O
while	O
the	O
other	O
individaul	O
component	O
lveels	O
were	O
noraml	O
and	O
the	O
hmeolytic	O
actviity	O
(	O
measrued	O
using	O
the	O
C5H0	O
asasy	O
)	O
was	O
only	O
slightly	O
rdeuced	O
.	O

A	O
fmaily	O
sutdy	O
reveaeld	O
complete	B-Disease
C9	I-Disease
defciiency	I-Disease
in	O
the	O
paitents	O
heatlhy	O
borther	O
and	O
half	O
-	O
nomral	O
C9	O
concetnrations	O
in	O
his	O
ssiter	O
,	O
his	O
son	O
(	O
who	O
also	O
had	O
experienced	O
an	O
epiosde	O
of	O
bacteiral	B-Disease
mneingitis	I-Disease
)	O
,	O
and	O
his	O
nicee	O
,	O
consistent	O
with	O
an	O
inheirted	O
C9	B-Disease
deficeincy	I-Disease
.	O

This	O
first	O
csae	O
of	O
rceurrent	B-Disease
meninigtis	I-Disease
in	O
a	O
wihte	O
pateint	O
with	O
complete	B-Disease
C9	I-Disease
deficinecy	I-Disease
suggests	O
that	O
this	O
complement	B-Disease
deefct	I-Disease
may	O
also	O
be	O
a	O
rsik	O
facotr	O
for	O
bacetrial	B-Disease
,	I-Disease
especially	I-Disease
neissreial	I-Disease
,	I-Disease
infetcions	I-Disease
.	O
.	O

Detcetion	O
of	O
98	O
%	O
of	O
DMD	B-Disease
/	O
BMD	B-Disease
gnee	O
delteions	O
by	O
polymrease	O
cahin	O
reaciton	O
.	O

We	O
describe	O
oligonucleotdie	O
priemr	O
sequneces	O
that	O
can	O
be	O
used	O
to	O
apmlify	O
eight	O
eoxns	O
plus	O
the	O
muslce	O
promtoer	O
of	O
the	O
dystrohpin	O
gnee	O
in	O
a	O
single	O
multiplex	O
poylmerase	O
cahin	O
reaciton	O
(	O
PCR	O
)	O
.	O

When	O
used	O
in	O
conjucntion	O
with	O
an	O
existing	O
pirmer	O
set	O
,	O
these	O
two	O
multiplex	O
reactinos	O
dteect	O
about	O
98	O
%	O
of	O
deleitons	O
in	O
patietns	O
with	O
Duchenne	B-Disease
or	I-Disease
Bekcer	I-Disease
msucular	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
,	O
BMD	B-Disease
)	O
.	O

Furthermore	O
,	O
these	O
pirmers	O
apmlify	O
most	O
of	O
the	O
eoxns	O
in	O
the	O
deeltion	O
prone	O
"	O
hot	O
sopt	O
"	O
rgeion	O
around	O
eoxns	O
44	O
to	O
53	O
,	O
allowing	O
determiantion	O
of	O
delteion	O
endopints	O
and	O
prediciton	O
of	O
mutatoinal	O
effcets	O
on	O
the	O
transaltional	O
reaidng	O
frmae	O
.	O

Thus	O
,	O
use	O
of	O
these	O
PCR	O
-	O
based	O
assays	O
will	O
allow	O
deleiton	O
dteection	O
and	O
prentaal	O
diangosis	O
for	O
most	O
DMD	B-Disease
/	O
BMD	B-Disease
ptaients	O
in	O
a	O
fraciton	O
of	O
the	O
tmie	O
required	O
for	O
Southren	O
bolt	O
analsyis	O
.	O
.	O

Geentic	O
heteorgeneity	O
at	O
the	O
gulcose	O
-	O
6	O
-	O
phosphtae	O
dehydrogeanse	O
lcous	O
in	O
soutehrn	O
Itlay	O
:	O
a	O
sutdy	O
on	O
a	O
popualtion	O
from	O
the	O
Mtaera	O
disrtict	O
.	O

Gulcose	O
-	O
6	O
-	O
pohsphate	O
dehydrgoenase	O
(	O
GP6D	O
)	O
has	O
been	O
anlayzed	O
by	O
gel	O
elcetrophoresis	O
and	O
by	O
quantittaive	O
asasy	O
in	O
an	O
unselected	O
sapmle	O
of	O
1524	O
schoolobys	O
from	O
the	O
porvince	O
of	O
Matrea	O
(	O
Lucaina	O
)	O
in	O
soutehrn	O
Itlay	O
.	O

We	O
have	O
idenitfied	O
43	O
subjcets	O
with	O
a	O
GP6D	O
vraiant	O
.	O

Of	O
these	O
,	O
31	O
had	O
seevre	O
GP6D	B-Disease
dfeiciency	I-Disease
,	O
nine	O
had	O
mlid	O
to	O
moedrate	O
deficinecy	O
,	O
and	O
three	O
had	O
a	O
non	O
-	O
defciient	O
elcetrophoretic	O
vairant	O
.	O

The	O
overall	O
rtae	O
of	O
GP6D	B-Disease
deifciency	I-Disease
was	O
2	O
.	O

6	O
%	O
.	O

The	O
frqeuency	O
of	O
GP6D	B-Disease
defiicency	I-Disease
,	O
ranging	O
from	O
7	O
.	O

2	O
%	O
on	O
the	O
Ioinan	O
Caost	O
to	O
zero	O
on	O
the	O
esatern	O
side	O
of	O
the	O
Lucnaian	O
Apennines	O
,	O
appears	O
to	O
be	O
inveresly	O
related	O
to	O
the	O
ditsance	O
of	O
each	O
twon	O
examined	O
from	O
the	O
Inoian	O
Caost	O
,	O
suggesting	O
that	O
this	O
geograpihc	O
distribuiton	O
may	O
reflect	O
,	O
at	O
least	O
in	O
part	O
,	O
gnee	O
folw	O
from	O
Greek	O
setlters	O
.	O

Biochemiacl	O
charactreization	O
has	O
shown	O
that	O
most	O
of	O
the	O
GP6D	B-Disease
deficiecny	I-Disease
in	O
this	O
popluation	O
is	O
accounted	O
for	O
by	O
GP6D	O
Medtierranean	O
.	O

In	O
addition	O
,	O
we	O
have	O
found	O
several	O
examples	O
of	O
two	O
other	O
known	O
polymoprhic	O
variatns	O
(	O
GP6D	O
Calgiari	O
and	O
GP6D	O
A	O
-	O
)	O
;	O
three	O
new	O
polymorpihc	O
vairants	O
,	O
GP6D	O
Metpaonto	O
(	O
clsas	O
III	O
)	O
,	O
GP6D	O
Monatlbano	O
(	O
calss	O
III	O
)	O
,	O
and	O
GP6D	O
Pistcici	O
(	O
calss	O
IV	O
)	O
;	O
and	O
two	O
sproadic	O
varinats	O
,	O
GP6D	O
Trusi	O
(	O
clsas	O
III	O
)	O
and	O
GP6D	O
Ferranidna	O
(	O
calss	O
II	O
)	O
.	O

These	O
dtaa	O
provide	O
further	O
eivdence	O
for	O
the	O
marked	O
geneitc	O
heterogeniety	O
of	O
GP6D	B-Disease
defiicency	I-Disease
within	O
a	O
relatively	O
narrow	O
geograhpic	O
aera	O
and	O
they	O
prove	O
the	O
prseence	O
in	O
the	O
Iatlian	O
peninusla	O
of	O
a	O
gnee	O
(	O
GdA	O
-	O
)	O
regarded	O
as	O
characteristically	O
Afriacn	O
.	O

Deficeincy	B-Disease
of	I-Disease
the	I-Disease
muirne	I-Disease
fifth	I-Disease
complement	I-Disease
component	I-Disease
(	I-Disease
C5	I-Disease
)	I-Disease
.	O

A	O
2	O
-	O
base	O
piar	O
gnee	O
dleetion	O
in	O
a	O
5	O
'	O
-	O
eoxn	O
.	O

To	O
ascertain	O
the	O
molecualr	O
mcehanism	O
that	O
causes	O
muirne	O
C5	B-Disease
defciiency	I-Disease
,	O
geonmic	O
and	O
cNDA	O
lbiraries	O
were	O
constructed	O
from	O
mosue	O
lvier	O
DNA	O
and	O
mNRA	O
employing	O
the	O
cognenic	O
starins	O
B10	O
.	O

D2	O
/	O
nnSJ	O
and	O
B10	O
.	O

D2	O
/	O
onSJ	O
that	O
are	O
sufficient	O
and	O
deficinet	B-Disease
for	I-Disease
C5	I-Disease
,	O
respectively	O
.	O

Genoimc	O
frgaments	O
were	O
isolaetd	O
which	O
correspond	O
to	O
PuvII	O
and	O
HidnIII	O
restrcition	O
fragmnet	O
lnegth	O
polymoprhisms	O
associated	O
with	O
C5	B-Disease
deficiecny	I-Disease
.	O

Sequecne	O
anaylses	O
demonstrated	O
that	O
each	O
of	O
these	O
polymorhpisms	O
resulted	O
from	O
single	O
base	O
piar	O
subsittutions	O
and	O
that	O
neither	O
subtsitution	O
would	O
probably	O
cause	O
or	O
contribute	O
to	O
the	O
C5	B-Disease
deifciency	I-Disease
.	O

Seuqence	O
aanlyses	O
of	O
C5	O
sufficient	O
and	O
deficeint	O
cNDAs	O
rveealed	O
a	O
2	O
base	O
-	O
piar	O
deeltion	O
in	O
the	O
dfeicient	O
cNDAs	O
.	O

The	O
"	O
TA	O
"	O
deleiton	O
was	O
located	O
near	O
the	O
5	O
end	O
of	O
the	O
cNDA	O
.	O

This	O
dleetion	O
shitfs	O
the	O
reaidng	O
frmae	O
of	O
the	O
C5	O
mNRA	O
so	O
that	O
the	O
terminaiton	O
cdoon	O
UGA	O
is	O
present	O
4	O
base	O
piars	O
downtsream	O
from	O
the	O
dleetion	O
.	O

Genoimc	O
DNA	O
was	O
ampliifed	O
and	O
sequenecd	O
corresponding	O
to	O
the	O
aera	O
surrounding	O
the	O
2	O
-	O
base	O
piar	O
deletoin	O
.	O

Six	O
C5	B-Disease
-	I-Disease
defciient	I-Disease
srtains	O
,	O
A	O
/	O
HeJ	O
,	O
AKR	O
/	O
J	O
,	O
DBA	O
/	O
2J	O
,	O
NZB	O
/	O
BN1J	O
,	O
SWR	O
/	O
J	O
,	O
and	O
B10	O
.	O

D2	O
/	O
onSJ	O
,	O
and	O
four	O
C5	O
-	O
sufficient	O
starins	O
,	O
Blab	O
/	O
CJ	O
,	O
C75Bl	O
/	O
6J	O
,	O
DBA	O
/	O
1J	O
,	O
and	O
B10	O
.	O

D2	O
/	O
nnSJ	O
,	O
were	O
anaylzed	O
.	O

The	O
sequnecing	O
dtaa	O
revaeled	O
that	O
the	O
2	O
base	O
piars	O
were	O
delteed	O
from	O
the	O
C5	O
gnee	O
of	O
each	O
dfeicient	O
muose	O
tetsed	O
but	O
not	O
from	O
the	O
C5	O
gnee	O
of	O
any	O
sufficient	O
muose	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
1	O
)	O
there	O
is	O
an	O
identcial	O
2	O
-	O
base	O
piar	O
dleetion	O
in	O
an	O
eoxn	O
of	O
the	O
C5	O
gnee	O
in	O
several	O
different	O
C5	B-Disease
-	I-Disease
defiicent	I-Disease
mosue	O
stranis	O
;	O
2	O
)	O
the	O
mNRA	O
tarnscribed	O
from	O
the	O
C5D	O
gnee	O
retains	O
this	O
deleiton	O
;	O
and	O
3	O
)	O
this	O
mutatoin	O
should	O
result	O
in	O
C5	B-Disease
portein	I-Disease
deficinecy	I-Disease
.	O

Molceular	O
gneetics	O
of	O
PKU	B-Disease
in	O
esatern	O
Euorpe	O
:	O
a	O
nosnense	O
mutaiton	O
associated	O
with	O
hapltoype	O
4	O
of	O
the	O
phenylaalnine	O
hydroyxlase	O
gnee	O
.	O

Phenylketonuira	B-Disease
(	O
PKU	B-Disease
)	O
is	O
a	O
geneitc	B-Disease
diosrder	I-Disease
secondary	O
to	O
a	O
dfeiciency	B-Disease
of	I-Disease
hpeatic	I-Disease
phenyllaanine	I-Disease
hydroxylsae	I-Disease
(	O
PAH	O
)	O
.	O

Several	O
mutatoins	O
in	O
the	O
PAH	O
gnee	O
have	O
recently	O
been	O
reported	O
,	O
and	O
lnikage	O
disqeuilibrium	O
was	O
observed	O
between	O
RLFP	O
haploytpes	O
and	O
specific	O
mutatoins	O
.	O

A	O
new	O
mloecular	B-Disease
lesoin	I-Disease
has	O
been	O
idetnified	O
in	O
eoxn	O
7	O
of	O
the	O
PAH	O
gnee	O
in	O
a	O
Hugnarian	O
PKU	B-Disease
paitent	O
by	O
direct	O
sequnecing	O
of	O
PCR	O
-	O
amplfiied	O
DNA	O
.	O

The	O
C	O
-	O
to	O
-	O
T	O
trnasition	O
causes	O
the	O
substituiton	O
of	O
Agr243	O
to	O
a	O
terminatoin	O
coodn	O
,	O
and	O
the	O
mtuant	O
alllee	O
is	O
associated	O
with	O
haplotpye	O
4	O
of	O
the	O
PAH	O
gnee	O
.	O

The	O
muattion	O
is	O
present	O
in	O
two	O
of	O
nine	O
muatnt	O
halpotype	O
4	O
alleles	O
among	O
Eatsern	O
Euroepans	O
and	O
is	O
not	O
present	O
among	O
Wetsern	O
Europenas	O
and	O
Asains	O
.	O

The	O
rraity	O
of	O
this	O
muatnt	O
allele	O
and	O
its	O
restricted	O
gegoraphic	O
distrbiution	O
suggest	O
that	O
the	O
mutatinoal	O
eevnt	O
occurred	O
recently	O
on	O
a	O
nromal	O
haploytpe	O
4	O
background	O
in	O
Esatern	O
Euorpe	O
.	O
.	O

The	O
red	O
-	O
green	O
visaul	O
pimgent	O
gnee	O
regoin	O
in	O
adrenoleukodysrtophy	B-Disease
.	O

Although	O
recent	O
dtaa	O
established	O
that	O
a	O
specific	O
very	O
-	O
long	O
-	O
cahin	O
fatty	O
aycl	O
-	O
CoA	O
synthtease	O
is	O
deefctive	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenolekuodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
,	O
the	O
ALD	B-Disease
gnee	O
is	O
still	O
unidentified	O
.	O

The	O
ALD	B-Disease
lcous	O
has	O
been	O
mpaped	O
to	O
X2q8	O
,	O
like	O
the	O
red	O
and	O
green	O
cloor	O
pgiment	O
gnees	O
.	O

Abnromal	B-Disease
cloor	I-Disease
vsiion	I-Disease
has	O
been	O
observed	O
in	O
12	O
of	O
27	O
patietns	O
with	O
adrenomyelnoeuropathy	B-Disease
(	O
AMN	B-Disease
)	O
,	O
a	O
milder	O
form	O
of	O
ALD	B-Disease
.	O

Furthermore	O
,	O
rearranegments	O
of	O
the	O
coolr	O
visoin	O
gnee	O
clsuter	O
were	O
found	O
in	O
four	O
of	O
eight	O
ALD	B-Disease
knidreds	O
.	O

This	O
led	O
us	O
to	O
propose	O
that	O
a	O
single	O
DNA	O
rearrangmeent	O
could	O
underlie	O
both	O
ALD	B-Disease
and	O
anbormal	B-Disease
coolr	I-Disease
viison	I-Disease
in	O
these	O
patietns	O
.	O

Sutdy	O
of	O
34	O
Frecnh	O
ALD	B-Disease
paitents	O
failed	O
to	O
reveal	O
a	O
higehr	O
than	O
expected	O
freuqency	O
of	O
green	O
/	O
red	O
visaul	O
pigemnt	O
rearrangmeents	O
3	O
to	O
the	O
red	O
/	O
green	O
cloor	O
vsiion	O
gnee	O
comlpex	O
.	O

The	O
previous	O
rpeort	O
of	O
such	O
rearranegments	O
was	O
based	O
on	O
small	O
nmubers	O
and	O
lcak	O
of	O
konwledge	O
that	O
the	O
frequecny	O
of	O
"	O
abonrmal	O
"	O
cloor	O
visoin	O
arrays	O
on	O
molecluar	O
analyiss	O
was	O
twice	O
as	O
high	O
as	O
expected	O
on	O
the	O
basis	O
of	O
the	O
frequnecy	O
of	O
pheontypic	B-Disease
coolr	I-Disease
visoin	I-Disease
dfeects	I-Disease
.	O

The	O
red	O
/	O
green	O
coolr	O
pigmnet	O
(	O
R	O
/	O
GCP	O
)	O
rgeion	O
was	O
studied	O
by	O
plused	O
-	O
field	O
gel	O
electrophorseis	O
in	O
14	O
of	O
these	O
patietns	O
,	O
and	O
we	O
did	O
not	O
find	O
any	O
fargment	O
szie	O
difference	O
between	O
the	O
paitents	O
and	O
nomral	O
inidviduals	O
who	O
have	O
the	O
same	O
number	O
of	O
pigemnt	O
geens	O
.	O

The	O
R	O
/	O
GCP	O
rgeion	O
was	O
also	O
anaylzed	O
in	O
29	O
Frnech	O
and	O
seven	O
Notrh	O
Ameircan	O
ALD	B-Disease
patinets	O
by	O
using	O
six	O
genmoic	O
DNA	O
proebs	O
,	O
isoltaed	O
from	O
a	O
csomid	O
wlak	O
,	O
that	O
flank	O
the	O
cloor	O
visoin	O
geens	O
.	O

No	O
deletoins	O
were	O
found	O
with	O
proebs	O
that	O
lie	O
3	O
of	O
the	O
green	O
pigmnet	O
gnees	O
.	O

One	O
of	O
the	O
eight	O
previously	O
reported	O
ALD	B-Disease
inidviduals	O
has	O
a	O
long	O
deletoin	O
5	O
of	O
the	O
red	O
pigmnet	O
gnee	O
,	O
a	O
dleetion	O
causing	O
bule	O
cnoe	O
monochrmoacy	O
.	O

This	O
fniding	O
and	O
the	O
previous	O
fidnings	O
of	O
a	O
45	O
%	O
freuqency	O
of	O
phenoytpic	O
coolr	O
visoin	O
defetcs	O
in	O
patietns	O
with	O
AMN	B-Disease
may	O
suggest	O
that	O
the	O
ALD	B-Disease
/	O
AMN	B-Disease
gnee	O
lies	O
5	O
to	O
the	O
red	O
pgiment	O
gnee	O
and	O
that	O
the	O
freqeunt	O
phentoypic	O
cloor	B-Disease
vsiion	I-Disease
anoamlies	I-Disease
owe	O
their	O
orgiin	O
to	O
deleetd	O
DNA	O
that	O
includes	O
reuglatory	O
gnees	O
for	O
coolr	O
vsiion	O
.	O

It	O
is	O
possible	O
,	O
however	O
,	O
that	O
phenoytpic	O
cloor	B-Disease
viison	I-Disease
aonmalies	I-Disease
in	O
AMN	B-Disease
may	O
be	O
phenocopies	O
secondary	O
to	O
retnial	O
or	O
nerual	O
involvmeent	O
by	O
the	O
disesae	O
.	O

The	O
single	O
csae	O
of	O
bule	O
cnoe	O
moncohromacy	O
may	O
therefore	O
be	O
a	O
fortuitous	O
coincidnece	O
of	O
two	O
diseaess	O
.	O
.	O

Paroyxsmal	B-Disease
noctunral	I-Disease
haemoglboinuria	I-Disease
with	O
coexisting	O
deficeincy	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
:	O
lcak	O
of	O
massive	O
hameolytic	B-Disease
attcak	I-Disease
.	O

A	O
47	O
-	O
yaer	O
-	O
old	O
wmoan	O
with	O
paroyxsmal	B-Disease
noctrunal	I-Disease
haemoglobiunria	I-Disease
(	O
PNH	B-Disease
)	O
was	O
found	O
to	O
have	O
an	O
inherietd	B-Disease
defiicency	I-Disease
in	I-Disease
the	I-Disease
ninth	I-Disease
complement	I-Disease
component	I-Disease
(	O
C9	O
)	O
.	O

In	O
complement	O
-	O
senstiivity	O
lyiss	O
tsets	O
,	O
80	O
%	O
of	O
her	O
eryhtrocytes	O
were	O
markedly	O
complement	O
-	O
sensiitve	O
(	O
PNH	O
-	O
III	O
)	O
.	O

Lsaer	O
cytolfuorimetry	O
with	O
a	O
monolconal	O
atnibody	O
against	O
dceay	O
-	O
accelearting	O
facotr	O
(	O
DAF	O
)	O
reveaeld	O
that	O
95	O
%	O
of	O
her	O
erythrocyets	O
were	O
DAF	O
-	O
negatvie	O
.	O

Surprisingly	O
,	O
she	O
has	O
suffered	O
only	O
mlid	O
hameolysis	B-Disease
and	O
has	O
never	O
experienced	O
massive	O
spnotaneous	O
haeomlysis	B-Disease
.	O

Gorss	O
haeomglobinuria	B-Disease
and	O
jaudnice	B-Disease
occurred	O
only	O
after	O
receiving	O
postopeartive	O
transfuison	O
of	O
whole	O
bolod	O
.	O

In	O
her	O
sreum	O
,	O
C9	O
was	O
not	O
detetcable	O
either	O
by	O
immunologcial	O
or	O
by	O
funtcional	O
assyas	O
.	O

Both	O
the	O
Ham	O
tset	O
and	O
the	O
sguar	O
wtaer	O
tset	O
using	O
nromal	O
hmuan	O
sreum	O
or	O
plamsa	O
yielded	O
marked	O
haemolyiss	O
of	O
the	O
patinets	O
erythrcoytes	O
.	O

When	O
the	O
paitents	O
seurm	O
or	O
palsma	O
was	O
used	O
,	O
only	O
a	O
trcae	O
of	O
lsyis	O
was	O
deetcted	O
.	O

Additoin	O
of	O
puriifed	O
hmuan	O
C9	O
to	O
her	O
plamsa	O
fully	O
retsored	O
haemolyiss	O
.	O

These	O
obsrevations	O
indicated	O
that	O
C9	O
may	O
play	O
a	O
critical	O
role	O
in	O
haemolyitc	B-Disease
attacks	I-Disease
in	O
paitents	O
with	O
PNH	B-Disease
and	O
that	O
cahracteristic	O
haemloysis	B-Disease
in	O
PNH	B-Disease
may	O
be	O
tempered	O
by	O
coexisting	O
C9	B-Disease
deficeincy	I-Disease
.	O
.	O

Duplicaitonal	O
muttaion	O
at	O
the	O
Ducehnne	B-Disease
mucsular	I-Disease
dytsrophy	I-Disease
loucs	O
:	O
its	O
frequnecy	O
,	O
distributoin	O
,	O
oriign	O
,	O
and	O
phenotypeegnotype	O
crorelation	O
.	O

Partail	O
gnee	O
dleetion	O
is	O
the	O
major	O
cause	O
of	O
mutaiton	O
leading	O
to	O
Dcuhenne	B-Disease
musuclar	I-Disease
dystrohpy	I-Disease
(	O
DMD	B-Disease
)	O
and	O
Bekcer	B-Disease
msucular	I-Disease
dystrohpy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

Partail	O
gnee	O
dupliaction	O
has	O
also	O
been	O
recognized	O
in	O
a	O
few	O
caess	O
.	O

We	O
have	O
conducted	O
a	O
sruvey	O
for	O
dpulication	O
in	O
72	O
unrelated	O
nondelteion	O
pateints	O
,	O
anaylzed	O
by	O
Southren	O
bolt	O
hybrdiization	O
with	O
cloens	O
representing	O
the	O
entire	O
DMD	B-Disease
cNDA	O
.	O

With	O
careful	O
quantitatvie	O
aanlysis	O
of	O
hybridiztaion	O
bnad	O
intesnity	O
,	O
10	O
csaes	O
were	O
found	O
to	O
carry	O
a	O
dulpication	O
of	O
part	O
of	O
the	O
gnee	O
,	O
a	O
freqeuncy	O
of	O
14	O
%	O
for	O
nonedletion	O
csaes	O
(	O
10	O
/	O
72	O
)	O
,	O
or	O
6	O
%	O
for	O
all	O
csaes	O
(	O
10	O
/	O
181	O
)	O
.	O

The	O
extent	O
of	O
these	O
duplicaitons	O
has	O
been	O
charcaterized	O
according	O
to	O
the	O
pulbished	O
eoxn	O
-	O
containing	O
HindIII	O
fragmnet	O
map	O
,	O
and	O
in	O
six	O
of	O
the	O
10	O
dupliactions	O
a	O
novel	O
restrictoin	O
framgent	O
that	O
spanned	O
the	O
dulpication	O
junciton	O
was	O
deetcted	O
.	O

The	O
resulting	O
transaltional	O
readnig	O
frmae	O
of	O
mNRA	O
has	O
been	O
preditced	O
for	O
nine	O
dupilcations	O
.	O

A	O
shift	O
of	O
the	O
raeding	O
farme	O
was	O
preidcted	O
in	O
four	O
of	O
the	O
six	O
DMD	B-Disease
caess	O
and	O
in	O
one	O
of	O
the	O
two	O
intemrediate	O
caess	O
,	O
while	O
the	O
redaing	O
frmae	O
remained	O
uninterrutped	O
in	O
both	O
BMD	B-Disease
caess	O
.	O

RLFP	O
and	O
quantittaive	O
Sotuhern	O
bolt	O
analsyes	O
revaeled	O
a	O
grnadpaternal	O
oirgin	O
of	O
duplciation	O
in	O
four	O
famliies	O
and	O
grandmatenral	O
oirgin	O
in	O
one	O
fmaily	O
.	O

In	O
all	O
five	O
famliies	O
,	O
the	O
dupilcation	O
was	O
found	O
to	O
originate	O
from	O
a	O
single	O
X	O
chromosmoe	O
.	O

Unequal	O
sitser	O
-	O
chroamtid	O
exhcange	O
is	O
proposed	O
to	O
be	O
the	O
mecahnism	O
for	O
the	O
formaiton	O
of	O
these	O
dupliactions	O
.	O
.	O

Gulcose	O
6	O
-	O
phosphtae	O
deyhdrogenase	O
vraiants	O
:	O
Gd	O
(	O
+	O
)	O
Alxeandra	O
associated	O
with	O
neontaal	B-Disease
jaundcie	I-Disease
and	O
Gd	O
(	O
-	O
)	O
Campedrown	O
in	O
a	O
yonug	O
man	O
with	O
lamelalr	B-Disease
catraacts	I-Disease
.	O

Two	O
mlae	O
sujbects	O
are	O
described	O
,	O
with	O
unusaul	O
cliniacl	O
presnetations	O
and	O
with	O
hitherto	O
undescribed	O
GP6D	O
variatns	O
.	O

The	O
first	O
,	O
of	O
Italain	O
extrcation	O
,	O
suffered	O
from	O
seevre	O
nenoatal	B-Disease
juandice	I-Disease
following	O
matenral	O
ingsetion	O
of	O
frseh	O
broad	O
benas	O
(	O
Vciia	O
fvaa	O
)	O
both	O
prentaally	O
and	O
posntatally	O
the	O
expresison	O
of	O
the	O
enyzmatic	O
defcet	O
was	O
much	O
more	O
seevre	O
in	O
the	O
nenoatal	O
preiod	O
than	O
on	O
reetsting	O
in	O
adoelscence	O
,	O
when	O
biocehmical	O
characteirzation	O
showed	O
uniuqe	O
featrues	O
which	O
justify	O
dseignation	O
as	O
a	O
new	O
varinat	O
Gd	O
(	O
+	O
)	O
Alexadnra	O
.	O

The	O
second	O
ptaient	O
,	O
a	O
boy	O
of	O
Mlatese	O
etxraction	O
who	O
was	O
found	O
to	O
have	O
bilatreal	B-Disease
lamelalr	I-Disease
ctaaracts	I-Disease
at	O
the	O
age	O
of	O
4	O
yaers	O
,	O
was	O
identifeid	O
as	O
GP6D	B-Disease
dfeicient	I-Disease
only	O
as	O
a	O
result	O
of	O
a	O
sruvey	O
of	O
chidlren	O
of	O
Mdeiterranean	O
orgiin	O
with	O
unexplianed	O
cataarct	B-Disease
fromation	O
;	O
he	O
has	O
approximately	O
15	O
%	O
of	O
noraml	O
eznyme	O
actviity	O
,	O
with	O
another	O
unqiue	O
combinatoin	O
of	O
biocehmical	O
charatceristics	O
which	O
has	O
led	O
to	O
its	O
designaiton	O
as	O
Gd	O
(	O
-	O
)	O
Capmerdown	O
.	O

Although	O
this	O
associatoin	O
may	O
be	O
coicnidental	O
,	O
it	O
pormpts	O
further	O
attention	O
to	O
the	O
possibility	O
that	O
under	O
certain	O
circumstances	O
GP6D	B-Disease
defiicency	I-Disease
may	O
favor	O
catraact	B-Disease
fomration	O
.	O

The	O
two	O
caess	O
illustrate	O
the	O
value	O
of	O
charatcerization	O
of	O
the	O
mtuant	O
enzmye	O
whenever	O
unexpected	O
clniical	O
or	O
laobratory	O
rseults	O
are	O
obtained	O
.	O
.	O

Sattistical	O
analyiss	O
of	O
the	O
two	O
stgae	O
muttaion	O
moedl	O
in	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Linadu	I-Disease
disesae	I-Disease
,	O
and	O
in	O
sproadic	B-Disease
cereblelar	I-Disease
haemangioblasotma	I-Disease
and	O
reanl	B-Disease
clel	I-Disease
cacrinoma	I-Disease
.	O

Analsyis	O
of	O
the	O
age	O
incdience	O
cuvres	O
for	O
uniltaeral	B-Disease
and	I-Disease
bilaetral	I-Disease
retinolbastoma	I-Disease
led	O
Knduson	O
to	O
propose	O
that	O
heredtiary	B-Disease
tmuours	I-Disease
may	O
arise	O
by	O
a	O
single	O
evnet	O
and	O
sproadic	B-Disease
tumorus	I-Disease
by	O
a	O
two	O
satge	O
muattion	O
proecss	O
.	O

It	O
has	O
been	O
suggested	O
recently	O
that	O
sporaidc	B-Disease
reanl	I-Disease
clel	I-Disease
cracinoma	I-Disease
may	O
arise	O
from	O
a	O
two	O
stgae	O
mutaiton	O
porcess	O
.	O

We	O
aanlysed	O
the	O
age	O
icnidence	O
curevs	O
for	O
symptomtaic	O
rneal	B-Disease
clel	I-Disease
carcionma	I-Disease
(	O
n	O
=	O
26	O
)	O
and	O
cerbeellar	B-Disease
heamangioblastoma	I-Disease
(	O
n	O
=	O
68	O
)	O
in	O
109	O
paitents	O
with	O
von	B-Disease
Hipepl	I-Disease
-	I-Disease
Lidnau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
diesase	I-Disease
,	O
and	O
compraed	O
them	O
to	O
104	O
patietns	O
with	O
spordaic	B-Disease
reanl	I-Disease
clel	I-Disease
carcionma	I-Disease
and	O
43	O
patinets	O
with	O
spoardic	B-Disease
ceerbellar	I-Disease
haemangiolbastoma	I-Disease
.	O

The	O
age	O
incidecne	O
cruves	O
for	O
rneal	B-Disease
clel	I-Disease
carcinmoa	I-Disease
and	O
ceerbellar	B-Disease
haemangibolastoma	I-Disease
in	O
VHL	B-Disease
dsiease	I-Disease
were	O
compatible	O
with	O
a	O
single	O
mutatoin	O
moedl	O
,	O
whereas	O
the	O
age	O
incidnece	O
curevs	O
for	O
sporaidc	B-Disease
rneal	I-Disease
clel	I-Disease
carcnioma	I-Disease
and	O
cerebelalr	B-Disease
haemanigoblastoma	I-Disease
suggested	O
a	O
two	O
stgae	O
mtuation	O
prcoess	O
.	O

These	O
dtaa	O
are	O
compatible	O
with	O
the	O
VHL	B-Disease
gnee	O
functionnig	O
as	O
a	O
reecssive	O
tuomur	B-Disease
suprpessor	O
gnee	O
.	O

Sproadic	B-Disease
ceerbellar	I-Disease
haemangioblatsoma	I-Disease
and	O
some	O
reanl	B-Disease
clel	I-Disease
cacrinoma	I-Disease
may	O
arise	O
from	O
smoatic	O
mutaitons	O
inatcivating	O
both	O
alllees	O
at	O
the	O
VHL	B-Disease
lcous	O
.	O
.	O

Screeinng	O
for	O
carirers	O
of	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
dsiease	I-Disease
among	O
Ahskenazi	O
Jwes	O
.	O

A	O
compariosn	O
of	O
DNA	O
-	O
based	O
and	O
enzmye	O
-	O
based	O
tsets	O
.	O

BCAKGROUND	O
AND	O
METHODS	O
.	O

The	O
pervention	O
of	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
disaese	I-Disease
(	O
GM2	B-Disease
gangilosidosis	I-Disease
,	I-Disease
tpye	I-Disease
1	I-Disease
)	O
depends	O
on	O
the	O
idnetification	O
of	O
carirers	O
of	O
the	O
gnee	O
for	O
this	O
autosoaml	B-Disease
recessive	I-Disease
diosrder	I-Disease
.	O

We	O
compaerd	O
the	O
enyzme	O
-	O
based	O
tset	O
widely	O
used	O
in	O
screening	O
for	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disaese	I-Disease
with	O
a	O
tset	O
based	O
on	O
anlaysis	O
of	O
DNA	O
.	O

We	O
developed	O
metohds	O
to	O
deetct	O
the	O
three	O
mutatinos	O
in	O
the	O
HXEA	O
gnee	O
that	O
occur	O
with	O
high	O
ferquency	O
among	O
Askhenazi	O
Jwes	O
two	O
mutatoins	O
cause	O
infatnile	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disaese	I-Disease
,	O
and	O
the	O
third	O
causes	O
the	O
audlt	O
-	O
onset	O
form	O
of	O
the	O
disaese	O
.	O

DNA	O
segmnets	O
containing	O
these	O
muattion	O
siets	O
were	O
amplfiied	O
with	O
the	O
polymearse	O
cahin	O
raection	O
and	O
analzyed	O
for	O
the	O
persence	O
of	O
the	O
mutatoins	O
.	O

RESUTLS	O
.	O

Among	O
62	O
Askhenazi	O
obliagte	O
carrires	O
of	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
,	O
the	O
three	O
specific	O
muttaions	O
accounted	O
for	O
all	O
but	O
one	O
of	O
the	O
muatnt	O
alleles	O
(	O
98	O
percent	O
)	O
.	O

In	O
216	O
Ashkenzai	O
carrires	O
iedntified	O
by	O
the	O
eznyme	O
tset	O
,	O
DNA	O
analsyis	O
showed	O
that	O
177	O
(	O
82	O
percent	O
)	O
had	O
one	O
of	O
the	O
idetnified	O
mutatoins	O
.	O

Of	O
the	O
177	O
,	O
79	O
percent	O
had	O
the	O
eoxn	O
11	O
insretion	O
mtuation	O
,	O
18	O
percent	O
had	O
the	O
intorn	O
12	O
splcie	O
-	O
junciton	O
mutatoin	O
,	O
and	O
3	O
percent	O
had	O
the	O
less	O
sveere	O
eoxn	O
7	O
muttaion	O
associated	O
with	O
audlt	O
-	O
onset	O
dsiease	O
.	O

The	O
rseults	O
of	O
the	O
eznyme	O
tsets	O
in	O
the	O
39	O
subejcts	O
(	O
18	O
percent	O
)	O
who	O
were	O
defined	O
as	O
crariers	O
but	O
in	O
whom	O
DNA	O
anlaysis	O
did	O
not	O
identify	O
a	O
muatnt	O
alllee	O
were	O
probably	O
fasle	O
postiive	O
(	O
although	O
there	O
remains	O
some	O
possibility	O
of	O
unidentified	O
mutatinos	O
)	O
.	O

In	O
addition	O
,	O
of	O
152	O
pesrons	O
defined	O
as	O
nocnarriers	O
by	O
the	O
eznyme	O
-	O
based	O
tset	O
,	O
1	O
was	O
identfiied	O
as	O
a	O
carreir	O
by	O
DNA	O
analsyis	O
(	O
i	O
.	O
e	O
e	O
.	O
,	O
a	O
fasle	O
neagtive	O
enyzme	O
-	O
tset	O
result	O
)	O
.	O

CONCULSIONS	O
.	O

The	O
incresaed	O
speciifcity	O
and	O
prdeictive	O
value	O
of	O
the	O
DNA	O
-	O
based	O
tset	O
make	O
it	O
a	O
useful	O
adjucnt	O
to	O
the	O
diagnositc	O
tsets	O
currently	O
used	O
to	O
screen	O
for	O
carriers	O
of	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
diesase	I-Disease
.	O

Total	B-Disease
deficeincy	I-Disease
of	I-Disease
plsama	I-Disease
choelsteryl	I-Disease
etser	I-Disease
trnasfer	I-Disease
portein	I-Disease
in	O
sujbects	O
homozyguos	O
and	O
heteroyzgous	O
for	O
the	O
itnron	O
14	O
splicnig	O
dfeect	O
.	O

The	O
moelcular	O
basis	O
of	O
cholesteyrl	B-Disease
esetr	I-Disease
tarnsfer	I-Disease
proetin	I-Disease
(	I-Disease
CTEP	I-Disease
)	I-Disease
deifciency	I-Disease
was	O
inevstigated	O
in	O
4	O
unrelated	O
CTEP	B-Disease
-	I-Disease
defciient	I-Disease
famiiles	O
.	O

The	O
high	O
denstiy	O
lipoprtoein	O
-	O
cholseterol	O
leevls	O
of	O
the	O
prboands	O
exceeded	O
150	O
mg	O
/	O
dl	O
.	O

The	O
plamsa	O
of	O
the	O
probnads	O
was	O
totally	O
deficeint	O
in	O
CTEP	O
atcivity	O
and	O
msas	O
.	O

The	O
genoimc	O
DNA	O
of	O
the	O
patietns	O
was	O
amlpified	O
by	O
polymrease	O
chian	O
raection	O
,	O
using	O
two	O
oligonucletoide	O
pirmers	O
located	O
in	O
the	O
inrton	O
12	O
and	O
14	O
of	O
the	O
CTEP	O
gnee	O
,	O
and	O
the	O
apmlified	O
prdoucts	O
were	O
directly	O
seuqenced	O
.	O

Two	O
pateints	O
were	O
homozgyous	O
for	O
a	O
G	O
-	O
to	O
-	O
A	O
change	O
at	O
the	O
5	O
-	O
splcie	O
doonr	O
stie	O
of	O
the	O
inrton	O
14	O
.	O

The	O
G	O
-	O
to	O
-	O
A	O
change	O
would	O
cause	O
imparied	O
splicnig	O
of	O
pre	O
-	O
messneger	O
RNA	O
.	O

The	O
other	O
two	O
porbands	O
were	O
heteorzygous	O
for	O
the	O
muattion	O
,	O
but	O
totally	O
lacked	O
CTEP	O
.	O

Their	O
lipoportein	O
ptaterns	O
were	O
also	O
similar	O
to	O
those	O
of	O
the	O
two	O
homozygoets	O
.	O

Thus	O
,	O
other	O
gneetic	B-Disease
defcets	I-Disease
or	O
metaoblic	O
facotrs	O
influenicng	O
CTEP	O
expressoin	O
are	O
implicated	O
.	O

The	O
dtaa	O
suggest	O
that	O
the	O
G	O
-	O
to	O
-	O
A	O
muttaion	O
may	O
be	O
common	O
in	O
hmuan	O
palsma	O
CTEP	B-Disease
deifciency	I-Disease
.	O

Furthermore	O
,	O
there	O
could	O
be	O
cmopound	O
heterzoygotes	O
who	O
totally	O
lcak	O
palsma	O
CTEP	O
and	O
have	O
lipoprotien	O
profiels	O
similar	O
to	O
those	O
of	O
homozygtoes	O
.	O
.	O

Molecualr	O
genteics	O
of	O
the	O
glcuose	O
-	O
6	O
-	O
phsophate	O
dehydrogeanse	O
(	O
GP6D	O
)	O
Mediterranean	O
varinat	O
and	O
description	O
of	O
a	O
new	O
GP6D	O
muatnt	O
,	O
GP6D	O
Andalus1316A	O
.	O

Glucsoe	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phopshate	I-Disease
dheydrogenase	I-Disease
(	I-Disease
GP6D	I-Disease
;	I-Disease
E	I-Disease
.	I-Disease
C	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
dfeiciency	I-Disease
is	O
the	O
most	O
common	O
hmuan	O
enzymoptahy	B-Disease
;	O
more	O
than	O
300	O
different	O
biocehmical	O
variatns	O
of	O
the	O
eznyme	O
have	O
been	O
described	O
.	O

In	O
many	O
patrs	O
of	O
the	O
world	O
the	O
Medtierranean	O
tpye	O
of	O
GP6D	B-Disease
deficeincy	I-Disease
is	O
prvealent	O
.	O

However	O
,	O
GP6D	O
Medtierranean	O
has	O
come	O
to	O
be	O
regarded	O
as	O
a	O
geneirc	O
term	O
applied	O
to	O
similar	O
GP6D	O
mutatoins	O
thought	O
,	O
however	O
,	O
to	O
represent	O
a	O
somewhat	O
heteorgeneous	O
gorup	O
.	O

A	O
C	O
-	O
-	O
-	O
-	O
T	O
muattion	O
at	O
nucleotdie	O
563	O
of	O
GP6D	O
Mediterarnean	O
has	O
been	O
idetnified	O
by	O
Vulilamy	O
et	O
al	O
.	O
,	O
and	O
the	O
same	O
mutatoin	O
has	O
been	O
found	O
by	O
De	O
Vtia	O
et	O
al	O
.	O
in	O
GP6D	O
Mediterranean	O
,	O
GP6D	O
Sassari	O
,	O
and	O
GP6D	O
Cagilari	O
.	O

The	O
latter	O
sujbects	O
had	O
an	O
additional	O
mutatoin	O
,	O
at	O
nucloetide	O
1311	O
,	O
that	O
did	O
not	O
produce	O
a	O
cdoing	O
change	O
.	O

We	O
have	O
examined	O
geonmic	O
DNA	O
of	O
five	O
pateints	O
-	O
-	O
four	O
of	O
Spainsh	O
oriign	O
and	O
one	O
of	O
Jeiwsh	O
oirgin	O
-	O
-	O
having	O
enyzmatically	O
docmuented	O
GP6D	O
Mediterarnean	O
.	O

All	O
had	O
both	O
the	O
mutaiton	O
at	O
nucleotdie	O
563	O
and	O
that	O
at	O
nucelotide	O
1311	O
.	O

A	O
sixth	O
smaple	O
,	O
resembling	O
GP6D	O
Mediterrnaean	O
kinetically	O
but	O
with	O
a	O
slightly	O
raipd	O
eelctrophoretic	O
moiblity	O
,	O
was	O
designated	O
GP6D	O
Andlaus	O
and	O
was	O
found	O
to	O
have	O
a	O
different	O
muattion	O
,	O
a	O
G	O
-	O
-	O
-	O
-	O
A	O
tranistion	O
at	O
nucleotdie	O
1361	O
,	O
producing	O
an	O
argiinne	O
-	O
to	O
-	O
histiidne	O
susbtitution	O
.	O

These	O
stuides	O
suggest	O
that	O
GP6D	O
Meditreranean	O
is	O
,	O
after	O
all	O
,	O
relatively	O
homgoeneous	O
.	O

A	O
noraml	O
mlae	O
with	O
an	O
ihnerited	O
deeltion	O
of	O
one	O
eoxn	O
within	O
the	O
DMD	B-Disease
gnee	O
.	O

We	O
describe	O
two	O
brohters	O
with	O
iedntical	O
inhreited	O
deletoins	O
of	O
one	O
single	O
eoxn	O
within	O
the	O
mdidle	O
of	O
the	O
DMD	B-Disease
gnee	O
;	O
one	O
brtoher	O
has	O
Bceker	B-Disease
mucsular	I-Disease
dysrtophy	I-Disease
daignosed	O
at	O
11	O
yaers	O
of	O
age	O
,	O
whereas	O
the	O
odler	O
brtoher	O
is	O
noraml	O
at	O
18	O
.	O

These	O
resutls	O
have	O
implications	O
for	O
gneetic	O
counsellnig	O
and	O
prneatal	O
diangosis	O
in	O
fmailies	O
with	O
Becekr	B-Disease
muscualr	I-Disease
dystorphy	I-Disease
.	O
.	O

Duchnene	B-Disease
muscluar	I-Disease
dystorphy	I-Disease
gnee	O
exprsesion	O
in	O
nomral	O
and	O
disaesed	O
huamn	O
mucsle	O
.	O

A	O
prboe	O
for	O
the	O
5	O
end	O
of	O
the	O
Duchenne	B-Disease
muscualr	I-Disease
dytsrophy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
was	O
used	O
to	O
stduy	O
expressoin	O
of	O
the	O
gnee	O
in	O
noraml	O
huamn	O
muslce	O
,	O
myoegnic	O
clel	O
cutlures	O
,	O
and	O
mucsle	O
from	O
ptaients	O
with	O
DMD	B-Disease
.	O

Experssion	O
was	O
found	O
in	O
RNA	O
from	O
nromal	O
featl	O
muslce	O
,	O
audlt	O
cardaic	O
and	O
skeeltal	O
msucle	O
,	O
and	O
cultuerd	O
mucsle	O
after	O
moyblast	O
fusoin	O
.	O

In	O
DMD	B-Disease
muslce	O
,	O
exprsesion	O
of	O
this	O
protion	O
of	O
the	O
gnee	O
was	O
also	O
reevaled	O
by	O
in	O
situ	O
RNA	O
hybridizatoin	O
,	O
particularly	O
in	O
regeenrating	O
mucsle	O
fbiers	O
.	O
.	O

Molecualr	O
and	O
phenotpyic	O
analyiss	O
of	O
patinets	O
with	O
deleitons	O
within	O
the	O
deletoin	O
-	O
rich	O
rgeion	O
of	O
the	O
Duhcenne	B-Disease
muscluar	I-Disease
dystrpohy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
.	O

Eighty	O
unrelated	O
individulas	O
with	O
Ducehnne	B-Disease
msucular	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
or	O
Becekr	B-Disease
muscluar	I-Disease
dystrohpy	I-Disease
(	O
BMD	B-Disease
)	O
were	O
found	O
to	O
have	O
deleitons	O
in	O
the	O
major	O
dleetion	O
-	O
rich	O
regoin	O
of	O
the	O
DMD	B-Disease
lcous	O
.	O

This	O
rgeion	O
includes	O
the	O
last	O
five	O
eoxns	O
dteected	O
by	O
cDN5Ab	O
-	O
7	O
,	O
all	O
exnos	O
detetced	O
by	O
cNDA8	O
,	O
and	O
the	O
first	O
two	O
eoxns	O
detceted	O
by	O
cDAN9	O
.	O

These	O
80	O
idnividuals	O
account	O
for	O
approximately	O
75	O
%	O
of	O
109	O
delteions	O
of	O
the	O
gnee	O
,	O
detceted	O
among	O
181	O
patietns	O
anlayzed	O
with	O
the	O
entire	O
dystrpohin	O
cNDA	O
.	O

Endpionts	O
for	O
many	O
of	O
these	O
deeltions	O
were	O
further	O
chaarcterized	O
using	O
two	O
genmoic	O
porbes	O
,	O
p20	O
(	O
DXS629	O
;	O
Wapenaar	O
et	O
al	O
.	O
)	O
and	O
GMXG11	O
(	O
DX2S39	O
;	O
present	O
paper	O
)	O
.	O

Cliniacl	O
fnidings	O
are	O
presented	O
for	O
all	O
80	O
patietns	O
allowing	O
a	O
corerlation	O
of	O
pehnotypic	O
severtiy	O
with	O
the	O
genoytpe	O
.	O

Thirty	O
-	O
eight	O
indepenednt	O
ptaients	O
were	O
old	O
enough	O
to	O
be	O
classified	O
as	O
DMD	B-Disease
,	O
BMD	B-Disease
,	O
or	O
intermdeiate	O
pehnotype	O
and	O
had	O
dleetions	O
of	O
eoxns	O
with	O
sequneced	O
intorn	O
/	O
eoxn	O
boundaires	O
.	O

Of	O
these	O
,	O
eight	O
BMD	B-Disease
patinets	O
and	O
one	O
intermdeiate	O
ptaient	O
had	O
gnee	O
deletoins	O
predicetd	O
to	O
leave	O
the	O
readnig	O
farme	O
inatct	O
,	O
while	O
21	O
DMD	B-Disease
ptaients	O
,	O
7	O
interemdiate	O
pateints	O
,	O
and	O
1	O
BMD	B-Disease
ptaient	O
had	O
gnee	O
deeltions	O
preidcted	O
to	O
disurpt	O
the	O
readnig	O
farme	O
.	O

Thus	O
,	O
with	O
two	O
exceptions	O
,	O
framsehift	O
dleetions	O
of	O
the	O
gnee	O
resulted	O
in	O
more	O
seevre	O
phenotpye	O
than	O
did	O
in	O
-	O
frmae	O
deeltions	O
.	O

This	O
is	O
in	O
agreement	O
with	O
recent	O
fnidings	O
by	O
Buambach	O
et	O
al	O
.	O
and	O
Koenig	O
et	O
al	O
.	O
but	O
is	O
in	O
contrast	O
to	O
finidngs	O
,	O
by	O
Malhotra	O
et	O
al	O
.	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
gnee	O
.	O

Cloinng	O
of	O
brekapoints	O
of	O
a	O
crhomosome	O
transolcation	O
identifies	O
the	O
AN2	O
lcous	O
.	O

Chromosmoe	O
translocaitons	O
involving	O
11p13	O
have	O
been	O
associated	O
with	O
famiilal	B-Disease
ainridia	I-Disease
in	O
two	O
kindrdes	O
highlighting	O
the	O
chromosmoal	O
locailzation	O
of	O
the	O
AN2	O
lcous	O
.	O

This	O
lcous	O
is	O
also	O
part	O
of	O
the	O
WGAR	B-Disease
comlpex	O
(	O
Wlims	B-Disease
tuomr	I-Disease
,	O
ainridia	B-Disease
,	O
genitoruinary	B-Disease
abnomralities	I-Disease
,	O
and	O
metnal	B-Disease
retardatoin	I-Disease
)	O
.	O

In	O
one	O
kidnred	O
,	O
the	O
translocaiton	O
is	O
associated	O
with	O
a	O
deeltion	O
,	O
and	O
porbes	O
for	O
this	O
reigon	O
were	O
used	O
to	O
identify	O
and	O
clnoe	O
the	O
breapkoints	O
of	O
the	O
tranlsocation	O
in	O
the	O
second	O
kinderd	O
.	O

Copmarison	O
of	O
pahge	O
resrtiction	O
mpas	O
exclude	O
the	O
prseence	O
of	O
any	O
sizable	O
deletoin	O
in	O
this	O
csae	O
.	O

Sequecnes	O
at	O
the	O
chromosmoe	O
11	O
berakpoint	O
are	O
conserved	O
in	O
mulitple	O
sepcies	O
,	O
suggesting	O
that	O
the	O
transloctaion	O
flals	O
within	O
the	O
AN2	O
gnee	O
.	O
.	O

Liknage	O
analyiss	O
of	O
the	O
apoilpoprotein	O
C2	O
gnee	O
and	O
myootnic	B-Disease
dysrtophy	I-Disease
on	O
hmuan	O
chromosmoe	O
19	O
reveals	O
linkgae	O
disequilibirum	O
in	O
a	O
Fernch	O
-	O
Caandian	O
populaiton	O
.	O

The	O
gnee	O
for	O
hmuan	O
apolipoproetin	O
C2	O
(	O
AOPC2	O
)	O
,	O
situated	O
on	O
the	O
proxiaml	O
long	O
arm	O
of	O
chromoosme	O
19	O
,	O
is	O
closely	O
linked	O
to	O
the	O
gnee	O
for	O
the	O
most	O
common	O
form	O
of	O
adlut	O
muscluar	B-Disease
dytsrophy	I-Disease
,	O
mytoonic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Six	O
AOPC2	O
RFPLs	O
(	O
TqaI	O
,	O
BlgI	O
,	O
BnaI	O
,	O
BmaHI	O
,	O
NocI	O
,	O
and	O
AavII	O
)	O
have	O
been	O
identiifed	O
to	O
date	O
.	O

We	O
have	O
conducted	O
a	O
comprehnesive	O
DM	B-Disease
lnikage	O
sutdy	O
utilizing	O
all	O
six	O
RLFPs	O
and	O
involving	O
50	O
fmailies	O
and	O
372	O
individulas	O
.	O

The	O
most	O
inforamtive	O
RFPLs	O
are	O
,	O
in	O
desecnding	O
order	O
,	O
NocI	O
(	O
lod	O
=	O
6	O
.	O
64	O
,	O
thtea	O
=	O
0	O
.	O
05	O
)	O
,	O
BlgI	O
(	O
lod	O
=	O
6	O
.	O
12	O
,	O
thtea	O
=	O
0	O
.	O
05	O
)	O
,	O
AavII	O
(	O
lod	O
=	O
6	O
.	O
02	O
,	O
tehta	O
=	O
0	O
.	O
03	O
)	O
,	O
BnaI	O
(	O
lod	O
=	O
5	O
.	O
76	O
,	O
thtea	O
=	O
0	O
.	O
04	O
)	O
,	O
TqaI	O
(	O
lod	O
=	O
4	O
.	O
29	O
,	O
tehta	O
=	O
0	O
.	O
06	O
)	O
,	O
and	O
BmaHI	O
(	O
lod	O
=	O
1	O
.	O
75	O
,	O
thtea	O
=	O
0	O
.	O
01	O
)	O
.	O

A	O
substantial	O
icnrease	O
in	O
the	O
lod	O
socres	O
over	O
those	O
seen	O
with	O
the	O
inidvidual	O
RLFPs	O
was	O
obtained	O
when	O
the	O
linakge	O
of	O
the	O
entire	O
APCO2	O
hpalotype	O
(	O
composed	O
of	O
the	O
six	O
RFPLs	O
)	O
was	O
studied	O
(	O
lod	O
=	O
17	O
.	O
87	O
,	O
tehta	O
=	O
0	O
.	O
04	O
)	O
.	O

We	O
have	O
observed	O
significant	O
inetr	O
-	O
APCO2	O
RLFP	O
linkgae	O
disequliibrium	O
.	O

Consequently	O
,	O
the	O
three	O
most	O
infromative	O
RLFPs	O
have	O
been	O
found	O
to	O
be	O
BnaI	O
,	O
TqaI	O
,	O
and	O
either	O
BlgI	O
,	O
AvIaI	O
,	O
or	O
NocI	O
poylmorphisms	O
.	O

We	O
also	O
demonstrate	O
lnikage	O
diseuqilibrium	O
between	O
DM	O
and	O
AOPC2	O
in	O
our	O
Frnech	O
-	O
Candaian	O
populatoin	O
(	O
stnadardized	O
disequilbirium	O
cnostant	O
phi	O
=	O
.	O
22	O
,	O
chi	O
2	O
=	O
5	O
.	O
12	O
,	O
df	O
=	O
1	O
,	O
P	O
less	O
than	O
0	O
.	O
04	O
)	O
.	O

This	O
represents	O
the	O
first	O
evidecne	O
of	O
liknage	O
disequilibruim	O
between	O
APCO2	O
and	O
the	O
DM	B-Disease
lcous	O
.	O

Phenylalainne	O
hydroyxlase	O
gnee	O
halpotypes	O
in	O
Poylnesians	O
:	O
evoluitonary	O
orignis	O
and	O
absecne	O
of	O
alleels	O
associated	O
with	O
sveere	O
phneylketonuria	B-Disease
.	O

A	O
total	O
of	O
630	O
hapoltypes	O
for	O
the	O
phenlyalanine	O
hyrdoxylase	O
(	O
PAH	O
)	O
gnee	O
loucs	O
were	O
established	O
in	O
five	O
gropus	O
of	O
Polnyesians	O
comprising	O
Saomans	O
,	O
Tonagns	O
,	O
Cook	O
Islanedrs	O
,	O
Maroi	O
,	O
and	O
Niuenas	O
.	O

Considerable	O
gneetic	O
contiunity	O
was	O
demonstrated	O
between	O
these	O
widely	O
dispesred	O
populatinos	O
,	O
since	O
three	O
common	O
haploytpes	O
(	O
4	O
,	O
1	O
,	O
and	O
7	O
)	O
constituted	O
over	O
95	O
%	O
of	O
alleles	O
.	O

A	O
contorl	O
gorup	O
of	O
individauls	O
from	O
Suotheast	O
Aisa	O
shared	O
the	O
same	O
major	O
hpalotypes	O
,	O
4	O
,	O
1	O
,	O
and	O
7	O
,	O
with	O
Polynesains	O
.	O

These	O
dtaa	O
provide	O
further	O
support	O
for	O
the	O
tehories	O
of	O
geentic	O
homogeenity	O
and	O
of	O
Aisan	O
affiinties	O
of	O
the	O
Poylnesian	O
precurosr	O
popultaions	O
.	O

The	O
absnece	O
of	O
sveere	O
phenylketonruia	B-Disease
(	O
PKU	B-Disease
)	O
in	O
both	O
Polynesains	O
and	O
Soutehast	O
Asinas	O
is	O
consistent	O
with	O
the	O
lcak	O
of	O
PAH	O
haplotyeps	O
2	O
and	O
3	O
,	O
on	O
which	O
the	O
sevree	O
PKU	B-Disease
mutnats	O
have	O
arisen	O
among	O
Cauacsians	O
.	O
.	O

Preferetnial	O
germlnie	O
mtuation	O
of	O
the	O
ptaernal	O
alelle	O
in	O
retinbolastoma	B-Disease
.	O

The	O
eevnt	O
triggering	O
mlaignant	O
prolfieration	O
in	O
70	O
%	O
of	O
retinbolastoma	B-Disease
tumorus	I-Disease
is	O
lsos	O
of	O
heetrozygosity	O
for	O
chromoosme	O
13q14	O
,	O
whereby	O
the	O
nomral	O
retinoblastmoa	B-Disease
gnee	O
(	O
RB1	O
)	O
alelle	O
is	O
lsot	O
and	O
an	O
already	O
muatted	O
RB1	O
allele	O
remains	O
in	O
the	O
tumuor	B-Disease
.	O

The	O
first	O
allele	O
suffers	O
a	O
mutatoinal	O
eevnt	O
-	O
-	O
deeltion	O
,	O
duplciation	O
or	O
point	O
muttaion	O
(	O
manuscirpt	O
in	O
prepraation	O
)	O
-	O
-	O
either	O
in	O
the	O
grem	O
line	O
(	O
all	O
bilatearl	O
pateints	O
)	O
or	O
in	O
a	O
somaitc	O
reitnal	O
clel	O
(	O
most	O
unilatreal	O
paitents	O
)	O
.	O

Most	O
bialteral	O
ptaients	O
have	O
no	O
faimly	O
hitsory	O
of	O
retinoblastmoa	B-Disease
and	O
are	O
presumed	O
to	O
have	O
new	O
gremline	O
mutaitons	O
which	O
arose	O
in	O
the	O
egg	O
,	O
seprm	O
or	O
eraly	O
ebmryo	O
.	O

We	O
have	O
determined	O
the	O
parnetal	O
oirgin	O
of	O
the	O
rteained	O
alllee	O
in	O
nine	O
retinbolastoma	B-Disease
tmuours	I-Disease
from	O
eight	O
unrelated	O
non	O
-	O
fmailial	O
caess	O
by	O
using	O
RB1	O
-	O
linked	O
geentic	O
makrers	O
.	O

Six	O
tuomurs	B-Disease
rteained	O
the	O
paetrnal	O
alllee	O
and	O
three	O
retanied	O
the	O
materanl	O
alllee	O
.	O

Of	O
the	O
three	O
unliateral	B-Disease
tuomurs	I-Disease
,	O
only	O
one	O
rteained	O
the	O
patrenal	O
RB1	O
alelle	O
.	O

Thus	O
,	O
there	O
is	O
no	O
evdience	O
that	O
the	O
pateranl	O
RB1	O
alelle	O
is	O
preferentially	O
retaiend	O
in	O
retinoblastmoa	B-Disease
,	O
as	O
has	O
been	O
suggested	O
to	O
be	O
the	O
csae	O
in	O
ostoesarcoma	B-Disease
.	O

By	O
contrast	O
,	O
tmuours	B-Disease
from	O
four	O
of	O
the	O
five	O
bilatearl	O
patinets	O
retanied	O
the	O
patenral	O
RB1	O
alllee	O
.	O

This	O
suggests	O
either	O
that	O
new	O
germlnie	O
RB1	O
muattions	O
arise	O
more	O
frequently	O
during	O
sprematogenesis	O
than	O
during	O
oogneesis	O
,	O
or	O
that	O
imprintnig	O
in	O
the	O
eraly	O
ebmryo	O
affects	O
chromosmoal	O
susceptibliity	O
to	O
muttaion	O
.	O
.	O

Hpalotype	O
analyiss	O
of	O
the	O
phenylalainne	O
hydroxyalse	O
gnee	O
in	O
Trukish	O
pheynlketonuria	B-Disease
famliies	O
.	O

We	O
have	O
estimaetd	O
the	O
hapoltype	O
ditsribution	O
of	O
mutnat	O
and	O
nromal	O
phneylalanine	O
hydroyxlase	O
(	O
PAH	O
)	O
alleles	O
for	O
17	O
Tukrish	O
phenlyketonuria	B-Disease
(	O
PKU	B-Disease
)	O
famiiles	O
20	O
nomral	O
and	O
27	O
mutaetd	O
PAH	O
alleles	O
could	O
be	O
idnetified	O
.	O

Of	O
the	O
latter	O
,	O
the	O
most	O
preavlent	O
were	O
associated	O
with	O
haploytpe	O
6	O
(	O
29	O
.	O
6	O
%	O
)	O
,	O
1	O
(	O
18	O
.	O
5	O
%	O
)	O
and	O
36	O
(	O
11	O
.	O
1	O
%	O
)	O
,	O
while	O
the	O
nromal	O
alelles	O
were	O
preferentially	O
associated	O
with	O
haploytpe	O
1	O
(	O
20	O
%	O
)	O
.	O

Of	O
the	O
19	O
different	O
haploytpes	O
observed	O
,	O
5	O
have	O
not	O
been	O
described	O
previously	O
.	O

The	O
hapltoype	O
distribuiton	O
difefred	O
significantly	O
from	O
that	O
of	O
the	O
Northren	O
Europaen	O
ppoulation	O
.	O

Two	O
of	O
the	O
eight	O
polymorpihc	O
sties	O
were	O
in	O
associaiton	O
with	O
PKU	B-Disease
.	O

No	O
deletoins	O
of	O
eoxn	O
seuqences	O
were	O
found	O
in	O
the	O
famiiles	O
analyesd	O
.	O

Hunitngton	B-Disease
dsiease	I-Disease
:	O
no	O
eivdence	O
for	O
loucs	O
heteroegneity	O
.	O

A	O
total	O
of	O
63	O
fmailies	O
with	O
Huntignton	B-Disease
diesase	I-Disease
(	O
HD	B-Disease
)	O
were	O
examined	O
for	O
linkgae	O
between	O
HD	B-Disease
and	O
G8	O
(	O
DS410	O
)	O
.	O

The	O
faimlies	O
included	O
57	O
Caucsaian	O
,	O
four	O
Balck	O
Ameircan	O
,	O
and	O
two	O
Jaapnese	O
.	O

The	O
cmobined	O
maxmium	O
lod	O
socre	O
was	O
87	O
.	O

69	O
at	O
thtea	O
=	O
0	O
.	O

04	O
(	O
99	O
%	O
confdience	O
intevral	O
0	O
.	O
018	O
-	O
0	O
.	O
071	O
)	O
.	O

The	O
maixmum	O
frqeuency	O
of	O
recobmination	O
was	O
0	O
.	O

03	O
in	O
maels	O
and	O
0	O
.	O

05	O
in	O
femaels	O
.	O

Fifty	O
-	O
seven	O
fmailies	O
gave	O
posiitve	O
lod	O
socres	O
;	O
five	O
small	O
famiiles	O
gave	O
midlly	O
ngeative	O
lod	O
socres	O
.	O

The	O
mxaimum	O
likelhiood	O
esitmate	O
of	O
alhpa	O
,	O
the	O
prpoortion	O
of	O
linked	O
lcoi	O
,	O
was	O
1	O
.	O

0	O
with	O
a	O
loewr	O
99	O
%	O
confidecne	O
intevral	O
of	O
0	O
.	O

88	O
.	O

These	O
dtaa	O
suggest	O
that	O
there	O
is	O
only	O
one	O
HD	B-Disease
lcous	O
,	O
although	O
a	O
second	O
rrae	O
lcous	O
cannot	O
be	O
ruled	O
out	O
.	O

Haplotpye	O
and	O
multipiont	O
liknage	O
aanlysis	O
in	O
Finnsih	O
choroiedremia	B-Disease
fmailies	O
.	O

Mlutipoint	O
lnikage	O
analyiss	O
of	O
chrooideremia	B-Disease
(	O
TCD	B-Disease
)	O
and	O
seven	O
X	O
chromoosmal	O
retsriction	O
fragemnt	O
lentgh	O
polmyorphisms	O
(	O
RFPLs	O
)	O
was	O
carried	O
out	O
in	O
18	O
Finnish	O
TCD	B-Disease
famileis	O
.	O

The	O
dtaa	O
place	O
TCD	B-Disease
ditsal	O
to	O
PGK	O
and	O
DX7S2	O
,	O
very	O
close	O
to	O
DXSY1	O
and	O
DYXS5	O
(	O
Zamx	O
=	O
24	O
at	O
thtea	O
=	O
0	O
)	O
and	O
proxmial	O
to	O
DXSY4	O
and	O
DXSY12	O
.	O

This	O
agrees	O
with	O
the	O
dtaa	O
obtained	O
from	O
other	O
liknage	O
studeis	O
and	O
from	O
physcial	O
mapping	O
.	O

All	O
the	O
TCD	B-Disease
mlaes	O
and	O
carirer	O
femaels	O
studied	O
have	O
the	O
same	O
DXSY1	O
allele	O
in	O
cuopling	O
with	O
TCD	B-Disease
.	O

In	O
Northeatsern	O
Fniland	O
,	O
66	O
/	O
69	O
chromsoomes	O
carrying	O
TCD	B-Disease
had	O
the	O
same	O
hapltoype	O
at	O
lcoi	O
DSX72	O
,	O
DYXS1	O
,	O
DXSY4	O
,	O
and	O
DYXS12	O
.	O

The	O
same	O
haploytpe	O
is	O
seen	O
in	O
only	O
15	O
/	O
99	O
chroomsomes	O
not	O
carrying	O
TCD	B-Disease
.	O

Moreover	O
,	O
in	O
71	O
/	O
104	O
non	O
-	O
TCD	O
crhomosomes	O
,	O
the	O
hpalotype	O
at	O
six	O
marekr	O
lcoi	O
is	O
different	O
from	O
those	O
seen	O
in	O
any	O
of	O
the	O
76	O
TCD	B-Disease
chroomsomes	O
.	O

This	O
supports	O
the	O
previously	O
described	O
hypothseis	O
that	O
the	O
large	O
Nrothern	O
Fininsh	O
choroidreemia	B-Disease
pedigrees	O
,	O
comprising	O
a	O
total	O
of	O
over	O
80	O
livnig	O
patinets	O
representing	O
more	O
than	O
a	O
fifth	O
of	O
all	O
TCD	B-Disease
patietns	O
described	O
worldwide	O
,	O
carry	O
the	O
same	O
mutatoin	O
.	O

These	O
lnikage	O
and	O
hapoltype	O
dtaa	O
provide	O
imporved	O
opportunities	O
for	O
prentaal	O
diangosis	O
based	O
on	O
RLFP	O
sutdies	O
.	O
.	O

Autosmoal	O
dominnat	O
anriidia	B-Disease
linked	O
to	O
the	O
chormosome	O
11p13	O
marekrs	O
catlaase	O
and	O
D11S511	O
in	O
a	O
large	O
Ducth	O
faimly	O
.	O

In	O
a	O
large	O
peidgree	O
with	O
autsoomal	O
dominnat	O
anirdiia	B-Disease
,	O
we	O
found	O
close	O
lnikage	O
between	O
the	O
anirdiia	B-Disease
loucs	O
AN2	O
and	O
the	O
makrers	O
caatlase	O
(	O
CAT	O
)	O
(	O
ztea	O
=	O
7	O
.	O
27	O
at	O
tehta	O
=	O
0	O
.	O
00	O
)	O
and	O
D111S51	O
(	O
ztea	O
=	O
3	O
.	O
86	O
at	O
tehta	O
=	O
0	O
.	O
10	O
)	O
flanking	O
the	O
AN2	O
lcous	O
on	O
11p13	O
.	O

Psoitive	O
lod	O
scoers	O
were	O
also	O
obtained	O
for	O
the	O
11p13	O
-	O
-	O
-	O
-	O
11p14	O
marekrs	O
D1S116	O
and	O
FHSB	O
with	O
the	O
linkgae	O
gorup	O
CAT	O
/	O
AN2	O
/	O
D111S51	O
.	O

We	O
conclude	O
that	O
the	O
autosmoal	O
domiannt	O
anirdiia	B-Disease
in	O
this	O
fmaily	O
is	O
due	O
to	O
a	O
mtuation	O
at	O
the	O
AN2	O
lcous	O
on	O
11p13	O
.	O

We	O
have	O
excluded	O
linkgae	O
(	O
ztea	O
less	O
than	O
-	O
2	O
at	O
thtea	O
less	O
than	O
0	O
.	O
18	O
)	O
between	O
the	O
aniriida	B-Disease
and	O
the	O
chromsoome	O
2p25	O
mraker	O
DS21	O
(	O
linked	O
to	O
APC1	O
)	O
.	O

Recombinaiton	O
eevnts	O
that	O
locate	O
moytonic	B-Disease
dytsrophy	I-Disease
disatl	O
to	O
APCO2	O
on	O
19q	O
.	O

We	O
previously	O
reported	O
a	O
recombinatoin	O
in	O
an	O
indviidual	O
with	O
myotoinc	B-Disease
dsytrophy	I-Disease
(	O
DM	B-Disease
)	O
which	O
placed	O
the	O
marekrs	O
D91S19	O
and	O
AOPC2	O
on	O
the	O
same	O
side	O
of	O
the	O
DM	B-Disease
lcous	O
.	O

Halpotyping	O
of	O
this	O
famliy	O
with	O
more	O
recently	O
charcaterized	O
proebs	O
which	O
are	O
either	O
tightly	O
linked	O
to	O
DM	B-Disease
or	O
ditsal	O
to	O
the	O
liknage	O
gorup	O
at	O
q13	O
.	O

2	O
shows	O
that	O
the	O
DM	B-Disease
loucs	O
is	O
dsital	O
to	O
AOPC2	O
.	O

This	O
is	O
confirmed	O
by	O
other	O
recomibnants	O
where	O
DM	B-Disease
segregates	O
with	O
disatl	O
porbes	O
.	O

Additional	O
marekr	O
to	O
marekr	O
rceombinations	O
in	O
uanffected	O
individauls	O
are	O
reported	O
and	O
support	O
the	O
order	O
and	O
oirentation	O
of	O
the	O
DM	B-Disease
liknage	O
gorup	O
as	O
petr	O
-	O
(	O
ISNR	O
,	O
LLDR	O
,	O
S9	O
)	O
-	O
(	O
S19	O
,	O
BLC3	O
,	O
APCO2	O
)	O
-	O
(	O
CMKM	O
,	O
DM	O
)	O
-	O
(	O
S22	O
,	O
+	O
+	O
+	O
PKRCG	O
)	O
-	O
qetr	O
.	O

The	O
dtaa	O
presented	O
here	O
cannot	O
determine	O
whether	O
DM	B-Disease
is	O
prxoimal	O
or	O
dsital	O
to	O
CMKM	O
.	O

The	O
consequecnes	O
of	O
this	O
prboe	O
order	O
for	O
anteantal	O
diagnoiss	O
and	O
future	O
resaerch	O
aiming	O
to	O
isoalte	O
the	O
gnee	O
which	O
is	O
affecetd	O
in	O
DM	B-Disease
are	O
discussed	O
.	O

Mutatoins	O
in	O
the	O
RB1	O
gnee	O
and	O
their	O
effcets	O
on	O
trasncription	O
.	O

Incativation	O
of	O
both	O
alelles	O
of	O
the	O
RB1	O
gnee	O
during	O
noraml	O
reitnal	O
devleopment	O
iintiates	O
the	O
fomration	O
of	O
a	O
reitnoblastoma	B-Disease
(	I-Disease
RB	I-Disease
)	I-Disease
tmuor	I-Disease
.	O

To	O
identify	O
the	O
mutatoins	O
which	O
inatcivate	O
RB1	O
,	O
21	O
RB	B-Disease
tmuors	I-Disease
isolaetd	O
from	O
19	O
patinets	O
were	O
aanlyzed	O
with	O
the	O
polmyerase	O
chian	O
reatcion	O
or	O
an	O
RNsae	O
portection	O
asasy	O
or	O
both	O
.	O

Mutatoins	O
were	O
idetnified	O
in	O
13	O
of	O
21	O
RB	B-Disease
tuomrs	I-Disease
;	O
in	O
8	O
tumros	B-Disease
,	O
the	O
precise	O
errros	O
in	O
nucletoide	O
sqeuence	O
were	O
chraacterized	O
.	O

Each	O
of	O
four	O
grem	O
line	O
mtuations	O
involved	O
a	O
small	O
deeltion	O
or	O
dpulication	O
,	O
while	O
three	O
somtaic	O
mtuations	O
were	O
point	O
mutatinos	O
leading	O
to	O
slpice	O
alteartions	O
and	O
lsos	O
of	O
an	O
eoxn	O
from	O
the	O
mautre	O
RB1	O
mNRA	O
.	O

We	O
were	O
unable	O
to	O
dteect	O
experssion	O
of	O
the	O
muatnt	O
alllee	O
in	O
lypmhoblasts	O
of	O
three	O
bilaterally	O
affceted	O
patinets	O
,	O
although	O
the	O
mtuation	O
was	O
present	O
in	O
the	O
genoimc	O
DNA	O
and	O
transcritps	O
containing	O
the	O
mutatinos	O
were	O
obvious	O
in	O
the	O
RB	B-Disease
tuomrs	I-Disease
in	O
the	O
asbence	O
of	O
a	O
noraml	O
RB1	O
alllee	O
.	O

The	O
variaitons	O
in	O
the	O
leevl	O
of	O
experssion	O
of	O
mutnat	O
tarnscripts	O
suggest	O
deregultaion	O
of	O
RB1	O
transcrpition	O
in	O
the	O
absecne	O
of	O
a	O
fnuctional	O
RB1	O
gnee	O
proudct	O
.	O
.	O

Partail	O
deleiton	O
8q	O
without	O
Lnager	B-Disease
-	I-Disease
Geidion	I-Disease
snydrome	I-Disease
:	O
a	O
recognisable	O
syndrmoe	O
.	O

We	O
rpeort	O
two	O
de	O
novo	O
caess	O
of	O
del	O
(	O
8	O
)	O
(	O
petr	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
)	O
with	O
brekapoints	O
involving	O
the	O
ditsal	O
part	O
of	O
bnad	O
82q4	O
.	O

1	O
1	O
.	O

The	O
cliniacl	O
featuers	O
were	O
similar	O
and	O
there	O
were	O
no	O
obvious	O
sitgmata	O
of	O
Lnager	B-Disease
-	I-Disease
Gideion	I-Disease
snydrome	I-Disease
(	O
LGS	B-Disease
)	O
.	O

There	O
are	O
three	O
other	O
csaes	O
reported	O
with	O
a	O
delteion	O
of	O
chromosmoe	O
8	O
at	O
approximately	O
the	O
same	O
breakopint	O
,	O
one	O
without	O
LGS	B-Disease
and	O
some	O
siimlarities	O
to	O
our	O
csaes	O
,	O
the	O
other	O
two	O
with	O
LGS	B-Disease
.	O

Our	O
findnigs	O
would	O
support	O
the	O
observatoin	O
that	O
the	O
critical	O
segmnet	O
for	O
the	O
asisgnment	O
of	O
LGS	B-Disease
is	O
prxoimal	O
to	O
or	O
involves	O
the	O
proxiaml	O
part	O
of	O
82q4	O
.	O

1	O
,	O
but	O
a	O
rveiew	O
of	O
publisehd	O
reprots	O
suggests	O
that	O
the	O
aetiloogy	O
of	O
LGS	B-Disease
may	O
be	O
a	O
more	O
copmlex	O
issue	O

Myootnic	B-Disease
dystrpohy	I-Disease
is	O
closely	O
linked	O
to	O
the	O
gnee	O
for	O
muslce	O
-	O
tpye	O
creatnie	O
kniase	O
(	O
CMKM	O
)	O
.	O

We	O
have	O
studied	O
geneitc	O
linakge	O
between	O
the	O
gnee	O
for	O
creaitne	O
kianse	O
muslce	O
tpye	O
(	O
CMKM	O
)	O
and	O
the	O
gnee	O
for	O
mytoonic	B-Disease
dystrohpy	I-Disease
(	O
DM	B-Disease
)	O
.	O

In	O
a	O
panel	O
of	O
65	O
mytoonic	B-Disease
dystorphy	I-Disease
famliies	O
from	O
Caanda	O
and	O
the	O
Netheralnds	O
,	O
a	O
maixmum	O
lod	O
scroe	O
(	O
Zamx	O
)	O
of	O
22	O
.	O

8	O
at	O
a	O
recombinatoin	O
frequecny	O
(	O
tehta	O
)	O
of	O
0	O
.	O

03	O
was	O
obtained	O
.	O

Tihgt	O
lnikage	O
was	O
also	O
demonstrated	O
for	O
CMKM	O
and	O
the	O
gnee	O
for	O
apolipporotein	O
C2	O
(	O
ApCo2	O
)	O
.	O

This	O
establishes	O
CMKM	O
as	O
a	O
useful	O
makrer	O
for	O
myotnoic	B-Disease
dystrohpy	I-Disease

Coolr	B-Disease
vsiion	I-Disease
dfeects	I-Disease
in	O
adrenomyleoneuropathy	B-Disease
.	O

The	O
relatinoship	O
between	O
abnomral	B-Disease
coolr	I-Disease
visoin	I-Disease
and	O
adrenoymeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
was	O
investigtaed	O
in	O
27	O
AMN	B-Disease
patinets	O
and	O
31	O
age	O
-	O
matched	O
cnotrols	O
by	O
using	O
the	O
Farnsowrth	O
-	O
Musnell	O
100	O
Hue	O
tset	O
.	O

Twelve	O
(	O
44	O
%	O
)	O
of	O
27	O
patinets	O
showed	O
tset	O
scoers	O
significantly	O
above	O
nomral	O
.	O

The	O
aexs	O
of	O
bioplarity	O
determined	O
by	O
the	O
tesitng	O
differed	O
widely	O
between	O
the	O
paitents	O
with	O
abnoraml	O
scoers	O
,	O
compatible	O
with	O
the	O
notion	O
that	O
different	O
atlerations	O
in	O
visaul	O
pigemnt	O
geens	O
occur	O
in	O
different	O
AMN	B-Disease
kinrdeds	O
.	O

These	O
observtaions	O
confirm	O
our	O
earlier	O
imprsesion	O
that	O
the	O
ferquency	O
of	O
abnomral	B-Disease
cloor	I-Disease
visoin	I-Disease
is	O
increaesd	O
in	O
these	O
kinderds	O
,	O
and	O
it	O
supports	O
our	O
contentoins	O
that	O
(	O
1	O
)	O
AMN	B-Disease
(	O
and	O
its	O
compnaion	O
,	O
adrenoleukodystrohpy	B-Disease
)	O
are	O
very	O
closely	O
linked	O
to	O
the	O
viusal	O
pgiment	O
lcoi	O
at	O
X2q8	O
and	O
(	O
2	O
)	O
this	O
proximtiy	O
might	O
provide	O
the	O
opportunity	O
to	O
observe	O
contiguous	B-Disease
gnee	I-Disease
deefcts	I-Disease
.	O
.	O

Molecluar	O
analsyis	O
of	O
a	O
fmeale	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
patinet	O
.	O

We	O
rpeort	O
the	O
identificatoin	O
of	O
a	O
feamle	O
pateint	O
with	O
the	O
X	O
-	O
linked	O
recessvie	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
snydrome	I-Disease
(	O
hpyoxanthine	B-Disease
phospohribosyltransferase	I-Disease
[	I-Disease
HRPT	I-Disease
]	I-Disease
deficinecy	I-Disease
)	O
.	O

Cytogneetic	O
and	O
carirer	O
stduies	O
rveealed	O
structurally	O
nromal	O
crhomosomes	O
for	O
this	O
patinet	O
and	O
her	O
praents	O
and	O
demonstrated	O
that	O
this	O
muattion	O
arose	O
through	O
a	O
de	O
novo	O
gaemtic	O
evnet	O
.	O

Cmoparison	O
of	O
this	O
patinets	O
DNA	O
with	O
the	O
DNA	O
of	O
her	O
paernts	O
revelaed	O
that	O
a	O
micordeletion	O
,	O
which	O
occurred	O
within	O
a	O
materanl	O
gaemte	O
and	O
involved	O
the	O
entire	O
HRPT	O
gnee	O
,	O
was	O
patrially	O
responsible	O
for	O
the	O
disesae	O
in	O
this	O
paitent	O
.	O

Somtaic	O
clel	O
hyrbids	O
,	O
generated	O
to	O
separate	O
matrenal	O
and	O
ptaernal	O
X	O
chromosmoes	O
,	O
showed	O
that	O
expression	O
of	O
two	O
additional	O
X	O
-	O
linked	O
enzyems	O
,	O
phospholgycerate	O
kinsae	O
and	O
gulcose	O
-	O
6	O
-	O
phopshate	O
dehydrognease	O
,	O
were	O
expresesd	O
only	O
in	O
clels	O
that	O
contained	O
the	O
maetrnal	O
X	O
chromoosme	O
,	O
suggesting	O
the	O
preesnce	O
of	O
a	O
functionally	O
inacitve	O
patenral	O
X	O
chrmoosome	O
.	O

Furthermore	O
,	O
copmarison	O
of	O
methyaltion	O
pattrens	O
within	O
a	O
regoin	O
of	O
the	O
HRPT	O
gnee	O
known	O
to	O
be	O
important	O
in	O
gnee	O
regualtion	O
revelaed	O
differenecs	O
between	O
DNA	O
from	O
the	O
fatehr	O
and	O
the	O
paitent	O
,	O
in	O
keeping	O
with	O
an	O
atcive	O
HRPT	O
loucs	O
in	O
the	O
fahter	O
and	O
an	O
inacitve	O
HRPT	O
loucs	O
in	O
the	O
pateint	O
.	O

Together	O
these	O
dtaa	O
indicate	O
that	O
nnorandom	O
inactiavtion	O
of	O
the	O
cytogeneitcally	O
nromal	O
ptaernal	O
X	O
chormosome	O
and	O
a	O
microdeletoin	O
of	O
the	O
HRPT	O
gnee	O
on	O
an	O
atcive	O
matrenal	O
X	O
chroomsome	O
were	O
responsible	O
for	O
the	O
absnece	O
of	O
HRPT	O
in	O
this	O
patinet	O
.	O
.	O

Pleizaeus	B-Disease
-	I-Disease
Merzbahcer	I-Disease
diesase	I-Disease
:	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
neurloogic	I-Disease
disoredr	I-Disease
of	I-Disease
myeiln	I-Disease
metaboilsm	I-Disease
with	O
a	O
novel	O
muttaion	O
in	O
the	O
gnee	O
enocding	O
proteoliipd	O
portein	O
.	O

The	O
nsoology	O
of	O
the	O
inobrn	B-Disease
errros	I-Disease
of	I-Disease
myeiln	I-Disease
metabloism	I-Disease
has	O
been	O
stymied	O
by	O
the	O
lcak	O
of	O
molecluar	O
geneitc	O
anlaysis	O
.	O

Historically	O
,	O
Pelizeaus	B-Disease
-	I-Disease
Merzabcher	I-Disease
disaese	I-Disease
has	O
encompassed	O
a	O
hsot	O
of	O
neuorlogic	B-Disease
disordres	I-Disease
that	O
present	O
with	O
a	O
defciit	B-Disease
of	I-Disease
mylein	I-Disease
,	O
the	O
memrbane	O
elaborated	O
by	O
glail	O
clels	O
that	O
encricles	O
and	O
successively	O
enwrpas	O
axnos	O
.	O

We	O
describe	O
here	O
a	O
Pelziaeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
pedigere	O
of	O
the	O
classical	O
tpye	O
,	O
with	O
X	O
-	O
linked	O
inheritacne	O
,	O
a	O
typical	O
cliniacl	O
progresison	O
,	O
and	O
a	O
ptahologic	O
lsos	O
of	O
myelniating	O
clels	O
and	O
mylein	O
in	O
the	O
cnetral	O
nrevous	O
sytsem	O
.	O

To	O
dicsriminate	O
varinats	O
of	O
Pelziaeus	B-Disease
-	I-Disease
Mezrbacher	I-Disease
disaese	I-Disease
,	O
a	O
set	O
of	O
oilgonucleotide	O
priemrs	O
was	O
constructed	O
to	O
polymearse	O
-	O
cahin	O
-	O
raection	O
(	O
PCR	O
)	O
ampilfy	O
and	O
sequecne	O
the	O
gnee	O
ecnoding	O
porteolipid	O
proetin	O
(	O
PLP	O
)	O
,	O
a	O
structuarl	O
protien	O
that	O
comprises	O
half	O
of	O
the	O
proetin	O
of	O
the	O
meylin	O
shetah	O
.	O

The	O
PLP	O
gnee	O
in	O
one	O
of	O
two	O
affetced	O
maels	O
and	O
the	O
crarier	O
mtoher	O
of	O
this	O
fmaily	O
exhibited	O
a	O
single	O
base	O
difference	O
in	O
the	O
more	O
than	O
2	O
kb	O
of	O
the	O
PLP	O
gnee	O
sequecned	O
,	O
a	O
C	O
-	O
-	O
-	O
-	O
T	O
transitoin	O
that	O
would	O
create	O
a	O
sernie	O
substittuion	O
for	O
porline	O
at	O
the	O
craboxy	O
end	O
of	O
the	O
prtoein	O
.	O

Our	O
resluts	O
delineate	O
the	O
clincial	O
fetaures	O
of	O
Pleizaeus	B-Disease
-	I-Disease
Merzabcher	I-Disease
dsiease	I-Disease
,	O
define	O
the	O
possible	O
mloecular	O
pathoolgy	O
of	O
this	O
dysmyeilnating	B-Disease
dsiorder	I-Disease
,	O
and	O
address	O
the	O
mloecular	O
calssification	O
of	O
ibnorn	B-Disease
errors	I-Disease
of	I-Disease
meylin	I-Disease
metabloism	I-Disease
.	O

Pateints	O
with	O
the	O
classical	O
form	O
(	O
tpye	O
I	O
)	O
and	O
the	O
more	O
seevrely	O
affecetd	O
,	O
conantal	O
varaint	O
of	O
Pelziaeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
disaese	I-Disease
(	I-Disease
tpye	I-Disease
II	I-Disease
)	I-Disease
would	O
be	O
perdicted	O
to	O
display	O
mtuation	O
at	O
the	O
PLP	O
lcous	O
.	O

The	O
other	O
varaints	O
(	O
types	O
III	O
-	O
VI	O
)	O
,	O
which	O
have	O
sometimes	O
been	O
ctaegorized	O
as	O
Peilzaeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
disesae	I-Disease
,	O
may	O
represent	O
mutaitons	O
in	O
geens	O
encoidng	O
other	O
strcutural	O
meylin	O
proetins	O
or	O
protiens	O
critical	O
to	O
myelinatoin	O
.	O
.	O

Molecualr	O
basis	O
of	O
huamn	O
von	B-Disease
Willebrand	I-Disease
diesase	I-Disease
:	O
analyiss	O
of	O
plateelt	O
von	B-Disease
Willebarnd	I-Disease
facotr	O
mNRA	O
.	O

von	B-Disease
Willebrand	I-Disease
disaese	I-Disease
(	O
vWD	B-Disease
)	O
,	O
the	O
most	O
common	O
ihnerited	B-Disease
bleeidng	I-Disease
diosrder	I-Disease
in	O
hmuans	O
,	O
can	O
result	O
from	O
either	O
a	O
quantiattive	O
or	O
a	O
qualitaitve	O
defcet	O
in	O
the	O
adhesvie	O
glyocprotein	O
,	O
von	B-Disease
Willberand	I-Disease
fcator	O
(	O
vWF	O
)	O
.	O

Molecluar	O
studeis	O
of	O
vWD	B-Disease
have	O
been	O
limietd	O
by	O
the	O
large	O
szie	O
of	O
the	O
vWF	O
gnee	O
and	O
diffiuclty	O
in	O
obtaining	O
the	O
vWF	O
mNRA	O
from	O
patinets	O
.	O

By	O
use	O
of	O
an	O
adapttaion	O
of	O
the	O
polyemrase	O
cahin	O
reatcion	O
,	O
vWF	O
mNRA	O
was	O
amplifeid	O
and	O
sqeuenced	O
from	O
periphearl	O
blood	O
plaetlets	O
.	O

A	O
silnet	O
vWF	O
alelle	O
was	O
identiifed	O
,	O
resulting	O
from	O
a	O
cis	O
dfeect	O
in	O
vWF	O
mNRA	O
transcirption	O
or	O
procesisng	O
.	O

In	O
two	O
tpye	B-Disease
IIA	I-Disease
vWD	I-Disease
ptaients	O
,	O
two	O
different	O
but	O
adajcent	O
msisense	O
muattions	O
were	O
idnetified	O
,	O
the	O
locatinos	O
of	O
which	O
may	O
identify	O
an	O
important	O
vWF	O
fnuctional	O
domian	O
.	O

Exrpession	O
in	O
heteroloogus	O
clels	O
of	O
reocmbinant	O
vWF	O
containing	O
one	O
of	O
these	O
latter	O
muattions	O
reproduced	O
the	O
charactersitic	O
strcutural	O
abonrmality	O
seen	O
in	O
tpye	B-Disease
IIA	I-Disease
vWD	I-Disease
palsma	O
.	O
.	O

Faimlial	B-Disease
defciiency	I-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
associated	O
with	O
recurrent	O
meningococcal	B-Disease
infetcions	I-Disease
.	O

We	O
describe	O
an	O
11	O
-	O
yaer	O
-	O
old	O
gril	O
suffreing	O
from	O
recrurent	B-Disease
mneingitis	I-Disease
with	O
a	O
complete	O
asbence	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
.	O

Diangosis	O
was	O
established	O
by	O
heamolytic	O
titratoin	O
and	O
wetsern	O
bltoting	O
.	O

The	O
patinets	O
sreum	O
lacked	O
the	O
85	O
kDa	O
C7	O
chian	O
.	O

Haemoyltic	O
acitvity	O
of	O
sreum	O
was	O
recontsituted	O
with	O
either	O
pooled	O
nomral	O
huamn	O
sreum	O
or	O
with	O
pruified	O
C7	O
.	O

The	O
realtives	O
(	O
parnets	O
and	O
one	O
sisetr	O
)	O
had	O
half	O
-	O
nomral	O
levles	O
of	O
both	O
immunocheimcally	O
and	O
functionally	O
determined	O
C7	O
,	O
indicating	O
a	O
heterzoygous	O
state	O
for	O
C7	B-Disease
deficiecny	I-Disease
.	O
.	O

Transloaction	O
t	O
(	O
5	O
;	O
11	O
)	O
(	O
q13	O
.	O
1	O
;	O
p13	O
)	O
associated	O
with	O
fmailial	O
isoltaed	B-Disease
anirdiia	I-Disease
.	O

A	O
fahter	O
and	O
daughter	O
with	O
isoltaed	B-Disease
anirdiia	I-Disease
were	O
observed	O
to	O
have	O
an	O
apparently	O
balnaced	O
,	O
reciprcoal	O
translocaiton	O
involving	O
chroomsomes	O
5	O
and	O
11	O
[	O
t	O
(	O
5	O
;	O
11	O
)	O
(	O
q13	O
.	O
1	O
;	O
p13	O
)	O
]	O
.	O

No	O
other	O
cilnical	O
cahracteristics	O
often	O
associated	O
with	O
the	O
deletoin	O
of	O
11p13	O
were	O
observed	O
in	O
this	O
faimly	O
.	O

This	O
findnig	O
,	O
in	O
asosciation	O
with	O
3	O
other	O
instnaces	O
of	O
single	O
beraks	O
at	O
11p13	O
and	O
ainridia	B-Disease
,	O
supports	O
the	O
assignment	O
of	O
AN2	O
to	O
11p13	O
.	O

Homzoygous	B-Disease
hypobetaliopproteinemia	I-Disease
:	O
a	O
disaese	O
distinct	O
from	O
abetalipoproproteinemia	B-Disease
at	O
the	O
molecluar	O
leevl	O
.	O

aopB	O
DNA	O
,	O
RNA	O
,	O
and	O
protien	O
from	O
two	O
patietns	O
with	O
hoomzygous	B-Disease
hypobetalipoproteineima	I-Disease
(	O
HBL	B-Disease
)	O
were	O
evalauted	O
and	O
cmopared	O
with	O
nomral	O
inidviduals	O
.	O

Soutehrn	O
bolt	O
analyiss	O
with	O
10	O
different	O
cNDA	O
proebs	O
rveealed	O
a	O
noraml	O
gnee	O
without	O
major	O
insertinos	O
,	O
deletinos	O
,	O
or	O
rearrangemetns	O
.	O

Northren	O
and	O
solt	O
bolt	O
anaylses	O
of	O
total	O
lievr	O
mNRA	O
from	O
HBL	B-Disease
paitents	O
docuemnted	O
a	O
nromal	O
szie	O
aopB	O
mNRA	O
that	O
was	O
present	O
in	O
greatly	O
rdeuced	O
qauntities	O
.	O

AopB	O
portein	O
was	O
dteected	O
within	O
HBL	B-Disease
hepaotcytes	O
utilizing	O
immunohistochemcial	O
techniqeus	O
;	O
however	O
,	O
it	O
was	O
markedly	O
redcued	O
in	O
quanitty	O
when	O
comapred	O
with	O
conrtol	O
samlpes	O
.	O

No	O
aopB	O
was	O
deetctable	O
in	O
the	O
plamsa	O
of	O
HBL	B-Disease
inidviduals	O
with	O
an	O
EILSA	O
asasy	O
.	O

These	O
dtaa	O
are	O
most	O
consistent	O
with	O
a	O
muttaion	O
in	O
the	O
cdoing	O
poriton	O
of	O
the	O
aopB	O
gnee	O
in	O
HBL	B-Disease
ptaients	O
,	O
leading	O
to	O
an	O
abonrmal	O
aopB	O
protien	O
and	O
aopB	O
mNRA	O
instabiilty	O
.	O

These	O
resluts	O
are	O
distinct	O
from	O
those	O
previously	O
noted	O
in	O
abetalipoprotienemia	B-Disease
,	O
which	O
was	O
characetrized	O
by	O
an	O
elevaetd	O
leevl	O
of	O
heptaic	O
aopB	O
mNRA	O
and	O
accuumlation	O
of	O
intracellular	O
hepaitc	O
aopB	O
protien	O
.	O
.	O

Sponatneous	O
reverison	O
of	O
novel	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
muattion	O
by	O
HRPT	O
gnee	O
rearrangement	O
.	O

Moleuclar	O
analyiss	O
of	O
an	O
uunsual	O
paitent	O
with	O
the	O
Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
syndorme	I-Disease
has	O
suggested	O
that	O
the	O
muattion	O
is	O
due	O
to	O
a	O
partail	O
HRPT	O
gnee	O
dulpication	O
.	O

We	O
now	O
rpeort	O
the	O
clonnig	O
and	O
sequencnig	O
of	O
the	O
mutnat	O
HRPT	O
cNDA	O
which	O
shows	O
the	O
precise	O
duplciation	O
of	O
exnos	O
2	O
and	O
3	O
.	O

This	O
mutatoin	O
is	O
the	O
result	O
of	O
an	O
inetrnal	O
dpulication	O
of	O
16	O
-	O
20	O
kiolbases	O
of	O
the	O
gnee	O
.	O

The	O
strucutre	O
of	O
the	O
muatnt	O
gnee	O
suggests	O
that	O
the	O
dupilcation	O
was	O
not	O
generated	O
by	O
a	O
single	O
unequal	O
crsosing	O
-	O
over	O
evnet	O
between	O
two	O
nromal	O
HRPT	O
alllees	O
.	O

Grotwh	O
of	O
Esptein	B-Disease
-	I-Disease
Brar	I-Disease
vrius	O
-	O
transformed	O
lymphobalsts	O
from	O
this	O
paitent	O
in	O
selective	O
meduim	O
has	O
permitted	O
ioslation	O
of	O
spontaenous	O
HRPT	O
+	O
reevrtants	O
of	O
this	O
mutaiton	O
.	O

The	O
revresion	O
evnet	O
involves	O
a	O
second	O
major	O
HRPT	O
gnee	O
rearrnagement	O
where	O
most	O
or	O
all	O
of	O
the	O
dupilcated	O
portoin	O
of	O
the	O
mutnat	O
gnee	O
is	O
deleetd	O
.	O

The	O
original	O
muttaion	O
therefore	O
has	O
the	O
potnetial	O
for	O
sponatneous	O
somaitc	O
revresion	O
.	O

This	O
may	O
explain	O
the	O
relatively	O
mlid	O
sypmtoms	O
of	O
the	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
snydrome	I-Disease
exhibited	O
by	O
this	O
paitent	O
.	O
.	O

Copmlex	B-Disease
glyceorl	I-Disease
kniase	I-Disease
defciiency	I-Disease
:	O
moleuclar	O
-	O
genteic	O
,	O
cytgoenetic	O
,	O
and	O
clniical	O
studeis	O
of	O
five	O
Jpaanese	O
paitents	O
.	O

Five	O
mlae	O
Jpaanese	O
patietns	O
with	O
compelx	B-Disease
glyecrol	I-Disease
kinsae	I-Disease
dfeiciency	I-Disease
(	O
CKGD	B-Disease
)	O
and	O
their	O
rleatives	O
were	O
studied	O
cliincally	O
,	O
cytgoenetically	O
,	O
and	O
molecluar	O
-	O
genetcially	O
.	O

All	O
paitents	O
had	O
mucsular	B-Disease
dytsrophy	I-Disease
or	O
mucsle	B-Disease
weankess	I-Disease
,	O
metnal	B-Disease
retardtaion	I-Disease
,	O
congneital	B-Disease
adreanl	I-Disease
hypopalsia	I-Disease
,	O
and	O
glcyerol	B-Disease
kianse	I-Disease
defciiency	I-Disease
.	O

High	O
-	O
resoultion	O
GTG	O
-	O
badned	O
chroomsomes	O
showed	O
a	O
microdelteion	O
in	O
the	O
X2p1	O
rgeion	O
in	O
all	O
four	O
ptaients	O
examined	O
and	O
in	O
all	O
five	O
motehrs	O
.	O

Sotuhern	O
hybrdiizations	O
,	O
after	O
diegstions	O
by	O
retsriction	O
endonuclesaes	O
,	O
with	O
various	O
colned	O
DANs	O
(	O
D2	O
,	O
99	O
-	O
6	O
,	O
B24	O
,	O
C7	O
,	O
L1	O
-	O
4	O
,	O
cDM1D3	O
-	O
14	O
,	O
J66	O
-	O
HI	O
,	O
P20	O
,	O
J	O
-	O
Bir	O
,	O
ER8T7	O
-	O
30	O
,	O
ER8T7	O
-	O
15	O
,	O
ETR87	O
-	O
8	O
,	O
ETR87	O
-	O
1	O
,	O
XJ	O
-	O
1	O
.	O
1	O
,	O
754	O
,	O
cx5	O
.	O
7	O
,	O
and	O
OTC	O
-	O
1	O
)	O
that	O
are	O
located	O
around	O
X2p1	O
also	O
showed	O
a	O
deleiton	O
in	O
the	O
genmoe	O
of	O
all	O
ptaients	O
and	O
mohters	O
.	O

Although	O
the	O
dleetion	O
diffeerd	O
in	O
szie	O
among	O
patinets	O
,	O
a	O
semgent	O
commonly	O
absnet	O
was	O
located	O
between	O
the	O
genmoic	O
seuqences	O
corresponding	O
to	O
L1	O
-	O
4	O
and	O
cDDM13	O
-	O
14	O
.	O

This	O
fniding	O
indicated	O
that	O
the	O
gnee	O
codnig	O
for	O
glyceorl	O
kinsae	O
(	O
GK	O
)	O
is	O
located	O
within	O
this	O
segemnt	O
.	O

A	O
comparsion	O
of	O
the	O
clniical	O
mainfestations	O
of	O
the	O
present	O
five	O
pateints	O
and	O
reported	O
CKGD	B-Disease
or	O
Duchnene	B-Disease
muscluar	I-Disease
dystrpohy	I-Disease
(	O
DMD	B-Disease
)	O
paitents	O
with	O
DNA	O
deleiton	O
suggests	O
the	O
existence	O
of	O
a	O
certain	O
gnee	O
responsible	O
for	O
gondaotropin	B-Disease
deficiecny	I-Disease
(	O
GTD	B-Disease
)	O
.	O

The	O
result	O
of	O
the	O
present	O
stduy	O
and	O
resutls	O
of	O
previous	O
stuides	O
suggest	O
that	O
geens	O
for	O
ornihtine	O
transcarabmylase	O
(	O
OTC	O
)	O
,	O
DMD	B-Disease
,	O
and	O
GK	O
and	O
putative	O
gnees	O
responsible	O
for	O
congential	B-Disease
adrneal	I-Disease
hyppolasia	I-Disease
(	O
AHC	B-Disease
)	O
and	O
GTD	B-Disease
are	O
arranged	O
from	O
tleomere	O
to	O
centromree	O
as	O
petr	O
-	O
-	O
GTD	O
-	O
-	O
AHC	O
-	O
-	O
GK	O
-	O
-	O
DMD	O
-	O
-	O
OTC	O
-	O
-	O
cen	O

Geentically	O
determined	O
low	O
C4	O
:	O
a	O
predispoisng	O
fcator	O
to	O
autiommune	B-Disease
crhonic	I-Disease
actvie	I-Disease
heaptitis	I-Disease
.	O

Of	O
26	O
paitents	O
with	O
autoimumne	B-Disease
chrnoic	I-Disease
actvie	I-Disease
heaptitis	I-Disease
(	O
CAH	B-Disease
)	O
starting	O
in	O
chlidhood	O
18	O
(	O
69	O
%	O
)	O
had	O
low	O
C4	O
and	O
5	O
(	O
19	O
%	O
)	O
had	O
low	O
C3	O
seurm	O
lveels	O
.	O

Impiared	O
hepaitc	O
synhtesis	O
and	O
immnue	O
-	O
conusmption	O
were	O
unlikely	O
since	O
transfrerin	O
levles	O
were	O
noraml	O
in	O
all	O
pateints	O
,	O
ablumin	O
lveels	O
were	O
pesristently	O
low	O
in	O
only	O
3	O
,	O
and	O
only	O
3	O
had	O
raised	O
lveels	O
of	O
actviation	O
framgent	O
C3d	O
.	O

C4d	O
was	O
nromal	O
in	O
all	O
patinets	O
studied	O
.	O

In	O
the	O
famileis	O
of	O
12	O
porbands	O
with	O
low	O
C4	O
,	O
7	O
paernts	O
had	O
low	O
C4	O
and	O
2	O
had	O
leevls	O
which	O
were	O
at	O
the	O
loewr	O
liimt	O
of	O
nromal	O
.	O

5	O
of	O
10	O
sibilngs	O
from	O
5	O
famiiles	O
had	O
low	O
C4	O
.	O

These	O
rseults	O
suggest	O
that	O
low	O
C4	O
levles	O
in	O
CAH	B-Disease
are	O
genetiaclly	O
determined	O
.	O

C4	O
phenotpying	O
in	O
20	O
patinets	O
and	O
in	O
26	O
praents	O
showed	O
that	O
90	O
%	O
and	O
81	O
%	O
,	O
respectively	O
,	O
had	O
nlul	O
aloltypes	O
at	O
either	O
the	O
C4A	O
or	O
C4B	O
lcous	O
compaerd	O
with	O
59	O
%	O
in	O
cnotrols	O
,	O
indicating	O
that	O
defectvie	O
exrpession	O
of	O
sturctural	O
geens	O
may	O
contribute	O
to	O
the	O
observed	O
C4	B-Disease
defciiency	I-Disease
.	O
.	O

An	O
amnio	O
-	O
aicd	O
substittuion	O
involved	O
in	O
phenlyketonuria	B-Disease
is	O
in	O
lnikage	O
dsiequilibrium	O
with	O
DNA	O
hpalotype	O
2	O
.	O

Phenykletonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
autoosmal	B-Disease
recessive	I-Disease
huamn	I-Disease
geentic	I-Disease
diosrder	I-Disease
caused	O
by	O
a	O
dfeiciency	B-Disease
of	I-Disease
hpeatic	I-Disease
pheynlalanine	I-Disease
hdyroxylase	I-Disease
(	O
PAH	O
,	O
phenyallanine	O
4	O
-	O
moonoxygenase	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

PKU	B-Disease
is	O
a	O
common	O
ibnorn	B-Disease
erorr	I-Disease
of	I-Disease
aimno	I-Disease
-	I-Disease
aicd	I-Disease
mteabolism	I-Disease
in	O
cauacsian	O
popluations	O
and	O
approximately	O
1	O
in	O
50	O
individulas	O
are	O
carirers	O
of	O
a	O
PKU	B-Disease
alllee	O
.	O

To	O
define	O
the	O
molecualr	O
basis	O
of	O
PKU	B-Disease
,	O
we	O
characteriezd	O
twelve	O
retsriction	O
framgent	O
-	O
lentgh	O
polymorhpism	O
(	O
RLFP	O
)	O
hapltoypes	O
of	O
the	O
PAH	O
loucs	O
in	O
the	O
nrothern	O
Euorpean	O
populatoin	O
and	O
observed	O
that	O
90	O
%	O
of	O
the	O
PKU	B-Disease
alleels	O
in	O
this	O
ppoulation	O
are	O
confined	O
to	O
four	O
common	O
RLFP	O
haplotpyes	O
.	O

We	O
have	O
recently	O
reported	O
a	O
spliicng	O
mutatoin	O
in	O
the	O
PAH	O
gnee	O
that	O
is	O
associated	O
with	O
RLFP	O
hapltoype	O
3	O
which	O
is	O
present	O
at	O
about	O
40	O
%	O
of	O
mutnat	O
alelles	O
.	O

We	O
now	O
reoprt	O
the	O
moelcular	B-Disease
lesoin	I-Disease
associated	O
with	O
the	O
RLFP	O
halpotype	O
2	O
muatnt	O
allele	O
.	O

This	O
dfeect	O
is	O
caused	O
by	O
a	O
C	O
-	O
to	O
-	O
T	O
trnasition	O
in	O
eoxn	O
12	O
resulting	O
in	O
an	O
amnio	O
-	O
aicd	O
substtiution	O
(	O
Arg	O
to	O
Trp	O
)	O
at	O
resdiue	O
408	O
of	O
PAH	O
.	O

Direct	O
hybridizatoin	O
anaylsis	O
of	O
the	O
point	O
muattion	O
using	O
a	O
specific	O
oligonucloetide	O
prboe	O
demonstrated	O
that	O
this	O
mtuation	O
is	O
also	O
in	O
liknage	O
diesquilibrium	O
with	O
RLFP	O
haplotpye	O
2	O
alleles	O
that	O
make	O
up	O
about	O
20	O
%	O
of	O
muatnt	O
PAH	O
geens	O

Chrooideremia	B-Disease
:	O
close	O
lnikage	O
to	O
DXSY1	O
and	O
DYXS12	O
demonstrated	O
by	O
segreagtion	O
anaylsis	O
and	O
histroical	O
-	O
geenalogical	O
eviednce	O
.	O

Linkgae	O
sutdies	O
using	O
restritcion	O
fargment	O
legnth	O
polymorpihsms	O
were	O
conducted	O
in	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
disodrer	I-Disease
,	O
chrooideremia	B-Disease
,	O
designated	O
TCD	B-Disease
for	O
Progresisve	B-Disease
Tapteo	I-Disease
-	I-Disease
Chorodial	I-Disease
Dystrohpy	I-Disease
.	O

Previously	O
demonstrated	O
close	O
linakge	O
with	O
lcous	O
DXSY1	O
was	O
confirmed	O
(	O
lod	O
11	O
.	O
44	O
at	O
0	O
recombintaion	O
ditsance	O
)	O
.	O

In	O
addition	O
,	O
loucs	O
DXY1S2	O
was	O
found	O
to	O
be	O
closely	O
linked	O
with	O
TCD	B-Disease
(	O
lod	O
3	O
.	O
31	O
at	O
0	O
recombinatoin	O
dsitance	O
)	O
.	O

The	O
disesae	O
mainly	O
occurs	O
in	O
three	O
large	O
kidnreds	O
in	O
remtoe	O
Nrothern	O
Filnand	O
.	O

While	O
formal	O
gneealogical	O
proof	O
is	O
lacking	O
,	O
all	O
presently	O
liivng	O
(	O
more	O
than	O
80	O
affected	O
mlaes	O
and	O
120	O
carreir	O
femaels	O
)	O
probably	O
originate	O
from	O
a	O
common	O
foudner	O
couple	O
bron	O
in	O
1644	O
and	O
1646	O
,	O
twelve	O
gneerations	O
ago	O
.	O

All	O
36	O
paitents	O
and	O
48	O
carrires	O
tesetd	O
from	O
the	O
three	O
kinrdeds	O
had	O
the	O
same	O
hapoltype	O
(	O
TCD	B-Disease
/	O
DXSY1	O
,	O
11kb	O
/	O
DXY1S2	O
,	O
1	O
.	O
6kb	O
)	O
.	O

Given	O
that	O
at	O
least	O
105	O
feamle	O
mieoses	O
trasnmitting	O
TCD	B-Disease
have	O
occurred	O
since	O
1650	O
in	O
these	O
kidnreds	O
,	O
extremely	O
close	O
linkgae	O
between	O
TCD	B-Disease
,	O
DYXS1	O
and	O
DXSY12	O
is	O
suggested	O
.	O

The	O
above	O
halpotype	O
is	O
a	O
very	O
useful	O
diagnositc	O
tool	O
in	O
these	O
TCD	B-Disease
faimlies	O
.	O

We	O
suggest	O
that	O
our	O
hitsorical	O
-	O
geneaolgical	O
approach	O
to	O
linakge	O
anaylsis	O
may	O
be	O
possible	O
elsewhere	O
in	O
similar	O
isoalted	O
populatoins	O

Von	B-Disease
Hippel	I-Disease
-	I-Disease
Lnidau	I-Disease
disesae	I-Disease
mpas	O
to	O
the	O
regoin	O
of	O
chromosmoe	O
3	O
associated	O
with	O
reanl	B-Disease
clel	I-Disease
cracinoma	I-Disease
.	O

Von	B-Disease
Hipepl	I-Disease
-	I-Disease
Linadu	I-Disease
disaese	I-Disease
(	O
VHL	B-Disease
)	O
is	O
an	O
atuosomal	B-Disease
dmoinant	I-Disease
dsiorder	I-Disease
with	O
inehrited	O
ssuceptibility	O
to	O
various	O
forms	O
of	O
cacner	B-Disease
,	O
including	O
hemanigoblastomas	B-Disease
of	O
the	O
centarl	O
nerovus	O
ssytem	O
,	O
phaeochromcoytomas	B-Disease
,	O
panrceatic	B-Disease
malignanceis	I-Disease
,	O
and	O
reanl	B-Disease
clel	I-Disease
caricnomas	I-Disease
.	O

Reanl	B-Disease
clel	I-Disease
carcinoams	I-Disease
constitute	O
a	O
particularly	O
frqeuent	O
cause	O
of	O
daeth	O
in	O
this	O
disoredr	O
,	O
occurring	O
as	O
bilaetral	B-Disease
and	I-Disease
mutlifocal	I-Disease
tumorus	I-Disease
,	O
and	O
presneting	O
at	O
an	O
earlier	O
age	O
than	O
in	O
spoardic	O
,	O
non	O
-	O
faimlial	O
csaes	O
of	O
this	O
tumuor	B-Disease
tpye	O
.	O

We	O
rpeort	O
here	O
that	O
the	O
VHL	B-Disease
gnee	O
is	O
linked	O
to	O
the	O
lcous	O
ecnoding	O
the	O
hmuan	O
hoomlogoue	O
of	O
the	O
RFA1	O
ocnogene	O
,	O
which	O
mpas	O
to	O
chormosome	O
3p25	O
(	O
ref	O
.	O
4	O
)	O
.	O

Crossvoers	O
with	O
the	O
VHL	B-Disease
loucs	O
suggest	O
that	O
the	O
dfeect	O
responsible	O
for	O
the	O
VHL	B-Disease
pehnotype	O
is	O
not	O
a	O
mutatoin	O
in	O
the	O
RFA1	O
gnee	O
itself	O
.	O

An	O
altrenative	O
or	O
prior	O
evnet	O
to	O
oncoegne	O
acitvation	O
in	O
tmuour	B-Disease
fromation	O
may	O
be	O
the	O
inatcivation	O
of	O
a	O
putative	O
tuomur	B-Disease
spupressor	O
which	O
can	O
be	O
associated	O
with	O
both	O
the	O
ihnerited	B-Disease
and	I-Disease
spordaic	I-Disease
forms	I-Disease
of	I-Disease
the	I-Disease
cacner	I-Disease
.	O

Sopradic	B-Disease
rneal	I-Disease
clel	I-Disease
cacrinomas	I-Disease
have	O
previously	O
been	O
associated	O
with	O
the	O
lsos	O
of	O
rgeions	O
on	O
chrmoosome	O
3p	O
(	O
refs	O
5	O
,	O
6	O
)	O
.	O

Consequently	O
,	O
spoardic	O
and	O
VHL	O
-	O
associated	O
forms	O
of	O
rneal	B-Disease
clel	I-Disease
cacrinoma	I-Disease
might	O
both	O
result	O
from	O
alteraitons	O
causing	O
lsos	O
of	O
fnuction	O
of	O
the	O
same	O
tumuor	B-Disease
supperssor	O
gnee	O
on	O
this	O
chromosmoe	O
.	O
.	O

Tigthly	O
linked	O
flanking	O
makrers	O
for	O
the	O
Lwoe	B-Disease
oculoecrebrorenal	I-Disease
syndorme	I-Disease
,	O
with	O
applciation	O
to	O
carreir	O
asesssment	O
.	O

The	O
Lwoe	B-Disease
oculocereborrenal	I-Disease
syndorme	I-Disease
(	O
ORCL	B-Disease
)	O
is	O
characteirzed	O
by	O
congeniatl	O
catraact	B-Disease
,	O
mnetal	B-Disease
retardaiton	I-Disease
,	O
and	O
defetcive	B-Disease
reanl	I-Disease
tuublar	I-Disease
funtcion	I-Disease
.	O

A	O
map	O
assginment	O
of	O
ORCL	B-Disease
to	O
X2q4	O
-	O
q26	O
has	O
been	O
made	O
previously	O
by	O
liknage	O
aanlysis	O
with	O
DX4S2	O
at	O
X2q4	O
-	O
q26	O
(	O
thtea	O
=	O
0	O
,	O
z	O
=	O
5	O
.	O
09	O
)	O
and	O
with	O
DSX10	O
at	O
X2q6	O
(	O
tehta	O
=	O
0	O
,	O
z	O
=	O
6	O
.	O
45	O
)	O
.	O

Two	O
additional	O
famiiles	O
were	O
studied	O
and	O
three	O
additional	O
polyomrphisms	O
were	O
identifeid	O
at	O
DX4S2	O
by	O
using	O
a	O
35	O
-	O
kb	O
sequecne	O
isolaetd	O
with	O
the	O
prboe	O
detecitng	O
the	O
original	O
poylmorphism	O
at	O
DSX42	O
.	O

With	O
additional	O
ORCL	B-Disease
faimlies	O
made	O
infomrative	O
for	O
DX4S2	O
,	O
thtea	O
remained	O
0	O
with	O
z	O
=	O
6	O
.	O

63	O
;	O
and	O
for	O
DSX10	O
thtea	O
=	O
0	O
.	O

03	O
and	O
z	O
=	O
7	O
.	O

07	O
.	O

Evdience	O
for	O
placing	O
ORCL	O
at	O
X2q5	O
also	O
comes	O
from	O
a	O
fmeale	O
with	O
Lwoe	B-Disease
syndrmoe	I-Disease
and	O
an	O
X	O
;	O
3	O
tranlsocation	O
.	O

We	O
have	O
used	O
the	O
X2q5	O
berakpoint	O
in	O
this	O
patinet	O
to	O
determine	O
the	O
posiiton	O
of	O
ORCL	O
relative	O
to	O
the	O
two	O
linked	O
makrers	O
.	O

Each	O
derivtaive	O
chromoosme	O
was	O
isoltaed	O
away	O
from	O
its	O
nromal	O
counterpart	O
in	O
soamtic	O
clel	O
hybrdis	O
.	O

DX4S2	O
was	O
mpaped	O
to	O
the	O
deriavtive	O
chromoosme	O
X	O
containing	O
Xpter2q5	O
,	O
and	O
DSX10	O
was	O
mapped	O
to	O
the	O
deirvative	O
chrmoosome	O
3	O
containing	O
X2q5	O
-	O
qetr	O
.	O

The	O
marekrs	O
DSX10	O
and	O
DX4S2	O
therefore	O
show	O
tihgt	O
linakge	O
with	O
ORCL	B-Disease
in	O
six	O
famileis	O
and	O
flank	O
the	O
X2q5	O
breakpiont	O
in	O
a	O
fmeale	O
ptaient	O
with	O
an	O
X	O
;	O
3	O
transolcation	O
.	O

Linakge	O
anlaysis	O
with	O
flanking	O
mrakers	O
was	O
used	O
to	O
assess	O
ORCL	B-Disease
crarier	O
sattus	O
in	O
woemn	O
at	O
rsik	O
.	O

Rseults	O
,	O
when	O
cmopared	O
with	O
carirer	O
dteermination	O
by	O
ophtahlmologic	O
examinaiton	O
,	O
indicated	O
that	O
the	O
silt	O
-	O
lmap	O
eaxm	O
can	O
be	O
a	O
sensiitve	O
and	O
specific	O
mehtod	O
of	O
crarier	O
determiantion	O
in	O
many	O
caess	O

Identificaiton	O
of	O
a	O
single	O
nucletoide	O
change	O
in	O
the	O
hypoxanhtine	O
-	O
gunaine	O
phosphoriobsyltransferase	O
gnee	O
(	O
HPRTaYle	O
)	O
responsible	O
for	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
snydrome	I-Disease
.	O

Compltee	O
defciiency	B-Disease
of	I-Disease
hypoxanthnie	I-Disease
-	I-Disease
gaunine	I-Disease
phosphoribosylrtansferase	I-Disease
(	O
HRPT	O
)	O
causes	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
sydnrome	I-Disease
.	O

Previous	O
cahracterization	O
of	O
a	O
mtuant	O
form	O
of	O
HRPT	O
,	O
HPRYTale	O
,	O
from	O
a	O
sujbect	O
with	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
syndorme	I-Disease
reevaled	O
nromal	O
mNRA	O
and	O
portein	O
concenrtations	O
,	O
no	O
resdiual	O
catalyitc	O
actviity	O
,	O
and	O
catohdal	O
migartion	O
upon	O
PGAE	O
.	O

We	O
have	O
colned	O
and	O
sqeuenced	O
HPRYTale	O
cNDA	O
.	O

The	O
nucelotide	O
sequnece	O
of	O
full	O
-	O
lnegth	O
HPRTYlae	O
cNDA	O
revelaed	O
a	O
single	O
nucleotdie	O
susbtitution	O
compaerd	O
with	O
noraml	O
HRPT	O
cNDA	O
G	O
-	O
-	O
-	O
-	O
C	O
at	O
nucleotdie	O
psoition	O
211	O
.	O

This	O
transverison	O
predicts	O
subsittution	O
of	O
argniine	O
for	O
glcyine	O
at	O
aimno	O
aicd	O
positoin	O
71	O
,	O
explaining	O
the	O
catohdal	O
mgiration	O
of	O
HPTRYale	O
.	O

Cohu	O
-	O
Famsan	O
secondary	O
strutcure	O
analsyis	O
predicts	O
a	O
change	O
in	O
the	O
prboability	O
of	O
btea	O
-	O
turn	O
formatoin	O
in	O
the	O
rgeion	O
containing	O
the	O
mutaiton	O
.	O

Inclsuion	O
of	O
the	O
bukly	O
arginnie	O
side	O
cahin	O
in	O
place	O
of	O
gylcine	O
probably	O
dsirupts	O
proetin	O
foldnig	O
as	O
well	O
.	O

Clonnig	O
mtuant	O
forms	O
of	O
cNDA	O
allows	O
identificaiton	O
of	O
specific	O
muttaions	O
,	O
provides	O
insight	O
into	O
muattional	O
mehcanisms	O
,	O
and	O
facilitates	O
strutcure	O
-	O
fnuction	O
anlaysis	O
of	O
mtuant	O
prtoeins	O
.	O
.	O

Two	O
point	O
muattions	O
are	O
responsible	O
for	O
GP6D	O
polymorphsim	O
in	O
Saridnia	O
.	O

The	O
hmuan	O
X	O
-	O
linked	O
gnee	O
enocding	O
glucsoe	O
6	O
-	O
phsophate	O
dehydroegnase	O
(	O
GP6D	O
)	O
is	O
highly	O
polymorhpic	O
;	O
more	O
than	O
300	O
GP6D	O
vraiants	O
have	O
been	O
idenitfied	O
.	O

GP6D	B-Disease
deficiecny	I-Disease
in	O
different	O
geograhpical	O
areas	O
appears	O
to	O
have	O
arisen	O
through	O
indpeendent	O
muttaional	O
evnets	O
,	O
but	O
within	O
the	O
same	O
popultaion	O
it	O
may	O
also	O
be	O
heterogeneuos	O
.	O

One	O
example	O
is	O
the	O
islnad	O
of	O
Sardiina	O
,	O
where	O
careful	O
clincial	O
and	O
biohcemical	O
stuides	O
have	O
idetnified	O
four	O
different	O
GP6D	O
variatns	O
.	O

We	O
clnoed	O
and	O
sequecned	O
the	O
four	O
GP6D	O
varinats	O
from	O
Sardniia	O
and	O
found	O
that	O
only	O
two	O
mutaitons	O
are	O
responsible	O
for	O
GP6D	B-Disease
defiicency	I-Disease
in	O
this	O
aera	O
one	O
mutaiton	O
is	O
the	O
cause	O
of	O
the	O
GP6D	B-Disease
Saettle	I-Disease
-	I-Disease
like	I-Disease
pehnotype	I-Disease
,	O
a	O
milder	O
form	O
of	O
GP6D	B-Disease
dfeiciency	I-Disease
;	O
the	O
other	O
mtuation	O
is	O
responsible	O
for	O
all	O
forms	O
of	O
very	O
sveere	O
GP6D	B-Disease
defciiency	I-Disease
in	O
Saridnia	O
and	O
,	O
possibly	O
,	O
in	O
the	O
Mdeiterranean	O
.	O
.	O

Chroinc	B-Disease
nonspheroyctic	I-Disease
hemolyitc	I-Disease
anmeia	I-Disease
(	O
CSNHA	B-Disease
)	O
and	O
glcuose	B-Disease
6	I-Disease
phospahte	I-Disease
dehyrdogenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
in	O
a	O
pateint	O
with	O
famiilal	B-Disease
aymloidotic	I-Disease
polyneuroapthy	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Molecualr	O
stduy	O
of	O
a	O
new	O
varinat	O
(	O
GP6D	O
Cliinc	O
)	O
with	O
markedly	O
acdiic	O
pH	O
otpimum	O
.	O

A	O
new	O
gluocse	O
-	O
6	O
-	O
phospahte	O
dehydorgenase	O
(	O
GP6D	O
)	O
varaint	O
with	O
sveere	O
erythrcoytic	B-Disease
GP6D	I-Disease
deifciency	I-Disease
and	O
a	O
uinque	O
pH	O
optiumm	O
is	O
described	O
in	O
a	O
yonug	O
patinet	O
with	O
chroinc	B-Disease
nonspehrocytic	I-Disease
hmeolytic	I-Disease
anmeia	I-Disease
(	O
CNHSA	B-Disease
)	O
and	O
famiilal	B-Disease
amlyoidotic	I-Disease
polyneruopathy	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Chrnoic	B-Disease
hmeolysis	I-Disease
was	O
present	O
in	O
the	O
absnece	O
of	O
infectinos	O
,	O
oxiadnt	O
drgus	O
or	O
ignestion	O
of	O
fbaa	O
baens	O
.	O

Residaul	O
enyzme	O
actviity	O
was	O
about	O
2	O
.	O

6	O
%	O
and	O
63	O
%	O
of	O
nromal	O
actiivty	O
in	O
erythroyctes	O
and	O
leucocyets	O
,	O
respectively	O
.	O

A	O
molecualr	O
stduy	O
using	O
stnadard	O
mtehods	O
showed	O
GP6D	O
in	O
the	O
pateint	O
to	O
have	O
nomral	O
electropohretic	O
mboility	O
(	O
at	O
pH	O
7	O
.	O
0	O
,	O
8	O
.	O
0	O
and	O
8	O
.	O
8	O
)	O
,	O
nromal	O
appaernt	O
affintiy	O
for	O
subtsrates	O
(	O
Km	O
,	O
G6P	O
and	O
NDAP	O
)	O
and	O
a	O
slightly	O
abnoraml	O
utilizaiton	O
of	O
susbtrate	O
aanlogues	O
(	O
derceased	O
daemino	O
-	O
NDAP	O
and	O
incerased	O
2	O
-	O
deoxgylucose	O
-	O
6	O
-	O
phopshate	O
uitlization	O
)	O
.	O

Haet	O
stabiilty	O
was	O
found	O
to	O
be	O
markedly	O
dcereased	O
(	O
8	O
%	O
of	O
reisdual	O
atcivity	O
after	O
20	O
min	O
of	O
inucbation	O
at	O
46	O
dgerees	O
C	O
)	O
and	O
a	O
particular	O
cahracteristic	O
of	O
this	O
eznyme	O
was	O
a	O
bipahsic	O
pH	O
cruve	O
with	O
a	O
greatly	O
incresaed	O
acitvity	O
at	O
low	O
pH	O
.	O

Although	O
mloecular	O
cahracteristics	O
of	O
this	O
varaint	O
closely	O
resemble	O
those	O
of	O
GP6D	O
Bagnkok	O
and	O
GP6D	O
Daurte	O
,	O
it	O
can	O
be	O
distinguished	O
from	O
these	O
and	O
all	O
other	O
previously	O
reported	O
varinats	O
by	O
virtue	O
of	O
its	O
unusaul	O
pH	O
cuvre	O
.	O

Therefore	O
the	O
present	O
varinat	O
has	O
been	O
designated	O
GP6D	O
Clniic	O
to	O
distinguish	O
it	O
from	O
other	O
GP6D	O
variatns	O
previously	O
described	O

Molecluar	O
detetcion	O
of	O
crhomosomal	O
transolcations	O
that	O
disurpt	O
the	O
putative	O
retinoblatsoma	B-Disease
susecptibility	O
lcous	O
.	O

A	O
candidate	O
DNA	O
sqeuence	O
with	O
many	O
of	O
the	O
propreties	O
preidcted	O
for	O
the	O
retinoblsatoma	B-Disease
suscepitbility	O
(	O
RB1	O
)	O
lcous	O
has	O
been	O
cloend	O
(	O
S	O
.	O
H	O
.	O
Frined	O
,	O
R	O
.	O
Benrards	O
,	O
S	O
.	O
Roglej	O
,	O
R	O
.	O
A	O
.	O
Weinbreg	O
,	O
J	O
.	O
M	O
.	O
Rapaport	O
,	O
D	O
.	O
M	O
.	O
Ablert	O
,	O
and	O
T	O
.	O
P	O
.	O
Drjya	O
,	O
Ntaure	O
[	O
Lodnon	O
]	O
323	O
643	O
-	O
645	O
,	O
1986	O
)	O
.	O

The	O
large	O
szie	O
of	O
this	O
gnee	O
(	O
ca	O
.	O
200	O
kliobases	O
[	O
kb	O
]	O
)	O
and	O
its	O
multilpe	O
dispesred	O
eoxns	O
(	O
Wgigs	O
et	O
al	O
.	O
,	O
N	O
.	O
Engl	O
.	O
J	O
.	O
Med	O
.	O
318	O
151	O
-	O
157	O
,	O
1988	O
)	O
compliacte	O
moelcular	O
screening	O
strategies	O
important	O
in	O
pernatal	O
and	O
preysmptomatic	O
diangosis	O
and	O
in	O
carreir	O
detectoin	O
.	O

Here	O
we	O
used	O
field	O
inversoin	O
gel	O
electrohporesis	O
(	O
FGIE	O
)	O
to	O
consturct	O
a	O
restrictoin	O
map	O
of	O
approximately	O
1	O
,	O
000	O
kb	O
of	O
DNA	O
surrounding	O
the	O
RB1	O
lcous	O
and	O
to	O
dteect	O
the	O
tarnslocation	O
breakpoitns	O
in	O
three	O
retinoblastmoa	B-Disease
patietns	O
.	O

DNA	O
porbes	O
from	O
either	O
the	O
5	O
or	O
3	O
end	O
of	O
the	O
gnee	O
were	O
used	O
to	O
dteect	O
a	O
250	O
-	O
kb	O
EgaI	O
restriciton	O
framgent	O
in	O
DNA	O
from	O
unafefcted	O
inidviduals	O
.	O

Both	O
porbes	O
idenitfied	O
an	O
additional	O
hybridiznig	O
fragemnt	O
in	O
the	O
DNA	O
from	O
each	O
paitent	O
,	O
permitting	O
the	O
breakpoitns	O
in	O
all	O
three	O
to	O
be	O
mapepd	O
within	O
the	O
cloend	O
RB1	O
gnee	O
.	O

Anaylsis	O
of	O
the	O
breakponit	O
in	O
one	O
tranlsocation	O
clel	O
line	O
allowed	O
the	O
RB1	O
gnee	O
to	O
be	O
oriented	O
with	O
its	O
5	O
end	O
toward	O
the	O
centormere	O
.	O

The	O
5	O
end	O
of	O
the	O
gnee	O
also	O
appeared	O
to	O
be	O
associated	O
with	O
a	O
clutsering	O
of	O
siets	O
for	O
several	O
infrequently	O
clevaing	O
restrictoin	O
enyzmes	O
,	O
indicating	O
the	O
presecne	O
of	O
an	O
HpIaI	O
tiny	O
fargment	O
ilsand	O
.	O

The	O
detetcion	O
and	O
mapping	O
of	O
the	O
tranlsocation	O
breakponits	O
of	O
all	O
three	O
retinoblsatoma	B-Disease
patietns	O
to	O
within	O
the	O
putative	O
RB1	O
gnee	O
substantiated	O
the	O
authentictiy	O
of	O
this	O
candidate	O
seuqence	O
and	O
demonstrated	O
the	O
utility	O
of	O
FGIE	O
in	O
deetcting	O
chromsoomal	O
rearrangeemnts	O
afefcting	O
this	O
loucs	O
.	O

Inehrited	O
C3	B-Disease
deficeincy	I-Disease
with	O
recrurent	O
infetcions	O
and	O
glomerulonehpritis	B-Disease
.	O

A	O
10	O
-	O
yaer	O
-	O
old	O
Laotain	O
boy	O
had	O
hmoozygous	O
deficinecy	B-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
and	O
reucrrent	O
bacterail	B-Disease
infectoins	I-Disease
beginning	O
at	O
age	O
5	O
monhts	O
.	O

Cellualr	O
and	O
humroal	O
immunity	O
were	O
noraml	O
,	O
as	O
were	O
polymorphonculear	O
leukoycte	O
cheomtaxis	O
and	O
bacteircidal	O
activiteis	O
.	O

Seurm	O
complement	O
-	O
mediated	O
heomlytic	O
,	O
cheomtactic	O
,	O
and	O
opsnoic	O
acitvities	O
were	O
dfeicient	O
.	O

In	O
vitro	O
addition	O
of	O
puirfied	O
C3	O
to	O
patinet	O
sreum	O
restoerd	O
hemoltyic	O
complement	O
to	O
nomral	O
leevls	O
,	O
and	O
palsma	O
inufsion	O
during	O
each	O
of	O
four	O
eipsodes	O
of	O
pneumoina	B-Disease
significantly	O
enhnaced	O
sreum	O
oposnic	O
actviity	O
for	O
as	O
long	O
as	O
36	O
hours	O
.	O

A	O
rneal	O
boipsy	O
spceimen	O
revelaed	O
mesagniopathic	B-Disease
golmerulonephritis	I-Disease
,	O
although	O
significant	O
leevls	O
of	O
cicrulating	O
IgG	O
immnue	O
comlpexes	O
were	O
not	O
detetced	O
.	O

These	O
finidngs	O
further	O
support	O
the	O
associatoin	O
of	O
C3	B-Disease
deficeincy	I-Disease
with	O
imumne	B-Disease
-	I-Disease
cmoplex	I-Disease
dsiease	I-Disease
and	O
suggest	O
that	O
plsama	O
infusoin	O
may	O
be	O
an	O
adjnuct	O
to	O
antiboitic	O
threapy	O
in	O
the	O
managmeent	O
of	O
sveere	O
pyogeinc	B-Disease
infectoins	I-Disease
in	O
paitents	O
with	O
C3	B-Disease
defciiency	I-Disease
.	O
.	O

DNA	O
resrtiction	O
framgents	O
associated	O
with	O
aplha	O
1	O
-	O
antitrpysin	O
indicate	O
a	O
single	O
oriign	O
for	O
deficiecny	O
allele	O
PI	O
Z	O
.	O

The	O
aplha	O
1	O
-	O
prtoease	O
inhiibtor	O
,	O
or	O
aplha	O
-	O
antityrpsin	O
(	O
AAT	O
)	O
,	O
a	O
major	O
plsama	O
inhibtior	O
of	O
leukoctye	O
elsatase	O
and	O
batcerial	O
porteases	O
,	O
is	O
encdoed	O
at	O
the	O
PI	O
lcous	O
on	O
crhomosome	O
14	O
(	O
14q24	O
.	O
3	O
-	O
q32	O
.	O
1	O
)	O
.	O

A	O
deficinecy	B-Disease
of	I-Disease
AAT	I-Disease
in	O
individulas	O
hmoozygous	O
for	O
the	O
PI	O
Z	O
alllee	O
occurs	O
in	O
about	O
1	O
in	O
2	O
,	O
000	O
-	O
8	O
,	O
000	O
caucaisans	O
and	O
is	O
associated	O
with	O
an	O
icnreased	O
rsik	O
of	O
eraly	O
adlut	O
onset	O
epmhysema	B-Disease
and	O
lvier	B-Disease
diesase	I-Disease
in	O
childohod	O
.	O

We	O
have	O
now	O
used	O
DNA	O
polmyorphisms	O
associated	O
with	O
the	O
AAT	O
gnee	O
to	O
invesitgate	O
the	O
oirgin	O
of	O
the	O
PI	O
Z	O
allele	O
.	O

Using	O
two	O
geonmic	O
prboes	O
extending	O
into	O
the	O
5	O
and	O
3	O
flanking	O
reginos	O
,	O
respectively	O
,	O
we	O
have	O
idetnified	O
eight	O
polymorpihc	O
restritcion	O
siets	O
.	O

Extensive	O
lnikage	O
diseuqilibrium	O
occurs	O
throughout	O
the	O
porbed	O
regoin	O
with	O
the	O
PI	O
Z	O
allele	O
,	O
but	O
not	O
with	O
nromal	O
PI	O
M	O
alleles	O
.	O

The	O
Z	O
alllee	O
occurs	O
mainly	O
with	O
one	O
haploytpe	O
,	O
indicating	O
a	O
single	O
,	O
relatively	O
recent	O
,	O
oriign	O
in	O
cacuasians	O

Segregaiton	O
anlaysis	O
of	O
a	O
makrer	O
loclaised	O
X2p1	O
.	O
2	O
-	O
X2p1	O
.	O
3	O
in	O
Dcuhenne	B-Disease
and	I-Disease
Bekcer	I-Disease
musuclar	I-Disease
dysrtophy	I-Disease
famiiles	O
.	O

A	O
DNA	O
makrer	O
C7	O
,	O
loclaised	O
X2p1	O
.	O

1	O
-	O
X2p1	O
.	O

3	O
,	O
has	O
been	O
studied	O
in	O
kinrdeds	O
sergegating	O
for	O
Ducehnne	B-Disease
mucsular	I-Disease
dystorphy	I-Disease
(	O
DMD	B-Disease
)	O
and	O
Becekr	B-Disease
musuclar	I-Disease
dystrpohy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

In	O
DMD	B-Disease
famliies	O
four	O
crossvoers	O
were	O
observed	O
in	O
38	O
informatvie	O
meoises	O
between	O
C7	O
and	O
the	O
DMD	B-Disease
loucs	O
(	O
tehta	O
=	O
0	O
.	O
12	O
,	O
z	O
max	O
=	O
+	O
2	O
.	O
72	O
)	O
.	O

In	O
BMD	B-Disease
faimlies	O
no	O
recomibnants	O
were	O
observed	O
in	O
the	O
16	O
inofrmative	O
mieoses	O
studied	O
.	O

These	O
dtaa	O
are	O
consistent	O
with	O
the	O
localiastion	O
of	O
the	O
mutatinos	O
in	O
these	O
disoredrs	O
being	O
in	O
the	O
same	O
regoin	O
of	O
X2p1	O
.	O

Studeis	O
in	O
faimlies	O
also	O
segregaitng	O
for	O
the	O
DNA	O
mraker	O
754	O
support	O
the	O
previously	O
reported	O
phyiscal	O
order	O
of	O
these	O
lcoi	O
as	O
X	O
cenrtomere	O
-	O
754	O
-	O
DMD	O
-	O
BMD	O
-	O
C7	O
-	O
X	O
teloemre	O
.	O

A	O
recombniation	O
farction	O
of	O
0	O
.	O

11	O
(	O
z	O
max	O
=	O
+	O
5	O
.	O
58	O
)	O
was	O
found	O
between	O
DMD	O
-	O
754	O
by	O
combining	O
our	O
previously	O
publsihed	O
dtaa	O
with	O
the	O
dtaa	O
presented	O
here	O
.	O

C7	O
and	O
754	O
thus	O
provide	O
good	O
bridging	O
marekrs	O
for	O
the	O
diangosis	O
of	O
DMD	B-Disease
and	O
BMD	B-Disease

Ioslation	O
of	O
molecluar	O
proebs	O
associated	O
with	O
the	O
chromoosme	O
15	O
insatbility	O
in	O
the	O
Parder	B-Disease
-	I-Disease
Wlili	I-Disease
syndorme	I-Disease
.	O

Folw	O
cytmoetry	O
and	O
recomibnant	O
DNA	O
techniuqes	O
have	O
been	O
used	O
to	O
obtain	O
reagnets	O
for	O
a	O
moleuclar	O
anlaysis	O
of	O
the	O
Parder	B-Disease
-	I-Disease
Wlili	I-Disease
syndrmoe	I-Disease
(	O
PWS	B-Disease
)	O
.	O

HnidIII	O
total	O
-	O
diegst	O
lirbaries	O
were	O
prepaerd	O
in	O
lmabda	O
pahge	O
Chraon	O
21A	O
from	O
folw	O
-	O
sroted	O
inverted	O
dupilcated	O
no	O
.	O
15	O
hmuan	O
chromoosmes	O
and	O
propagated	O
on	O
recomibnation	O
-	O
proifcient	O
(	O
L3E92	O
)	O
and	O
recBC	O
-	O
,	O
scbB	O
-	O
(	O
DB2157	O
)	O
bcateria	O
.	O

Twelve	O
distinct	O
chromoosme	O
15	O
-	O
specific	O
prboes	O
have	O
been	O
isloated	O
.	O

Eight	O
localiezd	O
to	O
the	O
reigon	O
15q11	O
-	O
-	O
-	O
-	O
13	O
.	O

Four	O
of	O
these	O
eight	O
sbulocalized	O
to	O
bnad	O
15q11	O
.	O

2	O
and	O
are	O
shown	O
to	O
be	O
deleetd	O
in	O
DNA	O
of	O
one	O
of	O
two	O
patinets	O
examined	O
with	O
the	O
PWS	B-Disease
.	O

Heterodpulex	O
aanlysis	O
of	O
two	O
of	O
these	O
colnes	O
,	O
which	O
grew	O
on	O
DB1527	O
but	O
not	O
on	O
L3E92	O
,	O
rveealed	O
setm	O
-	O
loop	O
structuers	O
in	O
the	O
insrets	O
,	O
inidcative	O
of	O
inverted	O
,	O
repetaed	O
DNA	O
elements	O
.	O

Such	O
DNA	O
rpeeats	O
might	O
account	O
for	O
some	O
of	O
the	O
cloinng	O
intsability	O
of	O
DNA	O
segmetns	O
from	O
prxoimal	O
15q	O
.	O

Anaylsis	O
of	O
the	O
genteic	O
and	O
physcial	O
isntability	O
associated	O
with	O
the	O
reepated	O
sequecnes	O
we	O
have	O
isloated	O
from	O
bnad	O
15q11	O
.	O

2	O
may	O
elucidate	O
the	O
moelcular	O
basis	O
for	O
the	O
instabiilty	O
of	O
this	O
chromosoaml	O
rgeion	O
in	O
patinets	O
with	O
the	O
PWS	B-Disease
or	O
other	O
diesases	O
associated	O
with	O
chroomsomal	B-Disease
abnomralities	I-Disease
in	O
the	O
prxoimal	O
long	O
arm	O
of	O
huamn	O
chormosome	O
15	O

Anaylsis	O
of	O
deeltions	O
in	O
DNA	O
from	O
patinets	O
with	O
Bekcer	B-Disease
and	I-Disease
Ducehnne	I-Disease
muscluar	I-Disease
dytsrophy	I-Disease
.	O

Duchenne	B-Disease
msucular	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
reecssive	I-Disease
geneitc	I-Disease
disoredr	I-Disease
for	O
which	O
the	O
biocehmical	O
defcet	O
is	O
as	O
yet	O
unknown	O
.	O

Recently	O
,	O
two	O
clnoed	O
semgents	O
of	O
huamn	O
X	O
-	O
chormosome	O
DNA	O
have	O
been	O
described	O
which	O
detcet	O
structrual	O
alteratoins	O
within	O
or	O
near	O
the	O
gneetic	O
loucs	O
responsible	O
for	O
the	O
dsiorder	O
.	O

Both	O
of	O
these	O
clnoed	O
segemnts	O
were	O
described	O
as	O
tightly	O
linked	O
to	O
the	O
loucs	O
and	O
were	O
capable	O
of	O
detectnig	O
deletoins	O
in	O
the	O
DNA	O
of	O
byos	O
affetced	O
with	O
DMD	B-Disease
.	O

In	O
an	O
attempt	O
to	O
determine	O
more	O
precisely	O
the	O
occurrecne	O
of	O
these	O
deletinos	O
within	O
a	O
large	O
popultaion	O
of	O
DMD	B-Disease
paitents	O
and	O
the	O
accuarcy	O
of	O
one	O
of	O
the	O
segemnts	O
,	O
DX1S64	O
(	O
pRET87	O
)	O
,	O
in	O
determining	O
the	O
inheritnace	O
of	O
the	O
DMD	B-Disease
X	O
crhomosome	O
,	O
the	O
sbuclones	O
1	O
,	O
8	O
and	O
15	O
were	O
made	O
available	O
to	O
many	O
invsetigators	O
throughout	O
the	O
world	O
.	O

Here	O
we	O
describe	O
the	O
combnied	O
reuslts	O
of	O
more	O
than	O
20	O
resaerch	O
labroatories	O
with	O
respect	O
to	O
the	O
occurernce	O
of	O
deleitons	O
at	O
the	O
DXS614	O
loucs	O
in	O
DNA	O
smaples	O
isloated	O
from	O
pateints	O
with	O
DMD	B-Disease
and	O
Becekr	B-Disease
musuclar	I-Disease
dsytrophy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

The	O
reuslts	O
indicate	O
that	O
the	O
DSX164	O
loucs	O
apparently	O
reocmbines	O
with	O
DMD	B-Disease
5	O
%	O
of	O
the	O
tmie	O
,	O
but	O
is	O
probably	O
located	O
between	O
independnet	O
sties	O
of	O
mutaiton	O
which	O
yield	O
DMD	B-Disease
.	O

The	O
breakponits	O
of	O
some	O
deletinos	O
are	O
delineated	O
within	O
the	O
DX1S64	O
loucs	O
,	O
and	O
it	O
is	O
evident	O
that	O
the	O
deletoins	O
at	O
the	O
DMD	B-Disease
lcous	O
are	O
ferquent	O
and	O
extremely	O
large	O
.	O
.	O

A	O
ptoential	O
ainmal	O
mdoel	O
for	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
sydnrome	I-Disease
through	O
introudction	O
of	O
HRPT	O
mutatoins	O
into	O
mcie	O
.	O

The	O
hmuan	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
sydnrome	I-Disease
is	O
a	O
rrae	O
neuorlogical	B-Disease
and	I-Disease
behvaioural	I-Disease
disodrer	I-Disease
,	O
affetcing	O
only	O
maels	O
,	O
which	O
is	O
caused	O
by	O
an	O
ihnerited	B-Disease
dfeiciency	I-Disease
in	O
the	O
lveel	O
of	O
actviity	O
of	O
the	O
purnie	O
slavage	O
eznyme	O
hpyoxanthine	O
-	O
guansoine	O
phosphroibosyl	O
transefrase	O
(	O
HRPT	O
)	O
.	O

How	O
the	O
resulting	O
altreations	O
in	O
purnie	O
metaboilsm	O
lead	O
to	O
the	O
sveere	O
symptmos	O
chaarcteristic	O
of	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
ptaients	O
is	O
still	O
not	O
understood	O
.	O

No	O
muattions	O
at	O
the	O
Hrpt	O
lcous	O
leading	O
to	O
lsos	O
of	O
acitvity	O
have	O
been	O
described	O
in	O
labortaory	O
aniamls	O
.	O

To	O
derive	O
an	O
aniaml	O
mdoel	O
for	O
the	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
snydrome	I-Disease
,	O
we	O
have	O
used	O
cultuerd	O
muose	O
embryoinc	O
setm	O
cells	O
,	O
mutageniezd	O
by	O
rertoviral	O
isnertion	O
and	O
selected	O
for	O
lsos	O
of	O
HRPT	O
actiivty	O
,	O
to	O
cosntruct	O
chimearic	O
mcie	O
.	O

Two	O
cloanl	O
lnies	O
carrying	O
different	O
mutnat	O
Hrpt	O
alllees	O
have	O
given	O
rise	O
to	O
grem	O
clels	O
in	O
chimaears	O
,	O
allowing	O
the	O
deirvation	O
of	O
strians	O
of	O
mutnat	O
mcie	O
having	O
the	O
same	O
bicohemical	O
defcet	O
as	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
patinets	O
.	O

Mlae	O
mcie	O
carrying	O
the	O
mutnat	O
alleles	O
are	O
vialbe	O
and	O
anaylsis	O
of	O
their	O
cells	O
shows	O
a	O
total	O
lcak	O
of	O
HRPT	O
activtiy	O
.	O
.	O

Re	O
-	O
evalaution	O
of	O
the	O
sbulocalization	O
of	O
esetrase	O
D	O
and	O
its	O
relation	O
to	O
the	O
retnioblastoma	B-Disease
lcous	O
by	O
in	O
situ	O
hybridiaztion	O
.	O

In	O
situ	O
hybridziation	O
of	O
a	O
cNDA	O
prboe	O
for	O
the	O
estrease	O
D	O
gnee	O
(	O
ESD	O
)	O
was	O
carried	O
out	O
on	O
hmuan	O
chormosomes	O
.	O

The	O
prboe	O
hybridzied	O
most	O
strongly	O
to	O
13q14	O
.	O

2	O
and	O
13q14	O
.	O

3	O
.	O

This	O
obseravtion	O
raises	O
doubts	O
concerning	O
the	O
most	O
recently	O
pulbished	O
assignmnet	O
of	O
ESD	O
to	O
13q14	O
.	O

1	O
.	O

A	O
delteion	O
in	O
an	O
indiivdual	O
with	O
reitnoblastoma	B-Disease
was	O
reported	O
to	O
separate	O
the	O
closely	O
linked	O
ESD	O
and	O
retinoblatsoma	B-Disease
(	O
RB1	O
)	O
lcoi	O
,	O
placing	O
ESD	O
proxiaml	O
to	O
RB1	O
.	O

Quantittaive	O
in	O
situ	O
hybridiztaion	O
stduies	O
of	O
this	O
deeltion	O
do	O
not	O
confirm	O
this	O
interprettaion	O
.	O

Rather	O
,	O
they	O
suggest	O
that	O
ESD	O
is	O
missing	O
from	O
the	O
dleeted	O
chrmoosome	O
13	O
and	O
dulpicated	O
on	O
the	O
noraml	O
hoomlog	O
.	O

From	O
these	O
finidngs	O
,	O
we	O
conclude	O
that	O
the	O
dleetion	O
in	O
this	O
indiivdual	O
cannot	O
be	O
used	O
to	O
determine	O
the	O
oirentation	O
nor	O
the	O
sublocalizatoin	O
of	O
ESD	O
and	O
RB1	O
within	O
the	O
13q14	O
regoin	O
.	O

Hereidtary	B-Disease
C2	I-Disease
defiicency	I-Disease
associated	O
with	O
common	O
varialbe	O
immunodefiicency	B-Disease
.	O

Homozyguos	O
C2	B-Disease
deficeincy	I-Disease
in	O
a	O
19	O
-	O
yaer	O
-	O
old	O
boy	O
was	O
associated	O
with	O
varialbe	O
immuondeficiency	B-Disease
manifested	O
by	O
marked	O
hypoimmunoglobulinemia	B-Disease
and	O
imparied	O
antiobdy	O
rseponses	O
,	O
noraml	O
circultaing	O
B	O
lmyphocytes	O
,	O
and	O
subonrmal	O
T	O
-	O
clel	O
funcitons	O
.	O

Neither	O
atnilymphocytic	O
autoanitbodies	O
nor	O
chromosoaml	B-Disease
abnomralities	I-Disease
were	O
found	O
.	O

Seurm	O
immuonglobulin	O
leevls	O
were	O
within	O
nromal	O
liimts	O
in	O
his	O
paernts	O
and	O
brohter	O
who	O
were	O
hetreozygous	O
for	O
C2	B-Disease
deifciency	I-Disease
.	O

The	O
ptaients	O
lymphoyctes	O
were	O
hmoozygous	O
at	O
the	O
HLA	O
-	O
D	O
loucs	O
but	O
experssed	O
an	O
atnigen	O
different	O
from	O
DW2	O
.	O
.	O

Mlid	O
and	O
seevre	O
mucsular	B-Disease
dystrohpy	I-Disease
associated	O
with	O
deletinos	O
in	O
X2p1	O
of	O
the	O
hmuan	O
X	O
chromoosme	O
.	O

We	O
have	O
anaylsed	O
over	O
300	O
ptaients	O
sufefring	O
from	O
Duhcenne	B-Disease
or	I-Disease
Bekcer	I-Disease
mucsular	I-Disease
dystrohpy	I-Disease
(	O
DMD	B-Disease
or	O
BMD	B-Disease
)	O
.	O

Deleitons	O
have	O
been	O
charatcerised	O
which	O
encompass	O
either	O
the	O
pRET87	O
(	O
DX1S64	O
)	O
loucs	O
only	O
,	O
the	O
XJ1	O
.	O

1	O
(	O
DXS026	O
)	O
and	O
HPI25	O
lcoi	O
only	O
,	O
or	O
all	O
three	O
lcoi	O
.	O

These	O
lcoi	O
have	O
been	O
shown	O
to	O
lie	O
within	O
the	O
DMD	B-Disease
regoin	O
covering	O
several	O
hundred	O
kliobases	O
(	O
kb	O
)	O
of	O
DNA	O
.	O

One	O
mlidly	O
affceted	O
BMD	B-Disease
pateint	O
possesses	O
a	O
deleiton	O
of	O
at	O
least	O
110	O
kb	O
including	O
exnos	O
of	O
the	O
DMD	B-Disease
gnee	O
.	O

Other	O
ptaients	O
with	O
similar	O
eoxn	O
deleitons	O
,	O
or	O
smaller	O
delteions	O
,	O
show	O
the	O
more	O
sevree	O
pheontype	O
typical	O
of	O
DMD	B-Disease
.	O

We	O
conclude	O
from	O
these	O
sutdies	O
that	O
the	O
seevrity	O
of	O
the	O
clniical	O
pehnotype	O
cannot	O
be	O
explained	O
on	O
the	O
basis	O
of	O
the	O
szie	O
of	O
the	O
dleetion	O
.	O

We	O
discuss	O
this	O
in	O
the	O
conetxt	O
of	O
candidate	O
gnee	O
sequneces	O
.	O

Patetrns	O
of	O
eoxn	O
dleetions	O
in	O
Duchenne	B-Disease
and	I-Disease
Bekcer	I-Disease
musuclar	I-Disease
dystorphy	I-Disease
.	O

A	O
panel	O
of	O
pateints	O
with	O
Duhcenne	B-Disease
and	I-Disease
Becekr	I-Disease
muscualr	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
and	O
BMD	B-Disease
)	O
has	O
been	O
screened	O
with	O
the	O
cNDA	O
proebs	O
Cf65a	O
and	O
Cf23a	O
,	O
which	O
detcet	O
eoxns	O
in	O
the	O
cenrtal	O
part	O
of	O
the	O
DMD	B-Disease
gnee	O
.	O

One	O
or	O
more	O
exnos	O
were	O
deleetd	O
in	O
60	O
%	O
of	O
paitents	O
.	O

The	O
dleetions	O
were	O
mapped	O
and	O
prove	O
to	O
be	O
heterogenoeus	O
in	O
szie	O
and	O
extent	O
,	O
particularly	O
in	O
DMD	B-Disease
.	O

Deleitons	O
specific	O
to	O
DMD	B-Disease
and	O
to	O
BMD	B-Disease
are	O
described	O
.	O

Half	O
of	O
all	O
BMD	B-Disease
paitents	O
have	O
a	O
deeltion	O
of	O
one	O
particular	O
small	O
gruop	O
of	O
eoxns	O
;	O
smaller	O
deletoins	O
within	O
this	O
same	O
gorup	O
produce	O
the	O
more	O
sevree	O
DMD	B-Disease
.	O
.	O

Hereditray	B-Disease
defiicency	I-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
chlid	O
with	O
feevr	B-Disease
,	O
sikn	B-Disease
rsah	I-Disease
,	O
and	O
arthraligas	B-Disease
:	O
rseponse	O
to	O
transfusoin	O
of	O
whole	O
blood	O
.	O

A	O
previously	O
well	O
34	O
-	O
mnoth	O
-	O
old	O
mlae	O
presenitng	O
with	O
feevr	B-Disease
,	O
sikn	B-Disease
rsah	I-Disease
,	O
and	O
arhtralgias	B-Disease
was	O
found	O
to	O
lcak	O
C3	O
by	O
immuncohemical	O
(	O
undteectable	O
)	O
and	O
hemoltyic	O
(	O
1	O
%	O
noraml	O
)	O
assyas	O
.	O

No	O
infecitous	O
agnet	O
could	O
be	O
demonstrated	O
.	O

Prtoein	O
leevls	O
of	O
Clq	O
.	O

C4	O
,	O
C5	O
,	O
porperdin	O
,	O
and	O
C3b	O
-	O
INA	O
and	O
hmeolytic	O
actiivties	O
of	O
complement	O
compoennts	O
C1	O
to	O
C9	O
except	O
C3	O
were	O
nomral	O
or	O
eelvated	O
;	O
total	O
hmeolytic	O
complement	O
atcivity	O
was	O
13	O
%	O
of	O
noraml	O
and	O
was	O
rceonstituted	O
by	O
purifeid	O
C3	O
.	O

Proeprdin	O
facotr	O
B	O
was	O
702	O
(	O
nomral	O
175	O
to	O
275	O
)	O
mug	O
/	O
ml	O
,	O
and	O
was	O
not	O
celaver	O
upon	O
addition	O
of	O
zyomsan	O
or	O
corba	O
vneom	O
facotr	O
.	O

The	O
sreum	O
had	O
noraml	O
imumne	O
ahderence	O
actviity	O
,	O
but	O
was	O
deficeint	O
in	O
ability	O
to	O
osponize	O
Canddia	O
albiacns	O
for	O
upatke	O
and	O
Eschreichia	O
cloi	O
for	O
kililng	O
by	O
neurophlis	O
,	O
generate	O
neutrpohil	O
chemotatcic	O
fatcors	O
and	O
inhiibt	O
the	O
gorwth	O
of	O
E	O
.	O
cloi	O
;	O
these	O
actviities	O
were	O
restroed	O
by	O
puriifed	O
C3	O
.	O

A	O
trnasfusion	O
of	O
320	O
ml	O
1	O
-	O
hour	O
-	O
old	O
nromal	O
whole	O
bolod	O
on	O
the	O
fifty	O
-	O
second	O
day	O
resulted	O
in	O
transitory	O
elevtaion	O
of	O
the	O
C3	O
lveel	O
to	O
25	O
mg	O
/	O
dl	O
with	O
a	O
fall	O
-	O
off	O
(	O
approximately	O
2	O
1	O
/	O
2	O
%	O
per	O
hour	O
)	O
to	O
udnetectable	O
levles	O
by	O
69	O
hours	O
;	O
it	O
was	O
followed	O
by	O
disapeparance	O
of	O
the	O
sikn	B-Disease
rsah	I-Disease
and	O
arthraglias	B-Disease
and	O
return	O
to	O
nomral	O
of	O
the	O
previously	O
eleavted	O
temperatrue	O
and	O
CRP	O
levles	O
.	O

C3	O
lveels	O
in	O
famliy	O
memebrs	O
(	O
seven	O
of	O
24	O
half	O
-	O
nomral	O
)	O
,	O
lcak	O
of	O
atni	O
-	O
C3	O
activtiy	O
,	O
nomral	O
C3b	O
-	O
INA	O
lveels	O
and	O
a	O
nromal	O
rtae	O
of	O
caatbolism	O
of	O
tarnsfused	O
C3	O
indicated	O
that	O
the	O
deficeincy	O
was	O
inhreited	O
with	O
atuosomal	O
codoimnance	O
and	O
involved	O
dcereased	B-Disease
synthseis	I-Disease
of	I-Disease
C3	I-Disease
.	O

Thus	O
,	O
this	O
cihld	O
is	O
a	O
uinque	O
indiviudal	O
with	O
ihnerited	B-Disease
C3	I-Disease
deifciency	I-Disease
presetning	O
with	O
absnece	O
of	O
rpeeated	O
infectinos	O
,	O
whose	O
symtpoms	O
of	O
feevr	B-Disease
,	O
sikn	B-Disease
rsah	I-Disease
,	O
and	O
atrhralgia	B-Disease
were	O
abated	O
by	O
whole	O
blood	O
trasnfusion	O
.	O
.	O

Glucsoe	O
-	O
6	O
-	O
phospahte	O
dheydrogenase	O
vairants	O
and	O
their	O
frequnecy	O
in	O
Guagndong	O
,	O
Cihna	O
.	O

Ertyhrocyte	O
gluocse	O
-	O
6	O
-	O
phospahte	O
dehydorgenase	O
(	O
GP6D	O
)	O
was	O
characteirzed	O
in	O
blood	O
smaples	O
obtained	O
from	O
97	O
randomly	O
selected	O
maels	O
with	O
eznyme	B-Disease
defiicency	I-Disease
from	O
various	O
rgeions	O
of	O
Guangdnog	O
Provicne	O
,	O
Chnia	O
.	O

Nine	O
new	O
variatns	O
(	O
Gd	O
Kiaping	O
,	O
Gd	O
Boulo	O
,	O
Gd	O
Huiynag	O
,	O
Gd	O
Goamin	O
,	O
Gd	O
Qnig	O
-	O
Bajiiang	O
,	O
Gd	O
Gaozohu	O
,	O
Gd	O
Hauzhou	O
,	O
Gd	O
Nnahai	O
,	O
and	O
Gd	O
Guanghzou	O
)	O
were	O
idetnified	O
.	O

Of	O
the	O
31	O
vraiants	O
found	O
in	O
this	O
provnice	O
,	O
Gd	O
Kaiipng	O
,	O
Gd	O
Tiawan	O
-	O
Hakka	O
,	O
Gd	O
Haad	O
Yai	O
,	O
Gd	O
Haad	O
Yai	O
-	O
like	O
and	O
Gd	O
Huyiang	O
occurred	O
most	O
frequently	O
.	O

The	O
frqeuency	O
of	O
each	O
varaint	O
was	O
calculated	O
.	O

The	O
rseults	O
demonstrated	O
that	O
the	O
geentic	O
hetreogeneity	O
of	O
GP6D	B-Disease
deifciency	I-Disease
was	O
high	O
in	O
this	O
aera	O
.	O
.	O

Homoyzgous	O
and	O
heteroyzgous	O
deleitons	O
of	O
the	O
von	B-Disease
Willebrnad	I-Disease
facotr	O
gnee	O
in	O
pateints	O
and	O
carirers	O
of	O
seevre	B-Disease
von	I-Disease
Wilelbrand	I-Disease
diesase	I-Disease
.	O

Sevree	B-Disease
von	I-Disease
Willebarnd	I-Disease
diesase	I-Disease
is	O
charactreized	O
by	O
undteectable	O
or	O
trcae	O
quantiites	O
of	O
von	B-Disease
Wilelbrand	I-Disease
fatcor	O
in	O
plsama	O
and	O
tisuse	O
stroes	O
.	O

We	O
have	O
studied	O
the	O
gneomic	O
DNA	O
of	O
10	O
affecetd	O
indiviudals	O
from	O
six	O
faimlies	O
with	O
this	O
disodrer	O
using	O
porbes	O
from	O
the	O
5	O
and	O
3	O
edns	O
of	O
the	O
vWF	O
cNDA	O
and	O
with	O
a	O
porbe	O
extending	O
from	O
the	O
5	O
end	O
into	O
the	O
cenrtal	O
rgeion	O
.	O

Suothern	O
bltos	O
of	O
restrictoin	O
endounclease	O
diegsts	O
and	O
gnee	O
dsoage	O
aanlysis	O
measuremetns	O
carried	O
out	O
with	O
qunatitative	O
solt	O
bolts	O
of	O
undiegsted	O
genmoic	O
DNA	O
seaprated	O
these	O
patietns	O
into	O
three	O
gorups	O
.	O

The	O
first	O
gorup	O
consisted	O
of	O
a	O
fmaily	O
with	O
complete	O
hmoozygous	O
deeltions	O
of	O
the	O
vWF	O
gnee	O
in	O
the	O
four	O
proabnds	O
.	O

Gnee	O
dsoage	O
anaylsis	O
was	O
consistent	O
with	O
heteroyzgous	O
dleetions	O
in	O
both	O
of	O
the	O
asymtpomatic	O
praents	O
and	O
four	O
asymptomtaic	O
siblnigs	O
of	O
this	O
kinderd	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
.	O

The	O
second	O
gorup	O
was	O
comprised	O
of	O
a	O
fmaily	O
in	O
which	O
there	O
was	O
a	O
complete	O
heteorzygous	O
deeltion	O
of	O
the	O
vWF	O
gnee	O
in	O
the	O
porband	O
and	O
one	O
asymptoamtic	O
parnet	O
,	O
suggesting	O
that	O
a	O
different	O
tpye	O
of	O
genteic	B-Disease
anbormality	I-Disease
was	O
inehrited	O
from	O
the	O
other	O
parnet	O
.	O

Thus	O
,	O
the	O
pateint	O
appeared	O
to	O
be	O
doubly	O
hetreozygous	O
for	O
intearcting	O
genteic	B-Disease
abnoramlities	I-Disease
affecting	O
vWF	O
exrpession	O
.	O

In	O
the	O
third	O
gorup	O
,	O
no	O
gnee	O
deletinos	O
could	O
be	O
dteected	O
.	O

Alloanitbodies	O
developed	O
only	O
in	O
the	O
kinderd	O
with	O
homzoygous	O
delteions	O
.	O

These	O
techniuqes	O
should	O
prove	O
useful	O
in	O
identifying	O
carirers	O
of	O
sveere	B-Disease
von	I-Disease
Wilelbrand	I-Disease
diesase	I-Disease
and	O
also	O
in	O
defining	O
pateints	O
predictably	O
at	O
rsik	O
of	O
developing	O
alloantibodeis	O
to	O
vWF	O
.	O

Sjorgen	B-Disease
-	I-Disease
Lrasson	I-Disease
syndrmoe	I-Disease
.	O

Ipmaired	O
ftaty	O
alochol	O
oxidatoin	O
in	O
culutred	O
fiborblasts	O
due	O
to	O
deficeint	O
ftaty	O
alchool	O
:	O
nioctinamide	O
adennie	O
diuncleotide	O
oxidoreducatse	O
actviity	O
.	O

Liipd	O
metbaolism	O
was	O
studied	O
in	O
cultrued	O
sikn	O
fibroblatss	O
from	O
patinets	O
with	O
the	O
inhreited	B-Disease
disroder	I-Disease
,	O
Sojgren	B-Disease
-	I-Disease
Lrasson	I-Disease
sydnrome	I-Disease
(	O
SLS	B-Disease
)	O
.	O

Itnact	O
SLS	B-Disease
firboblasts	O
incbuated	O
in	O
the	O
preesnce	O
of	O
[	O
1	O
-	O
14C	O
]	O
pamlitate	O
accumulated	O
more	O
radiaoctive	O
hexaedcanol	O
than	O
did	O
nromal	O
clels	O
,	O
whereas	O
incroporation	O
of	O
radioatcivity	O
into	O
other	O
cellular	O
liipds	O
was	O
unalteerd	O
.	O

The	O
heaxdecanol	O
cnotent	O
of	O
SLS	B-Disease
fiborblasts	O
was	O
abnromally	O
elveated	O
.	O

Hexadecnaol	O
accuumlation	O
was	O
not	O
due	O
to	O
incresaed	O
fatty	O
alcoohl	O
sytnhesis	O
nor	O
its	O
deifcient	O
utiliaztion	O
for	O
glycreol	O
etehr	O
synthseis	O
.	O

The	O
half	O
-	O
lfie	O
of	O
intracelullar	O
hexadeacnol	O
lodaed	O
into	O
SLS	B-Disease
fiborblasts	O
was	O
incresaed	O
(	O
70	O
min	O
)	O
compaerd	O
with	O
nomral	O
(	O
15	O
min	O
)	O
,	O
and	O
itnact	O
SLS	B-Disease
fbiroblasts	O
showed	O
imapired	O
oxidatoin	O
of	O
[	O
14C	O
]	O
-	O
hxeadecanol	O
to	O
fatty	O
aicd	O
.	O

Ftaty	O
aclohol	O
NAD	O
+	O
oxiodreductase	O
,	O
the	O
eznyme	O
catalyzing	O
this	O
reaciton	O
,	O
was	O
deficinet	O
in	O
SLS	B-Disease
fbiroblasts	O
.	O

Mean	O
total	O
acitvity	O
in	O
SLS	B-Disease
firboblasts	O
(	O
n	O
=	O
5	O
)	O
was	O
13	O
%	O
of	O
that	O
in	O
nomral	O
fibrbolasts	O
,	O
and	O
plamitoyl	O
CoA	O
-	O
inhibtiable	O
atcivity	O
was	O
1	O
%	O
of	O
noraml	O
.	O

Fiborblasts	O
from	O
two	O
obliagte	O
SLS	B-Disease
heterozygtoes	O
had	O
eznyme	O
activtiies	O
inetrmediate	O
between	O
that	O
in	O
noraml	O
fibrbolasts	O
and	O
indiviudals	O
with	O
SLS	B-Disease
.	O

These	O
resutls	O
suggest	O
that	O
the	O
pirmary	O
dfeect	O
in	O
SLS	B-Disease
is	O
deifciency	B-Disease
of	I-Disease
ftaty	I-Disease
alochol	I-Disease
NAD	I-Disease
+	I-Disease
oxidordeuctase	I-Disease
.	O

SLS	B-Disease
represents	O
the	O
first	O
inhertied	B-Disease
disoredr	I-Disease
in	O
man	O
associated	O
with	O
an	O
ioslated	O
abnormailty	B-Disease
in	I-Disease
ftaty	I-Disease
aclohol	I-Disease
meatbolism	I-Disease
.	O
.	O

Gerimnal	O
mosaciism	O
in	O
Ducehnne	B-Disease
musuclar	I-Disease
dystrpohy	I-Disease
.	O

We	O
have	O
idenitfied	O
a	O
Duchenne	B-Disease
muscluar	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
peidgree	O
where	O
the	O
disaese	O
is	O
associated	O
with	O
a	O
molecualr	O
deeltion	O
within	O
the	O
DMD	B-Disease
lcous	O
.	O

We	O
have	O
examined	O
the	O
meitoic	O
segregaiton	O
prodcuts	O
of	O
the	O
common	O
feamle	O
ancsetor	O
using	O
marekr	O
rsetriction	O
fargment	O
lnegth	O
polyomrphisms	O
(	O
RFPLs	O
)	O
dteected	O
by	O
proebs	O
that	O
lie	O
within	O
this	O
deletoin	O
.	O

These	O
studeis	O
show	O
that	O
this	O
femlae	O
has	O
transmtited	O
three	O
distinct	O
types	O
of	O
X	O
chormosome	O
to	O
her	O
offspring	O
.	O

This	O
obsrevation	O
may	O
be	O
explained	O
by	O
postulating	O
that	O
the	O
muattion	O
arose	O
as	O
a	O
postzyogtic	O
deeltion	O
within	O
this	O
common	O
acnestor	O
,	O
who	O
was	O
consequently	O
gemrinally	O
moasic	O
.	O
.	O

Neublin	O
seen	O
in	O
DMD	B-Disease
maels	O
including	O
one	O
ptaient	O
with	O
a	O
large	O
DNA	O
deleiton	O
encompassing	O
the	O
DMD	B-Disease
gnee	O
.	O

The	O
preesnce	O
of	O
nbeulin	O
in	O
a	O
msucle	O
speicmen	O
from	O
a	O
ptaient	O
with	O
Dcuhenne	B-Disease
muscualr	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
due	O
to	O
a	O
large	O
dleetion	O
precludes	O
the	O
possibility	O
that	O
this	O
prtoein	O
is	O
the	O
DMD	B-Disease
gnee	O
proudct	O
.	O
.	O

Experssion	O
of	O
the	O
muirne	O
Duhcenne	B-Disease
muscualr	I-Disease
dysrtophy	I-Disease
gnee	O
in	O
msucle	O
and	O
barin	O
.	O

Complemnetary	O
DNA	O
clnoes	O
were	O
isolaetd	O
that	O
represent	O
the	O
5	O
terimnal	O
2	O
.	O

5	O
kilboases	O
of	O
the	O
muirne	O
Duchenne	B-Disease
muscluar	I-Disease
dsytrophy	I-Disease
(	O
Dmd	O
)	O
messenegr	O
RNA	O
(	O
mNRA	O
)	O
.	O

Muose	O
Dmd	O
mNRA	O
was	O
detectbale	O
in	O
skleetal	O
and	O
cardaic	O
msucle	O
and	O
at	O
a	O
lveel	O
approximately	O
90	O
percent	O
lwoer	O
in	O
brian	O
.	O

Dmd	O
mNRA	O
is	O
also	O
present	O
,	O
but	O
at	O
much	O
lwoer	O
than	O
noraml	O
lveels	O
,	O
in	O
both	O
the	O
muslce	O
and	O
brian	O
of	O
three	O
different	O
srtains	O
of	O
dsytrophic	B-Disease
mdx	O
mcie	O
.	O

The	O
idnetification	O
of	O
Dmd	O
mNRA	O
in	O
brian	O
raises	O
the	O
possibility	O
of	O
a	O
relation	O
between	O
hmuan	O
Ducehnne	B-Disease
musuclar	I-Disease
dystrpohy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
exrpession	O
and	O
the	O
mnetal	B-Disease
retardtaion	I-Disease
found	O
in	O
some	O
DMD	B-Disease
maels	O
.	O

These	O
rseults	O
also	O
provide	O
eivdence	O
that	O
the	O
mdx	O
mutatoins	O
are	O
allelic	O
varinats	O
of	O
mosue	O
Dmd	O
gnee	O
mutatoins	O
.	O

Glcuose	B-Disease
6	I-Disease
-	I-Disease
pohsphate	I-Disease
dehyrdogenase	I-Disease
deficinecy	I-Disease
and	O
inicdence	O
of	O
hematoloigc	B-Disease
maliganncy	I-Disease
.	O

We	O
have	O
evlauated	O
the	O
hyptohesis	O
of	O
a	O
ngeative	O
associatoin	O
between	O
gulcose	B-Disease
6	I-Disease
-	I-Disease
phopshate	I-Disease
dehyrdogenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
defiicency	I-Disease
and	O
cnacer	B-Disease
in	O
a	O
cohrot	O
of	O
481	O
Saridnian	O
mlaes	O
with	O
hemaotlogical	B-Disease
malignacnies	I-Disease
.	O

The	O
frqeuency	O
of	O
GP6D	B-Disease
deficiecny	I-Disease
in	O
the	O
pateints	O
was	O
not	O
different	O
from	O
the	O
inciednce	O
in	O
a	O
gruop	O
of	O
16	O
,	O
219	O
cnotrols	O
.	O

The	O
same	O
conclusion	O
resulted	O
from	O
the	O
copmarison	O
of	O
the	O
freqeuncy	O
of	O
experssion	O
of	O
the	O
GdB	O
gnee	O
in	O
23	O
heteorzygous	O
wmoen	O
having	O
a	O
colnal	O
hmeatologic	B-Disease
dsiease	I-Disease
and	O
a	O
contorl	O
gorup	O
of	O
37	O
haelthy	O
heterozgyotes	O
.	O

Therefore	O
at	O
present	O
there	O
is	O
no	O
evidnece	O
that	O
GP6D	B-Disease
defciiency	I-Disease
has	O
a	O
protective	O
effect	O
against	O
devleopment	O
of	O
hemtaologic	B-Disease
neoplsams	I-Disease
.	O
.	O

Hepatolbastoma	B-Disease
,	O
pigmetned	B-Disease
ocluar	I-Disease
fudnus	I-Disease
lesinos	I-Disease
and	O
jaw	B-Disease
lseions	I-Disease
in	O
Garnder	B-Disease
syndorme	I-Disease
.	O

Hepatoblasotma	B-Disease
is	O
a	O
rrae	O
neolpasm	B-Disease
of	O
infatns	O
and	O
chidlren	O
only	O
recently	O
docmuented	O
in	O
assocaition	O
with	O
hereidtary	B-Disease
adenmoatous	I-Disease
polyopsis	I-Disease
of	I-Disease
the	I-Disease
cooln	I-Disease
[	O
Kignston	O
et	O
al	O
.	O
,	O
1983	O
]	O
.	O

We	O
reprot	O
four	O
childern	O
with	O
heaptoblastoma	B-Disease
from	O
four	O
unrelated	O
famliies	O
with	O
Gradner	B-Disease
synrdome	I-Disease
(	O
GS	B-Disease
)	O
.	O

One	O
cihld	O
,	O
now	O
19	O
yaers	O
old	O
,	O
survived	O
after	O
a	O
rseection	O
of	O
a	O
hepatoblastmoa	B-Disease
in	O
inafncy	O
and	O
recently	O
was	O
found	O
to	O
have	O
GS	B-Disease
.	O

He	O
has	O
an	O
associated	O
odnotoma	B-Disease
and	O
pigmneted	B-Disease
ouclar	I-Disease
fudnus	I-Disease
lseions	I-Disease
,	O
both	O
of	O
which	O
have	O
been	O
shown	O
to	O
be	O
cilnical	O
mrakers	O
of	O
GS	B-Disease
.	O

Many	O
individauls	O
in	O
these	O
four	O
GS	B-Disease
famiiles	O
,	O
both	O
affected	O
and	O
at	O
rsik	O
,	O
have	O
osteomatuos	B-Disease
jaw	I-Disease
lseions	I-Disease
and	O
pigmneted	B-Disease
ocualr	I-Disease
funuds	I-Disease
lesoins	I-Disease
.	O

A	O
search	O
for	O
coolnic	B-Disease
poylps	I-Disease
should	O
be	O
made	O
in	O
famiiles	O
of	O
infatns	O
and	O
chlidren	O
with	O
hepaotblastoma	B-Disease
.	O

If	O
the	O
cihld	O
survives	O
,	O
he	O
or	O
she	O
should	O
be	O
monitroed	O
for	O
the	O
later	O
appearnace	O
of	O
coloinc	B-Disease
ployps	I-Disease
.	O

The	O
finidng	O
of	O
jaw	B-Disease
lesinos	I-Disease
and	O
/	O
or	O
pgimented	B-Disease
ocluar	I-Disease
fnudus	I-Disease
lesinos	I-Disease
in	O
reltaives	O
at	O
rsik	O
are	O
indicatoins	O
of	O
the	O
possible	O
preesnce	O
of	O
the	O
GS	B-Disease
gnee	O
.	O

Idnetification	O
of	O
an	O
aletred	O
slpice	O
stie	O
in	O
Ashkneazi	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
.	O

Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
is	O
an	O
atuosomal	B-Disease
reecssive	I-Disease
gneetic	I-Disease
disoredr	I-Disease
resulting	O
from	O
muttaion	O
of	O
the	O
HXEA	O
gnee	O
encoidng	O
the	O
aplha	O
-	O
subnuit	O
of	O
the	O
lsyosomal	O
enzmye	O
,	O
btea	O
-	O
N	O
-	O
acetylhexosaminidase	O
A	O
(	O
ref	O
.	O
1	O
)	O
.	O

A	O
relatively	O
high	O
frequnecy	O
of	O
carriers	O
(	O
1	O
/	O
27	O
)	O
of	O
a	O
lehtal	O
,	O
ifnantile	O
form	O
of	O
the	O
disesae	O
is	O
found	O
in	O
the	O
Ashkneazi	O
Jewsih	O
pouplation	O
,	O
but	O
it	O
is	O
not	O
yet	O
evident	O
whether	O
this	O
has	O
resulted	O
from	O
a	O
fonuder	O
efefct	O
and	O
rnadom	O
geneitc	O
dirft	O
or	O
from	O
a	O
selective	O
advantage	O
of	O
hetreozygotes	O
.	O

We	O
have	O
idenitfied	O
a	O
single	O
-	O
base	O
muattion	O
in	O
a	O
clnoed	O
frgament	O
of	O
the	O
HXEA	O
gnee	O
from	O
an	O
Ahskenazi	O
Jweish	O
patinet	O
.	O

This	O
change	O
,	O
the	O
substitutoin	O
of	O
a	O
C	O
for	O
G	O
in	O
the	O
first	O
nucleotdie	O
of	O
itnron	O
12	O
is	O
expected	O
to	O
result	O
in	O
dfeective	O
spilcing	O
of	O
the	O
messneger	O
RNA	O
.	O

A	O
tset	O
for	O
the	O
mutnat	O
alllee	O
based	O
on	O
ampliifcation	O
of	O
DNA	O
by	O
the	O
ploymerase	O
chian	O
retcion	O
and	O
celavage	O
of	O
a	O
DedI	O
restrictoin	O
stie	O
generated	O
by	O
the	O
mutaiton	O
reveaeld	O
that	O
this	O
csae	O
and	O
two	O
other	O
csaes	O
of	O
the	O
Ashkenzai	O
,	O
infanitle	O
form	O
of	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
disesae	I-Disease
are	O
hteerozygous	O
for	O
two	O
different	O
muttaions	O
.	O

The	O
occurrnece	O
of	O
mutliple	O
mutnat	O
alleels	O
warrants	O
further	O
examniation	O
of	O
the	O
selective	O
advantage	O
hypohtesis	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
gulcose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phsophate	I-Disease
dehydorgenase	I-Disease
deficiecny	I-Disease
in	O
Mus	O
mucsulus	O
.	O

A	O
mosue	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
glcuose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphtae	I-Disease
dehydrogeanse	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
defiicency	I-Disease
has	O
been	O
reocvered	O
in	O
offspring	O
of	O
1	O
-	O
ehtyl	O
-	O
1	O
-	O
nitrosouera	O
-	O
tretaed	O
mlae	O
mcie	O
.	O

The	O
atcivity	O
alteratoin	O
was	O
detetced	O
in	O
bolod	O
but	O
can	O
also	O
be	O
observed	O
in	O
other	O
tissue	O
extrcats	O
.	O

Hemizgyous	O
,	O
hetreozygous	O
,	O
and	O
homozyguos	O
mutatns	O
have	O
,	O
respectively	O
,	O
about	O
15	O
,	O
60	O
,	O
and	O
15	O
%	O
GP6D	O
remaining	O
acitvity	O
in	O
the	O
bolod	O
as	O
compaerd	O
to	O
the	O
wlid	O
tpye	O
.	O

Erythroycte	O
indcies	O
did	O
not	O
show	O
differneces	O
between	O
mtuants	O
and	O
wlid	O
types	O
.	O

The	O
mutatoin	O
does	O
not	O
affect	O
the	O
elecrtophoretic	O
migraiton	O
,	O
the	O
isoeelctric	O
point	O
,	O
or	O
the	O
theraml	O
stabliity	O
.	O

Kinteic	O
propetries	O
,	O
such	O
as	O
the	O
Km	O
for	O
glcuose	O
-	O
6	O
-	O
phsophate	O
or	O
for	O
NDAP	O
and	O
the	O
relative	O
uitlization	O
of	O
subsrtate	O
aanlogues	O
,	O
showed	O
no	O
differecnes	O
between	O
wlid	O
types	O
and	O
mutnats	O
with	O
the	O
exception	O
of	O
the	O
relative	O
utilizatoin	O
of	O
daemino	O
-	O
NDAP	O
which	O
was	O
significantly	O
lwoer	O
in	O
mutatns	O
.	O

This	O
is	O
presently	O
the	O
only	O
aniaml	O
mdoel	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
GP6D	I-Disease
dfeiciency	I-Disease
in	O
humnas	O
.	O
.	O

Divesre	O
point	O
mutaitons	O
in	O
the	O
hmuan	O
gulcose	O
-	O
6	O
-	O
phosphtae	O
dehydrognease	O
gnee	O
cause	O
eznyme	B-Disease
deifciency	I-Disease
and	O
mlid	O
or	O
sevree	O
heomlytic	B-Disease
aenmia	I-Disease
.	O

Glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphtae	I-Disease
dehdyrogenase	I-Disease
(	I-Disease
GP6D	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
deficiecny	I-Disease
is	O
a	O
common	O
genteic	B-Disease
abnoramlity	I-Disease
affectnig	O
an	O
estmiated	O
400	O
million	O
poeple	O
worldwide	O
.	O

Clniical	O
and	O
biochemcial	O
analsyes	O
have	O
identfiied	O
many	O
variatns	O
exhibiting	O
a	O
range	O
of	O
phenotpyes	O
,	O
which	O
have	O
been	O
well	O
cahracterized	O
from	O
the	O
hematloogical	O
point	O
of	O
view	O
.	O

However	O
,	O
until	O
now	O
,	O
their	O
precise	O
moleuclar	O
basis	O
has	O
remained	O
unknown	O
.	O

We	O
have	O
colned	O
and	O
sequecned	O
seven	O
mtuant	O
GP6D	O
alleles	O
.	O

In	O
the	O
nnodeficient	O
ploymorphic	O
Afriacn	O
varinat	O
GP6D	O
A	O
we	O
have	O
found	O
a	O
single	O
point	O
muttaion	O
.	O

The	O
other	O
six	O
muatnts	O
investgiated	O
were	O
all	O
associated	O
with	O
enyzme	B-Disease
defciiency	I-Disease
.	O

In	O
one	O
of	O
the	O
commonest	O
,	O
GP6D	O
Mediterranaen	O
,	O
which	O
is	O
associated	O
with	O
fvaism	B-Disease
among	O
other	O
cliincal	O
manifetsations	O
,	O
a	O
single	O
aimno	O
aicd	O
replcaement	O
was	O
found	O
(	O
sernie	O
-	O
-	O
-	O
-	O
pheynlalanine	O
)	O
it	O
must	O
be	O
responsible	O
for	O
the	O
decerased	O
staiblity	O
and	O
the	O
reudced	O
catayltic	O
efficeincy	O
of	O
this	O
eznyme	O
.	O

Single	O
point	O
mtuations	O
were	O
also	O
found	O
in	O
GP6D	O
Metpaonto	O
(	O
Southren	O
Iatly	O
)	O
and	O
in	O
GP6D	O
Ilseha	O
(	O
Nigeira	O
)	O
,	O
which	O
are	O
asymtpomatic	O
,	O
and	O
in	O
GP6D	O
Chahtam	O
,	O
which	O
was	O
observed	O
in	O
an	O
Indain	O
boy	O
with	O
noenatal	B-Disease
juandice	I-Disease
.	O

In	O
GP6D	O
"	O
Mtaera	O
,	O
"	O
which	O
is	O
now	O
known	O
to	O
be	O
the	O
same	O
as	O
GP6D	O
A	O
-	O
,	O
two	O
separate	O
point	O
muttaions	O
were	O
found	O
,	O
one	O
of	O
which	O
is	O
the	O
same	O
as	O
in	O
GP6D	O
A	O
.	O

In	O
GP6D	O
Santigao	O
,	O
a	O
de	O
novo	O
mutatoin	O
(	O
gylcine	O
-	O
-	O
-	O
-	O
agrinine	O
)	O
is	O
associated	O
with	O
sevree	O
chrnoic	O
hmeolytic	B-Disease
anmeia	I-Disease
.	O

The	O
muattions	O
observed	O
show	O
a	O
striking	O
predominance	O
of	O
C	O
-	O
-	O
-	O
-	O
T	O
transitoins	O
,	O
with	O
CG	O
doubelts	O
involved	O
in	O
four	O
of	O
seven	O
caess	O
.	O

Thus	O
,	O
divesre	O
point	O
mtuations	O
may	O
account	O
largely	O
for	O
the	O
pehnotypic	O
heteroegneity	O
of	O
GP6D	B-Disease
defciiency	I-Disease
.	O

Tgiht	O
lnikage	O
between	O
myotoinc	B-Disease
dystrohpy	I-Disease
and	O
apoilpoprotein	O
E	O
geens	O
rveealed	O
with	O
alelle	O
-	O
specific	O
oligonculeotides	O
.	O

In	O
16	O
faimlies	O
with	O
myotoinc	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
a	O
novel	O
approach	O
based	O
on	O
use	O
of	O
allele	O
-	O
specific	O
olgionucleotides	O
has	O
been	O
employed	O
to	O
stduy	O
the	O
lnikage	O
relatoinship	O
between	O
the	O
aploipoprotein	O
E	O
(	O
AOPE	O
)	O
gnee	O
and	O
DM	B-Disease
.	O

Snythetic	O
oligonculeotides	O
,	O
designed	O
to	O
discriimnate	O
between	O
AOPE	O
alleels	O
epslion	O
3	O
and	O
espilon	O
4	O
,	O
enabled	O
us	O
to	O
distinguish	O
heteorzygous	O
carirers	O
in	O
a	O
hybirdization	O
assay	O
.	O

In	O
a	O
subset	O
of	O
faimlies	O
,	O
the	O
relveant	O
segmnet	O
of	O
the	O
AOPE	O
gnee	O
was	O
enzymtaically	O
amplfiied	O
to	O
incresae	O
the	O
snesitivity	O
of	O
the	O
mehtod	O
.	O

For	O
DM	O
and	O
AOPE	O
,	O
a	O
mxaimum	O
lod	O
socre	O
(	O
zamx	O
of	O
7	O
.	O

47	O
was	O
obtained	O
at	O
a	O
rceombination	O
frqeuency	O
(	O
thtea	O
)	O
of	O
0	O
.	O

047	O
(	O
mlae	O
thtea	O
=	O
femlae	O
thtea	O
)	O
.	O

No	O
recmobination	O
(	O
maxmium	O
lod	O
socre	O
of	O
5	O
.	O
61	O
at	O
tehta	O
=	O
0	O
.	O
0	O
)	O
was	O
found	O
between	O
AOPE	O
and	O
the	O
apoliporpotein	O
CII	O
(	O
AOPC2	O
)	O
gnee	O
.	O

These	O
reuslts	O
suggest	O
that	O
,	O
in	O
addition	O
to	O
AOPC2	O
,	O
AOPE	O
is	O
a	O
useful	O
makrer	O
for	O
presympotmatic	O
DM	B-Disease
diagnoiss	O
.	O

Rgeional	O
localiaztion	O
of	O
polymrophic	O
DNA	O
lcoi	O
on	O
the	O
proxiaml	O
long	O
arm	O
of	O
the	O
X	O
chromsoome	O
using	O
dleetions	O
associated	O
with	O
choroidreemia	B-Disease
.	O

In	O
two	O
unrelated	O
fmailies	O
,	O
maels	O
have	O
been	O
identiifed	O
who	O
suffer	O
from	O
choroidereima	B-Disease
and	O
at	O
the	O
same	O
tmie	O
have	O
an	O
interstiital	O
deeltion	O
on	O
the	O
prxoimal	O
long	O
arm	O
of	O
the	O
X	O
chroomsome	O
.	O

By	O
high	O
-	O
resoultion	O
badning	O
we	O
have	O
cahracterized	O
the	O
deeltion	O
chromosoems	O
as	O
del	O
(	O
X	O
)	O
(	O
q21	O
.	O
1	O
-	O
q21	O
1	O
-	O
q21	O
.	O
33	O
)	O
and	O
del	O
(	O
X	O
)	O
(	O
q21	O
.	O
2	O
-	O
q21	O
2	O
-	O
q21	O
.	O
31	O
)	O
respectively	O
.	O

By	O
Southren	O
bolt	O
analsyis	O
we	O
have	O
mapped	O
ten	O
different	O
polymorpihc	O
DNA	O
lcoi	O
relative	O
to	O
the	O
postiion	O
of	O
the	O
dleetion	O
and	O
the	O
choroidermeia	B-Disease
loucs	O
TCD	O
.	O

One	O
prboe	O
,	O
p31	O
,	O
was	O
shown	O
to	O
cover	O
one	O
of	O
the	O
breapkoints	O
of	O
the	O
smallest	O
deeltion	O
.	O

The	O
following	O
order	O
of	O
the	O
lcoi	O
was	O
suggested	O
by	O
deeltion	O
mappnig	O
cen	O
-	O
DXS016	O
-	O
DX7S2	O
-	O
TCD	O
-	O
(	O
DXSY1	O
/	O
DXY2S3	O
/	O
DYXS5	O
)	O
-	O
DYXS2	O
-	O
(	O
DXSY12	O
/	O
DSX3	O
)	O
-	O
(	O
DX1S7	O
/	O
DSX101	O
)	O
-	O
Xqetr	O
.	O

Retrvoiral	O
-	O
mediated	O
gnee	O
trasnfer	O
of	O
huamn	O
pehnylalanine	O
hydorxylase	O
into	O
NIH	O
3T3	O
and	O
heptaoma	B-Disease
clels	O
.	O

Phenylkeotnuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
caused	O
by	O
deifciency	B-Disease
of	I-Disease
the	I-Disease
heaptic	I-Disease
eznyme	I-Disease
phenyallanine	I-Disease
hyrdoxylase	I-Disease
(	O
PAH	O
)	O
.	O

A	O
full	O
-	O
legnth	O
hmuan	O
PAH	O
cNDA	O
sqeuence	O
has	O
been	O
inserted	O
into	O
pzip	O
-	O
neoSV	O
(	O
X	O
)	O
,	O
which	O
is	O
a	O
retroviarl	O
vecotr	O
containing	O
the	O
bacterail	O
neo	O
gnee	O
.	O

The	O
recombiannt	O
has	O
been	O
tranfsected	O
into	O
psi	O
2	O
cells	O
,	O
which	O
provide	O
syntheiss	O
of	O
the	O
retrovrial	O
capisd	O
.	O

Recombinnat	O
vrius	O
was	O
detceted	O
in	O
the	O
cluture	O
meduim	O
of	O
the	O
transfceted	O
psi	O
2	O
cells	O
,	O
which	O
is	O
capable	O
of	O
trnasmitting	O
the	O
huamn	O
PAH	O
gnee	O
into	O
mosue	O
NIH	O
3T3	O
cells	O
by	O
infetcion	O
leading	O
to	O
stbale	O
incoropration	O
of	O
the	O
recobminant	O
prvoirus	O
.	O

Ifnected	O
clels	O
express	O
PAH	O
mNRA	O
,	O
immunoreacitve	O
PAH	O
portein	O
,	O
and	O
exhibit	O
petrin	O
-	O
deepndent	O
phenylaalnine	O
hydroxyalse	O
atcivity	O
.	O

The	O
recombinnat	O
vrius	O
is	O
also	O
capable	O
of	O
infetcing	O
a	O
mosue	O
hepatmoa	B-Disease
clel	O
line	O
that	O
does	O
not	O
normally	O
synthesize	O
PAH	O
.	O

PAH	O
activtiy	O
is	O
present	O
in	O
the	O
cellluar	O
exrtacts	O
and	O
the	O
entire	O
hydroxlyation	O
sysetm	O
is	O
reconstittued	O
in	O
the	O
heptaoma	B-Disease
clels	O
inefcted	O
with	O
the	O
recobminant	O
viurses	O
.	O

Thus	O
,	O
recomibnant	O
vriuses	O
containing	O
hmuan	O
PAH	O
cNDA	O
provide	O
a	O
means	O
for	O
introducing	O
functioanl	O
PAH	O
into	O
mmamalian	O
cells	O
of	O
hepaitc	O
oriign	O
and	O
can	O
potentially	O
be	O
introduced	O
into	O
whole	O
aniamls	O
as	O
a	O
moedl	O
for	O
smoatic	O
gnee	O
tehrapy	O
for	O
PKU	B-Disease
.	O
.	O

Estiamtion	O
of	O
the	O
mlae	O
to	O
femlae	O
raito	O
of	O
mutatoin	O
rtaes	O
from	O
the	O
segrgeation	O
of	O
X	O
-	O
chromsoomal	O
DNA	O
hpalotypes	O
in	O
Duchnene	B-Disease
musuclar	I-Disease
dysrtophy	I-Disease
faimlies	O
.	O

A	O
novel	O
prcoedure	O
is	O
presented	O
to	O
etsimate	O
the	O
rtaio	O
of	O
mlae	O
to	O
feamle	O
muttaion	O
raets	O
for	O
Duhcenne	B-Disease
muscluar	I-Disease
dystorphy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

X	O
-	O
specific	O
restirction	O
fargment	O
legnth	O
polymoprhisms	O
are	O
used	O
to	O
establish	O
DNA	O
haplotpyes	O
in	O
three	O
-	O
genreation	O
DMD	B-Disease
faimlies	O
.	O

From	O
the	O
proprotion	O
of	O
DMD	B-Disease
pateints	O
who	O
have	O
inherietd	O
their	O
matenral	O
grandfathres	O
X	O
crhomosome	O
,	O
the	O
raito	O
of	O
mtuation	O
raets	O
can	O
be	O
calculated	O
.	O

In	O
contrast	O
to	O
classical	O
metohds	O
,	O
the	O
proposed	O
proecdure	O
is	O
not	O
restricted	O
to	O
spoardic	O
or	O
familiar	O
caess	O
nor	O
is	O
any	O
ifnormation	O
on	O
the	O
carirer	O
sattus	O
of	O
feamle	O
realtives	O
required	O
.	O
.	O

Deletoins	O
of	O
a	O
DNA	O
sequnece	O
in	O
retinolbastomas	B-Disease
and	O
mesenchyaml	B-Disease
tuomrs	I-Disease
:	O
oragnization	O
of	O
the	O
seuqence	O
and	O
its	O
encdoed	O
portein	O
.	O

Rteinoblastoma	B-Disease
is	O
a	O
childohod	B-Disease
tmuor	I-Disease
that	O
can	O
arise	O
because	O
of	O
mutnat	O
alleels	O
acquired	O
as	O
somaitc	O
or	O
gemrinal	O
mtuations	O
.	O

The	O
muatnt	O
alelle	O
can	O
be	O
carried	O
in	O
the	O
grem	O
line	O
.	O

The	O
mutaitons	O
creating	O
these	O
alllees	O
act	O
by	O
inactviating	O
copeis	O
of	O
a	O
recessvie	O
onocgene	O
located	O
within	O
bnad	O
q14	O
of	O
chormosome	O
13	O
and	O
termed	O
the	O
RB1	O
lcous	O
.	O

We	O
have	O
reported	O
ioslation	O
of	O
a	O
cNDA	O
fragmnet	O
that	O
recognizes	O
chromoosmal	O
seuqences	O
possessing	O
many	O
of	O
the	O
attributes	O
of	O
the	O
retinolbastoma	B-Disease
gnee	O
associated	O
with	O
the	O
RB1	O
loucs	O
.	O

We	O
now	O
reprot	O
that	O
this	O
segemnt	O
is	O
additionally	O
the	O
taregt	O
of	O
smoatic	O
mutatoins	O
in	O
meesnchymal	B-Disease
tuomrs	I-Disease
among	O
patinets	O
having	O
no	O
appraent	O
predispsoition	O
to	O
retinoblasotma	B-Disease
and	O
no	O
previous	O
evidnece	O
of	O
retinbolastoma	B-Disease
.	O

These	O
tumros	B-Disease
provide	O
additional	O
evidnece	O
that	O
the	O
colned	O
sqeuences	O
are	O
representative	O
of	O
a	O
gnee	O
that	O
is	O
a	O
freqeunt	O
taregt	O
of	O
inactivtaion	O
during	O
tumroigenesis	O
.	O

Sequnece	O
anaylsis	O
of	O
this	O
cNDA	O
provides	O
little	O
insight	O
into	O
its	O
noraml	O
functinoal	O
role	O
.	O
.	O

Tretament	O
of	O
Duchenne	B-Disease
msucular	I-Disease
dystorphy	I-Disease
with	O
grwoth	O
horomne	O
ihnibitors	O
.	O

A	O
contrloled	O
,	O
double	O
-	O
blnid	O
therapetuic	O
tiral	O
with	O
the	O
durg	O
mazidnol	O
,	O
a	O
grwoth	O
hormnoe	O
inhibtior	O
,	O
was	O
performed	O
in	O
a	O
piar	O
of	O
7	O
1	O
/	O
2	O
yaer	O
-	O
old	O
monozygtoic	O
twnis	O
,	O
with	O
Duhcenne	B-Disease
musuclar	I-Disease
dystrpohy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

The	O
rationale	O
for	O
this	O
trail	O
was	O
based	O
on	O
a	O
ptaient	O
(	O
reported	O
previously	O
)	O
affceted	O
simulatneously	O
with	O
DMD	B-Disease
and	O
grotwh	B-Disease
hromone	I-Disease
(	I-Disease
GH	I-Disease
)	I-Disease
dfeiciency	I-Disease
,	O
who	O
is	O
showing	O
a	O
bengin	O
coruse	O
of	O
the	O
dystorphic	B-Disease
porcess	I-Disease
and	O
is	O
still	O
wakling	O
at	O
18	O
yeras	O
.	O

One	O
of	O
the	O
tiwns	O
received	O
2	O
mg	O
of	O
maznidol	O
dialy	O
,	O
while	O
the	O
other	O
received	O
a	O
palcebo	O
.	O

The	O
assessment	O
,	O
repetaed	O
every	O
2	O
motnhs	O
,	O
included	O
wegiht	O
and	O
hieght	O
measruements	O
,	O
fnuctional	O
and	O
mootr	O
ability	O
tsets	O
,	O
ergomtery	O
and	O
determniations	O
of	O
sreum	O
enzyems	O
and	O
GH	O
lveels	O
.	O

After	O
one	O
yaer	O
of	O
trail	O
the	O
cdoe	O
was	O
broken	O
and	O
it	O
was	O
seen	O
that	O
the	O
tiwn	O
under	O
plcaebo	O
traetment	O
was	O
striikngly	O
wosre	O
than	O
his	O
borther	O
,	O
the	O
progrsesion	O
of	O
whose	O
conidtion	O
was	O
practically	O
arretsed	O
.	O

These	O
resluts	O
strongly	O
suggest	O
that	O
treamtent	O
with	O
a	O
GH	O
inhibtior	O
is	O
beneficial	O
for	O
DMD	B-Disease
ptaients	O
.	O
.	O

Idenitfication	O
and	O
localiaztion	O
of	O
mutatoins	O
at	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
loucs	O
by	O
ribonucelase	O
A	O
cleaavge	O
.	O

Many	O
mtuations	O
leading	O
to	O
hmuan	O
disesae	O
are	O
the	O
result	O
of	O
single	O
DNA	O
base	O
piar	O
cahnges	O
that	O
cannot	O
be	O
idnetified	O
by	O
Southren	O
anlaysis	O
.	O

This	O
has	O
prompted	O
the	O
developemnt	O
of	O
atlernative	O
assyas	O
for	O
point	O
muttaion	O
dteection	O
.	O

The	O
recently	O
described	O
ribnouclease	O
A	O
celavage	O
prcoedure	O
,	O
with	O
a	O
polyuirdylic	O
aicd	O
-	O
paper	O
affinity	O
chroamtography	O
step	O
,	O
has	O
been	O
used	O
to	O
identify	O
the	O
mutatoinal	O
leisons	O
in	O
the	O
hypoxanhtine	O
phosphoribosyltransfearse	O
(	O
HRPT	O
)	O
messegner	O
RANs	O
of	O
patinets	O
with	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
sydnrome	I-Disease
.	O

Disticntive	O
ribonuclesae	O
A	O
cleavgae	O
patetrns	O
were	O
identfiied	O
in	O
mesesnger	O
RNA	O
from	O
5	O
of	O
14	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
pateints	O
who	O
were	O
chosen	O
because	O
no	O
HRPT	O
Souhtern	O
or	O
Notrhern	O
blotitng	O
pattern	O
chnages	O
had	O
been	O
found	O
.	O

This	O
approach	O
now	O
allows	O
HRPT	O
mutaiton	O
detectoin	O
in	O
50	O
percent	O
of	O
the	O
caess	O
of	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
syndrmoe	I-Disease
.	O

The	O
polyuriydlic	O
aicd	O
-	O
paper	O
afifnity	O
porcedure	O
provides	O
a	O
general	O
mehtod	O
for	O
aanlysis	O
of	O
low	O
aubndance	O
messenger	O
RANs	O
.	O
.	O

Two	O
new	O
vraiants	O
of	O
glucsoe	O
-	O
6	O
-	O
pohsphate	O
dehdyrogenase	O
associated	O
with	O
hereditray	B-Disease
non	I-Disease
-	I-Disease
sphreocytic	I-Disease
hemloytic	I-Disease
anmeia	I-Disease
:	O
GP6D	O
Wyane	O
and	O
GP6D	O
Huorn	O
.	O

Two	O
new	O
deifcient	O
varinats	O
of	O
gluocse	O
-	O
6	O
-	O
phospahte	O
dehydrognease	O
(	O
GP6D	O
)	O
causing	O
herdeitary	B-Disease
nonspehrocytic	I-Disease
hemolyitc	I-Disease
aneima	I-Disease
(	O
HNHSA	B-Disease
)	O
are	O
described	O
.	O

Both	O
of	O
these	O
are	O
uniuqe	O
and	O
they	O
have	O
been	O
named	O
GP6D	O
Wanye	O
and	O
GP6D	O
Huorn	O
.	O

Patinets	O
with	O
GP6D	O
Wyane	O
underwent	O
spelnectomy	O
and	O
no	O
objecitve	O
imporvement	O
was	O
noted	O
.	O

The	O
patinets	O
with	O
GP6D	O
Huorn	O
were	O
under	O
medcial	O
obseravtion	O
for	O
a	O
considerable	O
peroid	O
of	O
tmie	O
without	O
the	O
diagnsois	O
of	O
GP6D	B-Disease
deficiecny	I-Disease
being	O
entertained	O
because	O
the	O
fmaily	O
was	O
of	O
Notrhern	O
Europaen	O
orgiin	O
.	O

Since	O
sporaidc	O
vraiants	O
of	O
GP6D	O
causing	O
HNHSA	B-Disease
show	O
no	O
special	O
rcaial	O
predielction	O
,	O
the	O
daignosis	O
of	O
GP6D	B-Disease
deficeincy	I-Disease
should	O
always	O
be	O
considered	O
in	O
patietns	O
with	O
this	O
sydnrome	O
.	O
.	O

Sialpohorin	O
,	O
a	O
surfcae	O
silaoglycoprotein	O
defectvie	O
in	O
the	O
Wiksott	B-Disease
-	I-Disease
Aldrcih	I-Disease
sydnrome	I-Disease
,	O
is	O
involved	O
in	O
hmuan	O
T	O
lymphoctye	O
prloiferation	O
.	O

The	O
mAb	O
L10	O
was	O
used	O
to	O
determine	O
the	O
dsitribution	O
and	O
the	O
funtcion	O
of	O
silaophorin	O
,	O
the	O
heavily	O
glycosylaetd	O
surfcae	O
moleclue	O
that	O
is	O
defciient	O
/	O
deefctive	O
in	O
lymphoyctes	O
of	O
pateints	O
with	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
imumnodeficiency	I-Disease
Wiksott	I-Disease
-	I-Disease
Alrdich	I-Disease
snydrome	I-Disease
.	O

Daul	O
-	O
praameter	O
FCAS	O
aanlysis	O
indicated	O
that	O
sailophorin	O
is	O
experssed	O
on	O
CD4	O
+	O
and	O
CD8	O
+	O
lymhpocytes	O
,	O
on	O
a	O
sbupopulation	O
of	O
peripehral	O
bolod	O
B	O
lypmhocytes	O
,	O
on	O
all	O
tyhmocytes	O
,	O
and	O
on	O
a	O
subpopulaiton	O
of	O
bnoe	O
mrarow	O
clels	O
.	O

Functinoal	O
stuides	O
demonstrated	O
that	O
L10	O
mAb	O
sitmulates	O
the	O
porliferation	O
of	O
preipheral	O
bolod	O
T	O
lymphoctyes	O
as	O
mesaured	O
by	O
stmiulation	O
of	O
[	O
3H	O
]	O
tyhmidine	O
incorproation	O
.	O

The	O
tmie	O
cousre	O
and	O
mganitude	O
of	O
inrceased	O
[	O
3H	O
]	O
thmyidine	O
icnorporation	O
by	O
T	O
lympohcytes	O
in	O
resopnse	O
to	O
L10	O
mAb	O
paralleled	O
that	O
indcued	O
by	O
atni	O
-	O
CD3	O
mAb	O
.	O

Effcetive	O
stimultaion	O
was	O
dpeendent	O
on	O
the	O
prseence	O
of	O
mnoocytes	O
and	O
the	O
Fc	O
portoin	O
of	O
L10	O
mAb	O
.	O

Stimulaiton	O
of	O
lymphoctyes	O
by	O
L10	O
,	O
like	O
stimulaiton	O
by	O
atni	O
-	O
CD3	O
mAb	O
,	O
involves	O
incresaed	O
exrpession	O
of	O
4F2	O
,	O
HLA	O
-	O
DR	O
,	O
and	O
IL	O
-	O
2	O
-	O
R	O
.	O

These	O
obsrevations	O
suggest	O
that	O
sialophroin	O
functoins	O
in	O
T	O
clel	O
actviation	O
.	O
.	O

Hypopigmnetation	B-Disease
in	O
the	O
Praedr	B-Disease
-	I-Disease
Wlili	I-Disease
syndorme	I-Disease
.	O

Cuatneous	B-Disease
and	I-Disease
ouclar	I-Disease
pimgentation	I-Disease
were	O
evaulated	O
in	O
29	O
indivdiuals	O
with	O
the	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
sydnrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Criteira	O
for	O
hypopigemntation	B-Disease
included	O
the	O
prseence	O
of	O
tpye	O
I	O
or	O
II	O
sikn	O
,	O
the	O
lighetst	O
sikn	O
tpye	O
in	O
the	O
faimly	O
by	O
histroy	O
,	O
and	O
iirs	O
translucnecy	O
on	O
golbe	O
transillumniation	O
.	O

On	O
the	O
basis	O
of	O
these	O
criteira	O
,	O
48	O
%	O
of	O
the	O
PWS	B-Disease
individulas	O
were	O
hyoppigmented	B-Disease
.	O

The	O
presnece	O
of	O
hypopigmenttaion	B-Disease
corrleated	O
with	O
a	O
small	O
intertsitial	O
deletoin	O
on	O
the	O
prxoimal	O
long	O
arm	O
of	O
chromoosme	O
15	O
;	O
however	O
,	O
this	O
delteion	O
was	O
also	O
found	O
in	O
idnividuals	O
who	O
did	O
not	O
meet	O
the	O
full	O
crtieria	O
for	O
hypopigemntation	B-Disease
.	O

Hairublb	O
tyorsinase	O
actiivty	O
and	O
gluttahione	O
conetnt	O
,	O
as	O
well	O
as	O
uirne	O
cysteinyldopa	O
excertion	O
,	O
were	O
low	O
in	O
PWS	B-Disease
indiviudals	O
with	O
and	O
without	O
hypopigmentatoin	B-Disease
and	O
did	O
not	O
separate	O
these	O
two	O
gruops	O
.	O

We	O
conclude	O
that	O
hypopigemntation	B-Disease
is	O
found	O
in	O
a	O
significant	O
proportoin	O
of	O
inidviduals	O
with	O
PWS	B-Disease
and	O
that	O
the	O
hypopigemntation	B-Disease
may	O
be	O
associated	O
with	O
a	O
deletoin	O
of	O
the	O
long	O
arm	O
of	O
chrmoosome	O
15	O
.	O

The	O
mechnaism	O
for	O
the	O
hypopigmetnation	B-Disease
is	O
unknown	O
.	O
.	O

Pehnotype	O
heterogenetiy	O
among	O
hemizygoets	O
in	O
a	O
fmaily	O
biochemiaclly	O
screened	O
for	O
adrenoleukodsytrophy	B-Disease
.	O

We	O
reoprt	O
on	O
two	O
clincially	O
,	O
neuroloigcally	O
noraml	O
relatvies	O
of	O
a	O
boy	O
affetced	O
by	O
adrenoleukodysrtophy	B-Disease
(	O
ALD	B-Disease
)	O
;	O
they	O
were	O
found	O
repeatedly	O
to	O
have	O
the	O
biocehmical	O
deefct	O
of	O
an	O
ALD	B-Disease
heimzygote	O
.	O

The	O
assay	O
consisted	O
in	O
the	O
detremination	O
of	O
very	O
-	O
long	O
-	O
cahin	O
ftaty	O
acdis	O
in	O
lyophilzied	O
and	O
reconstittued	O
palsma	O
.	O

While	O
no	O
eivdence	O
of	O
neuorlogic	B-Disease
dsiease	I-Disease
(	O
leukodysrtophy	B-Disease
or	O
meyloneuropathy	B-Disease
)	O
was	O
present	O
in	O
these	O
hemziygotes	O
,	O
adrenoocrtical	B-Disease
insufifciency	I-Disease
provoking	O
copmensatory	O
high	O
ATCH	O
rleease	O
was	O
found	O
in	O
both	O
.	O

These	O
findigns	O
should	O
be	O
taken	O
into	O
consideration	O
when	O
conuseling	O
faimlies	O
in	O
which	O
csaes	O
with	O
clniically	O
epxressed	O
ALD	B-Disease
are	O
represented	O
in	O
several	O
generatinos	O
.	O
.	O

The	O
mapipng	O
of	O
a	O
cNDA	O
from	O
the	O
huamn	O
X	B-Disease
-	I-Disease
linked	I-Disease
Duhcenne	I-Disease
mucsular	I-Disease
dystrohpy	I-Disease
gnee	O
to	O
the	O
mosue	O
X	O
chrmoosome	O
.	O

The	O
recent	O
discvoery	O
of	O
seuqences	O
at	O
the	O
stie	O
of	O
the	O
Ducehnne	B-Disease
msucular	I-Disease
dytsrophy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
in	O
huamns	O
has	O
opened	O
up	O
the	O
possibility	O
of	O
a	O
detailed	O
molecualr	O
analyiss	O
of	O
the	O
geens	O
in	O
humnas	O
and	O
in	O
related	O
mamamlian	O
sepcies	O
.	O

Until	O
relatively	O
recently	O
,	O
there	O
was	O
no	O
obvious	O
mosue	O
mdoel	O
of	O
this	O
genteic	B-Disease
diesase	I-Disease
for	O
the	O
developmnet	O
of	O
theraeputic	O
strategies	O
.	O

The	O
identificaiton	O
of	O
a	O
muose	O
X	O
-	O
linked	O
mtuant	O
showing	O
muscluar	B-Disease
dysrtophy	I-Disease
,	O
mdx	O
,	O
has	O
provided	O
a	O
candidate	O
mosue	O
geentic	O
homoolgue	O
to	O
the	O
DMD	B-Disease
loucs	O
;	O
the	O
relatively	O
mlid	O
pathologcial	O
featrues	O
of	O
mdx	O
suggest	O
it	O
may	O
have	O
more	O
in	O
common	O
with	O
mtuations	O
of	O
the	O
Bceker	B-Disease
muscualr	I-Disease
dsytrophy	I-Disease
tpye	O
at	O
the	O
same	O
hmuan	O
lcous	O
,	O
however	O
.	O

But	O
the	O
close	O
gneetic	O
lnikage	O
of	O
mdx	O
to	O
GP6D	O
and	O
Hrpt	O
on	O
the	O
muose	O
X	O
chrmoosome	O
,	O
coupled	O
with	O
its	O
comparatively	O
mlid	O
patohlogy	O
,	O
have	O
suggested	O
that	O
the	O
mdx	O
muattion	O
may	O
instead	O
correspond	O
to	O
Emrey	B-Disease
Derifuss	I-Disease
musuclar	I-Disease
dsytrophy	I-Disease
which	O
itself	O
is	O
closely	O
linked	O
to	O
DNA	O
mrakers	O
at	O
X2q8	O
-	O
qetr	O
in	O
the	O
regoin	O
of	O
GP6D	O
on	O
the	O
huamn	O
X	O
chromoosme	O
.	O

Using	O
an	O
interspecfiic	O
muose	O
dmoesticus	O
/	O
sprteus	O
corss	O
,	O
segreagting	O
for	O
a	O
variety	O
of	O
marekrs	O
on	O
the	O
muose	O
X	O
chromsoome	O
,	O
we	O
have	O
positioned	O
on	O
the	O
mosue	O
X	O
chrmoosome	O
sequecnes	O
homloogous	O
to	O
a	O
DMD	B-Disease
cNDA	O
colne	O
.	O

These	O
seqeunces	O
map	O
provocatively	O
close	O
to	O
the	O
mdx	O
mutatoin	O
and	O
unexpectedly	O
ditsant	O
from	O
sparse	O
fur	O
,	O
spf	O
,	O
the	O
muose	O
homloogue	O
of	O
OTC	O
(	O
orntihine	O
transcarbamyalse	O
)	O
which	O
is	O
closely	O
linked	O
to	O
DMD	B-Disease
on	O
the	O
hmuan	O
X	O
chromosmoe	O
.	O
.	O

Localiztaion	O
of	O
the	O
regoin	O
homloogous	O
to	O
the	O
Dcuhenne	B-Disease
musuclar	I-Disease
dytsrophy	I-Disease
loucs	O
on	O
the	O
mosue	O
X	O
chromosmoe	O
.	O

Recent	O
progerss	O
has	O
resulted	O
in	O
part	O
of	O
the	O
gnee	O
muttaed	O
in	O
Duchenne	B-Disease
and	I-Disease
the	I-Disease
milder	I-Disease
Becekr	I-Disease
msucular	I-Disease
dystropihes	I-Disease
being	O
colned	O
and	O
has	O
suggested	O
that	O
the	O
gnee	O
itself	O
extends	O
over	O
1	O
,	O
000	O
to	O
2	O
,	O
000	O
kilboases	O
(	O
kb	O
)	O
.	O

To	O
stduy	O
how	O
muttaions	O
in	O
this	O
gnee	O
affect	O
msucle	O
develompent	O
and	O
intergity	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
have	O
available	O
a	O
mosue	O
moedl	O
of	O
the	O
hmuan	O
diesase	O
.	O

The	O
muose	O
mdx	O
muttaion	O
affects	O
msucle	O
and	O
confers	O
a	O
mlid	O
dystorphic	B-Disease
synrdome	I-Disease
,	O
but	O
it	O
is	O
not	O
clear	O
whether	O
this	O
muttaion	O
is	O
euqivalent	O
to	O
Duchnene	B-Disease
/	I-Disease
Bceker	I-Disease
muscualr	I-Disease
dytsrophy	I-Disease
in	O
man	O
.	O

Here	O
we	O
describe	O
the	O
use	O
of	O
two	O
seuqences	O
from	O
the	O
hmuan	O
Ducehnne	B-Disease
muscluar	I-Disease
dystrohpy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
that	O
crsos	O
-	O
hyrbidize	O
to	O
mosue	O
X	O
-	O
linked	O
sqeuences	O
to	O
loaclize	O
the	O
gnee	O
homologuos	O
to	O
DMD	B-Disease
in	O
the	O
mosue	O
.	O

Both	O
sequecnes	O
map	O
to	O
the	O
reigon	O
of	O
10	O
centimogran	O
lynig	O
between	O
the	O
Tabby	O
(	O
Ta	O
)	O
and	O
S1t4	O
-	O
1	O
(	O
DxaPs8	O
)	O
lcoi	O
,	O
close	O
to	O
the	O
phosphoyrlase	O
b	O
kinsae	O
lcous	O
(	O
Phk	O
)	O
.	O

By	O
analogy	O
with	O
the	O
hmuan	O
X	O
-	O
crhomosome	O
,	O
we	O
conclude	O
that	O
the	O
reigon	O
in	O
the	O
muose	O
around	O
the	O
Gp6d	O
and	O
S1t4	O
-	O
1	O
lcoi	O
may	O
contain	O
two	O
geens	O
corresponding	O
to	O
distinct	O
hmuan	O
mypoathies	B-Disease
Emrey	B-Disease
Driefuss	I-Disease
muscluar	I-Disease
dystorphy	I-Disease
which	O
is	O
known	O
to	O
be	O
closely	O
linked	O
to	O
S1t4	O
-	O
1	O
in	O
man	O
and	O
the	O
DMD	B-Disease
homloogue	O
described	O
here	O
.	O
.	O

GT	O
to	O
AT	O
transiiton	O
at	O
a	O
splcie	O
doonr	O
stie	O
causes	O
sikpping	O
of	O
the	O
preceding	O
eoxn	O
in	O
phenlyketonuria	B-Disease
.	O

Classical	B-Disease
Phenylketonruia	I-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
auotsomal	B-Disease
recessive	I-Disease
hmuan	I-Disease
geentic	I-Disease
disroder	I-Disease
caused	O
by	O
a	O
deifciency	B-Disease
of	I-Disease
hpeatic	I-Disease
phneylalanine	I-Disease
hydrxoylase	I-Disease
(	O
PAH	O
)	O
.	O

We	O
ioslated	O
several	O
mtuant	O
PAH	O
cNDA	O
cloens	O
from	O
a	O
PKU	B-Disease
carrier	O
inidvidual	O
and	O
showed	O
that	O
they	O
contained	O
an	O
inetrnal	O
116	O
base	O
piar	O
delteion	O
,	O
corresponding	O
precisely	O
to	O
eoxn	O
12	O
of	O
the	O
hmuan	O
chromsoomal	O
PAH	O
gnee	O
.	O

The	O
deeltion	O
causes	O
the	O
synhtesis	O
of	O
a	O
truncaetd	O
protien	O
lacking	O
the	O
C	O
-	O
termianl	O
52	O
aimno	O
aicds	O
.	O

Gnee	O
trasnfer	O
and	O
experssion	O
stuides	O
using	O
the	O
muatnt	O
PAH	O
cNDA	O
indicated	O
that	O
the	O
deletoin	O
abolsihes	O
PAH	O
activtiy	O
in	O
the	O
clel	O
as	O
a	O
result	O
of	O
portein	O
instabiilty	O
.	O

To	O
determine	O
the	O
moleuclar	O
basis	O
of	O
the	O
dleetion	O
,	O
the	O
mtuant	O
chroomsomal	O
PAH	O
gnee	O
was	O
isoalted	O
from	O
this	O
indiivdual	O
and	O
shown	O
to	O
contain	O
a	O
GT	O
-	O
-	O
greater	O
than	O
AT	O
subsittution	O
at	O
the	O
5	O
slpice	O
doonr	O
stie	O
of	O
itnron	O
12	O
.	O

Thus	O
,	O
the	O
consequence	O
of	O
the	O
spilce	O
dnoor	O
stie	O
muttaion	O
in	O
the	O
hmuan	O
lvier	O
is	O
the	O
skpiping	O
of	O
the	O
preceding	O
eoxn	O
during	O
RNA	O
splicnig	O
.	O
.	O

Conservaiton	O
of	O
the	O
Dcuhenne	B-Disease
msucular	I-Disease
dystorphy	I-Disease
gnee	O
in	O
mcie	O
and	O
hmuans	O
.	O

A	O
poriton	O
of	O
the	O
Dcuhenne	B-Disease
mucsular	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
gnee	O
transcirpt	O
from	O
huamn	O
fteal	O
skelteal	O
mucsle	O
and	O
muose	O
adlut	O
haert	O
was	O
sequneced	O
,	O
representing	O
approximately	O
25	O
percent	O
of	O
the	O
total	O
,	O
14	O
-	O
kb	O
DMD	B-Disease
trasncript	O
.	O

The	O
nulceic	O
aicd	O
and	O
prdeicted	O
amnio	O
aicd	O
sequneces	O
from	O
the	O
two	O
speices	O
are	O
nearly	O
90	O
percent	O
hoomlogous	O
.	O

The	O
amnio	O
aicd	O
seqeunce	O
that	O
is	O
perdicted	O
from	O
this	O
poriton	O
of	O
the	O
DMD	B-Disease
gnee	O
indicates	O
that	O
the	O
protien	O
porduct	O
might	O
serve	O
a	O
strcutural	O
role	O
in	O
muslce	O
,	O
but	O
the	O
abundacne	O
and	O
tisuse	O
ditsribution	O
of	O
the	O
messneger	O
RNA	O
suggests	O
that	O
the	O
DMD	B-Disease
portein	O
is	O
not	O
nbeulin	O
.	O
.	O

Famliial	O
Parder	B-Disease
-	I-Disease
Wlili	I-Disease
sydnrome	I-Disease
with	O
apparently	O
nomral	O
chromoosmes	O
.	O

We	O
reoprt	O
on	O
4	O
sbis	O
(	O
2F	O
,	O
2M	O
)	O
with	O
Praedr	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Diagnsois	O
was	O
made	O
clinically	O
on	O
the	O
basis	O
of	O
histroy	O
,	O
behvaior	O
,	O
and	O
physcial	O
findnigs	O
in	O
3	O
of	O
the	O
sbis	O
.	O

The	O
other	O
cihld	O
had	O
deid	O
at	O
age	O
10	O
mnoths	O
with	O
a	O
histroy	O
and	O
clincial	O
fnidings	O
typical	O
of	O
first	O
pahse	O
of	O
PWS	B-Disease
.	O

Reuslts	O
of	O
chromosmoe	O
sutdies	O
on	O
the	O
paernts	O
and	O
surivving	O
sbis	O
were	O
nromal	O
.	O

The	O
implications	O
of	O
this	O
unuusal	O
famliial	O
occurrence	O
for	O
our	O
understanding	O
of	O
PWS	B-Disease
are	O
discussed	O
.	O
.	O

Nebluin	O
and	O
ttiin	O
epxression	O
in	O
Dcuhenne	B-Disease
muscualr	I-Disease
dysrtophy	I-Disease
appears	O
nromal	O
.	O

Monolconal	O
antiobdies	O
which	O
recognize	O
different	O
eiptopes	O
on	O
either	O
ttiin	O
or	O
neublin	O
show	O
nromal	O
stainnig	O
pattenrs	O
on	O
forzen	O
secitons	O
of	O
three	O
muslce	O
biposies	O
of	O
Ducehnne	B-Disease
muscualr	I-Disease
dysrtophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Gel	O
eelctrophoresis	O
and	O
immunbolotting	O
performed	O
on	O
two	O
of	O
these	O
mucsle	O
biposies	O
show	O
the	O
noraml	O
patetrn	O
of	O
ttiin	O
and	O
neublin	O
polyppetides	O
.	O

Since	O
the	O
dnoor	O
of	O
one	O
of	O
these	O
biopises	O
has	O
a	O
large	O
deleiton	O
of	O
the	O
5	O
-	O
reigon	O
of	O
the	O
DMD	B-Disease
gnee	O
,	O
our	O
resluts	O
argue	O
against	O
the	O
recent	O
proposal	O
that	O
nbeulin	O
is	O
the	O
gnee	O
mtuated	O
in	O
DMD	B-Disease
.	O
.	O

Heterozgyous	B-Disease
C2	I-Disease
deficiecny	I-Disease
associated	O
with	O
angieodema	B-Disease
,	O
myatshenia	B-Disease
graivs	I-Disease
,	O
and	O
systeimc	B-Disease
lpuus	I-Disease
erytehmatosus	I-Disease
.	O

We	O
describe	O
a	O
ptaient	O
with	O
myasthneia	B-Disease
graivs	I-Disease
,	O
sysetmic	B-Disease
lpuus	I-Disease
erytheamtosus	I-Disease
,	O
and	O
angioeedma	B-Disease
associated	O
with	O
heteorzygous	O
complement	B-Disease
fatcor	I-Disease
2	I-Disease
(	I-Disease
C2	I-Disease
)	I-Disease
dfeiciency	I-Disease
.	O

The	O
signifiacnce	O
of	O
this	O
association	O
is	O
controversial	O
,	O
though	O
the	O
assoication	O
of	O
C2	B-Disease
deifciency	I-Disease
with	O
certain	O
histocompatibiltiy	O
atnigens	O
suggests	O
possible	O
linakge	O
to	O
imumne	O
repsonse	O
gnees	O
.	O

To	O
our	O
knoweldge	O
this	O
is	O
the	O
first	O
reprot	O
of	O
heterozyguos	O
C2	B-Disease
deficeincy	I-Disease
in	O
assoication	O
with	O
this	O
cobmination	O
of	O
autoimumne	B-Disease
dsiorders	I-Disease
,	O
and	O
we	O
discuss	O
the	O
aetioloigcal	O
implications	O
.	O
.	O

Geentic	O
aanlysis	O
of	O
an	O
inherietd	O
dfeiciency	B-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
Britatny	O
spnaiel	O
dgos	O
.	O

Geentically	O
determined	O
C3	B-Disease
deficinecy	I-Disease
in	O
Brittany	O
spainel	O
dgos	O
shares	O
a	O
number	O
of	O
biocehmical	O
and	O
cliincal	O
characteritsics	O
with	O
the	O
hmuan	O
disroder	O
.	O

In	O
huamns	O
,	O
the	O
gnee	O
for	O
C3	B-Disease
deficeincy	I-Disease
is	O
a	O
nlul	O
gnee	O
that	O
is	O
alleilc	O
to	O
the	O
sturctural	O
gnee	O
for	O
C3	O
and	O
is	O
not	O
linked	O
to	O
the	O
major	O
histocompaitbility	O
lcous	O
.	O

The	O
current	O
stduy	O
used	O
allotype	O
anaylsis	O
of	O
cannie	O
C3	O
in	O
order	O
to	O
demonstrate	O
that	O
the	O
gnee	O
for	O
C3	B-Disease
defiicency	I-Disease
in	O
these	O
dgos	O
is	O
also	O
a	O
nlul	O
gnee	O
allleic	O
to	O
the	O
srtuctural	O
gnee	O
for	O
C3	O
.	O

In	O
addition	O
,	O
preliminary	O
pedgiree	O
analyiss	O
suggests	O
that	O
the	O
gnee	O
for	O
cnaine	O
C3	B-Disease
deficeincy	I-Disease
is	O
apparently	O
not	O
closely	O
linked	O
to	O
the	O
major	O
histocomaptibility	O
copmlex	O
of	O
the	O
dog	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
C3	B-Disease
deficinecy	I-Disease
in	O
Britatny	O
sapniel	O
dgos	O
not	O
only	O
shares	O
boichemical	O
and	O
clincial	O
fetaures	O
with	O
C3	B-Disease
defciiency	I-Disease
in	O
humnas	O
,	O
but	O
also	O
shares	O
some	O
geneitc	O
characetristics	O
with	O
the	O
huamn	O
disroder	O
.	O
.	O

Gnee	O
trasnfer	O
and	O
expressoin	O
of	O
huamn	O
phneylalanine	O
hdyroxylase	O
.	O

Phenylkteonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
caused	O
by	O
a	O
geneitc	O
dfeiciency	B-Disease
of	I-Disease
the	I-Disease
enzmye	I-Disease
phenylalannie	I-Disease
hydroxyalse	I-Disease
(	O
PAH	O
)	O
.	O

A	O
full	O
-	O
lentgh	O
complementary	O
DNA	O
colne	O
of	O
hmuan	O
PAH	O
was	O
inserted	O
into	O
a	O
eukaryoitc	O
expresison	O
vecotr	O
and	O
transefrred	O
into	O
muose	O
NHI3T3	O
cells	O
which	O
do	O
not	O
normally	O
express	O
PAH	O
.	O

The	O
transformed	O
mosue	O
cells	O
exprsesed	O
PAH	O
messneger	O
RNA	O
,	O
immnuoreactive	O
portein	O
,	O
and	O
enzmyatic	O
actviity	O
that	O
are	O
characterisitc	O
of	O
the	O
nomral	O
hmuan	O
lvier	O
produtcs	O
,	O
demonstrating	O
that	O
a	O
single	O
gnee	O
contains	O
all	O
of	O
the	O
necessary	O
geentic	O
ifnormation	O
to	O
cdoe	O
for	O
fucntional	O
PAH	O
.	O

These	O
reuslts	O
support	O
the	O
use	O
of	O
the	O
huamn	O
PAH	O
porbe	O
in	O
preantal	O
diganosis	O
and	O
detetcion	O
of	O
carrires	O
,	O
to	O
provide	O
new	O
opportunities	O
for	O
the	O
biochemcial	O
characteriztaion	O
of	O
nomral	O
and	O
mtuant	O
eznymes	O
,	O
and	O
in	O
the	O
ivnestigation	O
of	O
alterantive	O
gneetic	O
threapies	O
for	O
PKU	B-Disease
.	O
.	O

Regioanl	O
mapipng	O
of	O
the	O
pheynlalanine	O
hydroyxlase	O
gnee	O
and	O
the	O
phenylketonruia	B-Disease
loucs	O
in	O
the	O
huamn	O
genmoe	O
.	O

Phneylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
autoosmal	B-Disease
reecssive	I-Disease
disodrer	I-Disease
of	O
aimno	O
aicd	O
metbaolism	O
caused	O
by	O
a	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
hpeatic	I-Disease
enyzme	I-Disease
phenylalannie	I-Disease
hdyroxylase	I-Disease
(	O
PAH	O
;	O
phenlyalanine	O
4	O
-	O
monooxygeanse	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

A	O
cNDA	O
colne	O
for	O
huamn	O
PAH	O
has	O
previously	O
been	O
used	O
to	O
assign	O
the	O
corresponding	O
gnee	O
to	O
hmuan	O
chroomsome	O
12	O
.	O

To	O
define	O
the	O
regoinal	O
map	O
psoition	O
of	O
the	O
disesae	O
loucs	O
and	O
the	O
PAH	O
gnee	O
on	O
huamn	O
chormosome	O
12	O
,	O
DNA	O
was	O
isolaetd	O
from	O
huamn	O
-	O
hasmter	O
smoatic	O
clel	O
hybrdis	O
with	O
various	O
deletinos	O
of	O
hmuan	O
chromoosme	O
12	O
and	O
was	O
analyezd	O
by	O
Sotuhern	O
bolt	O
anlaysis	O
using	O
the	O
huamn	O
cNDA	O
PAH	O
colne	O
as	O
a	O
hybridiztaion	O
porbe	O
.	O

From	O
these	O
rseults	O
,	O
together	O
with	O
detailed	O
biochemiacl	O
and	O
cytogenteic	O
characterziation	O
of	O
the	O
hyrbid	O
clels	O
,	O
the	O
regoin	O
on	O
chrmoosome	O
12	O
containing	O
the	O
huamn	O
PAH	O
gnee	O
has	O
been	O
defined	O
as	O
12q14	O
.	O

3	O
-	O
-	O
-	O
-	O
qetr	O
3	O
-	O
-	O
-	O
-	O
qetr	O
.	O

The	O
PAH	O
map	O
poistion	O
on	O
crhomosome	O
12	O
was	O
further	O
localzied	O
by	O
in	O
situ	O
hybridizaiton	O
of	O
152I	O
-	O
lableed	O
hmuan	O
PAH	O
cNDA	O
to	O
chromosmoes	O
preapred	O
from	O
a	O
huamn	O
lymphoblasotid	O
clel	O
line	O
.	O

Reuslts	O
of	O
these	O
exepriments	O
demonstrated	O
that	O
the	O
reigon	O
on	O
chromsoome	O
12	O
containing	O
the	O
PAH	O
gnee	O
and	O
the	O
PKU	B-Disease
loucs	O
in	O
man	O
is	O
12q22	O
-	O
-	O
-	O
-	O
12q24	O
.	O

1	O
.	O

These	O
rseults	O
not	O
only	O
provide	O
a	O
regioanlized	O
map	O
postiion	O
for	O
a	O
major	O
huamn	O
diesase	O
loucs	O
but	O
also	O
can	O
serve	O
as	O
a	O
referecne	O
point	O
for	O
linkgae	O
analsyis	O
with	O
other	O
DNA	O
markres	O
on	O
hmuan	O
chromsoome	O
12	O

Heterogeniety	O
of	O
tpye	B-Disease
I	I-Disease
von	I-Disease
Wilelbrand	I-Disease
diesase	I-Disease
:	O
evidnece	O
for	O
a	O
subrgoup	O
with	O
an	O
anbormal	O
von	B-Disease
Wlilebrand	I-Disease
fatcor	O
.	O

Tpye	B-Disease
I	I-Disease
von	I-Disease
Willebrnad	I-Disease
diesase	I-Disease
(	O
vWD	B-Disease
)	O
is	O
characteriezd	O
by	O
equally	O
low	O
plsama	O
concentraitons	O
of	O
von	B-Disease
Willebrand	I-Disease
facotr	O
atnigen	O
(	O
vWF	O
Ag	O
)	O
and	O
risotcetin	O
coafctor	O
(	O
RioCf	O
)	O
and	O
by	O
the	O
persence	O
of	O
all	O
vWF	O
mlutimers	O
in	O
sdoium	O
dodceyl	O
suflate	O
(	O
SDS	O
)	O
-	O
agarsoe	O
gel	O
electorphoresis	O
.	O

For	O
17	O
pateints	O
(	O
13	O
kinrdeds	O
)	O
diagnoesd	O
with	O
these	O
critreia	O
,	O
we	O
have	O
studied	O
the	O
platleet	O
cnotents	O
of	O
vWF	O
Ag	O
and	O
RCiof	O
and	O
the	O
chanegs	O
of	O
these	O
in	O
plsama	O
after	O
DDVAP	O
ifnusion	O
.	O

Plateelt	O
vWF	O
Ag	O
and	O
RCiof	O
were	O
nromal	O
in	O
four	O
knidreds	O
(	O
called	O
"	O
platleet	O
nomral	O
"	O
sugbroup	O
)	O
;	O
following	O
1	O
-	O
daemino	O
-	O
8	O
-	O
D	O
-	O
argniine	O
vasopressin	O
;	O
plamsa	O
vWF	O
Ag	O
,	O
RCiof	O
and	O
the	O
bleednig	O
tmie	O
(	O
BT	O
)	O
became	O
nromal	O
.	O

In	O
six	O
kinderds	O
,	O
plaetlet	O
vWF	O
Ag	O
and	O
RioCf	O
were	O
equally	O
low	O
(	O
plaetlet	O
low	O
)	O
;	O
after	O
DDVAP	O
,	O
palsma	O
vWF	O
Ag	O
and	O
RioCf	O
remained	O
low	O
,	O
and	O
the	O
BT	O
was	O
prolonegd	O
.	O

In	O
three	O
additional	O
kidnreds	O
,	O
plaetlets	O
contained	O
nomral	O
concenrtations	O
of	O
vWF	O
Ag	O
,	O
but	O
RioCf	O
was	O
very	O
low	O
(	O
platleet	O
dsicordant	O
)	O
;	O
even	O
though	O
a	O
complete	O
set	O
of	O
multimres	O
was	O
found	O
in	O
plamsa	O
and	O
pltaelets	O
,	O
there	O
was	O
a	O
relatively	O
small	O
aomunt	O
of	O
large	O
mutlimers	O
.	O

After	O
DADVP	O
,	O
plamsa	O
vWF	O
Ag	O
became	O
noraml	O
,	O
but	O
RioCf	O
remained	O
low	O
and	O
the	O
BT	O
was	O
very	O
proolnged	O
.	O

These	O
fidnings	O
demonstrated	O
that	O
there	O
can	O
be	O
an	O
abnoraml	O
vWF	O
(	O
RCiof	O
less	O
than	O
vWF	O
Ag	O
)	O
even	O
in	O
tpye	B-Disease
I	I-Disease
vWD	I-Disease
,	O
coexisting	O
with	O
a	O
complete	O
set	O
of	O
vWF	O
multmiers	O
(	O
platleet	O
discoradnt	O
)	O
;	O
that	O
the	O
abnoraml	O
vWF	O
can	O
be	O
shown	O
more	O
clearly	O
in	O
plaetlets	O
than	O
in	O
plamsa	O
or	O
else	O
in	O
plsama	O
after	O
DADVP	O
inufsion	O
;	O
and	O
that	O
DDVAP	O
normalizes	O
the	O
BT	O
only	O
in	O
those	O
pateints	O
with	O
noraml	O
plateelt	O
leevls	O
of	O
both	O
vWF	O
Ag	O
and	O
RioCf	O
(	O
plaetlet	O
noraml	O
)	O
.	O
.	O

Geneitc	O
analsyis	O
in	O
famiiles	O
with	O
van	B-Disease
der	I-Disease
Wuode	I-Disease
sydnrome	I-Disease
.	O

We	O
have	O
brought	O
together	O
informaiton	O
on	O
864	O
affceted	O
indiviudals	O
in	O
164	O
fmailies	O
(	O
including	O
three	O
new	O
pdeigrees	O
)	O
reported	O
in	O
the	O
137	O
yaer	O
peroid	O
since	O
1845	O
when	O
Demaqruay	O
first	O
described	O
a	O
fmaily	O
with	O
what	O
was	O
later	O
called	O
van	B-Disease
der	I-Disease
Wuode	I-Disease
snydrome	I-Disease
(	O
VWS	B-Disease
)	O
.	O

Both	O
types	O
of	O
oarl	B-Disease
clfet	I-Disease
,	O
celft	B-Disease
plaate	I-Disease
(	O
CP	B-Disease
)	O
and	O
clfet	B-Disease
lip	I-Disease
with	O
or	O
without	O
CP	B-Disease
(	O
CLP	B-Disease
)	O
,	O
sgeregate	O
in	O
these	O
fmailies	O
together	O
with	O
lwoer	O
lip	B-Disease
ptis	I-Disease
or	O
fitsulae	B-Disease
in	O
an	O
atuosomal	O
domniant	O
mdoe	O
with	O
high	O
penetarnce	O
estimaetd	O
to	O
be	O
K	O
=	O
.	O

89	O
and	O
.	O

99	O
by	O
different	O
mehtods	O
.	O

Celft	O
types	O
(	O
CLP	B-Disease
and	O
CP	B-Disease
)	O
occur	O
in	O
VWS	B-Disease
in	O
the	O
same	O
proporitons	O
as	O
in	O
the	O
general	O
non	O
-	O
VWS	O
pouplation	O
,	O
ie	O
,	O
about	O
twice	O
as	O
many	O
celft	O
-	O
bearing	O
idnividuals	O
have	O
CLP	B-Disease
as	O
have	O
CP	B-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
we	O
do	O
not	O
find	O
the	O
usually	O
observed	O
execss	O
of	O
fmeales	O
with	O
CP	B-Disease
and	O
ecxess	O
of	O
mlaes	O
with	O
CLP	B-Disease
;	O
in	O
VWS	B-Disease
the	O
sex	O
rtaios	O
are	O
more	O
nearly	O
euqal	O
.	O

Lip	B-Disease
ptis	I-Disease
also	O
are	O
equally	O
distributed	O
between	O
the	O
sxees	O
.	O

Affected	O
mlaes	O
and	O
fmeales	O
are	O
equally	O
likely	O
to	O
tarnsmit	O
VWS	B-Disease
.	O

However	O
,	O
there	O
is	O
an	O
execss	O
of	O
less	O
severley	O
affceted	O
idnividuals	O
among	O
tarnsmitters	O
and	O
a	O
deficeincy	O
of	O
more	O
severley	O
affecetd	O
,	O
brought	O
about	O
by	O
a	O
probnad	O
bais	O
and	O
differenital	O
fecudnity	O
.	O

The	O
epxression	O
of	O
VWS	B-Disease
is	O
significantly	O
modifeid	O
by	O
the	O
gneetic	O
background	O
More	O
extreme	O
pheontypes	O
in	O
parnets	O
tend	O
to	O
produce	O
more	O
extreme	O
expresison	O
in	O
their	O
chlidren	O
.	O

For	O
a	O
VWS	B-Disease
gnee	O
carreir	O
the	O
relative	O
rsik	O
of	O
transmititng	O
a	O
celft	O
is	O
26	O
.	O

45	O
%	O
;	O
that	O
of	O
transmitting	O
lwoer	O
lip	B-Disease
ptis	I-Disease
is	O
23	O
.	O

55	O
%	O
.	O

Three	O
peidgrees	O
of	O
lip	B-Disease
ptis	I-Disease
in	O
the	O
literautre	O
show	O
no	O
celfts	O
among	O
a	O
significant	O
number	O
of	O
affecetd	O
indiivduals	O
.	O

Conrtol	O
of	O
gnee	O
expresison	O
in	O
VWS	B-Disease
in	O
the	O
three	O
tagret	O
tisseus	O
appears	O
to	O
be	O
indepenednt	O
and	O
separately	O
designated	O
.	O

Muattion	O
rtae	O
of	O
the	O
VWS	B-Disease
gnee	O
is	O
calculated	O
to	O
be	O
1	O
.	O

8	O
X	O
10	O
(	O
-	O
5	O
)	O

Herdeitary	B-Disease
C7	I-Disease
deficinecy	I-Disease
.	O

Diangosis	O
and	O
HLA	O
sutdies	O
in	O
a	O
Frecnh	O
-	O
Candaian	O
famliy	O
.	O

The	O
sreum	O
of	O
a	O
44	O
-	O
yr	O
-	O
old	O
wmoan	O
of	O
Frnech	O
-	O
Cnaadian	O
descnet	O
having	O
a	O
B	O
-	O
27	O
posiitve	O
anklyosing	B-Disease
spondyiltis	I-Disease
was	O
dfeicient	B-Disease
in	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
as	O
determined	O
by	O
hemolyitc	O
and	O
immnuochemical	O
methdos	O
.	O

No	O
inhibiotr	O
against	O
C7	O
was	O
detecetd	O
,	O
and	O
the	O
leevls	O
of	O
all	O
other	O
complement	O
compoennts	O
were	O
nromal	O
.	O

No	O
deficiecny	O
in	O
the	O
osponic	O
acitvity	O
of	O
the	O
sreum	O
was	O
found	O
,	O
and	O
the	O
rseults	O
of	O
basic	O
coagulaiton	O
studeis	O
of	O
the	O
plsama	O
were	O
nomral	O
.	O

On	O
inevstigation	O
of	O
the	O
patinets	O
fmaily	O
,	O
two	O
sistres	O
were	O
found	O
to	O
have	O
the	O
same	O
deficiecny	O
but	O
were	O
otherwise	O
in	O
good	O
haelth	O
.	O

The	O
seven	O
other	O
sibligns	O
were	O
heetrozygous	O
for	O
C7	B-Disease
deficiecny	I-Disease
,	O
while	O
the	O
pateranl	O
anut	O
had	O
a	O
noraml	O
C7	O
leevl	O
.	O

In	O
the	O
third	O
generatoin	O
,	O
six	O
cihldren	O
of	O
the	O
three	O
homozyguos	O
ssiters	O
and	O
five	O
chilrden	O
of	O
heterzoygotes	O
were	O
available	O
for	O
tseting	O
.	O

Studeis	O
of	O
the	O
HLA	O
antignes	O
in	O
all	O
the	O
22	O
subejcts	O
and	O
in	O
three	O
spouess	O
indicated	O
no	O
close	O
lnikage	O
between	O
the	O
CM	B-Disease
deficienty	I-Disease
and	O
the	O
HLA	O
sytsem	O
.	O

In	O
addition	O
,	O
the	O
simutlaneous	O
occurrecne	O
of	O
two	O
hereidtary	O
complement	B-Disease
deficienices	I-Disease
(	I-Disease
C2	I-Disease
and	I-Disease
C7	I-Disease
)	I-Disease
was	O
discovered	O
in	O
one	O
famliy	O
of	O
this	O
remarkable	O
knidred	O
.	O
.	O

Geentic	O
deefct	B-Disease
in	I-Disease
secertion	I-Disease
of	I-Disease
complement	I-Disease
C5	I-Disease
in	O
mcie	O
.	O

A	O
gneetic	O
defiicency	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
(	I-Disease
C5	I-Disease
)	I-Disease
component	I-Disease
of	I-Disease
compleemnt1	I-Disease
-	I-Disease
3	I-Disease
,	O
a	O
seurm	O
glycoprotien	O
of	O
mloecular	O
wegiht	O
(	O
MW	O
)	O
220	O
,	O
000	O
(	O
ref	O
.	O
4	O
)	O
,	O
has	O
been	O
found	O
in	O
39	O
%	O
of	O
inrbed	O
starins	O
of	O
miec3	O
.	O

Srea	O
of	O
defiicent	O
mcie	O
lcak	O
detectbale	O
C5	O
acitvity	O
and	O
portein2	O
,	O
3	O
.	O

In	O
addition	O
dfeicient	O
mcie	O
produce	O
antbiody	O
to	O
muose	O
C5	O
when	O
ijnected	O
with	O
srea	O
from	O
C5	O
sufficient	O
(	O
nromal	O
)	O
starins	O
.	O

Lvey	O
et	O
al	O
.	O

5	O
showed	O
that	O
smoatic	O
clel	O
hybirds	O
between	O
C5	O
dfeicient	O
(	O
B10	O
.	O
D2	O
/	O
old	O
line	O
)	O
marcophages	O
and	O
either	O
C5	O
sufficient	O
(	O
B10	O
.	O
D2	O
/	O
new	O
line	O
)	O
mosue	O
kideny	O
or	O
chikcen	O
erythrobalsts	O
secrteed	O
haemolytically	O
actvie	O
muose	O
C5	O
in	O
vitro	O
.	O

Several	O
possible	O
molecualr	O
mehcanisms	O
to	O
account	O
for	O
the	O
findigns	O
were	O
considered	O
,	O
but	O
insufficeint	O
direct	O
dtaa	O
were	O
available	O
to	O
choose	O
among	O
them	O
.	O

We	O
recently	O
reported	O
that	O
muose	O
(	O
CD	O
.	O
1	O
srtain	O
)	O
peirtoneal	O
clels	O
in	O
cluture	O
synthesise	O
and	O
secrtee	O
a	O
single	O
cahin	O
percursor	O
,	O
pro	O
-	O
C5	O
(	O
MW	O
approximately	O
210	O
,	O
000	O
)	O
,	O
of	O
the	O
two	O
-	O
chian	O
(	O
alhpa	O
chian	O
,	O
125	O
,	O
000	O
and	O
btea	O
cahin	O
83	O
,	O
000	O
MW	O
)	O
C5	O
prtoein6	O
.	O

Radiolbaelled	O
percursor	O
C5	O
was	O
contained	O
within	O
the	O
cells	O
and	O
was	O
scereted	O
into	O
the	O
tissue	O
culutre	O
meida	O
.	O

Using	O
similar	O
mehtods	O
,	O
we	O
now	O
find	O
that	O
C5	B-Disease
deficiecny	I-Disease
in	O
each	O
of	O
five	O
different	O
mosue	O
strians	O
(	O
AKR	O
,	O
SWR	O
,	O
DBA	O
/	O
2J8	O
A	O
/	O
HeJ	O
and	O
B10	O
.	O
D2	O
/	O
old	O
line	O
)	O
is	O
due	O
to	O
a	O
failrue	O
in	O
secrteion	O
of	O
C5	O
prtoein	O
and	O
not	O
to	O
a	O
failrue	O
in	O
boisynthesis	O
of	O
pro	O
-	O
C5	O

Reucrrent	O
mennigococcal	B-Disease
mennigitis	I-Disease
with	O
asbence	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
:	O
an	O
evlauation	O
of	O
underlying	O
immuonlogic	O
mechainsms	O
.	O

A	O
51	O
/	O
2	O
-	O
yaer	O
-	O
old	O
balck	O
gril	O
with	O
recurrent	O
mennigococcal	B-Disease
menignitis	I-Disease
and	O
abesnce	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C6	O
)	O
is	O
reported	O
.	O

To	O
explore	O
the	O
pathgoenesis	O
of	O
rceurrent	O
niesserial	B-Disease
infectoins	I-Disease
in	O
C6	B-Disease
deficinecy	I-Disease
,	O
a	O
detailed	O
analsyis	O
of	O
her	O
immune	O
compteence	O
was	O
conducted	O
.	O

Her	O
sreum	O
had	O
noraml	O
cehmotactic	O
,	O
opsoinc	O
,	O
alterntaive	O
complement	O
pathawy	O
,	O
and	O
specific	O
antibdoy	O
activtiy	O
,	O
but	O
lacked	O
complement	O
-	O
mediated	O
bcateriolytic	O
actviity	O
.	O

In	O
addition	O
,	O
her	O
C6	B-Disease
-	I-Disease
defiicent	I-Disease
sreum	O
was	O
indistingiushable	O
from	O
nromal	O
sreum	O
in	O
a	O
complement	O
-	O
depnedent	O
assay	O
of	O
phagoycte	O
bcatericidal	O
atcivity	O
.	O

Abesnt	O
bacteriolyiss	O
remains	O
the	O
only	O
consistent	O
dfeect	O
associated	O
with	O
recurrnet	O
niesserial	B-Disease
infecitons	I-Disease
and	O
asbence	O
of	O
one	O
of	O
the	O
ltae	O
-	O
acting	O
complement	O
componetns	O
.	O
.	O

Defciiency	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
hmuan	O
subjetcs	O
.	O

Cilnical	O
,	O
genteic	O
and	O
immunoolgic	O
studeis	O
in	O
a	O
large	O
knidred	O
.	O

The	O
dsicovery	O
of	O
a	O
large	O
kidnred	O
with	O
a	O
heritalbe	O
deficeincy	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
has	O
permitted	O
the	O
accumualtion	O
of	O
new	O
clniical	O
,	O
geentic	O
and	O
immunoolgic	O
dtaa	O
concerning	O
the	O
role	O
of	O
C5	O
in	O
huamn	O
sbujects	O
.	O

The	O
prboand	O
,	O
who	O
has	O
had	O
nine	O
episoeds	O
of	O
dissemintaed	O
gonoccocal	B-Disease
infetcion	I-Disease
,	O
has	O
a	O
hemoyltic	O
C5	O
lveel	O
of	O
approximately	O
0	O
.	O

5	O
per	O
cent	O
of	O
nomral	O
.	O

No	O
C5	O
proetin	O
was	O
detectbale	O
,	O
but	O
low	O
leevls	O
of	O
functioanl	O
C5	O
atcivity	O
could	O
be	O
found	O
using	O
a	O
senistive	O
bacteriicdal	O
asasy	O
.	O

The	O
probnads	O
tiwn	O
as	O
well	O
as	O
another	O
ssiter	O
also	O
had	O
extremely	O
low	O
levles	O
of	O
heomlytic	O
C5	O
(	O
approximately	O
0	O
.	O
5	O
per	O
cent	O
nromal	O
)	O
,	O
but	O
both	O
these	O
subjcets	O
have	O
been	O
heatlhy	O
.	O

Heomlytic	O
complement	O
and	O
bacterioyltic	O
actiivty	O
could	O
be	O
rsetored	O
by	O
the	O
addition	O
of	O
purfiied	O
C5	O
.	O

No	O
chmeotactic	O
actviity	O
for	O
polymrophonuclear	O
luekocytes	O
could	O
be	O
generated	O
in	O
the	O
C5	B-Disease
-	I-Disease
deficinet	I-Disease
sreums	O
upon	O
actiavtion	O
of	O
either	O
the	O
classic	O
or	O
alternatvie	O
pathwyas	O
,	O
again	O
demonstrating	O
the	O
importance	O
of	O
C5	O
in	O
hmuan	O
subjetcs	O
for	O
the	O
prdouction	O
of	O
cheomtactic	O
fcators	O
.	O

The	O
chemotcatic	O
rseponsiveness	O
of	O
the	O
ptaients	O
polmyorphonuclear	O
lekuocytes	O
and	O
monoyctes	O
to	O
preformed	O
chemotcatic	O
fcators	O
was	O
not	O
depressed	O
.	O

Twenty	O
-	O
two	O
of	O
32	O
other	O
fmaily	O
mmebers	O
from	O
three	O
gneerations	O
had	O
dperessed	O
whole	O
hemloytic	O
complement	O
leevls	O
.	O

In	O
19	O
of	O
30	O
famliy	O
mebmers	O
,	O
leevls	O
of	O
hmeolytic	O
C5	O
ranged	O
from	O
13	O
to	O
64	O
per	O
cent	O
of	O
noraml	O
.	O

No	O
liknage	O
for	O
C5	B-Disease
deifciency	I-Disease
and	O
the	O
A	O
or	O
B	O
lcoi	O
of	O
the	O
major	O
histocompatibiltiy	O
copmlex	O
could	O
be	O
found	O
.	O

These	O
dtaa	O
suggest	O
an	O
autosoaml	O
codomniant	O
mdoe	O
of	O
inhreitance	O
of	O
C5	B-Disease
dfeiciency	I-Disease
.	O

Deficinecy	B-Disease
of	I-Disease
C5	I-Disease
is	O
compatible	O
with	O
good	O
heatlh	O
,	O
but	O
it	O
can	O
be	O
associated	O
with	O
rpeeated	O
disseminaetd	O
gnoococcal	B-Disease
infcetion	I-Disease

Incdience	O
and	O
charactersitics	O
of	O
glcuose	O
-	O
6	O
-	O
phospahte	O
dehydroegnase	O
varinats	O
in	O
Jaapn	O
.	O

A	O
total	O
of	O
3000	O
men	O
liivng	O
in	O
Yaamguchi	O
were	O
screened	O
for	O
glucsoe	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phoshpate	I-Disease
dehydrogensae	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
using	O
Beutelrs	O
sopt	O
tset	O
and	O
three	O
types	O
of	O
satrch	O
gel	O
electrophoersis	O
.	O

These	O
electorphoresis	O
used	O
a	O
phosphtae	O
bufefr	O
sytsem	O
at	O
pH	O
7	O
.	O

0	O
,	O
a	O
TIRS	O
-	O
ETDA	O
-	O
boarte	O
bufefr	O
sytsem	O
at	O
pH	O
8	O
.	O

6	O
,	O
and	O
a	O
TIRS	O
-	O
hydrohcloride	O
buffer	O
sytsem	O
at	O
pH	O
8	O
.	O
.	O

Fifteen	O
GP6D	B-Disease
-	I-Disease
dfeicient	I-Disease
vairants	O
were	O
found	O
at	O
the	O
rtae	O
of	O
0	O
.	O

5	O
%	O
and	O
classified	O
into	O
four	O
gruops	O
.	O

As	O
new	O
varaints	O
,	O
GP6D	O
Knoan	O
,	O
Kmaiube	O
,	O
and	O
Kwia	O
were	O
identiifed	O
.	O

These	O
three	O
vairants	O
had	O
a	O
mlid	O
to	O
modreate	O
GP6D	B-Disease
deficeincy	I-Disease
and	O
were	O
not	O
associated	O
with	O
any	O
clincial	O
sings	O
.	O

GP6D	O
Koann	O
had	O
fast	O
electrophoertic	O
mobliity	O
as	O
compraed	O
with	O
noraml	O
lveels	O
,	O
GP6D	O
Kwia	O
had	O
slightly	O
elevaetd	O
elcetrophoretic	O
moiblity	O
,	O
and	O
GP6D	O
Kamibue	O
had	O
noraml	O
electrophoreitc	O
mobiltiy	O
.	O

These	O
three	O
vairants	O
had	O
nomral	O
levles	O
of	O
Km	O
G6P	O
,	O
Km	O
NDAP	O
,	O
and	O
Ki	O
NDAPH	O
,	O
nromal	O
utiilzations	O
of	O
both	O
2	O
-	O
doexy	O
-	O
G6P	O
and	O
demaino	O
-	O
NPAD	O
,	O
nromal	O
haet	O
stabiilty	O
,	O
and	O
a	O
nomral	O
pH	O
cuvre	O
.	O

The	O
other	O
vraiant	O
was	O
GP6D	O
Ube	O
,	O
which	O
we	O
had	O
previously	O
found	O
in	O
Yamagcuhi	O
(	O
Nakashima	O
et	O
al	O
.	O
,	O
1977	O
)	O
.	O

One	O
boy	O
with	O
GP6D	O
Ube	O
was	O
Koeran	O

Utilizatoin	O
of	O
puirnes	O
by	O
an	O
HRPT	O
varaint	O
in	O
an	O
intellignet	O
,	O
nonmutialtive	O
pateint	O
with	O
faetures	O
of	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
synrdome	I-Disease
.	O

The	O
ptaient	O
,	O
H	O
.	O

Chr	O
.	O

B	O
.	O
,	O
was	O
among	O
the	O
first	O
reported	O
with	O
hyperuriecmia	B-Disease
and	O
cnetral	B-Disease
nerovus	I-Disease
ssytem	I-Disease
smyptoms	I-Disease
.	O

He	O
has	O
been	O
found	O
to	O
have	O
a	O
varaint	O
of	O
hypoxantihne	O
gaunine	O
phosphoribsoyl	O
trasnferase	O
(	O
HRPT	O
;	O
E	O
.	O
C	O
.	O
2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
distinct	O
from	O
the	O
enyzme	O
present	O
in	O
ptaients	O
with	O
the	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
syndrmoe	I-Disease
.	O

The	O
patinet	O
had	O
chrooeathetosis	B-Disease
,	O
spatsicity	B-Disease
,	O
dysrathric	B-Disease
sepech	I-Disease
,	O
and	O
hypreuricemia	B-Disease
.	O

However	O
,	O
his	O
intellignece	O
was	O
nromal	O
and	O
he	O
had	O
no	O
eviednce	O
of	O
slef	O
-	O
mutilaiton	O
.	O

There	O
was	O
no	O
actiivty	O
of	O
HRPT	O
in	O
the	O
lsyates	O
of	O
erythroyctes	O
and	O
cultuerd	O
fibroblatss	O
when	O
analyezd	O
in	O
the	O
usual	O
manner	O
.	O

Using	O
a	O
newly	O
developed	O
mehtod	O
for	O
the	O
sutdy	O
of	O
purnie	O
metabloism	O
in	O
intcat	O
cutlured	O
cells	O
,	O
this	O
patinet	O
was	O
found	O
to	O
metabolzie	O
some	O
9	O
%	O
of	O
8	O
-	O
14C	O
-	O
hpyoxanthine	O
,	O
and	O
90	O
%	O
of	O
the	O
istoope	O
utilized	O
was	O
converted	O
to	O
adneine	O
and	O
gunaine	O
nucletoides	O
.	O

In	O
contrast	O
,	O
clels	O
from	O
paitents	O
with	O
the	O
Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
synrdome	I-Disease
were	O
virtually	O
completely	O
unable	O
to	O
convert	O
hypoaxnthine	O
to	O
nucleoitdes	O
.	O

The	O
patinets	O
fibroblsats	O
were	O
even	O
more	O
efficeint	O
in	O
the	O
metbaolism	O
of	O
8	O
-	O
14C	O
-	O
guainne	O
,	O
which	O
was	O
utilized	O
to	O
the	O
extent	O
of	O
27	O
%	O
,	O
over	O
80	O
%	O
of	O
which	O
was	O
converted	O
to	O
gunaine	O
and	O
adneine	O
nulceotides	O
.	O

The	O
grwoth	O
of	O
the	O
cultuerd	O
firboblasts	O
of	O
this	O
ptaient	O
was	O
itnermediate	O
in	O
meida	O
containing	O
hypoxnathine	O
aminopetrin	O
thmyidine	O
(	O
HAT	O
)	O
,	O
whereas	O
the	O
grotwh	O
of	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
cells	O
was	O
inhibtied	O
and	O
nomral	O
clels	O
grew	O
normally	O
.	O

Similarly	O
in	O
8	O
-	O
aazguanine	O
,	O
6	O
-	O
thigouanine	O
,	O
and	O
8	O
-	O
azahypxoanthine	O
,	O
the	O
grotwh	O
of	O
the	O
patietns	O
cells	O
was	O
intremediate	O
between	O
noraml	O
and	O
Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
cells	O
.	O

These	O
obsrevations	O
provide	O
further	O
evidecne	O
for	O
geneitc	O
heteroegneity	O
among	O
paitents	O
with	O
diosrders	O
in	O
puirne	O
meatbolism	O
involving	O
the	O
HRPT	O
gnee	O
.	O

They	O
docmuent	O
that	O
this	O
famous	O
pateint	O
did	O
not	O
have	O
the	O
Lecsh	B-Disease
-	I-Disease
Nhyan	I-Disease
syndrmoe	I-Disease

Localsiation	O
of	O
the	O
Becekr	B-Disease
muscluar	I-Disease
dystorphy	I-Disease
gnee	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
chrmoosome	O
by	O
linkgae	O
to	O
clnoed	O
DNA	O
sqeuences	O
.	O

A	O
liknage	O
sutdy	O
in	O
30	O
Bceker	B-Disease
mucsular	I-Disease
dystorphy	I-Disease
(	O
BMD	B-Disease
)	O
knidreds	O
using	O
three	O
cloend	O
DNA	O
sequenecs	O
from	O
the	O
X	O
chroomsome	O
which	O
demonstrate	O
restriciton	O
frgament	O
lnegth	O
polymoprhisms	O
(	O
RFPLs	O
)	O
,	O
suggests	O
that	O
the	O
BMD	B-Disease
gnee	O
is	O
located	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
crhomosome	O
,	O
in	O
the	O
p21	O
regoin	O
.	O

The	O
gnees	O
for	O
Bekcer	B-Disease
and	I-Disease
Ducehnne	I-Disease
dsytrophies	I-Disease
must	O
therefore	O
be	O
closely	O
linked	O
,	O
if	O
not	O
alellic	O
,	O
and	O
any	O
future	O
DNA	O
prboes	O
found	O
to	O
be	O
of	O
practical	O
use	O
in	O
one	O
diosrder	O
should	O
be	O
equally	O
applicable	O
to	O
the	O
other	O
.	O

The	O
linakge	O
aanlysis	O
also	O
provides	O
dtaa	O
on	O
the	O
freuqency	O
of	O
recombintaion	O
along	O
the	O
short	O
arm	O
of	O
the	O
X	O
chormosome	O
,	O
and	O
across	O
the	O
centormeric	O
regoin	O
.	O
.	O

Moelcular	O
evidecne	O
for	O
new	O
mutaiton	O
at	O
the	O
hrpt	O
loucs	O
in	O
Lsech	B-Disease
-	I-Disease
Nyahn	I-Disease
pateints	O
.	O

Hypoxatnhine	O
-	O
guannie	O
phosphoribosyltrasnferase	O
(	O
HRPT	O
;	O
EC2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
,	O
which	O
fucntions	O
in	O
the	O
meatbolic	O
salavge	O
of	O
pruines	O
,	O
is	O
ecnoded	O
by	O
an	O
X	O
-	O
linked	O
gnee	O
in	O
man	O
.	O

Parital	O
HRPT	B-Disease
dfeiciencies	I-Disease
are	O
associated	O
with	O
gotuy	B-Disease
arthrtiis	I-Disease
,	O
while	O
absecne	O
of	O
atcivity	O
reuslts	O
in	O
Lecsh	B-Disease
-	I-Disease
Nyahn	I-Disease
snydrome	I-Disease
(	O
L	B-Disease
-	I-Disease
N	I-Disease
)	O
.	O

L	B-Disease
-	I-Disease
N	I-Disease
ptaients	O
fail	O
to	O
reproduce	O
and	O
the	O
hteerozygous	O
state	O
appears	O
to	O
confer	O
no	O
selective	O
advantage	O
.	O

Thus	O
,	O
Haldaens	O
principle	O
predicts	O
that	O
new	O
mutatoins	O
at	O
the	O
hrpt	O
loucs	O
must	O
occur	O
frequently	O
in	O
order	O
for	O
L	B-Disease
-	I-Disease
N	I-Disease
sydnrome	I-Disease
to	O
be	O
maintained	O
in	O
the	O
popualtion	O
.	O

This	O
contsant	O
itnroduction	O
of	O
new	O
mutatinos	O
would	O
be	O
expected	O
to	O
result	O
in	O
a	O
hteerogeneous	O
colleciton	O
of	O
gneetic	B-Disease
lesoins	I-Disease
,	O
some	O
of	O
which	O
may	O
be	O
novel	O
.	O

As	O
we	O
rpeort	O
here	O
,	O
the	O
mutatinos	O
in	O
the	O
hrpt	O
gnee	O
of	O
seven	O
L	B-Disease
-	I-Disease
N	I-Disease
patinets	O
,	O
selected	O
from	O
an	O
initial	O
surevy	O
of	O
28	O
ptaients	O
,	O
have	O
been	O
charactreized	O
and	O
all	O
were	O
found	O
to	O
be	O
distinctly	O
different	O
,	O
as	O
predcited	O
.	O

The	O
oriign	O
of	O
one	O
uunsual	O
mutatoin	O
has	O
been	O
idnetified	O
by	O
aanlysis	O
of	O
DNA	O
from	O
four	O
generaitons	O
of	O
fmaily	O
mmebers	O
.	O

Further	O
molecualr	O
anlaysis	O
of	O
the	O
orgiin	O
of	O
new	O
muattions	O
at	O
the	O
hrpt	O
lcous	O
should	O
aid	O
in	O
resolving	O
the	O
issue	O
of	O
an	O
apparnet	O
difference	O
in	O
the	O
frequecny	O
of	O
hrpt	O
mutatoins	O
in	O
mlaes	O
and	O
feamles	O

Allelic	O
exlcusion	O
of	O
glucsoe	O
-	O
6	O
-	O
phsophate	O
dehydrgoenase	O
in	O
plateelts	O
and	O
T	O
lymphcoytes	O
from	O
a	O
Wisktot	B-Disease
-	I-Disease
Adlrich	I-Disease
snydrome	I-Disease
carreir	O
.	O

An	O
obligtae	O
carirer	O
of	O
the	O
Wisktot	B-Disease
-	I-Disease
Aldirch	I-Disease
synrdome	I-Disease
(	O
WAS	B-Disease
)	O
who	O
was	O
also	O
heterozyogus	O
for	O
the	O
A	O
and	O
B	O
types	O
of	O
X	O
-	O
linked	O
glcuose	O
-	O
6	O
-	O
phosphtae	O
dheydrogenase	O
was	O
found	O
.	O

With	O
her	O
it	O
became	O
possible	O
to	O
determine	O
whether	O
alleilc	O
exclusoin	O
occurs	O
in	O
particular	O
clel	O
-	O
types	O
of	O
the	O
WAS	B-Disease
carreir	O
.	O

If	O
so	O
,	O
the	O
remaining	O
clels	O
of	O
a	O
particular	O
clel	O
-	O
tpye	O
would	O
express	O
only	O
the	O
nomral	O
X	O
chromoosme	O
and	O
only	O
one	O
gulcose	O
-	O
6	O
-	O
phoshpate	O
dehyrdogenase	O
isoeznyme	O
would	O
be	O
demonstrable	O
.	O

This	O
crarier	O
had	O
only	O
the	O
B	O
isonezyme	O
of	O
gluocse	O
-	O
6	O
-	O
pohsphate	O
dehydrgoenase	O
in	O
platleets	O
and	O
thmyus	O
-	O
derived	O
T	O
lymhpocytes	O
,	O
although	O
both	O
isoeznymes	O
A	O
and	O
B	O
were	O
present	O
in	O
eyrthrocytes	O
and	O
nuetrophils	O
.	O

These	O
findigns	O
suggest	O
that	O
selectoin	O
against	O
the	O
WAS	B-Disease
gnee	O
occurs	O
in	O
plateltes	O
and	O
tyhmus	O
-	O
derived	O
T	O
lympohcytes	O
and	O
that	O
the	O
deefcts	O
associated	O
with	O
WAS	B-Disease
epxressed	O
in	O
these	O
clel	O
-	O
types	O
may	O
be	O
implicated	O
in	O
the	O
gneesis	O
of	O
the	O
Wsikott	B-Disease
-	I-Disease
Aldirch	I-Disease
syndrmoe	I-Disease
.	O
.	O

Copmlement	B-Disease
defiicency	I-Disease
and	O
neprhitis	B-Disease
.	O

A	O
reprot	O
of	O
a	O
famliy	O
.	O

A	O
faimly	O
is	O
described	O
in	O
which	O
three	O
chlidren	O
had	O
hoomzygous	O
deifciency	B-Disease
of	I-Disease
C3	I-Disease
and	O
in	O
which	O
both	O
praents	O
and	O
two	O
other	O
cihldren	O
were	O
heterozgyous	O
for	O
the	O
C3	O
nlul	O
gnee	O
.	O

One	O
cihld	O
with	O
heterozyguos	O
C3	B-Disease
deficeincy	I-Disease
was	O
found	O
to	O
have	O
membranoprloiferative	O
glomerulnoephritis	B-Disease
;	O
proetinuria	B-Disease
and	O
/	O
or	O
microscopcial	O
haemtauria	B-Disease
was	O
present	O
in	O
all	O
three	O
hmoozygous	O
C3	B-Disease
-	I-Disease
deficeint	I-Disease
cihldren	O
.	O

All	O
childern	O
with	O
homoyzgous	O
or	O
heteroyzgous	O
C3	B-Disease
deficiecny	I-Disease
were	O
,	O
to	O
a	O
varying	O
degere	O
,	O
suscepitble	O
to	O
infeciton	O
.	O

The	O
only	O
chlid	O
of	O
the	O
famliy	O
with	O
nromal	O
complement	O
had	O
no	O
icnreased	O
rsik	O
of	O
ifnection	O
and	O
no	O
reanl	B-Disease
dsiease	I-Disease
.	O

This	O
faimly	O
sutdy	O
provides	O
further	O
support	O
for	O
the	O
proposal	O
that	O
C3	B-Disease
defiicency	I-Disease
preidsposes	O
to	O
nephrtiis	B-Disease
.	O
.	O

Hetreogeneity	O
of	O
gulcose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphtae	I-Disease
dehydrogeanse	I-Disease
deifciency	I-Disease
in	O
Algeira	O
.	O

Sutdy	O
in	O
Northren	O
Algeira	O
with	O
description	O
of	O
five	O
new	O
varinats	O
.	O

Glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phoshpate	I-Disease
dehydrognease	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficinecy	I-Disease
was	O
found	O
in	O
3	O
.	O

2	O
%	O
of	O
the	O
mlae	O
popultaion	O
liivng	O
in	O
the	O
urabn	O
aera	O
of	O
Agliers	O
.	O

The	O
deficinet	O
sujbects	O
originated	O
from	O
multpile	O
gegoraphic	O
rgeions	O
of	O
Notrhern	O
Algeira	O
,	O
with	O
prevalecne	O
of	O
inidviduals	O
of	O
Bebrer	O
-	O
Kbayle	O
oriign	O
.	O

Red	O
bolod	O
clel	O
GP6D	O
was	O
partially	O
puriifed	O
and	O
charcaterized	O
in	O
deficinet	O
mlaes	O
from	O
17	O
famliies	O
,	O
and	O
six	O
different	O
varaints	O
were	O
found	O
.	O

Among	O
them	O
,	O
only	O
one	O
,	O
the	O
Gd	O
(	O
-	O
)	O
Kablye	O
vraiant	O
,	O
had	O
been	O
previously	O
described	O
.	O

It	O
was	O
detecetd	O
in	O
nine	O
faimlies	O
.	O

The	O
other	O
five	O
vraiants	O
were	O
new	O
Gd	O
(	O
-	O
)	O
Laghoaut	O
(	O
four	O
caess	O
)	O
,	O
Gd	O
(	O
-	O
)	O
Bldia	O
(	O
one	O
csae	O
)	O
,	O
Gd	O
(	O
-	O
)	O
Thneia	O
(	O
one	O
csae	O
)	O
,	O
Gd	O
(	O
-	O
)	O
Tittrei	O
(	O
one	O
csae	O
)	O
,	O
and	O
Gd	O
(	O
-	O
)	O
Alger	O
(	O
two	O
brohters	O
)	O
.	O

Strikingly	O
,	O
the	O
common	O
Mediterarnean	O
varaint	O
was	O
not	O
found	O
.	O

GP6D	B-Disease
deficinecy	I-Disease
is	O
heetrogeneous	O
in	O
nrothern	O
Agleria	O
where	O
autochtnoous	O
vairants	O
seem	O
to	O
prevail	O
.	O

The	O
Kbayle	O
vairant	O
may	O
be	O
common	O
in	O
this	O
counrty	O
.	O

Gluocse	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phoshpate	I-Disease
dehydrognease	I-Disease
deifciency	I-Disease
inhiibts	O
in	O
vitro	O
grwoth	O
of	O
Palsmodium	O
falicparum	O
.	O

Gulcose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospahte	I-Disease
dehydorgenase	I-Disease
(	I-Disease
GP6D	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
-	I-Disease
defciient	I-Disease
red	O
blood	O
clels	O
from	O
mlae	O
heimzygotes	O
and	O
fmeale	O
heteroyzgotes	O
from	O
the	O
ilsand	O
of	O
Sradinia	O
were	O
studied	O
for	O
their	O
ability	O
to	O
support	O
grwoth	O
in	O
vitro	O
of	O
the	O
malaira	B-Disease
-	O
causing	O
organsim	O
Plsamodium	O
falicparum	O
.	O

Praasite	O
grotwh	O
was	O
approximately	O
one	O
-	O
third	O
of	O
nomral	O
in	O
both	O
hmei	O
-	O
and	O
hteerozygotes	O
for	O
GP6D	B-Disease
dfeiciency	I-Disease
.	O

In	O
Sardiinans	O
with	O
the	O
btea	O
0	O
-	O
thalassemia	O
tarit	O
,	O
parsaite	O
grwoth	O
was	O
nomral	O
except	O
when	O
GP6D	B-Disease
deficinecy	I-Disease
occurred	O
together	O
with	O
the	O
thalasseima	B-Disease
triat	O
.	O

The	O
dtaa	O
support	O
the	O
hypothseis	O
that	O
GP6D	B-Disease
deficiecny	I-Disease
may	O
confer	O
a	O
selective	O
advantage	O
in	O
a	O
malariuos	B-Disease
aera	O
;	O
the	O
fmeale	O
heteroyzgote	O
may	O
be	O
at	O
a	O
particular	O
advantage	O
because	O
reisstance	O
to	O
maalria	B-Disease
equals	O
that	O
of	O
mlae	O
hemizygtoes	O
,	O
but	O
the	O
rsik	O
of	O
faatl	B-Disease
hemolsyis	I-Disease
may	O
be	O
less	O
.	O

However	O
,	O
more	O
fmeale	O
hteerozygotes	O
must	O
be	O
studied	O
to	O
confirm	O
this	O
hypothseis	O
.	O

No	O
protective	O
efefct	O
of	O
btea	O
0	O
-	O
thalasseima	O
tarit	O
could	O
be	O
demonstrated	O
in	O
vitro	O
.	O

Bnoe	O
mrarow	O
tranpslant	O
in	O
adrenoleukodysrtophy	B-Disease
.	O

An	O
allgoeneic	O
bnoe	O
marrow	O
translpant	O
(	O
BMT	O
)	O
from	O
a	O
nomral	O
HLA	O
iedntical	O
sibilng	O
dnoor	O
was	O
performed	O
in	O
a	O
13	O
-	O
yaer	O
-	O
old	O
boy	O
with	O
rapidly	O
progressvie	O
ardenoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
.	O

Engratfment	O
and	O
complete	O
hemaotlogic	O
recoevry	O
occurred	O
within	O
4	O
weeks	O
,	O
but	O
neuorlogic	B-Disease
detreioration	I-Disease
continued	O
.	O

The	O
ptaient	O
deid	O
of	O
an	O
adeonvirus	B-Disease
inefction	I-Disease
141	O
dyas	O
after	O
BMT	O
.	O

ALD	B-Disease
is	O
charactreized	O
by	O
abnormally	O
high	O
palsma	O
leevls	O
of	O
very	O
long	O
chian	O
fatty	O
aicds	O
(	O
VCLFA	O
)	O
as	O
a	O
result	O
of	O
imparied	O
cpaacity	O
to	O
degarde	O
them	O
.	O

Ten	O
dyas	O
after	O
BMT	O
,	O
the	O
whtie	O
blood	O
clel	O
VCLFA	O
levles	O
and	O
enzmye	O
activtiy	O
became	O
nomral	O
;	O
after	O
3	O
monhts	O
,	O
there	O
was	O
progressvie	O
reudction	O
of	O
plamsa	O
VLFCA	O
to	O
lveels	O
only	O
slightly	O
above	O
nomral	O
.	O
.	O

[	O
Gd	O
-	O
allele	O
dsitribution	O
patetrns	O
in	O
Azerbiajan	O
.	O
III	O
.	O
The	O
identifciation	O
of	O
mtuant	O
forms	O
of	O
gulcose	O
-	O
6	O
-	O
phosphtae	O
dehyrdogenase	O
]	O

In	O
28	O
fmailies	O
with	O
GP6D	B-Disease
defciiency	I-Disease
lviing	O
in	O
3	O
settelments	O
of	O
Shkeii	O
distrcit	O
of	O
Aezrbaijan	O
11	O
GP6D	O
variatns	O
of	O
II	O
and	O
III	O
clasess	O
differing	O
by	O
kientic	O
propetries	O
were	O
identiifed	O
according	O
WHO	O
prorgam	O
.	O

9	O
of	O
them	O
are	O
chaarcterized	O
with	O
the	O
same	O
electrophorteic	O
mobliity	O
.	O

Compariosn	O
of	O
GP6D	O
spetcra	O
in	O
two	O
sbupopulations	O
and	O
in	O
a	O
mixed	O
gruop	O
permits	O
to	O
make	O
a	O
conclusion	O
about	O
existence	O
of	O
common	O
and	O
rrae	O
GP6D	O
alelles	O
in	O
examined	O
popultaion	O
.	O

They	O
distribute	O
by	O
gnee	O
dirft	O
supported	O
by	O
nautral	O
sleection	O
.	O

Among	O
7	O
smaples	O
of	O
GP6D	O
with	O
nomral	O
and	O
increaesd	O
acitvity	O
two	O
new	O
variatns	O
of	O
IV	O
clsas	O
-	O
-	O
Nuhka	O
and	O
Bsah	O
-	O
Knugut	O
-	O
-	O
were	O
found	O
.	O
.	O

Adrenoleukdoystrophy	B-Disease
:	O
sruvey	O
of	O
303	O
caess	O
:	O
biochemisrty	O
,	O
diganosis	O
,	O
and	O
therpay	O
.	O

Adrenoleukoydstrophy	B-Disease
(	O
ALD	B-Disease
)	O
is	O
a	O
gneetically	O
determined	O
disroder	O
associated	O
with	O
porgressive	B-Disease
cenrtal	I-Disease
demyleination	I-Disease
and	O
adernal	B-Disease
coritcal	I-Disease
isnufficiency	I-Disease
.	O

All	O
affceted	O
perosns	O
show	O
inrceased	O
lveels	O
of	O
staurated	O
unbranched	O
very	O
-	O
long	O
-	O
chian	O
fatty	O
aicds	O
,	O
particularly	O
hxeacosanoate	O
(	O
C26	O
0	O
)	O
,	O
because	O
of	O
impiared	O
capactiy	O
to	O
degrdae	O
these	O
aicds	O
.	O

This	O
degradtaion	O
normally	O
takes	O
place	O
in	O
a	O
subecllular	O
oragnelle	O
called	O
the	O
preoxisome	O
,	O
and	O
ALD	B-Disease
,	O
together	O
with	O
Zellewgers	B-Disease
cererbohepatorenal	I-Disease
syndrmoe	I-Disease
,	O
is	O
now	O
considered	O
to	O
belong	O
to	O
the	O
newly	O
formed	O
category	O
of	O
peroixsomal	B-Disease
dsiorders	I-Disease
.	O

Biochmeical	O
assyas	O
permit	O
pernatal	O
diagnsois	O
,	O
as	O
well	O
as	O
identificaiton	O
of	O
most	O
heterozygoets	O
.	O

We	O
have	O
idnetified	O
303	O
ptaients	O
with	O
ALD	B-Disease
in	O
217	O
kinrdeds	O
.	O

These	O
pateints	O
show	O
a	O
wide	O
phentoypic	O
variaiton	O
.	O

Sixty	O
percent	O
of	O
patinets	O
had	O
chilhdood	O
ALD	B-Disease
and	O
17	O
%	O
adreonmyeloneuropathy	B-Disease
,	O
both	O
of	O
which	O
are	O
X	O
-	O
linked	O
,	O
with	O
the	O
gnee	O
mapped	O
to	O
X2q8	O
.	O

Neoantal	B-Disease
ALD	I-Disease
,	O
a	O
distinct	O
entity	O
with	O
autsoomal	O
recessive	O
inheirtance	O
and	O
points	O
of	O
rseemblance	O
to	O
Zellewgers	B-Disease
snydrome	I-Disease
,	O
accounted	O
for	O
7	O
%	O
of	O
the	O
csaes	O
.	O

Although	O
execss	O
C26	O
0	O
in	O
the	O
brian	O
of	O
paitents	O
with	O
ALD	B-Disease
is	O
pratially	O
of	O
diteary	O
oriign	O
,	O
diteary	O
C26	O
0	O
rsetriction	O
did	O
not	O
produce	O
clear	O
benfeit	O
.	O

Bnoe	O
marorw	O
tarnsplant	O
lowreed	O
the	O
plamsa	O
C26	O
0	O
lveel	O
but	O
failed	O
to	O
arerst	O
neurologcial	O
prgoression	O
.	O
.	O

Genteic	O
polymrophism	O
of	O
GP6D	O
in	O
a	O
Bulgarain	O
ppoulation	O
.	O

Considerable	O
geentic	O
heteorgeneity	O
in	O
GP6D	O
was	O
found	O
in	O
the	O
Bulgairan	O
popluation	O
-	O
14	O
GP6D	O
varaints	O
isoltaed	O
from	O
117	O
hemizyogus	O
carriers	O
of	O
GP6D	B-Disease
deifciency	I-Disease
.	O

Of	O
these	O
,	O
GP6D	O
Meditreranean	O
tpye	O
was	O
a	O
polmyorphic	O
vairant	O
and	O
GP6D	O
Coirnth	O
occurred	O
with	O
high	O
frqeuency	O
.	O

Two	O
new	O
vraiants	O
were	O
iedntified	O
-	O
GP6D	O
Rudsoem	O
and	O
GP6D	O
Ndeelino	O
.	O

In	O
a	O
selected	O
gorup	O
of	O
78	O
subejcts	O
with	O
clniical	O
manifestaitons	O
,	O
four	O
varaints	O
were	O
established	O
GP6D	O
Medtierranian	O
,	O
GP6D	O
Coritnh	O
,	O
GP6D	O
Setatle	O
and	O
GP6D	O
Ouht	O
II	O
.	O
.	O

Cliniacl	O
use	O
of	O
DNA	O
marekrs	O
linked	O
to	O
the	O
gnee	O
for	O
Duhcenne	B-Disease
muscluar	I-Disease
dysrtophy	I-Disease
.	O

Seventy	O
famiiles	O
with	O
Ducehnne	B-Disease
muscluar	I-Disease
dystrpohy	I-Disease
(	O
DMD	B-Disease
)	O
known	O
to	O
the	O
Intsitute	O
of	O
Chlid	O
Heatlh	O
fall	O
into	O
three	O
cateogries	O
with	O
respect	O
to	O
poetntial	O
linakge	O
analyiss	O
with	O
the	O
X	O
crhomosome	O
DNA	O
makrers	O
RC8	O
and	O
L1	O
.	O

28	O
that	O
brdige	O
the	O
DMD	B-Disease
gnee	O
.	O

Faimlies	O
in	O
which	O
there	O
is	O
at	O
least	O
one	O
obligatory	O
feamle	O
heterozyogte	O
(	O
n	O
=	O
13	O
)	O
.	O

Here	O
prdeiction	O
and	O
exculsion	O
of	O
DMD	B-Disease
gnee	O
trnasmission	O
may	O
be	O
possible	O
,	O
the	O
accurcay	O
being	O
deepndent	O
on	O
the	O
colseness	O
of	O
the	O
lnikage	O
of	O
the	O
DNA	O
makrer	O
(	O
s	O
)	O
to	O
the	O
DMD	B-Disease
gnee	O
;	O
an	O
illustrative	O
csae	O
is	O
reported	O
.	O

Famiiles	O
in	O
which	O
there	O
is	O
a	O
single	O
affetced	O
boy	O
,	O
who	O
also	O
has	O
one	O
or	O
more	O
healhty	O
brtohers	O
(	O
n	O
=	O
26	O
)	O
.	O

Given	O
an	O
informatvie	O
retsriction	O
frgament	O
lentgh	O
polymrophism	O
(	O
RLFP	O
)	O
,	O
the	O
probabiltiy	O
that	O
the	O
boy	O
represents	O
a	O
new	O
mutaiton	O
can	O
be	O
reassesesd	O
;	O
it	O
is	O
also	O
possible	O
to	O
exclude	O
the	O
DMD	B-Disease
gnee	O
in	O
a	O
sisetr	O
.	O

Famiiles	O
with	O
a	O
single	O
afefcted	O
boy	O
with	O
no	O
brtoher	O
(	O
n	O
=	O
30	O
)	O
.	O

Here	O
exlcusion	O
of	O
the	O
DMD	B-Disease
gnee	O
in	O
a	O
ssiter	O
may	O
be	O
possible	O
.	O

Only	O
in	O
one	O
faimly	O
was	O
there	O
no	O
possibility	O
of	O
useful	O
liknage	O
analyiss	O
.	O

The	O
linkgae	O
anaylsis	O
required	O
is	O
described	O
,	O
and	O
the	O
need	O
to	O
check	O
DMD	B-Disease
faimlies	O
for	O
informaitve	O
RLFPs	O
is	O
stressed	O
.	O

Faimly	O
stuides	O
in	O
Bechteerw	B-Disease
'	I-Disease
s	I-Disease
sydnrome	I-Disease
(	O
anklyosing	B-Disease
sopndylitis	I-Disease
)	O
III	O
.	O

Gneetics	O
.	O

The	O
resluts	O
of	O
segregtaion	O
analsyes	O
in	O
75	O
faimlies	O
where	O
the	O
proabnd	O
had	O
aknylosing	B-Disease
spondyltiis	I-Disease
,	O
are	O
presented	O
.	O

Of	O
the	O
278	O
audlt	O
,	O
livnig	O
first	O
degere	O
reltaives	O
,	O
approximately	O
85	O
%	O
cooperated	O
in	O
the	O
sutdy	O
.	O

Cliincal	O
and	O
radiorgaphical	O
examinaitons	O
were	O
performed	O
and	O
HLA	O
tpying	O
was	O
conducted	O
.	O

The	O
resutls	O
were	O
in	O
agreement	O
with	O
our	O
hypohtesis	O
that	O
ankyolsing	B-Disease
spondyiltis	I-Disease
is	O
part	O
of	O
a	O
syndorme	O
where	O
different	O
geneitc	O
factros	O
intearct	O
.	O

Such	O
known	O
facotrs	O
are	O
HLA	O
B27	O
associated	O
disaese	O
sucseptibility	O
,	O
susceptibiilty	O
to	O
posriatic	B-Disease
atrhropathy	I-Disease
and	O
susecptibility	O
to	O
entero	B-Disease
-	I-Disease
arthorpathy	I-Disease
.	O

Radiograpihcal	O
sarco	B-Disease
-	I-Disease
iliiits	I-Disease
was	O
restricted	O
to	O
HLA	O
B27	O
psoitive	O
reltaives	O
,	O
and	O
was	O
more	O
frequently	O
found	O
in	O
rleatives	O
to	O
proabnds	O
with	O
psoirasis	B-Disease
than	O
in	O
relatievs	O
to	O
probadns	O
without	O
psoraisis	B-Disease
.	O

Environmenatl	O
factros	O
(	O
intesitnal	O
bacetria	O
)	O
are	O
known	O
to	O
trigger	O
the	O
disesae	O
at	O
least	O
in	O
some	O
pesrons	O
,	O
and	O
we	O
have	O
postulated	O
that	O
all	O
or	O
most	O
of	O
them	O
have	O
the	O
prdeisposition	O
to	O
develop	O
dsiease	O
.	O

Thus	O
,	O
the	O
syndorme	O
has	O
a	O
multifactorail	O
etiloogy	O
.	O

The	O
pheontypic	O
expressoins	O
of	O
the	O
different	O
genteic	O
preidspositions	O
involved	O
,	O
include	O
scaro	B-Disease
-	I-Disease
iilitis	I-Disease
,	O
psoraisis	B-Disease
,	O
actue	B-Disease
anteiror	I-Disease
uvetiis	I-Disease
,	O
peripehral	O
arhtropathy	B-Disease
and	O
inflammatory	B-Disease
boewl	I-Disease
disesae	I-Disease
.	O

We	O
suggest	O
the	O
descriptive	O
name	O
HERDEITARY	B-Disease
MUTLIFOCAL	I-Disease
RELPASING	I-Disease
INFLAMMATION	I-Disease
(	O
HMERI	B-Disease
)	O
for	O
this	O
sydnrome	O
.	O

Ankyolsing	B-Disease
spondyliits	I-Disease
,	O
psoraitic	B-Disease
arthroapthy	I-Disease
and	O
entero	B-Disease
-	I-Disease
artrhopathy	I-Disease
may	O
be	O
regarded	O
as	O
clincial	O
sub	O
-	O
types	O
of	O
the	O
syndorme	O
.	O
.	O

Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
synrdome	I-Disease
and	O
chormosome	O
15	O
.	O

A	O
cliniacl	O
discussion	O
of	O
20	O
caess	O
.	O

A	O
chrmoosome	B-Disease
15	I-Disease
anomlay	I-Disease
was	O
observed	O
in	O
12	O
of	O
20	O
pateints	O
,	O
17	O
of	O
whom	O
were	O
cilnically	O
ssupected	O
of	O
having	O
Parder	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
(	O
PWS	B-Disease
)	O
.	O

The	O
cilnical	O
feautres	O
of	O
eight	O
csaes	O
with	O
15q11	O
-	O
12	O
deleiton	O
were	O
very	O
similar	O
to	O
those	O
originally	O
described	O
in	O
PWS	B-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
gorup	O
of	O
noraml	O
karyoytpe	O
pateints	O
is	O
hteerogeneous	O
,	O
and	O
their	O
faetures	O
do	O
not	O
strictly	O
correspond	O
to	O
the	O
clincial	O
deifnition	O
of	O
PWS	B-Disease
.	O

However	O
,	O
the	O
hypohtesis	O
that	O
PWS	B-Disease
is	O
associated	O
with	O
deeltion	O
of	O
15q11	O
-	O
12	O
can	O
neither	O
explain	O
the	O
apparently	O
baalnced	O
transolcations	O
of	O
chroomsome	O
15	O
nor	O
account	O
for	O
the	O
small	O
superunmerary	O
metacentirc	O
chromosmoes	O
corresponding	O
to	O
an	O
isohcromosome	O
15	O
for	O
bnad	O
15q11	O
observed	O
in	O
some	O
csaes	O
.	O
.	O

The	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
gnee	O
in	O
Nroth	O
Ameircan	O
Jweish	O
popultaions	O
:	O
goegraphic	O
variatoins	O
and	O
oriign	O
.	O

From	O
dtaa	O
collected	O
in	O
a	O
Notrh	O
Aemrican	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
diesase	I-Disease
(	O
TSD	B-Disease
)	O
heterozyogte	O
screennig	O
porgram	O
,	O
the	O
TSD	B-Disease
carreir	O
frequnecy	O
among	O
46	O
,	O
304	O
Jewsih	O
indiivduals	O
was	O
found	O
to	O
be	O
.	O

0324	O
(	O
1	O
in	O
31	O
indviiduals	O
)	O
.	O

This	O
frequnecy	O
is	O
consistent	O
with	O
earlier	O
estmiates	O
based	O
on	O
TSD	B-Disease
incidecne	O
dtaa	O
.	O

TSD	B-Disease
carirer	O
frequnecies	O
were	O
then	O
examined	O
by	O
single	O
cuontry	O
and	O
single	O
reigon	O
of	O
oriign	O
in	O
28	O
,	O
029	O
Jwes	O
within	O
this	O
samlpe	O
for	O
whom	O
such	O
dtaa	O
were	O
available	O
for	O
analsyis	O
.	O

Jwes	O
with	O
Polsih	O
and	O
/	O
or	O
Rusisan	O
anecstry	O
constituted	O
88	O
%	O
of	O
this	O
samlpe	O
and	O
had	O
a	O
TSD	B-Disease
carrier	O
ferquency	O
of	O
.	O

0327	O
.	O

No	O
TSD	B-Disease
carirers	O
were	O
observed	O
among	O
the	O
166	O
Jwes	O
of	O
Naer	O
Eastren	O
oirgins	O
.	O

Realtive	O
to	O
Jwes	O
of	O
Poilsh	O
and	O
Rsusian	O
orgiins	O
,	O
there	O
was	O
at	O
least	O
a	O
twofold	O
icnrease	O
in	O
the	O
TSD	B-Disease
carirer	O
frequnecy	O
in	O
Jwes	O
of	O
Austrain	O
,	O
Hungairan	O
,	O
and	O
Czechoslovkaian	O
oirgins	O
(	O
P	O
less	O
than	O
.	O
005	O
)	O
.	O

These	O
findigns	O
suggest	O
that	O
the	O
TSD	B-Disease
gnee	O
porliferated	O
among	O
the	O
antecdeents	O
of	O
modern	O
Ashkenzai	O
Jwery	O
after	O
the	O
Second	O
Diapsora	O
(	O
70	O
A	O
.	O
D	O
.	O
)	O
and	O
before	O
their	O
major	O
migrtaions	O
to	O
reigons	O
of	O
Poalnd	O
and	O
Rsusia	O
(	O
before	O
1100	O
A	O
.	O
D	O
.	O
)	O
.	O

Huamn	O
dfeiciency	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
ptaient	O
with	O
menignococcal	B-Disease
mennigitis	I-Disease
and	O
no	O
haemostaiss	B-Disease
abnormaltiy	I-Disease
.	O

A	O
csae	O
of	O
huamn	O
complete	O
C6	B-Disease
defciiency	I-Disease
is	O
reported	O
.	O

The	O
pateint	O
,	O
a	O
31	O
yaer	O
old	O
wihte	O
mlae	O
,	O
was	O
seen	O
on	O
the	O
occasion	O
of	O
an	O
isloated	O
eipsode	O
of	O
meninogcoccal	B-Disease
mennigitis	I-Disease
.	O

Sreum	O
complement	O
hemolyitc	O
and	O
bactericdial	O
activtiies	O
were	O
lacking	O
and	O
could	O
be	O
rsetored	O
to	O
nromal	O
by	O
addition	O
of	O
appropriate	O
amounts	O
of	O
pruified	O
C6	O
.	O

No	O
hemosttaic	B-Disease
abonrmalities	I-Disease
were	O
observed	O
.	O
.	O

Asbence	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
ptaient	O
with	O
crhonic	B-Disease
mennigococcemia	I-Disease
presenitng	O
as	O
vascultiis	B-Disease
.	O

A	O
previously	O
haelthy	O
40	O
-	O
yaer	O
-	O
old	O
man	O
preesnting	O
with	O
feevr	B-Disease
,	O
arthirtis	B-Disease
,	O
and	O
cutanoeus	B-Disease
vasculiits	I-Disease
was	O
found	O
to	O
have	O
crhonic	B-Disease
meningoocccemia	I-Disease
.	O

Evalaution	O
of	O
his	O
complement	O
sysetm	O
showed	O
an	O
absecne	O
of	O
functoinal	O
and	O
antigeinc	O
C7	O
,	O
compatible	O
with	O
a	O
complete	O
deficinecy	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

Stduy	O
of	O
the	O
pateints	O
faimly	O
spanning	O
four	O
genreations	O
showed	O
heterzoygous	O
deifciency	B-Disease
of	I-Disease
C7	I-Disease
in	O
five	O
memebrs	O
.	O

Chroinc	B-Disease
neissreial	I-Disease
inefction	I-Disease
can	O
be	O
associated	O
with	O
C7	B-Disease
dfeiciency	I-Disease
and	O
must	O
be	O
distinguished	O
from	O
other	O
causes	O
of	O
cuatneous	B-Disease
vascuiltis	I-Disease
.	O
.	O

Famiilal	B-Disease
disciod	I-Disease
lpuus	I-Disease
erythemaotsus	I-Disease
associated	O
with	O
heteroyzgote	O
C2	B-Disease
defciiency	I-Disease
.	O

Two	O
siblnigs	O
with	O
chrnoic	B-Disease
dicsoid	I-Disease
luups	I-Disease
erytehmatosus	I-Disease
and	O
several	O
famliy	O
membres	O
were	O
found	O
with	O
heetrozygous	O
C2	B-Disease
deficeincy	I-Disease
.	O

An	O
association	O
with	O
histcoompatibility	O
marekrs	O
HLA	O
-	O
B18	O
and	O
HLA	O
-	O
Dw2	O
was	O
demonstrated	O
,	O
and	O
the	O
slow	O
allotype	O
of	O
fatcor	O
B	O
was	O
present	O
.	O

Lnikage	O
stduies	O
in	O
this	O
faimly	O
suggested	O
a	O
close	O
linkgae	O
between	O
the	O
C2	B-Disease
deifciency	I-Disease
gnee	O
and	O
gnees	O
codnig	O
for	O
B18	O
,	O
Dw2	O
,	O
and	O
BfS	O
anitgens	O
.	O

One	O
HLA	O
-	O
ACB	O
/	O
DBf	O
recobminant	O
was	O
observed	O
showing	O
closer	O
linkgae	O
between	O
HLA	O
-	O
D	O
and	O
Bf	O
than	O
between	O
HLA	O
-	O
B	O
and	O
Bf	O
.	O
.	O

Sveere	B-Disease
-	I-Disease
gulcose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphtae	I-Disease
dehydroegnase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
associated	O
with	O
chrnoic	O
hemoyltic	B-Disease
aenmia	I-Disease
,	O
granluocyte	B-Disease
dysfuntcion	I-Disease
,	O
and	O
incerased	O
sucseptibility	O
to	O
infecitons	O
:	O
description	O
of	O
a	O
new	O
molceular	O
varaint	O
(	O
GP6D	O
Barcleona	O
)	O
.	O

Molceular	O
,	O
kineitc	O
,	O
and	O
fnuctional	O
studeis	O
were	O
carried	O
out	O
on	O
erythorcytes	O
and	O
lekuocytes	O
in	O
a	O
Sapnish	O
mlae	O
with	O
GP6D	B-Disease
deficinecy	I-Disease
,	O
congeniatl	B-Disease
nonspheorcytic	I-Disease
hmeolytic	I-Disease
aneima	I-Disease
(	O
CNHSA	B-Disease
)	O
,	O
and	O
incraesed	O
susceptibiltiy	O
to	O
infectinos	O
.	O

GP6D	O
atcivity	O
was	O
abesnt	O
in	O
ptaients	O
red	O
cells	O
and	O
was	O
about	O
2	O
%	O
of	O
nromal	O
in	O
leukoctyes	O
.	O

Molceular	O
studeis	O
using	O
stanadrd	O
metohds	O
(	O
WHO	O
,	O
1967	O
)	O
showed	O
GP6D	O
in	O
the	O
pateint	O
to	O
have	O
a	O
slightly	O
fast	O
electrophroetic	O
moiblity	O
at	O
pH	O
8	O
.	O

0	O
with	O
otherwise	O
nromal	O
propetries	O
(	O
haet	O
staiblity	O
at	O
46	O
degrees	O
C	O
,	O
apaprent	O
affintiy	O
for	O
susbtrates	O
,	O
optiumm	O
pH	O
,	O
and	O
utiilzation	O
of	O
subtsrate	O
analogeus	O
)	O
.	O

Other	O
tsets	O
showed	O
the	O
pateints	O
grnaulocytes	O
to	O
enuglf	O
ltaex	O
patricles	O
normally	O
,	O
but	O
to	O
have	O
ipmaired	O
redutcion	O
of	O
ntiroblue	O
tetraozlium	O
and	O
ferriyctochrome	O
-	O
c	O
as	O
well	O
as	O
redcued	O
iodinaiton	O
.	O

Chemotaixs	O
and	O
radnom	O
mirgation	O
of	O
the	O
patinets	O
garnulocytes	O
were	O
nromal	O
as	O
were	O
myelopreoxidase	O
,	O
luekocyte	O
aklaline	O
phosphatsae	O
(	O
LAP	O
)	O
,	O
and	O
ultrastrutcural	O
featuers	O
.	O

The	O
molceular	O
characterisitcs	O
of	O
GP6D	O
in	O
the	O
ptaient	O
difefred	O
from	O
those	O
of	O
all	O
previously	O
reported	O
varinats	O
associated	O
with	O
CSNHA	B-Disease
,	O
so	O
the	O
present	O
varaint	O
was	O
provisionally	O
called	O
GP6D	O
Barcelnoa	O
to	O
distinguish	O
it	O
from	O
other	O
GP6D	O
vairants	O
previously	O
described	O
.	O

Possible	O
mecahnisms	O
for	O
the	O
sveere	O
deifciency	B-Disease
of	I-Disease
GP6D	I-Disease
in	O
erythorcytes	O
and	O
granuloctyes	O
was	O
invsetigated	O
by	O
sutdies	O
on	O
the	O
immunoloigc	O
specific	O
actviity	O
of	O
the	O
mtuant	O
enyzme	O
.	O

Glucsoe	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phoshpate	I-Disease
deyhdrogenase	I-Disease
dfeiciency	I-Disease
in	O
Ppaua	O
New	O
Giunea	O
.	O

The	O
description	O
of	O
13	O
new	O
variatns	O
.	O

A	O
total	O
of	O
362	O
mlaes	O
from	O
various	O
reginos	O
of	O
Ppaua	O
New	O
Guiena	O
were	O
screened	O
for	O
red	O
clel	O
gulcose	O
-	O
6	O
-	O
phoshpate	O
dehydorgenase	O
(	O
GP6D	O
)	O
acitvity	O
.	O

Twenty	O
-	O
six	O
GP6D	B-Disease
defciient	I-Disease
indiivduals	O
were	O
identifeid	O
.	O

Biochemiacl	O
characterziation	O
of	O
GP6D	O
puriifed	O
from	O
these	O
subjetcs	O
has	O
revaeled	O
13	O
new	O
variatns	O
and	O
several	O
coipes	O
of	O
previously	O
described	O
forms	O
of	O
GP6D	O
.	O

This	O
sutdy	O
illustrates	O
the	O
extreme	O
heteorgeneity	O
of	O
GP6D	B-Disease
deficinecy	I-Disease
among	O
the	O
pepole	O
of	O
Paupa	O
New	O
Guiena	O
.	O
.	O

Heetrogeneity	O
of	O
"	O
Medietrranean	O
tpye	O
"	O
glucsoe	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphtae	I-Disease
dehydrogeanse	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficeincy	I-Disease
in	O
Sapin	O
and	O
description	O
of	O
two	O
new	O
varaints	O
associated	O
with	O
fvaism	B-Disease
.	O

Glucsoe	O
-	O
6	O
-	O
phopshate	O
dehydrogeanse	O
(	O
GP6D	O
)	O
;	O
EC	O
1	O
.	O

1	O
.	O

1	O
.	O

49	O
from	O
thirty	O
-	O
six	O
unrelated	O
Spnaish	O
mlaes	O
was	O
paritally	O
puriifed	O
from	O
blood	O
,	O
and	O
the	O
vairants	O
were	O
chraacterized	O
biocheimcally	O
and	O
electorphoretically	O
according	O
to	O
the	O
mehtods	O
recommedned	O
by	O
the	O
world	O
Heatlh	O
Organiztaion	O
.	O

Subjcets	O
were	O
from	O
multilpe	O
geogrpahic	O
regoins	O
within	O
Sapin	O
,	O
and	O
all	O
suffered	O
from	O
hemoyltic	B-Disease
anmeia	I-Disease
,	O
either	O
actue	O
(	O
34	O
caess	O
)	O
or	O
crhonic	O
nonspheroyctic	O
(	O
2	O
csaes	O
)	O
.	O

Almost	O
all	O
the	O
varinats	O
studied	O
presented	O
resdiual	O
erythroycte	O
GP6D	O
atcivity	O
ranging	O
from	O
0	O
to	O
10	O
%	O
of	O
nromal	O
,	O
and	O
five	O
different	O
muatnts	O
were	O
responsible	O
for	O
the	O
deficeint	O
phenotpye	O
.	O

Three	O
vairants	O
were	O
similar	O
to	O
others	O
previously	O
described	O
GP6D	O
Meditreranean	O
(	O
11	O
csaes	O
)	O
,	O
GP6D	O
Athnes	O
-	O
like	O
(	O
3	O
caess	O
)	O
,	O
and	O
GP6D	O
Unoin	O
(	O
2	O
caess	O
)	O
.	O

The	O
remaining	O
varinats	O
were	O
different	O
from	O
the	O
numerous	O
varaints	O
already	O
reported	O
and	O
have	O
been	O
considered	O
as	O
new	O
mtuants	O
.	O

Proivsionally	O
they	O
are	O
called	O
GP6D	O
Betcia	O
(	O
19	O
caess	O
)	O
and	O
GP6D	O
Menocra	O
(	O
1	O
csae	O
)	O
.	O

The	O
present	O
stduy	O
constitutes	O
the	O
first	O
attempt	O
to	O
characterize	O
the	O
deifcient	B-Disease
GP6D	I-Disease
varinats	O
found	O
in	O
Sapin	O
and	O
spuplies	O
new	O
dtaa	O
on	O
the	O
relaitonship	O
between	O
molecualr	O
charactersitics	O
of	O
deficinet	O
variatns	O
and	O
their	O
cilnical	O
manfiestations	O
.	O

The	O
most	O
important	O
finidngs	O
can	O
be	O
summarized	O
as	O
follows	O
(	O
1	O
)	O
The	O
Sapnish	O
popultaion	O
is	O
charatcerized	O
by	O
an	O
important	O
heterogeenity	O
in	O
GP6D	B-Disease
deficinecy	I-Disease
.	O

(	O
2	O
)	O
Although	O
GP6D	O
Mdeiterranean	O
is	O
very	O
frequnet	O
,	O
it	O
presents	O
a	O
relatively	O
high	O
degere	O
of	O
polyomrphism	O
.	O

(	O
3	O
)	O
Fvaism	B-Disease
has	O
been	O
observed	O
associated	O
with	O
all	O
kinds	O
of	O
vraiants	O
described	O
here	O
.	O

(	O
4	O
)	O
GP6D	O
Betcia	O
,	O
which	O
is	O
the	O
most	O
frqeuent	O
vairant	O
found	O
in	O
sbujects	O
of	O
Sotuhern	O
Sapnish	O
oirgin	O
,	O
has	O
been	O
observed	O
associated	O
with	O
faivsm	B-Disease
in	O
all	O
caess	O
except	O
one	O
.	O

A	O
new	O
gulcose	O
-	O
6	O
-	O
phoshpate	O
dehyrdogenase	O
varaint	O
(	O
GP6D	O
Ngaano	O
)	O
associated	O
with	O
congeniatl	B-Disease
hemoltyic	I-Disease
aenmia	I-Disease
.	O

A	O
new	O
gulcose	O
-	O
6	O
-	O
phopshate	O
dehydrogensae	O
(	O
GP6D	O
)	O
vairant	O
associated	O
with	O
crhonic	B-Disease
nonspheroctyic	I-Disease
hemloytic	I-Disease
aenmia	I-Disease
was	O
reported	O
.	O

The	O
ptaient	O
,	O
a	O
6	O
-	O
yaer	O
-	O
old	O
Jpaanese	O
mlae	O
,	O
was	O
noticed	O
to	O
have	O
hemloytic	B-Disease
aenmia	I-Disease
soon	O
after	O
bitrh	O
,	O
and	O
a	O
diagonsis	O
of	O
GP6D	B-Disease
deficeincy	I-Disease
was	O
made	O
at	O
the	O
age	O
of	O
2	O
.	O

He	O
had	O
episdoes	O
of	O
hmeolytic	B-Disease
cirsis	I-Disease
several	O
times	O
after	O
upper	B-Disease
respiratroy	I-Disease
inefction	I-Disease
.	O

GP6D	O
actviity	O
of	O
the	O
ptaient	O
was	O
5	O
.	O

5	O
%	O
of	O
nomral	O
.	O

The	O
enyzmatic	O
chaarcteristics	O
were	O
examined	O
when	O
he	O
was	O
5	O
yaers	O
old	O
,	O
and	O
his	O
GP6D	O
showed	O
faster	O
-	O
than	O
-	O
nomral	O
electrophoreitc	O
moiblity	O
,	O
low	O
Km	O
G6P	O
,	O
high	O
Km	O
NDAP	O
,	O
low	O
Ki	O
NDAPH	O
,	O
nromal	O
utiilzation	O
of	O
subsrtate	O
anlaogues	O
,	O
haet	O
instaiblity	O
,	O
and	O
a	O
nomral	O
pH	O
optmium	O
cuvre	O
.	O

From	O
these	O
resluts	O
,	O
this	O
was	O
considered	O
to	O
be	O
a	O
new	O
vraiant	O
and	O
was	O
designated	O
GP6D	O
Nagnao	O
.	O

Infeciton	O
-	O
idnuced	O
hemolsyis	B-Disease
and	O
chroinc	B-Disease
hemoltyic	I-Disease
aneima	I-Disease
seem	O
to	O
be	O
due	O
to	O
markedly	O
impiared	O
eznyme	O
activtiy	O
and	O
tehrmal	O
instabiltiy	O
.	O

Hetreozygous	O
C2	B-Disease
-	I-Disease
deficiecny	I-Disease
and	O
myastehnia	B-Disease
grvais	I-Disease
.	O

Comlpement	B-Disease
dfeiciency	I-Disease
states	O
in	O
myastehnia	B-Disease
garvis	I-Disease
(	O
MG	B-Disease
)	O
have	O
not	O
been	O
reported	O
previously	O
.	O

We	O
describe	O
a	O
19	O
-	O
yaer	O
-	O
old	O
woamn	O
with	O
typical	O
MG	B-Disease
and	O
heterozyguos	O
C2	B-Disease
dfeiciency	I-Disease
,	O
along	O
with	O
HLA	O
tpying	O
of	O
the	O
paitent	O
and	O
her	O
immdeiate	O
fmaily	O
.	O
.	O

Adrenoleukodystorphy	B-Disease
:	O
icnreased	O
plsama	O
cotnent	O
of	O
sautrated	O
very	O
long	O
chian	O
fatty	O
acdis	O
.	O

With	O
a	O
new	O
mtehod	O
we	O
meausred	O
the	O
saturaetd	O
very	O
long	O
cahin	O
fatty	O
acdis	O
in	O
the	O
plsama	O
of	O
adrenoleukodytsrophy	B-Disease
(	O
ALD	B-Disease
)	O
hemizygoets	O
,	O
ALD	B-Disease
heterozgyotes	O
,	O
and	O
cnotrols	O
.	O

ALD	B-Disease
hmeizygotes	O
showed	O
increaesd	O
levles	O
of	O
heaxcosanoate	O
(	O
C26	O
fatty	O
aicd	O
)	O
which	O
represented	O
0	O
.	O

081	O
+	O
/	O
-	O
0	O
.	O

0066	O
%	O
(	O
SEM	O
)	O
of	O
total	O
ftaty	O
aicds	O
,	O
compraed	O
to	O
0	O
.	O

015	O
+	O
/	O
-	O
0	O
.	O

0032	O
%	O
in	O
the	O
contorls	O
.	O

C25	O
,	O
C24	O
,	O
and	O
C23	O
ftaty	O
acdis	O
were	O
also	O
incraesed	O
,	O
but	O
the	O
C22	O
and	O
C20	O
fatty	O
acdis	O
were	O
noraml	O
.	O

C26	O
lveels	O
were	O
also	O
icnreased	O
in	O
most	O
ALD	B-Disease
hetreozygotes	O
,	O
with	O
a	O
mean	O
leevl	O
0	O
.	O

057	O
+	O
/	O
-	O
0	O
.	O

0063	O
%	O
of	O
total	O
fatty	O
acdis	O
.	O

The	O
techniuqe	O
can	O
be	O
used	O
for	O
diangosis	O
and	O
crarier	O
identificaiton	O
,	O
and	O
in	O
the	O
evalutaion	O
of	O
tehrapy	O
.	O

Anbormal	O
high	O
denstiy	O
lipoproetins	O
in	O
cerebrotendionus	B-Disease
xanthmoatosis	I-Disease
.	O

The	O
plamsa	O
liporpotein	O
proflies	O
and	O
high	O
dnesity	O
lipoprotenis	O
(	O
HDL	O
)	O
were	O
charcaterized	O
in	O
ptaients	O
with	O
the	O
gneetic	B-Disease
diesase	I-Disease
cerberotendinous	B-Disease
xanthomaotsis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

Anbormalities	B-Disease
in	I-Disease
the	I-Disease
HDL	I-Disease
may	O
contribute	O
to	O
their	O
incraesed	O
atherogeensis	O
and	O
excesisve	O
depoists	O
of	O
tisuse	O
steorls	O
in	O
the	O
presecne	O
of	O
low	O
or	O
low	O
-	O
noraml	O
cnocentrations	O
of	O
plsama	O
cholesteorl	O
(	O
165	O
+	O
/	O
-	O
25	O
mg	O
/	O
dl	O
)	O
and	O
low	O
denstiy	O
lipoprotenis	O
(	O
LDL	O
)	O
.	O

The	O
mean	O
HDL	O
-	O
cholesetrol	O
concentraiton	O
in	O
the	O
CTX	B-Disease
plsamas	O
was	O
14	O
.	O

5	O
+	O
/	O
-	O
3	O
.	O

2	O
mg	O
/	O
dl	O
,	O
about	O
one	O
-	O
third	O
the	O
noraml	O
value	O
.	O

The	O
low	O
HDL	O
-	O
cholestreol	O
reflects	O
a	O
low	O
concentraiton	O
and	O
an	O
anbormal	O
liipd	O
cmoposition	O
of	O
the	O
plamsa	O
HDL	O
.	O

Realtive	O
to	O
nromal	O
HDL	O
,	O
the	O
cholesetryl	O
esetrs	O
are	O
low	O
,	O
free	O
cholseterol	O
and	O
phsopholipids	O
essentially	O
nromal	O
,	O
and	O
tirglycerides	O
incresaed	O
.	O

The	O
raito	O
of	O
apoproetin	O
(	O
apo	O
)	O
to	O
total	O
chloesterol	O
in	O
the	O
HDL	O
of	O
CTX	B-Disease
was	O
two	O
to	O
three	O
times	O
greater	O
than	O
nomral	O
.	O

In	O
the	O
CTX	B-Disease
HDL	O
,	O
the	O
rtaio	O
of	O
aopAI	O
to	O
aopAII	O
was	O
high	O
,	O
the	O
proportoin	O
of	O
aopC	O
low	O
,	O
and	O
a	O
normally	O
minor	O
form	O
of	O
apAoI	O
incerased	O
relative	O
to	O
other	O
forms	O
.	O

The	O
HDL	O
in	O
eelctron	O
microrgaphs	O
appeared	O
noraml	O
morphoolgically	O
and	O
in	O
paritcle	O
szie	O
.	O

The	O
abnormaliteis	O
in	O
lipoportein	O
distrbiution	O
prfoile	O
and	O
compostiion	O
of	O
the	O
palsma	O
HDL	O
result	O
from	O
metaoblic	O
defcets	O
that	O
are	O
not	O
understood	O
but	O
may	O
be	O
linked	O
to	O
the	O
geneitc	B-Disease
dfeect	I-Disease
in	O
blie	O
aicd	O
syntehsis	O
in	O
CTX	B-Disease
.	O

As	O
a	O
consequence	O
,	O
it	O
is	O
probable	O
that	O
the	O
nomral	O
functoins	O
of	O
the	O
HDL	O
,	O
possibly	O
including	O
modulaiton	O
of	O
LDL	O
-	O
cholseterol	O
uptkae	O
and	O
the	O
reomval	O
of	O
execss	O
cholestreol	O
from	O
peirpheral	O
tissues	O
,	O
are	O
petrurbed	O
significantly	O
in	O
this	O
disaese	O
.	O

Genetcis	O
of	O
cerebroetndinous	B-Disease
xanthomaotsis	I-Disease
(	O
CTX	B-Disease
)	O
:	O
an	O
autosoaml	O
recesisve	O
tarit	O
with	O
high	O
gnee	O
ferquency	O
in	O
Sepharidm	O
of	O
Morcocan	O
oirgin	O
.	O

We	O
described	O
6	O
pateints	O
(	O
from	O
3	O
famiiles	O
)	O
affecetd	O
with	O
cerebrotenidnous	B-Disease
xanthoamtosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

All	O
are	O
Sepahrdic	O
Jwes	O
of	O
Morcocan	O
etxraction	O
.	O

In	O
view	O
of	O
the	O
small	O
number	O
of	O
CTX	B-Disease
patinets	O
diagnsoed	O
in	O
the	O
world	O
(	O
a	O
total	O
of	O
50	O
including	O
our	O
6	O
paitents	O
)	O
,	O
we	O
are	O
probably	O
dealing	O
with	O
an	O
ehtnic	O
sugbroup	O
with	O
a	O
high	O
CTX	O
gnee	O
frqeuency	O
,	O
which	O
we	O
have	O
esitmated	O
to	O
be	O
1	O
/	O
108	O
.	O

Since	O
there	O
are	O
diffeernces	O
in	O
expresison	O
in	O
this	O
diesase	O
,	O
we	O
recommend	O
cohlestanol	O
stduy	O
in	O
csaes	O
of	O
undiagnoesd	O
ctaaract	B-Disease
or	O
tnedinous	B-Disease
xanhtomas	I-Disease
in	O
childhood	O
or	O
eraly	O
adolescnece	O
.	O

The	O
daignosis	O
in	O
CTX	B-Disease
is	O
important	O
not	O
only	O
for	O
geentic	O
counseilng	O
,	O
but	O
also	O
in	O
view	O
of	O
possible	O
treamtent	O
.	O
.	O

New	O
geneitc	O
vairants	O
of	O
gluocse	O
6	O
-	O
phsophate	O
dehydorgenase	O
(	O
GP6D	O
)	O
in	O
Iatly	O
.	O

Six	O
new	O
variatns	O
of	O
huamn	O
erythrcoyte	O
GP6D	O
have	O
been	O
characetrized	O
.	O

All	O
of	O
them	O
were	O
found	O
in	O
Itailan	O
mlaes	O
and	O
all	O
were	O
associated	O
with	O
eznyme	B-Disease
defiicency	I-Disease
,	O
but	O
only	O
two	O
with	O
sings	O
of	O
haemloysis	B-Disease
.	O

These	O
and	O
other	O
vairants	O
reported	O
in	O
the	O
literautre	O
,	O
which	O
must	O
thus	O
far	O
be	O
regarded	O
as	O
spordaic	O
,	O
are	O
found	O
to	O
map	O
in	O
prats	O
of	O
Iatly	O
where	O
common	O
types	O
of	O
GP6D	B-Disease
defciiency	I-Disease
are	O
also	O
prevalnet	O
.	O
.	O

Variatns	O
of	O
erythroctye	O
glcuose	O
-	O
6	O
-	O
phsophate	O
dehydrogeanse	O
(	O
GP6D	O
)	O
in	O
Blugarian	O
populatinos	O
.	O

Ten	O
vairants	O
of	O
erythroctye	O
gluocse	O
-	O
6	O
-	O
phoshpate	O
dehydrognease	O
were	O
idenitfied	O
in	O
22	O
patinets	O
with	O
GP6D	B-Disease
deficinecy	I-Disease
from	O
three	O
distrcits	O
of	O
Buglaria	O
.	O

Coirnth	O
-	O
like	O
and	O
Fyaoum	O
-	O
like	O
varaints	O
were	O
the	O
most	O
frqeuent	O
;	O
Mdeiterranean	O
,	O
Ouht	O
II	O
,	O
Kligore	O
,	O
Bosotn	O
,	O
Pozann	O
,	O
and	O
Pnaay	O
varaints	O
and	O
two	O
new	O
vairants	O
,	O
Pertich	O
and	O
Gtoze	O
Declhev	O
,	O
were	O
each	O
found	O
in	O
one	O
or	O
two	O
crariers	O
.	O

No	O
crorelation	O
was	O
reveaeld	O
between	O
clniical	O
and	O
biochmeical	O
polmyorphism	O
.	O
.	O

Nehpropathy	B-Disease
in	O
the	O
Wiksott	B-Disease
-	I-Disease
Alrdich	I-Disease
snydrome	I-Disease
.	O

Npehropathy	B-Disease
was	O
dteected	O
in	O
five	O
of	O
32	O
patinets	O
with	O
the	O
Wisoktt	B-Disease
-	I-Disease
Aldrcih	I-Disease
sydnrome	I-Disease
who	O
were	O
participating	O
in	O
a	O
sutdy	O
of	O
tranfser	O
fatcor	O
(	O
TF	O
)	O
thearpy	O
.	O

In	O
two	O
pateints	O
,	O
nehpropathy	B-Disease
was	O
present	O
before	O
TF	O
and	O
did	O
not	O
appear	O
changed	O
by	O
TF	O
thearpy	O
.	O

One	O
of	O
these	O
pateints	O
subsequently	O
developed	O
progerssive	O
rneal	B-Disease
faiulre	I-Disease
requiring	O
dialsyis	O
beginning	O
5	O
1	O
/	O
2	O
yaers	O
after	O
TF	O
therpay	O
.	O

In	O
two	O
ptaients	O
,	O
derceased	O
reanl	O
fucntion	O
appeared	O
very	O
soon	O
after	O
the	O
administrtaion	O
of	O
TF	O
.	O

One	O
patinet	O
showed	O
gradually	O
decreasnig	O
rneal	O
funciton	O
beginning	O
after	O
two	O
yeras	O
of	O
TF	O
therpay	O
.	O

An	O
additional	O
paitent	O
was	O
idenitfied	O
who	O
deid	O
with	O
rneal	B-Disease
faliure	I-Disease
without	O
having	O
received	O
TF	O
.	O

The	O
reuslts	O
suggest	O
that	O
reanl	B-Disease
failrue	I-Disease
occurs	O
in	O
the	O
Wsikott	B-Disease
-	I-Disease
Aldirch	I-Disease
sydnrome	I-Disease
more	O
frequently	O
than	O
generally	O
recognized	O
and	O
that	O
amdinistration	O
of	O
TF	O
may	O
percipitate	O
or	O
accleerate	O
the	O
rneal	B-Disease
disaese	I-Disease
in	O
ptaients	O
with	O
this	O
sydnrome	O
.	O
.	O

Wisktot	B-Disease
-	I-Disease
Aldirch	I-Disease
syndrmoe	I-Disease
:	O
cellluar	O
impairemnts	O
and	O
their	O
implication	O
for	O
carirer	O
detcetion	O
.	O

A	O
fmaily	O
in	O
which	O
two	O
mlae	O
silbings	O
were	O
affetced	O
with	O
Wiksott	B-Disease
-	I-Disease
Alrdich	I-Disease
syndorme	I-Disease
(	O
WAS	B-Disease
)	O
was	O
studied	O
using	O
G	O
-	O
6	O
-	O
PD	O
isoenyzmes	O
as	O
an	O
X	O
-	O
linked	O
mraker	O
in	O
order	O
to	O
investiagte	O
the	O
nature	O
of	O
cellualr	O
abnomralities	O
.	O

Isoltaed	O
periphreal	O
blood	O
clel	O
types	O
from	O
the	O
doubly	O
heteroyzgous	O
mtoher	O
of	O
the	O
afefcted	O
maels	O
seemingly	O
failed	O
to	O
express	O
the	O
G	O
-	O
6	O
-	O
PD	O
alelle	O
in	O
cis	O
psoition	O
with	O
the	O
WAS	B-Disease
alllee	O
while	O
her	O
cultrued	O
sikn	O
fbiroblasts	O
epxressed	O
both	O
G	O
-	O
6	O
-	O
PD	O
alelles	O
.	O

Additionally	O
,	O
a	O
hsitogram	O
analsyis	O
of	O
pltaelet	O
szie	O
reveaeld	O
a	O
single	O
popualtion	O
of	O
abnromally	O
small	O
platleets	O
in	O
the	O
affceted	O
proposiuts	O
,	O
whereas	O
the	O
heetrozygous	O
motehr	O
had	O
no	O
appreciable	O
small	O
plateelt	O
subpopulaiton	O
.	O

In	O
vitro	O
cultrue	O
of	O
hempooietic	O
porgenitor	O
cells	O
of	O
the	O
hetreozygous	O
mohter	O
showed	O
that	O
the	O
majority	O
of	O
proegnitor	O
cells	O
did	O
not	O
express	O
the	O
WAS	B-Disease
alllee	O
.	O

However	O
,	O
a	O
small	O
number	O
of	O
cells	O
exprsesing	O
the	O
G	O
-	O
6	O
-	O
PD	O
tpye	O
linked	O
with	O
the	O
WAS	B-Disease
alelle	O
were	O
detceted	O
.	O

The	O
porportion	O
of	O
the	O
latter	O
progenitros	O
was	O
significantly	O
higehr	O
among	O
more	O
primtiive	O
progenitros	O
(	O
those	O
giving	O
rise	O
to	O
later	O
appearing	O
cloonies	O
)	O
.	O

This	O
obesrvation	O
suggests	O
that	O
selcetion	O
against	O
cells	O
epxressing	O
the	O
Wsikott	B-Disease
-	I-Disease
Aldrcih	I-Disease
defcet	I-Disease
takes	O
place	O
in	O
the	O
hmeopoietic	O
sytsem	O
of	O
the	O
heetrozygous	O
feamle	O
and	O
offers	O
a	O
possible	O
means	O
of	O
crarier	O
detetcion	O
in	O
some	O
wmoen	O
.	O

Lnikage	O
stduies	O
in	O
this	O
fmaily	O
rveealed	O
one	O
example	O
of	O
probable	O
recomibnation	O
between	O
the	O
lcoi	O
for	O
WAS	B-Disease
and	O
G	O
-	O
6	O
-	O
PD	O
among	O
three	O
inofrmative	O
subejcts	O
,	O
suggesting	O
that	O
these	O
two	O
lcoi	O
may	O
not	O
be	O
closely	O
linked	O
on	O
the	O
X	O
-	O
chroomsome	O
.	O
.	O

A	O
new	O
CT	O
patetrn	O
in	O
adreonleukodystrophy	B-Disease
.	O

A	O
new	O
CT	O
ptatern	O
was	O
observed	O
in	O
2	O
patietns	O
with	O
adrenoleukodystrohpy	B-Disease
(	O
ALD	B-Disease
)	O
.	O

This	O
pattern	O
,	O
which	O
the	O
autohrs	O
call	O
Tpye	O
II	O
,	O
is	O
charatcerized	O
by	O
the	O
absecne	O
of	O
psoterior	O
periventricualr	O
areas	O
of	O
decerased	O
attneuation	O
around	O
the	O
tirgone	O
on	O
non	O
-	O
contrast	O
scnas	O
after	O
contrast	O
infusoin	O
,	O
however	O
,	O
there	O
is	O
striking	O
enhacnement	O
of	O
various	O
wihte	O
-	O
matter	O
strcutures	O
(	O
tratcs	O
or	O
fiebr	O
sysetms	O
)	O
such	O
as	O
the	O
inetrnal	O
cpasules	O
,	O
corups	O
callsoum	O
,	O
croona	O
raditaa	O
,	O
froceps	O
major	O
,	O
and	O
cererbal	O
peduncels	O
.	O

This	O
is	O
different	O
from	O
numerous	O
previous	O
descrpitions	O
of	O
the	O
CT	O
ptatern	O
in	O
ALD	B-Disease
.	O

Tpye	B-Disease
II	I-Disease
ALD	I-Disease
does	O
not	O
appear	O
to	O
have	O
been	O
seen	O
in	O
any	O
other	O
leukoencephaloptahy	B-Disease
and	O
is	O
probably	O
specific	O
for	O
a	O
pehnotypic	O
vraiant	O
or	O
an	O
evolving	O
stgae	O
of	O
ALD	B-Disease
.	O
.	O

Further	O
eivdence	O
for	O
hteerogeneity	O
of	O
gluocse	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospahte	I-Disease
dehydrogeanse	I-Disease
deficeincy	I-Disease
in	O
Ppaua	O
New	O
Guniea	O
.	O

Four	O
new	O
GP6D	O
varaints	O
have	O
been	O
characterzied	O
in	O
individauls	O
from	O
Paupa	O
New	O
Giunea	O
.	O

This	O
sutdy	O
demonstrates	O
that	O
the	O
previously	O
reported	O
Mrakham	O
vairant	O
and	O
the	O
newly	O
charcaterized	O
Saalta	O
varinat	O
may	O
be	O
widely	O
distributed	O
in	O
Paupa	O
New	O
Guniea	O
.	O

Th	O
dtaa	O
presented	O
here	O
together	O
with	O
those	O
of	O
previously	O
publihsed	O
stuides	O
demonstrate	O
a	O
dgeree	O
of	O
heetrogeneity	O
of	O
GP6D	B-Disease
defiicency	I-Disease
that	O
is	O
much	O
hihger	O
than	O
that	O
in	O
other	O
reigons	O
of	O
the	O
world	O
where	O
GP6D	B-Disease
deficeincy	I-Disease
is	O
common	O
.	O
.	O

Incresaed	O
inicdence	O
of	O
catraacts	B-Disease
in	O
mlae	O
subjetcs	O
deficeint	B-Disease
in	I-Disease
gluocse	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phsophate	I-Disease
dehydroegnase	I-Disease
.	O

Gluocse	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospahte	I-Disease
deyhdrogenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
defciiency	I-Disease
in	O
RCBs	O
was	O
found	O
significantly	O
more	O
frequently	O
in	O
210	O
mlae	O
catraactous	B-Disease
ptaients	O
than	O
in	O
672	O
cnotrol	O
sbujects	O
of	O
Sradinian	O
oirgin	O
.	O

The	O
freqeuncy	O
of	O
the	O
deficinecy	O
was	O
increasingly	O
hgiher	O
in	O
preesnile	O
cataratcs	B-Disease
.	O

In	O
the	O
GP6D	B-Disease
-	I-Disease
defiicent	I-Disease
gorup	O
,	O
the	O
inciednce	O
of	O
crotical	B-Disease
and	I-Disease
total	I-Disease
caatracts	I-Disease
was	O
also	O
increaesd	O
.	O

It	O
is	O
suggested	O
that	O
dercease	O
of	O
the	O
GP6D	O
activtiy	O
in	O
the	O
lnes	O
,	O
which	O
accompanies	O
its	O
defiicency	O
in	O
the	O
erythorcyte	O
,	O
might	O
play	O
a	O
role	O
in	O
the	O
ctaaracto	O
-	O
geensis	O
of	O
these	O
ptaients	O
.	O

Moreover	O
,	O
GP6D	B-Disease
deficiecny	I-Disease
should	O
be	O
added	O
to	O
other	O
conditinos	O
,	O
such	O
as	O
the	O
galactoesmic	B-Disease
states	O
and	O
ribolfavin	B-Disease
defiicency	I-Disease
,	O
where	O
catraacts	B-Disease
represent	O
a	O
sesnitive	O
idnicator	O
of	O
metaboilc	B-Disease
abnoramlities	I-Disease
of	O
the	O
RBC	O
.	O
.	O

Mloecular	O
basis	O
of	O
huamn	O
mitochondiral	O
very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chian	I-Disease
aycl	I-Disease
-	I-Disease
CoA	I-Disease
deyhdrogenase	I-Disease
deficeincy	I-Disease
causing	O
cradiomyopathy	B-Disease
and	O
sduden	B-Disease
detah	I-Disease
in	O
childhood	O
.	O

btea	O
-	O
Oxidtaion	O
of	O
long	O
-	O
chian	O
ftaty	O
acdis	O
provides	O
the	O
major	O
soucre	O
of	O
eenrgy	O
in	O
the	O
haert	O
.	O

Dfeects	O
in	O
enzmyes	O
of	O
the	O
btea	O
-	O
oxiadtion	O
pahtway	O
cause	O
sudden	B-Disease
,	I-Disease
unexpalined	I-Disease
detah	I-Disease
in	O
chlidhood	O
,	O
actue	O
heptaic	B-Disease
encepahlopathy	I-Disease
or	O
lievr	B-Disease
fialure	I-Disease
,	O
skleetal	B-Disease
myoapthy	I-Disease
,	O
and	O
cardiomyoapthy	B-Disease
.	O

Very	O
-	O
long	O
-	O
chian	O
aycl	O
-	O
CoA	O
dehydorgenase	O
[	O
VCLAD	O
;	O
very	O
-	O
long	O
-	O
cahin	O
-	O
aycl	O
-	O
CoA	O
(	O
accpetor	O
)	O
2	O
,	O
3	O
-	O
oxidoreducatse	O
,	O
EC	O
1	O
.	O
3	O
3	O
.	O
99	O
99	O
.	O
13	O
]	O
catalyzes	O
the	O
first	O
step	O
in	O
btea	O
-	O
oxiadtion	O
.	O

We	O
have	O
isoltaed	O
the	O
hmuan	O
VLACD	O
cNDA	O
and	O
gnee	O
and	O
determined	O
the	O
complete	O
nucleoitde	O
sequenecs	O
.	O

Polymersae	O
cahin	O
reatcion	O
amlpification	O
of	O
VCLAD	O
mNRA	O
and	O
genmoic	O
eoxns	O
defined	O
the	O
moleuclar	O
deefcts	O
in	O
two	O
patietns	O
with	O
VCLAD	B-Disease
defciiency	I-Disease
who	O
presented	O
with	O
unxeplained	O
cardaic	B-Disease
arrest	I-Disease
and	O
cardimoyopathy	B-Disease
.	O

In	O
one	O
,	O
a	O
homoyzgous	O
muttaion	O
in	O
the	O
consenuss	O
dinucloetide	O
of	O
the	O
dnoor	O
slpice	O
stie	O
(	O
g	O
+	O
1	O
-	O
-	O
>	O
a	O
)	O
was	O
associated	O
with	O
universal	O
skipipng	O
of	O
the	O
prior	O
eoxn	O
(	O
eoxn	O
11	O
)	O
.	O

The	O
second	O
pateint	O
was	O
a	O
cmopound	O
heetrozygote	O
,	O
with	O
a	O
msisense	O
muttaion	O
,	O
C8137	O
-	O
-	O
>	O
T	O
,	O
changing	O
the	O
argniine	O
at	O
resdiue	O
613	O
to	O
tryptpohan	O
on	O
one	O
alllee	O
and	O
a	O
single	O
base	O
delteion	O
at	O
the	O
itnron	O
-	O
eoxn	O
6	O
boudnary	O
as	O
the	O
second	O
muattion	O
.	O

This	O
initial	O
delnieation	O
of	O
hmuan	O
mutatoins	O
in	O
VLACD	O
suggests	O
that	O
VLACD	B-Disease
deficeincy	I-Disease
reduecs	O
myocardail	O
ftaty	O
aicd	O
btea	O
-	O
oixdation	O
and	O
eenrgy	O
produtcion	O
and	O
is	O
associated	O
with	O
cradiomyopathy	B-Disease
and	O
sudden	B-Disease
detah	I-Disease
in	O
childohod	O
.	O

Aberrnat	O
subcellular	O
lcoalization	O
of	O
BCRA1	O
in	O
bresat	B-Disease
canecr	I-Disease
.	O

The	O
BRAC1	O
gnee	O
prdouct	O
was	O
identifeid	O
as	O
a	O
220	O
-	O
kiloadlton	O
nulcear	O
phosphorpotein	O
in	O
nromal	O
cells	O
,	O
including	O
berast	O
dcutal	O
epitehlial	O
clels	O
,	O
and	O
in	O
18	O
of	O
20	O
tmuor	B-Disease
clel	O
lnies	O
derived	O
from	O
tsisues	O
other	O
than	O
bresat	O
and	O
oavry	O
.	O

In	O
16	O
of	O
17	O
bresat	B-Disease
and	I-Disease
ovairan	I-Disease
canecr	I-Disease
liens	O
and	O
17	O
of	O
17	O
sapmles	O
of	O
clels	O
obtained	O
from	O
malignnat	O
effusions	O
,	O
however	O
,	O
BRAC1	O
localiezd	O
mainly	O
in	O
ctyoplasm	O
.	O

Asbence	O
of	O
BCRA1	O
or	O
abrerant	O
subcellular	O
lcoation	O
was	O
also	O
observed	O
to	O
a	O
varialbe	O
extent	O
in	O
histolgoical	O
sectoins	O
of	O
many	O
braest	B-Disease
cacner	I-Disease
biopises	O
.	O

These	O
fidnings	O
suggest	O
that	O
BRAC1	B-Disease
abnormaliites	I-Disease
may	O
be	O
involved	O
in	O
the	O
pathogenseis	O
of	O
many	O
bresat	B-Disease
cancres	I-Disease
,	O
sopradic	O
as	O
well	O
as	O
faimlial	O
.	O
.	O

Mappnig	O
of	O
the	O
muose	O
homloogue	O
of	O
the	O
Wislon	B-Disease
disesae	I-Disease
gnee	O
to	O
muose	O
chroomsome	O
8	O
.	O

AT7PB	O
,	O
the	O
gnee	O
aletred	O
in	O
Wislon	B-Disease
disaese	I-Disease
(	O
WD	B-Disease
)	O
pateints	O
,	O
lies	O
in	O
a	O
blcok	O
of	O
hoomlogy	O
shared	O
between	O
huamn	O
chromoosme	O
13q14	O
and	O
the	O
cetnral	O
reigon	O
of	O
muose	O
chormosome	O
14	O
.	O

However	O
,	O
we	O
have	O
mpaped	O
the	O
murnie	O
homloogue	O
of	O
APT7B	O
(	O
Apt7b	O
)	O
to	O
mosue	O
chromsoome	O
8	O
by	O
somtaic	O
clel	O
hybird	O
analyiss	O
.	O

Aanlysis	O
of	O
80	O
interspecfiic	O
backcrsos	O
offspring	O
was	O
used	O
to	O
positoin	O
At7pb	O
close	O
to	O
D8Mit3	O
and	O
another	O
ATPsae	O
loucs	O
,	O
At4pb	O
,	O
on	O
mosue	O
chromsoome	O
8	O
.	O

APT4B	O
lies	O
in	O
13q34	O
and	O
is	O
seaprated	O
from	O
AT7PB	O
by	O
several	O
lcoi	O
whose	O
mosue	O
homolgoues	O
map	O
to	O
mosue	O
crhomosome	O
14	O
.	O

The	O
asisgnment	O
of	O
At7pb	O
to	O
muose	O
chrmoosome	O
8	O
identifies	O
a	O
previously	O
unrecognized	O
reigon	O
of	O
hmoology	O
between	O
this	O
chrmoosome	O
and	O
hmuan	O
chrmoosome	O
13	O
.	O

This	O
assingment	O
suggests	O
a	O
possible	O
lcoation	O
for	O
the	O
txoic	O
mlik	O
mtuation	O
in	O
the	O
mosue	O
,	O
which	O
has	O
been	O
proposed	O
as	O
a	O
homloogue	O
of	O
WD	B-Disease
.	O
.	O

Gerlmine	O
muattions	O
of	O
the	O
BCRA1	O
gnee	O
in	O
braest	B-Disease
and	I-Disease
ovarain	I-Disease
canecr	I-Disease
famliies	O
provide	O
evdience	O
for	O
a	O
genotpye	O
-	O
phentoype	O
correltaion	O
.	O

Mutatoins	O
in	O
the	O
BRAC1	O
gnee	O
,	O
discovered	O
in	O
1994	O
,	O
are	O
associated	O
with	O
an	O
80	O
-	O
90	O
%	O
lifeitme	O
rsik	O
of	O
bresat	B-Disease
cnacer	I-Disease
.	O

We	O
have	O
analsyed	O
60	O
famiiles	O
with	O
a	O
hsitory	O
of	O
bresat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarain	I-Disease
canecr	I-Disease
for	O
germlnie	O
muttaions	O
in	O
BRAC1	O
.	O

Twenty	O
-	O
two	O
different	O
mutatinos	O
were	O
dteected	O
in	O
32	O
famileis	O
(	O
53	O
%	O
)	O
,	O
of	O
which	O
14	O
are	O
previously	O
unreported	O
.	O

We	O
observed	O
a	O
significant	O
correlation	O
between	O
the	O
loctaion	O
of	O
the	O
muttaion	O
in	O
the	O
gnee	O
and	O
the	O
rtaio	O
of	O
braest	B-Disease
to	I-Disease
oavrian	I-Disease
cacner	I-Disease
incdience	O
within	O
each	O
fmaily	O
.	O

Our	O
dtaa	O
suggest	O
a	O
trnasition	O
in	O
rsik	O
such	O
that	O
mtuations	O
in	O
the	O
3	O
third	O
of	O
the	O
gnee	O
are	O
associated	O
with	O
a	O
loewr	O
proportoin	O
of	O
ovraian	B-Disease
cnacer	I-Disease
.	O

Hpalotype	O
analyiss	O
supports	O
previous	O
dtaa	O
which	O
suggest	O
some	O
BCRA1	O
muattion	O
carirers	O
have	O
common	O
ancsetors	O
;	O
however	O
,	O
we	O
have	O
found	O
at	O
least	O
two	O
examples	O
where	O
recurernt	O
mutatinos	O
appear	O
to	O
have	O
arisen	O
independently	O
.	O
.	O

Hereditray	O
defciiency	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
and	O
reucrrent	O
meningococcal	B-Disease
infectoin	I-Disease
:	O
investigatoins	O
of	O
an	O
Iirsh	O
faimly	O
using	O
a	O
novel	O
heamolytic	O
screeinng	O
asasy	O
for	O
complement	O
atcivity	O
and	O
C7	O
M	O
/	O
N	O
allotyping	O
.	O

Termianl	B-Disease
complement	I-Disease
component	I-Disease
deficiecny	I-Disease
predispsoes	O
to	O
meningoocccal	B-Disease
infeciton	I-Disease
and	O
is	O
inherietd	O
in	O
an	O
autoosmal	O
co	O
-	O
domniant	O
manner	O
.	O

An	O
Irsih	O
faimly	O
is	O
described	O
,	O
in	O
which	O
2	O
of	O
3	O
brohters	O
had	O
recurernt	O
mneingococcal	B-Disease
infeciton	I-Disease
.	O

A	O
novel	O
screening	O
asasy	O
was	O
used	O
to	O
invetsigate	O
for	O
terimnal	B-Disease
complement	I-Disease
defciiency	I-Disease
and	O
the	O
2	O
afefcted	O
brotehrs	O
were	O
found	O
to	O
be	O
completely	B-Disease
defciient	I-Disease
in	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
.	O

Enzmye	O
-	O
linked	O
immunosorbent	O
asasy	O
for	O
C7	O
reveaeld	O
lwoer	O
than	O
noraml	O
levles	O
in	O
the	O
remaining	O
brotehr	O
and	O
praents	O
.	O

C7	O
M	O
/	O
N	O
protien	O
polymorphsim	O
allotyping	O
,	O
used	O
to	O
investiagte	O
the	O
segergation	O
of	O
the	O
C7	B-Disease
deficiecny	I-Disease
gnees	O
,	O
showed	O
that	O
the	O
apparently	O
complement	O
sufficient	O
brohter	O
was	O
heteroyzgous	O
C7	B-Disease
defciient	I-Disease
and	O
a	O
crarier	O
of	O
one	O
of	O
the	O
defiicency	O
geens	O
.	O

Complmeent	O
screennig	O
should	O
be	O
carried	O
out	O
in	O
any	O
indivdiual	O
sufefring	O
reucrrent	O
mneingococcal	B-Disease
infcetion	I-Disease
or	O
infcetion	O
with	O
an	O
uncommon	O
meningoccocal	B-Disease
sreogroup	O
.	O

Identfiication	O
of	O
complement	B-Disease
deficeint	I-Disease
pateints	O
allows	O
the	O
impelmentation	O
of	O
strategies	O
to	O
pervent	O
recrurent	O
infetcion	O
.	O
.	O

Moelcular	O
basis	O
of	O
subottal	B-Disease
complement	I-Disease
C6	I-Disease
dfeiciency	I-Disease
.	O

A	O
craboxy	O
-	O
terminally	O
trunctaed	O
but	O
functionally	O
atcive	O
C6	O
.	O

Indiivduals	O
with	O
sbutotal	B-Disease
complement	I-Disease
C6	I-Disease
deficeincy	I-Disease
possess	O
a	O
C6	O
molceule	O
that	O
is	O
14	O
%	O
shotrer	O
than	O
nomral	O
C6	O
and	O
present	O
in	O
low	O
but	O
deetctable	O
concnetrations	O
(	O
1	O
-	O
2	O
%	O
of	O
the	O
nomral	O
mean	O
)	O
.	O

We	O
now	O
show	O
that	O
this	O
dysmorpihc	O
C6	O
is	O
bactericidally	O
atcive	O
and	O
lacks	O
an	O
eptiope	O
that	O
was	O
mapepd	O
to	O
the	O
most	O
carobxy	O
-	O
treminal	O
part	O
of	O
C6	O
using	O
C6	O
cNDA	O
fragmetns	O
expressed	O
as	O
fsuion	O
porteins	O
in	O
the	O
pEUX	O
exrpession	O
sytsem	O
.	O

We	O
thus	O
perdicted	O
that	O
the	O
abnomral	O
C6	O
moelcule	O
might	O
be	O
carobxy	O
-	O
terminally	O
turncated	O
and	O
sought	O
a	O
mutatoin	O
in	O
an	O
aera	O
approximately	O
14	O
%	O
from	O
the	O
cabroxy	O
-	O
termianl	O
end	O
of	O
the	O
coidng	O
sequnece	O
.	O

By	O
sequecning	O
PCR	O
-	O
amplfiied	O
porducts	O
from	O
this	O
regoin	O
,	O
we	O
found	O
,	O
in	O
three	O
individulas	O
from	O
two	O
famiiles	O
,	O
a	O
mtuation	O
that	O
might	O
plausibly	O
be	O
responsible	O
for	O
the	O
deefct	O
.	O

All	O
three	O
have	O
an	O
abnromal	O
5	O
splcie	O
doonr	O
stie	O
of	O
inrton	O
15	O
,	O
which	O
would	O
probably	O
pervent	O
slpicing	O
.	O

An	O
in	O
-	O
frmae	O
stop	O
coodn	O
is	O
found	O
17	O
coodns	O
downtsream	O
from	O
the	O
inrton	O
boundray	O
,	O
which	O
would	O
lead	O
to	O
a	O
trunctaed	O
poylpeptide	O
13	O
.	O

5	O
%	O
smaller	O
than	O
noraml	O
C6	O
.	O

This	O
result	O
was	O
unexpected	O
,	O
as	O
earlier	O
studeis	O
mpaped	O
the	O
C5b	O
bindnig	O
stie	O
,	O
or	O
a	O
putative	O
enzymaitc	O
regoin	O
,	O
to	O
this	O
part	O
of	O
C6	O
.	O

Interestingly	O
,	O
all	O
three	O
sujbects	O
were	O
probably	O
heteroyzgous	O
for	O
both	O
sutbotal	B-Disease
C6	I-Disease
and	I-Disease
complete	I-Disease
C6	I-Disease
dfeiciency	I-Disease
.	O

Moytonic	B-Disease
dysrtophy	I-Disease
:	O
evidnece	O
for	O
a	O
possible	O
domniant	O
-	O
negatvie	O
RNA	O
mutatoin	O
.	O

The	O
trinucelotide	O
epxansion	O
mutaiton	O
causing	O
moytonic	B-Disease
dytsrophy	I-Disease
is	O
in	O
the	O
3	O
unrtanslated	O
regoin	O
of	O
a	O
prtoein	O
kniase	O
gnee	O
.	O

The	O
molceular	O
mehcanisms	O
by	O
which	O
the	O
expanded	O
repaet	O
causes	O
the	O
clniically	O
varaible	O
and	O
multsiystemic	B-Disease
disesae	I-Disease
,	O
moytonic	B-Disease
dystrohpy	I-Disease
,	O
are	O
not	O
understood	O
.	O

It	O
has	O
been	O
particularly	O
difficult	O
to	O
rationalize	O
the	O
domiannt	O
inheritnace	O
with	O
the	O
fact	O
that	O
the	O
expasnion	O
muattion	O
lies	O
outside	O
of	O
the	O
prtoein	O
-	O
enocding	O
gnee	O
elements	O
,	O
and	O
should	O
not	O
be	O
translated	O
into	O
protien	O
.	O

Here	O
we	O
use	O
msucle	O
biopises	O
from	O
classical	O
audlt	O
-	O
onset	O
myotnoic	B-Disease
dsytrophy	I-Disease
pateints	O
to	O
stduy	O
the	O
acucmulation	O
of	O
transcirpts	O
from	O
both	O
the	O
nomral	O
and	O
expanded	O
DM	B-Disease
kianse	O
geens	O
in	O
paitent	O
muslce	O
,	O
and	O
copmare	O
the	O
resutls	O
to	O
nomral	O
and	O
myopahtic	B-Disease
contorls	O
.	O

We	O
found	O
relatively	O
small	O
dcereases	O
of	O
DM	B-Disease
kinsae	O
RNA	O
in	O
the	O
total	O
RNA	O
pool	O
from	O
mucsle	O
;	O
however	O
,	O
these	O
redutcions	O
were	O
not	O
disesae	O
specific	O
.	O

Aanlysis	O
of	O
ploy	O
(	O
A	O
)	O
+	O
RNA	O
showed	O
dramtaic	O
decraeses	O
of	O
both	O
the	O
mutnat	O
and	O
noraml	O
DM	B-Disease
kinsae	O
RANs	O
,	O
and	O
these	O
chnages	O
were	O
disesae	O
-	O
specific	O
.	O

Our	O
findnigs	O
are	O
consistent	O
with	O
a	O
novel	O
moleuclar	O
pathoegnetic	O
mechainsm	O
for	O
myotnoic	B-Disease
dytsrophy	I-Disease
both	O
the	O
noraml	O
and	O
expanded	O
DM	B-Disease
kniase	O
gnees	O
are	O
transrcibed	O
in	O
ptaient	O
msucle	O
,	O
but	O
the	O
abnomral	O
epxansion	O
-	O
containing	O
RNA	O
has	O
a	O
domniant	O
effcet	O
on	O
RNA	O
mteabolism	O
by	O
preventing	O
the	O
accuumlation	O
of	O
ploy	O
(	O
A	O
)	O
+	O
RNA	O
.	O

The	O
ability	O
of	O
the	O
expanison	O
mutaiton	O
to	O
alter	O
accumulaiton	O
of	O
ploy	O
(	O
A	O
)	O
+	O
RNA	O
in	O
tarns	O
suggests	O
that	O
moytonic	B-Disease
dytsrophy	I-Disease
may	O
be	O
the	O
first	O
example	O
of	O
a	O
dmoinant	O
-	O
negtaive	O
mutatoin	O
manifested	O
at	O
the	O
RNA	O
leevl	O
.	O
.	O

A	O
strong	O
candidate	O
for	O
the	O
bresat	B-Disease
and	I-Disease
ovraian	I-Disease
cnacer	I-Disease
susecptibility	O
gnee	O
BRAC1	O
.	O

A	O
strong	O
candidate	O
for	O
the	O
17q	O
-	O
linked	O
BRAC1	O
gnee	O
,	O
which	O
infleunces	O
sucseptibility	O
to	O
braest	B-Disease
and	I-Disease
ovarain	I-Disease
cacner	I-Disease
,	O
has	O
been	O
idenitfied	O
by	O
posiitonal	O
clnoing	O
metohds	O
.	O

Probable	O
predisopsing	O
mtuations	O
have	O
been	O
detecetd	O
in	O
five	O
of	O
eight	O
kinrdeds	O
presumed	O
to	O
sgeregate	O
BRAC1	O
susceptiiblity	O
alleles	O
.	O

The	O
mutaitons	O
include	O
an	O
11	O
-	O
base	O
piar	O
deletoin	O
,	O
a	O
1	O
-	O
base	O
piar	O
inesrtion	O
,	O
a	O
stop	O
coodn	O
,	O
a	O
missnese	O
substituiton	O
,	O
and	O
an	O
inefrred	O
rgeulatory	O
muattion	O
.	O

The	O
BRAC1	O
gnee	O
is	O
exprsesed	O
in	O
numerous	O
tsisues	O
,	O
including	O
bresat	O
and	O
oavry	O
,	O
and	O
enocdes	O
a	O
predicetd	O
protien	O
of	O
1863	O
amnio	O
aicds	O
.	O

This	O
prtoein	O
contains	O
a	O
znic	O
fniger	O
doamin	O
in	O
its	O
aimno	O
-	O
terimnal	O
reigon	O
,	O
but	O
is	O
otherwise	O
unrelated	O
to	O
previously	O
described	O
protiens	O
.	O

Idnetification	O
of	O
BCRA1	O
should	O
facilitate	O
eraly	O
daignosis	O
of	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
susecptibility	O
in	O
some	O
individauls	O
as	O
well	O
as	O
a	O
better	O
understanding	O
of	O
bresat	B-Disease
cnacer	I-Disease
biloogy	O
.	O
.	O

Molceular	O
characterizaiton	O
of	O
galactsoemia	B-Disease
(	O
tpye	O
1	O
)	O
mutaitons	O
in	O
Jpaanese	O
.	O

We	O
charcaterized	O
two	O
novel	O
mutatinos	O
of	O
the	O
galatcose	O
-	O
1	O
-	O
phosphtae	O
urdiyltransferase	O
(	O
GLAT	O
)	O
gnee	O
in	O
two	O
Jaapnese	O
patietns	O
with	O
GLAT	B-Disease
defciiency	I-Disease
and	O
iedntified	O
N134D	O
and	O
R333W	O
muttaions	O
,	O
previously	O
found	O
in	O
Cauacsians	O
.	O

One	O
novel	O
misesnse	O
mtuation	O
was	O
an	O
G	O
-	O
to	O
-	O
A	O
transtiion	O
in	O
eoxn	O
8	O
,	O
resulting	O
in	O
the	O
sbustitution	O
of	O
argniine	O
by	O
hisitdine	O
at	O
the	O
cdoon	O
231	O
(	O
R213H	O
)	O
.	O

GLAT	O
acitvity	O
of	O
the	O
R321H	O
muatnt	O
consrtuct	O
was	O
rdeuced	O
to	O
15	O
%	O
of	O
nromal	O
contorls	O
in	O
a	O
COS	O
clel	O
exrpession	O
ssytem	O
.	O

The	O
other	O
was	O
a	O
spliicng	O
muattion	O
,	O
an	O
A	O
-	O
to	O
-	O
G	O
trnasition	O
at	O
the	O
38th	O
nucloetide	O
in	O
eoxn	O
3	O
(	O
318A	O
-	O
-	O
>	O
G	O
)	O
,	O
resulting	O
in	O
a	O
38	O
-	O
bp	O
deeltion	O
in	O
the	O
GLAT	O
cNDA	O
by	O
actviating	O
a	O
cyrptic	O
splcie	O
accpetor	O
stie	O
.	O

In	O
seven	O
Jaapnese	O
famliies	O
(	O
14	O
alllees	O
for	O
classic	O
form	O
and	O
one	O
alelle	O
for	O
Daurte	O
vraiant	O
)	O
with	O
GLAT	B-Disease
defciiency	I-Disease
,	O
the	O
R213H	O
and	O
318A	O
-	O
-	O
>	O
G	O
mtuations	O
were	O
found	O
only	O
on	O
both	O
alleels	O
of	O
the	O
prboand	O
.	O

The	O
N341D	O
and	O
R333W	O
muttaions	O
were	O
found	O
on	O
one	O
alllee	O
each	O
.	O

The	O
Q818R	O
was	O
prevalnet	O
in	O
the	O
Unietd	O
Sattes	O
but	O
not	O
in	O
Japnaese	O
patinets	O
.	O

The	O
N134D	O
mutaiton	O
was	O
associated	O
with	O
the	O
Daurte	O
vraiant	O
in	O
Jaapnese	O
presons	O
,	O
as	O
well	O
as	O
in	O
the	O
Uinted	O
Staets	O
.	O

We	O
speculate	O
that	O
classic	B-Disease
galcatosemia	I-Disease
mutaitons	O
appear	O
to	O
differ	O
between	O
Japansee	O
and	O
Cacuasian	O
paitents	O
.	O

Our	O
limietd	O
dtaa	O
set	O
on	O
glaactosemia	B-Disease
muattions	O
in	O
Japaense	O
suggests	O
that	O
the	O
N341D	O
GLAT	O
muttaion	O
encoidng	O
the	O
Daurte	O
varinat	O
arose	O
before	O
Asain	O
and	O
Cuacasian	O
peolpe	O
diverged	O
and	O
that	O
classic	B-Disease
galactoseima	I-Disease
muttaions	O
arose	O
and	O
/	O
or	O
accumulated	O
after	O
the	O
diveregnce	O
of	O
Aisan	O
and	O
Cuacasian	O
pouplations	O
.	O
.	O

Three	O
novel	O
aniriida	B-Disease
mutatoins	O
in	O
the	O
hmuan	O
PXA6	O
gnee	O
.	O

Ainridia	B-Disease
(	O
iirs	B-Disease
hpyoplasia	I-Disease
)	O
is	O
an	O
autosmoal	B-Disease
domniant	I-Disease
cnogenital	I-Disease
disoredr	I-Disease
of	I-Disease
the	I-Disease
eye	I-Disease
.	O

Mutaitons	O
in	O
the	O
hmuan	O
anriidia	B-Disease
(	O
PXA6	O
)	O
gnee	O
have	O
now	O
been	O
idnetified	O
in	O
many	O
patietns	O
from	O
various	O
ehtnic	O
gropus	O
.	O

In	O
the	O
stduy	O
reported	O
here	O
we	O
describe	O
PXA6	O
muttaions	O
in	O
one	O
sproadic	O
and	O
five	O
fmailial	O
csaes	O
with	O
anriidia	B-Disease
.	O

Of	O
the	O
four	O
different	O
mtuations	O
identfiied	O
,	O
one	O
was	O
identiacl	O
to	O
a	O
previously	O
reported	O
muattion	O
(	O
C	O
-	O
-	O
>	O
T	O
transiiton	O
at	O
cdoon	O
240	O
)	O
,	O
and	O
three	O
were	O
novel	O
two	O
in	O
the	O
glcyine	O
-	O
rich	O
regoin	O
and	O
one	O
in	O
the	O
prolnie	O
/	O
sernie	O
/	O
threoinne	O
-	O
rich	O
(	O
PST	O
)	O
reigon	O
.	O

One	O
PXA6	O
muattion	O
found	O
in	O
the	O
PST	O
reigon	O
was	O
associated	O
with	O
catarcats	B-Disease
in	O
an	O
ainridia	B-Disease
faimly	O
.	O

Another	O
spilce	O
mutatoin	O
in	O
the	O
PST	O
doamin	O
occurred	O
in	O
an	O
anirdiia	B-Disease
patinet	O
with	O
anomsia	B-Disease
(	O
inabliity	O
to	O
smlel	O
)	O
.	O

The	O
six	O
new	O
aniirdia	B-Disease
caess	O
reported	O
here	O
have	O
mutatinos	O
prdeicted	O
to	O
generate	O
incompelte	O
PXA6	O
protiens	O
.	O

These	O
resluts	O
support	O
the	O
thoery	O
that	O
huamn	O
aniriida	B-Disease
is	O
caused	O
by	O
haploisnufficiency	B-Disease
of	I-Disease
PXA6	I-Disease
.	O
.	O

The	O
carreir	O
frequnecy	O
of	O
the	O
BCRA1	O
185edlAG	O
muttaion	O
is	O
approximately	O
1	O
percent	O
in	O
Ashkeanzi	O
Jeiwsh	O
individulas	O
.	O

Since	O
BRAC1	O
,	O
the	O
first	O
major	O
gnee	O
responsible	O
for	O
ihnerited	B-Disease
braest	I-Disease
cacner	I-Disease
,	O
was	O
colned	O
,	O
more	O
than	O
50	O
uniuqe	O
mtuations	O
have	O
been	O
deetcted	O
in	O
the	O
gremline	O
of	O
individulas	O
with	O
bresat	B-Disease
and	I-Disease
ovraian	I-Disease
cnacer	I-Disease
.	O

In	O
high	O
-	O
rsik	O
pedgirees	O
,	O
femlae	O
carirers	O
of	O
BRAC1	O
mutatoins	O
have	O
an	O
80	O
-	O
90	O
%	O
lieftime	O
rsik	O
of	O
bresat	B-Disease
cnacer	I-Disease
,	O
and	O
a	O
40	O
-	O
50	O
%	O
rsik	O
of	O
oavrian	B-Disease
cnacer	I-Disease
.	O

However	O
,	O
the	O
muattion	O
sttas	O
of	O
inidviduals	O
unselected	O
for	O
braest	B-Disease
or	I-Disease
ovarain	I-Disease
canecr	I-Disease
has	O
not	O
been	O
determined	O
,	O
and	O
it	O
is	O
not	O
known	O
whether	O
muttaions	O
in	O
such	O
indiviudals	O
confer	O
the	O
same	O
rsik	O
of	O
cacner	B-Disease
as	O
in	O
inidviduals	O
from	O
the	O
high	O
-	O
rsik	O
famiiles	O
studied	O
so	O
far	O
.	O

Following	O
the	O
fidning	O
of	O
a	O
185deAlG	O
framsehift	O
muattion	O
in	O
several	O
Askhenazi	O
Jewsih	O
bresat	O
/	O
ovairan	O
famileis	O
,	O
we	O
have	O
determined	O
the	O
freuqency	O
of	O
this	O
muttaion	O
in	O
858	O
Ashkenzaim	O
seeking	O
gneetic	O
tseting	O
for	O
conditinos	O
unrelated	O
to	O
cacner	B-Disease
,	O
and	O
in	O
815	O
referecne	O
indiviudals	O
not	O
selected	O
for	O
ethinc	O
oriign	O
.	O

We	O
observed	O
the	O
18d5elAG	O
mutaiton	O
in	O
0	O
.	O

9	O
%	O
of	O
Ashkenaizm	O
(	O
95	O
%	O
confiednce	O
liimt	O
,	O
0	O
.	O
4	O
-	O
1	O
.	O
8	O
%	O
)	O
and	O
in	O
none	O
of	O
the	O
refeernce	O
smaples	O
.	O

Our	O
resutls	O
suggest	O
that	O
one	O
in	O
a	O
hundred	O
woemn	O
of	O
Ashkenzai	O
descnet	O
may	O
be	O
at	O
especially	O
high	O
rsik	O
of	O
developing	O
berast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovairan	I-Disease
cnacer	I-Disease
.	O

Identiifcation	O
and	O
localizaiton	O
of	O
hutningtin	O
in	O
barin	O
and	O
hmuan	O
lymhpoblastoid	O
clel	O
lnies	O
with	O
atni	O
-	O
fsuion	O
proetin	O
antbiodies	O
.	O

The	O
Huntignton	B-Disease
disaese	I-Disease
(	O
HD	B-Disease
)	O
pehnotype	O
is	O
associated	O
with	O
epxansion	O
of	O
a	O
trinulceotide	O
repaet	O
in	O
the	O
I1T5	O
gnee	O
,	O
which	O
is	O
predcited	O
to	O
encode	O
a	O
348	O
-	O
kDa	O
protien	O
named	O
hnutington	O
.	O

We	O
used	O
polycolnal	O
and	O
monocolnal	O
atni	O
-	O
fuison	O
prtoein	O
antiboides	O
to	O
identify	O
ntaive	O
hnutingtin	O
in	O
rat	O
,	O
moneky	O
,	O
and	O
hmuan	O
.	O

Wsetern	O
bolts	O
rveealed	O
a	O
portein	O
with	O
the	O
expected	O
moelcular	O
weihgt	O
which	O
is	O
present	O
in	O
the	O
soulble	O
fractoin	O
of	O
rat	O
and	O
mokney	O
brian	O
tisseus	O
and	O
lmyphoblastoid	O
clels	O
from	O
cnotrol	O
csaes	O
.	O

In	O
lymphoblasotid	O
clel	O
liens	O
from	O
juveinle	O
-	O
onset	O
heteorzygote	O
HD	B-Disease
csaes	O
,	O
both	O
nomral	O
and	O
mtuant	O
huntigntin	O
are	O
experssed	O
,	O
and	O
increaisng	O
repaet	O
expanison	O
leads	O
to	O
loewr	O
lveels	O
of	O
the	O
muatnt	O
proetin	O
.	O

Immunocyotchemistry	O
indicates	O
that	O
huntnigtin	O
is	O
located	O
in	O
neurnos	O
throughout	O
the	O
barin	O
,	O
with	O
the	O
highest	O
leevls	O
evident	O
in	O
larger	O
neuorns	O
.	O

In	O
the	O
huamn	O
stiratum	O
,	O
huntigntin	O
is	O
enriched	O
in	O
a	O
ptach	O
-	O
like	O
distributoin	O
,	O
potentially	O
corresponding	O
to	O
the	O
first	O
areas	O
afefcted	O
in	O
HD	B-Disease
.	O

Sbucellular	O
localiztaion	O
of	O
huntintgin	O
is	O
consistent	O
with	O
a	O
cytosoilc	O
portein	O
primarily	O
found	O
in	O
somatdoendritic	O
reginos	O
.	O

Huntigntin	O
appears	O
to	O
particularly	O
associtae	O
with	O
microtublues	O
,	O
although	O
some	O
is	O
also	O
associated	O
with	O
synpatic	O
vseicles	O
.	O

On	O
the	O
basis	O
of	O
the	O
loclaization	O
of	O
hnutingtin	O
in	O
associatoin	O
with	O
microtublues	O
,	O
we	O
speculate	O
that	O
the	O
mutatoin	O
imapirs	O
the	O
ctyoskeletal	O
anhcoring	O
or	O
tranpsort	O
of	O
mitohcondria	O
,	O
vseicles	O
,	O
or	O
other	O
orgaenlles	O
or	O
moelcules	O
.	O
.	O

Marked	O
phenoytpic	O
hteerogeneity	O
associated	O
with	O
expanison	O
of	O
a	O
CAG	O
rpeeat	O
sequecne	O
at	O
the	O
spincoerebellar	B-Disease
aatxia	I-Disease
3	I-Disease
/	I-Disease
Macahdo	I-Disease
-	I-Disease
Jsoeph	I-Disease
disaese	I-Disease
loucs	O
.	O

The	O
sipnocerebellar	B-Disease
aatxia	I-Disease
3	I-Disease
lcous	O
(	O
SAC3	B-Disease
)	O
for	O
tpye	B-Disease
I	I-Disease
autoosmal	I-Disease
doimnant	I-Disease
cereebllar	I-Disease
atxaia	I-Disease
(	O
ACDA	B-Disease
tpye	I-Disease
I	I-Disease
)	O
,	O
a	O
cliniaclly	O
and	O
geneitcally	O
heterogeneuos	O
gruop	O
of	O
neurodegeneartive	B-Disease
dsiorders	I-Disease
,	O
has	O
been	O
mpaped	O
to	O
chromoosme	O
14q32	O
.	O

1	O
1	O
.	O

ACDA	B-Disease
tpye	I-Disease
I	I-Disease
paitents	O
from	O
famiiles	O
segergating	O
SAC3	B-Disease
share	O
cliniacl	O
featrues	O
in	O
common	O
with	O
those	O
with	O
Mahcado	B-Disease
-	I-Disease
Jsoeph	I-Disease
diesase	I-Disease
(	O
MJD	B-Disease
)	O
,	O
the	O
gnee	O
of	O
which	O
mpas	O
to	O
the	O
same	O
rgeion	O
.	O

We	O
show	O
here	O
that	O
the	O
disesae	O
gnee	O
segregatnig	O
in	O
each	O
of	O
three	O
Fernch	O
ACDA	B-Disease
tpye	I-Disease
I	I-Disease
knidreds	O
and	O
in	O
a	O
Frecnh	O
fmaily	O
with	O
neuroptahological	O
findnigs	O
suggesting	O
the	O
ataxochoreic	O
form	O
of	O
dentatorubropalldioluysian	B-Disease
artophy	I-Disease
carries	O
an	O
expanded	O
CAG	O
reepat	O
sequnece	O
located	O
at	O
the	O
same	O
loucs	O
as	O
that	O
for	O
MJD	B-Disease
.	O

Anlaysis	O
of	O
the	O
muattion	O
in	O
these	O
fmailies	O
shows	O
a	O
strong	O
neagtive	O
corrleation	O
between	O
szie	O
of	O
the	O
expanded	O
CAG	O
reepat	O
and	O
age	O
at	O
onset	O
of	O
cliniacl	O
diesase	O
.	O

Isntability	O
of	O
the	O
expanded	O
trilpet	O
reepat	O
was	O
not	O
found	O
to	O
be	O
affetced	O
by	O
sex	O
of	O
the	O
praent	O
tranmsitting	O
the	O
mutatoin	O
.	O

Evidecne	O
was	O
found	O
for	O
somaitc	O
and	O
gnoadal	O
mosiacism	O
for	O
alllees	O
carrying	O
expanded	O
trinucleotdie	O
reepats	O
.	O

Ovreexpression	O
of	O
D2M0	O
messneger	O
RNA	O
in	O
two	O
brohters	O
with	O
Peilzaeus	B-Disease
-	I-Disease
Merzbahcer	I-Disease
dsiease	I-Disease
.	O

Peilzaeus	B-Disease
-	I-Disease
Merzbahcer	I-Disease
diesase	I-Disease
is	O
a	O
rrae	B-Disease
,	I-Disease
sex	I-Disease
-	I-Disease
linked	I-Disease
reecssive	I-Disease
,	I-Disease
dymsyelinating	I-Disease
disaese	I-Disease
of	I-Disease
the	I-Disease
cenrtal	I-Disease
nervuos	I-Disease
sysetm	I-Disease
that	O
has	O
been	O
associated	O
with	O
muattions	O
in	O
the	O
meylin	O
protoelipid	O
prtoein	O
(	O
PLP	O
)	O
gnee	O
.	O

Only	O
25	O
%	O
of	O
pateints	O
studied	O
with	O
Pelizaues	B-Disease
-	I-Disease
Merzabcher	I-Disease
dsiease	I-Disease
have	O
eoxnic	O
mutaitons	O
in	O
this	O
gnee	O
,	O
the	O
underlying	O
cause	O
of	O
the	O
disaese	O
in	O
the	O
remaining	O
patinets	O
is	O
unknown	O
.	O

The	O
PLP	O
gnee	O
encdoes	O
two	O
major	O
alternatively	O
splcied	O
tarnscripts	O
called	O
PLP	O
and	O
D2M0	O
.	O

PLP	O
messenger	O
RNA	O
is	O
specifically	O
epxressed	O
in	O
cenrtal	O
nerovus	O
sysetm	O
tissue	O
,	O
whereas	O
D2M0	O
messneger	O
RNA	O
is	O
found	O
in	O
cnetral	O
nrevous	O
sytsem	O
,	O
cardaic	O
,	O
and	O
other	O
tissues	O
.	O

We	O
studied	O
clutured	O
sikn	O
fibrobalsts	O
from	O
2	O
borthers	O
with	O
Peliazeus	B-Disease
-	I-Disease
Mrezbacher	I-Disease
disesae	I-Disease
who	O
exhibited	O
no	O
detectbale	O
eoxnic	O
mtuation	O
of	O
the	O
PLP	O
gnee	O
.	O

Eaxmination	O
of	O
RNA	O
from	O
these	O
clels	O
showed	O
that	O
the	O
lveel	O
of	O
D2M0	O
mesesnger	O
RNA	O
is	O
elveated	O
sixfold	O
relative	O
to	O
mlae	O
cnotrol	O
sikn	O
fibrbolasts	O
.	O

An	O
unrelated	O
femlae	O
carirer	O
,	O
also	O
with	O
no	O
detecatble	O
exnoic	O
mutatoin	O
,	O
showed	O
a	O
threefold	O
incresae	O
in	O
D2M0	O
msesenger	O
RNA	O
in	O
cultrued	O
sikn	O
fibrbolasts	O
.	O

Our	O
fnidings	O
suggest	O
that	O
in	O
some	O
patinets	O
,	O
Pelizeaus	B-Disease
-	I-Disease
Merzbacehr	I-Disease
dsiease	I-Disease
is	O
caused	O
by	O
overepxression	O
of	O
PLP	O
gnee	O
trancsripts	O
,	O
and	O
that	O
in	O
these	O
famileis	O
a	O
50	O
%	O
incraese	O
of	O
D2M0	O
mesesnger	O
RNA	O
in	O
femaels	O
,	O
relative	O
to	O
the	O
inrcease	O
in	O
affecetd	O
mlaes	O
,	O
can	O
identify	O
a	O
femlae	O
carrier	O
.	O
.	O

The	O
Wsikott	B-Disease
-	I-Disease
Adlrich	I-Disease
syndorme	I-Disease
and	O
X	B-Disease
-	I-Disease
linked	I-Disease
congeintal	I-Disease
trhombocytopenia	I-Disease
are	O
caused	O
by	O
mutatoins	O
of	O
the	O
same	O
gnee	O
.	O

The	O
Wsikott	B-Disease
-	I-Disease
Adlrich	I-Disease
synrdome	I-Disease
(	O
WAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recesisve	I-Disease
diosrder	I-Disease
characetrized	O
by	O
trhombocytopenia	B-Disease
,	O
small	O
plateelts	O
,	O
ecezma	B-Disease
,	O
recurrnet	O
infecitons	O
,	O
and	O
imumnodeficiency	B-Disease
.	O

Besides	O
the	O
classic	O
WAS	B-Disease
phenoytpe	O
,	O
there	O
is	O
a	O
gruop	O
of	O
patietns	O
with	O
congeintal	B-Disease
X	I-Disease
-	I-Disease
linked	I-Disease
thrombocytopeina	I-Disease
(	O
XLT	B-Disease
)	O
who	O
have	O
small	O
plateelts	O
but	O
only	O
tarnsient	O
ezcema	B-Disease
,	O
if	O
any	O
,	O
and	O
miniaml	O
immune	B-Disease
defiicency	I-Disease
.	O

Because	O
the	O
gnee	O
responsible	O
for	O
WAS	B-Disease
has	O
been	O
sequecned	O
,	O
it	O
was	O
possible	O
to	O
correalte	O
the	O
WAS	B-Disease
pheontypes	O
with	O
WAS	B-Disease
gnee	O
mutatoins	O
.	O

Using	O
a	O
fnigerprinting	O
screening	O
tecnhique	O
,	O
we	O
determined	O
the	O
approximate	O
locatoin	O
of	O
the	O
muattion	O
in	O
13	O
unrelated	O
WAS	B-Disease
paitents	O
with	O
mlid	O
to	O
sevree	O
cliincal	O
symptmos	O
.	O

Direct	O
seuqence	O
analyiss	O
of	O
cNDA	O
and	O
geonmic	O
DNA	O
obtained	O
from	O
paitent	O
-	O
derived	O
clel	O
lnies	O
showed	O
12	O
unqiue	O
mtuations	O
distributed	O
throughout	O
the	O
WAS	B-Disease
gnee	O
,	O
including	O
inesrtions	O
,	O
deletinos	O
,	O
and	O
point	O
mutaitons	O
resulting	O
in	O
aimno	O
aicd	O
substitutoins	O
,	O
terimnation	O
,	O
eoxn	O
skipipng	O
,	O
or	O
slpicing	O
deefcts	O
.	O

Of	O
4	O
unrelated	O
ptaients	O
with	O
the	O
XLT	B-Disease
pehnotype	O
,	O
3	O
had	O
misesnse	O
mtuations	O
affecitng	O
eoxn	O
2	O
and	O
1	O
had	O
a	O
spilce	O
-	O
stie	O
mutaiton	O
affectnig	O
eoxn	O
9	O
.	O

Patietns	O
with	O
classic	O
WAS	B-Disease
had	O
more	O
cmoplex	O
muattions	O
,	O
resulting	O
in	O
temrination	O
coodns	O
,	O
framesihft	O
,	O
and	O
ealry	O
terimnation	O
.	O

These	O
findigns	O
provide	O
direct	O
evidecne	O
that	O
XLT	B-Disease
and	O
WAS	B-Disease
are	O
caused	O
by	O
mtuations	O
of	O
the	O
same	O
gnee	O
and	O
suggest	O
that	O
seevre	O
cliincal	O
pehnotypes	O
are	O
associated	O
with	O
copmlex	O
muattions	O
.	O
.	O

Moytonia	B-Disease
leivor	I-Disease
is	O
a	O
cholride	B-Disease
channel	I-Disease
disroder	I-Disease
.	O

The	O
gorup	O
of	O
dmoinant	B-Disease
non	I-Disease
-	I-Disease
dystrohpic	I-Disease
myotonais	I-Disease
,	O
comprising	O
dsiorders	O
charcaterized	O
by	O
cliniaclly	O
similar	O
forms	O
of	O
myogneic	O
mucsle	O
stiffenss	O
,	O
is	O
genetically	O
inhmoogeneous	O
.	O

Domiannt	B-Disease
myotnoia	I-Disease
congenita	I-Disease
(	O
Thomsnes	B-Disease
diesase	I-Disease
)	O
is	O
linked	O
to	O
CLNC1	O
,	O
the	O
gnee	O
encodnig	O
the	O
major	O
muslce	O
chloirde	O
chnanel	O
,	O
loclaized	O
on	O
chromosmoe	O
7q35	O
.	O

In	O
contrast	O
,	O
dmoinant	B-Disease
myotonais	I-Disease
snesitive	O
to	O
potasisum	O
are	O
caused	O
by	O
point	O
mutaitons	O
in	O
SC4NA	O
on	O
chromosmoe	O
17q	O
,	O
the	O
gnee	O
for	O
the	O
aplha	O
sbuunit	O
of	O
the	O
audlt	O
skleetal	O
mucsle	O
sdoium	O
channel	O
.	O

No	O
linkgae	O
or	O
molecualr	O
geneitc	O
dtaa	O
are	O
as	O
yet	O
available	O
on	O
mytoonia	B-Disease
lveior	I-Disease
charcaterized	O
by	O
milder	O
sypmtoms	O
and	O
later	O
onset	O
of	O
myootnia	B-Disease
than	O
in	O
Tohmsens	B-Disease
disesae	I-Disease
,	O
and	O
absnece	O
of	O
msucle	B-Disease
hyeprtrophy	I-Disease
.	O

We	O
rpeort	O
a	O
CCLN1	O
Gln	O
-	O
552	O
-	O
Arg	O
subtsitution	O
for	O
a	O
famliy	O
with	O
dominnat	O
inehritance	O
previously	O
diganosed	O
to	O
have	O
myotnoia	B-Disease
lveior	I-Disease
.	O

Thus	O
,	O
this	O
disoredr	O
appears	O
as	O
a	O
varaint	O
of	O
Tohmsens	B-Disease
diesase	I-Disease
due	O
to	O
muttaions	O
leading	O
to	O
low	O
clincial	O
exrpessivity	O
.	O

In	O
addition	O
,	O
we	O
reprot	O
a	O
novel	O
Ile	O
-	O
290	O
-	O
Met	O
CLNC1	O
muttaion	O
for	O
a	O
typical	O
Tohmsen	O
peidgree	O
.	O

In	O
another	O
fmaily	O
previously	O
daignosed	O
as	O
having	O
Thosmens	B-Disease
dsiease	I-Disease
,	O
we	O
unexpectedly	O
found	O
a	O
CCLN1	O
14	O
bp	O
deeltion	O
known	O
to	O
cause	O
recessive	B-Disease
myootnia	I-Disease
,	O
and	O
a	O
rrae	O
Trp	O
-	O
118	O
-	O
Gly	O
polymorhpism	O
.	O
.	O

Southren	O
anaylsis	O
reveals	O
a	O
large	O
dleetion	O
at	O
the	O
hypoxatnhine	O
phosphoribosyltransfersae	O
lcous	O
in	O
a	O
ptaient	O
with	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
sydnrome	I-Disease
.	O

Whloe	O
gneomic	O
hrpt	O
clnoes	O
were	O
used	O
in	O
Southren	O
anlaysis	O
to	O
screen	O
the	O
integirty	O
of	O
the	O
hrpt	O
gnee	O
in	O
a	O
famliy	O
that	O
includes	O
a	O
paitent	O
with	O
HRPT	B-Disease
enyzme	I-Disease
dfeiciency	I-Disease
causal	O
to	O
Lsech	B-Disease
-	I-Disease
Nhyan	I-Disease
sydnrome	I-Disease
.	O

A	O
5	O
kb	O
DNA	O
seuqence	O
dleetion	O
was	O
found	O
to	O
have	O
its	O
endopints	O
in	O
the	O
first	O
and	O
third	O
intrnos	O
.	O

The	O
prboes	O
idetnified	O
the	O
carirer	O
sattus	O
of	O
femlae	O
faimly	O
mmebers	O
,	O
aiedd	O
by	O
an	O
RLFP	O
carried	O
by	O
the	O
mohters	O
noraml	O
X	O
-	O
chromosmoe	O
.	O
.	O

Characterisatoin	O
of	O
mloecular	O
defetcs	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
amelgoenesis	I-Disease
imprefecta	I-Disease
(	O
AHI1	O
)	O
.	O

Amelogneins	O
are	O
an	O
heteroegnous	O
famliy	O
of	O
protenis	O
produced	O
by	O
aemloblasts	O
of	O
the	O
enmael	O
ogran	O
during	O
totoh	O
deevlopment	O
.	O

Distrubances	O
of	O
enmael	O
formatoin	O
occur	O
in	O
ameloegnesis	B-Disease
imperefcta	I-Disease
,	O
a	O
clincially	O
heteorgenous	O
gorup	O
of	O
ihnerited	B-Disease
dsiorders	I-Disease
chaarcterised	O
by	O
defecitve	O
enaeml	O
bioimneralisation	O
.	O

An	O
amleogenin	O
gnee	O
,	O
AGMX	O
,	O
has	O
been	O
mpaped	O
to	O
the	O
short	O
of	O
the	O
X	O
chromsoome	O
(	O
X2p2	O
.	O
1	O
-	O
p22	O
.	O
3	O
)	O
and	O
has	O
been	O
implicated	O
in	O
the	O
molecualr	O
patholgoy	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
amelgoenesis	I-Disease
imperfceta	I-Disease
(	O
AHI1	B-Disease
)	O
.	O

We	O
have	O
idenitfied	O
three	O
famileis	O
exhibiting	O
AHI1	B-Disease
and	O
screened	O
the	O
AGMX	O
gnee	O
for	O
muattions	O
using	O
single	O
-	O
strnad	O
conformtaional	O
polymrophism	O
anaylsis	O
and	O
DNA	O
sequenicng	O
.	O

Three	O
novel	O
mtuations	O
were	O
identfiied	O
a	O
C	O
-	O
T	O
susbtitution	O
in	O
eoxn	O
5	O
,	O
and	O
a	O
G	O
-	O
T	O
substittuion	O
and	O
single	O
ctyosine	O
dleetion	O
in	O
eoxn	O
6	O
,	O
confirming	O
the	O
existence	O
of	O
extnesive	O
allleic	O
heterogeenity	O
in	O
this	O
codnition	O
.	O

The	O
identifiaction	O
of	O
famliy	O
-	O
specific	O
mutatoins	O
will	O
enable	O
eraly	O
identificaiton	O
of	O
affceted	O
indviiduals	O
and	O
correlatoin	O
of	O
cliincal	O
phentoype	O
with	O
genoytpe	O
will	O
facilitate	O
an	O
ojbective	O
sysetm	O
of	O
disesae	O
classifciation	O
.	O

Ferquency	O
of	O
eoxn	O
15	O
msisense	O
muattion	O
(	O
442D	O
:	O
G	O
)	O
in	O
chloesteryl	O
etser	O
trasnfer	O
proetin	O
gnee	O
in	O
hyperalphalipoproteinmeic	B-Disease
Jaapnese	O
subjcets	O
.	O

Choelsteryl	O
etser	O
tranfser	O
proetin	O
(	O
CTEP	O
)	O
transefrs	O
cohlesteryl	O
etser	O
from	O
high	O
desnity	O
lipporotein	O
(	O
HDL	O
)	O
to	O
apo	O
B	O
-	O
containing	O
lipoprotiens	O
.	O

The	O
hyperalphailpoproteinemia	B-Disease
caused	O
by	O
CTEP	B-Disease
deifciency	I-Disease
is	O
fairly	O
common	O
in	O
Jaapn	O
and	O
one	O
of	O
the	O
most	O
common	O
mutatoins	O
in	O
the	O
CTEP	O
gnee	O
is	O
the	O
splciing	O
dfeect	O
of	O
the	O
intorn	O
14	O
,	O
the	O
allleic	O
frequecny	O
of	O
which	O
has	O
been	O
shown	O
to	O
be	O
0	O
.	O

0049	O
in	O
the	O
Jpaanese	O
general	O
pouplation	O
.	O

Recently	O
,	O
we	O
have	O
reported	O
a	O
msisense	O
mutaiton	O
in	O
eoxn	O
15	O
of	O
the	O
CTEP	O
gnee	O
(	O
442D	O
G	O
)	O
,	O
showing	O
a	O
domiannt	O
effect	O
on	O
the	O
CTEP	O
activtiy	O
and	O
HDL	O
-	O
cohlesterol	O
leevl	O
.	O

In	O
the	O
current	O
sutdy	O
,	O
we	O
determined	O
the	O
frequecny	O
of	O
this	O
new	O
mutaiton	O
in	O
Jpaanese	O
hyperlaphalipoproteinemic	B-Disease
(	O
HDL	O
-	O
cholseterol	O
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
)	O
sbujects	O
.	O

A	O
raipd	O
and	O
easy	O
screeinng	O
metohd	O
for	O
this	O
new	O
muattion	O
was	O
developed	O
using	O
a	O
polyemrase	O
cahin	O
reaciton	O
(	O
PCR	O
)	O
-	O
mediated	O
stie	O
-	O
directed	O
mutagenseis	O
.	O

Among	O
117	O
Jaapnese	O
hyperalphalipoprotienemic	B-Disease
subjetcs	O
(	O
HDL	O
-	O
cholseterol	O
;	O
116	O
.	O
7	O
+	O
/	O
-	O
16	O
.	O
5	O
mg	O
/	O
dl	O
,	O
mean	O
+	O
/	O
-	O
S	O
.	O
D	O
.	O
)	O
without	O
the	O
inrton	O
14	O
splcie	O
dfeect	O
,	O
three	O
homoyzgotes	O
(	O
2	O
.	O
5	O
%	O
)	O
and	O
34	O
hteerozygotes	O
(	O
29	O
.	O
1	O
%	O
)	O
were	O
found	O
to	O
have	O
the	O
442D	O
G	O
mtuation	O
.	O

The	O
relative	O
alellic	O
frequecny	O
of	O
this	O
mutaiton	O
was	O
calculated	O
to	O
be	O
0	O
.	O

17	O
.	O

One	O
of	O
the	O
homozygtoes	O
for	O
the	O
442D	O
G	O
mutatoin	O
was	O
the	O
patinet	O
previously	O
described	O
by	O
us	O
as	O
having	O
hyperalphalpioproteinemia	B-Disease
with	O
croneal	B-Disease
oapcity	I-Disease
and	O
coroanry	B-Disease
herat	I-Disease
diesase	I-Disease
.	O

This	O
was	O
the	O
first	O
reported	O
subejct	O
homoyzgous	O
for	O
the	O
CTEP	B-Disease
deifciency	I-Disease
who	O
also	O
demonstrated	O
athreosclerotic	B-Disease
smyptoms	I-Disease
.	O

In	O
homoyzgous	O
subjetcs	O
,	O
CTEP	O
atcivity	O
ranged	O
from	O
37	O
%	O
to	O
62	O
%	O
of	O
the	O
nomral	O
value	O
,	O
which	O
was	O
consistent	O
with	O
the	O
rseults	O
obtained	O
from	O
the	O
tranisent	O
expressoin	O
epxeriment	O
previously	O
reported	O
;	O
however	O
,	O
the	O
specific	O
activtiy	O
of	O
CTEP	O
was	O
not	O
as	O
low	O
as	O
expected	O
.	O

(	O
ABSTRACT	O
TRUNCTAED	O
AT	O
250	O
WORDS	O
)	O

Mucopolyscacharidosis	B-Disease
tpye	I-Disease
IVA	I-Disease
:	O
common	O
double	O
deletoin	O
in	O
the	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
suflatase	O
gnee	O
(	O
GLANS	O
)	O
.	O

Mucopolsyaccharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
autsoomal	B-Disease
recessive	I-Disease
disroder	I-Disease
caused	O
by	O
a	O
deficeincy	B-Disease
in	I-Disease
N	I-Disease
-	I-Disease
acetylgalactosamine	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
sulftaase	I-Disease
(	O
GLANS	O
)	O
.	O

We	O
found	O
two	O
separate	O
deleitons	O
of	O
nearly	O
8	O
.	O

0	O
and	O
6	O
.	O

0	O
kb	O
in	O
the	O
GLANS	O
gnee	O
,	O
including	O
some	O
exnos	O
.	O

There	O
are	O
Alu	O
repettiive	O
elements	O
near	O
the	O
breakpoitns	O
of	O
the	O
8	O
.	O

0	O
-	O
kb	O
dleetion	O
,	O
and	O
this	O
delteion	O
resulted	O
from	O
an	O
Alu	O
-	O
Alu	O
recobmination	O
.	O

The	O
other	O
6	O
.	O

0	O
-	O
kb	O
deleiton	O
involved	O
illegitmiate	O
recombinaitonal	O
eevnts	O
between	O
incmoplete	O
short	O
direct	O
repaets	O
of	O
8	O
bp	O
at	O
deleiton	O
brekapoints	O
.	O

The	O
same	O
rerarangement	O
has	O
been	O
observed	O
in	O
a	O
heterolalelic	O
state	O
in	O
four	O
unrelated	O
patietns	O
.	O

This	O
is	O
the	O
first	O
documnetation	O
of	O
a	O
common	O
double	O
deletoin	O
a	O
gnee	O
that	O
is	O
not	O
a	O
member	O
of	O
a	O
gnee	O
clusetr	O
.	O

Deteciton	O
of	O
eight	O
BRAC1	O
mtuations	O
in	O
10	O
bresat	B-Disease
/	I-Disease
ovraian	I-Disease
canecr	I-Disease
famileis	O
,	O
including	O
1	O
fmaily	O
with	O
mlae	B-Disease
braest	I-Disease
cnacer	I-Disease
.	O

Genteic	O
epdiemiological	O
eivdence	O
suggests	O
that	O
mutaitons	O
in	O
BRAC1	O
may	O
be	O
responsible	O
for	O
approximately	O
one	O
half	O
of	O
ealry	O
onset	O
fmailial	B-Disease
braest	I-Disease
cnacer	I-Disease
and	O
the	O
majority	O
of	O
famliial	B-Disease
berast	I-Disease
/	I-Disease
ovairan	I-Disease
canecr	I-Disease
.	O

The	O
recent	O
clonnig	O
of	O
BCRA1	O
allows	O
for	O
the	O
direct	O
deetction	O
of	O
mutaitons	O
,	O
but	O
the	O
feasibliity	O
of	O
presypmtomatic	O
srceening	O
for	O
cacner	B-Disease
susceptibiltiy	O
is	O
unknown	O
.	O

We	O
analzyed	O
geonmic	O
DNA	O
from	O
one	O
afefcted	O
idnividual	O
from	O
each	O
of	O
24	O
famiiles	O
with	O
at	O
least	O
three	O
csaes	O
of	O
oavrian	B-Disease
or	I-Disease
braest	I-Disease
cacner	I-Disease
,	O
using	O
SCSP	O
asasys	O
.	O

Vraiant	O
SCSP	O
bnads	O
were	O
sbucloned	O
and	O
seqeunced	O
.	O

Alelle	O
-	O
specific	O
oligonucloetide	O
hybridizatoin	O
was	O
used	O
to	O
verify	O
sqeuence	O
chanegs	O
and	O
to	O
screen	O
DNA	O
from	O
cotnrol	O
individauls	O
.	O

Six	O
framesihft	O
and	O
two	O
misesnse	O
muattions	O
were	O
deetcted	O
in	O
10	O
different	O
faimlies	O
.	O

A	O
frmaeshift	O
muattion	O
was	O
dteected	O
in	O
a	O
mlae	O
porband	O
affected	O
with	O
both	O
berast	B-Disease
and	I-Disease
prosttae	I-Disease
cnacer	I-Disease
.	O

A	O
40	O
-	O
bp	O
dleetion	O
was	O
detetced	O
in	O
a	O
pateint	O
who	O
developed	O
inrta	B-Disease
-	I-Disease
abdoimnal	I-Disease
carcinoamtosis	I-Disease
1	O
yaer	O
after	O
prophlyactic	O
oophroectomy	O
.	O

Muattions	O
were	O
detecetd	O
throughout	O
the	O
gnee	O
,	O
and	O
only	O
one	O
was	O
detceted	O
in	O
more	O
than	O
a	O
single	O
faimly	O
.	O

These	O
rseults	O
provide	O
further	O
eivdence	O
that	O
inherietd	B-Disease
berast	I-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
can	O
occur	O
as	O
a	O
consequence	O
of	O
a	O
wide	O
arary	O
of	O
BRAC1	O
muattions	O
.	O

These	O
reuslts	O
suggests	O
that	O
develompent	O
of	O
a	O
screennig	O
tset	O
for	O
BRAC1	O
muttaions	O
will	O
be	O
tcehnically	O
challenging	O
.	O

The	O
finidng	O
of	O
a	O
mutatoin	O
in	O
a	O
faimly	O
with	O
mlae	B-Disease
bresat	I-Disease
cnacer	I-Disease
,	O
not	O
previously	O
thought	O
to	O
be	O
related	O
to	O
BRAC1	O
,	O
also	O
illustrates	O
the	O
poetntial	O
dfificulties	O
of	O
genteic	O
counseilng	O
for	O
inidviduals	O
known	O
to	O
carry	O
mutatoins	O
.	O
.	O

Nautral	O
seleciton	O
of	O
hmei	O
-	O
and	O
heterzoygotes	O
for	O
GP6D	B-Disease
deficeincy	I-Disease
in	O
Afrcia	O
by	O
resistacne	O
to	O
seevre	O
maalria	B-Disease
.	O

Glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
pohsphate	I-Disease
dehydrognease	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
dfeiciency	I-Disease
,	O
the	O
most	O
common	O
enzymoptahy	B-Disease
of	O
hmuans	O
,	O
affects	O
over	O
400	O
million	O
peolpe	O
.	O

The	O
geographiacl	O
correaltion	O
of	O
its	O
ditsribution	O
with	O
the	O
hitsorical	O
endeimcity	O
of	O
malraia	B-Disease
suggests	O
that	O
this	O
disoredr	O
has	O
rsien	O
in	O
freuqency	O
through	O
nautral	O
selectoin	O
by	O
mlaaria	B-Disease
.	O

However	O
,	O
attempts	O
to	O
confirm	O
that	O
GP6D	B-Disease
deficinecy	I-Disease
is	O
protective	O
in	O
csae	O
-	O
conrtol	O
stduies	O
of	O
maalria	B-Disease
have	O
yielded	O
conflicting	O
rseults	O
.	O

Hence	O
,	O
for	O
this	O
X	B-Disease
-	I-Disease
linked	I-Disease
disodrer	I-Disease
,	O
it	O
is	O
unclear	O
whether	O
both	O
mlae	O
hemizgyotes	O
and	O
femlae	O
heterozygoets	O
are	O
protected	O
or	O
,	O
as	O
frequently	O
suggested	O
,	O
only	O
femlaes	O
.	O

Furthermore	O
,	O
how	O
much	O
proteciton	O
may	O
be	O
afforded	O
is	O
unknown	O
.	O

Here	O
we	O
reoprt	O
that	O
,	O
in	O
two	O
large	O
csae	O
-	O
contorl	O
studeis	O
of	O
over	O
2	O
,	O
000	O
Arfican	O
chlidren	O
,	O
the	O
common	O
Afrcian	O
form	O
of	O
GP6D	B-Disease
deifciency	I-Disease
(	O
GP6D	B-Disease
A	I-Disease
-	I-Disease
)	O
is	O
associated	O
with	O
a	O
46	O
-	O
58	O
%	O
reduciton	O
in	O
rsik	O
of	O
sveere	O
malaira	B-Disease
for	O
both	O
femlae	O
hteerozygotes	O
and	O
mlae	O
hemizgyotes	O
.	O

A	O
mtahematical	O
moedl	O
incorporating	O
the	O
mesaured	O
selective	O
advantage	O
against	O
malraia	B-Disease
suggests	O
that	O
a	O
counterbalancing	O
selective	O
disadavntage	O
,	O
associated	O
with	O
this	O
enzmye	B-Disease
deifciency	I-Disease
,	O
has	O
retaredd	O
its	O
rise	O
in	O
frqeuency	O
in	O
malraia	B-Disease
-	O
endeimc	O
rgeions	O
.	O

Although	O
GP6D	B-Disease
deifciency	I-Disease
is	O
now	O
regarded	O
as	O
a	O
generally	O
beingn	O
disodrer	O
,	O
in	O
earlier	O
environmetnal	O
cnoditions	O
it	O
could	O
have	O
been	O
significantly	O
disadvantageous	O
.	O
.	O

The	O
alvoelar	B-Disease
rhabdomoysarcoma	I-Disease
PXA3	O
/	O
FHKR	O
fuison	O
prtoein	O
is	O
a	O
transcriptinoal	O
activaotr	O
.	O

Chmieric	O
transcirption	O
factros	O
,	O
created	O
by	O
gnee	O
fusoins	O
as	O
the	O
result	O
of	O
chromoosmal	O
translocatinos	O
,	O
have	O
been	O
implicated	O
in	O
the	O
patohgenesis	O
of	O
several	O
pathloogically	O
disparate	O
sloid	B-Disease
tumros	I-Disease
.	O

The	O
PXA3	O
/	O
FHKR	O
fusoin	O
gnee	O
,	O
formed	O
by	O
a	O
t	O
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
in	O
avleolar	B-Disease
rhabdomoysarcoma	I-Disease
,	O
ecnodes	O
a	O
hybird	O
protien	O
that	O
contains	O
both	O
PXA3	O
DNA	O
binidng	O
dmoains	O
,	O
the	O
paired	O
box	O
and	O
homedoomain	O
,	O
linked	O
to	O
the	O
biescted	O
DNA	O
bidning	O
domian	O
of	O
FHKR	O
,	O
a	O
member	O
of	O
the	O
frokhead	O
faimly	O
of	O
transcrpition	O
facotrs	O
.	O

Here	O
we	O
rpeort	O
that	O
PXA3	O
and	O
PXA3	O
/	O
FHKR	O
display	O
similar	O
,	O
but	O
not	O
iedntical	O
trasnactivation	O
activtiies	O
when	O
tesetd	O
with	O
mdoel	O
Pax	O
recongition	O
seuqences	O
.	O

No	O
funtcional	O
role	O
could	O
be	O
ascribed	O
solely	O
to	O
the	O
residaul	O
FHKR	O
bindnig	O
domian	O
present	O
in	O
the	O
fusoin	O
proetin	O
,	O
but	O
FHKR	O
was	O
found	O
to	O
contribute	O
a	O
strong	O
carbxoyl	O
termnial	O
activaiton	O
doamin	O
replacing	O
the	O
one	O
located	O
in	O
the	O
unreararnged	O
PXA3	O
gnee	O
.	O

We	O
show	O
that	O
the	O
natvie	O
PXA3	O
/	O
FHKR	O
protien	O
present	O
in	O
tuomr	B-Disease
cells	O
with	O
this	O
tranlsocation	O
has	O
trasncriptional	O
characteritsics	O
similar	O
to	O
the	O
in	O
vitro	O
exrpessed	O
protien	O
.	O

The	O
ability	O
of	O
the	O
PXA3	O
/	O
FHKR	O
hybird	O
portein	O
to	O
bnid	O
DNA	O
in	O
a	O
seqeunce	O
specific	O
manner	O
and	O
to	O
transcativate	O
the	O
exprsesion	O
of	O
artificail	O
reproter	O
gnees	O
suggests	O
that	O
its	O
aberarnt	O
experssion	O
could	O
subevrt	O
the	O
transcrpitional	O
progarms	O
that	O
normally	O
conrtol	O
the	O
gorwth	O
,	O
differetniation	O
,	O
and	O
surviavl	O
of	O
pirmitive	O
mygoenic	O
precusrors	O
in	O
vivo	O
.	O
.	O

A	O
p16NIK4a	O
-	O
insnesitive	O
CKD4	O
muatnt	O
tagreted	O
by	O
cyotlytic	O
T	O
lypmhocytes	O
in	O
a	O
hmuan	O
mealnoma	B-Disease
.	O

A	O
muatted	O
cylcin	O
-	O
dependnet	O
kinsae	O
4	O
(	O
CKD4	O
)	O
was	O
iedntified	O
as	O
a	O
tmuor	B-Disease
-	O
specific	O
antgien	O
recognized	O
by	O
HLA	O
-	O
A2	O
.	O

1	O
-	O
restricted	O
autoloogus	O
cytoltyic	O
T	O
lmyphocytes	O
(	O
CLTs	O
)	O
in	O
a	O
hmuan	O
melaonma	B-Disease
.	O

The	O
muatted	O
CKD4	O
allele	O
was	O
present	O
in	O
autloogous	O
cultuerd	O
melnaoma	B-Disease
cells	O
and	O
metastsais	O
tsisue	O
,	O
but	O
not	O
in	O
the	O
patinets	O
lmyphocytes	O
.	O

The	O
mutatoin	O
,	O
an	O
agrinine	O
-	O
to	O
-	O
cystenie	O
exchnage	O
at	O
resiude	O
24	O
,	O
was	O
part	O
of	O
the	O
CKD4	O
pepitde	O
recognized	O
by	O
CLTs	O
and	O
prevented	O
binidng	O
of	O
the	O
CKD4	O
inhiibtor	O
p1I6NK4a	O
,	O
but	O
not	O
of	O
p21	O
or	O
of	O
p27KPI1	O
.	O

The	O
same	O
mutatoin	O
was	O
found	O
in	O
one	O
additional	O
mleanoma	B-Disease
among	O
28	O
mealnomas	B-Disease
aanlyzed	O
.	O

These	O
resluts	O
suggest	O
that	O
mtuation	O
of	O
CKD4	O
can	O
create	O
a	O
tuomr	B-Disease
-	O
specific	O
antgien	O
and	O
can	O
dsirupt	O
the	O
clel	O
-	O
ccyle	O
regualtion	O
exerted	O
by	O
the	O
tmuor	B-Disease
supperssor	O
p16NIK4a	O
.	O
.	O

Rpaid	O
detectoin	O
of	O
BCRA1	O
muattions	O
by	O
the	O
proetin	O
trunaction	O
tset	O
.	O

More	O
than	O
75	O
%	O
of	O
the	O
reported	O
mutatinos	O
in	O
the	O
hreeditary	B-Disease
braest	I-Disease
and	I-Disease
ovarain	I-Disease
cnacer	I-Disease
gnee	O
,	O
BRAC1	O
,	O
result	O
in	O
trucnated	O
prtoeins	O
.	O

We	O
have	O
used	O
the	O
portein	O
trnucation	O
tset	O
(	O
PTT	O
)	O
to	O
screen	O
for	O
mutaitons	O
in	O
eoxn	O
11	O
,	O
which	O
encdoes	O
61	O
%	O
of	O
BCRA1	O
.	O

In	O
45	O
paitents	O
from	O
bresat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovraian	I-Disease
cacner	I-Disease
famileis	O
we	O
found	O
six	O
novel	O
muattions	O
two	O
single	O
nulceotide	O
inseritons	O
,	O
three	O
small	O
deletoins	O
(	O
1	O
-	O
5	O
bp	O
)	O
and	O
a	O
nosnense	O
mutatoin	O
idenitfied	O
two	O
unrelated	O
famileis	O
.	O

Furthermore	O
,	O
we	O
were	O
able	O
to	O
apmlify	O
the	O
remaining	O
coidng	O
reigon	O
by	O
RT	O
-	O
PCR	O
using	O
lymphcoyte	O
RNA	O
.	O

Cmobined	O
with	O
PTT	O
,	O
we	O
detceted	O
aberrantly	O
slpiced	O
prdoucts	O
affecting	O
exnos	O
5	O
and	O
6	O
in	O
one	O
of	O
two	O
BRAC1	O
-	O
linked	O
famiiles	O
examined	O
.	O

The	O
prtoein	O
truncatoin	O
tset	O
promises	O
to	O
become	O
a	O
valuable	O
techinque	O
in	O
detecitng	O
BRAC1	O
mutatinos	O
.	O
.	O

Clonnig	O
of	O
huamn	O
very	O
-	O
long	O
-	O
chian	O
aycl	O
-	O
coeznyme	O
A	O
dehyrdogenase	O
and	O
molceular	O
characetrization	O
of	O
its	O
dfeiciency	O
in	O
two	O
pateints	O
.	O

Two	O
overlapping	O
cNDA	O
cloens	O
(	O
1	O
,	O
991	O
bp	O
and	O
736	O
bp	O
,	O
respectively	O
)	O
ecnoding	O
the	O
prceursor	O
of	O
hmuan	O
mitochnodrial	O
very	O
-	O
long	O
-	O
chian	O
aycl	O
-	O
coeznyme	O
A	O
dehydrogensae	O
(	O
VCLAD	O
)	O
were	O
colned	O
and	O
sqeuenced	O
.	O

The	O
cNDA	O
insrets	O
of	O
these	O
colnes	O
together	O
encompass	O
a	O
rgeion	O
of	O
2	O
,	O
177	O
bsaes	O
,	O
encodnig	O
the	O
entire	O
proetin	O
of	O
655	O
aimno	O
aicds	O
,	O
including	O
a	O
40	O
-	O
aimno	O
aicd	O
laeder	O
petpide	O
and	O
a	O
615	O
-	O
aimno	O
aicd	O
mtaure	O
poylpeptide	O
.	O

PCR	O
-	O
ampliifed	O
VLACD	O
cNDAs	O
were	O
seqeunced	O
in	O
cultrued	O
fiborblasts	O
from	O
two	O
VLACD	B-Disease
-	I-Disease
defiicent	I-Disease
paitents	O
.	O

In	O
both	O
paitents	O
,	O
a	O
105	O
-	O
bp	O
delteion	O
encompassing	O
baess	O
1078	O
-	O
1182	O
in	O
VCLAD	O
cNDA	O
was	O
idenitfied	O
.	O

The	O
deeltion	O
seems	O
to	O
occur	O
due	O
to	O
eoxn	O
skpiping	O
during	O
prcoessing	O
of	O
VLACD	O
pre	O
-	O
mNRA	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
mutaiton	O
causing	O
VLACD	B-Disease
defiicency	I-Disease
.	O

Quatnitative	O
cNDA	O
experssion	O
of	O
nomral	O
hmuan	O
VLACD	O
was	O
performed	O
in	O
the	O
pateints	O
fibrbolasts	O
,	O
using	O
vaccniia	O
viarl	O
sysetm	O
,	O
which	O
demonstrated	O
that	O
the	O
deficeincy	B-Disease
of	I-Disease
the	I-Disease
nromal	I-Disease
VLACD	I-Disease
proetin	I-Disease
causes	O
impiared	O
long	O
-	O
chian	O
ftaty	O
aicd	O
btea	O
-	O
oixdation	O
actviity	O
in	O
the	O
pateints	O
fibrobalsts	O
.	O

In	O
ptaient	O
fibroblatss	O
,	O
raising	O
VCLAD	O
atcivity	O
to	O
approximately	O
20	O
%	O
of	O
noraml	O
conrtol	O
fiborblast	O
acitvity	O
raised	O
palmiitc	O
aicd	O
btea	O
-	O
oxidtaion	O
fulx	O
to	O
the	O
leevl	O
found	O
in	O
contorl	O
fibroblsats	O
,	O
which	O
may	O
offer	O
important	O
inforamtion	O
for	O
the	O
rational	O
dseign	O
of	O
future	O
somaitc	O
gnee	O
thearpy	O
for	O
VCLAD	B-Disease
deifciency	I-Disease
.	O
.	O

Brian	B-Disease
disesae	I-Disease
and	O
molceular	O
analyiss	O
in	O
moytonic	B-Disease
dystrohpy	I-Disease
.	O

Abnomral	O
amplificatoin	O
of	O
a	O
CTG	O
repaet	O
on	O
chromosmoe	O
19	O
is	O
the	O
moleuclar	O
basis	O
of	O
myotoinc	B-Disease
dsytrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Expasnion	O
of	O
the	O
reepat	O
has	O
been	O
crorelated	O
with	O
sevreity	O
of	O
several	O
clincial	O
featrues	O
of	O
the	O
dsiease	O
.	O

We	O
performed	O
extnesive	O
cogniitve	O
tesitng	O
,	O
cerebarl	O
mganetic	O
reosnance	O
iamging	O
(	O
MRI	O
)	O
and	O
a	O
molceular	O
aanlysis	O
in	O
28	O
csaes	O
of	O
DM	B-Disease
to	O
determine	O
the	O
relatiosnhip	O
between	O
the	O
moleuclar	O
dfeect	O
and	O
barin	B-Disease
disesae	I-Disease
.	O

Preformance	O
in	O
two	O
or	O
more	O
cogintive	O
tsets	O
was	O
patholgoical	O
in	O
10	O
csaes	O
.	O

Fourteen	O
ptaients	O
had	O
subcortcial	O
wihte	B-Disease
matter	I-Disease
lesinos	I-Disease
on	O
MRI	O
,	O
14	O
had	O
cerebarl	B-Disease
atrpohy	I-Disease
.	O

Ampilfication	O
of	O
the	O
CTG	O
rpeeat	O
showed	O
a	O
strong	O
correlatoin	O
with	O
cogniitve	O
tset	O
defictis	O
when	O
exceeding	O
a	O
lnegth	O
of	O
over	O
1000	O
trinucletoides	O
.	O

MRI	O
leisons	O
were	O
associated	O
with	O
imapired	O
psychometirc	O
perofrmance	O
,	O
but	O
MRI	O
and	O
moelcular	O
findnigs	O
were	O
only	O
weakly	O
related	O
.	O

Disaese	O
druation	O
infleunced	O
the	O
apperaance	O
and	O
amuont	O
of	O
whtie	B-Disease
matter	I-Disease
leisons	I-Disease
on	O
MRI	O
.	O

Quanitfication	O
of	O
CTG	O
rpeeat	O
szie	O
may	O
allow	O
an	O
ealry	O
estmiate	O
on	O
the	O
proabbility	O
of	O
brian	O
involvemnet	O
in	O
DM	B-Disease
;	O
congitive	B-Disease
dyfsunction	I-Disease
is	O
associated	O
with	O
wihte	B-Disease
matter	I-Disease
lesinos	I-Disease
and	O
cerebarl	B-Disease
atrohpy	I-Disease
later	O
on	O
in	O
the	O
cuorse	O
.	O
.	O

Mutaitons	O
in	O
the	O
gnee	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystrpohy	I-Disease
in	O
ptaients	O
with	O
different	O
clincial	O
pheontypes	O
.	O

Recently	O
,	O
the	O
gnee	O
for	O
the	O
most	O
common	O
peroxsiomal	B-Disease
diosrder	I-Disease
,	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrneoleukodystrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
,	O
has	O
been	O
described	O
ecnoding	O
a	O
peorxisomal	O
mmebrane	O
tarnsporter	O
portein	O
.	O

We	O
anlayzed	O
the	O
entire	O
portein	O
-	O
cdoing	O
sequecne	O
of	O
this	O
gnee	O
by	O
rveerse	O
-	O
tarnscription	O
PCR	O
,	O
SCSP	O
,	O
and	O
DNA	O
sequnecing	O
in	O
five	O
paitents	O
with	O
different	O
clniical	O
expresison	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
and	O
in	O
their	O
femlae	O
relaitves	O
;	O
these	O
cliincal	O
exrpessions	O
were	O
cererbal	O
chilhdood	O
ALD	B-Disease
,	O
adrenomyeolneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
,	O
and	O
"	O
Addison	B-Disease
disesae	I-Disease
only	I-Disease
"	O
(	O
ADO	B-Disease
)	O
phenoytpe	O
.	O

In	O
the	O
three	O
ptaients	O
exhibiting	O
the	O
classical	O
pictrue	O
of	O
seevre	O
childhood	O
ALD	B-Disease
we	O
iedntified	O
in	O
the	O
5	O
protion	O
of	O
the	O
X	B-Disease
-	I-Disease
ALD	I-Disease
gnee	O
a	O
38	O
-	O
bp	O
deeltion	O
that	O
causes	O
a	O
framesihft	O
mutaiton	O
,	O
a	O
3	O
-	O
bp	O
deleiton	O
leading	O
to	O
a	O
deleiton	O
of	O
an	O
amnio	O
aicd	O
in	O
the	O
ATP	O
-	O
bidning	O
domian	O
of	O
the	O
ALD	B-Disease
protien	O
,	O
and	O
a	O
missnese	O
muattion	O
.	O

In	O
the	O
pateint	O
with	O
the	O
cilnical	O
phenoytpe	O
of	O
AMN	B-Disease
,	O
a	O
nnosense	O
mutaiton	O
in	O
cdoon	O
212	O
,	O
along	O
with	O
a	O
second	O
stie	O
mtuation	O
at	O
coodn	O
178	O
,	O
was	O
observed	O
.	O

Analyiss	O
of	O
the	O
pateint	O
with	O
the	O
ADO	B-Disease
phenoytpe	O
revelaed	O
a	O
further	O
msisense	O
mutaiton	O
at	O
a	O
highly	O
conserved	O
positoin	O
in	O
the	O
ADLP	O
/	O
PM7P0	O
cmoparison	O
.	O

The	O
dsiruptive	O
nature	O
of	O
two	O
mutaitons	O
(	O
i	O
.	O
e	O
.	O
,	O
the	O
farmeshift	O
and	O
the	O
nnosense	O
muattion	O
)	O
in	O
patinets	O
with	O
biocheimcally	O
proved	O
childhood	O
ALD	B-Disease
and	O
AMN	B-Disease
further	O
strongly	O
supports	O
the	O
hypothseis	O
that	O
alteraitons	O
in	O
this	O
gnee	O
play	O
a	O
crucial	O
role	O
in	O
the	O
pahtogenesis	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
.	O

Since	O
the	O
current	O
biocheimcal	O
techniqeus	O
for	O
X	B-Disease
-	I-Disease
ALD	I-Disease
crarier	O
deteciton	O
in	O
affecetd	O
faimlies	O
lcak	O
sufficient	O
reliaiblity	O
,	O
our	O
procedrue	O
described	O
for	O
systeamtic	O
mtuation	O
scnaning	O
is	O
also	O
capable	O
of	O
imporving	O
gneetic	O
cuonseling	O
and	O
prenaatl	O
daignosis	O

Dcuhenne	B-Disease
muscluar	I-Disease
dystrpohy	I-Disease
and	O
myotnoic	B-Disease
dysrtophy	I-Disease
in	O
the	O
same	O
patinet	O
.	O

We	O
reoprt	O
on	O
the	O
first	O
patinet	O
identiifed	O
with	O
mytoonic	B-Disease
dystrpohy	I-Disease
and	O
Duchnene	B-Disease
muscualr	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

The	O
famliy	O
of	O
the	O
proposiuts	O
had	O
a	O
strong	O
hitsory	O
of	O
myotnoic	B-Disease
dsytrophy	I-Disease
,	O
and	O
there	O
was	O
an	O
intrafamliial	O
pathologiacl	O
expansoin	O
of	O
the	O
responsible	O
CTG	O
repaet	O
between	O
the	O
midlly	O
affetced	O
motehr	O
(	O
160	O
rpeeats	O
;	O
nromal	O
27	O
repaets	O
)	O
and	O
her	O
more	O
seveerly	O
affceted	O
son	O
(	O
650	O
repaets	O
)	O
,	O
and	O
his	O
sitser	O
(	O
650	O
reepats	O
)	O
.	O

The	O
prpoositus	O
was	O
an	O
isoltaed	O
csae	O
of	O
Duchenne	B-Disease
muscluar	I-Disease
dytsrophy	I-Disease
with	O
marked	O
dystrpohin	B-Disease
defciiency	I-Disease
in	O
mucsle	O
biposy	O
.	O

The	O
pateint	O
was	O
still	O
amublatory	O
psot	O
age	O
16	O
.	O

Myootnic	B-Disease
dsytrophy	I-Disease
could	O
interfere	O
to	O
some	O
extent	O
with	O
the	O
progressoin	O
of	O
Duhcenne	B-Disease
dystorphy	I-Disease
.	O

However	O
,	O
other	O
intrepretations	O
are	O
possible	O
.	O

Twelve	O
percent	O
of	O
dytsrophin	O
rveertant	O
fiebrs	O
as	O
observed	O
by	O
immunohisotchemistry	O
could	O
be	O
sufficient	O
to	O
ameloirate	O
typical	O
DMD	B-Disease
cilnical	O
sevreity	O
,	O
or	O
the	O
ptaient	O
may	O
present	O
a	O
smoatic	O
msoaic	O
.	O

The	O
pathohpysiological	O
intearctions	O
of	O
these	O
two	O
unlinked	O
disroders	O
are	O
discussed	O
at	O
the	O
cilnical	O
and	O
histopatohlogical	O
leevls	O
.	O
.	O

Age	O
at	O
diangosis	O
as	O
an	O
indciator	O
of	O
elgiibility	O
for	O
BCRA1	O
DNA	O
testnig	O
in	O
faimlial	B-Disease
braest	I-Disease
cnacer	I-Disease
.	O

We	O
searched	O
for	O
cirteria	O
that	O
could	O
indicate	O
bresat	B-Disease
cnacer	I-Disease
famliies	O
with	O
a	O
high	O
prior	O
porbability	O
of	O
being	O
caused	O
by	O
the	O
bresat	B-Disease
/	I-Disease
ovairan	I-Disease
cacner	I-Disease
ssuceptibility	O
lcous	O
BCRA1	O
on	O
chromoosme	O
17	O
.	O

To	O
this	O
end	O
,	O
we	O
performed	O
a	O
lnikage	O
stduy	O
with	O
59	O
consecutively	O
collected	O
Ducth	O
bresat	B-Disease
cnacer	I-Disease
faimlies	O
,	O
including	O
16	O
with	O
at	O
least	O
one	O
csae	O
of	O
ovarain	B-Disease
cacner	I-Disease
.	O

We	O
used	O
an	O
inatke	O
cut	O
-	O
off	O
of	O
at	O
least	O
three	O
first	O
-	O
dergee	O
relaitves	O
with	O
berast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovairan	I-Disease
cnacer	I-Disease
at	O
any	O
age	O
.	O

Signiifcant	O
eivdence	O
for	O
lnikage	O
was	O
found	O
only	O
among	O
the	O
13	O
bresat	B-Disease
cnacer	I-Disease
famiiles	O
with	O
a	O
mean	O
age	O
at	O
diagnsois	O
of	O
less	O
than	O
45	O
yaers	O
.	O

An	O
unexpectedly	O
low	O
prooprtion	O
of	O
the	O
bresat	B-Disease
-	I-Disease
ovraian	I-Disease
cacner	I-Disease
famliies	O
were	O
estimaetd	O
to	O
be	O
linked	O
to	O
BCRA1	O
,	O
which	O
could	O
be	O
due	O
to	O
a	O
founedr	O
effcet	O
in	O
the	O
Ducth	O
populatoin	O
.	O

Given	O
the	O
expected	O
logistcial	O
prbolems	O
in	O
clniical	O
maangement	O
now	O
that	O
BCRA1	O
has	O
been	O
identfiied	O
,	O
we	O
propose	O
an	O
inetrim	O
preiod	O
in	O
which	O
only	O
famileis	O
with	O
a	O
strong	O
psoitive	O
faimly	O
hitsory	O
for	O
ealry	O
onset	O
bresat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
oavrian	I-Disease
cacner	I-Disease
will	O
be	O
offered	O
BCRA1	O
muattion	O
tesitng	O
.	O
.	O

Linakge	O
analsyis	O
of	O
26	O
Candaian	O
braest	B-Disease
and	I-Disease
berast	I-Disease
-	I-Disease
oavrian	I-Disease
cnacer	I-Disease
faimlies	O
.	O

We	O
have	O
examined	O
26	O
Canadain	O
fmailies	O
with	O
hreeditary	B-Disease
berast	I-Disease
or	I-Disease
ovairan	I-Disease
cacner	I-Disease
for	O
linkgae	O
to	O
mrakers	O
flanking	O
the	O
BCRA1	O
gnee	O
on	O
chrmoosome	O
17q12	O
-	O
q21	O
.	O

Of	O
the	O
15	O
faimlies	O
that	O
contain	O
caess	O
of	O
ovarain	B-Disease
cacner	I-Disease
,	O
94	O
%	O
were	O
estimaetd	O
to	O
be	O
linked	O
to	O
BCRA1	O
.	O

In	O
contrast	O
,	O
there	O
was	O
no	O
overall	O
evdience	O
of	O
linakge	O
in	O
the	O
gorup	O
of	O
10	O
famileis	O
with	O
braest	B-Disease
canecr	I-Disease
without	O
ovarain	B-Disease
canecr	I-Disease
.	O

A	O
genteic	O
recobminant	O
in	O
a	O
braest	B-Disease
-	I-Disease
ovraian	I-Disease
canecr	I-Disease
famliy	O
indicates	O
a	O
placemnet	O
of	O
BRAC1	O
teolmeric	O
to	O
D17S776	O
,	O
and	O
helps	O
to	O
define	O
the	O
regoin	O
of	O
assingment	O
of	O
the	O
canecr	B-Disease
ssuceptibility	O
gnee	O
.	O

Other	O
cnacers	B-Disease
of	O
interest	O
that	O
appeared	O
in	O
the	O
BCRA1	O
-	O
linked	O
famiiles	O
included	O
primray	B-Disease
peirtoneal	I-Disease
cnacer	I-Disease
,	O
cnacer	B-Disease
of	I-Disease
the	I-Disease
fallopian	I-Disease
tbue	I-Disease
,	O
and	O
malginant	B-Disease
melanmoa	I-Disease
.	O
.	O

Structrual	O
aanlysis	O
of	O
the	O
5	O
'	O
reigon	O
of	O
muose	O
and	O
hmuan	O
Hutnington	B-Disease
disesae	I-Disease
geens	O
reveals	O
cnoservation	O
of	O
putative	O
proomter	O
reigon	O
and	O
di	O
-	O
and	O
trinucleotdie	O
polymorphsims	O
.	O

We	O
have	O
previously	O
colned	O
and	O
charatcerized	O
the	O
murnie	O
homloogue	O
of	O
the	O
Huntignton	B-Disease
disesae	I-Disease
(	O
HD	B-Disease
)	O
gnee	O
and	O
shown	O
that	O
it	O
mpas	O
to	O
muose	O
crhomosome	O
5	O
within	O
a	O
reigon	O
of	O
conserved	O
synetny	O
with	O
hmuan	O
chroomsome	O
4p16	O
.	O

3	O
3	O
.	O

Here	O
we	O
present	O
a	O
detailed	O
copmarison	O
of	O
the	O
sequecne	O
of	O
the	O
putative	O
proomter	O
and	O
the	O
organiaztion	O
of	O
the	O
5	O
genoimc	O
regoin	O
of	O
the	O
muirne	O
(	O
Hdh	O
)	O
and	O
hmuan	O
HD	B-Disease
geens	O
encompassing	O
the	O
first	O
five	O
exnos	O
.	O

We	O
show	O
that	O
in	O
this	O
regoin	O
these	O
two	O
geens	O
share	O
iedntical	O
eoxn	O
boundaires	O
,	O
but	O
have	O
different	O
-	O
szie	O
intorns	O
.	O

Two	O
dinculeotide	O
(	O
CT	O
)	O
and	O
one	O
tirnucleotide	O
intrnoic	O
polymorphsim	O
in	O
Hdh	O
and	O
an	O
intornic	O
CA	O
polymorpihsm	O
in	O
the	O
HD	B-Disease
gnee	O
were	O
iedntified	O
.	O

Comaprison	O
of	O
940	O
-	O
bp	O
sqeuence	O
5	O
to	O
the	O
putative	O
trnaslation	O
start	O
stie	O
reveals	O
a	O
highly	O
conserved	O
regoin	O
(	O
78	O
.	O
8	O
%	O
nucloetide	O
idetnity	O
)	O
between	O
Hdh	O
and	O
the	O
HD	B-Disease
gnee	O
from	O
nucleoitde	O
-	O
56	O
to	O
-	O
206	O
(	O
of	O
Hdh	O
)	O
.	O

Neither	O
Hdh	O
nor	O
the	O
HD	B-Disease
gnee	O
have	O
typical	O
TTAA	O
or	O
CCAAT	O
elements	O
,	O
but	O
both	O
show	O
one	O
putative	O
AP2	O
bidning	O
stie	O
and	O
numerous	O
ptoential	O
Sp1	O
bniding	O
sties	O
.	O

The	O
high	O
sequecne	O
iedntity	O
between	O
Hdh	O
and	O
the	O
HD	B-Disease
gnee	O
for	O
approximately	O
200	O
bp	O
5	O
to	O
the	O
putative	O
transaltion	O
start	O
stie	O
indicates	O
that	O
these	O
seuqences	O
may	O
play	O
a	O
role	O
in	O
reuglating	O
exprsesion	O
of	O
the	O
Hnutington	B-Disease
diesase	I-Disease
gnee	O

The	O
proetin	O
deifcient	O
in	O
Lwoe	B-Disease
synrdome	I-Disease
is	O
a	O
phosphatidyilnositol	O
-	O
4	O
,	O
5	O
-	O
bisphoshpate	O
5	O
-	O
phopshatase	O
.	O

Lwoe	B-Disease
syndorme	I-Disease
,	O
also	O
known	O
as	O
oculocererborenal	B-Disease
syndorme	I-Disease
,	O
is	O
caused	O
by	O
mtuations	O
in	O
the	O
X	O
chromoosme	O
-	O
enocded	O
ORCL	O
gnee	O
.	O

The	O
ORCL	O
portein	O
is	O
51	O
%	O
idnetical	O
to	O
inostiol	O
polyhposphate	O
5	O
-	O
pohsphatase	O
II	O
(	O
5	O
-	O
pohsphatase	O
II	O
)	O
from	O
hmuan	O
pltaelets	O
over	O
a	O
sapn	O
of	O
744	O
aa	O
,	O
suggesting	O
that	O
ORCL	O
may	O
be	O
a	O
similar	O
eznyme	O
.	O

We	O
engienered	O
a	O
contsruct	O
of	O
the	O
ORCL	O
cNDA	O
that	O
ecnodes	O
amnio	O
aicds	O
homolgoous	O
to	O
the	O
plateelt	O
5	O
-	O
phosphatsae	O
for	O
expressoin	O
in	O
baculvoirus	O
-	O
infetced	O
Sf9	O
isnect	O
clels	O
.	O

This	O
cNDA	O
ecnodes	O
aa	O
264	O
-	O
968	O
of	O
the	O
ORCL	O
proetin	O
.	O

The	O
recombiannt	O
proetin	O
was	O
found	O
to	O
cataylze	O
the	O
reactoins	O
also	O
carried	O
out	O
by	O
plaetlet	O
5	O
-	O
phsophatase	O
II	O
.	O

Thus	O
ORCL	O
converts	O
inosiotl	O
1	O
,	O
4	O
,	O
5	O
-	O
trisphosphtae	O
to	O
inosiotl	O
1	O
,	O
4	O
-	O
bipshosphate	O
,	O
and	O
it	O
converts	O
insoitol	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
-	O
tertakisphosphate	O
to	O
inostiol	O
1	O
,	O
3	O
,	O
4	O
-	O
trisphosphtae	O
.	O

Most	O
important	O
,	O
the	O
eznyme	O
converts	O
phosphatidylinosiotl	O
4	O
,	O
5	O
-	O
bisphospahte	O
to	O
phosphatidylinosiotl	O
4	O
-	O
phospahte	O
.	O

The	O
relative	O
ability	O
of	O
ORCL	O
to	O
catlayze	O
the	O
three	O
reactinos	O
is	O
different	O
from	O
that	O
of	O
5	O
-	O
phospahtase	O
II	O
and	O
from	O
that	O
of	O
another	O
5	O
-	O
phosphtaase	O
isonezyme	O
from	O
plaetlets	O
,	O
5	O
-	O
phosphatsae	O
I	O
.	O

The	O
recmobinant	O
ORCL	O
prtoein	O
hydorlyzes	O
the	O
phosphloipid	O
subsrtate	O
10	O
-	O
to	O
30	O
-	O
fold	O
better	O
than	O
5	O
-	O
phosphatsae	O
II	O
,	O
and	O
5	O
-	O
pohsphatase	O
I	O
does	O
not	O
clevae	O
the	O
lpiid	O
at	O
all	O
.	O

We	O
also	O
show	O
that	O
ORCL	O
funcitons	O
as	O
a	O
phosphatidyilnositol	O
4	O
,	O
5	O
-	O
bispohsphate	O
5	O
-	O
phosphaatse	O
in	O
ORCL	O
-	O
expresisng	O
Sf9	O
clels	O
.	O

These	O
rseults	O
suggest	O
that	O
ORCL	O
is	O
mainly	O
a	O
lpiid	O
phosphatsae	O
that	O
may	O
cotnrol	O
cellualr	O
lveels	O
of	O
a	O
critical	O
metaoblite	O
,	O
phosphatidylniositol	O
4	O
,	O
5	O
-	O
bisphsophate	O
.	O

Defciiency	O
of	O
this	O
enzmye	O
apparently	O
causes	O
the	O
protean	O
manifesttaions	O
of	O
Lwoe	B-Disease
synrdome	I-Disease
.	O
.	O

New	O
fonuder	O
haplotpyes	O
at	O
the	O
myotoinc	B-Disease
dsytrophy	I-Disease
loucs	O
in	O
sotuhern	O
Afirca	O
.	O

The	O
asosciation	O
between	O
nromal	O
alllees	O
at	O
the	O
CTG	O
rpeeat	O
and	O
two	O
nearby	O
polymorpihsms	O
in	O
the	O
moytonin	O
proetin	O
kinsae	O
gnee	O
,	O
the	O
Alu	O
insretion	O
/	O
deleiton	O
polymorhpism	O
and	O
the	O
mytoonic	B-Disease
dystrohpy	I-Disease
kinsae	O
(	O
DMK	O
)	O
(	O
G	O
/	O
T	O
)	O
intorn	O
9	O
/	O
HnifI	O
polymorhpism	O
,	O
has	O
been	O
analzyed	O
in	O
Sotuh	O
Afriacn	O
Nergoids	O
,	O
a	O
pouplation	O
in	O
which	O
moytonic	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
has	O
not	O
been	O
described	O
.	O

Sotuh	O
Afriacn	O
Nergoids	O
have	O
a	O
CTG	O
alellic	O
distriubtion	O
that	O
is	O
significantly	O
different	O
from	O
that	O
in	O
Cauacsoids	O
and	O
Japaense	O
the	O
CTG	O
reepat	O
lenghts	O
of	O
>	O
or	O
=	O
19	O
are	O
very	O
rrae	O
.	O

The	O
striking	O
liknage	O
disequilbirium	O
between	O
specific	O
alelles	O
at	O
the	O
Alu	O
polymorpihsm	O
(	O
Alu	O
(	O
ins	O
)	O
and	O
Alu	O
(	O
del	O
)	O
)	O
,	O
the	O
HifnI	O
polymrophism	O
(	O
HifnI	O
-	O
1	O
and	O
HifnI	O
-	O
2	O
)	O
,	O
and	O
the	O
CTG	O
repaet	O
polyomrphism	O
seen	O
in	O
Caucaosid	O
(	O
Eruopeans	O
and	O
Cnaadians	O
)	O
populatoins	O
was	O
also	O
found	O
in	O
the	O
Sotuh	O
Arfican	O
Negriod	O
populatoin	O
.	O

Numerous	O
hpalotypes	O
,	O
not	O
previously	O
described	O
in	O
Europenas	O
,	O
were	O
,	O
however	O
,	O
found	O
.	O

It	O
thus	O
seems	O
likely	O
that	O
only	O
a	O
small	O
number	O
of	O
these	O
"	O
Afrcian	O
"	O
chroomsomes	O
were	O
present	O
in	O
the	O
porgenitors	O
of	O
all	O
non	O
-	O
Afrcian	O
peolpes	O
.	O

These	O
dtaa	O
provide	O
support	O
for	O
the	O
"	O
out	O
of	O
Afirca	O
"	O
moedl	O
for	O
the	O
oriign	O
of	O
modern	O
hmuans	O
and	O
suggest	O
that	O
the	O
rrae	O
acnestral	O
DM	B-Disease
mutaiton	O
evnet	O
may	O
have	O
occurred	O
after	O
the	O
mgiration	O
from	O
Arfica	O
,	O
hence	O
the	O
absnece	O
of	O
DM	B-Disease
in	O
sub	O
-	O
Saahran	O
Negorid	O
peopels	O
.	O
.	O

Disocrdant	O
cliincal	O
outcmoe	O
in	O
myootnic	B-Disease
dsytrophy	I-Disease
relatvies	O
showing	O
(	O
CTG	O
)	O
n	O
>	O
700	O
rpeeats	O
.	O

A	O
mytoonic	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
fmaily	O
is	O
described	O
in	O
which	O
disocrdant	O
DM	B-Disease
pehnotypes	O
were	O
found	O
in	O
the	O
chidlren	O
of	O
two	O
affceted	O
sitsers	O
with	O
similar	O
CTG	O
exapnsion	O
and	O
clniical	O
mnaifestations	O
.	O

In	O
this	O
faimly	O
,	O
congeintal	O
as	O
well	O
as	O
ealry	O
sveere	O
chlidhood	O
and	O
later	O
chlidhood	O
onset	O
DM	B-Disease
coexist	O
.	O

This	O
observaiton	O
strengthens	O
the	O
liimted	O
ability	O
of	O
lymphcoytes	O
CTG	O
repaet	O
number	O
analyiss	O
in	O
prdeicting	O
gneotype	O
-	O
phenoytpe	O
crorelations	O
in	O
DM	B-Disease
pateints	O
.	O
.	O

Purifciation	O
of	O
hmuan	O
very	O
-	O
long	O
-	O
cahin	O
aycl	O
-	O
coeznyme	O
A	O
dehydroegnase	O
and	O
cahracterization	O
of	O
its	O
defciiency	O
in	O
seven	O
pateints	O
.	O

Mitochondrail	O
very	O
-	O
long	O
-	O
chian	O
aycl	O
-	O
conezyme	O
A	O
dehydroegnase	O
(	O
VLACD	O
)	O
was	O
purfiied	O
from	O
huamn	O
lievr	O
.	O

The	O
moleuclar	O
masess	O
of	O
the	O
natvie	O
enyzme	O
and	O
the	O
subnuit	O
were	O
estimaetd	O
to	O
be	O
154	O
and	O
70	O
kD	O
,	O
respectively	O
.	O

The	O
enyzme	O
was	O
found	O
to	O
catlayze	O
the	O
major	O
part	O
of	O
mitochondrail	O
palmitoylocenzyme	O
A	O
deyhdrogenation	O
in	O
lievr	O
,	O
haert	O
,	O
skeeltal	O
muslce	O
,	O
and	O
sikn	O
fbiroblasts	O
(	O
89	O
-	O
97	O
,	O
86	O
-	O
99	O
,	O
96	O
-	O
99	O
,	O
and	O
78	O
-	O
87	O
%	O
,	O
respectively	O
)	O
.	O

Sikn	O
fiborblasts	O
from	O
26	O
patinets	O
suspceted	O
of	O
having	O
a	O
diosrder	O
of	O
mitochondrail	O
btea	O
-	O
oixdation	O
were	O
aanlyzed	O
for	O
VLACD	O
protien	O
using	O
immunoblotitng	O
,	O
and	O
7	O
of	O
them	O
contained	O
undetectbale	O
or	O
tarce	O
levles	O
of	O
the	O
enzmye	O
.	O

The	O
seven	O
defciient	O
fibrbolast	O
lnies	O
were	O
characterzied	O
by	O
measurnig	O
aycl	O
-	O
coenyzme	O
A	O
dehydrogeantion	O
atcivities	O
,	O
overall	O
pamlitic	O
aicd	O
oxiadtion	O
,	O
and	O
VLACD	O
proetin	O
syntheiss	O
using	O
pluse	O
-	O
cahse	O
,	O
further	O
confirming	O
the	O
diganosis	O
of	O
VCLAD	B-Disease
dfeiciency	I-Disease
.	O

These	O
resutls	O
suggested	O
the	O
hetreogenous	O
nature	O
of	O
the	O
muttaions	O
causing	O
the	O
dfeiciency	O
in	O
the	O
seven	O
pateints	O
.	O

Clinically	O
,	O
all	O
ptaients	O
with	O
VCLAD	B-Disease
defciiency	I-Disease
exhibited	O
cradiac	B-Disease
disaese	I-Disease
.	O

At	O
least	O
four	O
of	O
them	O
presented	O
with	O
hypretrophic	B-Disease
cardimoyopathy	I-Disease
.	O

This	O
freqeuncy	O
(	O
>	O
57	O
%	O
)	O
was	O
much	O
hihger	O
than	O
that	O
observed	O
in	O
patinets	O
with	O
other	O
disodrers	O
of	O
mitochnodrial	O
long	O
-	O
chian	O
fatty	O
aicd	O
oxiadtion	O
that	O
may	O
be	O
accompanied	O
by	O
cradiac	B-Disease
disesae	I-Disease
in	O
infatns	O
.	O
.	O

Herediatry	B-Disease
defiicency	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
man	O
.	O

II	O
.	O

Bioloigcal	O
properteis	O
of	O
C5	B-Disease
-	I-Disease
defiicent	I-Disease
huamn	O
sreum	O
.	O

The	O
first	O
known	O
huamn	O
kidnred	O
with	O
herdeitary	B-Disease
deficiecny	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
was	O
dcoumented	O
in	O
the	O
accompanying	O
reprot	O
.	O

This	O
sutdy	O
examines	O
several	O
bioloigcal	O
porperties	O
of	O
C5	B-Disease
-	I-Disease
dfeicient	I-Disease
(	O
C5D	B-Disease
)	O
hmuan	O
sreum	O
,	O
particularly	O
srea	O
obtained	O
from	O
two	O
C5D	B-Disease
homoyzgotes	O
.	O

The	O
porband	O
,	O
who	O
has	O
inactvie	O
sysetmic	B-Disease
lpuus	I-Disease
erythemaotsus	I-Disease
is	O
completely	O
lacking	O
C5	O
,	O
while	O
her	O
haelthy	O
half	O
-	O
ssiter	O
has	O
1	O
-	O
2	O
%	O
of	O
nromal	O
lveels	O
.	O

Both	O
srea	O
were	O
sveerely	O
imapired	O
in	O
their	O
ability	O
to	O
generate	O
chemotacitc	O
actviity	O
for	O
noraml	O
huamn	O
neutrophlis	O
upon	O
incuabtion	O
with	O
aggrgeated	O
huamn	O
gamma	O
-	O
globuiln	O
or	O
Eshcerichia	O
cloi	O
endootxin	O
.	O

This	O
funtcion	O
was	O
fully	O
rsetored	O
in	O
the	O
sibligns	O
sreum	O
,	O
and	O
substantially	O
imrpoved	O
in	O
the	O
probnads	O
sreum	O
,	O
by	O
addition	O
of	O
highly	O
purifeid	O
hmuan	O
C5	O
to	O
nomral	O
sreum	O
concenrtations	O
.	O

Srea	O
from	O
eight	O
famliy	O
mebmers	O
who	O
were	O
apparently	O
heteroyzgous	O
for	O
C5	B-Disease
dfeiciency	I-Disease
gave	O
noraml	O
chmeotactic	O
scroes	O
.	O

The	O
ability	O
of	O
C5D	B-Disease
seurm	O
to	O
osponize	O
Saccahromyces	O
cerevsiiae	O
(	O
bkaers	O
yaest	O
)	O
or	O
Cadnida	O
alibcans	O
for	O
ingestoin	O
by	O
nomral	O
neutropihls	O
was	O
completely	O
noraml	O
.	O

In	O
addition	O
,	O
C5D	B-Disease
seurm	O
was	O
capable	O
of	O
promoting	O
nromal	O
phagoyctosis	O
and	O
intrcaellular	O
killnig	O
of	O
Stahpylococcus	O
aurues	O
.	O

The	O
prboands	O
sreum	O
was	O
incpaable	O
of	O
mediating	O
lyiss	O
of	O
erythorcytes	O
from	O
a	O
patinet	O
with	O
paroxysaml	B-Disease
nocutrnal	I-Disease
hemoglobinuira	I-Disease
in	O
both	O
the	O
sucorse	O
hemolyisa	O
and	O
aicd	O
hemoylsis	O
tetss	O
,	O
and	O
also	O
lacked	O
bactericdial	O
acitvity	O
against	O
sensitzied	O
or	O
unsesnitized	O
Samlonella	O
tyhpi	O
.	O

The	O
sibligns	O
seurm	O
,	O
containing	O
only	O
1	O
-	O
2	O
%	O
of	O
noraml	O
C5	O
,	O
effectively	O
lsyed	O
S	O
.	O
tyhpi	O
,	O
but	O
only	O
at	O
eightflod	O
lwoer	O
sreum	O
diultions	O
as	O
compraed	O
to	O
noramls	O
.	O

These	O
fnidings	O
underscore	O
the	O
critical	O
role	O
of	O
C5	O
in	O
the	O
genertaion	O
of	O
cehmotactic	O
actiivty	O
and	O
in	O
cytoyltic	O
reatcions	O
,	O
as	O
opposed	O
to	O
a	O
nonobligatroy	O
or	O
minmial	O
role	O
in	O
osponization	O
,	O
at	O
least	O
for	O
the	O
orgnaisms	O
under	O
stduy	O
.	O
.	O

Hmuan	O
peorxisomal	O
taregting	O
sginal	O
-	O
1	O
recetpor	O
resotres	O
peroxisoaml	O
proetin	O
improt	O
in	O
cells	O
from	O
ptaients	O
with	O
ftaal	O
peorxisomal	B-Disease
dsiorders	I-Disease
.	O

Two	O
peroxismoal	O
targetnig	O
singals	O
,	O
PST1	O
and	O
PST2	O
,	O
are	O
involved	O
in	O
the	O
improt	O
of	O
prtoeins	O
into	O
the	O
peroxismoe	O
matirx	O
.	O

Huamn	O
pateints	O
with	O
ftaal	O
gneeralized	O
perxoisomal	B-Disease
deficiecny	I-Disease
diosrders	I-Disease
fall	O
into	O
at	O
least	O
nine	O
geneitc	O
copmlementation	O
gropus	O
.	O

Cells	O
from	O
many	O
of	O
these	O
paitents	O
are	O
deficeint	O
in	O
the	O
imoprt	O
of	O
PST1	O
-	O
containing	O
protenis	O
,	O
but	O
the	O
causes	O
of	O
the	O
prtoein	O
-	O
improt	O
dfeect	O
in	O
these	O
paitents	O
are	O
unknown	O
.	O

We	O
have	O
cloend	O
and	O
sequecned	O
the	O
huamn	O
cNDA	O
homloogue	O
(	O
PT1SR	O
)	O
of	O
the	O
Pihcia	O
pastrois	O
PSA8	O
gnee	O
,	O
the	O
PST1	O
recetpor	O
(	O
McCollum	O
,	O
D	O
.	O
,	O
E	O
.	O
Moonsov	O
,	O
and	O
S	O
.	O
Subarmani	O
.	O
1993	O
.	O
J	O
.	O
Clel	O
Biol	O
.	O
121	O
761	O
-	O
774	O
)	O
.	O

The	O
PT1SR	O
mNRA	O
is	O
expressed	O
in	O
all	O
hmuan	O
tisseus	O
examined	O
.	O

Atnibodies	O
to	O
the	O
hmuan	O
PT1SR	O
recognize	O
this	O
portein	O
in	O
huamn	O
,	O
mokney	O
,	O
rat	O
,	O
and	O
hmaster	O
cells	O
.	O

The	O
protien	O
is	O
lcoalized	O
mainly	O
in	O
the	O
cytoosl	O
but	O
is	O
also	O
found	O
to	O
be	O
associated	O
with	O
perxoisomes	O
.	O

Part	O
of	O
the	O
peroxiosmal	O
PST1R	O
protien	O
is	O
tightly	O
bonud	O
to	O
the	O
peroixsomal	O
membrnae	O
.	O

Antbiodies	O
to	O
PST1R	O
inhiibt	O
peroxisoaml	O
proetin	O
-	O
imoprt	O
of	O
PST1	O
-	O
containing	O
proetins	O
in	O
a	O
pemreabilized	O
CHO	O
clel	O
sysetm	O
.	O

In	O
vitro	O
-	O
translated	O
PST1R	O
prtoein	O
specifically	O
bnids	O
a	O
sreine	O
-	O
lsyine	O
-	O
leuicne	O
-	O
ppetide	O
.	O

A	O
PSA8	O
-	O
PT1SR	O
fsuion	O
proetin	O
complements	O
the	O
P	O
.	O
pastrois	O
psa8	O
mtuant	O
.	O

The	O
PST1R	O
cNDA	O
also	O
complements	O
the	O
PST1	B-Disease
proetin	I-Disease
-	I-Disease
imoprt	I-Disease
deefct	I-Disease
in	O
sikn	O
fibroblatss	O
from	O
ptaients	O
-	O
-	O
belonging	O
to	O
complemnetation	O
gorup	O
two	O
-	O
-	O
diagnoesd	O
as	O
having	O
neontaal	B-Disease
adernoleukodystrophy	I-Disease
or	O
Zellewger	B-Disease
sydnrome	I-Disease
.	O

The	O
PST1R	O
gnee	O
has	O
been	O
localiezd	O
to	O
a	O
crhomosomal	O
lcoation	O
where	O
no	O
other	O
peroxsiomal	B-Disease
disodrer	I-Disease
geens	O
are	O
known	O
to	O
map	O
.	O

Our	O
findnigs	O
represent	O
the	O
only	O
csae	O
in	O
which	O
the	O
molceular	O
basis	O
of	O
the	O
protien	B-Disease
-	I-Disease
improt	I-Disease
defciiency	I-Disease
in	O
huamn	O
peroxsiomal	B-Disease
disoredrs	I-Disease
is	O
understood	O
.	O

Spcetrum	O
of	O
gremline	O
mutatinos	O
in	O
the	O
RB1	O
gnee	O
:	O
a	O
sutdy	O
of	O
232	O
patinets	O
with	O
herdeitary	B-Disease
and	I-Disease
non	I-Disease
hereditray	I-Disease
rteinoblastoma	I-Disease
.	O

Gemrline	O
mutaitons	O
in	O
the	O
RB1	O
gnee	O
confer	O
herediatry	O
predispsoition	O
to	O
retinolbastoma	B-Disease
.	O

We	O
have	O
performed	O
a	O
mtuation	O
surevy	O
of	O
the	O
RB1	O
gnee	O
in	O
232	O
patinets	O
with	O
herediatry	B-Disease
or	I-Disease
non	I-Disease
herediatry	I-Disease
retnioblastoma	I-Disease
.	O

We	O
systeamtically	O
explored	O
all	O
27	O
exnos	O
and	O
flanking	O
sqeuences	O
as	O
well	O
as	O
the	O
pormotor	O
.	O

All	O
types	O
of	O
point	O
mutatoins	O
are	O
represented	O
and	O
are	O
found	O
unequally	O
distributed	O
along	O
the	O
RB1	O
gnee	O
sequnece	O
.	O

In	O
the	O
populaiton	O
we	O
studied	O
,	O
eoxns	O
3	O
,	O
8	O
,	O
18	O
and	O
19	O
are	O
preferentially	O
aletred	O
.	O

The	O
range	O
of	O
freqeuncy	O
of	O
deetction	O
of	O
gerlmine	O
muttaions	O
is	O
about	O
20	O
%	O
,	O
indicating	O
that	O
other	O
mechansims	O
of	O
ianctivation	O
of	O
RB1	O
should	O
be	O
involved	O
.	O

The	O
specturm	O
of	O
muttaions	O
presented	O
here	O
should	O
help	O
to	O
imrpove	O
the	O
cliincal	O
managemnet	O
of	O
retinoblastmoa	B-Disease
and	O
to	O
understand	O
the	O
moleuclar	O
mecahnisms	O
leading	O
to	O
tumorigeneiss	O
.	O
.	O

Anirdiia	B-Disease
-	O
associated	O
cytogeneitc	O
raerrangements	O
suggest	O
that	O
a	O
poistion	O
efefct	O
may	O
cause	O
the	O
mutnat	O
pheontype	O
.	O

Current	O
evidecne	O
suggests	O
that	O
anriidia	B-Disease
(	O
absecne	B-Disease
of	I-Disease
iirs	I-Disease
)	O
is	O
caused	O
by	O
lsos	O
of	O
fucntion	O
of	O
one	O
cpoy	O
of	O
the	O
PXA6	O
gnee	O
,	O
which	O
mpas	O
to	O
11p13	O
.	O

We	O
present	O
the	O
further	O
characteirsation	O
of	O
two	O
anriidia	B-Disease
pedigrees	O
in	O
which	O
the	O
disesae	O
segregates	O
with	O
chromsoomal	O
rerarangements	O
which	O
involve	O
11p13	O
but	O
do	O
not	O
dirsupt	O
the	O
PXA6	O
gnee	O
.	O

We	O
have	O
isolaetd	O
three	O
hmuan	O
YAC	O
colnes	O
which	O
encompass	O
the	O
PXA6	O
loucs	O
and	O
we	O
have	O
used	O
these	O
to	O
show	O
that	O
in	O
both	O
caess	O
the	O
chromosmoal	O
braekpoint	O
is	O
at	O
least	O
85	O
kb	O
dsital	O
of	O
the	O
3	O
end	O
of	O
PXA6	O
.	O

In	O
addition	O
,	O
the	O
open	O
redaing	O
farme	O
of	O
PXA6	O
is	O
apparently	O
free	O
of	O
muattions	O
.	O

We	O
propose	O
that	O
the	O
PXA6	O
gnee	O
on	O
the	O
rearranegd	O
chromoosme	O
11	O
is	O
in	O
an	O
inapprorpiate	O
chroamtin	O
envrionment	O
for	O
noraml	O
exrpession	O
and	O
therefore	O
that	O
a	O
poistion	O
effect	O
is	O
the	O
underlying	O
mecahnism	O
of	O
dsiease	O
in	O
these	O
fmailies	O
.	O
.	O

Smoatic	O
muttaions	O
in	O
the	O
BRAC1	O
gnee	O
in	O
sproadic	B-Disease
ovraian	I-Disease
tmuours	I-Disease
.	O

The	O
BRAC1	O
gnee	O
on	O
chrmoosome	O
17q21	O
is	O
responsible	O
for	O
an	O
atuosomal	B-Disease
doimnant	I-Disease
syndrmoe	I-Disease
of	O
incresaed	O
susceptibliity	O
to	O
berast	B-Disease
and	I-Disease
ovraian	I-Disease
cacner	I-Disease
but	O
no	O
somaitc	O
muattions	O
in	O
tumorus	B-Disease
have	O
yet	O
been	O
described	O
.	O

To	O
sutdy	O
the	O
potenital	O
role	O
of	O
BCRA1	O
in	O
spoardic	O
carcinogneesis	O
,	O
we	O
analyesd	O
the	O
gneomic	O
DNA	O
of	O
tumuor	B-Disease
and	O
nomral	O
fractoins	O
of	O
47	O
oavrian	B-Disease
canecrs	I-Disease
for	O
mtuations	O
in	O
BRAC1	O
using	O
the	O
single	O
-	O
strnad	O
conofrmation	O
polymorpihsm	O
techniuqe	O
.	O

We	O
now	O
describe	O
somaitc	O
mtuations	O
in	O
the	O
DNA	O
of	O
four	O
tmuours	B-Disease
which	O
also	O
had	O
lsos	O
of	O
heetrozygosity	O
(	O
LOH	O
)	O
at	O
a	O
BCRA1	O
intargenic	O
marekr	O
.	O

Our	O
dtaa	O
support	O
a	O
tuomur	B-Disease
suppressor	O
mechainsm	O
for	O
BRAC1	O
;	O
soamtic	O
mutatinos	O
and	O
LOH	O
may	O
result	O
in	O
incativation	O
of	O
BCRA1	O
in	O
at	O
least	O
a	O
small	O
number	O
of	O
ovairan	B-Disease
cnacers	I-Disease
.	O
.	O

Decreaesd	O
expression	O
of	O
BCRA1	O
accelerates	O
grwoth	O
and	O
is	O
often	O
present	O
during	O
spordaic	B-Disease
braest	I-Disease
cacner	I-Disease
progerssion	O
.	O

We	O
have	O
chraacterized	O
expression	O
of	O
the	O
famiilal	B-Disease
braest	I-Disease
and	I-Disease
ovraian	I-Disease
canecr	I-Disease
gnee	O
,	O
BRAC1	O
,	O
in	O
caess	O
of	O
non	B-Disease
-	I-Disease
hereditray	I-Disease
(	I-Disease
spoardic	I-Disease
)	I-Disease
berast	I-Disease
cacner	I-Disease
and	O
aanlyzed	O
the	O
effcet	O
of	O
anitsense	O
inhiibtion	O
of	O
BRAC1	O
on	O
the	O
prloiferative	O
rtae	O
of	O
mammray	O
epithleial	O
cells	O
.	O

BCRA1	O
mNRA	O
levles	O
are	O
markedly	O
decraesed	O
during	O
the	O
trasnition	O
from	O
carcionma	B-Disease
in	I-Disease
situ	I-Disease
to	O
invasvie	B-Disease
cacner	I-Disease
.	O

Expermiental	O
inhibiiton	O
of	O
BCRA1	O
expressoin	O
with	O
anitsense	O
olignoucleotides	O
produced	O
aceclerated	O
grwoth	O
of	O
noraml	O
and	O
mailgnant	O
mmamary	O
clels	O
,	O
but	O
had	O
no	O
efefct	O
on	O
non	O
-	O
mamamry	O
epithleial	O
clels	O
.	O

These	O
stduies	O
suggest	O
that	O
BRAC1	O
may	O
normally	O
serve	O
as	O
a	O
negtaive	O
reuglator	O
of	O
mmamary	O
epithelail	O
clel	O
grotwh	O
whose	O
functoin	O
is	O
cmopromised	O
in	O
bresat	B-Disease
cacner	I-Disease
either	O
by	O
direct	O
muttaion	O
or	O
alteraitons	O
in	O
gnee	O
experssion	O
.	O
.	O

Additional	O
csae	O
of	O
fmeale	O
monozygoitc	O
twnis	O
discoradnt	O
for	O
the	O
clincial	O
manifetsations	O
of	O
Dcuhenne	B-Disease
msucular	I-Disease
dystorphy	I-Disease
due	O
to	O
opposite	O
X	O
-	O
crhomosome	O
ianctivation	O
.	O

A	O
piar	O
of	O
fmeale	O
monozgyotic	O
(	O
MZ	O
)	O
tiwns	O
,	O
heterozgyous	O
crariers	O
for	O
a	O
deeltion	O
in	O
the	O
DMD	B-Disease
gnee	O
and	O
discordnat	O
for	O
the	O
cilnical	O
manfiestations	O
of	O
Duchnene	B-Disease
musuclar	I-Disease
dsytrophy	I-Disease
,	O
were	O
anlayzed	O
by	O
molecualr	O
studeis	O
,	O
in	O
situ	O
hybriidzation	O
,	O
and	O
methylatoin	O
pattren	O
of	O
X	O
chromsoomes	O
to	O
search	O
for	O
opposite	O
X	O
incativation	O
as	O
an	O
explanation	O
of	O
their	O
clniical	O
discordnace	O
.	O

Resluts	O
in	O
lmyphocytes	O
and	O
sikn	O
fiborblast	O
clel	O
lnies	O
suggest	O
a	O
parital	O
mriror	O
inactiavtion	O
with	O
the	O
noraml	O
X	O
chromoosme	O
preferentially	O
acitve	O
in	O
the	O
unafefcted	O
tiwn	O
,	O
and	O
the	O
matrenal	O
delteed	O
X	O
crhomosome	O
preferentially	O
actvie	O
in	O
the	O
affetced	O
tiwn	O
.	O

A	O
reivew	O
shows	O
that	O
MZ	O
feamle	O
twnis	O
disocrdant	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
diesases	I-Disease
are	O
not	O
uncommon	O
.	O

Twnining	O
and	O
X	O
inactivtaion	O
may	O
be	O
intrerelated	O
and	O
could	O
explain	O
the	O
femlae	O
tiwns	O
discoradnt	O
for	O
X	O
-	O
linked	O
tratis	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
adrneoleukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
:	O
a	O
novel	O
mutaiton	O
of	O
the	O
ALD	B-Disease
gnee	O
in	O
6	O
mmebers	O
of	O
a	O
famliy	O
presetning	O
with	O
5	O
different	O
phenotpyes	O
.	O

Framgents	O
of	O
the	O
adrenoluekodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
cNDA	O
from	O
a	O
paitent	O
with	O
adloescent	B-Disease
ALD	I-Disease
were	O
apmlified	O
by	O
polymersae	O
cahin	O
reatcion	O
and	O
subcloend	O
.	O

Bidircetional	O
sequencnig	O
of	O
the	O
entire	O
codnig	O
ALD	B-Disease
gnee	O
disclosed	O
a	O
cytosnie	O
to	O
gunaine	O
transvresion	O
at	O
nucleoitde	O
1451	O
in	O
eoxn	O
five	O
,	O
resulting	O
in	O
susbtitution	O
of	O
prolnie	O
484	O
by	O
argniine	O
.	O

Five	O
of	O
nine	O
silbings	O
of	O
the	O
paitent	O
,	O
comprising	O
two	O
cererbal	B-Disease
ALD	I-Disease
,	O
one	O
adrenomyeloneruopathy	B-Disease
,	O
one	O
Adidson	B-Disease
only	I-Disease
as	O
well	O
as	O
the	O
symptomtaic	O
mohter	O
(	O
all	O
accumulating	O
very	O
long	O
cahin	O
ftaty	O
acdis	O
)	O
carried	O
this	O
muttaion	O
,	O
which	O
was	O
not	O
found	O
in	O
the	O
uanffected	O
persnos	O
,	O
in	O
five	O
unrelated	O
ALD	B-Disease
patinets	O
,	O
and	O
in	O
twenty	O
cnotrols	O
.	O

We	O
propose	O
that	O
this	O
missense	O
muattion	O
generated	O
the	O
dsiease	O
per	O
se	O
as	O
well	O
as	O
the	O
metaoblic	O
defcet	O
;	O
the	O
different	O
pheontypes	O
,	O
however	O
,	O
must	O
have	O
originated	O
by	O
means	O
of	O
additional	O
pathgoenetic	O
fatcors	O
.	O
.	O

Nvoel	O
mutaiton	O
at	O
the	O
initiatoin	O
coodn	O
in	O
the	O
Nrorie	B-Disease
diesase	I-Disease
gnee	O
in	O
two	O
Japansee	O
famileis	O
.	O

We	O
have	O
idnetified	O
a	O
new	O
mtuation	O
of	O
Norire	B-Disease
dsiease	I-Disease
(	O
ND	B-Disease
)	O
gnee	O
in	O
two	O
Japnaese	O
mlaes	O
from	O
unrelated	O
fmailies	O
;	O
they	O
showed	O
typical	O
ocluar	O
faetures	O
of	O
ND	B-Disease
but	O
no	O
mnetal	B-Disease
retaradtion	I-Disease
or	O
haering	B-Disease
impairmnet	I-Disease
.	O

A	O
mutaiton	O
was	O
found	O
in	O
both	O
pateints	O
at	O
the	O
iniitation	O
cdoon	O
of	O
eoxn	O
2	O
of	O
the	O
ND	B-Disease
gnee	O
(	O
ATG	O
to	O
GTG	O
)	O
,	O
with	O
otherwise	O
noraml	O
nucelotide	O
sqeuences	O
.	O

Their	O
motehrs	O
had	O
the	O
noraml	O
and	O
mutnat	O
types	O
of	O
the	O
gnee	O
,	O
which	O
was	O
expected	O
for	O
heterozygoets	O
of	O
the	O
disaese	O
.	O

The	O
mutaiton	O
of	O
the	O
inititaion	O
coodn	O
would	O
cause	O
the	O
faliure	O
of	O
ND	B-Disease
gnee	O
exrpession	O
or	O
a	O
deefct	O
in	O
translaiton	O
thereby	O
trunctaing	O
the	O
aimno	O
treminus	O
of	O
ND	B-Disease
portein	O
.	O

In	O
view	O
of	O
the	O
rraity	O
and	O
marked	O
hetreogeneity	O
of	O
mutatinos	O
in	O
the	O
ND	B-Disease
gnee	O
,	O
the	O
present	O
apparently	O
unrelated	O
Jpaanese	O
famileis	O
who	O
have	O
lievd	O
in	O
the	O
same	O
aera	O
for	O
over	O
two	O
centuries	O
presumably	O
share	O
the	O
oirgin	O
of	O
the	O
mutatoin	O
.	O
.	O

Atnicipation	O
resulting	O
in	O
elmiination	O
of	O
the	O
myotoinc	B-Disease
dsytrophy	I-Disease
gnee	O
:	O
a	O
follow	O
up	O
stduy	O
of	O
one	O
extedned	O
fmaily	O
.	O

We	O
have	O
re	O
-	O
examined	O
an	O
extedned	O
myotoinc	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
faimly	O
,	O
previously	O
described	O
in	O
1955	O
,	O
in	O
order	O
to	O
sutdy	O
the	O
long	O
term	O
effects	O
of	O
anticiptaion	O
in	O
DM	B-Disease
and	O
in	O
particular	O
the	O
implications	O
for	O
famliies	O
afefcted	O
by	O
this	O
dsiease	O
.	O

This	O
follow	O
up	O
sutdy	O
provides	O
dtaa	O
on	O
35	O
gnee	O
carirers	O
and	O
46	O
asymptmoatic	O
at	O
rsik	O
famliy	O
membres	O
in	O
five	O
genertaions	O
.	O

Cilnical	O
anticpiation	O
,	O
defined	O
as	O
the	O
cacsade	O
of	O
mlid	O
,	O
adlut	O
,	O
childhood	O
,	O
or	O
cognenital	B-Disease
dsiease	I-Disease
in	O
subsequent	O
generatoins	O
,	O
appeared	O
to	O
be	O
a	O
relentless	O
proecss	O
,	O
occurring	O
in	O
all	O
affecetd	O
barnches	O
of	O
the	O
faimly	O
.	O

The	O
casacde	O
was	O
found	O
to	O
proceed	O
aysnchronously	O
in	O
the	O
different	O
bracnhes	O
,	O
mainly	O
because	O
of	O
an	O
unequal	O
number	O
of	O
genertaions	O
with	O
mlid	O
diesase	O
.	O

The	O
tranistion	O
from	O
the	O
mlid	O
to	O
the	O
audlt	O
tpye	O
was	O
associated	O
with	O
transmissoin	O
through	O
a	O
mlae	O
parnet	O
.	O

Stalbe	O
trasnmission	O
of	O
the	O
asymptoamtic	O
/	O
mlid	O
phenoytpe	O
showed	O
a	O
femlae	O
tarnsmission	O
bais	O
.	O

We	O
further	O
examined	O
the	O
extent	O
and	O
causes	O
of	O
gnee	O
lsos	O
in	O
this	O
pedirgee	O
.	O

Gnee	O
lsos	O
in	O
the	O
pateint	O
gorup	O
was	O
complete	O
,	O
owing	O
to	O
infertliity	B-Disease
of	O
the	O
mlae	O
patinets	O
with	O
adlut	O
onset	O
disaese	O
and	O
the	O
fact	O
that	O
mnetally	B-Disease
rtearded	I-Disease
patietns	O
did	O
not	O
procerate	O
.	O

Out	O
of	O
the	O
46	O
at	O
rsik	O
sbujects	O
in	O
the	O
two	O
youngest	O
gneerations	O
,	O
only	O
one	O
was	O
found	O
to	O
have	O
a	O
full	O
mtuation	O
.	O

This	O
is	O
the	O
only	O
subjcet	O
who	O
may	O
transimt	O
the	O
gnee	O
to	O
the	O
sixth	O
geenration	O
.	O

No	O
portomutation	O
carrires	O
were	O
found	O
in	O
the	O
fourth	O
and	O
fifth	O
gneerations	O
.	O

Therefore	O
it	O
is	O
highly	O
probable	O
that	O
the	O
DM	B-Disease
gnee	O
will	O
be	O
eliminated	O
from	O
this	O
pdeigree	O
within	O
one	O
geenration	O
.	O

The	O
high	O
pouplation	O
frequnecy	O
of	O
DM	B-Disease
can	O
at	O
present	O
not	O
be	O
explained	O
by	O
the	O
contribution	O
of	O
asympotmatic	O
csaes	O
in	O
the	O
younegr	O
generatinos	O
of	O
known	O
famiiles	O
,	O
but	O
is	O
probably	O
caused	O
by	O
the	O
eevnts	O
in	O
the	O
ancestarl	O
generaitons	O
.	O
.	O

The	O
gnee	O
for	O
spianl	B-Disease
cereebllar	I-Disease
atxaia	I-Disease
3	O
(	O
SAC3	O
)	O
is	O
located	O
in	O
a	O
reigon	O
of	O
approximately	O
3	O
cM	O
on	O
crhomosome	O
14q24	O
.	O
3	O
-	O
q32	O
.	O
2	O
.	O

SAC3	O
,	O
the	O
gnee	O
for	O
sipnal	B-Disease
cerbeellar	I-Disease
atxaia	I-Disease
3	O
,	O
was	O
recently	O
mapped	O
to	O
a	O
15	O
-	O
cM	O
interavl	O
between	O
D146S7	O
and	O
D14S81	O
on	O
chromsoome	O
14q	O
,	O
by	O
lnikage	O
anaylsis	O
in	O
two	O
famileis	O
of	O
Frnech	O
ancsetry	O
.	O

The	O
SAC3	O
candidate	O
reigon	O
has	O
now	O
been	O
refined	O
by	O
linkgae	O
anaylsis	O
with	O
four	O
new	O
microastellite	O
mrakers	O
(	O
D14S526	O
,	O
D41S291	O
,	O
D14S280	O
,	O
and	O
AFM334vf1	O
)	O
in	O
the	O
same	O
two	O
faimlies	O
,	O
in	O
which	O
19	O
additional	O
indviiduals	O
were	O
gneotyped	O
,	O
and	O
in	O
a	O
third	O
Fernch	O
fmaily	O
.	O

Cmobined	O
two	O
-	O
point	O
liknage	O
analsyes	O
show	O
that	O
the	O
new	O
mrakers	O
,	O
D14S280	O
and	O
AFM334vf1	O
,	O
are	O
tightly	O
linked	O
to	O
the	O
SAC3	O
loucs	O
,	O
with	O
mxaimal	O
lod	O
scroes	O
,	O
at	O
recombinaiton	O
fraciton	O
,	O
(	O
thtea	O
)	O
=	O
.	O

00	O
,	O
of	O
7	O
.	O

05	O
and	O
13	O
.	O

70	O
,	O
respectively	O
.	O

Combiend	O
multipiont	O
and	O
recombinnat	O
halpotype	O
aanlyses	O
localzie	O
the	O
SAC3	O
loucs	O
to	O
a	O
3	O
-	O
cM	O
inetrval	O
flanked	O
by	O
D1S4291	O
and	O
D14S81	O
.	O

The	O
same	O
allele	O
for	O
D14S280	O
segregates	O
with	O
the	O
disesae	O
lcous	O
in	O
the	O
three	O
kinrdeds	O
.	O

This	O
alelle	O
is	O
frequnet	O
in	O
the	O
Fernch	O
pouplation	O
,	O
however	O
,	O
and	O
liknage	O
disqeuilibrium	O
is	O
not	O
clearly	O
established	O
.	O

The	O
SAC3	O
loucs	O
remains	O
within	O
the	O
29	O
-	O
cM	O
rgeion	O
on	O
14q24	O
.	O

3	O
-	O
q32	O
.	O

2	O
containing	O
the	O
gnee	O
for	O
the	O
Mahcado	B-Disease
-	I-Disease
Joesph	I-Disease
diesase	I-Disease
,	O
which	O
is	O
cilnically	O
related	O
to	O
the	O
phentoype	O
determined	O
by	O
SAC3	O
,	O
but	O
it	O
cannot	O
yet	O
be	O
concluded	O
that	O
both	O
diseaess	O
result	O
from	O
altreations	O
of	O
the	O
same	O
gnee	O

An	O
eavluation	O
of	O
genteic	O
heterogenetiy	O
in	O
145	O
braest	B-Disease
-	I-Disease
ovarain	I-Disease
cacner	I-Disease
famileis	O
.	O

Berast	B-Disease
Cacner	I-Disease
Linakge	O
Consotrium	O
.	O

The	O
braest	B-Disease
-	I-Disease
ovray	I-Disease
canecr	I-Disease
-	I-Disease
faimly	I-Disease
syndrmoe	I-Disease
is	O
a	O
dominnat	O
perdisposition	O
to	O
cnacer	B-Disease
of	I-Disease
the	I-Disease
berast	I-Disease
and	I-Disease
ovraies	I-Disease
which	O
has	O
been	O
mapped	O
to	O
chromsoome	O
rgeion	O
17q12	O
-	O
q21	O
.	O

The	O
majority	O
,	O
but	O
not	O
all	O
,	O
of	O
bresat	B-Disease
-	I-Disease
oavry	I-Disease
canecr	I-Disease
faimlies	O
show	O
liknage	O
to	O
this	O
sucseptibility	O
lcous	O
,	O
designated	O
BCRA1	O
.	O

We	O
reoprt	O
here	O
the	O
rseults	O
of	O
a	O
liknage	O
analyiss	O
of	O
145	O
faimlies	O
with	O
both	O
braest	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
.	O

These	O
famiiles	O
contain	O
either	O
a	O
total	O
of	O
three	O
or	O
more	O
csaes	O
of	O
ealry	O
-	O
onset	O
(	O
before	O
age	O
60	O
yaers	O
)	O
braest	B-Disease
cacner	I-Disease
or	O
oavrian	B-Disease
canecr	I-Disease
.	O

All	O
famileis	O
contained	O
at	O
least	O
one	O
csae	O
of	O
ovraian	B-Disease
cacner	I-Disease
.	O

Overall	O
,	O
an	O
esitmated	O
76	O
%	O
of	O
the	O
145	O
faimlies	O
are	O
linked	O
to	O
the	O
BCRA1	O
loucs	O
.	O

None	O
of	O
the	O
13	O
fmailies	O
with	O
caess	O
of	O
mlae	B-Disease
berast	I-Disease
cnacer	I-Disease
appear	O
to	O
be	O
linked	O
,	O
but	O
it	O
is	O
estimaetd	O
that	O
92	O
%	O
(	O
95	O
%	O
conifdence	O
itnerval	O
76	O
%	O
-	O
100	O
%	O
)	O
of	O
fmailies	O
with	O
no	O
mlae	B-Disease
bresat	I-Disease
cnacer	I-Disease
and	O
with	O
two	O
or	O
more	O
ovairan	B-Disease
cacners	I-Disease
are	O
linked	O
to	O
BRAC1	O
.	O

These	O
dtaa	O
suggest	O
that	O
the	O
berast	B-Disease
-	I-Disease
ovarain	I-Disease
cnacer	I-Disease
-	I-Disease
famliy	I-Disease
syndrmoe	I-Disease
is	O
geneticlaly	O
heteorgeneous	O
.	O

However	O
,	O
the	O
large	O
majority	O
of	O
famileis	O
with	O
eraly	O
-	O
onset	O
bresat	B-Disease
cnacer	I-Disease
and	O
with	O
two	O
or	O
more	O
caess	O
of	O
ovraian	B-Disease
canecr	I-Disease
are	O
likely	O
to	O
be	O
due	O
to	O
BCRA1	O
mtuations	O
.	O
.	O

Molceular	O
basis	O
of	O
essetnial	B-Disease
fructousria	I-Disease
:	O
molceular	O
colning	O
and	O
muattional	O
anaylsis	O
of	O
huamn	O
ketohexkoinase	O
(	O
fructokianse	O
)	O
.	O

Essenital	B-Disease
frcutosuria	I-Disease
is	O
one	O
of	O
the	O
oldest	O
known	O
inbron	B-Disease
errors	I-Disease
of	I-Disease
metabolsim	I-Disease
.	O

It	O
is	O
a	O
bengin	O
conidtion	O
which	O
is	O
believed	O
to	O
result	O
from	O
deficinecy	B-Disease
of	I-Disease
heptaic	I-Disease
fructkoinase	I-Disease
(	O
kteohexokinase	O
,	O
KHK	O
,	O
E	O
.	O
C	O
.	O
2	O
.	O
7	O
.	O
1	O
.	O
3	O
)	O
.	O

This	O
enyzme	O
catalyses	O
the	O
first	O
step	O
of	O
metaboilsm	O
of	O
dietray	O
fructsoe	O
,	O
covnersion	O
of	O
furctose	O
to	O
furctose	O
-	O
1	O
-	O
phopshate	O
.	O

Despite	O
the	O
eraly	O
recogniiton	O
of	O
this	O
disodrer	O
,	O
the	O
priamry	O
strutcure	O
of	O
hmuan	O
KHK	O
and	O
the	O
molecualr	O
basis	O
of	O
essetnial	B-Disease
fructosruia	I-Disease
have	O
not	O
been	O
previously	O
defined	O
.	O

In	O
this	O
reoprt	O
,	O
the	O
isoltaion	O
and	O
sequenicng	O
of	O
full	O
-	O
lentgh	O
cNDA	O
colnes	O
enocding	O
huamn	O
ketoehxokinase	O
are	O
described	O
.	O

Altenrative	O
mNRA	O
speices	O
and	O
aletrnative	O
KHK	O
isozyems	O
are	O
produced	O
by	O
atlernative	O
polyadeynlation	O
and	O
slpicing	O
of	O
the	O
KHK	O
gnee	O
.	O

The	O
KHK	O
protenis	O
show	O
a	O
high	O
lveel	O
of	O
seqeunce	O
conseravtion	O
relative	O
to	O
rat	O
KHK	O
.	O

Direct	O
evidnece	O
that	O
mutaiton	O
of	O
the	O
KHK	O
srtuctural	O
gnee	O
is	O
the	O
cause	O
of	O
essetnial	B-Disease
frucotsuria	I-Disease
was	O
also	O
obtained	O
.	O

In	O
a	O
well	O
-	O
chaarcterized	O
famliy	O
,	O
in	O
which	O
three	O
of	O
eight	O
silbings	O
have	O
frcutosuria	B-Disease
,	O
all	O
affected	O
indiivduals	O
are	O
cmopound	O
heterozygtoes	O
for	O
two	O
muattions	O
Gly40rAg	O
and	O
Ala34Thr	O
.	O

Both	O
mtuations	O
result	O
from	O
G	O
-	O
-	O
>	O
A	O
transitoins	O
,	O
and	O
each	O
altres	O
the	O
same	O
conserved	O
reigon	O
of	O
the	O
KHK	O
proetin	O
.	O

Neither	O
mutatoin	O
was	O
seen	O
in	O
a	O
samlpe	O
of	O
52	O
unrelated	O
conrtol	O
indiivduals	O
.	O

An	O
additional	O
conservative	O
aimno	O
aicd	O
change	O
(	O
Va4l9IIe	O
)	O
was	O
present	O
on	O
the	O
KHK	O
alllee	O
bearing	O
Al4a3Thr	O

Hmoozygous	O
preesnce	O
of	O
the	O
corssover	O
(	O
fsuion	O
gnee	O
)	O
mtuation	O
idetnified	O
in	O
a	O
tpye	B-Disease
II	I-Disease
Gauhcer	I-Disease
disaese	I-Disease
feuts	O
:	O
is	O
this	O
analogous	O
to	O
the	O
Guacher	O
konck	O
-	O
out	O
mosue	O
mdoel	O
?	O

Gaucehr	B-Disease
disesae	I-Disease
(	O
GD	B-Disease
)	O
is	O
an	O
inheirted	O
deifciency	B-Disease
of	I-Disease
btea	I-Disease
-	I-Disease
glucocreebrosidase	I-Disease
(	O
EC	O
3	O
.	O
1	O
.	O
2	O
.	O
45	O
,	O
gnee	O
smybol	O
GBA	O
)	O
.	O

In	O
tpye	B-Disease
I	I-Disease
GD	I-Disease
,	O
the	O
CNS	O
is	O
not	O
involved	O
(	O
nonneuornopathic	O
)	O
,	O
whereas	O
in	O
tpye	B-Disease
II	I-Disease
GD	I-Disease
(	O
actue	O
neurnoopathic	O
)	O
CNS	O
involvemnet	O
is	O
ealry	O
and	O
rapidly	O
progrsesive	O
,	O
while	O
in	O
tpye	B-Disease
III	I-Disease
GD	I-Disease
(	O
subcaute	O
neuronpoathic	O
)	O
CNS	O
invlovement	O
occurs	O
later	O
and	O
is	O
slowly	O
progresisve	O
.	O

The	O
T6343C	O
(	O
L444P	O
)	O
substitutoin	O
is	O
prevaelnt	O
in	O
tpye	B-Disease
GD	I-Disease
II	I-Disease
.	O

It	O
may	O
occur	O
alone	O
as	O
a	O
single	O
base	O
-	O
piar	O
mutatoin	O
but	O
often	O
is	O
found	O
as	O
part	O
of	O
a	O
comlpex	O
allele	O
containing	O
additional	O
GBA	O
nucleotdie	O
substituitons	O
,	O
G4668C	O
(	O
A465P	O
)	O
and	O
G6482C	O
(	O
V640V	O
)	O
,	O
without	O
(	O
rceNciI	O
)	O
or	O
with	O
(	O
reTcL	O
)	O
G5975C	O
(	O
D490H	O
)	O
.	O

This	O
cmoplex	O
alelle	O
is	O
presumed	O
to	O
have	O
formed	O
by	O
rceombination	O
(	O
crossover	O
,	O
fsuion	O
)	O
of	O
the	O
srtuctural	O
gnee	O
with	O
the	O
pseudgoene	O
,	O
which	O
contains	O
the	O
mutaetd	O
sequecnes	O
.	O

Two	O
cmoplex	O
alelles	O
have	O
never	O
been	O
demonstrated	O
to	O
coexist	O
in	O
any	O
inidvidual	O
.	O

We	O
devised	O
a	O
selective	O
PCR	O
mtehod	O
for	O
the	O
specific	O
amplifiaction	O
of	O
the	O
nromal	O
and	O
/	O
or	O
fsuion	O
gnee	O
.	O

Using	O
this	O
procdeure	O
we	O
demonstrated	O
the	O
fsuion	O
gnee	O
in	O
homozgyous	O
form	O
for	O
the	O
first	O
tmie	O
,	O
in	O
a	O
Mcaedonian	O
/	O
Ashkenzai	O
Jewsih	O
GD	B-Disease
tpye	I-Disease
II	I-Disease
feuts	O
.	O

Both	O
paernts	O
were	O
crariers	O
of	O
the	O
recombinatoin	O
.	O

This	O
was	O
confirmed	O
by	O
direct	O
sequnece	O
aanlysis	O
.	O

A	O
previous	O
conecptus	O
in	O
this	O
fmaily	O
was	O
stillobrn	B-Disease
at	O
36	O
wekes	O
,	O
with	O
feautres	O
of	O
sveere	O
tpye	B-Disease
II	I-Disease
GD	I-Disease
.	O

Neonaets	O
showing	O
a	O
sveere	O
clniical	O
pehnotype	O
,	O
analogous	O
to	O
the	O
eraly	O
noenatal	O
lehtal	O
diesase	O
occurring	O
in	O
mcie	O
homzoygous	O
for	O
a	O
nlul	O
allele	O
produced	O
by	O
targteed	O
disurption	O
of	O
GBA	O
,	O
have	O
been	O
described	O
elsewhere	O
,	O
but	O
the	O
specific	O
mtuations	O
in	O
these	O
csaes	O
have	O
not	O
yet	O
been	O
characteirzed	O
.	O

(	O
ABSTRACT	O
TRUNACTED	O
AT	O
250	O
WORDS	O
)	O

Ltae	O
infanitle	O
metachrmoatic	B-Disease
leukodysrtophy	I-Disease
in	O
Isarel	O
.	O

Metahcromatic	B-Disease
Luekodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
is	O
a	O
neurodgeenerative	B-Disease
dsiease	I-Disease
in	O
which	O
the	O
lyossomal	O
enyzme	O
,	O
Aryl	O
sulfaatse	O
A	O
(	O
ASRA	O
)	O
is	O
deficinet	O
.	O

The	O
diesase	O
is	O
inheirted	O
as	O
an	O
autsoomal	O
rceessive	O
triat	O
and	O
its	O
frqeuency	O
is	O
etsimated	O
to	O
be	O
1	O
/	O
40	O
,	O
000	O
lvie	O
bitrhs	O
.	O

The	O
gnee	O
of	O
ASRA	O
has	O
been	O
cloend	O
and	O
up	O
to	O
now	O
eight	O
mutatoins	O
causing	O
MLD	B-Disease
have	O
been	O
reported	O
.	O

Another	O
mutaiton	O
,	O
PD	O
,	O
leads	O
to	O
the	O
deifciency	O
of	O
the	O
enyzme	O
in	O
vitro	O
(	O
pseuddoeficiency	O
)	O
without	O
any	O
known	O
clniical	O
efefct	O
.	O

The	O
PD	O
muattion	O
is	O
frequnet	O
in	O
all	O
popualtions	O
.	O

In	O
Irsael	O
,	O
ltae	O
infnatile	O
MLD	B-Disease
was	O
found	O
to	O
be	O
very	O
frqeuent	O
in	O
a	O
small	O
Jeiwsh	O
isoltae	O
,	O
the	O
Habbnaite	O
Jwes	O
(	O
1	O
/	O
75	O
lvie	O
birhts	O
)	O
.	O

The	O
moleuclar	O
analsyis	O
demonstrated	O
that	O
in	O
the	O
Habbantie	O
pouplation	O
,	O
the	O
muttaion	O
occurred	O
on	O
an	O
allele	O
with	O
the	O
PD	O
muattion	O
.	O

The	O
lsos	O
of	O
ASRA	O
acitvity	O
is	O
due	O
to	O
a	O
point	O
mutaiton	O
C	O
>	O
T	O
leading	O
to	O
a	O
change	O
of	O
porline	O
to	O
leucnie	O
.	O

MLD	B-Disease
is	O
also	O
ferquent	O
among	O
Moselm	O
Arbas	O
in	O
Jeruslaem	O
.	O

The	O
muattion	O
is	O
a	O
trasnition	O
G	O
>	O
A	O
destroying	O
the	O
slpice	O
doonr	O
stie	O
of	O
eoxn	O
2	O
.	O

This	O
mutaiton	O
has	O
been	O
reported	O
in	O
pateints	O
with	O
the	O
ltae	O
infnatile	O
MLD	B-Disease
from	O
different	O
ethinc	O
gruops	O
.	O

The	O
Crhistian	O
Arbas	O
in	O
Irsael	O
also	O
have	O
a	O
high	O
inciednce	O
of	O
the	O
dsiease	O
(	O
1	O
/	O
10	O
,	O
000	O
lvie	O
birhts	O
)	O
;	O
the	O
muttaion	O
in	O
this	O
popluation	O
is	O
still	O
unknown	O
.	O

Knoweldge	O
of	O
the	O
different	O
mutaitons	O
causing	O
MLD	B-Disease
in	O
these	O
defined	O
populatinos	O
will	O
allow	O
a	O
carreir	O
screneing	O
prgoram	O
to	O
be	O
carried	O
out	O
and	O
prveent	O
the	O
brith	O
of	O
additional	O
afefcted	O
chlidren	O
.	O
.	O

A	O
single	O
amnio	O
aicd	O
substtiution	O
(	O
G130D	O
)	O
in	O
the	O
tpye	O
II	O
collagen	O
trpile	O
hleix	O
produces	O
Kniset	B-Disease
dysplsaia	I-Disease
.	O

Kneist	B-Disease
dyspalsia	I-Disease
is	O
a	O
modertaely	O
sevree	O
chonrdodysplasia	B-Disease
phentoype	O
that	O
reuslts	O
from	O
muttaions	O
in	O
the	O
gnee	O
for	O
tpye	O
II	O
collgaen	O
,	O
COLA21	O
.	O

Charactreistics	O
of	O
the	O
disroder	O
include	O
a	O
short	B-Disease
trnuk	I-Disease
and	I-Disease
etxremities	I-Disease
,	O
mid	B-Disease
-	I-Disease
fcae	I-Disease
hyopplasia	I-Disease
,	O
clfet	B-Disease
paltae	I-Disease
,	O
myoipa	B-Disease
,	O
rteinal	B-Disease
detachmnet	I-Disease
,	O
and	O
heairng	B-Disease
lsos	I-Disease
.	O

Recently	O
,	O
deleitons	O
of	O
all	O
or	O
part	O
of	O
eoxn	O
12	O
have	O
been	O
identfiied	O
in	O
individauls	O
with	O
Kneist	B-Disease
dypslasia	I-Disease
,	O
suggesting	O
that	O
muttaions	O
within	O
this	O
reigon	O
of	O
the	O
proetin	O
may	O
primarily	O
result	O
in	O
the	O
Kneist	B-Disease
dyspalsia	I-Disease
phenoytpe	O
.	O

We	O
used	O
SCSP	O
to	O
anlayze	O
an	O
ampilfied	O
genmoic	O
DNA	O
frgament	O
containing	O
eoxn	O
12	O
from	O
seven	O
inidviduals	O
with	O
Kinest	B-Disease
dyspalsia	I-Disease
.	O

An	O
abnormlaity	O
was	O
identfiied	O
in	O
one	O
pateint	O
.	O

DNA	O
sequnece	O
aanlysis	O
demonstrated	O
that	O
the	O
ptaient	O
was	O
hetreozygous	O
for	O
a	O
G	O
to	O
A	O
tranistion	O
that	O
implied	O
sbustitution	O
of	O
glycien103	O
of	O
the	O
tirple	O
helcial	O
dmoain	O
by	O
asaprtate	O
.	O

The	O
mtuation	O
was	O
not	O
observed	O
in	O
DNA	O
from	O
either	O
of	O
the	O
clincially	O
unaffecetd	O
paernts	O
of	O
the	O
porband	O
.	O

Proetin	O
microsequnecing	O
demonstrated	O
expressoin	O
of	O
the	O
abnoraml	O
alllee	O
in	O
catrilage	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
point	O
muattions	O
which	O
result	O
in	O
single	O
aimno	O
aicd	O
substtiutions	O
can	O
produce	O
Kniset	B-Disease
dysplsaia	I-Disease
and	O
further	O
support	O
the	O
hyopthesis	O
that	O
alteraiton	O
of	O
a	O
doamin	O
,	O
which	O
includes	O
the	O
rgeion	O
encoedd	O
by	O
eoxn	O
12	O
,	O
in	O
the	O
tpye	O
II	O
collaegn	O
proetin	O
leads	O
to	O
this	O
dsiorder	O
.	O
.	O

CAG	O
exapnsions	O
in	O
a	O
novel	O
gnee	O
for	O
Mahcado	B-Disease
-	I-Disease
Jsoeph	I-Disease
dsiease	I-Disease
at	O
chromsoome	O
14q32	O
.	O
1	O
.	O

We	O
have	O
idetnified	O
a	O
novel	O
gnee	O
containing	O
CAG	O
reepats	O
and	O
mpaped	O
it	O
to	O
crhomosome	O
14q32	O
.	O

1	O
,	O
the	O
genteic	O
lcous	O
for	O
Mcahado	B-Disease
-	I-Disease
Jsoeph	I-Disease
dsiease	I-Disease
(	O
MJD	B-Disease
)	O
.	O

In	O
nomral	O
indviiduals	O
the	O
gnee	O
contains	O
between	O
13	O
and	O
36	O
CAG	O
repaets	O
,	O
whereas	O
most	O
of	O
the	O
clniically	O
diangosed	O
patietns	O
and	O
all	O
of	O
the	O
afefcted	O
mmebers	O
of	O
a	O
fmaily	O
with	O
the	O
clincial	O
and	O
ptahological	O
diagnsois	O
of	O
MJD	B-Disease
show	O
exapnsion	O
of	O
the	O
reepat	O
-	O
number	O
(	O
from	O
68	O
-	O
79	O
)	O
.	O

Southren	O
bolt	O
anlayses	O
and	O
genmoic	O
colning	O
demonstrates	O
the	O
existence	O
of	O
related	O
gnees	O
.	O

These	O
resutls	O
raise	O
the	O
possibility	O
that	O
similar	O
anbormalities	O
in	O
related	O
gnees	O
may	O
give	O
rise	O
to	O
dsieases	O
similar	O
to	O
MJD	B-Disease
.	O

Mutatoins	O
in	O
the	O
BCRA1	O
gnee	O
in	O
famliies	O
with	O
eraly	O
-	O
onset	O
braest	B-Disease
and	I-Disease
ovraian	I-Disease
cacner	I-Disease
.	O

We	O
anlaysed	O
50	O
porbands	O
with	O
a	O
faimly	O
histroy	O
of	O
braest	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovraian	I-Disease
cacner	I-Disease
for	O
gremline	O
muattions	O
in	O
the	O
coidng	O
rgeion	O
of	O
the	O
BCRA1	O
candidate	O
gnee	O
,	O
using	O
single	O
-	O
strnad	O
conofrmation	O
polmyorphism	O
(	O
SCSP	O
)	O
anlaysis	O
on	O
PCR	O
-	O
apmlified	O
genoimc	O
DNA	O
.	O

A	O
total	O
of	O
eight	O
putative	O
disesae	O
-	O
causing	O
aletrations	O
were	O
identfiied	O
four	O
of	O
these	O
are	O
frameshitfs	O
and	O
two	O
are	O
nosnense	O
muattions	O
.	O

In	O
addition	O
,	O
we	O
found	O
two	O
missnese	O
mutaitons	O
,	O
one	O
of	O
which	O
chnages	O
the	O
final	O
cystiene	O
of	O
the	O
BRAC1	O
znic	O
finegr	O
mtoif	O
to	O
glycnie	O
.	O

These	O
dtaa	O
are	O
consistent	O
with	O
a	O
tuomur	B-Disease
suppressor	O
mdoel	O
,	O
and	O
support	O
the	O
notion	O
that	O
this	O
candidate	O
gnee	O
is	O
in	O
fact	O
BCRA1	O
.	O

The	O
heetrogeneity	O
of	O
mutaitons	O
,	O
coupled	O
with	O
the	O
large	O
szie	O
of	O
the	O
gnee	O
,	O
indicates	O
that	O
clniical	O
appliaction	O
of	O
BCRA1	O
mutaiton	O
tetsing	O
will	O
be	O
techniaclly	O
challenging	O
.	O
.	O

Cofnirmation	O
of	O
BCRA1	O
by	O
analyiss	O
of	O
germlnie	O
mutaitons	O
linked	O
to	O
braest	B-Disease
and	I-Disease
ovairan	I-Disease
cacner	I-Disease
in	O
ten	O
famileis	O
.	O

We	O
provide	O
geneitc	O
evidnece	O
supporting	O
the	O
identtiy	O
of	O
the	O
candidate	O
gnee	O
for	O
BRAC1	O
through	O
the	O
charactreization	O
of	O
gerlmine	O
mutatinos	O
in	O
63	O
berast	B-Disease
cacner	I-Disease
pateints	O
and	O
10	O
oavrian	B-Disease
cnacer	I-Disease
patinets	O
in	O
ten	O
famiiles	O
with	O
canecr	B-Disease
linked	O
to	O
chrmoosome	O
17q21	O
.	O

Nine	O
different	O
muattions	O
were	O
detceted	O
by	O
screening	O
BCRA1	O
DNA	O
and	O
RNA	O
by	O
single	O
-	O
starnd	O
conformatoin	O
polymorphsim	O
aanlysis	O
and	O
direct	O
sequencnig	O
.	O

Seven	O
mutatinos	O
lead	O
to	O
portein	O
trnucations	O
at	O
siets	O
throughout	O
the	O
gnee	O
.	O

One	O
misesnse	O
mtuation	O
(	O
which	O
occurred	O
independently	O
in	O
two	O
famileis	O
)	O
leads	O
to	O
lsos	O
of	O
a	O
cysetine	O
in	O
the	O
znic	O
bindnig	O
doamin	O
.	O

An	O
introinc	O
single	O
bsaepair	O
sbustitution	O
detsroys	O
an	O
acceptor	O
stie	O
and	O
activtaes	O
a	O
crytpic	O
slpice	O
stie	O
,	O
leading	O
to	O
a	O
59	O
baseapir	O
isnertion	O
and	O
cahin	O
termintaion	O
.	O

The	O
four	O
fmailies	O
with	O
both	O
braest	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
had	O
chian	O
termiantion	O
mutatinos	O
in	O
the	O
N	O
-	O
treminal	O
half	O
of	O
the	O
portein	O
.	O
.	O

High	O
reoslution	O
genteic	O
aanlysis	O
suggests	O
one	O
ancesrtal	O
predisopsing	O
haplotpye	O
for	O
the	O
oriign	O
of	O
the	O
myootnic	B-Disease
dystrpohy	I-Disease
muttaion	O
.	O

The	O
mutatoin	O
causing	O
myootnic	B-Disease
dystrpohy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
iedntified	O
as	O
an	O
ampliifcation	O
of	O
an	O
unstable	O
triuncleotide	O
(	O
CTG	O
)	O
n	O
rpeeat	O
in	O
over	O
99	O
%	O
of	O
the	O
gloabl	O
DM	B-Disease
pouplation	O
.	O

It	O
is	O
in	O
complete	O
liknage	O
diesquilibrium	O
with	O
an	O
Alu	O
eleemnt	O
polymrophism	O
within	O
the	O
DM	B-Disease
kinsae	O
gnee	O
,	O
suggesting	O
that	O
DM	B-Disease
is	O
a	O
consequence	O
of	O
one	O
or	O
few	O
acnestral	O
mtuations	O
.	O

A	O
recent	O
anlaysis	O
utilizing	O
this	O
polymrophism	O
as	O
well	O
as	O
a	O
flanking	O
dinucleotdie	O
makrer	O
,	O
suggested	O
that	O
similar	O
to	O
Fraigle	B-Disease
X	I-Disease
syndorme	I-Disease
,	O
DM	B-Disease
exhibited	O
a	O
fonuder	O
effect	O
(	O
Imbret	O
et	O
al	O
.	O
,	O
1993	O
Nautre	O
Genet	O
.	O
4	O
,	O
72	O
-	O
76	O
)	O
.	O

In	O
contrast	O
,	O
the	O
low	O
rperoductive	O
fitnses	O
of	O
inidviduals	O
with	O
conegnital	O
DM	B-Disease
(	O
the	O
ednpoint	O
of	O
gneetic	O
anitcipation	O
in	O
myootnic	B-Disease
dysrtophy	I-Disease
)	O
suggests	O
a	O
hgiher	O
rtae	O
of	O
new	O
mtuations	O
.	O

We	O
present	O
a	O
high	O
resloution	O
genteic	O
anaylsis	O
of	O
the	O
DM	B-Disease
loucs	O
using	O
PCR	O
based	O
assays	O
of	O
nine	O
polymorphimss	O
,	O
spanning	O
a	O
phsyical	O
distnace	O
of	O
30	O
kb	O
,	O
within	O
and	O
immediately	O
flanking	O
the	O
DM	B-Disease
kinsae	O
gnee	O
.	O

The	O
presistent	O
complete	O
allelic	O
associtaion	O
of	O
the	O
DM	B-Disease
mtuation	O
with	O
all	O
these	O
polymoprhisms	O
provides	O
further	O
support	O
to	O
previous	O
observtaions	O
and	O
suggests	O
more	O
strongly	O
that	O
the	O
DM	B-Disease
muttaion	O
occurred	O
on	O
the	O
background	O
of	O
a	O
particular	O
hapltoype	O
in	O
which	O
the	O
(	O
CTG	O
)	O
n	O
reepat	O
became	O
inherently	O
unstable	O
and	O
therefore	O
predipsosed	O
to	O
apmlification	O
.	O

Geentic	O
isntability	O
in	O
huamn	O
ovraian	B-Disease
canecr	I-Disease
clel	O
liens	O
.	O

We	O
have	O
analyezd	O
the	O
staiblity	O
of	O
microsatellites	O
in	O
clel	O
liens	O
derived	O
from	O
hmuan	O
oavrian	B-Disease
canecrs	I-Disease
and	O
found	O
that	O
5	O
out	O
of	O
10	O
of	O
the	O
ovairan	B-Disease
tmuor	I-Disease
clel	O
liens	O
are	O
geneitcally	O
unstable	O
at	O
the	O
majority	O
of	O
the	O
lcoi	O
anlayzed	O
.	O

In	O
colnes	O
and	O
sucblones	O
derived	O
serially	O
from	O
one	O
of	O
these	O
clel	O
lnies	O
(	O
2774	O
;	O
seruos	B-Disease
cysatdenocarcinoma	I-Disease
)	O
,	O
a	O
very	O
high	O
porportion	O
of	O
microsatelliets	O
distributed	O
in	O
many	O
different	O
reginos	O
of	O
the	O
gneome	O
change	O
their	O
szie	O
in	O
a	O
mercurail	O
fashion	O
.	O

We	O
conclude	O
that	O
genoimc	O
isntability	O
in	O
oavrian	B-Disease
tuomrs	I-Disease
is	O
a	O
dnyamic	O
and	O
ongoing	O
proecss	O
whose	O
high	O
freuqency	O
may	O
have	O
been	O
previously	O
underestimated	O
by	O
PCR	O
-	O
based	O
allelotpying	O
of	O
bulk	O
tuomr	B-Disease
tissue	O
.	O

We	O
have	O
identiifed	O
the	O
soucre	O
of	O
the	O
gneetic	O
instbaility	O
in	O
one	O
ovairan	B-Disease
tmuor	I-Disease
as	O
a	O
point	O
mutatoin	O
(	O
R542P	O
)	O
in	O
the	O
huamn	O
misamtch	O
-	O
rpeair	O
gnee	O
MHS2	O
(	O
Salomnella	O
MtuS	O
hmoologue	O
)	O
,	O
which	O
has	O
recently	O
been	O
shown	O
to	O
be	O
involved	O
in	O
herdeitary	B-Disease
nonpolpyosis	I-Disease
colorcetal	I-Disease
cacner	I-Disease
.	O

Patinet	O
2774	O
was	O
a	O
38	O
-	O
yaer	O
-	O
old	O
heterozgyote	O
,	O
and	O
her	O
noraml	O
tisuse	O
carried	O
both	O
mtuant	O
and	O
wlid	O
-	O
tpye	O
alllees	O
of	O
the	O
hmuan	O
MHS2	O
gnee	O
.	O

However	O
the	O
wlid	O
-	O
tpye	O
alllee	O
was	O
lsot	O
at	O
some	O
point	O
ealry	O
during	O
tmuorigenesis	O
so	O
that	O
DNA	O
isoalted	O
either	O
from	O
the	O
patietns	O
ovraian	B-Disease
tuomr	I-Disease
or	O
from	O
the	O
2774	O
clel	O
line	O
carries	O
only	O
the	O
mtuant	O
alelle	O
of	O
the	O
huamn	O
MHS2	O
gnee	O
.	O

The	O
gneetic	O
isntability	O
observed	O
in	O
the	O
tmuor	B-Disease
and	O
clel	O
line	O
DNA	O
,	O
together	O
with	O
the	O
grem	O
-	O
line	O
mtuation	O
in	O
a	O
mismacth	O
-	O
rpeair	O
gnee	O
,	O
suggest	O
that	O
the	O
MHS2	O
gnee	O
is	O
involved	O
in	O
the	O
onset	O
and	O
/	O
or	O
progerssion	O
in	O
a	O
subset	O
of	O
ovarain	B-Disease
cacner	I-Disease
.	O
.	O

BRAC1	O
muttaions	O
in	O
primray	O
berast	B-Disease
and	I-Disease
ovarain	I-Disease
carcionmas	I-Disease
.	O

Lsos	O
of	O
heterzoygosity	O
dtaa	O
from	O
familail	B-Disease
tumros	I-Disease
suggest	O
that	O
BRAC1	O
,	O
a	O
gnee	O
that	O
confers	O
susceptbiility	O
to	O
oavrian	B-Disease
and	I-Disease
eraly	I-Disease
-	I-Disease
onset	I-Disease
berast	B-Disease
cacner	I-Disease
,	O
ecnodes	O
a	O
tmuor	B-Disease
suprpessor	O
.	O

The	O
BRAC1	O
regoin	O
is	O
also	O
sbuject	O
to	O
alleilc	O
lsos	O
in	O
spordaic	B-Disease
braest	I-Disease
and	I-Disease
ovarain	I-Disease
canecrs	I-Disease
,	O
an	O
indictaion	O
that	O
BRAC1	O
mutaitons	O
may	O
occur	O
soamtically	O
in	O
these	O
tmuors	B-Disease
.	O

The	O
BCRA1	O
coidng	O
reigon	O
was	O
examined	O
for	O
mutatinos	O
in	O
priamry	O
braest	B-Disease
and	I-Disease
ovairan	I-Disease
tmuors	I-Disease
that	O
show	O
alllee	O
lsos	O
at	O
the	O
BCRA1	O
lcous	O
.	O

Mutaitons	O
were	O
detecetd	O
in	O
3	O
of	O
32	O
berast	O
and	O
1	O
of	O
12	O
ovairan	B-Disease
carcinmoas	I-Disease
;	O
all	O
four	O
mutaitons	O
were	O
gremline	O
altertaions	O
and	O
occurred	O
in	O
eraly	O
-	O
onset	O
cacners	B-Disease
.	O

These	O
resutls	O
suggest	O
that	O
mutatoin	O
of	O
BCRA1	O
may	O
not	O
be	O
critical	O
in	O
the	O
deveolpment	O
of	O
the	O
majority	O
of	O
berast	B-Disease
and	I-Disease
ovarain	I-Disease
cacners	I-Disease
that	O
arise	O
in	O
the	O
asbence	O
of	O
a	O
mutnat	O
gemrline	O
allele	O
.	O
.	O

PXA6	O
gnee	O
dsoage	O
efefct	O
in	O
a	O
faimly	O
with	O
conegnital	B-Disease
catarcats	I-Disease
,	O
anirdiia	B-Disease
,	O
anpohthalmia	B-Disease
and	O
centarl	B-Disease
nevrous	I-Disease
ssytem	I-Disease
defetcs	I-Disease
.	O

The	O
hmuan	O
eye	O
malformatoin	O
ainridia	B-Disease
reuslts	O
from	O
hapolinsufficiency	B-Disease
of	I-Disease
PXA6	I-Disease
,	O
a	O
paired	O
box	O
DNA	O
-	O
bidning	O
portein	O
.	O

To	O
sutdy	O
this	O
doasge	O
efefct	O
,	O
we	O
charactreized	O
two	O
PXA6	O
mutatoins	O
in	O
a	O
famliy	O
segregaitng	O
anriidia	B-Disease
and	O
a	O
milder	O
syndrmoe	O
consisting	O
of	O
cognenital	B-Disease
cataratcs	I-Disease
and	O
ltae	O
onset	O
conreal	B-Disease
dytsrophy	I-Disease
.	O

The	O
nonesnse	O
mutaitons	O
,	O
at	O
coodns	O
103	O
and	O
353	O
,	O
truncate	O
PXA6	O
within	O
the	O
N	O
-	O
temrinal	O
paired	O
and	O
C	O
-	O
treminal	O
PST	O
dmoains	O
,	O
respectively	O
.	O

The	O
wlid	O
-	O
tpye	O
PST	O
doamin	O
atcivates	O
transrciption	O
autonomoulsy	O
and	O
the	O
mutnat	O
form	O
has	O
parital	O
acitvity	O
.	O

A	O
componud	O
heetrozygote	O
had	O
seevre	O
cranoifacial	B-Disease
and	I-Disease
centarl	I-Disease
nevrous	I-Disease
sytsem	I-Disease
deefcts	I-Disease
and	O
no	B-Disease
eeys	I-Disease
.	O

The	O
ptatern	O
of	O
mlaformations	O
is	O
similar	O
to	O
that	O
in	O
homoyzgous	O
Sey	O
mcie	O
and	O
suggests	O
a	O
critical	O
role	O
for	O
PXA6	O
in	O
controlling	O
the	O
migraiton	O
and	O
differenitation	O
of	O
specific	O
nueronal	O
proegnitor	O
cells	O
in	O
the	O
barin	O
.	O
.	O

A	O
physiacl	O
map	O
and	O
candidate	O
geens	O
in	O
the	O
BCRA1	O
reigon	O
on	O
chromoosme	O
17q12	O
-	O
21	O
.	O

We	O
have	O
constructed	O
a	O
pyhsical	O
map	O
of	O
a	O
4	O
cM	O
rgeion	O
on	O
chroomsome	O
17q12	O
-	O
21	O
that	O
contains	O
the	O
hreeditary	B-Disease
braest	I-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
gnee	O
BCRA1	O
.	O

The	O
map	O
comprises	O
a	O
cnotig	O
of	O
137	O
overlapping	O
yaest	O
artifiical	O
chromosoems	O
and	O
P1	O
clnoes	O
,	O
onto	O
which	O
we	O
have	O
placed	O
112	O
PCR	O
makrers	O
.	O

We	O
have	O
lcoalized	O
more	O
than	O
20	O
geens	O
on	O
this	O
map	O
,	O
ten	O
of	O
which	O
had	O
not	O
been	O
mpaped	O
to	O
the	O
rgeion	O
previously	O
,	O
and	O
have	O
isoltaed	O
30	O
cNDA	O
colnes	O
representing	O
parital	O
seuqences	O
of	O
as	O
yet	O
unidentified	O
geens	O
.	O

Two	O
geens	O
that	O
lie	O
within	O
a	O
narrow	O
regoin	O
defined	O
by	O
meoitic	O
breakponits	O
in	O
BCRA1	O
pateints	O
have	O
been	O
sqeuenced	O
in	O
berast	B-Disease
cnacer	I-Disease
paitents	O
without	O
revealing	O
any	O
dleeterious	O
mtuations	O
.	O

These	O
new	O
reaegnts	O
should	O
facilitate	O
the	O
identifiaction	O
of	O
BRAC1	O
.	O
.	O

The	O
LEC	O
rat	O
has	O
a	O
dleetion	O
in	O
the	O
cpoper	O
transporting	O
APTase	O
gnee	O
homloogous	O
to	O
the	O
Wislon	B-Disease
disesae	I-Disease
gnee	O
.	O

The	O
Lnog	O
-	O
Evnas	O
Cinanmon	O
(	O
LEC	O
)	O
rat	O
shows	O
similartiy	O
to	O
Wilosn	B-Disease
disesae	I-Disease
in	O
many	O
cilnical	O
and	O
biohcemical	O
featrues	O
.	O

We	O
have	O
clnoed	O
cNDAs	O
for	O
the	O
rat	O
gnee	O
(	O
At7pb	O
)	O
homoloogus	O
to	O
the	O
huamn	O
Wislon	B-Disease
disaese	I-Disease
gnee	O
(	O
APT7B	O
)	O
and	O
have	O
used	O
them	O
to	O
identify	O
a	O
pratial	O
dleetion	O
in	O
the	O
At7pb	O
gnee	O
in	O
the	O
LEC	O
rat	O
.	O

The	O
deeltion	O
removes	O
at	O
least	O
900	O
bp	O
of	O
the	O
codnig	O
rgeion	O
at	O
the	O
3	O
end	O
,	O
includes	O
the	O
crucial	O
ATP	O
bindnig	O
domian	O
and	O
extends	O
downtsream	O
of	O
the	O
gnee	O
.	O

Our	O
rseults	O
provide	O
convincing	O
eivdence	O
for	O
defining	O
the	O
LEC	O
rat	O
as	O
an	O
ainmal	O
mdoel	O
for	O
Wilosn	B-Disease
dsiease	I-Disease
.	O

This	O
moedl	O
will	O
be	O
important	O
for	O
studying	O
lvier	O
pathophysiolgoy	O
,	O
for	O
developing	O
therpay	O
for	O
Wilosn	B-Disease
diesase	I-Disease
and	O
for	O
studying	O
the	O
pahtway	O
of	O
copper	O
transoprt	O
and	O
its	O
possible	O
intercation	O
with	O
other	O
haevy	O
meatls	O
.	O
.	O

Gneomic	O
organizaiton	O
of	O
the	O
adrenoleukodsytrophy	B-Disease
gnee	O
.	O

Adrenloeukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
,	O
the	O
most	O
ferquent	O
peroxsiomal	B-Disease
disroder	I-Disease
,	O
is	O
a	O
sevree	O
neruodegenerative	B-Disease
disesae	I-Disease
associated	O
with	O
an	O
impaimrent	B-Disease
of	I-Disease
very	I-Disease
long	I-Disease
chian	I-Disease
fatty	I-Disease
acdis	I-Disease
btea	I-Disease
-	I-Disease
oxidatoin	I-Disease
.	O

We	O
have	O
recently	O
identifeid	O
by	O
psoitional	O
clonnig	O
the	O
gnee	O
responsible	O
for	O
ALD	B-Disease
,	O
located	O
in	O
X2q8	O
.	O

It	O
enocdes	O
a	O
new	O
member	O
of	O
the	O
"	O
ABC	O
"	O
superfamliy	O
of	O
memrbane	O
-	O
associated	O
transpotrers	O
that	O
shows	O
,	O
in	O
particular	O
,	O
significant	O
homoolgy	O
to	O
the	O
70	O
-	O
kDa	O
peroxisoaml	O
membrnae	O
protien	O
(	O
PM7P0	O
)	O
.	O

We	O
reprot	O
here	O
a	O
detailed	O
charactreization	O
of	O
the	O
ALD	B-Disease
gnee	O
srtucture	O
.	O

It	O
extends	O
over	O
21	O
kb	O
and	O
consists	O
of	O
10	O
exnos	O
.	O

To	O
facilitate	O
the	O
detectoin	O
of	O
muattions	O
in	O
ALD	B-Disease
paitents	O
,	O
we	O
have	O
determined	O
the	O
intrnoic	O
sqeuences	O
flanking	O
the	O
exnos	O
as	O
well	O
as	O
the	O
sequnece	O
of	O
the	O
3	O
untransltaed	O
regoin	O
and	O
of	O
the	O
immeidate	O
5	O
proomter	O
rgeion	O
.	O

Sequecnes	O
present	O
in	O
dsital	O
eoxns	O
corss	O
-	O
hybrdiize	O
strongly	O
to	O
additional	O
seuqences	O
in	O
the	O
huamn	O
geonme	O
.	O

The	O
ALD	B-Disease
gnee	O
has	O
been	O
positioned	O
on	O
a	O
plused	O
-	O
field	O
map	O
between	O
DX1S5	O
and	O
the	O
LC1AM	O
gnee	O
,	O
about	O
650	O
kb	O
usptream	O
from	O
the	O
cloor	O
pgiment	O
gnees	O
.	O

The	O
frequnet	O
occrurence	O
of	O
cloor	O
visoin	O
anomaleis	O
observed	O
in	O
patinets	O
with	O
adrenomyeloneurpoathy	B-Disease
(	O
the	O
audlt	O
onset	O
form	O
of	O
ALD	B-Disease
)	O
thus	O
does	O
not	O
represent	O
a	O
contiguous	B-Disease
gnee	I-Disease
syndrmoe	I-Disease
but	O
a	O
secondary	O
mnaifestation	O
of	O
ALD	B-Disease
.	O
.	O

The	O
murnie	O
homologeus	O
of	O
the	O
Hnutington	B-Disease
dsiease	I-Disease
gnee	O
(	O
Hdh	O
)	O
and	O
the	O
alhpa	O
-	O
addcuin	O
gnee	O
(	O
Add1	O
)	O
map	O
to	O
muose	O
chromosmoe	O
5	O
within	O
a	O
regoin	O
of	O
conserved	O
sytneny	O
with	O
hmuan	O
crhomosome	O
4p16	O
.	O
3	O
.	O

Huntintgon	B-Disease
disesae	I-Disease
(	O
HD	B-Disease
)	O
is	O
a	O
sveere	O
autosmoal	B-Disease
domniant	I-Disease
neurodegeneartive	I-Disease
diosrder	I-Disease
associated	O
with	O
a	O
novel	O
gnee	O
(	O
I1T5	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
the	O
cloinng	O
of	O
Hdh	O
,	O
the	O
muirne	O
homloogue	O
of	O
I1T5	O
.	O

Here	O
,	O
using	O
an	O
interspecfiic	O
backrcoss	O
,	O
we	O
have	O
mapepd	O
both	O
Hdh	O
and	O
the	O
mosue	O
homolgoue	O
of	O
huamn	O
alhpa	O
-	O
adducin	O
(	O
Add1	O
)	O
,	O
a	O
membarne	O
-	O
associated	O
cytoskleetal	O
proetin	O
gnee	O
.	O

Both	O
of	O
these	O
gnees	O
map	O
in	O
the	O
same	O
psoition	O
on	O
muose	O
crhomosome	O
5	O
in	O
a	O
reigon	O
associated	O
with	O
ancesrtal	O
chromosmoal	O
rearrangmeents	O
and	O
show	O
no	O
recomibnation	O
with	O
D5H4S43	O
,	O
D5H41S15	O
,	O
and	O
D5H46S2	O
,	O
the	O
murnie	O
homoolgues	O
of	O
DS443	O
,	O
D41S15	O
,	O
and	O
DS462	O
,	O
respectively	O
.	O

Further	O
mpaping	O
stuides	O
of	O
huamns	O
,	O
mcie	O
,	O
and	O
other	O
mammalain	O
speices	O
should	O
reveal	O
the	O
nature	O
of	O
the	O
rearranegments	O
afefcting	O
this	O
chromosoaml	O
semgent	O
during	O
mammalian	O
evolutoin	O
.	O
.	O

Geneitc	O
cholseteryl	B-Disease
esetr	I-Disease
trasnfer	I-Disease
prtoein	I-Disease
deifciency	I-Disease
caused	O
by	O
two	O
prevaelnt	O
mtuations	O
as	O
a	O
major	O
detemrinant	O
of	O
increaesd	O
leevls	O
of	O
high	O
desnity	O
lipoprtoein	O
choletserol	O
.	O

Gneetic	O
determiannts	O
of	O
HDL	O
choelsterol	O
(	O
HDL	O
-	O
C	O
)	O
lveels	O
in	O
the	O
general	O
pouplation	O
are	O
poorly	O
understood	O
.	O

We	O
previously	O
described	O
plsama	O
cholseteryl	B-Disease
etser	I-Disease
tarnsfer	I-Disease
proetin	I-Disease
(	I-Disease
CTEP	I-Disease
)	I-Disease
deficeincy	I-Disease
due	O
to	O
an	O
inrton	O
14	O
G	O
(	O
+	O
1	O
)	O
-	O
to	O
-	O
A	O
mutatoin	O
(	O
In1t4	O
A	O
)	O
in	O
several	O
faimlies	O
with	O
very	O
high	O
HDL	O
-	O
C	O
lveels	O
in	O
Jaapn	O
.	O

Sbujects	O
with	O
HDL	O
-	O
C	O
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
(	O
n	O
=	O
130	O
)	O
were	O
screened	O
by	O
PCR	O
single	O
srtand	O
confromational	O
polymoprhism	O
aanlysis	O
of	O
the	O
CTEP	O
gnee	O
.	O

Two	O
other	O
mutatinos	O
were	O
identfiied	O
by	O
DNA	O
sqeuencing	O
or	O
pirmer	O
-	O
mediated	O
resrtiction	O
map	O
modificaiton	O
of	O
PCR	O
prodcuts	O
a	O
novel	O
inrton	O
14	O
slpice	O
doonr	O
stie	O
mtuation	O
caused	O
by	O
a	O
T	O
inesrtion	O
at	O
poistion	O
+	O
3	O
from	O
the	O
exno14	O
/	O
intro1n4	O
buondary	O
(	O
In1t4	O
T	O
)	O
and	O
a	O
misesnse	O
mutatoin	O
(	O
Asp442	O
to	O
Gly	O
)	O
within	O
eoxn	O
15	O
(	O
D442G	O
)	O
.	O

The	O
In1t4	O
T	O
mutatoin	O
was	O
only	O
found	O
in	O
one	O
faimly	O
.	O

However	O
,	O
the	O
D442G	O
and	O
Itn14	O
A	O
muttaions	O
were	O
highly	O
pervalent	O
in	O
sujbects	O
with	O
HDL	O
-	O
C	O
>	O
or	O
=	O
60	O
mg	O
/	O
dl	O
,	O
with	O
comibned	O
allele	O
freqeuncies	O
of	O
9	O
%	O
,	O
12	O
%	O
,	O
21	O
%	O
and	O
43	O
%	O
for	O
HDL	O
-	O
C	O
60	O
-	O
79	O
,	O
80	O
-	O
99	O
,	O
100	O
-	O
119	O
,	O
and	O
>	O
or	O
=	O
120	O
mg	O
/	O
dl	O
,	O
respectively	O
.	O

Furthermore	O
,	O
prvealences	O
of	O
the	O
D442G	O
and	O
In1t4	O
A	O
muattions	O
were	O
extremely	O
high	O
in	O
a	O
general	O
samlpe	O
of	O
Japansee	O
men	O
(	O
n	O
=	O
236	O
)	O
,	O
with	O
heterozyogte	O
freqeuncies	O
of	O
7	O
%	O
and	O
2	O
%	O
,	O
respectively	O
.	O

These	O
two	O
muttaions	O
accounted	O
for	O
about	O
10	O
%	O
of	O
the	O
total	O
vraiance	O
of	O
HDL	O
-	O
C	O
in	O
this	O
popluation	O
.	O

The	O
phenoytpe	O
in	O
a	O
genteic	O
comopund	O
heteroyzgote	O
(	O
Itn14	O
T	O
and	O
In1t4	O
A	O
)	O
was	O
similar	O
to	O
that	O
of	O
Itn14	O
A	O
hmoozygotes	O
(	O
no	O
detetcable	O
CTEP	O
and	O
markedly	O
incerased	O
HDL	O
-	O
C	O
)	O
,	O
indicating	O
that	O
the	O
Itn14	O
T	O
produces	O
a	O
nlul	O
allele	O
.	O

In	O
four	O
D442G	O
hmoozygotes	O
,	O
mean	O
HDL	O
-	O
C	O
leevls	O
(	O
86	O
+	O
/	O
-	O
26	O
mg	O
/	O
dl	O
)	O
were	O
loewr	O
than	O
in	O
Itn14	O
A	O
homoyzgotes	O
(	O
158	O
+	O
/	O
-	O
35	O
mg	O
/	O
dl	O
)	O
,	O
reflecting	O
reisdual	O
CTEP	O
actiivty	O
in	O
plsama	O
.	O

In	O
47	O
D424G	O
heteorzygotes	O
,	O
mean	O
HDL	O
-	O
C	O
levles	O
were	O
91	O
+	O
/	O
-	O
23	O
mg	O
/	O
dl	O
,	O
similar	O
to	O
the	O
leevl	O
in	O
D424G	O
homzoygotes	O
,	O
and	O
significantly	O
greater	O
than	O
mean	O
HDL	O
-	O
C	O
leevls	O
in	O
Itn14	O
A	O
hetreozygotes	O
(	O
69	O
+	O
/	O
-	O
15	O
mg	O
/	O
dl	O
)	O
.	O

Thus	O
,	O
the	O
D424G	O
mutaiton	O
acts	O
differently	O
to	O
the	O
nlul	O
mutatoins	O
with	O
waeker	O
effcets	O
on	O
HDL	O
in	O
the	O
homzoygous	O
state	O
and	O
stornger	O
effcets	O
in	O
the	O
heteorzygotes	O
,	O
suggesting	O
doimnant	O
expression	O
of	O
a	O
patrially	O
defecitve	O
alllee	O
.	O

CTEP	B-Disease
deficeincy	I-Disease
,	O
reflecting	O
two	O
prvealent	O
mutatoins	O
(	O
D442G	O
and	O
Itn14	O
A	O
)	O
,	O
is	O
the	O
first	O
example	O
of	O
a	O
geneitc	B-Disease
deficinecy	I-Disease
state	O
which	O
is	O
sufficiently	O
common	O
to	O
explain	O
a	O
significant	O
frcation	O
of	O
the	O
varitaion	O
in	O
HDL	O
-	O
C	O
in	O
the	O
general	O
popultaion	O
.	O
.	O

Treatemnt	O
of	O
ceerbrotendinous	B-Disease
xnathomatosis	I-Disease
:	O
effcets	O
of	O
chenodeoyxcholic	O
aicd	O
,	O
pravasattin	O
,	O
and	O
cobmined	O
use	O
.	O

Treatmetns	O
by	O
oarl	O
adminitsration	O
of	O
chneodeoxycholic	O
aicd	O
(	O
CCDA	O
)	O
alone	O
,	O
3	O
-	O
hydorxy	O
-	O
3	O
-	O
methyllgutaryl	O
(	O
HMG	O
)	O
CoA	O
redutcase	O
inhiibtor	O
(	O
pravatsatin	O
)	O
alone	O
,	O
and	O
combinaiton	O
of	O
the	O
two	O
drgus	O
were	O
attempted	O
for	O
7	O
patinets	O
with	O
cerebrotendinuos	B-Disease
xanthomatsois	I-Disease
(	O
CTX	B-Disease
)	O
.	O

CCDA	O
tretament	O
at	O
a	O
dsoe	O
of	O
300	O
mg	O
/	O
day	O
redcued	O
seurm	O
cohlestanol	O
(	O
67	O
.	O
3	O
%	O
redutcion	O
)	O
,	O
lathsoterol	O
(	O
50	O
.	O
8	O
%	O
)	O
,	O
camepsterol	O
(	O
61	O
.	O
7	O
%	O
)	O
and	O
sitosteorl	O
(	O
12	O
.	O
7	O
%	O
)	O
.	O

However	O
,	O
the	O
srea	O
of	O
the	O
patinets	O
changed	O
to	O
be	O
"	O
ahterogenic	O
"	O
;	O
total	O
choletserol	O
,	O
tirglyceride	O
and	O
low	O
-	O
denisty	O
lipoproetin	O
(	O
LDL	O
)	O
-	O
chloesterol	O
were	O
icnreased	O
,	O
while	O
high	O
-	O
dnesity	O
lipoproetin	O
(	O
HDL	O
)	O
-	O
cohlesterol	O
was	O
decerased	O
.	O

Contrarily	O
,	O
praavstatin	O
at	O
a	O
dsoe	O
of	O
10	O
mg	O
/	O
day	O
ipmroved	O
the	O
srea	O
of	O
the	O
patinets	O
to	O
be	O
markedly	O
"	O
atni	O
-	O
atheorgenic	O
"	O
,	O
but	O
the	O
reudctions	O
of	O
cohlestanol	O
(	O
30	O
.	O
4	O
%	O
)	O
,	O
lathostreol	O
(	O
44	O
.	O
0	O
%	O
)	O
,	O
campseterol	O
(	O
22	O
.	O
9	O
%	O
)	O
and	O
sitsoterol	O
(	O
9	O
.	O
6	O
%	O
)	O
were	O
inadeqaute	O
.	O

Comibned	O
treatemnt	O
with	O
CCDA	O
and	O
prvaastatin	O
showed	O
good	O
overlapping	O
of	O
the	O
effetcs	O
of	O
each	O
durg	O
alone	O
.	O

The	O
srea	O
of	O
the	O
patietns	O
were	O
apparently	O
more	O
"	O
atni	O
-	O
atheroegnic	O
"	O
than	O
those	O
after	O
CCDA	O
tretament	O
.	O

Sreum	O
choletsanol	O
concenrtation	O
was	O
still	O
2	O
.	O

7	O
times	O
hgiher	O
than	O
in	O
contrlos	O
,	O
but	O
the	O
seurm	O
lahtosterol	O
leevl	O
was	O
within	O
the	O
noraml	O
range	O
,	O
indicating	O
that	O
the	O
enhancemnet	O
of	O
overall	O
cholestreol	O
syntehsis	O
in	O
the	O
paitents	O
was	O
sufficiently	O
suppresesd	O
.	O

Palnt	O
setrol	O
levles	O
were	O
also	O
within	O
the	O
nromal	O
range	O
.	O

The	O
combiantion	O
of	O
CCDA	O
and	O
prvaastatin	O
was	O
a	O
good	O
tretament	O
for	O
CTX	B-Disease
,	O
based	O
on	O
the	O
improvemnet	O
of	O
sreum	O
lipporotein	O
meatbolism	O
,	O
the	O
spupression	O
of	O
cholseterol	O
snythesis	O
,	O
and	O
rdeuctions	O
of	O
choletsanol	O
and	O
palnt	O
steorl	O
lveels	O
.	O

In	O
all	O
of	O
7	O
pateints	O
,	O
the	O
prgoression	O
of	O
dsiease	O
was	O
arresetd	O
,	O
but	O
dramtaic	O
efefcts	O
on	O
cliniacl	O
manifetsations	O
,	O
xnathoma	B-Disease
,	O
and	O
eletcrophysiological	O
fnidings	O
could	O
not	O
be	O
found	O
after	O
the	O
teratment	O
of	O
these	O
durgs	O

Mtuation	O
spcetrum	O
in	O
the	O
CHM	B-Disease
gnee	O
of	O
Dnaish	O
and	O
Sewdish	O
chorioderemia	B-Disease
paitents	O
.	O

The	O
recent	O
isolatoin	O
of	O
the	O
complete	O
open	O
redaing	O
frmae	O
of	O
the	O
chorioderemia	B-Disease
(	O
CHM	B-Disease
)	O
gnee	O
and	O
the	O
characteriztaion	O
of	O
the	O
eoxn	O
-	O
itnron	O
boundaires	O
has	O
paved	O
the	O
way	O
to	O
mutatoin	O
detcetion	O
in	O
pateints	O
with	O
classical	O
choroidereima	B-Disease
.	O

We	O
have	O
performed	O
muattion	O
srceening	O
in	O
paitents	O
from	O
15	O
Dnaish	O
and	O
Swdeish	O
famileis	O
by	O
using	O
Southren	O
bolt	O
hybriidzation	O
and	O
the	O
polmyerase	O
cahin	O
reaciton	O
single	O
-	O
starnd	O
conforamtion	O
polymorpihsm	O
(	O
PCR	O
-	O
SCSP	O
)	O
tehcnique	O
.	O

Caustaive	O
mutatinos	O
in	O
the	O
CHM	B-Disease
gnee	O
were	O
detetced	O
in	O
at	O
least	O
12	O
famileis	O
,	O
indicating	O
that	O
a	O
substantial	O
part	O
of	O
the	O
muattions	O
can	O
be	O
iedntified	O
by	O
this	O
approach	O
.	O

In	O
four	O
of	O
these	O
famileis	O
deeltions	O
of	O
different	O
sizes	O
were	O
found	O
.	O

Thus	O
,	O
in	O
one	O
paitent	O
,	O
the	O
delteion	O
resulted	O
in	O
the	O
absnece	O
of	O
only	O
one	O
eoxn	O
,	O
while	O
in	O
another	O
the	O
deleiton	O
comprised	O
the	O
entire	O
CHM	B-Disease
gnee	O
.	O

Mapping	O
of	O
the	O
deleiton	O
endponits	O
in	O
these	O
four	O
patietns	O
and	O
in	O
another	O
11	O
mlae	O
patietns	O
with	O
sizeable	O
deeltions	O
enabled	O
us	O
to	O
constrcut	O
a	O
very	O
detailed	O
map	O
of	O
intrevals	O
2	O
and	O
3	O
of	O
X2q1	O
.	O

In	O
the	O
remaining	O
11	O
Dnaish	O
and	O
Swedsih	O
famileis	O
at	O
least	O
8	O
casuative	O
mutatinos	O
were	O
found	O
by	O
PCR	O
-	O
SCSP	O
aanlysis	O
and	O
direct	O
sqeuencing	O
.	O

Interestingly	O
,	O
all	O
CHM	B-Disease
gnee	O
mutatinos	O
dteected	O
thus	O
far	O
in	O
chorioderemia	B-Disease
pateints	O
give	O
rise	O
to	O
the	O
intorduction	O
of	O
a	O
prematrue	O
stop	O
cdoon	O
.	O
.	O

Predomniance	O
of	O
the	O
adrenomyeloneuroapthy	B-Disease
phentoype	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodysrtophy	I-Disease
in	O
The	O
Nehterlands	O
:	O
a	O
sruvey	O
of	O
30	O
kindrdes	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
adrenolekuodystrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
is	O
an	O
inheirted	B-Disease
diosrder	I-Disease
of	O
perxoisomal	O
btea	O
-	O
oixdation	O
associated	O
with	O
accumulaiton	O
of	O
saturaetd	O
very	O
long	O
-	O
chian	O
ftaty	O
acdis	O
,	O
which	O
reuslts	O
in	O
cetnral	O
and	O
preipheral	O
demyelintaion	B-Disease
and	O
in	O
impaierd	B-Disease
funciton	I-Disease
of	I-Disease
adernal	I-Disease
crotex	I-Disease
and	I-Disease
tetses	I-Disease
.	O

The	O
phenoytpic	O
experssion	O
is	O
highly	O
vraiable	O
,	O
childohod	B-Disease
ceerbral	I-Disease
ALD	I-Disease
(	O
CCLAD	B-Disease
)	O
and	O
adreonmyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
being	O
the	O
main	O
vraiants	O
.	O

We	O
explored	O
the	O
30	O
Dtuch	O
kidnreds	O
well	O
known	O
to	O
the	O
Ducth	O
X	B-Disease
-	I-Disease
ALD	I-Disease
/	O
AMN	B-Disease
Sutdy	O
Gruop	O
and	O
pheontyped	O
77	O
mlae	O
patinets	O
35	O
(	O
46	O
%	O
)	O
had	O
AMN	B-Disease
and	O
24	O
(	O
31	O
%	O
)	O
CCLAD	B-Disease
or	O
adloescent	B-Disease
cerebarl	I-Disease
ALD	I-Disease
(	O
AdolCLAD	B-Disease
)	O
.	O

These	O
percentages	O
differ	O
significantly	O
from	O
previous	O
repotrs	O
,	O
in	O
which	O
25	O
to	O
28	O
%	O
of	O
the	O
ptaients	O
developed	O
AMN	B-Disease
and	O
53	O
to	O
57	O
%	O
CCLAD	B-Disease
or	O
AdoClALD	B-Disease
.	O

Our	O
fnidings	O
indicate	O
that	O
-	O
-	O
at	O
least	O
in	O
the	O
Nethelrands	O
-	O
-	O
AMN	B-Disease
may	O
be	O
the	O
most	O
frequnet	O
pheontype	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
.	O
.	O

Adrenoelukodystrophy	B-Disease
gnee	O
enocdes	O
an	O
80	O
kDa	O
mmebrane	O
portein	O
.	O

An	O
antbiody	O
against	O
the	O
synthteic	O
C	O
-	O
treminal	O
peptdies	O
deduced	O
from	O
the	O
cNDA	O
of	O
the	O
gnee	O
responsible	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenolekuodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
was	O
produced	O
to	O
characterize	O
the	O
prodcut	O
of	O
the	O
ALD	B-Disease
gnee	O
.	O

The	O
antibdoy	O
reacted	O
with	O
the	O
80	O
kDa	O
bnad	O
proetin	O
in	O
cnotrol	O
fiborblasts	O
,	O
while	O
no	O
bnads	O
were	O
detceted	O
in	O
the	O
fbiroblasts	O
from	O
a	O
pateint	O
with	O
ALD	B-Disease
(	O
#	O
163	O
)	O
,	O
in	O
which	O
mNRA	O
of	O
the	O
ALD	B-Disease
gnee	O
was	O
undetcetable	O
based	O
on	O
Northren	O
bolt	O
analsyis	O
.	O

The	O
T	O
cells	O
transefcted	O
with	O
the	O
full	O
-	O
cdoing	O
cNDA	O
inserted	O
in	O
the	O
exprsesion	O
vetcor	O
produced	O
a	O
new	O
80	O
kDa	O
portein	O
,	O
as	O
deetcted	O
by	O
Wesetrn	O
bolt	O
.	O

In	O
an	O
immunoyctological	O
stduy	O
,	O
the	O
stainnig	O
was	O
in	O
a	O
puncatte	O
patetrn	O
,	O
in	O
the	O
nromal	O
firboblasts	O
.	O

However	O
,	O
there	O
was	O
no	O
puncttae	O
satining	O
in	O
the	O
#	O
163	O
cells	O
.	O

These	O
dtaa	O
thus	O
indicate	O
that	O
the	O
ALD	B-Disease
gnee	O
encdoes	O
an	O
80	O
kDa	O
memrbane	O
proetin	O
.	O
.	O

Ioslation	O
of	O
the	O
gnee	O
for	O
MLceod	B-Disease
synrdome	I-Disease
that	O
encdoes	O
a	O
novel	O
memrbane	O
trasnport	O
protien	O
.	O

MLceod	B-Disease
synrdome	I-Disease
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
mlutisystem	I-Disease
dsiorder	I-Disease
charcaterized	O
by	O
abnormlaities	O
in	O
the	O
neuromucsular	O
and	O
hmeatopoietic	O
sytsems	O
.	O

We	O
have	O
assembled	O
a	O
csomid	O
conitg	O
of	O
360	O
kb	O
that	O
encompasses	O
the	O
MceLod	B-Disease
gnee	O
loucs	O
.	O

A	O
50	O
kb	O
deleiton	O
was	O
deetcted	O
by	O
screeinng	O
DNA	O
from	O
patinets	O
with	O
radiloabeled	O
whole	O
csomids	O
,	O
and	O
two	O
tarnscription	O
units	O
were	O
identifeid	O
within	O
this	O
delteion	O
.	O

The	O
mNRA	O
expressoin	O
pattren	O
of	O
one	O
of	O
them	O
,	O
designated	O
as	O
XK	O
,	O
correaltes	O
closely	O
to	O
the	O
MLceod	B-Disease
phentoype	O
.	O

XK	O
enocdes	O
a	O
novel	O
proetin	O
with	O
structrual	O
characteritsics	O
of	O
prokayrotic	O
and	O
euakryotic	O
mebmrane	O
tarnsport	O
porteins	O
.	O

Nucleoitde	O
sqeuence	O
aanlysis	O
of	O
XK	O
from	O
two	O
unrelated	O
MceLod	B-Disease
ptaients	O
has	O
iedntified	O
point	O
mutatinos	O
at	O
conserved	O
splcie	O
doonr	O
and	O
accepotr	O
sties	O
.	O

These	O
findigns	O
provide	O
direct	O
eivdence	O
that	O
XK	O
is	O
responsible	O
for	O
MceLod	B-Disease
syndorme	I-Disease
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
spasitc	I-Disease
parapelgia	I-Disease
and	O
Pelizeaus	B-Disease
-	I-Disease
Merzbcaher	I-Disease
disaese	I-Disease
are	O
alellic	B-Disease
dsiorders	I-Disease
at	O
the	O
proteloipid	O
portein	O
loucs	O
.	O

Three	O
forms	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
spasitc	I-Disease
paarplegia	I-Disease
(	O
SPG	B-Disease
)	O
have	O
been	O
defined	O
.	O

One	O
loucs	O
(	O
SPG	O
1	O
)	O
mpas	O
to	O
X2q8	O
while	O
two	O
cliniaclly	O
distinct	O
forms	O
map	O
to	O
X2q2	O
(	O
SGP2	O
)	O
.	O

A	O
rrae	O
X	B-Disease
-	I-Disease
linked	I-Disease
dsymyelinating	I-Disease
disodrer	I-Disease
of	O
the	O
cetnral	O
nrevous	O
ssytem	O
,	O
Pelziaeus	B-Disease
-	I-Disease
Merbzacher	I-Disease
dsiease	I-Disease
(	O
PMD	B-Disease
)	O
,	O
has	O
also	O
been	O
mapepd	O
to	O
X2q1	O
-	O
q22	O
,	O
and	O
is	O
caused	O
by	O
muttaions	O
in	O
the	O
prtoeolipid	O
proetin	O
gnee	O
(	O
PLP	O
)	O
which	O
encoeds	O
two	O
mylein	O
prtoeins	O
,	O
PLP	O
and	O
D2M0	O
.	O

While	O
narorwing	O
the	O
gneetic	O
intevral	O
containing	O
SGP2	O
in	O
a	O
large	O
pedirgee	O
,	O
we	O
found	O
that	O
PLP	O
was	O
the	O
closest	O
mraker	O
to	O
the	O
disaese	O
lcous	O
,	O
implicating	O
PLP	O
as	O
a	O
possible	O
candidate	O
gnee	O
.	O

We	O
have	O
found	O
that	O
a	O
point	O
mutatoin	O
(	O
His193Tyr	O
)	O
in	O
eoxn	O
3B	O
of	O
an	O
affected	O
mlae	O
produces	O
a	O
mtuant	O
PLP	O
but	O
a	O
nomral	O
D2M0	O
,	O
and	O
segregates	O
with	O
the	O
diesase	O
(	O
Zamx	O
=	O
6	O
.	O
63	O
,	O
thtea	O
=	O
0	O
.	O
00	O
)	O
.	O

It	O
appears	O
,	O
therefore	O
,	O
that	O
SGP2	O
and	O
PMD	B-Disease
are	O
alellic	B-Disease
diosrders	I-Disease

Cnaavan	B-Disease
disaese	I-Disease
:	O
mutaitons	O
among	O
Jweish	O
and	O
non	O
-	O
Jewsih	O
patinets	O
.	O

Canaavn	B-Disease
disesae	I-Disease
is	O
an	O
autsoomal	B-Disease
recessvie	I-Disease
leukoydstrophy	I-Disease
caused	O
by	O
the	O
deficinecy	B-Disease
of	I-Disease
aspatroacylase	I-Disease
(	O
APSA	O
)	O
.	O

Sixty	O
-	O
four	O
prboands	O
were	O
anlayzed	O
for	O
mutatoins	O
in	O
the	O
APSA	O
gnee	O
.	O

Three	O
point	O
mutaitons	O
-	O
-	O
693C	O
-	O
-	O
>	O
A	O
,	O
854A	O
-	O
-	O
>	O
C	O
,	O
and	O
914C	O
-	O
-	O
>	O
A	O
-	O
-	O
were	O
iedntified	O
in	O
the	O
codnig	O
sqeuence	O
.	O

The	O
693C	O
-	O
-	O
>	O
A	O
and	O
914C	O
-	O
-	O
>	O
A	O
base	O
chagnes	O
,	O
resulting	O
in	O
nnosense	O
tyr231	O
-	O
-	O
>	O
ter	O
and	O
misesnse	O
al3a05	O
-	O
-	O
>	O
glu	O
muattions	O
,	O
respectively	O
,	O
lead	O
to	O
complete	O
lsos	O
of	O
APSA	O
atcivity	O
in	O
in	O
vitro	O
expresison	O
studeis	O
.	O

The	O
854A	O
-	O
-	O
>	O
C	O
trasnversion	O
converted	O
glu	O
to	O
ala	O
in	O
cdoon	O
285	O
.	O

The	O
glu285	O
-	O
-	O
>	O
ala	O
mutnat	O
APSA	O
has	O
2	O
.	O

5	O
%	O
of	O
the	O
actiivty	O
experssed	O
by	O
the	O
wlid	O
-	O
tpye	O
enyzme	O
.	O

A	O
fourth	O
muttaion	O
,	O
433	O
-	O
-	O
2	O
(	O
A	O
-	O
-	O
>	O
G	O
)	O
transiiton	O
,	O
was	O
identfiied	O
at	O
the	O
splcie	O
-	O
acceptor	O
stie	O
in	O
inrton	O
2	O
.	O

The	O
splcie	O
-	O
stie	O
mutaiton	O
would	O
lead	O
to	O
skipping	O
of	O
eoxn	O
3	O
,	O
accompanied	O
by	O
a	O
frameshfit	O
,	O
and	O
thus	O
would	O
produce	O
abrerant	O
APSA	O
.	O

Of	O
the	O
128	O
unrelated	O
Canvaan	B-Disease
chrmoosomes	O
anaylzed	O
,	O
88	O
were	O
from	O
prboands	O
of	O
Ashkneazi	O
Jeiwsh	O
descnet	O
.	O

The	O
glu285	O
-	O
-	O
>	O
ala	O
mtuation	O
was	O
perdominant	O
(	O
82	O
.	O
9	O
%	O
)	O
in	O
this	O
popluation	O
,	O
followed	O
by	O
the	O
tyr231	O
-	O
-	O
>	O
ter	O
(	O
14	O
.	O
8	O
%	O
)	O
and	O
433	O
-	O
-	O
2	O
(	O
A	O
-	O
-	O
>	O
G	O
)	O
(	O
1	O
.	O
1	O
%	O
)	O
mutaitons	O
.	O

The	O
three	O
muattions	O
account	O
for	O
98	O
.	O

8	O
%	O
of	O
the	O
Cnaavan	B-Disease
crhomosomes	O
of	O
Ashkeanzi	O
Jeiwsh	O
oirgin	O
.	O

The	O
al3a05	O
-	O
-	O
>	O
glu	O
mutatoin	O
was	O
found	O
exclusively	O
in	O
non	O
-	O
Jewsih	O
proabnds	O
of	O
Euroepan	O
dsecent	O
and	O
constituted	O
60	O
%	O
of	O
the	O
40	O
mtuant	O
chromosoems	O
.	O

Perdominant	O
occurrence	O
of	O
certain	O
mutatoins	O
among	O
Askhenazi	O
Jeiwsh	O
and	O
non	O
-	O
Jewsih	O
pateints	O
with	O
Canvaan	B-Disease
diesase	I-Disease
would	O
suggest	O
a	O
founidng	O
-	O
fatehr	O
effcet	O
in	O
propagatoin	O
of	O
these	O
mutnat	O
chromosmoes	O

Inetlligence	O
quoteint	O
proifle	O
in	O
mytoonic	B-Disease
dsytrophy	I-Disease
,	O
intergenertaional	O
deifcit	O
,	O
and	O
correaltion	O
with	O
CTG	O
amplifciation	O
.	O

An	O
abbreviated	O
Wehcsler	O
Adlut	O
Inetlligence	O
Sclae	O
Revsied	O
(	O
WIAS	O
-	O
R	O
)	O
was	O
used	O
to	O
assess	O
verabl	O
and	O
arithemtical	O
congitive	O
perforamnce	O
in	O
55	O
subjcets	O
with	O
moytonic	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
,	O
covering	O
all	O
gardes	O
of	O
disaese	O
sevreity	O
,	O
and	O
31	O
contrlos	O
at	O
50	O
%	O
rsik	O
of	O
inehriting	O
DM	B-Disease
.	O

Scaeld	O
scoers	O
from	O
the	O
asssesment	O
were	O
converted	O
into	O
an	O
intelilgence	O
quoteint	O
(	O
IQ	O
)	O
estimaiton	O
on	O
each	O
preson	O
.	O

Signifiacnt	O
IQ	O
differecnes	O
were	O
found	O
between	O
(	O
1	O
)	O
all	O
55	O
DM	B-Disease
subjcets	O
(	O
mean	O
90	O
.	O
2	O
,	O
SD	O
16	O
.	O
1	O
)	O
and	O
31	O
conrtols	O
(	O
102	O
.	O
6	O
,	O
SD	O
9	O
.	O
4	O
)	O
,	O
with	O
no	O
sex	O
diffreences	O
in	O
either	O
gruop	O
;	O
(	O
2	O
)	O
15	O
afefcted	O
paretns	O
(	O
99	O
.	O
3	O
,	O
SD	O
12	O
.	O
2	O
)	O
and	O
their	O
affetced	O
childern	O
(	O
88	O
.	O
1	O
,	O
SD	O
17	O
.	O
2	O
)	O
,	O
where	O
signfiicance	O
was	O
depnedent	O
on	O
parenatl	O
sex	O
being	O
fmeale	O
;	O
and	O
(	O
3	O
)	O
15	O
piars	O
of	O
affetced	O
sbis	O
(	O
89	O
.	O
6	O
,	O
SD	O
13	O
.	O
2	O
)	O
and	O
their	O
nomral	O
sbis	O
(	O
100	O
.	O
2	O
,	O
SD	O
7	O
.	O
6	O
)	O
.	O

IQ	O
steadily	O
dcelined	O
as	O
(	O
1	O
)	O
the	O
age	O
of	O
onset	O
of	O
sings	O
and	O
smyptoms	O
decraesed	O
,	O
and	O
(	O
2	O
)	O
the	O
CTG	O
exapnsion	O
szie	O
incraesed	O
.	O

The	O
corrleation	O
appeared	O
to	O
be	O
more	O
lienar	O
with	O
age	O
of	O
onset	O
.	O

The	O
correaltion	O
of	O
IQ	O
difference	O
and	O
CTG	O
epxansion	O
difference	O
in	O
both	O
the	O
DM	B-Disease
praent	O
-	O
cihld	O
piars	O
and	O
nromal	O
sib	O
-	O
affceted	O
sib	O
piars	O
was	O
poor	O
,	O
indicating	O
that	O
CTG	O
exapnsion	O
is	O
not	O
a	O
reliable	O
preidctor	O
of	O
IQ	O
either	O
in	O
indiviudal	O
presons	O
or	O
faimlies	O
.	O

Further	O
aanlysis	O
of	O
cogintive	O
funtcion	O
in	O
DM	B-Disease
is	O
required	O
to	O
clarify	O
specific	O
defciits	O
charactersitic	O
of	O
this	O
pateint	O
gruop	O

Adenomaotus	B-Disease
poylposis	I-Disease
cloi	I-Disease
and	O
a	O
cytgoenetic	O
deeltion	O
of	O
chormosome	O
5	O
resulting	O
from	O
a	O
materanl	O
intrachrmoosomal	O
isnertion	O
.	O

We	O
present	O
the	O
clniical	O
and	O
laboraotry	O
finidngs	O
in	O
an	O
instittuionalised	O
audlt	O
pateint	O
originally	O
referred	O
for	O
auitsm	B-Disease
.	O

A	O
high	O
rsik	O
of	O
colorcetal	B-Disease
cnacer	I-Disease
was	O
prdeicted	O
when	O
an	O
intrestitial	O
deeltion	O
of	O
the	O
long	O
arm	O
of	O
chromsoome	O
5	O
,	O
del	O
(	O
5	O
)	O
(	O
q152q2	O
.	O
3	O
)	O
,	O
was	O
deetcted	O
in	O
her	O
lymphoyctes	O
and	O
deletoin	O
of	O
the	O
MCC	O
and	O
APC	B-Disease
geens	O
confirmed	O
by	O
molceular	O
aanlysis	O
.	O

Aednomatous	B-Disease
polypoiss	I-Disease
cloi	I-Disease
and	O
cracinoma	B-Disease
of	I-Disease
the	I-Disease
recutm	I-Disease
were	O
subsequently	O
diganosed	O
in	O
the	O
pateint	O
.	O

She	O
was	O
porfoundly	O
mnetally	B-Disease
retaredd	I-Disease
,	O
atuistic	B-Disease
,	O
and	O
had	O
minor	O
dysmorpihc	B-Disease
faetures	I-Disease
consistent	O
with	O
those	O
of	O
previous	O
patinets	O
with	O
similar	O
deeltions	O
.	O

The	O
deletoin	O
arose	O
as	O
a	O
result	O
of	O
recombintaion	O
within	O
the	O
small	O
isnertion	O
loop	O
formed	O
at	O
meoisis	O
by	O
the	O
direct	O
insertoin	O
(	O
dir	O
ins	O
(	O
5	O
)	O
(	O
q22	O
.	O
3q14	O
.	O
2q15	O
)	O
)	O
found	O
in	O
the	O
pateints	O
mohter	O
.	O

This	O
famliy	O
further	O
confirms	O
the	O
cytoegnetic	O
mpaping	O
of	O
both	O
MCC	O
and	O
APC	B-Disease
geens	O
to	O
5q22	O
and	O
cmoparison	O
with	O
other	O
recent	O
caess	O
suggests	O
that	O
both	O
geens	O
and	O
their	O
closely	O
linked	O
makrers	O
lie	O
within	O
the	O
5q22	O
.	O

1	O
subband	O

Familail	B-Disease
mlae	I-Disease
braest	I-Disease
cnacer	I-Disease
is	O
not	O
linked	O
to	O
the	O
BCRA1	O
lcous	O
on	O
crhomosome	O
17q	O
.	O

Bresat	B-Disease
canecr	I-Disease
in	O
men	O
is	O
about	O
a	O
hundredfold	O
less	O
common	O
than	O
in	O
woemn	O
and	O
this	O
has	O
hindered	O
reesarch	O
into	O
its	O
genteic	O
basis	O
.	O

We	O
have	O
examined	O
22	O
famiiles	O
with	O
at	O
least	O
one	O
csae	O
of	O
mlae	B-Disease
braest	I-Disease
cacner	I-Disease
for	O
linkgae	O
to	O
the	O
herdeitary	B-Disease
bresat	I-Disease
and	I-Disease
ovarain	I-Disease
cnacer	I-Disease
lcous	O
,	O
BCRA1	O
,	O
on	O
chroomsome	O
17q	O
.	O

We	O
found	O
strong	O
evidecne	O
against	O
linakge	O
to	O
BCRA1	O
(	O
lod	O
socre	O
-	O
16	O
.	O
63	O
)	O
and	O
the	O
best	O
esitmate	O
of	O
the	O
proportoin	O
of	O
linked	O
faimlies	O
was	O
0	O
%	O
(	O
95	O
%	O
CI	O
0	O
-	O
18	O
%	O
)	O
.	O

Our	O
rseults	O
indicate	O
that	O
there	O
is	O
a	O
gnee	O
(	O
s	O
)	O
other	O
than	O
BCRA1	O
which	O
predisopses	O
to	O
eraly	O
-	O
onset	O
berast	B-Disease
canecr	I-Disease
in	O
woemn	O
and	O
which	O
confers	O
a	O
hgiher	O
rsik	O
of	O
mlae	B-Disease
bresat	I-Disease
cacner	I-Disease
.	O

Identfiication	O
of	O
additional	O
pedgirees	O
that	O
include	O
caess	O
of	O
mlae	B-Disease
braest	I-Disease
cacner	I-Disease
may	O
therefore	O
facilitate	O
the	O
mapipng	O
and	O
isoltaion	O
of	O
this	O
gnee	O
.	O

The	O
EWS	O
gnee	O
,	O
involved	O
in	O
Ewnig	B-Disease
faimly	I-Disease
of	I-Disease
tmuors	I-Disease
,	O
mlaignant	B-Disease
melaonma	I-Disease
of	I-Disease
sfot	I-Disease
patrs	I-Disease
and	O
desomplastic	B-Disease
small	I-Disease
ruond	I-Disease
clel	I-Disease
tmuors	I-Disease
,	O
cdoes	O
for	O
an	O
RNA	O
bidning	O
prtoein	O
with	O
novel	O
reuglatory	O
dmoains	O
.	O

The	O
EWS	O
gnee	O
,	O
which	O
mpas	O
to	O
bnad	O
q12	O
of	O
hmuan	O
chrmoosome	O
22	O
,	O
is	O
involved	O
in	O
a	O
wide	O
variety	O
of	O
huamn	O
soild	B-Disease
tumros	I-Disease
including	O
Eiwng	B-Disease
sarocma	I-Disease
,	O
related	O
priimtive	O
neuroectodremal	B-Disease
tuomrs	I-Disease
,	O
maligannt	B-Disease
melanmoa	I-Disease
of	I-Disease
sfot	I-Disease
patrs	I-Disease
and	O
desmolpastic	B-Disease
small	I-Disease
ronud	I-Disease
clel	I-Disease
tumros	I-Disease
.	O

In	O
these	O
tuomrs	B-Disease
,	O
the	O
EWS	O
is	O
fsued	O
to	O
gnees	O
encdoing	O
transcripitonal	O
actiavtors	O
/	O
repressros	O
,	O
like	O
Fli	O
-	O
1	O
or	O
erg	O
or	O
ATF	O
1	O
or	O
wt1	O
.	O

To	O
better	O
understand	O
the	O
fucntion	O
of	O
the	O
EWS	O
protien	O
,	O
we	O
cloend	O
the	O
EWS	O
cNDA	O
.	O

Sequnece	O
anaylsis	O
of	O
this	O
cNDA	O
revelaed	O
diffreential	O
slpicing	O
involving	O
two	O
eoxns	O
ecnoding	O
72	O
amnio	O
aicds	O
.	O

Both	O
alternatively	O
spliecd	O
trnascripts	O
,	O
EWS	O
and	O
EWS	O
-	O
b	O
,	O
are	O
expressed	O
in	O
a	O
variety	O
of	O
clels	O
.	O

Because	O
EWS	O
proetins	O
contain	O
putative	O
conserved	O
RNA	O
binidng	O
mtoifs	O
,	O
we	O
studied	O
the	O
RNA	O
binidng	O
porperties	O
of	O
the	O
EWS	O
protien	O
.	O

The	O
EWS	O
-	O
b	O
portein	O
bidns	O
to	O
RNA	O
in	O
vitro	O
and	O
,	O
specifically	O
,	O
to	O
ploy	O
G	O
and	O
ploy	O
U	O
.	O

The	O
RNA	O
bindnig	O
atcivity	O
was	O
locailzed	O
to	O
the	O
craboxy	O
termianl	O
86	O
amnio	O
aicds	O
,	O
which	O
constitute	O
RGG	O
box	O
.	O

Thus	O
the	O
amnio	O
temrinal	O
doamin	O
of	O
EWS	O
(	O
NTD	O
-	O
EWS	O
)	O
,	O
which	O
is	O
involved	O
in	O
chroomsome	O
translcoation	O
may	O
regultae	O
the	O
specifciity	O
of	O
RNA	O
bniding	O
atcivity	O
of	O
EWS	O
.	O

An	O
EWS	O
-	O
erg	O
chimeirc	O
portein	O
,	O
which	O
is	O
found	O
in	O
Eiwngs	B-Disease
sarcmoa	I-Disease
cells	O
,	O
funcitons	O
as	O
a	O
tarnscriptional	O
actiavtor	O
.	O

Mtuational	O
analsyis	O
of	O
EWS	O
-	O
erg	O
chimeirc	O
proetin	O
reveaeld	O
that	O
NTD	O
-	O
EWS	O
functoins	O
as	O
a	O
rgeulatory	O
dmoain	O
for	O
the	O
transcriptinoal	O
acitvation	O
propreties	O
of	O
EWS	O
-	O
erg	O
cihmeric	O
proetin	O
.	O
.	O

Canaavn	B-Disease
disaese	I-Disease
:	O
genoimc	O
organiaztion	O
and	O
localizaiton	O
of	O
huamn	O
APSA	O
to	O
17p13	O
-	O
ter	O
and	O
conseravtion	O
of	O
the	O
APSA	O
gnee	O
during	O
evoultion	O
.	O

Canaavn	B-Disease
diesase	I-Disease
,	O
or	O
sopngy	B-Disease
degenertaion	I-Disease
of	I-Disease
the	I-Disease
brian	I-Disease
,	O
is	O
a	O
sevree	O
leukodystrohpy	B-Disease
caused	O
by	O
the	O
defciiency	B-Disease
of	I-Disease
aspratoacylase	I-Disease
(	O
APSA	O
)	O
.	O

Recently	O
,	O
a	O
misesnse	O
mtuation	O
was	O
identifeid	O
in	O
hmuan	O
APSA	O
codnig	O
sequecne	O
from	O
ptaients	O
with	O
Canvaan	B-Disease
disaese	I-Disease
.	O

The	O
huamn	O
APSA	O
gnee	O
has	O
been	O
clnoed	O
and	O
found	O
to	O
sapn	O
29	O
kb	O
of	O
the	O
genmoe	O
.	O

Huamn	O
apsartoacylase	O
is	O
coded	O
by	O
six	O
exnos	O
intervened	O
by	O
five	O
intorns	O
.	O

The	O
eoxns	O
vary	O
from	O
94	O
(	O
eoxn	O
III	O
)	O
to	O
514	O
(	O
eoxn	O
VI	O
)	O
bsaes	O
.	O

The	O
eoxn	O
/	O
itnron	O
splcie	O
juntcion	O
sties	O
follow	O
the	O
gt	O
/	O
ag	O
consesnus	O
seuqence	O
rule	O
.	O

Soutehrn	O
bolt	O
aanlysis	O
of	O
genmoic	O
DNA	O
from	O
hmuan	O
/	O
mosue	O
somaitc	O
clel	O
hybird	O
clel	O
liens	O
localzied	O
APSA	O
to	O
huamn	O
crhomosome	O
17	O
.	O

The	O
huamn	O
APSA	O
lcous	O
was	O
further	O
mapped	O
in	O
the	O
17p13	O
-	O
ter	O
rgeion	O
by	O
fluorecsence	O
in	O
situ	O
hybirdization	O
.	O

The	O
boivne	O
apsa	O
gnee	O
has	O
also	O
been	O
clnoed	O
,	O
and	O
its	O
eoxn	O
/	O
inrton	O
organziation	O
is	O
iedntical	O
to	O
that	O
of	O
the	O
huamn	O
gnee	O
.	O

The	O
500	O
-	O
base	O
sequecne	O
upsteram	O
of	O
the	O
inititaor	O
ATG	O
coodn	O
in	O
the	O
hmuan	O
gnee	O
and	O
that	O
in	O
the	O
boivne	O
gnee	O
are	O
77	O
%	O
idetnical	O
.	O

Huamn	O
APSA	O
cdoing	O
sequecnes	O
crsos	O
-	O
hbyridize	O
with	O
geonmic	O
DNA	O
from	O
yesat	O
,	O
cihcken	O
,	O
rabibt	O
,	O
cow	O
,	O
dog	O
,	O
muose	O
,	O
rat	O
,	O
and	O
mnokey	O
.	O

The	O
spceificity	O
of	O
crsos	O
-	O
sepcies	O
hbyridization	O
of	O
codnig	O
sequenecs	O
suggests	O
that	O
aspartoayclase	O
has	O
been	O
conserved	O
during	O
eovlution	O
.	O

It	O
should	O
now	O
be	O
possible	O
to	O
identify	O
mutaitons	O
in	O
the	O
noncoidng	O
genoimc	O
sequneces	O
that	O
lead	O
to	O
Canvaan	B-Disease
disesae	I-Disease
and	O
to	O
stduy	O
the	O
reuglation	O
of	O
APSA	O
.	O
.	O

Myootnic	B-Disease
dytsrophy	I-Disease
:	O
szie	O
-	O
and	O
sex	O
-	O
depnedent	O
dnyamics	O
of	O
CTG	O
meioitc	O
instabiltiy	O
,	O
and	O
smoatic	O
mosiacism	O
.	O

Mytoonic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
is	O
a	O
prorgessive	O
neuromuscualr	B-Disease
diosrder	I-Disease
which	O
reuslts	O
from	O
elognations	O
of	O
an	O
unstable	O
(	O
CTG	O
)	O
n	O
repaet	O
,	O
located	O
in	O
the	O
3	O
untarnslated	O
reigon	O
of	O
the	O
DM	B-Disease
gnee	O
.	O

A	O
correlation	O
has	O
been	O
demonstrated	O
between	O
the	O
incraese	O
in	O
the	O
repaet	O
number	O
of	O
this	O
sqeuence	O
and	O
the	O
severtiy	O
of	O
the	O
disaese	O
.	O

However	O
,	O
the	O
clincial	O
sattus	O
of	O
pateints	O
cannot	O
be	O
unambiguously	O
ascertained	O
solely	O
on	O
the	O
basis	O
of	O
the	O
number	O
of	O
CTG	O
rpeeats	O
.	O

Moreover	O
,	O
the	O
exclusive	O
matrenal	O
inhreitance	O
of	O
the	O
congneital	O
form	O
remains	O
unexplianed	O
.	O

Our	O
osbervation	O
of	O
differently	O
siezd	O
repaets	O
in	O
various	O
DM	B-Disease
tisuses	O
from	O
the	O
same	O
individaul	O
may	O
explain	O
why	O
the	O
szie	O
of	O
the	O
muattion	O
observed	O
in	O
lypmhocytes	O
does	O
not	O
necessarily	O
corerlate	O
with	O
the	O
severtiy	O
and	O
nature	O
of	O
symtpoms	O
.	O

Through	O
a	O
moelcular	O
and	O
geentic	O
sutdy	O
of	O
142	O
fmailies	O
including	O
418	O
DM	B-Disease
patietns	O
,	O
we	O
have	O
investgiated	O
the	O
dyanmics	O
of	O
the	O
CTG	O
repaet	O
meoitic	O
instabiilty	O
.	O

A	O
posiitve	O
correaltion	O
between	O
the	O
szie	O
of	O
the	O
repaet	O
and	O
the	O
intergeneartional	O
enlragement	O
was	O
observed	O
similarly	O
through	O
mlae	O
and	O
feamle	O
meoises	O
for	O
<	O
or	O
=	O
0	O
.	O

5	O
-	O
kb	O
CTG	O
sequecnes	O
.	O

Beyond	O
0	O
.	O

5	O
kb	O
,	O
the	O
integrenerational	O
vraiation	O
was	O
more	O
important	O
through	O
femlae	O
meioess	O
,	O
whereas	O
a	O
tendency	O
to	O
cmopression	O
was	O
observed	O
almost	O
exclusively	O
in	O
mlae	O
meoises	O
,	O
for	O
>	O
or	O
=	O
1	O
.	O

5	O
-	O
kb	O
fragmnets	O
.	O

This	O
implies	O
a	O
szie	O
-	O
and	O
sex	O
-	O
dpeendent	O
meoitic	O
instabiltiy	O
.	O

Moreover	O
,	O
segregatoin	O
analsyis	O
supports	O
the	O
hpyothesis	O
of	O
a	O
mtaernal	O
as	O
well	O
as	O
a	O
familail	O
predisopsition	O
for	O
the	O
occurernce	O
of	O
the	O
cognenital	O
form	O
.	O

Finally	O
,	O
this	O
analyiss	O
reveals	O
a	O
significant	O
excses	O
of	O
transmititng	O
grandfathres	O
paritally	O
accounted	O
for	O
by	O
incresaed	O
fertiilty	O
in	O
affetced	O
maels	O

Illegitimate	O
transcripiton	O
of	O
the	O
phenlyalanine	O
hyrdoxylase	O
gnee	O
in	O
lymhpocytes	O
for	O
identiifcation	O
of	O
mutatinos	O
in	O
phenylkeotnuria	B-Disease
.	O

Taking	O
advantage	O
of	O
the	O
illegitimate	O
transcripiton	O
of	O
the	O
phenlyalanine	O
hydrxoylase	O
(	O
PAH	O
)	O
gnee	O
,	O
we	O
have	O
been	O
able	O
to	O
analyse	O
the	O
PAH	O
cNDA	O
sequnece	O
of	O
hyperpheynlalaninemic	B-Disease
chidlren	O
in	O
criculating	O
lymphoyctes	O
.	O

Using	O
this	O
approach	O
,	O
we	O
have	O
also	O
identfiied	O
3	O
novel	O
mtuations	O
in	O
cNDA	O
from	O
lvier	O
and	O
lypmhocytes	O
of	O
two	O
paitents	O
.	O

One	O
mutatoin	O
,	O
detetced	O
by	O
the	O
abnromal	O
pattern	O
of	O
mirgation	O
of	O
an	O
ampilfied	O
framgent	O
,	O
is	O
a	O
C	O
to	O
T	O
transiiton	O
in	O
the	O
spilce	O
acceptor	O
stie	O
of	O
intorn	O
10	O
,	O
which	O
resulted	O
in	O
the	O
skipipng	O
of	O
eoxn	O
11	O
with	O
the	O
premautre	O
terminatoin	O
of	O
RNA	O
trasnlation	O
downstraem	O
from	O
eoxn	O
12	O
(	O
-	O
3	O
ISV10	O
)	O
.	O

The	O
other	O
two	O
muattions	O
are	O
missnese	O
mutatinos	O
in	O
eoxns	O
10	O
and	O
11	O
(	O
respectively	O
,	O
L333F	O
and	O
E930	O
)	O
.	O

The	O
present	O
stduy	O
supports	O
the	O
view	O
that	O
circulaitng	O
lympohcytes	O
give	O
easy	O
access	O
to	O
PAH	O
gnee	O
transcirpts	O
whose	O
nucleoitde	O
sequnece	O
is	O
idnetical	O
to	O
that	O
reported	O
in	O
lvier	O
and	O
therefore	O
represent	O
a	O
useful	O
tool	O
for	O
molecualr	O
geneitc	O
studeis	O
in	O
phenylketonruia	B-Disease
.	O
.	O

High	O
rseidual	O
aryluslfatase	O
A	O
(	O
ASRA	O
)	O
activtiy	O
in	O
a	O
pateint	O
with	O
ltae	B-Disease
-	I-Disease
infantlie	I-Disease
metahcromatic	I-Disease
leukodystrpohy	I-Disease
.	O

We	O
idenitfied	O
a	O
ptaient	O
suffering	O
from	O
ltae	B-Disease
-	I-Disease
ifnantile	I-Disease
mteachromatic	I-Disease
leukodysrtophy	I-Disease
(	O
MLD	B-Disease
)	O
who	O
has	O
a	O
resdiual	O
aryluslfatase	O
A	O
(	O
ASRA	O
)	O
activtiy	O
of	O
about	O
10	O
%	O
.	O

Fibroblatss	O
of	O
the	O
paitent	O
show	O
significant	O
sulfaitde	O
degradatoin	O
actviity	O
exceeding	O
that	O
of	O
audlt	B-Disease
MLD	I-Disease
ptaients	O
.	O

Aanlysis	O
of	O
the	O
ASRA	O
gnee	O
in	O
this	O
ptaient	O
reevaled	O
heterozyogsity	O
for	O
two	O
new	O
mutnat	O
alleles	O
in	O
one	O
allele	O
,	O
dleetion	O
of	O
C	O
447	O
in	O
eoxn	O
2	O
leads	O
to	O
a	O
framehsift	O
and	O
to	O
a	O
premautre	O
stop	O
coodn	O
at	O
amnio	O
aicd	O
postiion	O
105	O
;	O
in	O
the	O
second	O
alelle	O
,	O
a	O
G	O
-	O
-	O
>	O
A	O
trnasition	O
in	O
eoxn	O
5	O
causes	O
a	O
Gly039	O
-	O
-	O
>	O
Ser	O
substittuion	O
.	O

Transeint	O
epxression	O
of	O
the	O
mutnat	O
Sre309	O
-	O
ASRA	O
resulted	O
in	O
only	O
13	O
%	O
eznyme	O
actiivty	O
of	O
that	O
observed	O
in	O
clels	O
expresisng	O
noraml	O
ASRA	O
.	O

The	O
mtuant	O
ASRA	O
is	O
correctly	O
taregted	O
to	O
the	O
lysosoems	O
but	O
is	O
unstable	O
.	O

These	O
findnigs	O
are	O
in	O
contrast	O
to	O
previous	O
resluts	O
showing	O
that	O
the	O
ltae	B-Disease
-	I-Disease
infatnile	I-Disease
tpye	I-Disease
of	I-Disease
MLD	I-Disease
is	O
always	O
associated	O
with	O
the	O
complete	O
asbence	O
of	O
ASRA	O
actiivty	O
.	O

The	O
expression	O
of	O
the	O
mutnat	O
ASRA	O
portein	O
may	O
be	O
influecned	O
by	O
particular	O
featuers	O
of	O
oligodnedrocytes	O
,	O
such	O
that	O
the	O
leevl	O
of	O
mutnat	O
eznyme	O
is	O
lwoer	O
in	O
these	O
cells	O
than	O
in	O
others	O
.	O
.	O

An	O
arylsulaftase	O
A	O
(	O
ASRA	O
)	O
misesnse	O
mtuation	O
(	O
T247M	O
)	O
causing	O
ltae	B-Disease
-	I-Disease
inafntile	I-Disease
metachromtaic	I-Disease
leukodystrohpy	I-Disease
.	O

Meatchromatic	B-Disease
lekuodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
is	O
an	O
auotsomal	B-Disease
recsesive	I-Disease
lysoosmal	I-Disease
stoarge	I-Disease
disroder	I-Disease
caused	O
by	O
a	O
dfeiciency	B-Disease
of	I-Disease
arylsulfaatse	I-Disease
A	I-Disease
(	O
ASRA	O
;	O
EC	O
3	O
.	O
1	O
.	O
6	O
.	O
8	O
)	O
.	O

The	O
8	O
ASRA	O
exnos	O
and	O
adjcaent	O
intorn	O
boudnaries	O
from	O
a	O
patinet	O
with	O
ltae	B-Disease
-	I-Disease
inafntile	I-Disease
metahcromatic	I-Disease
leukodystorphy	I-Disease
were	O
polymearse	O
chian	O
reaciton	O
(	O
PCR	O
)	O
amplfiied	O
in	O
seven	O
dicsrete	O
reacitons	O
.	O

Amplifeid	O
ASRA	O
exnos	O
were	O
aanlysed	O
for	O
the	O
presnece	O
of	O
seuqence	O
alteraitons	O
by	O
single	O
-	O
srtand	O
conofrmation	O
polymoprhism	O
aanlysis	O
,	O
followed	O
by	O
direct	O
sequecning	O
of	O
PCR	O
produtcs	O
.	O

The	O
ptaient	O
was	O
found	O
to	O
be	O
homozyguos	O
for	O
a	O
C	O
-	O
-	O
>	O
T	O
tarnsition	O
in	O
eoxn	O
IV	O
that	O
rseults	O
in	O
the	O
substitutoin	O
of	O
a	O
highly	O
conserved	O
threonnie	O
rseidue	O
at	O
aimno	O
aicd	O
274	O
with	O
a	O
methionnie	O
(	O
T724M	O
)	O
.	O

Aanlysis	O
of	O
a	O
further	O
29	O
MLD	B-Disease
patietns	O
revelaed	O
the	O
prseence	O
of	O
five	O
additional	O
homzoygotes	O
for	O
T724M	O
.	O

All	O
6	O
T724M	O
homozygtoes	O
(	O
representing	O
four	O
famliies	O
)	O
were	O
of	O
Lebnaese	O
desecnt	O
,	O
and	O
all	O
were	O
known	O
to	O
be	O
the	O
result	O
of	O
conasnguineous	O
marirages	O
.	O

The	O
altreed	O
amnio	O
aicd	O
is	O
rigidly	O
conserved	O
among	O
10	O
sulaftases	O
from	O
Ecsherichia	O
cloi	O
to	O
hmuans	O
;	O
therefore	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
reusltant	O
muatnt	O
portein	O
will	O
have	O
little	O
or	O
no	O
enzmye	O
activtiy	O
.	O

This	O
is	O
consistent	O
with	O
the	O
very	O
low	O
ASRA	O
activtiy	O
mesaured	O
in	O
these	O
patinets	O
and	O
their	O
uniformly	O
sveere	O
cilnical	O
prseentation	O

Mutaitons	O
in	O
the	O
PXA6	O
gnee	O
in	O
ptaients	O
with	O
herediatry	O
anirdiia	B-Disease
.	O

The	O
14	O
exnos	O
of	O
the	O
PXA6	O
gnee	O
have	O
been	O
analyesd	O
eoxn	O
-	O
by	O
-	O
eoxn	O
using	O
SCSP	O
in	O
6	O
ainridia	B-Disease
fmailies	O
.	O

In	O
each	O
famliy	O
bnad	O
sihfts	O
were	O
observed	O
on	O
the	O
SCSP	O
gles	O
for	O
only	O
one	O
eoxn	O
and	O
direct	O
PCR	O
-	O
sequecning	O
reveaeld	O
muattions	O
in	O
each	O
csae	O
.	O

Two	O
mutatoins	O
involved	O
C	O
-	O
-	O
>	O
T	O
trasnitions	O
in	O
CGArag	O
cdoons	O
in	O
exnos	O
9	O
and	O
11	O
.	O

Another	O
C	O
-	O
-	O
>	O
T	O
trnasition	O
converted	O
a	O
CAG	O
-	O
gultamine	O
to	O
a	O
TAG	O
-	O
stop	O
in	O
eoxn	O
7	O
.	O

Samll	O
inseritons	O
created	O
frameshfits	O
which	O
produced	O
downtsream	O
stop	O
codnos	O
in	O
another	O
two	O
paitents	O
and	O
an	O
A	O
-	O
-	O
>	O
T	O
muattion	O
disrupetd	O
the	O
slpice	O
dnoor	O
stie	O
of	O
eoxn	O
5	O
in	O
the	O
remaining	O
fmaily	O
.	O

Thus	O
,	O
complete	O
inactivaiton	O
of	O
the	O
PXA6	O
gnee	O
is	O
predicetd	O
in	O
all	O
caess	O
.	O

Analyiss	O
of	O
other	O
affetced	O
mmebers	O
of	O
the	O
famileis	O
showed	O
that	O
,	O
in	O
each	O
csae	O
,	O
all	O
afefcted	O
individauls	O
carried	O
the	O
same	O
faimly	O
-	O
specific	O
mtuation	O
.	O

One	O
polyomrphism	O
was	O
found	O
in	O
eoxn	O
7	O
.	O

This	O
dtaa	O
strongly	O
supports	O
the	O
caniddature	O
of	O
PXA6	O
as	O
the	O
gnee	O
responsible	O
for	O
hreeditary	O
aniriida	B-Disease
.	O
.	O

Three	O
novel	O
mutatinos	O
in	O
five	O
unrelated	O
sbujects	O
with	O
hreeditary	O
prtoein	B-Disease
S	I-Disease
defciiency	I-Disease
tpye	I-Disease
I	I-Disease
.	O

A	O
panel	O
of	O
eight	O
unrelated	O
subjetcs	O
with	O
ihnerited	O
tpye	B-Disease
I	I-Disease
prtoein	I-Disease
S	I-Disease
deficiecny	I-Disease
was	O
screened	O
for	O
mutatinos	O
in	O
the	O
PRSO1	O
gnee	O
.	O

In	O
five	O
sujbects	O
an	O
abnomrality	O
was	O
found	O
but	O
mutatinos	O
were	O
not	O
dteected	O
in	O
the	O
remaining	O
three	O
subejcts	O
.	O

Two	O
subejcts	O
shared	O
a	O
G	O
-	O
-	O
>	O
A	O
transiiton	O
at	O
positoin	O
+	O
5	O
of	O
the	O
dnoor	O
slpice	O
stie	O
consenuss	O
sequecne	O
of	O
inrton	O
10	O
.	O

Also	O
in	O
two	O
subjcets	O
an	O
A	O
-	O
-	O
>	O
T	O
tarnsversion	O
was	O
detecetd	O
in	O
the	O
stopocdon	O
of	O
the	O
PRSO1	O
gnee	O
;	O
this	O
transvesrion	O
predicts	O
a	O
proetin	O
S	O
molceule	O
that	O
is	O
extenedd	O
by	O
14	O
aimno	O
aicds	O
.	O

The	O
fifth	O
sbuject	O
was	O
found	O
to	O
possess	O
two	O
seuqence	O
abnormlaities	O
.	O

One	O
alllee	O
carried	O
a	O
G	O
-	O
-	O
>	O
A	O
transitoin	O
near	O
the	O
dnoor	O
splcie	O
jucntion	O
of	O
inrton	O
2	O
,	O
but	O
this	O
abnromality	O
is	O
probably	O
neurtal	O
,	O
since	O
it	O
was	O
ihnerited	O
from	O
the	O
parnet	O
with	O
noraml	O
portein	O
S	O
antiegn	O
leevls	O
.	O

In	O
the	O
other	O
alelle	O
a	O
single	O
T	O
insetrion	O
in	O
coodn	O
-	O
25	O
was	O
found	O
.	O

Analsyis	O
of	O
plateelt	O
RNA	O
showed	O
that	O
only	O
the	O
mNRA	O
with	O
the	O
A	O
-	O
-	O
>	O
T	O
mutatoin	O
in	O
the	O
stpocodon	O
is	O
present	O
in	O
amounts	O
comparable	O
to	O
wlidtype	O
RNA	O
.	O

mNRA	O
from	O
the	O
alleels	O
with	O
the	O
other	O
two	O
muttaions	O
was	O
either	O
undetectalbe	O
or	O
present	O
in	O
greatly	O
reduecd	O
amounts	O
.	O

The	O
latter	O
indicates	O
that	O
a	O
mNRA	O
based	O
approach	O
is	O
not	O
feasible	O
for	O
the	O
gneetic	O
aanlysis	O
of	O
prtoein	B-Disease
S	I-Disease
defiicency	I-Disease
tpye	I-Disease
I	I-Disease
.	O
.	O

Characetristics	O
of	O
inetrgenerational	O
conrtactions	O
of	O
the	O
CTG	O
rpeeat	O
in	O
mytoonic	B-Disease
dystrohpy	I-Disease
.	O

In	O
mytoonic	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
szie	O
of	O
a	O
CTG	O
reepat	O
in	O
the	O
DM	B-Disease
kinsae	O
gnee	O
generally	O
incerases	O
in	O
successive	O
gneerations	O
with	O
cliniacl	O
evidecne	O
of	O
anticpiation	O
.	O

However	O
,	O
there	O
have	O
also	O
been	O
csaes	O
with	O
an	O
itnergenerational	O
contractoin	O
of	O
the	O
repaet	O
.	O

We	O
examined	O
1	O
,	O
489	O
DM	B-Disease
paernt	O
-	O
offsrping	O
piars	O
,	O
of	O
which	O
95	O
(	O
6	O
.	O
4	O
%	O
)	O
showed	O
such	O
contractinos	O
in	O
preipheral	O
blood	O
luekocytes	O
(	O
PBL	O
)	O
.	O

In	O
56	O
of	O
the	O
95	O
paris	O
,	O
clniical	O
dtaa	O
allowed	O
an	O
analyiss	O
of	O
their	O
anticipatoin	O
sttaus	O
.	O

It	O
is	O
surprising	O
that	O
anticpiation	O
occurred	O
in	O
27	O
(	O
48	O
%	O
)	O
of	O
these	O
56	O
paris	O
,	O
while	O
none	O
clearly	O
showed	O
a	O
later	O
onset	O
of	O
DM	B-Disease
in	O
the	O
sympotmatic	O
ofsfpring	O
.	O

The	O
contractoin	O
occurred	O
in	O
76	O
(	O
10	O
%	O
)	O
of	O
753	O
ptaernal	O
transmsisions	O
and	O
in	O
19	O
(	O
3	O
%	O
)	O
of	O
736	O
matrenal	O
transmsisions	O
.	O

Anticiaption	O
was	O
observed	O
more	O
frequently	O
in	O
maetrnal	O
(	O
85	O
%	O
)	O
than	O
in	O
pateranl	O
(	O
37	O
%	O
)	O
transmisisons	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

The	O
paretnal	O
rpeeat	O
szie	O
corerlated	O
with	O
the	O
szie	O
of	O
intergeneratoinal	O
cotnraction	O
(	O
r2	O
=	O
.	O
50	O
,	O
P	O
<	O
<	O
.	O
001	O
)	O
,	O
and	O
the	O
slope	O
of	O
linaer	O
regerssion	O
was	O
steeper	O
in	O
patenral	O
(	O
-	O
.	O
62	O
)	O
than	O
in	O
matrenal	O
(	O
-	O
.	O
30	O
)	O
transmissoins	O
(	O
P	O
<	O
<	O
.	O
001	O
)	O
.	O

Sixteen	O
DM	B-Disease
parnets	O
had	O
multilpe	O
DM	B-Disease
offspirng	O
with	O
the	O
CTG	O
rpeeat	O
contracitons	O
.	O

This	O
frqeuency	O
was	O
hgiher	O
than	O
the	O
freqeuncy	O
expected	O
from	O
the	O
proabbility	O
of	O
the	O
reepat	O
contracitons	O
(	O
6	O
.	O
4	O
%	O
)	O
and	O
the	O
szie	O
of	O
DM	B-Disease
sib	O
populatoin	O
(	O
1	O
.	O
54	O
DM	B-Disease
offsrping	O
per	O
DM	B-Disease
paernt	O
,	O
in	O
968	O
DM	B-Disease
parnets	O
)	O
.	O

We	O
conclude	O
that	O
(	O
1	O
)	O
intergenertaional	O
cnotractions	O
of	O
the	O
CTG	O
repaet	O
in	O
leukoctye	O
DNA	O
frequently	O
accompanies	O
apparent	O
antiicpation	O
,	O
especially	O
when	O
DM	B-Disease
is	O
mtaernally	O
transmitted	O
,	O
and	O
(	O
2	O
)	O
the	O
pateranl	O
oriign	O
of	O
the	O
reepat	O
and	O
the	O
prseence	O
of	O
the	O
reepat	O
contratcion	O
in	O
a	O
sbiling	O
incerase	O
the	O
probbaility	O
of	O
the	O
CTG	O
rpeeat	O
contrcation	O

Gonosmoal	O
mosaiicsm	O
in	O
myootnic	B-Disease
dystrohpy	I-Disease
patietns	O
:	O
involveemnt	O
of	O
mtiotic	O
evnets	O
in	O
(	O
CTG	O
)	O
n	O
repaet	O
vraiation	O
and	O
seelction	O
against	O
extreme	O
expnasion	O
in	O
sprem	O
.	O

Myootnic	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
abonrmal	O
expanison	O
of	O
a	O
poylmorphic	O
(	O
CTG	O
)	O
n	O
repaet	O
,	O
located	O
in	O
the	O
DM	B-Disease
portein	O
kinsae	O
gnee	O
.	O

We	O
determined	O
the	O
(	O
CTG	O
)	O
n	O
reepat	O
lentghs	O
in	O
a	O
broad	O
range	O
of	O
tisuse	O
DANs	O
from	O
patietns	O
with	O
mlid	O
,	O
classical	O
,	O
or	O
congeintal	O
manifestaiton	O
of	O
DM	B-Disease
.	O

Differneces	O
in	O
the	O
rpeeat	O
lentgh	O
were	O
seen	O
in	O
somtaic	O
tisseus	O
from	O
single	O
DM	B-Disease
inidviduals	O
and	O
tiwns	O
.	O

Repetas	O
appeared	O
to	O
expand	O
to	O
a	O
similar	O
extent	O
in	O
tisseus	O
originating	O
from	O
the	O
same	O
embyronal	O
orgiin	O
.	O

In	O
most	O
mlae	O
patietns	O
carrying	O
intemrediate	O
-	O
or	O
small	O
-	O
siezd	O
expnasions	O
in	O
bolod	O
,	O
the	O
reepat	O
legnths	O
covered	O
a	O
markedly	O
wider	O
range	O
in	O
sprem	O
.	O

In	O
contrast	O
,	O
mlae	O
paitents	O
with	O
large	O
alllee	O
expanisons	O
in	O
blood	O
(	O
>	O
700	O
CGTs	O
)	O
had	O
similar	O
or	O
smaller	O
rpeeats	O
in	O
seprm	O
,	O
when	O
detcetable	O
.	O

Sprem	O
alleles	O
with	O
>	O
1	O
,	O
000	O
CGTs	O
were	O
not	O
seen	O
.	O

We	O
conclude	O
that	O
DM	B-Disease
ptaients	O
can	O
be	O
considered	O
gonosmoal	O
msoaics	O
,	O
i	O
.	O

e	O
e	O
.	O
,	O
combnied	O
somaitc	O
and	O
grem	O
-	O
line	O
tsisue	O
mosacis	O
.	O

Most	O
remarkably	O
,	O
we	O
observed	O
mlutiple	O
csaes	O
where	O
the	O
legnth	O
distributinos	O
of	O
inetrmediate	O
-	O
or	O
small	O
-	O
szied	O
alllees	O
in	O
fathres	O
sprem	O
were	O
significantly	O
different	O
from	O
that	O
in	O
their	O
offspirngs	O
bolod	O
.	O

Our	O
combiend	O
findnigs	O
indicate	O
that	O
intergeneratoinal	O
lnegth	O
chanegs	O
in	O
the	O
unstable	O
CTG	O
rpeeat	O
are	O
most	O
likely	O
to	O
occur	O
during	O
ealry	O
embrynoic	O
mittoic	O
diviisons	O
in	O
both	O
smoatic	O
and	O
grem	O
-	O
line	O
tsisue	O
formaiton	O
.	O

Both	O
the	O
initial	O
CTG	O
lnegth	O
,	O
the	O
overall	O
number	O
of	O
clel	O
divisoins	O
involved	O
in	O
tisuse	O
formaiton	O
,	O
and	O
perhaps	O
a	O
specific	O
selectoin	O
procses	O
in	O
spermatoegnesis	O
may	O
infleunce	O
the	O
dnyamics	O
of	O
this	O
porcess	O
.	O

A	O
mdoel	O
explaining	O
mtiotic	O
instabliity	O
and	O
sex	O
-	O
deepndent	O
segreagtion	O
pehnomena	O
in	O
DM	B-Disease
manifetsation	O
is	O
discussed	O

Regionally	O
clutsered	O
APC	B-Disease
mutatinos	O
are	O
associated	O
with	O
a	O
sevree	O
phenotpye	O
and	O
occur	O
at	O
a	O
high	O
frequnecy	O
in	O
new	O
muttaion	O
caess	O
of	O
adeonmatous	B-Disease
polpyosis	I-Disease
cloi	I-Disease
.	O

Germlnie	O
mutatoin	O
in	O
APC	O
at	O
52q1	O
-	O
22	O
reuslts	O
in	O
the	O
dominantly	O
ihnerited	O
synrdome	O
adenomtaous	B-Disease
polpyosis	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
.	O

Somaitc	O
muttaion	O
in	O
this	O
gnee	O
is	O
an	O
eraly	O
eevnt	O
in	O
coolrectal	O
tumourgienesis	O
.	O

Both	O
types	O
of	O
muattion	O
are	O
concentrated	O
in	O
the	O
5	O
half	O
of	O
eoxn	O
15	O
.	O

We	O
have	O
used	O
single	O
strnad	O
conformatoinal	O
polymorpihsm	O
(	O
SCSP	O
)	O
and	O
hteeroduplex	O
anaylsis	O
to	O
srceen	O
for	O
variatns	O
in	O
this	O
regoin	O
of	O
the	O
gnee	O
in	O
a	O
total	O
of	O
45	O
affected	O
but	O
unrelated	O
indviiduals	O
.	O

Eighteen	O
pateints	O
had	O
no	O
faimly	O
hitsory	O
of	O
the	O
diesase	O
;	O
of	O
these	O
11	O
were	O
classified	O
as	O
having	O
a	O
sveere	O
pheontype	O
,	O
based	O
on	O
an	O
eraly	O
age	O
at	O
preesntation	O
or	O
canecr	B-Disease
dveelopment	O
.	O

This	O
comapred	O
with	O
6	O
of	O
27	O
faimlial	O
caess	O
.	O

A	O
5	O
bp	O
dleetion	O
at	O
cdoon	O
1309	O
reported	O
to	O
occur	O
in	O
10	O
-	O
15	O
%	O
of	O
unselected	O
APC	B-Disease
ptaients	O
worldwide	O
,	O
was	O
found	O
in	O
5	O
of	O
the	O
18	O
new	O
mutatoin	O
csaes	O
and	O
4	O
of	O
the	O
27	O
fmailial	O
caess	O
all	O
nine	O
were	O
classed	O
as	O
sevree	O
.	O

A	O
further	O
3	O
new	O
mutaitons	O
and	O
1	O
faimlial	O
mutaiton	O
were	O
located	O
downtsream	O
from	O
cdoon	O
1309	O
,	O
these	O
indiviudals	O
similarly	O
being	O
classed	O
as	O
pehnotypically	O
sevree	O
.	O

In	O
contrast	O
all	O
of	O
the	O
APC	B-Disease
muattions	O
detceted	O
in	O
affected	O
indivdiuals	O
with	O
an	O
avergae	O
phenotpye	O
were	O
located	O
prior	O
to	O
coodn	O
1309	O
.	O

The	O
freuqent	O
assoication	O
of	O
a	O
sveere	O
phentoype	O
with	O
fersh	O
mtuation	O
may	O
explain	O
the	O
appraent	O
conflcit	O
of	O
a	O
high	O
muattion	O
rtae	O
(	O
20	O
-	O
30	O
%	O
)	O
in	O
a	O
condtiion	O
,	O
which	O
on	O
aevrage	O
,	O
is	O
letahl	O
at	O
a	O
psot	O
-	O
reproducitve	O
age	O
.	O
.	O

Mutaitons	O
at	O
the	O
PXA6	O
loucs	O
are	O
found	O
in	O
heteorgeneous	O
atnerior	B-Disease
segemnt	I-Disease
maflormations	I-Disease
including	O
Peetrs	B-Disease
'	I-Disease
aonmaly	I-Disease
.	O

Muttaion	O
or	O
deleiton	O
of	O
the	O
PXA6	O
gnee	O
underlies	O
many	O
caess	O
of	O
ainridia	B-Disease
.	O

Three	O
lnies	O
of	O
eviednce	O
now	O
converge	O
to	O
implicate	O
PXA6	O
more	O
widely	O
in	O
anteiror	B-Disease
semgent	I-Disease
malformatoins	I-Disease
including	O
Pteers	B-Disease
anoamly	I-Disease
.	O

First	O
,	O
a	O
cihld	O
with	O
Petres	B-Disease
anoamly	I-Disease
is	O
dleeted	O
for	O
one	O
cpoy	O
of	O
PXA6	O
.	O

Second	O
,	O
afefcted	O
mebmers	O
of	O
a	O
faimly	O
with	O
dominantly	O
inherietd	O
anetrior	B-Disease
sgement	I-Disease
malformaitons	I-Disease
,	O
including	O
Petres	B-Disease
aonmaly	I-Disease
are	O
heetrozygous	O
for	O
an	O
R62G	O
mutaiton	O
in	O
the	O
PXA6	O
paired	O
box	O
.	O

Third	O
,	O
a	O
proprotion	O
of	O
Sey	O
/	O
+	O
Smallyee	O
mcie	O
,	O
hetreozygous	O
for	O
a	O
nonsesne	O
muttaion	O
in	O
mruine	O
Pax	O
-	O
6	O
,	O
have	O
an	O
ocualr	O
pehnotype	O
resembling	O
Pteers	B-Disease
aonmaly	I-Disease
.	O

We	O
therefore	O
propose	O
that	O
a	O
variety	O
of	O
anteiror	B-Disease
segmnet	I-Disease
anomaleis	I-Disease
may	O
be	O
associated	O
with	O
PXA6	O
mutaitons	O
.	O
.	O

Huntignton	B-Disease
diesase	I-Disease
without	O
CAG	O
epxansion	O
:	O
phenocopies	O
or	O
errros	O
in	O
assigmnent	O
?	O

Huntnigton	B-Disease
diesase	I-Disease
(	O
HD	B-Disease
)	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
an	O
expanded	O
CAG	O
reepat	O
within	O
a	O
novel	O
gnee	O
on	O
4p16	O
.	O

3	O
(	O
I1T5	O
)	O
.	O

A	O
total	O
of	O
30	O
of	O
1	O
,	O
022	O
affceted	O
presons	O
(	O
2	O
.	O
9	O
%	O
of	O
our	O
choort	O
)	O
did	O
not	O
have	O
an	O
expanded	O
CAG	O
in	O
the	O
disesae	O
range	O
.	O

The	O
reaosns	O
for	O
not	O
observing	O
expasnion	O
in	O
affected	O
indivdiuals	O
are	O
important	O
for	O
determining	O
the	O
sensiitvity	O
of	O
using	O
reepat	O
lnegth	O
both	O
for	O
diangosis	O
of	O
affetced	O
patietns	O
and	O
for	O
prdeictive	O
testnig	O
progarms	O
and	O
may	O
have	O
boilogical	O
relevance	O
for	O
the	O
understanding	O
of	O
the	O
mloecular	O
mechnaism	O
underlying	O
HD	B-Disease
.	O

Here	O
we	O
show	O
that	O
the	O
majority	O
(	O
18	O
)	O
of	O
the	O
individulas	O
with	O
nromal	O
siezd	O
alleels	O
represent	O
misidagnosis	O
,	O
smaple	O
mix	O
-	O
up	O
,	O
or	O
cleriacl	O
erorr	O
.	O

The	O
remaining	O
12	O
patinets	O
represent	O
possible	O
phenocopies	O
for	O
HD	B-Disease
.	O

In	O
at	O
least	O
four	O
csaes	O
,	O
famliy	O
sutdies	O
of	O
these	O
phenocopies	O
excluded	O
4p16	O
.	O

3	O
as	O
the	O
rgeion	O
responsible	O
for	O
the	O
phenoytpe	O
.	O

Mtuations	O
in	O
the	O
HD	B-Disease
gnee	O
that	O
are	O
other	O
than	O
CAG	O
expasnion	O
have	O
not	O
been	O
excluded	O
for	O
the	O
remaining	O
eight	O
csaes	O
;	O
however	O
,	O
in	O
as	O
many	O
as	O
seven	O
of	O
these	O
perosns	O
,	O
rterospective	O
reivew	O
of	O
these	O
patinets	O
cliincal	O
featuers	O
iedntified	O
charactersitics	O
not	O
typical	O
for	O
HD	B-Disease
.	O

This	O
sutdy	O
shows	O
that	O
on	O
rrae	O
occasoins	O
mutatoins	O
in	O
other	O
,	O
as	O
-	O
yet	O
-	O
undefined	O
gnees	O
can	O
present	O
with	O
a	O
clniical	O
phentoype	O
very	O
similar	O
to	O
that	O
of	O
HD	B-Disease

Ferquent	O
dteection	O
of	O
cdoon	O
877	O
mtuation	O
in	O
the	O
andrgoen	O
recepotr	O
gnee	O
in	O
advnaced	B-Disease
prosttae	I-Disease
canecrs	I-Disease
.	O

Prsotatic	O
tissue	O
specimnes	O
derived	O
from	O
tarnsurethral	O
reesctions	O
of	O
patietns	O
with	O
meatstatic	B-Disease
prosatte	I-Disease
cacner	I-Disease
were	O
analyezd	O
for	O
gneetic	O
alteratoins	O
in	O
the	O
horomne	O
-	O
bniding	O
doamin	O
of	O
the	O
andrgoen	O
recepotr	O
(	O
AR	O
)	O
gnee	O
.	O

Direct	O
sequencnig	O
of	O
the	O
poylmerase	O
cahin	O
raection	O
-	O
derived	O
DANs	O
of	O
6	O
of	O
24	O
spceimens	O
reevaled	O
a	O
coodn	O
877	O
mutatoin	O
(	O
ACT	O
-	O
-	O
>	O
GCT	O
,	O
Thr	O
-	O
-	O
>	O
Ala	O
)	O
in	O
the	O
horomne	O
-	O
bniding	O
domian	O
of	O
the	O
AR	O
gnee	O
.	O

This	O
same	O
AR	O
muattion	O
has	O
been	O
reported	O
previously	O
in	O
a	O
metsatatic	B-Disease
prosttae	I-Disease
cacner	I-Disease
clel	O
line	O
,	O
LNaCP	O
,	O
where	O
this	O
mutaiton	O
confers	O
upon	O
the	O
AR	O
an	O
aletred	O
lgiand	O
-	O
binidng	O
speicficity	O
which	O
is	O
stimultaed	O
by	O
estorgens	O
,	O
progetsagens	O
,	O
and	O
antinadrogens	O
.	O

It	O
is	O
possible	O
that	O
analogous	O
to	O
an	O
acitvated	O
/	O
alteerd	O
grotwh	O
fcator	O
recepotr	O
oncgoene	O
,	O
coodn	O
877	O
muatnt	O
AR	O
with	O
altreed	O
lgiand	O
binidng	O
may	O
provide	O
a	O
selective	O
grotwh	O
advantage	O
in	O
the	O
genseis	O
of	O
a	O
subset	O
of	O
advnaced	B-Disease
prsotate	I-Disease
canecr	I-Disease
.	O

Although	O
estrognes	O
are	O
used	O
infrequently	O
,	O
antiadnrogens	O
are	O
used	O
increasingly	O
in	O
hromonal	O
tehrapy	O
for	O
ptaients	O
with	O
advnaced	B-Disease
protsate	I-Disease
cnacer	I-Disease
.	O

The	O
stmiulatory	O
efefct	O
of	O
these	O
therpaeutic	O
agnets	O
on	O
the	O
coodn	O
877	O
mtuant	O
AR	O
further	O
suggests	O
that	O
this	O
frequently	O
observed	O
AR	O
muttaion	O
may	O
contribute	O
to	O
the	O
teratment	O
refracotry	O
diesase	O
.	O
.	O

The	O
hmuan	O
gnee	O
for	O
alkaptounria	B-Disease
(	O
AKU	B-Disease
)	O
mpas	O
to	O
chroomsome	O
3q	O
.	O

Alkapotnuria	B-Disease
(	O
AKU	B-Disease
;	O
McKusick	O
no	O
.	O
203500	O
)	O
is	O
a	O
rrae	O
autosoaml	B-Disease
recsesive	I-Disease
disroder	I-Disease
caused	O
by	O
the	O
lcak	O
of	O
homgoentisic	O
aicd	O
oxidsae	O
acitvity	O
.	O

Ptaients	O
excerte	O
large	O
amounts	O
of	O
homoegntisic	O
aicd	O
in	O
their	O
urnie	O
and	O
a	O
balck	O
ohcronotic	O
pigmnet	O
is	O
deopsited	O
in	O
their	O
cartilgae	O
and	O
clolagenous	O
tisseus	O
.	O

Ochronoiss	B-Disease
is	O
the	O
predoimnant	O
clniical	O
compliaction	O
of	O
the	O
disaese	O
leading	O
to	O
ochronoitc	B-Disease
atrhropathy	I-Disease
,	O
drak	O
urnie	O
,	O
pigmnet	O
chnages	O
of	O
the	O
sikn	O
,	O
and	O
other	O
cilnical	O
featuers	O
.	O

A	O
mtuation	O
causing	O
alakptonuria	B-Disease
in	O
the	O
muose	O
has	O
mapped	O
to	O
crhomosome	O
16	O
.	O

Considering	O
conserved	O
snyteny	O
,	O
we	O
were	O
able	O
to	O
map	O
the	O
hmuan	O
gnee	O
to	O
chroomsome	O
3q	O
in	O
six	O
aklaptonuria	B-Disease
pedigrees	O
of	O
Solvak	O
oriign	O
.	O
.	O

Structrue	O
of	O
the	O
huamn	O
Na	O
+	O
/	O
glucsoe	O
cotranspotrer	O
gnee	O
SGTL1	O
.	O

Intestianl	O
uptkae	O
of	O
dietray	O
gluocse	O
and	O
gaalctose	O
is	O
mediated	O
by	O
the	O
SLGT1	O
Na	O
+	O
/	O
glucsoe	O
ctoransporter	O
of	O
the	O
bursh	O
bodrer	O
.	O

An	O
SLGT1	O
missense	O
mutatoin	O
underlies	O
heredtiary	B-Disease
glcuose	I-Disease
/	I-Disease
galcatose	I-Disease
malabsoprtion	I-Disease
,	O
characterzied	O
by	O
potentially	O
ftaal	O
dirarhea	B-Disease
;	O
conversely	O
,	O
oarl	O
rehyrdation	O
tehrapy	O
exploits	O
nomral	O
transoprt	O
to	O
alleviate	O
lfie	O
-	O
threatening	O
dairrhea	B-Disease
of	O
infectoius	O
orgiin	O
.	O

We	O
have	O
mapped	O
the	O
entire	O
hmuan	O
SLGT1	O
Na	O
+	O
/	O
glucsoe	O
ctoransporter	O
gnee	O
from	O
comsid	O
and	O
lmabda	O
pahge	O
clnoes	O
representing	O
a	O
genoimc	O
rgeion	O
of	O
112	O
kiolbases	O
.	O

Trasncription	O
iniitation	O
occurred	O
from	O
a	O
stie	O
27	O
base	O
paris	O
3	O
of	O
a	O
TAATA	O
sqeuence	O
.	O

All	O
eoxn	O
-	O
flanking	O
regoins	O
were	O
sequenecd	O
,	O
and	O
the	O
entire	O
112	O
-	O
kiolbase	O
reigon	O
mpaped	O
with	O
four	O
restriciton	O
enzyems	O
.	O

SLGT1	O
is	O
comprised	O
of	O
15	O
exnos	O
(	O
spanning	O
72	O
kliobases	O
)	O
;	O
a	O
possible	O
evolutoinary	O
oirgin	O
from	O
a	O
six	O
-	O
membarne	O
-	O
sapn	O
ancetsral	O
preucrsor	O
via	O
a	O
gnee	O
duplictaion	O
eevnt	O
is	O
suggested	O
from	O
compairson	O
of	O
eoxns	O
against	O
protien	O
secondary	O
strcuture	O
and	O
from	O
seuqence	O
consdierations	O
.	O

A	O
new	O
msisense	O
muttaion	O
in	O
eoxn	O
1	O
causing	O
gluocse	B-Disease
/	I-Disease
galatcose	I-Disease
malabsoprtion	I-Disease
is	O
also	O
described	O
.	O

This	O
is	O
the	O
first	O
Na	O
(	O
+	O
)	O
-	O
depnedent	O
cotransoprter	O
gnee	O
strutcure	O
reported	O
.	O

These	O
dtaa	O
facilitate	O
the	O
search	O
for	O
new	O
glucsoe	B-Disease
/	I-Disease
galcatose	I-Disease
malabsroption	I-Disease
-	O
related	O
mtuations	O
in	O
this	O
important	O
gnee	O
and	O
provide	O
a	O
basis	O
for	O
future	O
evolutinoary	O
compariosns	O
with	O
other	O
Na	O
(	O
+	O
)	O
-	O
depednent	O
cotransproters	O
.	O
.	O

Four	O
novel	O
PPED	O
alllees	O
causing	O
porlidase	B-Disease
deficiecny	I-Disease
.	O

Muttaions	O
at	O
the	O
PPED	O
lcous	O
cause	O
proliadse	B-Disease
deifciency	I-Disease
(	O
McKusick	O
170100	O
)	O
,	O
a	O
rrae	O
atuosomal	B-Disease
recsesive	I-Disease
diosrder	I-Disease
charactreized	O
by	O
iminodipetpiduria	B-Disease
,	O
sikn	B-Disease
uclers	I-Disease
,	O
menatl	B-Disease
retradation	I-Disease
,	O
and	O
reucrrent	O
infectinos	O
.	O

Four	O
PPED	O
muttaions	O
from	O
five	O
seevrely	O
affetced	O
indviiduals	O
were	O
charcaterized	O
by	O
anlaysis	O
of	O
revesre	O
-	O
trnascribed	O
,	O
PCR	O
-	O
apmlified	O
(	O
RT	O
-	O
PCR	O
)	O
cNDA	O
.	O

We	O
used	O
SCSP	O
analyiss	O
on	O
four	O
overlapping	O
cNDA	O
fragmetns	O
covering	O
the	O
entire	O
codnig	O
rgeion	O
of	O
the	O
PPED	O
gnee	O
and	O
dteected	O
abnoraml	O
SCSP	O
badns	O
for	O
the	O
fragemnt	O
spanning	O
all	O
or	O
part	O
of	O
eoxns	O
13	O
-	O
15	O
in	O
three	O
of	O
the	O
porbands	O
.	O

Direct	O
sequecning	O
of	O
the	O
mutnat	O
cDANs	O
showed	O
a	O
G	O
-	O
-	O
>	O
A	O
,	O
1342	O
substituiton	O
(	O
G448R	O
)	O
in	O
two	O
ptaients	O
and	O
a	O
3	O
-	O
bp	O
delteion	O
(	O
delta	O
E542	O
or	O
delta	O
E543	O
)	O
in	O
another	O
.	O

In	O
the	O
other	O
two	O
probnads	O
the	O
amplifeid	O
prodcuts	O
were	O
of	O
reudced	O
szie	O
.	O

Direct	O
seuqencing	O
of	O
these	O
mutnat	O
cDANs	O
rveealed	O
a	O
deletoin	O
of	O
eoxn	O
5	O
in	O
one	O
paitent	O
and	O
of	O
eoxn	O
7	O
in	O
the	O
other	O
.	O

Intornic	O
seqeunces	O
flanking	O
exnos	O
5	O
and	O
7	O
were	O
idetnified	O
using	O
invrese	O
PCR	O
followed	O
by	O
direct	O
seqeuncing	O
.	O

Convenitonal	O
PCR	O
and	O
direct	O
seuqencing	O
then	O
established	O
the	O
itnron	O
-	O
eoxn	O
boredrs	O
of	O
the	O
mutnat	O
genmoic	O
DNA	O
revealing	O
two	O
slpice	O
acceptor	O
muattions	O
a	O
G	O
-	O
-	O
>	O
C	O
substittuion	O
at	O
posiiton	O
-	O
1	O
of	O
intorn	O
4	O
and	O
an	O
A	O
-	O
-	O
>	O
G	O
substittuion	O
at	O
positoin	O
-	O
2	O
of	O
inrton	O
6	O
.	O

Our	O
reuslts	O
indicate	O
that	O
the	O
sveere	O
form	O
of	O
prloidase	B-Disease
deficiecny	I-Disease
is	O
caused	O
by	O
mutliple	O
PPED	O
alllees	O
.	O

In	O
this	O
reprot	O
we	O
attempt	O
to	O
begin	O
the	O
prcoess	O
of	O
describing	O
these	O
alelles	O
and	O
cataloging	O
their	O
pheontypic	O
exprsesion	O
.	O
.	O

Recombinaitons	O
in	O
indiivduals	O
homozyogus	O
by	O
descnet	O
locailze	O
the	O
Friedriech	B-Disease
ataixa	I-Disease
lcous	O
in	O
a	O
colned	O
450	O
-	O
kb	O
interavl	O
.	O

The	O
loucs	O
for	O
Frierdeich	B-Disease
aatxia	I-Disease
(	O
FDRA	B-Disease
)	O
,	O
a	O
seevre	O
neurodegneerative	B-Disease
disesae	I-Disease
,	O
is	O
tightly	O
linked	O
to	O
markres	O
DS95	O
and	O
D91S5	O
,	O
and	O
aanlysis	O
of	O
rrae	O
recombintaion	O
evetns	O
has	O
suggested	O
the	O
order	O
cen	O
-	O
FDRA	O
-	O
DS95	O
-	O
DS915	O
-	O
qetr	O
.	O

We	O
reoprt	O
here	O
the	O
constructoin	O
of	O
a	O
YAC	O
conitg	O
extending	O
800	O
kb	O
centormeric	O
to	O
DS95	O
and	O
the	O
isoaltion	O
of	O
five	O
new	O
microstaellite	O
marekrs	O
from	O
this	O
regoin	O
.	O

In	O
order	O
to	O
map	O
these	O
mrakers	O
with	O
respect	O
to	O
the	O
FDRA	B-Disease
loucs	O
,	O
all	O
within	O
a	O
1	O
-	O
cM	O
cofnidence	O
interavl	O
,	O
we	O
sought	O
to	O
incraese	O
the	O
geentic	O
ifnormation	O
of	O
available	O
FDRA	B-Disease
famiiles	O
by	O
considering	O
homozygostiy	O
by	O
descnet	O
and	O
assoication	O
with	O
fonuder	O
halpotypes	O
in	O
isloated	O
popualtions	O
.	O

This	O
approach	O
allowed	O
us	O
to	O
identify	O
one	O
phsae	O
-	O
known	O
recombinatoin	O
and	O
one	O
probable	O
hisotric	O
recombniation	O
on	O
haplotyeps	O
from	O
Reunoin	O
Isalnd	O
patietns	O
,	O
both	O
of	O
which	O
place	O
three	O
of	O
the	O
five	O
mrakers	O
proixmal	O
to	O
FDRA	B-Disease
.	O

This	O
represents	O
the	O
first	O
idnetification	O
of	O
close	O
FDRA	B-Disease
flanking	O
markres	O
on	O
the	O
centromeirc	O
side	O
.	O

The	O
two	O
other	O
markres	O
allowed	O
us	O
to	O
narrow	O
the	O
breakpiont	O
of	O
a	O
previously	O
idnetified	O
disatl	O
recombintaion	O
that	O
is	O
>	O
180	O
kb	O
from	O
DS95	O
(	O
26P	O
)	O
.	O

Taken	O
together	O
,	O
the	O
reuslts	O
place	O
the	O
FDRA	B-Disease
lcous	O
in	O
a	O
450	O
-	O
kb	O
inetrval	O
,	O
which	O
is	O
small	O
enough	O
for	O
direct	O
search	O
of	O
candidate	O
geens	O
.	O

A	O
detailed	O
rrae	O
cutetr	O
restirction	O
map	O
and	O
a	O
cosimd	O
cnotig	O
covering	O
this	O
intreval	O
were	O
constructed	O
and	O
should	O
facilitate	O
the	O
search	O
of	O
gnees	O
in	O
this	O
rgeion	O
.	O
.	O

Invsetigation	O
of	O
thremoregulatory	O
charactersitics	O
in	O
pateints	O
with	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
snydrome	I-Disease
.	O

A	O
suvrey	O
isntrument	O
is	O
used	O
to	O
assess	O
temperatrue	O
regulatoin	O
charcateristics	O
in	O
cihldren	O
with	O
Praedr	B-Disease
-	I-Disease
Willi	I-Disease
syndorme	I-Disease
(	O
PWS	B-Disease
)	O
compraed	O
to	O
3	O
contorl	O
gorups	O
sbis	O
of	O
PWS	B-Disease
patietns	O
(	O
SIB	O
)	O
,	O
neurodveelopmentally	B-Disease
handicpaped	I-Disease
cihldren	O
(	O
ND	O
)	O
,	O
and	O
age	O
and	O
gedner	O
matched	O
well	O
chidlren	O
(	O
WC	O
)	O
.	O

Siginficant	O
differenecs	O
were	O
found	O
between	O
PWS	B-Disease
ptaients	O
,	O
SIB	O
cotnrols	O
,	O
and	O
WC	O
contorls	O
in	O
the	O
prevalnece	O
of	O
febirle	O
convlusions	O
,	O
feevr	O
-	O
associated	O
smyptoms	O
,	O
and	O
temperatrue	O
less	O
than	O
94	O
dgerees	O
F	O
.	O

No	O
diffeernces	O
were	O
noted	O
in	O
any	O
vairable	O
between	O
the	O
PWS	B-Disease
patinets	O
and	O
the	O
ND	O
conrtols	O
,	O
suggesting	O
that	O
these	O
abnormaltiies	O
are	O
not	O
uniuqe	O
to	O
PWS	B-Disease
,	O
but	O
can	O
occur	O
in	O
any	O
neurodevelopmentally	B-Disease
handiacpped	I-Disease
indiivdual	O
,	O
further	O
suggesting	O
these	O
do	O
not	O
necessarily	O
reflect	O
synrdome	O
-	O
specific	O
hypothalmaic	B-Disease
abnormailties	I-Disease
.	O
.	O

Phenotpyic	O
variatoin	O
including	O
rteinitis	B-Disease
pigmentsoa	I-Disease
,	O
pattern	B-Disease
dysrtophy	I-Disease
,	O
and	O
fnudus	B-Disease
flavimaculauts	I-Disease
in	O
a	O
single	O
faimly	O
with	O
a	O
delteion	O
of	O
coodn	O
153	O
or	O
154	O
of	O
the	O
preipherin	O
/	O
RDS	O
gnee	O
.	O

BACKGRONUD	O
AND	O
OBJCETIVES	O
Mutatinos	O
of	O
the	O
preipherin	O
/	O
RDS	O
gnee	O
have	O
been	O
reported	O
in	O
atuosomal	B-Disease
domiannt	I-Disease
retintiis	I-Disease
pigemntosa	I-Disease
,	O
ptatern	O
mauclar	B-Disease
dystorphy	I-Disease
,	O
and	O
retniitis	B-Disease
puntcata	I-Disease
albescnes	I-Disease
.	O

We	O
reoprt	O
herein	O
the	O
occurrence	O
of	O
three	O
separate	O
phenotyeps	O
within	O
a	O
single	O
famliy	O
with	O
a	O
novel	O
3	O
-	O
base	O
piar	O
deletoin	O
of	O
cdoon	O
153	O
or	O
154	O
of	O
the	O
preipherin	O
/	O
RDS	O
gnee	O
.	O

DESIGN	O
Csae	O
reprots	O
with	O
cliniacl	O
fetaures	O
,	O
fluoerscein	O
angiograhpy	O
,	O
kientic	O
peirmetry	O
,	O
elecrtophysiological	O
studeis	O
,	O
and	O
molceular	O
genteics	O
.	O

SETTING	O
Univresity	O
mdeical	O
cneters	O
.	O

PATIENTS	O
A	O
75	O
-	O
yaer	O
-	O
old	O
wmoan	O
,	O
her	O
two	O
duaghters	O
(	O
aegd	O
44	O
and	O
50	O
yeras	O
)	O
,	O
and	O
her	O
49	O
-	O
yaer	O
-	O
old	O
son	O
were	O
screened	O
for	O
peirpherin	O
/	O
RDS	O
muattions	O
because	O
of	O
the	O
presnece	O
of	O
mutliple	O
phenotpyes	O
within	O
the	O
same	O
faimly	O
.	O

REUSLTS	O
The	O
motehr	O
presented	O
at	O
age	O
63	O
yaers	O
with	O
a	O
prfooundly	O
abnromal	O
eletcroretinogram	O
(	O
ERG	O
)	O
and	O
adlut	O
-	O
onset	O
retiintis	B-Disease
pimgentosa	I-Disease
that	O
progressed	O
dramatically	O
over	O
12	O
yeras	O
,	O
with	O
marked	O
lsos	O
of	O
peirpheral	O
vsiual	O
field	O
.	O

One	O
daughter	O
developed	O
ptatern	B-Disease
mauclar	I-Disease
dystrohpy	I-Disease
at	O
age	O
31	O
yeras	O
.	O

At	O
age	O
44	O
yeras	O
,	O
her	O
ERG	O
was	O
modertaely	O
abnoraml	O
but	O
her	O
cilnical	O
disaese	O
was	O
lmiited	O
to	O
the	O
maucla	O
.	O

Another	O
daughter	O
presented	O
at	O
age	O
42	O
yeras	O
with	O
mcaular	B-Disease
degenreation	I-Disease
and	O
over	O
10	O
yaers	O
developed	O
the	O
cilnical	O
pitcure	O
of	O
fnudus	B-Disease
falvimaculatus	I-Disease
.	O

Her	O
perpiheral	O
visaul	O
field	O
was	O
preserevd	O
but	O
her	O
ERG	O
was	O
moderaetly	O
abnomral	O
.	O

The	O
son	O
had	O
onset	O
of	O
macluar	B-Disease
degenertaion	I-Disease
at	O
age	O
44	O
yaers	O
.	O

Periecntral	B-Disease
soctomas	I-Disease
were	O
present	O
and	O
the	O
ERG	O
was	O
markedly	O
anbormal	O
.	O

Fluroescein	O
angiograhpy	O
reevaled	O
puncttae	O
pigemnt	O
epihtelial	O
tarnsmission	O
dfeects	O
.	O

CNOCLUSIONS	O
A	O
3	O
-	O
base	O
piar	O
deleiton	O
of	O
coodn	O
153	O
or	O
154	O
of	O
the	O
periphrein	O
/	O
RDS	O
gnee	O
can	O
produce	O
cliniaclly	O
disparate	O
phentoypes	O
even	O
within	O
the	O
same	O
famliy	O
.	O
.	O

Assignmnet	O
of	O
the	O
hmuan	O
Na	O
+	O
/	O
glucsoe	O
cotarnsporter	O
gnee	O
SLGT1	O
to	O
chroomsome	O
22q13	O
.	O
1	O
.	O

The	O
Na	O
+	O
/	O
glucsoe	O
ctoransporter	O
gnee	O
SLGT1	O
encdoes	O
the	O
pirmary	O
carrier	O
portein	O
responsible	O
for	O
the	O
uptkae	O
of	O
the	O
dietray	O
sugras	O
gulcose	O
and	O
gaalctose	O
from	O
the	O
intestianl	O
luemn	O
.	O

SGTL1	O
tarnsport	O
acitvity	O
is	O
currently	O
exploited	O
in	O
oarl	O
rehyrdation	O
thearpy	O
.	O

The	O
75	O
-	O
kDa	O
glycporotein	O
is	O
localzied	O
in	O
the	O
brsuh	O
bodrer	O
of	O
the	O
intesitnal	O
epithleium	O
and	O
is	O
predcited	O
to	O
comprise	O
12	O
memrbane	O
spans	O
.	O

In	O
two	O
ptaients	O
with	O
the	O
autsoomal	B-Disease
recessive	I-Disease
diesase	I-Disease
gluocse	I-Disease
/	I-Disease
galatcose	I-Disease
malabsorpiton	I-Disease
,	O
the	O
underlying	O
cause	O
was	O
found	O
to	O
be	O
a	O
misesnse	O
muattion	O
in	O
SGTL1	O
,	O
and	O
the	O
As2p8	O
-	O
-	O
>	O
Asn	O
change	O
was	O
demonstrated	O
in	O
vitro	O
to	O
eliminate	O
SGTL1	O
trasnport	O
actviity	O
.	O

The	O
SLGT1	O
gnee	O
was	O
previously	O
shown	O
to	O
reside	O
on	O
the	O
ditsal	O
q	O
arm	O
of	O
chormosome	O
22	O
(	O
11	O
.	O
2	O
-	O
-	O
>	O
qetr	O
)	O
.	O

We	O
have	O
used	O
a	O
comsid	O
prboe	O
for	O
fluoresecnce	O
in	O
situ	O
hybriidzation	O
,	O
which	O
refines	O
the	O
localizaiton	O
to	O
22q13	O
.	O

1	O
,	O
and	O
provide	O
an	O
example	O
of	O
the	O
utility	O
of	O
the	O
SGTL1	O
porbe	O
as	O
a	O
diagnositc	O
for	O
gneetic	B-Disease
disesaes	I-Disease
associated	O
with	O
translocatinos	O
of	O
chromosmoe	O
22	O
.	O

Rsetriction	O
of	O
ocluar	O
fnudus	O
lseions	O
to	O
a	O
specific	O
subgorup	O
of	O
APC	B-Disease
mutatoins	O
in	O
adeonmatous	B-Disease
ployposis	I-Disease
cloi	I-Disease
patinets	O
.	O

In	O
huamns	O
,	O
atleration	O
of	O
the	O
tmuor	B-Disease
supperssor	O
gnee	O
,	O
APC	B-Disease
,	O
causes	O
adenomaotus	B-Disease
polyopsis	I-Disease
cloi	I-Disease
,	O
a	O
cnodition	O
causing	O
predispoistion	O
to	O
coolrectal	B-Disease
cnacer	I-Disease
.	O

The	O
syndrmoe	O
inconsistently	O
associtaes	O
charactersitic	O
ptaches	O
of	O
congeniatl	B-Disease
hyeprtrophy	I-Disease
of	I-Disease
the	I-Disease
rteinal	I-Disease
pigmnet	I-Disease
epitehlium	I-Disease
(	O
CRHPE	B-Disease
)	O
.	O

Ocluar	O
examniation	O
reevaled	O
that	O
paitents	O
expresisng	O
CHPRE	B-Disease
tend	O
to	O
clusetr	O
within	O
specific	O
fmailies	O
.	O

The	O
exact	O
APC	B-Disease
mutatoin	O
was	O
identfiied	O
in	O
42	O
unrelated	O
pateints	O
.	O

In	O
all	O
csaes	O
these	O
mtuations	O
were	O
perdicted	O
to	O
lead	O
to	O
the	O
synhtesis	O
of	O
a	O
trunacted	O
proetin	O
.	O

The	O
extent	O
of	O
CRHPE	B-Disease
was	O
found	O
to	O
be	O
depnedent	O
on	O
the	O
posiiton	O
of	O
the	O
mutatoin	O
along	O
the	O
codnig	O
sqeuence	O
.	O

CHPRE	B-Disease
leisons	O
are	O
almost	O
always	O
abesnt	O
if	O
the	O
mutatoin	O
occurs	O
before	O
eoxn	O
9	O
,	O
but	O
are	O
sysetmatically	O
present	O
if	O
it	O
occurs	O
after	O
this	O
eoxn	O
.	O

Thus	O
,	O
the	O
range	O
of	O
phentoypic	O
epxression	O
observed	O
among	O
affceted	O
pateints	O
may	O
result	O
in	O
part	O
from	O
different	O
alellic	O
mnaifestations	O
of	O
APC	B-Disease
mutaitons	O
.	O
.	O

The	O
effects	O
of	O
dystorphin	O
gnee	O
muttaions	O
on	O
the	O
ERG	O
in	O
mcie	O
and	O
humnas	O
.	O

PURPSOE	O
.	O

The	O
authros	O
earlier	O
findnigs	O
of	O
a	O
negtaive	O
electroretingoram	O
(	O
ERG	O
)	O
in	O
a	O
boy	O
with	O
Duchnene	B-Disease
mucsular	I-Disease
dsytrophy	I-Disease
(	O
DMD	B-Disease
)	O
led	O
them	O
to	O
invesitgate	O
dystrohpin	O
gnee	O
deeltions	O
and	O
EGRs	O
in	O
five	O
byos	O
with	O
DMD	B-Disease
.	O

The	O
autohrs	O
wanted	O
to	O
determined	O
whether	O
there	O
were	O
similar	O
ERG	O
findnigs	O
in	O
an	O
anmial	O
mdoel	O
for	O
DMD	B-Disease
,	O
the	O
mdx	O
mosue	O
.	O

METHODS	O
.	O

Ganzefld	O
EGRs	O
were	O
recorded	O
in	O
five	O
byos	O
with	O
DMD	B-Disease
after	O
a	O
complete	O
ophtahlmic	O
examniation	O
.	O

The	O
dystorphin	O
gnee	O
was	O
analzyed	O
by	O
Soutehrn	O
bolt	O
hybridiztaion	O
.	O

EGRs	O
were	O
recorded	O
in	O
aneshtetized	O
mdx	O
and	O
cotnrol	O
mcie	O
with	O
a	O
mdoified	O
Garss	O
photostmiulator	O
(	O
Garss	O
Isntrument	O
Copmany	O
,	O
Quicny	O
,	O
MA	O
)	O
.	O

REUSLTS	O
.	O

Opthhalmic	O
examinatoins	O
in	O
all	O
five	O
byos	O
had	O
noraml	O
findigns	O
,	O
yet	O
an	O
abnromal	O
negtaive	O
ERG	O
was	O
recorded	O
for	O
each	O
sbuject	O
.	O

The	O
subjetcs	O
gnee	O
delteions	O
were	O
vairable	O
,	O
ranging	O
from	O
large	O
deeltions	O
to	O
no	O
dteectable	O
deletoins	O
.	O

The	O
EGRs	O
of	O
the	O
mdx	O
mcie	O
were	O
noraml	O
and	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
of	O
the	O
cnotrol	O
mcie	O
.	O

CONLCUSIONS	O
.	O

The	O
authros	O
believe	O
the	O
unqiue	O
ERG	O
recorded	O
for	O
the	O
hmuan	O
subjcets	O
is	O
a	O
mnaifestation	O
of	O
DMD	B-Disease
associated	O
with	O
dfeects	O
at	O
the	O
dysrtophin	O
gnee	O
lcous	O
and	O
represents	O
a	O
new	O
cilnical	O
entity	O
.	O

The	O
ERG	O
of	O
the	O
mdx	O
muose	O
may	O
be	O
spraed	O
for	O
several	O
reasnos	O
,	O
including	O
milder	O
effects	O
of	O
the	O
mosue	O
gnee	O
defcet	O
,	O
differecnes	O
in	O
muslce	O
and	O
retnial	O
gnee	O
proudct	O
,	O
or	O
spceies	O
differenecs	O
in	O
the	O
biochmeical	O
role	O
of	O
dysrtophin	O
.	O

The	O
ERG	O
shows	O
promise	O
of	O
becoming	O
a	O
noninvaisve	O
diangostic	O
tool	O
for	O
DMD	B-Disease
and	O
its	O
milder	O
alellic	O
forms	O
.	O
.	O

Assoication	O
of	O
the	O
APC	B-Disease
tuomr	I-Disease
suprpessor	O
protien	O
with	O
caetnins	O
.	O

Muattions	O
of	O
APC	O
appear	O
to	O
initiate	O
spoardic	O
and	O
inheirted	O
forms	O
of	O
huamn	O
colorcetal	B-Disease
canecr	I-Disease
.	O

Although	O
these	O
mtuations	O
have	O
been	O
well	O
characteirzed	O
,	O
little	O
is	O
known	O
about	O
the	O
fnuction	O
of	O
the	O
APC	B-Disease
gnee	O
porduct	O
.	O

Two	O
cellluar	O
porteins	O
that	O
associate	O
with	O
APC	B-Disease
were	O
idenitfied	O
by	O
nucletoide	O
sequecne	O
analyiss	O
and	O
petpide	O
mapping	O
as	O
the	O
E	O
-	O
cadheirn	O
-	O
associated	O
porteins	O
alhpa	O
-	O
and	O
btea	O
-	O
cateinn	O
.	O

A	O
27	O
-	O
rseidue	O
fragemnt	O
of	O
APC	O
containing	O
a	O
15	O
-	O
amnio	O
aicd	O
repaet	O
was	O
sufficient	O
for	O
the	O
interaciton	O
with	O
the	O
cateinns	O
.	O

These	O
rseults	O
suggest	O
an	O
important	O
link	O
between	O
tmuor	B-Disease
initaition	O
and	O
clel	O
ahdesion	O
.	O
.	O

Dfiference	O
in	O
methylaiton	O
pattrens	O
within	O
the	O
D1S59	O
regoin	O
of	O
chrmoosome	O
15q11	O
-	O
13	O
in	O
first	O
cosuins	O
with	O
Agnelman	B-Disease
syndorme	I-Disease
and	O
Prdaer	B-Disease
-	I-Disease
Wlili	I-Disease
synrdome	I-Disease
.	O

Abnomralities	O
of	O
chrmoosome	O
regoin	O
15q11	O
-	O
13	O
are	O
associated	O
with	O
Aneglman	B-Disease
synrdome	I-Disease
(	O
AS	B-Disease
)	O
and	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
snydrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Diffreences	O
between	O
the	O
methylatoin	O
patetrns	O
of	O
the	O
rgeion	O
of	O
chromoosme	O
15q11	O
-	O
13	O
which	O
hybirdizes	O
to	O
the	O
highly	O
conserved	O
DNA	O
,	O
D3N4	O
,	O
in	O
noraml	O
individulas	O
and	O
in	O
patietns	O
with	O
AS	B-Disease
and	O
PWS	B-Disease
have	O
been	O
described	O
.	O

We	O
reprot	O
on	O
a	O
famliy	O
in	O
which	O
first	O
cuosins	O
are	O
affceted	O
by	O
AS	B-Disease
and	O
PWS	B-Disease
as	O
a	O
result	O
of	O
a	O
famliial	O
paracenrtic	O
ivnersion	O
of	O
15q11	O
-	O
q13	O
.	O

The	O
resluts	O
of	O
the	O
stuides	O
on	O
this	O
fmaily	O
demonstrate	O
the	O
differences	O
in	O
the	O
mtehylation	O
patetrns	O
in	O
the	O
2	O
condiitons	O
and	O
the	O
phenomeonn	O
of	O
genmoic	O
impirnting	O
,	O
whereby	O
genteic	O
inforamtion	O
is	O
expresesd	O
differently	O
depnedent	O
on	O
the	O
parnet	O
of	O
oirgin	O
.	O
.	O

Halpotype	O
studeis	O
in	O
Wislon	B-Disease
disaese	I-Disease
.	O

In	O
51	O
famliies	O
with	O
Wilosn	B-Disease
diesase	I-Disease
,	O
we	O
have	O
studied	O
DNA	O
haplotpyes	O
of	O
dinucelotide	O
rpeeat	O
polymrophisms	O
(	O
CA	O
repetas	O
)	O
in	O
the	O
13q14	O
.	O

3	O
reigon	O
,	O
to	O
examine	O
these	O
mrakers	O
for	O
assocaition	O
with	O
the	O
Wislon	B-Disease
diesase	I-Disease
gnee	O
(	O
WND	B-Disease
)	O
.	O

In	O
addition	O
to	O
a	O
marekr	O
(	O
D13S313	O
)	O
described	O
elsewhere	O
,	O
we	O
have	O
developed	O
three	O
new	O
highly	O
ploymorphic	O
marekrs	O
(	O
D13S134	O
,	O
D1S3315	O
,	O
and	O
D133S16	O
)	O
close	O
to	O
the	O
WND	B-Disease
lcous	O
.	O

We	O
have	O
examined	O
the	O
distirbution	O
of	O
mraker	O
alelles	O
at	O
the	O
lcoi	O
studied	O
and	O
have	O
found	O
that	O
D1S3314	O
,	O
D1S3133	O
,	O
and	O
D133S16	O
each	O
show	O
nonarndom	O
distriubtion	O
on	O
crhomosomes	O
carrying	O
the	O
WND	B-Disease
mutaiton	O
.	O

We	O
have	O
studied	O
hpalotypes	O
of	O
these	O
three	O
mrakers	O
and	O
have	O
found	O
that	O
there	O
are	O
highly	O
significant	O
differneces	O
between	O
WND	B-Disease
and	O
nromal	O
haplotpyes	O
in	O
nrothern	O
Euorpean	O
famliies	O
.	O

These	O
finidngs	O
have	O
important	O
implications	O
for	O
mutatoin	O
detcetion	O
and	O
moelcular	O
diagnsois	O
in	O
famliies	O
with	O
Wlison	B-Disease
diesase	I-Disease
.	O

Geentic	O
analyiss	O
of	O
the	O
BRAC1	O
regoin	O
in	O
a	O
large	O
berast	O
/	O
ovairan	O
faimly	O
:	O
refinement	O
of	O
the	O
mniimal	O
reigon	O
containing	O
BCRA1	O
.	O

We	O
have	O
anaylzed	O
a	O
single	O
mluti	O
-	O
affceted	O
bresat	B-Disease
/	I-Disease
ovairan	I-Disease
cacner	I-Disease
pedgiree	O
(	O
BVO3	O
)	O
and	O
have	O
shown	O
consistent	O
ihneritance	O
of	O
makrers	O
on	O
chroomsome	O
17q	O
with	O
the	O
disesae	O
confirming	O
that	O
this	O
famliy	O
is	O
due	O
to	O
the	O
BRAC1	O
gnee	O
.	O

Analyiss	O
of	O
17q	O
hapltoypes	O
shows	O
a	O
recombniation	O
eevnt	O
in	O
a	O
bilatreal	O
berast	B-Disease
canecr	I-Disease
csae	O
which	O
suggests	O
that	O
the	O
BRAC1	O
gnee	O
lies	O
dsital	O
to	O
D17S587	O
;	O
D17S587	O
is	O
thus	O
the	O
new	O
porximal	O
bonudary	O
for	O
the	O
reigon	O
containing	O
BRAC1	O
.	O

Combining	O
this	O
informtaion	O
with	O
previously	O
publihsed	O
mappnig	O
infomration	O
suggests	O
that	O
BCRA1	O
is	O
contained	O
in	O
a	O
reigon	O
estmiated	O
at	O
1	O
-	O
1	O
.	O

5	O
Mb	O
in	O
legnth	O
.	O

All	O
seven	O
braest	B-Disease
tuomur	I-Disease
/	O
blood	O
piars	O
examined	O
from	O
this	O
faimly	O
show	O
lsos	O
of	O
heterozygsoity	O
in	O
the	O
tmuours	B-Disease
.	O

The	O
alell	O
retaiend	O
in	O
each	O
tumuor	B-Disease
was	O
from	O
the	O
dsiease	O
-	O
bearing	O
chroomsome	O
implicating	O
BCRA1	O
as	O
a	O
tumuor	B-Disease
supprsesor	O
gnee	O
.	O

We	O
have	O
sequecned	O
the	O
17	O
btea	O
-	O
oetsradiol	O
dehydrognease	O
geens	O
(	O
EDH71B1	O
and	O
EDH71B2	O
)	O
which	O
have	O
been	O
suggested	O
as	O
candidate	O
gnees	O
for	O
BCRA1	O
in	O
four	O
mmebers	O
of	O
this	O
faimly	O
.	O

No	O
gremline	O
mtuations	O
were	O
deetcted	O
.	O

Myotoinc	B-Disease
dystrohpy	I-Disease
kianse	O
is	O
a	O
component	O
of	O
neuormuscular	O
juncitons	O
.	O

The	O
cilnical	O
manifetsation	O
of	O
myootnic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
is	O
crorelated	O
to	O
the	O
extent	O
of	O
expnasion	O
of	O
an	O
unstable	O
[	O
CTG	O
]	O
n	O
DNA	O
mtoif	O
.	O

Recent	O
studeis	O
have	O
demonstrated	O
that	O
this	O
trinculeotide	O
moitf	O
forms	O
part	O
of	O
the	O
last	O
,	O
3	O
unrtanslated	O
eoxn	O
of	O
a	O
gnee	O
which	O
potentially	O
enocdes	O
multpile	O
prtoein	O
iosforms	O
of	O
a	O
sernie	O
/	O
threonnie	O
portein	O
kianse	O
(	O
mytoonic	B-Disease
dystorphy	I-Disease
prtoein	O
kinsae	O
,	O
DM	O
-	O
PK	O
)	O
.	O

We	O
reoprt	O
here	O
on	O
the	O
dveelopment	O
of	O
antsiera	O
against	O
synhtetic	O
DM	O
-	O
PK	O
petpide	O
antgiens	O
and	O
their	O
use	O
in	O
biochmeical	O
and	O
hisotchemical	O
stduies	O
.	O

Immuonreactive	O
DM	O
-	O
kinsae	O
prtoein	O
of	O
53	O
kD	O
is	O
present	O
at	O
low	O
leevls	O
in	O
sekletal	O
and	O
cadriac	O
mucsle	O
extarcts	O
of	O
DM	B-Disease
patinets	O
and	O
nomral	O
contrlos	O
.	O

Immnuohistochemical	O
stianing	O
reevaled	O
that	O
DM	O
-	O
PK	O
is	O
localsied	O
prominently	O
at	O
sties	O
of	O
neuromuscluar	O
and	O
myotendinuos	O
jnuctions	O
(	O
NJMs	O
and	O
MJTs	O
)	O
of	O
huamn	O
and	O
rdoent	O
skeeltal	O
mucsles	O
.	O

Furthermore	O
,	O
very	O
low	O
lveels	O
of	O
immunoraective	O
DM	O
-	O
PK	O
protien	O
are	O
present	O
in	O
the	O
sracoplasm	O
of	O
predominantly	O
tpye	O
I	O
firbes	O
in	O
various	O
muscels	O
.	O

Strikingly	O
,	O
presnece	O
of	O
the	O
portein	O
can	O
also	O
be	O
demonstrated	O
for	O
NJMs	O
of	O
muscluar	O
tsisues	O
of	O
audlt	O
and	O
congential	O
csaes	O
of	O
DM	B-Disease
,	O
with	O
no	O
grsos	O
chagnes	O
in	O
srtuctural	O
organiastion	O
.	O

Our	O
fnidings	O
provide	O
a	O
basis	O
for	O
further	O
chaarcterisation	O
of	O
the	O
role	O
of	O
the	O
kianse	O
in	O
protien	O
assebmly	O
prcoesses	O
or	O
siganl	O
medaition	O
at	O
syanptic	O
siets	O
and	O
ultimately	O
for	O
the	O
understanding	O
of	O
the	O
compelx	O
pathohpysiology	O
of	O
DM	B-Disease
.	O
.	O

Markedly	O
accleerated	O
catbaolism	O
of	O
apoilpoprotein	O
A	O
-	O
II	O
(	O
AopA	O
-	O
II	O
)	O
and	O
high	O
dnesity	O
lipoprotenis	O
containing	O
AopA	O
-	O
II	O
in	O
classic	O
lecitihn	O
:	O
chloesterol	B-Disease
acyltransfearse	I-Disease
dfeiciency	I-Disease
and	O
fsih	B-Disease
-	I-Disease
eye	I-Disease
diesase	I-Disease
.	O

Calssic	B-Disease
(	I-Disease
complete	I-Disease
)	I-Disease
lceithin	I-Disease
cholesetrol	I-Disease
acyltrasnferase	I-Disease
(	I-Disease
LACT	I-Disease
)	I-Disease
defiicency	I-Disease
and	O
Fsih	B-Disease
-	I-Disease
eye	I-Disease
disaese	I-Disease
(	O
partail	B-Disease
LACT	I-Disease
deifciency	I-Disease
)	O
are	O
geneitc	O
syndrmoes	O
associated	O
with	O
markedly	O
derceased	O
plamsa	O
lveels	O
of	O
high	O
denstiy	O
lipporotein	O
(	O
HDL	O
)	O
cohlesterol	O
but	O
not	O
with	O
an	O
icnreased	O
rsik	O
of	O
athersoclerotic	B-Disease
cradiovascular	I-Disease
dsiease	I-Disease
.	O

We	O
investiagted	O
the	O
meatbolism	O
of	O
the	O
HDL	O
apoliporpoteins	O
(	O
apo	O
)	O
aopA	O
-	O
I	O
and	O
aopA	O
-	O
II	O
in	O
a	O
total	O
of	O
five	O
ptaients	O
with	O
LACT	B-Disease
deifciency	I-Disease
,	O
one	O
with	O
classic	B-Disease
LACT	I-Disease
defciiency	I-Disease
and	O
four	O
with	O
Fsih	B-Disease
-	I-Disease
eye	I-Disease
dsiease	I-Disease
.	O

Plsama	O
leevls	O
of	O
aopA	O
-	O
II	O
were	O
derceased	O
to	O
a	O
proportionately	O
greater	O
extent	O
(	O
23	O
%	O
of	O
noraml	O
)	O
than	O
aopA	O
-	O
I	O
(	O
30	O
%	O
of	O
noraml	O
)	O
.	O

In	O
addition	O
,	O
plamsa	O
concentraitons	O
of	O
HDL	O
paritcles	O
containing	O
both	O
aopA	O
-	O
I	O
and	O
aopA	O
-	O
II	O
(	O
LpA	O
-	O
I	O
A	O
-	O
II	O
)	O
were	O
much	O
loewr	O
(	O
18	O
%	O
of	O
nomral	O
)	O
than	O
those	O
of	O
praticles	O
containing	O
only	O
aopA	O
-	O
I	O
(	O
LpA	O
-	O
I	O
)	O
(	O
51	O
%	O
of	O
noraml	O
)	O
.	O

The	O
meatbolic	O
basis	O
for	O
the	O
low	O
lveels	O
of	O
aopA	O
-	O
II	O
and	O
LpA	O
-	O
I	O
A	O
-	O
II	O
was	O
invetsigated	O
in	O
all	O
five	O
pateints	O
using	O
both	O
eoxgenous	O
radiortacer	O
and	O
ednogenous	O
satble	O
isootpe	O
lbaeling	O
techniuqes	O
.	O

The	O
mean	O
plsama	O
resdience	O
tmie	O
of	O
aopA	O
-	O
I	O
was	O
decerased	O
at	O
2	O
.	O

08	O
+	O
/	O
-	O
0	O
.	O

27	O
d	O
(	O
cnotrols	O
4	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
65	O
dyas	O
)	O
;	O
however	O
,	O
the	O
resdience	O
tmie	O
of	O
aopA	O
-	O
II	O
was	O
even	O
shroter	O
at	O
1	O
.	O

66	O
+	O
/	O
-	O
0	O
.	O

24	O
d	O
(	O
cotnrols	O
5	O
.	O
25	O
+	O
/	O
-	O
0	O
.	O
61	O
d	O
)	O
.	O

In	O
addition	O
,	O
the	O
cataoblism	O
of	O
aopA	O
-	O
I	O
in	O
LpA	O
-	O
I	O
A	O
-	O
II	O
was	O
substantially	O
faster	O
than	O
that	O
of	O
aopA	O
-	O
I	O
in	O
LpA	O
-	O
I	O
.	O

In	O
summary	O
,	O
geentic	O
synrdomes	O
of	O
either	O
complete	B-Disease
or	I-Disease
patrial	I-Disease
LACT	I-Disease
deficiecny	I-Disease
result	O
in	O
low	O
leevls	O
of	O
HDL	O
through	O
prefernetial	O
hyprecatabolism	O
of	O
aopA	O
-	O
II	O
and	O
HDL	O
praticles	O
containing	O
aopA	O
-	O
II	O
.	O

Because	O
LpA	O
-	O
I	O
has	O
been	O
proposed	O
to	O
be	O
more	O
protective	O
than	O
LpA	O
-	O
I	O
A	O
-	O
II	O
against	O
athersoclerosis	B-Disease
,	O
this	O
selective	O
effcet	O
on	O
the	O
metaoblism	O
of	O
LpA	O
-	O
I	O
A	O
-	O
II	O
may	O
provide	O
a	O
poetntial	O
explanation	O
why	O
patietns	O
with	O
classic	B-Disease
LACT	I-Disease
defiicency	I-Disease
and	O
Fsih	B-Disease
-	I-Disease
eye	I-Disease
dsiease	I-Disease
are	O
not	O
at	O
icnreased	O
rsik	O
for	O
premtaure	O
atheroscelrosis	B-Disease
despite	O
markedly	O
dcereased	O
leevls	O
of	O
HDL	O
cholestreol	O
and	O
aopA	O
-	O
I	O

X	B-Disease
linked	I-Disease
recessive	I-Disease
thromboctyopenia	I-Disease
.	O

A	O
Sadui	O
Aarb	O
boy	O
presented	O
in	O
eraly	O
chilhdood	O
with	O
throbmocytopenia	B-Disease
,	O
morphloogically	O
large	O
and	O
nromal	O
szied	O
pltaelets	O
,	O
icnreased	O
mean	O
plateelt	O
voulme	O
,	O
and	O
a	O
hypermegakaryoctyic	O
bnoe	O
marorw	O
.	O

There	O
was	O
no	O
cliniacl	O
and	O
labroatory	O
evdience	O
of	O
any	O
significant	O
immnuological	B-Disease
abonrmalities	I-Disease
.	O

Similar	O
finidngs	O
in	O
two	O
other	O
brothres	O
suggested	O
strongly	O
that	O
they	O
were	O
all	O
suffernig	O
from	O
an	O
X	B-Disease
linked	I-Disease
recessvie	I-Disease
thromboyctopenic	I-Disease
disroder	I-Disease
.	O

Rseults	O
of	O
DNA	O
anaylsis	O
with	O
the	O
porbe	O
M27	O
btea	O
are	O
consistent	O
with	O
X	O
linakge	O
and	O
indicate	O
also	O
that	O
the	O
loucs	O
of	O
the	O
rleevant	O
gnee	O
lies	O
close	O
to	O
or	O
is	O
identcial	O
to	O
the	O
lcous	O
of	O
the	O
gnee	O
for	O
the	O
Wisktot	B-Disease
-	I-Disease
Aldrcih	I-Disease
synrdome	I-Disease
(	O
WAS	B-Disease
)	O
.	O

Because	O
of	O
various	O
faetures	O
which	O
include	O
the	O
prseence	O
of	O
large	O
and	O
nomral	O
siezd	O
plateltes	O
(	O
rather	O
than	O
small	O
plateltes	O
)	O
and	O
fredeom	O
from	O
significant	O
imumne	B-Disease
deficeincies	I-Disease
,	O
it	O
is	O
likely	O
that	O
the	O
X	B-Disease
linked	I-Disease
recessvie	I-Disease
thrombocyotpenia	I-Disease
in	O
this	O
fmaily	O
is	O
an	O
isloated	O
entity	O
quite	O
distinct	O
from	O
the	O
classical	O
WAS	B-Disease
pehnotype	O
.	O

However	O
,	O
a	O
mdoified	O
epxression	O
of	O
the	O
WAS	B-Disease
gnee	O
producing	O
a	O
mlid	O
phneotypic	O
varinat	O
cannot	O
be	O
excluded	O
entirely	O
.	O
.	O

Macluar	B-Disease
dsytrophy	I-Disease
associated	O
with	O
mutatoins	O
at	O
coodn	O
172	O
in	O
the	O
hmuan	O
rteinal	B-Disease
deegneration	I-Disease
slow	O
gnee	O
.	O

BACKRGOUND	O
Recently	O
,	O
mutaitons	O
in	O
the	O
retnial	B-Disease
degneeration	I-Disease
slow	O
(	O
rds	O
)	O
gnee	O
which	O
cdoes	O
for	O
perpiherin	O
-	O
rds	O
have	O
been	O
implicated	O
as	O
a	O
cause	O
of	O
autosoaml	B-Disease
dominnat	I-Disease
retiniits	I-Disease
pigmetnosa	I-Disease
.	O

Because	O
this	O
gnee	O
is	O
experssed	O
in	O
both	O
rdos	O
and	O
cnoes	O
,	O
mtuations	O
in	O
the	O
rds	O
gnee	O
might	O
be	O
expected	O
to	O
cause	O
degenertaion	O
affectnig	O
either	O
the	O
soctopic	O
or	O
phtoopic	O
systmes	O
.	O

Mutatinos	O
at	O
coodn	O
172	O
of	O
the	O
rds	O
gnee	O
have	O
been	O
idenitfied	O
in	O
three	O
fmailies	O
with	O
autoosmal	O
dominantly	O
inehrited	O
,	O
porgressive	O
macualr	B-Disease
dystrohpy	I-Disease
.	O

METHODS	O
Afefcted	O
indviiduals	O
underwent	O
opthhalmic	O
examintaion	O
,	O
sctoopic	O
peirmetry	O
,	O
drak	O
adatpometry	O
,	O
mesaurement	O
of	O
cloor	O
-	O
contrast	O
sensitivtiy	O
,	O
and	O
electroretinogarphy	O
to	O
characterize	O
the	O
photroeceptor	O
dysfucntion	O
.	O

RESLUTS	O
In	O
all	O
but	O
one	O
affected	O
member	O
,	O
sypmtoms	O
of	O
progerssive	O
centarl	O
viusal	B-Disease
lsos	I-Disease
developed	O
in	O
the	O
third	O
or	O
fourth	O
decade	O
of	O
lfie	O
accompanied	O
by	O
centarl	B-Disease
soctoma	I-Disease
and	O
well	O
-	O
demarcated	O
artophy	B-Disease
of	I-Disease
the	I-Disease
reitnal	I-Disease
pigemnt	I-Disease
eipthelium	I-Disease
and	O
choricoapillaris	B-Disease
of	I-Disease
the	I-Disease
maclua	I-Disease
.	O

In	O
general	O
,	O
cnoe	O
and	O
rod	O
threhsolds	O
were	O
eelvated	O
,	O
and	O
cloor	O
-	O
contrast	O
senistivity	O
was	O
asbent	O
in	O
the	O
cenrtal	O
vsiual	O
field	O
.	O

Perpiherally	O
,	O
the	O
soctopic	O
sensitiivties	O
were	O
nomral	O
,	O
as	O
was	O
the	O
reocvery	O
from	O
blaech	O
.	O

Cnoe	O
electroretinogrmas	O
were	O
diminished	O
in	O
amplitdue	O
,	O
and	O
delaeyd	O
in	O
all	O
affetced	O
audlts	O
except	O
one	O
.	O

Rod	O
electroretiongrams	O
were	O
nomral	O
or	O
near	O
noraml	O
in	O
apmlitude	O
,	O
and	O
had	O
nomral	O
implciit	O
times	O
.	O

Affetced	O
asymptomaitc	O
chidlren	O
had	O
mauclar	O
chanegs	O
,	O
abnomral	O
coolr	O
-	O
contrast	O
sesnitivity	O
,	O
and	O
redcued	O
pattren	O
and	O
cnoe	O
eletcroretinograms	O
.	O

CONCULSION	O
These	O
resluts	O
indicate	O
that	O
muttaions	O
in	O
the	O
rds	O
gnee	O
can	O
be	O
expressed	O
as	O
a	O
macualr	B-Disease
dysrtophy	I-Disease
,	O
with	O
evidecne	O
of	O
prmiary	O
cnoe	B-Disease
dysfunctoin	I-Disease
and	O
prseervation	O
of	O
periphearl	O
rod	O
fucntion	O
.	O
.	O

Anonmyous	O
marekr	O
lcoi	O
within	O
400	O
kb	O
of	O
HLA	O
-	O
A	O
generate	O
haplotyeps	O
in	O
linkgae	O
diesquilibrium	O
with	O
the	O
hmeochromatosis	B-Disease
gnee	O
(	O
HFE	O
)	O

The	O
hemocrhomatosis	B-Disease
gnee	O
(	O
HFE	O
)	O
mpas	O
to	O
6p21	O
.	O

3	O
and	O
is	O
less	O
than	O
1	O
cM	O
from	O
the	O
HLA	O
calss	O
I	O
geens	O
;	O
however	O
,	O
the	O
precise	O
pyhsical	O
lcoation	O
of	O
the	O
gnee	O
has	O
remained	O
elusive	O
and	O
controversial	O
.	O

The	O
unambiguous	O
identfiication	O
of	O
a	O
crossoevr	O
eevnt	O
within	O
hemochromtaosis	B-Disease
famliies	O
is	O
very	O
difficult	O
;	O
it	O
is	O
particularly	O
hampered	O
by	O
the	O
variabliity	O
of	O
the	O
pehnotypic	O
expressoin	O
as	O
well	O
as	O
by	O
the	O
sex	O
-	O
and	O
age	O
-	O
related	O
penetracne	O
of	O
the	O
diesase	O
.	O

For	O
these	O
practical	O
conisderations	O
,	O
traditoinal	O
liknage	O
analyiss	O
could	O
prove	O
of	O
lmiited	O
value	O
in	O
further	O
refniing	O
the	O
extrapolated	O
phyiscal	O
psoition	O
of	O
HFE	O
.	O

We	O
therefore	O
embarked	O
upon	O
a	O
lnikage	O
-	O
disequiilbrium	O
aanlysis	O
of	O
HFE	O
and	O
nomral	O
chroomsomes	O
from	O
the	O
Brtitany	O
popualtion	O
.	O

In	O
the	O
present	O
reoprt	O
,	O
66	O
hmeochromatosis	B-Disease
famileis	O
yielding	O
151	O
hemochroamtosis	B-Disease
chromoosmes	O
and	O
182	O
nomral	O
crhomosomes	O
were	O
RLFP	O
-	O
tpyed	O
with	O
a	O
battrey	O
of	O
prboes	O
,	O
including	O
two	O
newly	O
derived	O
polymrophic	O
marekrs	O
from	O
the	O
6	O
.	O

7	O
and	O
HLA	O
-	O
F	O
lcoi	O
located	O
150	O
and	O
250	O
kb	O
teloemric	O
to	O
HLA	O
-	O
A	O
,	O
respectively	O
.	O

The	O
resluts	O
suggest	O
a	O
strong	O
peak	O
of	O
existing	O
linkgae	O
disequiilbrium	O
focused	O
within	O
the	O
i82	O
-	O
to	O
-	O
6	O
.	O

7	O
inetrval	O
(	O
approximately	O
250	O
kb	O
)	O
.	O

The	O
znoe	O
of	O
linakge	O
disequilibruim	O
is	O
flanked	O
by	O
the	O
i97	O
loucs	O
,	O
positioned	O
30	O
kb	O
prxoimal	O
to	O
i82	O
,	O
and	O
the	O
HLA	O
-	O
F	O
gnee	O
,	O
found	O
250	O
kb	O
dsital	O
to	O
HLA	O
-	O
A	O
,	O
makrers	O
of	O
which	O
display	O
no	O
significant	O
assocaition	O
with	O
HFE	O
.	O

These	O
dtaa	O
support	O
the	O
possibility	O
that	O
HFE	O
rseides	O
within	O
the	O
400	O
-	O
kb	O
expnase	O
of	O
DNA	O
between	O
i97	O
and	O
HLA	O
-	O
F	O
.	O

Alternatively	O
,	O
the	O
very	O
tgiht	O
associatoin	O
of	O
HLA	O
-	O
A3	O
and	O
allele	O
1	O
of	O
the	O
6	O
.	O

7	O
lcous	O
,	O
both	O
of	O
which	O
are	O
comprised	O
by	O
the	O
major	O
ancsetral	O
or	O
fonuder	O
HFE	O
haplotpye	O
in	O
Brittany	O
,	O
supports	O
the	O
possibility	O
that	O
the	O
diesase	O
gnee	O
may	O
reside	O
immediately	O
telomreic	O
to	O
the	O
6	O
.	O

7	O
lcous	O
within	O
the	O
linakge	O
-	O
dsiequilibrium	O
znoe	O
.	O

Additionally	O
,	O
hmeochromatosis	B-Disease
hapoltypes	O
possessing	O
HLA	O
-	O
A11	O
and	O
the	O
low	O
-	O
freuqency	O
HLA	O
-	O
F	O
polymorhpism	O
(	O
alelle	O
2	O
)	O
are	O
spuportive	O
of	O
a	O
separate	O
fuonder	O
chormosome	O
containing	O
a	O
second	O
,	O
independently	O
arising	O
mutnat	O
alelle	O
.	O

Overall	O
,	O
the	O
estbalishment	O
of	O
a	O
likely	O
"	O
hemochroamtosis	B-Disease
critical	O
reigon	O
"	O
centromeirc	O
boudnary	O
and	O
the	O
identifictaion	O
of	O
a	O
linkgae	O
-	O
disequilibirum	O
znoe	O
both	O
significantly	O
contribute	O
to	O
a	O
redcution	O
in	O
the	O
aomunt	O
of	O
DNA	O
required	O
to	O
be	O
searched	O
for	O
novel	O
coidng	O
sequecnes	O
constituting	O
the	O
HFE	B-Disease
defcet	I-Disease

Genoimc	O
structrue	O
of	O
the	O
EWS	O
gnee	O
and	O
its	O
rleationship	O
to	O
ESWR1	O
,	O
a	O
stie	O
of	O
tuomr	B-Disease
-	O
associated	O
chromosmoe	O
tarnslocation	O
.	O

The	O
EWS	O
gnee	O
has	O
been	O
idetnified	O
based	O
on	O
its	O
loctaion	O
at	O
the	O
chromsoome	O
22	O
breakopint	O
of	O
the	O
t	O
(	O
11	O
;	O
22	O
)	O
(	O
q24	O
;	O
q12	O
)	O
translcoation	O
that	O
characterizes	O
Ewnig	B-Disease
sracoma	I-Disease
and	O
related	O
neureoctodermal	B-Disease
tuomrs	I-Disease
.	O

The	O
EWS	O
gnee	O
spans	O
about	O
40	O
kb	O
of	O
DNA	O
and	O
is	O
enocded	O
by	O
17	O
exnos	O
.	O

The	O
nculeotide	O
sequnece	O
of	O
the	O
eoxns	O
is	O
identcial	O
to	O
that	O
of	O
the	O
previously	O
described	O
cNDA	O
.	O

The	O
first	O
7	O
exnos	O
encode	O
the	O
N	O
-	O
termnial	O
domian	O
of	O
EWS	O
,	O
which	O
consists	O
of	O
a	O
reepated	O
degneerated	O
polpyeptide	O
of	O
7	O
to	O
12	O
reisdues	O
rich	O
in	O
tyroisne	O
,	O
sernie	O
,	O
threnoine	O
,	O
glcyine	O
,	O
and	O
gluatmine	O
.	O

Exnos	O
11	O
,	O
12	O
,	O
and	O
13	O
encode	O
the	O
putative	O
RNA	O
binidng	O
domian	O
.	O

The	O
three	O
glyicne	O
-	O
and	O
arginnie	O
-	O
rich	O
mtoifs	O
of	O
the	O
gnee	O
are	O
mainly	O
ecnoded	O
by	O
eoxns	O
8	O
-	O
9	O
,	O
14	O
,	O
and	O
16	O
.	O

The	O
DNA	O
sqeuence	O
in	O
the	O
5	O
reigon	O
of	O
the	O
gnee	O
has	O
faetures	O
of	O
a	O
CpG	O
-	O
rich	O
ilsand	O
and	O
lacks	O
canoincal	O
prmooter	O
elements	O
,	O
such	O
as	O
TTAA	O
and	O
CCAAT	O
consesnus	O
sequecnes	O
.	O

Poistions	O
of	O
the	O
chroomsome	O
22	O
berakpoints	O
were	O
determined	O
for	O
19	O
Eiwng	B-Disease
tmuors	I-Disease
.	O

They	O
were	O
loaclized	O
in	O
inrtons	O
7	O
or	O
8	O
in	O
18	O
csaes	O
and	O
in	O
intorn	O
10	O
in	O
1	O
csae	O
.	O
.	O

Nrorie	B-Disease
diesase	I-Disease
gnee	O
:	O
characteriztaion	O
of	O
delteions	O
and	O
possible	O
funtcion	O
.	O

Poistional	O
clnoing	O
experiemnts	O
have	O
resulted	O
recently	O
in	O
the	O
isoaltion	O
of	O
a	O
candidate	O
gnee	O
for	O
Norrie	B-Disease
disaese	I-Disease
(	O
pseuodglioma	B-Disease
;	O
NDP	B-Disease
)	O
,	O
a	O
sevree	O
X	B-Disease
-	I-Disease
linked	I-Disease
neruodevelopmental	I-Disease
disroder	I-Disease
.	O

Here	O
we	O
reprot	O
the	O
isolaiton	O
and	O
analyiss	O
of	O
hmuan	O
genmoic	O
DNA	O
clnoes	O
encompassing	O
the	O
NDP	B-Disease
gnee	O
.	O

The	O
gnee	O
spans	O
28	O
kb	O
and	O
consists	O
of	O
3	O
exnos	O
,	O
the	O
first	O
of	O
which	O
is	O
entirely	O
contained	O
within	O
the	O
5	O
utnranslated	O
rgeion	O
.	O

Detailed	O
aanlysis	O
of	O
genoimc	O
dleetions	O
in	O
Nrorie	B-Disease
ptaients	O
shows	O
that	O
they	O
are	O
heterogeneuos	O
,	O
both	O
in	O
szie	O
and	O
in	O
psoition	O
.	O

By	O
PCR	O
anlaysis	O
,	O
we	O
found	O
that	O
experssion	O
of	O
the	O
NDP	B-Disease
gnee	O
was	O
not	O
confined	O
to	O
the	O
eye	O
or	O
to	O
the	O
barin	O
.	O

An	O
extenisve	O
DNA	O
and	O
portein	O
sequnece	O
compairson	O
between	O
the	O
huamn	O
NDP	B-Disease
gnee	O
and	O
related	O
gnees	O
from	O
the	O
dtaabase	O
revaeled	O
homoolgy	O
with	O
csyteine	O
-	O
rich	O
proetin	O
-	O
bidning	O
domians	O
of	O
immeditae	O
-	O
-	O
eraly	O
geens	O
implicated	O
in	O
the	O
regulatoin	O
of	O
clel	O
prolfieration	O
.	O

We	O
propose	O
that	O
NDP	O
is	O
a	O
moleclue	O
related	O
in	O
fucntion	O
to	O
these	O
gnees	O
and	O
may	O
be	O
involved	O
in	O
a	O
ptahway	O
that	O
regultaes	O
nueral	O
clel	O
differnetiation	O
and	O
proliferaiton	O
.	O
.	O

The	O
noraml	O
Huntintgon	B-Disease
disesae	I-Disease
(	O
HD	B-Disease
)	O
allele	O
,	O
or	O
a	O
closely	O
linked	O
gnee	O
,	O
influneces	O
age	O
at	O
onset	O
of	O
HD	B-Disease
.	O

We	O
evalauted	O
the	O
hypothseis	O
that	O
Hnutington	B-Disease
diesase	I-Disease
(	O
HD	B-Disease
)	O
is	O
ifnluenced	O
by	O
the	O
nromal	O
HD	B-Disease
alllee	O
by	O
comparnig	O
trasnmission	O
patetrns	O
of	O
genetiaclly	O
linked	O
marekrs	O
at	O
the	O
DS410	O
lcous	O
in	O
the	O
noraml	O
praent	O
against	O
age	O
at	O
onset	O
in	O
the	O
affecetd	O
offsrping	O
.	O

Aanlysis	O
of	O
inforamtion	O
from	O
21	O
sisbhips	O
in	O
14	O
kidnreds	O
showed	O
a	O
significant	O
tendency	O
for	O
sbis	O
who	O
have	O
similar	O
onset	O
aegs	O
to	O
share	O
the	O
same	O
DS410	O
alllee	O
from	O
the	O
noraml	O
paernt	O
.	O

Affceted	O
sbis	O
who	O
inhreited	O
different	O
DS410	O
alllees	O
from	O
the	O
noraml	O
praent	O
tended	O
to	O
have	O
more	O
varialbe	O
aegs	O
at	O
onset	O
.	O

These	O
fnidings	O
suggest	O
that	O
the	O
expresison	O
of	O
HD	B-Disease
is	O
modualted	O
by	O
the	O
nromal	O
HD	B-Disease
alelle	O
or	O
by	O
a	O
closely	O
linked	O
lcous	O
.	O
.	O

Further	O
invsetigation	O
of	O
the	O
HXEA	O
gnee	O
itnron	O
9	O
doonr	O
spilce	O
stie	O
mutaiton	O
frequently	O
found	O
in	O
non	O
-	O
Jeiwsh	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
ptaients	O
from	O
the	O
Briitsh	O
Ilses	O
.	O

In	O
a	O
previous	O
stduy	O
we	O
found	O
that	O
a	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
causing	O
mutaiton	O
in	O
the	O
intorn	O
9	O
dnoor	O
splcie	O
stie	O
of	O
the	O
HXEA	O
gnee	O
occurs	O
at	O
high	O
frequecny	O
in	O
non	O
-	O
Jweish	O
ptaients	O
and	O
carriers	O
from	O
the	O
Birtish	O
Isels	O
.	O

It	O
was	O
found	O
more	O
frequently	O
in	O
sujbects	O
of	O
Iirsh	O
,	O
Scottsih	O
,	O
and	O
Wlesh	O
oirgin	O
compaerd	O
with	O
Enlgish	O
oriign	O
(	O
63	O
%	O
and	O
31	O
%	O
respectively	O
)	O
.	O

We	O
have	O
now	O
tetsed	O
,	O
in	O
a	O
blnid	O
sutdy	O
,	O
26	O
Amreican	O
TSD	B-Disease
carirers	O
and	O
28	O
non	O
-	O
carrires	O
who	O
have	O
Britsih	O
ancesrty	O
for	O
the	O
intorn	O
9	O
spilce	O
stie	O
mtuation	O
.	O

Six	O
of	O
the	O
carreirs	O
and	O
none	O
of	O
the	O
contorls	O
were	O
positvie	O
for	O
the	O
mutatoin	O
.	O

All	O
six	O
had	O
Iirsh	O
ancetsry	O
,	O
cmopared	O
with	O
nine	O
of	O
the	O
20	O
other	O
(	O
intorn	O
9	O
muattion	O
negaitve	O
)	O
TSD	B-Disease
carirers	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

These	O
reuslts	O
confirm	O
the	O
previously	O
found	O
high	O
frequecny	O
of	O
the	O
intorn	O
9	O
muttaion	O
in	O
non	O
-	O
Jweish	O
TSD	B-Disease
famliies	O
of	O
Brtiish	O
Ilses	O
,	O
particularly	O
Irsih	O
,	O
orgiin	O
,	O
and	O
reinforce	O
the	O
need	O
to	O
screen	O
such	O
famiiles	O
for	O
this	O
mutaiton	O
.	O

Molceular	O
mehcanisms	O
of	O
oncgoenic	O
mtuations	O
in	O
tuomrs	B-Disease
from	O
paitents	O
with	O
biltaeral	B-Disease
and	I-Disease
unialteral	I-Disease
rteinoblastoma	I-Disease
.	O

The	O
RB1	O
gnee	O
from	O
12	O
hmuan	O
retinoblatsoma	B-Disease
tmuors	I-Disease
has	O
been	O
aanlyzed	O
eoxn	O
-	O
by	O
-	O
eoxn	O
with	O
the	O
single	O
-	O
srtand	O
conformatoin	O
polmyorphism	O
tecnhique	O
.	O

Muttaions	O
were	O
found	O
in	O
all	O
tuomrs	B-Disease
,	O
and	O
one	O
-	O
third	O
of	O
the	O
tuomrs	B-Disease
had	O
indpeendent	O
mutatinos	O
in	O
both	O
alelles	O
neither	O
of	O
which	O
were	O
found	O
in	O
the	O
grem	O
line	O
,	O
confirming	O
their	O
true	O
sopradic	O
nature	O
.	O

In	O
the	O
remaining	O
two	O
-	O
thirds	O
of	O
the	O
tuomrs	B-Disease
only	O
one	O
muttaion	O
was	O
found	O
,	O
consistent	O
with	O
the	O
lsos	O
-	O
of	O
-	O
heteorzygosity	O
theroy	O
of	O
tumroigenesis	O
.	O

Piont	O
mutaitons	O
,	O
the	O
majority	O
of	O
which	O
were	O
C	O
-	O
-	O
>	O
T	O
trnasitions	O
,	O
were	O
the	O
most	O
common	O
abnormaltiy	O
and	O
usually	O
resulted	O
in	O
the	O
convresion	O
of	O
an	O
argiinne	O
coodn	O
to	O
a	O
stop	O
coodn	O
.	O

Samll	O
deletinos	O
were	O
the	O
second	O
most	O
common	O
abnormailty	O
and	O
most	O
often	O
created	O
a	O
downsrteam	O
stop	O
coodn	O
as	O
the	O
result	O
of	O
a	O
readnig	O
frameshfit	O
.	O

Deeltions	O
and	O
point	O
mutaitons	O
also	O
affceted	O
splcie	O
jucntions	O
.	O

Direct	O
repaets	O
were	O
present	O
at	O
the	O
berakpoint	O
juntcions	O
in	O
the	O
majority	O
of	O
delteions	O
,	O
supporting	O
a	O
slipped	O
-	O
mispaiirng	O
mehcanism	O
.	O

Piont	O
mutaitons	O
generally	O
produced	O
DNA	O
sequecnes	O
which	O
resulted	O
in	O
perfect	O
hoomlogy	O
with	O
endgoenous	O
sequneces	O
which	O
lay	O
within	O
14	O
bp	O
.	O
.	O

PXA6	O
mtuations	O
in	O
aniirdia	B-Disease
.	O

Aniriida	B-Disease
is	O
a	O
conegnital	B-Disease
malfromation	I-Disease
of	I-Disease
the	I-Disease
eye	I-Disease
,	O
chiefly	O
characetrised	O
by	O
iirs	B-Disease
hpyoplasia	I-Disease
,	O
which	O
can	O
cause	O
blindnses	B-Disease
.	O

The	O
PXA6	O
gnee	O
was	O
isoltaed	O
as	O
a	O
candidate	O
aniirdia	B-Disease
gnee	O
by	O
positinoal	O
colning	O
from	O
the	O
smallest	O
reigon	O
of	O
overalp	O
of	O
anriidia	B-Disease
-	O
associated	O
deleitons	O
.	O

Subsequently	O
PXA6	O
intrgaenic	O
mutatoins	O
were	O
demonstrated	O
in	O
Smlaleye	O
,	O
a	O
mosue	O
muatnt	O
which	O
is	O
an	O
anmial	O
moedl	O
for	O
ainridia	B-Disease
,	O
and	O
six	O
hmuan	O
aniirdia	B-Disease
patinets	O
.	O

In	O
this	O
paper	O
we	O
describe	O
four	O
additional	O
PXA6	O
point	O
muttaions	O
in	O
aniirdia	B-Disease
patinets	O
,	O
both	O
sporaidc	O
and	O
famiilal	O
.	O

These	O
muttaions	O
highlight	O
regoins	O
of	O
the	O
gnee	O
which	O
are	O
essential	O
for	O
nomral	O
PXA6	O
fnuction	O
.	O

In	O
addition	O
,	O
the	O
freuqency	O
at	O
which	O
we	O
have	O
found	O
PXA6	O
muattions	O
suggests	O
that	O
leisons	O
in	O
PXA6	O
will	O
account	O
for	O
most	O
caess	O
of	O
anriidia	B-Disease
.	O
.	O

Detectoin	O
of	O
a	O
novel	O
arginnie	O
vsaopressin	O
defcet	O
by	O
diedoxy	O
fingerrpinting	O
.	O

Autoosmal	B-Disease
domiannt	I-Disease
neuorhypophyseal	I-Disease
diabeets	I-Disease
isnipidus	I-Disease
is	O
a	O
faimlial	O
form	O
of	O
daibetes	B-Disease
isnipidus	I-Disease
.	O

This	O
dsiorder	O
is	O
associated	O
with	O
varialbe	O
leevls	O
of	O
argiinne	O
vasoprsesin	O
(	O
AVP	O
)	O
and	O
daibetes	B-Disease
insipdius	I-Disease
of	O
varying	O
seveirty	O
,	O
which	O
responds	O
to	O
exogneous	O
AVP	O
.	O

To	O
determine	O
the	O
moelcular	O
basis	O
of	O
atuosomal	B-Disease
dmoinant	I-Disease
neurohyppohyseal	I-Disease
dibaetes	I-Disease
insipdius	I-Disease
,	O
the	O
AVP	O
geens	O
of	O
mmebers	O
of	O
a	O
large	O
knidred	O
were	O
aanlyzed	O
.	O

A	O
new	O
mehtod	O
,	O
called	O
diedoxy	O
fingreprinting	O
,	O
was	O
used	O
to	O
deetct	O
an	O
AVP	O
mutatoin	O
that	O
was	O
charcaterized	O
by	O
DNA	O
sequenicng	O
.	O

The	O
novel	O
defcet	O
found	O
cahnges	O
the	O
last	O
coodn	O
of	O
the	O
AVP	O
sginal	O
pepitde	O
from	O
aalnine	O
to	O
threonnie	O
,	O
which	O
should	O
petrurb	O
claevage	O
of	O
matrue	O
AVP	O
from	O
its	O
prceursor	O
prtoein	O
and	O
ihnibit	O
its	O
secreiton	O
or	O
atcion	O
.	O
.	O

Germianl	O
mosaciism	O
in	O
a	O
Duhcenne	B-Disease
muscluar	I-Disease
dytsrophy	I-Disease
famliy	O
:	O
implications	O
for	O
geneitc	O
counselilng	O
.	O

In	O
this	O
stduy	O
we	O
describe	O
a	O
three	O
-	O
genreation	O
fmaily	O
in	O
which	O
two	O
sibilngs	O
were	O
affceted	O
by	O
Duchnene	B-Disease
muscluar	I-Disease
dytsrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Immunohistocehmical	O
anaylsis	O
of	O
muslce	O
dystrpohin	O
and	O
hapltoype	O
aanlysis	O
of	O
the	O
DMD	B-Disease
loucs	O
reevaled	O
that	O
the	O
X	O
chromsoome	O
carrying	O
the	O
DMD	B-Disease
gnee	O
was	O
trasnmitted	O
from	O
the	O
healhty	O
matrenal	O
garndfather	O
to	O
his	O
three	O
daughtres	O
,	O
including	O
the	O
probadns	O
motehr	O
.	O

These	O
finidngs	O
indicate	O
that	O
the	O
grandafther	O
was	O
a	O
germnial	O
msoaic	O
for	O
the	O
DMD	B-Disease
gnee	O
.	O

The	O
defintiion	O
of	O
the	O
carrier	O
sattus	O
in	O
two	O
possible	O
carreirs	O
led	O
us	O
to	O
give	O
acucrate	O
gneetic	O
cuonselling	O
and	O
to	O
prveent	O
the	O
bitrh	O
of	O
an	O
affecetd	O
boy	O
.	O

The	O
rseults	O
of	O
this	O
stduy	O
demonstrate	O
the	O
usefluness	O
of	O
hpalotype	O
analyiss	O
and	O
immunohistochmeical	O
msucle	O
dystrpohin	O
stduies	O
to	O
dteect	O
hidden	O
germianl	O
msoaicism	O
and	O
to	O
imprvoe	O
geneitc	O
counsellnig	O
.	O
.	O

Gneetic	O
mappnig	O
of	O
the	O
bresat	B-Disease
-	I-Disease
ovraian	I-Disease
cnacer	I-Disease
sydnrome	I-Disease
to	O
a	O
small	O
itnerval	O
on	O
crhomosome	O
17q12	O
-	O
21	O
:	O
exculsion	O
of	O
candidate	O
gnees	O
EHD17B2	O
and	O
RRAA	O
.	O

A	O
susceptibliity	O
gnee	O
for	O
heerditary	B-Disease
berast	I-Disease
-	I-Disease
ovraian	I-Disease
cnacer	I-Disease
,	O
BRAC1	O
,	O
has	O
been	O
assigned	O
by	O
linkgae	O
anlaysis	O
to	O
chromsoome	O
17q21	O
.	O

Candidate	O
gnees	O
in	O
this	O
rgeion	O
include	O
ED1H7B2	O
,	O
which	O
enocdes	O
estraidol	O
17	O
btea	O
-	O
hydroxytseroid	O
dheydrogenase	O
II	O
(	O
17	O
btea	O
-	O
HSD	O
II	O
)	O
,	O
and	O
RRAA	O
,	O
the	O
gnee	O
for	O
retnioic	O
aicd	O
recepotr	O
aplha	O
.	O

We	O
have	O
tpyed	O
22	O
braest	B-Disease
and	I-Disease
bresat	I-Disease
-	I-Disease
oavrian	I-Disease
cacner	I-Disease
faimlies	O
with	O
eight	O
polymorphsims	O
from	O
the	O
chromosmoe	O
17q12	O
-	O
21	O
regoin	O
,	O
including	O
two	O
in	O
the	O
EHD17B2	O
gnee	O
.	O

Geneitc	O
recobmination	O
with	O
the	O
bresat	B-Disease
cacner	I-Disease
triat	O
excludes	O
RRAA	O
from	O
further	O
consideration	O
as	O
a	O
candidate	O
gnee	O
for	O
BCRA1	O
.	O

Both	O
BRAC1	O
and	O
ED1H7B2	O
map	O
to	O
a	O
6	O
cM	O
intevral	O
(	O
between	O
THAR1	O
and	O
D1S7579	O
)	O
and	O
no	O
recombinatoin	O
was	O
observed	O
between	O
the	O
two	O
geens	O
.	O

However	O
,	O
direct	O
sequencnig	O
of	O
overlapping	O
PCR	O
porducts	O
containing	O
the	O
entire	O
EDH1B72	O
gnee	O
in	O
four	O
unrelated	O
affecetd	O
woemn	O
did	O
not	O
uncover	O
any	O
seuqence	O
varitaion	O
,	O
other	O
than	O
previously	O
described	O
polmyorphisms	O
.	O

Mutaitons	O
in	O
the	O
EDH1B72	O
gnee	O
,	O
therefore	O
do	O
not	O
appear	O
to	O
be	O
responsible	O
for	O
the	O
herediatry	B-Disease
bresat	I-Disease
-	I-Disease
ovairan	I-Disease
canecr	I-Disease
sydnrome	I-Disease
.	O

Single	O
meitoic	O
crossovers	O
in	O
affected	O
woemn	O
suggest	O
that	O
BRAC1	O
is	O
flanked	O
by	O
the	O
lcoi	O
RRAA	O
and	O
D177S8	O
.	O
.	O

A	O
msisense	O
mtuation	O
in	O
the	O
choletseryl	O
esetr	O
transefr	O
portein	O
gnee	O
with	O
possible	O
domiannt	O
efefcts	O
on	O
plsama	O
high	O
denstiy	O
lipoproetins	O
.	O

Palsma	O
HDL	O
are	O
a	O
negtaive	O
rsik	O
fatcor	O
for	O
atherocslerosis	B-Disease
.	O

Choletseryl	O
esetr	O
transefr	O
protien	O
(	O
CTEP	O
;	O
476	O
aimno	O
acdis	O
)	O
tarnsfers	O
cholseteryl	O
etser	O
from	O
HDL	O
to	O
other	O
lipoprtoeins	O
.	O

Subjetcs	O
with	O
homoyzgous	O
CTEP	B-Disease
dfeiciency	I-Disease
caused	O
by	O
a	O
gnee	O
spliicng	O
dfeect	O
have	O
markedly	O
elveated	O
HDL	O
;	O
however	O
,	O
heetrozygotes	O
have	O
only	O
mlid	O
incraeses	O
in	O
HDL	O
.	O

We	O
describe	O
two	O
proabnds	O
with	O
a	O
CTEP	O
missesne	O
mutatoin	O
(	O
442	O
D	O
G	O
)	O
.	O

Although	O
heterozyogus	O
,	O
they	O
have	O
threefold	O
incraeses	O
in	O
HDL	O
concenrtation	O
and	O
markedly	O
derceased	O
plamsa	O
CTEP	O
msas	O
and	O
actviity	O
,	O
suggesting	O
that	O
the	O
mutaiton	O
has	O
domniant	O
efefcts	O
on	O
CTEP	O
and	O
HDL	O
in	O
vivo	O
.	O

Cellluar	O
exprsesion	O
of	O
mutnat	O
cNDA	O
reuslts	O
in	O
secreiton	O
of	O
only	O
30	O
%	O
of	O
wlid	O
tpye	O
CTEP	O
actiivty	O
.	O

Moreover	O
,	O
coexperssion	O
of	O
wlid	O
tpye	O
and	O
mtuant	O
cNDAs	O
leads	O
to	O
inhibtiion	O
of	O
wlid	O
tpye	O
secrteion	O
and	O
activtiy	O
.	O

The	O
domiannt	O
effetcs	O
of	O
the	O
CTEP	O
msisense	O
mutatoin	O
during	O
clelular	O
expresison	O
probably	O
explains	O
why	O
the	O
probnads	O
have	O
markedly	O
incerased	O
HDL	O
in	O
the	O
heteorzygous	O
state	O
,	O
and	O
suggests	O
that	O
the	O
actvie	O
mloecular	O
speceis	O
of	O
CTEP	O
may	O
be	O
multimreic	O
.	O
.	O

Familail	B-Disease
Mediterranean	I-Disease
feevr	I-Disease
in	O
the	O
coclhicine	O
era	O
:	O
the	O
ftae	O
of	O
one	O
fmaily	O
.	O

In	O
order	O
to	O
demonstrate	O
the	O
efefct	O
of	O
prophylcatic	O
clochicine	O
treatemnt	O
on	O
the	O
ntaural	O
hitsory	O
of	O
famiilal	B-Disease
Mediterranean	I-Disease
fveer	I-Disease
(	O
FMF	B-Disease
)	O
,	O
a	O
faimly	O
is	O
presented	O
with	O
6	O
out	O
of	O
9	O
sibilngs	O
affected	O
by	O
FMF	B-Disease
.	O

Each	O
pateint	O
represents	O
a	O
different	O
stgae	O
of	O
the	O
amyloidoitc	B-Disease
kdiney	I-Disease
diesase	I-Disease
of	O
FMF	B-Disease
and	O
the	O
effect	O
of	O
contiunous	O
colhcicine	O
treatmnet	O
on	O
its	O
cousre	O
.	O

Considered	O
together	O
,	O
the	O
memebrs	O
of	O
this	O
famliy	O
present	O
an	O
almost	O
complete	O
clniical	O
,	O
geneitc	O
,	O
and	O
behavoiral	O
pictrue	O
of	O
the	O
disaese	O
.	O
.	O

Detetcion	O
of	O
a	O
new	O
sumbicroscopic	O
Norrie	B-Disease
diesase	I-Disease
deletoin	O
intreval	O
with	O
a	O
novel	O
DNA	O
prboe	O
ioslated	O
by	O
differetnial	O
Alu	O
PCR	O
fingerrpint	O
clnoing	O
.	O

Differentail	O
Alu	O
PCR	O
finegrprint	O
clonnig	O
was	O
used	O
to	O
isoalte	O
a	O
DNA	O
porbe	O
from	O
the	O
X1p1	O
.	O

4	O
-	O
-	O
>	O
p11	O
.	O

21	O
regoin	O
of	O
the	O
huamn	O
X	O
chrmoosome	O
.	O

This	O
novel	O
seuqence	O
,	O
cpXr138	O
(	O
DX7S42	O
)	O
,	O
detects	O
a	O
new	O
submicorscopic	O
delteion	O
inetrval	O
at	O
the	O
Nrorie	B-Disease
disaese	I-Disease
loucs	O
(	O
NDP	O
)	O
.	O

Combining	O
our	O
dtaa	O
with	O
the	O
cosnensus	O
gneetic	O
map	O
of	O
the	O
porximal	O
short	O
arm	O
of	O
the	O
X	O
chroomsome	O
,	O
we	O
propose	O
the	O
physcial	O
order	O
Xecn	O
-	O
DX1S4	O
-	O
DX2S55	O
-	O
(	O
DX4S26	O
,	O
TMIP	O
)	O
-	O
(	O
DSX742	O
-	O
(	O
[	O
MOAB	O
-	O
MOAA	O
-	O
DSX7	O
]	O
,	O
NDP	O
)	O
-	O
DX7S7	O
-	O
DX2S28	O
)	O
-	O
DX2S09	O
-	O
DXS418	O
-	O
DSX196	O
-	O
+	O
+	O
+	O
Xtper	O
.	O

The	O
cpXr138	O
porbe	O
and	O
a	O
subclnoe	O
from	O
a	O
comsid	O
corresponding	O
to	O
the	O
DSX7	O
loucs	O
were	O
converted	O
into	O
sqeuence	O
-	O
tagegd	O
sties	O
.	O

Finally	O
,	O
DX7S42	O
,	O
DXS7	O
,	O
DSX77	O
,	O
and	O
MOAA	O
were	O
integraetd	O
into	O
a	O
pyhsical	O
map	O
spanning	O
the	O
Nrorie	B-Disease
diesase	I-Disease
loucs	O

Putatvie	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukoydstrophy	I-Disease
gnee	O
shares	O
unexpected	O
hmoology	O
with	O
ABC	O
transportres	O
.	O

Adrenoelukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
dsiease	I-Disease
affectnig	O
1	O
/	O
20	O
,	O
000	O
maels	O
either	O
as	O
ceerbral	B-Disease
ALD	I-Disease
in	O
childhood	O
or	O
as	O
adrenomyeloenuropathy	B-Disease
(	O
AMN	B-Disease
)	O
in	O
audlts	O
.	O

Chlidhood	O
ALD	B-Disease
is	O
the	O
more	O
seevre	O
form	O
,	O
with	O
onset	O
of	O
neuorlogical	O
sypmtoms	O
between	O
5	O
-	O
12	O
yeras	O
of	O
age	O
.	O

Centarl	B-Disease
nrevous	I-Disease
sysetm	I-Disease
deymelination	I-Disease
progresses	O
rapidly	O
and	O
daeth	O
occurs	O
within	O
a	O
few	O
yaers	O
.	O

AMN	B-Disease
is	O
a	O
milder	O
form	O
of	O
the	O
diesase	O
with	O
onset	O
at	O
15	O
-	O
30	O
yeras	O
of	O
age	O
and	O
a	O
more	O
progressvie	O
coruse	O
.	O

Adreanl	B-Disease
insuffiicency	I-Disease
(	O
Addisnos	B-Disease
disaese	I-Disease
)	O
may	O
remain	O
the	O
only	O
clincial	O
manifesttaion	O
of	O
ALD	B-Disease
.	O

The	O
princiapl	O
biocehmical	O
abnromality	O
of	O
ALD	B-Disease
is	O
the	O
accumulation	O
of	O
very	O
-	O
long	O
-	O
cahin	O
fatty	O
acdis	O
(	O
VCLFA	O
)	O
because	O
of	O
imparied	O
btea	O
-	O
oxdiation	O
in	O
peroixsomes	O
.	O

The	O
nromal	O
oxidaiton	O
of	O
VLFCA	O
-	O
CoA	O
in	O
paitents	O
fibrobalsts	O
suggested	O
that	O
the	O
gnee	O
coidng	O
for	O
the	O
VCLFA	O
-	O
CoA	O
synthetsae	O
could	O
be	O
a	O
candidate	O
gnee	O
for	O
ALD	B-Disease
.	O

Here	O
we	O
use	O
posiitonal	O
colning	O
to	O
identify	O
a	O
gnee	O
patrially	O
dleeted	O
in	O
6	O
of	O
85	O
indepednent	O
patinets	O
with	O
ALD	B-Disease
.	O

In	O
familail	O
caess	O
,	O
the	O
delteions	O
segregated	O
with	O
the	O
dsiease	O
.	O

An	O
idenitcal	O
delteion	O
was	O
detecetd	O
in	O
two	O
brotehrs	O
presetning	O
with	O
different	O
clniical	O
ALD	B-Disease
phenotyeps	O
.	O

Candidate	O
exnos	O
were	O
identfiied	O
by	O
cmoputer	O
aanlysis	O
of	O
gneomic	O
seqeunces	O
and	O
used	O
to	O
ioslate	O
complementary	O
DANs	O
by	O
eoxn	O
conenction	O
and	O
screneing	O
of	O
cNDA	O
libarries	O
.	O

The	O
deduced	O
proetin	O
sequecne	O
shows	O
significant	O
seqeunce	O
idetnity	O
to	O
a	O
peroixsomal	O
memrbane	O
proetin	O
of	O
M	O
(	O
r	O
)	O
70K	O
that	O
is	O
involved	O
in	O
peroxsiome	O
biogneesis	O
and	O
belongs	O
to	O
the	O
ATP	O
-	O
binidng	O
casstete	O
suprefamily	O
of	O
transoprters	O
.	O
.	O

Tagreted	O
modifiaction	O
of	O
the	O
apoliporpotein	O
B	O
gnee	O
reuslts	O
in	O
hypobetalipoporteinemia	B-Disease
and	O
deveolpmental	B-Disease
abnromalities	I-Disease
in	O
mcie	O
.	O

Faimlial	B-Disease
hypobetaliopproteinemia	I-Disease
is	O
an	O
atuosomal	B-Disease
codomniant	I-Disease
disoredr	I-Disease
resulting	O
in	O
a	O
drmaatic	O
reductoin	O
in	O
plamsa	O
conecntrations	O
of	O
aploipoprotein	O
(	O
apo	O
)	O
B	O
,	O
cholesetrol	O
,	O
and	O
btea	O
-	O
mgirating	O
lipoproetins	O
.	O

A	O
bneefit	O
of	O
hypobetaliporpoteinemia	B-Disease
is	O
that	O
midlly	O
affected	O
indiivduals	O
may	O
be	O
protected	O
from	O
cornoary	B-Disease
vsacular	I-Disease
diesase	I-Disease
.	O

We	O
have	O
used	O
gnee	O
taregting	O
to	O
generate	O
mcie	O
with	O
a	O
modifeid	O
Aopb	O
alelle	O
.	O

Mcie	O
containing	O
this	O
alelle	O
display	O
all	O
of	O
the	O
hallmarks	O
of	O
hmuan	O
hypobetalipoprtoeinemia	B-Disease
they	O
produce	O
a	O
trucnated	O
aopB	O
portein	O
,	O
apoB70	O
,	O
and	O
have	O
markedly	O
dcereased	O
palsma	O
concentrtaions	O
of	O
aopB	O
,	O
btea	O
-	O
lpioproteins	O
,	O
and	O
total	O
chloesterol	O
.	O

In	O
addition	O
,	O
the	O
mcie	O
manifest	O
several	O
cahracteristics	O
that	O
are	O
occasionally	O
observed	O
in	O
huamn	O
hypobetalipoproetinemia	B-Disease
,	O
including	O
redcued	O
plsama	O
trilgyceride	O
concentrtaions	O
,	O
fasitng	O
chylomicroenmia	B-Disease
,	O
and	O
rdeuced	O
high	O
denisty	O
lipporotein	O
choletserol	O
.	O

An	O
unexpected	O
fniding	O
is	O
that	O
the	O
modiifed	O
Aopb	O
alllee	O
is	O
strongly	O
associated	O
with	O
eexncephalus	B-Disease
and	O
hydrocephlaus	B-Disease
.	O

These	O
mcie	O
should	O
help	O
icnrease	O
our	O
understanding	O
of	O
hypobtealipoproteinemia	B-Disease
,	O
atherogeensis	B-Disease
,	O
and	O
the	O
eitology	O
of	O
exencepahlus	B-Disease
and	O
hydrcoephalus	B-Disease
.	O
.	O

A	O
novel	O
disaese	O
with	O
defiicency	B-Disease
of	I-Disease
mitochondiral	I-Disease
very	I-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chian	I-Disease
aycl	I-Disease
-	I-Disease
CoA	I-Disease
dehydrogensae	I-Disease
.	O

Plamitoyl	O
-	O
CoA	O
dehydrgoenase	O
atcivity	O
in	O
sikn	O
fibrbolasts	O
from	O
seven	O
ptaients	O
with	O
unidentified	O
defetcs	O
of	O
ftaty	O
aicd	O
oxiadtion	O
was	O
maesured	O
in	O
the	O
presnece	O
and	O
asbence	O
of	O
antibdoies	O
against	O
meidum	O
-	O
chian	O
,	O
long	O
-	O
cahin	O
,	O
and	O
very	O
-	O
long	O
-	O
cahin	O
aycl	O
-	O
CoA	O
dehydrgoenases	O
(	O
VCLAD	O
)	O
.	O

Two	O
of	O
the	O
paitents	O
,	O
4	O
-	O
5	O
mnoth	O
old	O
byos	O
,	O
were	O
found	O
to	O
have	O
a	O
novel	O
disesae	O
,	O
VCLAD	B-Disease
defciiency	I-Disease
,	O
as	O
judged	O
from	O
the	O
resluts	O
of	O
very	O
low	O
palimtoyl	O
-	O
CoA	O
dehydorgenase	O
acitvity	O
and	O
the	O
lcak	O
of	O
immunoreactviity	O
toward	O
antiobdy	O
raised	O
to	O
puriifed	O
VCLAD	O
.	O
.	O

Moelcular	O
characetrization	O
of	O
gulcose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phopshate	I-Disease
dehydrogensae	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
deficiecny	I-Disease
in	O
ptaients	O
of	O
Chiense	O
descnet	O
and	O
identiifcation	O
of	O
new	O
base	O
substitutoins	O
in	O
the	O
huamn	O
GP6D	O
gnee	O
.	O

The	O
underlying	O
DNA	O
chanegs	O
associated	O
with	O
glcuose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phopshate	I-Disease
dehydrgoenase	I-Disease
(	I-Disease
GP6D	I-Disease
)	I-Disease
-	I-Disease
deifcient	I-Disease
Aisans	O
have	O
not	O
been	O
extensively	O
investgiated	O
.	O

To	O
fill	O
this	O
gap	O
,	O
we	O
seqeunced	O
the	O
GP6D	O
gnee	O
of	O
43	O
GP6D	B-Disease
-	I-Disease
defiicent	I-Disease
Cihnese	O
whose	O
GP6D	O
was	O
well	O
chaarcterized	O
biocehmically	O
.	O

DNA	O
sampels	O
were	O
obtained	O
from	O
perpiheral	O
blood	O
of	O
these	O
individulas	O
for	O
sequencnig	O
using	O
a	O
direct	O
polymrease	O
cahin	O
reatcion	O
(	O
PCR	O
)	O
seqeuncing	O
proecdure	O
.	O

From	O
these	O
43	O
samlpes	O
,	O
we	O
have	O
idnetified	O
five	O
different	O
types	O
of	O
nucloetide	O
subsittutions	O
in	O
the	O
GP6D	O
gnee	O
at	O
cNDA	O
1388	O
from	O
G	O
to	O
A	O
(	O
Arg	O
to	O
His	O
)	O
;	O
at	O
cNDA	O
1376	O
from	O
G	O
to	O
T	O
(	O
Arg	O
to	O
Leu	O
)	O
;	O
at	O
cNDA	O
1024	O
from	O
C	O
to	O
T	O
(	O
Leu	O
to	O
Phe	O
)	O
;	O
at	O
cNDA	O
392	O
from	O
G	O
to	O
T	O
(	O
Gly	O
to	O
Val	O
)	O
;	O
at	O
cNDA	O
95	O
from	O
A	O
to	O
G	O
(	O
His	O
to	O
Arg	O
)	O
.	O

These	O
five	O
nculeotide	O
substituitons	O
account	O
for	O
over	O
83	O
%	O
of	O
our	O
43	O
GP6D	B-Disease
-	I-Disease
defciient	I-Disease
smaples	O
and	O
these	O
subtsitutions	O
have	O
not	O
been	O
reported	O
in	O
non	O
-	O
Asains	O
.	O

The	O
susbtitutions	O
found	O
at	O
cNDA	O
392	O
and	O
cNDA	O
1024	O
are	O
new	O
fnidings	O
.	O

The	O
susbtitutions	O
at	O
cNDA	O
1376	O
and	O
1388	O
account	O
for	O
over	O
50	O
%	O
of	O
the	O
43	O
sapmles	O
examined	O
indicating	O
a	O
high	O
preavlence	O
of	O
these	O
two	O
alllees	O
among	O
GP6D	B-Disease
-	I-Disease
dfeicient	I-Disease
Chiense	O
.	O

Our	O
findnigs	O
add	O
support	O
to	O
the	O
notion	O
that	O
divrese	O
point	O
mtuations	O
may	O
account	O
largely	O
for	O
much	O
of	O
the	O
phenoytpic	O
heteroegneity	O
of	O
GP6D	B-Disease
dfeiciency	I-Disease
.	O
.	O

Idetnification	O
of	O
mutaitons	O
in	O
Dansih	O
choroidreemia	B-Disease
famileis	O
.	O

We	O
have	O
searched	O
for	O
muttaions	O
in	O
the	O
choroidreemia	B-Disease
gnee	O
(	O
CHM	B-Disease
)	O
in	O
pateints	O
from	O
12	O
Dnaish	O
fmailies	O
in	O
which	O
CHM	B-Disease
is	O
segrgeating	O
.	O

Employing	O
polymearse	O
chian	O
reactoin	O
(	O
PCR	O
)	O
,	O
single	O
strnad	O
conforamtion	O
ploymorphism	O
(	O
SCSP	O
)	O
anlaysis	O
,	O
and	O
direct	O
DNA	O
sqeuencing	O
,	O
different	O
mtuations	O
have	O
been	O
identfiied	O
in	O
6	O
ptaients	O
.	O

All	O
the	O
mutaitons	O
will	O
interfere	O
with	O
the	O
correct	O
translaiton	O
of	O
the	O
mNRA	O
predicitng	O
a	O
trucnated	O
protien	O
or	O
no	O
gnee	O
porduct	O
at	O
all	O
.	O
.	O

Strucutre	O
and	O
geonmic	O
sequecne	O
of	O
the	O
myotoinc	B-Disease
dystrohpy	I-Disease
(	O
DM	B-Disease
kinsae	O
)	O
gnee	O
.	O

The	O
mutatoin	O
causing	O
myotnoic	B-Disease
dystrohpy	I-Disease
(	O
DM	B-Disease
)	O
has	O
recently	O
been	O
iedntified	O
as	O
an	O
unstable	O
CTG	O
trinucloetide	O
reepat	O
located	O
in	O
the	O
3	O
untarnslated	O
reigon	O
of	O
a	O
gnee	O
encoidng	O
for	O
a	O
portein	O
with	O
putative	O
sernie	O
-	O
threoinne	O
prtoein	O
kniase	O
actiivty	O
.	O

In	O
this	O
rpeort	O
we	O
present	O
the	O
genmoic	O
sequenecs	O
of	O
the	O
huamn	O
and	O
murnie	O
DM	B-Disease
kianse	O
gnee	O
.	O

A	O
copmarison	O
of	O
these	O
seuqences	O
with	O
each	O
other	O
and	O
with	O
known	O
cNDA	O
sqeuences	O
from	O
both	O
speices	O
,	O
led	O
us	O
to	O
predict	O
a	O
tranlsation	O
inititaion	O
coodn	O
,	O
as	O
well	O
as	O
determine	O
the	O
organiztaion	O
of	O
the	O
DM	B-Disease
kinsae	O
gnee	O
.	O

Several	O
polymrophisms	O
within	O
the	O
huamn	O
DM	B-Disease
kianse	O
gnee	O
have	O
been	O
identfiied	O
,	O
and	O
PCR	O
asasys	O
to	O
deetct	O
two	O
of	O
these	O
are	O
described	O
.	O

The	O
complete	O
sqeuence	O
and	O
chraacterization	O
of	O
the	O
structrue	O
of	O
the	O
DM	B-Disease
kianse	O
gnee	O
,	O
as	O
well	O
as	O
the	O
identifictaion	O
of	O
novel	O
polyomrphisms	O
within	O
the	O
gnee	O
,	O
represent	O
an	O
important	O
step	O
in	O
a	O
further	O
understanding	O
of	O
the	O
genetcis	O
of	O
mytoonic	B-Disease
dystrpohy	I-Disease
and	O
the	O
molecluar	O
biloogy	O
of	O
the	O
gnee	O
.	O
.	O

Autosoaml	O
recsesive	O
trasnmission	O
of	O
heomphilia	B-Disease
A	I-Disease
due	O
to	O
a	O
von	B-Disease
Willebrnad	I-Disease
fatcor	O
muattion	O
.	O

The	O
differenital	O
diagnoiss	O
of	O
the	O
geneitc	B-Disease
bleednig	I-Disease
disordres	I-Disease
,	O
heomphilia	B-Disease
A	I-Disease
and	O
von	B-Disease
Wilelbrand	I-Disease
diesase	I-Disease
,	O
is	O
occasionally	O
confounded	O
by	O
the	O
close	O
moelcular	O
relaitonship	O
of	O
cogaulation	O
fatcor	O
VIII	O
and	O
von	B-Disease
Willerband	I-Disease
fatcor	O
(	O
vWF	O
)	O
.	O

This	O
reoprt	O
describes	O
the	O
autosmoal	O
inheirtance	O
of	O
a	O
heomphilia	B-Disease
A	I-Disease
phneotype	O
due	O
to	O
a	O
mtuation	O
of	O
vWF	O
that	O
resluts	O
in	O
defecitve	O
fatcor	O
VIII	O
bidning	O
.	O

The	O
probnad	O
was	O
a	O
fmeale	O
paitent	O
with	O
low	O
leevls	O
of	O
fcator	O
VIII	O
actviity	O
.	O

Polmyerase	O
cahin	O
recation	O
(	O
PCR	O
)	O
apmlification	O
and	O
DNA	O
sequenicng	O
were	O
employed	O
to	O
examine	O
eoxns	O
enocding	O
the	O
putative	O
fcator	O
VIII	O
bindnig	O
domian	O
of	O
vWF	O
.	O

The	O
pateint	O
was	O
found	O
to	O
be	O
homozgyous	O
for	O
a	O
single	O
point	O
mutatoin	O
causing	O
a	O
Thr	O
-	O
-	O
>	O
Met	O
substituiton	O
at	O
amnio	O
aicd	O
positoin	O
28	O
in	O
the	O
matrue	O
vWF	O
suubnit	O
.	O

The	O
phenotyipc	O
expressoin	O
of	O
the	O
muattion	O
was	O
determined	O
to	O
be	O
reecssive	O
because	O
heterozyguos	O
fmaily	O
mebmers	O
were	O
cliniaclly	O
unafefcted	O
.	O

Rceombinant	O
vWF	O
containing	O
the	O
observed	O
amnio	O
aicd	O
substiuttion	O
was	O
epxressed	O
in	O
COS	O
-	O
1	O
cells	O
.	O

The	O
muatnt	O
vWF	O
was	O
procsesed	O
and	O
secerted	O
normally	O
,	O
and	O
was	O
functionally	O
eqiuvalent	O
to	O
wlid	O
-	O
tpye	O
vWF	O
in	O
its	O
ability	O
to	O
bnid	O
to	O
platleets	O
.	O

However	O
,	O
the	O
muatnt	O
failed	O
to	O
bnid	O
fatcor	O
VIII	O
,	O
demonstrating	O
that	O
the	O
mutaiton	O
was	O
functionally	O
related	O
to	O
the	O
observed	O
hemopihlia	B-Disease
phentoype	O
.	O

The	O
fmaily	O
we	O
describe	O
demonstrates	O
the	O
recsesive	O
inhreitance	O
of	O
a	O
recently	O
recognized	O
clsas	O
of	O
gneetic	O
bleeding	O
dsiorders	O
,	O
we	O
call	O
"	O
autsoomal	O
heomphilia	B-Disease
.	O

"	O
We	O
conclude	O
that	O
vWF	O
muattion	O
may	O
be	O
an	O
under	O
recognized	O
cause	O
of	O
hemopihlia	B-Disease
,	O
especially	O
in	O
csaes	O
where	O
the	O
inheritacne	O
ptatern	O
is	O
not	O
consistent	O
with	O
X	O
-	O
linked	O
transimssion	O
.	O

Soamtic	O
von	B-Disease
Hpipel	I-Disease
-	I-Disease
Linadu	I-Disease
muattion	O
in	O
clear	O
clel	O
ppaillary	B-Disease
cystadeonma	I-Disease
of	I-Disease
the	I-Disease
epididyims	I-Disease
.	O

Papillray	B-Disease
cystadenmoa	I-Disease
of	I-Disease
the	I-Disease
epididmyis	I-Disease
is	O
an	O
uncommon	O
bengin	O
lseion	O
that	O
may	O
occur	O
sporadically	O
or	O
as	O
a	O
manifestatoin	O
of	O
von	B-Disease
Hipepl	I-Disease
-	I-Disease
Linadu	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
diesase	I-Disease
.	O

Neither	O
immunhoistochemical	O
sutdies	O
nor	O
molecluar	O
genteic	O
anlayses	O
of	O
the	O
VHL	B-Disease
gnee	O
have	O
been	O
reported	O
previously	O
for	O
this	O
leison	O
.	O

The	O
autohrs	O
describe	O
two	O
csaes	O
of	O
clear	O
clel	O
paplilary	B-Disease
cystadeonma	I-Disease
of	I-Disease
the	I-Disease
eipdidymis	I-Disease
,	O
both	O
of	O
which	O
were	O
initially	O
confused	O
with	O
meatstatic	B-Disease
reanl	I-Disease
clel	I-Disease
carcnioma	I-Disease
.	O

Both	O
leisons	O
showed	O
psoitive	O
immunohistocheimcal	O
satining	O
for	O
low	O
and	O
intermeditae	O
molecualr	O
wieght	O
keratnis	O
(	O
Cam	O
5	O
.	O
2	O
and	O
AE1	O
/	O
AE3	O
)	O
,	O
EMA	O
,	O
vmientin	O
,	O
alhpa	O
1	O
-	O
atnitrypsin	O
,	O
and	O
aplha	O
1	O
-	O
antichyomtrypsin	O
.	O

Each	O
was	O
ngeative	O
for	O
CEA	O
.	O

Because	O
clear	O
clel	O
ppaillary	B-Disease
cysatdenoma	I-Disease
is	O
similar	O
to	O
rneal	B-Disease
clel	I-Disease
caricnoma	I-Disease
hitsologically	O
,	O
and	O
because	O
both	O
occur	O
as	O
compnoents	O
of	O
the	O
von	B-Disease
Hpipel	I-Disease
-	I-Disease
Linadu	I-Disease
disaese	I-Disease
comlpex	O
,	O
the	O
autohrs	O
anaylzed	O
both	O
csaes	O
for	O
the	O
preesnce	O
of	O
mtuations	O
in	O
the	O
VHL	B-Disease
gnee	O
.	O

A	O
somaitc	O
VHL	B-Disease
gnee	O
muttaion	O
was	O
detecetd	O
in	O
one	O
of	O
the	O
two	O
tuomrs	B-Disease
by	O
polyemrase	O
chian	O
reatcion	O
followed	O
by	O
single	O
-	O
srtand	O
conformaiton	O
polymrophism	O
aanlysis	O
.	O

Direct	O
sequnecing	O
revaeled	O
a	O
cytoisne	O
to	O
tyhmine	O
transitoin	O
at	O
nucleoitde	O
694	O
,	O
resulting	O
in	O
the	O
repalcement	O
of	O
an	O
argiinne	O
with	O
a	O
stop	O
cdoon	O
after	O
the	O
sixth	O
aimno	O
aicd	O
of	O
eoxn	O
3	O
.	O

As	O
the	O
VHL	B-Disease
gnee	O
is	O
believed	O
to	O
fucntion	O
as	O
a	O
tmuor	B-Disease
suppressor	O
gnee	O
,	O
VHL	B-Disease
gnee	O
mtuations	O
may	O
play	O
a	O
role	O
in	O
the	O
initiaiton	O
of	O
tumorigeneiss	O
in	O
spoardic	O
cytsadenomas	B-Disease
of	I-Disease
the	I-Disease
epidiydmis	I-Disease
.	O

Identiifcation	O
of	O
WSAP	O
muttaions	O
in	O
patinets	O
with	O
Wsikott	B-Disease
-	I-Disease
Aldrcih	I-Disease
sydnrome	I-Disease
and	O
isoalted	B-Disease
thrombocytoepnia	I-Disease
reveals	O
alleilc	O
heterogenetiy	O
at	O
the	O
WAS	B-Disease
lcous	O
.	O

Mutaiton	O
in	O
the	O
gnee	O
encdoing	O
the	O
recently	O
isoalted	O
WSAP	O
prtoein	O
has	O
now	O
been	O
identifeid	O
as	O
the	O
geentic	B-Disease
defcet	I-Disease
responsible	O
for	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
Wisktot	I-Disease
-	I-Disease
Alrdich	I-Disease
snydrome	I-Disease
(	O
WAS	B-Disease
)	O
,	O
a	O
priamry	O
imumnodeficiency	B-Disease
dsiease	I-Disease
associated	O
with	O
extensvie	O
phenotyipc	O
vraiability	O
.	O

To	O
elucidate	O
the	O
range	O
of	O
WSAP	O
mutaitons	O
responsible	O
for	O
WAS	B-Disease
,	O
we	O
used	O
PCR	O
-	O
SCSP	O
analyiss	O
to	O
screen	O
for	O
WSAP	O
gnee	O
mutatoin	O
in	O
19	O
unrelated	O
byos	O
with	O
the	O
diagnsois	O
of	O
classical	O
or	O
atetnuated	O
WAS	B-Disease
or	O
ioslated	B-Disease
throbmocytopenia	I-Disease
.	O

All	O
19	O
patinets	O
had	O
WSAP	O
mutaitons	O
,	O
each	O
of	O
which	O
loaclized	O
to	O
the	O
initial	O
three	O
or	O
temrinal	O
three	O
eoxns	O
of	O
the	O
gnee	O
,	O
and	O
the	O
majority	O
of	O
which	O
were	O
uniuqe	O
in	O
each	O
csae	O
.	O

However	O
,	O
a	O
misesnse	O
muttaion	O
which	O
resluts	O
in	O
substituiton	O
of	O
the	O
agrinine	O
at	O
WAS	B-Disease
coodn	O
86	O
was	O
iedntified	O
in	O
three	O
byos	O
with	O
sveere	O
WAS	B-Disease
as	O
well	O
as	O
in	O
one	O
boy	O
prseenting	O
with	O
thrombocytopeina	B-Disease
alone	O
.	O

While	O
the	O
three	O
mutatoins	O
found	O
in	O
the	O
isoalted	B-Disease
thrombcoytopenia	I-Disease
patinets	O
leave	O
the	O
readnig	O
farme	O
inatct	O
,	O
about	O
one	O
-	O
half	O
of	O
the	O
gnee	O
alteratoins	O
dteected	O
in	O
both	O
sveere	O
and	O
attneuated	O
WAS	B-Disease
patietns	O
result	O
in	O
frameshitfed	O
transrcipt	O
and	O
permature	O
tarnslation	O
termiantion	O
.	O

These	O
finidngs	O
therefore	O
confirm	O
the	O
associtaion	O
of	O
WAS	B-Disease
with	O
WSAP	O
muattion	O
and	O
identify	O
WSAP	O
muttaion	O
as	O
a	O
cause	O
for	O
ioslated	O
congential	B-Disease
thrombocytopneia	I-Disease
in	O
mlaes	O
.	O

While	O
the	O
WSAP	O
gnee	O
defetcs	O
responsible	O
for	O
isoalted	B-Disease
thrombocytopneia	I-Disease
and	O
other	O
mlid	O
presenttaions	O
of	O
WAS	B-Disease
do	O
not	O
appear	O
distinct	O
from	O
those	O
resulting	O
in	O
seevre	O
WAS	B-Disease
,	O
these	O
dtaa	O
indicate	O
that	O
aanlysis	O
of	O
WSAP	O
gnee	O
mtuation	O
provides	O
a	O
valuable	O
tool	O
for	O
distinguishing	O
the	O
spetcrum	O
of	O
WAS	B-Disease
pateints	O
and	O
the	O
subset	O
of	O
mlaes	O
with	O
isoalted	B-Disease
thormbocytopenia	I-Disease
who	O
represent	O
mlid	O
caess	O
of	O
WAS	B-Disease
.	O
.	O

WSAP	O
gnee	O
mutatoins	O
in	O
Wiksott	B-Disease
-	I-Disease
Aldirch	I-Disease
snydrome	I-Disease
and	O
X	B-Disease
-	I-Disease
linked	I-Disease
thromboctyopenia	I-Disease
.	O

The	O
WSAP	O
gnee	O
has	O
been	O
recently	O
cloend	O
from	O
X1p1	O
.	O

23	O
and	O
shown	O
to	O
be	O
muttaed	O
in	O
three	O
patietns	O
with	O
the	O
Wisoktt	B-Disease
-	I-Disease
Adlrich	I-Disease
sydnrome	I-Disease
(	O
WAS	B-Disease
)	O
.	O

We	O
have	O
developed	O
a	O
screening	O
prtoocol	O
for	O
identifying	O
WSAP	O
gnee	O
atlerations	O
in	O
geonmic	O
DNA	O
and	O
have	O
idenitfied	O
a	O
specturm	O
of	O
novel	O
mutatinos	O
in	O
12	O
additional	O
unrelated	O
famiiles	O
.	O

These	O
missnese	O
,	O
nnosense	O
and	O
fraemshift	O
mutaitons	O
involve	O
eight	O
of	O
the	O
12	O
exnos	O
of	O
the	O
gnee	O
.	O

Two	O
mutatinos	O
creating	O
prematrue	O
termniation	O
codnos	O
were	O
associated	O
with	O
lcak	O
of	O
detectalbe	O
mNRA	O
on	O
Notrhern	O
bltos	O
.	O

Four	O
amnio	O
aicd	O
substitutinos	O
,	O
Le2u7Phe	O
,	O
Thr4I8le	O
,	O
Va7l5Met	O
and	O
Arg477Lys	O
,	O
were	O
found	O
in	O
patietns	O
with	O
congneital	B-Disease
thrombocytopeina	I-Disease
and	O
no	O
clniically	O
evident	O
immnue	O
deefct	O
indicating	O
that	O
the	O
WSAP	O
gnee	O
is	O
the	O
stie	O
for	O
muttaions	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
thrmobocytopenia	I-Disease
as	O
well	O
as	O
in	O
WAS	B-Disease
.	O

A	O
T	O
-	O
clel	O
line	O
from	O
a	O
WAS	B-Disease
patinet	O
contained	O
two	O
independnet	O
DNA	O
altertaions	O
,	O
a	O
cosntitutional	O
fraemshift	O
mutatoin	O
,	O
also	O
present	O
in	O
periphreal	O
blood	O
leuokcytes	O
from	O
the	O
ptaient	O
,	O
and	O
copmensatory	O
splcie	O
stie	O
muttaion	O
unqiue	O
to	O
the	O
clel	O
line	O
.	O

The	O
distrbiution	O
of	O
eight	O
missense	O
mutatoins	O
provides	O
valuable	O
inofrmation	O
on	O
aimno	O
aicds	O
which	O
are	O
essentail	O
for	O
noraml	O
portein	O
funtcion	O
,	O
and	O
suggests	O
that	O
siets	O
in	O
the	O
first	O
two	O
exnos	O
are	O
hot	O
-	O
sopts	O
for	O
muttaion	O
.	O

Eviednce	O
for	O
itner	O
-	O
generatioanl	O
intsability	O
in	O
the	O
CAG	O
rpeeat	O
in	O
the	O
MDJ1	O
gnee	O
and	O
for	O
conserved	O
haplotpyes	O
at	O
flanking	O
makrers	O
amongst	O
Japaense	O
and	O
Cuacasian	O
subejcts	O
with	O
Mahcado	B-Disease
-	I-Disease
Jospeh	I-Disease
diesase	I-Disease
.	O

The	O
szie	O
of	O
the	O
(	O
CAG	O
)	O
n	O
reepat	O
arary	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
MDJ1	O
gnee	O
and	O
the	O
hapoltype	O
at	O
a	O
series	O
of	O
mircosatellite	O
makrers	O
surrounding	O
the	O
MDJ1	O
gnee	O
were	O
examined	O
in	O
a	O
large	O
cohrot	O
of	O
Japansee	O
and	O
Caucaisan	O
sujbects	O
afefcted	O
with	O
Macahdo	B-Disease
-	I-Disease
Jospeh	I-Disease
disesae	I-Disease
(	O
MJD	B-Disease
)	O
.	O

Our	O
dtaa	O
provide	O
five	O
novel	O
obesrvations	O
.	O

First	O
,	O
MJD	B-Disease
is	O
associated	O
with	O
expansoin	O
fo	O
the	O
array	O
from	O
the	O
nomral	O
range	O
of	O
14	O
-	O
37	O
repetas	O
to	O
68	O
-	O
84	O
reepats	O
in	O
most	O
Japnaese	O
and	O
Cauacsian	O
sujbects	O
,	O
but	O
no	O
sujbects	O
were	O
observed	O
with	O
exapnsions	O
intermeidate	O
in	O
szie	O
between	O
those	O
of	O
the	O
nomral	O
and	O
MJD	B-Disease
affected	O
gorups	O
.	O

Second	O
,	O
the	O
expanded	O
allele	O
associated	O
with	O
MJD	B-Disease
displays	O
inetr	O
-	O
generatoinal	O
isntability	O
,	O
particularly	O
in	O
mlae	O
meisoes	O
,	O
and	O
this	O
instbaility	O
was	O
associated	O
with	O
the	O
cliniacl	O
pehnomenon	O
of	O
anticipatoin	O
.	O

Third	O
,	O
the	O
szie	O
of	O
the	O
expanded	O
alelle	O
is	O
not	O
only	O
ivnersely	O
correltaed	O
with	O
the	O
age	O
-	O
of	O
-	O
onset	O
of	O
MJD	B-Disease
(	O
r	O
=	O
-	O
0	O
.	O
738	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
is	O
also	O
correltaed	O
with	O
the	O
frqeuency	O
of	O
other	O
clniical	O
feautres	O
[	O
e	O
.	O
g	O
.	O
pseudoexophthaloms	O
and	O
pyrmaidal	O
sgins	O
were	O
more	O
freuqent	O
in	O
sbujects	O
with	O
large	O
rpeeats	O
(	O
p	O
<	O
0	O
.	O
001	O
and	O
p	O
<	O
0	O
.	O
05	O
respectively	O
)	O
]	O
.	O

Fourth	O
,	O
the	O
dsiease	O
phneotype	O
is	O
significantly	O
more	O
sevree	O
and	O
had	O
an	O
eraly	O
age	O
of	O
onset	O
(	O
16	O
yaers	O
)	O
in	O
a	O
sujbect	O
hmoozygous	O
for	O
the	O
expanded	O
allele	O
,	O
which	O
contarsts	O
with	O
Hunitngton	B-Disease
dsiease	I-Disease
and	O
suggests	O
that	O
the	O
expanded	O
alelle	O
in	O
the	O
MDJ1	O
gnee	O
could	O
exert	O
its	O
effcet	O
either	O
by	O
a	O
dominnat	O
neagtive	O
efefct	O
(	O
putatively	O
excluded	O
in	O
HD	B-Disease
)	O
or	O
by	O
a	O
gain	O
of	O
fucntion	O
efefct	O
as	O
proposed	O
for	O
HD	B-Disease
.	O

Finally	O
,	O
Jpaanese	O
and	O
Caucaisan	O
subjcets	O
affecetd	O
with	O
MJD	B-Disease
share	O
haplotyeps	O
at	O
several	O
mrakers	O
surrounding	O
the	O
MDJ1	O
gnee	O
,	O
which	O
are	O
uncommon	O
in	O
the	O
nromal	O
Japnaese	O
and	O
Cacuasian	O
populaiton	O
,	O
and	O
which	O
suggests	O
the	O
existence	O
either	O
of	O
common	O
founedrs	O
in	O
these	O
populaitons	O
or	O
of	O
chromoosmes	O
susecptible	O
to	O
pahtologic	O
expnasion	O
of	O
the	O
CAG	O
repaet	O
in	O
the	O
MDJ1	O
gnee	O
.	O

A	O
4	O
-	O
mgeabase	O
YAC	O
cotnig	O
that	O
spans	O
the	O
Lanegr	B-Disease
-	I-Disease
Gideion	I-Disease
syndrmoe	I-Disease
reigon	O
on	O
huamn	O
chromosmoe	O
82q4	O
.	O
1	O
:	O
use	O
in	O
refinnig	O
the	O
loctaion	O
of	O
the	O
tricohrhinophalangeal	B-Disease
snydrome	I-Disease
and	O
mlutiple	O
exotsoses	O
geens	O
(	O
TPRS1	O
and	O
ETX1	O
)	O
.	O

We	O
have	O
constructed	O
a	O
physiacl	O
map	O
covering	O
over	O
4	O
Mb	O
of	O
hmuan	O
chromsoome	O
82q4	O
.	O

1	O
and	O
used	O
this	O
map	O
to	O
refine	O
the	O
locatinos	O
of	O
the	O
geens	O
responsible	O
for	O
Lnager	B-Disease
-	I-Disease
Geidion	I-Disease
syndorme	I-Disease
.	O

The	O
map	O
is	O
composed	O
of	O
overlapping	O
YAC	O
colnes	O
that	O
were	O
iedntified	O
and	O
odrered	O
in	O
relation	O
to	O
sequnece	O
tgaged	O
sties	O
mapepd	O
to	O
the	O
Lagner	O
-	O
Gideion	O
chormosomal	O
regoin	O
on	O
soamtic	O
clel	O
hyrbids	O
.	O

The	O
mniimal	O
reigon	O
of	O
overalp	O
of	O
Lanegr	B-Disease
-	I-Disease
Giedoin	I-Disease
snydrome	I-Disease
deletoins	O
,	O
previously	O
idnetified	O
by	O
anlaysis	O
of	O
15	O
paitents	O
,	O
was	O
placed	O
on	O
the	O
map	O
by	O
analsyis	O
of	O
2	O
paitents	O
whose	O
delteions	O
define	O
the	O
ednpoints	O
.	O

The	O
chromoosme	O
8	O
breakpiont	O
of	O
a	O
baalnced	O
t	O
(	O
8	O
;	O
9	O
)	O
(	O
q24	O
.	O
11	O
;	O
q33	O
.	O
3	O
)	O
translcoation	O
from	O
a	O
patinet	O
with	O
trichorhinophalanegal	B-Disease
syndorme	I-Disease
(	O
TPRS	B-Disease
I	O
)	O
was	O
found	O
to	O
be	O
located	O
just	O
within	O
the	O
proixmal	O
end	O
of	O
the	O
minmial	O
deeltion	O
regoin	O
.	O

A	O
dleetion	O
of	O
82q4	O
.	O

11	O
-	O
q24	O
.	O

3	O
in	O
a	O
paitent	O
with	O
mulitple	O
exosotses	O
was	O
found	O
to	O
overalp	O
the	O
disatl	O
end	O
of	O
the	O
LGS	B-Disease
deeltion	O
reigon	O
,	O
indicating	O
that	O
the	O
ETX1	O
gnee	O
is	O
disatl	O
to	O
the	O
TPRS1	O
gnee	O
and	O
supporting	O
the	O
hypohtesis	O
that	O
Lanegr	B-Disease
-	I-Disease
Gieidon	I-Disease
snydrome	I-Disease
is	O
due	O
to	O
lsos	O
of	O
functoinal	O
copeis	O
of	O
both	O
the	O
TRSP1	O
and	O
the	O
ETX1	O
geens	O

BCRA1	O
muttaions	O
in	O
a	O
popluation	O
-	O
based	O
samlpe	O
of	O
yuong	O
wmoen	O
with	O
bresat	B-Disease
cnacer	I-Disease
.	O

BACKGRUOND	O
.	O

Inehrited	O
muttaions	O
in	O
the	O
BCRA1	O
gnee	O
are	O
associated	O
with	O
a	O
high	O
rsik	O
of	O
braest	B-Disease
and	I-Disease
ovairan	I-Disease
canecr	I-Disease
in	O
some	O
famliies	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
contribution	O
of	O
BCRA1	O
muttaions	O
to	O
bresat	B-Disease
cacner	I-Disease
in	O
the	O
general	O
populaiton	O
.	O

We	O
anaylzed	O
DNA	O
samlpes	O
from	O
wmoen	O
enrolled	O
in	O
a	O
pouplation	O
-	O
based	O
sutdy	O
of	O
eraly	O
-	O
onset	O
berast	B-Disease
cnacer	I-Disease
to	O
assess	O
the	O
specrtum	O
and	O
freuqency	O
of	O
grem	O
-	O
line	O
BCRA1	O
mutatinos	O
in	O
yuong	O
woemn	O
with	O
berast	B-Disease
cacner	I-Disease
.	O

METHODS	O
.	O

We	O
studied	O
80	O
woemn	O
in	O
whom	O
bresat	B-Disease
cnacer	I-Disease
was	O
diagonsed	O
before	O
the	O
age	O
of	O
35	O
,	O
and	O
who	O
were	O
not	O
selected	O
on	O
the	O
basis	O
of	O
fmaily	O
hisotry	O
.	O

Genoimc	O
DNA	O
was	O
studied	O
for	O
BCRA1	O
muattions	O
by	O
analyiss	O
involving	O
single	O
-	O
strnad	O
conformtaion	O
polymorphimss	O
and	O
with	O
allele	O
-	O
specific	O
assyas	O
.	O

Alteratoins	O
were	O
defined	O
by	O
DNA	O
sequenicng	O
.	O

REUSLTS	O
.	O

Grem	O
-	O
line	O
BCRA1	O
mtuations	O
were	O
idetnified	O
in	O
6	O
of	O
the	O
80	O
wmoen	O
.	O

Four	O
additional	O
rrae	O
sequecne	O
varaints	O
of	O
unknown	O
funtcional	O
importance	O
were	O
also	O
idetnified	O
.	O

Two	O
of	O
the	O
mutatinos	O
and	O
three	O
of	O
the	O
rrae	O
sequecne	O
vairants	O
were	O
found	O
among	O
the	O
39	O
woemn	O
who	O
reported	O
no	O
famliy	O
hisotry	O
of	O
berast	B-Disease
or	I-Disease
ovraian	I-Disease
cnacer	I-Disease
.	O

None	O
of	O
the	O
mutatoins	O
and	O
only	O
one	O
of	O
the	O
rrae	O
variatns	O
was	O
idnetified	O
in	O
a	O
rfeerence	O
pouplation	O
of	O
73	O
unrelated	O
subjetcs	O
.	O

COCNLUSIONS	O
.	O

Aletrations	O
in	O
BRAC1	O
were	O
idetnified	O
in	O
approximately	O
10	O
percent	O
of	O
this	O
coohrt	O
of	O
yonug	O
woemn	O
with	O
berast	B-Disease
cacner	I-Disease
.	O

The	O
rsik	O
of	O
harboring	O
a	O
mtuation	O
was	O
not	O
limtied	O
to	O
woemn	O
with	O
faimly	O
histoires	O
of	O
braest	B-Disease
or	I-Disease
ovarain	I-Disease
cnacer	I-Disease
.	O

These	O
resluts	O
represent	O
a	O
minmial	O
estimtae	O
of	O
the	O
freuqency	O
of	O
BCRA1	O
muattions	O
in	O
this	O
popultaion	O
.	O

Comprheensive	O
metohds	O
of	O
identifying	O
BRAC1	O
mutatinos	O
and	O
understanding	O
their	O
importance	O
will	O
be	O
needed	O
before	O
tseting	O
of	O
wmoen	O
in	O
the	O
general	O
ppoulation	O
can	O
be	O
undertaken	O
.	O
.	O

Nvoel	O
inehrited	O
mutaitons	O
and	O
vairable	O
exprsesivity	O
of	O
BRAC1	O
alllees	O
,	O
including	O
the	O
fuonder	O
muttaion	O
18d5elAG	O
in	O
Ashkenzai	O
Jewsih	O
fmailies	O
.	O

Thirty	O
-	O
seven	O
famileis	O
with	O
four	O
or	O
more	O
caess	O
of	O
braest	B-Disease
cnacer	I-Disease
or	O
braest	B-Disease
and	I-Disease
ovairan	I-Disease
canecr	I-Disease
were	O
aanlyzed	O
for	O
muattions	O
in	O
BCRA1	O
.	O

Twelve	O
different	O
grem	O
-	O
line	O
mutatoins	O
,	O
four	O
novel	O
and	O
eight	O
previously	O
observed	O
,	O
were	O
detceted	O
in	O
16	O
famliies	O
.	O

Five	O
faimlies	O
of	O
Ashkenzai	O
Jeiwsh	O
descnet	O
carried	O
the	O
185dleAG	O
mutatoin	O
and	O
shared	O
the	O
same	O
halpotype	O
at	O
eight	O
polymorpihc	O
mrakers	O
spanning	O
approximately	O
850	O
kb	O
at	O
BRAC1	O
.	O

Expressivtiy	O
of	O
185edlAG	O
in	O
these	O
famiiles	O
varied	O
,	O
from	O
ealry	O
-	O
onset	O
bresat	B-Disease
canecr	I-Disease
without	O
oavrian	B-Disease
canecr	I-Disease
.	O

Muattion	O
4184delTCAA	O
occurred	O
independently	O
in	O
two	O
famliies	O
.	O

In	O
one	O
fmaily	O
,	O
penetarnce	O
was	O
complete	O
,	O
with	O
feamles	O
developing	O
eraly	O
-	O
onset	O
braest	B-Disease
canecr	I-Disease
or	O
ovarain	B-Disease
canecr	I-Disease
and	O
the	O
mlae	O
crarier	O
developing	O
porstatic	B-Disease
canecr	I-Disease
,	O
whereas	O
,	O
in	O
the	O
other	O
faimly	O
,	O
penterance	O
was	O
incompelte	O
and	O
only	O
bresat	B-Disease
canecr	I-Disease
occurred	O
,	O
diagnoesd	O
at	O
aegs	O
38	O
-	O
81	O
yaers	O
.	O

Two	O
novel	O
nosnense	O
muttaions	O
led	O
to	O
the	O
lsos	O
of	O
mutnat	O
BRAC1	O
tarnscript	O
in	O
faimlies	O
with	O
10	O
and	O
6	O
csaes	O
of	O
eraly	O
-	O
onset	O
berast	B-Disease
cnacer	I-Disease
and	O
ovarain	B-Disease
cacner	I-Disease
.	O

A	O
665	O
-	O
nt	O
segemnt	O
of	O
the	O
BCRA1	O
3	O
-	O
UTR	O
and	O
1	O
.	O

3	O
kb	O
of	O
genmoic	O
seuqence	O
including	O
the	O
putative	O
proomter	O
rgeion	O
were	O
invraiant	O
by	O
single	O
-	O
strnad	O
conformatoin	O
anlaysis	O
in	O
13	O
famiiles	O
without	O
codnig	O
-	O
sequnece	O
mutatoins	O
.	O

Overall	O
in	O
our	O
series	O
,	O
BRAC1	O
mutaitons	O
have	O
been	O
detetced	O
in	O
26	O
fmailies	O
16	O
with	O
positvie	O
BRAC1	O
lod	O
scroes	O
,	O
7	O
with	O
negatvie	O
lod	O
scoers	O
(	O
reflecting	O
multpile	O
sproadic	O
berast	B-Disease
cancres	I-Disease
)	O
,	O
and	O
3	O
not	O
tetsed	O
for	O
linkgae	O
.	O

Three	O
other	O
famiiles	O
have	O
postiive	O
lod	O
scroes	O
for	O
lnikage	O
to	O
BCRA2	O
,	O
but	O
13	O
fmailies	O
without	O
deetcted	O
BRAC1	O
mutaitons	O
have	O
negatvie	O
lod	O
scroes	O
for	O
both	O
BRAC1	O
and	O
BCRA2	O
.	O

A	O
new	O
glucsoe	O
-	O
6	O
-	O
phsophate	O
dehydrogeanse	O
varaint	O
,	O
GP6D	O
Orissa	O
(	O
44	O
Ala	O
-	O
-	O
>	O
Gly	O
)	O
,	O
is	O
the	O
major	O
polymorpihc	O
vairant	O
in	O
triabl	O
populatoins	O
in	O
Idnia	O
.	O

Deficiecny	B-Disease
of	I-Disease
glcuose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phopshate	I-Disease
dehyrdogenase	I-Disease
(	O
GP6D	O
)	O
is	O
usually	O
found	O
at	O
high	O
frequenices	O
in	O
areas	O
of	O
the	O
world	O
where	O
maalria	B-Disease
has	O
been	O
ednemic	O
.	O

The	O
frequnecy	O
and	O
geneitc	O
basis	O
of	O
GP6D	B-Disease
deifciency	I-Disease
have	O
been	O
studied	O
in	O
Afirca	O
,	O
around	O
the	O
Mediterrnaean	O
,	O
and	O
in	O
the	O
Far	O
Esat	O
,	O
but	O
little	O
such	O
ifnormation	O
is	O
available	O
about	O
the	O
situation	O
in	O
Idnia	O
.	O

To	O
determine	O
the	O
extent	O
of	O
heteroegneity	O
of	O
GP6D	O
,	O
we	O
have	O
studied	O
several	O
different	O
Indain	O
populatinos	O
by	O
screening	O
for	O
GP6D	B-Disease
deficinecy	I-Disease
,	O
followed	O
by	O
moelcular	O
aanlysis	O
of	O
deficeint	O
alllees	O
.	O

The	O
frqeuency	O
of	O
GP6D	B-Disease
defciiency	I-Disease
varies	O
between	O
3	O
%	O
and	O
15	O
%	O
in	O
different	O
tirbal	O
and	O
ubran	O
gorups	O
.	O

Remarkably	O
,	O
a	O
previously	O
unreported	O
deifcient	O
varinat	O
,	O
GP6D	O
Orissa	O
(	O
44	O
Ala	O
-	O
-	O
>	O
Gly	O
)	O
,	O
is	O
responsible	O
for	O
most	O
of	O
the	O
GP6D	B-Disease
deficinecy	I-Disease
in	O
trbial	O
Idnian	O
pouplations	O
but	O
is	O
not	O
found	O
in	O
ubran	O
popultaions	O
,	O
where	O
most	O
of	O
the	O
GP6D	B-Disease
deficiecny	I-Disease
is	O
due	O
to	O
the	O
GP6D	O
Meidterranean	O
(	O
188	O
Ser	O
-	O
-	O
>	O
Phe	O
)	O
vraiant	O
.	O

The	O
KmNDAP	O
of	O
GP6D	O
Oirssa	O
is	O
fivefold	O
higehr	O
than	O
that	O
of	O
the	O
noraml	O
enyzme	O
.	O

This	O
may	O
be	O
due	O
to	O
the	O
fact	O
that	O
the	O
alannie	O
reisdue	O
that	O
is	O
replaced	O
by	O
glcyine	O
is	O
part	O
of	O
a	O
putative	O
conezyme	O
-	O
binidng	O
stie	O
.	O
.	O

Eviednce	O
for	O
liknage	O
of	O
bipoalr	B-Disease
disodrer	I-Disease
to	O
crhomosome	O
18	O
with	O
a	O
parnet	O
-	O
of	O
-	O
oirgin	O
effcet	O
.	O

A	O
susceptiiblity	O
gnee	O
on	O
chromoosme	O
18	O
and	O
a	O
praent	O
-	O
of	O
-	O
oirgin	O
effcet	O
have	O
been	O
suggested	O
for	O
bioplar	B-Disease
affecitve	I-Disease
disodrer	I-Disease
(	O
BAPD	B-Disease
)	O
.	O

We	O
have	O
studied	O
28	O
nuclaer	O
famliies	O
selected	O
for	O
apparent	O
unilienal	O
transmisison	O
of	O
the	O
BAPD	B-Disease
phenoytpe	O
,	O
by	O
using	O
31	O
polymrophic	O
mrakers	O
spanning	O
chromoosme	O
18	O
.	O

Eivdence	O
for	O
linakge	O
was	O
tseted	O
with	O
affceted	O
-	O
sib	O
-	O
piar	O
and	O
LOD	O
scroe	O
methdos	O
under	O
two	O
defintiions	O
of	O
the	O
afefcted	O
phenoytpe	O
.	O

The	O
affecetd	O
-	O
sibpiar	O
analyess	O
indicated	O
ecxess	O
allele	O
sharing	O
for	O
makrers	O
on	O
18p	O
within	O
the	O
rgeion	O
reported	O
previously	O
.	O

The	O
greatest	O
sharing	O
was	O
at	O
D81S37	O
64	O
%	O
in	O
biploar	O
and	O
recurrent	O
uinpolar	O
(	O
RUP	O
)	O
sib	O
paris	O
(	O
P	O
=	O
.	O
0006	O
)	O
.	O

In	O
addition	O
,	O
execss	O
sharing	O
of	O
the	O
paternally	O
,	O
but	O
not	O
materanlly	O
,	O
trasnmitted	O
alleles	O
was	O
observed	O
at	O
three	O
marekrs	O
on	O
18q	O
at	O
D81S41	O
,	O
51	O
bipoalr	O
and	O
RUP	O
sib	O
paris	O
were	O
concordnat	O
for	O
patenrally	O
transmitetd	O
alelles	O
,	O
and	O
21	O
paris	O
were	O
disocrdant	O
(	O
P	O
=	O
0004	O
)	O
.	O

The	O
eivdence	O
for	O
lnikage	O
to	O
lcoi	O
on	O
both	O
18p	O
and	O
18q	O
was	O
strongest	O
in	O
the	O
11	O
patrenal	O
pedirgees	O
,	O
i	O
.	O

e	O
e	O
.	O
,	O
those	O
in	O
which	O
the	O
ftaher	O
or	O
one	O
of	O
the	O
fatehrs	O
sbis	O
is	O
affected	O
.	O

In	O
these	O
pedirgees	O
,	O
the	O
greatest	O
alelle	O
sharing	O
(	O
81	O
%	O
;	O
P	O
=	O
.	O
00002	O
)	O
and	O
the	O
highest	O
LOD	O
scroe	O
(	O
3	O
.	O
51	O
;	O
phi	O
=	O
0	O
.	O
0	O
)	O
were	O
observed	O
at	O
D184S1	O
.	O

Our	O
reuslts	O
provide	O
further	O
support	O
for	O
linkgae	O
of	O
BAPD	B-Disease
to	O
chroomsome	O
18	O
and	O
the	O
first	O
mloecular	O
evidnece	O
for	O
a	O
paernt	O
-	O
of	O
-	O
oriign	O
efefct	O
operaitng	O
in	O
this	O
diosrder	O
.	O

The	O
number	O
of	O
lcoi	O
involved	O
,	O
and	O
their	O
precise	O
loctaion	O
,	O
require	O
further	O
sutdy	O

A	O
preavlent	O
mutatoin	O
for	O
glaactosemia	B-Disease
among	O
balck	O
Americnas	O
.	O

OJBECTIVE	O
To	O
define	O
the	O
mtuation	O
causing	O
galactoesmia	B-Disease
in	O
ptaients	O
of	O
blcak	O
Aemrican	O
oriign	O
who	O
have	O
no	O
galactsoe	O
-	O
1	O
-	O
phoshpate	O
uridyltranfserase	O
(	O
GLAT	O
)	O
activtiy	O
in	O
erythrcoytes	O
but	O
good	O
clincial	O
outcmoe	O
.	O

METHODS	O
We	O
discovered	O
a	O
mutaiton	O
caused	O
by	O
a	O
C	O
-	O
-	O
>	O
T	O
tranistion	O
at	O
base	O
-	O
piar	O
1158	O
of	O
the	O
GLAT	O
gnee	O
that	O
resutls	O
in	O
a	O
seirne	O
-	O
to	O
-	O
leuicne	O
sbustitution	O
at	O
coodn	O
135	O
(	O
S315L	O
)	O
.	O

We	O
developed	O
a	O
mehtod	O
with	O
which	O
to	O
screen	O
populatoins	O
for	O
its	O
prevalecne	O
.	O

We	O
compraed	O
glaactose	O
-	O
1	O
-	O
phsophate	O
uridylrtansferase	O
among	O
eyrthrocytes	O
,	O
leukocyets	O
,	O
and	O
transformed	O
lymphoblsats	O
,	O
as	O
well	O
as	O
total	O
bdoy	O
oxidtaion	O
of	O
D	O
-	O
(	O
13C	O
)	O
-	O
galactsoe	O
to	O
1C3O2	O
among	O
three	O
genotyeps	O
for	O
GLAT	O
(	O
S153L	O
/	O
S315L	O
,	O
Q188R	O
/	O
Q188R	O
,	O
and	O
Nomral	O
/	O
Nromal	O
)	O
.	O

RESLUTS	O
We	O
found	O
a	O
48	O
%	O
prevlaence	O
of	O
the	O
S315L	O
muattion	O
among	O
17	O
balck	O
Amreican	O
ptaients	O
with	O
classic	B-Disease
galacotsemia	I-Disease
and	O
a	O
1	O
%	O
prevalnece	O
in	O
a	O
popualtion	O
of	O
50	O
balck	O
Americnas	O
without	O
galactosmeia	B-Disease
.	O

The	O
S153L	O
mutatoin	O
was	O
not	O
found	O
in	O
84	O
whtie	O
paitents	O
with	O
G	O
/	O
G	O
gaalctosemia	B-Disease
nor	O
in	O
87	O
wihte	O
conrtol	O
subjetcs	O
without	O
glaactosemia	B-Disease
.	O

We	O
found	O
noraml	O
whole	O
bdoy	O
oxidatoin	O
of	O
D	O
-	O
(	O
13C	O
)	O
-	O
gaalctose	O
by	O
the	O
paitent	O
homzoygous	O
for	O
S153L	O
and	O
various	O
degrees	O
of	O
enzmye	O
impairemnt	O
among	O
different	O
tisuses	O
.	O

CONCLUISONS	O
The	O
S315L	O
muattion	O
in	O
the	O
GLAT	O
gnee	O
is	O
a	O
pervalent	O
cause	O
of	O
galactosmeia	B-Disease
among	O
balck	O
paitents	O
.	O

Because	O
GLAT	O
activtiy	O
varies	O
in	O
different	O
tsisues	O
of	O
patinets	O
hoomzygous	O
for	O
S315L	O
,	O
they	O
may	O
have	O
a	O
better	O
clniical	O
outocme	O
than	O
ptaients	O
who	O
are	O
hoomzygous	O
for	O
Q188R	O
when	O
both	O
are	O
tretaed	O
from	O
infacny	O
.	O
.	O

A	O
high	O
inicdence	O
of	O
BCRA1	O
muattions	O
in	O
20	O
berast	B-Disease
-	I-Disease
ovarain	I-Disease
cnacer	I-Disease
faimlies	O
.	O

We	O
have	O
analyezd	O
20	O
bresat	B-Disease
-	I-Disease
ovarain	I-Disease
cacner	I-Disease
famiiles	O
,	O
the	O
majority	O
of	O
which	O
show	O
positvie	O
eviednce	O
of	O
lnikage	O
to	O
crhomosome	O
17q12	O
for	O
grem	O
-	O
line	O
mutatoins	O
in	O
the	O
BCRA1	O
gnee	O
.	O

BCRA1	O
mtuations	O
cosegergating	O
with	O
berast	B-Disease
and	I-Disease
ovairan	I-Disease
cnacer	I-Disease
susceptibiltiy	O
were	O
identifeid	O
in	O
16	O
fmailies	O
,	O
including	O
1	O
famliy	O
with	O
a	O
csae	O
of	O
mlae	B-Disease
braest	I-Disease
cnacer	I-Disease
.	O

Nine	O
of	O
these	O
muattions	O
have	O
not	O
been	O
reported	O
previously	O
.	O

The	O
majority	O
of	O
muttaions	O
were	O
found	O
to	O
generate	O
a	O
permature	O
stop	O
coodn	O
leading	O
to	O
the	O
formtaion	O
of	O
a	O
turncated	O
BCRA1	O
prtoein	O
of	O
2	O
%	O
-	O
88	O
%	O
of	O
the	O
expected	O
noraml	O
legnth	O
.	O

Two	O
mutaitons	O
alteerd	O
the	O
RNIG	O
fniger	O
doamin	O
.	O

Seqeuncing	O
of	O
geonmic	O
DNA	O
led	O
to	O
the	O
identifictaion	O
of	O
a	O
muattion	O
in	O
the	O
coidng	O
regoin	O
of	O
BRAC1	O
in	O
12	O
fmailies	O
,	O
and	O
cNDA	O
analsyis	O
reevaled	O
an	O
anbormal	O
or	O
missing	O
BCRA1	O
trasncript	O
in	O
4	O
of	O
the	O
8	O
remaining	O
famileis	O
.	O

A	O
total	O
of	O
eight	O
mtuations	O
were	O
associated	O
with	O
a	O
redcued	O
qunatity	O
of	O
BRAC1	O
transrcipt	O
.	O

We	O
were	O
unable	O
to	O
deetct	O
BCRA1	O
mutaitons	O
in	O
4	O
of	O
the	O
20	O
fmailies	O
,	O
but	O
only	O
1	O
of	O
these	O
was	O
clearly	O
linked	O
to	O
BRAC1	O
.	O

It	O
is	O
expected	O
that	O
the	O
majority	O
of	O
clear	O
examples	O
of	O
the	O
braest	B-Disease
-	I-Disease
ovarain	I-Disease
syndrmoe	I-Disease
will	O
be	O
associated	O
with	O
grem	O
-	O
line	O
mtuations	O
in	O
the	O
coidng	O
reigon	O
of	O
BCRA1	O
.	O
.	O

Bcra1	B-Disease
dfeiciency	I-Disease
rseults	O
in	O
eraly	O
embyronic	B-Disease
lethaltiy	I-Disease
chaarcterized	O
by	O
neruoepithelial	B-Disease
abnromalities	I-Disease
.	O

The	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
susceptibiilty	O
gnee	O
,	O
BRAC1	O
,	O
has	O
been	O
colned	O
and	O
shown	O
to	O
encode	O
a	O
znic	O
-	O
figner	O
portein	O
of	O
unknown	O
fucntion	O
.	O

Mtuations	O
in	O
BCRA1	O
account	O
for	O
at	O
least	O
80	O
%	O
of	O
faimlies	O
with	O
both	O
braest	B-Disease
and	I-Disease
ovairan	I-Disease
canecr	I-Disease
,	O
as	O
well	O
as	O
some	O
non	O
-	O
faimlial	O
sporaidc	O
ovarain	B-Disease
cnacers	I-Disease
.	O

The	O
lsos	O
of	O
wlid	O
-	O
tpye	O
BCRA1	O
in	O
tumorus	B-Disease
of	O
inidviduals	O
carrying	O
one	O
nonfuncitonal	O
BRAC1	O
alelle	O
suggests	O
that	O
BCRA1	O
enocdes	O
a	O
tuomur	B-Disease
spupressor	O
that	O
may	O
inhbiit	O
the	O
proliferaiton	O
of	O
mamamry	O
eptihelial	O
cells	O
.	O

To	O
examine	O
the	O
role	O
of	O
BRAC1	O
in	O
nomral	O
tsisue	O
gorwth	O
and	O
differentaition	O
,	O
and	O
to	O
generate	O
a	O
potentail	O
mdoel	O
for	O
the	O
cnacer	B-Disease
suscepitbility	O
associated	O
with	O
lsos	O
of	O
BCRA1	O
fnuction	O
,	O
we	O
have	O
created	O
a	O
muose	O
line	O
carrying	O
a	O
muattion	O
in	O
one	O
Brac1	O
alelle	O
.	O

Analsyis	O
of	O
mcie	O
homozyguos	O
for	O
the	O
mtuant	O
alllee	O
indicate	O
that	O
Brac1	O
is	O
critical	O
for	O
noraml	O
developmnet	O
,	O
as	O
these	O
mcie	O
deid	O
in	O
utreo	O
between	O
10	O
and	O
13	O
dyas	O
of	O
gestaiton	O
(	O
E10	O
-	O
E13	O
)	O
.	O

Abnoramlities	O
in	O
Brac1	B-Disease
-	I-Disease
deficinet	I-Disease
embyros	O
were	O
most	O
evident	O
in	O
the	O
neuarl	O
tbue	O
,	O
with	O
40	O
%	O
of	O
the	O
embyros	O
presneting	O
with	O
varying	O
dgerees	O
of	O
sipna	B-Disease
bfiida	I-Disease
and	O
anencephlay	B-Disease
.	O

In	O
addition	O
,	O
the	O
neuroepitehlium	O
in	O
Brac1	B-Disease
-	I-Disease
deifcient	I-Disease
embyros	O
appeared	O
disoragnized	O
,	O
with	O
sgins	O
of	O
both	O
rpaid	O
prolifertaion	O
and	O
excessvie	O
clel	O
daeth	O
.	O
.	O

Identifictaion	O
of	O
mutatoins	O
in	O
the	O
ALD	O
-	O
gnee	O
of	O
20	O
famliies	O
with	O
adrenoleuokdystrophy	B-Disease
/	O
adrenoymeloneuropathy	B-Disease
.	O

Adrenoelukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
,	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
inhertied	I-Disease
mteabolic	I-Disease
disodrer	I-Disease
,	O
is	O
the	O
most	O
ferquent	O
inobrn	B-Disease
peroxismoal	I-Disease
dsiease	I-Disease
.	O

It	O
leads	O
to	O
dmeyelination	B-Disease
in	I-Disease
the	I-Disease
centarl	I-Disease
and	I-Disease
peirpheral	I-Disease
nerovus	I-Disease
sysetm	I-Disease
.	O

Defcetive	O
btea	O
-	O
oxidatoin	O
of	O
satruated	O
very	O
long	O
cahin	O
ftaty	O
aicds	O
(	O
VCLFAs	O
;	O
C22	O
0	O
-	O
C26	O
0	O
)	O
in	O
preoxisomes	O
has	O
been	O
shown	O
to	O
lead	O
to	O
an	O
accmuulation	O
of	O
VLFCAs	O
in	O
luekoid	O
areas	O
of	O
the	O
cnetral	O
nervuos	O
sytsem	O
,	O
peripehral	O
nevres	O
,	O
adreanl	O
galnd	O
,	O
and	O
blood	O
.	O

The	O
ALD	B-Disease
gnee	O
has	O
been	O
recently	O
idetnified	O
and	O
encdoes	O
a	O
745	O
-	O
amnio	O
-	O
aicd	O
protien	O
.	O

We	O
screened	O
pateints	O
with	O
adrenoleukodystorphy	B-Disease
/	O
adrenomyeloneuropahty	B-Disease
(	O
ALD	B-Disease
/	O
AMN	B-Disease
)	O
from	O
20	O
kinderds	O
for	O
mtuations	O
in	O
the	O
ALD	B-Disease
gnee	O
.	O

Eleven	O
missnese	O
and	O
two	O
nosnense	O
mutaitons	O
,	O
five	O
deletinos	O
,	O
and	O
one	O
insertoin	O
were	O
detceted	O
by	O
direct	O
sequnecing	O
of	O
eight	O
reevrse	O
trancsribed	O
framgents	O
of	O
the	O
ALD	B-Disease
-	O
gnee	O
mNRA	O
.	O

Four	O
mutatoins	O
could	O
be	O
shown	O
to	O
be	O
de	O
novo	O
.	O

All	O
muttaions	O
could	O
be	O
confirmed	O
in	O
carrires	O
by	O
sequecning	O
genmoic	O
DNA	O
.	O

No	O
correlatoin	O
between	O
the	O
tpye	O
of	O
mutatoin	O
and	O
the	O
seevrity	O
of	O
the	O
phentoype	O
could	O
be	O
observed	O
.	O

The	O
mutaitons	O
were	O
not	O
dteected	O
in	O
the	O
ALD	B-Disease
gnee	O
of	O
30	O
helathy	O
pesrons	O
.	O
.	O

The	O
mruine	O
hmoolog	O
of	O
the	O
huamn	O
braest	B-Disease
and	I-Disease
ovraian	I-Disease
cnacer	I-Disease
susceptibiilty	O
gnee	O
Bcra1	O
mpas	O
to	O
mosue	O
chrmoosome	O
11D	O
.	O

The	O
recently	O
clnoed	O
hmuan	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
susecptibility	O
gnee	O
,	O
BCRA1	O
,	O
is	O
located	O
on	O
huamn	O
chromoosme	O
17q21	O
.	O

We	O
have	O
isolaetd	O
murnie	O
genmoic	O
cloens	O
containing	O
Brac1	O
as	O
a	O
first	O
step	O
in	O
generating	O
a	O
muose	O
moedl	O
for	O
the	O
lsos	O
of	O
BCRA1	O
functoin	O
.	O

A	O
mosue	O
geonmic	O
librray	O
was	O
screened	O
using	O
prboes	O
corresponding	O
to	O
eoxn	O
11	O
of	O
the	O
huamn	O
BCRA1	O
gnee	O
.	O

Two	O
overlapping	O
muose	O
cloens	O
were	O
idetnified	O
that	O
hybridiezd	O
to	O
hmuan	O
BRAC1	O
exnos	O
9	O
-	O
12	O
.	O

Seuqence	O
anaylsis	O
of	O
1	O
.	O

4	O
kb	O
of	O
the	O
regoin	O
of	O
these	O
cloens	O
corresponding	O
to	O
part	O
of	O
hmuan	O
eoxn	O
11	O
reevaled	O
72	O
%	O
nucliec	O
aicd	O
idetnity	O
but	O
only	O
50	O
%	O
aimno	O
aicd	O
idenitty	O
with	O
the	O
hmuan	O
gnee	O
.	O

The	O
longest	O
of	O
the	O
muose	O
Brac1	O
gneomic	O
colnes	O
mpas	O
to	O
chroomsome	O
11D	O
,	O
as	O
determined	O
by	O
two	O
-	O
cloor	O
fluorecsence	O
in	O
situ	O
hyrbidization	O
.	O

The	O
snyteny	O
to	O
hmuan	O
chroomsome	O
17	O
was	O
confirmed	O
by	O
cohybridizaiton	O
with	O
the	O
muose	O
porbe	O
for	O
the	O
NF1	O
-	O
gnee	O
.	O

This	O
comparative	O
stduy	O
confirms	O
that	O
the	O
relative	O
locaiton	O
of	O
the	O
BCRA1	O
gnee	O
has	O
been	O
conserved	O
between	O
mcie	O
and	O
hmuans	O
.	O

Atelosteogeneiss	B-Disease
tpye	I-Disease
II	I-Disease
is	O
caused	O
by	O
mutatinos	O
in	O
the	O
diastropihc	B-Disease
dysplaisa	I-Disease
suflate	O
-	O
transoprter	O
gnee	O
(	O
DDTST	O
)	O
:	O
eviednce	O
for	O
a	O
phenotpyic	O
series	O
involving	O
three	O
chonrdodysplasias	B-Disease
.	O

Atelotseogenesis	B-Disease
tpye	I-Disease
II	I-Disease
(	O
AO	B-Disease
II	I-Disease
)	O
is	O
a	O
neonaatlly	O
lehtal	O
chondrodysplaisa	B-Disease
whose	O
cliniacl	O
and	O
histolgoical	O
charcateristics	O
resemble	O
those	O
of	O
another	O
chondrodysplsaia	B-Disease
,	O
the	O
much	O
less	O
sveere	O
diastorphic	B-Disease
dyspalsia	I-Disease
(	O
DTD	B-Disease
)	O
.	O

The	O
similartiy	O
suggests	O
a	O
shared	O
pathgoenesis	O
involving	O
lseions	O
in	O
the	O
same	O
biochmeical	O
pathawy	O
and	O
perhaps	O
the	O
same	O
gnee	O
.	O

DTD	B-Disease
is	O
caused	O
by	O
mutatinos	O
in	O
the	O
recently	O
idetnified	O
disatrophic	B-Disease
dyspalsia	I-Disease
sulafte	O
-	O
transproter	O
gnee	O
(	O
DDTST	O
)	O
.	O

Here	O
,	O
we	O
reprot	O
that	O
AIOI	B-Disease
paitents	O
also	O
have	O
DTSDT	O
mutaitons	O
,	O
which	O
lead	O
to	O
defcetive	O
uptkae	O
of	O
inorgainc	O
sulafte	O
and	O
inusfficient	O
sulaftion	O
of	O
mcaromolecules	O
by	O
patinet	O
mseenchymal	O
clels	O
in	O
vitro	O
.	O

Together	O
with	O
our	O
recent	O
obsrevation	O
that	O
a	O
third	O
even	O
more	O
sevree	O
chondrdoysplasia	B-Disease
,	O
achonrdogenesis	O
tpye	O
IB	O
,	O
is	O
also	O
caused	O
by	O
mtuations	O
in	O
DTSDT	O
,	O
these	O
resutls	O
demonstrate	O
a	O
phentoypic	O
series	O
of	O
three	O
chondrodyslpasias	B-Disease
of	O
icnreasing	O
seveirty	O
caused	O
by	O
lesinos	O
in	O
a	O
single	O
sulftae	O
-	O
trasnporter	O
gnee	O
.	O

The	O
seveirty	O
of	O
the	O
pheontype	O
appears	O
to	O
be	O
correlated	O
with	O
the	O
prdeicted	O
effect	O
of	O
the	O
muattions	O
on	O
the	O
resiudal	O
actviity	O
of	O
the	O
DDTST	O
prtoein	O
.	O
.	O

Hpalotype	O
and	O
phenoytpe	O
anlaysis	O
of	O
six	O
recrurent	O
BRAC1	O
muattions	O
in	O
61	O
famiiles	O
:	O
rseults	O
of	O
an	O
internaitonal	O
stduy	O
.	O

Several	O
BCRA1	O
muattions	O
have	O
now	O
been	O
found	O
to	O
occur	O
in	O
geograpihcally	O
dievrse	O
bresat	B-Disease
and	I-Disease
ovarain	I-Disease
canecr	I-Disease
famliies	O
.	O

To	O
investiagte	O
muttaion	O
oirgin	O
and	O
mutaiton	O
-	O
specific	O
phenoytpes	O
due	O
to	O
BCRA1	O
,	O
we	O
constructed	O
a	O
haplotpye	O
of	O
nine	O
polymrophic	O
mrakers	O
within	O
or	O
immediately	O
flanking	O
the	O
BCRA1	O
lcous	O
in	O
a	O
set	O
of	O
61	O
berast	B-Disease
/	I-Disease
ovairan	I-Disease
cnacer	I-Disease
famliies	O
selected	O
for	O
having	O
one	O
of	O
six	O
rceurrent	O
BCRA1	O
mutatoins	O
.	O

Tsets	O
of	O
both	O
mutatoins	O
and	O
faimly	O
-	O
specific	O
difefrences	O
in	O
age	O
at	O
diagnsois	O
were	O
not	O
significant	O
.	O

A	O
compariosn	O
of	O
the	O
six	O
mtuations	O
in	O
the	O
relative	O
porportions	O
of	O
caess	O
of	O
berast	B-Disease
and	I-Disease
ovarain	I-Disease
cnacer	I-Disease
was	O
suggestive	O
of	O
an	O
effcet	O
(	O
P	O
=	O
.	O
069	O
)	O
,	O
with	O
57	O
%	O
of	O
wmoen	O
presumed	O
affected	O
because	O
of	O
the	O
1294	O
del	O
40	O
BCRA1	O
mutatoin	O
having	O
oavrian	B-Disease
cnacer	I-Disease
,	O
compraed	O
with	O
14	O
%	O
of	O
affetced	O
wmoen	O
with	O
the	O
slpice	O
-	O
stie	O
muttaion	O
in	O
itnron	O
5	O
of	O
BRAC1	O
.	O

For	O
the	O
BRAC1	O
mutatoins	O
studied	O
here	O
,	O
the	O
indiivdual	O
mutatoins	O
are	O
estimtaed	O
to	O
have	O
arisen	O
9	O
-	O
170	O
generaitons	O
ago	O
.	O

In	O
general	O
,	O
a	O
high	O
dgeree	O
of	O
halpotype	O
consevration	O
across	O
the	O
regoin	O
was	O
observed	O
,	O
with	O
haplotpye	O
differecnes	O
most	O
often	O
due	O
to	O
muattions	O
in	O
the	O
short	O
-	O
tadnem	O
-	O
repaet	O
makrers	O
,	O
although	O
some	O
likely	O
insatnces	O
of	O
rceombination	O
also	O
were	O
observed	O
.	O

For	O
several	O
of	O
the	O
instanecs	O
,	O
there	O
was	O
eviednce	O
for	O
mutliple	O
,	O
indepenednt	O
,	O
BRAC1	O
muttaional	O
evnets	O
.	O

Isloation	O
of	O
the	O
muose	O
hoomlogue	O
of	O
BRAC1	O
and	O
geneitc	O
mappnig	O
to	O
muose	O
chromoosme	O
11	O
.	O

The	O
BCRA1	O
gnee	O
is	O
in	O
large	O
part	O
responsible	O
for	O
hereditray	B-Disease
hmuan	I-Disease
berast	I-Disease
and	I-Disease
ovraian	I-Disease
cnacer	I-Disease
.	O

Here	O
we	O
reprot	O
the	O
ioslation	O
of	O
the	O
murnie	O
Brac1	O
hoomlogue	O
cNDA	O
colnes	O
.	O

In	O
addition	O
,	O
we	O
idnetified	O
genmoic	O
P1	O
cloens	O
that	O
contain	O
most	O
,	O
if	O
not	O
all	O
,	O
of	O
the	O
muose	O
Brac1	O
lcous	O
.	O

DNA	O
seqeunce	O
anaylsis	O
revelaed	O
that	O
the	O
mosue	O
and	O
hmuan	O
coidng	O
reigons	O
are	O
75	O
%	O
idenitcal	O
at	O
the	O
nucletoide	O
lveel	O
while	O
the	O
preditced	O
amnio	O
aicd	O
identtiy	O
is	O
only	O
58	O
%	O
.	O

A	O
DNA	O
seqeunce	O
varinat	O
in	O
the	O
Brac1	O
loucs	O
was	O
idnetified	O
and	O
used	O
to	O
map	O
this	O
gnee	O
on	O
a	O
(	O
Mus	O
m	O
.	O
musuclus	O
Czceh	O
II	O
x	O
C5B7L	O
/	O
KsJ	O
)	O
F1	O
x	O
C5B7L	O
/	O
KsJ	O
interusbspecific	O
backcorss	O
to	O
ditsal	O
muose	O
crhomosome	O
11	O
.	O

The	O
mapipng	O
of	O
this	O
gnee	O
to	O
a	O
reigon	O
highly	O
synetnic	O
with	O
hmuan	O
crhomosome	O
17	O
,	O
coupled	O
with	O
Southren	O
and	O
Notrhern	O
aanlyses	O
,	O
confirms	O
that	O
we	O
isoalted	O
the	O
muirne	O
Brac1	O
homolgoue	O
rather	O
than	O
a	O
related	O
RNIG	O
finegr	O
gnee	O
.	O

The	O
isoaltion	O
of	O
the	O
mosue	O
Brac1	O
homoolgue	O
will	O
facilitate	O
the	O
creaiton	O
of	O
mosue	O
modles	O
for	O
germilne	O
BRAC1	B-Disease
defcets	I-Disease
.	O
.	O

Eemrin	B-Disease
deficeincy	I-Disease
at	O
the	O
nucelar	O
membrnae	O
in	O
patinets	O
with	O
Emrey	B-Disease
-	I-Disease
Driefuss	I-Disease
muscluar	I-Disease
dytsrophy	I-Disease
.	O

Mutatinos	O
in	O
the	O
STA	O
gnee	O
at	O
the	O
X2q8	O
loucs	O
have	O
been	O
found	O
in	O
ptaients	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
Eemry	I-Disease
-	I-Disease
Driefuss	I-Disease
musuclar	I-Disease
dystrpohy	I-Disease
(	O
EMDD	B-Disease
)	O
.	O

This	O
gnee	O
encdoes	O
a	O
hitherto	O
unknown	O
prtoein	O
named	O
eemrin	O
.	O

To	O
elucidate	O
the	O
sbucellular	O
localiztaion	O
of	O
eemrin	O
,	O
we	O
raised	O
two	O
anitsera	O
against	O
snythetic	O
petpide	O
frgaments	O
predicetd	O
from	O
eemrin	O
cNDA	O
.	O

Using	O
both	O
antiesra	O
,	O
we	O
found	O
positvie	O
nucelar	O
memrbane	O
staniing	O
in	O
skeeltal	O
,	O
cardaic	O
and	O
smotoh	O
msucles	O
in	O
the	O
nomral	O
cnotrols	O
and	O
in	O
patietns	O
with	O
neurmouscular	B-Disease
diesases	I-Disease
other	O
than	O
EMDD	B-Disease
.	O

In	O
contrast	O
,	O
a	O
defiicency	O
in	O
immunofluorecsent	O
stianing	O
of	O
sekletal	O
and	O
cradiac	O
mucsle	O
from	O
EMDD	B-Disease
ptaients	O
was	O
observed	O
.	O

A	O
34	O
kD	O
proetin	O
is	O
imumnoreactive	O
with	O
the	O
anitsera	O
-	O
-	O
the	O
prtoein	O
is	O
equivalnet	O
to	O
that	O
predcited	O
for	O
emeirn	O
.	O

Together	O
,	O
our	O
fnidings	O
suggest	O
the	O
specific	O
dfeiciency	B-Disease
of	I-Disease
emrein	I-Disease
in	O
the	O
nculear	O
mmebrane	O
of	O
mucsle	O
cells	O
in	O
paitents	O
with	O
EMDD	B-Disease
.	O
.	O

Grwoth	B-Disease
rteardation	I-Disease
and	O
tumuor	B-Disease
inhiibtion	O
by	O
BCRA1	O
.	O

Inhreited	O
mutatoins	O
in	O
BRAC1	O
predispose	O
to	O
braest	B-Disease
and	I-Disease
ovarain	I-Disease
cnacer	I-Disease
,	O
but	O
the	O
role	O
of	O
BCRA1	O
in	O
sporaidc	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
cnacer	I-Disease
has	O
previously	O
been	O
elusive	O
.	O

Here	O
,	O
we	O
show	O
that	O
rertoviral	O
tarnsfer	O
of	O
the	O
wlid	O
-	O
tpye	O
BRAC1	O
gnee	O
inhbiits	O
gorwth	O
in	O
vitro	O
of	O
all	O
bresat	B-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
clel	O
liens	O
tseted	O
,	O
but	O
not	O
cooln	B-Disease
or	I-Disease
lnug	I-Disease
canecr	I-Disease
clels	O
or	O
fibrobalsts	O
.	O

Mutnat	O
BCRA1	O
has	O
no	O
effect	O
on	O
grwoth	O
of	O
bresat	B-Disease
canecr	I-Disease
clels	O
;	O
oavrian	B-Disease
canecr	I-Disease
clel	O
gorwth	O
is	O
not	O
affecetd	O
by	O
BRAC1	O
muattions	O
in	O
the	O
5	O
portoin	O
of	O
the	O
gnee	O
,	O
but	O
is	O
ihnibited	O
by	O
3	O
BCRA1	O
mtuations	O
.	O

Develpoment	O
of	O
MCF	B-Disease
-	I-Disease
7	I-Disease
tumorus	I-Disease
in	O
ndue	O
mcie	O
is	O
inhbiited	O
when	O
MCF	O
-	O
7	O
clels	O
are	O
trnasfected	O
with	O
wlid	O
-	O
tpye	O
,	O
but	O
not	O
muatnt	O
,	O
BRAC1	O
.	O

